PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Kawa, L; Barde, S; Arborelius, UP; Theodorsson, E; Agoston, D; Risling, M; Hokfelt, T				Kawa, Lizan; Barde, Swapnali; Arborelius, Ulf P.; Theodorsson, Elvar; Agoston, Denes; Risling, Marten; Hokfelt, Tomas			Expression of galanin and its receptors are perturbed in a rodent model of mild, blast-induced traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Anxiety; Cholecystokinin (CCK); Depression; Neuropeptide; Periaqueductal gray; Receptor; Transcriptional regulation; Translational regulation; Transmitter coexistence	POSTTRAUMATIC-STRESS-DISORDER; PREPROGALANIN MESSENGER-RNA; LOCUS-COERULEUS NEURONS; NEUROPEPTIDE-Y; HUMANS AGE; RAT; DEPRESSION; ANXIETY; AFGHANISTAN; IRAQ	The symptomatology, mood and cognitive disturbances seen in post-traumatic stress disorder (PTSD) and mild blast-induced traumatic brain injury (mbTBI) overlap considerably. However the pathological mechanisms underlying the two conditions are currently unknown. The neuropeptide galanin has been suggested to play a role in the development of stress and mood disorders. Here we applied bio- and histochemical methods with the aim to elucidate the nature of any changes in the expression of galanin and its receptors in a rodent model of mbTBI. In situ hybridization and quantitative polymerase chain reaction studies revealed significant, injury induced changes, in some cases lasting at least for one week, in the mRNA levels of galanin and/or its three receptors, galanin receptor 1-3 (GalR1-3). Such changes were seen in several forebrain regions, and the locus coeruleus. In the ventral periaqueductal gray GalR1 mRNA levels were increased, while GalR2 were decreased. Analysis of galanin peptide levels using radioimmunoassay demonstrated an increase in several brain regions including the locus coeruleus, dorsal hippocampal formation and amygdala. These findings suggest a role for the galanin system in the endogenous response to mbTBI, and that pharmacological studies of the effects of activation or inhibition of different galanin receptors in combination with functional assays of behavioral recovery may reveal promising targets for new therapeutic strategies in mbTBI. (C) 2016 Elsevier Inc. All rights reserved.	[Kawa, Lizan; Barde, Swapnali; Arborelius, Ulf P.; Agoston, Denes; Risling, Marten; Hokfelt, Tomas] Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden; [Agoston, Denes] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Kawa, L (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden.	lizan.kawa@ki.se; Marten.Risling@ki.se	Theodorsson, Elvar/H-2096-2011	Theodorsson, Elvar/0000-0003-0756-7723	Swedish Armed Forces RD [AF.9221006]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [04X-2887]; Karolinska Institutet Funds	This work was supported by the Swedish Armed Forces R&D (AF.9221006) (MR), the Swedish Research Council (04X-2887) (TH) and Karolinska Institutet Funds (TH and MR). The valuable contribution of Maria Angeria is gratefully acknowledged. We thank Professor Jens Rehfeld, University of Copenhagen, Copenhagen, Denmark, for the generous donation of the CCK antiserum.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Barrera G, 2005, NEUROPEPTIDES, V39, P289, DOI 10.1016/j.npep.2004.12.008; Barrera G, 2006, SYNAPSE, V59, P27, DOI 10.1002/syn.20208; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BIGUET NF, 1986, EMBO J, V5, P287, DOI 10.1002/j.1460-2075.1986.tb04211.x; BRADWEJN J, 1984, NATURE, V312, P363, DOI 10.1038/312363a0; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brumovsky P, 2007, TRENDS PHARMACOL SCI, V28, P93, DOI 10.1016/j.tips.2006.12.003; Brunner SM, 2014, P NATL ACAD SCI USA, V111, P7138, DOI 10.1073/pnas.1318066111; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Davenport N.D., 2015, BRAIN IMAGING BEHAV; DODD J, 1981, BRAIN RES, V205, P337, DOI 10.1016/0006-8993(81)90344-9; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Fuxe K, 1998, ANN NY ACAD SCI, V863, P274, DOI 10.1111/j.1749-6632.1998.tb10702.x; FUXE K, 1990, SEROTONIN, P169; Fuxe K., 1991, GALANIN A NEW MULTIF; GABRIEL SM, 1995, J NEUROSCI, V15, P5526; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; HARRO J, 1993, TRENDS PHARMACOL SCI, V14, P244, DOI 10.1016/0165-6147(93)90020-K; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Hokfelt T, 1999, HORM METAB RES, V31, P330, DOI 10.1055/s-2007-978748; HOLETS VR, 1988, NEUROSCIENCE, V24, P893, DOI 10.1016/0306-4522(88)90076-0; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Holmes A., 2006, CNS & Neurological Disorders-Drug Targets, V5, P225, DOI 10.2174/187152706776359600; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Kawa L., 2014, J NEUROTRAUMA; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kozlovsky N, 2009, BIOL PSYCHIAT, V65, P383, DOI 10.1016/j.biopsych.2008.10.034; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Kuteeva E, 2010, EXPERIENTIA SUPPL, V102, P163, DOI 10.1007/978-3-0346-0228-0_12; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; LIU SL, 1994, J NEUROTRAUM, V11, P73, DOI 10.1089/neu.1994.11.73; Lu XY, 2008, NEUROPEPTIDES, V42, P387, DOI 10.1016/j.npep.2008.04.009; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maubach KA, 1999, CURR OPIN CHEM BIOL, V3, P481, DOI 10.1016/S1367-5931(99)80070-2; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mazarati AM, 1998, J NEUROSCI, V18, P10070; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MELANDER T, 1986, NEUROSCIENCE, V19, P223, DOI 10.1016/0306-4522(86)90017-5; MELANDER T, 1986, J COMP NEUROL, V248, P475, DOI 10.1002/cne.902480404; Melander T., 1986, GABA NEUROPEPTIDES R, V6, P3640; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Moller C, 1999, NEUROPSYCHOPHARMACOL, V21, P507, DOI 10.1016/S0893-133X(98)00102-X; Nemeroff CB, 2005, J CLIN PSYCHIAT, V66, P5; ODONNELL D, 2003, HAND CHEM N, V20, P195; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parker D, 1998, J NEUROSCI, V18, P4800; Paxinos G., 2007, THE RAT BRAIN IN STR; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Pieribone VA, 1998, ANN NY ACAD SCI, V863, P264, DOI 10.1111/j.1749-6632.1998.tb10701.x; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Rehfeld J.F., 1992, MULTIPLE CHOLECYSTOK, P117; REHFELD JF, 1987, P NATL ACAD SCI USA, V84, P3019, DOI 10.1073/pnas.84.9.3019; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sabban E. L., 2015, NEUROPEPTIDES; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; SEUTIN V, 1989, EUR J PHARMACOL, V164, P373, DOI 10.1016/0014-2999(89)90481-0; SEVCIK J, 1993, EUR J PHARMACOL, V230, P223, DOI 10.1016/0014-2999(93)90806-S; Shen PJ, 2003, EUR J NEUROSCI, V18, P1362, DOI 10.1046/j.1460-9568.2003.02860.x; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; Steckler T., 2008, HDB ANXIETY FEAR; SUTIN EL, 1988, J COMP NEUROL, V270, P243, DOI 10.1002/cne.902700206; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; Theodorsson E, 2000, SCAND J CLIN LAB INV, V60, P411; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vila-Porcile E, 2009, J COMP NEUROL, V516, P199, DOI 10.1002/cne.22105; Wang P., 2011, NEUROSCI, V2011; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Waters SM, 2000, NEUROSCIENCE, V95, P265; Weiss JM, 2005, NEUROPEPTIDES, V39, P281, DOI 10.1016/j.npep.2004.12.028; Weiss JM, 1998, ANN NY ACAD SCI, V863, P364, DOI 10.1111/j.1749-6632.1998.tb10707.x; WILKINSON LO, 1988, EXP NEUROL, V101, P445, DOI 10.1016/0014-4886(88)90055-6; Wu G, 2011, EXPERT OPIN THER TAR, V15, P1317, DOI 10.1517/14728222.2011.628314; XU Z, 1992, NEUROSCI LETT, V145, P185, DOI 10.1016/0304-3940(92)90018-3; Xu ZQD, 1998, J COMP NEUROL, V392, P227, DOI 10.1002/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4; Xu ZQD, 1998, ANN NY ACAD SCI, V863, P459, DOI 10.1111/j.1749-6632.1998.tb10724.x; Xu ZQD, 2005, NEUROPEPTIDES, V39, P269, DOI 10.1016/j.npep.2005.02.003; Xu ZQD, 1997, J CHEM NEUROANAT, V13, P169, DOI 10.1016/S0891-0618(97)00043-4; Yoshitake T, 2003, NEUROSCI LETT, V339, P239, DOI 10.1016/S0304-3940(03)00020-X	100	13	13	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						159	167		10.1016/j.expneurol.2016.02.019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DK0OU	WOS:000374612900014	26928087				2022-02-06	
J	Morland, C; Pettersen, MN; Hassel, B				Morland, Cecilie; Pettersen, Mi Nguyen; Hassel, Bjornar			Hyperosmolar sodium chloride is toxic to cultured neurons and causes reduction of glucose metabolism and ATP levels, an increase in glutamate uptake, and a reduction in cytosolic calcium	NEUROTOXICOLOGY			English	Article						Hyperosmolarity; Dehydration; Delirium; Neurotoxicity; Sodium; Calcium	CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN-INJURY; REGULATORY VOLUME DECREASE; RAT-BRAIN; AMINO-ACIDS; HYPERNATREMIA; ASTROCYTES; HYPOGLYCEMIA; DEPOLARIZATION; NEUROTOXICITY	Elevation of serum sodium, hypernatremia, which may occur during dehydration or treatment with sodium chloride, may cause brain dysfunction and damage, but toxic mechanisms are poorly understood. We found that exposure to excess NaCl, 10-100 mmol/L, for 20 h caused cell death in cultured cerebellar granule cells (neurons). Toxicity was due to Na+, since substituting excess Na+ with choline reduced cell death to control levels, whereas gluconate instead of excess Cl- did not. Prior to cell death from hyperosmolar NaCl, glucose consumption and lactate formation were reduced, and intracellular aspartate levels were elevated, consistent with reduced glycolysis or glucose uptake. Concomitantly, the level of ATP became reduced. Pyruvate, 10 mmol/L, reduced NaCl-induced cell death. The extracellular levels of glutamate, taurine, and GABA were concentration-dependently reduced by excess NaCl; high affinity glutamate uptake increased. High extracellular [Na+] caused reduction in intracellular free [Ca2+], but a similar effect was seen with mannitol, which was not neurotoxic. We suggest that inhibition of glucose metabolism with ensuing loss of ATP is a neurotoxic mechanism of hyperosmolar sodium, whereas increased uptake of extracellular neuroactive amino acids and reduced intracellular [Ca2+] may, if they occur in vivo, contribute to the cerebral dysfunction and delirium described in hypernatremia. (C) 2016 Elsevier Inc. All rights reserved.	[Morland, Cecilie; Pettersen, Mi Nguyen; Hassel, Bjornar] Norwegian Def Res Estab, N-2007 Kjeller, Norway; [Morland, Cecilie] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway; [Hassel, Bjornar] Oslo Univ Hosp, Dept Complex Neurol & Neurohabilitat, N-0450 Oslo, Norway; [Hassel, Bjornar] Univ Oslo, Oslo, Norway		Hassel, B (corresponding author), Norwegian Def Res Estab, N-2007 Kjeller, Norway.	bjornar.hassel@ffl.no	Morland, Cecilie/G-2536-2014	Morland, Cecilie/0000-0002-1776-1821	Norwegian Health Association [1513]; Norwegian Epilepsy Society (NES)	The authors are indebted to Dr. A. Ring for valuable discussion and help. This study was supported by The Norwegian Health Association (grant# 1513) and the Norwegian Epilepsy Society (NES).	Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Beetsch JW, 1996, BBA-GEN SUBJECTS, V1290, P141, DOI 10.1016/0304-4165(96)00011-6; Bhardwaj A, 2000, STROKE, V31, P1694, DOI 10.1161/01.STR.31.7.1694; Bruera E, 2005, J CLIN ONCOL, V23, P2366, DOI 10.1200/JCO.2005.04.069; CHOI DW, 1987, J NEUROSCI, V7, P369; CSERR HF, 1991, J PHYSIOL-LONDON, V442, P277, DOI 10.1113/jphysiol.1991.sp018793; CSERR HF, 1987, AM J PHYSIOL, V253, pF522, DOI 10.1152/ajprenal.1987.253.3.F522; Dreiem A, 2005, NEUROTOXICOLOGY, V26, P321, DOI 10.1016/j.neuro.2005.01.006; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; ENGELSEN B, 1986, J NEUROCHEM, V47, P1634, DOI 10.1111/j.1471-4159.1986.tb00806.x; ERECINSKA M, 1991, J NEUROSCI, V11, P2410; GALLO V, 1987, J NEUROSCI, V7, P2203; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gundersen V, 2001, J CEREBR BLOOD F MET, V21, P41, DOI 10.1097/00004647-200101000-00006; Haber B., 1989, DISSECTION TISSUE CU, P203; Han M.J., 2015, CASE OSMOTIC DEMYELI, V13, P30; HASSEL B, 1995, NEUROCHEM RES, V20, P413, DOI 10.1007/BF00973096; Himmelseher S, 2001, J NEUROSURG ANESTH, V13, P120, DOI 10.1097/00008506-200104000-00009; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Kanner B.I., 1994, J EXP BIOL, V19, P6237; Kealy J, 2013, J NEUROSCI METH, V215, P110, DOI 10.1016/j.jneumeth.2013.02.016; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lieberman HR, 2007, J AM COLL NUTR, V26, p555S, DOI 10.1080/07315724.2007.10719658; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lowry OH., 1972, FLEXIBLE SYSTEM ENZY; MEADOW R, 1993, ARCH DIS CHILD, V68, P448, DOI 10.1136/adc.68.4.448; Morales-Mulia S, 1998, J NEUROCHEM, V71, P2330; Morland C, 2007, NEUROCHEM INT, V50, P703, DOI 10.1016/j.neuint.2007.01.003; Ofran Y, 2004, J INTERN MED, V256, P525, DOI 10.1111/j.1365-2796.2004.01411.x; Oja SS, 2013, EPILEPSY RES, V104, P187, DOI 10.1016/j.eplepsyres.2013.01.010; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Olsen C, 1999, BRAIN RES, V850, P144, DOI 10.1016/S0006-8993(99)02115-0; Olsen SN, 2007, COMP BIOCHEM PHYS A, V148, P339, DOI 10.1016/j.cbpa.2007.05.009; PASANTESMORALES H, 1993, NEUROCHEM RES, V18, P445, DOI 10.1007/BF00967248; Pendlebury ST, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007808; Ring Avi, 2007, Journal of Pharmacological and Toxicological Methods, V56, P300, DOI 10.1016/j.vascn.2007.05.004; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sterns RH, 2015, NEW ENGL J MED, V372, P55, DOI 10.1056/NEJMra1404489; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; THURSTON JH, 1986, METAB BRAIN DIS, V1, P129, DOI 10.1007/BF00999383; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Unal S, 2008, PEDIATR INT, V50, P29, DOI 10.1111/j.1442-200X.2007.02507.x; VANDERVALK JBF, 1991, EUR J PHARMACOL, V201, P247; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; WHO, 2000, GLOB WAT SUPPL SAN A; Zhou XJ, 2015, REV NEUROSCIENCE, V26, P39, DOI 10.1515/revneuro-2014-0053	51	13	13	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAY	2016	54						34	43		10.1016/j.neuro.2016.03.005			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	DN4RE	WOS:000377054100004	26994581				2022-02-06	
J	Weber, KT; Guimaraes, VA; Pontes-Neto, OM; Leite, JP; Takayanagui, OM; Santos-Pontelli, TEG				Weber, Karina Tavares; Guimaraes, Viviane Assuncao; Pontes-Neto, Octavio M.; Leite, Joao P.; Takayanagui, Osvaldo Massaiti; Santos-Pontelli, Taiza E. G.			Predictors of quality of life after moderate to severe traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						brain injuries; epidemiology; quality of life	SYSTEMS NATIONAL DATABASE; LONGITUDINAL DESCRIPTION; OUTCOME MEASURES; MODEL SYSTEMS; SCALE; INDIVIDUALS; DISABILITY; INSTITUTE; DISCHARGE; MORTALITY	Objective: To verify correlations between age, injury severity, length of stay (LOS), cognition, functional capacity and quality of life (QOL) six months after hospital discharge (HD) of victims of traumatic brain injury (TBI). Method: 50 patients consecutively treated in a Brazilian emergency hospital were assessed at admission, HD and six months after HD. The assessment protocol consisted in Abbreviated Injury Scale, Injury Severity Score, Glasgow Coma Scale (GCS), Revised Trauma Score (RTS), Mini Mental Test, Barthel Index and World Health Organization QOL - Brief. Results: Strong negative correlation was observed between LOS and GCS and LOS and RTS. An almost maximal correlation was found between RTS and GCS and functional capacity and GCS at HD. Age and LOS were considered independent predictors of QOL. Conclusion: Age and LOS are independent predictors of QOL after moderate to severe TBI.	[Weber, Karina Tavares; Guimaraes, Viviane Assuncao; Pontes-Neto, Octavio M.; Leite, Joao P.; Takayanagui, Osvaldo Massaiti; Santos-Pontelli, Taiza E. G.] Univ Sao Paulo, Fac Med, Dept Neurociencias & Ciencias Comportamento, BR-14049900 Ribeirao Preto, SP, Brazil; [Pontes-Neto, Octavio M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA		Santos-Pontelli, TEG (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Santos, Taiza EG/F-9214-2012; Leite, Joao/B-9070-2012; Neto, Octavio Marques Pontes/G-4294-2012	Santos, Taiza EG/0000-0003-3033-2981; Leite, Joao/0000-0003-0558-3519; Neto, Octavio Marques Pontes/0000-0003-0317-843X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - BrazilCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil.	Vieira RDA, 2013, REV LAT-AM ENFERM, V21, P868, DOI 10.1590/S0104-11692013000400006; Alves ALA, 2009, REV SAUDE PUBL, V43, P154, DOI 10.1590/S0034-89102009000100020; Cartaxo CKA, 2012, CLINICS, V67, P1133, DOI 10.6061/clinics/2012(10)03; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Batista Sandra Elisa Adami, 2006, Rev. Col. Bras. Cir., V33, P6; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Carvalho AO, 2004, EINSTEIN, V2, P199; Costa Carlos Dario da Silva, 2012, Rev. Col. Bras. Cir., V39, P249; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Silva SCFE, 2012, REV ESC ENFERM USP, V46, P30, DOI 10.1590/S0080-62342012000700005; Fukuda CC, 2002, AVAL PSICOL, V1, P1; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Rocha GD, 2013, CIENC SAUDE COLETIVA, V18, P721, DOI 10.1590/S1413-81232013000300018; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shah S, 2003, OTJR-OCCUP PARTICI H, V23, P2, DOI 10.1177/153944920302300101; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sloan EP, 2012, PREHOSP DISASTER MED, V27, P330, DOI 10.1017/S1049023X12000970; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	30	13	17	0	8	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAY	2016	74	5					409	415		10.1590/0004-282X20160053			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DN3WT	WOS:000376995500010	27191238	Green Submitted, gold			2022-02-06	
J	Zarzaur, BL; Bell, T				Zarzaur, Ben L.; Bell, Teresa			Trajectory subtypes after injury and patient-centered outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article						Quality of life; Recovery trajectories; Injury; Trauma	QUALITY-OF-LIFE; HEALTH-CARE UTILIZATION; DEMENTIA CARE; MORTALITY; RECOVERY; MODELS; ASSOCIATIONS; DEPRESSION; TRAUMA; SF-36	Background: The recent focus on patient-centered outcomes highlights the need to better describe recovery trajectories after injury. The purpose of this study was to characterize recovery trajectory subtypes that exist after non-neurologic injury. Materials and methods: A prospective, observational cohort of 500 adults with an Injury Severity Score > 10 but without traumatic brain or spinal cord injury from 2009 to 2011 was formed. The Short Form-36 was administered at admission and repeated at 1, 2, 4, and 12 mo after injury. Group-based trajectory modeling was used to determine the number and shape of physical composite score (PCS) and mental composite score (MCS) trajectories. Results: Three PCS trajectories and five MCS trajectories were identified. For PCS, trajectory 1 (10.4%) has low baseline scores, followed by no improvement over time. Trajectory 2 (65.6%) declines 1 mo after injury then improves over time. Trajectory 3 (24.1%) has a sharp decline followed by rapid recovery. For MCS, trajectory 1 (9.4%) is low at baseline and remains low. Trajectory 2 (14.4%) has a large decrease after injury and does not recover over the next 12 mo. Trajectory 3 (22.7%) has an initial decrease in MCS early, followed by continuous recovery. Trajectory 4 (19.1%) has a steady decline over the study period. Trajectory 5 (34.3%) stays consistently high at all time points. Conclusions: Recovery after injury is complex and results in multiple recovery trajectories. This has implications for patient-centered clinical trial design and in development of patient-specific interventions to improve outcomes. (C) 2016 Elsevier Inc. All rights reserved.	[Zarzaur, Ben L.; Bell, Teresa] Indiana Univ Sch Med, Ctr Outcomes Res Surg, Dept Surg, Indianapolis, IN 46202 USA		Zarzaur, BL (corresponding author), Indiana Univ Sch Med, Ctr Outcomes Res Surg, 702 Rotary Circle,Room 022B, Indianapolis, IN 46202 USA.	bzarzaur@iupui.edu	Zarzaur, Ben/S-6572-2019; Bell, Teresa Maria/Q-9271-2019	Bell, Teresa/0000-0002-6519-4358; Zarzaur, Ben/0000-0001-9988-9572	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM084427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM084427] Funding Source: NIH RePORTER	The research reported in this publication was supported by National Institute of General Medical Sciences of the National Institutes of Health under award number K23GM084427.	Boustani MA, 2011, AGING MENT HEALTH, V15, P13, DOI 10.1080/13607863.2010.496445; Brown DS, 2015, PREV SCI, V16, P21, DOI 10.1007/s11121-013-0437-z; Callahan CM, 2011, AGING MENT HEALTH, V15, P5, DOI 10.1080/13607861003801052; Callahan CM, 2005, J AM GERIATR SOC, V53, P367, DOI 10.1111/j.1532-5415.2005.53151.x; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351; Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889; Gill TM, 2013, JAMA INTERN MED, V173, P1780, DOI 10.1001/jamainternmed.2013.9063; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V186, P302, DOI 10.1164/rccm.201206-1138ED; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kaplan RM, 2003, QUAL LIFE RES, V12, P3, DOI 10.1023/A:1023547632545; Kopjar B, 1996, Inj Prev, V2, P135, DOI 10.1136/ip.2.2.135; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Wang B, 2014, SOC SCI MED, V106, P43, DOI 10.1016/j.socscimed.2014.01.023; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zafar SY, 2015, J ONCOL PRACT, V11, P145, DOI 10.1200/JOP.2014.001542; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zimmer Z, 2014, J GERONTOL B-PSYCHOL, V69, P275, DOI 10.1093/geronb/gbt099	21	13	14	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY 1	2016	202	1					103	110		10.1016/j.jss.2015.12.038			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	DK5OR	WOS:000374969800014	27083954	Green Submitted, Green Accepted			2022-02-06	
J	Liu, XX; Wang, C; Huang, SF; Chen, Q; Hu, YF; Zhou, L; Gu, Y				Liu, Xiao-Xi; Wang, Chen; Huang, Shao-Fei; Chen, Qiong; Hu, Ya-Fang; Zhou, Liang; Gu, Yong			Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury	SCIENTIFIC REPORTS			English	Article							ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; MCP-INDUCED PROTEIN-1; ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; MESSENGER-RNA; 1 HMGB1; PROTECTS; ACTIVATION	Extracellular high mobility group box 1 (HMGB1) has been demonstrated to function as a proinflammatory cytokine and induces neuronal injury in response to various pathological stimuli in central nervous system (CNS). However, the regulatory factor involved in HMGB1-mediated inflammatory signaling is largely unclear. Regulatory RNase 1 (Regnase-1) is a potent anti-inflammation enzyme that can degrade a set of mRNAs encoding proinflammatory cytokines. The present study aims to determine the role of Regnase-1 in the regulation of HMGB1-mediated inflammatory injury in CNS. Cultured microglia and rat brain were treated with recombinant HMGB1 to examine the induction of Regnase-1 expression. Moreover, the role of Regnase-1 in modulating the expression of inflammatory cytokines and neuronal injury was then investigated in microglia by specific siRNA knockdown upon HMGB1 treatment. Results showed that HMGB1 could significantly induce the de novo synthesis of Regnase-1 in cultured microglia. Consistently, Regnase-1 was elevated and found to be co-localized with microglia marker in the brain of rat treated with HMGB1. Silencing Regnase-1 in microglia enhanced HMGB1-induced expression of proinflammatory cytokines and exacerbated neuronal toxicity. Collectively, these results suggest that Regnase-1 can be induced by HMGB1 in microglia and negatively regulates HMGB1-mediated neuroinflammation and neuronal toxicity.	[Liu, Xiao-Xi; Wang, Chen; Huang, Shao-Fei; Chen, Qiong; Hu, Ya-Fang; Zhou, Liang; Gu, Yong] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Chen] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Chen] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China		Zhou, L; Gu, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou 510515, Guangdong, Peoples R China.	zhouliang_1963@126.com; yonggu@smu.edu.cn		Wang, Chen/0000-0002-0213-9642	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400990]; Natural Science Foundation of Guangdong Province of ChinaNational Natural Science Foundation of Guangdong Province [2014A030310197]	We thank Dr. Shu-Zhen Zhu from Southern Medical University for her kindly donating BV2 and SH-SY5Y cell lines, and Dr Xiang Lin from the University of Hong Kong for the careful revision of the manuscript. This work was supported by the National Natural Science Foundation of China (No. 81400990), the Natural Science Foundation of Guangdong Province of China (No. 2014A030310197).	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Aneja RK, 2008, J LEUKOCYTE BIOL, V84, P1326, DOI 10.1189/jlb.0108030; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Colleran A, 2011, J BIOL CHEM, V286, P22886, DOI 10.1074/jbc.M110.199950; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Ghosh M, 2015, J IMMUNOL, V194, P4466, DOI 10.4049/jimmunol.1403133; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hu XR, 2010, INT J CARDIOL, V145, P111, DOI 10.1016/j.ijcard.2009.05.057; Huang SP, 2013, CELL SIGNAL, V25, P1228, DOI 10.1016/j.cellsig.2013.02.009; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Jang A, 2013, CURR ALZHEIMER RES, V10, P829; Jin Z, 2015, J NEUROINFLAMM, V12, P264; Jin ZQ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-63; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Kim ID, 2015, NEUROSCI LETT, V593, P40, DOI 10.1016/j.neulet.2015.03.012; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kumar A, 2015, J NEUROCHEM, V135, P1189, DOI 10.1111/jnc.13364; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-182; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lindersson EK, 2004, NEUROREPORT, V15, P2735; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Louw A. M., 2015, NANOMEDICINE; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; O'Neill S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12958; Okuma Y, 2014, YAKUGAKU ZASSHI, V134, P701, DOI 10.1248/yakushi.13-00255-2; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Skalniak L, 2009, FEBS J, V276, P5892, DOI 10.1111/j.1742-4658.2009.07273.x; Sta M, 2011, NEUROBIOL DIS, V42, P211, DOI 10.1016/j.nbd.2011.01.002; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Takata K, 2004, J NEUROSCI RES, V78, P880, DOI 10.1002/jnr.20340; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Wu CX, 2015, SHOCK, V43, P412, DOI 10.1097/SHK.0000000000000309; Wu HL, 2014, KIDNEY INT, V85, P824, DOI 10.1038/ki.2013.475; Yang CB, 2015, CRIT REV EUKAR GENE, V25, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2015013022; Yang H, 2005, CRIT CARE MED, V33, pS472, DOI 10.1097/01.CCM.0000187005.81616.A9; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Zhang Y, 2012, J BIOL CHEM, V287, P32546, DOI 10.1074/jbc.M112.348755; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	54	13	13	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 5	2016	6								24073	10.1038/srep24073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI2PV	WOS:000373339800003	27044405	Green Published, gold			2022-02-06	
J	Cinnera, AM; Bonni, S; Iosa, M; Ponzo, V; Fusco, A; Caltagirone, C; Koch, G				Cinnera, Alex Martino; Bonni, Sonia; Iosa, Marco; Ponzo, Viviana; Fusco, Augusto; Caltagirone, Carlo; Koch, Giacomo			Clinical effects of non-invasive cerebellar magnetic stimulation treatment combined with neuromotor rehabilitation in traumatic brain injury. A single case study	FUNCTIONAL NEUROLOGY			English	Article						cerebellar cortex; physical therapy; rehabilitation; transcranial magnetic stimulation; traumatic brain injury	MOTOR; CIRCUITS; HUMANS; STROKE	Multimodal treatments are emerging as effective approaches for motor recovery in traumatic brain injury (TBI). Various evidence has demonstrated that repetitive transcranial magnetic stimulation (rTMS) may improve outcomes in people with motor disorders. Behavioral gains from rTMS protocols may be maximized when brain stimulation is coupled with carefully designed occupational/physical therapy. We present the case of a 25-year-old man with chronic TBI (a bilateral cortico-subcortical parieto-occipital lesion) who underwent three weeks of cerebellar intermittent theta burst stimulation (iTBS), a form of rTMS, combined with neurorehabilitation treatment. The Fugl-Meyer Assessment (FMA), Berg Balance Scale (BBS), Jebsen-Taylor Hand Function Test, and accelerometer gait analysis were administered before and after treatment. The results showed improvements in balance performance (BBS: T0=47; T1=53; +10.72%), motor recovery (FMA: T0=93/100; T1=96/100; +3.00%), step length (T0=50.4 +/- 7.2; T1=53.8 +/- 2.2 cm, p<0.001), and walking speed (T0=0.87 +/- 0.06; T1=0.91 +/- 0.04 m/sec, p<0.001). Combined cerebellar rTMS and neurore-habilitation seems to be a promising treatment for motor and balance dysfunctions in TBI patients.	[Cinnera, Alex Martino; Bonni, Sonia; Ponzo, Viviana; Caltagirone, Carlo; Koch, Giacomo] IRCCS Santa Lucia Fdn, Non Invas Brain Stimulat Unit, Rome, Italy; [Iosa, Marco; Fusco, Augusto] IRCCS Santa Lucia Fdn, Clin Lab Expt Neurorehabil, Rome, Italy; [Caltagirone, Carlo] Tor Vergata Univ, Dept Syst Med, Rome, Italy; [Koch, Giacomo] Policlin Tor Vergata, Stroke Unit, Rome, Italy		Koch, G (corresponding author), IRCCS Santa Lucia Fdn, Non Invas Brain Stimulat Unit, Rome, Italy.; Koch, G (corresponding author), Policlin Tor Vergata, Stroke Unit, Rome, Italy.	g.koch@hsantalucia.it	Koch, Giacomo/G-3155-2012; Iosa, Marco/AAC-1693-2022; Iosa, Marco/B-9531-2012; Ponzo, Viviana/AAA-7894-2019; Fusco, Augusto/K-5794-2012; Cinnera, Alex Martino/K-4259-2018	Fusco, Augusto/0000-0002-8528-7834; Cinnera, Alex Martino/0000-0001-7267-3253; KOch, Giacomo/0000-0001-6155-9439			BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bonni S, 2014, FUNCT NEUROL, V29, P41, DOI 10.11138/FNeur/2014.29.1.041; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Groiss Stefan Jun, 2013, Handb Clin Neurol, V116, P643, DOI 10.1016/B978-0-444-53497-2.00051-6; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; KRAFT GH, 1992, ARCH PHYS MED REHAB, V73, P220; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Oliveri M, 2005, NEUROSCI LETT, V376, P188, DOI 10.1016/j.neulet.2004.11.053; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; Theoret H, 2001, NEUROSCI LETT, V306, P29, DOI 10.1016/S0304-3940(01)01860-2; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x	17	13	13	0	6	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	APR-JUN	2016	31	2					117	120					4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DR5RH	WOS:000379959600009	27358225				2022-02-06	
J	Hosmann, A; Schober, A; Gruber, A; Sterz, F; Testori, C; Warenits, A; Weihs, W; Hogler, S; Scherer, T; Janata, A; Laggner, A; Zeitlinger, M				Hosmann, A.; Schober, A.; Gruber, A.; Sterz, F.; Testori, C.; Warenits, A.; Weihs, W.; Hoegler, S.; Scherer, T.; Janata, A.; Laggner, A.; Zeitlinger, Markus			Cerebral and Peripheral Metabolism to Predict Successful Reperfusion After Cardiac Arrest in Rats: A Microdialysis Study	NEUROCRITICAL CARE			English	Article						Neuromonitoring; Microdialysis; Cardiac arrest; Resuscitation; Reperfusion; Cerebral metabolism; Ischemia; Animal model	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; CORTICAL CELL-CULTURE; INTRACEREBRAL MICRODIALYSIS; BEDSIDE MICRODIALYSIS; ENERGY-METABOLISM; GLUTAMATE NEUROTOXICITY; EXTRACELLULAR GLUCOSE; ISCHEMIC BRAIN	Background In clinical practice, monitoring of the efficacy of resuscitation can be challenging. The prediction of cerebral and overall outcome in particular is an unmet medical need. Microdialysis is a minimally invasive technique for the continuous determination of metabolic parameters in vivo. Using this technique, we set out to establish a model allowing for concomitant determination of cerebral and peripheral metabolism in a cardiac arrest setting in rodents. Methods Microdialysis settings were optimized in vitro and then used in male Sprague-Dawley rats. Probes were implanted into the CA1 region of the right hippocampus and the right femoral vein. With a time interval of 8 min, glucose, lactate, pyruvate, and glutamate levels were determined during baseline conditions, untreated ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation (CPR), reperfusion, and death. Results In 16 rodents, restoration of spontaneous circulation was achieved in seven animals. Characteristic metabolic changes were evident during cardiac arrest and reperfusion with both probes. Ischemic patterns in peripheral compartments were delayed and more variable compared to the changes in cerebral metabolism highlighting the importance of cerebral metabolic monitoring. Microdialysis allowed distinguishing between survivors and non-survivors 8 min after termination of CPR. Cerebral glutamate showed a trend toward higher levels in non-survivors during CPR. Conclusions We established a new rodent model for research in hypoxic ischemic encephalopathy. This setting allows to investigate the impact of resuscitation methods on cerebral and peripheral metabolism simultaneously. The present model may be used to evaluate different resuscitation strategies in order to optimize brain survival in future studies.	[Hosmann, A.; Gruber, A.] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Schober, A.; Sterz, F.; Testori, C.; Warenits, A.; Weihs, W.; Janata, A.; Laggner, A.] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Hoegler, S.] Univ Vet Med, Vienna, Austria; [Scherer, T.] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Zeitlinger, Markus] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria		Zeitlinger, M (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.	markus.zeitlinger@meduniwien.ac.at	Hosmann, Arthur/V-5385-2019	Zeitlinger, Markus/0000-0002-1873-3953; Hosmann, Arthur/0000-0001-7396-4239; Scherer, Thomas/0000-0003-4980-706X; Weihs, Wolfgang/0000-0002-3471-2925	Austrian Science FundAustrian Science Fund (FWF) [FWF-P24824-824, P26766, P24824-824]; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P 24824] Funding Source: researchfish	This study was funded by the Austrian Science Fund (Grant Number FWF-P24824-824). Thomas Scherer and Andreas Janata were funded by the Austrian Science Fund (Grant Number P26766 and P24824-824, respectively).	Bauer R, 2004, INTENS CARE MED, V30, P159, DOI 10.1007/s00134-003-2015-5; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1987, J NEUROSCI, V7, P357; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; deLange ECM, 1997, BRAIN RES REV, V25, P27, DOI 10.1016/S0165-0173(97)00014-3; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Goyagi T, 2011, J NEUROSURG ANESTH, V23, P131, DOI 10.1097/ANA.0b013e31820369c1; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Janata A, 2013, CRIT CARE MED, V41, pE211, DOI 10.1097/CCM.0b013e318287f51e; LIN BW, 1995, STROKE, V26, P1634, DOI 10.1161/01.STR.26.9.1634; Mapstone J, 2003, J TRAUMA, V55, P571, DOI 10.1097/01.TA.0000062968.69867.6F; Moller Fanny, 2011, J Diabetes Sci Technol, V5, P1099; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nordmark J, 2009, ACTA ANAESTH SCAND, V53, P289, DOI 10.1111/j.1399-6576.2008.01885.x; Nordmark J, 2009, RESUSCITATION, V80, P573, DOI 10.1016/j.resuscitation.2009.02.003; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Phillis JW, 2001, J NEUROCHEM, V76, P247, DOI 10.1046/j.1471-4159.2001.00050.x; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Ragoonanan TE, 2009, ANESTHESIOLOGY, V111, P988, DOI 10.1097/ALN.0b013e3181b87f0e; Rimpilainen J, 2001, J THORAC CARDIOV SUR, V121, P957, DOI 10.1067/mtc.2001.112934; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Runge M, 2006, SCAND CARDIOVASC J, V40, P186, DOI 10.1080/14017430600709043; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schierenbeck Fanny, 2014, J Diabetes Sci Technol, V8, P839, DOI 10.1177/1932296814532206; Schierenbeck F, 2014, CRIT CARE, V18, DOI 10.1186/cc13808; Schubert GA, 2008, J NEUROTRAUM, V25, P539, DOI 10.1089/neu.2007.0500; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schurr A, 1997, BRAIN RES, V744, P105, DOI 10.1016/S0006-8993(96)01106-7; Silva MA, 2005, TRANSPLANTATION, V79, P828, DOI 10.1097/01.TP.0000153156.38617.97; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P1; Takata K, 2005, CRIT CARE MED, V33, P1340, DOI 10.1097/01.CCM.0000166351.19369.D3; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Valen G, 2004, EUR J CARDIO-THORAC, V25, P69, DOI 10.1016/S1010-7940(03)00672-9; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Weld KJ, 2008, J ENDOUROL, V22, P571, DOI 10.1089/end.2007.0256; Zoremba N, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0072-0	49	13	13	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2016	24	2					283	293		10.1007/s12028-015-0214-x			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DJ3JN	WOS:000374101200019	26582187				2022-02-06	
J	Huang, YH; Ou, CY				Huang, Yu-Hua; Ou, Chien-Yu			Prognostic Impact of Intracranial Pressure Monitoring After Primary Decompressive Craniectomy for Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Intracranial pressure; Outcome measures; Traumatic brain injury	HEMICRANIECTOMY; HEMORRHAGE	OBJECTIVE: Decompressive craniectomy (DC) for traumatic brain injury (TBI) can be used in 2 completely different situations: primary and secondary DC. Although intracranial pressure (ICP) monitoring has proved to be helpful in guiding therapy for head injuries, its role after primary DC is not well analyzed. The aim of this study was to elucidate the relationship between ICP monitoring and outcomes in patients undergoing primary DC for TBI. METHODS: We enrolled 187 head-injured patients undergoing primary DC in this retrospective study. The patients were subdivided into 2 groups based on whether postoperative ICP was monitored (n = 34) or not (n = 153). We identified the intergroup differences in clinical parameters and prognosis. Unfavorable and favorable neurologic outcomes were defined by Glasgow Outcome Scale scores of 1-3 and 4-5, respectively. RESULTS: The rate of ICP monitoring was 18.2% for our head-injured patients after primary DC. There was no difference in preoperative Glasgow Coma Score, pupil reactivity, features of computed tomography images, or other demographic variables between patients with or without ICP monitoring. The mortality at discharge was 14.7% for patients with ICP monitoring and 32.7% for patients without, which showed a statistically significant difference (P = 0.037). The neurologic outcomes did not differ between the patient groups at discharge or the end of follow-up. CONCLUSIONS: Our data suggest that ICP monitoring after primary DC for head-injured patients significantly decreases in-hospital mortality and should be implemented in neurocritical care to ensure the highest chances of surviving TBI.	[Huang, Yu-Hua; Ou, Chien-Yu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Yu-Hua; Ou, Chien-Yu] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Ou, Chien-Yu] Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan		Ou, CY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Ou, CY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Ou, CY (corresponding author), Kaohsiung Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan.	oucu2003@yahoo.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2002, ACT NEUR S, V81, P81; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	19	13	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						59	63		10.1016/j.wneu.2015.12.041			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700012	26732966				2022-02-06	
J	Johnstone, B; Bhushan, B; Hanks, R; Yoon, DP; Cohen, D				Johnstone, Brick; Bhushan, Braj; Hanks, Robin; Yoon, Dong Pil; Cohen, Daniel			Factor Structure of the Brief Multidimensional Measure of Religiousness/Spirituality in US and Indian Samples with Traumatic Brain Injury	JOURNAL OF RELIGION & HEALTH			English	Article						Spirituality; Religion; Brief Multidimensional Measure of Religiousness/Spirituality; Factor analysis	RELIGIOUS PRACTICES; CONGREGATIONAL SUPPORT; MENTAL-HEALTH; SPIRITUALITY; INDIVIDUALS; IMPACT	The aim of this paper was to determine the factor structure of the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) based on a sample of individuals from diverse cultures (i.e., USA, India), ethnicities (i.e., Caucasian, African-American, South Asian), and religions (i.e., Christian, Muslim, Hindu). A total of 109 individuals with traumatic brain injury (TBI) were included. Participants completed the BMMRS as part of a broader study on spirituality, religion, prosocial behaviors, and neuropsychological function. A principal components factor analysis with varimax rotation and Kaiser normalization identified a six-factor solution accounting for 72 % of the variance in scores. Five of the factors were deemed to be interpretable and were labeled based on face validity as: (1) Positive Spirituality/Religious Practices; (2) Positive Congregational Support; (3) Negative Spirituality/Negative Congregational Support; (4) Organizational Religion; and (5) Forgiveness. The results were generally consistent with previous studies, suggesting the existence of universal religious, spiritual, and congregational support factors across different cultures and faith traditions. For health outcomes research, it is suggested that the BMMRS factors may be best conceptualized as measuring the following general domains: (a) emotional connectedness with a higher power (i.e., spirituality, positive/negative); (b) culturally based behavioral practices (i.e., religion); and (c) social support (i.e., positive/negative). The results indicate that factor relationships may differ among spiritual, religious, and congregational support variables according to culture and/or religious tradition.	[Johnstone, Brick] Univ Missouri, Dept Hlth Psychol, DC 116-88, Columbia, MO 65212 USA; [Bhushan, Braj] Indian Inst Technol, Kanpur 208016, Uttar Pradesh, India; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO USA; [Cohen, Daniel] Univ Missouri, Dept Religious Studies, Columbia, MO USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, DC 116-88, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu	Bhushan, Braj/B-1173-2008	Johnstone, Brick/0000-0001-8845-9649			Baskin TW, 2004, J COUNS DEV, V82, P79, DOI 10.1002/j.1556-6678.2004.tb00288.x; Bodling A., 2002, J SPIRITUALITY MENTA, V18, P109; Bodling A, 2013, INT J THER REHABIL, V20, P72, DOI 10.12968/ijtr.2013.20.2.72; Campbell JD, 2010, J RELIG HEALTH, V49, P3, DOI 10.1007/s10943-008-9227-5; Capanna C, 2013, PSYCHOL RELIG SPIRIT, V5, P316, DOI 10.1037/a0033642; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Ellison CG, 2000, RES AGING, V22, P630, DOI 10.1177/0164027500226003; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Fitzgerald Timothy, 2000, IDEOLOGY RELIG STUDI; Flood Gavin, 1996, INTRO HINDUISM; Hackney CH, 2003, J SCI STUD RELIG, V42, P43, DOI 10.1111/1468-5906.t01-1-00160; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Johnstone B, 2012, J RELIG HEALTH, V51, P1017, DOI 10.1007/s10943-012-9615-8; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; Mokuau N, 2001, Pac Health Dialog, V8, P407; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Pargament KI, 1998, LAWS LIF SYMP SER, V1, P59; Piedmont RL, 2002, AM BEHAV SCI, V45, P1888; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Thoresen C E, 1999, J Health Psychol, V4, P291, DOI 10.1177/135910539900400314; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Yoon DP, 2005, J HUM BEHAV SOC ENVI, V10, P191, DOI 10.1300/J137v10n01_05	27	13	13	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4197	1573-6571		J RELIG HEALTH	J. Relig. Health	APR	2016	55	2					572	586		10.1007/s10943-015-0170-y			15	Public, Environmental & Occupational Health; Religion	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Public, Environmental & Occupational Health; Religion	DG7ST	WOS:000372284700019	26708139				2022-02-06	
J	Ravesloot, C; Ward, B; Hargrove, T; Wong, J; Livingston, N; Torma, L; Ipsen, C				Ravesloot, Craig; Ward, Bryce; Hargrove, Tannis; Wong, Jennifer; Livingston, Nick; Torma, Linda; Ipsen, Catherine			Why stay home? Temporal association of pain, fatigue and depression with being at home	DISABILITY AND HEALTH JOURNAL			English	Article						Participation; Pain; Fatigue; Depression; Measurement	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; INTERFERENCE MEASURES; PARKINSONS-DISEASE; NATURAL-HISTORY; CEREBRAL-PALSY; PEOPLE; ADULTS	Background: Community participation is important to most people with disabilities despite the fact that common secondary conditions like pain, fatigue and depression may increase the difficulty of leaving home. Despite decades of research on these secondary conditions, little is known about how they are associated with being at home. Objective: We used Ecological Momentary Assessment data to examine within subject fluctuation in these secondary conditions to examine their effect on the likelihood that participants remain at or return home. Methods: Participants (n - 139) were recruited from a population based sampling frame to complete an Ecological Momentary Assessment that queried their location and experience with secondary conditions six times a day for two weeks. Results: Between subjects secondary condition ratings averaged across time periods indicated that pain and depression were associated with the share of measurement periods that respondents reported being at home. Within subject results indicated that a standard unit increase in pain, fatigue and depression was associated with being home one to two days later. Within day results indicated that increases in pain and fatigue were associated with increased likelihood of being home later, but increases in depression were associated with lower likelihood of being home later. Conclusion: These results suggest there may be a complicated relationship among these secondary conditions and community participation with effects observed both across and within days. One interpretation suggests that secondary condition severity is tempered by adjusting participation. These results may have implications for intervening on these secondary conditions. (C) 2016 Elsevier Inc. All rights reserved.	[Ravesloot, Craig; Hargrove, Tannis; Wong, Jennifer; Livingston, Nick; Ipsen, Catherine] Rural Inst Inclusive Communities, Missoula, MT USA; [Ward, Bryce] Bur Business & Econ Res, Missoula, MT USA; [Torma, Linda] Montclair State Univ, Sch Nursing, Montclair, NJ 07043 USA		Ravesloot, C (corresponding author), Univ Montana, Rural Inst, 52 Corbin Hall, Missoula, MT 59812 USA.	craig.ravesloot@mso.umt.edu			Department of Education, NIDRR [H133G110077]	The contents of this paper were developed under a grant from the Department of Education, NIDRR grant number H133G110077 awarded to Craig Ravesloot and Catherine Ipsen. However, those do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Arun MP, 2011, NEUROL INDIA, V59, P185, DOI 10.4103/0028-3886.79133; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; CSIKSZENTMIHALYI M, 1977, J YOUTH ADOLESCENCE, V6, P281, DOI 10.1007/BF02138940; Dillman DA., 2007, MAIL INTERNET SURVEY; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Flood SM, 2015, J HEALTH SOC BEHAV, V56, P74, DOI 10.1177/0022146514568669; Foley PL, 2013, PAIN, V154, P632, DOI 10.1016/j.pain.2012.12.002; Friedman JH, 2007, MOVEMENT DISORD, V22, P297, DOI 10.1002/mds.21240; Gagnon C, 2008, ARCH PHYS MED REHAB, V89, P1246, DOI 10.1016/j.apmr.2007.10.049; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; Induruwa I, 2012, J NEUROL SCI, V323, P9, DOI 10.1016/j.jns.2012.08.007; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Jakobsson U, 2002, J CLIN NURS, V11, P430, DOI 10.1046/j.1365-2702.2002.00624.x; Knaggs JD, 2011, J AM GERIATR SOC, V59, P2118, DOI 10.1111/j.1532-5415.2011.03655.x; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Malone LA, 2010, DISABIL REHABIL, V32, P385, DOI 10.3109/09638280903171550; Michael KM, 2006, REHABIL NURS, V31, P210, DOI 10.1002/j.2048-7940.2006.tb00137.x; Microsoft Corporation, 2013, MICR EXC; Mitra S., 2006, J DISABIL POLICY STU, V16, P236, DOI DOI 10.1177/10442073060160040501; Monaco J., 2013, ECOLOGICAL FALLACY E, P644; Motl RW, 2010, J PAIN SYMPTOM MANAG, V39, P1025, DOI 10.1016/j.jpainsymman.2009.11.312; Murphy SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P849, DOI 10.1002/art.23710; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; Osborne TL, 2006, J PAIN SYMPTOM MANAG, V32, P217, DOI 10.1016/j.jpainsymman.2006.03.008; Osborne TL, 2006, REHABIL PSYCHOL, V51, P166, DOI 10.1037/0090-5550.51.2.166; Piasecki TM, 2007, PSYCHOL ASSESSMENT, V19, P25, DOI 10.1037/1040-3590.19.1.25; Putzke JD, 2000, REHABIL PSYCHOL, V45, P386, DOI 10.1037/0090-5550.45.4.386; Raichle KA, 2006, J PAIN, V7, P179, DOI 10.1016/j.jpain.2005.10.007; Ravesloot C, 1997, REHABIL PSYCHOL, V42, P3, DOI 10.1037/0090-5550.42.1.3; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Saulino M, 2014, PHYS MED REH CLIN N, V25, P397, DOI 10.1016/j.pmr.2014.01.002; Saunders LL, 2012, SPINAL CORD, V50, P72, DOI 10.1038/sc.2011.83; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; United States Census Bureau, 2005, AM COMM SURV S1801 D; Van der Slot WMA, 2012, DEV MED CHILD NEUROL, V54, P836, DOI 10.1111/j.1469-8749.2012.04371.x; Von Korff M, 2005, PSYCHOSOM MED, V67, P233, DOI 10.1097/01.psy.0000155662.82621.50; Wilkie R, 2007, QUAL LIFE RES, V16, P1147, DOI 10.1007/s11136-007-9221-5; World Health Organization, 2007, INT CLASS FUNCT DIS	46	13	13	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	APR	2016	9	2					218	225		10.1016/j.dhjo.2015.10.010			8	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	DH3WT	WOS:000372718200008	26750976	Green Published			2022-02-06	
J	Rodriguez, O; Schaefer, ML; Wester, B; Lee, YC; Boggs, N; Conner, HA; Merkle, AC; Fricke, ST; Albanese, C; Koliatsos, VE				Rodriguez, Olga; Schaefer, Michele L.; Wester, Brock; Lee, Yi-Chien; Boggs, Nathan; Conner, Howard A.; Merkle, Andrew C.; Fricke, Stanley T.; Albanese, Chris; Koliatsos, Vassilis E.			Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast-induced neurotrauma; blast injury; manganese-enhanced MRI (MEMRI); traumatic brain injury	CONTRAST AGENTS; RAT-BRAIN; INTRAVENOUS-INJECTION; FREQUENCY-DEPENDENCE; CEREBROSPINAL-FLUID; BARRIER DISRUPTION; CHLORIDE EXPOSURE; BASAL GANGLIA; MOUSE MODEL; MRI	Traumatic brain injury (TBI) caused by explosive munitions, known as blast TBI, is the signature injury in recent military conflicts in Iraq and Afghanistan. Diagnostic evaluation of TBI, including blast TBI, is based on clinical history, symptoms, and neuropsychological testing, all of which can result in misdiagnosis or underdiagnosis of this condition, particularly in the case of TBI of mild-to-moderate severity. Prognosis is currently determined by TBI severity, recurrence, and type of pathology, and also may be influenced by promptness of clinical intervention when more effective treatments become available. An important task is prevention of repetitive TBI, particularly when the patient is still symptomatic. For these reasons, the establishment of quantitative biological markers can serve to improve diagnosis and preventative or therapeutic management. In this study, we used a shock-tube model of blast TBI to determine whether manganese-enhanced magnetic resonance imaging (MEMRI) can serve as a tool to accurately and quantitatively diagnose mild-to-moderate blast TBI. Mice were subjected to a 30 psig blast and administered a single dose of MnCl2 intraperitoneally. Longitudinal T1-magnetic resonance imaging (MRI) performed at 6, 24, 48, and 72 h and at 14 and 28 days revealed a marked signal enhancement in the brain of mice exposed to blast, compared with sham controls, at nearly all time-points. Interestingly, when mice were protected with a polycarbonate body shield during blast exposure, the marked increase in contrast was prevented. We conclude that manganese uptake can serve as a quantitative biomarker for TBI and that MEMRI is a minimally-invasive quantitative approach that can aid in the accurate diagnosis and management of blast TBI. In addition, the prevention of the increased uptake of manganese by body protection strongly suggests that the exposure of an individual to blast risk could benefit from the design of improved body armor.	[Rodriguez, Olga] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Med Ctr, 3970 Reservoir Rd NW,Res Bldg,Room WB01, Washington, DC 20057 USA; [Schaefer, Michele L.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wester, Brock; Boggs, Nathan; Conner, Howard A.; Merkle, Andrew C.] Johns Hopkins Univ, Appl Phys Lab, Res & Exploratory Dev Dept, Laurel, MD USA; [Lee, Yi-Chien; Albanese, Chris] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Albanese, Chris] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Fricke, Stanley T.] George Washington Univ, Pediat & Integrat Syst Biol, Washington, DC USA		Rodriguez, O (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Med Ctr, 3970 Reservoir Rd NW,Res Bldg,Room WB01, Washington, DC 20057 USA.	rodriguo@georgetown.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA051008] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA51008-18, P30 CA51008-21] Funding Source: Medline		ANDERSON DW, 1987, INVEST RADIOL, V22, pS9, DOI 10.1097/00004424-198709000-00052; ANDERSON DW, 1987, MED PHYS, V14, P709; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; ARIAS E, 1979, B ENVIRON CONTAM TOX, V22, P297, DOI 10.1007/BF02026946; Aschner M, 1999, ENVIRON RES, V80, P105, DOI 10.1006/enrs.1998.3918; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Baldea JD, 2014, CLIN J SPORT MED, V24, P521, DOI 10.1097/JSM.0000000000000157; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Blanchette M, 2014, J CEREBR BLOOD F MET, V34, P820, DOI 10.1038/jcbfm.2014.14; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Burke C, 2013, SEMIN ULTRASOUND CT, V34, P44, DOI 10.1053/j.sult.2012.11.004; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; CARIDE V J, 1984, Magnetic Resonance Imaging, V2, P107, DOI 10.1016/0730-725X(84)90064-X; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Conrad ME, 2000, AM J HEMATOL, V64, P287, DOI 10.1002/1096-8652(200008)64:4<287::AID-AJH9>3.0.CO;2-L; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; DESKIN R, 1981, NEUROTOXICOLOGY, V2, P65; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Dodd CA, 2005, INT J TOXICOL, V24, P389, DOI 10.1080/10915810500366500; Erikson KM, 2005, ENVIRON TOXICOL PHAR, V20, P390, DOI 10.1016/j.etap.2005.03.009; Essig Marco, 2006, Top Magn Reson Imaging, V17, P89, DOI 10.1097/01.rmr.0000245464.36148.dc; Fa ZQ, 2010, NEUROSCI LETT, V481, P110, DOI 10.1016/j.neulet.2010.06.063; Fricke ST, 2006, PROSTATE, V66, P708, DOI 10.1002/pros.20392; FURCHNER JE, 1966, HEALTH PHYS, V12, P1415, DOI 10.1097/00004032-196610000-00003; Gallez B, 1998, MAGN RESON IMAGING, V16, P1211, DOI 10.1016/S0730-725X(98)00082-4; Gallez B, 1997, CHEM RES TOXICOL, V10, P360, DOI 10.1021/tx960194p; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grunecker B, 2010, NMR BIOMED, V23, P913, DOI 10.1002/nbm.1508; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; KILBURN CJ, 1987, NEUROTOXICOLOGY, V8, P421; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; LAUTERBUR PC, 1989, CLIN ORTHOP RELAT R, P3; Lebda MA, 2012, NEUROTOXICOLOGY, V33, P98, DOI 10.1016/j.neuro.2011.12.008; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; LONDON RE, 1989, BRAIN RES BULL, V23, P229, DOI 10.1016/0361-9230(89)90152-4; LYDEN A, 1983, ACTA PHARMACOL TOX, V52, P205; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Ni Y, 1997, ACTA RADIOL, V38, P700; NORMAN AB, 1991, BRAIN RES BULL, V26, P593, DOI 10.1016/0361-9230(91)90100-X; Omalu BI, 2005, J FORENSIC SCI, V50, P1453; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pollock CB, 2010, PPAR RES, V2010, DOI 10.1155/2010/571783; Racette BA, 2005, MOVEMENT DISORD, V20, P492, DOI 10.1002/mds.20381; Rodriguez O, 2006, CELL CYCLE, V5, P113, DOI 10.4161/cc.5.1.2295; Rofsky N M, 1996, Magn Reson Imaging Clin N Am, V4, P73; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P43, DOI 10.1016/0730-725X(85)90008-6; RUNGE V M, 1985, Magnetic Resonance Imaging, V3, P27, DOI 10.1016/0730-725X(85)90006-2; SCHUHMANNGIAMPIERI G, 1993, INVEST RADIOL, V28, P753, DOI 10.1097/00004424-199308000-00018; SEMELKA RC, 1993, RADIOLOGY, V188, P593, DOI 10.1148/radiology.188.3.8351317; Shahlaie K, 2013, RESTOR NEUROL NEUROS, V31, P141, DOI 10.3233/RNN-120243; SHIRAKUNI T, 1985, NEUROSURGERY, V17, P557, DOI 10.1227/00006123-198510000-00004; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sirajuddin P, 2012, CELL CYCLE, V11, P3801, DOI 10.4161/cc.21988; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; STEINER E, 1989, AM J ROENTGENOL, V152, P487, DOI 10.2214/ajr.152.3.487; Tian Y, 2014, IEEE ACM T COMPUT BI, V11, P1009, DOI 10.1109/TCBB.2014.2338304; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; Vissapragada S, 2010, CELL CYCLE, V9, P1824, DOI 10.4161/cc.9.9.11542; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watts LT, 2014, J NEUROTRAUM; Waubant E, 2006, DIS MARKERS, V22, P235, DOI 10.1155/2006/709869; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Young GS, 2007, NEUROL CLIN, V25, P947, DOI 10.1016/j.ncl.2007.07.010; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhen ZP, 2012, THERANOSTICS, V2, P45, DOI 10.7150/thno.3448	88	13	14	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					662	671		10.1089/neu.2015.4002			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700005	26414591	Green Published			2022-02-06	
J	Wang, B; Kang, M; Marchese, M; Rodriguez, E; Lu, W; Li, XT; Maeda, Y; Dowling, P				Wang, Bo; Kang, Mitchell; Marchese, Michelle; Rodriguez, Esther; Lu, Wei; Li, Xintong; Maeda, Yasuhiro; Dowling, Peter			Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						Traumatic brain injury; Erythropoietin; Small peptide therapy; Neuroprotection	CONTROLLED CORTICAL IMPACT; NECROSIS-FACTOR-ALPHA; CARBAMYLATED ERYTHROPOIETIN; RAT MODEL; IMMUNO/INFLAMMATORY MODULATION; TISSUE PROTECTION; TEMPORAL PROFILE; EXPRESSION; ASIALOERYTHROPOIETIN; NEUROPROTECTION	There is currently no effective medical treatment for traumatic brain injury (TBI). Beyond the immediate physical damage caused by the initial impact, additional damage evolves due to the inflammatory response that follows brain injury. Here we show that therapy with JM4, a low molecular weight 19-amino acid nonhematopoietic erythropoietin (EPO) peptidyl fragment, containing amino acids 28-46 derived from the first loop of EPO, markedly reduces acute brain injury. Mice underwent controlled cortical injury and received either whole molecule EPO, JM4, or sham-treatment with phosphate-buffered saline. Animals treated with JM4 peptide exhibited a large decrease in number of dead neural cells and a marked reduction in lesion size at both 3 and 8 days postinjury. Therapy with JM4 also led to improved functional recovery and we observed a treatment window for JM4 peptide that remained open for at least 9 h postinjury. The full-length EPO molecule was divided into a series of 6 contiguous peptide segments; the JM4-containing segment and the adjoining downstream region contained the bulk of the death attenuating effects seen with intact EPO molecule following TBI. These findings indicate that the JM4 molecule substantially blocks cell death and brain injury following acute brain trauma and, as such, presents an excellent opportunity to explore the therapeutic potential of a small-peptide EPO derivative in the medical treatment of TBI.	[Wang, Bo; Kang, Mitchell; Marchese, Michelle; Rodriguez, Esther; Lu, Wei; Li, Xintong; Maeda, Yasuhiro; Dowling, Peter] VA Med Ctr East Orange, Neurol Serv, E Orange, NJ USA; [Maeda, Yasuhiro; Dowling, Peter] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA		Dowling, P (corresponding author), VA Med Ctr East Orange, Neurol Serv, E Orange, NJ USA.; Dowling, P (corresponding author), Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA.	dowlinpc@njms.rutgers.edu	Li, Xintong/G-5341-2016; Wang, Bo/ABC-5571-2020	Li, Xintong/0000-0002-7270-3376; 	VA Office of Research and Development [IO1 RX000220-01]; Segal Fund; NJ Brain Injury Commission [08-3208-BIR-E-1]; Veterans AffairsUS Department of Veterans Affairs [I01RX001305, I01RX000220] Funding Source: NIH RePORTER	We thank Kevin Pang, PhD, for his help with animal studies and clinical scoring data analysis. We also thank William Banks, MD (Seattle, WA, USA), for his aid with the blood-brain barrier JM4 studies. This work was funded by the VA Office of Research and Development (IO1 RX000220-01; PD), the Segal Fund, and the NJ Brain Injury Commission (08-3208-BIR-E-1; PD).	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen H, 2014, J NEUROIMMUNOL, V268, P64, DOI 10.1016/j.jneuroim.2014.01.006; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P1517, DOI 10.1517/13543784.13.11.1517; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Grasso G, 2001, J Neurosurg Sci, V45, P7; IMAI N, 1990, EUR J BIOCHEM, V194, P457, DOI 10.1111/j.1432-1033.1990.tb15639.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wei X, 2014, INFECT IMMUN, V82, P165, DOI 10.1128/IAI.00929-13; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Yuan RR, 2015, NEUROTHERAPEUTICS, V12, P850, DOI 10.1007/s13311-015-0379-1	34	13	14	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	APR	2016	13	2					418	427		10.1007/s13311-015-0418-y			10	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DI6WY	WOS:000373642100014	26715414	Bronze, Green Published			2022-02-06	
J	Schmitt-Sody, M; Kurz, S; REiser, M; Kanz, KG; Kirchhoff, C; Peschel, O; Kirchhoff, S				Schmitt-Sody, MArkus; Kurz, Stefanie; REiser, MAximilian; Kanz, Karl Georg; Kirchhoff, Chlodwig; Peschel, Oliver; Kirchhoff, Sonja			Analysis of death in major trauma: value of prompt post mortem computed tomography (pmCT) in comparison to office hour autopsy	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							VIRTUAL AUTOPSY; POSTMORTEM; INJURY; VIRTOPSY; RADIOLOGY; VICTIMS; UTILITY; MSCT; MRI	Background: To analyze diagnostic accuracy of prompt post mortem Computed Tomography (pmCT) in determining causes of death in patients who died during trauma room management and to compare the results to gold standard autopsy during office hours. Methods: Multiple injured patients who died during trauma room care were enrolled. PmCT was performed immediately followed by autopsy during office hours. PmCT and autopsy were analyzed primarily regarding pmCT ability to find causes of death and secondarily to define exact causes of death including accurate anatomic localizations. For the secondary analysis data was divided in group-I with equal results of pmCT and autopsy, group-II with autopsy providing superior results and group-III with pmCT providing superior information contributing to but not majorly causing death. Results: Seventeen multiple trauma patients were enrolled. Since multiple trauma patients were enrolled more injuries than patients are provided. Eight patients sustained deadly head injuries (47.1 %), 11 chest (64.7 %), 4 skeletal system (23.5 %) injuries and one patient drowned (5.8 %). Primary analysis revealed in 16/17 patients (94.1 %) causes of death in accordance with autopsy. Secondary analysis revealed in 9/17 cases (group-I) good agreement of autopsy and pmCT. In seven cases autopsy provided superior results (group-II) whereas in 1 case pmCT found more information (group-III). Discussion: The presented work studied the diagnostic value of pmCT in defining causes of death in comparison to standard autopsy. Primary analysis revealed that in 94.1% of cases pmCT was able to define causes of death even if only indirect signs were present. Secondary analysis showed that pmCT and autopsy showed equal results regarding causes of death in 52.9%. Conclusions: PmCT is useful in traumatic death allowing for an immediate identification of causes of death and providing detailed information on bony lesions, brain injuries and gas formations. It is advisable to conduct pmCT especially in cases without consent to autopsy to gain information about possible causes of death and to rule out possible clinical errors.	[Schmitt-Sody, MArkus; Kurz, Stefanie; REiser, MAximilian; Kanz, Karl Georg; Kirchhoff, Chlodwig; Peschel, Oliver; Kirchhoff, Sonja] Klinikum Univ Munchen, Munich, Germany		Kirchhoff, S (corresponding author), Klinikum Univ Munchen, Munich, Germany.	sonja.kirchhoff@med.uni-muenchen.de					Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Christe A, 2009, J TRAUMA, V66, P1302, DOI 10.1097/TA.0b013e31818c1441; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; DONCHIN Y, 1994, J TRAUMA, V37, P552, DOI 10.1097/00005373-199410000-00006; Eisenmenger W, 2001, DEUT MED WOCHENSCHR, V126, P257; Farkash U, 2000, J TRAUMA, V48, P303, DOI 10.1097/00005373-200002000-00018; Federal Statistical Office, 2008, TOD DEUTSCHL GEST DE; Hoey BA, 2007, J TRAUMA, V63, P979, DOI 10.1097/TA.0b013e318154011f; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Imanishi M, 1998, NEURORADIOLOGY, V40, P154, DOI 10.1007/s002340050557; Jacobsen C, 2010, FORENSIC SCI INT, V194, P9, DOI 10.1016/j.forsciint.2009.10.001; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leth PM, 2010, J TRAUMA, V68, P1413, DOI 10.1097/TA.0b013e3181b251b8; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Paperno S, 2005, ROFO-FORTSCHR RONTG, V177, P130, DOI 10.1055/s-2004-813735; Poulsen K, 2007, FORENSIC SCI INT, V171, P190, DOI 10.1016/j.forsciint.2006.05.041; Richens D, 2002, EUR J CARDIO-THORAC, V21, P288, DOI 10.1016/S1010-7940(01)01095-8; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Shiotani S, 2008, RADIAT MED, V26, P253, DOI 10.1007/s11604-007-0223-6; Sochor MR, 2008, J TRAUMA, V65, P659, DOI 10.1097/TA.0b013e3181238d66; Stein KM, 2009, RADIOLOGE, V49, P73, DOI 10.1007/s00117-008-1732-8; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027	27	13	13	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 29	2016	24								38	10.1186/s13049-016-0231-6			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI7FM	WOS:000373664700001	27025705	Green Published, gold			2022-02-06	
J	Sacco, K; Gabbatore, I; Geda, E; Duca, S; Cauda, F; Bara, BG; Bosco, FM				Sacco, Katiuscia; Gabbatore, Ilaria; Geda, Elisabetta; Duca, Sergio; Cauda, Franco; Bara, Bruno G.; Bosco, Francesca M.			Rehabilitation of Communicative Abilities in Patients with a History of TBI: Behavioral Improvements and Cerebral Changes in Resting-State Activity	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						cognitive rehabilitation; communicative abilities; traumatic brain injury (TBI); functional magnetic resonance imaging (fMRI); cerebral plasticity	TRAUMATIC BRAIN-INJURY; LOW-FREQUENCY FLUCTUATIONS; EMOTIONAL PROSODY; COGNITIVE REHABILITATION; FUNCTIONAL NEUROANATOMY; PRAGMATIC TREATMENT; CONNECTIVITY; PLASTICITY; AMPLITUDE; FMRI	A targeted training program for the rehabilitation of communicative abilities Cognitive Pragmatic Treatment (CPT) has been developed and previously tested on a sample of patients with traumatic brain injury (TBI), whose performance was found to have improved. Since cortical plasticity has been recognized as the main mechanism of functional recovery, we investigated whether and how behavioral improvements following the training program are accompanied by brain modifications. Eight TBI patients took part in the training program and were behaviorally assessed pre- and post-treatment; six of these patients were also evaluated with pre- and post-treatment resting state (rs) functional magnetic resonance imaging (fMRI). At the end of the rehabilitation program patients showed improvement in overall communicative performance, in both comprehension and production tasks. A follow-up retest revealed the stability of these results 3 months after completing the training program. At the brain level, we found significant increases in the amplitude of low frequency fluctuation (ALFF) index in the bilateral precentral gyrus, in the right middle and superior temporal gyri, in the right cingulate gyrus, and in the left inferior parietal lobule. We discuss these differences of brain activity in terms of their possible contribution to promoting recovery.	[Sacco, Katiuscia; Geda, Elisabetta] Univ Turin, Dept Psychol, Imaging & Cerebral Plast Res Grp, Turin, Italy; [Sacco, Katiuscia; Bara, Bruno G.; Bosco, Francesca M.] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Sacco, Katiuscia; Duca, Sergio; Cauda, Franco; Bara, Bruno G.; Bosco, Francesca M.] Univ Turin, Neurosci Inst Turin, Turin, Italy; [Gabbatore, Ilaria] Univ Oulu, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland; [Duca, Sergio; Cauda, Franco] Univ Turin, Dept Psychol, Koelliker Hosp, GCS fMRI, Turin, Italy		Gabbatore, I (corresponding author), Univ Oulu, Child Language Res Ctr, Res Unit Logoped, Fac Humanities, Oulu, Finland.	ilaria.gabbatore@oulu.fi	Cauda, Franco/G-5021-2010; bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019	Cauda, Franco/0000-0003-1526-8475; bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066	Brain Imaging Group ONL US	This study has been supported by Brain Imaging Group ONL US and by local research funds (ex 60%) managed by University of Turin, Department of Psychology, year 2014. We are grateful to the reviewers, whose comments helped us greatly to improve the article.	Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Barkley RA, 2001, J CONSULT CLIN PSYCH, V69, P926, DOI 10.1037//0022-006X.69.6.926; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berlucchi G, 2011, NEUROPSYCHOL REHABIL, V21, P560, DOI 10.1080/09602011.2011.573255; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Champagne-Lavau M, 2006, CURR PSYCHIATRY REV, V2, P309, DOI 10.2174/157340006778018184; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Eviatar Z, 2006, NEUROPSYCHOLOGIA, V44, P2348, DOI 10.1016/j.neuropsychologia.2006.05.007; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Huber W., 1983, AACHENER APHASIE TES; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Li CM, 2014, BEHAV BRAIN RES, V274, P205, DOI 10.1016/j.bbr.2014.08.019; Liu XN, 2014, J ALZHEIMERS DIS, V40, P387, DOI 10.3233/JAD-131322; Long DL, 2002, J COGNITIVE NEUROSCI, V14, P228, DOI 10.1162/089892902317236867; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; McDonald S., 2000, COMMUNICATION DISORD; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nordvik JE, 2014, NEUROREHABILITATION, V34, P81, DOI 10.3233/NRE-131017; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pieramico V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043901; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Robertson DA, 2000, PSYCHOL SCI, V11, P255, DOI 10.1111/1467-9280.00251; Sacco K, 2008, J COGN SCI, V9, P111; Sacco K., 2015, 5 SCI M ESN 12 NORD; Sacco K, 2013, B PSICOL APPL, P55; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Sacco K, 2009, BRAIN RES, V1297, P124, DOI 10.1016/j.brainres.2009.08.049; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; STARKSTEIN SE, 1994, NEUROLOGY, V44, P515, DOI 10.1212/WNL.44.3_Part_1.515; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Yin SF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07309; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	69	13	13	0	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 22	2016	10								48	10.3389/fnbeh.2016.00048			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DH1TR	WOS:000372568300001	27047353	Green Published, gold			2022-02-06	
J	Murugan, M; Santhakumar, V; Kannurpatti, SS				Murugan, Madhuvika; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Facilitating Mitochondria! Calcium Uptake Improves Activation-Induced Cerebral Blood Flow and Behavior after mTBI	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						TBI; mitochondria; CBF; dietary; calcium uniporter; kaempferol; whisker barrel; oxidative metabolism	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION MODEL; RAT BARREL CORTEX; NEURONAL-ACTIVITY; PLANT FLAVONOIDS; NEGATIVE BOLD; CBF RESPONSE; KAEMPFEROL; INCREASES; FMRI	Mild to moderate traumatic brain injury (mTBI) leads to secondary neuronal loss via excitotoxic mechanisms, including mitochondria' Ca2+ overload. However, in the surviving cellular population, mitochondrial Ca2+ influx, and oxidative metabolism are diminished leading to suboptimal neuronal circuit activity and poor prognosis. Hence we tested the impact of boosting neuronal electrical activity and oxidative metabolism by facilitating mitochondrial Ca2+ uptake in a rat model of mTBI. In developing rats (P25-P26) sustaining an mTBI, we demonstrate post-traumatic changes in cerebral blood flow (CBF) in the sensorimotor cortex in response to whisker stimulation compared to sham using functional Laser Doppler Imaging (fLDI) at adulthood (P67-P73). Compared to sham, whisker stimulation-evoked positive CBF responses decreased while negative CBF responses increased in the mTBI animals. The spatiotemporal CBF changes representing underlying neuronal activity suggested profound changes to neurovascular activity after mTBI. Behavioral assessment of the same cohort of animals prior to fLDI showed that mTBI resulted in persistent contralateral sensorimotor behavioral deficit along with ipsilateral neuronal loss compared to sham. Treating mTBI rats with Kaempferol, a dietary flavonol compound that enhanced mitochondrial Ca2+ uptake, eliminated the inter-hemispheric asymmetry in the whisker stimulation-induced positive CBF responses and the ipsilateral negative CBF responses otherwise observed in the untreated and vehicle-treated mTBI animals in adulthood. Kaempferol also improved somatosensory behavioral measures compared to untreated and vehicle treated mTBI animals without augmenting post-injury neuronal loss. The results indicate that reduced mitochondria' Ca2+ uptake in the surviving populations affect post-traumatic neural activation leading to persistent behavioral deficits. Improvement in sensorimotor behavior and spatiotemporal neurovascular activity following kaempferol treatment suggests that facilitation of mitochondria' Ca2+ uptake in the early window after injury may sustain optimal neural activity and metabolism and contribute to improved function of the surviving cellular populations after mTBI.	[Murugan, Madhuvika; Kannurpatti, Sridhar S.] Rutgers New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA		Kannurpatti, SS (corresponding author), Rutgers New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@njms.rutgers.edu	Murugan, Madhuvika/AAZ-8533-2020; Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Murugan, Madhuvika/0000-0002-0706-0730	New Jersey Commission for Brain Injury Research [CBIR12-PII.028]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	The study was supported by the grant from the New Jersey Commission for Brain Injury Research, CBIR12-PII.028 (SK).	Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Barve A, 2009, BIOPHARM DRUG DISPOS, V30, P356, DOI 10.1002/bdd.677; Calderon-Cortes E, 2008, MITOCHONDRION, V8, P262, DOI 10.1016/j.mito.2008.04.005; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dowling JL, 1996, J NEUROSCI METH, V66, P113, DOI 10.1016/0165-0270(96)00007-6; DuPont MS, 2004, EUR J CLIN NUTR, V58, P947, DOI 10.1038/sj.ejcn.1601916; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2006, BRAIN RES, V1089, P135, DOI 10.1016/j.brainres.2006.02.114; Kannurpatti SS, 2011, BRAIN RES, V1417, P16, DOI 10.1016/j.brainres.2011.08.026; Kannurpatti SS, 2004, NEUROCHEM INT, V44, P361, DOI 10.1016/S0197-0186(03)00164-5; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lagoa R, 2009, J NEUROCHEM, V111, P473, DOI 10.1111/j.1471-4159.2009.06331.x; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Liu RN, 2006, BIOMED CHROMATOGR, V20, P1178, DOI 10.1002/bmc.675; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Mathiesen C, 2011, J NEUROSCI, V31, P18327, DOI 10.1523/JNEUROSCI.4526-11.2011; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Middleton E, 2000, PHARMACOL REV, V52, P673; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shih TY, 2013, AAPS J, V15, P753, DOI 10.1208/s12248-013-9490-6; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Truong TK, 2009, NEUROIMAGE, V47, P65, DOI 10.1016/j.neuroimage.2009.04.045; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vissiennon C, 2012, J NUTR BIOCHEM, V23, P733, DOI 10.1016/j.jnutbio.2011.03.017; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805	59	13	13	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5137			FRONT SYST NEUROSCI	Front. Syst. Neurosci.	MAR 8	2016	10									10.3389/fnsys.2016.00019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF7XH	WOS:000371570600002	27013987	gold, Green Published			2022-02-06	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			"I won't be around forever": Understanding the decision-making experiences of adults with severe TBI and their parents	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Qualitative; Decision making; Parents; Caregivers; Brain injury	TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL DISTRESS; FAMILY CAREGIVERS; SOCIAL SUPPORT; OLDER PARENTS; FOLLOW-UP; CARERS; REHABILITATION; DISABILITIES; PREDICTORS	There is growing recognition of the right of all individuals, including those with cognitive impairment, to make decisions about their own lives. However, little is known about how the process of decision making is experienced after severe traumatic brain injury (TBI). This study used constructivist grounded theory to explore processes used by adults with severe TBI and their parents in making decisions about life after injury. Data consisted of 18 individual, in-depth interviews with four dyads (consisting of an individual with severe TBI and his or her parent). The overlying construct emerging from the data was a process of reimagining the future, which influenced how participants approached and participated in making decisions. In line with this construct, two central themes described processes of joint decision making within parent-adult child relationships after severe TBI over time: (1) making decisions with parental support, and (2) reducing parental involvement. These findings emphasise the complexity of supporting decision making after injury, and illustrate that both parents and their adult children with TBI use explicit and implicit strategies to facilitate increased participation in making decisions. This study also underscores the need for brain injury clinicians to consider the needs of parents who find themselves in this role.	[Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Fac Hlth Sci, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Melbourne, Vic, Australia; [Bigby, Christine] La Trobe Univ, Fac Hlth Sci, Dept Social Work & Social Policy, Bundoora, Vic 3086, Australia		Knox, L (corresponding author), La Trobe Univ, Fac Hlth Sci, Dept Human Commun Sci, Bundoora, Vic 3086, Australia.	l.knox@latrobe.edu.au	Knox, Lucy/E-8642-2013; bigby, Christine/I-8526-2015	Knox, Lucy/0000-0001-8331-6032; bigby, Christine/0000-0001-7001-8976; Douglas, Jacinta/0000-0003-0940-6624	University postgraduate scholarship; Victorian Brain Injury Recovery Association & East Kew Branch of the Community Bendigo Bank Research Scholarship	Sincere thanks are extended to the participants of this research who generously shared their experiences. This research was supported by a University postgraduate scholarship and Victorian Brain Injury Recovery Association & East Kew Branch of the Community Bendigo Bank Research Scholarship awarded to the first author.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Andreoli A., 2010, THESIS; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Bigby C., 2000, MOVING PARENTS PLANN; Bigby C, 1996, J INTELLECT DEV DIS, V21, P295, DOI 10.1080/13668259600033211; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Cairns D, 2013, BRIT J LEARN DISABIL, V41, P73, DOI 10.1111/j.1468-3156.2012.00729.x; Carson P, 1993, J Neurosci Nurs, V25, P165; Charmaz K., 2014, BROKERAGE CLOSURE IN; Charmaz K., 2008, HDB EMERGENT METHODS, P155; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corbin J, 2003, QUAL INQ, V9, P335, DOI 10.1177/1077800403009003001; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crotty M., 1998, FDN SOCIAL RES MEANI; Curry E. M., 2006, THESIS; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Grbich C., 2007, QUALITATIVE DATA ANA; Hunt MR, 2011, DISABIL REHABIL, V33, P961, DOI 10.3109/09638288.2010.515703; Ishikawa F., 2009, J NEUROSCIENCE NURSI, V41, P277, DOI [10.1097/JNN.0b013e3181b2c73c, DOI 10.1097/JNN.0B013E3181B2C73C]; Jones L, 2013, CLIN REHABIL, V27, P272, DOI 10.1177/0269215512455532; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Knox L., BRAIN INJUR IN PRESS; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Koepke S, 2012, DEV REV, V32, P67, DOI 10.1016/j.dr.2012.01.001; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Lunsky Y, 2014, J POLICY PRACT INTEL, V11, P8, DOI 10.1111/jppi.12068; Martin W, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8007; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; ROLLAND JS, 1987, FAM PROCESS, V26, P203, DOI 10.1111/j.1545-5300.1987.00203.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schipper K, 2011, NURS ETHICS, V18, P526, DOI 10.1177/0969733011403554; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Tabata B. J. G., 1998, THESIS; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tweed A., 2012, QUALITATIVE RES METH, P131; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Weeks LE, 2009, J POLICY PRACT INTEL, V6, P180, DOI 10.1111/j.1741-1130.2009.00222.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; Wongvatunyu S, 2008, J FAM NURS, V14, P314, DOI 10.1177/1074840708321473; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111	67	13	13	2	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 3	2016	26	2					236	260		10.1080/09602011.2015.1019519			25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DA5AT	WOS:000367815200004	25751119				2022-02-06	
J	Gorman, S; Barnes, MA; Swank, PR; Prasad, M; Cox, CS; Ewing-Cobbs, L				Gorman, Stephanie; Barnes, Marcia A.; Swank, Paul R.; Prasad, Mary; Cox, Charles S., Jr.; Ewing-Cobbs, Linda			Does Processing Speed Mediate the Effect of Pediatric Traumatic Brain Injury on Working Memory?	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; working memory; processing speed; outcome; mediation model	SHORT-TERM-MEMORY; ATTENTIONAL SKILLS; SELECTIVE METAANALYSIS; FLUID INTELLIGENCE; EXECUTIVE FUNCTION; HEAD-INJURY; CHILDREN; CHILDHOOD; RECOVERY; SPAN	Objective: Processing speed (PS) and working memory (WM), core abilities that support learning, are vulnerable to disruption following traumatic brain injury (TBI). Developmental increases in WM are related to age-related changes in PS. The purpose of this study was to investigate whether WM deficits in children with TBI are mediated by PS. Method: The performance of children with complicated mild, moderate, and severe TBI (n = 77) was examined relative to an orthopedic injury (n = 30) and a healthy comparison group (n = 40) an average of 4 years after injury (range 8 months to 12 years). Coding was utilized as a measure of PS, while the WM measures included complex verbal and visual-spatial span tasks with parallel processing requirements. Mediation analysis examined whether TBI might have an indirect effect on WM through PS. Results: Children in the TBI group performed more poorly than the combined comparison groups on coding and visual-spatial WM. Verbal WM scores were lower in TBI and the healthy comparison relative to the orthopedic group. TBI severity group differences were found on coding, but not WM measures. The relation between coding and both the WM tasks was similar. Bootstrap regression analyses suggested that PS, as measured by coding, might partially mediate the effect of group performance on WM. Conclusions: TBI disrupts core PS and WM abilities that scaffold more complex abilities. Importantly, slowed PS was associated with WM deficits commonly identified following pediatric TBI. Implications of our findings regarding the relation between PS and WM may suggest interventions for children and adolescents following TBI.	[Gorman, Stephanie] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Barnes, Marcia A.; Prasad, Mary; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA; [Barnes, Marcia A.; Prasad, Mary; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.; Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This manuscript was supported by Grant Number R01NS046308 from the National Institute of Neurological Disorders and Stroke to Dr. Linda Ewing-Cobbs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Baddeley A.D., 1986, WORKING MEMORY; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; CASE R, 1982, J EXP CHILD PSYCHOL, V33, P386, DOI 10.1016/0022-0965(82)90054-6; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Chiaravalloti ND, 2003, J CLIN EXP NEUROPSYC, V25, P489, DOI 10.1076/jcen.25.4.489.13878; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Chuah YML, 1999, J EXP CHILD PSYCHOL, V73, P7, DOI 10.1006/jecp.1999.2493; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cornoldi C, 2001, CHILD NEUROPSYCHOL, V7, P230, DOI 10.1076/chin.7.4.230.8735; D'Amico A, 2005, LEARN INDIVID DIFFER, V15, P189, DOI 10.1016/j.lindif.2005.01.002; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Beni R, 1998, Q J EXP PSYCHOL-A, V51, P305, DOI 10.1080/713755761; Dennis M., 2006, COGNITIVE RESERVE TH, P53; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hitch GJ, 2001, J EXP PSYCHOL GEN, V130, P184, DOI 10.1037//0096-3445.130.2.184; HULME C, 1984, J EXP CHILD PSYCHOL, V38, P241, DOI 10.1016/0022-0965(84)90124-3; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KAIL R, 1994, J EXP CHILD PSYCHOL, V57, P281, DOI 10.1006/jecp.1994.1013; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Mulder H, 2011, J INT NEUROPSYCH SOC, V17, P445, DOI 10.1017/S1355617711000373; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Passolunghi MC, 2008, CHILD NEUROPSYCHOL, V14, P387, DOI 10.1080/09297040701566662; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raghubar KP, 2013, J INT NEUROPSYCH SOC, V19, P254, DOI 10.1017/S1355617712001312; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; REUHKALA M, 2001, EDUC PSYCHOL-US, V21, P387, DOI DOI 10.1080/01443410120090786; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; SIEGEL LS, 1994, INT J BEHAV DEV, P109; Swanson HL, 2006, REV EDUC RES, V76, P249, DOI 10.3102/00346543076002249; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Towse JN, 1998, J MEM LANG, V39, P195, DOI 10.1006/jmla.1998.2574; TOWSE JN, 1995, Q J EXP PSYCHOL-A, V48, P108, DOI 10.1080/14640749508401379; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; Wass SV, 2012, DEV REV, V32, P360, DOI 10.1016/j.dr.2012.07.001; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	83	13	13	0	20	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2016	30	3					263	273		10.1037/neu0000214			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DF0ZS	WOS:000371068800001	26214659	Bronze, Green Accepted			2022-02-06	
J	Guernsey, DT; Leder, A; Yao, S				Guernsey, David T., III; Leder, Adena; Yao, Sheldon			Resolution of Concussion Symptoms After Osteopathic Manipulative Treatment: A Case Report	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; BALANCE	A concussion is the result of a biomechanical force directed toward the head, causing neurologic dysfunction. The inflammatory response and the production of reactive oxygen species are proposed mechanisms for the symptoms and long-term sequelae of concussion. Osteopathic manipulative treatment (OMT) may help reduce inflammation by improving glymphatic flow. The authors describe the effect of OMT on a patient with mild concussion symptoms, including nausea, dizziness, tinnitus, and imbalance. The patient was evaluated with the Sensory Organization Test before and after undergoing a 25-minute session of OMT. After the session, the patient reported resolution of symptoms, and his sensory organization test score improved by 6 points. The role of OMT must be further investigated as an essential and cost-effective tool in the management of concussions.	[Guernsey, David T., III; Leder, Adena; Yao, Sheldon] New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA		Yao, S (corresponding author), New York Inst Technol, Dept Osteopath Manipulat Med, Coll Osteopath Med, Northern Blvd,POB 8000, Old Westbury, NY 11568 USA.	syao@nyit.edu					Anderson RE, 2006, HEADACHE, V46, P1273, DOI 10.1111/j.1526-4610.2006.00535.x; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bell JM, 2015, J HEAD TRAUMA REHAB, V30, P148, DOI 10.1097/HTR.0000000000000143; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Brolinson P Gunnar, 2014, Clin J Sport Med, V24, P89, DOI 10.1097/JSM.0000000000000062; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraix M, 2013, J AM OSTEOPATH ASSOC, V113, P394; Knott EM, 2005, J AM OSTEOPATH ASSOC, V105, P447; Kraus J. F., 1999, REHABILITATION ADULT, P3; Lopez D, 2011, J AM OSTEOPATH ASSOC, V111, P382, DOI 10.7556/jaoa.2011.111.6.382; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; MCLAIN RF, 1994, SPINE, V19, P495, DOI 10.1097/00007632-199403000-00001; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Sergueef N, 2002, ALTERN THER HEALTH M, V8, P74	21	13	13	0	6	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	MAR	2016	116	3					E13	E17		10.7556/jaoa.2016.036			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DT8NE	WOS:000381746700001	26927914				2022-02-06	
J	Schulz-Heik, RJ; Poole, JH; Dahdah, MN; Sullivan, C; Date, ES; Salerno, RM; Schwab, K; Harris, O				Schulz-Heik, R. Jay; Poole, John H.; Dahdah, Marie N.; Sullivan, Campbell; Date, Elaine S.; Salerno, Rose M.; Schwab, Karen; Harris, Odette			Long-term outcomes after moderate-to-severe traumatic brain injury among military veterans: Successes and challenges	BRAIN INJURY			English	Article						rehabilitation; Outcome; social reintegration; work; traumatic brain injury	HEAD TRAUMA; PREDICTION; LIFE; REHABILITATION; SATISFACTION; SYMPTOMS	Objective: To assess long-term outcomes after traumatic brain injury (TBI) among veterans and service members. Setting: Regional Veterans Affairs medical centre. Participants: One hundred and eighteen veterans and military personnel, aged 23-70 years (median = 35 years), 90% male, had moderate-to-severe TBI (82% in coma > 1 day, 85% amnesic > 7 days), followed by acute interdisciplinary rehabilitation 5-16 years ago (median = 8 years). Design: Cross-sectional analysis of live interviews conducted via telephone. Main measures: TBI follow-up interview (occupational, social, cognitive, neurologic and psychiatric ratings), Community Integration Questionnaire, Disability Rating Scale (four indices of independent function) and Satisfaction with Life Scale. Results: At follow-up, 52% of participants were working or attending school; 34% ended or began marriages after TBI, but the overall proportion married changed little. Finally, 22% were still moderately-to-severely disabled. However, 62% of participants judged themselves to be as satisfied or more satisfied with life than before injury. Injury severity, especially post-traumatic amnesia, was correlated with poorer outcomes in all functional domains. Conclusions: After moderate-severe TBI, most veterans assume productive roles and are satisfied with life. However, widespread difficulties and functional limitations persist. These findings suggest that veteran and military healthcare systems should continue periodic, comprehensive follow-up evaluations long after moderate-to-severe TBI.	[Schulz-Heik, R. Jay; Poole, John H.; Salerno, Rose M.; Harris, Odette] Def & Vet Brain Injury Ctr, 3801 Miranda Ave,PSC-117, Palo Alto, CA 94304 USA; [Dahdah, Marie N.] Baylor Inst Rehabil, Baylor Reg Med Ctr Plano, Plano, TX USA; [Sullivan, Campbell] Johns Hopkins Sch Med, Baltimore, MD USA; [Date, Elaine S.] Remedy Med Grp, Redwood City, CA USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Rockville, MD USA		Schulz-Heik, RJ (corresponding author), Def & Vet Brain Injury Ctr, 3801 Miranda Ave,PSC-117, Palo Alto, CA 94304 USA.	jay.schulzheik@gmail.com			Defense and Veterans Brain Injury Center, US Army Medical Research and Materiel Command (USAMRMC)	This material is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Materiel Command (USAMRMC). The authors report no conflicts of interest. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy or decision unless so designated by other official documentation.	Bradshaw D., 2008, REPORT SURG GEN TRAU; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Department of Defense, 2012, TRAUM BRAIN INJ SPEC; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2014, UNDERSTANDING SCORES; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Faul M, TRAUMATIC BRAIN INJU; Gray M, 2011, J TRAUMA, V71, P1465, DOI 10.1097/TA.0b013e31821f82f5; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Institute of Medicine, 2008, GULF WAR AND HLTH, V7; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kreider RM, 2011, NUMBER TIMING MARRIA; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Poole Jh, FEASIBILITY NEUROPSY; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sherer M, 1999, BRAIN INJURY, V13, P973; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	46	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					271	279		10.3109/02699052.2015.1113567			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900004	26853377				2022-02-06	
J	Tverdov, AH; McClure, KS; Brownsberger, MG; Armstrong, SL				Tverdov, Alison H.; McClure, Kelly S.; Brownsberger, Mary G.; Armstrong, Sharon Lee			Family needs at a post-acute rehabilitation setting and suggestions for supports	BRAIN INJURY			English	Article						ABI; Family members; distress; needs; obstacles	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; LARGE NONCLINICAL SAMPLE; SOCIAL SUPPORT; INTERVENTION IMPACT; NORMATIVE DATA; CAREGIVERS; DEPRESSION; QUALITY; MEMBERS	Objective: To explore the perceived needs, obstacles to services, psychological distress and social problem-solving abilities of family members of persons with ABI at a post-acute community-based brain injury rehabilitation facility and offer suggestions for methods of assessment and providing support. Participants: Twenty-nine family members who did not provide daily care, but were involved in the care process. Design: Participants completed self-report questionnaires including the FNQ:R, SOS, DASS-21, WHO-QOL BREF and SPSI:R-S. Results: Participants reported informational and professional needs as most met and involvement in care, instrumental support and emotional support as most unmet. Most were satisfied with the amount of professional help and services and had confidence in the quality of care. Nearly half of the family members felt there were few ABI-related resources in the community and one third were unaware of good ABI treatment resources in their community. Psychosocial functioning was generally average. Conclusion: Family members who do not provide daily care are still impacted by the neurobehavioural changes that progress throughout the long-term, post-acute community phase. This study offers suggestions regarding an effective methodology for assessing family needs and recommends accessible and practical supports.	[Tverdov, Alison H.; McClure, Kelly S.; Armstrong, Sharon Lee] La Salle Univ, Dept Psychol, 1900 W Olney Ave, Philadelphia, PA 19141 USA; [Brownsberger, Mary G.] Bancroft NeuroRehab, Plainsboro, NJ USA		Tverdov, AH (corresponding author), La Salle Univ, Dept Psychol, 1900 W Olney Ave, Philadelphia, PA 19141 USA.	alison.tverdov@outlook.com					[Anonymous], 2013, PLOS ONE; [Anonymous], 2000, FAM NEEDS QUEST; Bonomi AE, 2000, J CLIN EPIDEMIOL, V53, P1, DOI 10.1016/S0895-4356(99)00123-7; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Commission on Accreditation of Rehabilitation Facilities, 2011, MED REH STAND MAN, P109; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla TJ., 2013, PROBLEM SOLVING THER; Damianakis T, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000178, DOI 10.1097/HTR.0000000000000178.ACCESSED]; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, SERVICE OBSTACLES SC; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 2008, FAMILY NEEDS QUESTIO; Hayas CL, 2015, REHABIL PSYCHOL, V60, P295, DOI 10.1037/rep0000040; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Marwitz J, 1996, SERVICE OBSTACLES SC; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Smith GC, 2012, REHABIL PSYCHOL, V57, P196, DOI 10.1037/a0029587; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; World Health Organization, 1998, PROBL INV VIL ENC CO, P13	49	13	13	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					324	333		10.3109/02699052.2015.1113566			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900010	26853184				2022-02-06	
J	Echemendia, RJ; Bruce, JM; Meeuwisse, W; Comper, P; Aubry, M; Hutchison, M				Echemendia, Ruben J.; Bruce, Jared M.; Meeuwisse, Willem; Comper, Paul; Aubry, Mark; Hutchison, Michael			Long-term reliability of ImPACT in professional ice hockey	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; ImPACT; reliability	TEST-RETEST RELIABILITY; SPORT-RELATED CONCUSSION; COUNSELING PSYCHOMETRIC ISSUES; REDICK CLINICAL UTILITY; NORMATIVE DATA; MANAGEMENT; MAYERS	Objective: This study sought to assess the test-retest reliability of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) across 2-4year time intervals and evaluate the utility of a newly proposed two-factor (Speed/Memory) model of ImPACT across multiple language versions. Method: Test-retest data were collected from non-concussed National Hockey League (NHL) players across 2-, 3-, and 4-year time intervals. The two-factor model was examined using different language versions (English, French, Czech, Swedish) of the test using a one-year interval, and across 2-4year intervals using the English version of the test. Results: The two-factor Speed index improved reliability across multiple language versions of ImPACT. The Memory factor also improved but reliability remained below the traditional cutoff of .70 for use in clinical decision-making. ImPACT reliabilities remained low (below .70) regardless of whether the four-composite or the two-factor model was used across 2-, 3-, and 4-year time intervals. Conclusions: The two-factor approach increased ImPACT's one-year reliability over the traditional four-composite model among NHL players. The increased stability in test scores improves the test's ability to detect cognitive changes following injury, which increases the diagnostic utility of the test and allows for better return to play decision-making by reducing the risk of exposing an athlete to additional trauma while the brain may be at a heightened vulnerability to such trauma. Although the Speed Index increases the clinical utility of the test, the stability of the Memory index remains low. Irrespective of whether the two-factor or traditional four-composite approach is used, these data suggest that new baselines should occur on a yearly basis in order to maximize clinical utility.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA; [Echemendia, Ruben J.; Bruce, Jared M.] Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA; [Meeuwisse, Willem] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Comper, Paul] Toronto Rehabil Inst, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Hutchison, Michael] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Echemendia, RJ (corresponding author), Psychol & Neurobehav Associates Inc, State Coll, PA USA.; Echemendia, RJ (corresponding author), Univ Missouri Kansas City, Dept Psychol, Kansas City, MO 64110 USA.	rechemendia@comcast.net	Echemendia, Ruben/R-6939-2019				Andrews G, 1994, MEASUREMENT CONSUMER; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J., 2013, CLIN NEUROPSYCHOL, P1; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P435, DOI 10.1080/13803395.2012.667790; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Spreen E., 2006, COMPENDIUM NEUROPSYC, P1; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	25	13	13	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2016	30	2					311	320		10.1080/13854046.2016.1158320			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DI3LQ	WOS:000373400600010	26999705				2022-02-06	
J	Allitt, BJ; Johnstone, VPA; Richards, K; Yan, EB; Rajan, R				Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina; Yan, Edwin B.; Rajan, Ramesh			Progesterone Exacerbates Short-Term Effects of Traumatic Brain Injury on Supragranular Responses in Sensory Cortex and Over-Excites Infragranular Responses in the Long Term	JOURNAL OF NEUROTRAUMA			English	Article						diffuse TBI; electrophysiology; neuronal encoding; progesterone; sensory cortex	RAT BARREL CORTEX; GABA-A RECEPTOR; SPREADING DEPRESSION; COGNITIVE DEFICITS; PREFRONTAL CORTEX; CLINICAL-TRIAL; AXONAL INJURY; CELL-DEATH; ALLOPREGNANOLONE; DYSFUNCTION	Progesterone (P4) has been suggested as a neuroprotective agent for traumatic brain injury (TBI) because it ameliorates many post-TBI sequelae. We examined the effects of P4 treatment on the short-term (4 days post-TBI) and long-term (8 weeks post-TBI) aftermath on neuronal processing in the rodent sensory cortex of impact acceleration-induced diffuse TBI. We have previously reported that in sensory cortex, diffuse TBI induces a short-term hypoexcitation that is greatest in the supragranular layers and decreases with depth, but a long-term hyperexcitation that is exclusive to the supragranular layers. Now, adult male TBI-treated rats administered P4 showed, in the short term, even greater suppression in neural responses in supragranular layers but a reversal of the TBI-induced suppression in granular and infragranular layers. In long-term TBI there were only inconsistent effects of P4 on the TBI-induced hyperexcitation in supragranular responses but infragranular responses, which were not affected by TBI alone, were elevated by P4 treatment. Intriguingly, the effects in the injured brain were almost identical to P4 effects in the normal brain, as seen in sham control animals treated with P4: in the short term, P4 effects in the normal brain were identical to those exercised in the injured brain and in the long term, P4 effects in the normal brain were rather similar to what was seen in the TBI brain. Overall, these results provide no support for any protective effects of P4 treatment on neuronal encoding in diffuse TBI, and this was reflected in sensorimotor and other behavior tasks also tested here. Additionally, the effects suggest that mechanisms used for P4 effects in the normal brain are also intact in the injured brain.	[Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Johnstone, Victoria P. A.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia		Allitt, BJ (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	Ben.allitt@monash.edu	rajan, ramesh/L-4842-2019	Richards, Katrina/0000-0002-0065-1255; Dell, Katrina/0000-0002-3552-6411; Rajan, Ramesh/0000-0001-9862-0520			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Johnstone V. P., 2015, J NEUROTRAUMA; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; Larkum ME, 2013, NAT NEUROSCI, V16, P114, DOI 10.1038/nn.3317; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Ma JP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen C. C., 2009, ENCY NEUROSCIENCE, P41; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Salin P, 1995, J NEUROSCI, V15, P8234; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH SS, 1987, BRAIN RES BULL, V18, P739, DOI 10.1016/0361-9230(87)90209-7; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	99	13	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					375	389		10.1089/neu.2015.3946			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800007	26258958				2022-02-06	
J	Bachstetter, AD; Zhou, ZQ; Rowe, RK; Xing, B; Goulding, DS; Conley, AN; Sompol, P; Meier, S; Abisambra, JF; Lifshitz, J; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Zhou, Zhengqiu; Rowe, Rachel K.; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Lifshitz, Jonathan; Watterson, D. Martin; Van Eldik, Linda J.			MW151 Inhibited IL-1 beta Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses	PLOS ONE			English	Article							ATTENUATES SYNAPTIC DYSFUNCTION; CYTOKINE UP-REGULATION; PROINFLAMMATORY CYTOKINE; ALZHEIMERS-DISEASE; MOUSE MODEL; GLIAL ACTIVATION; P38-ALPHA MAPK; INFLAMMATION; NEUROINFLAMMATION; PROGRESSION	A prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflammatory cytokine surge can attenuate the progressive pathology. However, other post-injury neuroinflammatory responses are key to endogenous recovery responses. Therefore, it is critical that pharmacological attenuation of detrimental or dysregulated neuroinflammatory processes avoid pan-suppression of inflammation. MW151 is a CNS-penetrant, small molecule experimental therapeutic that restores injuryor disease-induced overproduction of proinflammatory cytokines towards homeostasis without immunosuppression. Post-injury administration of MW151 in a closed head injury model of mild TBI suppressed acute cytokine up-regulation and downstream cognitive impairment. Here, we report results from a diffuse brain injury model in mice using midline fluid percussion. Low dose (0.5-5.0 mg/kg) administration of MW151 suppresses interleukin-1 beta (IL-1 beta) levels in the cortex while sparing reactive microglia and astrocyte responses. To probe molecular mechanisms, we used live cell imaging of the BV-2 microglia cell line to demonstrate that MW151 does not affect proliferation, migration, or phagocytosis of the cells. Our results provide insight into the roles of glial responses to brain injury and indicate the feasibility of using appropriate dosing for selective therapeutic modulation of injurious IL-1 beta increases while sparing other glial responses to injury.	[Bachstetter, Adam D.; Zhou, Zhengqiu; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Abisambra, Jose F.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Watterson, D. Martin] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA		Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	Abisambra, Jose/V-6860-2019; Abisambra, Joe/AAP-3269-2020	Abisambra, Jose/0000-0001-6341-679X; Meier, Shelby/0000-0003-1946-9004; Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866; Rowe, Rachel/0000-0002-9034-3159	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K99 AG044445, U01 AG050636]; Kentucky Spinal Cord and Head Injury Research Trust [12-20A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG050636, U01AG043415, K99AG044445] Funding Source: NIH RePORTER	This research was supported in part by NIH/NIA (K99 AG044445 to ADB, and U01 AG050636 to LVE and DMW), and the Kentucky Spinal Cord and Head Injury Research Trust (12-20A to LVE).	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Eakin K, 2015, FRONTIERS NEUROENGIN; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karpus WJ, 2008, J NEUROIMMUNOL, V203, P73, DOI 10.1016/j.jneuroim.2008.06.039; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranaivo HR, 2006, J NEUROSCI, V26, P662, DOI 10.1523/JNEUROSCI.4652-05.2006; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Roy SM, 2015, ACS CHEM NEUROSCI, V6, P666, DOI 10.1021/acschemneuro.5b00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Watterson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066226; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149451	10.1371/journal.pone.0149451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	WOS:000370054100159	26871438	Green Submitted, Green Published, gold			2022-02-06	
J	Lynall, RC; Kerr, ZY; Parr, MS; Hackney, AC; Mihalik, JP				Lynall, Robert C.; Kerr, Zachary Y.; Parr, Matthew S.; Hackney, Anthony C.; Mihalik, Jason P.			Division I College Football Concussion Rates Are Higher at Higher Altitudes	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						elevation; mild traumatic brain injury; sports epidemiology; sports injury	INJURY SURVEILLANCE SYSTEM; CONSENSUS STATEMENT; POSTURAL STABILITY; MOUNTAIN-SICKNESS; MOUTHGUARDS; SENSITIVITY; DEFICITS; IMPACTS; BATTERY; PLAYERS	STUDY DESIGN: Retrospective cohort. BACKGROUND: Participating in sports at high altitude may have a protective effect on the brain, according to research studies. Research using validated data-collection methods in a previously unexplored cohort may better estimate the association between concussion injury risk and altitude. OBJECTIVES: To determine the association between concussion rates and altitude during college football games. METHODS: Athletic trainers from 21 Division I football programs provided exposure and injury data to the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) from the 2009-2010 to 2013-2014 academic years. The elevation of each stadium was determined. Concussion rates per 1000 athlete-exposures (AEs) were compared in 2 ways, based on the sample of stadium elevations: (1) median split (elevation higher than 178 m or lower than 178 m), and (2) quartile split. Rate ratios (RRs), rate differences, and 95% confidence intervals (CIs) were computed. RESULTS: One hundred sixty-nine concussions were reported over 49 040 AEs (3.45/1000 AEs). Using the median split, the concussion rate above 178 m (RR = 4.18/1000 AEs) was 1.47 times the concussion rate below 178 m (RR = 2.84/1000 AEs; 95% CI: 1.09, 2.00; P =.01). The concussion rate at the highest altitude quartile (higher than 284 m; RR = 5.01/1000 AEs) was 1.67 times greater than the concussion rate at the lowest altitude quartile (lower than 43 m; RR = 3.00/1000 AEs; 95% CI: 1.13, 2.48; P =.01). CONCLUSION: College football game concussion rates appear to increase at higher altitudes. The clinical significance of this relatively small increase is unknown. Future research should explore potential physiologic underpinnings associated with concussion risk at relatively higher and lower altitudes.	[Lynall, Robert C.; Parr, Matthew S.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Lynall, Robert C.; Hackney, Anthony C.; Mihalik, Jason P.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Hackney, Anthony C.] Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC USA; [Hackney, Anthony C.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Mihalik, Jason P.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA		Lynall, RC (corresponding author), 2207 Stallings Evans Sports Med Ctr, Campus Box 8700, Chapel Hill, NC 27599 USA.	rlynall@live.unc.edu	Zavorsky, Gerald S./I-7753-2013; Lynall, Robert/M-2888-2014	Zavorsky, Gerald S./0000-0002-4473-1601; Lynall, Robert/0000-0002-0785-6640; Kerr, Zachary/0000-0003-1423-1259	NCAA	The Research Review Board of the National Collegiate Athletic Association (NCAA) approved the Injury Surveillance Program and the University of North Carolina-Chapel Hill Institutional Review Board deemed the additional altitude analyses exempt. The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA. The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Council of Ivy Group Presidents, 2011, IVY MANUAL 2011 2012; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Lewis MD, 2011, MIL MED, V176, P1120, DOI 10.7205/MILMED-D-10-00466; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; National Collegiate Athletic Association, FOOTBALL PRACTICE GU; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROSS RT, 1985, LANCET, V1, P990; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Weihe W H, 1966, Schweiz Z Sportmed, V14, P177; Yarnell PR, 2000, SEMIN NEUROL, V20, P209, DOI 10.1055/s-2000-9830; Zavorsky GS, 2014, J ORTHOP SPORT PHYS, V44, P458, DOI 10.2519/jospt.2014.0201	30	13	13	0	10	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	FEB	2016	46	2					96	103		10.2519/jospt.2016.6315			8	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	DC3NN	WOS:000369126100008	26755407				2022-02-06	
J	You, WD; Tang, QL; Wang, L; Lei, J; Feng, JF; Mao, Q; Gao, GY; Jiang, JY				You, Wen-Dong; Tang, Qi-Lin; Wang, Lei; Lei, Jin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao			Alteration of microRNA expression in cerebrospinal fluid of unconscious patients after traumatic brain injury and a bioinformatic analysis of related single nucleotide polymorphisms	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						microRNAs; Polymorphism; Single nucleotide; Computational biology; Brain injuries; Coma		Purpose: It is becoming increasingly clear that genetic factors play a role in traumatic brain injury (TBI), whether in modifying clinical outcome after TBI or determining susceptibility to it. MicroRNAs are small RNA molecules involved in various pathophysiological processes by repressing target genes at the post-transcriptional level, and TBI alters microRNA expression levels in the hippocampus and cortex. This study was designed to detect differentially expressed microRNAs in the cerebrospinal fluid (CSF) of TBI patients remaining unconscious two weeks after initial injury and to explore related single nucleotide polymorphisms (SNPs). Methods: We used a microarray platform to detect differential microRNA expression levels in CSF samples from patients with post-traumatic coma compared with samples from controls. A bioinformatic scan was performed covering microRNA gene promoter regions to identify potential functional SNPs. Results: Totally 26 coma patients and 21 controls were included in this study, with similar distribution of age and gender between the two groups. Microarray showed that fourteen microRNAs were differentially expressed, ten at higher and four at lower expression levels in CSF of traumatic coma patients compared with controls (p < 0.05). One SNP (rs11851174 allele: C/T) was identified in the motif area of the microRNA hsa-miR-431-3P gene promoter region. Conclusion: The altered microRNA expression levels in CSF after brain injury together with SNP identified within the microRNA gene promoter area provide a new perspective on the mechanism of impaired consciousness after TBI. Further studies are needed to explore the association between the specific microRNAs and their related SNPs with post-traumatic unconsciousness. (c) 2016 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[You, Wen-Dong; Tang, Qi-Lin; Wang, Lei; Lei, Jin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	gao3@sina.com					Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043939; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Chu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089930; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Dlouhy BJ, 2012, NEW ENGL J MED, V366, P2427, DOI 10.1056/NEJMc1204669; Edlow BL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0375-y; Feng W, 2011, SCI CHINA LIFE SCI, V54, P1103, DOI 10.1007/s11427-011-4249-8; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kashyap N, 2013, MOL BIOSYST, V9, P1919, DOI 10.1039/c3mb70043g; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Miao JL, 2013, TUMOR BIOL, V34, P2093, DOI 10.1007/s13277-013-0940-7; Estal RM, 2013, BREAST CANCER RES TR, V142, P19, DOI 10.1007/s10549-013-2723-7; Patel D, 2013, SURGERY, V154, P1224, DOI 10.1016/j.surg.2013.06.022; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tanaka T, 2014, INT J ONCOL, V44, P1685, DOI 10.3892/ijo.2014.2317; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; VILMING EB, 2014, BMC CANC, V0014; Xu HD, 2014, CELL BIOCHEM BIOPHYS, V69, P319, DOI 10.1007/s12013-013-9801-7; Zhao H, 2014, BIOCHEM J, V460, P117, DOI 10.1042/BJ20131535	32	13	16	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2016	19	1					11	15		10.1016/j.cjtee.2016.01.004			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1OQ	WOS:000442099200004	27033266	Green Published, gold			2022-02-06	
J	Willyerd, FA; Empey, PE; Philbrick, A; Ikonomovic, MD; Puccio, AM; Kochanek, PM; Okonkwo, DO; Clark, RSB				Willyerd, F. Anthony; Empey, Philip E.; Philbrick, Ashley; Ikonomovic, Milos D.; Puccio, Ava M.; Kochanek, Patrick M.; Okonkwo, David O.; Clark, Robert S. B.			Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans	JOURNAL OF NEUROTRAUMA			English	Article						ABCB1; ABCC1; MDR1; MRP1; multidrug resistance protein; multidrug resistance-associated protein; p-glycoprotein	SEVERE HEAD-INJURY; RESISTANCE-RELATED PROTEINS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; EFFLUX TRANSPORTERS; DRUG-TRANSPORTER; ABC TRANSPORTERS; HIT-I; BARRIER; PROTEOLYSIS	Adenosine triphosphate-binding cassette (ABC) transport proteins ABCC1 and ABCB1 (also known as multidrug resistance-associated protein 1 and p-glycoprotein, respectively), are key membrane efflux transporters of drugs and endogenous substrates, including in the brain. The impact of traumatic brain injury (TBI) on ABCC1 and ABCB1 expression in humans is unknown. We hypothesized that ABCC1 and ABCB1 expression would be altered in brain tissue from patients acutely after severe TBI. Archived TBI samples (n=10) from our Brain Trauma Research Center and control samples (n=7) from our Alzheimer Disease Research Center were obtained under Institutional Review Board approval. Protein was extracted from fresh frozen cortical brain tissue for Western blot analysis and sections were obtained from fixed cortical tissue for immunohistochemistry. Relative abundance of ABCC1 was increased in samples from TBI versus controls (2.8 +/- 2.5 fold; p=0.005). ABCC1 immunohistochemistry was consistent with Western blot data, with increased immunoreactivity in cerebral blood vessel walls, as well as cells with the morphological appearance of neurons and glia in TBI versus controls. Relative abundance of ABCB1 was similar between TBI and controls (p=0.76), and ABCB1 immunoreactivity was primarily associated with cerebral blood vessels in both groups. These human data show that TBI increases ABCC1 expression in the brain, consistent with possible implications for both patients receiving pharmacological inhibitors and/or substrates of ABCC1 after TBI.	[Willyerd, F. Anthony; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Empey, Philip E.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Empey, Philip E.; Clark, Robert S. B.] UPMC, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Empey, Philip E.; Clark, Robert S. B.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Empey, Philip E.; Philbrick, Ashley] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Willyerd, F. Anthony] Phoenix Childrens Childrens Hosp, Crit Care, Phoenix, AZ USA; [Willyerd, F. Anthony] Univ Arizona, Phoenix, AZ USA		Clark, RSB (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	clarkrs@ccm.upmc.edu	Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS069247, P50 NS30318, AG05133]; NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000146]; Children's Hospital of Pittsburgh of UPMC Scientific Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS069247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER	This work was supported by NIH grants R01 NS069247 (RSBC, PEE), P50 NS30318 (DOO, AMP, PMK, RSBC), and AG05133 (the University of Pittsburgh ADRC), and NCATS KL2 TR000146 (PEE); and the Children's Hospital of Pittsburgh of UPMC Scientific Program. We would like to thank Professor Piet Borst (Netherlands Cancer Institute) for generously providing the overexpressing cell lines.	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Aronica E, 2004, EPILEPSIA, V45, P441, DOI 10.1111/j.0013-9580.2004.57703.x; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bendayan R, 2002, MICROSC RES TECHNIQ, V57, P365, DOI 10.1002/jemt.10090; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Cascorbi I, 2013, PHARMACOGENOMICS, V14, P485, DOI [10.2217/PGS.13.18, 10.2217/pgs.13.18]; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cousar JL, 2013, NEUROCRIT CARE, V19, P192, DOI 10.1007/s12028-013-9881-7; Daood M, 2008, NEUROPEDIATRICS, V39, P211, DOI 10.1055/s-0028-1103272; Decory HH, 2001, DRUG METAB DISPOS, V29, P1256; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; Faul M, 2010, TRAUMATIC BRAIN INJU; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1995, J NEUROSURG, V83, P942; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Nuti SL, 2002, J BIOL CHEM, V277, P29417, DOI 10.1074/jbc.M204054200; Ohkawa K, 1999, INT J ONCOL, V15, P677; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Potschka H, 2010, PHARMACOL THERAPEUT, V125, P118, DOI 10.1016/j.pharmthera.2009.10.004; Ren XQ, 2005, J BIOL CHEM, V280, P6231, DOI 10.1074/jbc.M409498200; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Silva R, 2015, PHARMACOL THERAPEUT, V149, P1, DOI 10.1016/j.pharmthera.2014.11.013; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Wijesuriya HC, 2010, BRAIN RES, V1358, P228, DOI 10.1016/j.brainres.2010.08.034; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	53	13	13	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					226	231		10.1089/neu.2015.3879			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800008	25891836	Green Published			2022-02-06	
J	Sigsbee, B; Bever, CT; Jones, LK				Sigsbee, Bruce; Bever, Christopher T., Jr.; Jones, Lyell K., Jr.			Practice improvement requires more than guidelines and quality measures	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; OF-CARE; ACUTE STROKE; ADHERENCE; EPILEPSY; OUTCOMES; INTERVENTION; INDICATORS; REGISTRIES; CHILDREN	Increasing emphasis on improving health care quality has led to a variety of programs that require neurologists to be familiar with the concept of systematic quality improvement. While they vary in extent, these quality improvement programs and their attendant costs now have implications for physician payment and certification. In response to these factors, the American Academy of Neurology is establishing a clinical quality data registry. This article reviews evidence demonstrating the ability of quality improvement initiatives to improve care, the role of clinical quality data registries in the identification and mitigation of gaps in care, and the principles to be considered in development of registry-based quality improvement programs. It addresses the key question: Is the effort worthwhile?	[Sigsbee, Bruce] Penobscot Bay Med Ctr, Rockport, ME 04856 USA; [Bever, Christopher T., Jr.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Jones, Lyell K., Jr.] Mayo Clin, Rochester, MN USA		Sigsbee, B (corresponding author), Penobscot Bay Med Ctr, Rockport, ME 04856 USA.	bsigsbee@aan.com		Jones, Lyell/0000-0002-5851-8705	Department of Veterans AffairsUS Department of Veterans Affairs	B. Sigsbee reports no disclosures relevant to the manuscript. C. Bever is an employee of and has merit award and center of excellence award support from the Department of Veterans Affairs, is a grantee of the of the National Multiple Sclerosis Society, and is a co-holder of a patent on the use of hematogenous stem cells for cell replacement and gene delivery therapy. He serves on the Quality and Safety Subcommittee and the Registry Work group of the American Academy of Neurology, and the program committees of the Paralyzed Veterans of America, the Consortium of MS Clinics, and the Americas Committee on Research and Treatment of MS. L. Jones reports no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Barr CJ, 2012, J ARTHROPLASTY, V27, P1766, DOI 10.1016/j.arth.2012.04.028; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Bickell NA, 2013, MED CARE, V51, pE35, DOI 10.1097/MLR.0b013e3182422f7b; Cherry DL, 2004, AM J MANAG CARE, V10, P553; Donaldson M.S., 2000, ERR IS HUMAN BUILDIN; Ellrodt AG, 2013, CIRCULATION, V128, P2447, DOI 10.1161/01.cir.0000435779.48007.5c; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fritz JM, 2007, MED CARE, V45, P973, DOI 10.1097/MLR.0b013e318070c6cd; Goodman MJ, 2012, INT J QUAL HEALTH C, V24, P293, DOI 10.1093/intqhc/mzs017; Hall BL, 2009, SURGERY, V145, P602, DOI 10.1016/j.surg.2009.03.002; Hixson ED, 2005, JT COMM J QUAL PATIE, V31, P447, DOI 10.1016/S1553-7250(05)31058-0; Hoyt DB, 2014, J PEDIATR SURG, V49, P25, DOI 10.1016/j.jpedsurg.2013.09.026; Kampman MT, 2005, EPILEPSIA, V46, P1286, DOI 10.1111/j.1528-1167.2005.04205.x; Koch CG, 2012, J AM COLL SURGEONS, V214, P798, DOI 10.1016/j.jamcollsurg.2011.12.037; Mays GP, TIERED PROVIDER NETW; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Rao SV, 2013, JACC-CARDIOVASC INTE, V6, P897, DOI 10.1016/j.jcin.2013.04.016; Reinke CE, 2013, DIS COLON RECTUM, V56, P638, DOI 10.1097/DCR.0b013e31827886db; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Rutten GM, 2010, PHYS THER, V90, P1111, DOI 10.2522/ptj.20090173; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Shah BR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001588; Siracusa CM, 2014, BMJ QUAL SAF, V23, P56, DOI 10.1136/bmjqs-2013-002361; Strasser DC, 2010, TOP STROKE REHABIL, V17, P282, DOI 10.1310/tsr1704-282; Swarztrauber K, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-26; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wasade VS, 2012, EPILEPSY BEHAV, V24, P468, DOI 10.1016/j.yebeh.2012.05.017; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403	31	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 12	2016	86	2					188	193		10.1212/WNL.0000000000002116			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB4AJ	WOS:000368454800014	26519541				2022-02-06	
J	Oyesanya, TO; Ward, EC				Oyesanya, Tolu O.; Ward, Earlise C.			Mental Health in Women With Traumatic Brain Injury: A Systematic Review on Depression and Hope	HEALTH CARE FOR WOMEN INTERNATIONAL			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; MAJOR DEPRESSION; MODERATE; OUTCOMES; EXPERIENCE; PREDICTORS; ROLES	The prevalence of traumatic brain injury (TBI) in women has recently increased from 25% to 40%. Current literature inadequately captures challenges women face after injury, including depression. The limited focus on depression is problematic as rates of depression are increasing simultaneously with rates of TBI. A disabling symptom of depression is lack of hope; thus, depression, comorbid with TBI, leads to disability among women. Unfortunately, depression and hope among women with TBI has yet to be systematically examined. The purpose of this systematic review is to examine and synthesize current literature focusing on women with TBI, comorbid with depression, and hope.	[Oyesanya, Tolu O.; Ward, Earlise C.] Univ Wisconsin, Sch Nursing, Madison, WI 53705 USA		Oyesanya, TO (corresponding author), Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA.	toyesanya@wisc.edu		Oyesanya, Tolu/0000-0001-8821-4510	NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This research was supported by NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant# R25GM083252.	Agency for Healthcare Research and Quality, 2011, TRAUM BRIAN INJ DEPR; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Antetius E, 2007, MED ANTHROPOL Q, V21, P324, DOI 10.1525/MAQ.2007.21.3.324; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brain Injury Association of America (BIAA), 2012, BIAA FREQ ASK QUEST; Centers for Disease Control and Prevention, 2014, RAT TBI REL EM DEP V; Centre for Reviews and Dissemination, 2009, U YORK SYST REV CRDS; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chang EC, 2001, J SOC CLIN PSYCHOL, V20, P117, DOI 10.1521/jscp.20.2.117.22262; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Cook L.S., 2004, STANDARD QUALITY ASS; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finkelstein E., 2006, INCIDENCE EC BURDEN; Freeman M., 2000, LINES NARRATIVE PSYC, P81; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isaki E, 2000, BRAIN INJURY, V14, P441; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KANDEL DB, 1985, J HEALTH SOC BEHAV, V26, P64, DOI 10.2307/2136727; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P26, DOI 10.1310/tsr1304-26; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; RADLOFF L, 1975, SEX ROLES, V1, P249; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Vliet-Ruissen C, 2014, NEUROREHABILITATION, V34, P373, DOI 10.3233/NRE-131032; VENKATESH A, 1980, J CONSUM RES, V7, P189, DOI 10.1086/208806; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7	47	13	13	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0739-9332	1096-4665		HEALTH CARE WOMEN IN	Health Care Women Int.	JAN 2	2016	37	1					45	74		10.1080/07399332.2015.1005307			30	Public, Environmental & Occupational Health; Women's Studies	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Women's Studies	CZ3KY	WOS:000367004200004	25635844	Green Accepted			2022-02-06	
J	Willenbring, BD; Lerner, EB; Brasel, K; Cushman, JT; Guse, CE; Shah, MN; Swor, R				Willenbring, Brian D.; Lerner, E. Brooke; Brasel, Karen; Cushman, Jeremy T.; Guse, Clare E.; Shah, Manish N.; Swor, Robert			EVALUATION OF A CONSENSUS-BASED CRITERION STANDARD DEFINITION OF TRAUMA CENTER NEED FOR USE IN FIELD TRIAGE RESEARCH	PREHOSPITAL EMERGENCY CARE			English	Article						wounds and injury; field triage; emergency medical services; trauma centers	INJURY SEVERITY SCORE; VALIDATION	Research on field triage of injured patients is limited by the lack of a widely used criterion standard for defining trauma center need. Injury Severity Score (ISS) >15 has been a commonly used outcome measure in research for determining trauma center need that has never been validated. A multidisciplinary team recently published a consensus-based criterion standard definition of trauma center need, but this measure has not yet been validated. The objective was to determine if the consensus-based criterion standard can be obtained by medical record review and compare patients identified as needing a trauma center by the consensus-based criterion standard vs. ISS >15. A subanalysis of data collected during a 2-year prospective cohort study of 4,528 adult trauma patients transported by EMS to a single trauma center was conducted. These data included ICD-9-CM codes, treatment times, and other patient care data. Presence of the consensus-based criterion standard was determined for each patient. ISS was calculated based on ICD-9-CM codes assigned for billing. The consensus-based criterion standard could be applied to 4,471 (98.7%) cases. ISS could be determined for 4,506 (99.5%) cases. Based on an ISS >15, 8.9% of cases were identified as needing a trauma center. Of those, only 48.2% met the consensus-based criterion standard. Almost all patients that did not meet the consensus-based criterion standard, but had an ISS >15 were diagnosed with chest (rib fractures (100/205 cases)/pneumothorax (57/205 cases), closed head (without surgical intervention 88/205 cases), vertebral (without spinal cord injury 45/205 cases), and/or extremity injuries (39/205 cases). There were 4,053 cases with an ISS <15. 5.0% of those with an ISS <15 met the consensus-based criterion standard with the majority requiring surgery (139/203 cases) or a blood transfusion (60/203 cases). The kappa coefficient of agreement for ISS and the consensus-based criterion standard was 0.43. We determined that the consensus-based criterion standard could be identified through a medical record review. Use of the consensus-based criterion standard for field triage research will more accurately identify injured patients who need the resources of a trauma center when compared to ISS.	[Willenbring, Brian D.; Lerner, E. Brooke; Guse, Clare E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brasel, Karen] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Cushman, Jeremy T.; Shah, Manish N.] Univ Rochester, Rochester, NY USA; [Swor, Robert] William Beaumont Hosp, Royal Oak, MI 48072 USA		Lerner, EB (corresponding author), Med Coll Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	eblerner@mcw.edu		Shah, Manish/0000-0001-6331-1074; Cushman, Jeremy/0000-0003-4767-3731	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5R49CE001010]; Medical College of Wisconsin EMS philanthropy fund	This project was supported in part by grant 5R49CE001010 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. Mr. Willenbring was awarded a travel stipend from the Medical College of Wisconsin EMS philanthropy fund to offset the costs of presenting this project at a national meeting in Tucson, AZ.	[Anonymous], 1986, Bull Am Coll Surg, V71, P4; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAXT WG, 1990, ANN EMERG MED, V19, P1396, DOI 10.1016/S0196-0644(05)82606-X; Holcomb JB, 2005, MIL MED, V170, P7, DOI 10.7205/MILMED.170.1.7; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Leach SR, 2008, PREHOSP EMERG CARE, V12, P467, DOI 10.1080/10903120802290836; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Lerner EB, 2011, PREHOSP EMERG CARE, V15, P518, DOI 10.3109/10903127.2011.598617; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mackersie RC, 2004, J TRAUMA, V57, P49; Marx WH, 2004, J TRAUMA, V57, P46, DOI 10.1097/01.TA.0000135502.18989.61; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; RUTLEDGE R, 1995, J TRAUMA, V38, P590, DOI 10.1097/00005373-199504000-00022; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1	15	13	13	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 2	2016	20	1					1	5		10.3109/10903127.2015.1056896			5	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	DA1DI	WOS:000367536100001	26270033				2022-02-06	
J	Arndt, DH; Goodkin, HP; Giza, CC				Arndt, Daniel H.; Goodkin, Howard P.; Giza, Christopher C.			Early Posttraumatic Seizures in the Pediatric Population	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric; posttraumatic seizure; traumatic brain injury; epilepsy; seizure	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ANTIEPILEPTIC DRUGS; CONTINUOUS EEG; RISK-FACTORS; UNITED-STATES; SHORT-TERM; EPILEPSY; CHILDREN; PREVENTION	Early posttraumatic seizure is a paramount clinical issue in pediatric traumatic brain injury patients as it is a common occurrence, yet an understudied entity at present. Recent literature recognizes several posttraumatic seizure subtypes based on time of presentation and the underlying pathophysiology: impact, immediate, delayed early, and late/posttraumatic epilepsy. Appropriate classification of pediatric posttraumatic seizure subtypes can be helpful for appropriate management and prognosis. This review will focus on early posttraumatic seizures, and the subtypes of early posttraumatic seizure. Incidence, risk factors, diagnosis, seizure semiology, status epilepticus, management, risk of recurrence, and prognosis were reviewed. The integration of continuous electroencephalographic (EEG) monitoring into pediatric traumatic brain injury management may hold the key to better characterizing and understanding pediatric early posttraumatic seizures. Topics for future research pertaining to pediatric early posttraumatic seizure are identified.	[Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Childrens Hosp, Dept Pediat,Div Pediat Neurol, Royal Oak, MI USA; [Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Childrens Hosp, Dept Neurol, Royal Oak, MI USA; [Arndt, Daniel H.] Oakland Univ, William Beaumont Sch Med, Beaumont Hlth Syst Neurosci, Royal Oak, MI USA; [Goodkin, Howard P.] Univ Virginia, Sch Med, UVA Hlth Syst, Dept Neurol,Div Pediat Neurol, Charlottesville, VA 22908 USA; [Goodkin, Howard P.] Univ Virginia, Sch Med, UVA Hlth Syst, Dept Pediat, Charlottesville, VA 22908 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA		Arndt, DH (corresponding author), Beaumont Childrens Hosp & Hlth Syst, Med Off Bldg,Suite 302,3535 W 13 Mile Rd, Royal Oak, MI 48073 USA.	Daniel.Arndt@Beaumont.edu		Goodkin, Howard/0000-0003-0528-4949	Thrasher Research Foundation; Today's and Tomorrow's Children Fund; Winokur Family Foundation/Child Neurology Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Thrasher Research Foundation (CCG), Today's and Tomorrow's Children Fund (CCG), Winokur Family Foundation/Child Neurology Foundation (CCG).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arndt DH, 2008, PEDIAT EPILEPSY CASE; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Black P, 1975, Ciba Found Symp, P215; Black P, 1972, T AM NEUROL ASSOC, V97, P247; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P549, DOI DOI 10.1089/NEU.2000.17.549; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; DUSSER A, 1989, ELECTROEN CLIN NEURO, V73, P85, DOI 10.1016/0013-4694(89)90187-9; Elvidge A, 1939, T AM NEUROL ASSOC, V65, P125; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; FARWELL JR, 1990, NEW ENGL J MED, V322, P364, DOI 10.1056/NEJM199002083220604; Faul M, 2010, TRAUMATIC BRAIN INJU; FOULON M, 1977, ACTA NEUROL BELG, V77, P276; Gallentine WB, 2013, J CLIN NEUROPHYSIOL, V30, P126, DOI 10.1097/WNP.0b013e3182872adf; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hahn CD, 2013, NAT REV NEUROL, V9, P662, DOI 10.1038/nrneurol.2013.231; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hauser WA, 2003, EPILEPSIA, V44, P1, DOI 10.1046/j.1528-1157.44.s10.7.x; HENDRICK EB, 1968, J TRAUM, V8, P547; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; JENNETT B, 1973, DEV MED CHILD NEUROL, V15, P56; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; JENNETT WB, 1969, LANCET, V1, P1023; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; KIESLICH M, 1995, LANCET, V345, P187, DOI 10.1016/S0140-6736(95)90188-4; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kollevold T, 1976, J Oslo City Hosp, V26, P99; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Locke GE, 1991, EPILEPSIA S3, V32, pS104; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; Mandal K, 2001, CHILD NERV SYST, V17, P670, DOI 10.1007/s00381-001-0520-9; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; NINDS National Institute of Neurological Disorders and Stroke, 2000, INT HEAD INJ TASK FO; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; PAGNI CA, 1990, ACT NEUR S, V50, P38; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; PECHADRE JC, 1991, PRESSE MED, V20, P841; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Sahoo PK, 2007, INDIAN J NEUROTRAUM, V4, P11, DOI 10.1016/S0973-0508(07)80004-9; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Sills GJ, 2001, EPILEPTIC DISORD, V3, P165; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; STOWSAND D, 1970, Z NEUROL, V198, P201, DOI 10.1007/BF00316664; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; von Wild KRH, 2008, ACT NEUR S, V101, P55; YOUNG B, 1983, CHILD BRAIN, V10, P185; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	100	13	13	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		46	56		10.1177/0883073814562249			11	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400005	25564481				2022-02-06	
J	Boutte, AM; Deng-Bryant, Y; Johnson, D; Tortella, FC; Dave, JR; Shear, DA; Schmid, KE				Boutte, Angela M.; Deng-Bryant, Ying; Johnson, David; Tortella, Frank C.; Dave, Jitendra R.; Shear, Deborah A.; Schmid, Kara E.			Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; CsA; GFAP-BDP; neuroprotection; proteolysis; SBDP; serum; TBI	ALPHA-II-SPECTRIN; C-TERMINAL HYDROLASE; CEREBRAL-ARTERY OCCLUSION; CYCLOSPORINE-A; TRANSFORMING RESEARCH; INTRACRANIAL LESIONS; CLINICAL KNOWLEDGE; PROTEOMIC ANALYSIS; SYSTEMS BIOLOGY; BIOMARKERS	Acute traumatic brain injury (TBI) is associated with neurological dysfunction, changes in brain proteins, and increased serum biomarkers. However, the relationship between these brain proteins and serum biomarkers, and the ability of these serum biomarkers to indicate a neuroprotective/therapeutic response, remains elusive. Penetrating ballistic-like brain injury (PBBI) was used to systematically analyze several key TBI biomarkers, glial fibrillary acidic protein (GFAP) and its break-down products (BDPs)ubiquitin C-terminal hydrolase-L1 (UCH-L1), -II spectrin, and -II spectrin BDPs (SBDPs)in brain tissues and serum during an extended acute-subacute time-frame. In addition, neurological improvement and serum GFAP theranostic value was evaluated after neuroprotective treatment. In brain tissues, total GFAP increased more than three-fold 2 to 7 d after PBBI. However, this change was primarily due to GFAP-BDPs which increased to 2.7-4.8 arbitrary units (AU). Alpha-II spectrin was nearly ablated 3 d after PBBI, but somewhat recovered after 7 d. In conjunction with -II spectrin loss, SBDP-145/150 increased approximately three-fold 2 to 7 d after PBBI (vs. sham, p<0.05). UCH-L1 protein levels were slightly decreased 7 d after PBBI but otherwise were unaffected. Serum GFAP was elevated by 3.2- to 8.8-fold at 2 to 4h (vs. sham; p<0.05) and the 4h increase was strongly correlated to 3 d GFAP-BDP abundance (r=0.66; p<0.05). Serum GFAP showed such a strong injury effect that it also was evaluated after therapeutic intervention with cyclosporin A (CsA). Administration of 2.5mg/kg CsA significantly reduced serum GFAP elevation by 22.4-fold 2h after PBBI (vs. PBBI+vehicle; p<0.05) and improved neurological function 1 d post-injury. Serum biomarkers, particularly GFAP, may be correlative tools of brain protein changes and feasible theranostic markers of TBI progression and recovery.	[Boutte, Angela M.; Deng-Bryant, Ying; Johnson, David; Tortella, Frank C.; Dave, Jitendra R.; Shear, Deborah A.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Boutte, AM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	angela.m.boutte.civ@mail.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-12-2-0134]	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 43, AR 360-5). This research is funded by Combat Casualty Care Research Program and Congressionally Directed Medical Research Program (Contract #: W81XWH-12-2-0134). The authors thank Ms. Shonnette Grant, M.S.; SGT Myint, US Army; SPC Donkor, US Army; Ms. Rebecca Pedersen; and Mr. Francis Bustos for their technical expertise, as well as Dr. Ryan Readnower and Dr. Cartagena for their invaluable advice.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cartagena CM, 2013, J MOL NEUROSCI, V49, P301, DOI 10.1007/s12031-012-9828-z; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McMahon LW, 2009, BIOCHEM BIOPH RES CO, V381, P288, DOI 10.1016/j.bbrc.2009.02.038; McMahon LW, 2001, BIOCHEMISTRY-US, V40, P7025, DOI 10.1021/bi002917g; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Ozkisacik EA, 2006, ANN VASC SURG, V20, P243, DOI 10.1007/s10016-006-9022-2; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Rohn TT, 2013, INT J CLIN EXP PATHO, V6, P41; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shimshek DR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00262; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	50	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					147	156		10.1089/neu.2014.3672			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200017	25789543				2022-02-06	
J	Bruce, J; Echemendia, R; Tangeman, L; Meeuwisse, W; Comper, P; Hutchison, M; Aubry, M				Bruce, Jared; Echemendia, Ruben; Tangeman, Lindy; Meeuwisse, Willem; Comper, Paul; Hutchison, Michael; Aubry, Mark			Two baselines are better than one: Improving the reliability of computerized testing in sports neuropsychology	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Neuropsychology; practice; sports	TEST-RETEST RELIABILITY; NORMATIVE DATA; CONCUSSION; IMPACT; MANAGEMENT	Computerized neuropsychological tests are frequently used to assist in return-to-play decisions following sports concussion. However, due to concerns about test reliability, the Centers for Disease Control and Prevention recommends yearly baseline testing. The standard practice that has developed in baseline/postinjury comparisons is to examine the difference between the most recent baseline test and postconcussion performance. Drawing from classical test theory, the present study investigated whether temporal stability could be improved by taking an alternate approach that uses the aggregate of 2 baselines to more accurately estimate baseline cognitive ability. One hundred fifteen English-speaking professional hockey players with 3 consecutive Immediate Postconcussion Assessment and Testing (ImPACT) baseline tests were extracted from a clinical program evaluation database overseen by the National Hockey League and National Hockey League Players' Association. The temporal stability of ImPACT composite scores was significantly increased by aggregating test performance during Sessions 1 and 2 to predict performance during Session 3. Using this approach, the 2-factor Memory (r=.72) and Speed (r=.79) composites of ImPACT showed acceptable long-term reliability. Using the aggregate of 2 baseline scores significantly improves temporal stability and allows for more accurate predictions of cognitive change following concussion. Clinicians are encouraged to estimate baseline abilities by taking into account all of an athlete's previous baseline scores.	[Bruce, Jared; Echemendia, Ruben; Tangeman, Lindy] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben] Psychol & Neurobehav Associates, State Coll, PA USA; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Comper, Paul; Hutchison, Michael] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada		Bruce, J (corresponding author), Univ Missouri, Coll Arts & Sci, Dept Psychol, 5030 Cherry St,Cherry Hall Room 324, Kansas City, MO 64110 USA.	brucejm@umkc.edu	Echemendia, Ruben/R-6939-2019		National Hockey League	Drs. Echemendia, Meeuwisse, Comper, Hutchison, and Aubry are members of the National Hockey League/National Hockey League Players Association Concussion Subcommittee and that Dr. Bruce is a paid consultant to the National Hockey League.	ANASTASI A, 1998, PSYCHOL TESTING; Andrews G, 1994, MEASUREMENT CONSUMER; Baumgatner T., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field A., 2017, DISCOVERING STAT USI, V5th; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Spreen O., 2006, COMPENDIUM NEUROPSYC; Traub R. E, 1997, ED MEASUREMENT ISSUE, V16, P8, DOI [10.1111/j.1745-3992.1997.tb00603.x, DOI 10.1111/J.1745-3992.1997.TB00603.X]	22	13	13	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	5					336	342		10.1080/23279095.2015.1064002			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DR8DX	WOS:000380129700004	26786726				2022-02-06	
J	Choe, MC; Blume, HK				Choe, Meeryo C.; Blume, Heidi K.			Pediatric Posttraumatic Headache: A Review	JOURNAL OF CHILD NEUROLOGY			English	Article						posttraumatic headache; traumatic brain injury; concussion; child; adolescent; migraine	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; UNITED-STATES; US SOLDIERS; PREDICTORS; CHILDREN; RECOVERY	Head injuries are common in pediatrics, and headaches are the most common complaint following mild head trauma. Although moderate and severe traumatic brain injuries occur less frequently, headaches can complicate recovery. There is currently an intense spotlight on concussion and there has been a corresponding increase in the number of children seeking care for headache after mild traumatic brain injury or concussion. Understanding the natural history of, and recognition of factors that are associated with posttraumatic headache will help providers and families to limit disability and may prompt earlier intervention to address disabling headaches. While there are few studies on the treatment of posttraumatic headache, proper evaluation and management of posttraumatic headaches is essential to prevent further injury and to promote recovery. In this article, we will review the current definitions and epidemiology of pediatric posttraumatic headache and discuss current recommendations for the evaluation and management of this syndrome in children and adolescents.	[Choe, Meeryo C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Blume, Heidi K.] Univ Washington, Seattle Childrens Hosp, Ctr Integrat Brain Res, Div Pediat Neurol, Seattle, WA 98105 USA		Blume, HK (corresponding author), Univ Washington, Seattle Childrens Hosp, Ctr Integrat Brain Res, Div Pediat Neurol, 4800 Sandpoint Way,MS B-5552, Seattle, WA 98105 USA.	heidi.blume@seattlechildrens.org					Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blume HK, 2012, PEDIATR REV, V33, P562, DOI 10.1542/pir.33-12-562; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Gioia G, 2016, J CHILD NEUROL, V31; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer G, 2013, ANN NEUROL S17, V74, P128; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Landy SH, 1996, HEADACHE, V36, P44, DOI 10.1046/j.1526-4610.1996.3601044.x; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Saggese JA, 1998, HEADACHE, V38, P554, DOI 10.1046/j.1526-4610.1998.3807554.x; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Wang SJ, 2007, NEUROLOGY, V68, P591, DOI 10.1212/01.wnl.0000252800.82704.62; Wells E, 2016, J CHILD NEUROL, V31, P86; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	64	13	13	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		76	85		10.1177/0883073814568152			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400008	25670632				2022-02-06	
J	Chong, SL; Chew, SY; Feng, JXY; Teo, PYL; Chin, ST; Liu, N; Ong, MEH				Chong, Shu-Ling; Chew, Su Yah; Feng, Jasmine Xun Yi; Teo, Penny Yun Lin; Chin, Sock Teng; Liu, Nan; Ong, Marcus Eng Hock			A prospective surveillance of paediatric head injuries in Singapore: a dual-centre study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; POPULATION; CHILDREN; ACCIDENTS	Objective: To study the causes of head injuries among the paediatric population in Singapore, and the association between causes and mortality, as well as the need for airway or neurosurgical intervention. Design: This is a prospective observational study utilising data from the trauma surveillance system from January 2011 to March 2015. Setting: Paediatric emergency departments (EDs) of KK Women's and Children's Hospital and the National University Health System. Participants: We included children aged <16 years presenting to the paediatric EDs with head injuries who required a CT scan, admission for monitoring of persistent symptoms, or who died from the head injury. We excluded children who presented with minor mechanisms and those whose symptoms had spontaneously resolved. Primary and secondary outcome measures: Primary composite outcome was defined as death or the need for intubation or neurosurgical intervention. Secondary outcomes included length of hospital stay and type of neurosurgical intervention. Results: We analysed 1049 children who met the inclusion criteria. The mean age was 6.7 (SD 5.2) years. 260 (24.8%) had a positive finding on CT. 17 (1.6%) children died, 52 (5.0%) required emergency intubation in the ED and 58 (5.5%) underwent neurosurgery. The main causes associated with severe outcomes were motor vehicle crashes (OR 7.2, 95% CI 4.3 to 12.0) and non-accidental trauma (OR 5.8, 95% CI 1.8 to 18.6). This remained statistically significant when we stratified to children aged <2 years and performed a multivariable analysis adjusting for age and location of injury. For motor vehicle crashes, less than half of the children were using restraints. Conclusions: Motor vehicle crashes and non-accidental trauma causes are particularly associated with poor outcomes among children with paediatric head injury. Continued vigilance and compliance with injury prevention initiatives and legislature are vital.	[Chong, Shu-Ling] KK Womens & Childrens Hosp, Duke NUS Med Sch, Dept Emergency Med, Singapore, Singapore; [Chew, Su Yah] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Khoo Teck Puat Natl Univ Childrens Med Inst,Dept, Singapore, Singapore; [Feng, Jasmine Xun Yi] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Teo, Penny Yun Lin; Chin, Sock Teng] Natl Univ Hlth Syst, Dept Emergency Med, Singapore, Singapore; [Liu, Nan] Singapore Gen Hosp, Duke NUS Med Sch, Dept Emergency Med, Ctr Quantitat Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, HSSR, Duke NUS Med Sch, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Duke NUS Med Sch, Dept Emergency Med, Singapore, Singapore.	Chong.Shu-Ling@kkh.com.sg	Liu, Nan/L-9529-2013	Liu, Nan/0000-0003-3610-4883	SingHealth DUKE-NUS Paediatrics Academic Clinical Programme	The head injury surveillance work in KK Women's and Children's Hospital is funded by the SingHealth DUKE-NUS Paediatrics Academic Clinical Programme.	Befeler AR, 2014, J NEUROSURG-PEDIATR, V14, P414, DOI 10.3171/2014.7.PEDS1433; Bray Liz, 2015, Nurs Child Young People, V27, P22, DOI 10.7748/ncyp.27.7.22.e618; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Chong SL, 2015, INJURY, V46, P1270, DOI 10.1016/j.injury.2015.04.002; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Cusimano MD, 2016, J NEUROSURG-PEDIATR, V17, P3, DOI 10.3171/2015.2.PEDS14472; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; Hinds T, 2015, CURR PROB PEDIATR AD, V45, P71, DOI 10.1016/j.cppeds.2015.02.002; Johnston BD, 2013, ACAD PEDIATR, V13, P499, DOI 10.1016/j.acap.2013.04.016; Kiley K, 2014, PEDIATR EMERG CARE, V30, P631, DOI 10.1097/PEC.0000000000000210; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korley FK, 2015, J HEAD TRAUMA REHABI; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2015, J TRAUMA ACUTE CARE, V79, pS55, DOI 10.1097/TA.0000000000000673; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Nnadi MO, 2015, NEUROSCI J, V2015; Peden M, 2008, WORLD REPORT CHILD I; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Ward A, 2015, AM SURGEON, V81, P835	23	13	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	2							e010618	10.1136/bmjopen-2015-010618			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5HX	WOS:000381514500144	26908533	Green Published, gold			2022-02-06	
J	Guilliams, K; Wainwright, MS				Guilliams, Kristin; Wainwright, Mark S.			Pathophysiology and Management of Moderate and Severe Traumatic Brain Injury in Children	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric brain trauma; closed head injury; pediatric neurocritical care; intracranial pressure	REFRACTORY STATUS EPILEPTICUS; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; ELEVATED INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID PRESSURE; RECOVERY 10 YEARS; POSTTRAUMATIC SEIZURES; PEDIATRIC-PATIENTS; BLOOD-FLOW	Traumatic brain injury remains a leading cause of morbidity and mortality in children. Key pathophysiologic processes of traumatic brain injury are initiated by mechanical forces at the time of trauma, followed by complex excitotoxic cascades associated with compromised cerebral autoregulation and progressive edema. Acute care focuses on avoiding secondary insults, including hypoxia, hypotension, and hyperthermia. Children with moderate or severe traumatic brain injury often require intensive monitoring and treatment of multiple parameters, including intracranial pressure, blood pressure, metabolism, and seizures, to minimize secondary brain injury. Child neurologists can play an important role in acute and long-term care. Acutely, as members of a multidisciplinary team in the intensive care unit, child neurologists monitor for early signs of neurological change, guide neuroprotective therapies, and transition patients to long-term recovery. In the longer term, neurologists are uniquely positioned to treat complications of moderate and severe traumatic brain injury, including epilepsy and cognitive and behavioral issues.	[Guilliams, Kristin] Washington Univ, Sch Med, Dept Neurol, Div Pediat & Dev Neurol, St Louis, MO 63110 USA; [Guilliams, Kristin] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Neurol, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Div Crit Care Med, Chicago, IL 60611 USA		Guilliams, K (corresponding author), Washington Univ, Sch Med, Dept Neurol, Div Pediat & Dev Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	guilliamsk@neuro.wustl.edu	Guilliams, Kristin/U-7100-2019	Guilliams, Kristin/0000-0002-5518-3778			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Ben Yehuda Y, 2006, J CHILD NEUROL, V21, P441, DOI 10.2310/7010.2006.00097; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Claassen J, 2001, NEUROLOGY, V57, P1036, DOI 10.1212/WNL.57.6.1036; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Diringer MN, 2012, NEUROSURGERY, V70, P1215, DOI 10.1227/NEU.0b013e3182417bc2; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Garcia Paul, 2007, Epilepsy Curr, V7, P70, DOI 10.1111/j.1535-7511.2007.00173.x; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Herman BE, 2011, PEDIATR EMERG CARE, V27, P65, DOI 10.1097/PEC.0b013e31820349db; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kramer U, 2005, J CHILD NEUROL, V20, P184, DOI 10.1177/08830738050200030301; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Quinn CT, 2012, PEDIATR BLOOD CANCER, V59, P881, DOI 10.1002/pbc.24227; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sahin M, 2001, EPILEPSIA, V42, P1461, DOI 10.1046/j.1528-1157.2001.21301.x; SARI A, 1972, ANESTH ANAL CURR RES, V51, P560; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Spitzfaden AC, 1999, PEDIATR NEUROSURG, V31, P194, DOI 10.1159/000028861; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Tsai SF, 2010, CLIN NEPHROL, V74, P70; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Melo JRT, 2010, ARQ NEURO-PSIQUIAT, V68, P381, DOI 10.1590/S0004-282X2010000300010; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wainwright M, 2011, PEDIAT CRITICAL CARE, P746; Wainwright Mark S, 2012, Acta Neurochir Suppl, V114, P67, DOI 10.1007/978-3-7091-0956-4_12; Wainwright MS, 2011, PEDIAT NEUROLOGY PRI, P1185; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022	106	13	13	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		35	45		10.1177/0883073814562626			11	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400004	25512361				2022-02-06	
J	Hernandez, A; Donovan, V; Grinberg, YY; Obenaus, A; Carson, MJ				Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Obenaus, Andre; Carson, Monica J.			Differential detection of impact site versus rotational site injury by magnetic resonance imaging and microglial morphology in an unrestrained mild closed head injury model	JOURNAL OF NEUROCHEMISTRY			English	Article						confocal microscopy; traumatic brain injury; T2-weighted imaging; neuroinflammation	TRAUMATIC BRAIN-INJURY; IN-VIVO; RAT; FRACTALKINE; ACTIVATION; EXPRESSION; DISEASE; CELLS; MICE	Seventy-five percent of all traumatic brain injuries are mild and do not cause readily visible abnormalities on routine medical imaging making it difficult to predict which individuals will develop unwanted clinical sequelae. Microglia are brain-resident macrophages and early responders to brain insults. Their activation is associated with changes in morphology or expression of phenotypic markers including P2Y12 and major histocompatibility complex class II. Using a murine model of unrestrained mild closed head injury (mCHI), we used microglia as reporters of acute brain injury at sites of impact versus sites experiencing rotational stress 24h post-mCHI. Consistent with mild injury, a modest 20% reduction in P2Y12 expression was detected by quantitative real-time PCR (qPCR) analysis but only in the impacted region of the cortex. Furthermore, neither an influx of blood-derived immune cells nor changes in microglial expression of CD45, TREM1, TREM2, major histocompatibility complex class II or CD40 were detected. Using magnetic resonance imaging (MRI), small reductions in T2 weighted values were observed but only near the area of impact and without overt tissue damage (blood deposition, edema). Microglial morphology was quantified without cryosectioning artifacts using ScaleA(2) clarified brains from CX3CR1-green fluorescence protein (GFP) mice. The cortex rostral to the mCHI impact site receives greater rotational stress but neither MRI nor molecular markers of microglial activation showed significant changes from shams in this region. However, microglia in this rostral region did display signs of morphologic activation equivalent to that observed in severe CHI. Thus, mCHI-triggered rotational stress is sufficient to cause injuries undetectable by routine MRI that could result in altered microglial surveillance of brain homeostasis.	[Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Obenaus, Andre; Carson, Monica J.] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Hernandez, Alfredo] Univ Calif Riverside, MarcU Program, Riverside, CA 92521 USA; [Hernandez, Alfredo; Donovan, Virgina; Grinberg, Yelena Y.; Carson, Monica J.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Donovan, Virgina; Obenaus, Andre; Carson, Monica J.] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Donovan, Virgina; Obenaus, Andre] Loma Linda Univ, Sch Med, Loma Linda, CA 92354 USA		Carson, MJ (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.; Obenaus, A (corresponding author), Loma Linda Univ, Pediat Res Dept, Coleman Pavil,Room A-1120,11175 Campus St, Loma Linda, CA 92354 USA.	aobenaus@llu.edu; monica.carson@ucr.edu			MarcU scholarship; UCR PIC; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG048099]; DCMRP [DR080470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T34GM062756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG048099] Funding Source: NIH RePORTER	AH and VD contributed equally to these studies. AH was funded by a MarcU scholarship, VD is an IGERT fellow. Studies were supported by grants UCR PIC and NIH R01AG048099 (MJC) and DCMRP #DR080470 (AO).	Amadio S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/975849; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bianchi A, 2015, IEEE T BIO-MED ENG, V62, P145, DOI 10.1109/TBME.2014.2342653; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Faul M., 2015, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Obenaus A., 2015, ENCY MENTAL HLTH, P329; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Puntambekar S.S., 2011, BRAIN BEHAV IMMUN BB, V25, P883; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sakhony OS, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1004975; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schmid CD, 2009, J NEUROCHEM, V109, P117, DOI 10.1111/j.1471-4159.2009.05984.x; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang J, 2011, J IMMUNOL, V187, P5277, DOI 10.4049/jimmunol.1102077	43	13	13	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2016	136			1	SI		18	28		10.1111/jnc.13402			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DB8SH	WOS:000368786400003	26806371	Green Published, Green Accepted, hybrid			2022-02-06	
J	Humble, SS; Wilson, LD; McKenna, JW; Leath, TC; Song, Y; Davidson, MA; Ehrenfeld, JM; Guillamondegui, OD; Pandharipande, PP; Patel, MB				Humble, Stephen S.; Wilson, Laura D.; McKenna, John W.; Leath, Taylor C.; Song, Yanna; Davidson, Mario A.; Ehrenfeld, Jesse M.; Guillamondegui, Oscar D.; Pandharipande, Pratik P.; Patel, Mayur B.			Tracheostomy risk factors and outcomes after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; outcome; trauma; tracheostomy; insurance	SEVERE HEAD-INJURY; PROLONGED ENDOTRACHEAL INTUBATION; BEDSIDE PERCUTANEOUS TRACHEOSTOMY; RECEIVING MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; ICU PATIENTS; INTRACRANIAL-PRESSURE; LATE TRACHEOTOMY; IMPACT; PNEUMONIA	Objective: To determine risk factors associated with tracheostomy placement after severe traumatic brain injury (TBI) and subsequent outcomes among those who did and did not receive a tracheostomy. Methods: This retrospective cohort study compared adult trauma patients with severe TBI (n = 583) who did and did not receive tracheostomy. A multivariable logistic regression model assessed the associations between age, sex, race, insurance status, admission GCS, AIS (Head, Face, Chest) and tracheostomy placement. Ordinal logistic regression models assessed tracheostomy's influence on ventilator days and ICU LOS. To limit immortal time bias, Cox proportional hazards models assessed mortality at 1, 3 and 12-months. Results: In this multivariable model, younger age and private insurance were associated with increased probability of tracheostomy. AIS, ISS, GCS, race and sex were not risk factors for tracheostomy placement. Age showed a non-linear relationship with tracheostomy placement; likelihood peaked in the fourth decade and declined with age. Compared to uninsured patients, privately insured patients had an increased probability of receiving a tracheostomy (OR = 1.89 [95% CI = 1.09-3.23]). Mortality was higher in those without tracheostomy placement (HR = 4.92 [95% CI = 3.49-6.93]). Abbreviated injury scale-Head was an independent factor for time to death (HR = 2.53 [95% CI = 2.00-3.19]), but age, gender and insurance were not. Conclusions: Age and insurance status are independently associated with tracheostomy placement, but not with mortality after severe TBI. Tracheostomy placement is associated with increased survival after severe TBI.	[Humble, Stephen S.; McKenna, John W.; Leath, Taylor C.; Guillamondegui, Oscar D.; Patel, Mayur B.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA; [Humble, Stephen S.; McKenna, John W.; Leath, Taylor C.; Guillamondegui, Oscar D.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Div Trauma & Surg Crit Care, Nashville, TN USA; [Wilson, Laura D.; Patel, Mayur B.] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37212 USA; [Wilson, Laura D.] Univ Tulsa, Dept Commun Sci & Disorders, Tulsa, OK 74104 USA; [Song, Yanna; Davidson, Mario A.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Ehrenfeld, Jesse M.; Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Ehrenfeld, Jesse M.; Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA; [Ehrenfeld, Jesse M.; Pandharipande, Pratik P.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Pandharipande, Pratik P.; Patel, Mayur B.] Nashville VA Med Ctr, Vet Affairs VA Tennessee Valley Healthcare Syst, Nashville, TN USA		Patel, MB (corresponding author), 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37212 USA.	mayur.b.patel@vanderbilt.edu	Davidson, Mario/AAX-1102-2021; Ehrenfeld, Jesse/AAI-2951-2020	Pandharipande, Pratik/0000-0002-1389-8580	Clinical and Translational Science Award (CTSA) Grant from NCATS/NIH) [UL1 TR000448]; Vanderbilt Faculty Scholars Research Program; ABRQ Health Services [5T32HS013833-08]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL111111, R01AG027472, R01AG035117]; Eastern Association for the Surgery of Trauma Foundation Research Scholarship; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32HS013833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG035117, R01AG027472] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper. The project utilized REDCap, which is supported by Clinical and Translational Science Award (CTSA) Grant (UL1 TR000448 from NCATS/NIH). Author MBP was supported by the Vanderbilt Faculty Scholars Research Program, ABRQ Health Services (5T32HS013833-08), NIH R01HL111111, and the Eastern Association for the Surgery of Trauma Foundation Research Scholarship. Author PPP is supported by NIH grants (R01AG027472, R01HL111111, R01AG035117).	Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P76; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; BISHOP MJ, 1984, ANESTH ANALG, V63, P335; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Cobean R, 1996, ARCH SURG-CHICAGO, V131, P265; COLICE GL, 1989, CHEST, V96, P877, DOI 10.1378/chest.96.4.877; Dennis BM, 2013, J AM COLL SURGEONS, V216, P858, DOI 10.1016/j.jamcollsurg.2012.12.017; Durbin CG, 2010, RESP CARE, V55, P1056; Fernandez L, 1996, ARCH SURG-CHICAGO, V131, P129; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gurkin MA, 2002, AM SURGEON, V68, P324; GURKIN SA, 2002, AM SURGEON, V68, P328; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; House JC, 2011, LARYNGOSCOPE, V121, P596, DOI 10.1002/lary.21403; Jeon YT, 2014, J NEUROSURG ANESTH, V26, P22, DOI 10.1097/ANA.0b013e31829770a0; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Momin EN, 2012, ARCH SURG-CHICAGO, V147, P1017, DOI 10.1001/archsurg.2012.1459; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Scales DC, 2010, JAMA-J AM MED ASSOC, V303, P1537, DOI 10.1001/jama.2010.462; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Shintani AK, 2009, CRIT CARE MED, V37, P2939, DOI 10.1097/CCM.0b013e3181b7fbbb; Shirawi N, 2006, CRIT CARE, V10, DOI 10.1186/cc3828; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Wease GL, 1996, ARCH SURG-CHICAGO, V131, P552	40	13	13	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1642	1647		10.1080/02699052.2016.1199915			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800018	27740854	Green Accepted			2022-02-06	
J	Jones, DA; Gaewsky, JP; Kelley, ME; Weaver, AA; Miller, AN; Stitzel, JD				Jones, Derek A.; Gaewsky, James P.; Kelley, Mireille E.; Weaver, Ashley A.; Miller, Anna N.; Stitzel, Joel D.			Lumbar vertebrae fracture injury risk in finite element reconstruction of CIREN and NASS frontal motor vehicle crashes	TRAFFIC INJURY PREVENTION			English	Article						Lumbar; vertebra; finite element; injury; THUMS	SPINE; PREDICTION; COLLISIONS; OCCUPANT; MODEL; BONE	Introduction: The objective of this study was to reconstruct 4 real-world motor vehicle crashes (MVCs), 2 with lumbar vertebral fractures and 2 without vertebral fractures in order to elucidate the MVC and/or restraint variables that increase this injury risk.Methods: A finite element (FE) simplified vehicle model (SVM) was used in conjunction with a previously developed semi-automated tuning method to arrive at 4 SVMs that were tuned to mimic frontal crash responses of a 2006 Chevrolet Cobalt, 2012 Ford Escape, 2007 Hummer H3, and 2002 Chevrolet Cavalier. Real-world crashes in the first 2 vehicles resulted in lumbar vertebrae fractures, whereas the latter 2 did not. Once each SVM was tuned to its corresponding vehicle, the Total HUman Model for Safety (THUMS) v4.01 was positioned in 120 precrash configurations in each SVM by varying 5 parameters using a Latin hypercube design (LHD) of experiments: seat track position, seatback angle, steering column angle, steering column telescoping position, and d-ring height. For each case, the event data recorder (EDR) crash pulse was used to apply kinematic boundary conditions to the model. By analyzing cross-sectional vertebral loads, vertebral bending moments, and maximum principal strain and stress in both cortical and trabecular bone, injury metric response as a function of posture and restraint parameters was computed.Results: Tuning the SVM to specific vehicle models produced close matches between the simulated and experimental crash test responses for head, T6, and pelvis resultant acceleration; left and right femur loads; and shoulder and lap belt loads. Though vertebral load in the THUMS simulations was highly similar between injury cases and noninjury cases, the amount of bending moment was much higher for the injury cases. Seatback angle had a large effect on the maximum compressive load and bending moment in the lumbar spine, indicating the upward tilt of the seat pan in conjunction with precrash positioning may increase the likelihood of suffering lumbar injury even in frontal, planar MVCs.Conclusion: In conclusion, precrash positioning has a large effect on lumbar injury metrics. The lack of lumbar injury criteria in regulatory crash tests may have led to inadvertent design of seat pans that work to apply axial force to the spinal column during frontal crashes.	[Jones, Derek A.; Gaewsky, James P.; Kelley, Mireille E.; Weaver, Ashley A.; Stitzel, Joel D.] Virginia Tech Wake Forest Univ, Ctr Injury Biomech, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA; [Jones, Derek A.; Gaewsky, James P.; Kelley, Mireille E.; Weaver, Ashley A.; Miller, Anna N.; Stitzel, Joel D.] Wake Forest Sch Med, Winston Salem, NC USA		Weaver, AA (corresponding author), Virginia Tech Wake Forest Univ, Ctr Injury Biomech, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	asweaver@wakehealth.edu	Stitzel, Joel/B-4045-2012; Weaver, Ashley/ABB-5845-2021	Stitzel, Joel/0000-0001-9762-3033; Weaver, Ashley/0000-0002-4383-0106; Miller, Anna/0000-0002-7056-8502	Toyota's Collaborative Safety Research Center; CIREN program; WFU-VT CIREN Center [DTN22-10-11-00294]	Funding for this project was provided by Toyota's Collaborative Safety Research Center. We gratefully acknowledge the National Highway Traffic Safety Administration's support of the CIREN program and WFU-VT CIREN Center (Cooperative Agreement DTN22-10-11-00294). Views expressed are those of the authors and do not represent the views of any sponsors.	Anderson GC, 2013, ENG SS; Bilston LE, 2011, INJURY PREV, V17, P228, DOI 10.1136/ip.2010.028324; Blincoe LJ, 2015, 812013 NHTSA DOT HS; Campbell-Kyureghyan NH, 2011, J MECH BEHAV BIOMED, V4, P549, DOI 10.1016/j.jmbbm.2011.01.001; Comm STIS, 2003, INSTR IMP TEST 1; Dissanaike S, 2008, J TRAUMA, V64, P614, DOI 10.1097/TA.0b013e318164d071; Doud AN, 2015, CLIN ORTHOP RELAT R, V473, P297, DOI 10.1007/s11999-014-3870-9; Gaewsky JP, 2015, TRAFFIC INJ PREV, V16, pS124, DOI 10.1080/15389588.2015.1061666; Gaewsky James P, 2014, Biomed Sci Instrum, V50, P83; Golman AJ, 2016, COMPUT METHOD BIOMEC, V19, P717, DOI 10.1080/10255842.2015.1056523; Golman AJ, 2014, ACCIDENT ANAL PREV, V64, P1, DOI 10.1016/j.aap.2013.10.026; HANSSON TH, 1987, SPINE, V12, P56, DOI 10.1097/00007632-198701000-00011; Hollowell WT, 1999, UPDATED REV POTENTIA, P6407; Iraeus J, 2016, ACCIDENT ANAL PREV, V95, P42, DOI 10.1016/j.aap.2016.06.020; Jones D, 2016, SAE INT J TRANSP SAF, V4, P267, DOI 10.4271/2016-01-1488; Kaufman RP, 2013, ACCIDENT ANAL PREV, V59, P153, DOI 10.1016/j.aap.2013.05.023; Kopperdahl DL, 1998, J BIOMECH, V31, P601, DOI 10.1016/S0021-9290(98)00057-8; Miller L, 2016, 01487191 SAE; Muller CW, 2014, ACCIDENT ANAL PREV, V66, P15, DOI 10.1016/j.aap.2014.01.003; NHTSA, 2014, TRAFF SAF FACTS 2012; Pintar Frank A, 2012, Ann Adv Automot Med, V56, P277; Rao RD, 2014, SPINE J, V14, P2355, DOI 10.1016/j.spinee.2014.01.038; Shigeta K, 2009, ENH SAF VEH C JUN 20; SINGER K, 1995, BONE, V17, P167, DOI 10.1016/S8756-3282(95)00165-4; Sprague MA, 2004, INT J NUMER METH ENG, V60, P2467, DOI 10.1002/nme.1054; Stemper BD, 2015, J MECH BEHAV BIOMED, V41, P271, DOI 10.1016/j.jmbbm.2014.07.035; Yoganandan Narayan, 2013, Ann Adv Automot Med, V57, P155	27	13	13	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2016	17			1	SI		109	115		10.1080/15389588.2016.1195495			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	DW8ID	WOS:000383897600019	27586111				2022-02-06	
J	Jurick, SM; Twamley, EW; Crocker, LD; Hays, CC; Orff, HJ; Golshan, S; Jak, AJ				Jurick, Sarah M.; Twamley, Elizabeth W.; Crocker, Laura D.; Hays, Chelsea C.; Orff, Henry J.; Golshan, Shahrokh; Jak, Amy J.			Postconcussive symptom overreporting in Iraq/Afghanistan Veterans with mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						concussion; depression; mild traumatic brain injury; neurobehavioral symptoms; neuropsychology; Operation Enduring Freedom/Operation Iraqi Freedom; performance validity test; postconcussive symptoms; posttraumatic stress disorder; symptom validity test	POSTTRAUMATIC-STRESS-DISORDER; VALIDITY SCALES; TASK-FORCE; PERFORMANCE VALIDITY; SERVICE MEMBERS; MMPI-2 VALIDITY; RESPONSE BIAS; PERSISTENT; TBI; CONCUSSION	A comprehensive evaluation, including the assessment of neurobehavioral symptoms, has been instituted at the Department of Veterans Affairs (VA) healthcare system to address the large number of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans returning with mild traumatic brain injuries (mTBIs). The Validity-10 is a measure of symptom overreporting embedded within the Neurobehavioral Symptom Inventory, a component of the comprehensive evaluation that assesses postconcussive symptom severity. The Validity-10 is composed of 10 unlikely/low-frequency items and a validated cutoff score to identify postconcussive symptom overreporting. We examined the items and cutoff used in the initial development and validation study of the Validity-10 through retrospective chart reviews of 331 treatment-seeking Veterans who sustained an mTBI. The Validity-10 exhibited significant relationships with psychiatric variables, VA service connection, and neuropsychological performance validity (all p<0.01), but nonsignificant relationships with demographic and injury variables (all p>0.05). Furthermore, the Validity-10 modestly predicted neuropsychological performance validity test failure over and above psychiatric comorbidities and VA service connection. The present study supports the use of the Validity-10 to assess symptom validity in treatment-seeking OIF/OEF Veterans with a history of mTBI.	[Jurick, Sarah M.; Hays, Chelsea C.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Jurick, Sarah M.; Hays, Chelsea C.; Golshan, Shahrokh] Vet Med Res Fdn, San Diego, CA USA; [Twamley, Elizabeth W.; Orff, Henry J.; Jak, Amy J.] Dept Vet Affairs VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.; Orff, Henry J.; Golshan, Shahrokh] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu			VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship	This material was unfunded at the time of manuscript preparation. Laura D. Crocker was supported by the VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship.	Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Butcher J, 1989, MANUAL ADM SCORING M; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER SOCIAL SC; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D.C., 1999, CALIFORNIA VERBAL LE, VSecond; Green P., 2004, MED SYMPTOM VALIDITY; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miskey HM, 2015, BRAIN IMAGING BEHAV, V9, P461, DOI 10.1007/s11682-015-9391-7; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey LC, 2014, ENCY CLIN PSYCHOL; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F. W., 1993, P INT SOC TRAUM STRE; Whiteside DM, 2012, J CLIN EXP NEUROPSYC, V34, P172, DOI 10.1080/13803395.2011.630648; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	60	13	13	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	5					571	583		10.1682/JRRD.2015.05.0094			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EB7TH	WOS:000387593000006	27898153	gold			2022-02-06	
J	Kreutzer, JS; Sima, AP; Marwitz, JH; Lukow, HR				Kreutzer, Jeffrey S.; Sima, Adam P.; Marwitz, Jennifer H.; Lukow, Herman R., II			Marital instability after brain injury: An exploratory analysis	NEUROREHABILITATION			English	Article						Traumatic brain injury; marital stability; marital quality	DYADIC ADJUSTMENT SCALE; STATUS INVENTORY; HEAD-INJURY; QUALITY; SATISFACTION; PREDICTORS; DISSOLUTION; STABILITY; MARRIAGE; DIVORCE	BACKGROUND: Spousal caregivers have an important role in recovery after brain injury, and there is evidence that injury has an adverse impact on uninjured partners as well as survivors. Unfortunately, the impact of brain injury on coupled relationships has received limited attention from clinical researchers. OBJECTIVE: To characterize marital stability after traumatic brain injury considering the perspectives of the patient and the uninjured partner. To identify predictors of marital stability. METHODS: Forty-two couples with mild to severe injury completed the Marital Status Inventory, a measure of relationship stability, and the Revised Dyadic Adjustment Scale (RDAS), a measure of relationship quality. RESULTS: Twenty-four percent (24%) of patients viewed their marriage as unstable as did 29% of partners. Most individuals (72%) agreed with their partner regarding the stability of their relationship. About half of patients (52%) and partners (50%) reported clinically significant levels of marital dissatisfaction. Multivariate logistic regression indicated that the RDAS was a salient predictor of marital stability. Findings indicate relatively high levels of marital stability despite high levels of marital distress. CONCLUSIONS: Marital stability can be classified beyond labeling couples as married, separated, or divorced. Researchers have suggested that postinjury marital relationships are prone to instability and divorce in comparison to the general population. The present findings suggest otherwise.	[Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Lukow, Herman R., II] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.	jhmarwit@vcu.edu		Sima, Adam/0000-0001-8426-9987	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033, 90AR5002]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DP0033 and 90AR5002). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Braun M, 2009, AGING MENT HEALTH, V13, P426, DOI 10.1080/13607860902879441; Bultz BD, 2000, PSYCHO-ONCOL, V9, P303, DOI 10.1002/1099-1611(200007/08)9:4<303::AID-PON462>3.0.CO;2-M; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; BUSBY DM, 1995, J MARITAL FAM THER, V21, P289, DOI 10.1111/j.1752-0606.1995.tb00163.x; Chan RCK, 2000, CLIN REHABIL, V14, P137, DOI 10.1191/026921500675826560; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; CRANE DR, 1984, J MARITAL FAM THER, V10, P305, DOI 10.1111/j.1752-0606.1984.tb00021.x; CRANE DR, 1980, AM J FAM THER, V8, P31, DOI 10.1080/01926188008250362; Crane DR, 2000, AM J FAM THER, V28, P53, DOI 10.1080/019261800261815; Dehle C, 1998, J MARRIAGE FAM, V60, P1002, DOI 10.2307/353641; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P547, DOI 10.1037/0022-006X.59.4.547; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KURDEK LA, 1993, J PERS SOC PSYCHOL, V64, P221, DOI 10.1037/0022-3514.64.2.221; LARSON JH, 1994, FAM RELAT, V43, P228, DOI 10.2307/585327; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rohrbaugh MJ, 2006, AM J CARDIOL, V98, P1069, DOI 10.1016/j.amjcard.2006.05.034; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Simonelli C, 2008, INT J CLIN PRACT, V62, P47, DOI 10.1111/j.1742-1241.2007.01506.x; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; STANLEY SM, 1995, FAM RELAT, V44, P392, DOI 10.2307/584995; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WEISS RL, 1980, AM J FAM THER, V8, P80, DOI 10.1080/01926188008250358; Whiting JB, 2003, CONTEMP FAM THER, V25, P195, DOI 10.1023/A:1023672101157; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	41	13	13	2	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	3					271	279		10.3233/NRE-161318			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DM5PV	WOS:000376403300006	27030903				2022-02-06	
J	Lynch, CE; Crynen, G; Ferguson, S; Mouzon, B; Paris, D; Ojo, J; Leary, P; Crawford, F; Bachmeier, C				Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Leary, Paige; Crawford, Fiona; Bachmeier, Corbin			Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury	BRAIN INJURY			English	Article						Repetitive mild traumatic brain injury; cerebrovascular	CEREBRAL-BLOOD-FLOW; FOOTBALL-LEAGUE PLAYER; SMOOTH-MUSCLE-CELL; ALZHEIMERS-DISEASE; CAPILLARY PERICYTES; ENCEPHALOPATHY; HYPOPERFUSION; IMPAIRMENT; SPORT; ENDOTHELIN-1	Primary objective: To investigate the status of the cerebrovasculature following repetitive mild traumatic brain injury (r-mTBI).Research design: TBI is a risk factor for development of various neurodegenerative disorders. A common feature of neurodegenerative disease is cerebrovascular dysfunction which includes alterations in cerebral blood flow (CBF). TBI can result in transient reductions in CBF, with severe injuries often accompanied by varying degrees of vascular pathology post-mortem. However, at this stage, few studies have investigated the cerebrovasculature at chronic time points following repetitive mild brain trauma.Methods and procedures: r-mTBI was delivered to wild-type mice (12 months old) twice per week for 3 months and tested for spatial memory deficits (Barnes Maze task) at 1 and 6 months post-injury. At 7 months post-injury CBF was assessed via Laser Doppler Imaging and, following euthanasia, the brain was probed for markers of cerebrovascular dysfunction and inflammation.Main outcomes and results: Memory impairment was identified at 1 month post-injury and persisted as late as 6 months post-injury. Furthermore, significant immunopathological insult, reductions in global CBF and down-regulation of cerebrovascular-associated markers were observed.Conclusions: These results demonstrate impaired cognitive behaviour alongside chronic cerebrovascular dysfunction in a mouse model of repetitive mild brain trauma.	[Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Leary, Paige; Crawford, Fiona; Bachmeier, Corbin] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Crawford, Fiona; Bachmeier, Corbin] Open Univ, Dept Life Sci, Milton Keynes, Bucks, England; [Lynch, Cillian E.; Crynen, Gogce; Ferguson, Scott; Mouzon, Benoit; Paris, Daniel; Ojo, Joseph; Crawford, Fiona; Bachmeier, Corbin] James A Haley Vet Adm Ctr, Tampa, FL USA		Lynch, CE (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	clynch@roskampinstitute.net			Roskamp Foundation; Chronic Effects of Neurotrauma Consortium [CENC - VA I01 RX001774, DoD W81XWH-13-2-0095]	The authors report no conflicts of interest. This research was supported by the Roskamp Foundation and by the Chronic Effects of Neurotrauma Consortium (CENC - VA I01 RX001774 and DoD W81XWH-13-2-0095). Dr. Crawford is a VA Research Career Scientist.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; [Anonymous], NEUROSURGERY; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Kenney K, 2015, EXPT NEUROLOGY, V87, P95; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Millspaugh JA, 1937, US NAVAL MED B, V35, P261; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; O'Farrell FM, 2014, NAT REV CARDIOL, V11, P427, DOI 10.1038/nrcardio.2014.58; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Searcy JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089970; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392	54	13	15	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1414	1427		10.1080/02699052.2016.1219060			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100003	27834539				2022-02-06	
J	McKinlay, A; Linden, M; DePompei, R; Jonsson, CA; Anderson, V; Braga, L; Castelli, E; de Koning, P; Hawley, CA; Hermans, E; Kristiansen, I; Madden, A; Rumney, P; Savage, R; Wicks, B				McKinlay, Audrey; Linden, Mark; DePompei, Roberta; Jonsson, Catherine Aaro; Anderson, Vicki; Braga, Lucia; Castelli, Enrico; de Koning, Peter; Hawley, Carol A.; Hermans, Eric; Kristiansen, Ingela; Madden, Alison; Rumney, Peter; Savage, Ron; Wicks, Beth			Service provision for children and young people with acquired brain injury: Practice recommendations	BRAIN INJURY			English	Article						Rehabilitation; paediatric; recovery; education; neurotrauma	REPORTED PROBLEMS; RUGBY PLAYERS; MILD; SCHOOL; CHILDHOOD; NEEDS; TBI; ADOLESCENTS; TERM; REHABILITATION	Background: Providing appropriate rehabilitation services for Acquired Brain Injury (ABI) in childhood presents a number of challenges for caregivers, health and education professionals and the young person as they develop. Primary objective: To record the challenges and possible creative solutions generated by an international group of professionals to address the needs of children with ABI. Review of information: Recommendations were generated from children's special interest group meetings of the International Brain Injury Association (Turin, Italy, 2001; Stockholm, Sweden, 2003; Melbourne, Australia, 2005; Lisbon, Portugal, 2008) and through meetings of the International Paediatric Brain Injury Society (IPBIS), formed in 2009. Delegates participating in the workshops were representative of nations from around the world and included The Netherlands, New Zealand, Australia, the UK, Finland, Germany, South Africa, the US, Canada, Sweden, Brazil and Italy. Outcomes: The information presented is based on a retrospective review of those meetings and the summaries of the topics considered.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Linden, Mark] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [DePompei, Roberta] Univ Akron, Sch Speech & Language Pathol, Akron, OH 44325 USA; [Jonsson, Catherine Aaro] Ostersunds Hosp, Child & Youth Rehabil, Ostersund, Sweden; [Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Braga, Lucia] Rede Sarah Hosp Reabil, Salvador, BA, Brazil; [Castelli, Enrico] Osped Pediat Bambino Gesu, Rome, Italy; [de Koning, Peter] Heliomare Rehabil Ctr, Wijk Aan Zee, Netherlands; [Hawley, Carol A.] Univ Warwick, Fac Med, Coventry, W Midlands, England; [Hermans, Eric] Brain Project, Sittard, Netherlands; [Kristiansen, Ingela] Univ Uppsala Hosp, Dept Pediat Neurol, Uppsala, Sweden; [Madden, Alison] Goukam Hlth, Riversdale, South Africa; [Rumney, Peter] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Savage, Ron] Sarah Jane Brain Fdn, New York, NY USA; [Wicks, Beth] Beth Wicks Consultancy, Nottingham, England		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au	Linden, Mark/L-7754-2019; Hawley, Carol/AAG-3830-2019; Braga, Lucia/AAQ-1030-2020	Linden, Mark/0000-0002-3832-4102; McKinlay, Audrey/0000-0001-9846-8514			Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Bodde TRA, 2015, DEV NEUROPSYCHOL, V40, P254, DOI 10.1080/87565641.2015.1034864; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hermans E, 2014, 10 WORLD C BRAIN INJ; Hermans E, 2012, NEUROREHABILITATION, V30, P213, DOI 10.3233/NRE-2012-0747; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Kelley PW, 2014, QUALITATIVE HLTH RES, V25, P426; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Linden MA, 2013, NEUROTRAUMA, V33; Linden MA, 2013, INT NEUROTRAUMA LETT, P33; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2012, MILD TRAUMATIC BRAIN, P361; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mock C, 2001, WESTERN J MED, V175, P372, DOI 10.1136/ewjm.175.6.372; Moore C, 2004, NZ MED J, V117, P1; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Mukherjee S, 2000, EDUC RES, V42, P59, DOI 10.1080/001318800363917; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharmin N., 2014, J BIOMATER APPL, V0, P1; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wake-Dyster W, 2001, Aust Health Rev, V24, P34; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M, 1998, SCH REENTRY TRAUMATI, P369; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zirkle LG, 2008, CLIN ORTHOP RELAT R, V466, P2443, DOI 10.1007/s11999-008-0387-0	72	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1656	1664		10.1080/02699052.2016.1201592			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800020	27740853	Green Published			2022-02-06	
J	Meng, XF; Shi, BZ				Meng, Xiaofeng; Shi, Baozhong			Traumatic Brain Injury Patients With a Glasgow Coma Scale Score of <= 8, Cerebral Edema, and/or a Basal Skull Fracture are More Susceptible to Developing Hyponatremia	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						epidemiology; traumatic brain injury; serum sodium level; computed tomography	SODIUM; MILD	Background: Traumatic brain injury (TBI) is a common injury treated at the neurosurgery department. The incidence rate is approximately 3% in the general population and the mortality rate is 25%. The incidence of hyponatremia following TBI is 33%. Hyponatremia is one of the main causes of disability and/or death in TBI patients. This study investigated the epidemiology of hyponatremia following TBI. Methods: Patients who were admitted to our hospital with moderate or severe TBI were analyzed retrospectively. The relationship between the occurrence of hyponatremia and age, sex, type of injury, Glasgow coma scale (GCS) score, whether the patient underwent surgery, and the presence of cerebral edema and basal skull fracture was analyzed statistically using a chi(2) test and multivariate logistic regression analysis. Results: Out of the 136 patients recruited for the study (81 males and 55 females; mean +/- SD age of 48 +/- 13 y), 56 suffered from hyponatremia (ie, serum sodium level <135mmol/L). Univariate analysis indicated that hyponatremia following TBI was not related to age (P>0.05), sex (P= 0.347), or surgical history (P= 0.492) but that it was related to the type of injury (P= 0.031), a GCS score <= 8 (P< 0.001), the presence of cerebral edema (P< 0.001), and/or a basal skull fracture (P< 0.001). Multivariate logistic regression analysis confirmed a strong association between the occurrence of hyponatremia and a GCS score <= 8 (P< 0.016), the presence of cerebral edema (P< 0.001), and a basal skull fracture (P< 0.001). Conclusions: TBI patients with a GCS score <= 8, cerebral edema, and/or a basal skull fracture are particularly prone to developing hyponatremia. These patients require additional treatment that should entail the normalization of serum sodium levels to prevent deterioration of their condition.	[Meng, Xiaofeng; Shi, Baozhong] Henan Univ Sci & Technol, Dept Neurosurg, Affiliated Hosp 1, 24 Jinghua Rd, Luoyang 471003, Peoples R China		Shi, BZ (corresponding author), Henan Univ Sci & Technol, Dept Neurosurg, Affiliated Hosp 1, 24 Jinghua Rd, Luoyang 471003, Peoples R China.	sbzmd20569@163.com					American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP M; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Buckley MS, 2013, ANN PHARMACOTHER, V47, P1194, DOI 10.1177/1060028013503126; Cai Jia-ning, 2003, Chin J Traumatol, V6, P179; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; [董元训 Dong Yuanxun], 2012, [中华神经外科杂志, Chinese Journal of Neurosurgery], V28, P1160; Frey F J, 2004, Ther Umsch, V61, P583, DOI 10.1024/0040-5930.61.9.583; Harrigan MR, 2001, CRIT CARE CLIN, V17, P125, DOI 10.1016/S0749-0704(05)70155-X; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1977, LANCET, V1, P878; John CA, 2012, CRIT CARE NURSE, V32, pE1, DOI 10.4037/ccn2012904; Kirkman MA, 2014, MINERVA ENDOCRINOL, V39, P13; KROLL M, 1992, J INTERN MED, V232, P291; [刘伟 Liu Wei], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P299; Liu XY, 2012, J BRAIN NERV DIS, V20, P34; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Sajadieh A, 2009, AM J MED, V122, P679, DOI 10.1016/j.amjmed.2008.11.033; TEASDALE G, 1974, LANCET, V2, P81; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wu Z, 2008, SURGERY; Yao GJ, 1999, CHIN J TRAUMATOL, V15, P269; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; 丁之明, 2008, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V34, P237	25	13	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2016	28	1					21	26		10.1097/ANA.0000000000000192			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	DM3FY	WOS:000376233400004	25985316				2022-02-06	
J	Moreno-Lopez, L; Sahakian, BJ; Manktelow, A; Menon, DK; Stamatakis, EA				Moreno-Lopez, Laura; Sahakian, Barbara J.; Manktelow, Anne; Menon, David K.; Stamatakis, Emmanuel A.			Depression following traumatic brain injury: A functional connectivity perspective	BRAIN INJURY			English	Article						Traumatic brain injury; Resting state; Functional connectivity; Depression	DEFAULT MODE NETWORK; GLOBAL SIGNAL REGRESSION; RESTING-STATE NETWORKS; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; NEURAL BASIS; STRUCTURAL CONNECTIVITY; EMOTION PERCEPTION; SALIENCE NETWORK; ACTIVATION	Introduction: Despite the mounting evidence that depression is one of the most common psychiatric sequelae in survivors of traumatic brain injury (TBI), no studies so far have attempted to provide an explanation in terms of functional network integrity. This proof of concept study investigated the association between the severity of depressive symptoms and resting network integrity in a sample of patients with TBI and a group of healthy controls. Methods: We first examined the association between depression symptomatology and global functional connectivity and then attempted to characterize the extent of differences in functional network integrity. Results: The severity of depressive symptoms in patients with TBI was associated with neuroadaptations within the insula, the thalamus and the subgenual anterior cingulate cortex (ACC). Specifically, patients with TBI displayed increased connectivity between the insula and a region encompassing the rolandic operculum and the superior temporal cortex and reduced connectivity between the thalamus and the dorsolateral prefrontal cortex. Conclusions: These findings show the network level involvement of the insula, the thalamus and the subgenual ACC in the depressive symptomatology of patients with TBI and tentatively propose that TBI-induced depression may result from altered functional connectivity of a set of networks associated with emotional regulation. However, other factors including a number of adjustment issues and challenges may also lead to depression in this population.	[Moreno-Lopez, Laura; Manktelow, Anne; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England		Moreno-Lopez, L (corresponding author), Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	lm618@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601; Moreno Lopez, Laura/0000-0003-3687-7237	Evelyn Trust [06/20]; University of Granada; Janssen/JJJohnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc; CLAHRC-East of England awards; Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre; NIHR Senior Investigator awards; Framework Program 7 from the European Commission (TBIcare); Glaxo SmithKlineGlaxoSmithKline; SolvaySolvay SA; Linde; Stephen Erskine Fellowship, Queens' College, Cambridge, UK; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The study was funded by the Evelyn Trust- grant number 06/20. L.M.L. is funded by a Post-Doctoral Fellowship from the University of Granada. B.J.S. consults for Cambridge Cognition, Brainbow (Peak), Otsuka, Servier and Lundbeck. She holds a grant from Janssen/J&J and has share options in Cambridge Cognition. A.M. is supported by CLAHRC-East of England awards. D.K.M. is supported by the Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre and NIHR Senior Investigator awards, and by Framework Program 7 funding from the European Commission (TBIcare). He has received lecture and consultancy fees and support for research from Glaxo SmithKline, Solvay and Linde. E.A.S. is funded by the Stephen Erskine Fellowship, Queens' College, Cambridge, UK.	Alcaro A, 2010, NEUROSCI BIOBEHAV R, V34, P592, DOI 10.1016/j.neubiorev.2009.11.023; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brody AL, 2001, BIOL PSYCHIAT, V50, P171, DOI 10.1016/S0006-3223(01)01117-9; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Dillon DG, 2013, PSYCHIAT RES-NEUROIM, V212, P99, DOI 10.1016/j.pscychresns.2013.01.001; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Fales CL, 2009, J AFFECT DISORDERS, V112, P206, DOI 10.1016/j.jad.2008.04.027; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gotlib IH, 2005, NEUROREPORT, V16, P1731, DOI 10.1097/01.wnr.0000183901.70030.82; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Manoliu A, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00930; Martuzzi R, 2011, NEUROIMAGE, V58, P1044, DOI 10.1016/j.neuroimage.2011.06.075; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sliz D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00323; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Taber KH, 2004, J NEUROPSYCH CLIN N, V16, P127, DOI 10.1176/appi.neuropsych.16.2.127; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tavares JVT, 2008, NEUROIMAGE, V42, P1118, DOI 10.1016/j.neuroimage.2008.05.049; TEASDALE G, 1974, LANCET, V2, P81; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Ward B. D., 2000, SIMULTANEOUS INFEREN; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	78	13	13	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1319	1328		10.1080/02699052.2016.1186839			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900005	27467890				2022-02-06	
J	Mujdeci, B; Turkyilmaz, D; Yagcioglu, S; Aksoy, S				Mujdeci, Banu; Turkyilmaz, Didem; Yagcioglu, Suha; Aksoy, Songul			The effects of concurrent cognitive tasks on postural sway in healthy subjects	BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY			English	Article						Postural balance; Task performance and analysis; Memory, short-term; Attention	AGE-RELATED-CHANGES; ATTENTIONAL DEMANDS; BALANCE PERFORMANCE; MEMORY TASKS; STABILITY; ADULTS; YOUNG; INTERFERENCE; CONCUSSION	Introduction: Keeping balance of the upright stance is a highly practiced daily task for healthy adults and is effectively performed without overt attentional control in most. Objective: The purpose of this study was to examine the influence of concurrent cognitive tasks on postural sway in healthy participants. Methods: This was a prospective study. 20 healthy volunteer subjects were included. The cognitive and balance tasks were performed separately and then, concurrently. Postural control task consisted of 6 conditions (C) of the Sensory Organization Test. The cognitive task consisted of digit rehearsal task of varying presentation and varying levels of difficulty. Results: A statistically significant difference was noted between dual task and no task for C1, C2, C3 and C4 Sensory Organization Test scores (p < 0.05). There was no statistically significant difference between dual task versus non-task for C5, C6 and combined Sensory Organization Test scores (p > 0.05). Conclusion: During dual task, increase has been determined in postural sway for C1, C2, C3 and C4 for all presentation modes and difficulty levels of the cognitive tasks. (C) 2015 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda. All rights reserved.	[Mujdeci, Banu] Yildirim Beyazit Univ, Fac Hlth Sci, Dept Audiol, Ankara, Turkey; [Turkyilmaz, Didem; Aksoy, Songul] Hacettepe Univ, Inst Hlth Sci, Dept Audiol, Ankara, Turkey; [Yagcioglu, Suha] Hacettepe Univ, Fac Med, Dept Biophys, TR-06100 Ankara, Turkey		Mujdeci, B (corresponding author), Yildirim Beyazit Univ, Fac Hlth Sci, Dept Audiol, Ankara, Turkey.	banumujdeci@yahoo.com	AKSOY, SERCAN/J-1232-2013				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Barin K, 1994, ENGSYS DESIGN ANAL, V4, P163; Barra J, 2006, EXP BRAIN RES, V174, P734, DOI 10.1007/s00221-006-0519-2; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Chong RKY, 2010, NEUROPSYCHOLOGIA, V48, P2709, DOI 10.1016/j.neuropsychologia.2010.05.018; Cocchini G, 2002, MEM COGNITION, V30, P1086, DOI 10.3758/BF03194326; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Horak FB, 2009, AGE AGEING S2, V35, pii7; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Makizako H, 2010, J PHYS THER SCI, V22, P323, DOI 10.1589/jpts.22.323; Marsh AP, 2000, GAIT POSTURE, V12, P105, DOI 10.1016/S0966-6362(00)00074-6; Maylor EA, 2001, BRIT J PSYCHOL, V92, P319, DOI 10.1348/000712601162211; MCCULLOCH K, 2007, J NEUROL PHYS THER, V31, P104; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; Nascimbeni A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-47; Neurocom, 2001, INT NEUROCOM SYST OP; Nijhuis LBO, 2007, J NEUROPHYSIOL, V98, P3047, DOI 10.1152/jn.01303.2006; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Ramenzoni VC, 2007, GAIT POSTURE, V25, P368, DOI 10.1016/j.gaitpost.2006.04.014; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Redfern MS, 2004, GAIT POSTURE, V19, P105, DOI 10.1016/S0966-6362(03)00032-8; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riley MA, 2005, J MOTOR BEHAV, V37, P311, DOI 10.3200/JMBR.37.4.311-324; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118	40	13	13	0	14	ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL	SAO PAULO	AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL	1808-8694	1808-8686		BRAZ J OTORHINOLAR	Braz. J. Otorhinolaryngol.	JAN-FEB	2016	82	1					3	10		10.1016/j.bjorl.2015.10.011			8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology	DF9AI	WOS:000371652200002	26727605	Green Published, gold			2022-02-06	
J	Noel, F; Moniruzzaman, A; Somers, J; Frankish, J; Strehlau, V; Schutz, C; Krausz, M				Noel, Francois; Moniruzzaman, Akm; Somers, Julian; Frankish, Jim; Strehlau, Verena; Schuetz, Christian; Krausz, Michael			A longitudinal study of suicidal ideation among homeless, mentally ill individuals	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article						Suicidal ideation; Mood disorders; Substance-related disorders; Homeless persons	SUBSTANCE USE; SELF-HARM; DISORDERS; DEPRESSION; MORTALITY; PEOPLE; ASSOCIATIONS; SYMPTOMS; SHELTERS; BEHAVIOR	Purpose Previous cross-sectional studies have indicated that homeless individuals may present with high rates of suicidal ideation, which are strongly associated with completed suicide. We conducted the first known longitudinal study of suicidal ideation in the homeless. Methods We used data collected over 24 months in the Vancouver At Home project (N = 497), comprised two randomized-controlled trials of housing interventions for homeless individuals with mental disorders. Presence of suicidal ideation was determined using the Colorado symptom index. Results Suicidal ideation significantly decreased over time [odds ratio (OR) = 0.31 at 24 months, 95 % confidence interval (CI) 0.21-0.46]. Baseline diagnoses of mood (OR = 2.18, 95 % CI 1.48-3.21) and anxiety disorders (OR = 2.05, 95 % CI 1.42-2.97), as well as depressive mood (OR = 2.52, 95 % CI 1.90-3.33), use of any substance (OR = 1.59, 95 % CI 1.09-2.32), and polysubstance use (OR = 1.90, 95 % CI 1.40-2.60) were significantly associated with suicidal ideation in the multivariate model. Baseline diagnosis of a psychotic disorder (protective effect), daily substance use, intravenous drug use, recent arrest, multiple physical illnesses and history of traumatic brain injury were significantly associated with suicidal ideation in the unadjusted model only. Conclusions Interventions targeting depressive symptoms and substance use could help decrease suicide risk in homeless individuals. Mental health services need to be tailored to address the complex needs of socially marginalized individuals.	[Noel, Francois] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Moniruzzaman, Akm; Somers, Julian] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Frankish, Jim] Univ British Columbia, SPPH, Vancouver, BC V5Z 1M9, Canada; [Strehlau, Verena; Schuetz, Christian; Krausz, Michael] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Strehlau, Verena; Schuetz, Christian; Krausz, Michael] St Pauls Hosp, CHEOS, Vancouver, BC V6Z 1Y6, Canada; [Noel, Francois] Inst Univ Sante Mentale Montreal, 7401 Hochelaga, Montreal, PQ H1N 3M5, Canada		Noel, F (corresponding author), Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada.; Noel, F (corresponding author), Inst Univ Sante Mentale Montreal, 7401 Hochelaga, Montreal, PQ H1N 3M5, Canada.	francois.noel@umontreal.ca			Health Canada; Mental Health Commission of Canada	This research was funded by Health Canada and the Mental Health Commission of Canada. The views expressed herein solely represent the authors. The authors declare no conflict of interest.	Austin J, 2011, ADDICT BEHAV, V36, P941, DOI 10.1016/j.addbeh.2011.05.001; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P363, DOI 10.1007/BF02207489; Bickley H, 2006, SOC PSYCH PSYCH EPID, V41, P686, DOI 10.1007/s00127-006-0087-6; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Conrad K J, 2001, Ment Health Serv Res, V3, P141, DOI 10.1023/A:1011571531303; Cukrowicz K, 2010, SUICIDE LIFE-THREAT, V40, P535, DOI 10.1521/suli.2010.40.6.535; Desai RA, 2003, J NERV MENT DIS, V191, P365, DOI 10.1097/00005053-200306000-00003; Dietz TL, 2011, J SOC SERV RES, V37, P1, DOI 10.1080/01488376.2011.524511; Eynan R, 2002, SUICIDE LIFE-THREAT, V32, P418, DOI 10.1521/suli.32.4.418.22341; Fitzpatrick KM, 2007, J HEALTH PSYCHOL, V12, P750, DOI 10.1177/1359105307080604; Foster RP, 2007, AM J ORTHOPSYCHIAT, V77, P443, DOI 10.1037/0002-9432.77.3.443; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Goldstein G, 2012, PSYCHIAT RES, V199, P37, DOI 10.1016/j.psychres.2012.03.029; Gusmao R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066455; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Haw C, 2006, SOC PSYCH PSYCH EPID, V41, P918, DOI 10.1007/s00127-006-0106-7; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Howland RH, 2009, DRUG ALCOHOL DEPEN, V99, P248, DOI 10.1016/j.drugalcdep.2008.08.010; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Hunt GE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub3; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Krausz RM, 2013, SOC PSYCH PSYCH EPID, V48, P1235, DOI 10.1007/s00127-012-0649-8; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; Mathias CW, 2012, SUICIDE LIFE-THREAT, V42, P341, DOI 10.1111/j.1943-278X.2012.0095.x; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Nordentoft M, 2011, PROG NEURO-PSYCHOPH, V35, P848, DOI 10.1016/j.pnpbp.2010.11.038; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Sareen J, 2005, J NERV MENT DIS, V193, P450, DOI 10.1097/01.nmd.0000168263.89652.6b; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Somers JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-365; Walker J, 2010, GEN HOSP PSYCHIAT, V32, P218, DOI 10.1016/j.genhosppsych.2009.11.011; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867; Weitz E, 2014, J AFFECT DISORDERS, V167, P98, DOI 10.1016/j.jad.2014.05.036; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	13	13	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	JAN	2016	51	1					107	114		10.1007/s00127-015-1142-y			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DD8UR	WOS:000370202900011	26518774				2022-02-06	
J	Pagnozzi, AM; Dowson, N; Doecke, J; Fiori, S; Bradley, AP; Boyd, RN; Rose, S				Pagnozzi, Alex M.; Dowson, Nicholas; Doecke, James; Fiori, Simona; Bradley, Andrew P.; Boyd, Roslyn N.; Rose, Stephen			Automated, quantitative measures of grey and white matter lesion burden correlates with motor and cognitive function in children with unilateral cerebral palsy	NEUROIMAGE-CLINICAL			English	Article						Cerebral palsy; Magnetic resonance imaging; Brain lesion	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; BASAL GANGLIA; MRI; SEGMENTATION; INTEGRITY; VALIDITY; DAMAGE	White and grey matter lesions are the most prevalent type of injury observable in the Magnetic Resonance Images (MRIs) of children with cerebral palsy (CP). Previous studies investigating the impact of lesions in children with CP have been qualitative, limited by the lack of automated segmentation approaches in this setting. As a result, the quantitative relationship between lesion burden has yet to be established. In this study, we perform automatic lesion segmentation on a large cohort of data (107 children with unilateral CP and 18 healthy children) with a new, validated method for segmenting both white matter (WM) and grey matter (GM) lesions. The method has better accuracy (94%) than the best current methods (73%), and only requires standard structural MRI sequences. Anatomical lesion burdens most predictive of clinical scores of motor, cognitive, visual and communicative function were identified using the Least Absolute Shrinkage and Selection operator (LASSO). The improved segmentations enabled identification of significant correlations between regional lesion burden and clinical performance, which conform to known structure-function relationships. Model performance was validated in an independent test set, with significant correlations observed for both WM and GM regional lesion burden with motor function (p < 0.008), and between WM and GM lesions alone with cognitive and visual function respectively (p < 0.008). The significant correlation of GM lesions with functional outcome highlights the serious implications GM lesions, in addition to WM lesions, have for prognosis, and the utility of structural MRI alone for quantifying lesion burden and planning therapy interventions. (C) 2016 Commonwealth Scientific and Industrial Research Organisation. Published by Elsevier Inc.	[Pagnozzi, Alex M.; Dowson, Nicholas; Doecke, James; Rose, Stephen] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia; [Pagnozzi, Alex M.; Bradley, Andrew P.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia; [Fiori, Simona] IRCCS Stella Maris Fdn, Pisa, Italy; [Boyd, Roslyn N.] Univ Queensland, Queensland Cerebral Palsy & Rehabil Res Ctr, Ctr Childrens Hlth Res, Fac Med & Sci, Brisbane, Qld, Australia		Pagnozzi, AM (corresponding author), Royal Brisbane & Womens Hosp, Australian E Hlth Res Ctr, Level 5,UQ Hlth Sci Bldg, Herston, Qld 4029, Australia.	Alex.Pagnozzi@csiro.au	fiori, simona/K-7515-2016; Bradley, Andrew P./C-5685-2009; Bradley, Andrew P./O-8516-2019; Boyd, Roslyn N/A-4498-2011; Rose, Stephen/C-8044-2009; Dowson, Nicholas D H/B-7621-2017; Pagnozzi, Alex Michael/C-4777-2014	fiori, simona/0000-0002-0933-6120; Bradley, Andrew P./0000-0003-0109-6844; Bradley, Andrew P./0000-0003-0109-6844; Boyd, Roslyn N/0000-0002-4919-5975; Dowson, Nicholas D H/0000-0003-4694-5459; Pagnozzi, Alex Michael/0000-0001-7931-1204; Rose, Stephen/0000-0003-1558-6297	University of QueenslandUniversity of Queensland; Commonwealth Scientific Industrial and Research Organisation (CSIRO)Commonwealth Scientific & Industrial Research Organisation (CSIRO); Foundation for Children Grant; NHMRCNational Health and Medical Research Council of Australia [1003887]; Smart Futures Co-Investment Program Grant; ARCAustralian Research Council [FT110100623]	Alex M. Pagnozzi is supported by the Australian Postgraduate Award (APA) from The University of Queensland, and the Commonwealth Scientific Industrial and Research Organisation (CSIRO). Roslyn N. Boyd is supported by a Foundation for Children Grant, NHMRC Research Fellowship (2015-2020) and a NHMRC Project Grant COMBIT (1003887). Roslyn N. Boyd and Stephen Rose are supported by the by the Smart Futures Co-Investment Program Grant. Andrew Bradley is supported by an ARC Future fellowship (FT110100623). The funding bodies have not contributed to the study design, the collection, management, analysis and interpretation of data, the writing of final reports or the decision to submit findings for publication. No other authors have potential conflicts of interest to declare.	Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bernal B, 2010, MAGN RESON IMAGING, V28, P217, DOI 10.1016/j.mri.2009.07.008; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Boyd R. N., 2013, BMJ OPEN, P3, DOI [DOI 10.1136/BMJOPEN-2013-002853, 10.1136/bmjopen-2013-002853]; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Cioni G, 2011, PROG BRAIN RES, V189, P139, DOI 10.1016/B978-0-444-53884-0.00022-1; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Fiori S, 2015, NEUROIMAGE-CLIN, V8, P104, DOI 10.1016/j.nicl.2015.04.005; Frostig M., 1961, PERCEPT MOTOR SKILL, V12, P383, DOI DOI 10.2466/PMS.1961.12.3.383; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Himmelmann K, 2011, DEV MED CHILD NEUROL, V53, P516, DOI 10.1111/j.1469-8749.2011.03932.x; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krumlinde-Sundholm L, 2007, DEV MED CHILD NEUROL, V49, P259, DOI 10.1111/j.1469-8749.2007.00259.x; Llado X, 2012, INFORM SCIENCES, V186, P164, DOI 10.1016/j.ins.2011.10.011; Martinez-Biarge M, 2010, EARLY HUM DEV, V86, P675, DOI 10.1016/j.earlhumdev.2010.08.013; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Pagnozzi A. M., 2015, DIGITAL IMAGE COMPUT; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Reid SM, 2014, DEV MED CHILD NEUROL, V56, P178, DOI 10.1111/dmcn.12331; Rivest-Henault D., 2015, MED IMAGE ANAL; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wechsler D., 1967, WECHSLER PRESCHOOL P	30	13	13	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						751	759		10.1016/j.nicl.2016.05.018			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ9BD	WOS:000379504500082	27330975	Green Published, gold			2022-02-06	
J	Ray, JJ; Meizoso, JP; Satahoo, SS; Davis, JS; Van Haren, RM; Dermer, H; Jill, G; Bahouth, GT; Blackbourne, LH; Schulman, CI				Ray, Juliet J.; Meizoso, Jonathan P.; Satahoo, Shevonne S.; Davis, James S.; Van Haren, Robert M.; Dermer, Harrison; Jill, Graygo; Bahouth, George T.; Blackbourne, Lorne H.; Schulman, Carl I.			Potentially preventable prehospital deaths from motor vehicle collisions	TRAFFIC INJURY PREVENTION			English	Article						car; road; traffic; crash; accident; injury; mortality	TRAUMATIC BRAIN-INJURY; MEDICAL-MANAGEMENT; PATIENT SAFETY; CARE; HEMORRHAGE; IMPACT; ERRORS	Background: In 2011, about 30,000 people died in motor vehicle collisions (MVCs) in the United States. We sought to evaluate the causes of prehospital deaths related to MVCs and to assess whether these deaths were potentially preventable.Methods: Miami-Dade Medical Examiner records for 2011 were reviewed for all prehospital deaths of occupants of 4-wheeled motor vehicle collisions. Injuries were categorized by affected organ and anatomic location of the body. Cases were reviewed by a panel of 2 trauma surgeons to determine cause of death and whether the death was potentially preventable. Time to death and hospital arrival times were determined using the Fatality Analysis Reporting System (FARS) data from 2002 to 2012, which allowed comparison of our local data to national prevalence estimates.Results: Local data revealed that 39% of the 98 deaths reviewed were potentially preventable (PPD). Significantly more patients with PPD had neurotrauma as a cause of death compared to those with a nonpreventable death (NPD) (44.7% vs. 25.0%, P =.049). NPDs were significantly more likely to have combined neurotrauma and hemorrhage as cause of death compared to PPDs (45.0% vs. 10.5%, P <.001). NPDs were significantly more likely to have injuries to the chest, pelvis, or spine. NPDs also had significantly more injuries to the following organ systems: lung, cardiac, and vascular chest (all P <.05). In the nationally representative FARS data from 2002 to 2012, 30% of deaths occurred on scene and another 32% occurred within 1h of injury. When comparing the 2011 FARS data for Miami-Dade to the remainder of the United States in that year, percentage of deaths when reported on scene (25 vs. 23%, respectively) and within 1h of injury (35 vs. 32%, respectively) were similar.Conclusions: Nationally, FARS data demonstrated that two thirds of all MVC deaths occurred within 1h of injury. Over a third of prehospital MVC deaths were potentially preventable in our local sample. By examining injury patterns in PPDs, targeted intervention may be initiated.	[Ray, Juliet J.; Meizoso, Jonathan P.; Satahoo, Shevonne S.; Davis, James S.; Van Haren, Robert M.; Dermer, Harrison; Schulman, Carl I.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Miami, FL 33136 USA; [Jill, Graygo; Bahouth, George T.] Impact Res LLC, Columbia, MD USA; [Blackbourne, Lorne H.] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA		Schulman, CI (corresponding author), Univ Miami, Sch Med, DeWitt Daughtry Family Dept Surg, Ryder Trauma Ctr, 1800 NW 10th Ave,Suite T 215 D40, Miami, FL 33136 USA.	cschulman@med.miami.edu	Van Haren, Robert/T-8218-2019; Meizoso, Jonathan/AAF-5777-2019; Schulman, Carl/AAE-7448-2021	Meizoso, Jonathan/0000-0002-6616-6682; Bahouth, George/0000-0002-4891-7497; Schulman, Carl/0000-0001-8899-4350			American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP D; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bulger EM, 2014, PREHOSP EMERG CARE, V18, P163, DOI 10.3109/10903127.2014.896962; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CAYTEN CG, 1991, ANN SURG, V214, P510, DOI 10.1097/00000658-199110000-00015; Centers for Disease Control and Prevention, 2012, VIT SIGNS HLTH BURD; Centers for Disease Control and Prevention, INJ PREV CONTR MOT V; Chang A, 2005, INT J QUAL HEALTH C, V17, P95, DOI 10.1093/intqhc/mzi021; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Ivatury RR, 2008, J TRAUMA, V64, P265, DOI 10.1097/TA.0b013e318163359d; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Motomura T, 2014, J NIPPON MED SCH, V81, P320, DOI 10.1272/jnms.81.320; Passos E, 2014, INJURY, V45, P573, DOI 10.1016/j.injury.2013.11.031; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Rago AP, 2015, J TRAUMA ACUTE CARE, V78, P324, DOI 10.1097/TA.0000000000000507; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Scott I, 2013, EMERG MED J, V30, P1070, DOI 10.1136/emermed-2013-203211; SELECKI BR, 1986, AUST NZ J SURG, V56, P529, DOI 10.1111/j.1445-2197.1986.tb07095.x; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Vioque SM, 2014, AM J SURG, V208, P187, DOI 10.1016/j.amjsurg.2014.02.006; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; WEINBERG CR, 1994, AM J EPIDEMIOL, V140, P565, DOI 10.1093/oxfordjournals.aje.a117283; WEST JG, 1982, ARCH SURG-CHICAGO, V117, P1033; WILSON DS, 1992, J TRAUMA, V32, P45, DOI 10.1097/00005373-199201000-00010; World Health Organization, 2015, GLOB HLTH OBS DAT	31	13	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2016	17	7					676	680		10.1080/15389588.2016.1149580			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	DX4BC	WOS:000384322100003	26890273				2022-02-06	
J	Rosengren, L; Brogardh, C; Jacobsson, L; Lexell, J				Rosengren, Lina; Brogardh, Christina; Jacobsson, Lars; Lexell, Jan			Life satisfaction and associated factors in persons with mild to moderate Parkinson's disease	NEUROREHABILITATION			English	Article						Activities of daily living; disability evaluation; health services for persons with disabilities; Parkinson's disease; quality of life; questionnaires; rehabilitation; sense of coherence	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; NORMAL LIVING INDEX; GERIATRIC DEPRESSION SCALE; COHERENCE SCALE; NORTHERN SWEDEN; SENSE; DISABILITY; PEOPLE	BACKGROUND: Life satisfaction (LS) is an overall goal in the long-term management and rehabilitation of persons with Parkinson's disease (PD). However, very little is known about LS in persons with PD and no study has examined factors associated with their LS. OBJECTIVE: To describe LS in persons with mild to moderate PD and to evaluate the association with gender, age, years since diagnosis, and sense of coherence, perceived participation, and mental and emotional status. METHODS: Eighty persons with mild to moderate PD (46 men and 34 women, mean age 70.1 years, mean time since diagnosis 7.4 years) responded to a postal survey with the Swedish versions of the Satisfaction With Life Scale (SWLS), the Sense of Coherence scale (SOC-13), the Reintegration to Normal Living Index (RNLI) and the Geriatric Depression Scale (GDS-20). Hierarchical multiple regression analyses were used to evaluate the association with LS. RESULTS: The mean SWLS total score was 21.8 points, and 45% rated themselves as satisfied to highly satisfied with their lives. SOC and years since diagnosis explained 36% of the variance, where a strong SOC, indicating a person's capacity to adapt to the overall strains of the disease, showed the strongest association with a high LS. CONCLUSIONS: Persons with mild to moderate PD seem to be generally satisfied with their lives but LS may decrease as the disease progresses. The strong association with SOC implies that LS may increase through rehabilitation that support persons with PD to understand and confront the nature of problems arising in their lives as a result of their PD.	[Rosengren, Lina; Jacobsson, Lars; Lexell, Jan] Lund Univ, Rehabil Med Res Grp, Dept Hlth Sci, Lund, Sweden; [Brogardh, Christina] Lund Univ, Physiotherapy Res Grp, Dept Hlth Sci, Lund, Sweden; [Brogardh, Christina; Lexell, Jan] Skane Univ Hosp, Dept Neurol & Rehabil Med, Lund, Sweden; [Jacobsson, Lars; Lexell, Jan] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Jacobsson, Lars] Sunderby Hosp, Dept Rehabil Med, Lulea, Sweden		Rosengren, L (corresponding author), Lund Univ, Dept Hlth Sci, POB 157, SE-22100 Lund, Sweden.	lina.rosengren@med.lu.se		Jacobsson, Lars/0000-0002-1127-1178	Swedish Parkinson Foundation	This study was accomplished within the strategic research area for neuroscience at Lund University (MultiPark) and supported by a grant from the Swedish Parkinson Foundation.	Antonovsky A., 1987, UNRAVELING MYSTERY H; ARMITAGE P, 2002, STAT METHODS MED RES, P358; Bhatia S, 2003, NEUROREHABILITATION, V18, P209; Bluvol A, 2004, J ADV NURS, V48, P322, DOI 10.1111/j.1365-2648.2004.03004.x; Caap-Ahlgren M, 2004, SCAND J CARING SCI, V18, P154, DOI 10.1111/j.1471-6712.2004.00248.x; Carne W, 2005, NEUROREHABILITATION, V20, P161; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2006, UNDERSTANDNING SWLS; Duncan RP, 2011, DISABIL REHABIL, V33, P1440, DOI 10.3109/09638288.2010.533245; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Ertan FS, 2005, J NEUROL NEUROSUR PS, V76, P1445, DOI 10.1136/jnnp.2004.057984; Field A., 2014, DISCOVERING STAT USI, P293; Forsberg KA, 2010, J CLIN NURS, V19, P1519, DOI 10.1111/j.1365-2702.2009.03010.x; Franchignoni F, 2007, Eura Medicophys, V43, P451; Gottfries C G, 1997, Lakartidningen, V94, P1099; Gottfries GG, 1997, INT J GERIATR PSYCH, V12, P1029; Hitzig SL, 2012, ARCH PHYS MED REHAB, V93, P108, DOI 10.1016/j.apmr.2011.07.200; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Johnston M, 2010, NEUROREHABILITATION, V26, P375, DOI 10.3233/NRE-2010-0575; Kallenberg K., 1996, EUROPEAN J PUBLIC HL, V6, P175, DOI [10.1093/eurpub/6.3.175, DOI 10.1093/EURPUB/6.3.175]; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Langius A, 1993, Scand J Caring Sci, V7, P3; Langius A, 1992, Scand J Caring Sci, V6, P165; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lucas-Carrasco R, 2014, DISABIL REHABIL, V36, P1001, DOI 10.3109/09638288.2013.825650; Lucas-Carrasco R, 2014, SCI WORLD J, DOI 10.1155/2014/680659; Lund ML, 2007, DISABIL REHABIL, V29, P1417, DOI 10.1080/09638280601029068; Lund ML, 2009, DISABIL REHABIL, V31, P1592, DOI 10.1080/09638280802638881; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Martinez-Martin P, 2015, EUR J NEUROL, V22, P37, DOI 10.1111/ene.12165; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P316, DOI 10.1017/S1041610211001360; Mimura Masaru, 2007, Brain and Nerve (Tokyo), V59, P935; Oguru M, 2010, J GERIATR PSYCH NEUR, V23, P35, DOI 10.1177/0891988709351834; Pallant JF, 2002, PERS INDIV DIFFER, V33, P39, DOI 10.1016/S0191-8869(01)00134-9; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Post MWM, 1999, CLIN REHABIL, V13, P5, DOI 10.1191/026921599701532072; Pusswald G, 2009, Z GERONTOL GERIATR, V42, P220, DOI 10.1007/s00391-008-0009-1; Pusswald G, 2012, INT PSYCHOGERIATR, V24, P1972, DOI 10.1017/S1041610212001330; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Rosengren L, 2015, ACTA NEUROL SCAND, V132, P164, DOI 10.1111/ane.12380; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Stark SL, 2005, ARCH PHYS MED REHAB, V86, P344, DOI 10.1016/j.apmr.2004.03.020; Terriff DL, 2012, PARKINSONISM RELAT D, V18, P828, DOI 10.1016/j.parkreldis.2012.03.026; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088; van Koppenhagen CF, 2008, ARCH PHYS MED REHAB, V89, P1733, DOI 10.1016/j.apmr.2007.12.042; Vastamaki J, 2009, SCAND J PSYCHOL, V50, P161, DOI 10.1111/j.1467-9450.2008.00695.x; Williams JR, 2012, NEUROLOGY, V78, P998, DOI 10.1212/WNL.0b013e31824d587f; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 2007, INT CLASS FUNCT DIS; Zahodne LB, 2012, J GERIATR PSYCH NEUR, V25, P131, DOI 10.1177/0891988712455236	54	13	13	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	2					285	294		10.3233/NRE-161359			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DT7HD	WOS:000381656800011	27341371				2022-02-06	
J	Stone, JR; Wilde, EA; Taylor, BA; Tate, DF; Levin, H; Bigler, ED; Scheibel, RS; Newsome, MR; Mayer, AR; Abildskov, T; Black, GM; Lennon, MJ; York, GE; Agarwal, R; DeVillasante, J; Ritter, JL; Walker, PB; Ahlers, ST; Tustison, NJ				Stone, James R.; Wilde, Elisabeth A.; Taylor, Brian A.; Tate, David F.; Levin, Harvey; Bigler, Erin D.; Scheibel, Randall S.; Newsome, Mary R.; Mayer, Andrew R.; Abildskov, Tracy; Black, Garrett M.; Lennon, Michael J.; York, Gerald E.; Agarwal, Rajan; DeVillasante, Jorge; Ritter, John L.; Walker, Peter B.; Ahlers, Stephen T.; Tustison, Nicholas J.			Supervised learning technique for the automated identification of white matter hyperintensities in traumatic brain injury	BRAIN INJURY			English	Article						Neuroimaging; brain imaging; magnetic resonance imaging; machine learning; random forest decision tree; deep learning; TBI	IMAGE REGISTRATION; AXONAL INJURY; MR-IMAGES; SEGMENTATION; LESIONS; METAANALYSIS; FORESTS; VOLUME; ANTS	Background: White matter hyperintensities (WMHs) are foci of abnormal signal intensity in white matter regions seen with magnetic resonance imaging (MRI). WMHs are associated with normal ageing and have shown prognostic value in neurological conditions such as traumatic brain injury (TBI). The impracticality of manually quantifying these lesions limits their clinical utility and motivates the utilization of machine learning techniques for automated segmentation workflows.Methods: This study develops a concatenated random forest framework with image features for segmenting WMHs in a TBI cohort. The framework is built upon the Advanced Normalization Tools (ANTs) and ANTsR toolkits. MR (3D FLAIR, T2- and T1-weighted) images from 24 service members and veterans scanned in the Chronic Effects of Neurotrauma Consortium's (CENC) observational study were acquired. Manual annotations were employed for both training and evaluation using a leave-one-out strategy. Performance measures include sensitivity, positive predictive value, score and relative volume difference.Results: Final average results were: sensitivity = 0.68 0.38, positive predictive value = 0.51 +/- 0.40, = 0.52 +/- 0.36, relative volume difference = 43 +/- 26%. In addition, three lesion size ranges are selected to illustrate the variation in performance with lesion size.Conclusion: Paired with correlative outcome data, supervised learning methods may allow for identification of imaging features predictive of diagnosis and prognosis in individual TBI patients.	[Stone, James R.; Tustison, Nicholas J.] Univ Virginia, Dept Radiol & Med Imaging, Box 800170,1215 Lee St, Charlottesville, VA 22908 USA; [Stone, James R.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey; Scheibel, Randall S.; Newsome, Mary R.; Agarwal, Rajan] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey; Scheibel, Randall S.; Newsome, Mary R.; Black, Garrett M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Taylor, Brian A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Bigler, Erin D.; Abildskov, Tracy; Black, Garrett M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Mayer, Andrew R.] Mind Res Network, Dept Translat Neurosci, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico Hlth Ctr, Dept Neurol, Albuquerque, NM USA; [Lennon, Michael J.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [York, Gerald E.] Alaska Radiol Associates, Anchorage, AK USA; [DeVillasante, Jorge] USF Morsani Coll Med, Dept Radiol, Tampa, FL USA; [Ritter, John L.] San Antonio Mil Med Ctr, Dept Radiol, San Antonio, TX USA; [Ritter, John L.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Washington, DC USA; [Walker, Peter B.; Ahlers, Stephen T.] Naval Med Res Ctr, Silver Spring, MD USA		Stone, JR (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, Box 800170,1215 Lee St, Charlottesville, VA 22908 USA.	jrs7r@virginia.edu	Ritter, John/AAG-8899-2020; Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920; Taylor, Brian/0000-0001-9745-1075; TUSTISON, NICHOLAS/0000-0001-9418-5103	Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001135, I01 RX 002174]; USUHS Grant [HU 0001-08-0001]; Veterans AffairsUS Department of Veterans Affairs [I21RX001608, I01RX002174] Funding Source: NIH RePORTER	This project was jointly supported by the Department of Defense (W81XWH-13-2-0095), the US Department of Veterans Affairs (I01 CX001135 and I01 RX 002174), as well as USUHS Grant HU 0001-08-0001. The authors report no financial disclosures or conflicts of interest. The views expressed here are those of the authors and do not necessarily reflect the official policy of position of the Department of the Navy, Department of Defense, nor the US Government. This work was prepared as a part of official duties; Title 17 USC 105 provides that copyright protection under this title is not available for any work of the US Government. Title 17 USC 101 defines a US Governmentwork as awork prepared by a military service member of employee of the US Government as part of that person's official duties.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bauer S., 2012, MICCAI BRATS WORKSH, P10; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pustina D, 2016, HUM BRAIN MAPP, V37, P1405, DOI 10.1002/hbm.23110; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Tustison NJ, 2015, NEUROINFORMATICS, V13, P209, DOI 10.1007/s12021-014-9245-2; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Tustison NJ, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00039; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Van Ginneken B., 2007, P MICCAI WORKSH 3D S, V1, P7; Viola P, 2005, INT J COMPUT VISION, V63, P153, DOI 10.1007/s11263-005-6644-8; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Yi Z, 2009, LECT NOTES COMPUT SC, V5762, P558; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zikic, 2012, P MICCAI BRATS, P1	39	13	13	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1458	1468		10.1080/02699052.2016.1222080			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100008	27834541				2022-02-06	
J	Hwang, BW; Kim, SJ; Park, KM; Kim, H; Yeom, J; Yang, JA; Jeong, H; Jung, H; Kim, K; Sung, YC; Hahn, SK				Hwang, Byung Woo; Kim, Su Jin; Park, Kyeng Min; Kim, Hyemin; Yeom, Junseok; Yang, Jeong-A; Jeong, Hyeonseon; Jung, Hyuntae; Kim, Kimoon; Sung, Young Chul; Hahn, Sei Kwang			Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels	JOURNAL OF CONTROLLED RELEASE			English	Article						Hydrogel; Stem cell; Transgene expression; Cell therapy; Tissue regeneration	UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; BASEMENT-MEMBRANE MATRIX; TRAUMATIC BRAIN-INJURY; GENE-THERAPY; IN-VITRO; GROWTH-FACTOR; ADIPOSE-TISSUE; STROMAL CELLS; MYOCARDIAL-INFARCTION	Stem cell therapy has attracted a great deal of attention for treating intractable diseases such as cancer, stroke, liver cirrhosis, and ischemia. Especially, mesenchymal stemcells (MSCs) have been widely investigated for therapeutic applications due to the advantageous characteristics of long life-span, facile isolation, rapid proliferation, prolonged transgene expression, hypo-immunogenicity, and tumor tropism. MSCs can exert their therapeutic effects by releasing stress-induced therapeutic molecules after their rapid migration to damaged tissues. Recently, to improve the therapeutic efficacy, genetically engineered MSCs have been developed for therapeutic transgene expression by viral gene transduction and non-viral gene transfection. In general, the number of therapeutic cells for injection should be more than several millions for effective cell therapy. Adequate carriers for the controlled delivery of MSCs can reduce the required cell numbers and extend the duration of therapeutic effect, which provide great benefits for chronic disease patients. In this review, we describe genetic engineering of MSCs, recent progress of self-assembling supramolecular hydrogels, and their applications to cell therapy for intractable diseases and tissue regeneration. (C) 2015 Elsevier B.V. All rights reserved.	[Hwang, Byung Woo; Kim, Hyemin; Yeom, Junseok; Yang, Jeong-A; Jeong, Hyeonseon; Hahn, Sei Kwang] Dept Mat Sci & Engn, Pohang 790784, Gyeongbuk, South Korea; [Kim, Su Jin; Sung, Young Chul] Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea; [Park, Kyeng Min; Kim, Kimoon] Inst for Basic Sci Korea, Dept Chem, Div Adv Mat Sci, Ctr Self Assembly & Complex, Pohang 790784, Gyeongbuk, South Korea; [Jung, Hyuntae; Kim, Kimoon; Sung, Young Chul; Hahn, Sei Kwang] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Gyeongbuk, South Korea; [Park, Kyeng Min] UST, Dept Nanomat Sci & Engn, Daejeon 305333, South Korea		Kim, K (corresponding author), Inst for Basic Sci Korea, Dept Chem, Div Adv Mat Sci, Ctr Self Assembly & Complex, 77 Cheongam Ro, Pohang 790784, Gyeongbuk, South Korea.	kkim@postech.ac.kr; ycsung@postech.ac.kr; skhanb@postech.ac.kr	Hahn, Sei Kwang/L-6037-2019; Kim, Hyemin/I-1547-2018; Park, Kyeng Min/U-1370-2017; Kim, Kimoon/B-7181-2008; Park, Kyeng Min/I-5815-2019; Kim, Hyemin/AAP-1700-2020	Park, Kyeng Min/0000-0001-6089-6169; Park, Kyeng Min/0000-0001-6089-6169; Kim, Hyemin/0000-0001-8534-3886; Yeom, Junseok/0000-0003-3556-2911; Hahn, Sei Kwang/0000-0002-7718-6259	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C1658]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean Government (MEST) [2012M3A9C6049791]; Institute for Basic Science [IBS-R007-D1]	This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C1658) and the Bio & Medical Technology Development Program (No. 2012M3A9C6049791) of the National Research Foundation (NRF) funded by the Korean Government (MEST). This work was supported by Institute for Basic Science [IBS-R007-D1].	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; [Anonymous], 2012, NAT BIOTECHNOL, V30, P805, DOI 10.1038/nbt.2363; Appel EA, 2014, ANGEW CHEM INT EDIT, V53, P10038, DOI 10.1002/anie.201403192; Appel EA, 2010, J AM CHEM SOC, V132, P14251, DOI 10.1021/ja106362w; Aquino JB, 2010, GENE THER, V17, P692, DOI 10.1038/gt.2010.10; Ayhan MM, 2015, J AM CHEM SOC, V137, P10238, DOI 10.1021/jacs.5b04553; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Blow N, 2009, NAT METHODS, V6, P619, DOI 10.1038/nmeth0809-619; Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen Q, 2009, BIOCHEM BIOPH RES CO, V381, P192, DOI 10.1016/j.bbrc.2009.02.040; Cheng XJ, 2013, ANGEW CHEM INT EDIT, V52, P7252, DOI 10.1002/anie.201210267; Connors KA, 1997, CHEM REV, V97, P1325, DOI 10.1021/cr960371r; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; Devine SM, 2002, J CELL BIOCHEM, P73, DOI 10.1002/jcb.10046; Elzaouk L, 2006, EXP DERMATOL, V15, P865, DOI 10.1111/j.1600-0625.2006.00479.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Gomes CMF, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt189; Fridman R, 2012, NAT PROTOC, V7, P1138, DOI 10.1038/nprot.2012.053; Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009; Gage FH, 1998, NATURE, V392, P18; Gao ZB, 2013, NANOMED-NANOTECHNOL, V9, P174, DOI 10.1016/j.nano.2012.06.003; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Ha SJ, 2002, NAT BIOTECHNOL, V20, P381, DOI 10.1038/nbt0402-381; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663; Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934; Hou L, 2011, CARBOHYD POLYM, V86, P1157, DOI 10.1016/j.carbpol.2011.06.008; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jung H, 2014, BIOMACROMOLECULES, V15, P707, DOI 10.1021/bm401123m; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kedziorek DA, 2012, STEM CELLS, V30, P1286, DOI 10.1002/stem.1096; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim J, 2000, J AM CHEM SOC, V122, P540, DOI 10.1021/ja993376p; Kim K, 2004, CHEM COMMUN, P848, DOI 10.1039/b400783b; Kim SW, 2013, CLIN CANCER RES, V19, P415, DOI 10.1158/1078-0432.CCR-12-1568; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kim Y, 2009, CHEM-EUR J, V15, P6143, DOI 10.1002/chem.200900305; Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Ko YH, 2004, J AM CHEM SOC, V126, P1932, DOI 10.1021/ja031567t; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kretschmann O, 2006, ANGEW CHEM INT EDIT, V45, P4361, DOI 10.1002/anie.200504539; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee JW, 2003, ACCOUNTS CHEM RES, V36, P621, DOI 10.1021/ar020254k; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Liu SM, 2005, J AM CHEM SOC, V127, P16798, DOI 10.1021/ja056287n; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Loebinger MR, 2010, THORAX, V65, P362, DOI 10.1136/thx.2009.128025; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; Mishra A, 2011, NANO TODAY, V6, P232, DOI 10.1016/j.nantod.2011.05.001; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Moon HH, 2014, BIOMATERIALS, V35, P1744, DOI 10.1016/j.biomaterials.2013.11.019; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022; Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100; Nowakowski A, 2013, ACTA NEUROBIOL EXP, V73, P1; Oh HJ, 2012, CELL PROLIFERAT, V45, P438, DOI 10.1111/j.1365-2184.2012.00838.x; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parisi-Amon A, 2013, ADV HEALTHC MATER, V2, P428, DOI 10.1002/adhm.201200293; Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030; Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]; Park KM, 2012, ACS NANO, V6, P2960, DOI 10.1021/nn204123p; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002-0109; Rauwald U, 2010, J PHYS CHEM B, V114, P8606, DOI 10.1021/jp102933h; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shah K, 2012, ADV DRUG DELIVER REV, V64, P739, DOI 10.1016/j.addr.2011.06.010; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Studeny M, 2002, CANCER RES, V62, P3603; Sun B, 2010, CANCER LETT, V296, P178, DOI 10.1016/j.canlet.2010.04.007; Sun Xu-Yong, 2011, World J Stem Cells, V3, P96, DOI 10.4252/wjsc.v3.i11.96; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tomanin R, 2004, CURR GENE THER, V4, P357; Tondreau T., MESENCHYMAL STEM CEL, P1105; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tseng TC, 2014, BIOMATERIALS, V35, P2630, DOI 10.1016/j.biomaterials.2013.12.021; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uchibori R, 2009, J GENE MED, V11, P373, DOI 10.1002/jgm.1313; Vanderbyl S, 2004, STEM CELLS, V22, P324, DOI 10.1634/stemcells.22-3-324; Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Yeom J, 2015, ADV HEALTHC MATER, V4, P237, DOI 10.1002/adhm.201400304; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014	150	13	14	0	81	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	DEC 28	2015	220		A				119	129		10.1016/j.jconrel.2015.10.034			11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	CY0TN	WOS:000366119100014	26485045				2022-02-06	
J	Naro, A; Russo, M; Leo, A; Rifici, C; Pollicino, P; Bramanti, P; Calabro, RS				Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore			Cortical Responsiveness to Nociceptive Stimuli in Patients with Chronic Disorders of Consciousness: Do C-Fiber Laser Evoked Potentials Have a Role?	PLOS ONE			English	Article							COMA RECOVERY SCALE; BRAIN POTENTIALS; A-DELTA; SURFACE-AREAS; PAIN; HYPERALGESIA; GUIDELINES; RESPONSES; PATHWAYS; NOVELTY	It has been shown that the presence of Ad-fiber laser evoked potentials (Ad-LEP) in patients suffering from chronic disorders of consciousness (DOC), such as vegetative state (VS) and minimally conscious state (MCS), may be the expression of a residual cortical pain arousal. Interestingly, the study of C-fiber LEP (C-LEP) could be useful in the assessment of cortical pain arousal in the DOC individuals who lack of A delta-LEP. To this end, we enrolled 38 DOC patients following post-anoxic or post-traumatic brain injury, who met the international criteria for VS and MCS diagnosis. Each subject was clinically evaluated, through the coma recovery scale-revised (CRS-R) and the nociceptive coma scale-revised (NCS-R), and electrophysiologically tested by means of a solid-state laser for A delta-LEP and C-LEP. VS individuals showed increased latencies and reduced amplitudes of both the A delta-LEP and C-LEP components in comparison to MCS patients. Although nearly all of the patients had both the LEP components, some VS individuals showed only the C-LEP ones. Notably, such patients had a similar NCS-R score to those having both the LEP components. Hence, we could hypothesize that C-LEP generators may be rearranged or partially spared in order to still guarantee cortical pain arousal when A delta-LEP generators are damaged. Therefore, the residual presence of C-LEP should be assessed when A delta-LEP are missing, since a potential pain experience should be still present in some patients, so to properly initiate, or adapt, the most appropriate pain treatment.	[Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	Rifici, Carmela/ABH-4398-2020; Calabro, Rocco S/K-7520-2016; Leo, Antonino/K-7529-2016; calabro, rocco salvatore/L-9570-2019; Bramanti, Placido/K-5117-2016; Leo, Antonino/ABI-7198-2020	Leo, Antonino/0000-0003-4163-5830; calabro, rocco salvatore/0000-0002-8566-3166; Leo, Antonino/0000-0003-4163-5830			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BENNETT GJ, 1994, TXB PAIN; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98, DOI 10.1152/jn.1983.49.1.98; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; de Tommaso M, 2013, BRAIN INJURY, V27, P962, DOI 10.3109/02699052.2013.775507; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; LAMOTTE RH, 1983, J NEUROPHYSIOL, V50, P1; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Lenz FA, 1991, PAIN CENTRAL NERVOU; Letham B, 2011, J NEUROSCI METH, V194, P374, DOI 10.1016/j.jneumeth.2010.10.016; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; Montagna W, 1959, P BROWN U S BIOL SKI; Mouraux A, 2006, Suppl Clin Neurophysiol, V59, P197; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Perchet C, 2008, CLIN NEUROPHYSIOL, V119, P2615, DOI 10.1016/j.clinph.2008.06.021; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; Spiegel J, 2000, CLIN NEUROPHYSIOL, V111, P725, DOI 10.1016/S1388-2457(99)00297-7; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Treede RD, 1998, PAIN FORUM, V7, P191, DOI 10.1016/S1082-3174(98)80005-6; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Valeriani M, 2002, NEUROSCI LETT, V329, P329, DOI 10.1016/S0304-3940(02)00671-7; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wang AL, 2010, J NEUROPHYSIOL, V104, P2116, DOI 10.1152/jn.01088.2009; Weng HR, 2000, NEUROSCIENCE, V101, P393, DOI 10.1016/S0306-4522(00)00368-7; Wu Q, 1999, PAIN, V80, P209, DOI 10.1016/S0304-3959(98)00206-1; Zanatta P, 2012, MINERVA ANESTESIOL, V78, P749	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144713	10.1371/journal.pone.0144713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	WOS:000366722700055	26674634	Green Submitted, gold, Green Published			2022-02-06	
J	Arnould, A; Rochat, L; Azouvi, P; Van der Linden, M				Arnould, Annabelle; Rochat, Lucien; Azouvi, Philippe; Van der Linden, Martial			Apathetic symptom presentations in patients with severe traumatic brain injury: Assessment, heterogeneity and relationships with psychosocial functioning and caregivers' burden	BRAIN INJURY			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; EXECUTIVE DYSFUNCTION; DIAGNOSTIC-CRITERIA; EMOTION PERCEPTION; SCHIZOPHRENIA; BEHAVIOR; REHABILITATION; INTERVENTION; EXPRESSION		[Arnould, Annabelle; Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Geneva, Switzerland; [Arnould, Annabelle; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, F-92380 Garches, France; [Arnould, Annabelle; Azouvi, Philippe] Univ Versailles St Quentin, EA 4047, HANDIReSP, Versailles, France; [Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, B-4000 Liege, Belgium		Arnould, A (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France.	annabelle.arnould@rpc.aphp.fr		Rochat, Lucien/0000-0002-9992-2720			Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; BURGESS PW, 1996, BEHAV ASSESSMENT DYS, P7; Burkard C, 2014, NEUROPSYCHOL REHABIL, V24, P266, DOI 10.1080/09602011.2014.887023; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Cohen J., 2013, STAT POWER ANAL BEHA; Damasio A., 1994, DESCARTES ERROR EMOT; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Esposito F, 2014, ARCH GERONTOL GERIAT, V58, P43, DOI 10.1016/j.archger.2013.09.002; Esposito F, 2012, DEMENT GER COGN D EX, V2, P456, DOI 10.1159/000345037; Esposito F, 2010, ALZ DIS ASSOC DIS, V24, P131, DOI 10.1097/WAD.0b013e3181c9c168; Evans JJ, 2003, STUD NEUROPSYCHOL DE, P53; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Henry JD, 2007, SCHIZOPHR RES, V95, P197, DOI 10.1016/j.schres.2007.06.002; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Lee JS, 2014, SCHIZOPHR RES, V152, P268, DOI 10.1016/j.schres.2013.10.043; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Robert PH, 2008, AM J GERIAT PSYCHIAT, V16, P770, DOI 10.1097/JGP.0b013e31817e73db; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Zarit SH., 1985, HIDDEN VICTIMS ALZHE	38	13	13	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1597	1603		10.3109/02699052.2015.1075156			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800010	26452012				2022-02-06	
J	Bonds, BW; Hu, P; Li, Y; Yang, SM; Colton, K; Gonchigar, A; Cheriyan, J; Grissom, T; Fang, R; Stein, DM				Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Cheriyan, Jerry; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.			Predictive value of hyperthermia and intracranial hypertension on neurological outcomes in patients with severe traumatic brain injury	BRAIN INJURY			English	Article						Hyperthermia; intracranial hypertension; traumatic brain injury	INTENSIVE-CARE-UNIT; THERAPEUTIC HYPOTHERMIA; NEUROCRITICAL CARE; FEVER; MANAGEMENT; PRESSURE; MODERATE; BURDEN; TRIAL	Background: Intracranial hypertension (ICH) and hyperthermia are common after traumatic brain injury (TBI) and associated with worse neurological outcomes. This study sets out to determine the combined power of temperature and intracranial pressure (ICP) for predicting neurologic outcomes and prolonged length of stay (LOS) following severe TBI.Methods: High resolution (every 6 seconds) temperature and ICP data were collected in adults with severe TBI from 2008-2010. Temperatures were plotted against concurrent ICP and divided based on breakpoints (Temperature: <36, 36-38.5 or >38.5 degrees C, ICP: <20, 20-30 or >30mmHg). The percentage of time spent in each section, as well as several pooled unfavourable conditions (hyperthermiaICH), were then evaluated for predictive value for ICU-LOS>7 days and short-term (<6 months) vs. long-term (>6 months) dichotomized neurologic outcomes.Results: Fifty patients were included for analysis with severe TBI. Evaluation of the area under the operating receiver curve (AUC) showed significant periods of fever and high ICP (<30mmHg) had a strong association with poor long-term neurological outcomes (Day 3, AUC=0.71, p=0.04) and were higher than either condition alone. ICU-LOS>7 days was increased when hyperthermia and/or ICH remained uncontrolled by Day 5 (AUC=0.82, p=0.02).Summary: Hyperthermia combined with ICH were shown to be significant prognostic indicators of future poor neurologic outcomes in patients with severe traumatic brain injury.	[Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.] Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; [Bonds, Brandon W.; Hu, Peter; Li, Yao; Yang, Shiming; Colton, Katharine; Gonchigar, Anish; Grissom, Thomas; Fang, Raymond; Stein, Deborah M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Colton, Katharine] Duke Univ, Sch Med, Durham, NC USA; [Cheriyan, Jerry] Marshfield Clin Fdn Med Res & Educ, Dept Surg, Marshfield, WI USA		Bonds, BW (corresponding author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	bbonds@stapa.umm.edu	Yang, Shiming/I-3695-2015; Grissom, Thomas E./AAH-5749-2019	Yang, Shiming/0000-0003-0338-4268; Cheriyan, Jerry/0000-0002-4624-0291; Stein, Deborah/0000-0003-3683-3963	USAF	This work was funded in part through a grant provided by the USAF. The views expressed in this article are those of the authors and do not necessarily represent the official position or policy of the US Air Force, the Department of Defense or the US Government.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brinnel H., 1987, HEAT STRESS PHYS EXE, P209; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Faul M, 2010, TRAUMATIC BRAIN INJU; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Gozzoli V, 2001, ARCH INTERN MED, V161, P121, DOI 10.1001/archinte.161.1.121; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holtzclaw BJ, 2002, ONLINE J CLIN INNOVA, V5, P1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Plaisance KI, 2000, ARCH INTERN MED, V160, P449, DOI 10.1001/archinte.160.4.449; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; Rupich K, 2009, J NEUROSCI NURS, V41, P159, DOI 10.1097/JNN.0b013e3181a23ec1; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Segatore M, 1992, J Neurosci Nurs, V24, P104; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720	41	13	14	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1642	1647		10.3109/02699052.2015.1075157			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800015	26479461				2022-02-06	
J	Prasad, GL; Gupta, DK; Mahapatra, AK; Sharma, BS				Prasad, G. Lakshmi; Gupta, Deepak Kumar; Mahapatra, Ashok Kumar; Sharma, Bhawani Shankar			Surgical results of decompressive craniectomy in very young children: A level one trauma centre experience from India	BRAIN INJURY			English	Article						Decompressive craniectomy; intracranial hypertension; intracranial pressure monitoring; paediatric; traumatic; young children	REFRACTORY INTRACRANIAL HYPERTENSION; BRAIN-INJURY; PEDIATRIC-PATIENTS; SINGLE-CENTER; HEAD-INJURY; INTENSIVE-CARE; PRESSURE; COMPLICATIONS; MANAGEMENT; MULTICENTER	Introduction: Literature remains sparse regarding decompressive craniectomy (DC) in traumatic brain injury (TBI) in very young children. This study analysed the indications, complications and outcome of young children undergoing DC for TBI at our institute.Study design: Retrospective.Observations: The total number of patients was 71. Mean age was 1.6 years. Mean duration from injury to surgery was 11.9 hours (range=3-80 hours). Around 50% had severe head injury. Intracranial pressure (ICP) monitoring was done in 33 patients. Mean ICP was 22.2mm Hg (range=9-50mm Hg). The threshold ICP for surgery was 15mm Hg. Perioperative mortality was 50% each for severe TBI (18/36) and diffuse cerebral edema (7/14), and 58% for infants (4/7). Ninety per cent of expired patients had ICP>20mm Hg. Mean follow-up duration was 19.6 months (range=2-42 months). Except one, all survivors had good-to-excellent outcomes (Glasgow outcome scale extended; GOS-E=7-8).Conclusions: Decompressive craniectomy offers a survival advantage in almost 50% of young children with severe TBI and should be used judiciously. The highest mortality was within the 1st week of surgery. The cut-off limit of 20mm Hg for surgical decompression might not be applicable to young children and a low threshold ICP needs to be considered. Factors associated with increased mortality are high opening ICP (>20mm Hg), GCS <8, diffuse cerebral oedema and infant age group. Timing of DC remains crucial. Further prospective studies are necessary to optimize the timing and ICP limit for surgical decompression.	[Prasad, G. Lakshmi; Gupta, Deepak Kumar; Mahapatra, Ashok Kumar; Sharma, Bhawani Shankar] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi 110029, India		Gupta, DK (corresponding author), All India Inst Med Sci, JPNATC, Dept Neurosurg, Room 306, New Delhi 110029, India.	drdeepakgupta@gmail.com		Prasad, G Lakshmi/0000-0002-9264-5943			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Duhaime AC, 1997, PEDIAT NEUROSURGICAL, P125; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Khan SA, 2014, CHILD NERV SYST, V30, P277, DOI 10.1007/s00381-013-2225-2; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lane PL, 2000, CAN J SURG, V43, P442; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; Rosin D, 2001, Int J Surg Investig, V2, P335; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Valentin A, 2003, CRIT CARE MED, V31, P1539, DOI 10.1097/01.CCM.0000065270.53951.9E; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	46	13	13	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1717	1724		10.3109/02699052.2015.1075146			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800025	26399723				2022-02-06	
J	Amram, O; Schuurman, N; Pike, I; Yanchar, NL; Friger, M; McBeth, PB; Griesdale, D				Amram, Ofer; Schuurman, Nadine; Pike, Ian; Yanchar, Natalie L.; Friger, Michael; McBeth, Paul B.; Griesdale, Donald			Socio Economic Status and Traumatic Brain Injury amongst Pediatric Populations: A Spatial Analysis in Greater Vancouver	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; pediatric injury; injury hotspot; injury prevention; geographic information systems	CHILDREN; RATES; TERM; ASSOCIATIONS; OUTCOMES	Introduction: Within Canada, injuries are the leading cause of death amongst children fourteen years of age and younger, and also one of the leading causes of morbidity. Low Socio Economic Status (SES) seems to be a strong indicator of a higher prevalence of injuries. This study aims to identify hotspots for pediatric Traumatic Brain Injury (TBI) and examines the relationship between SES and pediatric TBI rates in greater Vancouver, British Columbia (BC), Canada. Methods: Pediatric TBI data from the BC Trauma Registry (BCTR) was used to identify all pediatric TBI patients admitted to BC hospitals between the years 2000 and 2013. Spatial analysis was used to identify hotspots for pediatric TBI. Multivariate analysis was used to distinguish census variables that were correlated with rates of injury. Results: Six hundred and fifty three severe pediatric TBI injuries occurred within the BC Lower Mainland between 2000 and 2013. High rates of injury were concentrated in the East, while low rate clusters were most common in the West of the region (more affluent neighborhoods). A low level of education was the main predictor of a high rate of injury (OR = 1.13, 95% CI = 1.03-1.23, p-Value 0.009). Conclusion: While there was a clear relationship between different SES indicators and pediatric TBI rates in greater Vancouver, income-based SES indicators did not serve as good predictors within this region.	[Amram, Ofer; Schuurman, Nadine] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada; [Pike, Ian] Univ British Columbia, Dept Pediat, Fac Med, Vancouver, BC V6T 1Z4, Canada; [Pike, Ian] BC Childrens Hosp, Child & Family Res Inst, BC Injury Res & Prevent Unit, Vancouver, BC V6H 3V4, Canada; [Yanchar, Natalie L.] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4R2, Canada; [Friger, Michael] Ben Gurion Univ Negev, Fac Hlth Sci, IL-8410501 Beer Sheva, Israel; [McBeth, Paul B.] Alberta Hlth Serv, Dept Surg, Calgary, AB T6G 2R3, Canada; [McBeth, Paul B.] Alberta Hlth Serv, Dept Crit Care Med, Calgary, AB T6G 2R3, Canada; [Griesdale, Donald] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z4, Canada		Amram, O (corresponding author), Simon Fraser Univ, Dept Geog, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	oamram@sfu.ca; nadine@sfu.ca; ipike@cw.bc.ca; Natalie.Yanchar@iwk.nshealth.ca; friger@bgu.ac.il; pmcbeth@gmail.com; Donald.Griesdale@vch.ca	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624; amram, ofer/0000-0002-8835-3104; Pike, Ian/0000-0002-6860-7760	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Ofer Amram was supported by the Canadian Institutes of Health Research. The authors would also like to acknowledge Nasira Lakha from the BC Trauma Registry for her assistance in the data acquisition.	[Anonymous], 2013, ARCGIS PROGR 10 1 VE; [Anonymous], 2013, SPSS PROGR 19 VERS; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Bell N., 2015, INJ PREV; Birken CS, 2006, CAN MED ASSOC J, V175, P867, DOI 10.1503/cmaj.051207; Birken Catherine S, 2004, Paediatr Child Health, V9, P323; Boyle J.M., 2007, MOTOR VEHICLE OCCUPA; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Davison C., 2015, INJURY YOUNG CANADIA; Faelker T, 2000, Inj Prev, V6, P203, DOI 10.1136/ip.6.3.203; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Harrop AR, 2007, PUBLIC HEALTH REP, V122, P339, DOI 10.1177/003335490712200307; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Kafadar K, 1996, STAT MED, V15, P2539, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2539::AID-SIM379>3.3.CO;2-2; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Oliver L.N., 2012, UNINTENTIONAL INJURY; Palmer CD, 2005, EMERG MED J, V22, P165, DOI 10.1136/emj.2003.007674; Pike I, 2014, CHRON DIS INJ CAN, V34, P203; Pike I., 2012, REV INT BEST PRACTIC; Potter BK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-132; Schuurman N, 2007, J URBAN HEALTH, V84, P591, DOI 10.1007/s11524-007-9193-3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723; Spatial D., 2011, GEOPINPOINT; Spatial D., 2011, ROUTE LOGISTIC; Statistics Canada, SEC DISS AR 2011; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Vandivere S., 2006, HOUSING AFECTS CHILD; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	33	13	13	0	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2015	12	12					15594	15604		10.3390/ijerph121215009			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	DA1EL	WOS:000367539000050	26670241	Green Published, gold, Green Submitted			2022-02-06	
J	Esquenazi, A; Moon, D; Wikoff, A; Sale, P				Esquenazi, Alberto; Moon, Daniel; Wikoff, Amanda; Sale, Patricio			Hemiparetic gait and changes in functional performance due to OnabotulinumtoxinA injection to lower limb muscles	TOXICON			English	Article; Proceedings Paper	TOXINS 2015 Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins	JAN 14-17, 2015	Lisbon, PORTUGAL	Intl Neurotoxin Assoc (INA)		Gait analysis; Hemiparesis; OnabotulinumtoxinA; Spasticity	BOTULINUM-TOXIN-A; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; STROKE; SPASTICITY; LOCOMOTION; VELOCITY; ADULTS; FOOT; HIP	Objective: To review gait alterations and evaluate the effects of OnabotulinumtoxinA on spatiotemporal walking parameters of patients with hemiparetic gait. Design: Retrospective pre- and post-intervention analysis. Setting: Gait analysis laboratory in a tertiary level rehabilitation hospital. Participants: 42 patients with hemiparesis. 19 males and 23 females, age 18-78 years were included. Intervention: Spatiotemporal parameters collected before and within 4-10 weeks after OnabotA injection to the ankle muscles. Data was recorded at self-selected velocity on a 12 m instrumented walkway. The most common muscles injected were medial and lateral gastrocnemius, soleus and tibialis posterior. Average total OnabotulinumtoxinA dose was 320 +/- 107 units. Main outcome: Spatiotemporal parameters of walking assessed before (T-0) and within 4-10 weeks post injection (T-1). Paired t-test was used to compare pre- and post-intervention data. A sequential Holm-Bonferroni procedure was used to adjust for multiple comparisons and minimize the risk of type I error. Statistical significance was set at p < 0.05. Results: Statistically significant increases were seen for walking velocity (20%) (T-0 = 0.40 +/- 0.26 m/s and T-1 = 0.48 +/- 0.29 m/s; p = 0.006), and increased cadence (T-0 = 63.48 +/- 23.93 steps/min, and T-1 = 70.88 +/- 23.65 steps/min; p = 0.006) following OnabotulinumtoxinA injections. Conclusion: This study demonstrates that injection of OnabotulinumtoxinA 320 units to ankle muscles selected with the aid of dynamic electromyography can significantly increase gait velocity and enhance functional ambulation in adults with hemiparesis due to upper motor neuron syndrome. (C) 2015 Elsevier Ltd. All rights reserved.	[Esquenazi, Alberto] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA; Dept PM&R MossRehab, Elkins Pk, PA USA		Esquenazi, A (corresponding author), MossRehab Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu	Sale, Patrizio/K-8757-2016	Sale, Patrizio/0000-0002-4850-3673			Barker S, 2006, MED ENG PHYS, V28, P460, DOI 10.1016/j.medengphy.2005.07.017; Beaman CB, 2010, GAIT POSTURE, V31, P311, DOI 10.1016/j.gaitpost.2009.11.011; Bohannon RW, 1989, CLIN REHABIL, V3, P47; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; Den Otter AR, 2007, GAIT POSTURE, V25, P342, DOI 10.1016/j.gaitpost.2006.04.007; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; Dietz V, 1997, ELECTROEN CLIN NEURO, V103, P333, DOI 10.1016/S0013-4694(97)00047-7; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; Esquenazi A, 2004, Eura Medicophys, V40, P111; Esquenazi A., 2001, PHYS MED REHABILITAT, P93; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P729, DOI 10.1097/PHM.0b013e31824fa9ca; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaji R, 2010, J NEUROL, V257, P1330, DOI 10.1007/s00415-010-5526-3; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Mayer M, 2002, Bratisl Lek Listy, V103, P3; Mayer N. H., 2010, OPEN REHABILITATION, V3, P143; Mayer NH, 2001, ADV NEUROL, V87, P311; Nadeau S, 1999, AM J PHYS MED REHAB, V78, P123, DOI 10.1097/00002060-199903000-00007; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; SCHNEIDER RJ, 1977, J NEUROL NEUROSUR PS, V40, P417, DOI 10.1136/jnnp.40.5.417; Taylor D.R, 1980, P INT C REHABILITATI, P278; WALL JC, 1986, ARCH PHYS MED REHAB, V67, P550	32	13	14	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	DEC 1	2015	107		A		SI		109	113		10.1016/j.toxicon.2015.08.004			5	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pharmacology & Pharmacy; Toxicology	CY6SP	WOS:000366539400018	26272707				2022-02-06	
J	Mihaljcic, T; Haines, TP; Ponsford, JL; Stolwyk, RJ				Mihaljcic, Tijana; Haines, Terry P.; Ponsford, Jennie L.; Stolwyk, Renerus J.			Self-Awareness of Falls Risk Among Elderly Patients: Characterizing Awareness Deficits and Exploring Associated Factors	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Accidental falls; Awareness; Rehabilitation	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; OLDER-ADULTS; GO TEST; REHABILITATION; INPATIENT; ADHERENCE; PEOPLE; ANOSOGNOSIA	Objective: To characterize self-awareness in older adults undergoing inpatient rehabilitation and explore factors associated with reduced awareness of falls risk. Design: Prospective, cross-sectional design. Setting: Older adult inpatient rehabilitation setting. Participants: Rehabilitation inpatients (N=91; mean age, 77.97+/-8.04y) and their treating physiotherapist. Interventions: None. Main Outcome Measures: Three aspects of self-awareness (intellectual, emergent, anticipatory) were measured using the Self-Awareness of Falls Risk Measure. Demographic, medical, and cognitive (Mini-Mental State Examination) information were collected. Current ability was measured using the FIM and timed Up and Go test. Results: Of the patients in the sample, 31% to 63% underestimated falls risk and 3% to 10% overestimated falls risk depending on the aspect of awareness measured. Different aspects of reduced self-awareness were correlated with being a man, higher educational attainment, neurologic history, lower cognitive ability, and lower functional ability. Regression analysis indicated that sex (beta=-.33, P=.004), education (beta=-.30, P=.006), and neurologic history (beta=-.22, P=.038) were independently associated with overall self-awareness. Conclusions: The results suggest that a proportion of older adults undergoing inpatient rehabilitation underestimate personal falls risk. Further research is required to investigate the contributors to and effects of reduced self-awareness of falls risk. Greater understanding of these factors will facilitate the development of strategies to increase awareness of falls risk and increase engagement in falls prevention. (C) 2015 by the American Congress of Rehabilitation Medicine	[Mihaljcic, Tijana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia; [Haines, Terry P.] Monash Univ, Dept Physiotherapy, Melbourne, Vic 3800, Australia; [Haines, Terry P.; Stolwyk, Renerus J.] Monash Hlth, Allied Hlth Res Unit, Melbourne, Vic, Australia; [Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3800, Australia.	Rene.Stolwyk@monash.edu	Haines, Terrence/E-9372-2015	Haines, Terrence/0000-0003-3150-6154	Monash UniversityMonash University [ECD013]	Supported by the Monash University Strategic Grant Scheme (grant no. ECD013).	Aizen E, 2007, ARCH GERONTOL GERIAT, V44, P1, DOI 10.1016/j.archger.2006.01.005; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P155, DOI 10.1348/014466504323088033; Cohen J., 2013, STAT POWER ANAL BEHA; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cumming RG, 2001, AM J OCCUP THER, V55, P641, DOI 10.5014/ajot.55.6.641; Delbaere K, 2010, BMJ-BRIT MED J, V341, P4165, DOI [DOI 10.1136/BMJ.C4165, DOI 10.1136/BMJ.ABSTRACT]; Ecklund-Johnson E, 2005, NEUROPSYCHOL REV, V15, P147, DOI 10.1007/s11065-005-9026-7; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillespie LD, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Haines T.P., 2011, OPEN LONGEVITY SCI, V5, P9; Haines T, 2009, MED CARE, V47, P448, DOI 10.1097/MLR.0b013e318190ccc0; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Haines TP, 2015, HEALTH EXPECT, V18, P233, DOI 10.1111/hex.12026; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hartman-Maeir A, 2003, DISABIL REHABIL, V25, P35, DOI 10.1080/0963828021000007897; Horne M, 2009, AGE AGEING, V38, P68, DOI 10.1093/ageing/afn237; Hughes K, 2008, AM J PUBLIC HEALTH, V98, P351, DOI 10.2105/AJPH.2007.115055; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kristensen MT, 2007, PHYS THER, V87, P24, DOI 10.2522/ptj.20050271; LOPEZ OL, 1994, EUR NEUROL, V34, P277, DOI 10.1159/000117056; MICHON A, 1994, J NEUROL NEUROSUR PS, V57, P805, DOI 10.1136/jnnp.57.7.805; Mihaljcic T, 2014, ARCH GERONTOL GERIAT, V59, P249, DOI 10.1016/j.archger.2014.06.001; Morrison G, 2011, DISABIL REHABIL, V33, P900, DOI 10.3109/09638288.2010.514019; Nordin E, 2008, AGE AGEING, V37, P442, DOI 10.1093/ageing/afn101; Nyberg L, 1997, STROKE, V28, P716, DOI 10.1161/01.STR.28.4.716; OConnell ME, 2014, J AGING RES, V2014; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pondal Margarita, 2008, J Geriatr Phys Ther, V31, P57; Robinovitch SN, 1999, J GERONTOL A-BIOL, V54, pB124, DOI 10.1093/gerona/54.3.B124; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Simek EM, 2012, PREV MED, V55, P262, DOI 10.1016/j.ypmed.2012.07.007; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Stenvall M, 2006, ARCH GERONTOL GERIAT, V43, P389, DOI 10.1016/j.archger.2006.01.004; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Vassallo M, 2008, AGE AGEING, V37, P277, DOI 10.1093/ageing/afn062; Wyrwich KW, 2005, QUAL LIFE RES, V14, P285, DOI 10.1007/s11136-004-0705-2; Yardley L, 2008, PREV MED, V47, P554, DOI 10.1016/j.ypmed.2008.09.001; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650; Zanetti O, 1999, J GERONTOL B-PSYCHOL, V54, pP100, DOI 10.1093/geronb/54B.2.P100	50	13	13	2	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2015	96	12					2145	2152		10.1016/j.apmr.2015.08.414			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CY6SZ	WOS:000366540400009	26301387				2022-02-06	
J	Nishijima, DK; Holmes, JF; Dayan, PS; Kuppermann, N				Nishijima, Daniel K.; Holmes, James F.; Dayan, Peter S.; Kuppermann, Nathan			Association of a Guardian's Report of a Child Acting Abnormally With Traumatic Brain Injury After Minor Blunt Head Trauma	JAMA PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER; RISK; YOUNGER; SCANS	IMPORTANCE Increased use of computed tomography (CT) in children is concerning owing to the cancer risk from ionizing radiation, particularly in children younger than 2 years. A guardian report that a child is acting abnormally is a risk factor for clinically important traumatic brain injury (ciTBI) and may be a driving factor for CT use in the emergency department. OBJECTIVE To determine the prevalence of ciTBIs and TBIs in children younger than 2 years with minor blunt head trauma and a guardian report of acting abnormally with (1) no other findings or (2) other concerning findings for TBI. DESIGN, SETTING, AND PARTICIPANTS Secondary analysis of a large, prospective, multicenter cohort study that included 43 399 children younger than 18 years with minor blunt head trauma evaluated in 25 emergency departments. The study was conducted on data obtained between June 2004 and September 2006. Data analysis was performed between August 21, 2014, and March 9, 2015. EXPOSURES A guardian report that the child was acting abnormally after minor blunt head trauma. MAIN OUTCOMES AND MEASURES The prevalence of ciTBI (defined as death, neurosurgery, intubation for > 24 hours, or hospitalization for >= 2 nights in association with TBI on CT imaging) and TBI on CT imaging in children with a guardian report of acting abnormally with (1) no other findings and (2) other concerning findings for TBI. RESULTS Of 43 399 children in the cohort study, a total of 1297 children had reports of acting abnormally, of whom 411 (31.7%) had this report as their only finding. Reported as percentage (95% CI), 1 of 411 (0.2%[0-1.3%]) had a ciTBI, and 4 TBIs were noted on the CT scans in 185 children who underwent imaging (2.2%[0.6%-5.4%]). In children with reports of acting abnormally and other concerning findings for TBI, 29 of 886 (3.3%[2.2%-4.7%]) had ciTBIs and 66 of 674 (9.8%[7.7%-12.3%]) had TBIs on CT. CONCLUSIONS AND RELEVANCE Clinically important TBIs are very uncommon, and TBIs noted on CT are uncommon in children younger than 2 years with minor blunt head trauma and guardian reports of the child acting abnormally with no other clinical findings suspicious for TBI. Computed tomographic scans are generally not indicated in these children although observation in the emergency department may be warranted.	[Nishijima, Daniel K.; Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Dayan, Peter S.] Columbia Univ, Coll Phys & Surg, Div Pediat Emergency Med, New York, NY USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 V St,Patient Serv Support Bldg 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu		Nishijima, Daniel/0000-0003-4952-8212	Clinical and Translational Science Center at the University of California at Davis; National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000134, UL1TR000002] Funding Source: NIH RePORTER	This work was supported by a grant from the Clinical and Translational Science Center at the University of California at Davis. Dr Nishijima was supported by grant UL1TR000002 and linked award KL2TR000134 through the Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Overview of the Nationwide Emergency Department Sample (NEDS), 2011, HEALTHC UT PROJ; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0	18	13	13	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	DEC	2015	169	12					1141	1147		10.1001/jamapediatrics.2015.2743			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CY3UE	WOS:000366334600018	26502172	Bronze, Green Accepted			2022-02-06	
J	Tackla, R; Hinzman, JM; Foreman, B; Magner, M; Andaluz, N; Hartings, JA				Tackla, Ryan; Hinzman, Jason M.; Foreman, Brandon; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.			Assessment of Cerebrovascular Autoregulation Using Regional Cerebral Blood Flow in Surgically Managed Brain Trauma Patients	NEUROCRITICAL CARE			English	Article						Pressure reactivity index (PRx); Oxygen reactivity index (ORx); Blood flow velocity index (Mx); Traumatic brain injury; Neurocritical care	PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; TISSUE OXYGEN; REACTIVITY; VALIDATION; INJURY	Impairment of cerebrovascular autoregulation is a risk factor for ischemic damage following severe brain injury. Autoregulation can be assessed indirectly using intracranial pressure monitoring as a surrogate of cerebral blood volume, but this measure may not be applicable to patients following decompressive craniectomy. Here, we describe assessment of autoregulation using regional cerebral blood flow (rCBF). In seven patients with severe brain trauma who underwent neurological surgery, a Hemedex(A (R)) rCBF probe was placed intraoperatively in peri-lesional tissue. Autoregulation was assessed as a moving Pearson correlation between CPP and rCBF (rCBFx). Composite data from all patients showed relatively constant perfusion over a wide CPP range (50-90 mmHg) and a U-shaped autoregulation curve with maximal autoregulation (CPPopt) at 55-60 mmHg. All rCBF values fell below the ischemic threshold (< 18 ml/100 g/min) when CPPs were < 50 mmHg compared with 11 % ischemia when CPPs > 50 mmHg (P < 0.05). We examined the percent time during which both autoregulation was intact and rCBF exceeded the ischemic threshold. In the composite data, this variable was maximal in the CPP range of 75-80 mmHg (CPPideal). In individual patients, the range of CPPs with intact autoregulation varied widely. Individual CPPopt values ranged between 60 and 100 mmHg and CPPideal ranged between 65 and 105 mmHg. Assessment of autoregulation with Hemedex(A (R)) rCBF monitor is feasible and could be used to guide CPP management strategies to optimize both autoregulation and perfusion. Autoregulatory impairment and CPPopt vary considerably between patients, and the addition of rCBF monitoring could help guide CPP targeting decisions.	[Tackla, Ryan; Hinzman, Jason M.; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.] Univ Cincinnati, Coll Med, Neurotrauma Ctr, Dept Neurosurg,UC Neurosci Inst, Cincinnati, OH 45267 USA; [Tackla, Ryan; Magner, Mark; Andaluz, Norberto; Hartings, Jed A.] Mayfield Clin, Cincinnati, OH USA; [Foreman, Brandon] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Neurotrauma Ctr,UC Neurosci Inst, Cincinnati, OH 45267 USA		Hinzman, JM (corresponding author), Univ Cincinnati, Coll Med, Neurotrauma Ctr, Dept Neurosurg,UC Neurosci Inst, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	jmhinz2@gmail.com		Foreman, Brandon/0000-0002-5418-674X; Hartings, Jed/0000-0001-8583-3471	Mayfield Education and Research Foundation	This work was funded by the Mayfield Education and Research Foundation and thermal diffusion probes were donated by Hemedex, Inc.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1998, ACT NEUR S, V71, P74; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2014, NEUROCRIT CARE; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Dias Celeste, 2015, NEUROCRIT CARE; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Naqvi J, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/629378; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Reinert M, 2007, NEUROL RES, V29, P455, DOI 10.1179/016164107X164175; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JA, 2013, ACTA NEUROCHIR SUPPL, V115, P67, DOI 10.1007/978-3-7091-1192-5_15; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	27	13	13	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2015	23	3					339	346		10.1007/s12028-015-0146-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV8WN	WOS:000364569000006	25948537				2022-02-06	
J	Teramoto, M; Petron, DJ; Cross, CL; Willick, SE				Teramoto, Masaru; Petron, David J.; Cross, Chad L.; Willick, Stuart E.			Style of Play and Rate of Concussions in the National Football League	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; style of play; National Football League (NFL); West Coast offense; epidemiology; risk factor; statistics	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; COLLEGIATE	Background: The majority of studies on concussion in the National Football League (NFL) focus on testing, evaluation, and outcomes. Meanwhile, there is a paucity of research on how a team's style of play influences the risk of concussion. Hypothesis: Style of play, such as offensive and defensive strategies, is associated with the rate of concussions in the NFL. Study Design: Descriptive epidemiology study. Methods: The current study retrospectively analyzed data from the 2012 to 2014 NFL regular seasons. Reported numbers of concussions were stratified by each team and each position and were compared based on style of play, including offensive scheme (West Coast offense, Air Coryell offense, or other offensive schemes) and defensive alignment (3-4 or 4-3), attempts statistics, per-drive statistics, and offensive and defensive productions, along with strength of schedule (SoS) and team quality measured by simple rating system (SRS). Data analyses included descriptive statistics, 1-way analysis of variance, correlation analysis, and regression analysis. Results: There were 437 documented concussions during the 2012 to 2014 NFL regular seasons, with a mean 4.6 concussions per season per team. In general, players most involved in pass plays reported more concussions. The number of concussions sustained by offensive players was significantly higher among the teams adopting the West Coast offense (mean, 3.0) than among those utilizing the Air Coryell offense (mean, 1.6; P =.006) or those with non-West Coast offenses combined (mean, 1.9; P =.004). The multiple regression analysis revealed that the West Coast offense or not, SoS, and SRS explained 25.3% of the variance in the number of concussions by offensive players. After accounting for SRS, the West Coast offense was found to be a significant predictor of the number of concussions (P =.007), while there was a tendency for SoS to be inversely associated with the number of concussions (P =.105). None of the variables for attempts statistics, per-drive statistics, and offensive production were significantly associated with the number of concussions in the regression analysis. Conclusion: In the NFL, players most involved in pass plays appear to be at increased risk for concussions. The West Coast offense may be associated with a greater risk of concussion. Furthermore, teams with easier schedules may have more players sustaining concussions.	[Teramoto, Masaru; Petron, David J.; Cross, Chad L.; Willick, Stuart E.] Univ Utah, Salt Lake City, UT 84108 USA		Teramoto, M (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, Univ Orthopaed Ctr, 590 Wakara Way, Salt Lake City, UT 84108 USA.	masaru.teramoto@hsc.utah.edu					Carroll B., 1988, HIDDEN GAME FOOTBALL; Carroll Bob, 1997, TOTAL FOOTBALL OFFIC; Casson IR, 2011, SPORTS HEALTH, V3, P130, DOI 10.1177/1941738110397876; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Jaworski R, 2011, GAMES CHANGED GAME E; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Maxcy JG, 2013, J SPORT ECON, V14, P368, DOI 10.1177/1527002513497170; National Football League, NFL EXPL AGR 765M SE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Tagliabue P, 2003, NEUROSURGERY, V53, P796, DOI 10.1227/01.NEU.0000083559.68424.3F; Zemper ED, 2003, RES SPORTS MED, V11, P157, DOI 10.1080/15438620390231175	23	13	13	2	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2015	3	12							2325967115620365	10.1177/2325967115620365			9	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	DE2AE	WOS:000370427600009	26740957	gold, Green Published			2022-02-06	
J	Webster, DL; Fei, L; Falcone, RA; Kaplan, J				Webster, Danielle L.; Fei, Lin; Falcone, Richard A.; Kaplan, JenniferM.			Higher-volume hypertonic saline and increased thrombotic risk in pediatric traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						TBI; Pediatrics; Hypertonic saline solution; Sodium; Venous thromboembolism	DEEP VENOUS THROMBOSIS; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; DIABETIC-KETOACIDOSIS; INTRACRANIAL-PRESSURE; UNITED-STATES; CHILDREN; THROMBOEMBOLISM; MANAGEMENT; CATHETERS	Purpose: Hyperosmolar therapy is a mainstay in the acute medical management of traumatic brain injury (TBI). Emerging literature suggests that a hyperosmolar state may lead to thrombotic complications. The primary objective of this study was to investigate associations between hypertonic saline (HTS) and the outcome of deep venous thrombosis (DVT) in pediatric patients with severe TBI. Materials and methods: This is a single-center retrospective cohort study of 58 patients admitted to the intensive care unit at a Level 1 pediatric trauma center between January 2010 and June 2013. Main measurements included volume of HTS administration, serum sodium levels, DVT confirmed with ultrasonography, survival at 30 days postinjury, and Glasgow Outcome Scale. Results: The cumulative total bolus volume of HTS (mL/kg) given to each subject was associated with DVT (P = .01). Peak sodium level and 72-hour sustained sodium levels were associated with DVT (P = .05). A sustained sodium level of at least 160 mmol/L was associated with DVT (P = .02). Conclusion: In children with severe TBI, the total bolus volume of 3% HTS and sustained sodium levels greater than 160 mmol/L are independently associated with DVT. (C) 2015 Elsevier Inc. All rights reserved.	[Webster, Danielle L.; Fei, Lin; Falcone, Richard A.; Kaplan, JenniferM.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Webster, Danielle L.; Falcone, Richard A.; Kaplan, JenniferM.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Webster, DL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Crit Care Med MLC 2005, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Danielle.Webster@cchmc.org	Fei, Lin/N-8299-2015		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Agbeko RS, 2012, PEDIATR CRIT CARE ME, V13, pE39, DOI 10.1097/PCC.0b013e31820ac2ad; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Candrilli SD, 2009, PEDIATR CRIT CARE ME, V10, P554, DOI 10.1097/PCC.0b013e3181a705d3; Faustino EVS, 2013, J PEDIATR-US, V162, P387, DOI 10.1016/j.jpeds.2012.06.059; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GRANT PJ, 1985, THROMB RES, V40, P393, DOI 10.1016/0049-3848(85)90274-9; Gutierrez JA, 2003, CRIT CARE MED, V31, P80, DOI 10.1097/00003246-200301000-00012; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kanin M, 2013, THROMB RES, V132, P527, DOI 10.1016/j.thromres.2013.08.018; Keenan CR, 2007, J THROMB HAEMOST, V5, P1185, DOI 10.1111/j.1538-7836.2007.02553.x; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mannucci PM, 1997, BLOOD, V90, P2515, DOI 10.1182/blood.V90.7.2515.2515_2515_2521; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrory MC, 2011, PEDIATR CRIT CARE ME, V12, P80, DOI 10.1097/PCC.0b013e3181ce7644; Monagle P, 2012, CHEST, V141, pE737S, DOI 10.1378/chest.11-2308; Morrow SE, 2010, SEMIN PEDIATR SURG, V19, P279, DOI 10.1053/j.sempedsurg.2010.07.001; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Setty BA, 2012, PEDIATR BLOOD CANCER, V59, P258, DOI 10.1002/pbc.23388; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Takemoto CM, 2014, J PEDIATR-US, V164, P332, DOI 10.1016/j.jpeds.2013.10.025; Vidal E, 2014, J THROMB HAEMOST, V12, P1096, DOI 10.1111/jth.12598; Wakefield TW, 2009, J VASC SURG, V49, P1620, DOI 10.1016/j.jvs.2009.01.058; Worly JM, 2004, PEDIATRICS, V113, pE57, DOI 10.1542/peds.113.1.e57	30	13	14	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2015	30	6					1267	1271		10.1016/j.jcrc.2015.07.022			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0MX	WOS:000363945900022	26307005				2022-02-06	
J	Swick, D; Honzel, N; Turken, U				Swick, Diane; Honzel, Nikki; Turken, U.			Intact error monitoring in combat Veterans with post-traumatic stress disorder	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Error-related negativity; Performance monitoring; Self-monitoring; Mild traumatic brain injury; Anterior cingulate cortex; Cognitive control; Anxiety	ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL-SIGNIFICANCE; PSYCHOMETRIC PROPERTIES; RESPONSE-INHIBITION; NEURAL EVIDENCE; ERP COMPONENTS; PERFORMANCE; SCHIZOPHRENIA; DYSFUNCTION	The error-related negativity (ERN) is a neuroelectric signature of performance monitoring during speeded response time tasks. Previous studies indicate that individuals with anxiety disorders show ERN enhancements that correlate with the degree of clinical symptomology. Less is known about the error monitoring system in post-traumatic stress disorder (PTSD). PTSD is characterized by impairments in the regulation of fear and other emotional responses, as well as deficits in maintaining cognitive control. Here, combat Veterans with PTSD were compared to control Veterans in two different versions of the flanker task (n = 13 or 14 per group). Replicating and extending previous findings, PTSD patients showed an intact ERN in both experiments. In addition, task performance and error compensation behavior were intact. Finally, ERN amplitude showed no relationship with self-reported PTSD, depression, or post-concussive symptoms. These results suggest that error monitoring represents a relative strength in PTSD that can dissociate from cognitive control functions that are impaired, such as response inhibition and sustained attention. A healthy awareness of errors in external actions could be leveraged to improve interoceptive awareness of emotional state. The results could have positive implications for PTSD treatments that rely on self-monitoring abilities, such as neurofeedback and mindfulness training. Published by Elsevier Ireland Ltd.	[Swick, Diane; Honzel, Nikki; Turken, U.] VA Northern Calif Hlth Care Syst, Martinez, CA 94553 USA; [Swick, Diane] Univ Calif Davis, Davis, CA 95616 USA; [Honzel, Nikki] Carroll Coll, Helena, MT USA		Swick, D (corresponding author), VA Northern Calif Hlth Care Syst, Res Serv 151, 150 Muir Rd, Martinez, CA 94553 USA.	swicklab@gmail.com			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0086]; VA Merit Review grant from Clinical Science Research and DevelopmentUS Department of Veterans Affairs [I01CX000566]; VA Career Development Award; Veterans AffairsUS Department of Veterans Affairs [I01CX000566] Funding Source: NIH RePORTER	We are grateful to Dr. Andrew Kayser for patient referrals and to all participants for taking part in the study. We thank Victoria Ashley, Julien Cayton, Dr. Jary Larsen, and Dr. Adrian Willoughby for their assistance in various stages of the project. This work was supported by the U.S. Army Medical Research and Materiel Command under W81XWH-08-2-0086 (D.S.), a VA Merit Review grant (I01CX000566) from Clinical Science Research and Development (D.S.), and a VA Career Development Award (A.T.). The contents reported within do not represent the views of the Department of Veterans Affairs or the United States Government.	Aarts K, 2013, J ABNORM PSYCHOL, V122, P939, DOI 10.1037/a0034616; Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Araki T, 2005, NEUROIMAGE, V25, P43, DOI 10.1016/j.neuroimage.2004.11.039; Araki T, 2013, SCHIZOPHR RES, V146, P336, DOI 10.1016/j.schres.2013.02.028; Ashley V, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-86; Bailey NW, 2015, BIOL PSYCHOL, V106, P1, DOI 10.1016/j.biopsycho.2015.01.011; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bilder Robert M, 2009, Cogn Neuropsychiatry, V14, P419, DOI 10.1080/13546800902787180; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Chao L, 2013, PSYCHIAT RES-NEUROIM, V213, P193, DOI 10.1016/j.pscychresns.2013.03.002; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; Chiu PH, 2007, AM J PSYCHIAT, V164, P608, DOI 10.1176/appi.ajp.164.4.608; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clemans ZA, 2012, NEUROSCI LETT, V525, P105, DOI 10.1016/j.neulet.2012.07.051; Compton RJ, 2008, EMOTION, V8, P58, DOI 10.1037/1528-3542.8.1.58; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Endrass T, 2014, NEUROSCI BIOBEHAV R, V46, P124, DOI 10.1016/j.neubiorev.2014.03.024; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischer H., 2014, GUID US MIL CAS STAT; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hamner M B, 1999, Depress Anxiety, V9, P1; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Holmes AJ, 2008, ARCH GEN PSYCHIAT, V65, P179, DOI 10.1001/archgenpsychiatry.2007.19; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Honzel N, 2014, COGN AFFECT BEHAV NE, V14, P792, DOI 10.3758/s13415-013-0219-x; Insel TR, 2009, BIOL PSYCHIAT, V66, P988, DOI 10.1016/j.biopsych.2009.10.008; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kappenman, 2012, OXFORD HDB EVENT REL, P231, DOI [10.1093/oxfordhb/9780195374148.013.0120, DOI 10.1093/OXFORDHB/9780195374148.013.0120]; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim MJ, 2008, J PSYCHIATR RES, V42, P268, DOI 10.1016/j.jpsychires.2007.02.003; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manoach DS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00350; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morey RA, 2008, PSYCHIAT RES-NEUROIM, V162, P59, DOI 10.1016/j.pscychresns.2007.07.007; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rabinak CA, 2013, PSYCHIAT RES-NEUROIM, V213, P71, DOI 10.1016/j.pscychresns.2013.01.002; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Ridderinkhof KR, 2007, COGN AFFECT BEHAV NE, V7, P261, DOI 10.3758/CABN.7.4.261; Rotteveel M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00335; Ruchsow M, 2006, J PSYCHIATR RES, V40, P37, DOI 10.1016/j.jpsychires.2005.02.002; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Salkovskis PM, 1999, BEHAV RES THER, V37, pS29, DOI 10.1016/S0005-7967(99)00049-2; Schrijvers D, 2009, INT J PSYCHOPHYSIOL, V71, P218, DOI 10.1016/j.ijpsycho.2008.09.005; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Solbakk AK, 2014, J COGNITIVE NEUROSCI, V26, P1528, DOI 10.1162/jocn_a_00561; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Turken U, 2003, AM J PSYCHIAT, V160, P1881, DOI 10.1176/appi.ajp.160.10.1881; Ullsperger M, 2002, NEUROPSYCHOLOGY, V16, P548, DOI 10.1037//0894-4105.16.4.548; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; Vaidyanathan U, 2012, PSYCHOL MED, V42, P447, DOI 10.1017/S0033291711001528; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Weathers F.W., 1994, PTSD CHECKLIST MILIT; Weinberg A, 2012, J ABNORM PSYCHOL, V121, P885, DOI 10.1037/a0028270; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Xiao ZP, 2011, PROG NEURO-PSYCHOPH, V35, P265, DOI 10.1016/j.pnpbp.2010.11.022	100	13	13	1	24	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	NOV 30	2015	234	2					227	238		10.1016/j.pscychresns.2015.09.016			12	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CW5RF	WOS:000365053600010	26481979	Green Accepted, Bronze			2022-02-06	
J	Kiefer, AW; Foss, KB; Reches, A; Gadd, B; Gordon, M; Rushford, K; Laufer, I; Weiss, M; Myer, GD				Kiefer, Adam W.; Foss, Kim Barber; Reches, Amit; Gadd, Brooke; Gordon, Michael; Rushford, Ken; Laufer, Ilan; Weiss, Michal; Myer, Gregory D.			Brain Network activation as a Novel Biomarker for the Return-to-play pathway Following sport-Related Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						brain network activation; EEG; concussion; hockey; return to play	CONCUSSION; MATURATION; DIAGNOSIS; POTENTIALS; ATTENTION; CHILDREN	Children and adolescent athletes are at a higher risk for concussion than adults, and also experience longer recovery times and increased associated symptoms. It has also recently been demonstrated that multiple, seemingly mild concussions may result in exacerbated and prolonged neurological deficits. Objective assessments and return-to-play criteria are needed to reduce risk and morbidity associated with concussive events in these populations. Recent research has pushed to study the use of electroencephalography as an objective measure of brain injury. In the present case study, we present a novel approach that examines event-related potentials via a brain network activation (BNA) analysis as a biomarker of concussion and recovery. Specifically, changes in BNA scores, as indexed through this approach, offer a potential indicator of neurological health as the BNA assessment qualitatively and quantitatively indexes the network dynamics associated with brain injury. Objective tools, such as these support accurate and efficient assessment of brain injury and may offer a useful step in categorizing the temporal and spatial changes in brain activity following concussive blows, as well as the functional connectivity of brain networks, associated with concussion.	[Kiefer, Adam W.; Foss, Kim Barber; Gadd, Brooke; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kiefer, Adam W.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Reches, Amit; Laufer, Ilan; Weiss, Michal] ElMindA Ltd, Herzliyya, Israel; [Gordon, Michael; Rushford, Ken] St Xavier High Sch, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Ohio State Univ, Sports Hlth & Performance Inst, Columbus, OH 43210 USA		Kiefer, AW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA.	adam.kiefer@cchmc.org	Meijer, Anna/K-5118-2016; Kiefer, Adam/F-1756-2018; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	Cincinnati Children's Research Foundation; Q30 Sports Science, LLC; Heidt Foundation; ElMindA, Ltd.	This research was funded, in part, by Cincinnati Children's Research Foundation; Q30 Sports Science, LLC; The Heidt Foundation; ElMindA, Ltd.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Mahajan Y, 2012, HEARING RES, V294, P82, DOI 10.1016/j.heares.2012.10.005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; MIZRAHI EM, 1984, PEDIATRICS, V73, P419; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Polich J., 1999, ELECTROEN CLIN NEURO, P1073; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reches A, 2016, EUR J PAIN, V20, P250, DOI 10.1002/ejp.716; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273	35	13	14	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 20	2015	6								243	10.3389/fneur.2015.00243			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA9AE	WOS:000368097800001	26635720	gold, Green Published			2022-02-06	
J	Acker, SN; Ross, JT; Partrick, DA; Bensard, DD				Acker, Shannon N.; Ross, James T.; Partrick, David A.; Bensard, Denis D.			A pediatric specific shock index in combination with GMS identifies children with life threatening or severe traumatic brain injury	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Children; Traumatic brain injury; Shock index; Hypotension; Age adjusted shock index	GLASGOW COMA SCALE; RISK; TRANSFUSION	We have previously demonstrated that a shock index, pediatric age adjusted (SIPA) accurately identifies severely blunt injured children. We aimed to determine if SIPA could more accurately identify children with severe traumatic brain injury (TBI) than hypotension alone. We performed subset analysis of those children with TBI among a cohort of children age 4-16 years with blunt trauma and injury severity score a parts per thousand yen15 from 1/07 to 6/13. We evaluated the ability of four markers to identify the most severely brain injured children. Markers included hypotension, elevated SIPA, abnormal GCS motor score (GMS), and elevated SIPA or abnormal GMS. We aimed to determine which of these four markers had the highest sensitivity in identifying severely injured children. Three hundred and ninety-two (392) children were included. Hypotension was present in 24 patients (6 %); elevated SIPA in 106 (27 %), abnormal GMS in 172 (44 %), and elevated SIPA or abnormal GMS in 206 (53 %). All markers were able to accurately identify severely injured children with TBI. Elevated SIPA or abnormal GMS identified a greater percentage of patients with each of seven complications with higher sensitivity than each of the three other markers. Among blunt injured children with TBI, elevated SIPA or abnormal GMS identifies severely brain injured children.	[Acker, Shannon N.; Ross, James T.; Partrick, David A.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO 80045 USA; [Bensard, Denis D.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA		Acker, SN (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Surg, 12631 E 17th Ave,C302, Aurora, CO 80045 USA.	shannon.acker@ucdenver.edu; James.ross2@ucsf.edu; david.partrick@childrenscolorado.org; denis.bensard@dhha.org					Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Atabaki SM, 2006, CLIN PEDIATR EMERG M, V7, P94, DOI 10.1016/j.cpem.2006.03.003; Barraco RD, 2010, PRACTICE MANAGEMENT; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	17	13	13	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2015	31	11					1041	1046		10.1007/s00383-015-3789-6			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	CT8BO	WOS:000363040200006	26349487				2022-02-06	
J	Ozyurt, E; Goksu, E; Cengiz, M; Yilmaz, M; Ramazanoglu, A				Ozyurt, Erhan; Goksu, Ethem; Cengiz, Melike; Yilmaz, Murat; Ramazanoglu, Atilla			Retrospective Analysis of Prognostic Factors of Severe Traumatic Brain Injury in a University Hospital in Turkey	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Prognostic factors; Outcome	IMPACT; COMA	AIM: To examine the use of prognostic factors such as age, Glasgow Coma Scale (GCS) score, pupil reactivity and computerized tomography (CT) findings for predicting the prognosis of severe traumatic brain injury (TBI) patients in Turkey. MATERIAL and METHODS: We retrospectively evaluated TBI patients who were accepted to Akdeniz University Intensive Care Unit between 1 January 2007 and 31 December 2009. Patient data were collected from the hospital information system. Marshall CT classification was performed and CT findings were noted. The Glasgow outcome scale (GOS) score of patients was calculated according to their 6-months follow up. RESULTS: A total of 101 patients with severe TBI were studied. The mean age of the patients was 34.7 +/- 14.1 years. Of these, male patients (81.2%) were dominant and road accidents (83.2%) were the most common mechanism of TBI development. In addition, poor neurological outcome was detected in 58.4% of the patients and 29 patients (28.7%) died. The mechanism of injury (p = 0.34), gender (p = 0.64) or age (p = 0.34) did not lead to a difference in neurologic outcomes while the GCS score (p = 0.01), pupillary reactivity (p = 0.000), Marshall CT classification (p = 0.01) and the presence of traumatic subarachnoid haemorrhage (p = 0.04) affected the GOS scores. CONCLUSION: In our study, GCS score, CT findings and pupil reactivity were prominent as prognostic factors, but a relationship between age and prognosis was not observed.	[Ozyurt, Erhan; Cengiz, Melike; Yilmaz, Murat; Ramazanoglu, Atilla] Akdeniz Univ, Sch Med, Dept Anaesthesiol & Reanimat, TR-07058 Antalya, Turkey; [Goksu, Ethem] Akdeniz Univ, Sch Med, Dept Neurosurg, TR-07058 Antalya, Turkey		Ozyurt, E (corresponding author), Akdeniz Univ, Sch Med, Dept Anaesthesiol & Reanimat, TR-07058 Antalya, Turkey.	eozyurt@hotmail.com	Yilmaz, Murat/I-6629-2017				Akyel S, 2012, ULUS TRAVMA ACIL CER, V18, P125, DOI 10.5505/tjtes.2012.37928; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sut N, 2010, ULUS TRAVMA ACIL CER, V16, P149; TEASDALE G, 1974, LANCET, V2, P81	19	13	16	0	6	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2015	25	6					877	882		10.5137/1019-5149.JTN.9181-13.0			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CY1FV	WOS:000366153000007	26617136				2022-02-06	
J	Roy, A; Allain, P; Roulin, JL; Fournet, N; Le Gall, D				Roy, Arnaud; Allain, Philippe; Roulin, Jean-Luc; Fournet, Nathalie; Le Gall, Didier			Ecological approach of executive functions using the Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C): Developmental and validity study	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; Development; Everyday life; Executive functions; Ecological assessment	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PERFORMANCE; DYSFUNCTION; DISORDER; TESTS; SCHIZOPHRENIA; INTELLIGENCE; IMPAIRMENTS; PERSPECTIVE	Introduction. Ecological assessment of executive functions (EF) with tasks simulating everyday-life difficulties in children remains poorly developed. The Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C) is one of the rare tools proposed in this perspective, for which developmental and convergent validity are, however, rather limited. The objectives of this study were to explore EF development using the BADS-C, while considering the effect of gender and parental education as well as controversial relationships between intelligence and EF. We also aimed to examine to what extent the BADS-C could reflect EF of children in everyday life, as reported by their parents on questionnaires. Method. A group of 120 healthy children aged from 7 to 12 years was recruited. Their executive performance was examined by means of the BADS-C, and their intellectual efficiency was tested with the Wechsler intelligence scales. Rating of EF in everyday life was simultaneously carried out by children's parents, using two questionnaires: the Dysexecutive Questionnaire for Children (DEX-C) of the BADS-C and the Behavior Rating Inventory of Executive Function (BRIEF). Results. Results showed a significant effect of age on BADS-C subtests, with inconsistencies from one subtest to another. Gender effect on EF performance was nonsignificant. Weak correlations were found between EF scores and parental education or intelligence quotient. Lastly, while the two questionnaires of everyday-life EF were strongly correlated with each other, their links with BADS-C subtests scores were weak. Conclusions. This study shows differentiated developmental curves on BADS-C, reflecting a variable implication of executive resources according to subtests. The limited relations between BADS-C performance and sociodemographic variables or IQ could be due to the fact that executive difficulties are moderate in healthy children at this age. Moreover, the capacity of the BADS-C to reflect EF as perceived by the child's relatives in everyday life remains questionable.	[Roy, Arnaud; Allain, Philippe; Le Gall, Didier] Univ Angers, LUNAM, EA4638, Psychol Lab Pays Loire, F-49045 Angers 01, France; [Roy, Arnaud] Nantes Univ Hosp, Neurofibromatosis Clin, Nantes, France; [Roy, Arnaud] Nantes Univ Hosp, Learning Disabil Reference Ctr, Nantes, France; [Roulin, Jean-Luc; Fournet, Nathalie] Savoie Univ, Neurocognit & Psychol Lab, Chambery, France; [Roulin, Jean-Luc; Fournet, Nathalie] CNRS, UMR 5105, Neurocognit & Psychol Lab, Grenoble, France		Roy, A (corresponding author), Univ Angers, Fac Lettres Langues & Sci Humaines, 11 Blvd Lavoisier, F-49045 Angers 01, France.	arnaud.roy@univ-angers.fr		ALLAIN, Philiooe/0000-0003-0668-0986	Direction of Clinical Research of University Hospital of Nantes (France) [BRD/05/1-K]; Recklinghausen and Neurofibromatosis Association (Blagnac, France)	This work was supported by the Direction of Clinical Research of University Hospital of Nantes (France) [grant number BRD/05/1-K]. Recklinghausen and Neurofibromatosis Association (Blagnac, France) is gratefully acknowledged for its generous financial contribution to this project.	Allain P, 2007, REV NEUROL-FRANCE, V163, P222, DOI 10.1016/S0035-3787(07)90393-8; Allain P, 2004, REV NEUROPSYCHOL, V14, P285; Allain P, 2005, BRAIN COGNITION, V57, P4, DOI 10.1016/j.bandc.2004.08.011; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2013, APPL NEUROPSYCH-CHIL, V2, P82, DOI 10.1080/21622965.2013.748388; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Benson D.F., 1986, FRONTAL LOBES; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2006, BEHAV BRAIN SCI, V29, P109; Bodimeade HL, 2013, DEV MED CHILD NEUROL, V55, P926, DOI 10.1111/dmcn.12195; Boghi A, 2006, NEUROIMAGE, V33, P999, DOI 10.1016/j.neuroimage.2006.07.022; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Christ SE, 2010, MOL GENET METAB, V99, pS22, DOI 10.1016/j.ymgme.2009.10.007; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dennis M, 2006, SER INT NEUROPSYCHOL, P128, DOI 10.1017/CBO9780511545917.007; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DIAMOND A, 1985, CHILD DEV, V56, P868, DOI 10.2307/1130099; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Emslie H., 2003, BEHAV ASSESSMENT DYS; Emslie H., 2013, PROFESSIONAL MANUA S; Engel-Yeger B, 2009, NEUROPSYCHOL REHABIL, V19, P662, DOI 10.1080/09602010802622730; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Espinosa A, 2009, J INT NEUROPSYCH SOC, V15, P751, DOI 10.1017/S135561770999035X; Fournet N., 2014, CHILD NEUROPSYCHOL, V22, P1; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; Kamei S, 2008, MOVEMENT DISORD, V23, P566, DOI 10.1002/mds.21890; Katz N, 2007, NEUROPSYCHOL REHABIL, V17, P192, DOI 10.1080/09602010600685053; Krabbendam L, 1999, CLIN NEUROPSYCHOL, V13, P370, DOI 10.1076/clin.13.3.370.1739; Lan XZ, 2011, J EXP CHILD PSYCHOL, V108, P677, DOI 10.1016/j.jecp.2010.11.001; Leaper C, 2004, DEV PSYCHOL, V40, P993, DOI 10.1037/0012-1649.40.6.993; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luria A.R., 1966, HIGHER CORTICAL FUNC; Moriyama Y, 2002, ALCOHOL CLIN EXP RES, V26, P1239, DOI 10.1097/01.ALC.0000026103.08053.86; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Pentland L., 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755572; Robinson S, 2009, BRAIN COGNITION, V71, P362, DOI 10.1016/j.bandc.2009.06.007; Roth RM, 2005, BRIEF A BEHAV RATING; Roulin J.-L., 2013, BRIEF INVENTAIRE EVA; Roy A, 2010, J INT NEUROPSYCH SOC, V16, P1056, DOI 10.1017/S135561771000086X; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shimoni M, 2012, RES DEV DISABIL, V33, P858, DOI 10.1016/j.ridd.2011.12.014; Shinagawa Y, 2007, INT J GERIATR PSYCH, V22, P951, DOI 10.1002/gps.1768; Siu AFY, 2014, J CHILD NEUROL, V29, P608, DOI 10.1177/0883073813516191; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Vargas ML, 2009, COGN BEHAV NEUROL, V22, P95, DOI 10.1097/WNN.0b013e318192cd08; Ward C, 2009, CHILD NERV SYST, V25, P663, DOI 10.1007/s00381-009-0832-8; Wechsler D., 1996, ECHELLE INTELLIGENCE; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; White SJ, 2009, AUTISM RES, V2, P138, DOI 10.1002/aur.78; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; WILSON BA, 1997, METHODOLOGY FRONTAL	73	13	13	0	51	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2015	37	9					956	971		10.1080/13803395.2015.1072138			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CQ5LZ	WOS:000360647100005	26332175				2022-02-06	
J	Lei, J; Wang, L; Gao, GY; Cooper, E; Jiang, JY				Lei, Jin; Wang, Lei; Gao, Guoyi; Cooper, Edwin; Jiang, Jiyao			Right Median Nerve Electrical Stimulation for Acute Traumatic Coma Patients	JOURNAL OF NEUROTRAUMA			English	Article						coma; efficacy; right median nerve stimulation; severe traumatic brain injury	ACQUIRED BRAIN-INJURY; VEGETATIVE STATE; CONSCIOUSNESS; DISORDERS; AROUSAL	The right median nerve as a peripheral portal to the central nervous system can be electrically stimulated to help coma arousal after traumatic brain injury (TBI). The present study set out to examine the efficacy and safety of right median nerve electrical stimulation (RMNS) in a cohort of 437 comatose patients after severe TBI from August 2005 to December 2011. The patients were enrolled 2 weeks after their injury and assigned to the RMNS group (n=221) receiving electrical stimulation for 2 weeks or the control group (n=216) treated by standard management according to the date of birth in the month. The baseline data were similar. After the 2-week treatment, the RMNS-treated patients demonstrated a more rapid increase of the mean Glasgow Coma Score, although statistical significance was not reached (8.43 +/- 4.98 vs. 7.47 +/- 5.37, p=0.0532). The follow-up data at 6-month post-injury showed a significantly higher proportion of patients who regained consciousness (59.8% vs. 46.2%, p=0.0073). There was a lower proportion of vegetative persons in the RMNS group than in the control group (17.6% vs. 22.0%, p=0.0012). For persons regaining consciousness, the functional independence measurement (FIM) score was higher among the RMNS group patients (91.45 +/- 8.65 vs. 76.23 +/- 11.02, p<0.001). There were no unique complications associated with the RMNS treatment. The current study, although with some limitations, showed that RMNS may serve as an easy, effective, and noninvasive technique to promote the recovery of traumatic coma in the early phase.	[Lei, Jin; Wang, Lei; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China; [Lei, Jin; Wang, Lei; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Cooper, Edwin] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, 1630 Dongfang Rd, Shanghai 200127, Peoples R China.	guoyigao@gmail.com			National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; National Natural Scientific grants [81271381]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from National Key Basic Research Project (No. 2012CB518100), National Natural Scientific grants (No. 81271381), and Program for Shanghai Outstanding Medical Academic Leader.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bagnato S, 2011, J PERIPHER NERV SYST, V16, P315, DOI 10.1111/j.1529-8027.2011.00363.x; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Buitrago MM, 2004, EXP BRAIN RES, V158, P336, DOI 10.1007/s00221-004-1906-1; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper EB, 2003, ACT NEUR S, V87, P7; Cooper EB, 1988, P AM INP OUTP SYST A; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Hayashi N., 1997, SOC TREAT COMA, V6, P133; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Oppel L, 2003, BRAIN INJURY, V17, P225, DOI 10.1080/0269905021000030814; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Yokoyama T, 1996, SOC TREAT COMA, V5, P117	33	13	25	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1584	1589		10.1089/neu.2014.3768			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500006	25664378				2022-02-06	
J	Vaaramo, K; Puljula, J; Tetri, S; Juvela, S; Hillbom, M				Vaaramo, Kalle; Puljula, Jussi; Tetri, Sami; Juvela, Seppo; Hillbom, Matti			Head Trauma with or without Mild Brain Injury Increases the Risk of Future Traumatic Death: A Controlled Prospective 15-Year Follow-Up Study	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; epidemiology; head trauma	SUICIDAL IDEATION; POPULATION; MORTALITY; PREDICTORS; SURVIVAL; BEHAVIOR; COHORT; RATES	Patients who have recovered from traumatic brain injury (TBI) show an increased risk of premature death. To investigate long-term mortality rates in a population admitted to the hospital for head injury (HI), we conducted a population-based prospective case-control, record-linkage study, All subjects who were living in Northern Ostrobothnia, and who were admitted to Oulu University Hospital in 1999 because of HI (n=737), and 2196 controls matched by age, gender, and residence randomly drawn from the population of Northern Ostrobothnia were included. Death rate and causes of death in HI subjects during 15 years of follow-up was compared with the general population controls. The crude mortality rates were 56.9, 18.6, and 23.8% for subjects having moderate-to-severe traumatic brain injury (TBI), mild TBI, and head injury without TBI, respectively. The corresponding approximate annual mortality rates were 6.7%, 1.4%, and 1.9%. All types of index HI predicted a significant risk of traumatic death in the future. Subjects who had HI without TBI had an increased risk of both death from all causes (hazard ratio 2.00; 95% confidence interval 1.57-2.55) and intentional or unintentional traumatic death (4.01, 2.20-7.30), compared with controls. The main founding was that even HI without TBI carries an increased risk of future traumatic death. The reason for this remains unknown and further studies are needed. To prevent such premature deaths, post-traumatic therapy should include an interview focusing on lifestyle factors.	[Vaaramo, Kalle; Puljula, Jussi; Hillbom, Matti] Univ Oulu, Dept Neurol, Oulu, Finland; [Tetri, Sami] Univ Oulu, Dept Neurosurg, Oulu, Finland; Oulu Univ Hosp, Oulu 90029, Finland; [Juvela, Seppo] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland		Tetri, S (corresponding author), Oulu Univ Hosp, Dept Neurosurg, Kajaanintie 52, Oulu 90029, Finland.	sami.tetri@ppshp.fi		Juvela, Seppo/0000-0003-4944-4983			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Giza CC, 2001, J ATHL TRAINING, V36, P228; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Koven R, 2005, PREV MED, V41, P240, DOI 10.1016/j.ypmed.2004.11.009; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Shi HY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1066; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	22	13	13	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1579	1583		10.1089/neu.2014.3757			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500005	25584928				2022-02-06	
J	Mollayeva, T; Shapiro, CM; Mollayeva, S; Cassidy, JD; Colantonio, A				Mollayeva, Tatyana; Shapiro, Colin M.; Mollayeva, Shirin; Cassidy, J. David; Colantonio, Angela			Modeling community integration in workers with delayed recovery from mild traumatic brain injury	BMC NEUROLOGY			English	Article						Insomnia; Traumatic brain injury; Concussion; Recovery; Community integration; Diagnostic modeling	QUALITY-OF-LIFE; SPINAL-CORD-INJURY; ASSESSING DEPRESSION; OUTCOME PREDICTION; INSOMNIA; HEALTH; REHABILITATION; SYMPTOMS; RISK; PSYCHOGENESIS	Background: Delayed recovery in persons after mild traumatic brain injury (mTBI) is poorly understood. Community integration (CI) is endorsed by persons with neurological disorders as an important outcome. We aimed to describe CI and its associated factors in insured Ontario workers with delayed recovery following mTBI. Methods: A cross-sectional study of insured workers in the chronic phase following mTBI was performed at a rehabilitation hospital in Ontario, Canada. Sociodemographic, occupational, injury-related, clinical, and claim-related data were collected from self-reports, medical assessments, and insurers' referral files. Community Integration Questionnaire (CIQ) scores were compared using analysis of variance or Spearman's correlation tests. Stepwise multivariable linear regression models were used to evaluate the associations with CI. Results: Ninety-four workers with mTBI (45.2 +/- 9.9 years old, 61.2 % male) at 197 days post-injury (interquartile range, 139-416 days) were included. The CIQ total and subscale scores were similar to those reported in more severe TBI samples. The CIQ scores were moderately to strongly correlated with various sociodemographic, claim-related, and clinical variables. In the multivariable regression analysis, several covariates accounted for 36.4 % of the CIQ variance in the final fully adjusted model. Discussion: This study evaluated CI in workers with mTBI, and analyzed its associated variables. Analysis revealed insomnia, head or neck pain, being married or in a relationship, time since injury, and a diagnosis of possible/probable malingering were independently associated with limited CI. Conclusions: Workers with delayed recovery from mTBI experience difficulty with CI. Insomnia is a particularly relevant covariate, explaining the greater part of its variance. To enhance participation, care should focus on clinical and non-clinical covariates.	[Mollayeva, Tatyana] Univ Toronto, Grad Dept Rehabil Sci, Collaborat Program Neurosci, Toronto, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Shapiro, Colin M.] Toronto Western Hosp, Univ Hlth Network, Toronto, ON, Canada; [Shapiro, Colin M.] Youthdale Child & Adolescent Sleep Clin, Toronto, ON, Canada; [Mollayeva, Shirin] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Mollayeva, Shirin] Univ Toronto, Aquired Brain Injury Res Lab, Toronto, ON, Canada; [Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Cassidy, J. David] Univ Southern Denmark, Dept Sport Sci & Clin Biomech, Fac Hlth, Odense, Denmark; [Colantonio, Angela] Univ Toronto Ontario, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Collaborat Program Neurosci, Toronto, ON, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Mollayeva, Shirin/0000-0001-9612-8655; Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Toronto Rehabilitation Institute Scholarship; Ontario Graduate ScholarshipOntario Graduate Scholarship; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Work Disability Prevention CIHR Strategic Training Program; CIHR Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	We gratefully acknowledge Mr. Kevin McCurley for his help with the data management, Mr. Chen Xiong for his help with the re-abstraction of the data, Ms. Lee Vernich (Dalla Lana School of Public Health) for her help with the statistical analysis. The first author was supported by 2012/2013 Toronto Rehabilitation Institute Scholarship, the Ontario Graduate Scholarship 2012/2013 and the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) and the Work Disability Prevention CIHR Strategic Training Program. AC was supported by the CIHR Chair in Gender, Work and Health (CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Alfoldi P, 2014, DISABIL REHABIL, V36, P1661, DOI 10.3109/09638288.2013.864712; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Bordini EJ, 2002, NEUROREHABILITATION, V17, P93; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Chang FH, 2012, ARCH PHYS MED REHAB, V93, P2264, DOI 10.1016/j.apmr.2012.06.008; Chung S, 2013, J CLIN SLEEP MED, V9, P1131, DOI 10.5664/jcsm.3150; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dupont DW, 2009, STAT MODELLING BIOME; Emery PC, 2014, PAIN RES MANAG, V19, P35, DOI 10.1155/2014/480859; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fayers PM, 1997, QUAL LIFE RES, V6, P139; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Holbrook AM, 2000, CAN MED ASSOC J, V162, P216; Holland P, 2007, HEADACHE, V47, P951, DOI 10.1111/j.1526-4610.2007.00842.x; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LoPiccolo CJ, 1999, ANN MED, V31, P166, DOI 10.3109/07853899909115975; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Maroon JC, 2014, PROG NEUROL SURG, V28, P1, DOI 10.1159/000358746; Mason EC, 2014, J AFFECT DISORDERS, V168, P415, DOI 10.1016/j.jad.2014.07.020; MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Norman G, 2000, BIOSTATISTICS BARE E; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parker G, 2010, 2400 SPRU SDO U YORK; Paunio T, 2015, J AFFECT DISORDERS, V172, P381, DOI 10.1016/j.jad.2014.10.002; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Quatrano LA, 2011, ARCH PHYS MED REHAB, V92, pS7, DOI 10.1016/j.apmr.2010.08.032; Rogers Sharon, 2014, Healthc Q, V17, P70; ROSS CE, 1995, J MARRIAGE FAM, V57, P129, DOI 10.2307/353822; Rosselli M, 2002, J INT NEUROPSYCH SOC, V8, P819, DOI 10.1017/S1355617702860106; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI 10.1111/jsr.12102; Soehner AM, 2014, J AFFECT DISORDERS, V167, P93, DOI 10.1016/j.jad.2014.05.060; Soons JPM, 2009, J MARRIAGE FAM, V71, P1254, DOI 10.1111/j.1741-3737.2009.00667.x; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Sutton EL, 2014, MED CLIN N AM, V98, P1123, DOI 10.1016/j.mcna.2014.06.009; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; von Bonsdorff Mikaela B, 2011, CMAJ, V183, pE235, DOI 10.1503/cmaj.100713; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization, 2006, TRAUM BRAIN INJ NEUR; World Health Organization, 2002, PROJ MORT BURD DIS 2; Zelnick LR, 2014, J NEUROTRAUM, V31, P1029, DOI 10.1089/neu.2013.3122	73	13	13	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	OCT 9	2015	15								194	10.1186/s12883-015-0432-z			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CT0LA	WOS:000362485800001	26452471	Green Published, gold			2022-02-06	
J	Chen, XM; Liu, Y; Zhang, L; Zhu, P; Zhu, HB; Yang, Y; Guan, P				Chen, Xiameng; Liu, Yuan; Zhang, Lin; Zhu, Peng; Zhu, Haibiao; Yang, Yu; Guan, Peng			Long-term neuroglobin expression of human astrocytes following brain trauma	NEUROSCIENCE LETTERS			English	Article						Neuroglobin; Astrocyte; TBI; Sub-acute; Chronic	PROTECTS PC12 CELLS; CEREBRAL-ISCHEMIA; GLOBIN GENE; 14-3-3 PROTEINS; MOUSE-BRAIN; INJURY; OVEREXPRESSION; HEMOGLOBIN; CYTOGLOBIN; OUTCOMES	Neuroglobin (Ngb), a 17 kDa monomeric protein, was initially described as a vertebrate oxygen-binding heme protein in 2000 and detected in metabolically active organs or cells, like the brain, peripheral nervous system as well as certain endocrine cells. A large array of initial experimental work reported that Ngb displayed a neuron restricted expression pattern in mammalian brains. However, growing evidence indicated astrocytes may also express Ngb under pathological conditions. To address the question whether human astrocytes express Ngb under traumatic insults, we investigated Ngb immuno-reactivity in post-mortem human brain tissues that died of acute, sub-acute and chronic brain trauma, respectively. We observed astrocytic Ngb expression in sub-acute and chronic traumatic brains rather than acute traumatic brains. Strikingly, the Ngb immuno-reactive astrocytes were still strongly detectable in groups that died 12 months after brain trauma. Our findings may imply an unexplored role of Ngb in astrocytes and the involved mechanisms were suggested to be further characterized. Also, therapeutic application of Ngb or Ngb-inducible chemical compounds in neuro-genesis or astrocytic scar forming can be expected. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Chen, Xiameng; Liu, Yuan; Zhu, Haibiao; Yang, Yu; Guan, Peng] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Forens Pathol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Lin] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth,Minist Edu, Lab Mol Translat Med,Key Lab Obstet & Gynecol & P, Chengdu 610041, Sichuan, Peoples R China; [Zhu, Peng] Peoples Procuratorate Chengdu, Chengdu, Sichuan, Peoples R China		Guan, P (corresponding author), Sichuan Univ, West China Sch Preclin & Forens Med, Dept Forens Pathol, Chengdu 610041, Sichuan, Peoples R China.	guanpengcn@hotmail.com		Chen, Xiameng/0000-0003-4393-9053	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30470660]; Natural Science Foundation of Sichuan Province [05JY029-020, 2011JY0007]	This study was supported by National Natural Science Foundation of China (NSFC, No.30470660) and the Natural Science Foundation of Sichuan Province (No.05JY029-020, No.2011JY0007).	Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Butler PJ, 2004, RESP PHYSIOL NEUROBI, V141, P297, DOI 10.1016/j.resp.2004.01.010; Chen XQ, 2005, GLIA, V50, P182, DOI 10.1002/glia.20147; Chen XQ, 2002, BIOCHEM BIOPH RES CO, V296, P657; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Haines B, 2013, NEUROSCI LETT, V549, P3, DOI 10.1016/j.neulet.2013.04.039; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Jin KL, 2011, PHARMACOLOGY, V87, P81, DOI 10.1159/000322998; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Meir JU, 2009, J EXP BIOL, V212, P3330, DOI 10.1242/jeb.033761; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Pirim I, 1998, INT J NEUROSCI, V95, P101, DOI 10.3109/00207459809000653; Qin HJ, 2012, BRAIN TUMOR PATHOL, V29, P10, DOI 10.1007/s10014-011-0066-9; QVIST J, 1986, J APPL PHYSIOL, V61, P1560, DOI 10.1152/jappl.1986.61.4.1560; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schneuer M, 2012, NEUROSCIENCE, V223, P35, DOI 10.1016/j.neuroscience.2012.07.052; Shang AJ, 2012, NEUROL SCI, V33, P551, DOI 10.1007/s10072-011-0772-4; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Verratti V, 2009, ADV EXP MED BIOL, V648, P191, DOI 10.1007/978-90-481-2259-2_22; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Wystub S, 2003, NEUROSCI LETT, V346, P114, DOI 10.1016/S0304-3940(03)00563-9; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	48	13	16	1	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	OCT 8	2015	606						194	199		10.1016/j.neulet.2015.09.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU2IJ	WOS:000363346900035	26362813				2022-02-06	
J	Bolkvadze, T; Rantala, J; Puhakka, N; Andrade, P; Pitkanen, A				Bolkvadze, Tamuna; Rantala, Jukka; Puhakka, Noora; Andrade, Pedro; Pitkanen, Asla			Epileptogenesis after traumatic brain injury in Plau-deficient mice	EPILEPSY & BEHAVIOR			English	Article						Controlled cortical impact; Disease-modification; Epilepsy; Epileptiform discharge; Extracellular matrix; Pentylenetetrazol; Seizure susceptibility; Traumatic brain injury	PLASMINOGEN-ACTIVATOR GENE; CONTROLLED CORTICAL IMPACT; TEMPORAL-LOBE EPILEPSY; UROKINASE-TYPE; POSTTRAUMATIC EPILEPSY; ALZHEIMERS-DISEASE; INCREASED EXPRESSION; SPONTANEOUS SEIZURES; STATUS EPILEPTICUS; RAT HIPPOCAMPUS	Several components of the urokinase-type plasminogen activator receptor (uPAR)-interactome, including uPAR and its ligand sushi-repeat protein 2, X-linked (SRPX2), are linked to susceptibility to epileptogenesis in animal models and/or humans. Recent evidence indicates that urokinase-type plasminogen activator (uPA), a uPAR ligand-with focal proteinase activity in the extracellular matrix, contributes to recovery-enhancing brain plasticity after various epileptogenic insults such as traumatic brain injury (TBI) and status epilepticus. Here, we examined whether deficiency of the uPA-encoding gene Plau augments epileptogenesis after TBI. Traumatic brain injury was induced by controlled cortical impact in the somatosensory cortex of adult male wild-type and Plau-deficient mice. Development of epilepsy and seizure susceptibility were assessed with a 3-week continuous video-electroencephalography monitoring and a pentylenetetrazol test, respectively. Traumatic brain injury-induced cortical or hippocampal pathology did not differ between genotypes. The pentylenetetrazol test revealed increased seizure susceptibility after TBI (p < 0.05) in injured mice. Epileptogenesis was not exacerbated, however, in Plau-deficient mice. Taken together, Plau deficiency did not worsen controlled cortical impact-induced brain pathology or epileptogenesis caused by TBI when assessed at chronic timepoints. These data expand previous observations on Plau deficiency in models of status epilepticus and suggest that inhibition of focal extracellular proteinase activity resulting from uPA-uPAR interactions does not modify epileptogenesis after TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Bolkvadze, Tamuna; Rantala, Jukka; Puhakka, Noora; Andrade, Pedro; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341	Academy of FinlandAcademy of FinlandEuropean Commission [267199]; UEF Spearhead Project "UEF-Brain"; COST Action ECMNETEuropean Cooperation in Science and Technology (COST) [BM1001]; ERA-NET Neuron [TBI Epilepsy] [271683]	This study was supported by the Academy of Finland (Grant Nr. 267199), UEF Spearhead Project "UEF-Brain", COST Action ECMNET [BM1001], and ERA-NET Neuron [TBI Epilepsy] (Grant Nr. 271683). We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Adhami F, 2008, AM J PATHOL, V172, P1704, DOI 10.2353/ajpath.2008.070979; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Archinti M, 2011, CNS NEUROL DISORD-DR, V10, P271, DOI 10.2174/187152711794480393; Aronica E, 2008, NEUROSCIENCE, V151, P272, DOI 10.1016/j.neuroscience.2007.10.036; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Diamond ML, 2014, EPILEPSIA, V55, P1313, DOI 10.1111/epi.12714; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Lahtinen L, 2006, EUR J NEUROSCI, V24, P1935, DOI 10.1111/j.1460-9568.2006.05062.x; Lahtinen L, 2010, NEUROBIOL DIS, V37, P692, DOI 10.1016/j.nbd.2009.12.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; MENOUD PA, 1989, DEVELOPMENT, V106, P685; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Patel TH, 2008, NEUROSCI LETT, V444, P222, DOI 10.1016/j.neulet.2008.08.020; Pesaresi M, 2007, NEUROBIOL DIS, V25, P609, DOI 10.1016/j.nbd.2006.10.017; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; R Core Team, 2012, LANG ENV STAT COMP; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rantala J, 2015, EPILEPSY BEHAV, V42, P117, DOI 10.1016/j.yebeh.2014.11.001; Riemenschneider M, 2006, HUM MOL GENET, V15, P2446, DOI 10.1093/hmg/ddl167; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; SUMI Y, 1992, DEVELOPMENT, V116, P625; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wu WL, 2013, AM J ALZHEIMERS DIS, V28, P517, DOI 10.1177/1533317513494450	46	13	14	1	31	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2015	51						19	27		10.1016/j.yebeh.2015.06.037			9	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CS7TW	WOS:000362290200004	26253597				2022-02-06	
J	Kuechler, JN; Abusamha, A; Ziemann, S; Tronnier, VM; Gliemroth, J				Kuechler, Jan Nils; Abusamha, Abdulkareem; Ziemann, Sandra; Tronnier, Volker Martin; Gliemroth, Jan			Impact of percutaneous dilatational tracheostomy in brain injured patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Percutaneously dilatative tracheostomy; Brain tissue oxygen tension; Intracranial pressure; Cerebral perfusion pressure	INTRACRANIAL-PRESSURE; SURGICAL TRACHEOTOMY; PERFUSION-PRESSURE; MORTALITY; TRIAL	Objective: Tracheostomy is an established method in the airway management of critically ill patients with traumatic and non-traumatic brain injuries. High priority in the treatment of those patients is to protect vulnerable brain tissue. While bedside percutaneously dilatative tracheostomy (PDT) technique is increasingly used, there is disagreement about the harms of this intervention for the damaged brain. Therefore, discussions about the safety of tracheostomy in those patients must consider direct and indirect cerebral parameters. Methods: We examined a series of 289 tracheostomies regarding vital signs, respiratory and intracranial parameters in a retrospective study. Complications were recorded and risk factors for a complicated scenario statistically determined. Results: Severe complications were rare (1/289). Arterial hypotension occurred in 3 of 289 cases with a systolic blood pressure below 90 mmHg. We had two patients (0.5%) with transient hypoxia, but 43 cases (15%) of severe hypercapnia during PDT. Invasive measurement of brain tissue oxygen tension (PBrO2) ruled out any cerebral hypoxia during the procedure in 39 available cases. Intracranial pressure (ICP) rose temporarily in 24% of the cases. Cerebral perfusion pressure (CPP) however remained unaffected. Surgery time and hypercapnia are capable risk factors for intraoperative ICP elevation. There is no significant difference in intraoperative ICP rises between disease entities. Conclusion: PDT is a safe procedure for the most common neurosurgical diseases, even for patients with respiratory insufficiency. Shortening surgical time seems to be the most important factor to avoid ICP increase. (C) 2015 Elsevier B.V. All rights reserved.	[Kuechler, Jan Nils; Abusamha, Abdulkareem; Ziemann, Sandra; Tronnier, Volker Martin; Gliemroth, Jan] Med Univ Lubeck, Dept Neurosurg, D-23538 Lubeck, Germany		Gliemroth, J (corresponding author), Med Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	jan.gliemroth@t-online.de		Kuchler, Jan/0000-0002-2587-3129			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Borm W, 2003, NEUROSURG REV, V26, P188, DOI 10.1007/s10143-002-0248-3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Byhahn C, 2000, ANAESTHESIST, V49, P202, DOI 10.1007/s001010050815; Cerejo A, 2012, NEUROL RES, V34, P181, DOI 10.1179/1743132811Y.0000000064; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Durbin CG, 2010, RESP CARE, V55, P1056; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fikkers BG, 2011, INTENS CARE MED, V37, P1103, DOI 10.1007/s00134-011-2222-4; HAZARD P, 1991, CRIT CARE MED, V19, P1018, DOI 10.1097/00003246-199108000-00008; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Higgins KM, 2007, LARYNGOSCOPE, V117, P447, DOI 10.1097/01.mlg.0000251585.31778.c9; Imperiale C, 2009, ANESTH ANALG, V108, P588, DOI 10.1213/ane.0b013e31818f601b; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kleffmann J, 2012, NEUROCRIT CARE, V17, P85, DOI 10.1007/s12028-012-9709-x; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Milanchi S, 2008, J TRAUMA, V65, P73, DOI 10.1097/TA.0b013e31814693f2; Oggiano M, 2014, Pneumologie, V68, P322, DOI 10.1055/s-0034-1365198; Oliver ER, 2007, LARYNGOSCOPE, V117, P1570, DOI 10.1097/MLG.0b013e318093edae; Simon M, 2013, CRIT CARE, V17, DOI 10.1186/cc13085; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2000, J NEUROSURG ANESTH, V12, P307, DOI 10.1097/00008506-200010000-00002; Weissbrod PA, 2012, LARYNGOSCOPE, V122, P1423, DOI 10.1002/lary.23289	24	13	13	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2015	137						137	141		10.1016/j.clineuro.2015.07.007			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CS2SD	WOS:000361921000028	26189073				2022-02-06	
J	Elliott, MR; Margulies, SS; Maltese, MR; Arbogast, KB				Elliott, Michael R.; Margulies, Susan S.; Maltese, Matthew R.; Arbogast, Kristy B.			Accounting for sampling variability, injury under-reporting, and sensor error in concussion injury risk curves	JOURNAL OF BIOMECHANICS			English	Article						Sensor error; Injury risk; Traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; HEAD IMPACTS; SIMULATION-EXTRAPOLATION; SYSTEM; BIOMECHANICS; VALIDATION; KINEMATICS	There has been recent dramatic increase in the use of sensors affixed to the heads or helmets of athletes to measure the biomechanics of head impacts that lead to concussion. The relationship between injury and linear or rotational head acceleration measured by such sensors can be quantified with an injury risk curve. The utility of the injury risk curve relies on the accuracy of both the clinical diagnosis and the biomechanical measure. The focus of our analysis was to demonstrate the influence of three sources of error on the shape and interpretation of concussion injury risk curves: sampling variability associated with a rare event, concussion under-reporting, and sensor measurement error. We utilized Bayesian statistical methods to generate synthetic data from previously published concussion injury risk curves developed using data from helmet-based sensors on collegiate football players and assessed the effect of the three sources of error on the risk relationship. Accounting for sampling variability adds uncertainty or width to the injury risk curve. Assuming a variety of rates of unreported concussions in the non-concussed group, we found that accounting for under-reporting lowers the rotational acceleration required for a given concussion risk. Lastly, after accounting for sensor error, we find strengthened relationships between rotational acceleration and injury risk, further lowering the magnitude of rotational acceleration needed for a given risk of concussion. As more accurate sensors are designed and more sensitive and specific clinical diagnostic tools are introduced, our analysis provides guidance for the future development of comprehensive concussion risk curves. (C) 2015 Elsevier Ltd. All rights reserved.	[Elliott, Michael R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Elliott, Michael R.] Univ Michigan, Inst Social Res, Survey Methodol Program, Ann Arbor, MI 48109 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Maltese, Matthew R.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.] Univ Penn, Dept Pediat, Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA		Arbogast, KB (corresponding author), Univ Penn, Dept Pediat, Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 34th & Civ,Ctr Blvd,Suite 1150, Philadelphia, PA 19104 USA.	Arbogast@email.chop.edu		Arbogast, Kristy/0000-0002-1694-4562			Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; CARROL RJ, 1995, MEASUREMENT ERROR NO; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gelman A., 2014, BAYESIAN DATA ANAL BAYESIAN DATA ANAL, V3rd; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Little R. J., 2019, STAT ANAL MISSING DA, V793; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; RICE SO, 1945, AT&T TECH J, V24, P46, DOI 10.1002/j.1538-7305.1945.tb00453.x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Stefanski LA, 1995, J AM STAT ASSOC, V90, P1247, DOI 10.2307/2291515; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005	24	13	13	1	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2015	48	12					3059	3065		10.1016/j.jbiomech.2015.07.026			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CT8ME	WOS:000363069900018	26296855				2022-02-06	
J	Auxemery, Y				Auxemery, Y.			Clinical forms of post-traumatic depression	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Psychic trauma; Traumatic depression; Posttraumatic depression; Post-concussive syndrome; Traumatic grief; Posttraumatic grief; Psychopathology; Psychopharmacology	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; STRESS-DISORDER; PSYCHOTIC FEATURES; MAJOR DEPRESSION; COMBAT VETERANS; SEVERITY; POLYMORPHISM; COMORBIDITY; PTSD	Introduction. - As a result of determinants specific to the psychopathological structure of the psychological trauma, psycho-traumatised patients very rarely solicit the health care system directly with a request for treatment centred on their trauma. The medical profession is consulted for non-specific symptoms and complications, which are mainly somatoform, addictions and depressive disorders. After a few epidemiological reminders followed by a discussion concerning contemporary depressive and post-traumatic nosographic features, we define, through our clinical experience collated with the data in the literature, different clinical and etiopathogenic contexts of post-traumatic depression in order to control their therapeutic treatment. Clinical findings. - Burnout post-traumatic depression in response to re-experiencing is the most common: it is a reactive psycho-physiological burnout in response to the emotional distress re-experienced during flashbacks, insomnia, a constant feeling of insecurity and the deleterious consequences of this symptomatology in terms of social adaptation. A common genetic predisposition affecting serotoninergic regulation seems to be a vulnerability marker of both depressive and psychotraumatic symptoms. In this case, SSRI will be effective on sadness. In addition, these antidepressants have been widely prescribed for the first-line treatment of depressive and psychotraumatic symptoms. However, this pharmacological class is often insufficient in relieving autonomic hyperactivity such as re-experiencing which are mediated more by noradrenergic hyperactivity. SNRI such as venlafaxine can be used as a first-line treatment. Post-traumatic depression with psychotic features congruent with mood is dominated by a feeling of incurability; the subject blames himself and feels guilty about the traumatic event and its consequences. Symptoms of denial of identity are sometimes observed: confined by an intense depersonalization, the psycho-traumatised subject evokes that he is "no longer himself" and that his mind "is disconnected". Confronted with the psychological emptiness of the traumatic scene, the psycho-traumatised subject remains devoid of thought as if their mind has left him. In addition to antidepressant therapy, an atypical antipsychotic drug must be prescribed to relieve the melancholic symptoms as well as the concomitant psychotraumatic symptoms. Post-traumatic depression masked by peripheral physical injuries is the result of accidents combining psychological and physical impairment. The physical pain resulting from the accident regularly recalls the drama in the same way as traumatic re-experiencing. Depression masked by this somatic suffering is difficult to diagnose, but the repeated somatic complaints at the forefront of the request for treatment, the breakdown of self-esteem as well as the level of subjective strain due to pain and dysesthesia are all indications. The psychotherapy will focus on the symbolic reconstruction of the organs that have been damaged or destroyed, with the aim of healing the extensive narcissistic impairment. Post-concussive depression is diagnosed following a head trauma, however severe. It is sometimes assigned to neurological lesions and at other times recognised as the expression of a purely psychological reaction. Antidepressant therapy, or possibly trial therapy, is often indicated. The terms traumatic grief and post-traumatic grief are often used synonymously in publications: a conceptual opposition must however been recalled. If the traumatic grief is the result of the loss of an object that holds much psychological importance for the individual, the subject has not however been traumatised by this event and is not suffering and will not suffer from re-experiencing. The therapy will include methods used in the psychotherapeutic treatment of grief; antidepressants are often insufficient. Differently, post-traumatic grief takes shape when the toss of another is concomitant with the confrontation with the reality of the death witnessed in a moment of peri-traumatic dissociation. This grief is often observed following the discovery of the body of a close friend or family member who has committed suicide, or when part of a family has been decimated by an accident whilst the survivors watch their close relations die pending the arrival of the emergency services, or when a military comrade is wounded in combat in front of his partner. The mourning process cannot really begin until the flashbacks cease. Conclusions. - Clinical depression or even melancholia, possibly masked by somatic or post concussive complaints, is often the initial mode of contact with the health care system for the psycho-traumatised subject. The different clinical and etiopathogenic contexts of post traumatic depression that we have developed in this work use specific therapies which need to be clarified by further research based on this nosography. (C) L'Encephale, Paris, 2014.	[Auxemery, Y.] Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse,BP406, F-92141 Clamart, France		Auxemery, Y (corresponding author), Hop Instruct Armees Percy, Serv Med Psychol Clin Appl Aeronaut, 101 Ave Henri Barbusse,BP406, F-92141 Clamart, France.	yann.auxemery@hotmail.fr					Alarcon RD, 1999, PSYCHIATRY, V62, P114, DOI 10.1080/00332747.1999.11024860; American Psychiatric Association, 2000, DSM 4 TR MAN DIAGN S; Auxemery Y, 2012, ENCEPHALE, V38, P329, DOI 10.1016/j.encep.2011.07.003; Auxemery Y, 2011, ENCEPHALE, V37, P433, DOI 10.1016/j.encep.2010.12.001; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; BOURGEOIS ML, 2003, DEUIL NORMAL DEUIL P; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; BRIOLE G, 1994, C PSYCH NEUR LANG FR; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2; Clervoy P., 2013, MED ARMEES, V41, P1; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; Davidson JRT, 1998, J PSYCHIAT RES, V32, P301, DOI 10.1016/S0022-3956(98)00016-8; Deb S, 1999, AM J PSYCHIAT, V156, P374; Ducrocq F, 2005, ENCEPHALE, V31, P212; Ducrocq F, 2001, ENCEPHALE, V27, P159; *ESEMED MHEDEA, 2004, ACTA PSYCHIAT SCAND, V420, P28; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ferreri M, 1996, LENCEPHALE SP, Vsp7, P7; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Lebigot F, 2011, TRAITER TRAUMATISMES; Lebigot F, 2003, MALADIES DEPRESSIVES, P306; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; MCGORRY PD, 1995, AUST NZ J PSYCHIAT, V29, P385, DOI 10.3109/00048679509064945; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; North CS, 1997, AM J PSYCHIAT, V154, P1696, DOI 10.1176/ajp.154.12.1696; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Pae CU, 2008, INT CLIN PSYCHOPHARM, V23, P1, DOI 10.1097/YIC.0b013e32825ea324; Petrakis IL, 2012, NEUROPSYCHOPHARMACOL, V37, P996, DOI 10.1038/npp.2011.283; ROCA RP, 1992, AM J PSYCHIAT, V149, P1234; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shad MU, 2011, HUM PSYCHOPHARM CLIN, V26, P4, DOI 10.1002/hup.1171; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Stroebe M, 2001, ISR J PSYCHIATR REL, V38, P185; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Vaiva G., 2007, STRESS TRAUMA, V7, P69; Waddington A, 2003, ENCEPHALE, V29, P20; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weathers F.W., 1993, PTSD CHECKLIST RELIA; Yao SN, 2003, ENCEPHALE, V29, P232; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006	51	13	13	1	19	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2015	41	4					346	354		10.1016/j.encep.2014.07.005			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DE4EE	WOS:000370581200010	25238908				2022-02-06	
J	del Mar, N; von Buttlar, X; Yu, AS; Guley, NH; Reiner, A; Honig, MG				del Mar, Nobel; von Buttlar, Xinyu; Yu, Angela S.; Guley, Natalie H.; Reiner, Anton; Honig, Marcia G.			A novel closed-body model of spinal cord injury caused by high-pressure air blasts produces extensive axonal injury and motor impairments	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord; Axonal injury; Trauma; Microtubule breakage; Axonal bulbs; Axonal degeneration; Neurofilaments; Calpain; Spectrin proteolysis; Motor impairment	TRAUMATIC BRAIN-INJURY; INTRAAXONAL NEUROFILAMENT COMPACTION; FUNCTIONAL RECOVERY; OPTIC-NERVE; IN-VIVO; STRETCH-INJURY; MOUSE MODEL; CALPAIN ACTIVATION; CONTUSION INJURY; CORPUS-CALLOSUM	Diffuse axonal injury is thought to be the basis of the functional impairments stemming from mild traumatic brain injury. To examine how axons are damaged by traumatic events, such as motor vehicle accidents, falls, sports activities, or explosive blasts, we have taken advantage of the spinal cord with its extensive white matter tracts. We developed a closed-body model of spinal cord injury in mice whereby high-pressure air blasts targeted to lower thoracic vertebral levels produce tensile, compressive, and shear forces within the parenchyma of the spinal cord and thereby cause extensive axonal injury. Markers of cytoskeletal integrity showed that spinal cord axons exhibited three distinct pathologies: microtubule breakage, neurofilament compaction, and calpain-mediated spectrin breakdown. The dorsally situated axons of the corticospinal tract primarily exhibited microtubule breakage, whereas all three pathologies were common in the lateral and ventral white matter. Individual axons typically demonstrated only one of the three pathologies during the first 24 h after blast injury, suggesting that the different perturbations are initiated independently of one another. For the first few days after blast, neurofilament compaction was frequently accompanied by autophagy, and subsequent to that, by the fragmentation of degenerating axons. TuJ1 immunolabeling and mice with YFP-reporter labeling each revealed more extensive microtubule breakage than did beta APP immunolabeling, raising doubts about the sensitivity of this standard approach for assessing axonal injury. Although motor deficits were mild and largely transient, some aspects of motor function gradually worsened over several weeks, suggesting that a low level of axonal degeneration continued past the initial wave. Our model can help provide further insight into how to intervene in the processes by which initial axonal damage culminates in axonal degeneration, to improve outcomes after traumatic injury. Importantly, our findings of extensive axonal injury also caution that repeated trauma is likely to have cumulative adverse consequences for both brain and spinal cord. (C) 2015 Elsevier Inc. All rights reserved.	[del Mar, Nobel; von Buttlar, Xinyu; Yu, Angela S.; Guley, Natalie H.; Reiner, Anton; Honig, Marcia G.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA		Honig, MG (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.	mhonig@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232	Neuroscience Institute at The University of Tennessee Health Science Center; Department of Anatomy and Neurobiology at The University of Tennessee Health Science Center; Spinal Cord Research Fund at The University of Tennessee Health Science Center; Office of the Dean of the College of Medicine; Methodist Hospitals Endowed Professorship in Neuroscience; Neuroscience Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS081370] Funding Source: NIH RePORTER	We are grateful to Tonia Rex (previously at The University of Tennessee Health Science Center, and currently at Vanderbilt University) for providing advice and allowing us to use the blast cannon system she developed. We thank Robert Siman and Virginia Lee, both at the University of Pennsylvania, for kindly providing the Ab37 and RMO14 antibodies, respectively. We thank Marion Joni, Josh Rogers, and Michael Cagle for technical assistance and Dr. Jeffrey Marchetta (Dept. of Mechanical Engineering, University of Memphis) for the use of his high-speed video camera. This study was supported by funds from The Neuroscience Institute, Department of Anatomy and Neurobiology, and Spinal Cord Research Fund, all at The University of Tennessee Health Science Center, to MGH and from The Neuroscience Institute, The Office of the Dean of the College of Medicine, and The Methodist Hospitals Endowed Professorship in Neuroscience to AR.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J HISTOCHEM CYTOCHEM, V48, P153; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Cantu Robert V, 2005, Curr Sports Med Rep, V4, P27; Castillo K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.421; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Clarke EC, 2008, J NEUROTRAUM, V25, P371, DOI 10.1089/neu.2007.0421; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Giza C.C., 2014, NEUROSURGERY, V75, pS24; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guley N.G., 2015, J NEUROTRAUMA UNPUB; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hendriks WTJ, 2006, J NEUROTRAUM, V23, P18, DOI 10.1089/neu.2006.23.18; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jin Y, 2014, EXP NEUROL, V257, P57, DOI 10.1016/j.expneurol.2014.04.016; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koopmans GC, 2012, J NEUROTRAUM, V29, P514, DOI 10.1089/neu.2011.1949; Krizsan-Agbas D, 2014, J NEUROTRAUM, V31, P846, DOI 10.1089/neu.2013.3115; Lam CJ, 2014, J NEUROTRAUM, V31, P1985, DOI 10.1089/neu.2014.3392; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li XF, 2009, SPINE, V34, P1140, DOI 10.1097/BRS.0b013e31819e2af1; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; Manning CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038313; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Redondo-Castro E, 2013, J NEUROSCI METH, V213, P165, DOI 10.1016/j.jneumeth.2012.12.024; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Russell CM, 2012, J NEUROTRAUM, V29, P1574, DOI 10.1089/neu.2011.2225; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Seifert JL, 2011, J NEUROSCI METH, V197, P97, DOI 10.1016/j.jneumeth.2011.02.003; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; Shitaka Y., 2001, J NEUROPATHOL EXP NE, V70, P551, DOI DOI 10.1097/NEN.0B013E31821F891F; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sparrey CJ, 2009, J NEUROTRAUM, V26, P585, DOI 10.1089/neu.2008.0654; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Watson C, 2012, ANAT REC, V295, P1692, DOI 10.1002/ar.22549; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Willenberg R., 2012, NEUROSCI; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	99	13	13	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2015	271						53	71		10.1016/j.expneurol.2015.04.023			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT2JG	WOS:000362627200006	25957630	Green Accepted			2022-02-06	
J	Flach, PM; Schroth, S; Schweitzer, W; Ampanozi, G; Slotboom, J; Kiefer, C; Germerott, T; Thali, MJ; El-Koussy, M				Flach, Patricia Mildred; Schroth, Sarah; Schweitzer, Wolf; Ampanozi, Garyfalia; Slotboom, Johannes; Kiefer, Claus; Germerott, Tanja; Thali, Michael J.; El-Koussy, Marwan			Deep Into the Fibers! Postmortem Diffusion Tensor Imaging in Forensic Radiology	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						diffusion tensor imaging; DTI; forensic radiology; magnetic resonance imaging; postmortem MR; Virtopsy	TRAUMATIC BRAIN-INJURY; WHITE-MATTER; VIRTUAL AUTOPSY; AXONAL INJURY; MRI; ANGIOGRAPHY; DEATH; WHOLE; TRACTOGRAPHY; FEASIBILITY	Purpose In traumatic brain injury, diffusion-weighted and diffusion tensor imaging of the brain are essential techniques for determining the pathology sustained and the outcome. Postmortem cross-sectional imaging is an established adjunct to forensic autopsy in death investigation. The purpose of this prospective study was to evaluate postmortem diffusion tensor imaging in forensics for its feasibility, influencing factors and correlation to the cause of death compared with autopsy. Methods Postmortem computed tomography, magnetic resonance imaging, and diffusion tensor imaging with fiber tracking were performed in 10 deceased subjects. The Likert scale grading of colored fractional anisotropy maps was correlated to the body temperature and intracranial pathology to assess the diagnostic feasibility of postmortem diffusion tensor imaging and fiber tracking. Results Optimal fiber tracking (>15,000 fiber tracts) was achieved with a body temperature at 10 degrees C. Likert scale grading showed no linear correlation (P > 0.7) to fiber tract counts. No statistically significant correlation between total fiber count and postmortem interval could be observed (P = 0.122). Postmortem diffusion tensor imaging and fiber tracking allowed for radiological diagnosis in cases with shearing injuries but was impaired in cases with pneumencephalon and intracerebral mass hemorrhage. Conclusions Postmortem diffusion tensor imaging with fiber tracking provides an exceptional in situ insight deep into the fibers of the brain with diagnostic benefit in traumatic brain injury and axonal injuries in the assessment of the underlying cause of death, considering influencing factors for optimal imaging technique.	[Flach, Patricia Mildred; Schweitzer, Wolf; Ampanozi, Garyfalia; Thali, Michael J.] Univ Zurich, Inst Forens Med, CH-8057 Zurich, Switzerland; [Flach, Patricia Mildred] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Flach, Patricia Mildred; Schroth, Sarah; Germerott, Tanja] Univ Bern, Inst Forens Med, Bern, Switzerland; [Schroth, Sarah; Slotboom, Johannes; Kiefer, Claus; El-Koussy, Marwan] Univ Bern, Inselspital, Univ Hosp Bern, Dept Intervent & Diagnost Neuroradiol, CH-3010 Bern, Switzerland; [Schroth, Sarah] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Germerott, Tanja] Hannover Med Sch, Inst Legal Med, Hannover, Germany		Flach, PM (corresponding author), Univ Zurich, Virtopsy, Inst Forens Med, Winterthurerstr 190-52, CH-8057 Zurich, Switzerland.	patricia.flach@irm.uzh.ch	Germerott, Tanja/AAC-5743-2019; Ampanozi, Garyfalia/ABG-7354-2021; Schweitzer, Wolf/ABE-9689-2020	Ampanozi, Garyfalia/0000-0002-9033-3161			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Auer RN, 2006, FORENSIC NEUROPATHOL, P177; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Arceuil H, 2007, NEUROIMAGE, V36, P64, DOI 10.1016/j.neuroimage.2007.02.039; Dellanoy J, 1991, MAGN RESON MED, V19, P333; DiMaio V J, 2001, FORENSIC PATHOLOGY, P147; Englund E, 2004, J NEUROL, V251, P350, DOI 10.1007/s00415-004-0318-2; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Filograna L, 2010, LEGAL MED, V12, P233, DOI 10.1016/j.legalmed.2010.04.003; Flach P.M., 2010, BROGDONS FORENSIC RA, P409; Flach PM, 2012, J FORENSIC SCI, V57, P1376, DOI 10.1111/j.1556-4029.2012.02144.x; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Hansen B, 2011, NEUROIMAGE, V57, P1458, DOI 10.1016/j.neuroimage.2011.04.052; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Ith M, 2011, NMR BIOMED, V24, P791, DOI 10.1002/nbm.1623; Jackowski C, 2008, J FORENSIC SCI, V53, P465, DOI 10.1111/j.1556-4029.2008.00673.x; Kim JH, 2007, NMR BIOMED, V20, P352, DOI 10.1002/nbm.1138; Kobayashi T, 2010, MAGN RESON MED SCI, V9, P101, DOI 10.2463/mrms.9.101; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Muir KW, 2006, LANCET NEUROL, V5, P755; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross S, 2012, AM J ROENTGENOL, V199, P1186, DOI 10.2214/AJR.12.8767; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130567; Ruder TD, 2012, EUR J RADIOL, V81, P1366, DOI 10.1016/j.ejrad.2011.02.062; Saukko P, 2004, KNIGHTS FORENSIC PAT, P174; Scheurer E, 2011, AM J NEURORADIOL, V32, P1518, DOI 10.3174/ajnr.A2508; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thali Michael J., 2007, Legal Medicine, V9, P100, DOI 10.1016/j.legalmed.2006.11.011; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Yen K, 2006, AM J NEURORADIOL, V27, P70; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027	41	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2015	36	3					153	161		10.1097/PAF.0000000000000177			9	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	CQ3UX	WOS:000360530200008	26132433	Green Published			2022-02-06	
J	Hayashi, T; Ago, K; Nakamae, T; Higo, E; Ogata, M				Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru			Two different immunostaining patterns of beta-amyloid precursor protein (APP) may distinguish traumatic from nontraumatic axonal injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic axonal injury; Beta-amyloid precursor protein (APP); Hypoxia; Immunostaining patterns	CLOSED-HEAD INJURY; BRAIN-INJURY; DAMAGE; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; MARKER; ADULTS	Immunostaining for beta-amyloid precursor protein (APP) is recognized as an effective tool for detecting traumatic axonal injury, but it also detects axonal injury due to ischemic or other metabolic causes. Previously, we reported two different patterns of APP staining: labeled axons oriented along with white matter bundles (pattern 1) and labeled axons scattered irregularly (pattern 2) (Hayashi et al. (Leg Med (Tokyo) 11:S171-173, 2009). In this study, we investigated whether these two patterns are consistent with patterns of trauma and hypoxic brain damage, respectively. Sections of the corpus callosum from 44 cases of blunt head injury and equivalent control tissue were immunostained for APP. APP was detected in injured axons such as axonal bulbs and varicose axons in 24 of the 44 cases of head injuries that also survived for three or more hours after injury. In 21 of the 24 APP-positive cases, pattern 1 alone was observed in 14 cases, pattern 2 alone was not observed in any cases, and both patterns 1 and 2 were detected in 7 cases. APP-labeled injured axons were detected in 3 of the 44 control cases, all of which were pattern 2. These results suggest that pattern 1 indicates traumatic axonal injury, while pattern 2 results from hypoxic insult. These patterns may be useful to differentiate between traumatic and nontraumatic axonal injuries.	[Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, Kagoshima 8908544, Japan		Hayashi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takahito@m2.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19590677, 22790599]	This study was financially supported by Grants-in-Aids for Scientific Research (C) (grant no. 19590677 to M. Ogata) and for Young Scientists (B) (grant no. 22790599 to T. Hayashi) from the Ministry of Education, Culture, Science, and Technology of Japan.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Harrington D, 2000, J Clin Forensic Med, V7, P19, DOI 10.1054/jcfm.2000.0359; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x	25	13	16	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1085	1090		10.1007/s00414-015-1245-8			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CQ0VM	WOS:000360315900021	26249371				2022-02-06	
J	Liu, WH; Zhu, JZ; Liu, J; Guo, Q				Liu, Weihua; Zhu, Jianzhong; Liu, Jing; Guo, Qing			Psychological state and needs of family member caregivers for victims of traumatic brain injury: A cross-sectional descriptive study	INTERNATIONAL JOURNAL OF NURSING SCIENCES			English	Article						Caregivers; Family member; Stress; Traumatic brain injury		Objective: Here we evaluated the impact of varying severity of traumatic brain injury on the psychological state and demands of family caregivers. Further, we determined the most significant and least significant daily needs among family caregivers. Methods: We performed a cross-sectional descriptive study in three public hospitals in Tai'an, China. Three hundred caregivers related to traumatic brain injury victims were randomly selected. Patients had varying degrees of injuries (mild to severe). The Symptom Checklist-90 (SCL-90) was used to assess family caregivers' psychological statuses. The Critical Care Family Needs Inventory (CCFNI) was used to determine family caregivers' needs. Finally, the Glasgow Coma Scale (GCS) was employed to define patients' level of traumatic brain injury. Results: SCL-90 scores for each psychological dimension were significantly higher with increasing TBI severity (p < 0.05). Similarly, CCFNI scores were significantly higher with increasing TBI severity (p < 0.05) for information, reassurance, and accessibility. These same dimensions were found to be the most important needs for family members of TBI injury victims, while support and comfort were the least important dimensions. Conclusions: The more severe pathogenic condition of the patient, the heavier the psychological pressure is on their family member caregivers. Medical staff should therefore pay close attention to the psychological health of family caregivers of TBI patients, especially family caregivers of critical cases. Interventions should be accordingly designed and conducted to meet the needs of family caregivers. Copyright (C) 2015, Chinese Nursing Association. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license	[Liu, Weihua; Liu, Jing; Guo, Qing] Taishan Med Univ, Sch Nursing, Tai An 271016, Shandong, Peoples R China; [Zhu, Jianzhong] Hosp Taishan Med Univ, Dept Med Imaging, Tai An 271000, Shandong, Peoples R China		Zhu, JZ (corresponding author), Hosp Taishan Med Univ, Dept Med Imaging, Tai An 271000, Shandong, Peoples R China.	mri1964@outlook.com			National Social Science Fund of China [15BRK023]	The labor costs of the graduate students is supported by the National Social Science Fund of China (No. 15BRK023).	Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Chien WT, 2005, RES NURS HEALTH, V28, P474, DOI 10.1002/nur.20103; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Duff Diane, 2002, Axone, V24, P14; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freitas KS, 2007, REV LAT-AM ENFERM, V15, P84, DOI 10.1590/S0104-11692007000100013; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Liu H, 2006, J NURS CHINA, V13, P84; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Moller-Leimkuhler AM, 2011, EUR ARCH PSY CLIN N, V261, P165, DOI 10.1007/s00406-010-0155-5; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Noor Siah A A, 2012, Clin Ter, V163, P63; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Ruis C, 2014, J CLIN EXP NEUROPSYC, V36, P170, DOI 10.1080/13803395.2013.875519; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Watanabe Y, 2001, DISABIL REHABIL, V23, P370	20	13	13	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2352-0132			Int J Nurs Sci	INT. J. NURS. SCI.	SEP	2015	2	3					231	236		10.1016/j.ijnss.2015.07.001			6	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V3Z2H	WOS:000218721400002		gold			2022-02-06	
J	Neselius, S; Brisby, H; Granholm, F; Zetterberg, H; Blennow, K				Neselius, Sanna; Brisby, Helena; Granholm, Fredrik; Zetterberg, Henrik; Blennow, Kaj			Monitoring concussion in a knocked-out boxer by CSF biomarker analysis	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Concussion; Traumatic brain injury (TBI); Mild traumatic brain injury; Boxing	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; PROTEIN; TAU; DISEASE; ELISA	Concussion is common in many sports, and the incidence is increasing. The medical consequences after a sport-related concussion have received increased attention in recent years since it is known that concussions cause axonal and glial damage, which disturbs the cerebral physiology and makes the brain more vulnerable for additional concussions. This study reports on a knocked-out amateur boxer in whom cerebrospinal fluid (CSF) neurofilament light (NFL) protein, reflecting axonal damage, was used to identify and monitor brain damage. CSF NFL was markedly increased during 36 weeks, suggesting that neuronal injury persists longer than expected after a concussion. CSF biomarker analysis may be valuable in the medical counselling of concussed athletes and in return-to-play considerations. Level of evidence IV.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Granholm, Fredrik] Sundsvall Cty Hosp, Dept Emergency Med, Sundsvall, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Clin Neurochem Lab, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London WC1N 3BG, England		Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden.	sanna.neselius@vgregion.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Swedish State Support for Clinical Research	This study has been funded by Swedish Research Council, the Knut and Alice Wallenberg Foundation and Swedish State Support for Clinical Research.	Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Petzold Axel, 2008, J Stroke Cerebrovasc Dis, V17, P196, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.002; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; ROSENGREN LE, 1992, J NEUROSCI METH, V44, P113, DOI 10.1016/0165-0270(92)90004-W; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	18	13	13	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	SEP	2015	23	9					2536	2539		10.1007/s00167-014-3066-6			4	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	CP6ND	WOS:000360003300011	24819180				2022-02-06	
J	Thiam, DW; Yap, SH; Chong, SL				Thiam, Desmond Wei; Yap, Si Hui; Chong, Shu Ling			Clinical Decision Rules for Paediatric Minor Head Injury: Are CT Scans a Necessary Evil?	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						Brain injuries; Children; Prediction rules; Traumatic brain injury	COMPUTED-TOMOGRAPHY SCANS; CHILDREN; PREDICTION; CHILDHOOD; ALGORITHM; EVENTS; CANCER; TRAUMA; RISK	Introduction: High performing clinical decision rules (CDRs) have been derived to predict which head-injured child requires a computed tomography (CT) of the brain. We set out to evaluate the performance of these rules in the Singapore population. Materials and Methods: This is a prospective observational cohort study of children aged less than 16 who presented to the emergency department (ED) from April 2014 to June 2014 with a history of head injury. Predictor variables used in the Canadian Assessment of Tomography for Childhood Head Injury (CATCH), Children's Head Injury Algorithm for the Prediction of Important Clinical Events (CHALICE) and Pediatric Emergency Care Applied Research Network (PECARN) CDRs were collected. Decisions on CT imaging and disposition were made at the physician's discretion. The performance of the CDRs were assessed and compared to current practices. Results: A total of 1179 children were included in this study. Twelve (1%) CT scans were ordered; 6(0.5%) of them had positive findings. The application of the CDRs would have resulted in a significant increase in the number of children being subjected to CT (as follows): CATCH 237 (20.1%), CHALICE 282 (23.9%), PECARN high- and intermediate-risk 456 (38.7%), PECARN high-risk only 45 (3.8%). The CDRs demonstrated sensitivities of: CATCH 100% (54.1 to 100), CHALICE 83.3% (35.9 to 99.6), PECARN 100% (54.1 to 100), and specificities of: CATCH 80.3% (77.9 to 82.5), CHALICE 76.4% (73.8 to 78.8), PECARN high- and intermediate-risk 61.6% (58.8 to 64.4) and PECARN high-risk only 96.7% (95.5 to 97.6). Conclusion: The CDRs demonstrated high accuracy in detecting children with positive CT findings but direct application in areas with low rates of significant traumatic brain injury (TBI) is likely to increase unnecessary CT scans ordered. Clinical observation in most cases may be a better alternative.	[Thiam, Desmond Wei; Yap, Si Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Chong, Shu Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore 229899, Singapore; [Chong, Shu Ling] Duke NUS, Grad Sch Med, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.	Chong.Shu-Ling@kkh.com.sg			Paediatrics Academic Clinical Program (Paeds ACP) Young Researcher Pilot Grant	The ongoing prospective head injury surveillance is supported by the Paediatrics Academic Clinical Program (Paeds ACP) Young Researcher Pilot Grant. The authors would like to thank Ms Dianna Sri for her contribution towards the data collection.	Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Faul M, 2010, TRAUMATIC BRAIN INJU; Griffin ES, 2014, J EMERG NURS, V40, P98, DOI 10.1016/j.jen.2013.07.001; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004	23	13	15	0	0	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	SEP	2015	44	9					335	341					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV4US	WOS:000364262600004	26584662				2022-02-06	
J	Lichte, P; Andruszkow, H; Kappe, M; Horst, K; Pishnamaz, M; Hildebrand, F; Lefering, R; Pape, HC; Kobbe, P				Lichte, Philipp; Andruszkow, Hagen; Kappe, Miriam; Horst, Klemens; Pishnamaz, Miguel; Hildebrand, Frank; Lefering, Rolf; Pape, Hans-Christoph; Kobbe, Philipp		TraumaRegister DGU	Increased in-hospital mortality following severe head injury in young children: results from a nationwide trauma registry	EUROPEAN JOURNAL OF MEDICAL RESEARCH			English	Article							GLASGOW COMA SCALE; RECOVERY 10 YEARS; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PEDIATRIC-PATIENTS; MULTIPLE INJURIES; AGE; OUTCOMES; SCORE; PREDICTORS	Background: In the current literature, the outcome of paediatric brain injury is controversially discussed. According to the majority of the studies, there seems to be a decreased mortality but worse recovery in paediatric, traumatic brain injury in comparison with adults. However, there is a lack of information concerning the differences in various stages of development in patients younger than 18 years. The aim of our study was to verify the in-hospital outcome of different paediatric age groups in comparison to adults with respect to the treatment strategy. Methods: We performed a retrospective analysis of the TraumaRegister DGU (R) from 2002 to 2012. Inclusion criteria were an Abbreviated Injury Scale (AIS) head >= 3 points and an AIS <= 2 points of the remaining body regions. The collective was divided into different subgroups according to age (1-3, 4-6, 7-10, 11-14, 15-17) and an adult control group aged between 18 and 55 years. We descriptively analysed the endpoint rate of sepsis, multiple organ failure, and mortality. Additionally, the Glasgow Outcome Scale (GOS) at discharge was observed. Results: Overall, 1110 children and 6491 adult control patients were included. Comparing the rate of intubation on-scene, the rate of cranial CT scans, the rate of craniotomies, and the rate and length of intensive care treatment, we could only identify minor differences between the age groups. The treatment after discharge from hospital was markedly different due to a very low rate of in-patient rehabilitation treatment in children. On one hand, the rate of systemic complications, such as sepsis and multiple organ failure increased with increasing age. On the other hand, we found a significantly increased mortality in children younger than 7 years after very (AIS head = 5) severe brain injury. The in-hospital functional outcome in survivors, according to the GOS, was beneficial for younger children in comparison to adolescents and adults. Conclusions: We were unable to identify marked age-related differences in the therapeutic approach. Nevertheless, we were able to demonstrate marked differences of outcome. Children younger than 7 years significantly die more often due to direct impact of severe trauma. But if they survive, they seem to develop less systemic complications and profit from a better functional outcome.	[Lichte, Philipp; Andruszkow, Hagen; Kappe, Miriam; Horst, Klemens; Pishnamaz, Miguel; Hildebrand, Frank; Pape, Hans-Christoph; Kobbe, Philipp] Univ Hosp Aachen, Dept Orthopaed Trauma Surg, D-52074 Aachen, Germany; [Horst, Klemens; Pishnamaz, Miguel] Univ Hosp RWTH Aachen, Dept Orthopaed Trauma Surg, Harald Tscherne Res Lab Orthoped Trauma, Aachen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; German Trauma Soc Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Cologne, Germany		Lichte, P (corresponding author), Univ Hosp Aachen, Dept Orthopaed Trauma Surg, Pauwelsstr 30, D-52074 Aachen, Germany.	plichte@ukaachen.de	Hildebrand, Frank/J-3176-2017; Lichte, Philipp/AAG-2263-2020	Pape, Hans-Christoph/0000-0002-2059-4980			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jakob H, 2009, UNFALLCHIRURG, V112, P951, DOI 10.1007/s00113-009-1682-2; JENNETT B, 1975, LANCET, V1, P480; KISSOON N, 1990, CAN MED ASSOC J, V142, P27; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Laurer H, 2009, UNFALLCHIRURG, V112, P771, DOI 10.1007/s00113-009-1589-y; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maegele M, 2008, NOTFALL RETTUNGSMED, V11, P266, DOI 10.1007/s10049-008-1060-6; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Remmers D, 1998, UNFALLCHIRURG, V101, P388, DOI 10.1007/s001130050285; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Stocchetti N, 2010, MINERVA ANESTESIOL, V76, P1052; Suominen P, 2000, Eur J Emerg Med, V7, P3; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Woischneck D., 2010, Intensivmedizin und Notfallmedizin, V47, P582, DOI 10.1007/s00390-010-0213-2; Zsoter A, 2011, MONATSSCHR KINDERH, V159, P634, DOI 10.1007/s00112-010-2326-x	43	13	13	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0949-2321	2047-783X		EUR J MED RES	Eur. J. Med. Res.	AUG 14	2015	20								65	10.1186/s40001-015-0159-8			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CP2FI	WOS:000359692500001	26272597	Green Published, gold			2022-02-06	
J	Hammond, FM; Horn, SD; Smout, RJ; Beaulieu, CL; Barrett, RS; Ryser, DK; Sommerfeld, T				Hammond, Flora M.; Horn, Susan D.; Smout, Randall J.; Beaulieu, Cynthia L.; Barrett, Ryan S.; Ryser, David K.; Sommerfeld, Teri			Readmission to an Acute Care Hospital During Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Hospitalization; Patient readmission; Rehabilitation	LENGTH-OF-STAY; MEDICAL REHABILITATION; RESOURCE USE; COMPLICATIONS; COMPLEXITY; MORTALITY; QUALITY; SYSTEM	Objective: To assess the incidence of, causes for, and factors associated with readmission to an acute care hospital (RTAC) during inpatient rehabilitation for traumatic brain injury (TBI). Design: Prospective observational cohort. Setting: Inpatient rehabilitation. Participants: Individuals with TBI admitted consecutively for inpatient rehabilitation (N=2130). Interventions: Not applicable. Main Outcome Measures: RTAC incidence, RTAC causes, rehabilitation length of stay (RLOS), and rehabilitation discharge location. Results: A total of 183 participants (9%) experienced RTAC for a total of 210 episodes. Of 183 participants, 161 patients experienced 1 RTAC episode, 17 had 2, and 5 had 3. The mean time from rehabilitation admission to first RTAC was 22 +/- 22 days. The mean duration in acute care during RTAC was 7 +/- 8 days. Eighty-four participants (46%) had >= 1 RTAC episodes for medical reasons, 102 (56%) had >= 1 RTAC episodes for surgical reasons, and 6 (3%) participants had RTAC episodes for unknown reasons. Most common surgical RTAC reasons were neurosurgical (65%), pulmonary (9%), infection (5%), and orthopedic (5%); most common medical reasons were infection (26%), neurological (23%), and cardiac (12%). Any RTAC was predicted as more likely for patients with older age, history of coronary artery disease, history of congestive heart failure, acute care diagnosis of depression, craniotomy or craniectomy during acute care, and presence of dysphagia at rehabilitation admission. RTAC was less likely for patients with higher admission FIM motor scores and education less than high school diploma. RTAC occurrence during rehabilitation was significantly associated with longer RLOS and smaller likelihood of discharge home. Conclusions: Approximately 9% of patients with TBI experienced RTAC episodes during inpatient rehabilitation for various medical and surgical reasons. This information may help inform interventions aimed at reducing interruptions in rehabilitation for RTAC. RTACs were associated with longer RLOS and discharge to an institutional setting. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Ryser, David K.] Intermt Med Ctr, Salt Lake City, UT USA; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P1094, DOI 10.1086/591743; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Centers for Medicare & Medicaid Services, SPEC ALL CAUS UNPL R; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corral L, 2012, CRITICAL CARE, V16, P2; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DOLCE G, 2008, J NEUROTRAUMA; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Gerhardt G, MED READMISSION RATE; Giaquinto S, 2003, EUR J NEUROL, V10, P235, DOI 10.1046/j.1468-1331.2003.00563.x; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Loeb M, 2008, J GEN INTERN MED, V23, P816, DOI 10.1007/s11606-008-0620-2; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; SIEGLER EL, 1994, ARCH INTERN MED, V154, P2185, DOI 10.1001/archinte.154.19.2185; Stineman MG, 2000, ARCH PHYS MED REHAB, V81, P549, DOI 10.1016/S0003-9993(00)90033-9; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; The Moran Company, 2011, UT TRENDS INP REH UP, P1; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	33	13	13	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S293	S303		10.1016/j.apmr.2014.08.026			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100011	26212405	Green Accepted, Bronze			2022-02-06	
J	Horn, SD; Kinikini, M; Moore, LW; Hammond, FM; Brandstater, ME; Smout, RJ; Barrett, RS				Horn, Susan D.; Kinikini, Merin; Moore, Linda W.; Hammond, Flora M.; Brandstater, Murray E.; Smout, Randall J.; Barrett, Ryan S.			Enteral Nutrition for Patients With Traumatic Brain Injury in the Rehabilitation Setting: Associations With Patient Preinjury and Injury Characteristics and Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comparative effectiveness research; Enteral nutrition; Propensity score; Rehabilitation	METABOLIC-RESPONSE; INTOLERANCE; SUPPORT; CARE	Objective: To determine the association of enteral nutrition (EN) with patient preinjury and injury characteristics and outcomes for patients receiving inpatient rehabilitation after traumatic brain injury (TBI). Design: Prospective observational study. Setting: Nine rehabilitation centers. Participants: Patients (N=1701) admitted for first full inpatient rehabilitation after TBI. Interventions: Not applicable. Main Outcome Measures: FIM at rehabilitation discharge, length of stay, weight loss, and various infections. Results: There were many significant differences in preinjury and injury characteristics between patients who received EN and patients who did not. After matching patients with a propensity score of >40% for the likely use of EN, patients receiving EN with either a standard or a high-protein formula (>20% of calories coming from protein) for >25% of their rehabilitation stay had higher HMI motor and cognitive scores at rehabilitation discharge and less weight loss than did patients with similar characteristics not receiving EN. Conclusions: For patients receiving inpatient rehabilitation after TBI and matched on a propensity score of >40% for the likely use of EN, clinicians should strongly consider, when possible, EN for >25% of the rehabilitation stay and especially with a formula that contains at least 20% protein rather than a standard formula. (C) 2015 by the American Congress of Rehabilitation Medicine	[Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Int Sever Informat Syst Inc, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Kinikini, Merin] Intermt Med Ctr, Neuro Specialty Rehabil Unit, Salt Lake City, UT USA; [Moore, Linda W.] Houston Methodist Hosp, Houston, TX USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Brandstater, Murray E.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA		Horn, SD (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Hlth Syst Innovat & Res Program, Williams Bldg,Rm 1N491,295 Chipeta Way, Salt Lake City, UT 84108 USA.	susan.horn@hsc.utah.edu		Moore, Linda W/0000-0003-2519-5150	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Doig GS, 2011, INJURY, V42, P50, DOI 10.1016/j.injury.2010.06.008; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; James R, 2005, ARCH PHYS MED REHAB, V86, pS82, DOI 10.1016/j.apmr.2005.07.314; JUSTO MCM, 2011, NUTR HOSP, V26, P1120, DOI DOI 10.3305/NH.2011.26.5.5133; Kennedy RE, 2006, J HEAD TRAUMA REHAB, V21, P260, DOI 10.1097/00001199-200605000-00006; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; McEvoy CT, 2009, CLIN NUTR, V28, P526, DOI 10.1016/j.clnu.2009.04.009; Parks J, 2013, AM J CRIT CARE, V22, P136, DOI 10.4037/ajcc2013105; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zampolini M, 2011, AM J PHYS MED REHAB, V90, P79, DOI 10.1097/PHM.0b013e318206c695	30	13	13	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S245	S255		10.1016/j.apmr.2014.06.024			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100007	26212401	Green Accepted			2022-02-06	
J	Hu, SL; Huang, YX; Hu, R; Li, F; Feng, H				Hu, Sheng-Li; Huang, Yu-Xing; Hu, Rong; Li, Fei; Feng, Hua			Osteopontin Mediates Hyperbaric Oxygen Preconditioning-Induced Neuroprotection Against Ischemic Stroke	MOLECULAR NEUROBIOLOGY			English	Article						Akt; Hyperbaric oxygen preconditioning; IL-1 beta; Middle cerebral artery occlusion; Neuroprotection; Osteopontin	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; RECOMBINANT OSTEOPONTIN; DEFICIENT MICE; HIGH-ALTITUDE; RAT-BRAIN; RECOVERY; ACTIVATION	Neurosurgical operations may result in surgical injury which would lead to postoperative neurological deficits. Hyperbaric oxygen preconditioning (HBO-PC) may be beneficial for such people. However, the exact mechanism underlying HBO-PC is not well known yet. The aim of this study is to explore the role of osteopontin (OPN) in HBO-PC-induced neuroprotection. The study consisted of two experiments. In experiment 1, Sprague Dawley (SD) rats were divided into four groups: sham group, HBO-PC sham group, stroke group, and HBO-PC group (HBO-PC + stroke). The animals in the second experiment were randomly assigned to one of two groups: OPN small interfering (siRNA) group (HBO-PC + stroke + OPN siRNA) and control siRNA group (HBO-PC + stroke + negative control siRNA). Neurological outcome in HBO-PC group was better than that of stroke group. After OPN siRNA was administered, neurological function aggravated compared with control siRNA group. Brain morphology and structure seen by light microscopy was diminished in stroke group and OPN siRNA group, while fewer pathological injuries occurred in HBO-PC and control siRNA group. The infarct volume in HBO-PC group was the lowest, followed by OPN siRNA group and stroke group, respectively. Preconditioning with HBO promoted expression of OPN, which reduced the expression of interleukin (IL)-1 beta/nuclear factor-kappa-gene binding (NF kappa B) and augmented protein kinase B (Akt). OPN siRNA reversed these changes. OPN plays an important role in the neuroprotection elicited by HBO-PC. Pretreatment with HBO may be beneficial for people going to undertake brain surgery.	[Hu, Sheng-Li; Huang, Yu-Xing; Hu, Rong; Li, Fei; Feng, Hua] Third Mil Med Univ, Dept Neurosurg, Southwest Hosp, Chongqing 400038, Peoples R China; [Huang, Yu-Xing] Chengdu Univ Tradit Chinese Med, Teaching Hosp, Dept Neurosurg, Chengdu 610075, Sichuang Provin, Peoples R China		Feng, H (corresponding author), Third Mil Med Univ, Dept Neurosurg, Southwest Hosp, Gaotanyan 29, Chongqing 400038, Peoples R China.	fenghua8888@vip.163.com	Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000532, 81471261]; National Key Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB541600]	This work was supported by grants from the National Natural Science Foundation of China (No. 81000532, 81471261) and National Key Basic Research Program of China (973 Program, 2014CB541600).	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Han QQ, 2011, BIOMATERIALS, V32, P5077, DOI 10.1016/j.biomaterials.2011.03.072; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Matula C, 2000, STEREOT FUNCT NEUROS, V75, P142, DOI 10.1159/000048396; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Ostrowski RP, 2010, ACTA NEUROCHIR SUPPL, V106, P47, DOI 10.1007/978-3-211-98811-4_7; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; Suzuki H, 2010, ANN NEUROL, V68, P650, DOI 10.1002/ana.22102; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Xie ZL, 2003, J BIOL CHEM, V278, P48546, DOI 10.1074/jbc.M302727200; Yan WJ, 2013, J CEREBR BLOOD F MET, V33, P396, DOI 10.1038/jcbfm.2012.179; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	31	13	14	3	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2015	52	1					236	243		10.1007/s12035-014-8859-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN3QO	WOS:000358341600022	25146847				2022-02-06	
J	Metzger, A; Rees, J; Kwon, Y; Matsuura, T; McKnite, S; Lurie, KG				Metzger, Anja; Rees, Jennifer; Kwon, Young; Matsuura, Timothy; McKnite, Scott; Lurie, Keith G.			INTRATHORACIC PRESSURE REGULATION IMPROVES CEREBRAL PERFUSION AND CEREBRAL BLOOD FLOW IN A PORCINE MODEL OF BRAIN INJURY	SHOCK			English	Article						Traumatic brain injury; intracranial pressure; intrathoracic pressure; intrathoracic pressure regulation; cerebral perfusion pressure; intracranial hypertension	STANDARD CARDIOPULMONARY-RESUSCITATION; IMPEDANCE THRESHOLD DEVICE; INSPIRATORY IMPEDANCE; INTRACRANIAL-PRESSURE; VALVE; SURVIVAL; PIGS	Brain injury is a leading cause of death and disability in children and adults in their most productive years. Use of intrathoracic pressure regulation (IPR) to generate negative intrathoracic pressure during the expiratory phase of positive pressure ventilation improves mean arterial pressure and 24-h survival in porcine models of hemorrhagic shock and cardiac arrest and has been demonstrated to decrease intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in these models. Application of IPR for 240 min in a porcine model of intracranial hypertension (ICH) will increase CPP when compared with controls. Twenty-three female pigs were subjected to focal brain injury by insertion of an epidural Foley catheter inflated with 3 mL of saline. Animals were randomized to treatment for 240 min with IPR set to a negative expiratory phase pressure of -12 cmH(2)O or no IPR therapy. Intracranial pressure, mean arterial pressure, CPP, and cerebral blood flow (CBF) were evaluated. Intrathoracic pressure regulation significantly improved mean CPP and CBF. Specifically, mean CPP after 90, 120, 180, and 240 min of IPR use was 43.7 +/- 2.8 mmHg, 44.0 +/- 2.7 mmHg, 44.5 +/- 2.8 mmHg, and 43.1 +/- 1.9 mmHg, respectively; a significant increase from ICH study baseline (39.5 +/- 1.7 mmHg) compared with control animals in which mean CPP was 36.7 +/- 1.4 mmHg (ICH study baseline) and then 35.9 +/- 2.1 mmHg, 33.7 +/- 2.8 mmHg, 33.9 +/- 3.0 mmHg, and 36.0 +/- 2.7 mmHg at 90, 120, 180, and 240 min, respectively (P < 0.05 for all time points). Cerebral blood flow, as measured by an invasive CBF probe, increased in the IPR group (34 +/- 4 mL/100 g-min to 49 +/- 7 mL/100 g-min at 90 min) but not in controls (27 +/- 1 mL/100 g-min to 25 +/- 5 mL/100 g-min at 90 min) (P = 0.01). Arterial pH remained unchanged during the entire period of IPR compared with baseline values and control values. In this anesthetized pig model of ICH, treatment with IPR significantly improved CPP and CBF. This therapy may be of clinical value by noninvasively improving cerebral perfusion in states of compromised cerebral perfusion.	[Metzger, Anja; Lurie, Keith G.] Univ Minnesota, Dept Emergency Med, Minneapolis, MN USA; [Metzger, Anja; Lurie, Keith G.] Adv Circulatory Syst Inc, Roseville, MN USA; [Rees, Jennifer; Kwon, Young; Matsuura, Timothy] Univ Minnesota, Dept Cardiol, Minneapolis, MN USA; [McKnite, Scott] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA		Metzger, A (corresponding author), 1905 Cty Rd C West, Roseville, MN 55113 USA.	ametzger@advancedcirculatory.com			Department of Defense Medical Research and Development Program Award: Regulation of Cerebral and Systemic Perfusion Following Traumatic Brain Injury grant [W81XWH-11-2-0094]	This study was supported by the Department of Defense Medical Research and Development Program Award: Regulation of Cerebral and Systemic Perfusion Following Traumatic Brain Injury (grant no. W81XWH-11-2-0094).	Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Convertino VA, 2005, AVIAT SPACE ENVIR MD, V76, P319; Convertino VA, 2004, CLIN AUTON RES, V14, P240, DOI 10.1007/s10286-004-0180-4; Convertino VA, 2005, EUR J APPL PHYSIOL, V94, P392, DOI 10.1007/s00421-005-1344-1; Convertino Victor A, 2004, Crit Care Med, V32, pS381, DOI 10.1097/01.CCM.0000134348.69165.15; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Kiehna EN, 2013, J NEUROSURG, V119, P756, DOI 10.3171/2013.4.JNS122489; Kroppenstedt SN, 1999, J NEUROTRAUM, V16, P629, DOI 10.1089/neu.1999.16.629; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266, DOI 10.1152/ajpheart.1989.257.1.H266; Lurie K, 2000, CRIT CARE MED, V28, pN207, DOI 10.1097/00003246-200011001-00009; Lurie K, 2000, RESUSCITATION, V44, P219, DOI 10.1016/S0300-9572(00)00160-X; Lurie Keith G, 2003, Respir Care, V48, P52; Lurie KG, 2004, CRIT CARE MED, V32, P1555, DOI 10.1097/01.CCM.0000131207.29081.A2; Lurie KG, 2003, CRIT CARE MED, V31, pA10; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Lurie KG, 2001, ANESTH ANALG, V93, P649, DOI 10.1097/00000539-200109000-00024; Lurie KG, 1998, CHEST, V113, P1084, DOI 10.1378/chest.113.4.1084; LURIE KG, 1995, CIRCULATION, V91, P1629, DOI 10.1161/01.CIR.91.6.1629; Marino Bradley S, 2004, Crit Care Med, V32, pS398, DOI 10.1097/01.CCM.0000139950.39972.68; Yannopoulos D, 2006, CRIT CARE MED, V34, pS495, DOI 10.1097/01.CCM.0000246082.10422.7E; Yannopoulos D, 2006, RESUSCITATION, V70, P445, DOI 10.1016/j.resuscitation.2006.02.005; Yannopoulos D, 2006, RESUSCITATION, V69, P487, DOI 10.1016/j.resuscitation.2005.11.005; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a	30	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2015	44			1			96	102		10.1097/SHK.0000000000000314			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DO3NA	WOS:000377687100015	25692250				2022-02-06	
J	Miao, XT; Yang, L; Gu, H; Ren, YY; Chen, GW; Liu, J; Wei, YX				Miao, Xutao; Yang, Ling; Gu, Hua; Ren, Yuanyuan; Chen, Guowei; Liu, Jia; Wei, Yongxiang			Evaluation of post-traumatic anosmia with MRI and chemosensory ERPs	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Olfactory disorder; Head injury, closed; Event-related potentials (ERPs); MRI; Anosmia	OLFACTORY-BULB VOLUME; EMISSION COMPUTED-TOMOGRAPHY; ORBITOFRONTAL CORTEX; DYSFUNCTION; SULCUS; DEPTH; IDENTIFICATION; PERCEPTION; PLASTICITY; CHILDREN	Magnetic resonance imaging (MRI) and chemosensory event-related potentials (ERPs) are important methods to evaluate olfactory function, but there is lack of study to explore the application of MRI and chemosensory ERPs in the patients with traumatic anosmia. The data of 26 post-traumatic anosmic patients and 21 healthy controls were retrospectively surveyed; olfaction and olfactory pathway of all participants were measured clinically using the T&T olfactometer, the Sniffin' Sticks, chemosensory ERPs and MRI. All patients were anosmic based on complaints and clinical examinations. In five patients, the olfactory bulb volume was significantly lower than control group. In 18 patients, the olfactory sulcus (OS) depth was similar to control group, but all the participants had a deeper right OS (right = 7.79 +/- A 1.31, left = 7.06 +/- A 1.44, p < 0.01). Olfactory ERPs (oERPs) could be evoked in 17 patients, but these signals showed longer latencies and lower amplitude than controls in the N1 (latency p < 0.05, amplitude p < 0.01) and P2 (latency p < 0.01, amplitude p < 0.05) waves. Nine traumatic anosmic patients had no identifiable oERPs; most of them had olfactory center injury. Trigeminal ERPs were detected in all anosmic patients and controls; patients had longer latencies for N1 (p < 0.05) and P2 (p < 0.05) waves, while there was no similar change in amplitude. Older subjects had smaller OB volume and OS depth. Closed head injury could induce anosmia; the severity extent, injury site and subsequent consciousness are related to the olfaction. oERP is the gold standard for olfactory subjective examination; MRI could indicate the lesions on the olfactory pathway and reflect the possibility of detectable oERPs.	[Miao, Xutao; Ren, Yuanyuan; Chen, Guowei; Liu, Jia; Wei, Yongxiang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Miao, Xutao] Beijing Jishuitan Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Yang, Ling] Capital Med Univ, Beijing Tongren Hosp, Ctr Lab, Beijing, Peoples R China; [Gu, Hua] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiol, Beijing, Peoples R China; [Wei, Yongxiang] Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China		Wei, YX (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	weiyongxiang@vip.sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271062]; Capital Application Research of Clinical Specialty [Z121107001012041]	The study was supported by National Natural Science Foundation of China (NSFC) under the project No. 81271062 and Capital Application Research of Clinical Specialty under the project No. Z121107001012041. We thank Dr. Jayant M. Pinto from Section of Otolaryngology-Head and Neck Surgery, the University of Chicago Medicine and Biological Sciences for reviewing the manuscript. The authors have no conflict of interest regarding this study.	Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Duprez TP, 2010, EUR J RADIOL, V74, P288, DOI 10.1016/j.ejrad.2009.05.065; Eftekhari M, 2006, AM J RHINOL, V20, P577, DOI 10.2500/ajr.2006.20.2906; Fitzek S, 2004, MAGN RESON IMAGING, V22, P205, DOI 10.1016/j.mri.2003.08.031; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V63, P145, DOI 10.1136/jnnp.63.2.145; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Huart C, 2011, AM J NEURORADIOL, V32, P1911, DOI 10.3174/ajnr.A2632; Hummel T, 2011, EXP BRAIN RES, V214, P285, DOI 10.1007/s00221-011-2832-7; Hummel T, 2003, BRAIN RES, V975, P85, DOI 10.1016/S0006-8993(03)02589-7; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; Ishimaru T, 2002, ANN OTO RHINOL LARYN, V111, P518, DOI 10.1177/000348940211100607; Jiang RS, 2009, AM J RHINOL ALLERGY, V23, P582, DOI 10.2500/ajra.2009.23.3370; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Kettenmann B, 1997, CHEM SENSES, V22, P493, DOI 10.1093/chemse/22.5.493; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Ren YY, 2012, ACTA OTO-LARYNGOL, V132, P974, DOI 10.3109/00016489.2012.663933; Rombaux P, 2010, EUR ARCH OTO-RHINO-L, V267, P1551, DOI 10.1007/s00405-010-1230-2; Rombaux P, 2007, AM J RHINOL, V21, P548, DOI 10.2500/ajr.2007.21.3067; Rombaux P, 2012, OTOLARYNG HEAD NECK, V147, P1136, DOI 10.1177/0194599812459704; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Seubert J, 2013, CEREB CORTEX, V23, P2448, DOI 10.1093/cercor/bhs230; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; Yang L, 2012, MED SCI MONITOR, V18, pCR154, DOI 10.12659/MSM.882520; Yang L, 2010, OTOLARYNG HEAD NECK, V143, P554, DOI 10.1016/j.otohns.2010.05.010; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Yousem DM, 1998, ANN NY ACAD SCI, V855, P546, DOI 10.1111/j.1749-6632.1998.tb10624.x	34	13	14	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	AUG	2015	272	8					1945	1953		10.1007/s00405-014-3278-x			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	CK8ZR	WOS:000356529500017	25253545				2022-02-06	
J	Wang, Y; Rao, W; Zhang, C; Zhang, C; Liu, MD; Han, F; Yao, LB; Han, H; Luo, P; Su, N; Fei, Z				Wang, Y.; Rao, W.; Zhang, C.; Zhang, C.; Liu, M-D; Han, F.; Yao, L-B; Han, H.; Luo, P.; Su, N.; Fei, Z.			Scaffolding protein Homer1a protects against NMDA-induced neuronal injury	CELL DEATH & DISEASE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; SYNAPTIC PLASTICITY; IN-VITRO; PSD-95; ACTIVATION; CALCIUM; 1A; BINDS	Excessive N-methyl-D-aspartate receptor (NMDAR) activation and the resulting activation of neuronal nitric oxide synthase (nNOS) cause neuronal injury. Homer1b/c facilitates NMDAR-PSD95-nNOS complex interactions, and Homer1a is a negative competitor of Homer1b/c. We report that Homer1a was both upregulated by and protected against NMDA-induced neuronal injury in vitro and in vivo. The neuroprotective activity of Homer1a was associated with NMDA-induced Ca2+ influx, oxidative stress and the resultant downstream signaling activation. Additionally, we found that Homer1a functionally regulated NMDAR channel properties in neurons, but did not regulate recombinant NR1/NR2B receptors in HEK293 cells. Furthermore, we found that Homer1a detached the physical links among NR2B, PSD95 and nNOS and reduced the membrane distribution of NMDAR. NMDA-induced neuronal injury was more severe in Homer1a homozygous knockout mice (KO, Homer1a(-/-)) when compared with NMDA-induced neuronal injury in wild-type mice (WT, Homer1a(+/+)). Additionally, Homer1a overexpression in the cortex of Homer1a(-/-) mice alleviated NMDA-induced neuronal injury. These findings suggest that Homer1a may be a key neuroprotective endogenous molecule that protects against NMDA-induced neuronal injury by disassembling NR2B-PSD95-nNOS complexes and reducing the membrane distribution of NMDARs.	[Wang, Y.; Rao, W.; Zhang, C.; Liu, M-D; Han, F.; Luo, P.; Su, N.; Fei, Z.] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Wang, Y.] Wuhan Zhong Xin Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Zhang, C.] Second Artillery Gen Hosp PLA, Dept Neurol, Beijing, Peoples R China; [Yao, L-B] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian, Peoples R China; [Han, H.] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Changle West Rd 127, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043, 30930093]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2013KTCQ03-01]	We would like to express our thanks to Prof. Bo Xiao and Paul Worley for providing the Homer1a KO mice, Prof. Jian-hong Luo for the gifts of the NR1A and NR2B plasmids, Prof. Jing-hua Yang, Dr Jie Zhu and Dr Sanzhong Li for helpful discussion and Jun-li Huo, Juan Li, Xiao-yan Chen and Yu-fen Shi for technical assistance. This work was supported by the National Natural Science Foundation of China (81430043 and 30930093), the National Science and Technology Major Project of China (2013ZX 09J13109-02C), the National Science and Technology Pillar Program of China (2012BAI11B02) and the Science and Technology Project of Shaanxi (2013KTCQ03-01).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Ayata C, 1997, J NEUROSCI, V17, P6908; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bertaso F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009755; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Cheng FR, 2011, J NEUROCHEM, V119, P815, DOI 10.1111/j.1471-4159.2011.07460.x; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Cook DJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003824; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; de Tassigny XD, 2007, J NEUROSCI, V27, P6103, DOI 10.1523/JNEUROSCI.5595-06-2007; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Haelewyn B, 2008, J NEUROSCI METH, V168, P479, DOI 10.1016/j.jneumeth.2007.10.015; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Kammermeier PJ, 2008, J NEUROSCI, V28, P8560, DOI 10.1523/JNEUROSCI.1830-08.2008; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kato A, 2003, MOL BRAIN RES, V118, P33, DOI 10.1016/j.molbrainres.2003.07.005; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu KT, 2014, PFLUGERS ARCH, V467, P1651; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Martel MA, 2009, CHANNELS, V3, P12, DOI 10.4161/chan.3.1.7864; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nikam SS, 2002, CURR PHARM DESIGN, V8, P845, DOI 10.2174/1381612024607072; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Park JM, 2013, CELL, V154, P637, DOI 10.1016/j.cell.2013.07.001; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Srejic LR, 2013, J CEREBR BLOOD F MET, V33, P1937, DOI 10.1038/jcbfm.2013.153; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Xu TL, 1999, NEUROPHARMACOLOGY, V38, P659, DOI 10.1016/S0028-3908(98)00227-5; Yuan JP, 2012, ACTA PHYSIOL, V204, P238, DOI 10.1111/j.1748-1716.2011.02319.x; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245	69	13	18	4	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG	2015	6								e1843	10.1038/cddis.2015.216			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CQ4NP	WOS:000360581900007	26247728	gold, Green Published			2022-02-06	
J	Rajtmajer, SM; Roy, A; Albert, R; Molenaar, PCM; Hillary, FG				Rajtmajer, Sarah M.; Roy, Arnab; Albert, Reka; Molenaar, Peter C. M.; Hillary, Frank G.			A voxelwise approach to determine consensus regions-of-interest for the study of brain network plasticity	FRONTIERS IN NEUROANATOMY			English	Article						fMRI; ROI selection; plasticity; modularity; label propagation; traumatic brain injury; hyperconnectivity	HUMAN CEREBRAL-CORTEX; FUNCTIONAL MRI DATA; CONNECTIVITY; PARCELLATION; ORGANIZATION; MODULARITY; REGRESSION; PATTERNS; RECOVERY; DEFICITS	Despite exciting advances in the functional imaging of the brain, it remains a challenge to define regions of interest (ROIs) that do not require investigator supervision and permit examination of change in networks over time (or plasticity). Plasticity is most readily examined by maintaining ROIs constant via seed-based and anatomical-atlas based techniques, but these approaches are not data-driven, requiring definition based on prior experience (e.g., choice of seed-region, anatomical landmarks). These approaches are limiting especially when functional connectivity may evolve over time in areas that are finer than known anatomical landmarks or in areas outside predetermined seeded regions. An ideal method would permit investigators to study network plasticity due to learning, maturation effects, or clinical recovery via multiple time point data that can be compared to one another in the same ROI while also preserving the voxel-level data in those ROIs at each time point. Data-driven approaches (e.g., whole-brain voxelwise approaches) ameliorate concerns regarding investigator bias, but the fundamental problem of comparing the results between distinct data sets remains. In this paper we propose an approach, aggregate-initialized label propagation (AILP), which allows for data at separate time points to be compared for examining developmental processes resulting in network change (plasticity). To do so, we use a whole-brain modularity approach to parcellate the brain into anatomically constrained functional modules at separate time points and then apply the AILP algorithm to form a consensus set of ROIs for examining change over time. To demonstrate its utility, we make use of a known dataset of individuals with traumatic brain injury sampled at two time points during the first year of recovery and show how the AILP procedure can be applied to select regions of interest to be used in a graph theoretical analysis of plasticity.	[Rajtmajer, Sarah M.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Roy, Arnab; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Albert, Reka] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Molenaar, Peter C. M.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Hillary, Frank G.] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021; Albert, Reka/E-2195-2011	Albert, Reka/0000-0002-9485-0828	New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Nicholas Gilbert for his ingenuity and dedication in creating the plots for images.	Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brier MR, 2014, NEUROBIOL AGING, V35, P757, DOI 10.1016/j.neurobiolaging.2013.10.081; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 1800, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Elston GN, 2005, ANAT REC PART A, V285A, P610, DOI 10.1002/ar.a.20198; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Elston GN, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00002; Gamboa OL, 2014, NEUROIMAGE, V94, P385, DOI 10.1016/j.neuroimage.2013.12.008; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Honnorat N, 2015, NEUROIMAGE, V106, P207, DOI 10.1016/j.neuroimage.2014.11.008; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; Mazaika P., 2009, HUM BRAIN MAPP C FLO; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; ROCKLAND K S, 1985, Society for Neuroscience Abstracts, V11, P17; Rockland KS, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00061; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Sorenson T, 1948, KONGELIGE DANSKE VID, V5, P1; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; TEASDALE G, 1974, LANCET, V2, P81; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]	55	13	13	0	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	JUL 28	2015	9								97	10.3389/fnana.7015.00097			13	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	CQ2LL	WOS:000360431800001	26283928				2022-02-06	
J	Johnson, EA; Guignet, MA; Dao, TL; Hamilton, TA; Kan, RK				Johnson, Erik A.; Guignet, Michelle A.; Dao, Thuy L.; Hamilton, Tracey A.; Kan, Robert K.			Interleukin-18 expression increases in response to neurovascular damage following soman-induced status epilepticus in rats	JOURNAL OF INFLAMMATION-LONDON			English	Article						Interleukin 18; Status epilepticus; Soman (GD); Macrophage; T-cell; Neutrophil; Piriform cortex; Hippocampus; Thalamus	SIGNAL-TRANSDUCTION PATHWAYS; INTERFERON-GAMMA PRODUCTION; TRAUMATIC BRAIN-INJURY; RHEUMATOID-ARTHRITIS; T-CELLS; MICROGLIAL ACTIVATION; MOLECULAR-MECHANISMS; INDUCED CONVULSIONS; INDUCED SEIZURES; B-CELLS	Background: Status epilepticus (SE) can cause neuronal cell death and impaired behavioral function. Acute exposure to potent acetylcholinesterase inhibitors such as soman (GD) can cause prolonged SE activity, micro-hemorrhage and cell death in the hippocampus, thalamus and piriform cortex. Neuroinflammation is a prominent feature of brain injury with upregulation of multiple pro-inflammatory cytokines including those of the IL-1 family. The highly pleiotropic pro-inflammatory cytokine interleukin-18 (IL-18) belongs to the IL-1 family of cytokines and can propagate neuroinflammation by promoting immune cell infiltration, leukocyte and lymphocyte activation, and angiogenesis and helps facilitate the transition from the innate to the adaptive immune response. The purpose of this study is to characterize the regional and temporal expression of IL -18 and related factors in the brain following SE in a rat GD seizure model followed by localization of IL-18 to specific cell types. Methods: The protein levels of IL-18, vascular endothelial growth factor and interferon gamma was quantified in the lysates of injured brain regions up to 72 h following GD-induced SE onset using bead multiplex immunoassays. IL-18 was localized to various cell types using immunohistochemistry and transmission electron microscopy. In addition, macrophage appearance scoring and T-cell quantification was determined using immunohistochemistry. Micro-hemorrhages were identified using hematoxylin and eosin staining of brain sections. Results: Significant increases in IL-18 occurred in the piriform cortex, hippocampus and thalamus following SE. IL-18 was primarily expressed by endothelial cells and astrocytes associated with the damaged neurovascular unit. The increase in IL-18 was not related to macrophage accumulation, neutrophil infiltration or T-cell appearance in the injured tissue. Conclusions: These data show that IL-18 is significantly upregulated following GD-induced SE and localized primarily to endothelial cells in damaged brain vasculature. IL-18 upregulation occurred following leukocyte/lymphocyte infiltration and in the absence of other IL-18-related cytokines, suggesting another function, potentially for angiogenesis related to GD-induced micro-hemorrhage formation. Further studies at more chronic time points may help to elucidate this function.	[Johnson, Erik A.; Guignet, Michelle A.; Dao, Thuy L.; Kan, Robert K.] US Army, Med Res Inst Chem Def, Div Res, Pharmacol Branch, Aberdeen Proving Ground, MD 21010 USA; [Hamilton, Tracey A.] US Army, Med Res Inst Chem Def, Res Support Div, Comparat Pathol Branch, Aberdeen Proving Ground, MD 21010 USA		Johnson, EA (corresponding author), US Army, Med Res Inst Chem Def, Div Res, Pharmacol Branch, Aberdeen Proving Ground, MD 21010 USA.	erik.a.johnson1.civ@mail.mil		Guignet, Michelle/0000-0003-4788-0175	Defense Threat Reduction Agency - Joint Science and Technology Office, Medical ST DivisionUnited States Department of DefenseDefense Threat Reduction Agency; U.S. Army's In-House Laboratory Independent Research (ILIR) program	The authors would like to thank Nicole Rosellini, Marissa Babnew, and Dominique Scutella for their technical contributions to the research. This research was supported by the Defense Threat Reduction Agency - Joint Science and Technology Office, Medical S&T Division and by the U.S. Army's In-House Laboratory Independent Research (ILIR) program. The views expressed herein are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government.	Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Andoh T, 2008, J IMMUNOL, V180, P2322, DOI 10.4049/jimmunol.180.4.2322; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Ariel A, 2002, J LEUKOCYTE BIOL, V72, P192; Baille V, 2005, TOXICOLOGY, V215, P1, DOI 10.1016/j.tox.2005.05.028; BATAILLARD A, 1990, PHARMACOL TOXICOL, V67, P27, DOI 10.1111/j.1600-0773.1990.tb00777.x; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; BOUCHAUD C, 1994, BRAIN RES, V660, P249, DOI 10.1016/0006-8993(94)91296-3; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Collombet JM, 2007, NEUROTOXICOLOGY, V28, P38, DOI 10.1016/j.neuro.2006.07.011; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Culhane AC, 1998, MOL PSYCHIATR, V3, P362, DOI 10.1038/sj.mp.4000389; Dai SM, 2007, ANN RHEUM DIS, V66, P1411, DOI 10.1136/ard.2006.067793; Dai SM, 2004, ARTHRITIS RHEUM-US, V50, P432, DOI 10.1002/art.20064; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; Jeon GS, 2008, NEUROCHEM RES, V33, P179, DOI 10.1007/s11064-007-9434-6; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Johnson EA, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-40; Koplovitz I, 1998, EPILEPSY RES, V30, P159, DOI 10.1016/S0920-1211(97)00100-9; Lallement G, 1999, ARCH TOXICOL, V73, P115, DOI 10.1007/s002040050595; LEMERCIER G, 1983, ACTA NEUROPATHOL, V61, P123, DOI 10.1007/BF00697391; Letienne R, 1999, FUND CLIN PHARMACOL, V13, P468, DOI 10.1111/j.1472-8206.1999.tb00005.x; Leung BP, 2001, J IMMUNOL, V167, P2879, DOI 10.4049/jimmunol.167.5.2879; MCDONOUGH JH, 1995, NEUROTOXICOLOGY, V16, P123; MCLEOD CG, 1984, NEUROTOXICOLOGY, V5, P53; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Morel JCM, 2002, J BIOL CHEM, V277, P34679, DOI 10.1074/jbc.M206337200; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Mori I, 2001, VIROLOGY, V287, P163, DOI 10.1006/viro.2001.1029; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Ogura T, 2001, BLOOD, V98, P2101, DOI 10.1182/blood.V98.7.2101; Park CC, 2001, J IMMUNOL, V167, P1644, DOI 10.4049/jimmunol.167.3.1644; Paxinos G, 2005, RAT BRAIN STEREOTAXI, P205; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shih TM, 1997, J APPL TOXICOL, V17, P255, DOI 10.1002/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D; SHIH TM, 1992, BRAIN RES BULL, V28, P735, DOI 10.1016/0361-9230(92)90253-T; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Walker W, 1999, J IMMUNOL, V162, P5894; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wheeler RD, 2000, MOL BRAIN RES, V77, P290, DOI 10.1016/S0169-328X(00)00069-3; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yoo JK, 2005, J IMMUNOL, V175, P8280, DOI 10.4049/jimmunol.175.12.8280; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zhang XM, 2007, EXP NEUROL, V205, P64, DOI 10.1016/j.expneurol.2007.01.019; Zhang XM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-26; Zimmer LA, 1997, J COMP NEUROL, V378, P482, DOI 10.1002/(SICI)1096-9861(19970224)378:4<482::AID-CNE4>3.0.CO;2-Z	54	13	14	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-9255			J INFLAMM-LOND	J. Inflamm.-Lond.	JUL 22	2015	12								43	10.1186/s12950-015-0089-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN1QR	WOS:000358195400001	26203299	Green Published, gold			2022-02-06	
J	Shijo, K; Ghavim, S; Harris, NG; Hovda, DA; Sutton, RL				Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.			Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes	BRAIN RESEARCH			English	Article						Beam-walking; Cognition; Controlled cortical impact; Contusion volume; Hippocampus; Hyperglycemia; Neurological exam; Rat; Spatial working memory	CORTICAL IMPACT INJURY; POSITRON-EMISSION-TOMOGRAPHY; PENTOSE-PHOSPHATE PATHWAY; INTENSIVE INSULIN THERAPY; FLUID-PERCUSSION INJURY; TIGHT GLYCEMIC CONTROL; CLOSED-HEAD TRAUMA; 5-PERCENT DEXTROSE; 0.9-PERCENT SALINE; CONTUSION VOLUME	The impact of hyperglycemia after traumatic brain injury (TBI), and even the administration of glucose-containing solutions to head injured patients, remains controversial. In the current study adult male Sprague-Dawley rats were tested on behavioral tasks and then underwent surgery to induce sham injury or unilateral controlled cortical impact (CCI) injury followed by injections (i.p.) with either a 50% glucose solution (Glc; 2 g/kg) or an equivalent volume of either 0.9% or 8% saline (Sal) at 0, 1, 3 and 6 h post-injury. The type of saline treatment did not significantly affect any outcome measures, so these data were combined. Rats with CCI had significant deficits in beam-walking traversal time and rating scores (p's < 0.001 versus sham) that recovered over test sessions from 1 to 13 days post-injury (p's < 0.001), but these beam-walking deficits were not affected by Glc versus Sal treatments. Persistent post-CCI deficits in forelimb contraflexion scores and forelimb tactile placing ability were also not differentially affected by Glc or Sal treatments. However, deficits in latency to retract the right hind limb after limb extension were significantly attenuated in the CCI-Glc group (p < 0.05 versus CCI-Sal). Both CCI groups were significantly impaired in a plus maze test of spatial working memory on days 4, 9 and 14 post-surgery (p < 0.001 versus sham), and there was no effect of Glc versus Sal on this cognitive outcome measure. At 15 days post-surgery the loss of cortical tissue volume (p < 0.001 versus sham) was significantly less in the CCI-Glc group (30.0%; p<0.05) compared to the CCI-Sal group (35.7%). Counts of surviving hippocampal hilar neurons revealed a significant (similar to 40%) loss ipsilateral to CCI (p<0.001 versus sham), but neuronal loss in the hippocampus was not different in the CCI-Sal and CCI-Glc groups. Taken together, these results indicate that an early elevation of blood glucose may improve some neurological outcomes and, importantly, the induction of hyperglycemia after isolated TBI did not adversely affect any sensorimotor, cognitive or histological outcomes. (C) 2015 Elsevier B.V. All rights reserved.	[Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Shijo, Katsunori; Ghavim, Sima; Harris, Neil G.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Sutton, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 300 Stein Plaza,Ste 562,Box 956901, Los Angeles, CA 90095 USA.	shijou-nsu@umin.ac.jp; sghavim@mednet.ucla.edu; ngharris@mednet.ucla.edu; dhovda@mednet.ucla.edu; rsutton@mednet.ucla.edu		Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PO1NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the UCLA Brain Injury Research Center and award PO1NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Cinotti R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0498-9; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Gurevich B, 1997, ANESTH ANALG, V84, P554, DOI 10.1097/00000539-199703000-00016; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kokiko-Cochran ON, 2008, NEUROSCI LETT, V436, P27, DOI 10.1016/j.neulet.2008.02.046; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Moro N, 2011, NEUROSCI LETT, V491, P158, DOI 10.1016/j.neulet.2011.01.029; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Stover JF, 2002, INTENS CARE MED, V28, P1491, DOI 10.1007/s00134-002-1431-2; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sugimori H, 1996, BRAIN RES BULL, V40, P263, DOI 10.1016/0361-9230(96)00052-4; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takahashi S, 2012, ASN NEURO, V4, P71, DOI 10.1042/AN20120002; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	77	13	15	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 21	2015	1614						94	104		10.1016/j.brainres.2015.04.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL0MW	WOS:000356637800010	25911580	Green Accepted			2022-02-06	
J	Wang, Z; Peng, WJ; Zhang, CH; Sheng, CX; Huang, W; Wang, Y; Fan, R				Wang, Zhe; Peng, Weijun; Zhang, Chunhu; Sheng, Chenxia; Huang, Wei; Wang, Yang; Fan, Rong			Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							AMYLOID-BETA DEPOSITION; TRAUMATIC BRAIN-INJURY; IMPROVE MEMORY DYSFUNCTION; NEURAL PRECURSOR CELLS; MOUSE MODEL; TRANSGENIC MICE; INTRACEREBRAL TRANSPLANTATION; RESTORE COGNITION; CONTROLLED-TRIALS; RESCUES MEMORY	Alzheimer's disease (AD), an irreversible progressive neurodegenerative disease, causes characteristic cognitive impairment, and no curative treatments are currently available. Stem cell transplantation offers a powerful tool for the treatment of AD. We conducted a systematic review and meta-analysis of data from controlled studies to study the impact of stem cell biology and experimental design on learning and memory function following stem cell transplantation in animal models of AD. A total of 58 eligible controlled studies were included by searching PubMed, EMBASE, and Web of Science up to April 13, 2015. Meta-analysis showed that stem cell transplantation could promote both learning and memory recovery. Stratified meta-analysis was used to explore the influence of the potential factors on the estimated effect size, and meta-regression analyses were undertaken to explore the sources of heterogeneity for learning and memory function. Publication bias was assessed using funnel plots and Egger's test. The present review reinforces the evidence supporting stem cell transplantation in experimental AD. However, it highlights areas that require well-designed and well-reported animal studies.	[Wang, Zhe; Peng, Weijun; Sheng, Chenxia; Huang, Wei] Cent S Univ, Xiangya Hosp 2, Dept Integrated Chinese & Western Med, Changsha 410011, Hunan, Peoples R China; [Zhang, Chunhu; Wang, Yang; Fan, Rong] Cent S Univ, Xiangya Hosp, Inst Integrated Med, Changsha 410008, Hunan, Peoples R China		Peng, WJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Integrated Chinese & Western Med, Changsha 410011, Hunan, Peoples R China.	pengweijun1987@gmail.com	Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	Young Scientists Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81403259]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8137370]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [13JJ3030]; special project of high-tech industrial development of Hunan Province [2012SK3212]	This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81303074, 81403259), the National Natural Science Foundation of China (Grant No.8137370), Natural Science Foundation of Hunan Province (Grant No. 13JJ3030) and the special project of high-tech industrial development of Hunan Province (Grant No. 2012SK3212).	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2008, CRTER; [Anonymous], 2009, CRTER; [Anonymous], 2010, CRTER; [Anonymous], 2013, NEUROSCI LETT; [Anonymous], 2010, CRTER; [Anonymous], 2011, PROGR ANATOMICAL SCI; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Babaei P, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/369417; Ben Menachem-Zidon O, 2014, NEUROPSYCHOPHARMACOL, V39, P401, DOI 10.1038/npp.2013.208; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bobkova NV, 2013, B EXP BIOL MED+, V156, P119, DOI 10.1007/s10517-013-2293-z; Chen SQ, 2014, AM J ALZHEIMERS DIS, V29, P142, DOI 10.1177/1533317513506776; Choi Sung S, 2014, Exp Neurobiol, V23, P45, DOI 10.5607/en.2014.23.1.45; Danos O, 2010, J GENE MED, V12, P559, DOI 10.1002/jgm.1472; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esmaeilzade Banafshe, 2012, Iranian Biomedical Journal, V16, P1, DOI 10.6091/IBJ.1029.2012; Garcia KO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00030; Garcia-Bonilla L, 2012, J NEUROCHEM, V122, P233, DOI 10.1111/j.1471-4159.2012.07773.x; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Glat MJ, 2013, STEM CELLS DEV, V22, P1490, DOI 10.1089/scd.2012.0633; Gu G, 2015, NEUROSCIENCE, V291, P81, DOI 10.1016/j.neuroscience.2015.01.073; [谷海刚 Gu Haigang], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P2235; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Ker K, 2009, CNS NEUROSCI THER, V15, P52, DOI 10.1111/j.1755-5949.2008.00069.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Lee HJ, 2012, CELL TRANSPLANT, V21, P2487, DOI 10.3727/096368912X638964; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee JK, 2010, CURR ALZHEIMER RES, V7, P540; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Li M, 2014, INT J MOL SCI, V15, P19226, DOI 10.3390/ijms151019226; Li Wen-yu, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P659; Li ZF, 2010, J ALZHEIMERS DIS, V21, P1233, DOI 10.3233/JAD-2010-100003; [李志方 LI Zhifang], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P595; Liao Y, 2014, BRIT J CLIN PHARMACO, V78, P718, DOI 10.1111/bcp.12382; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; Liu YH, 2013, DRUG DISCOV TODAY, V18, P1212, DOI 10.1016/j.drudis.2013.07.020; Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Moghadam FH, 2009, DIFFERENTIATION, V78, P59, DOI 10.1016/j.diff.2009.06.005; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Park D, 2013, NEUROBIOL AGING, V34, P2639, DOI 10.1016/j.neurobiolaging.2013.04.026; Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Peng WJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261409; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Tsai LH, 2014, NATURE, V507, P439, DOI 10.1038/nature13214; Wang QH, 2006, J MED INVESTIG, V53, P61, DOI 10.2152/jmi.53.61; [王卓 Wang Zhuo], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P8130; Wardlaw JM, 2000, LANCET, V356, P597, DOI 10.1016/S0140-6736(05)73980-5; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Wu S, 2008, PATHOBIOLOGY, V75, P186, DOI 10.1159/000124979; Xuan AG, 2009, NEUROSCI LETT, V450, P167, DOI 10.1016/j.neulet.2008.12.001; Xue SR, 2011, CHINESE MED J-PEKING, V124, P2642, DOI 10.3760/cma.j.issn.0366-6999.2011.17.014; Xue SR, 2012, SCI CHINA LIFE SCI, V55, P132, DOI 10.1007/s11427-012-4283-1; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yang Chun, 2007, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V23, P159; Yang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069129; Yang H, 2013, NEUROCHEM RES, V38, P2474, DOI 10.1007/s11064-013-1161-6; Yang H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt227; Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.490; Zhang P, 2012, NEURAL REGEN RES, V7, P245, DOI 10.3969/j.issn.1673-5374.2012.04.001; Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299; Zhang W, 2015, NEUROBIOL AGING, V36, P1282, DOI 10.1016/j.neurobiolaging.2014.10.040; Zhang W, 2014, MOL NEUROBIOL, V50, P423, DOI 10.1007/s12035-014-8640-x; Zhao Zhiying, 2005, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V19, P331	77	13	14	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2015	5								12134	10.1038/srep12134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM5HM	WOS:000357717900001	26159750	gold, Green Published			2022-02-06	
J	Barker-Collo, S; Jones, A; Jones, K; Theadom, A; Dowell, A; Starkey, N; Feigin, VL				Barker-Collo, S.; Jones, A.; Jones, K.; Theadom, A.; Dowell, A.; Starkey, N.; Feigin, V. L.		BIONIC Res Grp	Prevalence, natural course and predictors of depression 1 year following traumatic brain injury from a population-based study in New Zealand	BRAIN INJURY			English	Article						Depression; population-based; traumatic; brain injury	MAJOR DEPRESSION; HOSPITAL ANXIETY; RISK-FACTORS; HEAD-INJURY; SCALE; MANAGEMENT; DIAGNOSIS; MODERATE; OUTCOMES; ADULTS	Objective: Depression is common post-TBI, yet has not been studied longitudinally, nor at a population level. This study examined prevalence of depression in a population-based sample across the first year post-TBI. Design and methods: Prospective follow-up of 315 adults (>16 years) with assessments (Hospital Anxiety Depression Scale, DSM-IV criteria) at 1-, 6- and 12-months post-TBI. Demographic and injury-related predictors of depression at 1-year post-TBI were also explored. Results: The number of individuals identified as depressed reduced significantly between baseline and 12-months post-TBI from 21-12.4% using the HADS and 49-34% using DSM-IV criteria; with only 10 of the 28 individuals initially meeting criteria on the HADS continuing to do so at 12-month follow-up. Meeting HADS depression criteria was linked to pre-morbid depression and/or anxiety; while those meeting DSM-IV criteria were older, but not significantly so. Conclusions: The findings suggest depression is common post-TBI and that clinicians/researchers use caution in its diagnosis, as existing criteria have significant overlap with common TBI sequels.	[Barker-Collo, S.] Univ Auckland, Fac Sci, Sch Psychol, Auckland 1141, New Zealand; [Jones, A.; Jones, K.; Theadom, A.; Feigin, V. L.] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Dowell, A.] Univ Otago, Dept Primary Hlth Care & Gen Practice, Wellington, New Zealand; [Starkey, N.] Univ Waikato, Fac Sci, Sch Psychol, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Fac Sci, Sch Psychol, Private Bag 92019, Auckland 1141, New Zealand.	s.barker-collo@auckland.ac.nz	Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Theadom, Alice/0000-0003-0351-6216	New Zealand Health Research CouncilHealth Research Council of New Zealand	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was funded by the New Zealand Health Research Council.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hibbird MR, 1998, AM J PSYCHIAT, V156, P374; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; National Institute of Health, 2002, TRAUM BRAIN INJ HOP; Ozanne-Smith J, 2004, AUST NZ J PUBL HEAL, V28, P109, DOI 10.1111/j.1467-842X.2004.tb00921.x; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	13	15	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					859	865		10.3109/02699052.2015.1004759			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800010	25914943				2022-02-06	
J	Cao, Y; Walker, EA; Krause, JS				Cao, Yue; Walker, Elizabeth A.; Krause, James S.			Environmental barriers and subjective health among people with chronic spinal cord injury: A cohort study	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Health; Environment	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PHYSICAL-DISABILITIES; ACTIVITY PARTICIPATION; PERCEIVED HEALTH; YOUNG-ADULTS; COMMUNITY; MORTALITY; CHILDREN; SATISFACTION	Objective: Although previous studies have found environmental barriers to be associated with social participation and life satisfaction after spinal cord injury (SCI), few studies exist reporting their effects on subjective health after SCI. Our purpose was to identify the prevalence of perceived environmental barriers and their effects on subjective health in persons with chronic SCI who completed two repeated measurements during a 5-year longitudinal study. Design: This is a prospective cohort study. Environmental barriers were measured at baseline by the Craig Hospital Inventory of Environmental Factors-Short Form. Subjective health was measured at baseline and 5-year follow-up by days of physical and mental health not good. Other control variables included sex, race, age at injury, years since injury, and injury severity at baseline. Setting: Data were collected at a specialty hospital and analyzed at a medical university in the Southeastern USA. Participants: A total of 1635 participants completed both baseline and follow-up surveys. Results: Twenty per cent of participants reported at least one policy barrier, 46% at least one physical and structural barrier, 22% at least one attitudinal and support barrier, 26% at least one barrier to services and assistance, and 13% at least one barrier at work or school. After controlling for sex, race, age at injury, years since injury, and injury severity, the physical and structural barriers, and services and assistance barriers measured at baseline significantly predicted subjective physical and mental health measured at follow-up. Conclusion: Environmental barriers are prevalent among people with chronic SCI. They are important predictors for future subjective health.	[Cao, Yue; Walker, Elizabeth A.; Krause, James S.] Med Univ S Carolina, Coll Hlth Profess, Charleston, SC 29425 USA		Cao, Y (corresponding author), Med Univ S Carolina, Coll Hlth Profess, 77 President St,Suite C101A,MSC 700, Charleston, SC 29425 USA.	caoyu@musc.edu		Brown, Elizabeth/0000-0003-2436-5461	Department of Education, NIDRR [H133B090005]; South Carolina Spinal Cord Injury Research Fund [11-006]	This study was developed under a grant from the Department of Education, NIDRR grant numbers H133B090005, and grant SCIRF 11-006 from the South Carolina Spinal Cord Injury Research Fund.	Barf HA, 2009, DISABIL REHABIL, V31, P921, DOI 10.1080/09638280802358282; BULLARD RD, 1993, TOXICOL IND HEALTH, V9, P821, DOI 10.1177/074823379300900508; Cardol M, 2002, CLIN REHABIL, V16, P27, DOI 10.1191/0269215502cr464oa; *CDCP, 2006, BEH RISK FACT SURV S; Cockerham WC, 2013, SOCIAL CAUSES HLTH D; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; Farmer MM, 1997, J HEALTH SOC BEHAV, V38, P298, DOI 10.2307/2955372; Fougeyrollas P, 2002, TOPICS SPINAL CORD I, V7, P56, DOI DOI 10.1310/1UGA-EY2T-N6XP-1PHE; Fougeyrollas P., 2002, TOP SPINAL CORD INJ, V7, P1, DOI DOI 10.1310/QDNN-8FN0-NJMG-TVWB; Frohlich KL, 2001, SOCIOL HEALTH ILL, V23, P776, DOI 10.1111/1467-9566.00275; George LK, 1980, QUALITY LIFE OLDER P, Vxii, P238; Gray DB, 2003, J ARCHIT PLAN RES, V20, P29; Hays JC, 1996, J CLIN EPIDEMIOL, V49, P969, DOI 10.1016/0895-4356(96)00138-2; Houtrow A, 2012, ACAD PEDIATR, V12, P326, DOI 10.1016/j.acap.2012.03.004; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnson D, 2005, J MARRIAGE FAM, V67, P1061, DOI 10.1111/j.1741-3737.2005.00194.x; JOHNSON RJ, 1993, J HEALTH SOC BEHAV, V34, P105, DOI 10.2307/2137238; Kawachi I., 2003, NEIGHBORHOODS HLTH; Krause JS, 2009, SPINAL CORD, V47, P592, DOI 10.1038/sc.2009.15; Krause James S, 2010, Top Spinal Cord Inj Rehabil, V16, P53; Law M, 2007, ARCH PHYS MED REHAB, V88, P1636, DOI 10.1016/j.apmr.2007.07.035; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; MADDOX GL, 1964, J CHRON DIS, V17, P449, DOI 10.1016/0021-9681(64)90105-5; MADDOX GL, 1962, J GERONTOL, V17, P180, DOI 10.1093/geronj/17.2.180; Mihaylov SI, 2004, DEV MED CHILD NEUROL, V46, P299; Mohai P., 1992, RACE INCIDENCE ENV H; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; US Department of Education OoSEaRS National Institute on Disability and Rehabiliation Research, 2000, LONG RANG PLAN 2013; Viemero V, 1998, PSYCHOTHER PSYCHOSOM, V67, P317, DOI 10.1159/000012297; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeung P, 2014, DISABIL REHABIL, V36, P63, DOI 10.3109/09638288.2013.777808	38	13	13	0	12	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					557	562		10.1179/2045772314Y.0000000275			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL4RS	WOS:000356941800022	25329423	Green Published			2022-02-06	
J	Schober, K; Ondruschka, B; Dressler, J; Abend, M				Schober, K.; Ondruschka, B.; Dressler, J.; Abend, M.			Detection of hypoxia markers in the cerebellum after a traumatic frontal cortex injury: a human postmortem gene expression analysis	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Traumatic brain injury; Human; Post mortem; Gene expression; Biomarker; mRNA; miRNA; IL-6; FOSB; HSPA12B; HSD11B1; miR-138; miR-744; miR-195; miR-324-5p	BRAIN-INJURY; MICRORNA EXPRESSION; RATS; APOPTOSIS; MICROARRAY; MIRBASE; TARGETS; TISSUE; CELLS	The response to traumatic brain injury (TBI) is complex and induces various biological pathways in all brain regions that contribute to bad outcomes. The cerebellar hypoxia after a frontal cortex injury may potentiate the pathophysiological impacts of TBI. Therefore, a gene expression analysis was conducted to determine the influence of hypoxia on TBIs. Total RNA, including microRNAs, was isolated from the cerebellum of individuals who had died from severe frontal cortex injuries or due to natural causes of death (reference group). From a total of 19,596 genes, an average of 59.56 % messenger RNAs (mRNAs) appeared expressed with 42 of them showing significant > 2-fold differences of upregulated (n = 18) and downregulated (n = 24) genes. The validity of 14 candidate genes (with low p values and high fold differences or based on cited literature) was confirmed using qRT-PCR (Spearman correlation r (2) = 0.93). Only four genes appeared to be either upregulated (FOSB and IL6) or downregulated (HSD11B1 and HSPA12B). From a total of 667 microRNAs, altogether, 248 microRNAs appeared expressed with 13 of them showing significant differences in the mean gene expression. The combination of two mRNAs (HSPA12B/FOSB or IL6/HSD11B1) or two microRNAs (either miR-138/miR-744 or miR-195/miR-324-5p) completely discriminated both groups, a finding unaltered by potential confounders such as age at biosampling, survival time, and the postmortem interval. Cerebellar hypoxia markers are important to understand the pathophysiology of TBIs and could be used for therapeutic strategies or forensic purposes, e.g., to assess the severity of a brain injury.	[Schober, K.] German Air Force Ctr Aerosp Med, D-82242 Furstenfeldbruck, Germany; [Ondruschka, B.; Dressler, J.] Univ Leipzig, Inst Legal Med, Fac Med, D-04103 Leipzig, Germany; [Abend, M.] Bundeswehr Inst Radiobiol, D-80937 Munich, Germany		Schober, K (corresponding author), German Air Force Ctr Aerosp Med, Postfach 1264-KFL, D-82242 Furstenfeldbruck, Germany.	kristinschober@bundeswehr.org; Benjamin.Ondruschka@medizin.uni-leipzig.de; Jan.Dressler@medizin.uni-leipzig.de; michaelabend@bundeswehr.org			German Ministry of Defense	We would like to thank Sven Senf for his skillful technical assistance and his very sophisticated introduction into all methodological aspects of the qRT-PCR employed in this study. The German Ministry of Defense supported this work.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chesnut R M, 1995, New Horiz, V3, P366; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lidwell K, 2000, J NEUROSCI RES, V62, P427, DOI 10.1002/1097-4547(20001101)62:3<427::AID-JNR13>3.0.CO;2-O; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; PULSINELLI W, 1992, LANCET, V339, P533, DOI 10.1016/0140-6736(92)90347-6; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030; Yau JLW, 2001, P NATL ACAD SCI USA, V98, P4716, DOI 10.1073/pnas.071562698	40	13	14	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2015	129	4					701	707		10.1007/s00414-014-1129-3			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CK8ZW	WOS:000356530000004	25432860	Green Published, hybrid			2022-02-06	
J	Stelmaschuk, S; Will, MC; Meyers, T				Stelmaschuk, Stephanie; Will, Mary Colleen; Meyers, Tamara			Amantadine to Treat Cognitive Dysfunction in Moderate to Severe Traumatic Brain Injury	JOURNAL OF TRAUMA NURSING			English	Article							GLASGOW COMA SCALE; HEAD-INJURIES; RELIABILITY; HYDROCHLORIDE; DISABILITY; SYMPTOMS; EFFICACY	Traumatic brain injury (TBI) is a leading cause of injury, disability, and death in the United States. Amantadine is an established dopamine agonist that supports neurological function. The purpose of this literature review was to determine whether amantadine improves cognitive function post-TBI. PubMed and CINAHL were used to search the literature for articles using amantadine to treat TBI from 1994 to 2004. Outcomes were summarized and the evidence was appraised. Although earlier studies from 1994 to 2003 were lower-level studies and recommended further research on treatment of cognitive dysfunction in TBI, the literature from 2004 to present generally concluded that amantadine improved cognitive function related to arousal, memory, and aggression. It can be started days to months postinjury and still produces benefits.	[Stelmaschuk, Stephanie] Grant Med Ctr, Inpatient Trauma Serv, Columbus, OH 43215 USA; [Will, Mary Colleen] Cent Ohio Primary Care, Columbus, OH USA; [Meyers, Tamara] Grant Med Ctr, Outpatient Trauma & Acute Care Surg Off, Columbus, OH 43215 USA		Stelmaschuk, S (corresponding author), Grant Med Ctr, Inpatient Trauma Serv, 111 S Grant Ave,Ste 350, Columbus, OH 43215 USA.	Stephanie.Stelmaschuk@ohiohealth.com					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen JJ, 2007, PHARMACOTHERAPY, V27, p161S, DOI 10.1592/phco.27.12part2.161S; Colorado Division of Workers' Compensation, 2012, TRAUM BRAIN INJ MED, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Huang EY, 2014, PLOS ONE, V9, P1; Hughes S, 2005, BRAIN INJURY, V19, P1197, DOI 10.1080/02699050500309296; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Schneider WN, 1999, BRAIN INJURY, V13, P863; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	29	13	14	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	JUL-AUG	2015	22	4					194	203		10.1097/JTN.0000000000000138			10	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	CM8HV	WOS:000357941000005	26165872				2022-02-06	
J	Wahab, RA; Neuberger, EJ; Lyeth, BG; Santhakumar, V; Pfister, BJ				Wahab, Radia Abdul; Neuberger, Eric J.; Lyeth, Bruce G.; Santhakumar, Vijayalakshmi; Pfister, Bryan J.			Fluid percussion injury device for the precise control of injury parameters	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain injury; Fluid percussion injury; Injury rate; Injury biomechanics	TRAUMATIC BRAIN-INJURY; ACUTE NEURONAL DEGENERATION; ELASTIC BEHAVIOR; CORTICAL INJURY; AXONAL INJURY; HEAD TRAUMA; WATER MAZE; RAT; MODEL; TISSUE	Background: Injury to the brain can occur from a variety of physical insults and the degree of disability can greatly vary from person to person. It is likely that injury outcome is related to the biomechanical parameters of the traumatic event such as magnitude, direction and speed of the forces acting on the head. New method: To model variations in the biomechanical injury parameters, a voice coil driven fluid percussion injury (FPI) system was designed and built to generate fluid percussion waveforms with adjustable rise times, peak pressures, and durations. Using this system, pathophysiological outcomes in the rat were investigated and compared to animals injured with the same biomechanical parameters using the pendulum based FPI system. Results in comparison with existing methods: Immediate post-injury behavior shows similar rates of seizures and mortality in adolescent rats and similar righting times, toe pinch responses and mortality rates in adult rats. Interestingly, post injury mortality in adult rats was sensitive to changes in injury rate. Fluoro-Jade labeling of degenerating neurons in the hilus and CA2-3 hippocampus were consistent between injuries produced with the voice coil and pendulum operated systems. Granule cell population spike amplitude to afferent activation, a measure of dentate network excitability, also showed consistent enhancement 1 week after injury using either system. Conclusions: Overall our results suggest that this new FPI device produces injury outcomes consistent with the commonly used pendulum FPI system and has the added capability to investigate pathophysiology associated with varying rates and durations of injury. (C) 2015 Elsevier B.V. All rights reserved.	[Wahab, Radia Abdul; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Neuberger, Eric J.; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Pfister, BJ (corresponding author), Univ Hts, New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	pfister@njit.edu	mcDonald, Eric/G-8414-2015; Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187; Wahab, Razak/0000-0002-7167-8201; Lyeth, Bruce/0000-0003-4811-1474	New Jersey Commission on Brain Injury Research [CBIR11PJT003]	This research was funded by the New Jersey Commission on Brain Injury Research, CBIR11PJT003.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Cater HL, 2005, J BIOMECH; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Faul F., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; King A. I., 2003, IRCOBI C; KINGLIU Y, 1975, J BIOMECH, V8, P285, DOI 10.1016/0021-9290(75)90080-9; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; PAMIDI MR, 1978, J BIOMECH ENG-T ASME, V100, P44, DOI 10.1115/1.3426188; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SCHETTINI A, 1988, AM J PHYSIOL, V255, pR799, DOI 10.1152/ajpregu.1988.255.5.R799; SCHETTINI A, 1991, AM J PHYSIOL, V260, pR172, DOI 10.1152/ajpregu.1991.260.1.R172; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Shulyakov AV, 2011, J MECH BEHAV BIOMED, V4, P484, DOI 10.1016/j.jmbbm.2010.12.012; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; WALSH EK, 1976, AM J PHYSIOL, V230, P1058, DOI 10.1152/ajplegacy.1976.230.4.1058; WALSH EK, 1977, AM J PHYSIOL, V232, pR27, DOI 10.1152/ajpregu.1977.232.1.R27; WANG HC, 1972, J BIOMECH, V5, P431, DOI 10.1016/0021-9290(72)90002-4; Yu JD, 2013, J NEUROPHYSIOL, V109, P1746, DOI 10.1152/jn.00891.2012; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	57	13	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 15	2015	248						16	26		10.1016/j.jneumeth.2015.03.010			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CI8VA	WOS:000355048600003	25800515	Green Published			2022-02-06	
J	Casani, AP; Dallan, I; Navari, E; Franceschini, SS; Cerchiai, N				Casani, A. P.; Dallan, I.; Navari, E.; Franceschini, S. Sellari; Cerchiai, N.			Vertigo in childhood: proposal for a diagnostic algorithm based upon clinical experience	ACTA OTORHINOLARYNGOLOGICA ITALICA			English	Article						Vertigo; Benign paroxysmal vertigo; Head trauma; Diagnostic algorithm; Vestibular migraine	VESTIBULAR DISORDERS; CHILDREN	The aim of this paper is to analyse, after clinical experience with a series of patients with established diagnoses and review of the literature, all relevant anamnestic features in order to build a simple diagnostic algorithm for vertigo in childhood. This study is a retrospective chart review. A series of 37 children underwent complete clinical and instrumental vestibular examination. Only neurological disorders or genetic diseases represented exclusion criteria. All diagnoses were reviewed after applying the most recent diagnostic guidelines. In our experience, the most common aetiology for dizziness is vestibular migraine (38%), followed by acute labyrinthitis/neuritis (16%) and somatoform vertigo (16%). Benign paroxysmal vertigo was diagnosed in 4 patients (11%) and paroxysmal torticollis was diagnosed in a 1-year-old child. In 8% (3 patients) of cases, the dizziness had a post-traumatic origin: 1 canalolithiasis of the posterior semicircular canal and 2 labyrinthine concussions, respectively. Meniere's disease was diagnosed in 2 cases. A bilateral vestibular failure of unknown origin caused chronic dizziness in 1 patient. In conclusion, this algorithm could represent a good tool for guiding clinical suspicion to correct diagnostic assessment in dizzy children where no neurological findings are detectable. The algorithm has just a few simple steps, based mainly on two aspects to be investigated early: temporal features of vertigo and presence of hearing impairment. A different algorithm has been proposed for cases in which a traumatic origin is suspected.	[Casani, A. P.; Dallan, I.; Navari, E.; Franceschini, S. Sellari; Cerchiai, N.] Pisa Univ Hosp, Otorhinolaryngol Unit, Dept Med & Surg Pathol, I-56100 Pisa, Italy		Casani, AP (corresponding author), Pisa Univ Hosp, Otorhinolaryngol Unit, Dept Med & Surg Pathol, Via Paradisa 2, I-56100 Pisa, Italy.	augusto.casani@unipi.it					Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; BOWER CM, 1995, ARCH OTOLARYNGOL, V121, P911; Gioacchini FM, 2014, INT J PEDIATR OTORHI, V78, P718, DOI 10.1016/j.ijporl.2014.02.009; Gruber M, 2012, SCI WORLD J, DOI 10.1100/2012/109624; Jahn K, 2011, NEUROPEDIATRICS, V42, P129, DOI 10.1055/s-0031-1283158; Langhagen T, 2013, NEUROPEDIATRICS, V44, P55, DOI 10.1055/s-0032-1333433; Lehnen N, 2014, DEV MED CHILD NEUROL, V22, P1; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Marcelli V, 2015, CEPHALALGIA, V35, P538, DOI 10.1177/0333102414547781; Marcelli V, 2010, HEADACHE, V50, P71, DOI 10.1111/j.1526-4610.2009.01454.x; Miyahara M, 2009, LANCET, V373, P516, DOI 10.1016/S0140-6736(09)60173-2; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Pakalnis Ann, 2006, Expert Rev Neurother, V6, P291, DOI 10.1586/14737175.6.3.291; Riina N, 2005, ARCH OTOLARYNGOL, V131, P996, DOI 10.1001/archotol.131.11.996; Ruckenstein MJ, 2009, OTOLARYNG CLIN N AM, V42, P71, DOI 10.1016/j.otc.2008.09.011; Russell G, 1999, INT J PEDIATR OTORHI, V49, pS105, DOI 10.1016/S0165-5876(99)00143-3; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Szirmai A, 2000, J HEADACHE PAIN, V1, P39, DOI DOI 10.1007/S101940050008; Szirmai A, 2010, EUR ARCH OTO-RHINO-L, V267, P1801, DOI 10.1007/s00405-010-1283-2; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358	22	13	13	0	2	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	0392-100X	1827-675X		ACTA OTORHINOLARYNGO	Acta Otorhinolaryngol. Ital.	JUN	2015	35	3					180	185					6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	CJ2MK	WOS:000355318700006	26246662				2022-02-06	
J	Douglas, J				Douglas, Jacinta			Elizabeth Usher Memorial Lecture: Placing therapy in the context of the self and social connection	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Speech Pathology Australia National Conference	MAY 18-21, 2014	Melbourne, AUSTRALIA			Brain injury; therapy; social interaction	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INCOG RECOMMENDATIONS; COMMUNICATIVE ABILITY; COMMUNITY INTEGRATION; HEAD-INJURY; FOLLOW-UP; PEOPLE; REHABILITATION; IDENTITY	Background: The concept of self influences the choice of goals and helps to make sense of lives. Essentially, self-concept is a dynamic internal representation of the individual. This representation shapes behaviour and how information about oneself is processed. The self-story is developed and validated through social interactions and shaped continuously through life experiences. Method: The focus of this paper is the client's perspective of self and how one can actively use that perspective to plan therapy, particularly in the case of individuals with acquired brain injury (ABI). The paper draws upon the results of a number of research projects constructed around two primary aims: (1) to represent the perspectives of clients and their close others and (2) to maximize social connection through the delivery of effective communication intervention. Result: A model of self, derived from in-depth qualitative exploration of the experiences of people with ABI, is presented as a framework to guide collaborative therapy. The model depicts the multidimensional and cyclical nature of self-conceptualization supported by factors that facilitate social connection. Conclusion: Communication is crucial to maintaining social ties and communication breakdown is a significant predictor of participation. A new intervention that effectively improves coping with communication breakdown is presented.	[Douglas, Jacinta] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia; [Douglas, Jacinta] Summer Fdn, Blackburn, Vic, Australia		Douglas, J (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia.	j.douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624			Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Campbell JD, 1996, J PERS SOC PSYCHOL, V70, P141, DOI 10.1037/0022-3514.70.1.141; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K., 2014, BROKERAGE CLOSURE IN; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; *CRAIG HOSP RES DE, 1999, CRAIG HAND ASS REP T; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas J., 2014, J INT NEUROPSYCHO S1, V20, P239; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas J., 2010, BRAIN INJURY, V24, P153; Douglas J., 2012, BRAIN IMPAIR, V13, P170; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Durkheim E., 1951, SUICIDE; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Friedman A., 2005, BRAIN INJURY S, V19, P50; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Jetten J., 2012, SOCIAL CURE IDENTITY; Klein SB, 2010, WIRES COGN SCI, V1, P172, DOI 10.1002/wcs.25; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lin N., 1986, SOCIAL SUPPORT LIFE; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mackey J., 2007, BRAIN IMPAIR, V8, P207; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Morf C, 2005, SELF IDENTITY, V4, P97; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Muir A., 2007, BRAIN IMPAIR, V8, P83; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ownsworth T., 2014, SELF IDENTITY BRAIN; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Putnam RD., 2000, BOWLING ALONE COLLAP; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rutledge T, 2008, PSYCHOSOM MED, V70, P282, DOI 10.1097/PSY.0b013e3181656e09; Sabat Ayesha, 2006, S Afr J Commun Disord, V53, P17; Shaddon B., 2008, LIFE STORIES NARRATI; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein KF, 1996, J PSYCHOTHER INTEGR, V6, P349, DOI 10.1037/h0101118; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate R., 2005, BRAIN IMPAIR, V6, P81; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Umberson D, 2006, J HEALTH SOC BEHAV, V47, P1, DOI 10.1177/002214650604700101; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; von Hippel W., 2005, SOCIAL OUTCAST OSTRA, P227; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P235; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; [No title captured], DOI DOI 10.1375/BRIM.7.2.107	82	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	JUN	2015	17	3			SI		199	210		10.3109/17549507.2015.1016113			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CI5LC	WOS:000354796600002	25833073				2022-02-06	
J	Miller, D; Barnes, P; Miller, M				Miller, David; Barnes, Patrick; Miller, Marvin			The Significance of Macrocephaly or Enlarging Head Circumference in Infants With the Triad Further Evidence of Mimics of Shaken Baby Syndrome	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						shaken baby syndrome; abusive head trauma; cortical/sinus thrombosis; child abuse; macrocephaly; increased extra-axial fluid spaces	BENIGN EXTERNAL HYDROCEPHALUS; CHRONIC SUBDURAL-HEMATOMA; PERIMACULAR RETINAL FOLDS; TRAUMATIC BRAIN-INJURY; NONACCIDENTAL INJURY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; NATURAL-HISTORY; TERM INFANTS; ENLARGEMENT	Infants with the triad (neurologic dysfunction, subdural hematoma [SDH], and retinal hemorrhage) are often diagnosed as victims of shaken baby syndrome. Medical conditions/predisposing factors to developing the triad are often dismissed: short falls, birth-related SDH that enlarges, macrocephaly, sinus/cortical vein thrombosis, and others. Six infants with the triad are described in which child abuse was diagnosed, but parents denied wrongdoing. All 6 had either macrocephaly or enlarging head circumference, which suggested medical explanations. Three infants incurred short falls, 1 had a difficult delivery in which there was likely a rebleed of a birth-related SDH, 1 had a spontaneous SDH associated with increased extra-axial fluid spaces, and 1 had a sinus thrombosis. Following legal proceedings, all 6 infants were returned to their parents, and there has been no child maltreatment in follow-up, suggesting child abuse never happened. The results indicate that alternative medical explanations for causing the triad should be considered and that macrocephaly or an enlarging head circumference raises the possibility of a medical explanation.	[Miller, David] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Barnes, Patrick] Stanford Univ, Med Ctr, Lucile Packard Childrens Hosp, Dept Radiol, Palo Alto, CA 94304 USA; [Miller, Marvin] Wright State Univ, Boonshoft Sch Med, Dept Pediat Obstet Gynecol & Biomed Engn, Dayton, OH 45435 USA		Miller, M (corresponding author), Dayton Childrens Hosp, Dept Med Genet, 1 Childrens Plaza, Dayton, OH 45404 USA.	millerme@childrensdayton.org		Miller, David/0000-0002-6210-7941			ALVAREZ LA, 1986, PEDIATRICS, V77, P901; Amodio J, 2005, PEDIATR RADIOL, V35, P1113, DOI 10.1007/s00247-005-1503-x; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; AZAIS M, 1992, ANN PEDIATR-PARIS, V39, P550; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Bandak FA, 2006, FORENSIC SCI INT, V164, P282, DOI 10.1016/j.forsciint.2006.01.001; Barnes PD, 2011, RADIOL CLIN N AM, V49, P205, DOI 10.1016/j.rcl.2010.08.001; Center for Disease Control and Prevention, 2000, HEAD CIRC FOR AG CHA; Chamnanvanakij S, 2002, PEDIATR NEUROL, V26, P301, DOI 10.1016/S0887-8994(01)00420-9; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Gardner HB, 2004, NEUROPATH APPL NEURO, V30, P192, DOI 10.1111/j.1365-2990.2003.00503.x; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Girish M, 2013, J PEDIATR NEUROL, V11, P63, DOI 10.3233/JPN-120591; Greiner MV, 2013, AM J NEURORADIOL, V34, P2373, DOI 10.3174/ajnr.A3588; Gross Samuel R., 2012, EXONERATIONS US 1989; Hangique S, 2002, IND J RADIOL IMAG, V12, P197; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; ITO H, 1976, J NEUROSURG, V45, P26, DOI 10.3171/jns.1976.45.1.0026; ITO H, 1978, J NEUROSURG, V48, P197, DOI 10.3171/jns.1978.48.2.0197; Johnson K., 2015, US TODAY; Karimzadeh P, 2009, J PEDIATR NEUROL, V7, P157, DOI 10.3233/JPN-2009-0289; Krasnokutsky MV, 2011, AM J ROENTGENOL, V197, pW503, DOI 10.2214/AJR.10.5977; Lantz P, 2006, 58 ANN SCI M AM AC F; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma J., 2014, FORENSIC NEUROPATHOL, V3rd, P364; Lloyd J., 2011, J FORENSIC BIOMECH, V2, P1, DOI DOI 10.4303/jfb/F110601; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; Marino MA, 2014, NEURORADIOL J, V27, P245, DOI 10.15274/NRJ-2014-10020; McKeag H, 2013, J NEUROSURG-PEDIATR, V11, P438, DOI 10.3171/2012.12.PEDS12289; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Miller R, 2010, AM J FOREN MED PATH, V31, P165, DOI 10.1097/PAF.0b013e3181d96a8e; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; MULLER PJ, 1974, NEUROSURGERY, V41, P160; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Paterson CR, 2011, PEDIATR HEALTH MED T, V2, P55, DOI 10.2147/PHMT.S21449; Piatt JH, 1999, NEUROSURG FOCUS, V7, pE5; Plunkett J, 1999, AM J FOREN MED PATH, V20, P17, DOI 10.1097/00000433-199903000-00005; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Shapiro K, 1983, PEDIAT HEAD TRAUMA, P45; Sherwood D, 1930, AM J DIS CHILD, V39, P980; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Uscinski R, 2002, BRIT J NEUROSURG, V16, P217, DOI 10.1080/02688690220148978; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	52	13	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2015	36	2					111	120		10.1097/PAF.0000000000000152			10	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	CH9WV	WOS:000354388100015	25893912	Green Published			2022-02-06	
J	Ramesh, D; Keyser-Marcus, LA; Ma, L; Schmitz, JM; Lane, SD; Marwitz, JH; Kreutzer, JS; Moeller, FG				Ramesh, Divya; Keyser-Marcus, Lori A.; Ma, Liangsuo; Schmitz, Joy M.; Lane, Scott D.; Marwitz, Jennifer H.; Kreutzer, Jeffrey S.; Moeller, Frederick Gerard			Prevalence of Traumatic Brain Injury in Cocaine-Dependent Research Volunteers	AMERICAN JOURNAL ON ADDICTIONS			English	Article							SUBSTANCE-ABUSE; DECISION-MAKING; HEAD-INJURY; IMPULSIVITY; DISORDER; PREDICTION; HISTORY; UPDATE; RISK	BackgroundThere is a high prevalence of traumatic brain injury (TBI) among those with substance dependence. However, TBI often remains undiagnosed in these individuals, due to lack of routine screening in substance use treatment settings or due to overlap in some of the cognitive sequelae (eg impulsivity, disinhibition) of TBI and cocaine dependence. MethodsThe prevalence of self-reported mild to moderate TBI in a group of cocaine-dependent (n=95) and a group of healthy volunteers (n=75) enrolled at the same facility was assessed. Additionally, the relationship between TBI and clinically relevant correlates, including impulsivity, cocaine use history, and treatment outcome in the cocaine-dependent group was also examined. ResultsA higher proportion of individuals with cocaine dependence (29.5%) reported having suffered a TBI in their lifetime compared to controls (8%) on a Closed Head Injury scale. Among cocaine users, the average age of sustaining TBI was significantly lower than the age of initiating cocaine use. Presence of TBI was not associated with higher impulsivity on the Barratt Impulsiveness Scale-11 or self-reported years of cocaine use. No differences were noted on treatment outcome for cocaine dependence as measured by treatment effectiveness scores (TES) between cocaine users with TBI and their non-TBI counterparts. ConclusionsThese results are the first to highlight the high prevalence of TBI among individuals with cocaine dependence. This study underscores the possible role of TBI history as a risk factor for onset of cocaine use, however, more research is needed to determine the impact of co-morbid TBI as a complicating factor in the substance abuse treatment setting. (Am J Addict 2015;XX:XX-XX)	[Ramesh, Divya; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Dept Pharmacol Toxicol, Richmond, VA 23219 USA; [Keyser-Marcus, Lori A.; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23219 USA; [Ramesh, Divya; Keyser-Marcus, Lori A.; Ma, Liangsuo; Moeller, Frederick Gerard] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA 23219 USA; [Schmitz, Joy M.; Lane, Scott D.] Univ Texas Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Marwitz, Jennifer H.; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23219 USA		Ramesh, D (corresponding author), Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Dept Pharmacol & Toxicol, 203 East Cary St,Suite 202, Richmond, VA 23219 USA.	rameshd@vcu.edu		Schmitz, Joy/0000-0002-3561-4614	NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P50DA009262]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA034131, U54DA038999, P50DA009262] Funding Source: NIH RePORTER	This research was supported by NIDA grant P50DA009262 (PI. Moeller, Schmitz). The authors would like to acknowledge the technical assistance of Edward A. Zuniga, Nuvan Rathnayaka, and Zarha Kamdar.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; First M., 2002, STRUCTURED CLIN INTE; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Levin FR, 1998, DRUG ALCOHOL DEPEN, V52, P15, DOI 10.1016/S0376-8716(98)00049-0; Lindsay JA, 2009, AM J DRUG ALCOHOL AB, V35, P193, DOI 10.1080/00952990902933860; Ling W, 1997, NIDA Res Monogr, V175, P208; Ling W, 1994, NIDA RES MONOGR, V153, P495; Liu SJ, 2011, AM J DRUG ALCOHOL AB, V37, P117, DOI 10.3109/00952990.2010.543204; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Moeller FG, 2002, DRUG ALCOHOL DEPEN, V68, P105; Moeller FG, 2004, NEUROPSYCHOBIOLOGY, V50, P167, DOI 10.1159/000079110; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Report to Congress on Mild Traumatic Brain Injury in the United States, 2003, REP C MILD TRAUM BRA; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sofuoglu M, 2003, AM J DRUG ALCOHOL AB, V29, P713, DOI 10.1081/ADA-120026256; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Winhusen T, 2013, J SUBST ABUSE TREAT, V44, P541, DOI 10.1016/j.jsat.2012.12.005; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X	37	13	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1055-0496	1521-0391		AM J ADDICTION	Am. J. Addict.	JUN	2015	24	4					341	347		10.1111/ajad.12192			7	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	CH6YT	WOS:000354183200010	25662909	Green Accepted			2022-02-06	
J	Schmidt, AT; Li, XQ; Hanten, GR; McCauley, SR; Faber, J; Levin, HS				Schmidt, Adam T.; Li, Xiaoqi; Hanten, Gerri R.; McCauley, Stephen R.; Faber, Jessica; Levin, Harvey S.			A Longitudinal Investigation of Sleep Quality in Adolescents and Young Adults After Mild Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						mild traumatic brain injury; sleep; Pittsburgh Sleep Quality Index; adolescents; young adults	RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; IDENTIFICATION TEST AUDIT; ABUSE SCREENING-TEST; PRACTICAL SCALE; RISK-FACTORS; INSOMNIA; DISTURBANCE; INDEX; SYMPTOMS	Objective and Background:We examined sleep-related problems in adolescents and young adults after a mild traumatic brain injury (MTBI) or orthopedic injury. We extended the analysis of data from a study of early emotional and neuropsychological sequelae in these populations (McCauley et al. 2014. J Neurotrauma. 31:914).Methods:We gave the Pittsburgh Sleep Quality Index to 77 participants with MTBI, 71 with orthopedic injury, and 43 non-injured controls. The age range was 12 to 30 years. We tested sleep quality within 96 hours of injury and at 1- and 3-month follow-up. Participants also completed measures of pain and fatigue, drug and alcohol use, and post-traumatic stress symptoms.Results:Older participants (mean age=25 years) in the MTBI group exhibited a sharp increase in sleep-related symptoms between the baseline assessment and 1 month, and still had difficulties at 3 months. Younger participants with MTBI (mean age=15 years) and older participants with an orthopedic injury had modest increases in sleep difficulties between baseline and 1 month. The participants with MTBI also had more clinically significant sleep difficulties at all 3 assessments. At 3 months, Pittsburgh Sleep Quality Index scores in younger participants with MTBI and all participants with orthopedic injury did not differ significantly from the non-injured controls'. The controls had no significant change in their sleep symptoms during the 3 months.Conclusions:Sleep difficulties in young adults may persist for 3 months after MTBI and exceed those after orthopedic injury. Clinicians should seek and treat sleep-related problems after MTBI.	[Schmidt, Adam T.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA; [Li, Xiaoqi; Hanten, Gerri R.; McCauley, Stephen R.; Faber, Jessica; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Hanten, Gerri R.] Rice Univ, Dept Psychol, Houston, TX 77251 USA		Schmidt, AT (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Campus Box 2447, Huntsville, TX 77340 USA.	ats1978@gmail.com			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 P01 NS056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202] Funding Source: NIH RePORTER	Supported in part by National Institute of Neurological Disorders and Stroke Grant 5 P01 NS056202 (H.S.L.).	Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dewald-Kaufmann JF, 2014, J CHILD PSYCHOL PSYC, V55, P273, DOI 10.1111/jcpp.12157; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fichtenberg NL, 2012, BRAIN INJURY, V16, P197; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Geng FL, 2013, J CLIN PSYCHIAT, V74, P69, DOI 10.4088/JCP.12m07872; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lallukka T, 2012, SLEEP MED, V13, P680, DOI 10.1016/j.sleep.2011.10.036; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lunsford-Avery JR, 2013, SCHIZOPHR RES, V151, P148, DOI 10.1016/j.schres.2013.09.015; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Megdal SP, 2007, SLEEP MED, V9, P60, DOI 10.1016/j.sleep.2007.01.012; Moos RH, 1994, LISRES A LIFE STRESS; Morgan K, 2003, BRIT J GEN PRACT, V53, P923; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Petersen H, 2013, J SLEEP RES, V22, P50, DOI 10.1111/j.1365-2869.2012.01034.x; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Martinez MP, 2014, J BEHAV MED, V37, P683, DOI 10.1007/s10865-013-9520-y; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	51	13	13	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	JUN	2015	28	2					53	62		10.1097/WNN.0000000000000056			10	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	CL9RQ	WOS:000357316200003	26102995	Green Accepted			2022-02-06	
J	Shrivats, AR; Hsu, E; Averick, S; Klimak, M; Watt, ACS; DeMaio, M; Matyjaszewski, K; Hollinger, JO				Shrivats, Arun R.; Hsu, Eric; Averick, Saadyah; Klimak, Molly; Watt, April C. S.; DeMaio, Marlene; Matyjaszewski, Krzysztof; Hollinger, Jeffrey O.			Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							TRANSFER RADICAL POLYMERIZATION; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; HETEROTOPIC OSSIFICATION; TRANSCRIPTIONAL REGULATION; RISK-FACTORS; RADIATION PROPHYLAXIS; EARLY EXCISION; BONE-FORMATION	Heterotopic ossification (HO) may occur after musculoskeletal trauma, traumatic brain injury, and total joint arthroplasty. As such, HO is a compelling clinical concern in both military and civilian medicine. A possible etiology of HO involves dysregulated signals in the bone morphogenetic protein osteogenic cascade. Contemporary treatment options for HO (ie, nonsteroidal antiinflammatory drugs and radiation therapy) have adverse effects associated with their use and are not biologically engineered to abrogate the molecular mechanisms that govern osteogenic differentiation. We hypothesized that (1) nanogel-mediated short interfering RNA (siRNA) delivery against Runt-related transcription factor 2 (Runx2) and osterix (Osx) genes will decrease messenger RNA expression; (2) inhibit activity of the osteogenic marker alkaline phosphatase (ALP); and (3) inhibit hydroxyapatite (HA) deposition in osteoblast cell cultures. Nanogel nanostructured polymers delivered siRNA in 48-hour treatment cycles against master osteogenic regulators, Runx2 and Osx, in murine calvarial preosteoblasts (MC3T3-E1.4) stimulated for osteogenic differentiation by recombinant human bone morphogenetic protein (rhBMP-2). The efficacy of RNA interference (RNAi) therapeutics was determined by quantitation of messenger RNA knockdown (by quantitative reverse transcription-polymerase chain reaction), downstream protein knockdown (determined ALP enzymatic activity assay), and HA deposition (determined by OsteoImage (TM) assay). Gene expression assays demonstrated that nanogel-based RNAi treatments at 1:1 and 5:1 nanogel:short interfering RNA weight ratios reduced Runx2 expression by 48.59% +/- A 19.53% (p < 0.001) and 43.22% +/- A 18.01% (both p < 0.001). The same 1:1 and 5:1 treatments against both Runx2 and Osx reduced expression of Osx by 51.65% +/- A 10.85% and 47.65% +/- A 9.80% (both p < 0.001). Moreover, repeated 48-hour RNAi treatment cycles against Runx2 and Osx rhBMP-2 administration reduced ALP activity after 4 and 7 days. ALP reductions after 4 days in culture by nanogel 5:1 and 10:1 RNAi treatments were 32.4% +/- A 12.0% and 33.6% +/- A 13.8% (both p < 0.001). After 7 days in culture, nanogel 1:1 and 5:1 RNAi treatments produced 35.9% +/- A 14.0% and 47.7% +/- A 3.2% reductions in ALP activity. Osteoblast mineralization data after 21 days suggested that nanogel 1:1, 5:1, and 10:1 RNAi treatments decreased mineralization (ie, HA deposition) from cultures treated only with rhBMP-2 (p < 0.001). However, despite RNAi attack on Runx2 and Osx, HA deposition levels remained greater than non-rhBMP-2-treated cell cultures. Although mRNA and protein knockdown were confirmed as a result of RNAi treatments against Runx2 and Osx, complete elimination of mineralization processes was not achieved. RNAi targeting mid- and late-stage osteoblast differentiation markers such as ALP, osteocalcin, osteopontin, and bone sialoprotein) may produce the desired RNAi-nanogel nanostructured polymer HO prophylaxis. Successful HO prophylaxis should target and silence osteogenic markers critical for heterotopic bone formation processes. The identification of such markers, beyond RUNX2 and OSX, may enhance the effectiveness of RNAi prophylaxes for HO.	[Shrivats, Arun R.; Hsu, Eric; Klimak, Molly; Watt, April C. S.; Hollinger, Jeffrey O.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15219 USA; [Averick, Saadyah; Matyjaszewski, Krzysztof] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [DeMaio, Marlene] Naval Med Ctr Portsmouth, Dept Orthopaed Surg, Portsmouth, VA 23708 USA		Hollinger, JO (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.	hollinge@cs.cmu.edu	Averick, Saadyah/A-9999-2015; Matyjaszewski, Krzysztof/A-2508-2008	Averick, Saadyah/0000-0003-4775-2317; Matyjaszewski, Krzysztof/0000-0003-1960-3402	DoD - Defense Medical Research and Development Program [W81XWH1120073, DMR09-69301]	Two of the authors (ARS, EH) contributed equally. All institutions in this study, during the study period, received funding from DoD Grant W81XWH1120073, which was awarded by the Defense Medical Research and Development Program, and DMR09-69301.	AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Arikawa T, 2004, J CELL PHYSIOL, V200, P400, DOI 10.1002/jcp.20031; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Averick S, 2012, ACS MACRO LETT, V1, P6, DOI 10.1021/mz200020c; Averick SE, 2012, BIOMACROMOLECULES, V13, P3445, DOI 10.1021/bm301166s; Bal BS, 2010, J ARTHROPLASTY, V25, P538, DOI 10.1016/j.arth.2009.04.019; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P425; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Farris MK, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-140; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Gersbach CA, 2004, EXP CELL RES, V300, P406, DOI 10.1016/j.yexcr.2004.07.031; Gurkan UA, 2010, TISSUE ENG PT A, V16, P2295, DOI [10.1089/ten.tea.2009.0565, 10.1089/ten.TEA.2009.0565]; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Haversath M, 2012, CAN J PHYSIOL PHARM, V90, P1434, DOI 10.1139/y2012-123; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hsu EW, 2014, J BIOMED NANOTECHNOL, V10, P1130, DOI 10.1166/jbn.2014.1823; Huang WB, 2004, BONE, V34, P799, DOI 10.1016/j.bone.2003.11.027; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kan LX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/309287; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Lin L, 2006, BIOCHEM BIOPH RES CO, V349, P564, DOI 10.1016/j.bbrc.2006.08.089; Matyjaszewski K, 2014, J AM CHEM SOC, V136, P6513, DOI 10.1021/ja408069v; Matyjaszewski K, 2012, MACROMOLECULES, V45, P4015, DOI 10.1021/ma3001719; McCarthy TL, 2000, J BIOL CHEM, V275, P21746, DOI 10.1074/jbc.M002291200; McCarthy TL, 2003, J BIOL CHEM, V278, P43121, DOI 10.1074/jbc.M306531200; Medina A, 2014, J BURN CARE RES, V35, P251, DOI 10.1097/BCR.0b013e3182957768; Melcer T, 2011, J REHABIL RES DEV, V48, P1, DOI 10.1682/JRRD.2010.03.0033; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Mishra S, 2012, INTEGR BIOL-UK, V4, P1498, DOI 10.1039/c2ib20200j; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Oh JK, 2006, J AM CHEM SOC, V128, P5578, DOI 10.1021/ja060586a; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Oh JK, 2007, BIOMACROMOLECULES, V8, P3326, DOI 10.1021/bm070381+; Oh JK, 2007, J AM CHEM SOC, V129, P5939, DOI 10.1021/ja069150l; Oh JK, 2009, POLYMER, V50, P4407, DOI 10.1016/j.polymer.2009.06.045; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS191; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217; Seegenschmiedt MH, 2001, INT J RADIAT ONCOL, V51, P756, DOI 10.1016/S0360-3016(01)01640-6; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550; Shehab D, 2002, J NUCL MED, V43, P346; Shrivats A. R., 2013, BIOMIMETICS STEM CEL; Shrivats AR, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1201, DOI 10.1016/B978-0-12-398358-9.00055-0; Simakova A, 2012, MACROMOLECULES, V45, P6371, DOI 10.1021/ma301303b; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhu B, 2011, J TISSUE ENG REGEN M	70	13	15	1	33	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUN	2015	473	6					2139	2149		10.1007/s11999-014-4073-0			11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CH6FX	WOS:000354133000043	25448327	Bronze, Green Published			2022-02-06	
J	Young, J; Pionk, T; Hiatt, I; Geeck, K; Smith, JS				Young, Jennica; Pionk, Timothy; Hiatt, Ivy; Geeck, Katalin; Smith, Jeffrey S.			Environmental enrichment aides in functional recovery following unilateral controlled cortical impact of the forelimb sensorimotor area however intranasal administration of nerve growth factor does not	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; NGF; Intranasal administration; Enriched environment; FL-SMC CCI	TRAUMATIC BRAIN-INJURY; DENDRITIC STRUCTURAL PLASTICITY; COGNITIVE FUNCTION; CONTUSION INJURY; MOTOR CORTEX; ADULT RATS; TRANSPLANTATION; EXPRESSION; EXERCISE; DEFICITS	Purpose: An injury to the forelimb sensorimotor cortex results in the impairment of motor function in animals. Recent research has suggested that intranasal administration of nerve growth factor (NGF), a protein naturally found in the brain, and placement into enriched environments (EE) improves motor and cognitive function after traumatic brain injury (TBI). The purpose of this study was to determine whether NGF, EE, or the combination of both was beneficial in the recovery of motor function following TBI. Results: Uninjured animals had fewer foot faults than injured animals, displaying a lesion effect. Injured animals housed in EE were shown to have fewer foot faults whether or not they received NGF. Injured animals also displayed an increased reliance on the non-impaired limb further validating a lesion effect. Conclusion: EE is an effective treatment on the recovery of motor function after a TBI. Intranasal administration of NGF was found to not be an effective treatment for functional motor recovery after a TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Young, Jennica; Pionk, Timothy; Hiatt, Ivy; Geeck, Katalin; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jennicay@siu.edu; tdpionk@svsu.edu; ijhiatt@svsu.edu; kjgeeck@svsu.edu; jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Dow Student Research and Creativity Institute	Funding was provided by the Dow Student Research and Creativity Institute to Jennica Young. The authors would also like to thank Evan Nudi, Jacob Dunkerson, Kim Meerschaert, Justin Jacqmain, Garrick Salois, Kelsey Dubbs, and Madeleine Searles of The Brain Research Laboratory at Saginaw Valley State University.	Allred RP, 2004, EXP NEUROL, V190, P433, DOI 10.1016/j.expneurol.2004.08.005; Angelucci F, 2009, CEREBELLUM, V8, P499, DOI 10.1007/s12311-009-0129-1; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Branchi I, 2006, BIOL PSYCHIAT, V60, P690, DOI 10.1016/j.biopsych.2006.01.005; Bury SD, 2002, J NEUROSCI, V22, P8597; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; GAROFALO L, 1994, EXP NEUROL, V125, P195, DOI 10.1006/exnr.1994.1024; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoane MR, 2008, MAGNESIUM RES, V21, P29; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Jones TA, 1999, J NEUROSCI, V19, P10153; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SLAVIN MD, 1988, BRAIN INJURY RECOVER, P165; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WILL B, 1992, ADV EXP MED BIOL, V325, P79; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	35	13	15	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2015	115						17	22		10.1016/j.brainresbull.2015.04.003			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL2AG	WOS:000356745400003	25889001				2022-02-06	
J	Sherer, M; Davis, LC; Sander, AM; Nick, TG; Luo, CQ; Pastorek, N; Hanks, R				Sherer, Mark; Davis, Lynne C.; Sander, Angelle M.; Nick, Todd G.; Luo, Chunqiao; Pastorek, Nicholas; Hanks, Robin			Factors Associated with Word Memory Test Performance in Persons with Medically Documented Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Traumatic brain injury; Neuropsychological assessment.; Word Memory Test; Effort	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TESTS; HEAD-INJURY; COGNITIVE SYMPTOMS; TEST FAILURE; POOR EFFORT; TEST-SCORES; VETERANS; CLAIMANTS	Objectives: (1) To examine the rate of poor performance validity in a large, multicenter, prospectively accrued cohort of community dwelling persons with medically documented traumatic brain injury (TBI), (2) to identify factors associated with Word Memory Test (WMT) performance in persons with TBI. Method: This was a prospective cohort, observational study of 491 persons with medically documented TBI. Participants were administered a battery of cognitive tests, questionnaires on emotional distress and post-concussive symptoms, and a performance validity test (WMT). Additional data were collected by interview and review of medical records. Results: One hundred and seventeen participants showed poor performance validity using the standard cutoff. Variable cluster analysis was conducted as a data reduction strategy. Findings revealed that the 10 cognitive tests and questionnaires could be summarized as 4 indices of emotional distress, speed of cognitive processing, verbal memory, and verbal fluency. Regression models revealed that verbal memory, emotional distress, age, and injury severity (time to follow commands) made unique contribution to prediction of poor performance validity. Conclusions: Poor performance validity was common in a research sample of persons with medically documented TBI who were not evaluated in conjunction with litigation, compensation claims, or current report of symptoms. Poor performance validity was associated with poor performance on cognitive tests, greater emotional distress, lower injury severity, and greater age. Many participants expected to have residual deficits based on initial injury severity showed poor performance validity.	[Sherer, Mark; Davis, Lynne C.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Harris Hlth Syst, Houston, TX 77030 USA; [Nick, Todd G.; Luo, Chunqiao] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Pastorek, Nicholas] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, Rehabil & Extended Care Line, Houston, TX 77030 USA; [Hanks, Robin] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI USA		Sherer, M (corresponding author), TIRR Mem Hermann, Brain Injury Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org		Pastorek, Nicholas/0000-0002-9290-380X			[Anonymous], 2009, SAS STAT VERS 9 2 CO; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Armistead-Jehle P, 2013, ARCH CLIN NEUROPSYCH, V28, P297, DOI 10.1093/arclin/act017; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corrigan J.D., 2003, TECHNICAL REPORT PRO; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harrell F, 2009, RMS S FUNCTIONS BIOS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2000, J CLIN EXP NEUROPSYC, V22, P702, DOI 10.1076/1380-3395(200010)22:5;1-9;FT702; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, LEXAMEN CLINIQUE PSY; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Sherer M., REHABILITAT IN PRESS; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977	61	13	13	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY 19	2015	29	4					522	541		10.1080/13854046.2015.1052763			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CM8FZ	WOS:000357935100009	26063081				2022-02-06	
J	Bache, S; Rasmussen, R; Rossing, M; Hammer, NR; Juhler, M; Friis-Hansen, L; Nielsen, FC; Moller, K				Bache, Soren; Rasmussen, Rune; Rossing, Maria; Hammer, Niels Risor; Juhler, Marianne; Friis-Hansen, Lennart; Nielsen, Finn Cilius; Moller, Kirsten			Detection and quantification of microRNA in cerebral microdialysate	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; ISCHEMIA	Background: Secondary brain injury accounts for a major part of the morbidity and mortality in patients with spontaneous aneurysmal subarachnoid hemorrhage (SAH), but the pathogenesis and pathophysiology remain controversial. MicroRNAs (miRNAs) are important posttranscriptional regulators of complementary mRNA targets and have been implicated in the pathophysiology of other types of acute brain injury. Cerebral microdialysis is a promising tool to investigate these mechanisms. We hypothesized that miRNAs would be present in human cerebral microdialysate. Methods: RNA was extracted and miRNA profiles were established using high throughput real-time quantification PCR on the following material: 1) Microdialysate sampled in vitro from A) a solution of total RNA extracted from human brain, B) cerebrospinal fluid (CSF) from a neurologically healthy patient, and C) a patient with SAH; and 2) cerebral microdialysate and CSF sampled in vivo from two patients with SAH. MiRNAs were categorized according to their relative recovery (RR) and a pathway analysis was performed for miRNAs exhibiting a high RR in vivo. Results: Seventy-one of the 160 miRNAs detected in CSF were also found in in vivo microdialysate from SAH patients. Furthermore specific miRNAs consistently exhibited either a high or low RR in both in vitro and in vivo microdialysate. Analysis of repeatability showed lower analytical variation in microdialysate than in CSF. Conclusions: MiRNAs are detectable in cerebral microdialysate; a large group of miRNAs consistently showed a high RR in cerebral microdialysate. Measurement of cerebral interstitial miRNA concentrations may aid in the investigation of secondary brain injury in neurocritical conditions.	[Bache, Soren; Hammer, Niels Risor; Moller, Kirsten] Univ Copenhagen Hosp, Ctr Neurosci, Dept Neuroanaesthesiol, DK-2100 Copenhagen, Denmark; [Bache, Soren; Rossing, Maria; Friis-Hansen, Lennart; Nielsen, Finn Cilius] Univ Copenhagen Hosp, Ctr Diagnost, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Rasmussen, Rune; Juhler, Marianne] Univ Copenhagen Hosp, Dept Neurosurg, Ctr Neurosci, Rigshosp, DK-2100 Copenhagen, Denmark		Bache, S (corresponding author), Univ Copenhagen Hosp, Ctr Neurosci, Dept Neuroanaesthesiol, DK-2100 Copenhagen, Denmark.	bache@dadlnet.dk	Nielsen, Finn Cilius/AAA-4926-2020; Moller, Kirsten/A-4751-2009	Moller, Kirsten/0000-0003-3058-1072; Friis-Hansen, Lennart/0000-0002-7222-0163; Nielsen, Finn Cilius/0000-0002-9829-1031	Rigshospitalet's Board of Research; Lundbeck FoundationLundbeckfonden; Brodrene Hartmanns Fond; Grosserer Jakob Ehrenreich & Hustru Grethe Ehrenreichs Fond	Ms. Ewa Futoma from Centre for Genomic Medicine is gratefully acknowledged for her thorough teaching and supervision of SB in the necessary laboratory skills regarding RNA isolation and qRT-PCR. Dr. Soren Nielsen from Centre of Inflammation and Metabolism is gratefully acknowledged for his qualified introduction of SB to pre-processing and normalization of qRT-PCR data. Rigshospitalet's Board of Research, the Lundbeck Foundation, Brodrene Hartmanns Fond and Grosserer Jakob Ehrenreich & Hustru Grethe Ehrenreichs Fond funded this study.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui H, 2013, J CRANIOFAC SURG, V24, P2147, DOI 10.1097/SCS.0b013e3182a243f3; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Kim JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097946; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Ronald Zielke H, 2009, J NEUROCHEM, V109, P24, DOI 10.1111/j.1471-4159.2009.05941.x; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Su W, 2014, J IMMUNOL, V192, P358, DOI 10.4049/jimmunol.1301397; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	19	13	14	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	MAY 7	2015	13								149	10.1186/s12967-015-0505-1			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DD2YL	WOS:000369788000003	25947950	Green Published, gold			2022-02-06	
J	Fowler, JN; Pallanta, AA; Swanik, CB; Wagner, NJ				Fowler, Jeremy N.; Pallanta, Anthony A.; Swanik, Charles B.; Wagner, Norman J.			The Use of Shear Thickening Nanocomposites in Impact Resistant Materials	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; RHEOLOGICAL PROPERTIES; BRAIN-INJURY; CONCUSSION; EPIDEMIOLOGY; BIOMECHANICS	The work presented here demonstrates using a novel, field-responsive nanocomposite based on shear thickening fluids (STFs) as responsive protective materials with superior damping and energy adsorption properties. Peak forces and accelerations measured using an instrumented Instron (TM) drop tower demonstrate that STF nanocomposite prototypes and impact foam taken from a commercial football helmet have similar performance for low kinetic energy impacts. However, tests with STF nanocomposite samples exhibit significantly reduced peak acceleration and peak force for impacts above 15 J. Thus, the STF containing nanocomposite material provides improved energy adsorption upon impact as compared to the commercial foam. These tests suggest that STF nanocomposite materials have promising potential as novel energy dissipating components in personal protective equipment.	[Fowler, Jeremy N.; Pallanta, Anthony A.; Wagner, Norman J.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE 19716 USA; [Swanik, Charles B.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA		Fowler, JN (corresponding author), Syngenta Crop Protect LLC, POB 18300, Greensboro, NC 27419 USA.		Wagner, Norman J/B-6558-2012	Wagner, Norman J/0000-0001-9565-619X			Barth JT, 2001, J ATHL TRAINING, V36, P253; Bender J, 1996, J RHEOL, V40, P899, DOI 10.1122/1.550767; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Galindo-Rosales FJ, 2011, J NON-NEWTON FLUID, V166, P1421, DOI 10.1016/j.jnnfm.2011.08.008; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kalman DP, 2009, ACS APPL MATER INTER, V1, P2602, DOI 10.1021/am900516w; Kalman DP, 2009, RHEOL ACTA, V48, P897, DOI 10.1007/s00397-009-0351-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAUN HM, 1984, ANGEW MAKROMOL CHEM, V123, P335, DOI 10.1002/apmc.1984.051230115; Lee YS, 2006, IND ENG CHEM RES, V45, P7015, DOI 10.1021/ie0512690; Lee YS, 2003, J MATER SCI, V38, P2825, DOI 10.1023/A:1024424200221; Maranzano BJ, 2001, J CHEM PHYS, V114, P10514, DOI 10.1063/1.1373687; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Melrose JR, 2004, J RHEOL, V48, P937, DOI 10.1122/1.1784783; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Viano DC, 2005, SOLID MECH APPL, V124, P121; Wagner NJ, 2009, PHYS TODAY, V62, P27, DOI 10.1063/1.3248476; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659	31	13	15	0	51	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAY	2015	137	5							054504	10.1115/1.4029982			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CF0YQ	WOS:000352271000015	25751789				2022-02-06	
J	Hall, EE; Ketcham, CJ; Crenshaw, CR; Baker, MH; McConnell, JM; Patel, K				Hall, Eric E.; Ketcham, Caroline J.; Crenshaw, Cayce R.; Baker, Martin H.; McConnell, Jodi M.; Patel, Kirtida			Concussion Management in Collegiate Student-Athletes: Return-To-Academics Recommendations	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cognitive rest; brain injury; recovery	SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; SCHOOL; PATHOPHYSIOLOGY; ZURICH; REST	Concussions in collegiate athletics can affect student-athletes both on the field and in the classroom. As policies are made to outline return-to-play decisions and timelines, this article will make the case that return-to-academics should also be included and follow a step-wise protocol. Complete cognitive rest is a cornerstone of concussion recovery and slow reintroduction to academics should precede return-to-play. The college structure allows for student-athletes to begin small doses of cognitive activity after the recommended complete cognitive rest. It is recommended that return-to-academics involves a team approach to help the student-athlete navigate the responsibilities of course work while healing from a brain injury.	[Hall, Eric E.; Ketcham, Caroline J.] Elon Univ, Dept Exercise Sci, Elon, NC 27244 USA; [Crenshaw, Cayce R.; Baker, Martin H.; McConnell, Jodi M.; Patel, Kirtida] Elon Univ, Dept Athlet, Elon, NC 27244 USA		Hall, EE (corresponding author), Elon Univ, Dept Exercise Sci, 2525 Campus Box, Elon, NC 27244 USA.	ehall@elon.edu					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Collegiate Athletic Association, 2013, 2013 2014 NCAA SPORT; Nowinski C, 2013, CEREBRUM; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2006, SPORTS NEUROPSYCHOLO, P160; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123	26	13	13	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					291	296		10.1097/JSM.0000000000000133			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700015	25010153				2022-02-06	
J	Kowalski, RG; Buitrago, MM; Duckworth, J; Chonka, ZD; Puttgen, HA; Stevens, RD; Geocadin, RG				Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Chonka, Zachary D.; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.			Neuroanatomical Predictors of Awakening in Acutely Comatose Patients	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTERIZED-TOMOGRAPHY FINDINGS; SEVERE HEAD-INJURY; MIDLINE SHIFT; CT-SCAN; TRANSTENTORIAL HERNIATION; ADMISSION CHARACTERISTICS; INTRACEREBRAL HEMORRHAGE; SUBDURAL-HEMATOMA; CONSCIOUSNESS	ObjectiveLateral brain displacement has been associated with loss of consciousness and poor outcome in a range of acute neurologic disorders. We studied the association between lateral brain displacement and awakening from acute coma. MethodsThis prospective observational study included all new onset coma patients admitted to the Neurosciences Critical Care Unit (NCCU) over 12 consecutive months. Head computed tomography (CT) scans were analyzed independently at coma onset, after awakening, and at follow-up. Primary outcome measure was awakening, defined as the ability to follow commands before hospital discharge. Secondary outcome measures were discharge Glasgow Coma Scale (GCS), modified Rankin Scale, Glasgow Outcome Scale, and hospital and NCCU lengths of stay. ResultsOf the 85 patients studied, the mean age was 5816 years, 51% were female, and 78% had cerebrovascular etiology of coma. Fifty-one percent of patients had midline shift on head CT at coma onset and 43 (51%) patients awakened. In a multivariate analysis, independent predictors of awakening were younger age (odds ratio [OR]=1.039, 95% confidence interval [CI]=1.002-1.079, p=0.040), higher GCS score at coma onset (OR=1.455, 95% CI=1.157-1.831, p=0.001), nontraumatic coma etiology (OR=4.464, 95% CI=1.011-19.608, p=0.048), lesser pineal shift on follow-up CT (OR=1.316, 95% CI=1.073-1.615, p=0.009), and reduction or no increase in pineal shift on follow-up CT (OR=11.628, 95% CI=2.207-62.500, p=0.004). InterpretationReversal and/or limitation of lateral brain displacement are associated with acute awakening in comatose patients. These findings suggest objective parameters to guide prognosis and treatment in patients with acute onset of coma. Ann Neurol 2015;77:804-816	[Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Neurol, Baltimore, MD 21287 USA; [Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Neurosurg, Baltimore, MD 21287 USA; [Kowalski, Robert G.; Buitrago, Manuel M.; Duckworth, Josh; Puttgen, H. Adrian; Stevens, Robert D.; Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Neurosci Crit Care Div, Dept Anesthesiol Crit Care Med, Baltimore, MD 21287 USA; [Chonka, Zachary D.] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA; [Geocadin, Romergryko G.] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA		Kowalski, RG (corresponding author), Johns Hopkins Univ Hosp, Phipps 455,600 N Wolfe St, Baltimore, MD 21287 USA.	rkowalski@gmail.com		Puttgen, Hans/0000-0003-4016-6825	Johns Hopkins University School of MedicineJohns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071568] Funding Source: NIH RePORTER	Johns Hopkins University School of Medicine.	Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Ibrahim GM, 2011, J NEUROSURG, V115, P1191, DOI 10.3171/2011.7.JNS11725; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Song Z, 2012, CLIN NEUROL NEUROSUR, V114, P634, DOI 10.1016/j.clineuro.2011.12.029; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; WONG CW, 1995, ACTA NEUROCHIR, V135, P131, DOI 10.1007/BF02187756; Young GB, 2011, NEUROL CLIN, V29, P765, DOI 10.1016/j.ncl.2011.07.008; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	30	13	13	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	MAY	2015	77	5					804	816		10.1002/ana.24381			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG4EF	WOS:000353235400009	25628166	Green Accepted			2022-02-06	
J	Meares, S; Shores, EA; Smyth, T; Batchelor, J; Murphy, M; Vukasovic, M				Meares, Susanne; Shores, E. Arthur; Smyth, Tracy; Batchelor, Jennifer; Murphy, Margaret; Vukasovic, Matthew			Identifying Posttraumatic Amnesia in Individuals With a Glasgow Coma Scale of 15 After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amnesia; anterograde; Brain injuries; Rehabilitation	COGNITIVE IMPAIRMENT; RECOMMENDATIONS; MANAGEMENT; ACCURACY	Objective: To examine the utility of the Abbreviated Westmead Post-traumatic Amnesia Scale, which includes the Glasgow Coma Scale (GCS) and 3 picture cards used to measure amnesia, in identifying the presence or absence of posttraumatic amnesia in individuals with mild traumatic brain injury (mTBI). Design: Prospective study using data from the Abbreviated Westmead Post-traumatic Amnesia Scale. Setting: Trauma hospital. Participants: Individuals with possible mTBI who presented between April and September 2011 (N=252; age range, 18-65y; mean age, 37.4 +/- 13.9y; 77% men). Intervention: Administration of the Abbreviated Westmead Post-traumatic Amnesia Scale. Main Outcome Measures: GCS and Abbreviated Westmead Post-traumatic Amnesia Scale pass/fail rates. Results: Of the individuals, 169 (mean age, 35.1 +/- 13.6y; 77% men) received the scale. A pass/fail performance was achieved a median 121 minutes (interquartile range, 89-205min) after triage. Of the 45 who failed, 31(69%) had a GCS score of 15. The likelihood of failing was associated with being older (odds ratio [On 1.03; 95% confidence interval [CI], 1.02-1.06; P<.05), having consumed alcohol (OR, 3.09; 95% CI, 1.42-6.74; P<01), and the scale being administered closer to the time of the injury (OR, 0.99; 95% CI, 0.99-1.00; P<.05). Nineteen (42%) of those who failed had consumed alcohol, 11 had a GCS score of 15, and 8 had a GCS score of 14. Conclusions: A GCS score of 15 does not always signify return to normative cognitive function. Individuals with a GCS score of 15 who are acutely cognitively impaired are at risk of not being accurately identified. The addition of an amnesia score to the GCS in the Abbreviated Westmead Post-traumatic Amnesia Scale will assist in making a diagnosis of mTBI. (C) 2015 by the American Congress of Rehabilitation Medicine	[Meares, Susanne; Shores, E. Arthur; Smyth, Tracy; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia; [Meares, Susanne] Westmead Hosp, Dept Rehabil Med, Westmead, NSW 2145, Australia; [Smyth, Tracy; Murphy, Margaret; Vukasovic, Matthew] Westmead Hosp, Dept Emergency Serv, Westmead, NSW 2145, Australia		Meares, S (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.	sue.meares@mq.edu.au		Batchelor, Jennifer/0000-0003-4438-4993; Shores, Edwin A/0000-0003-1553-5131; Meares, Susanne/0000-0002-3859-9974	Motor Accidents Authority of New South Wales [09/915]	Supported by the Motor Accidents Authority of New South Wales (grant no. 09/915).	Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x	10	13	14	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2015	96	5					956	959		10.1016/j.apmr.2014.12.014			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CH6JL	WOS:000354142800024	25576643				2022-02-06	
J	Quartana, PJ; Wilk, JE; Balkin, TJ; Hoge, CW				Quartana, Phillip J.; Wilk, Joshua E.; Balkin, Thomas J.; Hoge, Charles W.			Indirect associations of combat exposure with post-deployment physical symptoms in US soldiers: Roles of post-traumatic stress disorder, depression and insomnia	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Combat exposure; Physical symptoms; PTSD; Insomnia; Depression; Pain; Military	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; SEVERITY INDEX; SLEEP DURATION; SOMATIC SYMPTOMS; WAR VETERANS; CHRONIC PAIN; IRAQ; PTSD	Objective: To characterize the indirect associations of combat exposure with post-deployment physical symptoms through shared associations with post-traumatic stress disorder (PTSD), depression and insomnia symptoms. Methods: Surveys were administered to a sample of U.S. soldiers (N = 587) three months after a 15-month deployment to Iraq. A multiple indirect effects model was used to characterize direct and indirect associations between combat exposure and physical symptoms. Results: Despite a zero-order correlation between combat exposure and physical symptoms, the multiple indirect effects analysis did not provide evidence of a direct association between these variables. Evidence for a significant indirect association of combat exposure and physical symptoms was observed through PTSD, depression, and insomnia symptoms. In fact, 92% of the total effect of combat exposure on physical symptoms scores was indirect. These findings were evident even after adjusting for the physical injury and relevant demographics. Conclusion: This is the first empirical study to suggest that PTSD, depression and insomnia collectively and independently contribute to the association between combat exposure and post-deployment physical symptoms. Limitations, future research directions, and potential policy implications are discussed. Published by Elsevier Inc.	[Quartana, Phillip J.; Wilk, Joshua E.; Balkin, Thomas J.; Hoge, Charles W.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Quartana, PJ (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	phillip.j.quartana2.civ@mail.mil			U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC)	The authors have no conflicts of interest to report. The U.S. Army Medical Research and Materiel Command (USAMRMC) provides intramural funding that supports enhancing the psychological resilience of the warfighter.	Abad VC, 2008, SLEEP MED REV, V12, P211, DOI 10.1016/j.smrv.2007.09.001; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benyamini Y, 2005, SOC SCI MED, V61, P1267, DOI 10.1016/j.socscimed.2005.01.023; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Britt TW, 2013, J TRAUMA STRESS, V26, P94, DOI 10.1002/jts.21775; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Elder GJ, 2014, SLEEP MED REV, V18, P215, DOI 10.1016/j.smrv.2013.05.001; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Goodin BR, 2012, BIOL PSYCHOL, V91, P36, DOI 10.1016/j.biopsycho.2012.02.020; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Killgore WDS, 2006, J PSYCHOSOM RES, V60, P379, DOI 10.1016/j.jpsychores.2006.02.012; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, P41, DOI 10.1207/s15327906mbr3001_3; Maia A, 2011, ANXIETY STRESS COPIN, V24, P309, DOI 10.1080/10615806.2010.521238; McCurry SM, 2014, SLEEP, V37, P299, DOI 10.5665/sleep.3402; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Motivala SJ, 2011, ANN BEHAV MED, V42, P141, DOI 10.1007/s12160-011-9280-2; Nissen LR, 2011, MIL MED, V176, P1138, DOI 10.7205/MILMED-D-11-00094; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Purvis Dianna L, 2013, US Army Med Dep J, P66; Quartana PJ, 2010, PAIN, V149, P325, DOI 10.1016/j.pain.2010.02.029; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shah AJ, 2013, BIOL PSYCHIAT, V73, P1103, DOI 10.1016/j.biopsych.2013.01.019; Sipos ML, 2014, DEPRESS ANXIETY, V31, P124, DOI 10.1002/da.22157; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith TJ, 2013, J ACAD NUTR DIET, V113, P907, DOI 10.1016/j.jand.2013.03.002; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Xia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071065; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	67	13	14	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	MAY	2015	78	5					478	483		10.1016/j.jpsychores.2014.11.017			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CF9ZO	WOS:000352926600011	25499887				2022-02-06	
J	Zhang, J; Niu, F; Dong, HM; Liu, L; Li, J; Li, SX				Zhang, Ji; Niu, Fei; Dong, Hongmei; Liu, Liang; Li, Jie; Li, Shangxun			Characterization of Protein Alterations in Damaged Axons in the Brainstem Following Traumatic Brain Injury Using Fourier Transform Infrared Microspectroscopy: A Preliminary Study	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic pathology; traumatic brain injury; axonal injury; Fourier transform infrared microspectroscopy; protein conformation	FT-IR SPECTROSCOPY; RAT-BRAIN; COMBINATION; TISSUE	Axonal injury contributes greatly to neurological dysfunction following traumatic brain injury (TBI), but current histological diagnostic methods are limited in identifying the pathological profiles of injured axons and unable to provide an objective and accurate quantification. Fourier transform infrared microspectroscopy (FTIRM) has the ability to offer macromolecular bioinformatics of the tissues including biochemical composition and structure by calculating band absorption intensity. In this study, axonal injury in the brainstem of rats with traumatic brain injury at 72h post-trauma, which was confirmed with beta-amyloid precursor protein (-APP) immunostaining, was detected with FTIRM technique. The lower intensity of infrared absorbance under the amide I band corresponds strongly to the area of axonal injury, and further analysis of amide I band shows significant differences in protein conformation between injured and normal axons. The findings indicate that using FTIRM technique, the amide I band has potentials to be a infrared spectral marker of axonal injury.	[Zhang, Ji; Dong, Hongmei; Liu, Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430030, Hubei, Peoples R China; [Niu, Fei] Wuhan Univ, Dept Chem & Mol Sci, Inst Anal, Wuhan 430072, Hubei, Peoples R China; [Li, Jie] Wuhan Publ Secur Bur, Dept Chem & Phys, Inst Forens Sci, Wuhan 430015, Hubei, Peoples R China; [Li, Shangxun] Dept Publ Secur Hubei Prov, Dept Chem & Phys, Wuhan 430064, Hubei, Peoples R China		Dong, HM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll Huazhong, Dept Forens Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.	hongmeidong1@hotmail.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102298]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2012TS002]	Supported by a grant from the National Nature Science Foundation of China (No. 81102298) and the Fundamental Research Funds for the Central Universities (No. 2012TS002).	Adekoya N., 2002, SURVEILLANCE TRAUMAT; Ali K, 2008, INT J MOL MED, V21, P297; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; CHOO LP, 1995, BIOSPECTROSCOPY, V1, P141, DOI 10.1002/bspy.350010208; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Kretlow A, 2008, BBA-MOL BASIS DIS, V1782, P559, DOI 10.1016/j.bbadis.2008.06.004; LeVine SM, 1998, FREE RADICAL BIO MED, V25, P33, DOI 10.1016/S0891-5849(98)00019-7; Richter T, 2002, VIB SPECTROSC, V28, P103, DOI 10.1016/S0924-2031(01)00149-7; Sivakumar S, 2013, SPECTROCHIM ACTA A, V110, P241, DOI 10.1016/j.saa.2013.03.056; Toyran N, 2004, EUR BIOPHYS J BIOPHY, V33, P549, DOI 10.1007/s00249-004-0396-1; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Whiteman S C, 2008, Ther Adv Respir Dis, V2, P23, DOI 10.1177/1753465807087972; Yang TAT, 2011, FORENSIC SCI INT, V207, pE34, DOI 10.1016/j.forsciint.2010.12.005	18	13	13	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAY	2015	60	3					759	763		10.1111/1556-4029.12743			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	CH4HI	WOS:000353994200031	25773901				2022-02-06	
J	Baschera, D; Hasler, RM; Taugwalder, D; Exadaktylos, A; Raabe, A				Baschera, Dominik; Hasler, Rebecca M.; Taugwalder, David; Exadaktylos, Aristomenis; Raabe, Andreas			Association between Head Injury and Helmet Use in Alpine Skiers: Cohort Study from a Swiss Level I Trauma Center	JOURNAL OF NEUROTRAUMA			English	Article						skiing; helmet; TBI; head trauma	SNOWBOARDING INJURIES; PRACTICAL SCALE; SLOPES; RISK	The association between helmet use during alpine skiing and incidence and severity of head injuries was analyzed. All patients admitted to a level 1 trauma center for traumatic brain injuries (TBIs) sustained from skiing accidents during the seasons 2000-2001 and 2010-2011 were eligible. Primary outcome was the association between helmet use and severity of TBI measured by Glasgow Coma Scale (GCS), computed tomography (CT) results, and necessity of neurosurgical intervention. Of 1362 patients injured during alpine skiing, 245 (18%) sustained TBI and were included. TBI was fatal in 3%. Head injury was in 76% minor (Glasgow Coma Scale, 13-15), 6% moderate, and 14% severe. Number and percentage of TBI patients showed no significant trend over the investigated seasons. Forty-five percent of the 245 patients had pathological CT findings and 26% of these required neurosurgical intervention. Helmet use increased from 0% in 2000-2001 to 71% in 2010-2011 (p<0.001). The main analysis, comparing TBI in patients with or without a helmet, showed an adjusted odds ratio (OR) of 1.44 (p=0.430) for suffering moderate-to-severe head injury in helmet users. Analyses comparing off-piste to on-slope skiers revealed a significantly increased OR among off-piste skiers of 7.62 (p=0.004) for sustaining a TBI requiring surgical intervention. Despite increases in helmet use, we found no decrease in severe TBI among alpine skiers. Logistic regression analysis showed no significant difference in TBI with regard to helmet use, but increased risk for off-piste skiers. The limited protection of helmets and dangers of skiing off-piste should be targeted by prevention programs.	[Baschera, Dominik; Raabe, Andreas] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Hasler, Rebecca M.; Taugwalder, David; Exadaktylos, Aristomenis] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland		Baschera, D (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurosurg, Freiburgstr 10, CH-3010 Bern, Switzerland.	dominik.baschera@insel.ch	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922			American Society for Testing and Materials (ASTM), 2011, F204011 ASTM; [Anonymous], 2007, 1077 CSN EN; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; JENNETT B, 1975, LANCET, V1, P480; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Montagne M. D., 2012, STUDY ACCIDENT WINTE; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sommer H., 2007, VOLKSWIRTSCHFTLICHE, VAvailable at; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; TEASDALE G, 1974, LANCET, V2, P81; Unfallverhutung B-Bf, 2013, ENTW ANT KOPFV SCHN; Unfallverhutung B-Bf. bfu-Erhebung, 2013, TRAGG SCHUTZ BEIM SK; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; Vanat L., 2013, SAISONBILANZ SCHWEIZ; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Wick MC, 2013, ARCH ORTHOP TRAUM SU, V133, P1367, DOI 10.1007/s00402-013-1822-6; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	28	13	13	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					557	562		10.1089/neu.2014.3604			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900005	25244343				2022-02-06	
J	Connesson, N; Clayton, EH; Bayly, PV; Pierron, F				Connesson, N.; Clayton, E. H.; Bayly, P. V.; Pierron, F.			Extension of the Optimised Virtual Fields Method to Estimate Viscoelastic Material Parameters from 3D Dynamic Displacement Fields	STRAIN			English	Article						elasticity; elasticity reconstruction; inverse problem; MR elastography; noise robustness; noise sensitivity; optimised virtual fields; virtual fields method; viscoelasticity	MAGNETIC-RESONANCE-ELASTOGRAPHY; ELASTIC PROPERTIES; VIBRATING PLATES; ANIMAL-MODEL; BRAIN-INJURY; IDENTIFICATION; STIFFNESS; TISSUE; STRAIN; DEFORMATION	In vivo measurement of the mechanical properties of soft tissues is essential to provide necessary data in biomechanics and medicine (early cancer diagnosis, study of traumatic brain injuries, etc.). Imaging techniques such as magnetic resonance elastography can provide 3D displacement maps in the bulk and in vivo, from which, using inverse methods, it is then possible to identify some mechanical parameters of the tissues (stiffness, damping, etc.). The main difficulties in these inverse identification procedures consist in dealing with the pressure waves contained in the data and with the experimental noise perturbing the spatial derivatives required during the processing. The optimised virtual fields method (OVFM) (Comput. Mech.34, 2004, 439), designed to be robust to noise, presents natural and rigorous solution to deal with these problems. The OVFM has been adapted to identify material parameter maps from magnetic resonance elastography data consisting of 3D displacement fields in harmonically loaded soft materials. In this work, the method has been developed to identify elastic and viscoelastic models. The OVFM sensitivity to spatial resolution and to noise has been studied by analysing 3D analytically simulated displacement data. This study evaluates and describes the OVFM identification performances: Different biases on the identified parameters are induced by the spatial resolution and experimental noise. The well-known identification problems in the case of quasi-incompressible materials also find a natural solution in the OVFM. Moreover, an a posteriori criterion to estimate the local identification quality is proposed. The identification results obtained on actual experiments are briefly presented.	[Connesson, N.] Univ Grenoble INPG UJF, Lab TIMC IMAG, BP 53, F-38041 Grenoble, France; [Clayton, E. H.; Bayly, P. V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Pierron, F.] Univ Southampton, Engn & Environm, Southampton SO17 1BJ, Hants, England		Connesson, N (corresponding author), Univ Grenoble INPG UJF, Lab TIMC IMAG, BP 53, F-38041 Grenoble, France.	nathanael.connesson@gmail.com	Pierron, Fabrice/D-2332-2011; Connesson, Nathanael/M-9709-2014	Pierron, Fabrice/0000-0003-2813-4994; Connesson, Nathanael/0000-0002-2945-4263; Bayly, Philip/0000-0003-4303-0704	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 055951]; Arts et Metiers ParisTech, France; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	Funding was provided from NIH grant NS 055951 (Bayly) and from Arts et Metiers ParisTech, France.	Avril S, 2008, EXP MECH, V48, P479, DOI 10.1007/s11340-008-9128-2; Avril S, 2004, COMPUT MECH, V34, P439, DOI 10.1007/s00466-004-0589-6; Avril S, 2008, EXP MECH, V48, P381, DOI 10.1007/s11340-008-9148-y; Avril S, 2010, J BIOMECH, V43, P2978, DOI 10.1016/j.jbiomech.2010.07.004; Baghani A, 2009, J ACOUST SOC AM, V126, P1541, DOI 10.1121/1.3180495; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2; Giraudeau A, 2005, J SOUND VIB, V284, P757, DOI 10.1016/j.jsv.2004.07.009; Giraudeau A, 2010, J SOUND VIB, V329, P1653, DOI 10.1016/j.jsv.2009.11.031; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; McGee KP, 2011, PHYS MED BIOL, V56, P4291, DOI 10.1088/0031-9155/56/14/006; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Oida T, 2004, INTERNATIONAL CONFERENCE ON INFORMATICS RESEARCH FOR DEVELOPMENT OF KNOWLEDGE SOCIETY INFRASTRUCTURE, PROCEEDINGS, P57, DOI 10.1109/ICKS.2004.1313409; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; Pierron F, 2007, STRAIN, V43, P250, DOI 10.1111/j.1475-1305.2007.00346.x; Pierron F, 2012, THE VIRTUAL FIELDS M; Pierron F., P 2010 SEM ANN C EXP, V1; Romano AJ, 2000, IEEE T ULTRASON FERR, V47, P1575, DOI 10.1109/58.883546; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Schmitt JM, 1998, OPT EXPRESS, V3, P199, DOI 10.1364/OE.3.000199; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Smith JA, 2000, MATER EVAL, V58, P1395; Soong T.T., 1993, RANDOM VIBRATION MEC; Toussaint E, 2006, INT J MECH SCI, V48, P256, DOI 10.1016/j.ijmecsci.2005.10.002; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Yin M, 2007, MAGN RESON MED, V58, P346, DOI 10.1002/mrm.21286; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	33	13	13	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-1305			STRAIN	Strain	APR	2015	51	2					110	134		10.1111/str.12126			25	Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	CE0BG	WOS:000351466500003	26146416	Green Submitted, Green Accepted			2022-02-06	
J	Hua, CA; Merchant, TE; Li, XY; Li, YM; Shulkin, BL				Hua, Chiaho; Merchant, Thomas E.; Li, Xingyu; Li, Yimei; Shulkin, Barry L.			Establishing Age-Associated Normative Ranges of the Cerebral F-18-FDG Uptake Ratio in Children	JOURNAL OF NUCLEAR MEDICINE			English	Article						PET; F-18-FDG; children; brain	POSITRON-EMISSION-TOMOGRAPHY; CROSSED CEREBELLAR DIASCHISIS; GLUCOSE-METABOLISM; HUMAN-BRAIN; FRONTAL-LOBE; FDG UPTAKE; CHILDHOOD; SPECT; ADOLESCENTS; NETWORKS	In this study, we reported age-associated ranges of the regional cerebral F-18-FDG uptake ratio in pediatric patients as a surrogate to normative data from healthy children. Methods: F-18-FDG PET scans of 132 children and adolescents (age, 1-20 y) with non-central nervous system-related diseases and normal-appearing tracer distributions in the brain were retrospectively analyzed. PET images of individual patients were warped to a 3-dimensional reference template. Uptake ratio was calculated for 63 anatomic regions by normalizing the regional count per voxel with the average count per voxel in all regions. Models of regional uptake ratio as a function of age and sex were developed to calculate the 95% prediction interval. Results: The paracentral lobule and cuneus had the highest resting metabolic state among all gray matter regions, whereas the brain stem, uncus, and hippocampus had the lowest uptake. A large left-right asymmetry was present in the angular gyrus and inferior occipital gyrus. Quantitative data of the regression, 95% confidence interval, and 95% prediction interval for each age were summarized for the 63 regions. In 52 of 63 regions, the F-18-FDG uptake ratio had a significant age effect. The linear model was optimal for 12 regions, whereas the spline model with 1 age knot was a better fit for 40 regions. In children younger than 5 y, frontal and temporal lobes had a lower uptake than parietal and occipital lobes in general. However, uptake in the frontal lobe continued to increase with age but it decreased in the parietal and occipital lobes. Conclusion: Anatomic regions of the brain in children and adolescents exhibited uniquely different F-18-FDG uptake trends with age. Our results may be useful for studying childhood development and possibly regional metabolic defects in children with traumatic brain injury or central nervous system disorders or children receiving cancer treatment.	[Hua, Chiaho; Merchant, Thomas E.; Shulkin, Barry L.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Li, Xingyu; Li, Yimei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA		Hua, CA (corresponding author), St Jude Childrens Res Hosp, Dept Radiol Sci, Mail Stop 220,262 Danny Thomas Pl, Memphis, TN 38105 USA.	chia-ho.hua@stjude.org	Hua, Chia-ho/D-4220-2018; shulkin, barry l/J-6268-2018; Merchant, Thomas E/N-3344-2018	shulkin, barry l/0000-0003-4784-7914; Merchant, Thomas E/0000-0002-0412-6255			Boellaard R, 2009, J NUCL MED, V50, p11S, DOI 10.2967/jnumed.108.057182; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cleveland W. S., 1996, STAT THEORY COMPUTAT, P10, DOI DOI 10.1007/978-3-642-48425-4_2; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/NMETH.2482, 10.1038/nmeth.2482]; Devous MD, 2006, J SPEECH LANG HEAR R, V49, P856, DOI 10.1044/1092-4388(2006/061); Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Garibotto V, 2013, CLIN NUCL MED, V38, pE112, DOI 10.1097/RLU.0b013e318279b991; Giedd JN, 2013, PRINCIPLES FRONTAL L, P135; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Kang EJ, 2004, NEUROIMAGE, V22, P1543, DOI 10.1016/j.neuroimage.2004.04.010; KUSHNER M, 1987, J NUCL MED, V28, P1667; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; London K, 2015, NEUROIMAGE, V106, P264, DOI 10.1016/j.neuroimage.2014.11.047; London K, 2014, EUR J NUCL MED MOL I, V41, P723, DOI 10.1007/s00259-013-2639-9; Montandon ML, 2007, COMPUT MED IMAG GRAP, V31, P28, DOI 10.1016/j.compmedimag.2006.09.017; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; Muzik O, 1999, PROG NEURO-PSYCHOPH, V23, P589, DOI 10.1016/S0278-5846(99)00018-4; Otte A, 1998, J NEUROL SCI, V156, P73, DOI 10.1016/S0022-510X(98)00019-7; R-project, R LANG ENV STAT COMP; Radau PE, 2001, MED PHYS, V28, P1660, DOI 10.1118/1.1388894; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Shamoto H, 1997, J CHILD NEUROL, V12, P407, DOI 10.1177/088307389701200701; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Shiee N, 2011, LECT NOTES COMPUT SC, V6801, P1, DOI 10.1007/978-3-642-22092-0_1; Slomka PJ, 2001, COMPUT MED IMAG GRAP, V25, P153, DOI 10.1016/S0895-6111(00)00044-6; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Van Bogaert P, 1998, NEUROIMAGE, V8, P62, DOI 10.1006/nimg.1998.0346; Van Laere K, 2001, J NUCL MED, V42, P361	33	13	13	0	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	APR	2015	56	4					575	579		10.2967/jnumed.114.146993			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CE9NL	WOS:000352170600041	25745092	Bronze			2022-02-06	
J	Ohye, BY; Brendel, RW; Fredman, SJ; Bui, E; Rauch, PK; Allard, MD; Pentel, KZ; Simon, NM				Ohye, Bonnie Y.; Brendel, Rebecca W.; Fredman, Steffany J.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.; Pentel, Kimberly Z.; Simon, Naomi M.			Three-Generation Model: A Family Systems Framework for the Assessment and Treatment of Veterans With Posttraumatic Stress Disorder and Related Conditions	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						PTSD; veteran; family-centered health care; family systems; traumatic brain injury	PSYCHOLOGICAL DISTRESS; HEALTH-CARE; SYMPTOMS; IRAQ; DEPLOYMENT; PTSD; AFGHANISTAN; CHILDREN; ADJUSTMENT; COUPLES	This article describes the three-generation family systems health care model developed at the Veteran and Family Clinic of the Home Base Program, a partnership between the Red Sox Foundation and Massachusetts General Hospital designed to improve treatment engagement of veterans with posttraumatic stress disorder (PTSD) and related conditions, and to provide care to the entire military-connected family. This clinical model was designed to address 3 interdependent facets of the PTSD-affected family system: (a) the multiple attachment relationships that are often strained; (b) the veteran's family roles, which may be impaired; and (c) the multiple pathways for treatment engagement and amelioration of the veteran's PTSD-related distress and behaviors within the family system. In addition, we describe the assessment system, designed to probe the interrelationships of individual veteran, couple, parenting, child, and family levels of functioning. Three cases illustrative of the three-generation model's clinical application, how it can address unmet needs, and its ability to overcome barriers to health care for military families are also discussed.	[Ohye, Bonnie Y.; Brendel, Rebecca W.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Fredman, Steffany J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Complicated Grief Program, Boston, MA 02114 USA; [Ohye, Bonnie Y.] Harvard Univ, Sch Med, Psychol, Cambridge, MA 02138 USA; [Brendel, Rebecca W.; Simon, Naomi M.] Harvard Univ, Sch Med, Psychiat, Cambridge, MA 02138 USA; [Fredman, Steffany J.; Bui, Eric; Rauch, Paula K.; Allard, Michael D.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Pentel, Kimberly Z.] Univ N Carolina, Chapel Hill, NC USA		Ohye, BY (corresponding author), Massachusetts Gen Hosp, Red Sox Fdn, Home Base Clin, 101 Merrimac St,Suite 250, Boston, MA 02114 USA.	bohye@mgh.harvard.edu	Bui, Eric/J-8347-2015	Bui, Eric/0000-0002-1413-6473; FREDMAN, STEFFANY/0000-0002-2053-8700	Red Sox Foundation; Massachusetts General Hospital Home Base Program	WE THANK THE PHILANTHROPIC SUPPORTERS of the Red Sox Foundation and Massachusetts General Hospital Home Base Program, who have supported this work. We would also like to thank all of the staff and clinicians of the Home Base Program (HBP) who have contributed to the development and implementation of this model. Finally, we thank Yang (Karen) Chen for her assistance with the revised manuscript.	Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Department of Defense, 2011, 2011 DEM PROF MIL CO; Department of Defense, 2010, REP IMP DEPL MEMB AR; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Erbes CR, 2011, J FAM PSYCHOL, V25, P479, DOI 10.1037/a0024007; Foa E.B., 2007, PROLONGED EXPOSURE T; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Fredman SJ, 2014, J ANXIETY DISORD, V28, P372, DOI 10.1016/j.janxdis.2014.04.001; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Gibaud-Wallston J., 1978, ANN M AM PSYCH ASS T; Grubaugh AL, 2008, J NERV MENT DIS, V196, P166, DOI 10.1097/NMD.0b013e318162aa2d; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; JACKSON D D, 1957, Psychiatr Q Suppl, V31, P79; JELLINEK MS, 1988, J PEDIATR-US, V112, P201, DOI 10.1016/S0022-3476(88)80056-8; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Lambert JE, 2012, J FAM PSYCHOL, V26, P729, DOI 10.1037/a0029341; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lyle A., 2012, DISABILITY ADVOCATE; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI [10.1177/088626087002002003, DOI 10.1177/088626087002002003]; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Meis LA, 2013, PSYCHOL TRAUMA-US, V5, P334, DOI 10.1037/a0028366; Meis LA, 2010, J FAM PSYCHOL, V24, P560, DOI 10.1037/a0020925; Miller IW, 2005, AM J PSYCHIAT, V162, P2131, DOI 10.1176/appi.ajp.162.11.2131; Monson C., 2012, COGNITIVE BEHAV CONJ; Monson CM, 2012, JAMA-J AM MED ASSOC, V308, P700, DOI 10.1001/jama.2012.9307; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; National Council for Behavioral Health, 2012, M BEH HLTH NEEDS VET; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Renshaw KD, 2011, J FAM PSYCHOL, V25, P461, DOI 10.1037/a0023994; Resick P. A., 2008, COGNITIVE PROCESSING; Sautter FJ, 2011, PROF PSYCHOL-RES PR, V42, P63, DOI 10.1037/a0022323; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sherman MD, 2012, PSYCHOL SERV, V9, P349, DOI 10.1037/a0028963; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V720; Weathers F.W., 1993, 9 ANN C ISTSS; Zerach G, 2012, J FAM PSYCHOL, V26, P274, DOI 10.1037/a0027159	48	13	13	1	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	APR	2015	46	2					97	106		10.1037/a0037735			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	CH3DL	WOS:000353906700004					2022-02-06	
J	Rodowicz, KA; Olberding, JE; Rau, AC				Rodowicz, Kathleen Allen; Olberding, Joseph E.; Rau, Andrew C.			Head Injury Potential and the Effectiveness of Headgear in Women's Lacrosse	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Sport-related concussion; Head impact testing; Ball impact testing; Stick impact testing; Headgear standards; Helmet; Soft headgear; Brine; Full90; ForceField; US lacrosse	FOOTBALL; CONCUSSION; HELMETS; IMPACT; ACCELERATION; ATTENUATE; CATCHERS; MASKS; FACE	Over the past 10 years, lacrosse has grown increasingly popular, making it one of the fastest growing team sports in the country. Similar to other sporting activities, head injuries in lacrosse can and do occur, and the number of lacrosse-related head injuries has increased in recent years. In women's lacrosse, protective headgear is not required, but U.S. Lacrosse and the American Society for Testing and Materials are currently working to develop a headgear standard for the women's game. In the interim, some female lacrosse programs and individual players are wearing soft headgear during play. The effectiveness of this headgear is unknown. Testing was conducted to better understand the material properties of various types of headgear that may be used in lacrosse and the effect of this headgear on head impact response and head injury potential. For the evaluation of head impact response, an instrumented Hybrid III anthropomorphic test device (ATD) was impacted on the side of the head with lacrosse balls and the front and side of the head with a lacrosse stick. The linear and rotational impact response of the head and corresponding acceleration-based injury metrics are reported. Testing was then repeated with the ATD wearing different types of headgear. Tested headgear included a men's lacrosse helmet and two brands of commercially-available soft headgear. For the higher velocity ball impacts, there was no statistically-significant difference in the measured linear and rotational response of the head for the no headgear and soft headgear test conditions. For the lower velocity ball impacts, there was a small, yet statistically-significant, reduction in head linear acceleration for one of the soft headgears tested in comparison to the no headgear test condition, but there was not a statistically-significant difference in the rotational impact response with this headgear. These results indicate that the soft headgear would not be effective in reducing head injury potential during higher velocity ball impacts, such as ball speeds associated with shooting in women's lacrosse. The men's lacrosse helmet reduced both the linear and rotational response of the head for the higher and lower velocity ball impacts. Material testing showed that the padding in the hard helmet exhibited larger strain energy than the padding within the soft headgears when tested in compression. These results correlate with the larger reductions in head accelerations during ball impacts by the hard helmet. For the stick impacts, there were no statistically-significant differences in the lateral impact response of the head for the helmeted and soft headgear test conditions in comparison to the no headgear test condition, but there were statistically-significant, albeit small, differences in the frontal impact response of the head. The similar impact responses of the head during the stick impacts with and without headgear can be attributed to the relatively low severity of these impacts and the characteristics of the impactor.	[Rodowicz, Kathleen Allen; Olberding, Joseph E.] Biomech Practice, Philadelphia, PA 19104 USA; [Rau, Andrew C.] Biomed Engn Practice, Philadelphia, PA 19104 USA		Rodowicz, KA (corresponding author), Biomech Practice, 3440 Market St Suite 600, Philadelphia, PA 19104 USA.	krodowicz@exponent.com			Exponent	The authors would like to acknowledge the contributions of the engineers and technicians at the Exponent Failure Analysis Associates Test and Engineering Center. Additionally, the authors would like to thank Michael Prange, Ph.D., P.E., for his technical guidance during the duration of this project and Glen DePalma, Ph.D., for his assistance with the statistical analysis of the results. This work was fully funded by Exponent Failure Analysis Associates.	[Anonymous], 2013, LACR YOUTH RUL BEST; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Crisco JJ, 2009, J APPL BIOMECH, V25, P184, DOI 10.1123/jab.25.2.184; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; FHSAA, 2014, BOARD MAND HELM GIRL; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; Johnson K., 2013, PRINCETON SCH BECOME; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Livingston LA, 2006, J SCI MED SPORT, V9, P299, DOI 10.1016/j.jsams.2006.05.022; MILLS NJ, 1991, ACCIDENT ANAL PREV, V23, P153, DOI 10.1016/0001-4575(91)90045-7; MURRAY TM, 1995, PEDIATRICS, V95, P419; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NCAA, 2013, LACR 2012 2013 NCAA; NCAA, 2014, LACR 2013 2014 NCAA; NOCSAE, 2012, STAND PERF SPEC NEWL; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; ROBEY JM, 1972, MED SCI SPORT EXER, V4, P170, DOI 10.1249/00005768-197200430-00012; Rodowicz K. A., 2014, ASTM SELECTED TECHNI, V1552; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; US, LACR 2012 WOM RUL BO; US, 2011, LACR 2011 PART SURV; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	31	13	13	0	14	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2015	43	4					949	957		10.1007/s10439-014-1154-x			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CE8CM	WOS:000352068700011	25326438				2022-02-06	
J	Scheetz, LJ				Scheetz, Linda J.			Injury patterns, severity and outcomes among older adults who sustained brain injury following a same level fall: A retrospective analysis	INTERNATIONAL EMERGENCY NURSING			English	Article						Brain injuries; Falls; Elderly; Aged; Trauma centers; Mortality; Length of stay	DESIGNATED TRAUMA CENTERS; PREEXISTING CONDITIONS; GERIATRIC TRAUMA; MORTALITY; CARE; AGE; PREVALENCE; SURVIVAL; IMPACT	Introduction: The objectives of this study were to: identify the incidence and types of brain injuries; classify brain injury severity; identify additional injuries; and identify predictors of length of stay, mortality and trauma center admission. Methods: This secondary analysis used the NY State Inpatient Databases Healthcare Cost and Utilization Project. Inclusion criteria were: age 65 years and older, admitted to a hospital following a same level fall, primary hospital discharge diagnosis of traumatic brain injury. Descriptive and regression analyses were performed. Results: 3331 patient records were analyzed. Intracranial hemorrhage accounted for 70% of the brain injuries. Younger age, higher household income, insurance status, ethnicity, patient location, increasing number of chronic diseases and diagnoses predicted trauma center admission. Age, trauma center admission, comorbidities, and brain injury severity predicted mortality. Age, race, major surgery, and number of diagnoses predicted length of stay. Discussion: Brain injuries are common sequelae from falls among older adults. Additional research is needed to understand sociodemographic factors that are associated with trauma center admission. (C) 2014 Elsevier Ltd. All rights reserved.	CUNY, Herbert H Lehman Coll, Bronx, NY 10468 USA		Scheetz, LJ (corresponding author), CUNY, Herbert H Lehman Coll, 250 Bedford Pk Blvd West, Bronx, NY 10468 USA.	linda.scheetz@lehman.cuny.edu	Scheetz, Linda/AAH-7479-2019; Scheetz, Linda J./A-8160-2009	Scheetz, Linda J./0000-0002-1947-5052	Lehman College, City University of New York	This study was supported by funding from Lehman College, City University of New York.	Agency for Healthcare Research and Quality, 2014, HCUP DAT; [Anonymous], 2013, CLASS DIS FUNCT DIS; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Centers for Disease Control and Prevention, 2013, FALLS OLD AD OV; Centers for Medicare & Medicaid Services, 2014, MED; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Drozdzowska B, 2013, INT J CLIN PRACT, V67, P673, DOI 10.1111/ijcp.12118; Expert Group on Injury Severity Measurement in Administrative Datasets, 2004, DISC DOC INJ SEV MEA; Gelbard R, 2014, AM J SURG, V208, P249, DOI 10.1016/j.amjsurg.2013.12.034; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hollis S, 2006, J TRAUMA, V61, P1255, DOI 10.1097/01.ta.0000243889.07090.da; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Ma MHM, 1999, J TRAUMA, V46, P168; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Pracht EE, 2007, MED CARE RES REV, V64, P83, DOI 10.1177/1077558706296241; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Scheetz Linda J, 2004, Prehosp Emerg Care, V8, P268, DOI 10.1016/j.prehos.2003.12.027; Scheetz LJ, 2005, RES NURS HEALTH, V28, P198, DOI 10.1002/nur.20075; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021	29	13	13	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1755-599X	1878-013X		INT EMERG NURS	Int. Emerg. Nurs.	APR	2015	23	2					162	167		10.1016/j.ienj.2014.09.003			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CH6HZ	WOS:000354139000023	25281285				2022-02-06	
J	Stricker, NH; Keller, JE; Castillo, DT; Haaland, KY				Stricker, Nikki H.; Keller, Jenna E.; Castillo, Diane T.; Haaland, Kathleen Y.			The Neurocognitive Performance of Female Veterans With Posttraumatic Stress Disorder	JOURNAL OF TRAUMATIC STRESS			English	Article							INTIMATE PARTNER VIOLENCE; MEMORY MALINGERING TOMM; PSYCHOMETRIC PROPERTIES; PTSD; ATTENTION; DYSFUNCTION; DEFICITS; INHIBITION; VICTIMS; ABUSE	Neurocognitive problems are common with posttraumatic stress disorder (PTSD) and are important to understand because of their association with the success of PTSD treatment and its potential neural correlates. To our knowledge, this is the first neurocognitive study in an all-female U.S. veteran sample, some of whom had PTSD. We examined neurocognitive performance and assessed whether learning deficits, common in PTSD, were associated with executive functioning. Veterans with PTSD (n = 56) and without (n = 53) were evaluated for psychiatric and neurocognitive status. The PTSD group had a lower estimated IQ (d = 0.53) and performed more poorly on all neurocognitive domains (d range = 0.57-0.88), except verbal retention (d = 0.04). A subset of the 2 groups that were matched on IQ and demographics similarly demonstrated poorer performance for the PTSD group on all neurocognitive domains (d range = 0.52-0.79), except verbal retention (d = 0.15). Within the PTSD group, executive functioning accounted for significant variance in verbal learning over and above IQ and processing speed (R-2 = .06), as well as depression (R-2 = .07) and PTSD severity (R-2 = .06). This study demonstrated that female veterans with PTSD performed more poorly than females without PTSD on several neurocognitive domains, including verbal learning, processing speed, and executive functioning. Replication of these results using a control group of veterans with more similar trauma exposure, history of mild traumatic brain injury, and psychiatric comorbidities would solidify these findings. Resumen Los problemas neurocognitivos son comunes en el trastorno por estres postraumatico (TEPT) y es importante entenderlos debido a su asociacion con el exito del tratamiento de TEPT y sus potenciales correlatos neurales. Hasta donde sabemos, es este el primer estudio neurocognitivo en una muestra solamente compuesta por mujeres veteranas, algunas de las cuales tenian TEPT. Examinamos el rendimiento neurocognitivo y evaluamos si los problemas de aprendizaje, comunes en TEPT, estaban asociados con el funcionamiento ejecutivo. Las veteranas con (56) y sin (53) TEPT fueron evaluadas en su estado psiquiatrico y neurocognitivo. El grupo TEPT tenia un CI estimado menor (d = 0.53) y rindieron mas pobremente en todos los dominios neurocognitivos (rango d = 0.57-0.88), excepto en la retencion verbal (d = 0.04). Un subconjunto de los 2 grupos, que tenian CI y datos demograficos comparables, demostraron rendimientos bajos similares en todos los dominios neurocognitivos (rango d = 0.52-0.79), excepto por la retencion verbal (d = 0.15). Dentro del grupo TEPT, el funcionamiento ejecutivo explica la varianza significativa en aprendizaje verbal por encima del CI y la velocidad de procesamiento (R2 = .06), como tambien la depresion (R2 = .07), y la gravedad del TEPT (R2 = .06). Este estudio demostro que las mujeres veteranas con TEPT rindieron peor que las mujeres sin TEPT en varios dominios neurocognitivos, incluyendo el aprendizaje verbal, la velocidad de procesamiento y el funcionamiento ejecutivo. La replicacion de estos resultados usando un grupo control de veteranos con exposicion similar al trauma, historia de leve LTC (lesion traumatica cerebral) y comorbilidades psiquiatricas podrian darle mayor solidez a estos hallazgos. Traditional and Simplified Chinese Abstracts by AsianSTSS ??: ?????????????????????? ??: ?????????????(PTSD)????????????PTSD?????????????????,??????????????????????,????????PTSD????????????????????????????????????PTSD?????????????????????PTSD?????(56)???PTSD?????(53)?????????????????PTSD??????IQ??? (d = 0.53),??????????????(d?? = 0.57-0.88),??????????(d = 0.04)? ?IQ???????????????,????????????????????(d?? = 0.52-0.79),??????????(d = 0.15)?PTSD??,????????IQ?????????????(R2 = .06)????(R2 = .07)?PTSD???(R2 = .06)???????????,??PTSD??????????PTSD???????????????????,????????????????????????????????????????????????????????????????,??????????? ??: ????????????????????? ??: ????????????(PTSD)???????????PTSD????????????????,?????????????????????,????????PTSD??????????????????????????????????PTSD?????????????????????PTSD?????(56)???PTSD?????(53)????????????????PTSD??????IQ??? (d = 0.53),??????????????(d?? = 0.57-0.88),??????????(d = 0.04)? ?IQ???????????????,???????????????????(d?? = 0.52-0.79),??????????(d = 0.15)?PTSD??,????????IQ?????????????(R2 = .06)????(R2 = .07)?PTSD???(R2 = .06)???????????,??PTSD??????????PTSD??????????????????,???????????????????????????????????????????????????????????????,???????????	[Stricker, Nikki H.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Stricker, Nikki H.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Keller, Jenna E.] Biomed Res Inst New Mexico, Albuquerque, NM USA; [Keller, Jenna E.; Castillo, Diane T.] New Mexico VA Healthcare Syst, Psychol Serv, Albuquerque, NM USA; [Castillo, Diane T.; Haaland, Kathleen Y.] New Mexico VA Healthcare Syst, Res Serv, Albuquerque, NM USA; [Castillo, Diane T.; Haaland, Kathleen Y.] Univ New Mexico, Sch Med, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Haaland, Kathleen Y.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA		Haaland, KY (corresponding author), Univ New Mexico, Psychiat & Behav Sci, Sch Med, Family Practice & Psychiat & Behav Sci Bldg, Albuquerque, NM 87131 USA.	khaaland@unm.edu		Haaland, Kathleen/0000-0002-8712-676X	Department of DefenseUnited States Department of Defense [PT074309, W81XWH-08-2-0022]; Department of Veterans Affairs Research Career Scientist AwardUS Department of Veterans Affairs; Research Service at the NM-VAHCS; Department of Veterans Affairs VISN 1 Career Development Award-MentoredUS Department of Veterans Affairs	Portions of this manuscript were previously featured in a paper entitled "Neuropsychological Deficits in Female Veterans with PTSD: Preliminary Findings" presented at the 26 Annual Meeting of the International Society for Traumatic Stress Studies, Montreal, Quebec, Canada, November 4-6, 2010. This study was supported by the Department of Defense (Grant #PT074309, Award Number W81XWH-08-2-0022 to DC), Department of Veterans Affairs Research Career Scientist Award (KYH), a grant from the Research Service at the NM-VAHCS (KYH), and Department of Veterans Affairs VISN 1 Career Development Award-Mentored (NHS).	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Andreano JM, 2009, LEARN MEMORY, V16, P248, DOI 10.1101/lm.918309; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beebe DW, 2000, J CLIN EXP NEUROPSYC, V22, P779, DOI 10.1076/jcen.22.6.779.950; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bremner JD, 2004, J NERV MENT DIS, V192, P643, DOI 10.1097/01.nmd.0000142027.52893.c8; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Delis D. C., 2000, CVLT II MANUAL; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; First M. B., 2002, STRUCTURED CLINICAL; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hill BD, 2012, APPL NEUROPSYCH-ADUL, V19, P198, DOI 10.1080/09084282.2011.643960; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Shimamura A. P., 2008, HDB METAMEM MEM, V11, P373; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Southwick S., 2010, HANDBOOK OF PTSD SCI, P166; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Vanderploeg R., 2013, NEUROPSYCHOLOGY SCIE, VI, P114; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2001, WECHSLER TEST OF ADU; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Zinzow HM, 2007, TRAUMA VIOLENCE ABUS, V8, P384, DOI 10.1177/1524838007307295	54	13	13	2	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	APR	2015	28	2					102	109		10.1002/jts.22000			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CF8NJ	WOS:000352818300003	25847622				2022-02-06	
J	Bolzenius, JD; Roskos, PT; Salminen, LE; Paul, RH; Bucholz, RD				Bolzenius, Jacob D.; Roskos, P. Tyler; Salminen, Lauren E.; Paul, Robert H.; Bucholz, Richard D.			Cognitive and Self-Reported Psychological Outcomes of Blast-Induced Mild Traumatic Brain Injury in Veterans: A Preliminary Study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						PTSD; blast injury; mild TBI; cognition; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; ENDURING FREEDOM; DEPRESSION; SYMPTOMS; COMPLAINTS; SEVERITY; VALIDITY; IRAQ; AFGHANISTAN	The increased use of explosives in combat has resulted in a large number of returning veterans suffering from blast-related mild traumatic brain injury (mTBI) and self-reported complications. It remains unclear whether this increase in self-reported difficulties is unique to the blast mechanism or stressful preinjury environment and whether cognitive-functioning deficits correspond with these difficulties in the postacute phase. This study examined the relationship between cognitive performance and self-reported psychological and somatic symptoms of blast-related mTBI compared with civilian mTBI, independent of comorbid posttraumatic stress disorder (PTSD) symptoms. Twelve veterans with blast-related mTBI were compared to 18 individuals with civilian mTBI on cognitive tests and self-report questionnaires. Univariate analyses failed to reveal differences on any individual cognitive test. Further, veterans reported more psychological and somatic complaints. These self-reported difficulties were not significantly correlated with neuropsychological performance. Overall, preliminary results suggest that in the postacute phase, subjective complaints related to blast-related mTBI do not covary with objective cognitive performance. Additionally, cognitive outcomes from blast-related mTBI were similar to those of civilian forms of mTBI. Future studies should identify the cognitive and self-reported sequelae of blast-related mTBI independent of comorbid PTSD in a larger sample of veterans.	[Bolzenius, Jacob D.; Salminen, Lauren E.; Paul, Robert H.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA; [Bolzenius, Jacob D.; Roskos, P. Tyler; Salminen, Lauren E.; Bucholz, Richard D.] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA		Bolzenius, JD (corresponding author), Univ Missouri, Dept Psychol, 1 Univ Blvd,Stadler Hall 443, St Louis, MO 63121 USA.	jdbdgf@umsl.edu	Salminen, Lauren/T-1400-2019	Salminen, Lauren/0000-0002-0684-9991	Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0191]	This research was supported by grant W81XWH-08-2-0191 from the Congressionally Directed Medical Research Program (PI: Richard Bucholz).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Army Individual Test Battery, 1944, MAN DIR SCOR; Barlow-Ogden K, 2012, J REHABIL RES DEV, V49, P1101, DOI 10.1682/JRRD.2010.09.0188; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Golden CJ, 1978, STROOP COLOR WORD TE; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matthews C, 1964, INSTRUCTIONAL MANUAL; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M	48	13	13	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2015	22	2					79	87		10.1080/23279095.2013.845823			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CC5DR	WOS:000350379400001	24940794				2022-02-06	
J	Afari, N; Pittman, J; Floto, E; Owen, L; Buttner, M; Hossain, N; Baker, DG; Lindamer, L; Lohr, JB				Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.			Differential Impact of Combat on Postdeployment Symptoms in Female and Male Veterans of Iraq and Afghanistan	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILITARY SEXUAL TRAUMA; MENTAL-HEALTH PROBLEMS; GENDER-DIFFERENCES; WOMEN VETERANS; WAR VETERANS; US MILITARY; DEPRESSION; DEPLOYMENT; VALIDITY	Objectives: We aimed to describe differences in combat experience for male and female veterans and characterize differential effects on postdeployment physical and mental health symptoms, including aggression. Methods: Retrospective cross-sectional health screening data from 554 Operation Enduring Freedom and Operation Iraqi Freedom veterans who enrolled for Veterans Affairs health care in San Diego were examined including measures of combat experience, pain intensity, traumatic brain injury symptoms, military sexual trauma, post-traumatic stress disorder, depression, alcohol use, and aggression. Results: Although male veterans (n = 458) experienced significantly higher rates of combat than female veterans (n = 96), both experienced similar levels of postdeployment post-traumatic stress disorder and depression symptoms as well self-reported aggressive behavior compared to male veterans. Female veterans had higher rates of military sexual trauma and lower alcohol consumption than male veterans. Conclusions: All Operation Enduring Freedom and Operation Iraqi Freedom veterans returning from deployment may benefit from broad-based screening of physical and mental health symptoms, beyond those currently mandated by Veterans Affairs, including anger and aggression.	[Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] VA Ctr Excellence Stress & Mental Hlth, La Jolla, CA 92161 USA; [Afari, Niloofar; Pittman, James; Floto, Elizabeth; Owen, Laura; Buttner, Melissa; Hossain, Nazia; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Afari, Niloofar; Baker, Dewleen G.; Lindamer, Laurie; Lohr, James B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA		Afari, N (corresponding author), VA Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr,MC116A, La Jolla, CA 92161 USA.		Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838; Floto, Elizabeth/0000-0002-8238-0793	Department of Veterans Affairs Center of Excellence for Stress and Mental Health; VA San Diego Healthcare SystemUS Department of Veterans Affairs	This material is based on work supported by the Department of Veterans Affairs Center of Excellence for Stress and Mental Health. This material is also the result of work supported with resources of the VA San Diego Healthcare System.	Angkaw AC, 2013, MIL MED, V178, P1044, DOI 10.7205/MILMED-D-13-00061; Aviram RB, 2006, HARVARD REV PSYCHIAT, V14, P249, DOI 10.1080/10673220600975121; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Butterfield MI, 2000, J TRAUMA STRESS, V13, P735, DOI 10.1023/A:1007874620024; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Department of Veterans Affairs, 2008, VHA HDB; Dixon-Gordon KL, 2014, J AFFECT DISORDERS, V166, P359, DOI 10.1016/j.jad.2014.05.033; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Dutra L, 2011, J TRAUMA DISSOCIATIO, V12, P25, DOI 10.1080/15299732.2010.496141; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Favaro A, 2007, J CLIN PSYCHIAT, V68, P122, DOI 10.4088/JCP.v68n0117; Fliege H, 2009, J PSYCHOSOM RES, V66, P477, DOI 10.1016/j.jpsychores.2008.10.013; Fontana A, 2008, J NERV MENT DIS, V196, P513, DOI 10.1097/NMD.0b013e31817cf6e6; Freedy JR, 2010, MIL MED, V175, P750, DOI 10.7205/MILMED-D-10-00123; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gerlock A A, 1994, Issues Ment Health Nurs, V15, P393, DOI 10.3109/01612849409006916; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heaton P., 2012, UNEMPLOYMENT POST 9; Hoge CW, 2007, INT J EPIDEMIOL, V36, P327, DOI 10.1093/ije/dym013; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehavot K, 2014, J COUNS PSYCHOL, V61, P392, DOI 10.1037/cou0000019; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Murdoch M, 2006, J GEN INTERN MED, V21, pS5, DOI 10.1111/j.1525-1497.2006.00368.x; Novaco RW, 2012, PSYCHOL ASSESSMENT, V24, P661, DOI 10.1037/a0026636; Owens G. P., 2009, TRAUMATOLOGY, V15, P31, DOI DOI 10.1177/1534765609336361; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Pierce PF, 2011, WOMEN HEALTH ISS, V21, pS152, DOI 10.1016/j.whi.2011.04.017; Prudential Financial Inc, 2012, 02240610000101 PRUD; Riddle JR, 2007, J CLIN EPIDEMIOL, V60, P192, DOI 10.1016/j.jclinepi.2006.04.008; Sanborn JK, 2013, MARINE CORPS TI 1118; Scott JC, 2014, J CLIN PSYCHIAT, V75, P637, DOI 10.4088/JCP.13m08808; Sorgi P, 1991, J Neuropsychiatry Clin Neurosci, V3, pS52; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wright KM, 2012, J CLIN PSYCHOL, V68, P782, DOI 10.1002/jclp.21864; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	48	13	13	0	16	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3					296	303		10.7205/MILMED-D-14-00255			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD3OI	WOS:000350987700015	25735020	Bronze, Green Submitted			2022-02-06	
J	Ashforda, S; Jackson, D; Turner-Stokes, L				Ashforda, Stephen; Jackson, Diana; Turner-Stokes, Lynne			Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function	PHYSIOTHERAPY			English	Article						Function; Upper limb; Outcome measurement; Goals	UPPER-LIMB SPASTICITY; BOTULINUM-TOXIN-A; QUALITY-OF-LIFE; DOUBLE-BLIND; OUTCOME MEASURES; STROKE; MULTICENTER; MANAGEMENT; REHABILITATION	Objective Following stroke or brain injury, goals for rehabilitation of the hemiparetic upper limb include restoring active function if there is return of motor control or, if none is possible, improving passive function, and facilitating care for the limb. To inform development of a new patient reported outcome measure (PROM) of active and passive function in the hemiparetic upper limb, the Arm Activity measure, we examined functional goals for the upper limb, identified during goal setting for spasticity intervention (physical therapy and concomitant botulinum toxin A interventions). Design Using secondary analysis of a prospective observational cohort study, functional goals determined between patients, their carers and the clinical team were assigned into categories by two raters. Goal category identification, followed by assignment of goals to a category, was undertaken and then confirmed by a second reviewer. Participants Participants comprised nine males and seven females of mean (SD) age 54.5 (15.7) years and their carers. Fifteen had sustained a stroke and one a traumatic brain injury. Results Goals were used to identify five categories: passive function, active function, symptoms, cosmesis and impairment. Two passive function items not previously identified by a previous systematic review were identified. Conclusions Analysis of goals important to patients and carers revealed items for inclusion in a new measure of arm function and provide a useful alternative method to involve patients and carers in standardised measure development. (C) 2014 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.	[Ashforda, Stephen; Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow, Middx, England; [Ashforda, Stephen; Jackson, Diana; Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England		Ashforda, S (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow, Middx, England.	Stephen.Ashford@nhs.net	Turner-Stokes, Lynne/F-4418-2012; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Ashford, Stephen/0000-0001-5541-7063	National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185, CAT-CL-03-2012-010] Funding Source: researchfish; Department of HealthEuropean Commission [CAT-CL-03-2012-010, RP-PG-0407-10185] Funding Source: Medline		Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2013, PHYSIOTHER RES INT, V18, P178, DOI 10.1002/pri.1554; Ashford S, 2013, DISABIL REHABIL, V35, P1513, DOI 10.3109/09638288.2012.743602; Ashford S, 2013, CLIN REHABIL, V27, P728, DOI 10.1177/0269215512474942; Ashford S, 2009, DISABIL REHABIL, V31, P220, DOI 10.1080/09638280801906388; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P665, DOI 10.1136/jnnp.2003.026096; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bergfeldt U, 2006, J REHABIL MED, V38, P166, DOI 10.1080/16501970500415348; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Borg J, 2011, J REHABIL MED, V43, P15, DOI 10.2340/16501977-0663; CALSYN RJ, 1978, COMMUNITY MENT HLT J, V14, P300, DOI 10.1007/BF00778605; Giordano A, 2009, J NEUROL NEUROSUR PS, V80, P1023, DOI 10.1136/jnnp.2008.171181; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; INVOLVE, 2009, PAT PUBL INV RES RES; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Latham GP, 2007, EUR PSYCHOL, V12, P290, DOI 10.1027/1016-9040.12.4.290; Locke E.A., 1990, THEORY GOAL SETTING; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; LOMAS J, 1987, MED CARE, V25, P764, DOI 10.1097/00005650-198708000-00009; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Norman, 2003, HLTH MEASUREMENT SCA; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Playford D, 2008, CURR OPIN NEUROL, V21, P649, DOI 10.1097/WCO.0b013e328318ecca; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Reed J, 1997, J ADV NURS, V26, P765, DOI 10.1046/j.1365-2648.1997.00395.x; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Rushton PW, 2002, ARCH PHYS MED REHAB, V83, P771, DOI 10.1053/apmr.2002.32636; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; STOLEE P, 1992, J AM GERIATR SOC, V40, P574, DOI 10.1111/j.1532-5415.1992.tb02105.x; Turner-Stokes L, 2014, REHABILITATION GOAL, P119; Turner-Stokes L., 2013, BMJ OPEN; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Wade D, 1992, MEASUREMENT NEUROLOG; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; WADE DT, 1992, SCAND J REHABIL MED, P97; WHO, 2002, INT CLASS FUNCT DIS	40	13	13	0	31	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0031-9406	1873-1465		PHYSIOTHERAPY	Physiotherapy	MAR	2015	101	1					88	94		10.1016/j.physio.2014.04.001			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AZ5XW	WOS:000348292800012	24954806				2022-02-06	
J	Hassett, L; Moseley, A; Harmer, A; van der Ploeg, HP				Hassett, Leanne; Moseley, Anne; Harmer, Alison; van der Ploeg, Hidde P.			The Reliability, Validity, and Feasibility of Physical Activity Measurement in Adults With Traumatic Brain Injury: An Observational Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; motor activity; physiotherapy specialty; questionnaires; reproducibility of results	ACTIVITY SCALE; INDIVIDUALS; PEOPLE; CALIBRATION; RECOMMENDATIONS; INACTIVITY; CHILDREN; MODERATE; FITNESS	Objective: To determine the reliability and validity of the Physical Activity Scale for Individuals with a Physical Disability (PASIPD) in adults with severe traumatic brain injury (TBI) and estimate the proportion of the sample participants who fail to meet the World Health Organization guidelines for physical activity. Design and Participants: A single-center observational study recruited a convenience sample of 30 community-based ambulant adults with severe TBI. Protocol: Participants completed the PASIPD on 2 occasions, 1 week apart, and wore an accelerometer (ActiGraph GT3X; ActiGraph LLC, Pensacola, Florida) for the 7 days between these 2 assessments. Results: The PASIPD test-retest reliability was substantial (intraclass correlation coefficient = 0.85; 95% confidence interval, 0.70-0.92), and the correlation with the accelerometer ranged from too low to be meaningful (R = 0.09) to moderate (R = 0.57). From device-based measurement of physical activity, 56% of participants failed to meet the World Health Organization physical activity guidelines. Conclusion: The PASIPD is a reliable measure of the type of physical activity people with severe TBI participate in, but it is not a valid measure of the amount of moderate to vigorous physical activity in which they engage. Accelerometers should be used to quantify moderate to vigorous physical activity in people with TBI.	[Hassett, Leanne; Harmer, Alison] Univ Sydney, Fac Hlth Sci, Clin & Rehabil Sci Res Grp, Sydney, NSW 2141, Australia; [Hassett, Leanne; Moseley, Anne] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW 2141, Australia; [van der Ploeg, Hidde P.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2141, Australia; [van der Ploeg, Hidde P.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands		Hassett, L (corresponding author), Univ Sydney, Discipline Physiotherapy, Fac Hlth Sci, 75 East St, Sydney, NSW 2141, Australia.	Leanne.hassett@sydney.edu.au	van der Ploeg, Hidde P/B-2599-2013; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; Hassett, Leanne/0000-0002-3546-1822	Menzies Foundation	This study was funding by the Menzies Foundation. The authors thank clients and physiotherapy staff of the Liverpool Brain Injury Rehabilitation Unit, and Christy Bruce and Anna Wong, from the Liverpool Hospital Physiotherapy Department.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Access Economics , 2009, EC COST SPIN CORD IN; Ainsworth BE, 2012, J PHYS ACT HEALTH, V9, pS76, DOI 10.1123/jpah.9.s1.s76; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Blair SN, 2009, BRIT J SPORT MED, V43, P1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Dusick DM, 2012, INTRO INFERENTIAL ST; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Pfaff A, 2004, MANUAL MODIFIED OXFO; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Raymond J, 2010, SPINAL CORD, V48, P591, DOI 10.1038/sc.2009.180; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2012, LANCET, V380, P193, DOI 10.1016/S0140-6736(12)61028-9; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68; Tweedy SM, 2005, MED SCI SPORT EXER, V37, P1474, DOI 10.1249/01.mss.0000177584.43330.ae; van den Berg-Emons RJ, 2011, ARCH PHYS MED REHAB, V92, P923, DOI 10.1016/j.apmr.2010.12.006; van der Ploeg Hidde P, 2007, J Phys Act Health, V4, P96; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; WHO, PHYS IN GLOB PUBL HL; WHO. World Health Organization, 2011, GLOBAL RECOMMENDATIO; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d	42	13	13	2	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E55	E61		10.1097/HTR.0000000000000047			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300006	24721810				2022-02-06	
J	Levan, A; Baxter, L; Kirwan, CB; Black, G; Gale, SD				Levan, Ashley; Baxter, Leslie; Kirwan, C. Brock; Black, Garrett; Gale, Shawn D.			Right Frontal Pole Cortical Thickness and Social Competence in Children With Chronic Traumatic Brain Injury: Cognitive Proficiency as a Mediator	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive proficiency; cortical thickness; pediatric; social competence; traumatic brain injury	WORKING-MEMORY; EXECUTIVE FUNCTIONS; FLUID INTELLIGENCE; PERSONALITY-CHANGE; PREFRONTAL CORTEX; PROCESSING SPEED; YOUNG-CHILDREN; OUTCOMES; TBI; RECOMMENDATIONS	Objective: To examine the association between right frontal pole cortical thickness, social competence, and cognitive proficiency in children participants with a history of chronic traumatic brain injury (TBI). Participants: Twenty-three children (65% male; M age = 12.8 years, SD = 2.3 years) at least 1 year post-injury (M = 3.3 years, SD = 1.7 years) were evaluated with the Cognitive Proficiency Index (CPI) from the Wechsler Intelligence Scale for Children, 4th Edition, and their caregiver completed the Child Behavior Checklist. Social competence was evaluated with the Social Competence and Social Problems subscales from the Child Behavior Checklist. Right frontal pole cortical thickness was calculated via FreeSurfer from high-resolution 3-dimensional T1 magnetic resonance imaging scans. Results: Direct effect of right frontal pole cortical thickness on social competence was significant (beta = 14.09, SE = 4.6, P < .01). Right frontal pole cortical thickness significantly predicted CPI (beta = 18.44, SE = 4.9, P < .05), and CPI significantly predicted social competence (beta = 0.503, SE = 0.17, P < .01). Findings were consistent with the hypothesized mediation model. Conclusions: The association between right frontal lobe cortical integrity and social competence in pediatric participants with chronic TBI may be mediated through cognitive proficiency.	[Levan, Ashley; Kirwan, C. Brock; Black, Garrett; Gale, Shawn D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Kirwan, C. Brock; Gale, Shawn D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Baxter, Leslie] St Josephs Hosp, Barrow Neurol Inst, Dept Neuroimaging, Phoenix, AZ USA		Gale, SD (corresponding author), Brigham Young Univ, Dept Psychol, 1060 SWKT, Provo, UT 84602 USA.	shawn_gale@byu.edu	Gale, Shawn/M-3144-2013; Kirwan, Brock/B-1520-2014	Gale, Shawn/0000-0002-8989-0964; Kirwan, Brock/0000-0003-0768-1446; Baxter, Leslie/0000-0002-3971-863X			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; [Anonymous], 2006, AMOS COMP PROGR; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gottlieb L, 2012, EPILEPSY BEHAV, V23, P146, DOI 10.1016/j.yebeh.2011.10.024; Kail R, 2000, J SCHOOL PSYCHOL, V38, P51, DOI 10.1016/S0022-4405(99)00036-9; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P123, DOI 10.1080/09084281003709009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PERRIN EC, 1991, J PEDIATR PSYCHOL, V16, P411, DOI 10.1093/jpepsy/16.4.411; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Prifitera A., 2008, WISC 4 CLIN ASSESSME; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Rackley C, 2012, CHILD NEUROPSYCHOL, V18, P512, DOI 10.1080/09297049.2011.628308; Salpekar JA, 2010, EPILEPSY BEHAV, V17, P50, DOI 10.1016/j.yebeh.2009.10.002; Sattler J. M., 2008, ASSESSMENT CHILDREN; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Swanson H. L., 2003, MEMORY DIFFICULTIES; Wechsler D, 2003, WECHSLER INTELLIGENC; Weiss LG, 2010, THEORETICAL EMPIRICA; Weiss LG, 2006, WISC 4 ADV CLIN INTE, P139; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zbikowski SM, 1998, J APPL DEV PSYCHOL, V19, P249, DOI 10.1016/S0193-3973(99)80039-2	51	13	13	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E24	E31		10.1097/HTR.0000000000000040			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300003	24714213				2022-02-06	
J	Li, YH; Zhang, CL; Zhang, XY; Zhou, HX; Meng, LL				Li, Yue-Hong; Zhang, Chun-Lai; Zhang, Xiao-Yan; Zhou, Hong-Xia; Meng, Ling-Li			Effects of mild induced hypothermia on hippocampal connexin 43 and glutamate transporter 1 expression following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; mild induced hypothermia; brain edema; connexin 43; glutamate transporter 1	THERAPEUTIC HYPOTHERMIA; MECHANISMS; DEATH; MODEL	Traumatic brain injury (TBI) is a common cause of worldwide disability and mortality. Currently, the incidence and prevalence of TBI is markedly increasing and an effective therapy is lacking. Therapeutic hypothermia (32-35 degrees C) has been reported to reduce intracranial pressure and induce putative neuroprotective effects. However, the underlying molecular mechanisms remain to be elucidated. The aim of the present study was to investigate the effects of mild induced hypothermia (MIH) on the expression of connexin 43 (Cx43) and glutamate transporter 1 (GLT-1) in the hippocampus following TBI in rats. A rat model of TBI was created using a modified weight-drop device, followed by 4 h of hypothermia (33 degrees C) or normothermia (37 degrees C). A wet-dry weight method was used to assess brain edema and spatial learning ability was evaluated using a Morris water maze The levels of Cx43 and GLT-1 were detected by immunohistochemical and western blot analysis, respectively. The results demonstrated that MIH treatment improved TBI-induced brain edema and neurological function deficits. In addition, therapeutic MIH significantly downregulated Cx43 expression and upregulated the levels of GLT-1 in the hippocampus post-TBI. These findings suggested that treatment with MIH may provide a novel neuroprotective therapeutic strategy for TBI through reversing the increase in Cx43 protein and the decrease in GLT-1.	[Li, Yue-Hong] Tangshan Gongren Hosp, Dept Obstetr & Gynecol, Tangshan 063000, Hebei, Peoples R China; [Zhang, Chun-Lai] Tangshan Gongren Hosp, Dept Cardiol, Tangshan 063000, Hebei, Peoples R China; [Zhang, Xiao-Yan; Zhou, Hong-Xia; Meng, Ling-Li] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China		Zhang, CL (corresponding author), Tangshan Gongren Hosp, Dept Cardiol, 27 Wenhua Rd, Tangshan 063000, Hebei, Peoples R China.	zhangchunlai1970@yeah.net			Science and Technology Development Project of Tangshan City [12140209A-31]	The present study was supported by a grant from the Science and Technology Development Project of Tangshan City (no. 12140209A-31).	Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Broessner G, 2012, CRITICAL CARE, V16, pA1, DOI DOI 10.1186/CC11259; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang S, 2014, NEUROCHEM RES, V39, P833, DOI 10.1007/s11064-014-1277-3; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Mroue RM, 2011, INTEGR BIOL-UK, V3, P255, DOI 10.1039/c0ib00158a; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Ongstad EL, 2013, ADV WOUND CARE, V2, P55, DOI 10.1089/wound.2011.0341; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu ML, 2014, ONCOL REP, V31, P2751, DOI 10.3892/or.2014.3163	28	13	14	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAR	2015	11	3					1991	1996		10.3892/mmr.2014.2928			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CD2OA	WOS:000350917700062	25394735	Bronze			2022-02-06	
J	Samadani, U; Farooq, S; Ritlop, R; Warren, F; Reyes, M; Lamm, E; Alex, A; Nehrbass, E; Kolecki, R; Jureller, M; Schneider, J; Chen, A; Shi, C; Mendhiratta, N; Huang, JH; Qian, M; Kwak, R; Mikheev, A; Rusinek, H; George, A; Fergus, R; Kondziolka, D; Huang, PP; Smith, RT				Samadani, Uzma; Farooq, Sameer; Ritlop, Robert; Warren, Floyd; Reyes, Marleen; Lamm, Elizabeth; Alex, Anastasia; Nehrbass, Elena; Kolecki, Radek; Jureller, Michael; Schneider, Julia; Chen, Agnes; Shi, Chen; Mendhiratta, Neil; Huang, Jason H.; Qian, Meng; Kwak, Roy; Mikheev, Artem; Rusinek, Henry; George, Ajax; Fergus, Robert; Kondziolka, Douglas; Huang, Paul P.; Smith, R. Theodore			Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip	JOURNAL OF NEUROSURGERY			English	Article						abducent nerve; diplopia; eye movement tracking; hydrocephalus; oculomotor nerve; prepontine cistern; diagnostic and operative techniques	TRAUMATIC BRAIN-INJURY; OCULOMOTOR DEFICITS; MOVEMENT-DISORDERS; OCULAR MOTILITY; CHILDREN; DYSFUNCTION; DISEASE; HYDROCEPHALUS; DEMENTIA	OBJECT Automated eye movement tracking may provide clues to nervous system function at many levels. Spatial calibration of the eye tracking device requires the subject to have relatively intact ocular motility that implies function of cranial nerves (CNs) III (oculomotor), IV (trochlear), and VI (abducent) and their associated nuclei, along with the multiple regions of the brain imparting cognition and volition. The authors have developed a technique for eye tracking that uses temporal rather than spatial calibration, enabling detection of impaired ability to move the pupil relative to normal (neurologically healthy) control volunteers. This work was performed to demonstrate that this technique may detect CN palsies related to brain compression and to provide insight into how the technique may be of value for evaluating neuropathological conditions associated with CN palsy, such as hydrocephalus or acute mass effect. METHODS The authors recorded subjects' eye movements by using an Eye link 1000 eye tracker sampling at 500 Hz over 200 seconds while the subject viewed a music video playing inside an aperture on a computer monitor. The aperture moved in a rectangular pattern over a fixed time period. This technique was used to assess ocular motility in 157 neurologically healthy control subjects and 12 patients with either clinical CN III or VI palsy confirmed by neuro-ophthalmological examination, or surgically treatable pathological conditions potentially impacting these nerves. The authors compared the ratio of vertical to horizontal eye movement (height/width defined as aspect ratio) in normal and test subjects. RESULTS In 157 normal controls, the aspect ratio (height/width) for the left eye had a mean value +/- SD of 1.0117 +/- 0.0706. For the right eye, the aspect ratio had a mean of 1.0077 +/- 0.0679 in these 157 subjects. There was no difference between sexes or ages. A patient with known CN VI palsy had a significantly increased aspect ratio (1.39), whereas 2 patients with known CN III palsy had significantly decreased ratios of 0.19 and 0.06, respectively. Three patients with surgically treatable pathological conditions impacting CN VI, such as infratentorial mass effect or hydrocephalus, had significantly increased ratios (1.84, 1.44, and 1.34, respectively) relative to normal controls, and 6 patients with supratentorial mass effect had significantly decreased ratios (0.27, 0.53, 0.62, 0.45, 0.49, and 0.41, respectively). These alterations in eye tracking all reverted to normal ranges after surgical treatment of underlying pathological conditions in these 9 neurosurgical cases. CONCLUSIONS This proof of concept series of cases suggests that the use of eye tracking to detect CN palsy while the patient watches television or its equivalent represents a new capacity for this technology. It may provide a new tool for the assessment of multiple CNS functions that can potentially be useful in the assessment of awake patients with elevated intracranial pressure from hydrocephalus or trauma.	[Samadani, Uzma; Warren, Floyd; Reyes, Marleen; Nehrbass, Elena; Shi, Chen; Mendhiratta, Neil; Kwak, Roy] NYU, Sch Med, Manhattan Vet Adm, New York Harbor Hlth Care Syst, New York, NY USA; [Samadani, Uzma; Farooq, Sameer; Ritlop, Robert; Reyes, Marleen; Lamm, Elizabeth; Nehrbass, Elena; Kolecki, Radek; Jureller, Michael; Schneider, Julia; Chen, Agnes; Shi, Chen; Mendhiratta, Neil; Kondziolka, Douglas; Huang, Paul P.] NYU, Sch Med, Dept Neurosurg, New York, NY USA; [Warren, Floyd; Alex, Anastasia; Smith, R. Theodore] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Qian, Meng] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Mikheev, Artem; Rusinek, Henry; George, Ajax] NYU, Sch Med, Dept Radiol, New York, NY USA; [Lamm, Elizabeth; Fergus, Robert] NYU, Courant Inst, Dept Comp Sci, New York, NY USA; [Huang, Jason H.] Scott & White Hlth Care, Dept Neurosurg, Temple, TX USA		Samadani, U (corresponding author), 423 E 23rd St,MC 112, New York, NY 10010 USA.	uzma.samadani@nyumc.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Huang, Paul/0000-0003-0563-921X; george, ajax/0000-0001-6355-2951; Warren, Floyd/0000-0001-7326-7142; smith, theodore/0000-0002-1693-943X	Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service via a VA Merit Award [1I01RX000319-01]; American College of Surgeons/Neurosurgery Research Education Foundation of the AANS; Steven and Alexandra Cohen Center for Veteran Post-Traumatic Stress and Traumatic Brain Injury; Thrasher Research Fund; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000319] Funding Source: NIH RePORTER	Dr. Samadani's work is supported in part by the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service, via a VA Merit Award (1I01RX000319-01), and she was supported by a Career Development Award from the American College of Surgeons/Neurosurgery Research Education Foundation of the AANS. She is also supported by the Steven and Alexandra Cohen Center for Veteran Post-Traumatic Stress and Traumatic Brain Injury; by the Thrasher Research Fund; and by Research to Prevent Blindness.	Adler DE, 2002, J NEUROSURG, V96, P1103, DOI 10.3171/jns.2002.96.6.1103; Alemdar M, 2006, J NEURO-OPHTHALMOL, V26, P173, DOI 10.1097/01.wno.0000235588.18169.de; Altintas O, 2005, GRAEF ARCH CLIN EXP, V243, P1213, DOI 10.1007/s00417-005-0001-z; Archibald NK, 2013, BRAIN, V136, P739, DOI 10.1093/brain/awt005; Beaufils E, 2012, AMYOTROPH LATERAL SC, V13, P84, DOI 10.3109/17482968.2011.580848; Brodsky MC, 2003, BRIT J OPHTHALMOL, V87, P1440, DOI 10.1136/bjo.87.12.1440; Brodsky Michael C, 2011, Am Orthopt J, V61, P28; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cavezian C, 2010, RES DEV DISABIL, V31, P1102, DOI 10.1016/j.ridd.2010.03.006; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Clark D, 2012, CURR OPIN OPHTHALMOL, V23, P491, DOI 10.1097/ICU.0b013e328358ba14; Matta APD, 2008, DEV NEUROREHABIL, V11, P159, DOI 10.1080/17518420701783622; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; DELEU D, 1989, ARCH NEUROL-CHICAGO, V46, P1361, DOI 10.1001/archneur.1989.00520480105028; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; Friedman DI, 2010, SEMIN NEUROL, V30, P54, DOI 10.1055/s-0029-1244995; FRIEDMAN DI, 1992, J CLIN NEURO-OPHTHAL, V12, P104; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hanson RA, 2004, NEUROLOGY, V62, P33, DOI 10.1212/WNL.62.1.33; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kerrison J B, 1997, Curr Opin Ophthalmol, V8, P35, DOI 10.1097/00055735-199712000-00006; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; Marx S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00088; Mikheev A, 2008, J MAGN RESON IMAGING, V27, P1235, DOI 10.1002/jmri.21372; NATHAN H, 1974, J NEUROSURG, V41, P561, DOI 10.3171/jns.1974.41.5.0561; Pelak VS, 2010, CURR NEUROL NEUROSCI, V10, P440, DOI 10.1007/s11910-010-0137-z; Pierrot-Deseilligny Charles, 2011, Handb Clin Neurol, V102, P319, DOI 10.1016/B978-0-444-52903-9.00018-2; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rogers GL, 2013, PEDIATR REV, V34, P126, DOI 10.1542/pir.34-3-126; Rudolph G, 2009, EUR J OPHTHALMOL, V19, P667, DOI 10.1177/112067210901900423; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Tamhankar MA, 2011, EYE, V25, P91, DOI 10.1038/eye.2010.160; Vaphiades MS, 2012, CURR OPIN OPHTHALMOL, V23, P537, DOI 10.1097/ICU.0b013e328358b94a; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364; ZEINER HK, 1985, CHILD NERV SYST, V1, P115, DOI 10.1007/BF00706692	37	13	15	0	18	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					707	720		10.3171/2014.10.JNS14762			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600030	25495739	Green Accepted, Bronze			2022-02-06	
J	Salottolo, K; Offner, PJ; Orlando, A; Slone, DS; Mains, CW; Carrick, M; Bar-Or, D				Salottolo, Kristin; Offner, Patrick J.; Orlando, Alessandro; Slone, Denetta S.; Mains, Charles W.; Carrick, Matthew; Bar-Or, David			The epidemiology of do-not-resuscitate orders in patients with trauma: a community level one trauma center observational experience	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Do-Not-Resuscitate; Trauma; Epidemiology; Outcomes; Elderly	SELF-DETERMINATION ACT; INTRACEREBRAL HEMORRHAGE; ADVANCE DIRECTIVES; SURGICAL-PATIENTS; DECISION-MAKING; BRAIN-INJURY; DNR ORDERS; CARE; MORTALITY; OUTCOMES	Background: Do-Not-Resuscitate (DNR) orders in patients with traumatic injury are insufficiently described. The objective is to describe the epidemiology and outcomes of DNR orders in trauma patients. Methods: We included all adults with trauma to a community Level I Trauma Center over 6 years (2008-2013). We used chi-square, Wilcoxon rank-sum, and multivariate stepwise logistic regression tests to characterize DNR (established in-house vs. pre-existing), describe predictors of establishing an in-house DNR, timing of an in-house DNR (early [within 1 day] vs late), and outcomes (death, ICU stay, major complications). Results: Included were 10,053 patients with trauma, of which 1523 had a DNR order in place (15%); 715 (7%) had a pre-existing DNR and 808 (8%) had a DNR established in-house. Increases were observed over time in both the proportions of patients with DNRs established in-house (p = 0.008) and age >= 65 (p < 0.001). Over 90% of patients with an in-house DNR were >= 65 years. The following covariates were independently associated with establishing a DNR in-house: age >= 65, severe neurologic deficit (GCS 3-8), fall mechanism of injury, ED tachycardia, female gender, and comorbidities (p < 0.05 for all). Age >= 65, female gender, non-surgical service admission and transfers-in were associated with a DNR established early (p < 0.05 for all). As expected, mortality was greater in patients with DNR than those without (22% vs. 1%), as was the development of a major complication (8% vs. 5%), while ICU admission was similar (19% vs. 17%). Poor outcomes were greatest in patients with DNR orders executed later in the hospital stay. Conclusions: Our analysis of a broad cohort of patients with traumatic injury establishes the relationship between DNR and patient characteristics and outcomes. At 15%, DNR orders are prevalent in our general trauma population, particularly in patients >= 65 years, and are placed early after arrival. Established prognostic factors, including age and physiologic severity, were determinants for in-house DNR orders. These data may improve physician predictions of outcomes with DNR and help inform patient preferences, particularly in an environment with increasing use of DNR and increasing age of patients with trauma.	[Salottolo, Kristin; Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80113 USA; [Salottolo, Kristin; Orlando, Alessandro; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO 80228 USA; [Offner, Patrick J.; Mains, Charles W.] St Anthony Hosp, Trauma Serv Dept, Lakewood, CO 80228 USA; [Slone, Denetta S.] Swedish Med Ctr, Trauma Serv Dept, Englewood, CO 80113 USA; [Slone, Denetta S.; Mains, Charles W.; Bar-Or, David] Rocky Vista Univ, Aurora, CO 80011 USA; [Carrick, Matthew] Med Ctr Plano, Trauma Serv Dept, Plano, TX 75075 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80113 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Adams SD, 2013, J TRAUMA ACUTE CARE, V74, P1327, DOI 10.1097/TA.0b013e31828c4698; Baker DW, 2003, J GEN INTERN MED, V18, P343, DOI 10.1046/j.1525-1497.2003.20522.x; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; Boyd K, 1996, ARCH INTERN MED, V156, P1821, DOI 10.1001/archinte.156.16.1821; Brizzi M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-36; Buchman TG, 2002, J AM COLL SURGEONS, V194, P665, DOI 10.1016/S1072-7515(02)01157-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen JLT, 2008, AM HEART J, V156, P78, DOI 10.1016/j.ahj.2008.01.030; Cherniack EP, 2002, J MED ETHICS, V28, P305, DOI 10.1136/jme.28.5.303; CURTIS JR, 1995, JAMA-J AM MED ASSOC, V273, P124, DOI 10.1001/jama.273.2.124; Eachempati SR, 2006, J TRAUMA, V60, P193, DOI 10.1097/01.ta.0000197683.89002.62; Emergency Medical and Trauma Services Section. Colorado Trauma Registry Inclusion/Exclusion Criteria, 2011, EM MED TRAUM SERV SE; GRECO PJ, 1991, ANN INTERN MED, V115, P639, DOI 10.7326/0003-4819-115-8-639; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Huang YC, 2010, J FORMOS MED ASSOC, V109, P201, DOI 10.1016/S0929-6646(10)60043-5; Jayes RL, 1996, CHEST, V110, P1332, DOI 10.1378/chest.110.5.1332; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; Kelly AG, 2014, STROKE, V45, P822, DOI 10.1161/STROKEAHA.113.004573; Mirarchi FL, 2012, J EMERG MED, V42, P511, DOI 10.1016/j.jemermed.2011.07.015; Mosenthal AC, 2003, J AM COLL SURGEONS, V197, P509, DOI 10.1016/S1072-7515(03)00651-3; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Rapoport J, 1996, AM J RESP CRIT CARE, V153, P185, DOI 10.1164/ajrccm.153.1.8542114; Saager L, 2011, CRIT CARE MED, V39, P1036, DOI 10.1097/CCM.0b013e31820eb4fc; Scarborough JE, 2012, ANN SURG, V256, P453, DOI 10.1097/SLA.0b013e31826578fb; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Silvennoinen K, 2013, STROKE INT J; Silvennoinen K, 2014, INT J STROKE, V9, P53, DOI 10.1111/ijs.12161; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Torke AM, 2011, J AM GERIATR SOC, V59, P1326, DOI 10.1111/j.1532-5415.2011.03480.x; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wade CE, 2013, J TRAUMA ACUTE CARE, V75, pS89, DOI 10.1097/TA.0b013e31828fa422; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wenger NS, 1997, MED CARE, V35, P311, DOI 10.1097/00005650-199704000-00003	36	13	13	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 3	2015	23								9	10.1186/s13049-015-0094-2			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CD1PD	WOS:000350845900001	25645242	Green Published, gold			2022-02-06	
J	Chen, HL; Lu, TW; Chou, LS				Chen, Hao-Ling; Lu, Tung-Wu; Chou, Li-Shan			Effect of Concussion on Inter-joint Coordination During Divided-Attention Gait	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Gait; Coordination; Concussion; Dual task; Attention	TRAUMATIC BRAIN-INJURY; COLLEGIATE	This study investigates the effect of concussion on the inter-joint coordination of the lower extremities during walking. Gait analyses were performed on 15 young adults who had suffered a concussion and 15 matched controls while walking on level ground with and without a concurrent cognitive task. The continuous relative phase (CRP), derived from phase planes of two adjacent joints, was used to assess the inter-joint coordination. Variability of coordination was assessed using the average value of all standard deviations calculated for each data point over the stance or swing phases from all CRP curves, namely the deviation phase. The results show that subjects who had had a concussion achieved a level of performance on the concurrent cognitive task similar to that of their matched controls, but had altered gait performance. The temporal-spatial gait control and the kinematic control of each individual joint were found to be altered immediately following a concussion. Patterns of the inter-joint coordination were similar to those of normal individuals. However, greater variability of inter-joint coordination patterns was found in swing phase hip-knee coordination. Examination of the inter-joint coordination could explain the observed deviations in gait performance and joint motion of individuals who had suffered a concussion.	[Chen, Hao-Ling] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 100, Taiwan; [Lu, Tung-Wu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 100, Taiwan; [Lu, Tung-Wu] Natl Taiwan Univ, Coll Med, Dept Orthopaed Surg, Taipei 106, Taiwan; [Chou, Li-Shan] Univ Oregon, Mot Anal Lab, Dept Human Physiol, Eugene, OR 97403 USA		Chen, HL (corresponding author), Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 100, Taiwan.	hlchen@ntu.edu.tw		CHEN, HAO-LING/0000-0001-5972-2778			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BELL R, 1977, AM FAM PHYSICIAN, V16, P145; Bernstein NA., 1967, COORDINATION REGULAT; BURGESSLIMERICK R, 1993, J BIOMECH, V26, P91, DOI 10.1016/0021-9290(93)90617-N; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Dvorak J, 2009, BRIT J SPORT MED, V43, pI1, DOI 10.1136/bjsm.2009.059360; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; KADABA MP, 1989, J ORTHOPAED RES, V7, P849, DOI 10.1002/jor.1100070611; Kelly JP, 1997, NEUROLOGY, V48, P581; KELSO JAS, 1987, PHYS SCRIPTA, V35, P79, DOI 10.1088/0031-8949/35/1/020; KELSO JAS, 1981, J MOTOR BEHAV, V13, P226; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peters BT, 2003, J BIOMECH, V36, P271, DOI 10.1016/S0021-9290(02)00341-X; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Stergiou N, 2001, GAIT POSTURE, V13, P210, DOI 10.1016/S0966-6362(00)00101-6; Stergiou N, 2001, CLIN BIOMECH, V16, P213, DOI 10.1016/S0268-0033(00)00090-5; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wang TM, 2009, J BIOMECH, V42, P2349, DOI 10.1016/j.jbiomech.2009.06.029; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Yen HC, 2009, J BIOMECH, V42, P2501, DOI 10.1016/j.jbiomech.2009.07.015	32	13	13	0	14	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	FEB	2015	35	1					28	33		10.1007/s40846-015-0002-2			6	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CC5XV	WOS:000350439200003					2022-02-06	
J	Davies, SW; Leonard, KL; Falls, RK; Mageau, RP; Efird, JT; Hollowell, JP; Trainor, WE; Kanaan, HA; Hickner, RC; Sawyer, RG; Poulin, NR; Waibel, BH; Toschlog, EA				Davies, Stephen W.; Leonard, Kenji L.; Falls, Randall K., Jr.; Mageau, Ronald P.; Efird, Jimmy T.; Hollowell, Joseph P.; Trainor, Wayne E., II; Kanaan, Hilal A.; Hickner, Robert C.; Sawyer, Robert G.; Poulin, Nathaniel R.; Waibel, Brett H.; Toschlog, Eric A.			Lung protective ventilation (ARDSNet) versus airway pressure release ventilation: Ventilatory management in a combined model of acute lung and brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Lung protective ventilation (ARDSNet); airway pressure release ventilation (APRV); adult respiratory distress syndrome (ARDS); traumatic brain injury (TBI); swine	FREQUENCY OSCILLATORY VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; RECRUITMENT	BACKGROUND: Concomitant lung/brain traumatic injury results in significant morbidity and mortality. Lung protective ventilation (Acute Respiratory Distress Syndrome Network [ARDSNet]) has become the standard for managing adult respiratory distress syndrome; however, the resulting permissive hypercapnea may compound traumatic brain injury. Airway pressure release ventilation (APRV) offers an alternative strategy for the management of this patient population. APRV was hypothesized to retard the progression of acute lung/brain injury to a degree greater than ARDSNet in a swine model. METHODS: Yorkshire swine were randomized to ARDSNet, APRV, or sham. Ventilatory settings and pulmonary parameters, vitals, blood gases, quantitative histopathology, and cerebral microdialysis were compared between groups using chi(2), Fisher's exact, Student's t test, Wilcoxon rank-sum, and mixed-effects repeated-measures modeling. RESULTS: Twenty-two swine (17 male, 5 female), weighing a mean (SD) of 25 (6.0) kg, were randomized to APRV (n = 9), ARDSNet (n = 12), or sham (n = 1). PaO2/FIO2 ratio dropped significantly, while intracranial pressure increased significantly for all three groups immediately following lung and brain injury. Over time, peak inspiratory pressure, mean airway pressure, and PaO2/FIO2 ratio significantly increased, while total respiratory rate significantly decreased within the APRV group compared with the ARDSNet group. Histopathology did not show significant differences between groups in overall brain or lung tissue injury; however, cerebral microdialysis trends suggested increased ischemia within the APRV group compared with ARDSNet over time. CONCLUSION: Previous studies have not evaluated the effects of APRV in this population. While our macroscopic parameters and histopathology did not observe a significant difference between groups, microdialysis data suggest a trend toward increased cerebral ischemia associated with APRV over time. Additional and future studies should focus on extending the time interval for observation to further delineate differences between groups. (Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.)	[Davies, Stephen W.; Sawyer, Robert G.] Univ Virginia, Sch Med, Dept Surg, Charlottesville, VA 22908 USA; [Leonard, Kenji L.; Poulin, Nathaniel R.; Waibel, Brett H.; Toschlog, Eric A.] E Carolina Univ, Div Trauma & Acute Care Surg, Brody Sch Med, Greenville, NC USA; [Falls, Randall K., Jr.; Mageau, Ronald P.] E Carolina Univ, Dept Surg, Brody Sch Med, Dept Pathol, Greenville, NC USA; [Hickner, Robert C.] E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC USA; [Efird, Jimmy T.] E Carolina Univ, Biostat Unit, Brody Sch Med, Greenville, NC USA; [Kanaan, Hilal A.] E Carolina Univ, Ctr Hlth Dispar, Brody Sch Med, Greenville, NC USA; [Kanaan, Hilal A.] E Carolina Univ, Div Neurosurg, Brody Sch Med, Greenville, NC USA; [Hollowell, Joseph P.; Trainor, Wayne E., II] Vidant Med Ctr, Greenville, NC USA		Davies, SW (corresponding author), Univ Virginia, Sch Med, Dept Surg, POB 800679, Charlottesville, VA 22908 USA.	sd2wf@virginia.edu		hickner, Robert/0000-0002-2683-1617; Leonard, Kenji/0000-0002-3580-1516; Sawyer, Robert/0000-0002-8155-2661	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32AI078875-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI078875] Funding Source: NIH RePORTER	This study was supported by NIH 5T32AI078875-05 (to S.W.D. and R.G.S.).	Albert S, 2011, J SURG RES, V166, pE71, DOI 10.1016/j.jss.2010.10.022; Ambrosio AM, 2012, ANESTHESIOLOGY, V117, P1322, DOI 10.1097/ALN.0b013e31827542aa; American Veterinary Medical Association, 2013, AM VET MED ASS GUID; ARDSnet, 2010, NIH NHLBI ARDS CLIN; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; David M, 2006, BRIT J ANAESTH, V97, P525, DOI 10.1093/bja/ael215; Dries DJ, 2009, J BURN CARE RES, V30, P929, DOI 10.1097/BCR.0b013e3181bfb84c; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Guldner A, 2014, ANESTHESIOLOGY, V120, P673, DOI 10.1097/ALN.0000000000000124; Heuer JF, 2012, NEUROCRIT CARE, V17, P281, DOI 10.1007/s12028-011-9566-z; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kreyer S, 2010, J NEUROSURG ANESTH, V22, P323, DOI 10.1097/ANA.0b013e3181e775f1; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; O'Rourke J, 2007, EUR J ANAESTH, V24, P454, DOI 10.1017/S0265021506002006; Pan ZY, 2005, BIOMETRICS, V61, P1000, DOI 10.1111/j.1541-0420.2005.00365.x; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Roy S, 2013, SHOCK, V39, P28, DOI 10.1097/SHK.0b013e31827b47bb; Roy S, 2012, J TRAUMA ACUTE CARE, V73, P391, DOI 10.1097/TA.0b013e31825c7a82; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sasidhar M, 2012, RESP CARE, V57, P1325, DOI 10.4187/respcare.01394; STOCK MC, 1987, CRIT CARE MED, V15, P462, DOI 10.1097/00003246-198705000-00002; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7	38	13	14	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2015	78	2					240	249		10.1097/TA.0000000000000518			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CA3TF	WOS:000348828300004	25757107	Green Accepted			2022-02-06	
J	Jang, SH; Choi, BY; Kim, SH; Chang, CLH; Jung, YJ; Yeo, SS				Jang, Sung Ho; Choi, Byung Yeon; Kim, Seong Ho; Chang, Chu L. Hoon; Jung, Young Jin; Yeo, Sang Seok			INJURY OF THE CORTICORETICULAR PATHWAY IN SUBARACHNOID HAEMORRHAGE AFTER RUPTURE OF A CEREBRAL ARTERY ANEURYSM	JOURNAL OF REHABILITATION MEDICINE			English	Article						diffusion tensor imaging; corticoreticular pathway; subarachnoid haemorrhage	DIFFUSION TENSOR TRACTOGRAPHY; INFERIOR CEREBELLAR ARTERY; CORTICOSPINAL TRACT; INTRACEREBRAL HEMORRHAGE; PROXIMAL WEAKNESS; HUMAN BRAIN; PATIENT; STAGE	Objective: Several studies have reported on injury of the corticoreticular pathway in patients with stroke and traumatic brain injury. However, little is known about injury of the corticoreticular pathway in patients with subarachnoid haemorrhage. The aim of the current study was to investigate corticoreticular pathway injury in patients with subarachnoid haemorrhage. Design: Comparative study. Subjects: Among 137 patients with subarachnoid haemorrhage, 17 patients with motor weakness who showed intact integrity of the corticospinal tract were recruited. Methods: Motricity Index was used for measurement of motor function. The fractional anisotropy value, apparent diffusion coefficient value, fibre volume, and integrity of the corticoreticular pathway were used for the diffusion tensor imaging parameters. Results: Twelve (70.6%) of 17 patients and 18 (52.9%) of 34 hemispheres showed a discontinuation of the corticoreticular pathway at the midbrain level. The contralateral shoulder, hip, and lower extremity of the discontinued corticoreticular pathway showed lower motor functions, in comparison with those of the contralateral side of the intact corticoreticular pathway (p<0.05). By contrast, the Motricity Index for distal joint, upper and total Motricity Index were not different irrespective of the state of the corticoreticular pathway (p>0.05). Conclusion: Corticoreticular pathway injury is common in patients with motor weakness after subarachnoid haemorrhage, and it appears to be related to weakness in the contralateral shoulder, hip and lower extremity.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Gyongsan, South Korea; [Choi, Byung Yeon; Kim, Seong Ho; Chang, Chu L. Hoon] Yeungnam Univ, Coll Med, Dept Neurosurg, Gyongsan, South Korea; [Jung, Young Jin; Yeo, Sang Seok] Dankook Univ, Dept Phys Therapy, Coll Hlth Sci, Cheonan Si 330714, Chungnam, South Korea		Yeo, SS (corresponding author), Dankook Univ, Dept Phys Therapy, Cheonan Si 330714, Chungnam, South Korea.	eangbul@hanmail.net			Ministry of Education, Science and Technology of KoreaMinistry of Education, Science and Technology, Republic of Korea [14-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (14-BD-0401).	ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Chua CO, 2009, STROKE, V40, P3369, DOI 10.1161/STROKEAHA.109.549212; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; Ellmore TM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00179; Endo H, 2005, SURG NEUROL, V64, P135, DOI 10.1016/j.surneu.2004.12.019; FERRANTE L, 1992, SURG NEUROL, V38, P43, DOI 10.1016/0090-3019(92)90210-E; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GREENE KA, 1995, NEUROLOGY, V45, P45, DOI 10.1212/WNL.45.1.45; Hara N, 2003, OPHTHALMOLOGICA, V217, P79, DOI 10.1159/000068247; Hong JH, 2012, NEUROSURGERY, V70, P819, DOI 10.1227/NEU.0b013e3182367124; HUDGINS RJ, 1983, J NEUROSURG, V58, P381, DOI 10.3171/jns.1983.58.3.0381; IRLE E, 1992, ANN NEUROL, V31, P473, DOI 10.1002/ana.410310503; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Kwak SY, 2010, EUR NEUROL, V63, P149, DOI 10.1159/000281108; LEE KS, 1989, SURG NEUROL, V31, P85; Liu YW, 2007, RADIOLOGY, V242, P518, DOI 10.1148/radiol.2422051698; MAIURI F, 1986, SURG NEUROL, V25, P397, DOI 10.1016/0090-3019(86)90217-X; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Mendoza J., 2007, CLIN NEUROANATOMY NE; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Rabinstein AA, 2013, NEUROLOGY, V80, pE56, DOI 10.1212/WNL.0b013e3182834b22; RUBEN S, 1991, J NEUROL NEUROSUR PS, V54, P1017, DOI 10.1136/jnnp.54.11.1017; SALCMAN M, 1990, NEUROSURGERY, V27, P12, DOI 10.1227/00006123-199007000-00002; SARNER M, 1967, J NEUROL NEUROSUR PS, V30, P67, DOI 10.1136/jnnp.30.1.67; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Son SM, 2009, NEUROSCI LETT, V451, P94, DOI 10.1016/j.neulet.2008.12.033; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, NEUROREHABILITATION, V32, P665, DOI 10.3233/NRE-130889; Yeo SS, 2013, NEUROREHABILITATION, V32, P305, DOI 10.3233/NRE-130848; Yeo SS, 2012, STROKE, V43, P2239, DOI 10.1161/STROKEAHA.112.661116; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030; YORK DH, 1987, NEUROSURGERY, V20, P70	38	13	13	1	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	FEB	2015	47	2					133	137		10.2340/16501977-1896			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CC0DR	WOS:000350006500005	25594856	gold, Green Submitted			2022-02-06	
J	Rike, PO; Johansen, HJ; Ulleberg, P; Lundqvist, A; Schanke, AK				Rike, Per-Ola; Johansen, Hans J.; Ulleberg, Pal; Lundqvist, Anna; Schanke, Anne-Kristine			Exploring associations between self-reported executive functions, impulsive personality traits, driving self-efficacy, and functional abilities in driver behaviour after brain injury	TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR			English	Article						Stroke; Traumatic brain injuries; Driving self-efficacy; Self-awareness; Executive function; Personality	INDIVIDUAL-DIFFERENCES; COMMUNITY INTEGRATION; OLDER-ADULTS; AWARENESS; MODEL; RISK; PREDICTORS; DEFICITS; DYSFUNCTION; ACCIDENTS	Objective: The assessment of self-awareness and self-efficacy as they relate to driving after stroke and TBI is lacking in the literature where the focus has tended to be on neuropsychological testing of underlying component of cognition in predicting driving outcome. Therefore, this study aims to investigate the associations between self-rating of higher-level functions and post-injury driving behaviour. Methods: The present one-year follow-up study included twenty-four adults with stroke and ten adults with traumatic brain injury (TBI) deemed suitable for driving after a comprehensive driving evaluation according to Norwegian regulations. In addition, but not part of the decision making, baseline measurements included self-rating of executive functions (Behaviour Rating of Executive Function (BRIEF-A)), impulsive personality traits (UPPS Impulsive Behaviour Scale), driving self-efficacy (Adelaide Driving Self-Efficacy Scale (ADSES)), and functional abilities (Awareness Questionnaire (AQ)). Follow-up measurements twelve months after baseline were collected, the ADSES, AQ and Swedish Driver Behaviour Questionnaire (Swedish DBQ). Results: Perceived driving self-efficacy and functional abilities did not change from baseline to follow-up. Baseline perceived executive functions and impulsive personality traits were significantly associated with driving self-efficacy at follow-up. Lower self-efficacy and functional abilities were associated with lower driving mileage and increased use of compensatory driving strategies, whereas lower self-efficacy beliefs were associated with driver mistakes and inattention. Driver violations and inattention were associated with minor accidents. Conclusion: The present study demonstrates that higher-level functions such as executive functions, impulsive personality traits, driving self-efficacy and functional abilities, influence post-injury accident involvement mediated through proximal driving factors such as driver inattention. Further evidence is warranted to explore self-rating measures compared to performance-based methods as predictors of risky driver behaviour, crashes, and near misses. (C) 2015 Elsevier Ltd. All rights reserved.	[Rike, Per-Ola; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway; [Johansen, Hans J.] Stavern Rehabil Hosp, Stavern, Norway; [Ulleberg, Pal; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Lundqvist, Anna] Linkoping Univ Hosp, Dept Rehabil Med, S-58185 Linkoping, Sweden		Rike, PO (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	perola.rike@sunnaas.no			Extrastiftelsen [2008/2/0113]	The authors thank all persons for their participation and Frank Becker, M.D. for the medical data quality assurance. The study was supported by grants from Extrastiftelsen (Grant Number 2008/2/0113). The authors declare that there are no conflicts of interest.	Aberg L, 1998, ERGONOMICS, V41, P39, DOI 10.1080/001401398187314; Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Af Wahlberg A, 2011, THEOR ISS ERGON SCI, V12, P66, DOI 10.1080/14639220903023376; af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005; Amado S, 2014, ACCIDENT ANAL PREV, V63, P65, DOI 10.1016/j.aap.2013.10.022; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baldock MRJ, 2006, ACCIDENT ANAL PREV, V38, P1038, DOI 10.1016/j.aap.2006.04.016; Bandura A., 1997, SELF EFFICACY EXERCI; Banfield J. F., 2004, HDB SELF REGULATION, P62; Baumeister Roy, 2011, HDB SELF REGULATION; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bjornskau T., 2003, ROAD TRAFFIC RISK NO; Cellar DF, 2000, PSYCHOL REP, V86, P454, DOI 10.2466/PR0.86.2.454-456; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Costa P. T., 1992, REVISED NEO PERSONAL; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; Dolan SL, 2008, BEHAV SCI LAW, V26, P799, DOI 10.1002/bsl.845; ELANDER J, 1993, PSYCHOL BULL, V113, P279, DOI 10.1037/0033-2909.113.2.279; Ellekjaer Hanne, 2007, Tidsskr Nor Laegeforen, V127, P740; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; George S., 2013, AUSTRALASIAN J AGEIN; George S, 2007, CLIN REHABIL, V21, P56, DOI 10.1177/0269215506071284; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Hatakka M., 2002, TRANSPORT RES F TRAF, V5, P201, DOI 10.1016/s1369-8478(02)00018-9; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Kay LG, 2009, ARCH PHYS MED REHAB, V90, P1514, DOI 10.1016/j.apmr.2009.03.011; Lajunen T, 2003, TRANSPORT RES F TRAF, V6, P97, DOI [DOI 10.1016/S1369-8478(03)00008-1, 10.1016/S1369-8478(03)00008-1, 10.1016/ S1369-8478(03)00008-1]; Ledesma RD, 2010, TRAFFIC INJ PREV, V11, P142, DOI 10.1080/15389580903497139; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Morisset N, 2010, SWISS J PSYCHOL, V69, P233, DOI 10.1024/1421-0185/a000027; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ortoleva C., 2011, J HEAD TRAUMA REHABI; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; PRIGATANO GP, 1991, AWARENESS DEFICITS B; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rike P. O., 2014, EXPLORING ASS UNPUB; Rike P. O., 2014, BRAIN INJURY, P1; Rimmo P.-A., 2014, TRANSPORT RES F-TRAF, V2, P151; Roca J, 2013, TRANSPORT RES F-TRAF, V17, P98, DOI 10.1016/j.trf.2012.10.005; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Sakai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045920; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Scialfa C, 2010, J GERONTOL B-PSYCHOL, V65, P434, DOI 10.1093/geronb/gbq032; Scott CA, 2009, J CLIN EXP NEUROPSYC, V31, P353, DOI 10.1080/13803390802169067; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Stapleton T, 2012, AUST OCCUP THER J, V59, P63, DOI 10.1111/j.1440-1630.2011.00980.x; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sumer N, 2003, ACCIDENT ANAL PREV, V35, P949, DOI 10.1016/S0001-4575(02)00103-3; Sundstrom A, 2011, EUR J PSYCHOL ASSESS, V27, P164, DOI 10.1027/1015-5759/a000063; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wood JM, 2013, J GERONTOL A-BIOL, V68, P559, DOI 10.1093/gerona/gls150; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	81	13	13	2	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8478	1873-5517		TRANSPORT RES F-TRAF	Transp. Res. Pt. F-Traffic Psychol. Behav.	FEB	2015	29						34	47		10.1016/j.trf.2015.01.004			14	Psychology, Applied; Transportation	Social Science Citation Index (SSCI)	Psychology; Transportation	CE6VV	WOS:000351977200004					2022-02-06	
J	Berlin, T; Murray-Krezan, C; Yonas, H				Berlin, Tracey; Murray-Krezan, Cristina; Yonas, Howard			Comparison of parenchymal and ventricular intracranial pressure readings utilizing a novel multi-parameter intracranial access system	SPRINGERPLUS			English	Article						Parenchymal ICP; Ventricular ICP; Intracranial pressure; External ventricular drain; Cerebrospinal fluid; Neurocritical care; Traumatic brain injury; Subarachnoid hemorrhage; InnerSpace Neuro Solutions, Inc; Hummingbird Synergy Ventricular System	AGREEMENT	Introduction: Both ventricular and parenchymal devices are available for measurement of intracranial pressure (ICP). The Hummingbird (R) Synergy Ventricular System is a novel device allowing multi-parametric neurological monitoring, including both ventricular and parenchymal ICP. The purpose of this study is to compare the congruence of the device's ventricular and parenchymal ICP readings. Methods: This single-center, quantitative, interventional study compared parenchymal and ventricular ICP readings from 35 patients with the Hummingbird (R) System. If a difference of > +/- 3 mmHg existed between an individual patient's parenchymal and ventricular values, progressive intervention strategies were applied to correct identified issues. Results: From a total of 2,259 observations, statistical analysis revealed congruence (within +/- 0-3 mmHg) of 93% of readings comparing parenchymal and ventricular ICP. Of the observations requiring intervention, 58% involved the parenchymal component, 30% involved the ventricular component, and 12% involved both components. Following prescribed interventions, 98% of readings became congruent (within +/- 0-3 mmHg). The adjusted mean difference between the two methods was -0.95 (95% CI: -0.97, -0.93) mmHg and all mean ICP readings fell between -2 and 2 mmHg. Conclusion: The Hummingbird (R) Synergy Ventricular System demonstrates congruence between ventricular and parenchymal ICP measurements within accepted parameters. Interventions required to realign parenchymal and ventricular readings serve as reminders to clinicians to be vigilant with catheter/cable connections and to maintain appropriate positioning of the ventricular drainage system. The results of this study support the recommendation to use the parenchymal ICP component for routine ICP monitoring, allowing dedication of the ventricular catheter to drainage of cerebrospinal fluid (CSF).	[Berlin, Tracey] Univ New Mexico Hosp, Dept Neurosurg, Albuquerque, NM 87131 USA; [Murray-Krezan, Cristina] Univ New Mexico, Sch Med, Dept Internal Med, Div Epidemiol Biostat & Prevent Med, Albuquerque, NM 87131 USA; [Yonas, Howard] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA		Berlin, T (corresponding author), Univ New Mexico Hosp, Dept Neurosurg, MSC10 5615,1 Univ New Mexico, Albuquerque, NM 87131 USA.	tmberlin@verizon.net	Murray-Krezan, Cristina/O-3834-2016	Murray-Krezan, Cristina/0000-0002-5488-1080	Department of Neurosurgery at the University of New Mexico Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001449] Funding Source: NIH RePORTER	This project was supported by the Department of Neurosurgery at the University of New Mexico Hospital. The authors wish to thank the dedicated nursing staff in the Neuroscience ICU for their involvement in this study. We wish to acknowledge Arthur Stidfole BSN, RN, MM, CNRN and Kim Olin MSN, RN, CCRN for their assistance with data validation. We also extend our gratitude to Kristina Anderson for her assistance with manuscript editing.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brean A, 2006, J Clin Monit Comput, V20, P411, DOI 10.1007/s10877-006-9047-7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Chohan MO, 2014, OPER NEUROSURG, V10, P400, DOI 10.1227/NEU.0000000000000451; Eide PK, 2008, J NEUROSURG, V109, P912, DOI 10.3171/JNS/2008/109/11/0912; Frattalone AR, 2011, INTENS CARE MED, V37, P1051, DOI 10.1007/s00134-011-2226-0; Hintze J., 2011, PASS 11; InnerSpace Neuro Solutions Inc, 2010, HUMM SYN VENTR SYST; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Littlejohns LR, 2008, AACN AACN PROTOCOLS; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; SAS Institute Inc, 2012, SAS 9 4; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stata Corp LP, 2014, STATA SE 13 1; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	18	13	13	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JAN 6	2015	4								10	10.1186/2193-1801-4-10			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4NP	WOS:000359137900001	25674495	Green Published, gold			2022-02-06	
J	Fraisier, C; Papa, A; Almeras, L				Fraisier, Christophe; Papa, Anna; Almeras, Lionel			High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severity	VIRUS RESEARCH			English	Article						West Nile virus; Encephalitis; Neuroinvasive disease; Serum biomarkers; ELISA	TRAUMATIC BRAIN-INJURY; NILE VIRUS-INFECTION; 1 HMGB1 PROTEIN; CEREBROSPINAL-FLUID; POSTISCHEMIC INFLAMMATION; WEST; SERUM; MARKERS; CELLS	The recent increase of West Nile neuroinvasive disease (WNND) incidence in southern Europe made this change in epidemiology a major concern for public health. The lack of a vaccine or specific treatment against human WNV infection imposes the need to discover biological markers associated with disease severity for diagnostic and/or therapeutic purposes. Recently, using a brain proteomic study from a mouse model of West Nile virus (WNV) infection with neuronal involvement, we reported the kinetic up-regulation of high-mobility group box-1 (HMGB1) and peroxiredoxin-6 (PRDX6), before and after onset of clinical symptoms, respectively. To evaluate whether these proteins could be useful biomarkers for the distinction of WNV disease severity in humans, HMBG1 and PRDX6 concentrations in serum from WNV-infected patients (n = 49) diagnosed for either WNF (n = 22) or WNND (n = 27), were measured by ELISA and compared to concentrations in serum from uninfected healthy individuals (n = 30). HMGB1 concentrations were significantly higher in WNND than in either WNF patients (p <0.05) or healthy individuals (p <0.001). In contrast, PRDX6 levels were significantly higher in healthy individuals compared with WNV-infected patients (p <0.001), regardless of clinical symptoms. The present study highlighted the deregulation of HMGB1 and PRDX6 serum level in WNV-infected patients and provided HMGB1 as candidate biomarker distinguishing disease severity. Further investigation in larger cohorts could confirm HMGB1 and PRDX6 as auxiliary biomarkers in confirmed cases of WNV infection and validate the usefulness of measuring HMBG1 for prediction of detrimental clinical outcome. (C) 2014 Elsevier B.V. All rights reserved.	[Fraisier, Christophe; Almeras, Lionel] Aix Marseille Univ, INSERM 1095, IRD 198,UM63, CNRS 7278,Unite Rech Maladies Infect & Trop Emerg, Marseille, France; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece		Almeras, L (corresponding author), Aix Marseille Univ, INSERM 1095, IRD 198,UM63, CNRS 7278,Unite Rech Maladies Infect & Trop Emerg, Marseille, France.	almeras.lionel@gmail.com		ALMERAS, Lionel/0000-0003-0490-5774			Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Fossati S, 2007, INT REV NEUROBIOL, V82, P137, DOI 10.1016/S0074-7742(07)82007-1; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; Hattori Fumiyuki, 2007, V44, P357; Higgins SJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-105; Kapoor H, 2004, J CLIN VIROL, V31, P289, DOI 10.1016/j.jcv.2004.05.017; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Momonaka H., 2013, BRAIN DEV; Neghina AM, 2011, VECTOR-BORNE ZOONOT, V11, P1289, DOI 10.1089/vbz.2010.0206; Nixon ML, 2006, J CLIN VIROL, V37, P174, DOI 10.1016/j.jcv.2006.07.005; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/eri.12.59, 10.1586/ERI.12.59]; Passali D, 2012, ACTA OTORHINOLARYNGO, V32, P46; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Rizzo C., 2012, EURO SURVEILL, V17; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Wang HC, 2006, VIRAL IMMUNOL, V19, P3, DOI 10.1089/vim.2006.19.3; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	27	13	13	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702	1872-7492		VIRUS RES	Virus Res.	JAN 2	2015	195						9	12		10.1016/j.virusres.2014.08.017			4	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	AY5EM	WOS:000347595900002	25197038				2022-02-06	
J	Bailie, JM; Cole, WR; Ivins, B; Boyd, C; Lewis, S; Neff, J; Schwab, K				Bailie, Jason M.; Cole, Wesley R.; Ivins, Brian; Boyd, Cynthia; Lewis, Steven; Neff, John; Schwab, Karen			The Experience, Expression, and Control of Anger Following Traumatic Brain Injury in a Military Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; explosive blast injury; military injury; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN WAR VETERANS; HEAD-INJURY; MANAGEMENT THERAPY; AGGRESSION; MILD; IRAQ; IRRITABILITY; HOSTILITY; SYMPTOMS	Objective: To investigate the impact of traumatic brain injury (TBI) on the experience and expression of anger in a military sample. Participants: A total of 661 military personnel with a history of TBI and 1204 military personnel with no history of TBI. Design: Cross-sectional, between-group design, using multivariate analysis of variance. Main Measure: State-Trait Anger Expression Inventory-2 (STAXI-2). Results: Participants with a history of TBI had higher scores on the STAXI-2 than controls and were 2 to 3 times more likely than the participants in the control group to have at least 1 clinically significant elevation on the STAXI-2. Results suggested that greater time since injury (ie, months between TBI and assessment) was associated with lower scores on the STAXI-2 State Anger scale. Conclusion: Although the results do not take into account confounding psychiatric conditions and cannot address causality, they suggest that a history of TBI increases the risk of problems with the experience, expression, and control of anger. This bolsters the need for proper assessment of anger when evaluating TBI in a military cohort.	[Bailie, Jason M.; Boyd, Cynthia; Neff, John] Naval Med Ctr San Diego, Def & Vet Brain Injury Ctr, San Diego, CA 92134 USA; [Bailie, Jason M.; Cole, Wesley R.; Boyd, Cynthia] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA; [Ivins, Brian] Adv Mil Med Inc, Henry M Jackson Fdn, Washington, DC USA; [Ivins, Brian] Def & Vet Brain Injury Ctr, Washington, DC USA; [Cole, Wesley R.; Lewis, Steven] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Lewis, Steven] Womack Army Med Ctr, Dept Traumat Brain Injury, Ft Bragg, NC USA; [Neff, John] US Navy, Rehabil Med, San Diego, CA 92152 USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Epidemiol & Res Support Serv, Washington, DC USA		Bailie, JM (corresponding author), Naval Med Ctr San Diego, Def & Vet Brain Injury Ctr, 34730 Bob Wilson Dr,Ste 201, San Diego, CA 92134 USA.	jason.bailie.ctr@med.navy.mil			 [W91YTZ-12-C-0132]	Research on this article was done under contract # W91YTZ-12-C-0132.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; [Anonymous], 2005, GAO05952; [Anonymous], 2008, REP SURG GEN TRAUM B; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cornell DG, 1999, J CONSULT CLIN PSYCH, V67, P108, DOI 10.1037/0022-006X.67.1.108; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Department of the Army, 2012, ARM 2020 GEN HLTH DI; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Elbogen EB, 2008, J TRAUMA STRESS, V21, P113, DOI 10.1002/jts.20283; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; LAMBERT SJ, 1990, HUM RELAT, V43, P239, DOI 10.1177/001872679004300303; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Murphy CM, 2007, J COUNS PSYCHOL, V54, P189, DOI 10.1037/0022-0167.54.2.189; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; Paniak C, 2000, BRAIN INJURY, V14, P219; Potegal M, 2010, INTERNATIONAL HANDBOOK OF ANGER, P3, DOI 10.1007/978-0-387-89676-2_1; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Spielberger CD., 1999, STAXI 2 STATE TRAIT; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Waller M, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-7; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	40	13	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					12	20		10.1097/HTR.0000000000000024			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400010	24590149				2022-02-06	
J	Bennett, TD; Dean, JM; Keenan, HT; McGlincy, MH; Thomas, AM; Cook, LJ				Bennett, T. D.; Dean, J. M.; Keenan, H. T.; McGlincy, M. H.; Thomas, A. M.; Cook, L. J.			Linked Records of Children with Traumatic Brain Injury Probabilistic Linkage without Use of Protected Health Information	METHODS OF INFORMATION IN MEDICINE			English	Article						Medical record linkage; pediatrics; brain injuries	CLINICAL REGISTRY DATA; IDENTIFIERS	Objective: Record linkage may create powerful datasets with which investigators can conduct comparative effectiveness studies evaluating the impact of tests or interventions on health. All linkages of health care data files to date have used protected health information (PHI) in their linkage variables. A technique to link datasets without using PHI would be advantageous both to preserve privacy and to increase the number of potential linkages. Methods: We applied probabilistic linkage to records of injured children in the National Trauma Data Bank (NTDB, N = 156,357) and the Pediatric Health Information Systems (PHIS, N = 104,049) databases from 2007 to 2010. 49 match variables without PHI were used, many of them administrative variables and indicators for procedures recorded as International Classification of Diseases, 9th revision, Clinical Modification codes. We validated the accuracy of the linkage using identified data from a single center that submits to both databases. Results: We accurately linked the PHIS and NTDB records for 69% of children with any injury, and 88010 of those with severe traumatic brain injury eligible for a study of intervention effectiveness (positive predictive value of 98%, specificity of 99.99%). Accurate linkage was associated with longer lengths of stay, more severe injuries, and multiple injuries. Conclusion: In populations with substantial illness or injury severity, accurate record linkage may be possible in the absence of PHI. This methodology may enable linkages and, in turn, comparative effectiveness studies that would be unlikely or impossible otherwise.	[Bennett, T. D.; Dean, J. M.; Keenan, H. T.; Thomas, A. M.; Cook, L. J.] Univ Utah, Sch Med, Salt Lake City, UT USA; [McGlincy, M. H.] Strateg Matching Inc, Morrisonville, NY USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Pediat Crit Care, Childrens Hosp Colorado,ACCORDS, 13199 E Montview Blvd,Suite 300,Campus Mail F443, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu		Bennett, Tellen/0000-0003-1483-4236	Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health [K23HD074620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health (Grant K23HD074620 to TB). We are indebted to David Bertoch and Matthew Hall at the Children's Hospital Association and to Melanie Neal and her team at the American College of Surgeons.	American College of Surgeons Committee on Trauma, 2010, NAT TRAUM DAT BANK R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Belin TR, 2004, APPL BAYESIAN MODELI; *CDCP, 1997, MMWR, V46; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Deans KJ, 2014, J PEDIATR SURG, V49, P207, DOI 10.1016/j.jpedsurg.2013.09.058; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Gelman A., 2004, BAYESIAN DATA ANAL, VVolume 2; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; HERZOG T., 2007, DATA QUALITY RECORD; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kuzu M, 2013, J AM MED INFORM ASSN, V20, P285, DOI 10.1136/amiajnl-2012-000917; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Larsen MD., JOINT STAT M P SURV, P1995; Mason CA, 2008, BIRTH DEFECTS RES A, V82, P812, DOI 10.1002/bdra.20510; McGlincy MH, 2004, BAYESIAN RECORD LINK, P4001; McGlincy MH, 2006, USING TEST DATABASES, P3404; Navathe AS, 2011, JAMA-J AM MED ASSOC, V306, P1254, DOI 10.1001/jama.2011.1341; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; NEWCOMBE HB, 1962, COMMUN ACM, V5, P563, DOI 10.1145/368996.369026; Pasquali SK, 2010, AM HEART J, V160, P1099, DOI 10.1016/j.ahj.2010.08.010; Quantin C, 1998, METHOD INFORM MED, V37, P271; Randall Sean M., 2013, J BIOMEDICAL INFORM; ROOS LL, 1991, METHOD INFORM MED, V30, P117; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneider TD, 2013, INFORM THEORY PRIMER; Schnell R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-41; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Tri-Analytics Inc. and The Johns Hopkins University, 1997, ICDMAP 90 SOFTW US G; United States Department of Health and Human Services, 2014, UND HLTH INF PRIV 20; Weber SC, 2012, J AM MED INFORM ASSN, V19, pE157, DOI 10.1136/amiajnl-2011-000329; Weiss NS, 2011, EPIDEMIOLOGY, V22, P292, DOI 10.1097/EDE.0b013e318210aca5; Weiss PF, 2009, J PEDIATR-US, V155, P812, DOI 10.1016/j.jpeds.2009.05.030; WINKLER W. E., 1993, IMPROVED DECISION RU; Winkler W. E., 2006, OVERVIEW RECORD LINK; Winkler W. E., 1994, ADV METHODS RECORD L	40	13	13	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0026-1270	2511-705X		METHOD INFORM MED	Methods Inf. Med.		2015	54	4					328	337		10.3414/ME14-01-0093			10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	CP6XQ	WOS:000360031900006	26021580	Green Accepted, Bronze			2022-02-06	
S	Chesnut, RM		Fink, ME; Barchas, JD; Sheikh, JI		Chesnut, Randall M.			A conceptual approach to managing severe traumatic brain injury in a time of uncertainty	AFFECTIVE DISORDERS AND TRAUMATIC BRAIN INJURY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	Qatar Clinical Neuroscience Conference	MAR 15-17, 2014	Doha, QATAR	Qatar Fdn Educ Sci & Community Dev			CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; BLOOD-FLOW; AUTOREGULATION; HYPERTENSION; THRESHOLDS; REACTIVITY; MANAGEMENT; RESISTANCE	Current controversies in the literature suggest that a reassessment of the current management of severe traumatic brain injury (sTBI) is necessary. This article presents a conceptual framework toward individualizing sTBI treatment with respect to targeting thresholds and strategies on the basis of known physiologic processes and available monitors. Intracranial pressure (ICP) is modeled as an epiphenomenon of cerebral compliance and herniation tendency, as well as cerebral ischemia. By combining serial neurological examinations, imaging studies, and ICP measurements (values, trends, and area-under-the-curve calculations) over time, evidence can be accrued on the necessity of maintaining ICP at a given threshold in the realm of physical changes in the brain. Similarly, by collecting and trending clinical, imaging, and monitoring data on the status of cerebral blood flow, the balance of oxygen consumption and delivery, and the status of cerebral static pressure autoregulation, and analyzing them with respect to measured parameters, such as blood pressure, ICP, and cerebral perfusion pressure, one can attempt to fine-tune these variables as well. Such individualization of management optimizes the possibility of successfully treating demonstrated pathophysiological processes while avoiding unnecessary interventions and treatment toxicity. Monitor values must not be seen as targets but rather as indicators of targetable pathology.	[Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Sch Global Hlth, Seattle, WA 98104 USA		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666			Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 2000, J NEUROTRAUM, V17, P538; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kuhn T.S., 1962, STRUCTURE SCI REVOLU; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E	41	13	13	0	1	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1345						99	107		10.1111/nyas.12483			9	Clinical Neurology; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	BC7XP	WOS:000355312300012	25040396				2022-02-06	
J	Deng-Bryant, Y; Readnower, RD; Leung, LY; Cunningham, TL; Shear, DA; Tortella, FC				Deng-Bryant, Ying; Readnower, Ryan D.; Leung, Lai Yee; Cunningham, Tracy L.; Shear, Deborah A.; Tortella, Frank C.			Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of penetrating ballistic-like brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Amnion-derived cellular cytokine solution; penetrating ballistic-like brain injury; rotarod; morris water maze; neuroinflammation; microglia; neutrophil; neurodegeneration	WHITE-MATTER INJURY; CLOSED-HEAD INJURY; BARRIER PERMEABILITY; GROWTH-FACTOR; NEONATAL-RAT; FUNCTIONAL RECOVERY; MICROGLIAL CELLS; IMMUNE-RESPONSE; EDEMA FORMATION; SMALL MOLECULES	Purpose: The present work compared the behavioral outcomes of ACCS therapy delivered either intravenously (i.v.) or intracerebroventricularly (i.c.v.) after penetrating ballistic-like brain injury (PBBI). Histological markers for neuroinflammation and neurodegeneration were employed to investigate the potential therapeutic mechanism of ACCS. Methods: Experiment-1, ACCS was administered either i.v. or i.c.v. for 1 week post-PBBI. Outcome metrics included behavioral (rotarod and Morris water maze) and gross morphological assessments. Experiment-2, rats received ACCS i.c.v for either 1 or 2 weeks post-PBBI. The inflammatory response was determined by immunohistochemistry for neutrophils and microglia reactivity. Neurodegeneration was visualized using silver staining. Results: Both i.v. and i.c.v. delivery of ACCS improved motor outcome but failed to improve cognitive outcome or tissue sparing. Importantly, only i.c.v. ACCS treatment produced persistent motor improvements at a later endpoint. The i.c.v. ACCS treatment significantly reduced PBBI-induced increase in myeloperoxidase (MPO) and ionized calcium binding adaptor molecule 1 (Iba1) expression. Concomitant reduction of both Iba1 and silver staining were detected in corpus callosum with i.c.v. ACCS treatment. Conclusions: ACCS, as a treatment for TBI, showed promise with regard to functional (motor) recovery and demonstrated strong capability to modulate neuroinflammatory responses that may underline functional recovery. However, the majority of beneficial effects appear restricted to the i.c.v. route of ACCS delivery, which warrants future studies examining delivery routes (e.g. intranasal delivery) which are more clinically viable for the treatment of TBI.	[Deng-Bryant, Ying; Readnower, Ryan D.; Leung, Lai Yee; Cunningham, Tracy L.; Shear, Deborah A.; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Deng-Bryant, Y (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave Room 2W12, Silver Spring, MD 20910 USA.	ying.d.bryant.civ@mail.mil			CDMRPUnited States Department of Defense [W81XWH-08-2-0127]	The authors are grateful for the excellent technical assistance provided by Christopher van der Merwe and Francis P. Bustos. This work was funded by CDMRP W81XWH-08-2-0127.	Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen ZY, 2011, BRAIN RES, V1368, P71, DOI 10.1016/j.brainres.2010.10.028; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Cunningham T.L., 2013, J NEUROTRAUMA; Deng-Bryant Y, 2012, J TRAUMA ACUTE CARE, V73, pS156, DOI 10.1097/TA.0b013e3182625f5f; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Franz Michael G, 2008, Eplasty, V8, pe21; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Iihara K, 1997, J CEREBR BLOOD F MET, V17, P1097, DOI 10.1097/00004647-199710000-00012; Kawabe T, 1997, NEUROSCI RES, V29, P335, DOI 10.1016/S0168-0102(97)00105-3; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Payne WG, 2010, WORLD J SURG, V34, P1663, DOI 10.1007/s00268-010-0420-9; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Steed David L, 2008, Eplasty, V8, pe18; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Uberti M Georgina, 2009, Eplasty, V9, pe12; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; ZHUANG J, 1993, J TRAUMA, V35, P415, DOI 10.1097/00005373-199309000-00014	53	13	13	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	2					189	203		10.3233/RNN-140455			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB7UX	WOS:000349835000009	25588460				2022-02-06	
J	Dutta, D; Fauer, C; Mulleneux, HL; Stabenfeldt, SE				Dutta, D.; Fauer, C.; Mulleneux, H. L.; Stabenfeldt, S. E.			Tunable controlled release of bioactive SDF-1 alpha via specific protein interactions within fibrin/nanoparticle composites	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; DRUG-DELIVERY SYSTEMS; NEURAL STEM-CELLS; PLGA NANOPARTICLES; TISSUE-REPAIR; FIBRIN; MIGRATION; HYDROGELS; FACTOR-1-ALPHA	The chemokine, stromal cell-derived factor 1 alpha (SDF-1 alpha), is a key regulator of the endogenous neural progenitor/stem cell-mediated regenerative response after neural injury. Increased and sustained bioavailability of SDF-1 alpha in the peri-injury region is hypothesized to modulate this endogenous repair response. Here, we describe poly(lactic-co-glycolic) acid (PLGA) nanoparticles capable of releasing bioactive SDF-1 alpha in a sustained manner over 60 days after a burst of 23%. Moreover, we report a biphasic cellular response to SDF-1 alpha concentrations thus the large initial burst release in an in vivo setting may result in supratherapeutic concentrations of SDF-1 alpha. Specific protein-protein interactions between SDF-1 alpha and fibrin (as well as its monomer, fibrinogen) were exploited to control the magnitude of the burst release. Nanoparticles embedded in fibrin significantly reduced the amount of SDF-1 alpha released after 72 h as a function of fibrin density. Therefore, the nanoparticle/fibrin composites represented a means to independently tune the magnitude of the burst phase release from the nanoparticles while perserving a bioactive depot of SDF-1 alpha for release over 60 days.	[Dutta, D.; Fauer, C.; Mulleneux, H. L.; Stabenfeldt, S. E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	sarah.stabenfeldt@asu.edu		Dutta, Dipankar/0000-0001-9864-1452	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2HD084067]; NSFNational Science Foundation (NSF) [1454282]; ASU Start-up Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	The authors acknowledge Dr Rachael Sirianni of Barrow Neurological Institute for technical training and support with the PLGA NP synthesis, Dr Vikram Kodibagkar of ASU for his assistance with the ultrasonicator, Caroline Addington as well as Christine Pauken for cell culture expertise and the John M. Cowley Center for High Resolution Electron Microscopy (CHREM) for assistance with the SEM. The following funding sources are acknowledged: NIH (1DP2HD084067; SES), NSF (1454282; SES), and ASU Start-up Funds (SES).	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Aprili D, 2009, ANESTHESIOLOGY, V111, P1346, DOI 10.1097/ALN.0b013e3181bfab9a; Asghar W, 2012, IEEE T NANOTECHNOL, V11, P546, DOI 10.1109/TNANO.2012.2183004; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI 10.1089/ten.TEB.2008.0527; Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215; Catelas I, 2008, TISSUE ENG PART C-ME, V14, P119, DOI 10.1089/ten.tec.2007.0262; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cross DP, 2011, PHARM RES-DORDR, V28, P2477, DOI 10.1007/s11095-011-0474-x; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Edith N. S. P., 1997, INT J PHARMACEUT, V153, P235; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Giteau A, 2008, INT J PHARMACEUT, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012; Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x; Hines DJ, 2013, CRIT REV THER DRUG, V30, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.2013006475; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Klein RS, 2001, DEVELOPMENT, V128, P1971; Kucia M, 2004, J MOL HISTOL, V35, P233; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; McCall RL, 2013, JOVE-J VIS EXP, DOI 10.3791/51015; Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054; Moon C, 2004, BRAIN RES, V1028, P238, DOI 10.1016/j.brainres.2004.09.022; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Overstreet DJ, 2012, J POLYM SCI POL PHYS, V50, P881, DOI 10.1002/polb.23081; Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riedel T, 2009, J BIOMED MATER RES A, V88A, P437, DOI 10.1002/jbm.a.31755; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Sirianni RW, 2014, BIOCONJUGATE CHEM, V25, P2157, DOI 10.1021/bc500315j; Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025; Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079; Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Wedgwood J, 2013, MACROMOL SYMP, V334, P117, DOI 10.1002/masy.201300111; Wong C, 2003, THROMB HAEMOSTASIS, V89, P573, DOI 10.1055/s-0037-1613389; Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043; Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037; Zamani M, 2015, J COLLOID INTERF SCI, V451, P144, DOI 10.1016/j.jcis.2015.04.005; Zhang JW, 2013, CHEM ENG PROG, V109, P25; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	61	13	14	0	14	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B		2015	3	40					7963	7973		10.1039/c5tb00935a			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	CT2VO	WOS:000362663000015	26660666	Green Accepted, hybrid, Green Submitted			2022-02-06	
J	Fortier, CB; Amick, MM; Kenna, A; Milberg, WP; McGlinchey, RE				Fortier, Catherine Brawn; Amick, Melissa M.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.			Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L) Clinical Interview and the VA TBI Screen	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						TBI; screen; Veteran; OEF/OIF	ADMINISTERED PTSD SCALE; VETERANS	Objective: Mild traumatic brain injury is the signature injury of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND), yet its identification and diagnosis is controversial and fraught with challenges. Setting: In 2007, the Department of Veterans Affairs (VA) implemented a policy requiring traumatic brain injury (TBI) screening on all individuals returning from deployment in the OEF/OIF/OND theaters of operation that lead to the rapid and widespread use of the VA TBI screen. The Boston Assessment of TBI-Lifetime (BAT-L) is the first validated, postcombat semistructured clinical interview to characterize head injuries and diagnose TBIs throughout the life span, including prior to, during, and post-military service. Participants: Community-dwelling convenience sample of 179 OEF/OIF/OND veterans. Main measures: BAT-L, VA TBI screen. Results: Based on BAT-L diagnosis of military TBI, the VA TBI screen demonstrated similar sensitivity (0.85) and specificity (0.82) when administered by research staff. When BAT-L diagnosis was compared with historical clinician-administered VA TBI screen in a subset of participants, sensitivity was reduced. Conclusions: The specificity of the research-administered VA TBI screen was more than adequate. The sensitivity of the VA TBI screen, although relatively high, suggests that it does not oversample or "catch all" possible military TBIs. Traumatic brain injuries identified by the BAT-L, but not identified by the VA TBI screen, were predominantly noncombat military injuries. There is potential concern regarding the validity and reliability of the clinician administered VA TBI screen, as we found poor correspondence between it and the BAT-L, as well as low interrater reliability between the clinician-administered and research-administered screen.	[Fortier, Catherine Brawn; Amick, Melissa M.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA 02130 USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Amick, Melissa M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Fortier, CB (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, Geriatr Res Educ & Clin Ctr JP 182, 150 South Huntington Ave, Boston, MA 02130 USA.	Catherine_Fortier@hms.harvard.edu	Fortier, Catherine/AAS-2163-2021; McGlinchey, Regina E/R-1971-2016	Fortier, Catherine/0000-0002-8953-9904; 	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258]; VA Merit Review AwardUS Department of Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258] Funding Source: NIH RePORTER	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), NIH NIA K23AG034258, and VA Merit Review Award to Regina McGlinchey.	Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Department of Veterans Affairs and Department of Defense, 2010, VA DOD CLIN PRACT GU; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	9	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E1	E7		10.1097/HTR.0000000000000008			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400001	24336147	Green Accepted			2022-02-06	
J	Gatto, R; Chauhan, M; Chauhan, N				Gatto, Rodolfo; Chauhan, Mihir; Chauhan, Neelima			Anti-edema effects of rhEpo in experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; controlled cortical impact injury; recombinant human erythropoietin; magnetic resonance imaging; edema; AQP4	RECOMBINANT-HUMAN-ERYTHROPOIETIN; NRF2 SIGNALING PATHWAY; AGED GARLIC EXTRACT; SPINAL-CORD-INJURY; AQP4 EXPRESSION; RAT MODEL; AQUAPORIN-4 EXPRESSION; CULTURED ASTROCYTES; CEREBRAL PROTECTION; RECEPTOR ANTAGONIST	Purpose: Traumatic brain injury (TBI) is one of the leading causes of disability and death which begins with the formation of edema as the persistent primary causative factor in TBI. Although medical management of cerebral edema by hypothermia, ventriculostomy, mannitol or hypertonic saline have been effective in treating edema, many of these therapies end up with some neurologic deficits, necessitating novel treatment options for treating post-TBI edema. This study investigated edema reducing effects of recombinant human Erythropoietin (rhEPO) in reducing acute brain edema in the CCI mouse model of TBI. Methods: Anti-edema effects of rhEpo in reducing acute brain edema after injury in the CCI mouse model of TBI were assessed by T2 weighted magnetic resonance imaging (T2wMRI) as the accurate detector of brain edema in correlation with Western blot analysis of cerebral aquaporin 4 (AQP4) index as the critical marker of edema. Results: Results show that rhEpo treatment significantly reduced brain edema with concomitant reduction in AQP4 immuno-expression in the CCI mouse model of TBI. Conclusion: Current results emphasize clinical utility of rhEpo in treating post-TBI edema.	[Gatto, Rodolfo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Chauhan, Mihir] Med Univ Lublin, Lublin, Poland; [Chauhan, Neelima] Jesse Brown VA Med Ctr, R&D, Neurosci Res, Chicago, IL 60612 USA; [Chauhan, Neelima] Univ Illinois, Dept Pediat, Chicago, IL USA		Chauhan, N (corresponding author), Jesse Brown VA Med Ctr, R&D 151, 820 South Damen Ave, Chicago, IL 60612 USA.	nchauhan@uic.edu	Gatto, Rodolfo Gabriel/R-7155-2018	Gatto, Rodolfo Gabriel/0000-0003-2170-6662	VA MERIT Grants (Rehab R&D, Department of Veterans Affairs, Jesse Brown VA Medical Center) [B6285R/NBC, I008880/NBC]; Westside Institute for Science & Education, Chicago, IL; Department of Pediatrics, University of Illinois at Chicago; Department of BioEngineering, University of Illinois at Chicago	This work was supported by VA MERIT Grants (#B6285R/NBC and #I008880/NBC, Rehab R&D, Department of Veterans Affairs, Jesse Brown VA Medical Center); Westside Institute for Science & Education, Chicago, IL; Departments of Pediatrics and Department of BioEngineering, University of Illinois at Chicago. Authors are thankful for the support provided by Dr. Robert Kleps (Research Resource Center, University of Illinois at Chicago) in collecting MRI data. Authors specially wish to thank Jesse Brown VA-Veterinary Medical Unit staff (Robin McWherter, Tyler Ridgeway, Nicholas Cronk and Carl Miller) for their valuable help and support in providing excellent environment and resources to conduct all animal procedures.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Brissaud O, 2010, PEDIATR RES, V68, P123, DOI 10.1203/00006450-201011001-00237; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chauhan NB, 2005, NEUROPHARMACOLOGY, V48, P93, DOI 10.1016/j.neuropharm.2004.09.014; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Franklin K, 1998, MOUSE BRAIN STEREOTA; Gaddam Samson Kumar, 2013, Methods Mol Biol, V982, P141, DOI 10.1007/978-1-62703-308-4_9; Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Kalinin S, 2006, ANTIOXID REDOX SIGN, V8, P873, DOI 10.1089/ars.2006.8.873; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Odri A, 2009, ANN FR ANESTH, V28, P352, DOI 10.1016/j.annfar.2009.02.023; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Ozisik K, 2006, TRANSPLANT P, V38, P2784, DOI 10.1016/j.transproceed.2006.08.100; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Pearse D, 2010, CURR OPIN INVEST DR, V11, P1207; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Ray B, 2011, CURR MED CHEM, V18, P3306, DOI 10.2174/092986711796504664; Ray B, 2011, J NEUROCHEM, V117, P388, DOI 10.1111/j.1471-4159.2010.07145.x; Romeiro RR, 2007, NEUROSCI LETT, V426, P133, DOI 10.1016/j.neulet.2007.09.004; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Shi ZF, 2015, BIOMED ENVIRON SCI, V28, P199, DOI 10.3967/bes2015.026; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Tang ZH, 2012, NEUROSCI LETT, V530, P23, DOI 10.1016/j.neulet.2012.09.029; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	75	13	18	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	6					927	941		10.3233/RNN-150577			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA1MU	WOS:000367560700011	26484701				2022-02-06	
J	Gould, KR; Ponsford, JL				Gould, Kate R.; Ponsford, Jennie L.			A longitudinal examination of positive changes in quality-of-life after traumatic brain injury	BRAIN INJURY			English	Article						Family; post-traumatic growth; psychiatric disorders; quality-of-life; response shift; traumatic brain injury	SEVERE HEAD-INJURY; POSTTRAUMATIC GROWTH; RESPONSE SHIFT; REHABILITATION; DISABILITY; ADJUSTMENT; PEOPLE	Purpose: Most studies of quality-of-life (QoL) after traumatic brain injury (TBI) reveal a largely negative picture, yet some survivors show positive changes (PC). Understanding PC in QoL may assist clinicians in facilitating post-injury adjustment. This study aimed to prospectively explore changes in QoL from pre- to post-injury, identify those with PC and examine predictive and associated factors. Methods: Ninety-five participants, recruited from consecutive admissions to a rehabilitation hospital, were prospectively assessed at least once over the first 4 years post-injury. Measures of QoL, psychiatric disorders, coping style and psychosocial outcome were administered at each assessment. Results: Participants' mean QoL was in the average range pre-injury and at follow-up. A third demonstrated PC post-injury, which tended to remain stable. PC participants tended to rate their relatives as of greater importance than other participants, but did not rate their health as high. Group membership was not predicted by pre-injury demographic or injury factors, but it was significantly associated with psychosocial and functional outcome. Conclusions: Even after a significant brain injury, some individuals show sustained improved QoL. Factors such as lack of 'good old days' bias and increased value placed on family may have important clinical utility.	[Gould, Kate R.; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Gould, Kate R.; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Gould, Kate R.; Ponsford, Jennie L.] Alfred Hosp, Natl Trauma Res Inst, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic, Australia		Gould, KR (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	kate.gould@monash.edu	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408	Transport Accident Commission; Centre of Excellence in Traumatic Brain Injury Research Rehabilitation Fellowship	This research was supported by the Transport Accident Commission. Dr Gould was the 2012-2013 recipient of the Centre of Excellence in Traumatic Brain Injury Research Rehabilitation Fellowship.	ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Australian Bureau of Statistics, 2009, NAT SURV MENT HLTH W; Blair H, 2010, BRAIN INJURY, V24, P833, DOI 10.3109/02699051003789203; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Camfield L, 2008, J HEALTH PSYCHOL, V13, P764, DOI 10.1177/1359105308093860; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Frisch M.B., 1994, QUALITY LIFE INVENTO; Frydenberg E, 1997, COPING SCALE ADULTS; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Nelson H.E., 1982, NATL ADULT READING T; Ownsworth T, 2011, BRAIN IMPAIRMENT, V12; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Retzlaff PJ, 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512	41	13	13	5	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					283	290		10.3109/02699052.2014.974671			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000001	25356859				2022-02-06	
J	Hart, T; Brockway, JA; Fann, JR; Maiuro, RD; Vaccaro, MJ				Hart, Tessa; Brockway, Jo Ann; Fann, Jesse R.; Maiuro, Roland D.; Vaccaro, Monica J.			Anger self-management in chronic traumatic brain injury: protocol for a psycho-educational treatment with a structurally equivalent control and an evaluation of treatment enactment	CONTEMPORARY CLINICAL TRIALS			English	Article						Brain injuries; Anger management; Psychological treatment; Problem solving	TREATMENT FIDELITY; CONTROLLED-TRIALS; BEHAVIOR-CHANGE; IRRITABILITY; RECOMMENDATIONS; INTERVENTIONS; AGGRESSION; PROGRAM; PSYCHOTHERAPY; AWARENESS	Anger and irritability are important and persistent clinical problems following traumatic brain injury (TBI). Treatment options include medications, behavioral modification, and psychotherapies, but some are impractical and none have proven efficacy with this population. We describe a randomized multi-center clinical trial testing a novel, one-on-one, 8-session psychoeducational treatment program, Anger Self-Manageinent Training (ASMT), designed specifically for people with TBI who have significant cognitive impairment. The trial is notable for its use of a structurally equivalent comparison treatment, called Personal Readjustment and Education (PRE), which was created for the study and is intended to maximize equipoise for both participants and treaters. Fidelity assessment is conducted in real time and used in therapist supervision sessions. The primary outcome is change in self-reported anger on validated measures from pre-treatment to 1 week after the final session. Secondary outcomes include participant anger as reported by a significant other; emotional distress in domains other than anger/irritability; behavioral functioning; and quality of life. An interim assessment after the 4th session will allow examination of the trajectory of any observed treatment effects, and a follow-up assessment 2 months after the end of intervention will allow examination of persistence of effects. A treatment enactment phase, in which participants are interviewed several months after the last therapy session, is designed to provide qualitative data on whether and to what extent the principles and techniques learned in treatment are still carried out in daily life. (C) 2014 Elsevier Inc. All rights reserved.	[Hart, Tessa; Vaccaro, Monica J.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Hart, Tessa] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Brockway, Jo Ann] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Maiuro, Roland D.] Seattle Anger Management Program, Seattle, WA USA; [Maiuro, Roland D.] Seattle Domest Violence Program, Seattle, WA USA		Hart, T (corresponding author), Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA.	thart@einstein.edu			National Institutes of Health (NICHD/NCMRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1HD061400]; Moss Rehabilitation Research Institute Peer Review Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061400] Funding Source: NIH RePORTER	This research is supported by the National Institutes of Health (NICHD/NCMRR) grant #1RO1HD061400 and by a grant from the Moss Rehabilitation Research Institute Peer Review Committee. We thank Sureyya Dikmen, PhD, Nancy Temkin, PhD, and Thomas Novack, PhD for their assistance in developing the trial protocol. Cindy Harrison-Felix, PhD, David Mellick, and Christopher Cusick contributed substantially to the plans for data quality assurance.	Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babor TF, 2001, AUDIT ALCOHOL USE DI; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burkhardt F, 2009, IEEE INT C AC SPEECH; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deffenbacher JL, 2002, COUNS PSYCHOL, V30, P262, DOI 10.1177/0011000002302004; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DiGiuseppe R, 2003, CLIN PSYCHOL-SCI PR, V10, P70, DOI 10.1093/clipsy/10.1.70; Eames P., 1990, NEUROBEHAVIORAL SEQU, P410; Eckhardt C, 2004, AGGRESS VIOLENT BEH, V9, P17, DOI 10.1016/S1359-1789(02)00116-7; Fleminger S, 2006, COCHRANE DATABASE SY, V3; GALSKI T, 1994, ARCH PHYS MED REHAB, V75, P380, DOI 10.1016/0003-9993(94)90158-9; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; LaBrie JW, 2005, PSYCHOL ADDICT BEHAV, V19, P112, DOI 10.1037/0893-164X.19.1.112; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI [10.1177/088626087002002003, DOI 10.1177/088626087002002003]; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; Robb SL, 2011, PSYCHO-ONCOLOGY, V20, P1193, DOI 10.1002/pon.1845; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; Schnurr PR, 2007, J TRAUMA STRESS, V20, P779, DOI 10.1002/jts.20292; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Silver J, 2007, BRAIN INJURY MED PRI, P963; Spielberger CD, 2000, STATE TRAIT ANGER EX; Taft CT, 2012, J REHABIL RES DEV, V49, P777, DOI 10.1682/JRRD.2011.09.0156; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Wechsler D., 2011, WECHSLER ABBREVIATED; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; WHO ASSIST Working Group, 2002, ALC SMOK SUBST INV S; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374	61	13	13	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						180	192		10.1016/j.cct.2014.12.005			13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000021	25530306	Green Accepted			2022-02-06	
J	Hawkins, BL; McGuire, FA; Britt, TW; Linder, SM				Hawkins, Brent L.; McGuire, Francis A.; Britt, Thomas W.; Linder, Sandra M.			Identifying contextual influences of community reintegration among injured servicemembers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						assistance barriers; community dwelling; community reintegration; contextual factors; CR; environmental factors; general self-efficacy; injured military servicemembers; personal factors; rehabilitation	SOCIAL COGNITIVE THEORY; TRAUMATIC BRAIN-INJURY; ENVIRONMENTAL-FACTORS; INTERNATIONAL CLASSIFICATION; MEASURING PARTICIPATION; DISABILITY; EMPLOYMENT; CHALLENGES; TYPOLOGY; OUTCOMES	Research suggests that community reintegration (CR) after injury and rehabilitation is difficult for many servicemembers. However, little is known about the influence of the contextual factors, both personal and environmental, on CR. Framed within the International Classification of Functioning, Disability and Health and social cognitive theory, the quantitative portion of a larger mixed-methods study of 51 injured, community-dwelling servicemembers compared the relative contribution of contextual factors between groups of servicemembers with different levels of CR. Cluster analysis indicated three groups of servicemembers showing low, moderate, and high levels of CR. Statistical analyses identified contextual factors that significantly discriminated between CR clusters. Multivariate analysis of variance and discriminant analysis indicated significant contributions of general self-efficacy, services and assistance barriers, physical and structural barriers, attitudes and support barriers, perceived level of disability and/or handicap, work and school barriers, and policy barriers to CR scores. Overall, analyses indicated that injured servicemembers with lower CR scores had lower general self-efficacy scores, reported more difficulty with environmental barriers, and reported their injuries as more disabling.	[Hawkins, Brent L.; McGuire, Francis A.] Clemson Univ, Dept Pk Recreat & Tourism Management, 128 McGinty Ct,263 Lehotsky Hall, Clemson, SC 29634 USA; [Britt, Thomas W.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA; [Linder, Sandra M.] Clemson Univ, Eugene T Moore Sch Educ, Clemson, SC 29634 USA		Hawkins, BL (corresponding author), Clemson Univ, Dept Pk Recreat & Tourism Management, 128 McGinty Ct,263 Lehotsky Hall, Clemson, SC 29634 USA.	blhawki@clemson.edu					Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A, 1986, SOCIAL FDN THOUGHT A; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Bryan CJ, 2010, MIL MED, V175, P713, DOI 10.7205/MILMED-D-09-00248; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Hawkins BL, 2011, THER RECREAT J, V45, P309; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Law M, 2007, ARCH PHYS MED REHAB, V88, P1636, DOI 10.1016/j.apmr.2007.07.035; Lysack Cathy, 2007, Can J Occup Ther, V74 Spec No., P243; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Mowatt RA, 2011, THER RECREAT J, V45, P286; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Resnik L, 2012, J REHABIL RES DEV, V49, P557, DOI 10.1682/JRRD.2011.04.0081; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Wang PP, 2006, DISABIL REHABIL, V28, P135, DOI 10.1080/09638280500167761; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; World Health Organization, 2007, INT CLASS FUNCT DIS; Yazicioglu K, 2006, MIL MED, V171, P1083, DOI 10.7205/MILMED.171.11.1083	31	13	13	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	2					235	246		10.1682/JRRD.2014.08.0195			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CK6DB	WOS:000356317600011	26237496	Bronze			2022-02-06	
J	Jin, XQ; Ye, F; Zhang, JJ; Zhao, Y; Zhou, XL				Jin, Xiao-Qing; Ye, Fei; Zhang, Jun-Jian; Zhao, Yan; Zhou, Xian-Long			Triptolide attenuates cerebral ischemia and reperfusion injury in rats through the inhibition the nuclear factor kappa B signaling pathway	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						ischemic stroke; inflammation; rat model; NF-kappa B pathway	TRAUMATIC BRAIN-INJURY; CELL-DEATH; STROKE; INFLAMMATION; ACTIVATION; EXPRESSION; CONTRIBUTES; INFARCTION; OCCLUSION; HEART	Inflammation plays critical roles in the acute progression of the pathology of ischemic injury. Previous studies have shown that triptolide interferes with a number of pro-inflammatory mechanisms. In this study, we investigated whether triptolide has protective effects during acute cerebral ischemia/reperfusion (I/R) injury. Male Sprague Dawley rats received triptolide or vehicle at the onset of reperfusion following middle cerebral artery occlusion. Twenty-four hours after reperfusion, we evaluated neurological injuries, the expression of pro-inflammatory markers, and NF-kappa B activation. I/R rats treated with triptolide showed significantly better neurological deficit scores, decreased neural apoptosis, and reduced cerebral infarct volume and brain edema, and triptolide treatment suppressed the activation of NF-kappa B following I/R injury. Furthermore, the expression levels of pro-inflammatory cytokines at both the mRNA and protein levels were significantly decreased in rats receiving triptolide. These results indicate that the neuroprotective effects of triptolide during acute cerebral I/R injury are possibly related to the inhibition of both the NF-kappa B signaling pathway and inflammation.	[Jin, Xiao-Qing; Ye, Fei; Zhang, Jun-Jian] Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430071, Hunan, Peoples R China; [Jin, Xiao-Qing; Zhao, Yan; Zhou, Xian-Long] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Hunan, Peoples R China		Zhang, JJ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurol, 169 Donghu Rd, Wuhan 430071, Hunan, Peoples R China.	xsssm@sina.cn			Emergency Diagnostic and Therapeutic Center of Central China	The authors would like to thank the Center for Animal Experiments, Wuhan University (Wuhan, Hubei, People's Republic of China) for assistance. This study was financially supported by the Emergency Diagnostic and Therapeutic Center of Central China.	Arrick DM, 1985, J APPL PHYSIOL, V2012, P1121; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Faul JL, 2000, AM J RESP CRIT CARE, V162, P2252, DOI 10.1164/ajrccm.162.6.2002018; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kwon SW, 2011, BIOCHEM BIOPH RES CO, V411, P354, DOI 10.1016/j.bbrc.2011.06.147; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Lu Y, 2006, INVEST OPHTH VIS SCI, V47, P3796, DOI 10.1167/iovs.06-0319; Mao YP, 1999, J LIQ CHROMATOGR R T, V22, P1355, DOI 10.1081/JLC-100101737; Matta R, 2009, AM J TRANSL RES, V1, P267; Meldrum DR, 1997, J MOL CELL CARDIOL, V29, P2849, DOI 10.1006/jmcc.1997.0506; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Murakami K, 1998, J NEUROSCI, V18, P205; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Patzer A, 2008, EUR J NEUROSCI, V28, P1786, DOI 10.1111/j.1460-9568.2008.06478.x; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shah IM, 2009, CURR MOL MED, V9, P336, DOI 10.2174/156652409787847236; Shao F, 2007, BIOL PHARM BULL, V30, P702, DOI 10.1248/bpb.30.702; Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004	30	13	14	1	10	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						1395	1403		10.2147/NDT.S82052			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CJ9UI	WOS:000355848300001	26082636	Green Submitted, Green Published, gold			2022-02-06	
J	Johansson, B; Ronnback, L				Johansson, Birgitta; Ronnback, Lars			Novel computer tests for identification of mental fatigue after traumatic brain injury	NEUROREHABILITATION			English	Article						Mental fatigue; novel computer test; traumatic brain injury; cognitive function	DIVIDED ATTENTION; HEAD-INJURY; MILD; SYMPTOMS; DEFICITS; STROKE	BACKGROUND: Mental fatigue is one of the most significant post-traumatic brain injury symptoms. It is currently not possible to objectively identify. OBJECTIVE: This study investigated whether a complex computer cognitive test with load on endurance, processing speed and attention were more demanding for participants suffering from mental fatigue after brain injury compared with a control group. METHOD: Seventy-six subjects of mild traumatic brain injury (mTBI) and 45 healthy controls were included in the study. All subjects with mTBI had been suffering from mental fatigue for six months or more. Mental fatigue was screened using the Mental Fatigue Scale (MFS). Cognitive function was measured for information processing speed and working memory, and with a novel computer test. RESULTS: The mTBI group rated MFS significantly higher than the control group. The results revealed a significantly slower information processing speed for the mTBI subjects and a poorer performance on the working memory test. The computer test revealed a less efficient performance over time for the TBI subjects compared to the control group. CONCLUSIONS: The results indicate a less efficient performance over time in complex and demanding cognitive tasks for individuals experiencing from mental fatigue after brain injury.	[Johansson, Birgitta; Ronnback, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, S-41345 Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	AFA Insurance; The Local Research and Development Board for Gothenburg and Sodra Bohuslan; Health & Medical Care Committee of the Vastra Gotaland Region; Swedish Stroke Association; Swedish Association for Survivors of Accident and Injury (RTP)	This work was supported by grants from AFA Insurance, The Local Research and Development Board for Gothenburg and Sodra Bohuslan, The Health & Medical Care Committee of the Vastra Gotaland Region, The Swedish Stroke Association and the Swedish Association for Survivors of Accident and Injury (RTP).	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Donkelaar P. V., 2005, BRAIN INJURY, V19, P1031; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jacobs L, 2011, MILD BRAIN INJURY IM; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Ronnback L, 2012, LONG LASTING MENTAL; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler D., 2004, WECHSLER ADULT INTEL; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zomeren V. A. H., 1999, J NEUROL NEUROSUR PS, V66, P207	32	13	13	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	2					195	202		10.3233/NRE-151207			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CK9CW	WOS:000356539100005	25882202				2022-02-06	
J	Liang, ZY; Luo, YH				Liang, Zhaoyang; Luo, Yunhua			A QCT-Based Nonsegmentation Finite Element Head Model for Studying Traumatic Brain Injury	APPLIED BIONICS AND BIOMECHANICS			English	Article							BONE-DENSITY; CT NUMBERS	In the existing finite element head models (FEHMs) that are constructed from medical images, head tissues are usually segmented into a number of components according to the interior anatomical structure of the head. Each component is represented by a homogenous material model. There are a number of disadvantages in the segmentation-based finite element head models. Therefore, we developed a nonsegmentation finite element head model with pointwise-heterogeneous material properties and corroborated it by available experiment data. Fromthe obtained results, it was found that although intracranial pressures predicted by the existing (piecewise-homogeneous) and the proposed (pointwise-heterogeneous) FEHM are very similar to each other, strain/stress levels in the head tissues are very different. The maximum peak strains/stresses predicted by the proposed FEHM are much higher than those by the existing FEHM, indicating that piecewise-homogeneous FEHM may have underestimated the stress/strain level induced by impact and thus may be inaccurate in predicting traumatic brain injuries.	[Liang, Zhaoyang; Luo, Yunhua] Univ Manitoba, Dept Mech Engn, Winnipeg, MB R3T 5V6, Canada		Luo, YH (corresponding author), Univ Manitoba, Dept Mech Engn, Winnipeg, MB R3T 5V6, Canada.	yunhua.luo@ad.umanitoba.ca			Manitoba Health Research Council (Canada)	The reported research has been supported by the Manitoba Health Research Council (Canada), which is gratefully acknowledged.	Adams JE, 2009, EUR J RADIOL, V71, P415, DOI 10.1016/j.ejrad.2009.04.074; [Anonymous], 2012, BIOM SOL ENG AN; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; du Plessis FCP, 1998, MED PHYS, V25, P1195, DOI 10.1118/1.598297; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Luo Y., 2008, ADV THEORETICAL APPL, V1, p225 ; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Nahum AM, 1977, P 21 STAPP CAR CRASH; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Schileo E, 2008, J BIOMECH, V41, P2483, DOI 10.1016/j.jbiomech.2008.05.017; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Simpleware, 2012, FAST EAS ROB WAY CON; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165	18	13	13	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1176-2322	1754-2103		APPL BIONICS BIOMECH	Appl. Bionics Biomech.		2015	2015						1	8	837585	10.1155/2015/837585			8	Engineering, Biomedical; Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Robotics	CC5XP	WOS:000350438600001	27019594	Green Published, Green Submitted, gold			2022-02-06	
J	Maddy, KM; Howell, DM; Capilouto, GJ				Maddy, Katherine McComas; Howell, Dana M.; Capilouto, Gilson J.			Current practices regarding discourse analysis and treatment following non-aphasic brain injury: A qualitative study	JOURNAL OF INTERACTIONAL RESEARCH IN COMMUNICATION DISORDERS			English	Article						DISCOURSE IMPAIRMENTS; SPEECH LANGUAGE PATHOLOGISTS; STROKE; TRAUMATIC BRAIN INJURY	OF-LIFE; ATTENTION; COHESION; LANGUAGE; STORY; REHABILITATION; COHERENCE; DEFICITS; STROKE	Discourse production deficits are a common feature of non-aphasic brain injury (NABI). However, little is known about current practices of speech-language pathologists in the assessment and treatment of discourse production deficits following NABI. A phenomenological approach of inquiry was used to examine the experiences of speech-language pathologists in the assessment and treatment of individuals with NABI, with a particular focus on discourse production deficits. Nine speech-language pathologists participated in semi-structured individual interviews. Participants identified common discourse production deficits and hypothesized about the impact on a person's quality of life. However, external influences negatively impacted participants' practice regarding discourse assessment and treatment. External influences included time constraints, lack of standardized data, and the lack of formalized education regarding discourse assessment and treatment. These findings suggest that there is a discrepancy between speech-language pathologists' values and their actual clinical practice related to the analysis and implementation of treatment for discourse production deficits.	[Maddy, Katherine McComas] Univ Kentucky, Rehabil Sci Interdisciplinary PhD Program, Lexington, KY 40506 USA; [Howell, Dana M.] Univ Kentucky, Lexington, KY 40506 USA; [Capilouto, Gilson J.] Univ Kentucky, Dept Rehabil Sci, Lexington, KY 40506 USA		Maddy, KM (corresponding author), Univ Kentucky, Rehabil Sci Interdisciplinary PhD Program, Lexington, KY 40506 USA.	klmc227@uky.edu					Ahern KJ, 1999, QUAL HEALTH RES, V9, P407, DOI 10.1177/104973299129121947; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Brady M, 2005, APHASIOLOGY, V19, P731, DOI 10.1080/02687030500141430; Brookshire R. H., 2003, INTRO NEUROGENIC COM; Brown J., 2013, ASHA LEADER, V18, P30; BRYAN KL, 1988, BRIT J DISORD COMMUN, V23, P111; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Cherney L., 1993, CLIN APHASIOLOGY, V21, P123; Christensen SC, 2009, APHASIOLOGY, V23, P898, DOI 10.1080/02687030802642010; Clarke P, 2002, STROKE, V33, P1016, DOI 10.1161/01.STR.0000013066.24300.F9; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Creswell J.W ., 2007, QUAL INQ; Davis GA, 1997, BRAIN LANG, V56, P183; Doody Owen, 2013, Nurse Res, V20, P28; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Fischler I, 2000, SCI PRACT NEUROPSYCH, P348; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gibbs G., 2007, ANAL QUALITATIVE DAT, DOI 10.4135/9781849208574; Glaser B., 1967, DISCOVERY GROUNDED T; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Groenewald T., 2008, SAGE ENCY QUALITATIV, P505; Halliday M. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hillis Trupe E., 1985, CLIN APHASIOLOGY, V15, P83; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Houghton Catherine, 2013, Nurse Res, V20, P12; Kaplan E., 2001, BOSTON NAMING TEST 2, V2nd; Mackenzie AE, 2002, DISABIL REHABIL, V24, P259, DOI 10.1080/09638380110081805; MALIA K, 2004, RECOMMENDATIONS BEST; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Miller J., 2012, SALT SYSTEMATIC ANAL; Murray L. L., 2001, LANGUAGE INTERVENTIO, P55; Myers P.S., 1999, RIGHT HEMISPHERE DAM; MYERS PS, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P279; O'Brien SR, 2013, PHYS THER, V93, P1592, DOI 10.2522/ptj.20120484; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Olness G, 2005, CLIN APH C SAN FL; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Plano Clark, 2018, DESIGNING CONDUCTING; REHAK A, 1992, BRAIN LANG, V42, P320, DOI 10.1016/0093-934X(92)90104-M; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rossman G. B., 1998, LEARNING FIELD INTRO; Rowles G., 2002, QUALITATIVE GERONTOL; Ska B., 2004, ENCY COMMUNICATION D, P302; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Srivastava P., 2009, INT J QUAL METHODS, V8, P76, DOI [DOI 10.1177/160940690900800107, 10.1177/160940690900800107]; Tesch R., 1990, QUALITATIVE RES ANAL; Tuckett Anthony G, 2004, Nurse Res, V12, P47; Turkstra L., 2005, SEMINARS SPEECH LANG, V26, P214; Ulatowska H. K., 2004, MIT ENCY COMMUNICATI, P300; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Van Manen M., 1990, RES LIVED EXPERIENCE; Youse KM, 2009, NEUROREHABILITATION, V24, P355, DOI 10.3233/NRE-2009-0490	61	13	13	0	9	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	2040-5111	2040-512X		J INTERACT RES COM D	J. Interact. Res. Commun. Disord.		2015	6	2					211	236		10.1558/jircd.v7i1.25519			26	Linguistics	Emerging Sources Citation Index (ESCI)	Linguistics	DK5MZ	WOS:000374965300005					2022-02-06	
J	Malpas, CB; Saling, MM; Velakoulis, D; Desmond, P; O'Brien, TJ				Malpas, Charles B.; Saling, Michael M.; Velakoulis, Dennis; Desmond, Patricia; O'Brien, Terence J.		Alzheimer's Disease Neuroimaging I	Tau and Amyloid-beta Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Amyloid-beta; cerebrospinal fluid; cognition; mild cognitive impairment; tau	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; CSF BIOMARKERS; EPISODIC MEMORY; OLDER-ADULTS; PHOSPHO-TAU; DEFICITS; DEPOSITION; PATHOLOGY	Alzheimer's disease (AD) is characterized by two primary pathologies: tau-related neurofibrillary tangles and the extracellular accumulation of amyloid-beta (A beta). The development of these pathologies is topologically distinct early in the disease, with A beta beginning to accumulate as a diffuse, neocortical pathology, while tau-related pathology begins to form in mesial temporal regions. This study investigated the hypothesis that, by virtue of this distinction, there exist preferential associations between the primary pathologies and aspects of the cognitive phenotype. We investigated the relationship between cerebrospinal fluid (CSF) biomarkers for tau and A beta pathologies with neurocognitive measures in 191 patients with mild cognitive impairment (MCI). Participants completed cognitive tests of new learning, information processing speed, and working memory. Separate regression models were computed and then followed up with mediation analyses to examine the predictive status of CSF biomarkers. The effect of A beta on learning was mediated by phospho-tau (p = 0.008). In contrast, A beta had a direct effect on information processing speed that was not mediated by phospho-tau (p = 0.59). No predictors were significant for working memory. This study provided evidence for a differential relationship of A beta and phospho-tau pathologies on the neurocognitive phenotype of MCI. This supports the proposition that these primary AD pathologies maximally affect different aspects of cognition, and has potential implications for cognitive assessments and the use of biomarkers in disease-modifying therapeutic trials.	[Malpas, Charles B.; Velakoulis, Dennis; Desmond, Patricia; O'Brien, Terence J.] Univ Melbourne, Dept Med Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3010, Australia; [Malpas, Charles B.; Saling, Michael M.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Saling, Michael M.] Austin Hlth, Dept Neuropsychol, Victoria, Australia; [Saling, Michael M.] Austin Hosp, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Velakoulis, Dennis] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Velakoulis, Dennis] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Desmond, Patricia] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; [Desmond, Patricia] Royal Melbourne Hosp, Dept Med Imaging, Melbourne, Vic, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia		Malpas, CB (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	charles.malpas@unimelb.edu.au	Malpas, Charles/L-4741-2019; O'Brien, Terence/L-8102-2013; Hsiung, Robin/AAT-1661-2021; O'Brien, Terence/AAU-5525-2021; Pasternak, Stephen H/A-3136-2011; Desmond, Patricia/D-1966-2014; Preda, Adrian/K-8889-2013	Hsiung, Robin/0000-0002-8017-0856; Pasternak, Stephen H/0000-0002-0204-0255; Ponto, Laura/0000-0003-1197-6714; Desmond, Patricia/0000-0002-4803-6323; Malpas, Charles/0000-0003-0534-3718; O'Brien, Terence/0000-0002-7198-8621; Preda, Adrian/0000-0003-3373-2438	Alzheimer's Australia Dementia Research Foundation Viertel postgraduate research scholarship; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio Clinica, Inc.; Biogen Idec Inc.Biogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; Euro Immun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE HealthcareGeneral ElectricGE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research and Development, LLC.; Johnson and Johnson Pharmaceutical Research and Development LLC.Johnson & JohnsonJohnson & Johnson USA; Medpace, Inc.; Merck and Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Synarc Inc.; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER	Charles Malpas is the recipient of an Alzheimer's Australia Dementia Research Foundation Viertel postgraduate research scholarship.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Bio Clinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Euro Immun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research and Development, LLC.; Johnson and Johnson Pharmaceutical Research and Development LLC.; Medpace, Inc.; Merck and Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Andreasen N, 2003, WORLD J BIOL PSYCHIA, V4, P147, DOI 10.1080/15622970310029912; Apostolova LG, 2008, BRAIN LANG, V104, P33, DOI 10.1016/j.bandl.2007.03.008; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Fripp J, 2008, NEUROIMAGE, V43, P430, DOI 10.1016/j.neuroimage.2008.07.053; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Gold G, 2001, J NEUROPATH EXP NEUR, V60, P946, DOI 10.1093/jnen/60.10.946; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayes, 2018, INTRO MEDIATION MODE; Hedden T, 2012, J NEUROSCI, V32, P16233, DOI 10.1523/JNEUROSCI.2462-12.2012; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hodges JR, 2006, BRAIN, V129, P2811, DOI 10.1093/brain/awl275; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JOLLIFFE IT, 2002, PRINCIPAL COMPONENTS; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lim YY, 2013, NEUROPSYCHOLOGY, V27, P322, DOI 10.1037/a0032321; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Nagy Z, 1999, DEMENT GERIATR COGN, V10, P115, DOI 10.1159/000017111; Nelson H.E., 1982, NATL ADULT READING T; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Nordlund A, 2008, J INT NEUROPSYCH SOC, V14, P582, DOI 10.1017/S135561770808079X; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rey A, 1958, LEXAMEN CLINIQUE PSY; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rolstad S, 2011, J ALZHEIMERS DIS, V26, P135, DOI 10.3233/JAD-2011-110038; Rosenmann H, 2012, J MOL NEUROSCI, V47, P1, DOI 10.1007/s12031-011-9665-5; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Seppala TT, 2012, NEUROLOGY, V78, P1568, DOI 10.1212/WNL.0b013e3182563bd0; Seppala TT, 2011, J ALZHEIMERS DIS, V25, P583, DOI 10.3233/JAD-2011-101911; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sobel M. E., 1986, SOCIOL METHODOL, V16, p159 , DOI DOI 10.2307/270922; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tosun D, 2010, NEUROBIOL AGING, V31, P1340, DOI 10.1016/j.neurobiolaging.2010.04.030; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Wallin AK, 2006, DEMENT GERIATR COGN, V21, P131, DOI 10.1159/000090631; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	74	13	14	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	47	4					965	975		10.3233/JAD-142643			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ9JS	WOS:000360931300015	26401775	Green Accepted			2022-02-06	
B	Mann, A; Chesselet, MF		LeDoux, MS		Mann, Amandeep; Chesselet, Marie-Francoise			Techniques for Motor Assessment in Rodents	MOVEMENT DISORDERS: GENETICS AND MODELS, 2ND EDITION			English	Article; Book Chapter							HUMAN ALPHA-SYNUCLEIN; TRAUMATIC BRAIN-INJURY; R6/2 MOUSE MODEL; STRIATAL DOPAMINE DEPLETION; TAIL SUSPENSION TEST; SPINAL-CORD-INJURY; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; TRANSGENIC MICE; BEHAVIORAL CHARACTERIZATION		[Mann, Amandeep; Chesselet, Marie-Francoise] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Mann, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.						Adwanikar H, 2011, NEUROMETHODS, V50, P237, DOI 10.1007/978-1-60761-883-6_10; Alam M, 2004, BEHAV BRAIN RES, V151, P117, DOI 10.1016/j.bbr.2003.08.014; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; BOISSIER J.-R, 1960, MED EXPTL, V3, P81; Bona E, 1997, PEDIATR RES, V42, P678, DOI 10.1203/00006450-199711000-00021; Borse L. B., 2011, PHARMACOLOGYONLINE, V3, P745; Bouet V., 2012, ADV PRECLINICAL STUD, P47, DOI 10.5772/32327; BROIDA J, 1982, PHYSIOL BEHAV, V29, P153, DOI 10.1016/0031-9384(82)90380-8; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen P, 2008, BIOMED ENVIRON SCI, V21, P233, DOI 10.1016/S0895-3988(08)60035-5; Chesselet M. F., 2007, WHATS WRONG MY MOUSE, P2; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; COURVOISIER SIMONE, 1956, JOUR CLIN AND EXPTL PSYCHOPATH AND QUART REV PSYCHIATRY AND NEUROL, V17, P25; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Cryan JF, 2004, P NATL ACAD SCI USA, V101, P8186, DOI 10.1073/pnas.0401080101; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Dauge V, 2001, NEUROPSYCHOPHARMACOL, V25, P690, DOI 10.1016/S0893-133X(01)00291-3; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; DELFS JM, 1995, NEUROSCIENCE, V66, P67, DOI 10.1016/0306-4522(94)00572-M; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Dluzen DE, 2001, EXP NEUROL, V170, P121, DOI 10.1006/exnr.2001.7698; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; DRUCKERCOLIN R, 1991, J NEUROSCI METH, V39, P153, DOI 10.1016/0165-0270(91)90081-A; Dunnett SB, 2011, NEUROMETHODS, V61, P299, DOI 10.1007/978-1-61779-298-4_15; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Glynn D, 2005, HUM MOL GENET, V14, P2369, DOI 10.1093/hmg/ddi239; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Gomez C, 2006, DRUG DEVELOP RES, V67, P752, DOI 10.1002/ddr.20117; Guillot TS, 2008, J MOTOR BEHAV, V40, P568, DOI 10.3200/JMBR.40.6.568-577; Gupta S, 2014, EUR J PHARMACOL, V732, P111, DOI 10.1016/j.ejphar.2014.03.032; Hamill RW, 2012, DEV NEUROBIOL, V72, P918, DOI 10.1002/dneu.20978; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Heuer A, 2012, BEHAV BRAIN RES, V228, P30, DOI 10.1016/j.bbr.2011.11.027; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Hickey MA, 2011, NEUROMETHODS, V62, P3, DOI 10.1007/978-1-61779-301-1_1; Hofele K, 2001, EXP NEUROL, V168, P116, DOI 10.1006/exnr.2000.7588; HOFFMAN DC, 1995, PSYCHOPHARMACOLOGY, V120, P128, DOI 10.1007/BF02246184; Hwang DY, 2005, J NEUROSCI, V25, P2132, DOI 10.1523/JNEUROSCI.3718-04.2005; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; JODOGNE C, 1991, PHARMACOL BIOCHEM BE, V40, P261, DOI 10.1016/0091-3057(91)90549-H; Karl JM, 2011, NEUROMETHODS, V61, P87, DOI 10.1007/978-1-61779-298-4_6; Karuppagounder SS, 2012, NEUROCHEM RES, V37, P1102, DOI 10.1007/s11064-012-0715-3; KENT S, 1991, PHYSIOL BEHAV, V49, P1079, DOI 10.1016/0031-9384(91)90334-K; Kleim JA, 2007, ILAR J, V48, P374, DOI 10.1093/ilar.48.4.374; Kuber R. B., 2011, J CHEM PHARM RES, V3, P143; Kumar A, 2012, EXP NEUROL, V237, P78, DOI 10.1016/j.expneurol.2012.05.015; Lalonde R, 2003, BEHAV GENET, V33, P59, DOI 10.1023/A:1021003600900; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Le Cudennec C, 2008, GENES BRAIN BEHAV, V7, P83, DOI 10.1111/j.1601-183X.2007.00374.x; Lee NC, 2013, NEUROBIOL DIS, V52, P177, DOI 10.1016/j.nbd.2012.12.005; Liebetanz D, 2007, EXP NEUROL, V205, P207, DOI 10.1016/j.expneurol.2007.01.030; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lorivel T, 2007, BEHAV BRAIN RES, V181, P248, DOI 10.1016/j.bbr.2007.04.011; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Luszczki JJ, 2005, NEUROPSYCHOPHARMACOL, V30, P958, DOI 10.1038/sj.npp.1300602; LYNCH CB, 1980, GENETICS, V96, P757; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARSHALL JF, 1971, SCIENCE, V174, P523, DOI 10.1126/science.174.4008.523; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Mendritzki S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/375462; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Olveczky BP, 2011, CURR OPIN NEUROBIOL, V21, P571, DOI 10.1016/j.conb.2011.05.002; OGAWA N, 1987, EUR NEUROL, V26, P16, DOI 10.1159/000116351; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Oliver PL, 2007, BEHAV BRAIN RES, V181, P239, DOI 10.1016/j.bbr.2007.04.012; OLSSON M, 1995, J NEUROSCI, V15, P3863; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Plaas M, 2008, J PHYSIOL PHARMACOL, V59, P205; Plowman EK, 2011, J COMMUN DISORD, V44, P549, DOI 10.1016/j.jcomdis.2011.04.008; Popovic N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100348; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Potashkin J., 2010, PARKINSONS DIS, V2011; Rauch F, 2010, BEHAV BRAIN RES, V210, P46, DOI 10.1016/j.bbr.2010.02.003; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Richter F, 2007, J NEUROSCI RES, V85, P681, DOI 10.1002/jnr.21159; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; SCHALLERT T, 1988, ANN NY ACAD SCI, V515, P108, DOI 10.1111/j.1749-6632.1988.tb32972.x; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1978, SCIENCE, V199, P1461, DOI 10.1126/science.564552; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; Sedy J, 2008, NEUROSCI BIOBEHAV R, V32, P550, DOI 10.1016/j.neubiorev.2007.10.001; Shen WB, 2010, ANN NEUROL, V68, P70, DOI 10.1002/ana.22018; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tang WL, 2010, BEHAV BRAIN RES, V210, P131, DOI 10.1016/j.bbr.2010.02.012; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Thifault S, 2001, BRAIN RES, V910, P99, DOI 10.1016/S0006-8993(01)02658-0; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; UPCHURCH M, 1983, BEHAV NEURAL BIOL, V39, P221, DOI 10.1016/S0163-1047(83)90876-2; Webb AA, 2005, BEHAV BRAIN RES, V165, P147, DOI 10.1016/j.bbr.2005.07.025; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	113	13	13	1	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-405516-2; 978-0-12-405195-9				2015							139	157		10.1016/B978-0-12-405195-9.00008-1			19	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BB9KO	WOS:000348389700010					2022-02-06	
J	Michalets, E; Creger, J; Shillinglaw, WR				Michalets, Elizabeth; Creger, Julie; Shillinglaw, William R.			Outcomes of expanded use of clinical pharmacist practitioners in addition to team-based care in a community health system intensive care unit	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							ADVERSE DRUG EVENTS; CRITICALLY-ILL PATIENTS; ECONOMIC OUTCOMES; INTERVENTIONS; IMPACT; PARTICIPATION; GUIDELINES; ERRORS; PROPHYLAXIS; SERVICES	Purpose. Clinical and cost benefits achieved through expanded use of state-licensed clinical pharmacist practitioners (CPPs) with prescribing authority on a critical care team are reported. Methods. A retrospective pre-post analysis was conducted to evaluate patient care outcomes and cost savings during one-year periods before and after the number of CPPs on a North Carolina community health system's neurotrauma intensive care unit (NTICU) team was increased from one to three. Outcomes assessed included the number and types of medication management encounters, estimated cost savings, and the rate of preventable adverse drug events (ADEs) with expanded use of CPPs. Results. During the two-year study period, CPPs conducted 13,386 documented medication encounters involving 2,198 patients; associated cost savings totaled an estimated $2,118,426. During the 12 months after CPP involvement on the NTICU team was increased, there was a 182% increase in encounters for therapeutic optimization (p = 0.01), with an associated 29% increase in cost savings and an improved return on investment. The CPP service expansion was also associated with a reduction in preventable ADEs, including a 75% reduction in prescribing-related ADEs (risk ratio [RR], 0.25; 95% confidence interval [CI], 0.05-1.2; p = 0.09) and a 37% reduction in higher-severity ADEs (RR, 0.63; 95% CI, 0.25-1.57; p = 0.36). Conclusion. With expanded CPP involvement on the NTICU team, there was a substantial increase in therapeutic optimization interventions and a clinically notable reduction in preventable ADEs, as well as an estimated 30% increase in associated cost savings.	[Michalets, Elizabeth; Creger, Julie] Univ N Carolina, Eshelman Sch Pharm, Mission Hlth Syst Dept Pharm, Neurotrauma Intens Care Unit, Asheville, NC 28804 USA; [Shillinglaw, William R.] Mission Hlth Syst Dept Trauma Surg & Crit Care, Asheville, NC USA		Michalets, E (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Mission Hlth Syst Dept Pharm, Neurotrauma Intens Care Unit, Asheville, NC 28804 USA.	elizabeth.michalets@msj.org					Bond CA, 2008, PHARMACOTHERAPY, V28, P1, DOI 10.1592/phco.28.1.1; Bourne RS, 2011, INT J CLIN PHARM-NET, V33, P755, DOI 10.1007/s11096-011-9538-6; Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026; Brophy GM, 2002, PHARMACOTHERAPY, V22, P251, DOI 10.1592/phco.22.3.251.33547; Bureau of Labor Statistics, 2010, OCC EMPL WAG, P29; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; Dennis B, OVERVIEW CLIN PHARM; Devlin JW, 1997, ANN PHARMACOTHER, V31, P689, DOI 10.1177/106002809703100604; Devlin JW, 2001, PHARMACOTHERAPY, V21, P740, DOI 10.1592/phco.21.7.740.34578; Hamblin S, 2012, J TRAUMA ACUTE CARE, V73, P1484, DOI 10.1097/TA.0b013e318267cd80; Haupt MT, 2003, CRIT CARE MED, V31, P2677, DOI 10.1097/01.CCM.0000094227.89800.93; Kane-Gill SL, 2012, CRIT CARE MED, V40, P823, DOI 10.1097/CCM.0b013e318236f473; Kaushal R, 2007, CRIT CARE MED, V35, P2479, DOI 10.1097/01.CCM.0000284510.04248.66; Klopotowska JE, 2010, CRIT CARE, V14, DOI 10.1186/cc9278; Kopp BJ, 2007, AM J HEALTH-SYST PH, V64, P2483, DOI 10.2146/ajhp060674; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; LEE AJ, 2007, HOSP PHARM, V42, P337; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; MacLaren R, 2009, PHARMACOTHERAPY, V29, P761, DOI 10.1592/phco.29.7.761; Marshall J, 2008, CRIT CARE MED, V36, P427, DOI 10.1097/01.CCM.0000300275.63811.B3; Mitchell P., 2012, NAM PERSPECTIVES, V2; MONTAZERI M, 1994, CRIT CARE MED, V22, P1044, DOI 10.1097/00003246-199406000-00027; Murawski M, 2011, AM J HEALTH-SYST PH, V68, P2341, DOI 10.2146/ajhp110351; Ng TM, 2008, ANN PHARMACOTHER, V42, P475, DOI 10.1345/aph.1K458; Patel NP, 2006, J BURN CARE RES, V27, P310, DOI 10.1097/01.BCR.0000216287.98801.96; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Rudis MI, 2000, PHARMACOTHERAPY, V20, P1400; Rudis MI, 2000, CRIT CARE MED, V28, P3746, DOI 10.1097/00003246-200011000-00037; Task Force on Guidelines Society of Critical Care Medicine, 1988, CRIT CARE MED, V16, P809; Weant KA, 2009, NEUROSURGERY, V65, P946, DOI 10.1227/01.NEU.0000347090.22818.35	31	13	14	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	JAN 1	2015	72	1					47	53		10.2146/ajhp140105			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AY0HJ	WOS:000347277700013	25511838				2022-02-06	
J	Miles, SR; Graham, DP; Teng, EJ				Miles, Shannon R.; Graham, David P.; Teng, Ellen J.			Examining the Influence of Mild Traumatic Brain Injury and Posttraumatic Stress Disorder on Alcohol Use Disorder in OEF/OIF Veterans	MILITARY MEDICINE			English	Article							COGNITIVE PROCESSING THERAPY; MENTAL-HEALTH DIAGNOSES; SUBSTANCE USE DISORDERS; AFGHANISTAN VETERANS; RISK-FACTORS; IRAQ; PTSD; DEPRESSION; DEPLOYMENT; HISTORY	Objectives: Examine (1) impact of mild traumatic brain injury (mTBI) on posttraumatic stress disorder (PTSD) symptoms, (2) frequency of alcohol use disorder in male and female combat Veterans, and (3) influence of PTSD and mTBI on alcohol use disorder. Method: A retrospective medical-record review extracted the following data for Operation Enduring Freedom/Operation Iraqi Freedom Veterans (N = 1,278) who completed a semi-structured mental health evaluation: alcohol use disorder diagnoses, PTSD symptom criteria, and Brief Traumatic Brain Injury Screen. Logistic regressions tested if PTSD and mTBI predicted which Veterans had an alcohol use disorder diagnosis. Results: Veterans with mTBI had more re-experiencing, avoidance, and hyperarousal symptoms than Veterans without mTBI. Men and women differed regarding alcohol use. For men, PTSD predicted alcohol use diagnosis while mTBI did not. For women, neither mTBI nor PTSD predicted alcohol use diagnosis. Conclusion: Findings from this study can inform treatment providers by alerting them to the possibility of subthreshold PTSD in Veterans with mTBI. Providers may begin PTSD treatments or consider targeting hyperarousal symptoms early in treatment to reduce distress. PTSD is also uniquely associated with alcohol use disorder in male Veterans, while more research on predictors of alcohol use disorder is needed for female Veterans.	[Miles, Shannon R.; Graham, David P.; Teng, Ellen J.] Michael E DeBakey Vet Affairs VA Med Ctr, Houston, TX 77030 USA; [Miles, Shannon R.; Graham, David P.; Teng, Ellen J.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Miles, Shannon R.; Graham, David P.; Teng, Ellen J.] South Cent Mental Illness Res Educ & Clin Ctr MI, Dept VA 152, Houston, TX 77021 USA; [Graham, David P.] Michael E DeBakey VA Med Ctr, Neurons Networks Traumat Braain Injuury Ctr Excel, Houston, TX 77030 USA; [Teng, Ellen J.] Ctr Innovat Qual Effectiveness & Safety, Dept VA 152, Houston, TX 77021 USA		Miles, SR (corresponding author), Michael E DeBakey Vet Affairs VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.		Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service: Neurorehabilitation: Neurons to Networks TBI Center of ExcellenceUS Department of Veterans Affairs [B6812C]; Office of Research and Development, Rehabilitation Research and Development Service Career Development Award-2 [B7496W]; VA Clinical Sciences Research and Development Career Development Award [CADE-MHN/F09]; Substance Use Disorders Quality Enhancement Research Initiative Program, at the Michael E. DeBakey Veterans Affairs Medical Center; VA HSR & D Houston Center of Excellence [HFP90-020]	The authors thank the MEDVAMC PTSD/Anxiety Disorder Research Team for their thoughtful comments and editing of the manuscript. This material is based on work supported (or supported in part) by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service: Neurorehabilitation: Neurons to Networks TBI Center of Excellence (grant no. B6812C), Office of Research and Development, Rehabilitation Research and Development Service Career Development Award-2 (grant no. B7496W), awarded to David P. Graham, VA Clinical Sciences Research and Development Career Development Award (no. CADE-MHN/F09) awarded to Ellen J. Teng, the Substance Use Disorders Quality Enhancement Research Initiative Program, at the Michael E. DeBakey Veterans Affairs Medical Center, and the VA HSR & D Houston Center of Excellence (HFP90-020). The funding sources had no role in the study design; in the collection, analysis, or interpretation of the data; in the writing of the manuscript; or in the decision to submit the article for publication.	American Psychological Association, 2000, DIAGN STAT MAN MENT, P463; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Association A.P., 2013, DIAGN STAT MAN MENT, P271; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Barrera TL, 2013, PSYCHOL SERV, V10, P168, DOI 10.1037/a0031178; Bombardier CH, 2009, HDB REHABILITATION P; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cukor J, 2010, J ANXIETY DISORD, V24, P918, DOI 10.1016/j.janxdis.2010.06.017; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Davis JL, 2007, J TRAUMA STRESS, V20, P123, DOI 10.1002/jts.20199; Defense and Veterans Brain Injury Center, 2006, DEF VET BRAIN INJ CT; Dickstein BD, 2013, J TRAUMA STRESS, V26, P703, DOI 10.1002/jts.21869; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Frayne S, 2010, J GEN INTERN MED, V25, P333; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Kaysen D, 2014, ADDICT BEHAV, V39, P420, DOI 10.1016/j.addbeh.2013.08.016; Kehle SM, 2012, PSYCHOL ADDICT BEHAV, V26, P42, DOI 10.1037/a0024663; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; McCrea M., 2008, MILD TRAUMATIC BRAIN; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Resick PA, 2007, HDB PTSD SCI PRACTIC, P330; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Tanielian T, 2008, INV WOUNDS WAR PSYCH; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Health Administration, 2013, WOM VET FOC RES NETW; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; Waldrop AE, 2007, ADDICT BEHAV, V32, P634, DOI 10.1016/j.addbeh.2006.06.001; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Williams JL, 2012, MIL MED, V177, P789, DOI 10.7205/MILMED-D-12-00019; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801; Zlontnic C, 2002, COMPR PSYCHIAT, V43, P413	48	13	13	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2015	180	1					45	52		10.7205/MILMED-D-14-00187			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7MM	WOS:000349101400025	25562857	Bronze			2022-02-06	
J	Songarj, P; Luh, C; Staib-Lasarzik, I; Engelhard, K; Moosmann, B; Thal, SC				Songarj, Phuriphong; Luh, Clara; Staib-Lasarzik, Irina; Engelhard, Kristin; Moosmann, Bernd; Thal, Serge C.			The antioxidative, non-psychoactive tricyclic phenothiazine reduces brain damage after experimental traumatic brain injury in mice	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Oxidative stress; Phenothiazine; Controlled cortical impact; Mice	NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; PATHOPHYSIOLOGY; INHIBITION; EXPRESSION; INDUCTION; THERAPIES; BINDING; MODELS; CELLS	Oxidative stress due to free radical formation is an important mechanism of secondary brain damage following traumatic brain injury (TBI). Phenothiazine has been found to be a strong antioxidant in eukaryotic cells in vitro and in invertebrates in vivo. The present study was designed to determine the neuroprotective potency of unsubstituted phenothiazine in a paradigm of acute brain injury. Thirty minutes after pneumatic, controlled cortical impact (CCI) injury, C57BI6 mice were randomly assigned to "low dose" (3 mg/kg, LD) or "high dose" (30 mg/kg, HD) s.c. phenothiazine or vehicle treatment. Brain lesion, neurofunctional impairment, body weight, and markers of cerebral inflammation were determined 24 h after the insult. Phenothiazine treatment dose-dependently reduced brain lesion volume (LD: -19.8%; HD: -26.1%) and posttraumatic body weight loss. There were no significant differences in the neurological function score and in markers of cerebral inflammation (Iba-1 positive cells, TNF alpha expression), whereas iNOS expression was significantly lower compared to vehicle-treated animals. Phenothiazine appears to modify in a post-treatment protocol certain aspects of secondary brain damage in vivo at unusually low concentrations, in particular the cortical contusion volume after TBI. The potential role of the reduced iNOS expression is unclear at present. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Songarj, Phuriphong; Luh, Clara; Staib-Lasarzik, Irina; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Moosmann, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55131 Mainz, Germany; [Songarj, Phuriphong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok 10700, Thailand		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Department of Anesthesiology, Johannes Gutenberg-University, Mainz, Germany	The authors thank Frida Kornes (Department of Anesthesiology) for her excellent technical assistance. This work was financially supported by institutional funding of the Department of Anesthesiology, Johannes Gutenberg-University, Mainz, Germany.	ANDERSEN PH, 1985, LIFE SCI, V37, P1971, DOI 10.1016/0024-3205(85)90028-1; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bulic B, 2013, J MED CHEM, V56, P4135, DOI 10.1021/jm3017317; Corcoran TB, 2011, ANTIOXID REDOX SIGN, V15, P2663, DOI 10.1089/ars.2011.4125; ECM, 2000, EUR CHEM BUR IUCLID; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hattori Y, 2001, ARTERIOSCL THROM VAS, V21, P1179, DOI 10.1161/hq0701.092135; Heneka MT, 2001, J NEUROPATH EXP NEUR, V60, P906, DOI 10.1093/jnen/60.9.906; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Koppula S, 2012, INT J MOL SCI, V13, P10608, DOI 10.3390/ijms130810608; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Mocko JB, 2010, NEUROBIOL DIS, V40, P120, DOI 10.1016/j.nbd.2010.03.019; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Moosmann B, 2001, BIOL CHEM, V382, P1601, DOI 10.1515/BC.2001.195; MURPHY CM, 1950, IND ENG CHEM, V42, P2479, DOI 10.1021/ie50492a027; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012; TADROS FW, 1962, J MENT SCI, V108, P816, DOI 10.1192/bjp.108.457.816; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tapias P. G. V. M., 2012, NEUR M NEW ORL, V856, P811; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; YU MJ, 1992, J MED CHEM, V35, P716, DOI 10.1021/jm00082a012	35	13	14	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 1	2015	584						253	258		10.1016/j.neulet.2014.10.037			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY4XS	WOS:000347579000048	25449871				2022-02-06	
J	Turner-Stokes, L; Bassett, P; Rose, H; Ashford, S; Thu, A				Turner-Stokes, Lynne; Bassett, Paul; Rose, Hilary; Ashford, Stephen; Thu, Aung			Serial measurement of Wessex Head Injury Matrix in the diagnosis of patients in vegetative and minimally conscious states: a cohort analysis	BMJ OPEN			English	Article							MEDICAL ASPECTS; RECOVERY; SCALE; DISORDERS; VALIDATION; ACCURACY	Objective: To evaluate serial application of the Wessex Head Injury Matrix (WHIM) in diagnosis of prolonged disorders of consciousness (PDOC). Specifically, to determine whether the trajectory of change predicts outcome status, and whether the current hierarchical order of WHIM items is correct for this context. Design: Analysis of prospectively gathered clinical cohort data. Setting: Consecutive admissions to a tertiary inpatient neurorehabilitation service for evaluation of PDOC in real-life clinical practice, over a 10-year period (2004-2014). Participants: Patients (n=65) presenting in sudden-onset vegetative (VS) or minimally conscious states (MCS). Mean age 38.4 (sd14.1) years; male: female ratio 66%: 33%. Aetiology of brain injury: 40(62%) traumatic; 12(19%) vascular; 11(17%) hypoxic; 3(3%) other. Primary outcome measure: WHIM alongside detailed clinical evaluation. Methods: The WHIM was administered serially by the multidisciplinary team throughout an in-patient evaluation programme (mean length 74 (sd42) days). Patients were divided into four groups, according to PDOC status on discharge (VS, MCS-Minus, MCS-Plus or Emerged). Results: WHIM hierarchical scores (Most Advanced Behaviour (MAB)) correlated with PDOC status at discharge (Pearson r=0.49, p<0.001). In the original order, the MAB distinguished the 'VS', 'MCS' and 'Emerged' categories (analysis of variance (ANOVA) post hoc p<0.001), but not the subgroups of MCS-Minus and MCS-Plus. In stepwise regression analysis, MAB-Ex (excluding two items) accounted for 68% of the variance in PDOC status at discharge. On multilevel statistical modelling, trajectory of change in MAB separated the four PDOC groups, both at individual and at group level (p<0.001). After reordering of items, the new-order MAB accounted for more (73%) of the variance in PDOC status, and also distinguished significantly between MCS-Minus and MCS-Plus groups at discharge (p<0.002). Conclusions: The WHIM is a useful diagnostic tool in PDOC, and trajectory of change is an important predictor of outcome. The proposed new hierarchical order requires further evaluation in future multicentre analyses.	[Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Turner-Stokes, Lynne; Rose, Hilary; Ashford, Stephen; Thu, Aung] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, London, England; [Bassett, Paul] Statsconsultancy Ltd, London, England		Turner-Stokes, L (corresponding author), Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.	Lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Ashford, Stephen/0000-0001-5541-7063; Bassett, Paul/0000-0001-7830-4563	National Institute for Health Research in England (NIHR)National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical TrustDunhill Medical Trust; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish	This manuscript presents independent research funded by the National Institute for Health Research in England (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10185). Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2013, PROL DIS CONSC NAT C; [Anonymous], 2003, THE VEG STAT; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Delargy M., 2013, REV PROLONGED DISORD; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Majerus S, 2000, NEUROPSYCHOL REHABIL, V10, P167, DOI 10.1080/096020100389237; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shiel A, 2000, WHIM WESSEX HEAD INJ; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Wilson FC, 2009, NEUROPSYCHOL REHABIL, V19, P754, DOI 10.1080/09602010902805318; Wilson FC, 2005, NEUROPSYCHOL REHABIL, V15, P431, DOI 10.1080/09602010543000091	25	13	13	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	4							e006051	10.1136/bmjopen-2014-006051			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4GB	WOS:000354705000007	25900459	gold, Green Published			2022-02-06	
J	Tzimenatos, L; Kim, E; Kuppermann, N				Tzimenatos, Leah; Kim, Emily; Kuppermann, Nathan			The Pediatric Emergency Care Applied Research Network A History of Multicenter Collaboration in the United States	PEDIATRIC EMERGENCY CARE			English	Article						PECARN; research infrastructure; multicenter collaboration	TRAUMATIC BRAIN-INJURIES; BLUNT HEAD TRAUMA; CHILDREN; SERVICES; DESIGN; SYSTEM; SAFETY; RISK	In this article, we review the history and progress of a large multicenter research network pertaining to emergency medical services for children. We describe the history, organization, infrastructure, and research agenda of the Pediatric Emergency Care Applied Research Network and highlight some of the important accomplishments since its inception. We also describe the network's strategy to grow its research portfolio, train new investigators, and study how to translate new evidence into practice. This strategy ensures not only the sustainability of the network in the future but the growth of research in emergency medical services for children in general.	[Tzimenatos, Leah; Kim, Emily; Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA		Tzimenatos, L (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Suite 2100, Sacramento, CA 95817 USA.	leah.tzimenatos@ucdmc.ucdavis.edu					Alessandrini E, 2011, ACAD EMERG MED, V18, P518, DOI 10.1111/j.1553-2712.2011.01057.x; Alessandrini EA, 2012, ACAD EMERG MED, V19, P70, DOI 10.1111/j.1553-2712.2011.01250.x; Alessandrini EA, 2010, ACAD EMERG MED, V17, P204, DOI 10.1111/j.1553-2712.2009.00635.x; Alpern ER, 2006, PEDIATR EMERG CARE, V22, P689, DOI 10.1097/01.pec.0000236830.39194.c0; Badaki-Makun O, 2014, PEDIATR BLOOD CANCER, V61, P1049, DOI 10.1002/pbc.24925; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Chamberlain JM, 2013, PEDIATR EMERG CARE, V29, P125, DOI 10.1097/PEC.0b013e31828043a5; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Dalziel SR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4836; Dayan P, 2006, CLIN PEDIATR EMERG M, V7, P128, DOI 10.1016/j.cpem.2006.03.006; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Deakyne SJ, 2013, HARMONIZING EHR DATA; Glaser NS, 2013, PEDIATR DIABETES, V14, P435, DOI 10.1111/pedi.12027; Goldkind Sara F, 2014, IRB, V36, P1; Gorelick MH, 2007, ACAD EMERG MED, V14, P646, DOI 10.1197/j.aem.2007.03.1357; Gorelick MH, 2005, ACAD EMERG MED, V12, P1195, DOI 10.1197/j.aem.2005.06.028; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Klassen TP, 2010, PEDIATR EMERG CARE, V26, P541, DOI 10.1097/PEC.0b013e3181e5bec1; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Leonard JC, 2011, ANN EMERG MED, V58, P145, DOI 10.1016/j.annemergmed.2010.08.038; Mahajan P, PEDIAT EMER IN PRESS; Mahajan P, 2012, RNA TRANSCRIPTIONAL; Miller SZ, 2008, ACAD EMERG MED, V15, P377, DOI 10.1111/j.1553-2712.2008.00072.x; Mintegi S, 2014, INT EPIDEMIOLOGICAL; Moler FW, 2013, PEDIATR CRIT CARE ME, V14, pE304, DOI 10.1097/PCC.0b013e31828a863a; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Pediat Emergency Care Applied Res, 2003, ACAD EMERG MED, V10, P661; Shaw KN, 2013, EMERG MED J, V30, P815, DOI 10.1136/emermed-2012-201642; Shaw KN, 2009, PEDIATRICS, V124, P485, DOI 10.1542/peds.2008-2858; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stanley RM, 2007, ACAD EMERG MED, V14, P532, DOI 10.1197/j.aem.2007.01.016	33	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2015	31	1					70	76		10.1097/PEC.0000000000000303			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AY2NK	WOS:000347426700017	25560626				2022-02-06	
J	Wang, H; Wang, B; Jackson, K; Miller, CM; Hasadsri, L; Llano, D; Rubin, R; Zimmerman, J; Johnson, C; Sutton, B				Wang, Huan; Wang, Bonnie; Jackson, Kevin; Miller, Claire M.; Hasadsri, Linda; Llano, Daniel; Rubin, Rachael; Zimmerman, Jarred; Johnson, Curtis; Sutton, Brad			A NOVEL HEAD-NECK COOLING DEVICE FOR CONCUSSION INJURY IN CONTACT SPORTS	TRANSLATIONAL NEUROSCIENCE			English	Article						Head-neck cooling; Mild traumatic brain injury; Brain hypothermia; Brain temperature; Sports	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; RANDOMIZED CONTROLLED-TRIAL; PROLONGED EXERCISE; HYPERTHERMIC EXERCISE; PROLACTIN RESPONSE; BODY HYPERTHERMIA; FOOTBALL LINEMEN; FIBER TRACKING; DIFFUSION	Emerging research on the long-term impact of concussions on athletes has allowed public recognition of the potentially devastating effects of these and other mild head injuries. Mild traumatic brain injury (mTBI) is a multifaceted disease for which management remains a clinical challenge. Recent pre-clinical and clinical data strongly suggest a destructive synergism between brain temperature elevation and mTBI; conversely, brain hypothermia, with its broader, pleiotropic effects, represents the most potent neuro-protectant in laboratory studies to date. Although well-established in selected clinical conditions, a systemic approach to accomplish regional hypothermia has failed to yield an effective treatment strategy in traumatic brain injury (TBI). Furthermore, although systemic hypothermia remains a potentially valid treatment strategy for moderate to severe TBIs, it is neither practical nor safe for mTBIs. Therefore, selective head-neck cooling may represent an ideal strategy to provide therapeutic benefits to the brain. Optimizing brain temperature management using a National Aeronautics and Space Administration (NASA) spacesuit spinoff head-neck cooling technology before and/or after mTBI in contact sports may represent a sensible, practical, and effective method to potentially enhance recover and minimize post-injury deficits. In this paper, we discuss and summarize the anatomical, physiological, preclinical, and clinical data concerning NASA spinoff head-neck cooling technology as a potential treatment for mTBIs, particularly in the context of contact sports.	[Wang, Huan] Univ Illinois Coll Med Urbana Champaign, Dept Neurosurg, Carle Fdn Hosp, Urbana, IL 61820 USA; [Wang, Huan; Jackson, Kevin] Univ Illinois, Beckman Inst, Thermal Neurosci Lab, Urbana, IL USA; [Wang, Bonnie] Univ Illinois Coll Med Urbana Champaign, Dept Internal Med, Carle Fdn Hosp, Urbana, IL USA; [Miller, Claire M.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Hasadsri, Linda] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Llano, Daniel] Univ Illinois Coll Med Urbana Champaign, Dept Mol & Integrat Physiol, Carle Fdn Hosp, Urbana, IL USA; [Llano, Daniel; Rubin, Rachael; Johnson, Curtis; Sutton, Brad] Univ Illinois, Beckman Inst, Urbana, IL USA; [Zimmerman, Jarred] Carle Fdn Hosp, Dept Sports Med, Urbana, IL USA; [Johnson, Curtis] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Sutton, Brad] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA		Wang, H (corresponding author), Univ Illinois Coll Med Urbana Champaign, Dept Neurosurg, Carle Fdn Hosp, Urbana, IL 61820 USA.	huanwang@illinois.edu	Johnson, Curtis/U-8372-2019; Sutton, Bradley P./A-4801-2008; Llano, Daniel/X-8184-2019	Sutton, Bradley P./0000-0002-8443-0408; Llano, Daniel/0000-0003-0933-1837; Jackson, kevin/0000-0001-9917-3312			Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bales James W, 2010, Open Drug Discov J, V2, P119; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOMALASKI JS, 1995, J IMMUNOL, V154, P4027; Bridge MW, 2003, EUR J APPL PHYSIOL, V89, P451, DOI 10.1007/s00421-003-0800-z; BRISSON GR, 1989, EUR J APPL PHYSIOL O, V58, P816, DOI 10.1007/BF02332212; BROOKS VB, 1982, REV PHYSIOL BIOCH P, V95, P1; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; CARLSSON C, 1976, J NEUROCHEM, V26, P1001, DOI 10.1111/j.1471-4159.1976.tb06484.x; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; COLESHAW SRK, 1983, J APPL PHYSIOL, V55, P27, DOI 10.1152/jappl.1983.55.1.27; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Connor NP, 1998, J COMMUN DISORD, V31, P535, DOI 10.1016/S0021-9924(98)00024-0; Coris EE, 2009, SOUTH MED J, V102, P569, DOI 10.1097/SMJ.0b013e3181a4f389; Covaciu L, 2011, INTENS CARE MED, V37, P1277, DOI 10.1007/s00134-011-2264-7; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DIESEL DA, 1990, J APPL PHYSIOL, V69, P1946, DOI 10.1152/jappl.1990.69.6.1946; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Ducreux D, 2005, AM J NEURORADIOL, V26, P1840; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza C. C., 2001, J ATHL TRAINING, P36228; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Godek SF, 2006, J ATHL TRAINING, V41, P8; Godek SF, 2005, AM J SPORT MED, V33, P843, DOI 10.1177/0363546504270999; Godek SF, 2005, BRIT J SPORT MED, V39, P205, DOI 10.1136/bjsm.2004.011767; Godek SF, 2004, J ATHL TRAINING, V39, P235; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Guest S, 2007, PHYSIOL BEHAV, V92, P975, DOI 10.1016/j.physbeh.2007.07.004; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; HAYWARD JN, 1969, BRAIN RES, V16, P417, DOI 10.1016/0006-8993(69)90236-4; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hootman JM, 2007, J ATHL TRAINING, V42, P311; HORI T, 1976, PFLUG ARCH EUR J PHY, V364, P205, DOI 10.1007/BF00585193; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATSUMURA H, 1995, ACTA NEUROCHIR, V135, P62, DOI 10.1007/BF02307416; Kawakami T, 2001, J DERMATOL, V28, P63, DOI 10.1111/j.1346-8138.2001.tb00091.x; KAWAKAMI Y, 1967, J APPL PHYSIOL, V23, P964, DOI 10.1152/jappl.1967.23.6.964; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KHURANA RK, 1980, ANN NEUROL, V7, P144, DOI 10.1002/ana.410070209; Kiang JG, 1996, J INVEST MED, V44, P53; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; Koehn J, 2012, STROKE, V43, P2142, DOI 10.1161/STROKEAHA.112.652248; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Low D, 2005, EXP PHYSIOL, V90, P909, DOI 10.1113/expphysiol.2005.031294; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADSEN PL, 1993, J APPL PHYSIOL, V74, P245, DOI 10.1152/jappl.1993.74.1.245; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCMURTRY IF, 1975, EXPERIENTIA, V31, P1303, DOI 10.1007/BF01945793; Miyazawa T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00308; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mundel T, 2007, EXP PHYSIOL, V92, P187, DOI 10.1113/expphysiol.2006.034934; Mundel T, 2006, EXP PHYSIOL, V91, P1007, DOI 10.1113/expphysiol.2006.034629; NORTHOFF H, 1994, INT J SPORTS MED, V15, pS167, DOI 10.1055/s-2007-1021132; Nybo L, 2002, J PHYSIOL-LONDON, V545, P697, DOI 10.1113/jphysiol.2002.030023; Nybo L, 2002, J APPL PHYSIOL, V93, P58, DOI 10.1152/japplphysiol.00049.2002; Nybo L, 2001, J PHYSIOL-LONDON, V534, P279, DOI 10.1111/j.1469-7793.2001.t01-1-00279.x; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Pitsiladis YP, 2002, EXP PHYSIOL, V87, P215, DOI 10.1113/eph8702342; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rasmussen P, 2006, EUR J APPL PHYSIOL, V96, P299, DOI 10.1007/s00421-005-0079-3; Rasmussen P, 2010, ACTA PHYSIOL, V199, P63, DOI 10.1111/j.1748-1716.2010.02084.x; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; SALTIN B, 1972, J APPL PHYSIOL, V32, P635, DOI 10.1152/jappl.1972.32.5.635; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Selkirk GA, 2004, J OCCUP ENVIRON HYG, V1, P521, DOI 10.1080/15459620490475216; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; Shen H, 2011, BRAIN RES, V1368, P248, DOI 10.1016/j.brainres.2010.10.014; Shirreffs SM, 2006, J SPORT SCI, V24, P699, DOI 10.1080/02640410500482677; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TIPTON MJ, 1994, UNDERSEA HYPERBAR M, V21, P305; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wang H, 2006, ACTA NEUROCHIR, V148, P681, DOI 10.1007/s00701-006-0748-y; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Wang H, 2012, J NEUROSURG, V116, P1159, DOI 10.3171/2009.8.JNS09929; Wegmann M, 2012, SPORTS MED, V42, P545, DOI 10.2165/11630550-000000000-00000; White MD, 1996, J APPL PHYSIOL, V81, P1249; WIERENGA PK, 1994, EUR J CELL BIOL, V63, P68; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	133	13	13	0	20	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					20	31		10.1515/tnsci-2015-0004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC8VE	WOS:000350645900004	28123788	Green Published, gold			2022-02-06	
J	Webb, TS; Whitehead, CR; Wells, TS; Gore, RK; Otte, CN				Webb, Timothy S.; Whitehead, Casserly R.; Wells, Timothy S.; Gore, Russell K.; Otte, Clifford N.			Neurologically-related sequelae associated with mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; mild brain injury; neurological; post-concussional syndrome	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POST-CONCUSSION SYNDROME; MINOR HEAD-INJURY; UNITED-STATES; WAR VETERANS; CHRONIC PAIN; IRAQ; EPILEPSY; SLEEP	Objective: Mild traumatic brain injury (mTBI) accounts for more than 75% of traumatic brain injuries every year. This study examines the temporal association between non-blast mTBI and the onset of neurologic sequelae to illuminate risks of post-concussive syndrome, epilepsy and chronic pain. Methods: A large historical prospective study was conducted utilizing electronically-recorded demographic, medical and military-specific data for over half a million active duty US Air Force Airmen. This study utilized diagnostic codes to identify mTBI exposures, two control groups and three post-mTBI time periods. Adjusted hazard ratios (HRs) were calculated using Cox proportional hazards modelling. Results: HRs were higher when mTBI exposed Airmen were compared with the full cohort and lower when compared with the other injured group. When compared to the other injured group, mTBI was positively associated with epilepsy/recurrent seizure outcomes, post-concussive syndrome and pain disorders. HRs tended to be highest within the first 30 days and decreased over time. Conclusions: Findings support that mTBI may have a prolonged neurological impact. Findings are also likely generalizable to young adult populations with exposure to non-blast related mTBI, including civilians, as those included in this study were young adults with a high prevalence of recreational/sports and motor vehicle injuries.	[Webb, Timothy S.; Wells, Timothy S.] Air Force Res Lab, Vulnerabil Anal Branch, Wright Patterson AFB, OH USA; [Whitehead, Casserly R.] Infoscitex Corp, Dayton, OH 45431 USA; [Gore, Russell K.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Otte, Clifford N.] Def Hlth Program Res Management Div, Plans & Programs Off, Wright Patterson AFB, OH USA		Whitehead, CR (corresponding author), Infoscitex Corp, 4027 Colonel Glenn Highway,Suite 210, Dayton, OH 45431 USA.	casserly.whitehead.ctr@wpafb.af.mil	Otte, Clifford/AAB-9991-2022; Gore, Russell/N-8988-2016	Gore, Russell/0000-0002-8012-1579	Defense Center of Excellence for Psychological Health and Traumatic Brain Injury	This study was conducted in accordance with all applicable federal regulations governing the protection of human subjects in research as approved by Air Force Research Laboratory/Wright Site Institutional Review Board (Protocol F-WR-2009-0066-H). This study was funded by the Defense Center of Excellence for Psychological Health and Traumatic Brain Injury. The statements herein do not necessarily reflect the opinions of the institutions represented by the authors. All authors made significant contributions to this study. The authors report no conflicts of interest.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Faul M, 2010, TRAUMATIC BRAIN INJU; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jabbari B, 2002, BRAIN INJURY, V16, P463, DOI 10.1080/02699050110102086; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V1; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V3.; U. S. Department of Health and Human Services, 2003, GEN ICD 9 CM HOSP VE, V2; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	57	13	13	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					430	437		10.3109/02699052.2014.989904			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300003	25541640				2022-02-06	
J	Worni, A; Gholami, H; Marchand, L; Katsoulis, J; Mericske-Stern, R; Enkling, N				Worni, Andreas; Gholami, Hadi; Marchand, Laurent; Katsoulis, Joannis; Mericske-Stern, Regina; Enkling, Norbert			Retrievability of Implant-Supported Crowns When Using Three Different Cements: A Controlled Clinical Trial	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							FIXED PARTIAL DENTURES; RETAINED CROWNS; DENTAL ANXIETY; IN-VITRO; RESTORATIONS; COMPLICATIONS; DENTISTRY; SURVIVAL; REMOVER	Purpose: The purpose of this study was to analyze the removal of implant-supported crowns retained by three different cements using an air-accelerated crown remover and to evaluate the patients' response to the procedure. Materials and Methods: This controlled clinical trial was conducted with 21 patients (10 women, 11 men; mean age: 51 +/- 10.2 years) who had received a total of 74 implants (all placed in the posterior zone of the mandible). Four months after implant surgery, the crowns were cemented on standard titanium abutments of different heights. Three different cements (two temporary: Harvard TEMP and Improv; and one definitive: Durelon) were used and randomly assigned to the patients. Eight months later, one blinded investigator removed all crowns. The number of activations of the instrument (CORONAflex, KaVo) required for crown removal was recorded. The patients completed a questionnaire retrospectively to determine the impact of the procedure and to gauge their subjective perception. A linear regression model and descriptive statistics were used for data analysis. Results: All crowns could be retrieved without any technical complications or damage. Both abutment height (P = .019) and cement type (P = .004) had a significant effect on the number of activations, but the type of cement was more important. An increased total number of activations had no or only a weak correlation to the patients' perception of concussion, noise, pain, and unwillingness to use the device. Conclusions: Cemented implant crowns can be removed, and the application of an air-accelerated device is a practicable method. A type of cement with appropriate retention force has to be selected. The impact on the patients' subjective perception should be taken into account.	[Worni, Andreas; Gholami, Hadi; Marchand, Laurent; Katsoulis, Joannis; Mericske-Stern, Regina] Univ Bern, Dept Prosthodont, CH-3010 Bern, Switzerland; [Enkling, Norbert] Univ Bonn, Dept Prosthodont, Bonn, Germany		Mericske-Stern, R (corresponding author), Univ Bern, Sch Dent Med, Dept Prosthodont, Freiburgstr 7, CH-3010 Bern, Switzerland.	regina.mericske@zmk.unibe.ch		Enkling, Norbert/0000-0002-4698-8101			Akca K, 2002, INT J ORAL MAX IMPL, V17, P536; Al Hamad KQ, 2011, CLIN ORAL IMPLAN RES, V22, P638, DOI 10.1111/j.1600-0501.2010.02011.x; Bertold M, 2006, FOGORV SZ, V99, P237; BROCKHURST PJ, 1983, OPER DENT, V8, P130; Chaar MS, 2011, J ORAL REHABIL, V38, P697, DOI 10.1111/j.1365-2842.2011.02209.x; Chee W W, 1998, J Prosthodont, V7, P120; de Jongh A, 2006, EUR J ORAL SCI, V114, P286, DOI 10.1111/j.1600-0722.2006.00384.x; DEDMON HW, 1982, OPER DENT, V7, P97; Diserens V, 2006, INT J PERIODONT REST, V26, P151; Ekfeldt A, 1994, Int J Oral Maxillofac Implants, V9, P179; Enkling N, 2013, J DENT RES, V92, p139S, DOI 10.1177/0022034513504953; Enkling N, 2013, QUINTESSENCE INT, V44, P363, DOI 10.3290/j.qi.a29148; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Hebel KS, 1997, J PROSTHET DENT, V77, P28, DOI 10.1016/S0022-3913(97)70203-8; Ichikawa Tetsuo, 2008, J Prosthodont, V17, P487, DOI 10.1111/j.1532-849X.2008.00329.x; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; Karl M, 2004, INT J ORAL MAX IMPL, V19, P30; Karl M, 2008, INT J ORAL MAX IMPL, V23, P648; Karl M, 2006, INT J ORAL MAX IMPL, V21, P756; LANG NP, 1983, J CLIN PERIODONTOL, V10, P563, DOI 10.1111/j.1600-051X.1983.tb01295.x; Mansour A, 2002, CLIN ORAL IMPLAN RES, V13, P343, DOI 10.1034/j.1600-0501.2002.130401.x; Mehl C, 2008, CLIN ORAL IMPLAN RES, V19, P1304, DOI 10.1111/j.1600-0501.2008.01587.x; Mehl C, 2012, CLIN ORAL IMPLAN RES, V23, P930, DOI 10.1111/j.1600-0501.2011.02236.x; Mericske-Stern R, 2001, CLIN ORAL IMPLAN RES, V12, P309, DOI 10.1034/j.1600-0501.2001.012004309.x; Michalakis KX, 2000, INT J ORAL MAX IMPL, V15, P545; Michalakis KX, 2003, INT J ORAL MAX IMPL, V18, P719; OLIVA RA, 1980, J PROSTHET DENT, V44, P267, DOI 10.1016/0022-3913(80)90008-6; Palmer RM, 2000, CLIN ORAL IMPLAN RES, V11, P179, DOI 10.1111/j.1600-0501.2000.tb00012.x; Ramp MH, 1999, J PROSTHET DENT, V81, P510, DOI 10.1016/S0022-3913(99)70203-9; Sailer I, 2012, CLIN ORAL IMPLAN RES, V23, P163, DOI 10.1111/j.1600-0501.2012.02538.x; Shapoff Cary A, 2012, Compend Contin Educ Dent, V33, P94; Vermaire JH, 2008, COMMUNITY DENT ORAL, V36, P409, DOI 10.1111/j.1600-0528.2007.00416.x; Vigolo P, 2004, INT J ORAL MAX IMPL, V19, P260; WALTON JN, 1994, J PROSTHET DENT, V71, P283, DOI 10.1016/0022-3913(94)90468-5; Wang JS, 1997, CHIN DENT J, V16, P218; Weber HP, 2006, CLIN ORAL IMPLAN RES, V17, P375, DOI 10.1111/j.1600-0501.2005.01232.x; WILLIAMSON RT, 1993, J PROSTHET DENT, V69, P634, DOI 10.1016/0022-3913(93)90297-2	37	13	13	0	6	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	JAN-FEB	2015	28	1					22	29		10.11607/ijp.4119			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	AZ8UE	WOS:000348489100005	25588168				2022-02-06	
J	Wu, X; Lu, X; Lu, XQ; Yu, J; Sun, YR; Du, ZY; Wu, XH; Mao, Y; Zhou, LF; Wu, SR; Hu, J				Wu, Xing; Lu, Xin; Lu, Xiangqiong; Yu, Jian; Sun, Yirui; Du, Zhuoying; Wu, Xuehai; Mao, Ying; Zhou, Liangfu; Wu, Sirong; Hu, Jin			Prevalence of severe hypokalaemia in patients with traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Hypokalaemia; Hypophosphataemia; Hypernatraemia; Mortality	HYPOPHOSPHATEMIA; POTASSIUM; HYPOMAGNESEMIA; HYPERNATREMIA; THERAPY	Introduction: Patients with traumatic brain injury (TBI) are more vulnerable to develop hypokalaemia, we sought to investigate the prevalence, and the relationship between severe hypokalaemia and the mortality of traumatic brain injury patients. Methods: Isolated traumatic brain patients who had hypokalaemia (serum potassium <3.5 mmol/L) and age >= 14 yrs were recruited into the study between January 2008 and March 2013. Hypokalaemia was defined as potassium level in the blood <3.5 mmol/L during the hospitalisation, which was classified by severity: mild (3.0 mmol/L <= K < 3.5 mmol/L), moderate (2.5 mmol/L <= K < 3.0 mmol/L) and severe (K < 2.5 mmol/L). Multivariable logistic regression was performed to find the impact of hypokalaemia on mortality. Results: A total 375 cases were included in analysis. The peak incidence of severe hypokalaemia occurred in the first 24-96 h. TBI patients with severe hypokalaemia had significantly higher serum sodium and lower serum phosphorus than those patients with mild or moderate hypokalaemia (p < 0.001). Compare to other groups, the severe hypokalaemia group had the worst outcome. Moreover, the patients (n = 15) who had severe hypokalaemia, hypernatraemia (Na > 160 mmol/L), and hypophosphataemia (P < 0.3 mmol/L) all died in hospital. Multiple logistic regression analysis resulted in decrease of GCS (OR = 1.27; 95% CI = 1.15-1.41; p < 0.001) and potassium (OR = 4.35; 95% CI = 2.04-9.26; p < 0.001) being associated with significant increased risk of mortality. Conclusions: The peak incidence of severe hypokalaemia occurred in the first 24-96 h. TBI patients with severe hypokalaemia are more vulnerable to develop hypophosphataemia and hypernatraemia than patients with mild and moderate hypokalaemia. Severe hypokalaemia are the independent risk factors for mortality in TBI patients. (C) 2014 Elsevier Ltd. All rights reserved.	[Wu, Xing; Yu, Jian; Sun, Yirui; Du, Zhuoying; Wu, Xuehai; Mao, Ying; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Lu, Xin; Lu, Xiangqiong; Wu, Sirong] Soochow Univ, Dept Emergency Med, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China		Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	bttnirvina@gmail.com; 87luxin@gmail.com; 809451680@qq.com; lance2002@hotmail.com; yirui.sun@live.cn; duzhuoying@gmail.com; 170529860@qq.com; yinmao.neuro@gmail.com; neuro.lfzhou@gmail.com; wusirongmd@163.com; tgzy125@gmail.com		Mao, Ying/0000-0001-8055-115X	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08djl400503]; National Basic Research ProgrammeNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from National Natural Science Foundation of China (NSFC Grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375 and 08djl400503), National Basic Research Programme (2009CB941100, 2010CB945500, 2012CB966300), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), Shanghai Nature Science Foundation (08411952000). The funders had no involvement in the study design; collection, analysis and interpretation of the study data; the writing of the manuscript; or the decision to submit the manuscript for publication.	Aibiki M, 2001, CRIT CARE MED, V29, P1726, DOI 10.1097/00003246-200109000-00012; AUBIER M, 1985, NEW ENGL J MED, V313, P420, DOI 10.1056/NEJM198508153130705; Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; BOLLAERT PE, 1995, CHEST, V107, P1698, DOI 10.1378/chest.107.6.1698; BROWN MJ, 1983, NEW ENGL J MED, V309, P1414, DOI 10.1056/NEJM198312083092303; Buckley MS, 2010, CRIT CARE MED, V38, pS253, DOI 10.1097/CCM.0b013e3181dda0be; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CRONIN D, 2012, BMJ CASE REP, V10, P2012; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; Fauci AS., 2008, HARRISONS PRINCIPLES, V17; FISHER J, 1983, CHEST, V83, P504, DOI 10.1378/chest.83.3.504; Fofi L, 2012, J CLIN NEUROSCI, V19, P513, DOI 10.1016/j.jocn.2011.07.041; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GRAVELYN TR, 1988, AM J MED, V84, P870, DOI 10.1016/0002-9343(88)90065-4; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Paltiel O, 2001, ARCH INTERN MED, V161, P1089, DOI 10.1001/archinte.161.8.1089; Polderman KH, 2008, INTENS CARE MED, V34, P1738, DOI 10.1007/s00134-008-1132-6; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; Schaefer FC, 2007, J TRAUMA STRESS, V20, P529, DOI 10.1002/jts.20240; Seo W, 2010, J NEUROSCI NURS, V42, P201, DOI 10.1097/JNN.0b013e3181e26b4a; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; Ng Y, 2011, INTENS CARE MED, V37, P1285, DOI 10.1007/s00134-011-2240-2; Suzuki S, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.10.011; TROUWBORST A, 1984, INJURY, V15, P293, DOI 10.1016/0020-1383(84)90048-2; Tse HF, 2000, AM J MED, V109, P599, DOI 10.1016/S0002-9343(00)00590-8; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; Ybanez N, 2014, AM J KIDNEY DIS, V63, P530, DOI 10.1053/j.ajkd.2013.07.005	34	13	13	2	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					35	41		10.1016/j.injury.2014.08.002			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600007	25195182				2022-02-06	
J	Yang, X; Shi, Z; Li, X; Li, J				Yang, Xi; Shi, Zhong; Li, Xia; Li, Jun			Impacts of stellate ganglion block on plasma NF-kappa B and inflammatory factors of TBI patients	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Traumatic brain injury; stellate ganglion; nerve block; inflammatory cytokine; calcitonin gene-related peptide	TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM; UP-REGULATION; EXPRESSION; CYTOKINES; ALPHA; MODEL	The aim of this study was to initially explore the regulatory mechanism of brain function protection of SGB from the view of nerve-endocrine-immune network. 50 patients with traumatic brain injury (TBI) were divided into the SGB treatment group and the control group, the changes of serum IL-6, IL-1 beta, TNF-alpha and CGRP levels were detected by ELISA, and the changes of lymphocyte NF-kappa B protein expression was detected by Western Blot. The control group exhibited the higher expression of IL-6, IL-1 beta and TNF-alpha, while the SGB treatment group exhibited various degrees of reduction. On the second day of TBI, the CGRP expression was significantly increased, which was much more significant in the SGB group, and the duration was much longer. The control group exhibited the increased NF-kappa B p65 and NF-kappa B p50 after TBI; after the SGB treatment, the NF-kappa B p65 protein level was significantly reduced, while the NF-kappa B p50 protein level would not be significantly changed. SGB could chronergically inhibit the excessive inflammatory response in the early post-TBI stage, which suggested that SGB might be involved into the regulation of post-TBI nerve-endocrine-immune system dysfunction.	[Yang, Xi; Shi, Zhong; Li, Xia; Li, Jun] Third Mil Med Univ, Xinqiao Hosp, Dept Emergency, Chongqing 400037, Peoples R China		Shi, Z (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Emergency, Chongqing 400037, Peoples R China.	zhongshidoc@163.com					Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Firat Y, 2008, AM J OTOLARYNG, V29, P339, DOI 10.1016/j.amjoto.2008.02.001; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hou LF, 2003, J NEUROSCI RES, V73, P188, DOI 10.1002/jnr.10651; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Iwama H, 2002, PAIN CLINIC, V13, P233; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kim EM, 2013, PAIN PHYSICIAN, V16, P117; Li WJ, 2006, AM J PHYSIOL-CELL PH, V291, pC456, DOI 10.1152/ajpcell.00538.2005; Luger TA, 2002, J DERMATOL SCI, V30, P87, DOI 10.1016/S0923-1811(02)00103-2; Marklund N, 2005, RESTOR NEUROL NEUROS, V23, P31; Millet I, 2000, J BIOL CHEM, V275, P15114, DOI 10.1074/jbc.275.20.15114; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Penkowa M, 2004, J NEUROSCI RES, V77, P35, DOI 10.1002/jnr.20154; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rovai D, 2014, J CARDIOVASC MED HAG; Segev-Amzaleg N, 2013, BRAIN BEHAV IMMUN, V30, P176, DOI 10.1016/j.bbi.2012.12.016; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Waschbisch A, 2006, J NEUROCHEM, V96, P680, DOI 10.1111/j.1471-4159.2005.03599.x; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290	24	13	17	0	1	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2015	8	9					15630	15638					9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DA6JX	WOS:000367911200070	26629057				2022-02-06	
J	Peck, KA; Calvo, RY; Sise, CB; Johnson, J; Yen, JW; Sise, MJ; Dunne, CE; Badiee, J; Shackford, SR; Lobatz, MA				Peck, Kimberly A.; Calvo, Richard Y.; Sise, C. Beth; Johnson, Jeffrey; Yen, Jessica W.; Sise, Michael J.; Dunne, Casey E.; Badiee, Jayraan; Shackford, Steven R.; Lobatz, Michael A.			Death after discharge: Predictors of mortality in older brain-injured patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	44th Annual Meeting of the Western-Trauma-Association	MAR 02-07, 2014	Steamboat Springs, CO	Western Trauma Assoc		Traumatic brain injury; postdischarge death; long-term mortality; older adults	LONG-TERM SURVIVAL; OUTCOMES; RATIO; RISK	BACKGROUND: Older patients with traumatic brain injury (TBI) may be at high risk of death after hospitalization. The purpose of this study was to characterize long-term mortality of older TBI patients who survived to discharge. We hypothesized that predictors of postdischarge mortality differed from those of inpatient mortality. METHODS: A retrospective cohort study was performed on TBI patients older than 55 years admitted to our Level I trauma center between July 1, 2006, and December 31, 2011. Postdischarge deaths were identified by matching patient data with local vital records up to December 31, 2011, when data collection was terminated (censoring). Patients were categorized by age, comorbidities, history of preinjury anticoagulant/prescription antiplatelet agent therapy, injury severity indices, initial TBI type, prehospital living status, discharge location, and discharge condition. The effect of risk factors on postdischarge mortality was evaluated by Cox proportional hazards modeling. RESULTS: Of 353 patients, 322 (91.2%) survived to discharge. Postdischarge mortality was 19.8% (n = 63) for the study period. Of the postdischarge deaths, 54.0% died within 6 months of discharge, and 68.3% died within 1 year. Median days to death after discharge or censoring were 149 and 410, respectively. Factors associated with death after discharge included age, preinjury anticoagulant use, higher number of Charlson comorbidities, discharge to a long-term care facility, and severe disability. Factors related to injury severity (i.e., Injury Severity Score [ISS], initial Glasgow Coma Scale [GCS] score) and preinjury prescription antiplatelet agent use, previously found to predict inpatient death, did not predict postdischarge mortality. CONCLUSION: Older TBI patients who survive to discharge have a significant risk of death within 1 year. Predictors of postdischarge mortality and inpatient death differ. Death after discharge is largely a function of overall health status. Monitoring health status and continued aggressive management of comorbidities after discharge may be essential in determining long-term outcomes. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Peck, Kimberly A.; Calvo, Richard Y.; Sise, C. Beth; Sise, Michael J.; Dunne, Casey E.; Badiee, Jayraan; Shackford, Steven R.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA 92103 USA; [Johnson, Jeffrey; Yen, Jessica W.] Publ Hlth Serv, Berkeley, CA USA; [Lobatz, Michael A.] Scripps Rehabil Ctr, Encinitas, CA USA		Peck, KA (corresponding author), Scripps Mercy Hosp, Trauma Serv MER62, 4077 Fifth Ave, San Diego, CA 92103 USA.	peck.kimberly@scrippshealth.org		Calvo, Richard/0000-0001-9147-2668			Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; CDC, 2010, MMWR-MORBID MORTAL W, V59, P303; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Faul M, 2010, TRAUMATIC BRAIN INJU; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Lai DJ, 1996, AM J EPIDEMIOL, V143, P832; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	17	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2014	77	6					978	983		10.1097/TA.0000000000000356			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	AU8EE	WOS:000345828500042	25248061				2022-02-06	
J	Quarrie, KL; Murphy, IR				Quarrie, Kenneth Lincoln; Murphy, Ian Robert			Towards an operational definition of sports concussion: identifying a limitation in the 2012 Zurich consensus statement and suggesting solutions	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURY DEFINITIONS; DATA-COLLECTION; RUGBY UNION; TIME		[Quarrie, Kenneth Lincoln; Murphy, Ian Robert] New Zealand Rugby, High Performance Unit, Wellington 6140, New Zealand		Quarrie, KL (corresponding author), New Zealand Rugby, High Performance Unit, 100 Molesworth St, Wellington 6140, New Zealand.	ken.quarrie@nzrugby.co.nz					Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Junge A, 2000, AM J SPORT MED, V28, pS40; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Langley J, 2004, INJURY PREV, V10, P69, DOI 10.1136/ip.2003.003715; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mueller-Wohlfahrt HW, 2013, BRIT J SPORT MED, V47, P342, DOI 10.1136/bjsports-2012-091448; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; Rosenberg M. L., 1991, VIOLENCE AM PUBLIC H; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	13	13	13	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2014	48	22					1589	1591		10.1136/bjsports-2014-094112			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AT7PU	WOS:000345130900005	25257231				2022-02-06	
J	Suderman, BL; Hoover, RW; Ching, RP; Scher, IS				Suderman, Bethany L.; Hoover, Ryan W.; Ching, Randal P.; Scher, Irving S.			The effect of hardhats on head and neck response to vertical impacts from large construction objects	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Hardhat; Vertical impact; Dropped object; Head acceleration; Neck compression	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; CONCUSSION	We evaluated the effectiveness of hardhats in attenuating head acceleration and neck force in vertical impacts from large construction objects. Two weight-matched objects (lead shot bag and concrete block) weighing 9.1 kg were dropped from three heights (0.91 m, 1.83 in and 2.74m) onto the head of a 50th percentile male Hybrid III anthropomorphic test device (ATD). Two headgear conditions were tested: no head protection and an ANSI Type-I, Class-E hardhat. A third headgear condition (snow sport helmet) was tested at 1.83 m for comparison with the hardhat. Hardhats significantly reduced the resultant linear acceleration for the concrete block impacts by 70-95% when compared to the unprotected head condition. Upper neck compression was also significantly reduced by 26-60% with the use of a hardhat when compared to the unprotected head condition for the 0.91 and 1.83 m drop heights for both lead shot and concrete block drop objects. In this study we found that hardhats can be effective in reducing both head accelerations and compressive neck forces for large construction objects in vertical impacts. (C) 2014 Elsevier Ltd. All rights reserved.	[Suderman, Bethany L.; Scher, Irving S.] Guidance Engn & Appl Res, Seattle, WA 98116 USA; [Hoover, Ryan W.] CAPE, Westfield, IN 46074 USA; [Ching, Randal P.; Scher, Irving S.] Univ Washington, Dept Mech Engn, Appl Biomech Lab, Seattle, WA 98109 USA		Suderman, BL (corresponding author), Guidance Engn & Appl Res, 3909 Calif Ave,SW Suite 202, Seattle, WA 98116 USA.	suderman@guidanceengineering.com; rhoover@imminet.com; rc@u.washington.edu					ANSI, 2009, Z8912009 ANSI, P1; Bacon K., 2001, OCCUP HLTH SAFETY; Bureau of Labor Statistics (BLS), 2013, INJ ILLN FAT DAT; CPSC, 2011, NEISS INJ DAT 2002 2; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Scher I., 2006, J ASTM INT, V3, P9; Scher I., 2009, SAE INT, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	16	13	13	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	DEC	2014	73						116	124		10.1016/j.aap.2014.08.011			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AW7OO	WOS:000346453600015	25215927				2022-02-06	
J	Chantong, B; Kratschmar, DV; Lister, A; Odermatt, A				Chantong, Boonrat; Kratschmar, Denise V.; Lister, Adam; Odermatt, Alex			Inhibition of metabotropic glutamate receptor 5 induces cellular stress through pertussis toxin-sensitive Gi-proteins in murine BV-2 microglia cells	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Glutamate receptor; mGluR5; Inflammation; Oxidative stress; Endoplasmic reticulum stress; Intracellular calcium	TRAUMATIC BRAIN-INJURY; MEDIATED SIGNAL-TRANSDUCTION; MGLUR5 ANTAGONISTS MPEP; NF-KAPPA-B; ER STRESS; MITOCHONDRIAL DYSFUNCTION; INTRACELLULAR CALCIUM; ENDOTHELIAL-CELLS; PHOSPHOLIPASE-C; ROS PRODUCTION	Background: Activation of metabotropic glutamate receptor 5 (mGluR5) by (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) was shown to suppress microglia activation and decrease the release of associated pro-inflammatory mediators. In contrast, the consequences of mGluR5 inhibition are less well understood. Here, we used BV-2 cells, retaining key characteristics of primary mouse microglia, to examine whether mGluR5 inhibition by 2-methyl-6-(phenylethynyl)-pyridine (MPEP) enhances cellular stress and production of inflammatory mediators. Methods: BV-2 cells were treated with MPEP, followed by determination of cellular stress using fluorescent dyes and high-content imaging. The expression of inflammatory mediators, endoplasmic reticulum (ER)-stress markers and phosphorylated AMPK alpha was analyzed by quantitative PCR, ELISA and Western blotting. Additionally, phospholipase C (PLC) activity, cellular ATP content and changes in intracellular free Ca2+ ([Ca2+] (i)) were measured using luminescence and fluorescence assays. Results: Treatment of BV-2 microglia with 100 mu M MPEP increased intracellular reactive oxygen species (ROS), mitochondrial superoxide, mitochondrial mass as well as inducible nitric oxide synthase (iNOS) and IL-6 expression. Furthermore, MPEP reduced cellular ATP and induced AMPKa phosphorylation and the expression of the ER-stress markers CHOP, GRP78 and GRP96. The MPEP-dependent effects were preceded by a rapid concentration-dependent elevation of [Ca2+](i), following Ca2+ release from the ER, mainly via inositol triphosphate-induced receptors (IP3R). The MPEP-induced ER-stress could be blocked by pretreatment with the chemical chaperone 4-phenylbutyrate and the Ca2+ chelator BAPTA-AM. Pretreatment with the AMPK agonist AICAR partially abolished, whilst the inhibitor compound C potentiated, the MPEP-dependent ER-stress. Importantly, the PLC inhibitor U-73122 and the Gi-protein inhibitor pertussis toxin (PTX) blocked the MPEP-induced increase in [Ca2+](i). Moreover, pretreatment of microglia with AICAR, BAPTA-AM, U-73122 and PTX prevented the MPEP-induced generation of oxidative stress and inflammatory mediators, further supporting a role for Gi-protein-mediated activation of PLC. Conclusions: The results emphasize the potential pathophysiological role of mGluR5 antagonism in mediating oxidative stress, ER-stress and inflammation through a Ca2+-dependent pathway in microglia. The induction of cellular stress and inflammatory mediators involves PTX-sensitive Gi-proteins and subsequent activation of PLC, IP3R and Ca2+ release from the ER.	[Kratschmar, Denise V.; Lister, Adam; Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, CH-4056 Basel, Switzerland		Odermatt, A (corresponding author), Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, Klingelbergstr 50, CH-4056 Basel, Switzerland.	alex.odermatt@unibas.ch		Winter, denise V./0000-0002-3764-1747	Swiss Center for Applied Human Toxicology; European CommunityEuropean Commission [246539]; Royal Thai Government	This work was supported by the Swiss Center for Applied Human Toxicology. AO has a Novartis Chair for Molecular and Systems Toxicology. AL has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 246539. BC was supported by a grant from the Royal Thai Government.	Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block L, 2012, NEUROSCIENCE, V205, P1, DOI 10.1016/j.neuroscience.2011.12.058; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brawek B, 2013, CELL CALCIUM, V53, P159, DOI 10.1016/j.ceca.2012.12.003; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cosford NDP, 2003, J MED CHEM, V46, P204, DOI 10.1021/jm025570j; D'Antoni S, 2011, NEUROBIOL DIS, V42, P252, DOI 10.1016/j.nbd.2011.01.013; Deng Yi Yu, 2011, Front Biosci (Schol Ed), V3, P884; Eichhoff G, 2011, BBA-MOL CELL RES, V1813, P1014, DOI 10.1016/j.bbamcr.2010.10.018; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Huang XX, 2000, MOL CELL BIOCHEM, V213, P29, DOI 10.1023/A:1007138818124; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Ikeda M, 2013, BBA-MOL CELL RES, V1833, P2573, DOI 10.1016/j.bbamcr.2013.06.022; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; KOROTZER AR, 1995, EUR J PHARM-MOLEC PH, V288, P125, DOI 10.1016/0922-4106(95)90006-3; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Labuzek K, 2010, NEUROTOXICOLOGY, V31, P134, DOI 10.1016/j.neuro.2009.10.006; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Lee S, 2013, NEUROTOX RES, V23, P249, DOI 10.1007/s12640-012-9353-4; Li XW, 2011, GLIA, V59, P569, DOI 10.1002/glia.21125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Maria DA, 2013, INVEST NEW DRUG, V31, P493, DOI 10.1007/s10637-012-9871-1; Mathiesen JM, 2003, BRIT J PHARMACOL, V138, P1026, DOI 10.1038/sj.bjp.0705159; McLarnon JG, 2005, J NEUROSCI RES, V81, P426, DOI 10.1002/jnr.20487; Mead EL, 2012, J NEUROCHEM, V121, P287, DOI 10.1111/j.1471-4159.2012.07659.x; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Nam HGW, 2013, NEUROL RES, V35, P395, DOI 10.1179/1743132813Y.0000000158; Noda M, 2013, ADV EXP MED BIOL, V961, P289, DOI 10.1007/978-1-4614-4756-6_24; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; Pajoohesh-Ganji A, 2011, NEUROTHERAPEUTICS, V8, P195, DOI 10.1007/s13311-011-0036-2; Park YJ, 2013, NEUROCHEM RES, V38, P1561, DOI 10.1007/s11064-013-1057-5; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rolin J, 2013, IMMUNOBIOLOGY, V218, P875, DOI 10.1016/j.imbio.2012.10.009; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sarnico I, 2008, J NEURAL TRANSM, V115, P669, DOI 10.1007/s00702-007-0007-2; Sauer H, 2012, INT J ONCOL, V40, P501, DOI 10.3892/ijo.2011.1230; Vernon AC, 2007, J NEUROCHEM, V103, P1075, DOI 10.1111/j.1471-4159.2007.04860.x; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang XJ, 2005, MECH AGEING DEV, V126, P1241, DOI 10.1016/j.mad.2005.06.012; Woo MS, 2008, J NEUROCHEM, V106, P770, DOI 10.1111/j.1471-4159.2008.05430.x; Yang L, 2013, J BIOL CHEM, V288, P13631, DOI 10.1074/jbc.M113.462762; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zou J, 2012, GLIA, V60, P661, DOI 10.1002/glia.22302	73	13	14	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	NOV 19	2014	11								190	10.1186/s12974-014-0190-7			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AY2NE	WOS:000347426100001	25407356	Green Published, gold			2022-02-06	
J	Bolos, M; Hu, YL; Young, KM; Foa, L; Small, DH				Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.			Neurogenin 2 Mediates Amyloid-beta Precursor Protein-stimulated Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; INTRACELLULAR DOMAIN; PYRAMIDAL NEURONS; BHLH GENES; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Amyloid-beta precursor protein (APP) is well studied for its role in Alzheimer disease, although its normal function remains uncertain. It has been reported that APP stimulates the proliferation and neuronal differentiation of neural stem/progenitor cells (NSPCs). In this study we examined the role of APP in NSPC differentiation. To identify proteins that may mediate the effect of APP on NSPC differentiation, we used a gene array approach to find genes whose expression correlated with APP-induced neurogenesis. We found that the expression of neurogenin 2 (Ngn2), a basic helix-loop-helix transcription factor, was significantly down-regulated in NSPCs from APP knock-out mice (APPKO) and increased in APP transgenic (Tg2576) mice. Ngn2 overexpression in APPKO NSPCs promoted neuronal differentiation, whereas siRNA knockdown of Ngn2 expression in wild-type NSPCs decreased neuronal differentiation. The results demonstrate that APP-stimulated neuronal differentiation of NSPCs is mediated by Ngn2.	[Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia		Small, DH (corresponding author), Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos, Marta/J-7620-2014	Foa, Lisa/0000-0003-4131-8341; Bolos, Marta/0000-0003-2652-8607; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	This work was supported by project grants from the National Health and Medical Research Council of Australia, BUPA/Alzheimer's Society UK and Multiple Sclerosis Research Australia.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Megason SG, 2002, DEVELOPMENT, V129, P2087; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Octave JN, 2013, J NEUROCHEM, V126, P183, DOI 10.1111/jnc.12239; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Small D H, 1999, J Alzheimers Dis, V1, P275; Small DH, 2014, NEURODEGENER DIS, V13, P96, DOI 10.1159/000353686; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	64	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31253	31261		10.1074/jbc.M114.581918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	WOS:000344549900030	25217641	Green Published, hybrid			2022-02-06	
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			"IN MY BEFORE LIFE": RELATIONSHIPS, COPING AND POST-TRAUMATIC GROWTH IN ADOLESCENT SURVIVORS OF A TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; adolescent; quality of life; adjustment, psychological; qualitative research	QUALITY-OF-LIFE; HEAD-INJURY; CHILDREN; SCHOOL; INTERVIEWS; TBI	Objective: Explore the individual, adolescent phenomenology of quality of life after traumatic brain injury. Subjects/Patients: Adolescent survivors of traumatic brain injury. Methods: Qualitative interviews with 10 adolescents, mean age at assessment 17.09 years (SD 1.81). Mean time since injury 4.62 years (SD 2.89). Data were analysed using a primarily interpretative phenomenological analysis approach. Results: Two major findings: (1) perceived quality of life was not automatically impacted by a traumatic brain injury, but when it was, the directionality of impact (positive, negative) varied depending on the life-domain; (2) changes in ability post-traumatic brain injury were attributed to the injury (more often cognitive and physical changes) or to a sense of normal maturation processes (72% and 28%, respectively). Attribution processing permeated themes of personal and social discrepancies, which also yielded themes of: altered family and relationships, roles, responsibilities, independence, coping and post-traumatic growth. All participants reported a happy life at the time of interview. Conclusion: The adolescents' appraisal of their identity from pre- to post-injury life was related to their current sense of well-being. Most notably was the sense of balance; participants addressed the negative and positive consequences of brain injury to qualify their sense of wellbeing.	[Di Battista, Ashley; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Di Battista, Ashley] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Di Battista, A (corresponding author), Hosp Sick Children, Dept Psychol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ashley.dibattista@sickkids.ca	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), CanadaCanadian Institutes of Health Research (CIHR); Victorian Government Operations Infrastructure Funding, Australia	This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), Canada - awarded to Ashley Di Battista, and the Victorian Government Operations Infrastructure Funding, Australia.	Apgar M., 1991, RIGHT BRAIN STRIKES; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; Cummins RA, 2005, J INTELL DISABIL RES, V49, P699, DOI 10.1111/j.1365-2788.2005.00738.x; Di Battista A., 2013, SPEAKING THEMSELVES; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Gracey F, 2009, NEUROPSYCHOL REHABIL, V22, P1; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mason M., 2010, FORUM QUALITATIVE SO, V11, P8, DOI [10.17169/fqs-11.3.1428, DOI 10.17169/FQS-11.3.1428]; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Organization WH, 2001, WHO DISABILITY ASSES; Padgett D. K., 1998, QUALITATIVE METHODS; Patton M.Q., 1990, QUALITATIVE EVALUATI; Patton M. Q., 2014, QUALITATIVE RES EVAL, V4th; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Rodset M, 2008, SCAND J DISABIL RES, V10, P90, DOI 10.1080/15017410801927807; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Seidel J.V., 1998, QUALITATIVE DATA ANA; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Smith A, 2003, INTERPRETATIVE PHENO; Staquet MJ, 1998, OX MED PUBL, P337; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	39	13	13	2	21	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2014	46	10					975	983		10.2340/16501977-1883			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AT7HD	WOS:000345106400005	25188467	gold, Green Submitted			2022-02-06	
J	Pachatouridis, D; Alexiou, GA; Zigouris, A; Michos, E; Drosos, D; Fotakopoulos, G; Voulgaris, S				Pachatouridis, Dimitrios; Alexiou, George A.; Zigouris, Andreas; Michos, Evaggelos; Drosos, Dimitrios; Fotakopoulos, George; Voulgaris, Spyridon			Management of Hydrocephalus After Decompressive Craniectomy	TURKISH NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Hydrocephalus	POSTTRAUMATIC HYDROCEPHALUS	AIM: We set out to investigate the optimal timing for shunt placement in patients with hydrocephalus after decompressive craniectomy (DC). MATERIAL and METHODS: We studied 63 consecutive patients that underwent DC because of traumatic brain injury, middle cerebral artery infarct or intracerebral hemorrhage. Hydrocephalus was diagnosed in 23/63 patients. The 23 patients were divided into two groups. The first group (A) consisted of 11 patients in whom a ventriculoperitoneal shunt was placed simultaneously or before cranioplasty. In the second group (B) of 12 patients, we performed cranioplasty and a ventriculostomy with monitoring of intracranial pressure was placed simultaneously. After 3 to 5 days, a ventriculoperitoneal shunt was placed with the most appropriate opening pressure. RESULTS: In group A, nine out of the eleven patients experienced complications, mainly hygromas or hematomas that required reoperation. In group B, none of the patients was reoperated. The use of programmable valves allowed for non-invasive revision of the opening pressure when required. CONCLUSION: Cranioplasty and ventriculostomy followed by a second stage placement of a ventriculoperitoneal shunt are associated with fewer complications in the treatment of hydrocephalus after DC.	[Pachatouridis, Dimitrios; Alexiou, George A.; Zigouris, Andreas; Michos, Evaggelos; Drosos, Dimitrios; Fotakopoulos, George; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece		Alexiou, GA (corresponding author), Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece.	alexiougrg@yahoo.gr	Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481; fotakopoulos, george/0000-0002-2491-2886			Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Clarke Michelle J, 2007, Neurosurg Focus, V22, pE3, DOI 10.3171/foc.2007.22.4.4; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Dandy WE, 1914, AM J DIS CHILD, V8, P406; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; GREITZ D, 1993, ACTA RADIOL, V34, P1; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Pollack IF, 1999, NEUROSURGERY, V45, P1399, DOI 10.1097/00006123-199912000-00026; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; RAIMONDI AJ, 1994, CHILD NERV SYST, V10, P2, DOI 10.1007/BF00313578; Rekate HL, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-2; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	15	13	14	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	NOV	2014	24	6					855	858		10.5137/1019-5149.JTN.8871-13.1			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AY0EI	WOS:000347270100009	25448200				2022-02-06	
J	Parchani, A; El-Menyar, A; Al-Thani, H; El-Faramawy, A; Zarour, A; Asim, M; Latifi, R				Parchani, Ashok; El-Menyar, Ayman; Al-Thani, Hassan; El-Faramawy, Ahmed; Zarour, Ahmad; Asim, Mohammad; Latifi, Rifat			Traumatic Subarachnoid Hemorrhage Due To Motor Vehicle Crash Versus Fall From Height: A 4-Year Epidemiologic Study	WORLD NEUROSURGERY			English	Article						Fall from height; Motor vehicle crash; Subarachnoid hemorrhage; Traumatic brain injury	NONPENETRATING HEAD-INJURY; BRAIN-INJURY; TOMOGRAPHY; VASOSPASM; MODERATE; IMPACT	BACKGROUND: Traumatic brain injury (TBI) is a common cause of morbidity and mortality worldwide. It is difficult to estimate the real incidence of traumatic subarachnoid hemorrhage (TSAH). Although TSAH after trauma is associated with poor prognoses, the impact of mechanism of injury (MOI) and the pathophysiology remains unknown. We hypothesized that outcome of TSAH caused by motor vehicle crash (MVC) or fall from height (FFH) varies based on the MOI. METHODS: Data were collected retrospectively from a prospectively created database registry in the section of Trauma Surgery at Hamad General Hospital between January 2008 and July 2012. All patients presented with head trauma and TSAH were included. Patient data included age, gender, nationality, mechanism of injury, injury severity score (ISS), types of head injuries, and associated injuries. Ventilator days, intensive care unit length of stay, pneumonia, and mortality were also studied. RESULTS: A total of 1665 patients with TBI were identified, of them 403 had TSAH with a mean age of 35 +/- 15 years. Of them 93% were male patients and 86% were expatriates. MVC (53%) and FFH (35%) were the major mechanisms of injury. The overall mean ISS and head abbreviated injury score were 19 +/- 10.6 and 3.4 +/- 0.96, respectively. Patients in MVC group sustained severe TSAH, had significantly greater head abbreviated injury score (3.5 +/- 0.9 vs. 3.2 +/- 0.9; P = 0.009) and ISS (21.6 +/- 10.6 vs. 15.9 +/- 9.5; P = 0.001), and lower scene Glasgow coma scale (10.8 +/- 4.8 vs. 13.2 +/- 3.4; P = 0.001) compared with the FFH group. In addition, the MVC group sustained more intraventricular hemorrhage (4.7 vs. 0.7; P = 0.001) and diffuse axonal injury (4.2 vs. 2.9; P = 0.001). In contrast, extradural hemorrhage (14.3% vs. 11.6%; P = 0.008) was higher in the FFH group. Lower extremities (14% vs. 4.3%; P = 0.004) injury was mainly associated with the MVC group. The overall mortality was 19 % among patients with TSAH. The mortality rate was higher in the MVC group when compared with the FFH group (24% vs. 10%; P = 0.001). In both groups, ISS and Glasgow coma scale at the scene were independent predictors of mortality. CONCLUSIONS: Patients with TSAH have a higher mortality rate. In this population, MVCs are associated with a 3-fold increased risk of mortality. Therefore, prevention of MVC and fall can reduce the incidence and severity of TBI in Qatar.	[Parchani, Ashok; Al-Thani, Hassan; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat] Hamad Gen Hosp, Dept Surg, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Dept Clin Surg, Doha, Qatar; [Parchani, Ashok; El-Menyar, Ayman; Latifi, Rifat] Weill Cornell Med Coll, Doha, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA		El-Menyar, A (corresponding author), Weill Cornell Med Coll, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X			Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO; Lee KH, 2006, NEUROCRIT CARE, V4, P68, DOI 10.1385/NCC:4:1:068; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Miki T, 1998, J CLIN NEUROSCI, V5, P49, DOI 10.1016/S0967-5868(98)90202-8; Morris GF, 1997, CLIN NEUROL NEURO S1, V99, pS16; National Institutes of Health (NIH), SUB HEM MEDLINEPLUS; Pobereskin LH, 2001, J NEUROL NEUROSUR PS, V70, P340, DOI 10.1136/jnnp.70.3.340; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyeberg EW, 2008, PLOS MED, V5, P2151; Tuma Mazin A, 2013, Int J Crit Illn Inj Sci, V3, P3, DOI 10.4103/2229-5151.109408; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	27	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2014	82	5					E639	E644		10.1016/j.wneu.2014.06.022			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX9XK	WOS:000347252300013	24947116				2022-02-06	
J	Studer, M; Simonetti, BG; Joeris, A; Margelisch, K; Steinlin, M; Roebers, CM; Heinks, T				Studer, Martina; Simonetti, Barbara Goeggel; Joeris, Alexander; Margelisch, Katja; Steinlin, Maja; Roebers, Claudia Maria; Heinks, Theda			Post-concussive Symptoms and Neuropsychological Performance in the Post-acute Period following Pediatric Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Concussion; Children; Recovery; Pre-injury attention problems; Everyday attention problems; Verbal learning and memory performance	DEFICIT HYPERACTIVITY DISORDER; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; NEUROCOGNITIVE OUTCOMES; EXECUTIVE FUNCTIONS; COGNITIVE RESERVE; AGED CHILDREN; ADOLESCENTS; PREDICTORS; MANAGEMENT	Objective: There is evidence that children after mild traumatic brain injuries (mTBI) suffer ongoing post-concussive symptoms (PCS). However, results concerning neuropsychological outcome after mTBI are controversial. Thus, our aim was to examine group differences regarding neuropsychological outcome and PCS. Additionally, we explored the influence of current and pre-injury everyday attention problems on neuropsychological outcome in children after mTBI. Method: In a prospective short-term longitudinal study, 40 children (aged 6-16 years) after mTBI and 38 children after orthopedic injury (OI) underwent neuropsychological, socio-behavioral and PCS assessments in the acute stage and at 1 week, at 4 weeks, and 4 months after the injury. Results: Parents of children after mTBI observed significantly more PCS compared to parents of children after OI, especially in the acute stage. Our results revealed no neuropsychological or socio-behavioral differences over time between both groups. However, in children after mTBI, we found negative correlations between elevated levels of everyday attention problems and reduced neuropsychological performance. Furthermore, there was a negative influence of pre-injury everyday attention problems on neuropsychological performance in children after mTBI. Conclusion: In accordance with earlier studies, parents of children after mTBI initially observed significantly more PCS compared to parents of children after OI. There were no neuropsychological or socio-behavioral group differences between children after mTBI and OI in the post-acute period. However, our exploratory findings concerning the influence of everyday attention problems on neuropsychological outcome indicate that current and pre-injury everyday attention problems were negatively associated with neuropsychological performance in children after mTBI.	[Studer, Martina; Simonetti, Barbara Goeggel; Margelisch, Katja; Steinlin, Maja; Heinks, Theda] Univ Childrens Hosp Bern, Dept Pediat Neurol Dev & Rehabil, Bern, Switzerland; [Studer, Martina; Simonetti, Barbara Goeggel; Margelisch, Katja; Steinlin, Maja; Roebers, Claudia Maria; Heinks, Theda] Univ Bern, Ctr Cognit & Learning, Bern, Switzerland; [Simonetti, Barbara Goeggel] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Joeris, Alexander] Univ Childrens Hosp Bern, Dept Pediat Surg, Bern, Switzerland; [Margelisch, Katja; Roebers, Claudia Maria] Univ Bern, Dept Dev Psychol, Bern, Switzerland		Studer, M (corresponding author), Univ Childrens Hosp, Inselspital, Dept Pediat Neurol Dev & Rehabil, CH-3010 Bern, Switzerland.	martina.studer@insel.ch	Joeris, Alexander/J-4688-2019	Joeris, Alexander/0000-0002-7748-7115; Margelisch, Katja/0000-0001-9594-4247	Johanna Durmuller-Bol Foundation; Batzebar Foundation of the University Children's Hospital of Bern; Anna Muller-Grocholski Foundation	This work was financially supported by following foundations: the Johanna Durmuller-Bol Foundation, the Batzebar Foundation of the University Children's Hospital of Bern, and the Anna Muller-Grocholski Foundation. There are no conflicts of interest. Portions of this research were presented at the Mid-Year Meeting of the International Neuropsychological Society (INS) in Amsterdam, 2013 as well as at the Annual Meeting of the INS in Seattle, 2014. We thank all parents and children for participating in this research project. In addition, we thank the Psychology graduate students Venera Gashaj, Sandra Hartmann, and Elisabeth Ruprecht for helping with data collection. Besides, the authors express gratitude to the anonymous Reviewers for their helpful suggestions and thank Thomas Mettler for support with data plotting.	Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brown L., 1997, TEST NONVERBAL INTEL, V3rd; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Conners C.K., 2004, CONNERS CONTINUOUS P; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delis DC., 2001, DELIS KAPLAN EXECUTI; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Duff K, 2005, ARCH CLIN NEUROPSYCH, V20, P111, DOI 10.1016/j.acn.2004.03.003; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gathercole S., 2001, WORKING MEMORY TEST; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2011, MANUAL PEDIAT IMMEDI; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Heim S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00277; Helmstaedter C., 2001, VERBALER LERN MERKFA; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Menascu S., 2007, HEAD INJURY CHILDREN, P41; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Petermann F, 2008, KINDH ENTWICKL, V17, P71, DOI 10.1026/0942-5403.17.2.71; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ramsay LJ, 2003, PUBLIC HEALTH, V117, P404, DOI 10.1016/S0033-3506(03)00072-6; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Roebers CM, 2011, EUR J DEV PSYCHOL, V8, P526, DOI 10.1080/17405629.2011.571841; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Smallwood J, 2007, PSYCHON B REV, V14, P230, DOI 10.3758/BF03194057; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	63	13	13	0	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2014	20	10					982	993		10.1017/S1355617714000927			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AW3FN	WOS:000346171700004	25382292	Green Submitted, Green Published			2022-02-06	
J	Chang, VC; Ruseckaite, R; Collie, A; Colantonio, A				Chang, Vicky C.; Ruseckaite, Rasa; Collie, Alex; Colantonio, Angela			Examining the epidemiology of work-related traumatic brain injury through a sex/gender lens: analysis of workers' compensation claims in Victoria, Australia	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							GENDER-DIFFERENCES; WASHINGTON-STATE; SEX-DIFFERENCES; DISABILITY; PATTERNS; ONTARIO; HEALTH; IMPACT; COSTS; RATES	Objectives To provide an overview of the epidemiology of work-related traumatic brain injury (wrTBI) in the state of Victoria, Australia. Specifically, we investigated sex differences in incidence, demographics, injury characteristics, in addition to outcomes associated with wrTBI. Methods This study involved secondary analysis of administrative workers' compensation claims data obtained from the Victorian WorkCover Authority for the period 2004-2011. Sex-specific and industry-specific rates of wrTBI were calculated using denominators derived from the Australian Bureau of Statistics. A descriptive analysis of all variables was conducted for the total wrTBI population and stratified by sex. Results Among 4186 wrTBI cases identified, 36.4% were females. The annual incidence of wrTBI was estimated at 19.8/100 000 workers. The rate for males was 1.43 (95% CI 1.35 to 1.53) times that for females, but the gap between the two sexes appeared to have narrowed over time. Compared to males, females were older at time of injury and had lower preinjury income. Males had higher rates than females across most industry sectors, with the exception of education/training (RR 0.77, 95% CI 0.64 to 0.93) and professional/scientific/technical services (RR 0.64, 95% CI 0.44 to 0.93). For both sexes, the most common injury mechanism was struck by/against, followed by falls. WrTBI among males was associated with longer duration of work disability and higher claim costs compared to females. Conclusions This study found significant sex differences in various risk factors and outcomes of wrTBI. Sex/gender should be taken into consideration in future research and prevention strategies.	[Chang, Vicky C.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Ruseckaite, Rasa; Collie, Alex] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Ruseckaite, Rasa; Collie, Alex] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Ruseckaite, Rasa/H-4060-2014	Colantonio, Angela/0000-0003-2094-4765; Ruseckaite, Rasa/0000-0002-9078-2696; Chang, Vicky/0000-0002-2528-9387; Collie, Alex/0000-0003-2617-9339	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [494372]	This study, including support for Dr. Colantonio and Ms. Chang, was funded by the Canadian Institutes of Health Research (grant #494372). Data for the analysis conducted was provided by the Victorian WorkCover Authority via a grant to the Institute for Safety, Compensation and Recovery Research.	[Anonymous], 2013, 4125 0 GEND IND AUST; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2006, AUSTR NZ STAND IND C; Australian Bureau of Statistics, 2014, 6291 0 55 003 LAB FO; Australian Safety and Compensation Council, 2008, TYP OCC CLASS SYST, V3rd; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Berecki-Gisolf J, 2012, J OCCUP ENVIRON MED, V54, P318, DOI 10.1097/JOM.0b013e31823fdf9d; Chang VH, 2011, PM&R, V3, pS387, DOI 10.1016/j.pmrj.2011.08.007; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Driscoll T, 2003, OCCUP ENVIRON MED, V60, P195, DOI 10.1136/oem.60.3.195; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; European Agency for Safety and Health at Work, 2003, GEND ISS SAF HLTH WO; Fan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038750; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; Harrold LR, 2008, DISABIL REHABIL, V30, P36, DOI 10.1080/09638280701192949; Helps Y, 2008, INJURY RES STAT SERI, V45; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institute for Safety Compensation and Recovery Research, 2014, WORKSAFE VICT DAT DI; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.3.CO;2-K; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Moore IC, 2011, OCCUP ENVIRON MED, V68, P837, DOI 10.1136/oem.2010.055913; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Ruseckaite R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002396; Ruseckaite R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-492; Safe Work Australia, 2013, COMP WORK COMP STAT; Safe Work Australia, 2013, WORK REL INJ RES HOS; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; Smith PM, 2004, OCCUP ENVIRON MED, V61, P750, DOI 10.1136/oem.2003.009860; Taiwo OA, 2009, AM J EPIDEMIOL, V169, P161, DOI 10.1093/aje/kwn304; Thompson A, 2007, CAN MED ASSOC J, V176, P343, DOI 10.1503/cmaj.060953; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	39	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	OCT	2014	71	10					695	703		10.1136/oemed-2014-102097			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AP1SC	WOS:000341850500007	25052083				2022-02-06	
J	Keilhoff, G; Lucas, B; Pinkernelle, J; Steiner, M; Fansa, H				Keilhoff, Gerburg; Lucas, Benjamin; Pinkernelle, Josephine; Steiner, Michael; Fansa, Hisham			Effects of cerebrolysin on motor-neuron-like NSC-34 cells	EXPERIMENTAL CELL RESEARCH			English	Article						BrdU; Calpain; Cerebrolysin; NSC-34 cells; Organotypic spinal cord culture; Spectrin; Src	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; GLUCOSE DEPRIVATION; SCHWANN-CELLS; IN-VITRO; MECHANICAL HYPERSENSITIVITY; TYROSINE PHOSPHORYLATION; PEPTIDE PREPARATION; SPINAL MICROGLIA; TRANSGENIC MODEL	Although the peripheral nervous system is capable of regeneration, this capability is limited. As a potential means of augmenting nerve regeneration, the effects of cerebrolysin (CL) - a proteolytic peptide fraction - were tested in vitro on the motor-neuron-like NSC-34 cell line and organotypic spinal cord cultures. Therefore, NSC-34 cells were subjected to mechanical stress by changing media and metabolic stress by oxygen glucose deprivation. Afterwards, cell survival/proliferation using MTT and BrdU-labeling (FACS) and neurite sprouting using ImageJ analysis were evaluated. Calpain-1, Src and alpha-spectrin protein expression were analyzed by Western blot. In organotypic cultures, the effect of CL on motor neuron survival and neurite sprouting was tested by immunohistochemistry. CL had a temporary anti-proliferative but initially neuroprotective effect on OGD-stressed NSC-34 cells. High-dosed or repeatedly applied CL was deleterious for cell survival. CL amplified neurite reconstruction to limited extent, affected calpain-1 protein expression and influenced calpain-mediated spectrin cleavage as a function of Src expression. In organotypic spinal cord slice cultures, CL was not able to support motor neuron survival/neurite sprouting. Moreover, it hampered astroglia and microglia activities. The data suggest that CL may have only isolated positive effects on injured spinal motor neurons. High-dosed or accumulated CL seemed to have adverse effects in treatment of spinal cord injury. Further experiments are required to optimize the conditions for a safe clinical administration of CL in spinal cord injuries. (C) 2014 Elsevier Inc. All rights reserved.	[Keilhoff, Gerburg; Lucas, Benjamin; Pinkernelle, Josephine; Steiner, Michael] Otto Von Guericke Univ, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany; [Fansa, Hisham] Klinikum Bielefeld, Dept Plast Reconstruct & Aesthet Surg Hand Surg, D-33604 Bielefeld, Germany		Keilhoff, G (corresponding author), Otto Von Guericke Univ, Inst Biochem & Cell Biol, Leipziger Str 44, D-39120 Magdeburg, Germany.	Gerburg.keilhoff@med.ovgu.de			DFGGerman Research Foundation (DFG)European Commission [KE 488/15-1]	This work was supported by a DFG grant (KE 488/15-1). We are grateful to Leona Buck and Susanne Bonifatius for their excellent technical help and advice.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P281; Vazquez-Roque RA, 2012, J NEUROSCI RES, V90, P288, DOI 10.1002/jnr.22753; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; BJELFMAN C, 1990, MOL CELL BIOL, V10, P361, DOI 10.1128/MCB.10.1.361; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Cali T, 2012, CELL CALCIUM, V52, P73, DOI 10.1016/j.ceca.2012.04.015; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Cao X, 2010, NEUROSCI LETT, V479, P118, DOI 10.1016/j.neulet.2010.05.040; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen ZP, 2001, J VIROL, V75, P3613, DOI 10.1128/JVI.75.8.3613-3625.2001; Chou HC, 2010, FREE RADICAL BIO MED, V49, P96, DOI 10.1016/j.freeradbiomed.2010.04.001; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Du BY, 2012, CHEMOTHERAPY, V58, P44, DOI 10.1159/000335603; Ebewe Arzneimittel, 1998, Patent, Patent No. [DE69126563T2, 69126563]; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8; Haninec P, 2003, ANN ANAT, V185, P233, DOI 10.1016/S0940-9602(03)80030-4; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Hishiki T, 2011, PEDIATR SURG INT, V27, P225, DOI 10.1007/s00383-010-2775-2; HONG SC, 1994, BRAIN RES, V661, P43, DOI 10.1016/0006-8993(94)91178-9; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P363; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P351; Isonaka R, 2012, BRAIN RES, V1470, P11, DOI 10.1016/j.brainres.2012.06.014; Juarez I, 2011, SYNAPSE, V65, P1128, DOI 10.1002/syn.20950; Kalluri HSG, 2007, NEUROSCI LETT, V426, P145, DOI 10.1016/j.neulet.2007.08.047; KANJE M, 1991, BRAIN RES, V550, P340, DOI 10.1016/0006-8993(91)91338-2; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Kieran D, 2004, NEUROSCIENCE, V125, P427, DOI 10.1016/j.neuroscience.2004.01.046; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Lucas B, 2014, ACTA HISTOCHEM, V116, P820, DOI 10.1016/j.acthis.2014.01.013; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; MacFarlane SN, 2000, J NEUROSCI, V20, P5245, DOI 10.1523/JNEUROSCI.20-14-05245.2000; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Matsunaga T, 1998, INT J CANCER, V79, P226, DOI 10.1002/(SICI)1097-0215(19980619)79:3<226::AID-IJC3>3.0.CO;2-R; MATSUNAGA T, 1993, CANCER RES, V53, P3179; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Mingorance-Le Meur A, 2009, EMBO J, V28, P248, DOI 10.1038/emboj.2008.265; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Nedrelow JH, 2003, J BIOL CHEM, V278, P7735, DOI 10.1074/jbc.M210988200; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Ohno H, 2007, BIOCHEM BIOPH RES CO, V353, P547, DOI 10.1016/j.bbrc.2006.12.061; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Paramo B, 2013, INT J BIOCHEM CELL B, V45, P2596, DOI 10.1016/j.biocel.2013.08.013; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Radi M, 2011, BIOORG MED CHEM LETT, V21, P5928, DOI 10.1016/j.bmcl.2011.07.079; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rasband W.S, 1997, IMAGEJ US; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Sahly I, 2006, J COMP NEUROL, V494, P705, DOI 10.1002/cne.20690; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Salotti J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072582; Samantaray S, 2008, CNS NEUROL DISORD-DR, V7, P305, DOI 10.2174/187152708784936680; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Sato K, 2008, J NEUROSCI RES, V86, P2179, DOI 10.1002/jnr.21668; Schauer E, 2006, J NEURAL TRANSM, V113, P855, DOI 10.1007/s00702-005-0384-3; Schwab M, 1998, J NEURAL TRANSM-SUPP, P299; Sheridan RE, 2006, LIFE SCI, V79, P591, DOI 10.1016/j.lfs.2006.02.002; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Simon CM, 2010, HUM MOL GENET, V19, P973, DOI 10.1093/hmg/ddp562; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stys PK, 2002, NEUROSCI LETT, V328, P150, DOI 10.1016/S0304-3940(02)00469-X; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Vyas A, 2010, EXP NEUROL, V223, P112, DOI 10.1016/j.expneurol.2009.05.022; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Xu P, 2013, GLIA, V61, P1029, DOI 10.1002/glia.22491; Xu XH, 2009, DIFFERENTIATION, V77, P38, DOI 10.1016/j.diff.2008.09.006; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhou LJ, 2011, BRAIN BEHAV IMMUN, V25, P322, DOI 10.1016/j.bbi.2010.09.025	96	13	14	1	12	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	OCT 1	2014	327	2					234	255		10.1016/j.yexcr.2014.06.020			22	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	AP3EU	WOS:000341959200006	24997385				2022-02-06	
J	Lange, RP; Everett, A; Dulloor, P; Korley, FK; Bettegowda, C; Blair, C; Grossman, SA; Holdhoff, M				Lange, Ryan P.; Everett, Allen; Dulloor, Pratima; Korley, Frederick K.; Bettegowda, Chetan; Blair, Cherie; Grossman, Stuart A.; Holdhoff, Matthias			Evaluation of Eight Plasma Proteins as Candidate Blood-Based Biomarkers for Malignant Gliomas	CANCER INVESTIGATION			English	Article						Brain Tumors; Cancer Biomarkers; Circulating Biomarkers; Proteins; Glioma	FIBRILLARY ACIDIC PROTEIN; NEUROTROPHIC FACTOR BDNF; TRAUMATIC BRAIN-INJURY; SOLUBLE TELENCEPHALIN; METALLOTHIONEIN-III; ADHESION MOLECULE; GAMMA-SYNUCLEIN; BETA-SYNUCLEIN; SERUM; EXPRESSION	Eight brain-derived proteins were evaluated regarding their potential for further development as a blood-based biomarker for malignant gliomas. Plasma levels for glial fibrillary acidic protein, neurogranin, brain-derived neurotrophic factor, intracellular adhesion molecule 5, metallothionein-3, beta-synuclein, S100 and neuron specific enolase were tested in plasma of 23 patients with high-grade gliomas (WHO grade IV), 11 low-grade gliomas (WHO grade II), and 15 healthy subjects. Compared to the healthy controls, none of the proteins appeared to be specific for glioblastomas. However, the data are suggestive of higher protein levels in gliosarcomas (n = 2), which may deserve further exploration.	[Everett, Allen; Dulloor, Pratima] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Korley, Frederick K.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Grossman, Stuart A.; Holdhoff, Matthias] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bettegowda, Chetan; Blair, Cherie; Grossman, Stuart A.; Holdhoff, Matthias] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA		Holdhoff, M (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Brain Canc Program, 1550 Orleans St,1M16, Baltimore, MD 21287 USA.	mholdho1@jhmi.edu			Robert H. Gross Memorial Fund; Retired Professional Fire Fighters Cancer Fund, Inc. (RPFFCF); Sidney Kimmel Comprehensive Cancer Center core grant [P30CA006973]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006973] Funding Source: NIH RePORTER	This study was supported by the Robert H. Gross Memorial Fund, and Retired Professional Fire Fighters Cancer Fund, Inc. (RPFFCF). Support also came from P30CA006973 (Sidney Kimmel Comprehensive Cancer Center core grant).	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Borusiak P, 2005, J NEUROL, V252, P493, DOI 10.1007/s00415-005-0668-4; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Brommeland T, 2007, ACTA NEUROL SCAND, V116, P380, DOI 10.1111/j.1600-0404.2007.00889.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Dabrowski W, 2012, J CARDIOTHOR VASC AN, V26, P395, DOI 10.1053/j.jvca.2011.10.014; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FAGNART OC, 1988, CLIN CHEM, V34, P1387; Fujita M, 2009, J NEUROL, V256, pS286, DOI 10.1007/s00415-009-5246-8; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; Gahmberg CG, 2008, IMMUNOL LETT, V117, P131, DOI 10.1016/j.imlet.2008.02.004; Gartner W, 2010, NEURO-ONCOLOGY, V12, P1004, DOI 10.1093/neuonc/noq034; George JM, 2002, GENOME BIOL, V3; Holdhoff M, 2013, J NEURO-ONCOL, V113, P345, DOI 10.1007/s11060-013-1144-0; Howells C, 2010, FEBS J, V277, P2931, DOI 10.1111/j.1742-4658.2010.07718.x; Husain H, 2012, J NEURO-ONCOL, V109, P123, DOI 10.1007/s11060-012-0874-8; Ilhan-Mutlu A, 2013, J NEURO-ONCOL, V113, P359, DOI 10.1007/s11060-013-1134-2; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Jansen JFA, 2008, ACTA NEUROL SCAND, V118, P232, DOI 10.1111/j.1600-0404.2008.01005.x; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Li Wen-bin, 2012, Cancer Biology Medicine, V9, P120, DOI 10.3969/j.issn.2095-3941.2012.02.007; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lindsberg PJ, 2002, NEUROLOGY, V58, P446, DOI 10.1212/WNL.58.3.446; Luo Y, 2013, J BIOL INORG CHEM, V18, P39, DOI 10.1007/s00775-012-0947-3; Lyubimova NV, 2011, B EXP BIOL MED+, V150, P732, DOI 10.1007/s10517-011-1236-9; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Morita K, 2009, J MOL NEUROSCI, V38, P31, DOI 10.1007/s12031-008-9156-5; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Rose EJ, 2012, TWIN RES HUM GENET, V15, P296, DOI 10.1017/thg.2012.7; Saruta J, 2012, ACTA HISTOCHEM CYTOC, V45, P211, DOI 10.1267/ahc.12005; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; Tian L, 2008, BLOOD, V111, P3615, DOI 10.1182/blood-2007-09-111179; Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vutskits L, 2008, NEUROCHEM RES, V33, P1325, DOI 10.1007/s11064-007-9586-4; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Werynska B, 2013, ANTICANCER RES, V33, P965; Wijeyaratne SM, 2009, EUR J VASC ENDOVASC, V38, P262, DOI 10.1016/j.ejvs.2009.05.011; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Xiong J, 2013, NEURO-ONCOLOGY, V15, P990, DOI 10.1093/neuonc/not039; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Yanagitani S, 1999, LIFE SCI, V64, P707, DOI 10.1016/S0024-3205(98)00612-2; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017	59	13	13	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0735-7907	1532-4192		CANCER INVEST	Cancer Invest.	OCT	2014	32	8					423	429		10.3109/07357907.2014.933237			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	AP3RA	WOS:000341993400007	25019213	Green Accepted			2022-02-06	
J	Perez-Barcena, J; Llompart-Pou, JA; O'Phelan, KH				Perez-Barcena, Jon; Antonio Llompart-Pou, Juan; O'Phelan, Kristine H.			Intracranial Pressure Monitoring and Management of Intracranial Hypertension	CRITICAL CARE CLINICS			English	Article						Intracranial pressure; Intracranial hypertension; Head injury	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTENSIVE INSULIN THERAPY; VENTRICULOSTOMY-RELATED INFECTIONS; POSTTRAUMATIC SEIZURE PROPHYLAXIS; WAKE-UP TEST; DECOMPRESSIVE CRANIECTOMY; MODERATE HYPOTHERMIA; HYPERTONIC SALINE	Intracranial pressure (ICP) monitoring is considered the standard of care in the majority of neurosurgical centers in North America and Europe. ICP is a reflection of the relationship between alterations in craniospinal volume and the ability of the craniospinal axis to accommodate added volume. ICP cannot be reliably estimated from any specific clinical feature or CT finding and must be directly measured. This review describes methods of monitoring ICP and how monitoring technique can provide additional information and provides key points regarding the treatment of intracranial hypertension in the neuro-ICU.	[Perez-Barcena, Jon; O'Phelan, Kristine H.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Antonio Llompart-Pou, Juan] Son Espases Hosp, Dept Intens Care, Palma De Mallorca 07010, Balearic Island, Spain		Perez-Barcena, J (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1120 Northwest 14th St, Miami, FL 33136 USA.	jperezbarcena@med.miami.edu	Viani, Rafael/V-1196-2018				Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS55, DOI DOI 10.1089/NEU.2007.9988; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS45; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation, 2007, NUTR J NEUROTRAUMA, V24, pS77; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Citerio G, 2004, INTENS CARE MED, V30, P1882, DOI 10.1007/s00134-004-2377-3; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DONATO T, 1994, ANESTH ANALG, V78, P58; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Foundation Brain Trauma, 2007, CEREBRAL PERFUSION T, V24, pS59; Frontera JA, 2006, STROKE, V37, P199, DOI 10.1161/01.STR.0000194960.73883.0f; Hartl R, 2013, WORLD NEUROSURG, V79, P599, DOI 10.1016/j.wneu.2013.03.046; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lane PL, 2000, CAN J SURG, V43, P442; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Mindermann T, 1998, ACT NEUR S, V71, P56; Monro A., 1823, OBSERVATIONS STRUCTU, P5; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Patel N, 2013, J TRAUMA ACUTE CARE, V74, P771; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2004, CURR PHARM DESIGN, V10, P2193, DOI 10.2174/1381612043384051; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Skoglund K, 2014, NEUROCRIT CARE, V20, P413, DOI 10.1007/s12028-013-9876-4; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661; Zornow M H, 1995, New Horiz, V3, P488	80	13	18	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	OCT	2014	30	4					735	+		10.1016/j.ccc.2014.06.005			17	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR5IY	WOS:000343619800007	25257738				2022-02-06	
J	Turner, RJ; Vink, R				Turner, Renee J.; Vink, Robert			NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke	NEUROPEPTIDES			English	Article						Neurogenic inflammation; Neuropeptides; Ischemic stroke; Capsaicin; NK1 tachykinin receptor antagonist	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; NF-KAPPA-B; CEREBRAL-ARTERY OCCLUSION; SUBSTANCE-P; NEUROGENIC INFLAMMATION; REPERFUSION INJURY; EDEMA FORMATION; HUMAN-MONOCYTES; CELL-DEATH	Previous results from our laboratory have shown that blockade of the substance P (SP) pathway with an NK1 tachykinin receptor antagonist significantly reduces blood brain barrier breakdown, cerebral edema and functional deficits following ischemic stroke. However, it is unclear whether removal of all neuropeptides is more efficacious than blocking SP alone. As such, the aim of the present study was to determine the effect of neuropeptide depletion with capsaicin pre-treatment on functional outcome following acute ischemic stroke in rats. Animals received 125 mg/kg of capsaicin or equal volume of saline vehicle, administered subcutaneously over a 3-day period. At 14 days following treatment animals were subject to 2 h of middle cerebral artery occlusion followed by reperfusion. A subset of animals was treated with an NK1 tachykinin receptor antagonist (NAT) or vehicle at 4 h after the onset of stroke only. The functional outcome of animals was assessed for a 7-day period following stroke using a rotarod device, the bilateral asymmetry test, modified neurological severity score, open field and angleboard. Although capsaicin pre-treatment improved outcome, treatment with an NK1 tachykinin receptor antagonist was superior in improving post-stroke functional outcome. This data suggests that some neuropeptides may play a beneficial role following stroke, whilst others such as SP are deleterious. (C) 2014 Elsevier Ltd. All rights reserved.	[Turner, Renee J.; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia; [Vink, Robert] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia		Turner, RJ (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia.	renee.turner@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	This work was supported, in part, by the National Health and Medical Research Council (NHMRC) of Australia.	Bardelli C, 2005, BRIT J PHARMACOL, V145, P385, DOI 10.1038/sj.bjp.0706198; BARSHAVIT Z, 1980, BIOCHEM BIOPH RES CO, V94, P1445, DOI 10.1016/0006-291X(80)90581-1; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Braun JS, 1996, ACTA NEUROPATHOL, V92, P255, DOI 10.1007/s004010050516; Bucinskaite V, 1998, NEUROPEPTIDES, V32, P179, DOI 10.1016/S0143-4179(98)90035-X; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476, DOI 10.1152/ajpregu.1999.277.2.R476; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Dembinski A., 2003, MED SCI MONITOR, V9, pBR418; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Guo CJ, 2004, GLIA, V48, P259, DOI 10.1002/glia.20079; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; Huang RP, 2008, AM J PHYSIOL-HEART C, V294, pH1291, DOI 10.1152/ajpheart.00749.2007; Kashiba H, 1997, NEUROSCIENCE, V76, P299; KJARTANSSON J, 1987, EUR J PHARMACOL, V142, P355, DOI 10.1016/0014-2999(87)90073-2; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lieberman DN, 1998, J NEUROPHYSIOL, V80, P113, DOI 10.1152/jn.1998.80.1.113; Liu Z, 2011, REGUL PEPTIDES, V171, P19, DOI 10.1016/j.regpep.2011.05.014; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; Mak IT, 2003, MAGNESIUM RES, V16, P91; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Pegorini S, 2005, BRIT J PHARMACOL, V144, P727, DOI 10.1038/sj.bjp.0706115; Ramos C, 2007, EXP LUNG RES, V33, P151, DOI 10.1080/01902140701364409; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Rittner HL, 2007, ANESTHESIOLOGY, V107, P1009, DOI 10.1097/01.anes.0000291454.90754.de; RUFF MR, 1985, PEPTIDES, V6, P107, DOI 10.1016/0196-9781(85)90142-1; Souza DG, 2002, BRIT J PHARMACOL, V135, P303, DOI 10.1038/sj.bjp.0704464; Stacey AE, 2002, EUR J NEUROSCI, V16, P1896, DOI 10.1046/j.1460-9568.2002.02266.x; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Turchanyi B, 2005, PHYSIOL RES, V54, P25; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2012, NEUROSCIENCE, V220, P1, DOI 10.1016/j.neuroscience.2012.06.047; Turner R, 2007, DRUG NEWS PERSPECT, V20, P221, DOI 10.1358/dnp.2007.20.4.1103527; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Wimalawansa SJ, 1996, ENDOCR REV, V17, P533, DOI 10.1210/er.17.5.533; Xu J, 2007, EXP LUNG RES, V33, P197, DOI 10.1080/01902140701459514; Yamaguchi M, 2004, INFLAMM RES, V53, P199, DOI 10.1007/s00011-003-1243-z; Zhang JY, 2011, EUR J PHARMACOL, V671, P61, DOI 10.1016/j.ejphar.2011.09.170	46	13	13	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4179	1532-2785		NEUROPEPTIDES	Neuropeptides	OCT	2014	48	5					267	272		10.1016/j.npep.2014.07.002			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	AQ5XB	WOS:000342880800002	25151181				2022-02-06	
J	Van Straten, AF; Fesler, JR; Hakimi, R; Sheng, TY; Thompson, DM; Hakimi, AS				Van Straten, Amanda F.; Fesler, Jessica R.; Hakimi, Ryan; Sheng, Tianyun; Thompson, David M.; Hakimi, Andrea S.			SIRPIDs: Prevalence and Outcome in Critically Ill Patients	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						SIRPID; EEG; Critical illness; Video EEG; Long-term monitoring; Critical care monitoring	ICTAL DISCHARGES SIRPIDS; PERIODIC EEG PATTERNS; CLINICAL-SIGNIFICANCE	Purpose:To determine the prevalence, associated factors, and outcomes of critically ill patients with stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs) on long-term video-EEG (VEEG).Methods:After IRB approval, we retrospectively reviewed patient characteristics and VEEG findings of all consecutive critical care unit patients who underwent VEEG monitoring between January 2012 and September 2012.Results:The prevalence of SIRPIDs was 12.1% (4 of 33 patients; exact 95% confidence interval, 3.4%-28.2%). Factors associated with SIRPIDs versus non-SIRPIDs patients included a higher prevalence of subclinical status epilepticus (100% vs. 17.2%, P = 0.003), longer total VEEG recording time (286 vs. 56.9 hours, P = 0.0004), and acute traumatic brain injury (75.0% vs. 17.2%, P = 0.036). Sex, age, a history of epilepsy, nonstatus epileptic seizures, other EEG periodic patterns, and background rhythm reactivity on VEEG did not correlate with the presence of SIRPIDs. The presence or absence of SIRPIDs had no bearing on outcome; however, the population studied was very small.Conclusions:This small series suggests that the presence of subclinical status epilepticus and traumatic brain injury correlated with the presence of SIRPIDs signifying that SIRPIDs may be due to a more focal etiology and may represent a more ictal pattern than previously thought. Longer recording times in those patient populations may yield more cases of SIRPIDs in which to base further studies.	[Van Straten, Amanda F.; Fesler, Jessica R.; Hakimi, Ryan; Hakimi, Andrea S.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA; [Sheng, Tianyun; Thompson, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA		Van Straten, AF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA.	afvanstraten@gmail.com		Fesler, Jessica/0000-0003-4969-5600			Alvarez V, 2013, CLIN NEUROPHYSIOL, V124, P204, DOI 10.1016/j.clinph.2012.06.017; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; GLOOR P, 1968, EPILEPSIA, V9, P249, DOI 10.1111/j.1528-1157.1968.tb04624.x; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hirsch LJ, 2008, EPILEPSIA, V49, P968, DOI 10.1111/j.1528-1167.2007.01481.x; Hirsch Lawrence J., 2002, Epilepsia, V43, P283; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; Kaplan PW, 2011, EPILEPTIC DISORD, V13, P291, DOI 10.1684/epd.2011.0463; KUROIWA Y, 1980, ARCH NEUROL-CHICAGO, V37, P15, DOI 10.1001/archneur.1980.00500500045005; Lin JH, 2012, CLIN NEUROL NEUROSUR, V114, P1283, DOI 10.1016/j.clineuro.2012.03.006; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Rossetti AO, 2007, CLIN NEUROPHYSIOL, V118, P2533, DOI 10.1016/j.clinph.2007.08.002; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Zeiler SR, 2011, J CLIN NEUROPHYSIOL, V28, P493, DOI 10.1097/WNP.0b013e318231c00a	17	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	OCT	2014	31	5					418	421		10.1097/WNP.0000000000000094			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ6CC	WOS:000342894400006	25271679				2022-02-06	
J	Varsos, GV; Budohoski, KP; Kolias, AG; Liu, XY; Smielewski, P; Varsos, VG; Hutchinson, PJ; Pickard, JD; Czosnyka, M				Varsos, Georgios V.; Budohoski, Karol P.; Kolias, Angelos G.; Liu, Xiuyun; Smielewski, Peter; Varsos, Vassilis G.; Hutchinson, Peter J.; Pickard, John D.; Czosnyka, Marek			Relationship of Vascular Wall Tension and Autoregulation Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Wall tension; Critical closing pressure; Autoregulation; Outcome	CRITICAL CLOSING PRESSURE; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; HEAD-INJURY; REACTIVITY; HYPOTENSION; FREQUENCY; IMPEDANCE	The vascular wall tension (WT) of small cerebral vessels can be quantitatively estimated through the concept of critical closing pressure (CrCP), which denotes the lower limit of arterial blood pressure (ABP), below which small cerebral arterial vessels collapse and blood flow ceases. WT can be expressed as the difference between CrCP and intracranial pressure (ICP) and represent active vasomotor tone. In this study, we investigated the association of WT and CrCP with autoregulation and outcome of a large group of patients after traumatic brain injury (TBI). We retrospectively analysed recordings of ABP, ICP and transcranial Doppler (TCD) blood flow velocity from 280 TBI patients (median age: 29 years; interquartile range: 20-43). CrCP and WT were calculated using the cerebrovascular impedance methodology. Autoregulation was assessed based on TCD-based indices, Mx and ARI. Low values of WT were found to be associated with an impaired autoregulatory capacity, signified by its correlation to FV-based indices Mx (R = -0.138; p = 0.021) and ARI (R = 0.118; p = 0.048). No relationship could be established between CrCP and any of the autoregulatory indices. Neither CrCP nor WT was found to correlate with outcome. Impaired autoregulation was found to be associated with a lower WT supporting the role of vasoparalysis in the loss of autoregulatory capacity. In contrast, no links between CrCP and autoregulation could be identified.	[Varsos, Georgios V.; Budohoski, Karol P.; Kolias, Angelos G.; Liu, Xiuyun; Smielewski, Peter; Hutchinson, Peter J.; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Varsos, Vassilis G.] Red Cross Hosp, Dept Neurosurg, Athens, Greece; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Varsos, GV (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	gv249@cam.ac.uk	Liu, Xiuyun/V-4427-2017	Liu, Xiuyun/0000-0001-9540-4865; Hutchinson, Peter/0000-0002-2796-1835; Kolias, Angelos/0000-0003-3992-0587; Smielewski, Peter/0000-0001-5096-3938	A. G. Leventis Foundation; St Edmund's College, Cambridge; Royal College of Surgeons of England Research Fellowship; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Senior Investigator Award; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G0600986, G0001237, G9439390, G1000183B, G0001354] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327, NIHR-RP-R3-12-013] Funding Source: researchfish	We would like to thank Gordon Stevenson, PhD, from Evelyn Perinatal Imaging Center, Rosie Hospital, Cambridge, for proof reading of this article. GVV is supported by an A. G. Leventis Foundation Scholarship, and a Charter Studentship from St Edmund's College, Cambridge. AGK is supported by a Royal College of Surgeons of England Research Fellowship, a National Institute for Health Research (NIHR) Academic Clinical Fellowship, and a Raymond and Beverly Sackler Studentship. PJH is supported by an NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative. JDP is supported by the NIHR Cambridge Biomedical Research Centre and an NIHR Senior Investigator Award. MC is NIHR Cambridge Biomedical Research Centre principal investigator on cerebrospinal dynamics.	Aaslid R, 1992, TRANSCRANIAL DOPPLER, P49; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Carrera E, 2011, EUR J NEUROL, V18, P711, DOI 10.1111/j.1468-1331.2010.03247.x; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Kasprowicz M, 2012, NEUROCRIT CARE, V16, P213, DOI 10.1007/s12028-011-9653-1; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; LASSEN NA, 1964, CIRC RES, V15, P201; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Menon DK, 2005, ANAEST INTENS CARE M, V6, P184, DOI 10.1383/anes.6.6.184.65786; Michel E, 1997, J CEREBR BLOOD F MET, V17, P1127, DOI 10.1097/00004647-199710000-00015; NICHOL J, 1951, AM J PHYSIOL, V164, P330, DOI 10.1152/ajplegacy.1951.164.2.330; OROURKE MF, 1967, CIRC RES, V20, P365, DOI 10.1161/01.RES.20.4.365; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Puppo Corina, 2012, Acta Neurochir Suppl, V114, P283, DOI 10.1007/978-3-7091-0956-4_55; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Varsos GV, 2013, NEUROCRIT CARE, V18, P341, DOI 10.1007/s12028-013-9830-5; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161	37	13	13	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					266	274		10.1007/s12028-014-9971-1			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900014	24682849				2022-02-06	
J	Bergsland, M; Covacu, R; Estrada, CP; Svensson, M; Brundin, L				Bergsland, Maria; Covacu, Ruxandra; Estrada, Cynthia Perez; Svensson, Mikael; Brundin, Lou			Nitric Oxide-Induced Neuronal to Glial Lineage Fate-Change Depends on NRSF/REST Function in Neural Progenitor Cells	STEM CELLS			English	Article						Stem cell-microenvironment interactions; Transcription factors; Oligodendrocytes; Neural stem cells; Differentiation	ADULT HUMAN BRAIN; MULTIPLE-SCLEROSIS; SUBVENTRICULAR ZONE; STEM-CELLS; TRANSCRIPTION FACTORS; CEREBROSPINAL-FLUID; NEUROGENESIS; REST; OLIGODENDROCYTES; INFLAMMATION	Degeneration of central nervous system tissue commonly occurs during neuroinflammatory conditions, such as multiple sclerosis and neurotrauma. During such conditions, neural stem/progenitor cell (NPC) populations have been suggested to provide new cells to degenerated areas. In the normal brain, NPCs from the subventricular zone generate neurons that settle in the olfactory bulb or striatum. However, during neuroinflammatory conditions NPCs migrate toward the site of injury to form oligodendrocytes and astrocytes, whereas newly formed neurons are less abundant. Thus, the specific NPC lineage fate decisions appear to respond to signals from the local environment. The instructive signals from inflammation have been suggested to rely on excessive levels of the free radical nitric oxide (NO), which is an essential component of the innate immune response, as NO promotes neuronal to glial cell fate conversion of differentiating rat NPCs in vitro. Here, we demonstrate that the NO-induced neuronal to glial fate conversion is dependent on the transcription factor neuron-restrictive silencing factor-1 (NRSF)/repressor element-1 silencing transcription (REST). Chromatin modification status of a number of neuronal and glial lineage restricted genes was altered upon NO-exposure. These changes coincided with gene expression alterations, demonstrating a global shift toward glial potential. Interestingly, by blocking the function of NRSF/REST, alterations in chromatin modifications were lost and the NO-induced neuronal to glial switch was suppressed. This implicates NRSF/REST as a key factor in the NPC-specific response to innate immunity and suggests a novel mechanism by which signaling from inflamed tissue promotes the formation of glial cells.	[Bergsland, Maria; Covacu, Ruxandra; Estrada, Cynthia Perez; Brundin, Lou] Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, Div Neurol, SE-17176 Stockholm, Sweden; [Bergsland, Maria; Svensson, Mikael] Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, Div Neurosurg, SE-17176 Stockholm, Sweden		Bergsland, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	maria.bergsland@ki.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003; Brundin, Lou/0000-0003-4408-7817; Covacu, Ruxandra/0000-0003-3183-2988	Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2013-62X-20724-06-3]; Torsten and Ragnar Soderberg Foundation; The Swedish Neuro Association; Karolinska Institutet Theme-center for Regenerative Medicine	We are grateful to Britt Meijer for assistance with human NPC culturing. This work is supported by the Swedish Research Council (K2013-62X-20724-06-3); Torsten and Ragnar Soderberg Foundation; The Swedish Neuro Association; and Karolinska Institutet Theme-center for Regenerative Medicine.	AMBER IJ, 1988, J LEUKOCYTE BIOL, V43, P187, DOI 10.1002/jlb.43.2.187; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Brundin L, 1998, ANN NEUROL, V44, P704, DOI 10.1002/ana.410440421; Brundin L, 1999, EUR J NEUROL, V6, P585, DOI 10.1046/j.1468-1331.1999.650585.x; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Covey MV, 2012, DEVELOPMENT, V139, P2878, DOI 10.1242/dev.074765; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; DeWald LE, 2011, J NEUROSCI, V31, P3470, DOI 10.1523/JNEUROSCI.2768-10.2011; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Forstermann U, 1998, FASEB J, V12, P773; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Mecha M, 2013, EXP NEUROL, V250, P348, DOI 10.1016/j.expneurol.2013.10.011; Mehler Mark F, 2002, Results Probl Cell Differ, V39, P27; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Moll NM, 2013, GLIA, V61, P1659, DOI 10.1002/glia.22547; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pfeifenbring S, 2013, GLIA, V61, P1250, DOI 10.1002/glia.22512; RAINE CS, 1989, LAB INVEST, V60, P714; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sequerra EB, 2013, DEVELOPMENT, V140, P3303, DOI 10.1242/dev.093096; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Svenningsson A, 1999, NEUROLOGY, V53, P1880, DOI 10.1212/WNL.53.8.1880; Taskiran D, 2000, INT J NEUROSCI, V101, P65, DOI 10.3109/00207450008986493; Tepavcevic V, 2011, J CLIN INVEST, V121, P4722, DOI 10.1172/JCI59145; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; VISSER JJ, 1994, ANN INTERN MED, V120, P345, DOI 10.7326/0003-4819-120-4-199402150-00023; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9	55	13	15	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	SEP	2014	32	9					2539	2549		10.1002/stem.1749			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AO4GM	WOS:000341294500022	24807147	hybrid			2022-02-06	
J	Latini, L; Bisicchia, E; Sasso, V; Chiurchiu, V; Cavallucci, V; Molinari, M; Maccarrone, M; Viscomi, MT				Latini, L.; Bisicchia, E.; Sasso, V.; Chiurchiu, V.; Cavallucci, V.; Molinari, M.; Maccarrone, M.; Viscomi, M. T.			Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation	CELL DEATH & DISEASE			English	Article							MESSENGER-RNA EXPRESSION; TRAUMATIC BRAIN-INJURY; RED NUCLEUS; ENDOCANNABINOID SYSTEM; MOTOR RECOVERY; BROWN-SEQUARD; CELL-DEATH; NEURONS; AXOTOMY; RAT	Spinal cord injury (SCI) is a devastating condition of CNS that often results in severe functional impairments for which there are no restorative therapies. As in other CNS injuries, in addition to the effects that are related to the primary site of damage, these impairments are caused by degeneration of distal regions that are connected functionally to the primary lesion site. Modulation of the endocannabinoid system (ECS) counteracts this neurodegeneration, and pharmacological modulation of type-2 cannabinoid receptor (CB2R) is a promising therapeutic target for several CNS pathologies, including SCI. This study examined the effects of CB2R modulation on the fate of axotomized rubrospinal neurons (RSNs) and functional recovery in a model of spinal cord dorsal hemisection (SCH) at the cervical level in rats. SCH induced CB2R expression, severe atrophy, and cell death in contralateral RSNs. Furthermore, SCH affected molecular changes in the apoptotic cascade in RSNs - increased cytochrome c release, apoptosome formation, and caspase-3 activity. CB2R stimulation by its selective agonist JWH-015 significantly increased the bcl-2/bax ratio, reduced cytochrome c release, delayed atrophy and degeneration, and improved spontaneous functional recovery through ERK1/2 inactivation. These findings implicate the ECS, particularly CB2R, as part of the endogenous neuroprotective response that is triggered after SCI. Thus, CB2R modulation might represent a promising therapeutic target that lacks psychotropic effects and can be used to exploit ECS-based approaches to counteract neuronal degeneration.	[Latini, L.; Bisicchia, E.; Sasso, V.; Chiurchiu, V.; Cavallucci, V.; Molinari, M.; Maccarrone, M.; Viscomi, M. T.] Santa Lucia Fdn, IRCCS 65, I-00179 Rome, Italy; [Chiurchiu, V.] Univ Teramo, Fac Vet Med, Teramo, Italy; [Maccarrone, M.] Campus Biomed Univ Rome, Ctr Integrated Res, Sch Med, Rome, Italy		Molinari, M (corresponding author), Santa Lucia Fdn, IRCCS 65, Via Ardeatina 354, I-00179 Rome, Italy.	m.molinari@hsantalucia.it; mt.viscomi@hsantalucia.it	Molinari, Marco/A-9624-2010; Viscomi, Maria Teresa/G-4173-2011; Viscomi, Maria Teresa/AAL-6625-2021; Latini, Laura/AAA-7654-2019; Viscomi, Maria Teresa/AAB-9412-2022; Maccarrone, Mauro/K-5398-2012; Bisicchia, Elisa/AAC-3703-2022; Chiurchiu, Valerio/G-6227-2011	Molinari, Marco/0000-0001-9808-9688; Viscomi, Maria Teresa/0000-0002-9096-4967; Viscomi, Maria Teresa/0000-0002-9096-4967; Maccarrone, Mauro/0000-0002-3990-2963; Latini, Laura/0000-0001-6480-0355; Chiurchiu, Valerio/0000-0002-0316-7311; Cavallucci, Virve/0000-0003-3082-6359	Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy; Wings for Life Spinal Cord Research Foundation; International Foundation for Research in Paraplegia (IFP); program Young Researchers of Italian Ministry of Health [GR10.184]; PRINMinistry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)	This work was supported by Italian Ministry of Health (Ricerca Corrente; to M Molinari); by Wings for Life Spinal Cord Research Foundation (to MTV); partially by International Foundation for Research in Paraplegia (IFP) (to MTV); by program Young Researchers of Italian Ministry of Health (GR10.184; to MTV); and by PRIN 2010-2011 (to M Maccarrone). We thank Professor G Bernardi for his continuous support and encouragement. The professional editorial work of Blue Pencil Science is also acknowledged.	Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; Ashton JC, 2007, NEUROSCI LETT, V412, P114, DOI 10.1016/j.neulet.2006.10.053; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; BARRON KD, 1989, J NEUROSCI RES, V22, P331, DOI 10.1002/jnr.490220313; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Chiurchiu V, 2013, ANN NEUROL, V73, P626, DOI 10.1002/ana.23875; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; EGAN DA, 1977, ACTA NEUROPATHOL, V37, P13, DOI 10.1007/BF00684534; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; FERINGA ER, 1988, EXP NEUROL, V100, P112, DOI 10.1016/0014-4886(88)90205-1; Fukuoka T, 1997, BRAIN RES, V767, P250, DOI 10.1016/S0006-8993(97)00715-4; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; JENKINS R, 1993, EUR J NEUROSCI, V5, P203, DOI 10.1111/j.1460-9568.1993.tb00486.x; Juan WS, 2012, CYTOM PART A, V81A, P400, DOI 10.1002/cyto.a.22021; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Kwon BK, 2007, SPINE, V32, P1164, DOI 10.1097/BRS.0b013e318053ec35; LITTLE JW, 1985, PARAPLEGIA, V23, P39, DOI 10.1038/sc.1985.7; Liu PH, 2003, EXP NEUROL, V179, P111, DOI 10.1006/exnr.2002.8057; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; MCBRIDE RL, 1989, J NEUROPATH EXP NEUR, V48, P568, DOI 10.1097/00005072-198909000-00007; Molina-Holgado F, 2005, MOL CELL NEUROSCI, V28, P189, DOI 10.1016/j.mcn.2004.09.004; Mori F, 1997, EXP NEUROL, V143, P45, DOI 10.1006/exnr.1996.6318; Oddi S, 2012, J MOL MED, V90, P371, DOI 10.1007/s00109-011-0846-z; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; ROTH EJ, 1991, PARAPLEGIA, V29, P582, DOI 10.1038/sc.1991.86; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Velayudhan L, 2014, CURR PHARM DESIGN, V20, P2218, DOI 10.2174/13816128113199990434; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Viscomi MT, 2014, MOL NEUROBIOL, V163, P1402; Xu M, 2000, EXP NEUROL, V161, P472, DOI 10.1006/exnr.1999.7278; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhou LQ, 1999, NEUROREPORT, V10, P3417, DOI 10.1097/00001756-199911080-00029	56	13	14	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	SEP	2014	5								e1404	10.1038/cddis.2014.364			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AQ9HS	WOS:000343162000005	25188514	Green Published, gold			2022-02-06	
J	Li, J; Shi, W; Li, M; Wang, Z; He, H; Xian, J; Lv, B; Yan, F				Li, J.; Shi, W.; Li, M.; Wang, Z.; He, H.; Xian, J.; Lv, B.; Yan, F.			Time-dependent diffusion tensor changes of optic nerve in patients with indirect traumatic optic neuropathy	ACTA RADIOLOGICA			English	Article						Trauma; optic neuropathy (ITON); MRI; diffusion tensor imaging (DTI)	AXONAL INJURY; BRAIN-INJURY; NEURITIS; COEFFICIENTS; TRANSPLANTS; CORRELATE; RECOVERY; DETECTS; CORTEX; RATS	Background: Indirect traumatic optic neuropathy (ITON) is a devastating cause of permanent visual loss. Axonal degeneration, the characteristic pathological change of ITON, cannot be assessed by conventional imaging. Diffusion tensor imaging (DTI) has been widely used as a sensitive non-invasive imaging technique to obtain information on axonal integrity. Purpose: To study time-dependent changes in ITON patients with DTI and to provide imaging evidence for clinical diagnosis and therapy. Material and Methods: We enrolled 28 subjects with unilateral ITON who underwent detailed ocular examinations and magnetic resonance imaging (MRI) examinations. The differences between injured optic nerve (ON) and contralateral ON were tested. The patients were divided into three groups based on time (from injury to examination). Groups 1, 2, and 3 corresponded to the time taken from injury to examination: <7 days, 7-30 days, and >30 days, respectively. DT magnetic resonance imaging (MRI) differences among the groups were compared, including the relationship between diffusion parameters and mean thicknesses of the peripapillary retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) in the macular area. Results: Compared with contralateral ON, we observed reduced fractional anisotropy (FA) of injured nerves in group 2. Reduced FA and decreased axial diffusivity (lambda//) and increased radial diffusivity (lambda perpendicular to) and mean diffusivity (MD) of injured nerves were observed in group 3. The mean FA value of injured nerves showed a progressive decreasing trend, and mean lambda perpendicular to value exhibited a progressive increasing trend. For injured eyes, the MD and lambda perpendicular to increases strongly correlated with the decreased mean thicknesses of RNFL and GCC. Conversely, FA was significantly associated with mean RNFL thickness. Conclusion: DT-MRI parameters could be useful biomarkers in detecting ON changes in ITON patients.	[Li, J.; Wang, Z.; Xian, J.; Yan, F.] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Li, M.; He, H.; Lv, B.] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing 100864, Peoples R China; [Shi, W.] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China		Wang, Z (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.wzhch@vip.163.com	He, Huiguang/AAD-7643-2020	He, Huiguang/0000-0002-0684-1711; Li, Jing/0000-0001-9392-6600	Beijing Keji Xinxing project [2004B36]	This work was supported by the Beijing Keji Xinxing project (2004B36).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Awan AH, 2007, PAK J OPHTHALMOL, V23, P100; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kovacic M, 2001, COLLEGIUM ANTROPOL, V25, P57; Lee KF, 2010, INT J OPHTHALMOL-CHI, V3, P175, DOI 10.3980/j.issn.2222-3959.2010.02.20; Li M, 2011, BRIT J RADIOL, V84, P304, DOI 10.1259/bjr/93494520; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mavrakanas NA, 2009, SURV OPHTHALMOL, V54, P412, DOI 10.1016/j.survophthal.2009.02.006; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Sadeghi-Tari A, 2005, ACTA MED IRANICA, V43, P110; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Schwartz ED, 2005, AM J NEURORADIOL, V26, P7; Schwartz ED, 2003, EXP NEUROL, V182, P49, DOI 10.1016/S0014-4886(03)00036-0; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Takagi ST, 2011, J OPHTHALMOL, V2011, P1, DOI DOI 10.1155/2011/914250; TAKAHASHI M, 1993, MAGNET RESON MED, V30, P485, DOI 10.1002/mrm.1910300411; Trip SA, 2006, NEUROIMAGE, V30, P498, DOI 10.1016/j.neuroimage.2005.09.024; Vorisek I, 2002, MAGNET RESON MED, V48, P994, DOI 10.1002/mrm.10305; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wheeler-Kingshott CAM, 2006, MAGN RESON MED, V56, P446, DOI 10.1002/mrm.20964; Yang WG, 2004, ANN PLAS SURG, V52, P36, DOI 10.1097/01.sap.0000096442.82059.6d	31	13	14	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	SEP	2014	55	7					855	863		10.1177/0284185113506900			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AQ1WS	WOS:000342575300012	24097827				2022-02-06	
J	Maller, JJ; Thomson, RHS; Pannek, K; Bailey, N; Lewis, PM; Fitzgerald, PB				Maller, Jerome J.; Thomson, Richard H. S.; Pannek, Kerstin; Bailey, Neil; Lewis, Philip M.; Fitzgerald, Paul B.			Volumetrics relate to the development of depression after traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Brain injury; Major depression; Volume; Neuroimaging	SURFACE-BASED ANALYSIS; MAJOR DEPRESSION; CEREBRAL-CORTEX; WHOLE-BRAIN; MRI; DISORDER; ABNORMALITIES; METAANALYSIS; 1ST-EPISODE; HIPPOCAMPUS	Previous research suggests that many people who sustain a traumatic brain injury (TBI), even of the mild form, will develop major depression (MD). We previously reported white matter integrity differences between those who did and did not develop MD after mild TBI. In this current paper, we aimed to investigate whether there were also volumetric differences between these groups, as suggested by previous volumetric studies in mild TBI populations. A sample of TBI-with-MD subjects (N = 14), TBI-without-MD subjects (N = 12), MD-without-TBI (N = 26) and control subjects (no TBI or MD, N = 23), received structural MRI brain scans. T1-weighted data were analysed using the Freesurfer software package which produces automated volumetric results. The findings of this study indicate that (1) TBI patients who develop MD have reduced volume in temporal, parietal and lingual regions compared to TBI patients who do not develop MD, and (2) MD patients with a history of TBI have decreased volume in the temporal region compared to those who had MD but without a history of TBI. We also found that more severe MD in those with TBI-with-MD significantly correlated with reduced volume in anterior cingulate, temporal lobe and insula. These findings suggest that volumetric reduction to specific regions, including parietal, temporal and occipital lobes, after a mild TBI may underlie the susceptibility of these patients developing major depression, in addition to altered white matter integrity. (C) 2014 Elsevier B.V. All rights reserved.	[Maller, Jerome J.; Thomson, Richard H. S.; Bailey, Neil; Fitzgerald, Paul B.] Alfred & Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Pannek, Kerstin] CSIRO Ctr Computat Informat, Australian EHlth Res Ctr, Brisbane, Qld, Australia; [Pannek, Kerstin] Sch Med, Brisbane, Qld, Australia; [Lewis, Philip M.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Maller, JJ (corresponding author), Alfred & Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia.	jerome.maller@monash.edu	Pannek, Kerstin/C-8059-2011; Maller, Jerome J/H-4963-2014; Bailey, Neil/AAB-2741-2021; Fitzgerald, Paul B/A-1225-2008	Pannek, Kerstin/0000-0002-6512-7630; Maller, Jerome J/0000-0003-4685-1508; Fitzgerald, Paul B/0000-0003-4217-8096; Bailey, Neil/0000-0002-8483-1068	NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Cervel Neurotech; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia	PBF is supported by a NHMRC Practitioner Fellowship. He has received equipment for research from Magventure A/S, Brainsway, and Cervel Neurotech and research funding from Cervel Neurotech. JJM is supported by a NHMRC Early Career Fellowship. The funding source had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Finset A, 2000, BRAIN INJURY, V14, P887; First MB, 2001, STRUCTURED CLIN INTE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Foster JK, 1999, MEMORY, V7, P715, DOI 10.1080/096582199387823; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nugent AC, 2013, PSYCHIAT RES-NEUROIM, V213, P179, DOI 10.1016/j.pscychresns.2013.05.004; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Yuan YG, 2007, NEUROREPORT, V18, P1845, DOI 10.1097/WNR.0b013e3282f1939f	54	13	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 1	2014	271						147	153		10.1016/j.bbr.2014.05.047			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	AN1DN	WOS:000340323000021	24886777				2022-02-06	
J	Messing, JA; Agnihothri, RV; Van Dusen, R; Najam, F; Dunne, JR; Honig, JR; Sarani, B				Messing, Jonathan A.; Agnihothri, Ritesh V.; Van Dusen, Rachel; Najam, Farzad; Dunne, James R.; Honig, Jacqueline R.; Sarani, Babak			Prolonged Use of Extracorporeal Membrane Oxygenation as a Rescue Modality Following Traumatic Brain Injury	ASAIO JOURNAL			English	Article						extracorporeal membrane oxygenation; traumatic brain injury; adult respiratory distress syndrome; anticoagulation	RESPIRATORY-FAILURE; LIFE-SUPPORT; ECMO; PROPHYLAXIS; CRANIOTOMY; BENEFITS; PATIENT; ADULT	A 21-year-old male trauma patient presented after a motor vehicle crash, witnessed massive aspiration and sustained traumatic brain injury. On postinjury day 3, the patient progressed to adult respiratory distress syndrome (ARDS) refractory to all conventional therapies, prompting the use of extracorporeal membrane oxygenation (ECMO). After 5 days of ECMO support and 3 thrombosed oxygenators, systemic anticoagulation was initiated. After 20 days of ECMO, 15 of which required systemic anticoagulation, the patient was decannulated and transferred to a rehabilitation facility. The patient is currently home without any neurological deficits. Although controversial, ECMO may serve a role as a rescue therapy in ARDS when conventional therapies fail in the brain-injured patient.	[Messing, Jonathan A.; Dunne, James R.; Sarani, Babak] George Washington Univ Hosp, Dept Trauma & Acute Care Surg, Washington, DC 20037 USA; [Agnihothri, Ritesh V.] George Washington Univ, Sch Med, Washington, DC USA; [Van Dusen, Rachel] George Washington Univ, Dept Surg Resident, Washington, DC USA; [Najam, Farzad] George Washington Univ Hosp, Dept Cardiothorac Surg, Washington, DC USA; [Honig, Jacqueline R.] George Washington Univ Hosp, Cardiothorac Intens Care Unit, Washington, DC USA		Messing, JA (corresponding author), George Washington Univ Hosp, Dept Trauma & Acute Care Surg, 900 23rd St, Washington, DC 20037 USA.	jmessing@mfa.gwu.edu		Sarani, Babak/0000-0001-6247-3004			Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Kasirajan V, 1999, EUR J CARDIO-THORAC, V15, P508, DOI 10.1016/S1010-7940(99)00061-5; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lidegran MK, 2007, ACAD RADIOL, V14, P62, DOI 10.1016/j.acra.2006.10.004; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Pranikoff T, 1997, CRIT CARE MED, V25, P28, DOI 10.1097/00003246-199701000-00008; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Yen TS, 2008, CLIN NEUROL NEUROSUR, V110, P295, DOI 10.1016/j.clineuro.2007.10.017	15	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1058-2916	1538-943X		ASAIO J	Asaio J.	SEP-OCT	2014	60	5					597	599		10.1097/MAT.0000000000000103			3	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transplantation	AO9UR	WOS:000341704100018	24830802				2022-02-06	
J	Mihindu, E; Bhullar, I; Tepas, J; Kerwin, A				Mihindu, Esther; Bhullar, Indermeet; Tepas, Joseph; Kerwin, Andrew			Computed Tomography of the Head in Children with Mild Traumatic Brain Injury	AMERICAN SURGEON			English	Article							CT	Pediatric Emergency Care Applied Research Network (PECARN) guidelines have a near 100 per cent negative predictive value for clinically important traumatic brain injury (ciTBI) in children with mild head injury (Glasgow Coma Score [GCS] 14 or 15). Our goal was to retrospectively apply their criteria to our database to determine the potential impact on the rates of unnecessary head computed tomography (CT) and ciTBI detection. The records of pediatric patients with GCS 14 to 15 that had a head CT for suspected TBI after blunt trauma from 2008 to 2010 were reviewed. Of 493 children, CT was negative in 447 (91%), but findings were present in 46 (9%). Applying PECARN recommendations, 178 (36%) met all six criteria but still underwent head CT; all were negative. The remaining 315 (64%) missed one or more PECARN criteria and underwent CT; only 46 (15%) had findings, and two (0.6%) required surgery. There were no false-negatives. The negative predictive value for ciTBI was 100 per cent. Observance of PECARN guidelines identifies children who do not require CT, increasing the yield of finding a ciTBI among those who cannot satisfy all six criteria.	[Mihindu, Esther; Bhullar, Indermeet; Tepas, Joseph; Kerwin, Andrew] Univ Florida, Coll Med Jacksonville, Dept Surg, Jacksonville, FL 32209 USA		Mihindu, E (corresponding author), Univ Florida, Coll Med Jacksonville, Dept Surg, 655 West Eight St, Jacksonville, FL 32209 USA.	Esther.Mihindu@jax.ufl.edu					Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Faul M, 2010, TRAUMATIC BRAIN INJU; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301	7	13	13	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2014	80	9					841	843					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AQ2KS	WOS:000342615200012	25197865				2022-02-06	
J	Pham, K; Kramer, ME; Slomine, BS; Suskauer, SJ				Pham, Kelly; Kramer, Megan E.; Slomine, Beth S.; Suskauer, Stacy J.			Emergence to the Conscious State During Inpatient Rehabilitation After Traumatic Brain Injury in Children and Young Adults: A Case Series	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; minimally conscious state; traumatic brain injury; vegetative state	DISORDERS; RECOVERY; AMANTADINE; SCALE; COMA	Objective: To describe clinical patterns related to emergence to the conscious state (CS) in children and young adults with traumatic brain injury receiving acute inpatient rehabilitation. Setting: One academically affiliated pediatric brain injury rehabilitation unit. Participants: Fourteen consecutive patients aged 1 to 20 years with traumatic brain injury and disorders of consciousness. Design: Retrospective case series. Main Measures: The primary outcome was emergence to CS during the inpatient rehabilitation admission. Factors evaluated for relationship to emergence to CS included age at injury, admission level of consciousness, admission Rappaport Coma/Near-Coma Scale score, and admission Cognitive and Linguistic Scale responsiveness item score. Results: Ten of 14 patients emerged to CS during the inpatient rehabilitation admission. Those who emerged to CS had higher levels of responsiveness at admission to rehabilitation. There was a trend toward older age in those who emerged to CS. Conclusions: In this limited cohort, the majority of patients with disorders of consciousness after traumatic brain injury emerged to CS during acute inpatient rehabilitation, underscoring the presence of functional goals for inpatient rehabilitation in this population. Larger cohorts are needed to further explore clinical variables associated with emergence to CS.	[Pham, Kelly; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Kramer, Megan E.; Slomine, Beth S.; Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER	Dr Suskauer is currently receiving a grant (K23HD061611) from National Institute of Child Health and Human Development. For the remaining authors none were declared.	Amari A, 2012, BRAIN INJURY, V26, P524; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Corder GW., 2009, NONPARAMETRIC STAT N; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3	21	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					E44	E48		10.1097/HTR.0000000000000022			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700004	24590150				2022-02-06	
J	Schreiber, S; Lin, R; Haim, L; Baratz-Goldstien, R; Rubovitch, V; Vaisman, N; Pick, CG				Schreiber, S.; Lin, R.; Haim, L.; Baratz-Goldstien, R.; Rubovitch, V.; Vaisman, N.; Pick, C. G.			Enriched environment improves the cognitive effects from traumatic brain injury in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Enriched environment (EE); (minimal) traumatic brain injury (mTBI); Mice; Novel Object Recognition task; Y maze; Elevated Plus maze	DEFICITS; PATTERNS; PROTECTS; BEHAVIOR; ANXIETY; STRESS; SYSTEM; CORTEX; MTBI	To date, there is yet no established effective treatment (medication or cognitive intervention) for post-traumatic brain injury (TBI) patients with chronic sequelae. Enriched environment (EE) has been recognized of importance in brain regulation, behaviour and physiology. Rodents reared in, or pre-exposed to EE, recovered better from brain insults. Using the concussive head trauma model of minimal TBI in mice, we evaluated the effect of transition to EE following a weight-drop (30g or 50g) induced mTBI on behavioural and cognitive parameters in mice in the Novel Object Recognition task, the Y- and the Elevated Plus mazes. In all assays, both mTBI groups (30 g, 50 g) housed in normal conditions were equally and significantly impaired 6 weeks post injury in comparison with the no-mTBI (p < 0.001 and p < 0.03, respectively) and the mTBI + EE groups (p < 0.001 for the 30 g, and p < 0.017 for the 50 g). No differences were found between the control and the EE mice. Two separate finding emerge: (1) the significantly positive effects of the placement in EE following mTBI, on the rehabilitative process of the tested behaviours in the affected mice; (2) the lack of difference between the groups of mice affected by 30g or by 50g. Further studies are needed in order to characterize the exact pathways involved in the positive effects of the EE on mice recovery from mTBI. Possible clinical implications indicate the importance of adapting correlates of EE to humans, i.e., prolonged and intensive physical activity - possibly combined with juggling training and intensive cognitive stimulation. (C) 2014 Elsevier B.V. All rights reserved.	[Schreiber, S.] Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-6423906 Tel Aviv, Israel; [Schreiber, S.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lin, R.; Haim, L.; Baratz-Goldstien, R.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Vaisman, N.] Tel Aviv Sourasky Med Ctr, Unit Clin Nutr, IL-6423906 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel		Schreiber, S (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-6423906 Tel Aviv, Israel.	shaulsch@tlvmc.gov.il	Schreiber, Shaul/E-5821-2010; Pick, Chaim/D-4789-2009	Schreiber, Shaul/0000-0002-2189-0693; 	Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel Aviv, Israel	This research was supported in part by the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel Aviv, Israel.	Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bondi CO, 2014, J NEUROTRAUM, V31, P1; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Gariepy JL, 2002, PHARMACOL BIOCHEM BE, V73, P7, DOI 10.1016/S0091-3057(02)00789-X; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Independent Review Group on Rehabilitative Care and Administrative Processes at Walter Reed Army Medical Center and National Naval Medical Center, 2007, REB TRUST REP REH CA; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Pryce C, 2002, PHARMACOL BIOCHEM BE, V73, P1, DOI 10.1016/S0091-3057(02)00861-4; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TEASDALE G, 1974, LANCET, V2, P81; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	32	13	14	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	SEP 1	2014	271						59	64		10.1016/j.bbr.2014.05.060			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AN1DN	WOS:000340323000009	24906196				2022-02-06	
J	Arien-Zakay, H; Gincberg, G; Nagler, A; Cohen, G; Liraz-Zaltsman, S; Trembovler, V; Alexandrovich, AG; Matok, I; Galski, H; Elchalal, U; Lelkes, PI; Lazarovici, P; Shohami, E				Arien-Zakay, Hadar; Gincberg, Galit; Nagler, Arnon; Cohen, Gadi; Liraz-Zaltsman, Sigal; Trembovler, Victoria; Alexandrovich, Alexander G.; Matok, Ilan; Galski, Hanan; Elchalal, Uriel; Lelkes, Peter I.; Lazarovici, Philip; Shohami, Esther			Neurotherapeutic Effect of Cord Blood Derived CD45(+) Hematopoietic Cells in Mice after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; CD45(+) hematopoietic cells; cell transplantation; cord blood; neurotherapy	MESENCHYMAL STEM-CELLS; CLOSED-HEAD INJURY; UMBILICAL-CORD; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; BONE-MARROW; IN-VITRO; RAT; TRANSPLANTATION; PROGENITORS	Treatment of traumatic brain injury (TBI) is still an unmet need. Cell therapy by human umbilical cord blood (HUCB) has shown promising results in animal models of TBI and is under evaluation in clinical trials. HUCB contains different cell populations but to date, only mesenchymal stem cells have been evaluated for therapy of TBI. Here we present the neurotherapeutic effect, as evaluated by neurological score, using a single dose of HUCB-derived mononuclear cells (MNCs) upon intravenous (IV) administration one day post-trauma in a mouse model of closed head injury (CHI). Delayed (eight days post-trauma) intracerebroventricular administration of MNCs showed improved neurobehavioral deficits thereby extending the therapeutic window for treating TBI. Further, we demonstrated for the first time that HUCB-derived pan-hematopoietic CD45 positive (CD45(+)) cells, isolated by magnetic sorting and characterized by expression of CD45 and CD11b markers (96-99%), improved the neurobehavioral deficits upon IV administration, which persisted for 35 days. The therapeutic effect was in a direct correlation to a reduction in the lesion volume and decreased by pre-treatment of the cells with anti-human-CD45 antibody. At the site of brain injury, 1.5-2 h after transplantation, HUCB-derived cells were identified by near infrared scanning and immunohistochemistry using anti-human-CD45 and anti-human-nuclei antibodies. Nerve growth factor and vascular endothelial growth factor levels were differentially expressed in both ipsilateral and contralateral brain hemispheres, thirty-five days after CHI, measured by enzyme-linked immunosorbent assay. These findings indicate the neurotherapeutic potential of HUCB-derived CD45(+) cell population in a mouse model of TBI and propose their use in the clinical setting of human TBI.	[Arien-Zakay, Hadar; Gincberg, Galit; Cohen, Gadi; Liraz-Zaltsman, Sigal; Trembovler, Victoria; Alexandrovich, Alexander G.; Matok, Ilan; Lazarovici, Philip; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel; [Nagler, Arnon; Galski, Hanan] Chaim Sheba Med Ctr, Bone Marrow Transplantat & Cord Blood Bank, IL-52621 Tel Hashomer, Israel; [Elchalal, Uriel] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Lelkes, Peter I.] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Lelkes, Peter I.] Temple Univ, Temple Inst Regenerat Med & Engn, Philadelphia, PA 19122 USA		Lazarovici, P (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Fac Med, IL-91120 Jerusalem, Israel.	philipl@ekmd.huji.ac.il	Lelkes, Peter I/S-1751-2019; Lazarovici, Philip/S-5261-2018; Matok, Ilan/H-1562-2016	Lazarovici, Philip/0000-0003-3650-4721; Matok, Ilan/0000-0003-1559-9258	Israel Ministry of Science, Technology and Space; David R. Bloom Center for Pharmacy; Dr. Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel; Israeli Council for Higher Education; Israeli Ministry of Science, Technology and Space	This study was supported by the Israel Ministry of Science, Technology and Space. PL holds the Jacob Gitlin Chair in Physiology and is affiliated with and supported by the David R. Bloom Center for Pharmacy and the Dr. Adolf and Klara Brettler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel. HAZ was supported by "VATAT" fellowship from the Israeli Council for Higher Education. GC is supported by "Eshkol fellowship" from the Israeli Ministry of Science, Technology and Space. PIL is the Laura H. Carnell Professor in the Department of Bioengineering, Temple University.	Andres RH, 2011, STROKE, V42, P2923, DOI 10.1161/STROKEAHA.110.606368; Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2; Arien-Zakay H, 2010, BEST PRACT RES CL HA, V23, P291, DOI 10.1016/j.beha.2010.04.001; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Augello A, 2010, EUR CELLS MATER, V20, P121; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chen Chun-Ta, 2008, Pediatrics and Neonatology, V49, P77, DOI 10.1016/S1875-9572(08)60017-0; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048803; CRAIG W, 1994, BRIT J HAEMATOL, V88, P24, DOI 10.1111/j.1365-2141.1994.tb04972.x; Dahlke MH, 2004, LEUKEMIA LYMPHOMA, V45, P229, DOI 10.1080/1042819031000151932; Davis SM, 2009, STROKE, V40, P2266, DOI 10.1161/STROKEAHA.108.544171; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Gincberg G, 2012, BRIT MED BULL, V104, P7, DOI 10.1093/bmb/lds024; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Harris David T, 2007, Curr Stem Cell Res Ther, V2, P301, DOI 10.2174/157488807782793790; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liraz-Zaltsman S, 2011, SYNAPSE, V65, P634, DOI 10.1002/syn.20889; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Maurya Dharmendra Kumar, 2011, World J Stem Cells, V3, P34, DOI 10.4252/wjsc.v3.i4.34; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Meregalli M, 2010, EXPERT OPIN BIOL TH, V10, P1521, DOI 10.1517/14712598.2010.528386; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Sanchez-Pernaute R, 2005, STEM CELLS, V23, P914, DOI 10.1634/stemcells.2004-0172; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Shivtiel S, 2011, EXP HEMATOL, V39, P1161, DOI 10.1016/j.exphem.2011.08.012; Shohami E., 2011, TRAUMATIC BRAIN SPIN; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Stanevsky A, 2011, STEM CELL REV REP, V7, P425, DOI 10.1007/s12015-010-9183-9; Stanevsky A, 2010, LEUKEMIA LYMPHOMA, V51, P975, DOI 10.3109/10428191003699886; Sugiyama T, 2011, NEUROSURGERY, V68, P1036, DOI 10.1227/NEU.0b013e318208f891; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoon JK, 2010, NUCL MED BIOL, V37, P381, DOI 10.1016/j.nucmedbio.2009.12.001; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zola H, 2006, MOL MED, V12, P312, DOI 10.2119/2006-00081.Zola	52	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1405	1416		10.1089/neu.2013.3270			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700004	24640955	Green Published			2022-02-06	
J	Xiong, GX; Elkind, JA; Kundu, S; Smith, CJ; Antunes, MB; Tamashiro, E; Kofonow, JM; Mitala, CM; Stein, SC; Grady, MS; Einhorn, E; Cohen, NA; Cohen, AS				Xiong, Guoxiang; Elkind, Jaclynn A.; Kundu, Suhali; Smith, Colin J.; Antunes, Marcelo B.; Tamashiro, Edwin; Kofonow, Jennifer M.; Mitala, Christina. M.; Stein, Sherman C.; Grady, M. Sean; Einhorn, Eugene; Cohen, Noam A.; Cohen, Akiva S.			Traumatic Brain Injury-Induced Ependymal Ciliary Loss Decreases Cerebral Spinal Fluid Flow	JOURNAL OF NEUROTRAUMA			English	Article						beta-tubulin; basal body; hydrocephalus; lateral fluid percussion; particle tracking	CEREBROSPINAL-FLUID; BEAT FREQUENCY; HYDROCEPHALUS; DYSKINESIA; MOTILITY; SLEEP; DYSFUNCTION; MOVEMENT; REVEALS; SYSTEM	Traumatic brain injury (TBI) afflicts up to 2 million people annually in the United States and is the primary cause of death and disability in young adults and children. Previous TBI studies have focused predominantly on the morphological, biochemical, and functional alterations of gray matter structures, such as the hippocampus. However, little attention has been given to the brain ventricular system, despite the fact that altered ventricular function is known to occur in brain pathologies. In the present study, we investigated anatomical and functional alterations to mouse ventricular cilia that result from mild TBI. We demonstrate that TBI causes a dramatic decrease in cilia. Further, using a particle tracking technique, we demonstrate that cerebrospinal fluid flow is diminished, thus potentially negatively affecting waste and nutrient exchange. Interestingly, injury-induced ventricular system pathology resolves completely by 30 days after injury as ependymal cell ciliogenesis restores cilia density to uninjured levels in the affected lateral ventricle.	[Xiong, Guoxiang; Elkind, Jaclynn A.; Kundu, Suhali; Smith, Colin J.; Mitala, Christina. M.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Antunes, Marcelo B.; Tamashiro, Edwin; Kofonow, Jennifer M.; Cohen, Noam A.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Stein, Sherman C.; Grady, M. Sean] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Einhorn, Eugene; Cohen, Noam A.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA		Cohen, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, 3615 Civ Ctr Blvd,816-H ARC, Philadelphia, PA 19104 USA.	cohena@email.chop.edu	Tamashiro, Edwin/C-5062-2012	Tamashiro, Edwin/0000-0002-3153-6292	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD059288, R01NS069629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288, R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	The authors thank Michael Schell for critiquing an earlier draft of the manuscript and Kathleen Joy Propert for statistical guidance. This study was supported in part by National Institutes of Health grants (R01HD059288 and R01NS069629; to A.S.C.).	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Al-Shroof M, 2001, MAYO CLIN PROC, V76, P1219, DOI 10.4065/76.12.1219; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; BANNISTER CM, 1980, DEV MED CHILD NEUROL, V22, P725; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bolt BA, 1993, EARTHQUAKES; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng CY, 2011, J NEUROSCI, V31, P9147, DOI 10.1523/JNEUROSCI.5018-10.2011; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gudis DA, 2010, OTOLARYNG CLIN N AM, V43, P461, DOI 10.1016/j.otc.2010.02.007; Guyot LL, 2000, NEUROL RES, V22, P25; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kiefer M, 1998, CHILD NERV SYST, V14, P263, DOI 10.1007/s003810050222; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Krueger JM, 1998, ANN NY ACAD SCI, V856, P148, DOI 10.1111/j.1749-6632.1998.tb08323.x; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lehman M, 2000, PROG BRAIN RES, V125, P415; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Monkkonen KS, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-26; NAKAMURA Y, 1993, CHILD NERV SYST, V9, P65, DOI 10.1007/BF00305310; Noback C.R., 2005, HUMAN NERVOUS SYSTEM; OPP MR, 1991, AM J PHYSIOL, V260, pR453, DOI 10.1152/ajpregu.1991.260.2.R453; OPP MR, 1991, AM J PHYSIOL, V260, pR52, DOI 10.1152/ajpregu.1991.260.1.R52; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Regenold WT, 2009, BIOL PSYCHIAT, V65, P489, DOI 10.1016/j.biopsych.2008.11.010; Reichler IM, 2001, J SMALL ANIM PRACT, V42, P345, DOI 10.1111/j.1748-5827.2001.tb02471.x; Rios M, 2007, REPROD FERT DEVELOP, V19, P634, DOI 10.1071/RD06146; ROTH Y, 1985, BRAIN RES, V330, P291, DOI 10.1016/0006-8993(85)90688-2; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; Rubenstein E, 1998, LANCET, V351, P283, DOI 10.1016/S0140-6736(97)09234-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SANTANDER RG, 1984, ACTA ANAT, V118, P82; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Skinner DC, 1999, ENDOCRINOLOGY, V140, P4399, DOI 10.1210/endo.140.10.7074; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Toth Z, 1997, J NEUROSCI, V17, P8106; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Winters SL, 2007, AM J PHYSIOL-LUNG C, V292, pL614, DOI 10.1152/ajplung.00288.2005; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	59	13	13	2	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1396	1404		10.1089/neu.2013.3110			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700003	24749541	Green Published			2022-02-06	
J	Leung, LY; Larimore, Z; Holmes, L; Cartagena, C; Mountney, A; Deng-Bryant, Y; Schmid, K; Shear, D; Tortella, F				Leung, Lai Yee; Larimore, Zachary; Holmes, Larry; Cartagena, Casandra; Mountney, Andrea; Deng-Bryant, Ying; Schmid, Kara; Shear, Deborah; Tortella, Frank			The WRAIR Projectile Concussive Impact Model of Mild Traumatic Brain Injury: Re-design, Testing and Preclinical Validation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Mild TBI; Projectile; Helmet; Impact energy; Head kinematics; Gait	AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; SOMATOSENSORY CORTEX; ANIMAL-MODELS; HEAD-INJURY; RAT; LOCOMOTION; BETA; MICE; GAIT	The WRAIR projectile concussive impact (PCI) model was developed for preclinical study of concussion. It represents a truly non-invasive closed-head injury caused by a blunt impact. The original design, however, has several drawbacks that limit the manipulation of injury parameters. The present study describes engineering advancements made to the PCI injury model including helmet material testing, projectile impact energy/head kinematics and impact location. Material testing indicated that among the tested materials, 'fiber-glass/carbon' had the lowest elastic modulus and yield stress for providing an relative high percentage of load transfer from the projectile impact, resulting in significant hippocampal astrocyte activation. Impact energy testing of small projectiles, ranging in shape and size, showed the steel sphere produced the highest impact energy and the most consistent impact characteristics. Additional tests confirmed the steel sphere produced linear and rotational motions on the rat's head while remaining within a range that meets the criteria for mTBI. Finally, impact location testing results showed that PCI targeted at the temporoparietal surface of the rat head produced the most prominent gait abnormalities. Using the parameters defined above, pilot studies were conducted to provide initial validation of the PCI model demonstrating quantifiable and significant increases in righting reflex recovery time, axonal damage and astrocyte activation following single and multiple concussions.	[Leung, Lai Yee; Cartagena, Casandra; Mountney, Andrea; Deng-Bryant, Ying; Schmid, Kara; Shear, Deborah; Tortella, Frank] WRAIR, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA; [Larimore, Zachary; Holmes, Larry] United States Army Res Labs, Composites & Hybrid Mat Branch, Aberdeen, MD USA		Leung, LY (corresponding author), WRAIR, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	laiyee.leung@us.army.mil			Combat Casualty Care Research ProgramUnited States Department of Defense; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-12-2-0134]	The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5). The authors declare that there are no conflicts of interest in this study. This research is funded by Combat Casualty Care Research Program and Congressionally Directed Medical Research Program (Contract #: W81XWH-12-2-0134). The authors would like to thank Weihong Yang, Francis Bustos, Megan Winter, David Miles and SGT Shawn McLoughlin for technical supports.	BLASZCZYK JW, 1995, ACTA NEUROBIOL EXP, V55, P133; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Defense and Veterans Brain Injury Center (DVBIC), 2013, DOD WORLDW NUMB TBI; Deliagina TG, 2006, PHYSIOLOGY, V21, P216, DOI 10.1152/physiol.00001.2006; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Godde B, 2002, NEUROSCI BIOBEHAV R, V26, P743, DOI 10.1016/S0149-7634(02)00061-1; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grant RA, 2012, DEV PSYCHOBIOL, V54, P151, DOI 10.1002/dev.20591; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hodgson V, 1983, 27 STAPP CAR CRASH C; Hong Y., 2010, ROUTLEDGE HDB BIOMEC; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nahum A., 2002, ACCIDENTAL INJURY BI; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2	30	13	13	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2014	42	8					1618	1630		10.1007/s10439-014-1014-8			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AL8OP	WOS:000339399000004	24756867				2022-02-06	
J	Peters, DM; Jain, S; Liuzzo, DM; Middleton, A; Greene, J; Blanck, E; Sun, S; Raman, R; Fritz, SL				Peters, Denise M.; Jain, Sonia; Liuzzo, Derek M.; Middleton, Addie; Greene, Jennifaye; Blanck, Erika; Sun, Shelly; Raman, Rema; Fritz, Stacy L.			Individuals With Chronic Traumatic Brain Injury Improve Walking Speed and Mobility With Intensive Mobility Training	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Gait; Rehabilitation	QUALITY-OF-LIFE; BALANCE; GAIT; STROKE; REHABILITATION; PROBABILITY; RELIABILITY; VALIDITY; FALLS	Objective: To determine the feasibility and impact of different dosages of Intensive Mobility Training (IMT) on mobility, balance, and gait speed in individuals with chronic traumatic brain injury (TBI). Design: Prospective, single group design with 3-month follow-up. Setting: University research laboratory. Participants: Volunteer sample of participants with chronic TBI (N=10; >= 3mo post-TBI; able to ambulate 3.05m with or without assistance; median age, 35.4y; interquartile range, 23.5-46y; median time post-TBI, 9.91y; interquartile range, 6.3-14.2y). Follow-up data were collected for all participants. Interventions: Twenty days (5d/wk for 4wk), with 150min/d of repetitive, task-specific training equally divided among balance; gait training; and strength, coordination, and range. Main Outcome Measures: Pain and fatigue were recorded before and after each session to assess feasibility. Treatment outcomes were assessed before training (pre), after 10 sessions (interim), after 20 sessions (post), and at 3-months follow-up and included the Berg Balance Scale and gait speed. Results: Participants averaged 150.1 +/- 2.7 minutes per session. Median presession and postsession pain scores were 0 (out of 10) for 20 sessions; median presession fatigue scores ranged from 0 to 2.5 (out of 10); and postsession scores ranged from 3 to 5.5 (out of 10). Four outcome measures demonstrated significant improvement from the pretest to interim, with 7 out of 10 participants exceeding the minimal detectable change (MDC) for fast walking speed. At the posttest, 2 additional measures were significant, with more participants exceeding the MDCs. Changes in fast walking speed and Timed Up and Go test were significant at follow-up. Conclusions: Limited fluctuations in pain and fatigue scores indicate feasibility of IMT in this population. Participants demonstrated improvements in walking speed, mobility, and balance postintervention and maintained gains in fast walking speed and mobility at 3 months. (C) 2014 by the American Congress of Rehabilitation Medicine	[Peters, Denise M.; Liuzzo, Derek M.; Middleton, Addie; Greene, Jennifaye; Fritz, Stacy L.] Univ S Carolina, Phys Therapy Program, Dept Exercise Sci, Columbia, SC 29208 USA; [Jain, Sonia] Univ Calif San Diego, Dept Family & Prevent Med, Div Biostat & Bioinformat, San Diego, CA 92103 USA; [Blanck, Erika] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Sun, Shelly] Univ Calif San Diego, Biostat Res Ctr, San Diego, CA 92103 USA; [Raman, Rema] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Raman, Rema] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA		Peters, DM (corresponding author), Univ S Carolina, Publ Hlth Res Ctr, 921 Assembly St,3rd Fl, Columbia, SC 29208 USA.	petersd20@gmail.com		Middleton, Addie/0000-0001-8970-3703	Posttraumatic Stress Coordinating Center and Clinical Site [W81XWH-08-2-0159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081740] Funding Source: NIH RePORTER	Supported by the Posttraumatic Stress Coordinating Center and Clinical Site (award no. W81XWH-08-2-0159).	Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Benedetti MG, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-64; Bowden MG, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/601416; Centers for Disease Control and Prevention, 30 SEC CHAIR STAND T; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Fritz NE, 2013, J NEUROL PHYS THER, V37, P37, DOI 10.1097/NPT.0b013e318282a20d; Fritz SL, 2011, EUR J PHYS REHAB MED, V47, P569; Fritz S, 2011, J NEUROL PHYS THER, V35, P141, DOI 10.1097/NPT.0b013e31822a2a09; Fritz Stacy L, 2007, J Neurol Phys Ther, V31, P71; Fritz SL, 2011, ARCH PHYS MED REHAB, V92, P1776, DOI 10.1016/j.apmr.2011.05.006; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Vearrier LA, 2005, GAIT POSTURE, V22, P154, DOI 10.1016/j.gaitpost.2004.09.001; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; Wevers LEG, 2011, J REHABIL MED, V43, P1027, DOI 10.2340/16501977-0881; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	29	13	13	0	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2014	95	8					1454	1460		10.1016/j.apmr.2014.04.006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AM2ND	WOS:000339687200006	24769069	Green Accepted			2022-02-06	
J	Koizumi, H; Ideguchi, M; Iwanaga, H; Shirao, S; Sadahiro, H; Oka, F; Suehiro, E; Yoneda, H; Ishihara, H; Nomura, S; Suzuki, M				Koizumi, Hiroyasu; Ideguchi, Makoto; Iwanaga, Hideyuki; Shirao, Satoshi; Sadahiro, Hirokazu; Oka, Fumiaki; Suehiro, Eiichi; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu			Cognitive dysfunction might be improved in association with recovered neuronal viability after intracranial meningioma resection	BRAIN RESEARCH			English	Article						Neurocognitive function; Cerebral cortical neuron; Radioligans	CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; STATISTICAL IMAGING ANALYSIS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; IODINE-123-IOMAZENIL SPECT; ALZHEIMERS-DISEASE; I-123-IOMAZENIL SPECT; RECEPTOR-BINDING; CORTICAL DAMAGE	Intracranial meningiomas are the most common types of neoplasms that cause mental disorders. Although higher brain function can be restored and even improved in some patients after tumor resection, the mechanisms remain unclear. We investigated changes in the brains of patients after resection of an intracranial meningioma using I-123-Iomazenil (IMZ)-single photon emission computed tomography (SPECT). Ten patients underwent IMZ-SPECT within 4 weeks before and 3 months after intracranial meningioma resection. Changes in IMZ accumulation in brain parenchyma were assessed as ratios of counts in the lesion-to-contralateral hemisphere (L/C ratios). Mean Mini-Mental State Examination scores before and after resection of 19.9 +/- 11.4 vs. 26.5 +/- 3.8, respectively (p =0.03) indicated that the cognitive function of these patients was significantly improved after tumor resection. The average WC ratios calculated from image counts of IMZ were 0.92 +/- 0.05 and 0.98 +/- 0.02 before and after surgery, respectively. The L/C ratio of IMZ accumulation was significantly decreased after tumor resection (p=0.0003). In contrast, regional cerebral blood flow calculated from I-123-Iodoamphetamine-SPECT images did not significantly differ after tumor resection. The recovered binding potential of IMZ in brain parenchyma surrounding the tumor bulk after resection indicates that the viability of central benzodiazepine receptors was reversibly depressed and recoverable after release from compression by the tumor. The recovered neuronal viability revealed by IMZ-SPECT might be responsible for the improved cognitive function after intracranial meningioma resection. (C) 2014 Published by Elsevier B.V.	[Koizumi, Hiroyasu; Ideguchi, Makoto; Shirao, Satoshi; Sadahiro, Hirokazu; Oka, Fumiaki; Suehiro, Eiichi; Yoneda, Hiroshi; Ishihara, Hideyuki; Nomura, Sadahiro; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Iwanaga, Hideyuki] Yamaguchi Univ, Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan		Koizumi, H (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan.	hiroyasu@yamaguchi-u.ac.jp	Suehiro, Eiichi/I-5852-2019				ANDY OJ, 1981, SOUTHERN MED J, V74, P968, DOI 10.1097/00007611-198108000-00022; Ball S, 1998, BIOL PSYCHIAT, V43, P107, DOI 10.1016/S0006-3223(97)00300-4; Bugnicourt JM, 2013, J NEUROL, V260, P1324, DOI 10.1007/s00415-012-6799-5; Caminiti G, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/218928; Carlsson G, 2010, CHILD NERV SYST, V26, P105, DOI 10.1007/s00381-009-0984-6; Chida K, 2011, J NUCL MED, V52, P511, DOI 10.2967/jnumed.110.084186; Chida K, 2009, STROKE, V40, P448, DOI 10.1161/STROKEAHA.108.515775; Dijkstra M, 2009, J NEUROL NEUROSUR PS, V80, P910, DOI 10.1136/jnnp.2007.138925; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Feder M., 1989, J NEURO REHAB, V3, P15; Fukuchi K, 1997, J NUCL MED, V38, P467; Gazzeri R, 2008, ACTA NEUROCHIR, V150, P1117, DOI 10.1007/s00701-008-0142-z; Goto H, 2003, J CLIN NEUROSCI, V10, P375, DOI 10.1016/S0967-5868(03)00023-7; Hanyu H, 2012, J NEUROL SCI, V323, P71, DOI 10.1016/j.jns.2012.08.013; HATAZAWA J, 1995, J NUCL MED, V36, P2154; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Hosoda K, 2003, STROKE, V34, P1187, DOI 10.1161/01.STR.0000068781.31429.BE; IIDA H, 1994, J NUCL MED, V35, P2019; Iida H, 2010, J NUCL MED, V51, P1624, DOI 10.2967/jnumed.110.078352; Kaneko K, 2006, NUCL MED COMMUN, V27, P893, DOI 10.1097/01.mnm.0000243380.79872.32; Kasama S, 2005, DEMENT GERIATR COGN, V19, P266, DOI 10.1159/000084551; Koizumi H, 2010, J CEREBR BLOOD F MET, V30, P1673, DOI 10.1038/jcbfm.2010.75; Krupp W, 2009, NEUROSURGERY, V64, P40, DOI 10.1227/01.NEU.0000336330.75381.39; LAMPL Y, 1995, PSYCHIAT RES, V58, P177, DOI 10.1016/0165-1781(95)02586-L; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; Louis DN, 2000, PATHOLOGY GENETICS T, P176; MAURICEWILLIAMS RS, 1988, BMJ-BRIT MED J, V296, P1785, DOI 10.1136/bmj.296.6639.1785; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Morimoto N, 2012, J NEUROL SCI, V319, P96, DOI 10.1016/j.jns.2012.04.020; Nakagawara J, 1997, STROKE, V28, P124, DOI 10.1161/01.STR.28.1.124; Nakagawara J, 2012, NEUROL MED-CHIR, V52, P318, DOI 10.2176/nmc.52.318; Nishimura T, 2007, ANN NUCL MED, V21, P15, DOI 10.1007/BF03033995; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Pappata S, 2010, EUR J NUCL MED MOL I, V37, P1156, DOI 10.1007/s00259-010-1409-1; Prohovnik I, 1998, J NUCL MED, V39, P927; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; SELECKI B R, 1965, Med J Aust, V1, P383; Sergides I, 2009, NEUROL RES, V31, P84, DOI 10.1179/174313208X331563; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Simoca I, 1994, Rom J Neurol Psychiatry, V32, P237; Takahashi K, 2005, AM J NEURORADIOL, V26, P2005; Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Tucha O, 2003, J NEUROSURG, V98, P21, DOI 10.3171/jns.2003.98.1.0021; Umeoka S, 2007, J NEUROSURG, V107, P352, DOI 10.3171/JNS-07/08/0352; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Varrone A, 1999, CLIN NUCL MED, V24, P660, DOI 10.1097/00003072-199909000-00004; Yamashita T, 2012, CLIN NUCL MED, V37, P128, DOI 10.1097/RLU.0b013e31823e9a9a	51	13	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 29	2014	1574						50	59		10.1016/j.brainres.2014.05.047			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM6ZM	WOS:000340014500006	24928615				2022-02-06	
J	Zhu, KJ; Huang, H; Chu, H; Yu, H; Zhang, SM				Zhu, Ke-Jun; Huang, Hong; Chu, Hui; Yu, Hang; Zhang, Shi-Ming			Alterations in enterocyte mitochondrial respiratory function and enzyme activities in gastrointestinal dysfunction following brain injury	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article						Mitochondria; Brain injury; Enterocyte; Rats; Malate dehydrogenase	INCREASED INTESTINAL PERMEABILITY; PYRUVATE-DEHYDROGENASE; ORGAN DYSFUNCTION; RATS; SEPSIS; MUCOSA; NEURODEGENERATION; SEVERITY; MOTILITY; BARRIER	AIM: To determine the alterations in rat enterocyte mitochondrial respiratory function and enzyme activities following traumatic brain injury (TBI). METHODS: Fifty-six male SD rats were randomly divided into seven groups (8 rats in each group): a control group (rats with sham operation) and traumatic brain injury groups at 6, 12, 24 h, days 2, 3, and 7 after operation. TBI models were induced by Feendy' s free-falling method. Mitochondrial respiratory function (respiratory control ratio and ADP/O ratio) was measured with a Clark oxygen electrode. The activities of respiratory chain complex I-IV and related enzymes were determined by spectrophotometry. RESULTS: Compared with the control group, the mitochondrial respiratory control ratio (RCR) declined at 6 h and remained at a low level until day 7 after TBI (control, 5.42 +/- 0.46; 6 h, 5.20 +/- 0.18; 12 h, 4.55 +/- 0.35; 24 h, 3.75 +/- 0.22; 2 d, 4.12 +/- 0.53; 3 d, 3.45 +/- 0.41; 7 d, 5.23 +/- 0.24, P < 0.01). The value of phosphate-to-oxygen (P/O) significantly decreased at 12, 24 h, day 2 and day 3, respectively (12 h, 3.30 +/- 0.10; 24 h, 2.61 +/- 0.21; 2 d, 2.95 +/- 0.18; 3 d, 2.76 +/- 0.09, P < 0.01) compared with the control group (3.46 +/- 0.12). Two troughs of mitochondrial respiratory function were seen at 24 h and day 3 after TBI. The activities of mitochondrial complex. (6 h: 110 +/- 10, 12 h: 115 +/- 12, 24 h: 85 +/- 9, day 2: 80 +/- 15, day 3: 65 +/- 16, P < 0.01) and complex. (6 h: 105 +/- 8, 12 h: 110 +/- 92, 24 h: 80 +/- 10, day 2: 76 +/- 8, day 3: 68 +/- 12, P < 0.01) were increased at 6 h and 12 h following TBI, and then significantly decreased at 24 h, day 2 and day 3, respectively. However, there were no differences in complex. and. activities between the control and TBI groups. Furthermore, pyruvate dehydrogenase (PDH) activity was significantly decreased at 6 h and continued up to 7 d after TBI compared with the control group (6 h: 90 +/- 8, 12 h: 85 +/- 10, 24 h: 65 +/- 12, day 2: 60 +/- 9, day 3: 55 +/- 6, day 7: 88 +/- 11, P < 0.01). The changes in alpha-ketoglutaric dehydrogenase (KGDH) activity were similar to PDH, except that the decrease in KGDH activity began at 12 h after TBI (12 h: 90 +/- 12, 24 h: 80 +/- 9, day 2: 76 +/- 15, day 3: 68 +/- 7, day 7: 90 +/- 13, P < 0.01). No significant change in malate dehydrogenase (MDH) activity was observed. CONCLUSION: Rat enterocyte mitochondrial respiratory function and enzyme activities are inhibited following TBI. Mitochondrial dysfunction may play an important role in TBI-induced gastrointestinal dysfunction. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.	[Zhu, Ke-Jun; Zhang, Shi-Ming] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China; [Zhu, Ke-Jun; Huang, Hong; Chu, Hui; Yu, Hang] PLA, Hosp 100, Dept Trauma Surg, Suzhou 215007, Jiangsu, Peoples R China		Zhang, SM (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi Jie, Suzhou 215006, Jiangsu, Peoples R China.	mmboyzkj@hotmail.com	Zhu, Ren-Yuan/V-8966-2019	Zhu, Ren-Yuan/0000-0003-3091-7461	Scientific Research Foundation of the Chinese PLA Medical Programs [ms031]	Supported by The Scientific Research Foundation of the Chinese PLA Medical Programs, No. ms031	Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; BROWN GC, 1992, BIOCHEM J, V284, P1; Dervenis Christos, 2003, J Hepatobiliary Pancreat Surg, V10, P415, DOI 10.1007/s00534-002-0727-5; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; GARDESTROM P, 1995, J BIOENERG BIOMEMBR, V27, P415, DOI 10.1007/BF02110004; Grivennikova VG, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1490, DOI 10.1134/S0006297913130087; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kemp CD, 2008, AM SURGEON, V74, P866; Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108; LAWRENCE CB, 1986, BIOCHIM BIOPHYS ACTA, V848, P35, DOI 10.1016/0005-2728(86)90157-X; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; Mei QA, 2011, ACTA PHARMACOL SIN, V32, P495, DOI 10.1038/aps.2010.225; Moran M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009; Overhaus M, 2009, SHOCK, V31, P382, DOI 10.1097/SHK.0b013e3181862ea4; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rocha Milagros, 2012, Infectious Disorders - Drug Targets, V12, P161; Rowlands BJ, 1999, BRIT MED BULL, V55, P196, DOI 10.1258/0007142991902213; Smith Katherine, 2013, Nat Rev Gastroenterol Hepatol, V10, P260, DOI 10.1038/nrgastro.2013.68; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Wang Yan-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1716; WANG YB, 2007, ZHONGHUA XIAOHUA ZAZ, V27, P103, DOI DOI 10.3760/J.ISSN:0254-1432.2007.02.008; Xiao SC, 2008, WORLD J GASTROENTERO, V14, P3231, DOI 10.3748/wjg.14.3231; Zhang XN, 2008, J ZHEJIANG UNIV-SC B, V9, P90, DOI 10.1631/jzus.B0710621	38	13	18	0	10	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	JUL 28	2014	20	28					9585	9591		10.3748/wjg.v20.i28.9585			7	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	AL8LI	WOS:000339389800043	25071356	Green Published, hybrid			2022-02-06	
J	Kim, SC; Park, SW; Ryoo, I; Jung, SC; Yun, TJ; Choi, SH; Kim, JH; Sohn, CH				Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho			Contrast-Enhanced FLAIR (Fluid-Attenuated Inversion Recovery) for Evaluating Mild Traumatic Brain Injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; SUBDURAL-HEMATOMA; MR; MENINGES; SEQUELAE; RESECTION; SPACE; SITE	Purpose: To evaluate whether adding a contrast-enhanced fluid-attenuated inversion recovery (FLAIR) sequence to routine magnetic resonance imaging (MRI) can detect additional abnormalities in the brains of symptomatic patients with mild traumatic brain injury. Materials and Methods: Fifty-four patients with persistent symptoms following mild closed head injury were included in our retrospective study (M:F = 32: 22, mean age: 59.8 +/- 16.4, age range: 26-84 years). All MRI examinations were obtained within 14 days after head trauma (mean: 3.2 +/- 4.1 days, range: 0.2-14 days). Two neuroradiologists recorded (1) the presence of traumatic brain lesions on MR images with and without contrast-enhanced FLAIR images and (2) the pattern and location of meningeal enhancement depicted on contrast-enhanced FLAIR images. The number of additional traumatic brain lesions diagnosed with contrast-enhanced FLAIR was recorded. Correlations between meningeal enhancement and clinical findings were also evaluated. Results: Traumatic brain lesions were detected on routine image sequences in 25 patients. Three additional cases of brain abnormality were detected with the contrast-enhanced FLAIR images. Meningeal enhancement was identified on contrast-enhanced FLAIR images in 9 cases while the other routine image sequences showed no findings of traumatic brain injury. Overall, the additional contrast-enhanced FLAIR images revealed more extensive abnormalities than routine imaging in 37 cases (p<0.001). In multivariate logistic regression analysis, subdural hematoma and posttraumatic loss of consciousness showed a significant association with meningeal enhancement on contrast-enhanced FLAIR images, with odds ratios 13.068 (95% confidence interval 2.037 to 83.852), and 15.487 (95% confidence interval 2.545 to 94.228), respectively. Conclusion: Meningeal enhancement on contrast-enhanced FLAIR images can help detect traumatic brain lesions as well as additional abnormalities not identified on routine unenhanced MRI. Therefore contrast-enhanced FLAIR MR imaging is recommended when a contrast MR study is indicated in a patient with a symptomatic prior closed mild head injury.	[Kim, Soo Chin; Park, Sun-Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea; [Kim, Soo Chin; Park, Sun-Won; Ryoo, Inseon; Jung, Seung Chai; Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ryoo, Inseon] Korea Univ, Guro Hosp, Dept Radiol, Seoul, South Korea; [Jung, Seung Chai] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Yun, Tae Jin; Choi, Seung Hong; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea		Park, SW (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea.	swpark8802@gmail.com	Sohn, ChulHo/AAV-4565-2021	Choi, Seung Hong/0000-0002-0412-2270			Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Atkinson JLD, 2003, J MAGN RESON IMAGING, V17, P484, DOI 10.1002/jmri.10275; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BURKE JW, 1990, RADIOLOGY, V174, P99, DOI 10.1148/radiology.174.1.2294579; Dolinskas CA, 1998, AM J NEURORADIOL, V19, P419; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; ELSTER AD, 1990, RADIOLOGY, V174, P93, DOI 10.1148/radiology.174.1.2294578; Ercan N, 2004, AM J NEURORADIOL, V25, P761; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fukuoka H, 2010, AM J NEURORADIOL, V31, P868, DOI 10.3174/ajnr.A1937; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Goo HW, 2003, PEDIATR RADIOL, V33, P843, DOI 10.1007/s00247-003-1057-8; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mathews VP, 1999, RADIOLOGY, V211, P257, DOI 10.1148/radiology.211.1.r99mr25257; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rapana A, 1997, CLIN NEUROL NEUROSUR, V99, P124, DOI 10.1016/S0303-8467(96)00585-9; Romano Valerie A., 1994, Journal of Emergency Medicine, V12, P369, DOI 10.1016/0736-4679(94)90280-1; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sato N, 1997, RADIOLOGY, V204, P839, DOI 10.1148/radiology.204.3.9280269; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Soman S, 2013, AM J NEURORADIOL, V34, P2092, DOI 10.3174/ajnr.A3595; SZE G, 1993, AM J ROENTGENOL, V160, P727, DOI 10.2214/ajr.160.4.8456653; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	33	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102229	10.1371/journal.pone.0102229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	WOS:000341306600049	25028975	Green Published, gold, Green Submitted			2022-02-06	
J	Hinkewich, C; Green, R				Hinkewich, Chris; Green, Robert			The impact of etomidate on mortality in trauma patients	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							RAPID-SEQUENCE INTUBATION; SINGLE-DOSE ETOMIDATE; ADRENAL INSUFFICIENCY; EMERGENCY-DEPARTMENT; BRAIN-INJURY; INDUCTION	Etomidate has a neutral hemodynamic profile which has made it an attractive medication for emergent intubation. Despite theoretical advantages of etomidate administration in the trauma patient, there are incomplete data to support its use. This study examined the association of etomidate use for emergent intubation in traumatic illness with patient mortality. This is a historical cohort study using the Nova Scotia Trauma Registry. It included all major adult trauma patients who required tracheal intubation at the Queen Elizabeth II Health Sciences Centre in Halifax, Canada from January 23, 2000 to March 25, 2012. Prospectively recorded data were analyzed, including patient demographics, presence of comorbidities, trauma specific variables, admission and discharge vitals, length of stay in the intensive care unit (ICU) and hospital, mechanical ventilation-free days, and mortality. Associations between the use of etomidate and 28-day mortality are presented as odds ratios. Multivariable logistic regression models were created adjusting for age, injury severity score (ISS), sex, comorbidities, presence of traumatic brain injury, and injury type. The effects of etomidate on other relevant outcome variables were assessed using unpaired Student's t-tests. Three hundred eight patients were included in the study, and there were 42 deaths. Patients receiving etomidate were similar to those who did not, including ISS and pre-intubation blood pressure. The 28-day mortality was 18.7% in the etomidate group and 11.1% in the non-etomidate group (odds ratio = 1.85; 95% confidence interval [CI] 0.96 to 3.57; P = 0.07). After adjustment for age, female sex, ISS, and comorbidity, the odds ratio was 1.94 (95% CI 0.87 to 4.37; P = 0.11). There were no differences between the two groups in ICU length of stay, hospital length of stay, or number of ventilation-free days. The association between use of a single dose of etomidate for emergency tracheal intubation in the trauma patient and mortality is inconclusive. Etomidate administration should be used with caution in trauma patients requiring tracheal intubation. Further data are required to determine the safety and risk-benefit of etomidate use in this patient population.	[Hinkewich, Chris; Green, Robert] Dalhousie Univ, Dept Anesthesia, Div Crit Care, Halifax, NS, Canada		Green, R (corresponding author), Room 377 Bethune Bldg,1276 South Pk St, Halifax, NS B3H 2Y9, Canada.	research.rsg@cdha.nshealth.ca					Asehnoune K, 2012, INTENS CARE MED, V38, P1673, DOI 10.1007/s00134-012-2619-8; Banh KV, 2012, J EMERG MED, V43, pE277, DOI 10.1016/j.jemermed.2012.02.027; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cuthbertson BH, 2009, INTENS CARE MED, V35, P1868, DOI 10.1007/s00134-009-1603-4; Green RS, 2012, CAN J EMERG MED, V14, P74, DOI 10.2310/8000.2012.110548; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; LEDINGHAM IM, 1983, LANCET, V1, P1270; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Sivilotti Marco L A, 2006, CJEM, V8, P351; Sivilotti MLA, 1998, ANN EMERG MED, V31, P313, DOI 10.1016/S0196-0644(98)70341-5; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y; Warner KJ, 2009, J TRAUMA, V67, P45, DOI 10.1097/TA.0b013e3181a92a70; Zed PJ, 2006, ACAD EMERG MED, V13, P378, DOI 10.1197/j.aem.2005.11.076	18	13	13	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUL	2014	61	7					650	655		10.1007/s12630-014-0161-6			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AI7OW	WOS:000337084200007	24723214	Bronze			2022-02-06	
J	Micieli, JA; Zurakowski, D; Ahmed, IIK				Micieli, Jonathan A.; Zurakowski, David; Ahmed, Iqbal Ike K.			Impact of visors on eye and orbital injuries in the National Hockey League	CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE			English	Article							ICE HOCKEY; CONCUSSIONS; HEAD	Objective: Eye and orbital injuries are a significant risk to professional hockey league players and have resulted in career-ending injuries. The goal of this study was to determine the incidence, value lost, mechanism, and effect of visors on eye and orbital injuries over the last 10 National Hockey League (NHL) seasons: 2002-2003 to 2012-2013. Design: Retrospective case control study. Participants: Participants were 8741 NHL players who had played at least 1 game during the last 10 seasons. Methods: Using The Sports Network (TSN), ProSports Transactions, and the Sporting News Hockey Register, NHL players were searched to identify eye and orbital injuries. The mechanism of injury was obtained from media reports and direct observation from online videos. The number of players wearing visors each year was obtained from The Hockey News annual visor survey. Results: A total of 149 eye or orbital injuries over the last 10 seasons resulted in an overall incidence of 2.48 per 10 000 athlete exposures. A total of 1120 missed games led to a lost financial value of more than $33 million. Visor use among players grew from 32% in 2002-2003 to 73% in 2012-2013, and there was a significantly increased risk for having an eye or orbital injury when a visor was not worn (OR 4.23, 95% CI 2.84-6.30). Most injuries were a result of being hit by a deflected or direct puck (37%) followed by being struck by a high stick (28%). Players who did not wear a visor were found to be involved in more fights, hits, and penalty minutes (p < 0.001). Conclusions: Eye and orbital injuries are mostly accidental in nature and represent a significant risk and cost to the NHL and its players. Eye and orbital injuries are significantly more likely in players who do not wear visors.	[Micieli, Jonathan A.; Ahmed, Iqbal Ike K.] Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; [Zurakowski, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Zurakowski, David] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Ahmed, Iqbal Ike K.] Trillium Hlth Partners, Mississauga, ON, Canada; [Ahmed, Iqbal Ike K.] Credit Valley EyeCare, Mississauga, ON, Canada		Micieli, JA (corresponding author), Dept Ophthalmol & Vis Sci, 340 Coll St,Suite 400, Toronto, ON M5T 3A9, Canada.	jonathanmicieli@gmail.com					Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernstein R., 2006, CODE UNWRITTEN RULES; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Brophy M., 2013, NHL NHLPA AGREE MAND; Campbell K, 2011, THN POLL NHL VISOR U; Cole C., 2013, NATL POST; McGran K., 2013, PLACE TRIVIA HIST AW; Morris DS, 2009, BMJ CASE REP; Orchard J, 2002, BRIT J SPORT MED, V36, P16, DOI 10.1136/bjsm.36.1.16; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stevens ST, 2008, SOUTH MED J, V101, P979, DOI 10.1097/SMJ.0b013e3181818107; The Canadian Press, 2013, COMP COMM TOUTS VIS; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Woods SE, 2008, SOUTH MED J, V101, P991, DOI 10.1097/SMJ.0b013e3181830d42	16	13	14	0	9	CANADIAN OPHTHAL SOC	OTTAWA	1525 CARLING AVE SUITE 610, OTTAWA, ONTARIO K1Z 8R9, CANADA	0008-4182	1715-3360		CAN J OPHTHALMOL	Can. J. Opthalmol.-J. Can. Opthalmol.	JUN	2014	49	3					243	248		10.1016/j.jcjo.2014.03.008			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	AI0GE	WOS:000336523400013	24862769				2022-02-06	
J	Poropatich, RK; Pavliscsak, HH; Tong, JC; Little, JR; McVeigh, FL				Poropatich, Ronald K.; Pavliscsak, Holly H.; Tong, James C.; Little, Jeanette R.; McVeigh, Francis L.			mCare: Using Secure Mobile Technology to Support Soldier Reintegration and Rehabilitation	TELEMEDICINE AND E-HEALTH			English	Article						health; military medicine; information management; rehabilitation; telecommunications	TRAUMATIC BRAIN-INJURY	Background: The U. S. Army Medical Department conducted a pilot mobile health project to determine the requirements for coordination of care for "Wounded Warriors'' using mobile messaging. The primary objective was to determine if a secure mobile health (mhealth) intervention provided to geographically dispersed patients would improve contact rates and positively impact the military healthcare system. Methods and Materials: Over 21 months, volunteers enrolled in a Health Insurance Portability and Accountability Act-compliant, secure mobile messaging initiative called mCare. The study included males and females, 18-61 years old, with a minimum of 60 days of outpatient recovery. Volunteers were required to have a compatible phone. The mhealth intervention included appointment reminders, health and wellness tips, announcements, and other relevant information to this population exchanged between care teams and patients. Results: Provider respondents reported that 85% would refer patients to mCare, and 56% noted improvement in appointment attendance (n = 90). Patient responses also revealed high acceptability of mCare and refined the frequency and delivery times (n = 114). The pilot project resulted in over 84,000 outbound messages and improved contact rates by 176%. Conclusions: The mCare pilot project demonstrated the feasibility and administrative effectiveness of a scalable mhealth application using secure mobile messaging and information exchanges, including personalized patient education.	[Poropatich, Ronald K.] Univ Pittsburgh, Ctr Mil Med Res, Pittsburgh, PA USA; [Pavliscsak, Holly H.; Little, Jeanette R.] US Army Med Res & Mat Command USAMRMC, Telemed & Adv Technol Res Ctr TATRC, Ft Gordon, GA 30905 USA; [Tong, James C.] PricewaterhouseCoopers LLP, Herndon, VA USA; [McVeigh, Francis L.] US Army Med Res & Mat Command, Telemed & Adv Technol Ctr, Ft Detrick, MD USA		Pavliscsak, HH (corresponding author), US Army Med Res & Mat Command USAMRMC, Mobile Hlth Innovat Ctr MHIC, Telemed & Adv Technol Res Ctr TATRC, mCare Project, Bldg 38711, Ft Gordon, GA 30905 USA.	holly.h.pavliscsak.ctr@mail.mil					[Anonymous], 2011, 26 MOBILE APPL USERS; Blumberg S. J., 2011, NATL HLTH STAT REPOR, V39, P28; Blumberg Stephen J, 2011, Natl Health Stat Report, P1; Canalys, 2012, SMART PHON OV CLIENT; CTIA The Wireless Association, 2012, WIR QUICK FACTS; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Health Resources and Services Administration, 2010, WHAT IS MHEALTH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Luxton DD, 2012, TELEMED E-HEALTH, V18, P409, DOI 10.1089/tmj.2011.0219; Obama B., 2012, PRESIDENTIAL MEMORAN; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ruby D., 2012, APP RETENTION INCREA; Smith A., 2012, CELL INTERNET USE 20; Tanielian T, 2008, PUBLICATION RAND COR; U.S. Department of Defense, 2012, CAS STAT	15	13	13	1	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	JUN	2014	20	6					563	569		10.1089/tmj.2013.0226			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	AJ8IA	WOS:000337945500010	24666038				2022-02-06	
J	Truntzer, J; Lynch, A; Kruse, D; Prislin, M				Truntzer, Jeremy; Lynch, Alison; Kruse, David; Prislin, Michael			Musculoskeletal education: an assessment of the clinical confidence of medical students	PERSPECTIVES ON MEDICAL EDUCATION			English	Article						Medical education; Sports medicine; Musculoskeletal education	JOINT DECADE; BONE	Musculoskeletal (MSK) conditions account for nearly 15-30 % of encounters in a primary care practice. Yet, studies demonstrate that medical students and residents lack the knowledge and confidence to care for many MSK conditions. This study addresses the design of focused MSK educational practices towards improving students' knowledge, interest, and confidence for conducting MSK examinations. Students attending a voluntary educational symposium on sports medicine were recruited to participate. The symposium was directed toward teaching elements of the MSK exam. Participants completed validated pre- and post-workshop surveys that assessed confidence in performing MSK examinations as well as satisfaction and perceived importance of MSK education. Additionally, mean survey responses from a convenience group of students who did not participate in the symposium were compared against the intervention group. Thirteen students participated in the educational symposium. Hundred and nine students completed the general survey. In the non-intervention group, students demonstrated knowledge and confidence improvements through the second year of medical school but did not show similar improvement in subsequent years. No difference in MSK confidence scores between fourth-year students going into high versus low MSK focused specialities was observed. In the intervention group students demonstrated improvements in confidence with respect to the knee, shoulder and ankle exams (p < 0.01). Areas not covered such as concussions and neuromuscular impairments failed to show significant change. Current core clinical training, at least at our school, does not achieve satisfactory levels of knowledge and confidence with respect to caring for MSK conditions. However, a focused didactic and skill development intervention does produce significant improvements. Follow-up is needed to determine whether these improvements are sustained.	[Truntzer, Jeremy] Univ Calif Irvine, Irvine, CA USA; [Lynch, Alison] Univ Calif San Diego, Dept Family Med, San Diego, CA 92103 USA; [Kruse, David] Orthopaed Specialty Inst, Sports Med Phys, Orange, CA USA; [Kruse, David] Univ Calif Irvine, Dept Family Med, Irvine, CA USA; [Prislin, Michael] Univ Calif Irvine, Student Affairs Sch Med, Dept Family Med, Irvine, CA USA		Truntzer, J (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Orthopaed, 593 Eddy St, Providence, RI 02903 USA.	jtruntzer@gmail.com; aliblynch@gmail.com; krusedw@gmail.com; mdprisli@uci.edu	Kruse, David/ABB-9110-2020				Bush GW, 2002, J BONE JOINT SURG AM, V84A, P1297, DOI 10.2106/00004623-200208000-00001; Clawson DR, 2001, ACAD MED, V76, P709, DOI 10.1097/00001888-200107000-00012; Day CS, 2008, CLIN ORTHOP RELAT R, V466, P2542, DOI 10.1007/s11999-008-0379-0; DiCaprio MR, 2003, J BONE JOINT SURG AM, V85A, P565, DOI 10.2106/00004623-200303000-00027; Freedman KB, 1998, J BONE JOINT SURG AM, V80A, P1421, DOI 10.2106/00004623-199810000-00003; Freedman KB, 2002, J BONE JOINT SURG AM, V84A, P604, DOI 10.2106/00004623-200204000-00015; Lidgren L, 2003, B WORLD HEALTH ORGAN, V81, P629; Pinney SJ, 2001, J BONE JOINT SURG AM, V83A, P1317, DOI 10.2106/00004623-200109000-00004; Skelley NW, 2012, J BONE JOINT SURG, V94, pe146, DOI [10.2106/JBJS.K.01286, DOI 10.2106/JBJS.K.01286]	9	13	13	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2212-2761	2212-277X		PERSPECT MED EDUC	Perspect. Med. Educ.	JUN	2014	3	3					238	244		10.1007/s40037-014-0124-1			7	Education, Scientific Disciplines; Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Education & Educational Research; Health Care Sciences & Services	VF5RM	WOS:000443136400012	24865889	Green Published, gold			2022-02-06	
J	Xu, BX; Chen, X; Lu, WY; Zhao, C; Qiao, Y				Xu, Baoxing; Chen, Xi; Lu, Weiyi; Zhao, Cang; Qiao, Yu			Non-dissipative energy capture of confined liquid in nanopores	APPLIED PHYSICS LETTERS			English	Article							TRAUMATIC BRAIN-INJURY; NANOSCALE; ABSORPTION; TRANSPORT; PRESSURE	In the past, energy absorption of protection/damping materials is mainly based on energy dissipation, which causes a fundamental conflict between the requirements of safety/comfort and efficiency. In the current study, a nanofluidic "energy capture" system is reported, which is based on nanoporous materials and nonwetting liquid. Both molecular dynamics simulations and experiments show that as the liquid overcomes the capillary effect and infiltrates into the nanopores, the mechanical energy of a stress wave could be temporarily stored by the confined liquid phase and isolated from the wave energy transmission path. Such a system can work under a relatively low pressure for mitigating high-pressure stress waves, not necessarily involved in any energy dissipation processes. (C) 2014 AIP Publishing LLC.	[Xu, Baoxing; Chen, Xi] Columbia Univ, Dept Earth & Environm Engn, Columbia Nanomech Res Ctr, New York, NY 10027 USA; [Lu, Weiyi; Zhao, Cang; Qiao, Yu] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Qiao, Yu] Univ Calif San Diego, Program Mat Sci & Engn, La Jolla, CA 92093 USA		Qiao, Y (corresponding author), Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA.	yqiao@ucsd.edu	Zhao, Cang/A-4633-2017; Chen, Xi/B-1539-2008; Lu, Weiyi/D-5001-2012; Xu, Baoxing/A-4777-2009	Zhao, Cang/0000-0002-2464-2409; Chen, Xi/0000-0002-1263-1024; 	National Science FoundationNational Science Foundation (NSF) [ECCS-1028010, CMMI-0643726]; Army Research Office [W91CRB-11-C-0112]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [W91CRB-11-C-0112]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11172231]	The concept generation, the theoretical analysis, and the system design were supported by the National Science Foundation under Grant No. ECCS-1028010. The experimental investigation was supported by the Army Research Office under Grant No. W91CRB-11-C-0112, and the materials preparation was supported by DARPA under Grant No. W91CRB-11-C-0112 (subaward to UCSD). The program development for the computer simulation was supported by the National Science Foundation under Grant No. CMMI-0643726. The computational case study was supported by DARPA under Grant No. W91CRB-11-C-0112 (subaward to Columbia University). The data analysis of computer simulation was supported by the Natural Science Foundation of China under Grant No. 11172231.	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Ando K, 2011, J FLUID MECH, V671, P339, DOI 10.1017/S0022112010005707; Brothers AH, 2006, SCRIPTA MATER, V54, P513, DOI 10.1016/j.scriptamat.2005.10.048; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Carretero-Gonzalez R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.024102; Chen X, 2008, NANO LETT, V8, P2988, DOI 10.1021/nl802046b; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cox BN, 2000, ACTA MATER, V48, P755, DOI 10.1016/S1359-6454(99)00344-4; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Dubey DD, 1998, J COMPOS MATER, V32, P158, DOI 10.1177/002199839803200204; Evans AG, 2001, PROG MATER SCI, V46, P309, DOI 10.1016/S0079-6425(00)00016-5; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gibson L. J., 1997, CELLULAR SOLIDS STRU, V2nd, DOI DOI 10.1017/CBO9781139878326; Han A, 2008, CHEM ENG J, V139, P426, DOI 10.1016/j.cej.2007.12.002; Hong J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108001; Lu G., 2003, ENERGY ABSORPTION ST; Lu WY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3534198; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Nesterenko V. F., 2003, MATER RES SOC S P, V729; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Tai K, 2007, NAT MATER, V6, P454, DOI 10.1038/nmat1911; Wang LF, 2011, ADV MATER, V23, P1524, DOI 10.1002/adma.201003956	26	13	14	1	35	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	MAY 19	2014	104	20							203107	10.1063/1.4878097			4	Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Physics	AI8EQ	WOS:000337140800060					2022-02-06	
J	Karver, CL; Wade, SL; Cassedy, A; Taylor, HG; Brown, TM; Kirkwood, MW; Stancin, T				Karver, Christine L.; Wade, Shari L.; Cassedy, Amy; Taylor, H. Gerry; Brown, Tanya M.; Kirkwood, Michael W.; Stancin, Terry			Cognitive reserve as a moderator of responsiveness to an online problem-solving intervention for adolescents with complicated mild-to-severe traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Problem solving; Telehealth; Cognitive reserve; Adolescents	TERM BEHAVIOR PROBLEMS; VERBAL-LEARNING-TEST; FAMILY INTERVENTION; PRELIMINARY EFFICACY; EXECUTIVE FUNCTION; ALZHEIMER-DISEASE; SELF-REGULATION; YOUNG-CHILDREN; CHILDHOOD; OUTCOMES	Children and adolescents with traumatic brain injury (TBI) often experience behavior difficulties that may arise from problem-solving deficits and impaired self-regulation. However, little is known about the relationship of neurocognitive ability to post-TBI behavioral recovery. To address this question, we examined whether verbal intelligence, as estimated by Vocabulary scores from the Wechsler Abbreviated Scale of Intelligence, predicted improvements in behavior and executive functioning following a problem-solving intervention for adolescents with TBI. One hundred and thirty-two adolescents with complicated mild-to-severe TBI were randomly assigned to a six-month Web-based problem-solving intervention (CAPS; n = 65) or to an Internet resource comparison (IRC; n = 67) group. Vocabulary moderated the association between treatment group and improvements in metacognitive abilities. Examination of the mean estimates indicated that for those with lower Vocabulary scores, pre-intervention Metacognition Index scores from the Behavior Rating Inventory of Executive Function (BRIEF) did not differ between the groups, but post-intervention scores were significantly lower (more improved) for those in the CAPS group. These findings suggest that low verbal intelligence was associated with greater improvements in executive functioning following the CAPS intervention and that verbal intelligence may have an important role in response to intervention for TBI. Understanding predictors of responsiveness to interventions allows clinicians to tailor treatments to individuals, thus improving efficacy.	[Karver, Christine L.; Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Karver, Christine L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MI USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA		Karver, CL (corresponding author), Univ Cincinnati, Dept Psychol, 1 Edwards Ctr,ML 0376, Cincinnati, OH 45221 USA.	karvercl@mail.uc.edu	Stancin, Terry/L-7993-2019		National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; University of Cincinnati, University Research Counsel; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (a) grant R01-MH073764 from the National Institute of Mental Health, (b) a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program, and (c) the University of Cincinnati, University Research Counsel. The authors wish to acknowledge the contributions of Kendra McMullen, Robert Blaha, Elizabeth Hagesfeld, Michelle Jacobs, Daniel Maier, and Nina Fox in data collection and entry and John Stullenberger in Web site support. We would also like to acknowledge the contributions of the therapists JoAnne Carey, PsyD, Britt Nielsen, PsyD, and Brad Jackson, PhD.	Achenbach T. M., 2001, CHILD BEHAV CHECKLIS; Achenbach TM., 2000, CHILD BEHAV CHECKLIS; Allison P, 1999, LOGISTIC REGRESSION; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Baum KT, 2010, EPILEPSY BEHAV, V17, P467, DOI 10.1016/j.yebeh.2010.01.010; Bierman KL, 2008, CHILD DEV, V79, P1802, DOI 10.1111/j.1467-8624.2008.01227.x; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hinshaw SP, 2007, AMBUL PEDIATR, V7, P91, DOI 10.1016/j.ambp.2006.04.012; Hodges K, 1999, USE PSYCHOL TESTING; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McLaughlin K., J HEAD TRAU IN PRESS; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Staff RT, 2004, BRAIN, V127, P1191, DOI 10.1093/brain/awh144; Stern RA, 1996, ARCH NEUROL-CHICAGO, V53, P148, DOI 10.1001/archneur.1996.00550020052015; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Taylor H. G., J HEAD TRAU IN PRESS; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Verger K, 2001, BRAIN INJURY, V15, P211; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	58	13	13	0	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAY 4	2014	20	3					343	357		10.1080/09297049.2013.796918			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AF8VJ	WOS:000334993400006	23710617	Green Accepted			2022-02-06	
J	Bailey, NW; Segrave, RA; Hoy, KE; Maller, JJ; Fitzgerald, PB				Bailey, Neil W.; Segrave, Rebecca A.; Hoy, Kate E.; Maller, Jerome J.; Fitzgerald, Paul B.			Impaired upper alpha synchronisation during working memory retention in depression and depression following traumatic brain injury	BIOLOGICAL PSYCHOLOGY			English	Article						Traumatic brain injury; Major depression; Working memory; EEG; Alpha	MAJOR DEPRESSION; EEG; INHIBITION	Rates of major depressive disorder (MDD) following traumatic brain injury (TBI) are higher than in the general population. Individuals with depression following traumatic brain injury (TBI-MDD) exhibit working memory (WM) impairments. Electrophysiological evidence has suggested that parieto-occipital upper alpha synchronisation may enhance WM retention by inhibiting irrelevant processes. The current research assessed whether retention period WM parieto-occipital upper alpha activity is disrupted in groups with TBI-only (N = 20), MDD (N = 17), and TBI-MDD (N = 15) compared to healthy controls (N = 31). Behavioural data indicated poorer performance in MDD and TBI-MDD. Parietal-occipital upper alpha was reduced in the MDD and TBI-MDD groups, but was unaffected in TBI-only. These results suggest inhibitory deficits may account for WM impairments in MDD and TBI-MDD, and that for individuals with TBI-MDD it may be the depression rather than the TBI that impairs WM. (C) 2014 Elsevier B.V. All rights reserved.	Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia		Bailey, NW (corresponding author), Monash Alfred Psychiat Res Ctr, Level 4,607 St Kilda Rd, Melbourne, Vic 3004, Australia.	neilwbailey@gmail.com	Fitzgerald, Paul B/A-1225-2008; Maller, Jerome J/H-4963-2014; Bailey, Neil/AAB-2741-2021; Segrave, Rebecca/H-4554-2014	Fitzgerald, Paul B/0000-0003-4217-8096; Maller, Jerome J/0000-0003-4685-1508; Segrave, Rebecca/0000-0002-1839-0794; Bailey, Neil/0000-0002-8483-1068; Hoy, Kate/0000-0003-0694-9674	Monash UniversityMonash University; Victorian Neurotrauma Initiative; Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia; NHMRC CDF FellowshipNational Health and Medical Research Council of Australia	Funding for this study was provided by Monash University and the Victorian Neurotrauma Initiative. Equipment funding was provided in part by the Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform. PBF is supported by a Practitioner Fellowship grant from the National Health and Medical Research Council (NHMRC). RAS and KEH are supported by Post Doctoral Training Fellowships from NHMRC. JJM is supported by an NHMRC CDF Fellowship.	ANDREW C, 1999, HANDB EL CL, V6, P119; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; CORSICABRERA M, 1993, INT J NEUROSCI, V72, P257, DOI 10.3109/00207459309024114; Croft RJ, 2000, CLIN NEUROPHYSIOL, V111, P444, DOI 10.1016/S1388-2457(99)00296-5; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lau MA, 2007, PSYCHOL MED, V37, P1249, DOI 10.1017/S0033291707000530; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Segrave RA, 2011, CLIN EEG NEUROSCI, V42, P45, DOI 10.1177/155005941104200110; Segrave RA, 2010, J AFFECT DISORDERS, V127, P191, DOI 10.1016/j.jad.2010.05.022; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; WechslerD, 2001, WECHSLER TEST ADULT; World Health Organization, 2001, WORLD HLTH REP 2001	36	13	13	2	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	MAY	2014	99						115	124		10.1016/j.biopsycho.2014.03.008			10	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	AH2CQ	WOS:000335928700013	24686072				2022-02-06	
J	Crutcher, CL; Ugiliweneza, B; Hodes, JE; Kong, MY; Boakye, M				Crutcher, Clifford L., II; Ugiliweneza, Beatrice; Hodes, Jonathan E.; Kong, Maiying; Boakye, Maxwell			Alcohol Intoxication and Its Effects on Traumatic Spinal Cord Injury Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						intoxication; alcohol; traumatic spinal cord injury; outcomes; acute	DEEP VENOUS THROMBOSIS; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; RISK; EPIDEMIOLOGY; PREDICTORS	There are sparse data regarding the impact of alcohol on in-hospital complications associated with traumatic spinal cord injuries (TSCIs). We set out to quantify the impact of alcohol on TSCI outcomes and its influence on health care cost and utilization. The National Trauma Data Bank (NTDB) Research Data Set version 7.2 (2000-2006) was utilized to gather data between 2007 and 2009. We extracted cases of TSCI (International Classification of Diseases, Ninth Revision, Clinical Modification codes 806.xx) without concurrent traumatic brain injury. Outcomes of interest were mortality, length of stay (LOS), intensive care unit (ICU) days, ventilator days, and complications. Continuous outcomes such as LOS, ICU days, and ventilator days were analyzed using linear regression. Risk-adjusted analysis of risk factors for mortality and complication rates were performed using multiple logistic regression. Of the 10,611 persons identified in the NTDB, alcohol was present in approximately one fifth of all cases (20.76%). A majority of TSCI patients were young (mean age, 39 years) Caucasian (65.07%) males (75.93%). Blunt injury was the most common mechanism of injury. The presence of alcohol did not significantly affect mortality or neurological complications. Alcohol in the blood was associated with extended LOS, longer ICU stays, more days spent ventilated, and increased risk of all-type complications. Further, there was a statistically significant association with the presence alcohol and increased risk for pulmonary, pneumonia, deep vein thrombosis and pulmonary embolism, urinary tract infection, and ulcer/skin complications. Alcohol intoxication is associated with increased in-hospital morbidity. The significant association with in-hospital complications increases health resource utilization after spinal cord injury.	[Crutcher, Clifford L., II] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr New Orleans, New Orleans, LA USA; [Ugiliweneza, Beatrice; Boakye, Maxwell] Univ Louisville, Dept Neurosurg, Louisville, KY 40202 USA; [Hodes, Jonathan E.] Baptist Hlth Ctr Adv Neurosurg, Louisville, KY USA; [Kong, Maiying] Univ Louisville, Dept Biostat & Bioinformat, Sch Publ Hlth & Informat Sci, Louisville, KY 40202 USA; [Boakye, Maxwell] Robley Rex Vet Affairs Med Ctr, Louisville, KY USA; [Boakye, Maxwell] Univ Louisville Phys, Louisville, KY USA		Boakye, M (corresponding author), Univ Louisville, Ctr Adv Neurosurg, Frazier Rehabil Inst, 220 Abraham Flexner Way,Suite 1105, Louisville, KY 40202 USA.	max.boakye@louisville.edu					Aito S, 2002, SPINAL CORD, V40, P300, DOI 10.1038/sj.sc.3101298; [Anonymous], 2007, NAT TRAUM DAT BANK V; Berlly M, 2007, J SPINAL CORD MED, V30, P309, DOI 10.1080/10790268.2007.11753946; Berry C, 2010, AM SURGEON, V76, P1067; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Clarke K, 2013, INT J QUAL HEALTH C, V25, P43, DOI 10.1093/intqhc/mzs077; Claxton AR, 1998, CAN J ANAESTH, V45, P144, DOI 10.1007/BF03013253; Curry K, 1992, J Neurosci Nurs, V24, P185; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Fayssoux RS, 2008, SPINE J, V8, P522, DOI 10.1016/j.spinee.2006.11.005; Frankel H, 2007, AM SURGEON, V73, P1215; Furlan JC, 2013, EUR J NEUROL, V20, P1101, DOI 10.1111/ene.12145; Gorman PH, 2009, J TRAUMA, V66, P707, DOI 10.1097/TA.0b013e318188beba; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Maxwell RA, 2002, J TRAUMA, V52, P902, DOI 10.1097/00005373-200205000-00013; NSCISC, 2012, SPIN CORD INJ FACTS; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Teasell RW, 2009, ARCH PHYS MED REHAB, V90, P232, DOI 10.1016/j.apmr.2008.09.557; Titsworth WL, 2012, J NEUROSURG, V116, P911, DOI 10.3171/2011.11.JNS11974; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	23	13	13	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2014	31	9					798	802		10.1089/neu.2014.3329			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AF6TQ	WOS:000334847900002	24617326				2022-02-06	
J	Fletcher, EN; McKenzie, LB; Comstock, RD				Fletcher, Erica N.; McKenzie, Lara B.; Comstock, R. Dawn			Epidemiologic Comparison of Injured High School Basketball Athletes Reporting to Emergency Departments and the Athletic Training Setting	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; adolescents; assessment	STATES HIGH-SCHOOL; SPORTS-RELATED FRACTURES; UNITED-STATES; PARTICIPATION; CONCUSSIONS; CHILDREN	Context: Basketball is a popular US high school sport with more than 1 million participants annually. Objective: To compare patterns of athletes with basketball-related injuries presenting to US emergency departments from 2005 through 2010 and the high school athletic training setting from the 2005-2011 seasons. Design: Descriptive epidemiology study. Setting: Data from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission and the High School Reporting Information Online database. Main Outcome Measure(s): Complex sample weights were used to calculate national estimates of basketball-related injuries for comparison. Patients or Other Participants: Adolescents from 13 to 19 years of age treated in US emergency departments for basketball-related injuries and athletes from 13 to 19 years of age from schools participating in High School Reporting Information Online who were injured while playing basketball. Results: Nationally, an estimated 1 514 957 (95% confidence interval = 1 337 441, 1 692 474) athletes with basketball-related injuries reported to the emergency department and 1 064 551 (95% confidence interval = 1 055 482, 1 073 620) presented to the athletic training setting. Overall, the most frequent injuries seen in the emergency department were lacerations and fractures (injury proportion ratios [IPRs] = 3.45 and 1.72, respectively), whereas those seen in the athletic training setting were more commonly concussions and strains/sprains (IPRs = 2.23 and 1.19, respectively; all P values < .0001). Comparisons of body site and diagnosis combinations revealed additional differences. For example, athletes with lower leg fractures more often presented to the emergency department (IPR = 6.53), whereas those with hand fractures more frequently presented to the athletic training setting (IPR = 1.18; all P values < .0001). Conclusions: Patterns of injury differed among high school basketball players presenting for treatment in the emergency department and the athletic training setting. Understanding differences specific to clinical settings is crucial to grasping the full epidemiologic and clinical picture of sport-related injuries. Certified athletic trainers play an important role in identifying, assessing, and treating athletes with sport-related injuries who might otherwise present to clinical settings with higher costs, such as the emergency department.	[Fletcher, Erica N.; McKenzie, Lara B.; Comstock, R. Dawn] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] PIPER Program, Aurora, CO USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@NationwideChildrens.org		McKenzie, Lara/0000-0003-2889-0001	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025754] Funding Source: NIH RePORTER	The content of this report was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and by award number KL2 RR025754 from the National Center for Research Resources. Funding was also provided by the National Federation of State High School Associations, National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack.	Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harrison PA, 2003, J SCHOOL HEALTH, V73, P113, DOI 10.1111/j.1746-1561.2003.tb03585.x; Hyman JE, 2011, J PEDIATR ORTHOPED, V31, P113, DOI 10.1097/BPO.0b013e3182093f8b; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Kowalczyk L, BOSTON GLOBE; Lawson BR, 2009, PEDIATRICS, V123, pE1028, DOI 10.1542/peds.2007-3796; Lyznicki JM, 1999, J ATHL TRAINING, V34, P272; McCabe JB, 2001, ACAD MED, V76, P672, DOI 10.1097/00001888-200107000-00005; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moskop John C, 2010, Virtual Mentor, V12, P476, DOI 10.1001/virtualmentor.2010.12.6.pfor1-1006; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; National Athletic Trainers Association, 2004, APPR MED CAR SEC SCH; National Athletic Trainers' Association, NATA STUD FINDS HEAD; National Federation of State High School Associations, PART STAT BASK; National Federation of State High School Associations, PART DAT; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Pitts SR, 2008, NATL HLTH STAT REPOR, V7, P1; Powell JW, 1999, J ATHL TRAINING, V34, P277; Randazzo C, 2010, PEDIATRICS, V126, P727, DOI 10.1542/peds.2009-2497; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; United States Census Bureau, CENS REG DIV US; US Bureau of the Census, US RES POP AG SEX; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Wham George, 2008, J S C Med Assoc, V104, P91; Wham GS, 2010, J ATHL TRAINING, V45, P75, DOI 10.4085/1062-6050-45.1.75; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; [No title captured]	33	13	13	1	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2014	49	3					381	388		10.4085/1062-6050-49.3.09			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AQ4LJ	WOS:000342768200014	24758246	Green Published			2022-02-06	
J	Guo, JD; Li, L; Shi, YM; Wang, HD; Yuan, YL; Shi, XX; Hou, SX				Guo, Ji-Dong; Li, Li; Shi, Ya-min; Wang, Hua-Dong; Yuan, Yan-Li; Shi, Xiu-Xiu; Hou, Shu-Xun			Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Spinal cord injury; Receptor for advanced glycation end products; Apoptosis; Inflammation; Oxidative stress; Nitrosative stress	TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; NITRIC-OXIDE; APOPTOSIS; EXPRESSION; RATS; PEROXYNITRITE; INFILTRATION; CONTUSION	Spinal cord injury (SCI) results in a loss of normal motor and sensory function, leading to severe disability and reduced quality of life. The aim of this work was to investigate the effect of receptor for advanced glycation end products (RAGE) deficiency on the function recovery in a mouse model of SCI. Mice received a mid-thoracic spinal contusion injury. Upregulation of RAGE protein expression in spinal cord tissue was evident at 12 h after SCI and continued at 2 and 5 days. Furthermore, we showed that locomotor recovery was improved and lesion pathology was reduced after SCI in RAGE-deficient mice. RAGE deficiency in mice attenuated apoptosis after SCI through inhibiting p53/Bax/caspase-3 pathway. RAGE deficiency in mice inhibited inflammation after SCI, marked by reduced myeloperoxidase activity, NF kappa B nuclear translocation, and TNF-alpha, IL-1 beta, and IL-6 mRNA and protein levels. RAGE deficiency in mice exposed to SCI suppressed the upregulation of inducible nitric oxide synthase (iNOS) and gp91-phox and attenuated oxidative and nitrosative stresses, marked by reduced formation of malondialdehyde, reactive oxygen species, peroxynitrite (OONO-), and 3-nitrotyrosine. RAGE deficiency in mice exposed to SCI attenuated glial scar at the injury site, marked by decreased expression of glial fibrillary acidic protein. These data indicate that the RAGE plays an important role in the development of SCI and might provide a therapeutic target to promote recovery from SCI.	[Guo, Ji-Dong; Li, Li; Shi, Ya-min; Wang, Hua-Dong; Yuan, Yan-Li; Shi, Xiu-Xiu; Hou, Shu-Xun] Peoples Liberat Army, Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China		Hou, SX (corresponding author), Peoples Liberat Army, Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing 100048, Peoples R China.	houshuxun2012@hotmail.com					ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bracchi-Ricard V, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-92; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Han X, 2012, NEUROSCI LETT, V511, P28, DOI 10.1016/j.neulet.2012.01.030; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kamide T, 2012, NEUROCHEM INT, V60, P220, DOI 10.1016/j.neuint.2011.12.008; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Leal-Filho Manoel Baldoino, 2011, Surg Neurol Int, V2, P112, DOI 10.4103/2152-7806.83732; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Tang SC, 2013, ARTERIOSCL THROM VAS, V33, P585, DOI 10.1161/ATVBAHA.112.300523; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184	42	13	14	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2014	390	1-2					215	223		10.1007/s11010-014-1972-z			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	AE8RA	WOS:000334267800023	24526523				2022-02-06	
J	Kumar, A; Rinwa, P; Dhar, H				Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh			Possible nitric oxide modulation in the protective effects of rutin against experimental head trauma-induced cognitive deficits: behavioral, biochemical, and molecular correlates	JOURNAL OF SURGICAL RESEARCH			English	Article						Apoptosis; Cognitive dysfunction; Head trauma; Neuroinflammation; Nitric oxide	BRAIN-INJURY; OXIDATIVE STRESS; MEMORY IMPAIRMENT; NERVOUS-SYSTEM; IMMATURE RATS; PLUS-MAZE; DAMAGE; MECHANISMS; MODEL; QUERCETIN	Background: Traumatic head injury is turning out to be a major cause of disability and death. Nitric oxide (NO), an intercellular messenger plays a crucial role in the pathophysiology of several neurologic disorders. Therefore, the present study was designed to investigate the effects of rutin, a well-known flavonoid against cognitive deficits and neuroinflammation associated with traumatic head injury and the probable role of NO pathway in this effect. Materials and methods: Wistar rats were exposed to head trauma using weight drop method and kept for a postsurgical rehabilitation period of 2 wk. Later, animals were administered with rutin (20, 40, and 80 mg/kg; per oral) alone and in combination with NO modulators such as NG-nitro-L-arginine methyl ester and L-arginine, daily for another 2 wk. Results: Head injury caused impaired spatial navigation in Morris water maze test and poor retention in elevated plus maze task. Furthermore, there was a significant rise in acetylcholinesterase activity, oxidative stress, neuroinflammation (tumor necrosis factor a), and neuronal apoptosis (caspase-3) in both cortex and hippocampal regions of traumatized rat brain. Rutin significantly attenuated these behavioral, biochemical, and molecular alterations associated with head trauma. Furthermore, pretreatment of NG-nitro-L-arginine methyl ester (10 mg/kg, intraperitoneally), a nonspecific nitric oxide synthase inhibitor, with subeffective dose of rutin (40 mg/kg) potentiated the protective effects; however, pretreatment of L-arginine (100 mg/kg; intraperitoneally), an NO donor, reversed the effects of rutin. Conclusions: The present study suggests that NO modulation could possibly be involved in the neuroprotective effects of rutin against head trauma-induced cognitive deficits, neuroinflammation, and apoptotic signaling cascade. (C) 2014 Elsevier Inc. All rights reserved.	[Kumar, Anil; Rinwa, Puneet; Dhar, Hitesh] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India		Kumar, A (corresponding author), Panjab Univ, Pharmacol Res Lab, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India.	kumaruips@rediffmail.com	KUMAR, ANIL -/D-7471-2011	KUMAR, ANIL -/0000-0002-9506-6197	Council of Scientific and Industrial Research (CSIR), New DelhiCouncil of Scientific & Industrial Research (CSIR) - India	The authors gratefully acknowledge the financial support of Council of Scientific and Industrial Research (CSIR), New Delhi for carrying out this work. Authors would like to thank Dr Thirunavukkarasu Angappan, Deputy General Manager, Panacea Biotec Ltd, Lalru for the supply of experimental animals.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Cahuana GM, 2004, EXP CELL RES, V293, P22, DOI 10.1016/j.yexcr.2003.10.004; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; Da Cunha IC, 2005, PHYSIOL BEHAV, V84, P351, DOI 10.1016/j.physbeh.2004.12.005; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Javadi-Paydar M, 2013, BEHAV PHARMACOL, V24, P195, DOI 10.1097/FBP.0b013e3283618a8c; Javed H, 2012, NEUROSCIENCE, V210, P340, DOI 10.1016/j.neuroscience.2012.02.046; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Kamalakkannan N, 2006, MOL CELL BIOCHEM, V293, P211, DOI 10.1007/s11010-006-9244-1; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Kim H, 2005, PHARM RES-DORDR, V22, P1499, DOI 10.1007/s11095-005-6250-z; Koda T, 2009, CELL MOL NEUROBIOL, V29, P523, DOI 10.1007/s10571-008-9344-4; Koppal T, 1999, J NEUROCHEM, V72, P310, DOI 10.1046/j.1471-4159.1999.0720310.x; Kumar A, 2007, J MED FOOD, V10, P486, DOI 10.1089/jmf.2006.076; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; Luck H., 1971, CATALASE METHODS ENZ, P885; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marzouk MS, 2007, NAT PROD RES, V21, P436, DOI 10.1080/14786410600943288; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mellou F, 2006, PROCESS BIOCHEM, V41, P2029, DOI 10.1016/j.procbio.2006.05.002; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nassiri-Asl M, 2008, PROG NEURO-PSYCHOPH, V32, P989, DOI 10.1016/j.pnpbp.2008.01.011; Nassiri-Asl M, 2010, PROG NEURO-PSYCHOPH, V34, P204, DOI 10.1016/j.pnpbp.2009.11.006; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pall ML, 2000, MED HYPOTHESES, V54, P115, DOI 10.1054/mehy.1998.0825; Palumbo A, 2000, J BIOL CHEM, V275, P16885, DOI 10.1074/jbc.M909509199; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Pu FL, 2005, J HEALTH SCI, V51, P636, DOI 10.1248/jhs.51.636; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; SHARMA AC, 1992, PROG NEURO-PSYCHOPH, V16, P117, DOI 10.1016/0278-5846(92)90014-6; Sheu JR, 2004, J AGR FOOD CHEM, V52, P4414, DOI 10.1021/jf040059f; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Virarkar M, 2013, CRIT REV FOOD SCI, V53, P1157, DOI 10.1080/10408398.2011.573885; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Yamada K, 1996, NEUROSCIENCE, V74, P365, DOI 10.1016/0306-4522(96)00161-3; Yang YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/980276; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	57	13	13	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY	2014	188	1					268	279		10.1016/j.jss.2013.12.028			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AE4RS	WOS:000333971300034	24484907				2022-02-06	
J	Olson-Madden, JH; Homaifar, BY; Hostetter, TA; Matarazzo, BB; Huggins, J; Forster, JE; Schneider, AL; Nagamoto, HT; Corrigan, JD; Brenner, LA				Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Hostetter, Trisha A.; Matarazzo, Bridget B.; Huggins, Joe; Forster, Jeri E.; Schneider, Alexandra L.; Nagamoto, Herbert T.; Corrigan, John D.; Brenner, Lisa A.			Validating the Traumatic Brain Injury-4 Screening Measure for Veterans Seeking Mental Health Treatment With Psychiatric Inpatient and Outpatient Service Utilization Data	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Hospitalization; Mental health; Rehabilitation; Utilization [subheading]	IDENTIFICATION; PREDICTORS; TBI	Objective: To determine whether a positive screen on the Traumatic Brain Injury-4 (TBI-4) can be used to identify veterans who use more inpatient and outpatient mental health services. Design: Validation cohort. Setting: Medical center. Participants: Individuals seeking Veterans Health Administration mental health services (N=1493). Interventions: Not applicable. Main Outcome Measures: One year of inpatient and outpatient mental health utilization data after the TBI-4 screen date. Results: In the year postmental health intake, those who answered positively to any of the 4 TBI-4 screening questions (criterion 1) or question 2 (criterion 2; ever having been knocked out) had significantly more psychiatric hospitalizations than those who met neither criterion. Those who were positive by criterion 2 also had significantly fewer outpatient mental health contacts. Conclusions: Veterans screening positive for history of traumatic brain injury on the TBI-4 had more hospital stays in the year postmental health intake. Those who reported having been knocked out also had fewer outpatient mental health visits. These findings may suggest an overall relation in this population between greater needs for mental health care and likelihood of prior injury. For those with a history of loss of consciousness, the reduced use of outpatient care may reflect greater problems engaging in treatment or with preventive aspects of the health care system during non-crisis periods. Using a screener (eg, the TBI-4) could facilitate identification of veterans who might benefit from targeted and intensive outpatient interventions to avoid frequent inpatient psychiatric hospitalization. (C) 2014 by the American Congress of Rehabilitation Medicine	[Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Hostetter, Trisha A.; Matarazzo, Bridget B.; Huggins, Joe; Forster, Jeri E.; Schneider, Alexandra L.; Brenner, Lisa A.] Vet Affairs Eastern Colorado Hlth Care Syst, Educ & Clin Ctr, VISN Mental Illness Res 19, Denver, CO 80220 USA; [Olson-Madden, Jennifer H.; Homaifar, Beeta Y.; Matarazzo, Bridget B.; Nagamoto, Herbert T.; Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Aurora, CO USA; [Forster, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Nagamoto, Herbert T.] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Rehabil & Neurol, Aurora, CO USA		Olson-Madden, JH (corresponding author), Vet Affairs Eastern Colorado Hlth Care Syst, Educ & Clin Ctr, VISN Mental Illness Res 19, 1055 Clermont St, Denver, CO 80220 USA.	Jennifer.Olson-Madden@va.gov	Brenner, Lisa A./AAG-2442-2019	Huggins, Joe/0000-0001-8151-5062	Colorado Traumatic Brain Injury Trust Fund Program; VISN 19 Mental Illness Research, Education and Clinical Center	Supported by the Colorado Traumatic Brain Injury Trust Fund Program and the VISN 19 Mental Illness Research, Education and Clinical Center.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Centers for Disease Control and Prevention, FASTSTATS; Corrigan JD, 2007, OHIO STATE U TBI IDE; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Klinkenberg WD, 1998, ADM POLICY MENT HLTH, V25, P403, DOI 10.1023/A:1022292407868; Lien L, 2002, NORD J PSYCHIAT, V56, P23, DOI 10.1080/08039480252803873; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002	14	13	13	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2014	95	5					925	929		10.1016/j.apmr.2014.01.008			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AG3CW	WOS:000335294400018	24480334				2022-02-06	
J	Schaefer, JH; Leung, WD; Wu, LM; Van Cott, EM; Lok, J; Whalen, M; van Leyen, K; Lauer, A; van Ryn, J; Lo, EH; Foerch, C				Schaefer, Jan Hendrik; Leung, Wendy; Wu, Limin; Van Cott, Elizabeth M.; Lok, Josephine; Whalen, Michael; van Leyen, Klaus; Lauer, Arne; van Ryn, Joanne; Lo, Eng H.; Foerch, Christian			Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						anticoagulation; dabigatran; intracerebral hemorrhage; novel oral anticoagulants; traumatic brain injury; warfarin	THROMBIN INHIBITOR DABIGATRAN; RE-LY TRIAL; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; FACTOR-XA INHIBITORS; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; ORAL THROMBIN; MICE; COMPLICATIONS; MANAGEMENT	To date, only limited data are available on the effects of pretreatment with novel oral anticoagulants in the event of traumatic brain injury (TBI). We determined intracerebral hemorrhage volume and functional outcome in a standardized TBI model in mice treated with warfarin or dabigatran. Additionally, we investigated whether excess concentrations of dabigatran could increase bleeding and whether this was preventable by using prothrombin complex concentrate (PCC). C57 mice were treated orally with warfarin or dabigatran; sham-treated mice served as controls. Effective anticoagulation was verified by measurement of international normalized ratio and diluted thrombin time, and TBI was induced by controlled cortical impact (CCI). Twenty-four hours after CCI, intracerebral hemorrhage volume was larger in warfarin-pretreated mice than in controls (10.1 +/- 4.9 vs 4.1 +/- 1.7 mu L; analysis of variance post hoc P=0.001), but no difference was found between controls and dabigatran-pretreated mice (5.3 +/- 1.5 mu L). PCC applied 30 minutes after CCI did not reliably reduce intracerebral hemorrhage induced by excess dabigatran concentration compared with saline (10.4 +/- 11.2 vs 8.7 +/- 7.1 mu L). Our data suggest pathophysiological differences in TBI occurring during warfarin and dabigatran anticoagulation. The reduced hemorrhage formation under dabigatran therapy could present a safety advantage compared with warfarin. An excess dabigatran concentration, however, can increase hemorrhage.	[Schaefer, Jan Hendrik; Lauer, Arne; Foerch, Christian] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; [Schaefer, Jan Hendrik; Leung, Wendy; Wu, Limin; Lok, Josephine; van Leyen, Klaus; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA USA; [Wu, Limin] Jilin Univ, Bethune Hosp 1, Dept Neurol, Changchun 130023, Peoples R China; [Van Cott, Elizabeth M.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lok, Josephine; Whalen, Michael] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Whalen, Michael] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci, Boston, MA USA; [van Ryn, Joanne] Boehringer Ingelheim GmbH & Co KG, CardioMetab Dis Res, Biberach, Germany		Schaefer, JH (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	jhs@stud.uni-frankfurt.de	van Leyen, Klaus/C-9126-2013	van Leyen, Klaus/0000-0003-1032-3754; /0000-0002-9465-3533	Boehringer IngelheimBoehringer Ingelheim; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055104, R01NS049430, R01NS076694, R37NS037074, K08NS057339] Funding Source: NIH RePORTER	This study was supported by Boehringer Ingelheim with a restricted grant.	Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Chen BC, 2012, CLIN TOXICOL, V50, P854, DOI 10.3109/15563650.2012.721888; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Foerch C, 2012, J NEUROTRAUM, V29, P1150, DOI 10.1089/neu.2011.2104; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Lauer A, 2013, LANCET NEUROL, V12, P394, DOI 10.1016/S1474-4422(13)70049-8; Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Love JE, 2007, THROMB HAEMOSTASIS, V98, P234, DOI 10.1160/TH06-10-0607; PARRA MW, 2013, J NEUROSURG, P1; Pernod G, 2013, ARCH CARDIOVASC DIS, V106, P382, DOI 10.1016/j.acvd.2013.04.009; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Pragst I, 2012, J THROMB HAEMOST, V10, P1841, DOI 10.1111/j.1538-7836.2012.04859.x; Stangier J, 2010, CLIN PHARMACOKINET, V49, P259, DOI 10.2165/11318170-000000000-00000; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f; Weitz JI, 2012, CIRCULATION, V126, P2428, DOI 10.1161/CIRCULATIONAHA.112.123224; Zhou W, 2011, STROKE, V42, P3594, DOI 10.1161/STROKEAHA.111.624650	25	13	13	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2014	34	5					870	875		10.1038/jcbfm.2014.31			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AG5AE	WOS:000335430700018	24549187	Bronze, Green Published			2022-02-06	
J	Yildirim, AO; Eryilmaz, M; Kaldirim, U; Eyi, YE; Tuncer, SK; Eroglu, M; Durusu, M; Topal, T; Kurt, B; Dilmen, S; Bilgic, S; Serdar, M				Yildirim, Ali Osman; Eryilmaz, Mehmet; Kaldirim, Umit; Eyi, Yusuf Emrah; Tuncer, Salim Kemal; Eroglu, Murat; Durusu, Murat; Topal, Turgut; Kurt, Bulent; Dilmen, Serkan; Bilgic, Serkan; Serdar, Muhittin			Effectiveness of hyperbaric oxygen and ozone applications in tissue healing in generated soft tissue trauma model in rats: an experimental study	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Experimental; hyperbaric oxygen; ozone; soft tissue trauma	BRAIN-INJURY; INTERMITTENT; EXPOSURE; THERAPY; HEME; PAIN	BACKGROUND: Soft tissue trauma is a type of acute traumatic ischemia. We investigated in this study whether the edema, inflammation and ischemia caused by the trauma could be affected positively by hyperbaric oxygen (HBO) and ozone therapy. METHODS: Soft tissue trauma was generated in a total of 63 adult male Sprague-Dawley rats. Subsequently, rats were divided into three groups. The first group was treated with ozone, the second group with HBO, and the third group served as controls. Tissue and blood samples were taken at the end of the procedures. Tissue lipid peroxidation (LPO), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), inducible nitric oxide synthase (iNOS), heme oxygenase (HO)-I, and hypoxia-inducible factor (HIF)-I levels were detected. Hematoxylin-eosin staining was used to determine the inflammation and edema histopathologically. RESULTS: We also detected HIF-I activity, which decreases when the oxygen concentration increases, HO-I activity, which has anti-inflammatory effects, and iNOS activity, which releases in any type of acute case. We determined a statistically significant reduction in iNOS and LPO levels in both the HBO and Ozone groups. A significant decrease in inflammation was detected in both the Ozone and HBO groups compared with the Control group, and a significant decrease in edema was detected in all three groups. CONCLUSION: We think that HBO and Ozone therapy have beneficial effects on biochemical and histopathological findings. Related clinical trials will be helpful in clarifying the effects.	[Yildirim, Ali Osman; Eroglu, Murat] Haydarpasa Mil Hosital, GATA, Dept Emergency Med, Istanbul, Turkey; [Eryilmaz, Mehmet; Kaldirim, Umit; Tuncer, Salim Kemal; Durusu, Murat] GATA Sch Med, Dept Emergency Med, Ankara, Turkey; [Eyi, Yusuf Emrah] Hakkari Mil Hosp, Dept Emergency Med, Hakkari, Turkey; [Topal, Turgut] GATA Sch Med, Dept Physiol, Ankara, Turkey; [Kurt, Bulent] GATA Sch Med, Dept Pathol, Ankara, Turkey; [Dilmen, Serkan] Elazig Mil Hosp, Dept Emergency Med, Elazig, Turkey; [Bilgic, Serkan] Haydarpasa Mil Hosital, GATA, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Serdar, Muhittin] GATA Sch Med, Dept Biochem, Ankara, Turkey		Yildirim, AO (corresponding author), GATA Haydarpasa Hastanesi, Acil Tip Anabilim Dali, Istanbul, Turkey.	draliosmanyildirim@gmail.com	SERDAR, Muhittin A./D-2493-2015	SERDAR, Muhittin A./0000-0002-3014-748X; ERYILMAZ, MEHMET/0000-0003-0551-1136			ALBERTS B, 2002, MOL BIOL CELL, P1259; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Bennett MH, 2009, COCHRANE DB SYST REV; Bocci V, 2007, BRIT J BIOMED SCI, V64, P44, DOI 10.1080/09674845.2007.11732755; Bocci V, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/26785; Bocci Velio, 2005, P1; Bywaters EGL, 1998, J AM SOC NEPHROL, V9, P322; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Communal C, 2002, P NATL ACAD SCI USA, V99, P6252, DOI 10.1073/pnas.092022999; Davies SL, 2005, J NEUROSCI METH, V148, P161, DOI 10.1016/j.jneumeth.2005.04.020; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FELDMEIER JJ, 2003, INDICATIONS RESULTS; Germain G, 2003, UNDERSEA HYPERBAR M, V30, P135; HARABIN AL, 1990, J APPL PHYSIOL, V69, P328, DOI 10.1152/jappl.1990.69.1.328; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Horvath I, 1998, THORAX, V53, P867, DOI 10.1136/thx.53.10.867; Kim HS, 2009, J KOREAN MED SCI, V24, P368, DOI 10.3346/jkms.2009.24.3.368; Koca K, 2010, J SURG RES, V164, pE83, DOI 10.1016/j.jss.2010.06.030; Kranke P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004123.pub3; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; Mabvuure Nigel Tapiwa, 2012, Open Orthop J, V6, P535, DOI 10.2174/1874325001206010535; Martinez-Sanchez G, 2005, EUR J PHARMACOL, V523, P151, DOI 10.1016/j.ejphar.2005.08.020; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; Muto M, 2008, RADIOL MED, V113, P695, DOI 10.1007/s11547-008-0302-5; Nogales Carlos Goes, 2008, J Contemp Dent Pract, V9, P75; Oter S, 2005, CLIN BIOCHEM, V38, P706, DOI 10.1016/j.clinbiochem.2005.04.005; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; SOOLSMA S, 1996, THESIS U BRIT COLUMB; Staples JR, 1999, AM J SPORT MED, V27, P600, DOI 10.1177/03635465990270050901; Stubinger S, 2006, QUINTESSENCE INT, V37, P353; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Yucesir I, 2010, TURKIYE KLIN J ORTHO, V3, P24	33	13	13	0	9	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2014	20	3					167	175		10.5505/tjtes.2014.09465			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AI8KU	WOS:000337163600003	24936837	Bronze			2022-02-06	
J	Narotam, PK; Morrison, JF; Schmidt, MD; Nathoo, N				Narotam, Pradeep K.; Morrison, John F.; Schmidt, Michael D.; Nathoo, Narendra			Physiological Complexity of Acute Traumatic Brain Injury in Patients Treated with a Brain Oxygen Protocol: Utility of Symbolic Regression in Predictive Modeling of a Dynamical System	JOURNAL OF NEUROTRAUMA			English	Article						intracranial pressure, symbolic regression in biologic systems; brain oxygen; complexity science; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; MAXIMUM-ENTROPY PRODUCTION; TISSUE OXYGEN; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; LUNG INJURY; REGIONAL OXYGENATION; CLINICAL ARTICLE; INSPIRED OXYGEN	Predictive modeling of emergent behavior, inherent to complex physiological systems, requires the analysis of large complex clinical data streams currently being generated in the intensive care unit. Brain tissue oxygen protocols have yielded outcome benefits in traumatic brain injury (TBI), but the critical physiological thresholds for low brain oxygen have not been established for a dynamical patho-physiological system. High frequency, multi-modal clinical data sets from 29 patients with severe TBI who underwent multi-modality neuro-clinical care monitoring and treatment with a brain oxygen protocol were analyzed. The inter-relationship between acute physiological parameters was determined using symbolic regression (SR) as the computational framework. The mean patient age was 44.4 +/- 15 with a mean admission GCS of 6.6 +/- 3.9. Sixty-three percent sustained motor vehicle accidents and the most common pathology was intra-cerebral hemorrhage (50%). Hospital discharge mortality was 21%, poor outcome occurred in 24% of patients, and good outcome occurred in 56% of patients. Criticality for low brain oxygen was intracranial pressure (ICP) >= 22.8 mm Hg, for mortality at ICP >= 37.1 mm Hg. The upper therapeutic threshold for cerebral perfusion pressure (CPP) was 75 mm Hg. Eubaric hyperoxia significantly impacted partial pressure of oxygen in brain tissue (PbtO(2)) at all ICP levels. Optimal brain temperature (T-br) was 34-35 degrees C, with an adverse effect when T-br >= 38 degrees C. Survivors clustered at \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm PbtO}_2\, \cong\, 25 { \rm mm}$$\end{document} Hg vs. non-survivors \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$$\cong $$\end{document} 18 mm Hg. There were two mortality clusters for ICP: High ICP/low PbtO(2) and low ICP/low PbtO(2). Survivors maintained PbtO(2) at all ranges of mean arterial pressure in contrast to non-survivors. The final SR equation for cerebral oxygenation is: \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$$PbtO_ {2} = 6.32774 + \cos ( - 12.9753*CPP ) + \frac {23.2796} {FiO_ {2}} - 1.32622*ICP$$\end{document}. The SR-model of acute TBI advances new physiological thresholds or boundary conditions for acute TBI management: PbtO(2)>= 25 mmHg; ICP <= 22 mmHg; CPP approximate to 60-75 mmHg; and T-br approximate to 34-37 degrees C. SR is congruous with the emerging field of complexity science in the modeling of dynamical physiological systems, especially during pathophysiological states. The SR model of TBI is generalizable to known physical laws. This increase in entropy reduces uncertainty and improves predictive capacity. SR is an appropriate computational framework to enable future smart monitoring devices.	[Narotam, Pradeep K.] Union Hosp Neurosci, Terre Haute, IN 47807 USA; [Morrison, John F.] Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Schmidt, Michael D.] Nutonian Inc, Cambridge, MA USA; [Schmidt, Michael D.] Cornell Univ, Fac Engn & Comp Sci, Ithaca, NY USA; [Nathoo, Narendra] Med Ctr, Bowling Green, KY USA; [Narotam, Pradeep K.; Morrison, John F.; Nathoo, Narendra] Creighton Univ, Med Ctr, Div Neurosurg, Omaha, NE USA		Narotam, PK (corresponding author), Union Hosp Neurosci, 1530 N 7th St,500, Terre Haute, IN 47807 USA.	narotam@mac.com	Viani, Rafael/V-1196-2018				Al-Rawi PG, 2000, ZBL NEUROCHIR, V61, P74, DOI 10.1055/s-2000-8263; Aldrich HE, 2008, J EVOL ECON, V18, P577, DOI 10.1007/s00191-008-0110-z; Anderson J. R., 1983, ARCHITECTURE COGNITI; Andrews P, 2003, BRIT J ANAESTH, V90, P251, DOI 10.1093/bja/aeg517; Andrews PJD, 2005, CRIT CARE, V9, P638, DOI 10.1186/cc3922; Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; [Anonymous], 2000, J Neurotrauma, V17, P471; Antoniewicz MR, 2006, METABOLOMICS, V2, P41, DOI 10.1007/s11306-006-0018-2; Bardt TF, 1998, ACT NEUR S, V71, P153; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; Bruzzone P, 1998, ACT NEUR S, V71, P111; Bullock MR, 2003, J NEUROSURG, V98, P943, DOI 10.3171/jns.2003.98.5.0943; Burggren WW, 2005, J EXP BIOL, V208, P3221, DOI 10.1242/jeb.01762; Carvalho C R, 1998, Curr Opin Pulm Med, V4, P300, DOI 10.1097/00063198-199809000-00010; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; CRUZ J, 1993, CRIT CARE MED, V21, P1242, DOI 10.1097/00003246-199308000-00027; DELOSSANTOS R, 1987, AM REV RESPIR DIS, V136, P657, DOI 10.1164/ajrccm/136.3.657; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; DEWAR RC, 2005, NONEQUILIBRIUM THERM; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Duffy J., 2002, EVOLUTIONARY COMPUTA, P461; Dyke J, 2010, ENTROPY-SWITZ, V12, P613, DOI 10.3390/e12030613; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Garat C, 1997, CHEST, V111, P1381, DOI 10.1378/chest.111.5.1381; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hii C., 2011, INT J MACH LEARN COM, V1, P30, DOI DOI 10.7763/IJMLC.2011.V1.5; Hodgson Geoffrey M., 2008, Journal of Bioeconomics, V10, P51, DOI 10.1007/s10818-008-9030-0; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Jenkinson S G, 1993, New Horiz, V1, P504; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Koza J. R., 1992, GENETIC PROGRAMMING, V1; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Longhi L, 2002, ACT NEUR S, V81, P315; Longhi Luca, 2004, Curr Opin Crit Care, V10, P105, DOI 10.1097/00075198-200404000-00005; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Manson SM, 2001, GEOFORUM, V32, P405, DOI 10.1016/S0016-7185(00)00035-X; MARSHALL LF, 1987, J NEUROSURG, V67, P952; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McKinley BA, 2002, J TRAUMA, V53, P825, DOI 10.1097/00005373-200211000-00004; McKinley Bruce A, 2003, Curr Opin Crit Care, V9, P292, DOI 10.1097/00075198-200308000-00007; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; NaderDjalal N, 1997, CHEST, V112, P1607, DOI 10.1378/chest.112.6.1607; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; POPPER KR, 1963, CONJECTURE REFUTATIO; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Rebitzer JB, 2008, ADV HEALTH ECON HEAL, V19, P43, DOI 10.1016/S0731-2199(08)19003-3; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; SMITH RA, 1990, CRIT CARE MED, V18, P198, DOI 10.1097/00003246-199002000-00014; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 1998, ACT NEUR S, V71, P162; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vanga S. R., 2013, AM J THER IN PRESS; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vath A, 2001, NEUROL RES, V23, P315, DOI 10.1179/016164101101198677; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Waite Gabi N, 2012, Biomed Sci Instrum, V48, P462; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9	90	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					630	641		10.1089/neu.2013.3104			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000004	24195645				2022-02-06	
J	Melo, JRT; Di Rocco, F; Bourgeois, M; Puget, S; Blauwblomme, T; Sainte-Rose, C; Meyer, PG; Zerah, M				Tude Melo, Jose Roberto; Di Rocco, Federico; Bourgeois, Marie; Puget, Stephanie; Blauwblomme, Thomas; Sainte-Rose, Christian; Meyer, Philippe G.; Zerah, Michel			Surgical options for treatment of traumatic subdural hematomas in children younger than 2 years of age	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						brain injury; craniocerebral trauma; surgical procedures; shaken baby syndrome; subdural hematoma; abusive head trauma	SHAKEN BABY SYNDROME; ABUSIVE HEAD TRAUMA; EARLY DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; PREDICTIVE FACTORS; INFANTS; MANAGEMENT; HEMORRHAGE; MORTALITY; DIAGNOSIS	Object. Subdural hematoma (SDH) is the most common finding on cranial CT in pediatric victims of abusive head trauma (AHT). The hematomas are commonly bilateral and sometimes associated with interhemispheric hyperdensity and/or convexity hemorrhages. There is no consensus regarding the best surgical treatment in such cases nor are there standardized surgical protocols. The authors report their experience and discuss the routine surgical options in the management of traumatic SDH at a Level 1 Pediatric Trauma Center. Methods. In this paper, the authors describe a cross-sectional study with consecutive revision of data described in the medical records of Hopital Universitaire Necker Enfants Malades between January 2008 and January 2013. During this period, all children younger than 2 years of age who were admitted with a traumatic SDH identified on CT scans were included in this study. Results. One hundred eighty-four children who had SDH and were younger than 2 years of age were included. Their median age was 5.8 months (range 5 days-23 months), and 70% of the children were male. On admission CT scans, the SDH was bilateral in 52% of cases and homogeneously hypodense in 77%. Neurosurgical treatment was undertaken in 111 children (60%) with an admission Glasgow Coma Scale score of 12 or less, bulging fontanels, or other signs suggestive of intracranial hypertension. The first surgical option was craniotomy in 1.8% (2) of these 111 cases, decompressive craniectomy in 1.8% (2), transcutaneous subdural puncture in 15% (17), external subdural drainage in 16% (18), subdural-subgaleal shunt placement in 17% (19), and subdural-peritoneal shunt placement in 48% (53). In 82% of the children initially treated with transcutaneous subdural puncture and in 50% of those treated with external subdural drainage, increase or persistence of the SDH, CSF or skin infection, or shunt system malfunction was observed and further surgical intervention was required. There was a 26% rate of complications in patients initially treated with a subdural-peritoneal shunt. Although 52% of the patients had bilateral SDH, bilateral drainage was only required in 9.4%. Conclusions. The choice of treatment should be determined by the clinical and radiological characteristics of the individual case. Although effective on an emergency basis, subdural puncture and external subdural drainage are frequently insufficient to obtain complete resolution of SDH, and temporary placement of a subdural-peritoneal shunt is needed in most cases.	[Tude Melo, Jose Roberto; Di Rocco, Federico; Bourgeois, Marie; Puget, Stephanie; Blauwblomme, Thomas; Sainte-Rose, Christian; Zerah, Michel] Hop Univ Necker Enfants Malad, AP HP, Dept Pediat Neurosurg, Paris, France; [Meyer, Philippe G.] Hop Univ Necker Enfants Malades, AP HP, Pediat Neurosurg Intens Care Unit, Paris, France; [Meyer, Philippe G.] Univ Paris 05, Paris, France; [Tude Melo, Jose Roberto] Hosp Pediat Martagao Gesteira Liga Alvaro Bahia C, Pediat Neurosurg Unit, Salvador, BA, Brazil		Melo, JRT (corresponding author), Rua Jose Duarte 114 CEP 40-000, Salvador, BA, Brazil.	robertotude@gmail.com	ZERAH, Michel/E-6473-2012; Meyer, Philippe/ABE-4242-2020; DI ROCCO, Federico/C-6343-2015	Meyer, Philippe/0000-0002-3829-6631; Di Rocco, Federico/0000-0003-2145-5533			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Galarza M, 2013, CHILD NERV SYST, V29, P973, DOI 10.1007/s00381-013-2051-6; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Jacobi G, 2010, DTSCH ARZTEBL INT, V107, P231, DOI 10.3238/arztebl.2010.0231; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kurschel S, 2007, J NEUROSURG, V106, P172, DOI 10.3171/ped.2007.106.3.172; Larionov SN, 2008, CHILD NERV SYST, V24, P437, DOI 10.1007/s00381-007-0496-1; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Paiva WS, 2011, ACTA MEDICA PORT, V 24, P805; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Sun DTF, 2006, CHILD NERV SYST, V22, P593, DOI 10.1007/s00381-006-0094-7; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Vinchon M, 2001, J NEUROSURG, V95, P249, DOI 10.3171/jns.2001.95.2.0249; Vinchon M, 2010, CHILD NERV SYST, V26, P755, DOI 10.1007/s00381-009-1047-8; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7	31	13	13	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2014	13	4					456	461		10.3171/2014.1.PEDS13393			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AD7IY	WOS:000333438700016	24559279				2022-02-06	
J	Sun, L; Qiang, R; Yang, Y; Jiang, ZL; Wang, GH; Zhao, GW; Ren, TJ; Jiang, R; Xu, LH				Sun, Li; Qiang, Ren; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua			L-Serine Treatment May Improve Neurorestoration of Rats after Permanent Focal Cerebral Ischemia Potentially Through Improvement of Neurorepair	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROMOTES NEURITE OUTGROWTH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TENASCIN-C; NEURONAL MIGRATION; NOGO-A; STROKE; MECHANISMS; GDNF	The present study was conducted to clarify whether treatment with L-serine can improve the brain repair and neurorestoration of rats after permanent middle cerebral artery occlusion (pMCAO). After pMCAO, the neurological functions, brain lesion volume, and cortical injury were determined. GDNF, NGF, NCAM L1, tenascin-C, and Nogo-A levels were measured. Proliferation and differentiation of the neural stem cells (NSCs) and proliferation of the microvessels in the ischemic boundary zone of the cortex were evaluated. Treatment with L-serine (168 mg/kg body weight, i.p.) began 3 h after pMCAO and was repeated every 12 h for 7 days or until the end of the experiment. L-Serine treatment: 1) reduced the lesion volume and neuronal loss; 2) improved the recovery of neurological functions; 3) elevated the expression of nerve growth-related factors; and 4) facilitated the proliferation of endogenous NSCs and microvessels activated after pMCAO and increased the number of new-born neurons. 5) D-cycloserine, an inhibitor of serine hydroxymethyltransferase, blunted the effects of L-serine on NSC proliferation, differentiation, microvascular proliferation. In conclusions, L-serine treatment in pMCAO rats can reduce brain injury and facilitate neurorestoration which is partly associated with the improvement of proliferation of NSCs and microvessels, reconstruction of neurovascular units and resultant neurorepair. The effects of L-serine on endogenous NSC proliferation and microvascular proliferation are partly mediated by the action of L-serine as a substrate for the production of one-carbon groups used for purine and pyrimidine synthesis and modulation of the expression of some nerve growth-related factors.	[Sun, Li; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua] Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp Nantong, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Jiang, Zheng-Lin; Zhao, Guang-Wei; Ren, Tao-Jie] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China		Yang, Y (corresponding author), Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China.	jsyangyao@126.com; jiangzl@ntu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000497, 81071614, 81372131]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bednar MM, 2012, NEUROL RES, V34, P129, DOI 10.1179/1743132811Y.0000000069; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Duan SR, 2010, NEUROL RES, V32, P835, DOI 10.1179/016164109X12581096870159; Duarte EP, 2012, GROWTH FACTORS, V30, P242, DOI 10.3109/08977194.2012.691478; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; He XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046223; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MANOHAR R, 1984, BIOCHEMISTRY-US, V23, P4116, DOI 10.1021/bi00313a016; Meiners S, 1999, J NEUROSCI, V19, P8443; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; RAMESH KS, 1980, BIOCHEM J, V187, P623, DOI 10.1042/bj1870623; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rigato F, 2002, J NEUROSCI, V22, P6596; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schulz F, 2013, NANOSCALE, V5, P10605, DOI 10.1039/c3nr02707d; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun CR, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-77; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	54	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93405	10.1371/journal.pone.0093405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	WOS:000333677000140	24671106	Green Published, Green Submitted, gold			2022-02-06	
J	Clark, RA; Weragoda, N; Paterson, K; Telianidis, S; Williams, G				Clark, Ross A.; Weragoda, Natasha; Paterson, Kade; Telianidis, Stacey; Williams, Gavin			A pilot investigation using global positioning systems into the outdoor activity of people with severe traumatic brain injury	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Physical activity; Activity monitor; GPS; Community mobility; HiMAT	PHYSICAL-ACTIVITY; MOBILITY; TRACKING; HEALTH	Background: Little is known about the post-discharge outdoor activities of people who have incurred severe traumatic brain injury (TBI). This study used a body-worn global positioning system (GPS) device to determine the outdoor activity per day performed by this population. Additionally, this study examined the association that mobility, time since injury and injury severity had with levels of outdoor physical activity. Findings: Seventeen people with TBI and 15 control subjects wore a GPS device for between 3-7 days to monitor their outdoor activity. Based on the individual's location and speed of movement the outdoor physical activity in minutes per day was derived. Assessments of duration of outdoor activity between groups, and the relationship that duration of outdoor activity had with results on the high-level mobility assessment tool, length of post-traumatic amnesia, and time since injury were performed. No significant (p = 0.153, effect size = 0.26) difference in time spent in outdoor physical activity was observed between the TBI (median[IQR] = 19[3-43] mins) and control (median[IQR] = 50 [18-65] mins) group. Interestingly, 35% of TBI subjects performed < 10 mins of outdoor activity per day compared to 13% of the control group. The TBI group also recorded three of the four highest values for outdoor physical activity. Higher levels of mobility were associated with more outdoor activity (Spearman's rho = 0.443, p = 0.038). No other significant associations were observed. Conclusions: While preliminary, our results indicate that a sub-group of people with TBI exists who restrict their outdoor activities. GPS has potential as an activity tracking tool, with implications for rehabilitation and exercise prescription.	[Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic 3065, Australia; [Paterson, Kade; Telianidis, Stacey; Williams, Gavin] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia		Clark, RA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic 3065, Australia.	ross.clark@acu.edu.au	Clark, Ross A/R-5664-2018; Paterson, Kade L/G-4715-2012; Clark, Ross/K-7613-2019	Clark, Ross A/0000-0002-7291-8553; Paterson, Kade L/0000-0002-0323-6129; Clark, Ross/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473			Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Isaacs K, 2013, J EXPO SCI ENV EPID, V23, P328, DOI 10.1038/jes.2012.94; Kerr J, 2011, AM J PREV MED, V41, P532, DOI 10.1016/j.amepre.2011.07.017; McCluskey A, 2012, ISRN REHABIL, V2012; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCurdy LE, 2010, CURR PROB PEDIATR AD, V40, P102, DOI 10.1016/j.cppeds.2010.02.003; MCLENNAN W, 1997, AUSTR STANDARD CLASS; Miskelly F, 2005, AGE AGEING, V34, P497, DOI 10.1093/ageing/afi145; Neven A, 2013, DISABIL REHABIL, V35, P1718, DOI 10.3109/09638288.2012.751137; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Pett MA, 1997, NONPARAMETRIC STAT H; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Schreuer N, 2014, RES DEV DISABIL, V35, P223, DOI 10.1016/j.ridd.2013.10.001; Shoval N, 2011, AGEING SOC, V31, P849, DOI 10.1017/S0144686X10001455; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395	19	13	13	1	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	MAR 19	2014	11								37	10.1186/1743-0003-11-37			5	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	AF4TM	WOS:000334707000001	24645752	Green Published, gold			2022-02-06	
J	Green, CM; Kirk, JW; Connery, AK; Baker, DA; Kirkwood, MW				Green, Cassie M.; Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			The use of the Rey 15-Item Test and recognition trial to evaluate noncredible effort after pediatric mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Postconcussion; Response bias; Recognition trial; Performance validity; Noncredible effort; Rey 15-Item Test	TEST-PERFORMANCE; MEMORY TEST; TEST-SCORES; VALIDITY; CHILDREN; TOMM; INDIVIDUALS; ADOLESCENTS; CAPACITY	The Rey 15-Item Test (FIT) is a performance validity test commonly used in adult neuropsychological assessment. FIT classification statistics across studies have been variable, so a recognition trial was created to enhance the measure (Boone, K. B., Salazar, X., Lu, P., Warner-Chacon, K., & Razani, J. (2002). The Rey 15-Item recognition trial: A technique to enhance sensitivity of the Rey 15-Item Memorization Test. Journal of Clinical and Experimental Neuropsychology, 24(5), 561-573.). The current study assessed the utility of the FIT and recognition trial in a pediatric mild traumatic brain injury sample (N=319, M=14.57 years). All participants were administered the FIT and recognition trial as part of an abbreviated clinical neuropsychological evaluation. Failure on the Medical Symptom Validity Test was used as the criterion for noncredible effort. Fifteen percent of the sample met the criterion. The traditional adult cutoff score of<9 on the FIT recall trial yielded excellent specificity (98%), but very poor sensitivity (12%). When the recognition trial was utilized, a total score of<26 resulted in the best combined cutoff score (sensitivity=55%, specificity=91%). Results indicate that the FIT with recognition trial may be useful in the assessment of noncredible effort with children and adolescents, at least among relatively high-functioning populations.	[Green, Cassie M.; Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Kirk, John W.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	michael.kirkwood@childrenscolorado.org					BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MANUAL MED SYMPTOM V; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Stimmel M, 2012, INT J FORENSIC MENT, V11, P51, DOI 10.1080/14999013.2012.676148	33	13	13	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 16	2014	36	3					261	267		10.1080/13803395.2013.879096			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AE5MG	WOS:000334032600004	24479707				2022-02-06	
J	Minter, MR; Zhang, M; Ates, RC; Taylor, JM; Crack, PJ				Minter, Myles Robert; Zhang, Moses; Ates, Robert Charles; Taylor, Juliet Marie; Crack, Peter John			Type-1 interferons contribute to oxygen glucose deprivation induced neuro-inflammation in BE(2) M17 human neuroblastoma cells	JOURNAL OF NEUROINFLAMMATION			English	Article						Type-1 interferon; Neuro-inflammation; Hypoxia-ischaemia; Cytokines; JAK-Stat	TOLL-LIKE RECEPTORS; AICARDI-GOUTIERES-SYNDROME; FOCAL CEREBRAL-ISCHEMIA; CYTOKINE EXPRESSION; ENDOGENOUS LIGAND; I INTERFERONS; BRAIN-INJURY; T-CELLS; ALPHA; LOCALIZATION	Background: Hypoxic-ischaemic injuries such as stroke and traumatic brain injury exhibit features of a distinct neuro-inflammatory response in the hours and days post-injury. Microglial activation, elevated pro-inflammatory cytokines and macrophage infiltration contribute to core tissue damage and contribute to secondary injury within a region termed the penumbra. Type-1 interferons (IFNs) are a super-family of pleiotropic cytokines that regulate pro-inflammatory gene transcription via the classical Jak/Stat pathway; however their role in hypoxia-ischaemia and central nervous system neuro-inflammation remains unknown. Using an in vitro approach, this study investigated the role of type-1 IFN signalling in an inflammatory setting induced by oxygen glucose deprivation (OGD). Methods: Human BE(2) M17 neuroblastoma cells or cells expressing a type-1 interferon-a receptor 1 (IFNAR1) shRNA or negative control shRNA knockdown construct were subjected to 4.5 h OGD and a time-course reperfusion period (0 to 24 h). Q-PCR was used to evaluate IFN alpha, IFN beta, IL-1 beta, IL-6 and TNF-alpha cytokine expression levels. Phosphorylation of signal transducers and activators of transcription (STAT)-1, STAT-3 and cleavage of caspase-3 was detected by western blot analysis. Post-OGD cellular viability was measured using a MTT assay. Results: Elevated IFNa and IFN beta expression was detected during reperfusion post-OGD in parental M17 cells. This correlated with enhanced phosphorylation of STAT-1, a downstream type-1 IFN signalling mediator. Significantly, ablation of type-1 IFN signalling, through IFNAR1 knockdown, reduced IFN alpha, IFN beta, IL-6 and TNF-alpha expression in response to OGD. In addition, MTT assay confirmed the IFNAR1 knockdown cells were protected against OGD compared to negative control cells with reduced pro-apoptotic cleaved caspase-3 levels. Conclusions: This study confirms a role for type-1 IFN signalling in the neuro-inflammatory response following OGD in vitro and suggests its modulation through therapeutic blockade of IFNAR1 may be beneficial in reducing hypoxia-induced neuro-inflammation.	[Minter, Myles Robert; Zhang, Moses; Ates, Robert Charles; Taylor, Juliet Marie; Crack, Peter John] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia		Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol, 8th Floor,Med Bldg,Grattan St, Parkville, Vic 3010, Australia.	pcrack@unimelb.edu.au	Crack, Peter/ABE-2065-2020	Crack, Peter/0000-0002-5030-0330	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	This study was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia. PJC is an Australian Research Council (ARC) Future Fellow. The authors thank Ms. Ila P. Karve for her critical analysis of this manuscript.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Akabayov SR, 2010, BIOCHEMISTRY-US, V49, P687, DOI 10.1021/bi901313x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Block F, 2000, NEUROREPORT, V11, P963, DOI 10.1097/00001756-200004070-00013; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; CICCARONE V, 1989, CANCER RES, V49, P219; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cunningham C, 2007, BRAIN BEHAV IMMUN, V21, P490, DOI 10.1016/j.bbi.2006.12.007; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Downes CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057948; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; GIULIAN D, 1993, STROKE, V24, pI84; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hilkens CMU, 2001, FEBS LETT, V505, P87, DOI 10.1016/S0014-5793(01)02783-1; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kwon SJ, 2008, BRAIN RES, V1205, P116, DOI 10.1016/j.brainres.2008.02.030; Lambertsen KL, 2005, J CEREBR BLOOD F MET, V25, P119, DOI 10.1038/sj.jcbfm.9600014; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; OHNO M, 1995, DEV BRAIN RES, V84, P294, DOI 10.1016/0165-3806(94)00194-5; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paul S, 2007, BIOCHIMIE, V89, P770, DOI 10.1016/j.biochi.2007.02.009; Petry KG, 2007, NEUROTHERAPEUTICS, V4, P434, DOI 10.1016/j.nurt.2007.05.005; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P23630, DOI 10.1074/jbc.271.39.23630; Pregi N, 2009, EXP CELL RES, V315, P419, DOI 10.1016/j.yexcr.2008.11.005; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Tang SC, 2013, EXP NEUROL, V250, P341, DOI 10.1016/j.expneurol.2013.10.012; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tough DF, 1999, IMMUNOL REV, V170, P39, DOI 10.1111/j.1600-065X.1999.tb01327.x; Vila N, 2001, STROKE, V32, P1234, DOI 10.1161/01.STR.32.5.1234-a; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; YAMADA T, 1995, NEUROSCI LETT, V189, P73, DOI 10.1016/0304-3940(95)11452-3; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhou W, 2013, BRAIN PATHOL, V23, P34, DOI 10.1111/j.1750-3639.2012.00614.x	58	13	15	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 6	2014	11								43	10.1186/1742-2094-11-43			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AF8DA	WOS:000334944400001	24602263	Green Published, gold			2022-02-06	
J	Reddy, S; Eckner, JT; Kutcher, JS				Reddy, Shailesh; Eckner, James T.; Kutcher, Jeffrey S.			Effect of Acute Exercise on Clinically Measured Reaction Time in Collegiate Athletes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						BRAIN CONCUSSION; SIMPLE REACTION TIME; PHYSICAL EXERTION; FATIGUE	CHOICE-REACTION TIME; PHYSICAL-EXERCISE; COGNITIVE PERFORMANCE; HIGH-SCHOOL; SPORTS CONCUSSION; RECOVERY; RELIABILITY; SYMPTOMS; EXERTION; PLAYERS	Purpose We have developed a reliable and valid clinical test of reaction time (RTclin) that is sensitive to the acute effects of concussion. If RTclin is to be used as a sideline concussion assessment tool then the acute effects of exercise on RTclin may need to be controlled for. The purpose of this study was therefore to determine the effect of exercise on RTclin. Methods A gender-balanced group of 42 collegiate athletes were assigned to an exercise (n = 28) and a control (n = 14) group using 2:1 block randomization. The exercise group completed a graded four-stage exercise protocol on a stationary bicycle (100 W x 5 min; 150 W x 5 min; 200 W x 5 min; sprint x 2 min), whereas the control group was tested at identical periods without exercising. Mean RTclin was calculated for eight trials as the fall time of a vertically suspended rigid shaft after its release by the examiner before being caught by the athlete. RTclin was measured at baseline and after each of the four stages. Results As both HR and RPE significantly increased for the four stages in the exercise group (P < 0.001), mean RTclin showed a significant overall decline during repeated test administration (P < 0.008). However, there were no significant group (exercise vs control, P = 0.822) or group-by-stage interaction (P = 0.169) effects on RTclin as assessed by repeated-measures analysis of variance. Conclusions Exercise did not appear to affect RTclin performance in this study. This suggests that RTclin measured during a sideline concussion assessment does not need to be adjusted to account for the acute effects of exercise.	[Reddy, Shailesh] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Eckner, James T.; Kutcher, Jeffrey S.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48108 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48108 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [2K12HD001097-16, L30 HD070467, K12 HD001097] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER		Ando S, 2010, J APPL PHYSIOL, V108, P1210, DOI 10.1152/japplphysiol.01115.2009; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brisswalter J, 1997, PERCEPT MOTOR SKILL, V85, P1019, DOI 10.2466/pms.1997.85.3.1019; Brisswalter J., 1995, J HUM MOV STUD, V29, P15; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brown AM, 2008, MED SCI SPORT EXER, V40, P1142, DOI 10.1249/MSS.0b013e31816770e1; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cohen J., 2013, STAT POWER ANAL BEHA; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Davranche K, 2006, J SPORT SCI, V24, P323, DOI 10.1080/02640410500132165; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Hogervorst E, 1996, PERCEPT MOTOR SKILL, V83, P479, DOI 10.2466/pms.1996.83.2.479; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kashihara K, 2005, PERCEPT MOTOR SKILL, V100, P275; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M., 2001, BRIT J SPORT MED, V35, P373; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McMorris T, 2000, INT J SPORT PSYCHOL, V31, P66; MCMORRIS T, 1994, PERCEPT MOTOR SKILL, V78, P123, DOI 10.2466/pms.1994.78.1.123; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tsorbatzoudis H, 1998, PERCEPT MOTOR SKILL, V86, P571, DOI 10.2466/pms.1998.86.2.571; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Welford A., 1980, REACTION TIMES, P73	38	13	13	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	MAR	2014	46	3					429	434		10.1249/MSS.0000000000000140			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AH0WG	WOS:000335840900001	24002343	Green Accepted			2022-02-06	
J	Wilson, DA; Selassie, AW				Wilson, Dulaney A.; Selassie, Anbesaw W.			Risk of severe and repetitive traumatic brain injury in persons with epilepsy: A population-based case-control study	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizure; Traumatic brain injury; Case-control; Population-based; Comorbidities	POSTTRAUMATIC EPILEPSY; HEAD-INJURY; ALZHEIMER-DISEASE; UNITED-STATES; SEIZURES; COMORBIDITY; HOSPITALIZATION; EPIDEMIOLOGY; PREVALENCE; CONCUSSION	Background: While traumatic brain injury (TBI) can lead to epilepsy, individuals with preexisting epilepsy or seizure disorder (ESD), depending on the type of epilepsy and the degree of seizure control, may have a greater risk of TBI from seizure activity or medication side effects. The joint occurrence of ESD and TBI can complicate recovery as signs and symptoms of TBI may be mistaken for postictal effects. Those with ESD are predicted to experience more deleterious outcomes either because of having a more severe TBI or because of the cumulative effects of repetitive TBI. Methods: We conducted a case-control study of all emergency department visits and hospital discharges for TBI from 1998 through 2011 in a statewide population. The severity of TBI, repetitive TBI, and other demographic and clinical characteristics were compared between persons with TBI with preexisting ESD (cases) and those without (controls). Significant differences in proportions were evaluated with confidence intervals. Logistic regression was used to examine the association of the independent variables with ESD. Results: During the study period, 236,164 individuals sustained TBI, 5646 (2.4%) of which had preexisting ESD. After adjustment for demographic and clinical characteristics, cases were more likely to have sustained a severe TBI (OR = 1.49; 95% CI = 1.38-1.60) and have had repetitive TBI (OR = 1.54; 95% CI = 1.41-1.69). Conclusion: The consequences of TBI may be greater in individuals with ESD owing to the potential for a more severe or repetitive TBI. Seizure control is paramount, and aggressive management of comorbid conditions among persons with ESD and increased awareness of the hazard of repetitive TBI is warranted. Furthermore, future studies are needed to examine the long-term outcomes of cases in comparison with controls to determine if the higher risk of severe or repetitive TBI translates into permanent deficits. (C) 2014 Elsevier Inc. All rights reserved.	[Wilson, Dulaney A.; Selassie, Anbesaw W.] Med Univ SC, Dept Publ Hlth Sci, Charleston, SC 29425 USA		Wilson, DA (corresponding author), 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA.	wilsonda@musc.edu		Wilson, Dulaney/0000-0003-4726-7848	National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention [DP003251]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01DP003251] Funding Source: NIH RePORTER	This study was funded by cooperative agreement DP003251 from the National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention (PI: Anbesaw Selassie).	Ahmad BS, 2012, NEUROLOGY, V79, P145, DOI 10.1212/WNL.0b013e31825f0466; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Beghi E, 2009, EXPERT REV NEUROTHER, V9, P291, DOI 10.1586/14737175.9.2.291; Berg AT, 2011, EPILEPSY BEHAV, V20, P550, DOI 10.1016/j.yebeh.2010.12.038; Bowman SM, 2010, EPILEPSIA, V51, P862, DOI 10.1111/j.1528-1167.2009.02492.x; Butler JA, 2000, CENTRAL NERVOUS SYST; Center for Injury Research and Policy of The Johns Hopkins University School of Public Health, 1997, ICDMAP 90 SOFTW; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; COWAN LD, 1989, EPILEPSIA, V30, P94, DOI 10.1111/j.1528-1157.1989.tb05289.x; DARLINGTON GA, 1998, ENCY BIOSTATISTICS, P788; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; Hosmer DW, 2000, MULTINOMINAL LOGISTI; JENSEN FE, 2009, EPILEPSIA S2, V50, P1, DOI DOI 10.1111/J.1528-1167.2008.02003.X; Krumholz A, 2008, NEUROLOGY, V70, P1874, DOI 10.1212/01.wnl.0000312285.73631.ff; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NAKKEN KO, 1993, EPILEPSIA, V34, P836, DOI 10.1111/j.1528-1157.1993.tb02099.x; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; National Center for Health Statistics, 2012, INT CLASS DIS; Nei M, 2007, CURR NEUROL NEUROSCI, V7, P335, DOI 10.1007/s11910-007-0051-1; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; Office, 2013, REV DEL METR STAT AR; Office of Management and Budget, 2010, FED REGISTER, V2010, P75; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pellock JM, 2004, EPILEPSY BEHAV, V5, pS3, DOI 10.1016/j.yebeh.2004.06.010; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Sapna CS, 2008, EPILEPTIC DISORD, V10, P276, DOI 10.1684/epd.2008.0222; SAS Institute Inc, 2008, SAS WIND 9 2; Saunders LL, 2009, ARCH PHYS MED REHAB, V90, P1853, DOI 10.1016/j.apmr.2009.05.020; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Si Y, 2012, SEIZURE-EUR J EPILEP, V21, P40, DOI 10.1016/j.seizure.2011.09.008; Spitz MC, 1998, EPILEPSIA, V39, P904, DOI 10.1111/j.1528-1157.1998.tb01189.x; Sztramko R, 2011, CAN GERIATR J, V14, P79, DOI 10.5770/cgj.v14i4.19; Tassinari CA, 1997, EPILEPSY COMPREHENSI, P601; Thurman DJ., 1995, GUIDELINES SURVEILLA; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	60	13	13	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2014	32						42	48		10.1016/j.yebeh.2013.12.035			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	AC3EU	WOS:000332398600009	24469016				2022-02-06	
J	Nikles, CJ; McKinlay, L; Mitchell, GK; Carmont, SAS; Senior, HE; Waugh, MCA; Epps, A; Schluter, PJ; Lloyd, OT				Nikles, Catherine J.; McKinlay, Lynne; Mitchell, Geoffrey K.; Carmont, Sue-Ann S.; Senior, Hugh E.; Waugh, Mary-Clare A.; Epps, Adrienne; Schluter, Philip J.; Lloyd, Owen T.			Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury - a pilot study	TRIALS			English	Article						Traumatic brain injury; Children; Methylphenidate; Dexamphetamine; n-of-1 trials	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; METHYLPHENIDATE; INVENTORY; SECONDARY; PREDICTORS; VALIDITY; ADHD; CARE	Background: In 2006 there were 432,700 people in Australia who had acquired brain injury (ABI) with some limitation of activities; 90% of these were traumatic brain injuries (TBIs) and nearly a third sustained injury below age 15 years. One to four years post injury, 20% to 46% of children with traumatic brain injury (TBI) have clinically significant disorders of attention. There is controversy as to whether central nervous system (CNS) stimulants can be an effective method of treating these. Objectives were to determine the efficacy of CNS stimulants for children with TBI, and to calculate the sample size for a larger trial using the Conners' 3 Parent Rating Scales Score as the primary endpoint. Methods: Pilot series of aggregated prospective randomised, double-blind, n-of-1 trials of stimulant versus placebo within individual patients. Setting: tertiary children's public hospital. Participants: ten children aged 6 to 16 years more than 12 months post TBI with attention, concentration and behavioral difficulties on stimulants. Interventions: Three cycles of methylphenidate or dexamphetamine orally at doses titrated by physician compared to placebo. Main Outcome Measures: Conners 3 Parent (Conners 3-P) and Teacher (Conners 3-T) Rating Scales (Global Index), Behaviour Rating Inventory of Executive Function (BRIEF) and Eyberg Child Behaviour Inventory (ECBI). Results: Five of ten patients completed the study. Data from 18 completed cycles from seven patients were analysed. The posterior mean difference between stimulant and placebo scores for the Conners 3-PS (Global Index) was 2.3 (SD 6.2; 95% credible region -1.0 to 6.1; posterior probability that this mean difference was greater than zero was 0.92), and for the Conners 3-T (Global Index) the posterior mean difference was 5.9 (SD 4.5; 95% credible region -3.1 to 14.9; posterior probability 0.93). Posterior mean differences suggest improvement in behaviour and executive function and a decrease in number and intensity of child behaviour problems when taking stimulants compared to placebo. Taken together these data are suggestive of a small benefit at group level. Conclusions: In this pilot study, there was sufficient evidence that stimulants may be useful in management of behavioral and cognitive sequelae following TBI, to warrant a larger trial.	[Nikles, Catherine J.; Mitchell, Geoffrey K.; Carmont, Sue-Ann S.; Senior, Hugh E.] Univ Queensland, Sch Med, Ipswich, Qld 4305, Australia; [McKinlay, Lynne; Lloyd, Owen T.] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Herston, Qld 4029, Australia; [Waugh, Mary-Clare A.] Childrens Hosp, Westmead, NSW 2145, Australia; [Epps, Adrienne] Sydney Childrens Hosp, Rehabil Dept, Randwick, NSW 2031, Australia; [Schluter, Philip J.] Univ Canterbury, Sch Hlth Sci, Christchurch 8020, New Zealand		Nikles, CJ (corresponding author), Univ Queensland, Sch Med, Ipswich Campus,Bldg 12,Salisbury Rd, Ipswich, Qld 4305, Australia.	uqjnikle@uq.edu.au	Carmont, Sue-Ann S/G-4769-2011; Nikles, Jane/F-4572-2010; Senior, Hugh/H-1579-2011; Mitchell, Geoffrey/F-1489-2010	Carmont, Sue-Ann S/0000-0001-6266-7757; Nikles, Jane/0000-0001-5356-2291; Schluter, Philip/0000-0001-6799-6779; Senior, Hugh/0000-0002-7081-2499; Mitchell, Geoffrey/0000-0001-7817-6821; McKinlay, Lynne/0000-0002-6677-0628	Royal Children's Hospital Foundation; Motor Accident Insurance Commission of Queensland; NHMRCNational Health and Medical Research Council of Australia [401780]	We thank Ms Carla Rogers, Ms Anne Bucetti and Mr Peter Mulvey, Research Assistants, for help with data collection. Funding was provided by the Royal Children's Hospital Foundation (Research project seed research, new investigator) and the Motor Accident Insurance Commission of Queensland. Jane Nikles was funded by an NHMRC post-doctoral research fellowship 401780.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Australian Government, 2007, BULLETIN, V55; Bakker K., 2008, EFFICACY STIMULANT M; Bakker K., 2000, BRAIN IMPAIR, V1, P29; BOGGS SR, 1990, J CLIN CHILD PSYCHOL, V19, P75, DOI 10.1207/s15374424jccp1901_9; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Clarke E, 1990, SCHOOL PSYCHOL INT, V11, P227; Conners C. K., 2008, CONNORS; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; EYBERG SM, 1978, J CLIN CHILD PSYCHOL, V7, P113, DOI 10.1080/15374417809532835; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Harvey DW, 2012, ARCH DIS CHILD, V97, P755, DOI 10.1136/archdischild-2012-302250; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Lee P.M., 1997, BAYESIAN STAT INTRO; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Nikles CJ, 2007, EUR J CLIN PHARMACOL, V63, P985, DOI 10.1007/s00228-007-0361-x; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Nikles J, 2011, J CLIN EPIDEMIOL, V64, P471, DOI 10.1016/j.jclinepi.2010.05.009; Pincus, 1999, EYBERG CHILD BEHAV I; Schluter PJ, 2005, STAT MED, V24, P2625, DOI 10.1002/sim.2132; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Swanson JM, 2003, NEUROSCI BIOBEHAV R, V27, P615, DOI 10.1016/j.neubiorev.2003.08.013; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	37	13	14	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	FEB 13	2014	15								54	10.1186/1745-6215-15-54			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AD7TL	WOS:000333469600001	24524676	Green Published, gold			2022-02-06	
J	Valk-Kleibeuker, L; Heijenbrok-Kal, MH; Ribbers, GM				Valk-Kleibeuker, Linda; Heijenbrok-Kal, Majanka H.; Ribbers, Gerard M.			Mood after Moderate and Severe Traumatic Brain Injury: A Prospective Cohort Study	PLOS ONE			English	Article							FUNCTIONAL ASSESSMENT MEASURE; DEPRESSION; REHABILITATION; RELIABILITY; DISORDERS; OUTCOMES; PEOPLE	Objective: To evaluate the course of mood and identify its determinants up to 3 years after moderate to severe traumatic brain injury (TBI). Design: Prospective cohort study. Patients: Patients hospitalised with moderate to severe TBI, who survived until hospital discharge. Methods: At 3, 6, 12, 18, 24, and 36 months post-injury, mood was assessed with the Wimbledon Self-Report Scale (WSRS) in the home environment. Motor and cognitive outcome were assessed with the Functional Independence Measure (FIM), and the Functional Assessment Measure (FAM), respectively. Repeated measurements analysis was performed to determine the course of mood over time and its determinants. Results: A total of 98 patients (72% men), aged 33 (SD 12.9) years, 78% with severe TBI, was included. Mood did not change until 18 months post TBI, after which it significantly improved (p = 0.016). The FIM score significantly improved up to 18 months post-TBI (p = 0.012) and the FAM score up to 12 months post-TBI (p = 0.000), after which both remained stable. In univariable analyses, time post TBI (beta = -0.04, p = 0.008), initial discharge destination (beta = 2.13, p = 0.010), FIM (beta = -0.22, p < 0.001) and FAM (beta = -0.29, p < 0.001) were significant predictors of mood. In a multivariable mixed model, time post TBI, FAM score, and discharge destination were the strongest predictors of mood. Higher FAM scores were related to better mood scores (beta = -0.28, p < 0.001). Patients initially discharged home tended to have better mood scores over time than patients first treated in inpatient rehabilitation centers or nursing homes (beta = 1.27; p = 0.071). Conclusion: Mood starts to improve 18 months after TBI when motor and cognitive outcome have stabilized. Time post TBI, cognitive outcome and initial discharge destination are the strongest predictors of mood up to 3 years after TBI. These data suggest that mood scores of patients with moderate and severe TBI should be frequently monitored, especially in rehabilitation centers and nursing homes.	[Valk-Kleibeuker, Linda] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med & Phys Therapy, Rotterdam, Netherlands; Rijndam Rehabil Ctr, Rotterdam, Netherlands		Valk-Kleibeuker, L (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Rehabil Med & Phys Therapy, Rotterdam, Netherlands.	gribbers@rijndam.nl	Ribbers, Gerard/N-3623-2019; Ribbers, Gerard M/C-1454-2014	Ribbers, Gerard M/0000-0002-6114-349X; Heijenbrok-Kal, Majanka H./0000-0002-2982-4404	Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development [1435.0020]	This study was financially supported by the Netherlands Organisation for Health Research and Development (project no.: 1435.0020; http://www.zonmw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawkins ML, 2005, AM SURGEON, V71, P920; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schonberger M, 2001, J INT NEUROPSYCH SOC, V17, P781; Stilwell P, 1998, CLIN REHABIL, V12, P521, DOI 10.1191/026921598673761855; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van Balen HG, 1992, MENSEN TRAUMATISCH H; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377	27	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87414	10.1371/journal.pone.0087414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302VA	WOS:000330631800032	24503864	gold, Green Published, Green Submitted			2022-02-06	
J	Ali, ZS; Lang, SS; Sutton, LN				Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.			Conservative Management of Presumed Low-Grade Gliomas in the Asymptomatic Pediatric Population	WORLD NEUROSURGERY			English	Article						Conservative; Incidentaloma; Low-grade gliomas; Nonsurgical; Pediatric brain tumors	PROGNOSTIC-FACTORS; HEMISPHERIC GLIOMAS; ADULT PATIENTS; RESECTION; EXTENT	OBJECTIVE: The optimal management of asymptomatic children with small, nonenhancing intracranial lesions presumed to be low-grade gliomas (LGGs) is not entirely clear in the literature. However, surgical intervention via resection or biopsy is not without risk and is of questionable long-term benefit in children with stable lesions. We present a series of 12 patients with incidentally detected, small, nonenhancing, intracranial lesions that were managed with watchful waiting and serial magnetic resonance imaging (MRI) scans. METHODS: We retrospectively reviewed a series of 12 children (eight boys, four girls) with T1 hypointense and T2 hyperintense intracranial lesions < 2 cm without enhancement or surrounding edema. RESULTS: Most patients (n = 5, 41.7%) received MRI studies after suffering a traumatic injury with evidence of an abnormality seen on computed tomography scan. Others received MRI scan as part of headache work-up (n = 4, 33.3%). The majority of lesions were located infratentorially (n = 8, 66.7%), whereas other locations included the frontal lobe and thalamus. The median age of the patients upon identification of the intracranial abnormality was 10 years (range, 1-19 years of age). Patients were followed for a median of 16.7 months (range, 2.7-59.5 months). The most common diagnosis based on clinical and radiographic features of these lesions consisted of LGG. No patient underwent surgery, radiation therapy, or chemotherapy except one patient, in whom the lesion grew in size. Surgical pathologic diagnosis in this case confirmed World Health Organization grade II astrocytoma. CONCLUSIONS: Our case series suggests that conservative management and close follow-up of incidental radiographic lesions consistent with LGGs is a safe and effective initial strategy in the pediatric population. In cases in which lesion size or quality changes, surgical resection may be necessary to confirm diagnosis. Further studies that include a larger number of patients and longer follow-up period are required to compare outcomes between this approach and initial surgical, radiation, or chemotherapy management strategies.	[Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Ali, Zarina S.; Lang, Shih-Shan; Sutton, Leslie N.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA		Ali, ZS (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	zarina.ali@uphs.upenn.edu					BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D; Brown PD, 2003, RADIOGRAPHICS, V23, P1591, DOI 10.1148/rg.236035109; CAIRNCROSS JG, 1989, ARCH NEUROL-CHICAGO, V46, P1238, DOI 10.1001/archneur.1989.00520470106035; Driever PH, 2010, J NEURO-ONCOL, V100, P199, DOI 10.1007/s11060-010-0159-z; Duffau H, 2012, ACTA NEUROCHIR, V154, P569, DOI 10.1007/s00701-012-1275-7; Guillevin R, 2008, J NEURO-ONCOL, V87, P181, DOI 10.1007/s11060-007-9508-y; JANNY P, 1994, CANCER, V73, P1937, DOI 10.1002/1097-0142(19940401)73:7<1937::AID-CNCR2820730727>3.0.CO;2-G; Keles GE, 2001, J NEUROSURG, V95, P735, DOI 10.3171/jns.2001.95.5.0735; Perret C, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11121; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Prabhu VC, 2010, NEUROL CLIN, V28, P1037, DOI 10.1016/j.ncl.2010.03.022; Rees J, 2009, EUR J RADIOL, V72, P54, DOI 10.1016/j.ejrad.2008.06.013; Reijneveld JC, 2005, NEURORADIOLOGY, V47, P887, DOI 10.1007/s00234-005-1435-z; Shastri-Hurst N, 2006, BRIT J NEUROSURG, V20, P222, DOI 10.1080/02688690600875507; Smith ATT, 2011, NEW ETHNOGRAPHIES, P1, DOI 10.1227/NEU.0b013e31820c3419; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x; van Veelen MLC, 1998, J NEUROL NEUROSUR PS, V64, P581, DOI 10.1136/jnnp.64.5.581; VECHT CJ, 1993, J NEUROL NEUROSUR PS, V56, P1259, DOI 10.1136/jnnp.56.12.1259; You G, 2012, NEURO-ONCOLOGY, V14, P230, DOI 10.1093/neuonc/nor205	20	13	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2014	81	2					368	373		10.1016/j.wneu.2013.01.038			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AE6IU	WOS:000334094900052	23321383				2022-02-06	
J	Vistisen, ST; Hansen, TK; Jensen, J; Nielsen, JF; Fleischer, J				Vistisen, Simon Tilma; Hansen, Troels Krarup; Jensen, Jim; Nielsen, Jorgen Feldbaek; Fleischer, Jesper			Heart rate variability in neurorehabilitation patients with severe acquired brain injury	BRAIN INJURY			English	Article						Acquired brain injury; autonomic nervous system; heart rate variability; neurorehabilitation	PATTERNS	Introduction: Acquired brain injury (ABI) cause neural deficits. In addition to motor and cognitive deficits, the autonomic nervous system may be affected. This has been shown for neurorehabilitation patients with traumatic brain injury (TBI) by means of reduced heart rate variability (HRV). It was hypothesized that patient groups with other ABI aetiology (mainly stroke, subarachnoid haemorrhage and anoxia) would also present reduced HRV. Methods: Patients consecutively admitted and severely ABI injured were considered for HRV measurements. HRV was extracted as a mean of four 5-minute ECG recordings at 6 pm, 10 pm, 2 am and 6 am the following day (scheduled resting periods). One 5-minute HRV recording from a sex-and age-matched group of healthy volunteers constituted control data. Standard deviation of normal-to-normal intervals (SDNN) and low frequency (LF) were primary HRV variables. Results: Of 71 admitted patients, HRV was extracted from 49 patients. Patient SDNN and LF were reduced compared to controls (SDNN: 13 ms (CI = [10.8; 15.3]) vs 40.3 ms (CI = [36.6; 44.2]), p<0.0001; LF: 29.4 ms(2) (CI = [19.8; 43.7]) vs 518 ms(2) (CI = [419; 639]), p<0.0001). HRV appeared identical across ABI aetiology. Conclusion: It was found that HRV was considerably reduced in an heterogenic ABI patient group admitted for neurorehabilitation.	[Vistisen, Simon Tilma; Jensen, Jim; Nielsen, Jorgen Feldbaek] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Vistisen, Simon Tilma; Jensen, Jim; Nielsen, Jorgen Feldbaek] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Vistisen, Simon Tilma] Aarhus Univ, Inst Clin Med, Res Ctr Emergency Med, Aarhus, Denmark; [Hansen, Troels Krarup; Fleischer, Jesper] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Hansen, Troels Krarup; Fleischer, Jesper] Aarhus Univ Hosp, Med Res Labs, DK-8000 Aarhus, Denmark		Vistisen, ST (corresponding author), Voldbyvej 15,Bldg 5,1st Floor, DK-8450 Hammel, Denmark.	vistisen@ki.au.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Vistisen, Simon Tilma/0000-0002-1297-1459	Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Novo Nordisk FondenNovo Nordisk Foundation [NNF13OC0003820] Funding Source: researchfish	JF is a stock owner in the company Medicus Engineering (whose equipment was used for acquiring ECG data from healthy volunteers). Apart from this, the authors report no conflicts of interest. The study was partly supported by the Novo Nordisk Foundation.	Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bracci F, 2007, WORLD J GASTROENTERO, V13, P3967, DOI 10.3748/wjg.v13.i29.3967; Burger AJ, 1999, INT J CARDIOL, V71, P41, DOI 10.1016/S0167-5273(99)00110-2; Camm AJ, 1996, EUR HEART J, V17, P354; Cichosz SL, 2013, DIABETIC MED, V30, P1063, DOI 10.1111/dme.12199; Gulichsen Elisabeth, 2012, J Diabetes Sci Technol, V6, P965; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; Vistisen ST, 2010, ACTA ANAESTH SCAND, V54, P199, DOI 10.1111/j.1399-6576.2009.02061.x	14	13	13	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					196	202		10.3109/02699052.2013.860477			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900009	24295072				2022-02-06	
J	Baker, JM; Good, DE				Baker, Julie M.; Good, Dawn E.			Physiological emotional under-arousal in individuals with mild head injury	BRAIN INJURY			English	Article						arousal; electrodermal activity; mild head injury; stress	TRAUMATIC BRAIN-INJURY; ACUTE STRESS DISORDER; DECISION-MAKING; POSTCONCUSSION SYMPTOMS; COGNITIVE NEUROSCIENCE; ORBITOFRONTAL CORTEX; UNIVERSITY-STUDENTS; AFFECTIVE SEQUELAE; FACIAL EXPRESSION; DIAGNOSIS THREAT	Primary objectives: This study examined the potential emotional sequelae following self-reported mild head injury (MHI; e. g. 'altered state of consciousness' [ASC]) in university students with a particular focus on arousal status and responsivity to experimental manipulation of arousal. Research design: A quasi-experimental design (n = 91) was used to examine arousal status (self-reported and physiological indices) and response to manipulated arousal (i.e. induced psychosocial stress/activation; reduced activation/relaxation) between persons who acknowledged prior MHI and persons with no-MHI. Main outcome and results: University students who self-reported MHI were physiologically under-aroused and less responsive to stressors (both laboratory and environmental) compared to their no-MHI cohort. Those with reported loss of consciousness demonstrated the most attenuated emotional arousal responses (i.e. flattened electrodermal responsivity) relative to those with only a reported ASC, followed by those with no-MHI. Conclusions: The under-arousal in traumatic brain injury has been hypothesized to be associated with ventromedial prefrontal cortex disruption. This under-arousal may be mirrored in persons who self-report experiencing subtle head trauma. Students who reported MHI may be less able to physiologically respond and/or cognitively appraise stressful experiences as compared to their no-MHI cohort; and experience subtle persistent consequences despite the subtle nature of the reported head trauma.	[Baker, Julie M.; Good, Dawn E.] Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, St Catharines, ON L2S 3A1, Canada; [Good, Dawn E.] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada		Baker, JM (corresponding author), Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	js01cb@brocku.ca			Social Sciences and Humanities Research Council of Canada (SSHRC) Joseph Bombardier Canada Graduate Scholarship; Ontario Graduate Scholarship (OGS)Ontario Graduate Scholarship; American Psychological Foundation (APF)/Council of Graduate Departments of Psychology (COGDOP) Graduate Research Scholarship; Ontario Neurotrauma Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. JB held funding from the Social Sciences and Humanities Research Council of Canada (SSHRC) Joseph Bombardier Canada Graduate Scholarship, Ontario Graduate Scholarship (OGS) and American Psychological Foundation (APF)/Council of Graduate Departments of Psychology (COGDOP) Graduate Research Scholarship during the collection and preparation of this research. DG holds funding from the Ontario Neurotrauma Foundation and is affiliated with the Ontario Brain Injury Association. The authors acknowledge that portions of this research have been presented at national and international conferences and abstracts related to this work have been published from conference proceedings [120-122].	AMARAL D G, 1992, P1; Andreassi J. L., 2007, PSYCHOPHYSIOLOGY HUM, P259; [Anonymous], 2007, STAT PACK SOC SCI SP; Baker J, 2010, FRONT HUM NEUROSCI, DOI [10.3389/conf.fnins.2010.14.00124, DOI 10.3389/C0NF.FNINS.2010.14.00124]; Baker J, 2008, EVERYDAY LIVING QUES; Baker J, 2010, BRAIN INJURY, V24, P106; Baker J, 2009, J HEAD TRAUMA REHAB, V24, P398; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Canadian Institutes of Health Research, 2006, HEAD INJ CAN DEC CHA; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Carr J, 2007, TRAUMA, V9, P21, DOI 10.1177/1460408607082845; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Damasio AR, 1998, HUMAN EMOTIONS READE, P122; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeBono A, 2008, C P 69 ANN CAN PSYCH; Delis DC, 2002, DELIS KAPLAN EXECUTI; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dzyundzyak A, 2008, C P 69 ANN CAN PSYCH; Epstein Richard S., 1994, P285; Gallagher R, 2000, NATL SURVEY COUNSELL; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P22; Iverson G. L., 2009, BLACK BOOK NEUROPSYC; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Jung YH, 2007, C P 68 ANN CAN PSYCH; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kitzrow M. A., 2003, NASPA J, V41, P167, DOI DOI 10.2202/0027-6014.1310; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Mateer CA, 2000, NEUROPSYCHOLOGICAL M, P3; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P347; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCormick CM, 2007, CONSCIOUS COGN, P205; McCrea M, 2008, MILD TRAUMATIC BRAIN, P129; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McMaster University, 2004, GUID REL COMP DISC G; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales D., 2007, BRAIN CONTUSION; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Polygraph Professional, 2008, POL PROF POL PROF SU; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Reimann M, 2010, J ECON PSYCHOL, V31, P767, DOI 10.1016/j.joep.2010.03.002; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sharan T, 2012, BRAIN INJURY, V26, P729; SHOSTAK BB, 1990, BEHAV RES THER, V28, P513, DOI 10.1016/0005-7967(90)90138-9; Soet J, 2006, J STUD AFF RES PRACT, V43, P410; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spielberger CD., 1983, STATE TRAIT ANXIETY; St Cyr J, 2007, C P 17 ANN ROTM RES; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; Tranel D., 2000, SER AFFECTIVE SCI, P192; van Noordt S, 2009, C P 70 ANN CAN PSYCH; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	119	13	14	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					51	65		10.3109/02699052.2013.857787			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700007	24328800				2022-02-06	
J	Bottari, C; Shun, PLW; Le Dorze, G; Gosselin, N; Dawson, D				Bottari, Carolina; Shun, Priscilla Lam Wai; Le Dorze, Guylaine; Gosselin, Nadia; Dawson, Deirdre			Self-Generated Strategic Behavior in an Ecological Shopping Task	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; cognition; decision making; executive function	EXECUTIVE DYSFUNCTION; IADL PROFILE; BRAIN-INJURY; VALIDATION; VALIDITY	OBJECTIVES. The use of cognitive strategies optimizes performance in complex everyday tasks such as shopping. This exploratory study examined the cognitive strategies people with traumatic brain injury (TBI) effectively use in an unstructured, real-world situation. METHOD. A behavioral analysis of the self-generated strategic behaviors of 5 people with severe TBI using videotaped sessions of an ecological shopping task (Instrumental Activities of Daily Living Profile) was performed. RESULTS. All participants used some form of cognitive strategy in an unstructured real-world shopping task, although the number, type, and degree of effectiveness of the strategies in leading to goal attainment varied. The most independent person used the largest number and a broader repertoire of self-generated strategies. CONCLUSION. These results provide initial evidence that occupational therapists should examine the use of self-generated cognitive strategies in real-world contexts as a potential means of guiding therapy aimed at improving independence in everyday activities for people with TBI.	[Bottari, Carolina; Shun, Priscilla Lam Wai] Univ Montreal, Occupat Therapy Program, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina; Shun, Priscilla Lam Wai; Le Dorze, Guylaine] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Shun, Priscilla Lam Wai] McGill Univ, Montreal Neurol Inst, Occupat Therapy Dept, Montreal, PQ, Canada; [Le Dorze, Guylaine] Univ Montreal, Sch Speech Language Therapy & Audiol, Montreal, PQ H3C 3J7, Canada; [Gosselin, Nadia] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Dawson, Deirdre] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Dawson, Deirdre] Rotman Res Inst, Toronto, ON, Canada		Bottari, C (corresponding author), Univ Montreal, Occupat Therapy Program, Sch Rehabil, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	carolina.bottari@umontreal.ca	Le Dorze, Guylaine/A-1790-2014; Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Lam Wai Shun, Priscilla/0000-0001-5642-7490			Alexander PA, 1998, EDUC PSYCHOL REV, V10, P129, DOI 10.1023/A:1022185502996; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Bouazzaoui B, 2010, ACTA PSYCHOL, V135, P59, DOI 10.1016/j.actpsy.2010.05.007; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Draucker CB, 2007, QUAL HEALTH RES, V17, P1137, DOI 10.1177/1049732307308450; Fertherlin J. M., 1989, OCCUPATIONAAL THERAP, V1, P75; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Haskins E.C., 2012, COGNITIVE REHABILITA; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Norman D. A., 1986, COGNITIVE NEUROSCIEN, P376; Patton MQ., 1990, QUALITATIVE EVALUATI; QSR International, 2012, NVIVO COMP SOFTW; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Walsh MM, 2009, COGNITIVE PSYCHOL, V58, P416, DOI 10.1016/j.cogpsych.2008.09.003; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Woods D. K., 2008, TRANSANA VERSION 2 2	29	13	13	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2014	68	1					67	76		10.5014/ajot.2014.008987			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	296CA	WOS:000330161500010	24367957				2022-02-06	
J	Edwards, J; Vess, J; Reger, G; Cernich, A				Edwards, Joe; Vess, James; Reger, Greg; Cernich, Alison			The Use of Virtual Reality in the Military's Assessment of Service Members With Traumatic Brain Injury: Recent Developments and Emerging Opportunities	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						assessment; ecological validity; military psychology; traumatic brain injury; virtual reality	NEUROPSYCHOLOGICAL ASSESSMENT; ECOLOGICAL VALIDITY; CLINICAL NEUROPSYCHOLOGY; COGNITIVE REHABILITATION; COMPUTERIZED VERSIONS; DRIVING PERFORMANCE; EXECUTIVE FUNCTION; TASK-PERFORMANCE; ENVIRONMENTS; SYSTEM	Traumatic brain injury (TBI) is a common event in the current extended conflicts by American service members, with estimates that as many as 300,000 have sustained combat-related concussions during Operation Iraqi Freedom and Operation Enduring Freedom. The limited ecological validity of traditional neuropsychological assessment measures presents a challenge to effective postconcussion evaluation of service members in relation to fitness-for-duty decisions or rehabilitation needs. Virtual reality (VR) technology offers a promising opportunity to advance the field of functional assessment for TBI. This article reviews the current professional literature on VR applications for TBI assessment, with special emphasis on those that are particularly relevant to U.S. service members. VR affords several advantages for clinical use. These include assessment of complex sets of cognitive and behavioral functions rather than the isolated components assessed by traditional measures; more precise control over the standardized presentation of task stimuli and the recording of response data; and enhanced ecological validity that can lead to more useful assessment data in the applied contexts faced by the U.S. military.	[Edwards, Joe] TBI Clin, Dept Behav Hlth, Ft Wainwright, AK USA; [Vess, James; Reger, Greg] Natl Ctr Telehlth & Technol, Emerging Technol Program, Tacoma, WA 98431 USA; [Cernich, Alison] US Dept Vet Affairs, Mental Hlth Serv, Silver Spring, MD USA; [Cernich, Alison] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Cernich, Alison] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Cernich, Alison] Def Ctr Excellence Psychol Hlth, Silver Spring, MD USA; [Cernich, Alison] TBI, Silver Spring, MD USA		Vess, J (corresponding author), Natl Ctr Telehlth & Technol, Emerging Technol Program, 9933 West Hayes St, Tacoma, WA 98431 USA.	james.d.vess3.civ@mail.mil		Edwards, Joe/0000-0003-4451-8103			ANDREWS TK, 1995, P 2 TIDE C AMST, P276; Armstrong CM, 2013, J CLIN EXP NEUROPSYC, V35, P113, DOI 10.1080/13803395.2012.740002; Bartlett J, 2010, NAVY MED RES DEV NEW, V2, P1; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Bedard M, 2010, AM J OCCUP THER, V64, P336, DOI 10.5014/ajot.64.2.336; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brownfield K., 2008, VIRTUAL LIB TASK; Buckwalter J G, 1997, Stud Health Technol Inform, V39, P17; Burgess P, 1996, BEHAV ASSESSMENT DYS; Campbell Z, 2009, APPL NEUROPSYCHOL, V16, P295, DOI 10.1080/09084280903297891; Castelnuovo G., 2003, PSYCH NOL J, V1, P310; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Choca J., 1992, CLIN NEUROPSYCHOL, V6, P9, DOI [10.1080/13854049208404112, DOI 10.1080/13854049208404112]; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P209, DOI 10.1080/713755574; Cruz-Neira C., 1993, Computer Graphics Proceedings, P135; Cyr AA, 2009, J CLIN EXP NEUROPSYC, V31, P472, DOI 10.1080/13803390802255627; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Dores AR, 2012, COMM COM INF SC, V248, P90; Elkind JS, 2001, CYBERPSYCHOL BEHAV, V4, P489, DOI 10.1089/109493101750527042; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fung J, 2006, CYBERPSYCHOL BEHAV, V9, P157, DOI 10.1089/cpb.2006.9.157; Gottshall KR, 2012, IEEE ENG MED BIO, P6141, DOI 10.1109/EMBC.2012.6347395; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hoskins LL, 2010, ARCH CLIN NEUROPSYCH, V25, P591, DOI 10.1093/arclin/acq060; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Kerrigan R., 2010, MILITARY MED TECHNOL, V14, P14; Kesztyues TI, 2000, CYBERPSYCHOL BEHAV, V3, P343, DOI 10.1089/10949310050078788; Kizony R, 2010, PHYS THER, V90, P252, DOI 10.2522/ptj.20090061; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Koenig St, 2012, P 9 INT C DIS VIRT R, P247; Kraft M, 2010, AM J PHYS MED REHAB, V89, P336, DOI 10.1097/PHM.0b013e3181d3eb5f; La Paglia F, 2012, STUD HEALTH TECHNOL, V181, P98, DOI 10.3233/978-1-61499-121-2-98; Laver K, 2012, PRESENCE-TELEOP VIRT, V21, P183, DOI 10.1162/PRES_a_00098; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; LeBlanc V. R., 2008, INT J STRESS MANAGE, V15, P7693; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liu L, 1999, Cyberpsychol Behav, V2, P53, DOI 10.1089/cpb.1999.2.53; Lo Priore C, 2003, CYBERPSYCHOL BEHAV, V6, P281, DOI 10.1089/109493103322011579; Loftin RB, 2004, IEEE COMPUT GRAPH, V24, P18, DOI 10.1109/MCG.2004.21; Long, 1996, ECOLOGICAL VALIDITY, P15; Mataix-Cols David, 2002, Appl Neuropsychol, V9, P117, DOI 10.1207/S15324826AN0902_8; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Milleville-Pennel I, 2010, BRAIN INJURY, V24, P678, DOI 10.3109/02699051003692159; Miotto EC, 1998, CORTEX, V34, P639, DOI 10.1016/S0010-9452(08)70770-6; Morganti F, 2004, ST HEAL T, V99, P55; Morris R. G., 2002, INT C DIS VIRT REAL, V4, P101; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2007, ANN REV CYBERTHERAPY, V5, P164; Parsons TD, 2012, IEEE T CONSUM ELECTR, V58, P197, DOI 10.1109/TCE.2012.6227413; Parsons Thomas D, 2012, Stud Health Technol Inform, V173, P331; Parsons TD, 2011, STUD COMPUT INTELL, V337, P271; Parsons TD, 2011, STUD HEALTH TECHNOL, V163, P433, DOI 10.3233/978-1-60750-706-2-433; Parsons TD, 2009, STUD HEALTH TECHNOL, V142, P247, DOI 10.3233/978-1-58603-964-6-247; Pfurtscheller G, 2006, BRAIN RES, V1071, P145, DOI 10.1016/j.brainres.2005.11.083; PUGNETTI L, 1995, COMPUT BIOL MED, V25, P213, DOI 10.1016/0010-4825(94)00040-W; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Raspelli S., 2009, J CYBER THER REHABIL, V2, P299; Raspelli S, 2012, PRESENCE-TELEOP VIRT, V21, P31, DOI 10.1162/PRES_a_00077; Raven, 1958, STANDARD PROGR MATRI; Reger GM, 2009, TELEMED J E-HEALTH, V15, P101, DOI 10.1089/tmj.2008.0050; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Riva G, 1997, VIRTUAL REALITY NEUR; Riva G, 2009, BRIT J GUID COUNS, V37, P337, DOI 10.1080/03069880902957056; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schultheis MT, 2007, ASSIST TECHNOL, V19, P1, DOI 10.1080/10400435.2007.10131860; Schultheis MT, 2003, REHABIL PSYCHOL, V48, P275, DOI 10.1037/0090-5550.48.4.275; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Subramanian S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-20; Suchy Y, 2009, ANN BEHAV MED, V37, P106, DOI 10.1007/s12160-009-9097-4; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; THOMPSON JA, 1982, INT J MAN MACH STUD, V17, P279, DOI 10.1016/S0020-7373(82)80028-X; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Tupper D., 1990, NEUROPSYCHOLOGY EVER, P3, DOI DOI 10.1007/978-1-4613-1503-2_1; van der Eerden WJ, 1999, ST HEAL T, V62, P373; Viau Antonin, 2004, J Neuroeng Rehabil, V1, P11, DOI 10.1186/1743-0003-1-11; Wald J, 2001, ST HEAL T, V81, P564; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Weirauch C, 2009, MILITARY SIMULATION, V3, P10; Wiederhold BK, 2006, COMMUNICATION PRESEN, P267; Williams JE, 2006, COMPUT HUM BEHAV, V22, P791, DOI 10.1016/j.chb.2004.03.005; Yancosek K, 2008, J HAND THER, V21, P189, DOI 10.1197/j.jht.2007.12.002; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	105	13	16	1	29	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	3					220	230		10.1080/09084282.2013.796554			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AM9VN	WOS:000340229200006	25084846				2022-02-06	
J	Feeney, TJ; Achilich, J				Feeney, Timothy J.; Achilich, Jason			Structured flexibility and context-sensitive behavioral support for the chronically cranky	NEUROREHABILITATION			English	Article						Behavior disorders; neurorehabilitation; traumatic brain injury; positive behavior support; cognitive-behavioral intervention; functional assessment; context sensitive treatment; multi-component intervention	TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; SHORT-TERM; REHABILITATION; ADOLESCENTS; IDENTITY; INTERVENTION; INDIVIDUALS; PEOPLE; CHOICE	BACKGROUND: A significant number of individuals with brain injury demonstrate behavioral challenges that negatively affect their ability to live successfully in community settings. While there are a number of treatment approaches that have demonstrable effects in well controlled clinical settings, it is very difficult to implement these approaches in natural settings. OBJECTIVES: The goal of this study was to report the results of an investigation of the effects of a multicomponent behavioral intervention on the challenging behavior of an adolescent and young adult with growing behavioral concerns after acquired brain injury (TBI). METHODS: The participants were an 16 year old adolescent male and a 24 year old female, with escalating behavior problems after severe TBI. Multiple baseline designs were used to document the effects of an intervention package that integrated cognitive and executive function intervention to address severe challenging behaviors in natural settings. The following dependent variables were used to establish the effectiveness of the interventions: frequency and intensity of aggressive behaviors and participation in scheduled activities. The intervention included integrated components of positive behavior supports, cognitive supports and specific executive function scripts. RESULTS: These single subject experiments demonstrated the effectiveness of a multicomponent intervention on the reduction of the frequency of problem behaviors and the increase of pro-social behaviors. CONCLUSION: These two successful interventions extended the findings of previously published data for the successful treatment of behavioral challenges using a flexible support-oriented intervention that combines behavioral, cognitive, and executive function components.	[Feeney, Timothy J.; Achilich, Jason] Transit Serv Youth & Families, Burlington, VT 05401 USA		Feeney, TJ (corresponding author), Transit Serv Youth & Families, 1 Mill St,Suite RL29, Burlington, VT 05401 USA.	tim@tsyf.org					Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Arco L, 2009, BRAIN IMPAIR, V10, P307, DOI 10.1375/brim.10.3.307; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barlow DH, 1984, SINGLE CASE EXPT DES; BIJOU SW, 1968, J APPL BEHAV ANAL, V1, P175, DOI 10.1901/jaba.1968.1-175; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; Damasio A., 1994, DESCARTES ERROR EMOT; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Durand V.M., 1992, MOTIVATION ASSESSMEN; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Feeney T., 2010, J HEAD TRAUMA REHABI; Feeney T., 1997, ACQUIRED BRAIN INJUR; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fledderus M, 2013, BEHAV RES THER, V51, P142, DOI 10.1016/j.brat.2012.11.007; Hayes S.C., 2004, MINDFULNESS ACCEPTAN, P1; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; KEPPEL G, 1991, DESIGN ANAL INVESTIG; Kolb B., 1995, BRAIN PLASTICITY BEH; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Lucyshyn J. M., 1996, J EXPT ANAL BEHAV, P99; Lucyshyn JM, 1997, J CONSULT CLIN PSYCH, V65, P241, DOI 10.1037/0022-006X.65.2.241; LUCYSHYN JM, 2002, FAMILIES POSITIVE BE, P3; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; McHugh RK, 2009, BEHAV RES THER, V47, P946, DOI 10.1016/j.brat.2009.07.005; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Segal D, 2010, INT J CHILD YOUTH FA, V1, P293, DOI 10.18357/ijcyfs13/420102093; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Vilardaga R, 2009, BEHAV ANALYST, V32, P105, DOI 10.1007/BF03392178; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Wood RL, 2001, BRAIN DAM B, P107; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; Ylvisaker M., 2006, BEHAV INTERVEN UNPUB; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P271; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	53	13	13	1	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					709	723		10.3233/NRE-141088			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100011	24784497				2022-02-06	
J	Gorji, MAH; Araghiyansc, F; Jafari, H; Morad, A; Gorgi, H; Yazdani, J				Gorji, Mohammad Ali Heidari; Araghiyansc, Fereshteh; Jafari, Hadayat; Morad, Ali; Gorgi, Heidari; Yazdani, Jamshid			Effect of auditory stimulation on traumatic coma duration in intensive care unit of Medical Sciences University of Mazandarn, Iran	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Auditory stimulation; coma patients; traumatic brain injury		Background: Sensory deprivation is one of the common complications of coma patients in the intensive care unit (ICU). The purpose of this study was to investigate the impact of a familiar voice to consciousness level in coma patients. Methods: A total of 13 patients with traumatic coma (8 = Glasgow's coma scale [GCS]) admitted in ICU ward were randomly assigned to control and experimental groups. The experimental group was treated twice a daily each time 15 min with a familiar recorded MP3 sound for 2 weeks. The control group received only natural voices of environment. GCS applied to evaluate patients' level of consciousness. Finding: Findings showed that duration to reach GCS = 15 was signifi cantly shorter in the experimental group (c2= 12/96, P < 0/001). Conclusion: These fi ndings imply that providing familiar auditory stimulation programs for coma patients in the ICU could be effective.	[Gorji, Mohammad Ali Heidari; Araghiyansc, Fereshteh; Jafari, Hadayat; Morad, Ali; Gorgi, Heidari; Yazdani, Jamshid] Med Sci Univ Mazandaran, Nursing & Midwifery Dept, Sari, Iran		Araghiyansc, F (corresponding author), Nasibeh Nursing & Midwifery Fac, Dept Med Surg Nursing, Vesal St,Amir Mazandarani Blvd, Sari, Iran.	gorjim29@yahoo.com		Yazdani-Charati, Jamshid/0000-0002-4721-225X			Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Atashzadeh-Shourideh F., 2008, NURSING FDN; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Derstine BJ, 2002, COMPREHENSIVE REHABI; Goudarzi F., 2010, IRAN J NURS, V23, P43; Hawks, 2005, MED SURG NURSING CLI; Hoeman Shirley P., 2002, REHABILITATION NURSI; Karma D, 2006, INDIAN PEDIATR, V43, P856; Mahdi-Zadeh E, 2001, J THEH U MED SCI, V60, P383; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Shadfar Z, 2002, J SABZEVAR U MED SCI, V9, P67; Smeltzer S.C., 2010, BRUNNER SUDDARTHS TX; Soleymani M, 1998, THESIS; Sosnowski C, 1994, J Neurosci Nurs, V26, P336; Taylor C., 2005, FUNDAMENTALS NURSING; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wurz J, 2010, J EURO SOCIE INTENS, V1, P1	17	13	13	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	JAN-MAR	2014	8	1					69	72		10.4103/1658-354X.125940			4	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V4P0J	WOS:000219132400014	24665243	Green Published, gold			2022-02-06	
J	Hampson, NE; Kemp, S; Coughlan, AK; Moulin, CJA; Bhakta, BB				Hampson, Natalie E.; Kemp, Steven; Coughlan, Anthony K.; Moulin, Chris J. A.; Bhakta, Bipin B.			Effort Test Performance in Clinical Acute Brain Injury, Community Brain Injury, and Epilepsy Populations	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						effort; malingering; symptom validity; WMT	SYMPTOM VALIDITY TEST; WORD MEMORY TEST; TEST FAILURE; DEMENTIA PROFILE; HIGH SPECIFICITY; TEST-SCORES; BASE RATES; ADULTS; SEVERITY; RECOGNITION	Effort tests have become commonplace within medico-legal and forensic contexts and their use is rising within clinical settings. It is recognized that some patients may fail effort tests due to cognitive impairment and not because of poor effort. However, investigation of the base rate of failure among clinical populations other than dementia is limited. Forty-seven clinical participants were recruited and comprised three subgroups: acute brain injury (N = 11), community brain injury (N = 20), and intractable epilepsy (N = 16). Base rates of failure on the Word Memory Test (WMT; Green, 2003) and six other less well-validated measures were investigated. A significant minority of patients failed effort tests according to standard cutoff scores, particularly patients with severe traumatic brain injury and marked frontal-executive features. The WMT was able to identify failures associated with significant cognitive impairment through the application of profile analysis and/or lowered cutoff levels. Implications for clinical assessment, effort test interpretation, and future research are discussed.	[Hampson, Natalie E.] Salford Royal NHS Fdn Trust, Dept Neuropsychol, Salford, Lancs, England; [Kemp, Steven; Coughlan, Anthony K.] St James Univ Hosp, Dept Neuropsychol, Leeds, W Yorkshire, England; [Moulin, Chris J. A.] CNRS, LEAD, UMR 5022, Dijon, France; [Bhakta, Bipin B.] Univ Leeds, Fac Med & Hlth, Acad Dept Rehabil Med, Leeds, W Yorkshire, England		Hampson, NE (corresponding author), Salford Royal Hosp, Dept Neuropsychol, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	natalie.hampson@srft.nhs.uk	Moulin, Chris/F-9324-2010	Moulin, Chris/0000-0001-9784-4362			Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BINDER LM, 1993, PORTLAND DIGIT RECOG; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Budson AE, 2002, BRAIN, V125, P2750, DOI 10.1093/brain/awf277; Bunnage M., 2008, J INT NEUROPSYCHO S1, V14, P138; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cochrane HJ, 1998, BRIT J CLIN PSYCHOL, V37, P31, DOI 10.1111/j.2044-8260.1998.tb01277.x; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Coughlan A. K., 2007, BIRT MEMORY INFORM P; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dodrill CB, 2008, EPILEPSIA, V49, P691, DOI 10.1111/j.1528-1167.2007.01457.x; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2008, GREENS NONVERBAL MED; Green P., 2004, MED SYMPTOM VALIDITY; Green P., 2003, WORD MEMORY TEST WIN; Green P., 2009, ADV INTERPRETATION P; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P385, DOI 10.1136/jnnp.57.3.385; Kelly PJ, 2005, BRIT J CLIN PSYCHOL, V44, P333, DOI 10.1348/014466505X35687; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; McCarter RJ, 2009, CLIN NEUROPSYCHOL, V23, P1050, DOI 10.1080/13854040802665790; McMillan T. M., 2009, ASSESSMENT EFFORT CL; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Rogers R., 2008, CLIN ASSESSMENT MALI; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Warrington EK, 1996, CAMDEN MEMORY TEST B; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Wehner DT, 2007, J SPEECH LANG HEAR R, V50, P716, DOI 10.1044/1092-4388(2007/050); West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	13	13	2	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	3					183	194		10.1080/09084282.2013.787425			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AM9VN	WOS:000340229200003	25084843				2022-02-06	
J	Ivanova, M; Belcheva, S; Belcheva, I; Stoyanov, Z; Tashev, R				Ivanova, Margarita; Belcheva, Stiliana; Belcheva, Iren; Stoyanov, Zlatislav; Tashev, Roman			Modulatory effect of VIP injected into hippocampal CA1 area on anxiety in olfactory bulbectomized rats	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						vasoactive intestinal peptide; olfactory bulbectomy; hippocampus; plus maze; anxiety; rat	VASOACTIVE INTESTINAL POLYPEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; ELEVATED PLUS-MAZE; TRAUMATIC BRAIN-INJURY; IMMUNOREACTIVE INTERNEURONS; NEUROCHEMICAL FEATURES; PEPTIDE; DEPRESSION; PACAP; NEUROPEPTIDES	Vasoactive intestinal peptide (VIP) is a neuropeptide, which is widely distributed in the central nervous system and peripheral tissues, acting both as a neurotransmitter and neuromodulator. Despite its extensive expression in the hippocampus, amygdala and other limbic system structures, the effects of VIP on anxiety and depression have not yet been fully investigated. The aim of the present study was to evaluate the involvement of VIP and VIP receptors in the mechanism of anxiety in rats with a model of depression (bilateral olfactory bulbectomy), using the elevated plus-maze test. VIP and a non-specific antagonist, of VIP receptors (VIP6-28) were administered unilaterally into the hippocampal CA1 area of bulbectomized (OBX) rats. VIP (10 ng) showed a tendency for an anxiety-modulatory effect upon right side injection, by reducing significantly the closed arm time and increasing the open arm time. VIP (100 ng) injected unilaterally (left or right) into CA1 area induced an anxiolytic-like effect on the activity of OBX rats (increased the number of open arms entries, open arm time and the ratio open/total number of entries).VIP6-28 failed to antagonize the anxiety-related behavior of OBX rats in the plus maze An unexpected finding in our study was that upon pretreatment with VIP6-28, VIP (10 ng), injected unilaterally (left or right) exerted an anti-anxiety like effect (increased the number of open arm entries, open arm time and the ratio open/total number of entries). Our data point to a possible involvement of hippocampal VIP-ergic neurons in modulating emotional processes or adaptive responses to stressful stimuli in a rat model of depression.	[Ivanova, Margarita; Stoyanov, Zlatislav] Med Univ, Dept Physiol & Pathophysiol, Varna, Bulgaria; [Belcheva, Stiliana; Belcheva, Iren; Tashev, Roman] Bulgarian Acad Sci, Inst Neurobiol, Dept Behav Neurobiol, Sofia, Bulgaria; [Belcheva, Stiliana] SU Sv Kl Ohridsky, Fac Presch & Primary Sch Educ, Sofia, Bulgaria; [Tashev, Roman] Med Univ Sofia, Dept Pathophysiol, Sofia, Bulgaria		Ivanova, M (corresponding author), Med Univ, Dept Physiol & Pathophysiol, Varna, Bulgaria.	msvelikova@yahoo.com		Tashev, Roman/0000-0002-5378-9282	MU-Varna	This study was supported by Grant from MU-Varna.	Acsady L, 1996, NEUROSCIENCE, V73, P299, DOI 10.1016/0306-4522(95)00610-9; Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Agarwal A, 2005, MOL BRAIN RES, V138, P45, DOI 10.1016/j.molbrainres.2005.03.016; Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Belcheva I, 1997, NEUROPEPTIDES, V31, P60, DOI 10.1016/S0143-4179(97)90021-4; Belcheva I, 2009, PEPTIDES, V30, P1497, DOI 10.1016/j.peptides.2009.05.015; CARLSEN J, 1982, J COMP NEUROL, V208, P196, DOI 10.1002/cne.902080208; Ciranna L, 2003, EXP NEUROL, V184, P778, DOI 10.1016/S0014-4886(03)00300-5; COTTRELL GA, 1984, NEUROPEPTIDES, V4, P331, DOI 10.1016/0143-4179(84)90008-8; CULIC M, 1995, NEUROPEPTIDES, V29, P59; Cunha-Reis D, 2004, BRIT J PHARMACOL, V143, P733, DOI 10.1038/sj.bjp.0705989; Degroot A, 2001, PHARMACOL BIOCHEM BE, V69, P391, DOI 10.1016/S0091-3057(01)00541-X; DESOUZA EB, 1985, NEUROSCI LETT, V56, P113, DOI 10.1016/0304-3940(85)90116-8; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; FISHBEIN VA, 1994, PEPTIDES, V15, P95, DOI 10.1016/0196-9781(94)90176-7; GJERRIS A, 1984, J AFFECT DISORDERS, V7, P325, DOI 10.1016/0165-0327(84)90054-5; GOZES I, 1989, MOL NEUROBIOL, V3, P201, DOI 10.1007/BF02740606; HAAS HL, 1992, NEUROSCIENCE, V47, P273, DOI 10.1016/0306-4522(92)90243-U; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Holmes PV, 1999, NEUROPEPTIDES, V33, P206, DOI 10.1054/npep.1999.0031; Holmes PV, 1998, NEUROSCIENCE, V86, P587, DOI 10.1016/S0306-4522(98)00029-3; Huang SK, 1996, NEUROENDOCRINOLOGY, V64, P208, DOI 10.1159/000127119; Ivanova M, 2012, PSYCHOPHARMACOLOGY, V221, P561, DOI 10.1007/s00213-011-2600-1; Ivanova M, 2011, CR ACAD BULG SCI, V64, P599; Ivanova M, 2010, CR ACAD BULG SCI, V63, P1829; JOLKKONEN J, 1991, NEUROPEPTIDES, V19, P97, DOI 10.1016/0143-4179(91)90138-9; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Kingsbury MA, 2013, HORM BEHAV, V64, P511, DOI 10.1016/j.yhbeh.2013.07.004; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Legradi Gabor, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/79102; Markos F, 2002, PHARMACOLOGY, V66, P206, DOI 10.1159/000065535; Markos F, 2001, NEUROPEPTIDES, V35, P238, DOI 10.1054/npep.2001.0881; MASUO Y, 1993, BRAIN RES, V611, P207, DOI 10.1016/0006-8993(93)90504-G; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; Otto C, 2001, MOL BRAIN RES, V92, P78, DOI 10.1016/S0169-328X(01)00153-X; Padovan CM, 2000, PHARMACOL BIOCHEM BE, V67, P325, DOI 10.1016/S0091-3057(00)00361-0; Pellegrino L. J., 1967, STEREOTAXIC ATLAS RA; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Powell KJ, 2002, J PHARMACOL EXP THER, V300, P588, DOI 10.1124/jpet.300.2.588; ROSTENE WH, 1983, J NEUROSCI, V3, P2414; RUIZ JS, 1992, ARCH NEUROBIOL, V55, P1; Saitoh A, 2008, BRAIN RES, V1208, P160, DOI 10.1016/j.brainres.2007.07.095; Saitoh A, 2007, PSYCHOPHARMACOLOGY, V191, P857, DOI 10.1007/s00213-007-0699-x; Sandford JJ, 2000, PHARMACOL THERAPEUT, V88, P197, DOI 10.1016/S0163-7258(00)00082-6; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Staines DR, 2007, MED HYPOTHESES, V69, P1208, DOI 10.1016/j.mehy.2007.04.004; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2000, PHARMACOL REV, V52, P269; Wang DY, 2007, BEHAV BRAIN RES, V178, P262, DOI 10.1016/j.bbr.2007.01.003; Yang K, 2009, HIPPOCAMPUS, V19, P779, DOI 10.1002/hipo.20559; Zaben MJ, 2013, NEUROPEPTIDES, V47, P431, DOI 10.1016/j.npep.2013.10.002	54	13	16	0	4	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2014	74	3					317	327					11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AQ2IJ	WOS:000342608700009	25231851				2022-02-06	
J	Katsifaraki, M; Wood, RL				Katsifaraki, Maria; Wood, Rodger Ll			The impact of alexithymia on burnout amongst relatives of people who suffer from traumatic brain injury	BRAIN INJURY			English	Article						Alexithymia; caregiver burden; emotional burnout	DEPRESSION INVENTORY-II; BLUNT HEAD-INJURY; SOCIAL SUPPORT; VALIDITY; RELIABILITY; SCALE	Background: Although previous research has provided some indication of the association of alexithymia and burnout, this is the first study exploring the association of these two variables in a sample of relatives of individuals who have sustained traumatic brain injury (TBI). Objective: To explore the degree to which relatives experience burnout and the extent to which alexithymia acts as a pre-disposing factor, controlling for depression and coping strategies. Method: Toronto Alexithymia Scale-20, Maslach Burnout Inventory-Human Services, Estonian COPE Dispositional Inventory and Beck Depression Inventory-II were completed by 60 relatives of patients with TBI drawn from a tertiary head injury clinic population. Results: Levels of emotional exhaustion, reduced personal accomplishment and depression were significantly higher in the sub-group of relatives with alexithymia than in the sub-group of relatives without alexithymia. Difficulty describing feelings and externally oriented thinking style were significant predictors of emotional exhaustion, while difficulty identifying feelings and difficulty describing feelings were important predictors of depersonalization. Conclusions: Relatives who present with alexithymia need to be identified at an early stage to minimize risks of burnout leading to adverse effects on patient-caregiver relationships.	[Katsifaraki, Maria; Wood, Rodger Ll] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Katsifaraki, M (corresponding author), Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	mariakatsifaraki@yahoo.gr					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bouteyre E, 2007, STRESS HEALTH, V9, P3, DOI 10.3109/02699052.2014.919538; Bratis D, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-72; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN BW, 1988, FAM RELAT, V37, P12, DOI 10.2307/584423; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cohen J, 1988, STAT POWER ANAL BEHA, DOI DOI 10.3109/02699052.2014.919538; COMPAS BE, 1988, J CONSULT CLIN PSYCH, V56, P405, DOI 10.1037/0022-006X.56.3.405; de Vente W, 2006, PSYCHOTHER PSYCHOSOM, V75, P304, DOI 10.1159/000093953; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; GREEN DE, 1991, J SOC BEHAV PERS, V6, P453; Greenglass ER, 2001, J COMMUNITY APPL SOC, V11, P211, DOI 10.1002/casp.614; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Katsifaraki M, 2013, J NURS EDUC, V52, P627, DOI 10.3928/01484834-20131014-04; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leiter MP, 2003, EMERALD GROUP PUBLIS, V3, P91, DOI DOI 10.1016/S1479-3555(03)03003-8; Lumley MA, 1996, J PSYCHOSOM RES, V41, P519, DOI 10.1016/S0022-3999(96)00227-9; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1986, MASLACH BURNOUT INVE; Mattila AK, 2007, J PSYCHOSOM RES, V62, P657, DOI 10.1016/j.jpsychores.2007.01.002; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Parker JDA, 1998, COMPR PSYCHIAT, V39, P91, DOI 10.1016/S0010-440X(98)90084-0; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; Saarijorvi S, 2001, J PSYCHOSOM RES, V51, P729, DOI 10.1016/S0022-3999(01)00257-4; Schaufeli W. B., 2003, S AFRICAN J IND PSYC, V29, P1, DOI DOI 10.4102/SAJIP.V29I4.127; Spitzer C, 2005, PSYCHOTHER PSYCHOSOM, V74, P240, DOI 10.1159/000085148; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Steer RA, 1997, MEAS EVAL COUNS DEV, V30, P128, DOI 10.1080/07481756.1997.12068933; Sundin L, 2007, INT J NURS STUD, V44, P758, DOI 10.1016/j.ijnurstu.2006.01.004; Taylor G. J., 1997, DISORDERS AFFECT REG; TAYLOR GJ, 1992, PSYCHOTHER PSYCHOSOM, V57, P34, DOI 10.1159/000288571; Vaezi S., 2011, J LANGUAGE TEACHING, V2, P1122, DOI [10.4304/jltr.2.5.1122-1129, DOI 10.4304/JLTR.2.5.1122-1129]; Williams C, 2013, J HEAD TRAUMA REHAB, V28, pE21, DOI 10.1097/HTR.0b013e318267b0ab; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029	47	13	15	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1389	1395		10.3109/02699052.2014.919538			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200005	24945712				2022-02-06	
J	Lee, HD; Jang, SH				Lee, Han Do; Jang, Sung Ho			Changes of an injured fornix in a patient with mild traumatic brain injury: Diffusion tensor tractography follow-up study	BRAIN INJURY			English	Article						Brain plasticity; diffusion tensor imaging; fornix; memory; traumatic brain injury	FIBER TRACTOGRAPHY; AXONAL INJURY	Background: This study investigated the changes of an injured fornix from early stage to chronic stage in a patient with mild traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Methods: A 25-year-old female suffered from head trauma resulting from a pedestrian car accident. The patient showed a total score of 86 for memory impairment on the Memory Assessment Scale at 2 weeks after onset; however, her memory has been recovered to within normal range, with a score of 105 at 9 months after onset. Results: The middle portion of the right fornical crus showed narrowing and the discontinued left fornical crus was shortened on 9-month DTT compared with 2-week DTT. Two branches from the right fornical column and body were observed on 9-month DTT; in contrast, the two branches from the left fornical column and the left fornical body were elongated and shortened, respectively, on 9-month DTT compared with 2-week DTT. Conclusions: The narrowed lesion in the middle of the right fornical crus and the shortening of the discontinued left fornical crus appear to indicate degeneration following traumatic axonal injury. In contrast, the neural branches from both fornices appear to be related to the functional recovery mechanisms of the injured fornix.	[Lee, Han Do; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Thomas AG, 2011, RADIOGRAPHICS, V31, P1107, DOI 10.1148/rg.314105729; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D, 1981, WECHSLER ADULT INTEL; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P1078, DOI 10.2340/16501977-1232; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, YONSEI MED J, V54, P315, DOI 10.3349/ymj.2013.54.2.315; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469	20	13	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1485	1488		10.3109/02699052.2014.930178			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200018	24960471				2022-02-06	
J	Loughan, AR; Perna, R				Loughan, Ashlee R.; Perna, Robert			Performance and Specificity Rates in the Test of Memory Malingering: An Investigation Into Pediatric Clinical Populations	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						clinical diagnosis; neuropsychology; pediatrics; Test of Memory Malingering; TOMM	COGNITIVELY INTACT; NORMATIVE DATA; TOMM; INDIVIDUALS; DEPRESSION	Symptom validity tests are becoming standard as an effort measure during pediatric neuropsychological assessment. An important component of symptom validity test use is understanding limitations of these measures and how select clinical groups may have difficulty with them. Research has begun to clarify the limits of the Test of Memory Malingering (TOMM) with diverse childhood diagnoses. This study compared TOMM scores of children (N = 86) classified with common childhood disorders. Findings suggest that a substantial proportion of children performed below the recommended cutoff score of 45 on Trial 2 and attained varied specificity rates. This included children with conduct disorders (85%), affective disorders (92%), traumatic brain injury (83%), attention-deficit hyperactivity disorder (93%), learning disabilities (100%), and pervasive developmental disorder (88%). The group with the most children scoring below the cutoff was children with intellectual disabilities (76%). This finding is consistent with some of the adult research suggesting that very limited cognitive ability may compromise TOMM performance. Caution may be necessary when drawing conclusions about test-taking effort based on the recommended TOMM cutoff scores when evaluating children with disabilities.	[Loughan, Ashlee R.] Westside NeuroRehabil Serv, Dept Neuropsychol, Goodwill Ind, Lewiston, ME 04240 USA; [Perna, Robert] Walton Rehabil Hosp, Behav Med Dept, Augusta, GA USA		Loughan, AR (corresponding author), Westside NeuroRehabil Serv, Dept Neuropsychol, 618 Main St, Lewiston, ME 04240 USA.	aspicer88@yahoo.com	Perna, Robert/AAA-3871-2020; Perna, Robert/AAQ-7719-2021				Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Gilliam JE, 1995, GILLIAM AUTISM RATIN; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Kovacs M, 1992, CHILD DEPRESSION INV; Langsford S., 2001, PSYCHIATRY, V22, P1; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Simon MJ, 2007, J CLIN PSYCHOL, V63, P339, DOI 10.1002/jclp.20351; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	18	13	13	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2014	3	1					26	30		10.1080/21622965.2012.670584			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AD0TI	WOS:000332946600003	24236938				2022-02-06	
J	Rike, PO; Ulleberg, P; Schultheis, MT; Lundqvist, A; Schanke, AK				Rike, Per-Ola; Ulleberg, Pal; Schultheis, Maria T.; Lundqvist, Anna; Schanke, Anne-Kristine			Behavioural ratings of self-regulatory mechanisms and driving behaviour after an acquired brain injury	BRAIN INJURY			English	Article						Automobile driving; executive function; neuropsychology; personality; self-regulation; stroke; traumatic brain injuries	EXECUTIVE FUNCTION; ACCIDENT RATE; FOLLOW-UP; PERSONALITY; DRIVERS; STROKE; PREDICTORS; AWARENESS; FITNESS; ABILITY	Objective: To explore whether measurements of self-regulatory mechanisms and cognition predict driving behaviour after an acquired brain injury (ABI). Design: Consecutive follow-up study. Participants: At baseline participants included 77 persons with stroke and 32 persons with a traumatic brain injury (TBI), all of whom completed a multidisciplinary driving assessment (MDA). A follow-up cohort of 34 persons that succeeded the MDA was included. Baseline measurements: Neuropsychological tests and measurements of self-regulatory mechanisms (BRIEF-A and UPPS Impulsive Behaviour Scale), driving behaviour (DBQ) and pre-injury driving characteristics (mileage, compensatory driving strategies and accident rates). Follow-up measurements: Post-injury driving characteristics were collected by mailed questionnaires from the participants who succeeded the MDA. Methods: A MDA, which included a medical examination, neuropsychological testing and an on-road driving test, was considered in the decision for or against granting a driver's license. Self-regulatory mechanisms and driving behaviour were examined for research purposes only. Results: At baseline, self-regulatory mechanisms were significantly associated to aberrant driving behaviour, but not with neuropsychological data or with the outcome of the on-road driving test. Aspects of self-regulation were associated to driving behaviour at follow-up. Conclusion: It is recommended that self-regulatory measurements should regularly be considered in the driving assessments after ABI.	[Rike, Per-Ola; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway; [Ulleberg, Pal; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Lundqvist, Anna] Linkoping Univ Hosp, Dept Rehabil Med, S-58185 Linkoping, Sweden		Rike, PO (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.	perola.rike@gmail.com		Schultheis, Maria/0000-0002-6558-548X	Extrastiftelsen [2008/2/0113]	The authors thank all persons for their participation and Frank Becker, MD, for the medical data quality assurance. The study was supported by grants from Extrastiftelsen (grant number 2008/2/0113).	Aberg L, 1998, ERGONOMICS, V41, P39, DOI 10.1080/001401398187314; Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Af Wahlberg A, 2011, THEOR ISS ERGON SCI, V12, P66, DOI 10.1080/14639220903023376; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Baumeister Roy, 2011, HDB SELF REGULATION; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Costa P. T., 1992, REVISED NEO PERSONAL; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; de Winter JCF, 2011, THEORETICAL ISSUES E, V13, P528; Delis D. C., 2001, EXAMINERS MANUAL DEL; Dolan SL, 2008, BEHAV SCI LAW, V26, P799, DOI 10.1002/bsl.845; Ellekjaer Hanne, 2007, Tidsskr Nor Laegeforen, V127, P740; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Galovski Tara E, 2006, ROAD RAGE ASSESSMENT, Vxi, P83, DOI [10.1037/11297-005, DOI 10.1037/11297-005]; Gianutsos R, 1981, COMPUTER PROGRAMS CO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; GRIFFITHS KM, 1988, J CLIN EXP NEUROPSYC, V10, P800, DOI 10.1080/01688638808402815; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hatakka M., 2002, TRANSPORT RES F TRAF, V5, P201, DOI 10.1016/s1369-8478(02)00018-9; Heaton RK, 1991, COMPREHENSIVE NORMS; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lundberg C, 2003, SCAND J PSYCHOL, V44, P23, DOI 10.1111/1467-9450.00317; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Morris LJ, 2008, RELATIONSHIPS AGE EX; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Nichols AL, 2012, TRAFFIC INJ PREV, V13, P133, DOI 10.1080/15389588.2011.644254; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peden M., 2004, WORLD REPORT ROAD TR; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Pietrzak RH, 2008, J RES PERS, V42, P1347, DOI 10.1016/j.jrp.2008.03.004; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Roca J, 2013, TRANSPORT RES F-TRAF, V17, P98, DOI 10.1016/j.trf.2012.10.005; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rodriguez-Bailon M, 2012, SPAN J PSYCHOL, V15, P967, DOI 10.5209/rev_SJOP.2012.v15.n3.39388; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Schwebel DC, 2007, J SAFETY RES, V38, P501, DOI 10.1016/j.jsr.2007.04.005; Scott CA, 2009, J CLIN EXP NEUROPSYC, V31, P353, DOI 10.1080/13803390802169067; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Smith A., 1982, SYMBOL DIGITS MODALI; Sommer M, 2010, ARCH CLIN NEUROPSYCH, V25, P99, DOI 10.1093/arclin/acp109; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Stuss D. T., 2009, REHABILITATION EXECU, P3; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sumer N, 2003, ACCIDENT ANAL PREV, V35, P949, DOI 10.1016/S0001-4575(02)00103-3; SUNDET K, 1995, SCAND J PSYCHOL, V36, P47, DOI 10.1111/j.1467-9450.1995.tb00967.x; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; TEMPLE CM, 1997, DEV COGNITIVE NEUROP; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Ulleberg P, 2002, SCAND J PSYCHOL, V43, P227, DOI 10.1111/1467-9450.00291; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, Vxiv, P479; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; [No title captured]	87	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1687	1699		10.3109/02699052.2014.947632			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600008	25158241				2022-02-06	
S	Rispoli, M; Machalicek, W; Lang, R		Lancioni, GE; Singh, NN		Rispoli, Mandy; Machalicek, Wendy; Lang, Russell			Assistive Technology for People with Acquired Brain Injury	ASSISTIVE TECHNOLOGIES FOR PEOPLE WITH DIVERSE ABILITIES	Autism and Child Psychopathology Series		English	Article; Book Chapter							POST-COMA PERSONS; MINIMALLY CONSCIOUS STATE; PROFOUND MULTIPLE DISABILITIES; PORTABLE ELECTRONIC DEVICES; CLOSED HEAD-INJURY; VIRTUAL-REALITY; COGNITIVE REHABILITATION; ENVIRONMENTAL STIMULI; MEMORY AID; COMMUNICATION OPPORTUNITIES		[Rispoli, Mandy] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Machalicek, Wendy] Univ Oregon, Dept Special Educ & Clin Sci, Eugene, OR 97403 USA; [Lang, Russell] SW Texas State Univ, Dept Curriculum & Instruct, San Marcos, TX 78666 USA		Rispoli, M (corresponding author), Texas A&M Univ, Dept Educ Psychol, MS 4225 TAMU, College Stn, TX 77843 USA.	mrispoli@tamu.edu					[Anonymous], 1998, ASSIST TECHNOL; [Anonymous], 2004, ASSIST TECHNOL; Anschutz JR, 2010, TOP STROKE REHABIL, V17, P337, DOI 10.1310/tsr1705-337; Beck A. R., 1998, AUGMENTATIVE ALTERNA, V14, P184; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Beukelman D. R., 1991, SURVEY AAC AUGMENTAT, V7, P100; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Broeren J, 2008, CEREBROVASC DIS, V26, P289, DOI 10.1159/000149576; Canedo A, 2002, BRAIN INJURY, V16, P453, DOI 10.1080/02699050110119853; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Crosbie JH, 2007, DISABIL REHABIL, V29, P1139, DOI 10.1080/09638280600960909; de Joode E, 2012, DISABIL REHABIL-ASSI, V7, P389, DOI 10.3109/17483107.2011.644623; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Doherty EP, 2002, INTERACT COMPUT, V14, P341, DOI 10.1016/S0953-5438(02)00022-X; Dry A, 2006, ASSIST TECHNOL, V18, P170, DOI 10.1080/10400435.2006.10131916; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fong K. N., 2010, J NEUROENG REHABIL, V30, P7; Fox LE, 2000, AUG ALTER COMMUN SER, P3; Fox LE, 2001, APHASIOLOGY, V15, P171, DOI 10.1080/02687040042000133; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; Garrett K. L., 1989, AUGMENT ALTERN COMM, V5, P55, DOI [10.1080/07434618912331274976, DOI 10.1080/07434618912331274976]; Gartland D, 2004, NEUROPSYCHOL REHABIL, V14, P61, DOI 10.1080/09602010343000165; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Gorman P, 2003, NEUROREHABILITATION, V18, P57; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hartmann KD, 2010, WORK, V36, P399, DOI 10.3233/WOR-2010-1048; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Holburn S, 2004, BEHAV INTERVENT, V19, P25, DOI 10.1002/bin.147; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Hux K, 2010, APHASIOLOGY, V24, P643, DOI 10.1080/02687030902869299; Inge KJ, 2000, NEUROREHABILITATION, V15, P175; JOHANNSENHORBACH H, 1985, BRAIN LANG, V24, P74, DOI 10.1016/0093-934X(85)90098-7; Johnson RK, 2008, AUGMENT ALTERN COMM, V24, P269, DOI 10.1080/07434610802463957; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kapur N., 2002, HDB MEMORY DISORDERS, P757; Kimberly MHA, 2005, AUGMENT ALTERN COMM, V21, P218, DOI 10.1080/07434610400016694; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; Klarborg B, 2012, ACCIDENT ANAL PREV, V48, P57, DOI 10.1016/j.aap.2011.05.004; Lancioni GE, 2008, RES DEV DISABIL, V29, P21, DOI 10.1016/j.ridd.2006.10.001; Lancioni GE, 2007, RES DEV DISABIL, V28, P50, DOI 10.1016/j.ridd.2005.12.001; Lancioni GE, 2006, RES DEV DISABIL, V27, P290, DOI 10.1016/j.ridd.2005.02.003; Lancioni GE, 2013, RES DEV DISABIL, V34, P809, DOI 10.1016/j.ridd.2012.10.008; Lancioni GE, 2012, RES DEV DISABIL, V33, P1964, DOI 10.1016/j.ridd.2012.05.027; Lancioni GE, 2012, RES DEV DISABIL, V33, P670, DOI 10.1016/j.ridd.2011.11.007; Lancioni GE, 2011, RES DEV DISABIL, V32, P1703, DOI 10.1016/j.ridd.2011.02.025; Lancioni GE, 2011, RES DEV DISABIL, V32, P1638, DOI 10.1016/j.ridd.2011.02.016; Lancioni GE, 2011, DISABIL REHABIL-ASSI, V6, P412, DOI 10.3109/17483107.2011.580899; Lancioni GE, 2011, J DEV PHYS DISABIL, V23, P173, DOI 10.1007/s10882-010-9212-2; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lancioni GE, 2010, PERCEPT MOTOR SKILL, V110, P488, DOI 10.2466/PMS.110.2.488-492; Lancioni GE, 2009, DISABIL REHABIL-ASSI, V4, P367, DOI 10.1080/17483100903038584; Lancioni GE, 2010, J DEV PHYS DISABIL, V22, P119, DOI 10.1007/s10882-009-9163-7; Lancioni GE, 2009, RES DEV DISABIL, V30, P1084, DOI 10.1016/j.ridd.2009.03.004; Lancioni GE, 2009, RES DEV DISABIL, V30, P689, DOI 10.1016/j.ridd.2008.09.002; Lane AK, 2011, NEUROREHABILITATION, V28, P221, DOI 10.3233/NRE-2011-0651; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Lemoncello R, 2010, BRAIN INJURY, V24, P550, DOI 10.3109/02699050903446807; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Linden A, 2011, DISABIL REHABIL-ASSI, V6, P214, DOI 10.3109/17483107.2010.528142; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McKelvey ML, 2007, J MED SPEECH-LANG PA, V15, P305; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; National Association of State Head Injury Administrators, 2006, TRAUMATIC BRAIN INJU; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Renton L. B. M., 1997, BRIT J OCCUPATIONAL, V60, P199; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; SANDLER AB, 1992, AM J OCCUP THER, V46, P163, DOI 10.5014/ajot.46.2.163; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30, DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30]; Schultheis MT, 2007, ASSIST TECHNOL, V19, P1, DOI 10.1080/10400435.2007.10131860; Singh S, 2000, APHASIOLOGY, V14, P157, DOI 10.1080/026870300401531; Sohlberg MM, 2007, BRAIN INJURY, V21, P531, DOI 10.1080/02699050701311000; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; U. S. Department of Health and Human Services Center for Disease Control, 2010, INJ PREV CONTR TRAUM; U. S. Department of Health and Human Services Center for Disease Control., 2012, STROK RISK FACT; U. S. Department of Health and Human Services National Institutes of Health, 1999, NIH CONS DEV C STAT; U. S. Department of Health and Human Services National Institutes of Health, 2013, NINDS TRAUM BRAIN IN; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Van Hulle A, 2006, BRAIN INJURY, V20, P101, DOI 10.1080/02699050500309684; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wald J, 2001, ST HEAL T, V81, P564; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace T, 2011, NEUROREHABILITATION, V28, P199, DOI 10.3233/NRE-2011-0649; Watson M., 1999, BRIT J THERAPY REHAB, V6, P436; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	116	13	13	0	7	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	2192-922X		978-1-4899-8029-8; 978-1-4899-8028-1	AUT CHILD PSYCHO			2014							21	52		10.1007/978-1-4899-8029-8_2	10.1007/978-1-4899-8029-8		32	Psychology, Developmental; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Rehabilitation	BB6LI	WOS:000344864800003					2022-02-06	
J	Shao, S; Huang, XT; Wang, YC; He, S; Xu, XH; Zhu, XH; Yang, XJ; Ding, ZM; Yao, L; Huang, YJ; Wang, C				Shao, Shan; Huang, Xianting; Wang, Yuchan; He, Song; Xu, Xiaohong; Zhu, Xinghua; Yang, Xiaojing; Ding, Zongmei; Yao, Li; Huang, Yuejiao; Wang, Chun			A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						AGS3; MM; Apoptosis; CAM-DR	MEDIATED DRUG-RESISTANCE; RECEPTOR-INDEPENDENT ACTIVATORS; TRAUMATIC BRAIN-INJURY; CELL-ADHESION; CAM-DR; BCL-2 EXPRESSION; REGULATOR AGS3; IN-VITRO; ALPHA; CREB	Previous studies have demonstrated that activator of G-protein signaling 3 (AGS3; also known as GPSM1), a member of the AGS family, plays an important anti-apoptotic role through enhancing the phosphorylation of cyclic AMP response element-binding protein (p-CREB). In this report, we delineate the anti-apoptotic role of AGS3 in multiple myeloma (MM). To do this, we developed a cell apoptotic model induced by doxorubicin in MM. Our data indicate that decreased expression of AGS3 is correlated with reduced levels of p-CREB in the apoptotic model. The negative role of AGS3 in cell apoptosis was further confirmed by knocking down AGS3. The microenvironment has been shown to influence tumor cell phenotype in response to chemotherapy. Since cell adhesion-mediated drug resistance remains a major obstacle for successful treatment of MM, we constructed a cell adhesion model in MM and detected the changing of AGS3 protein expression. AGS3 siRNA reversed the high rate of MM cell adhesion to either fibronectin or HS-5 cells. Consistent with the reduced adhesion rate, the cells also exhibited reduced drug resistance to doxorubicin, mitoxantrone, and dexamethasone. Collectively, these data indicate that AGS3 may be represented as a good candidate for pursuing clinical trials in MM. Moreover, our data provide a clinical therapeutic target for MM and potentially other tumors that home and/or metastasize to the bone.	[Shao, Shan; Wang, Chun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China; [Huang, Xianting; Wang, Yuchan; Yang, Xiaojing; Ding, Zongmei; Yao, Li; Huang, Yuejiao] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China; [He, Song; Xu, Xiaohong] Nantong Univ, Canc Hosp, Dept Pathol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Xiaohong] Nantong Univ, Canc Hosp, Dept Hematol, Nantong 226001, Jiangsu, Peoples R China		Wang, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China.	wangchunmd@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201858]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2012231]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81201858) and Natural Science Foundation of Jiangsu province Grant (BK2012231); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Anderson Kenneth C., 2000, Hematology Am Soc Hematol Educ Program, P147; Balakumaran A, 2010, EXPERT REV MOL DIAGN, V10, P465, DOI [10.1586/erm.10.31, 10.1586/ERM.10.31]; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Clark RSB, 1997, J NEUROSCI, V17, P9172; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Emmons MF, 2011, MOL CANCER THER, V10, P2257, DOI 10.1158/1535-7163.MCT-11-0149; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gauduchon J, 2005, CLIN CANCER RES, V11, P2345, DOI 10.1158/1078-0432.CCR-04-1668; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Lee SW, 2012, IMMUNOL LETT, V144, P41, DOI 10.1016/j.imlet.2012.03.005; Li B, 2013, LEUKEMIA RES, V37, P50, DOI 10.1016/j.leukres.2012.08.027; Lin J, 2013, ONCOL REP, V30, P731, DOI 10.3892/or.2013.2489; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tohnya TM, 2004, CANCER BIOL THER, V3, P1060, DOI 10.4161/cbt.3.11.1303; Wang W, 2013, J NEUROSCI RES, V91, P726, DOI 10.1002/jnr.23195; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yanamandra N, 2006, CLIN CANCER RES, V12, P591, DOI 10.1158/1078-0432.CCR-05-1792; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272	40	13	14	0	7	SPRINGER JAPAN KK	TOKYO	SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	JAN	2014	99	1					57	68		10.1007/s12185-013-1484-8			12	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	AA3KE	WOS:000330990500008	24307516				2022-02-06	
J	Shen, LJ; Yang, SB; Lv, QW; Zhang, GH; Zhou, J; Guo, M; Huang, HB; Li, Z; Yang, CS				Shen, Liang-Jun; Yang, Song-Bin; Lv, Qing-Wei; Zhang, Guo-Hai; Zhou, Jing; Guo, Mi; Huang, Hang-Bin; Li, Zhao; Yang, Chun-Song			High plasma adiponectin levels in patients with severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Adiponectin; Prognosis; Biomarker	CORONARY-HEART-DISEASE; SERUM ADIPONECTIN; MYOCARDIAL-INFARCTION; INDEPENDENT PREDICTOR; MORTALITY; LEPTIN; MEN; ASSOCIATION; RESISTIN; DECREASE	Background: Adiponectin plays an important role in the regulation of tissue inflammation. There is a paucity of data on circulating plasma adiponectin concentrations in human traumatic brain injury. This study is designed to investigate the potential associations between plasma adiponectin levels and clinical outcomes after traumatic brain injury. Methods: Plasma adiponectin levels of 86 patients with severe traumatic brain injury and 86 healthy subjects were determined. Clinical outcomes included in-hospital mortality, 6-month mortality and 6-month unfavorable outcome (Glasgow Outcome Scale score of 1-3). Results: Plasma adiponectin levels were significantly higher in patients compared to controls (20.5 +/- 5.9 vs. 7.7 +/- 2.0 mu g/ml; P< 0.001) and emerged as an independent predictor of in-hospital mortality [odds ratio (OR), 1318; 95% confidence interval (CI), 1.049-1.629; P = 0.0081, 6-month mortality (OR, 1328; 95% CI, 1.082-1.657; P = 0.007) and 6-month unfavorable outcome (OR, 1240; 95% CI, 1.066-1.443; P = 0.005) in a multivariate analysis. For predicting these clinical outcomes, areas under receiver operating characteristic curve of plasma adiponectin level were similar to those of Glasgow Coma scale scores (all P> 0.05). However, adiponectin did not improve predictive values of Glasgow Coma scale scores (all P> 0.05). Conclusion: Plasma adiponectin level may represent a novel biomarker for predicting clinical outcomes of traumatic brain injury. (C) 2013 Elsevier B.V. All rights reserved.	[Shen, Liang-Jun; Yang, Song-Bin; Lv, Qing-Wei; Zhang, Guo-Hai; Zhou, Jing; Guo, Mi; Huang, Hang-Bin; Li, Zhao; Yang, Chun-Song] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou 312400, Peoples R China		Shen, LJ (corresponding author), Shengzhou Peoples Hosp, Dept Neurosurg, 208 Yiyuan Rd, Shenzhou 312400, Peoples R China.	shengzhoushenlj@163.com			Shaoxing Science and Technology Research Fund Project [2012D10002]	The authors thank all staffs in the Department of Neurosurgery, Shengzhou People's Hospital (Shengzhou, China) for their technical support. This study was supported by a grant from the Shaoxing Science and Technology Research Fund Project (No. 2012D10002).	Blaslov K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/535906; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002; Chen MP, 2005, ARTERIOSCL THROM VAS, V25, P821, DOI 10.1161/01.ATV.0000157784.25920.a7; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Frystyk J, 2007, J CLIN ENDOCR METAB, V92, P571, DOI 10.1210/jc.2006-1067; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kizer JR, 2008, J CLIN ENDOCR METAB, V93, P3357, DOI 10.1210/jc.2008-0640; Marousi S, 2010, ACTA NEUROL SCAND, V121, P277, DOI 10.1111/j.1600-0404.2009.01231.x; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Nagasawa H, 2011, J NEUROL SCI, V304, P102, DOI 10.1016/j.jns.2011.02.002; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P4277, DOI 10.1210/jc.2006-0836; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Sada KE, 2006, J RHEUMATOL, V33, P1545; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Takeuchi S, 2013, TURK NEUROSURG, V23, P349, DOI 10.5137/1019-5149.JTN.7023-12.1; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang WH, 2011, CLIN CHIM ACTA, V412, P1626, DOI 10.1016/j.cca.2011.05.016; Yatomi K, 2009, BRAIN RES, V1297, P169, DOI 10.1016/j.brainres.2009.08.039	28	13	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 1	2014	427				SI		37	41		10.1016/j.cca.2013.09.047			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	AA0WX	WOS:000330819200010	24099881				2022-02-06	
J	Tsai, MC; Tsai, KJ; Wang, HK; Sung, PS; Wu, MH; Hung, KW; Lin, SH				Tsai, Meng-Che; Tsai, Kuen-Jer; Wang, Hao-Kuang; Sung, Pi-Shan; Wu, Ming-Hsiu; Hung, Kuo-Wei; Lin, Sheng-Hsiang			Mood Disorders after Traumatic Brain Injury in Adolescents and Young Adults: A Nationwide Population-Based Cohort Study	JOURNAL OF PEDIATRICS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; CHILDREN; TAIWAN; PREVALENCE; PREDICTORS; SEVERITY; PATTERNS	Objective To delineate the relationship between traumatic brain injury (TBI) and mood disorders from population-based data in Taiwan. Study design This prospectively followed cohort study involved a subset of the National Health Insurance Research Database containing complete inpatient and outpatient data of 1 million randomly drawn beneficiaries. We included 10- to 24-year-old patients (n = 15 203) receiving the diagnosis of TBI in ambulatory visits or hospitalization from 2000-2004 and their age-and sex-matched comparison insureds using health service in the same year (n = 76 015). Diagnosis of mood disorders was recorded within 5 years after the traumatic event or index use of health service. Baseline demographics, clinical characteristics, and premorbid psychiatric conditions were compared using chi(2) analysis. Increased risk during the 5-year follow-up period was represented by crude and adjusted hazard ratios with 95% CI using a Cox proportional hazard regression. Results A total of 451/15 203 patients with TBI (2.97%) received a diagnosis of mood disorders in the 5-year follow-up period compared with 1153/97 445 individuals (1.52%) without antecedent TBI. After adjusting for select premorbid comorbidities, TBI remained a significant predisposing factor with a 1.96-fold (95% CI 1.74-2.22) increase in risk of mood disorders. Conclusions Our findings show a higher likelihood of manifesting mood disorders in adolescents and young adults who sustained a prior TBI. Health professionals should carefully monitor both the physical and psychological impacts of head trauma.	[Tsai, Meng-Che; Tsai, Kuen-Jer; Wang, Hao-Kuang; Sung, Pi-Shan; Wu, Ming-Hsiu; Hung, Kuo-Wei; Lin, Sheng-Hsiang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Tsai, Meng-Che] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70101, Taiwan; [Wang, Hao-Kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Sung, Pi-Shan] Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan, Taiwan; [Wu, Ming-Hsiu] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hung, Kuo-Wei] Yuans Gen Hosp, Dept Neurol, Kaohsiung, Taiwan		Lin, SH (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, 138 Shengli Rd, Tainan 70101, Taiwan.	shlin922@mail.ncku.edu.tw	Tsai, Kuen-Jer/AAZ-2714-2021; Tsai, Kuen-Jer/B-9393-2009; Tsai, Meng-Che/AAE-6715-2021	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Meng-Che/0000-0003-1057-3315; Wang, Hao-Kuang/0000-0002-1928-7502	National Cheng Kung University Hospital [NCKUH-10001022]	Supported by the National Cheng Kung University Hospital (NCKUH-10001022). The authors declare no conflicts of interest.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Capizzano AA, 2010, J NEUROPSYCH CLIN N, V22, P370, DOI 10.1176/appi.neuropsych.22.4.370; Chang RE, 2002, J FORMOS MED ASSOC, V101, P52; Chen CF, 2009, ACCIDENT ANAL PREV, V41, P963, DOI 10.1016/j.aap.2009.05.013; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chen M-S, 2005, TW J PUBLIC HLTH, V24, P15; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Goldstein BI, 2012, ARCH PEDIAT ADOL MED, V166, P362, DOI 10.1001/archpediatrics.2011.832; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Lau JYF, 2008, J CHILD PSYCHOL PSYC, V49, P142, DOI 10.1111/j.1469-7610.2007.01803.x; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lundy CT, 2010, EMERG MED J, V27, P659, DOI 10.1136/emj.2009.079020; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Tsai MC, 2013, ARCH DIS CHILD, V98, P9, DOI 10.1136/archdischild-2012-301629; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wang JY, 2012, INT J SOC PSYCHIATR, V58, P425, DOI 10.1177/0020764011408000; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	37	13	13	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JAN	2014	164	1					136	+		10.1016/j.jpeds.2013.08.042			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	276FU	WOS:000328734700031	24112864				2022-02-06	
J	Wehman, P; Chen, CC; West, M; Cifu, G				Wehman, Paul; Chen, Chin-Chih; West, Michael; Cifu, Gabriella			Transition planning for youth with traumatic brain injury: Findings from the National Longitudinal Transition Survey-2	NEUROREHABILITATION			English	Article						Traumatic brain injury; school-to-work transition; postschool outcomes	SHORT-TERM; OUTCOMES; PREDICTORS; BEHAVIOR; WORK	BACKGROUND: Despite of a growing body of research on vocational and educational difficulties for students with traumatic brain injury (TBI), only limited empirical studies specifically examined how school transition services facilitate later employment outcomes. OBJECTIVE: This exploratory, prospective longitudinal study examined the prevalence of employment and characteristics of transition planning practices that promoted positive school-to-work transition for students with TBI. METHOD: The participants (n = 200) was drawn from the National Longitudinal Transition Study-2 (NLTS-2), a ten-year study which followed a large nationally representative sample of youth with disabilities through secondary education in into young adulthood. Logistic regression was used to investigate the associations between student, school, and collaborative engagement in the planning process and employment outcomes up to 8 years after high school. RESULTS: Among youth with TBI, 51% held current employment at the time of interview and 73% had been employed at any time after high school. Findings showed that students with TBI who had transition goals for postsecondary education were more likely to be employed at some point since leaving high school. The findings also support active student engagement and leadership in the transition planning process, and the inclusion of outside organizations and individuals. CONCLUSIONS: Findings indicate the impact of student, school and adult service agency engagement in transition planning processes. Implications for educational practices and future research are discussed.	[West, Michael; Cifu, Gabriella] Virginia Commonwealth Univ, Rehabil Res & Training Ctr, Richmond, VA 23284 USA; [Wehman, Paul] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Chen, Chin-Chih] Virginia Commonwealth Univ, Sch Educ, Richmond, VA USA		West, M (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr, Richmond, VA 23284 USA.	mdwest@vcu.edu	Chen, Chin-Chih/AAI-3139-2021	Chen, Chin-Chih/0000-0002-9503-8145	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133A100007]	Preparation of this manuscript was supported in part by Cooperative Agreement H133A100007 from the National Institute on Disability and Rehabilitation Research, U.S. Department of Education.	Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Cameto R., 2005, NLTS2 DATA BRIEF TRA; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, INTELLECT DEV DISAB, V49, P233, DOI 10.1352/1934-9556-49.4.233; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Cimera R. E., 2007, J VOCATIONAL REHABIL, V28, P15; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kaye HS, 2010, MON LABOR REV, V133, P19; Landmark LJ, 2010, CAREER DEV TRANSIT E, V33, P165, DOI 10.1177/0885728810376410; Martin JE, 2006, EXCEPT CHILDREN, V72, P299, DOI 10.1177/001440290607200303; Migliore A, 2007, J VOCAT REHABIL, V26, P5; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Test DW, 2009, CAREER DEV TRANSIT E, V32, P115, DOI 10.1177/0885728809336859; Thurman D. J., 2013, BRAIN INJURY MED PRI, P45; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Wagner M., 2012, J EMOT BEHAV DISORD, V14, P86; WEHMAN P, 2013, LIFE CLASSROOM TRANS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	23	13	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	2					365	372		10.3233/NRE-131029			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG3NM	WOS:000335326300018	24419015				2022-02-06	
J	West, TA; Sharp, S				West, Therese A.; Sharp, Stephen			Neuroendocrine dysfunction following mild TBI: When to screen for it	JOURNAL OF FAMILY PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; SECONDARY		[West, Therese A.] Def Ctr Excellence Psychol Hlth, Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [West, Therese A.] Def Ctr Traumat Brain, Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Sharp, Stephen] Walter Reed Natl Mil Med Ctr, Dept Anesthesia, Bethesda, MD USA; [Sharp, Stephen] Walter Reed Natl Mil Med Ctr, Dept Neurol, Bethesda, MD USA		West, TA (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,6th Floor, Silver Spring, MD 20910 USA.	therese.a.west.ctr@mail.mil					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Amar AP, 2003, NEUROSURG CLIN N AM, V14, P11, DOI 10.1016/S1042-3680(02)00017-7; Armed Forces Surveillance Center, DOD WORLDW NUMB TBI; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Defense Centers of Excellence, 2012, NEUR SCREEN POSTM TB; Department of Veterans Affairs, VA DOD CLIN PRACT GU; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011	24	13	13	0	3	DOWDEN HEALTH MEDIA	MONTVALE	110 SUMMIT AVE, MONTVALE, NJ 07645-1712 USA	0094-3509			J FAM PRACTICE	J. Fam. Pract.	JAN	2014	63	1					11	16					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298BD	WOS:000330298000005	24475461				2022-02-06	
J	Rognas, L; Hansen, TM; Kirkegaard, H; Tonnesen, E				Rognas, Leif; Hansen, Troels Martin; Kirkegaard, Hans; Tonnesen, Else			Standard operating procedure changed pre-hospital critical care anaesthesiologists' behaviour: a quality control study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Pre hospital; Out of hospital; Prehospital emergency care (MeSH); Emergency medical services (MeSH); Helicopter emergency medical service; Critical care (MeSH); Controlled ventilation; Standard operating procedure; Airway management (MeSH); Endotracheal intubation (MeSH); Patient safety	ADVANCED AIRWAY MANAGEMENT; TRAUMATIC BRAIN-INJURY; TIDAL VOLUME; VENTILATION; GUIDELINES; RESUSCITATION; INTUBATION; COUNCIL; DISEASE	Introduction: The ability of standard operating procedures to improve pre-hospital critical care by changing pre-hospital physician behaviour is uncertain. We report data from a prospective quality control study of the effect on pre-hospital critical care anaesthesiologists' behaviour of implementing a standard operating procedure for pre-hospital controlled ventilation. Materials and methods: Anaesthesiologists from eight pre-hospital critical care teams in the Central Denmark Region prospectively registered pre-hospital advanced airway-management data according to the Utstein-style template. We collected pre-intervention data from February 1st 2011 to January 31st 2012, implemented the standard operating procedure on February 1st 2012 and collected post intervention data from February 1st 2012 until October 31st 2012. We included transported patients of all ages in need of controlled ventilation treated with pre-hospital endotracheal intubation or the insertion of a supraglottic airways device. The objective was to evaluate whether the development and implementation of a standard operating procedure for controlled ventilation during transport could change pre-hospital critical care anaesthesiologists' behaviour and thereby increase the use of automated ventilators in these patients. Results: The implementation of a standard operating procedure increased the overall prevalence of automated ventilator use in transported patients in need of controlled ventilation from 0.40 (0.34-0.47) to 0.74 (0.69-0.80) with a prevalence ratio of 1.85 (1.57-2.19) (p = 0.00). The prevalence of automated ventilator use in transported traumatic brain injury patients in need of controlled ventilation increased from 0.44 (0.26-0.62) to 0.85 (0.62-0.97) with a prevalence ratio of 1.94 (1.26-3.0) (p = 0.0039). The prevalence of automated ventilator use in patients transported after return of spontaneous circulation following pre-hospital cardiac arrest increased from 0.39 (0.26-0.48) to 0.69 (0.58-0.78) with a prevalence ratio of 1.79 (1.36-2.35) (p = 0.00). Conclusion: We have shown that the implementation of a standard operating procedure for pre-hospital controlled ventilation can significantly change pre-hospital critical care anaesthesiologists' behaviour.	[Rognas, Leif] Norwegian Air Ambulance Fdn, Dept Res & Dev, N-1441 Drobak, Norway; [Rognas, Leif] Viborg Reg Hosp, Dept Anaesthesiol, Prehosp Crit Care Team, DK-8800 Viborg, Denmark; [Rognas, Leif; Hansen, Troels Martin] Aarhus Univ Hosp, Prehosp Crit Care Team, DK-8200 Aarhus N, Denmark; [Rognas, Leif; Hansen, Troels Martin] Dept Prehosp Med Serv, DK-8200 Aarhus N, Denmark; [Kirkegaard, Hans] Aarhus Univ Hosp, Ctr Emergency Med Res, DK-8200 Aarhus N, Denmark; [Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol, DK-8000 Aarhus, Denmark		Rognas, L (corresponding author), Norwegian Air Ambulance Fdn, Dept Res & Dev, POB 94, N-1441 Drobak, Norway.	leifrogn@rm.dk	Rognas, Leif/AAF-6182-2020; Rognas, Leif/AAI-9373-2020	Rognas, Leif/0000-0002-2542-565X	Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine; Central Denmark Region	A special thanks to EMT Tinna Hojmose Ostergaard for her invaluable assistance in all the practicalities of the implementation and data collection. The Norwegian Air Ambulance Foundation, The Laerdal Foundation for Acute Medicine and The Central Denmark Region founded the study by sponsoring the salary of LR. TMH, HK and ET were funded by their departments. The sponsors have had no influence on study design, data collection, data analysis and-interpretation, the writing of the manuscript or the decision to submit the paper for publication.	[Anonymous], 2000, NEW ENGL J MED, V342, P1301; Bosse G, 2011, J INT MED RES, V39, P267, DOI 10.1177/147323001103900129; Bosse G, 2006, BEST PRACT RES-CLIN, V20, P379, DOI 10.1016/j.bpa.2006.02.005; CHESTERS A, 2013, EMERGENCY MED J EMJ, V2013, P2013, DOI DOI 10.1136/EMERMED-2012-201846; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; de Oliveira RP, 2010, CRIT CARE, V14, DOI 10.1186/cc8919; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Forsetlund Louise, 2002, J Health Serv Res Policy, V7, P10, DOI 10.1258/1355819021927629; Francis RC, 2013, EUR J EMERG MED; Francis RCE, 2010, EMERG MED J, V27, P350, DOI 10.1136/emj.2008.070284; Haines A, 2001, EVIDENCE BASED PRACT, P157; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Hejselbaek J, 2012, DAN MED J, V59; Lee HM, 2008, EMERG MED J, V25, P632, DOI 10.1136/emj.2007.053678; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; OXMAN AD, 2001, EVIDENCE BASED PRACT, P101; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-75; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Rognas LK, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-10; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25	28	13	13	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 5	2013	21								84	10.1186/1757-7241-21-84			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	282OB	WOS:000329180200001	24308781	Green Published, gold			2022-02-06	
J	Forcelli, PA; Kalikhman, D; Gale, K				Forcelli, Patrick A.; Kalikhman, David; Gale, Karen			Delayed Effect of Craniotomy on Experimental Seizures in Rats	PLOS ONE			English	Article							EMBRYONIC DOPAMINE NEURONS; SEVERE PARKINSONS-DISEASE; SHAM NEUROSURGICAL PROCEDURES; INTRACTABLE PARTIAL EPILEPSY; TRAUMATIC BRAIN-INJURY; ELECTRICAL-STIMULATION; DEPTH ELECTRODES; ANTERIOR NUCLEUS; GENE-EXPRESSION; CLINICAL-TRIALS	Neurosurgical therapeutic interventions include components that are presumed to be therapeutically inert, such as craniotomy and electrode implantation. Because these procedures may themselves exert neuroactive actions, with anecdotal evidence suggesting that craniotomy and electrode placement may have a particularly significant impact on epileptic seizures, the importance of their inclusion in sham control groups has become more compelling. Here we set out to test the hypothesis that craniotomy alone is sufficient to alter experimental seizures in rats. We tested adult male rats for seizures evoked by pentylenetetrazole (70 mg/kg) between 3 and 20 days following placement of bilateral craniotomies (either 2.5 or 3.5 mm in diameter) in the parietal bone of the skull, without penetrating the dura. Control (sham-operated) animals underwent anesthesia and surgery without craniotomy. We found that craniotomy significantly decreased the severity of experimental seizures on postoperative days 3, 6, and 10; this effect was dependent on the size of craniotomy. Animals with craniotomies returned to control seizure severity by 20 days post-craniotomy. These data support the hypothesis that damage to the skull is sufficient to cause a significant alteration in seizure susceptibility over an extended postoperative period, and indicate that this damage should not be considered neurologically inert.	[Forcelli, Patrick A.; Kalikhman, David; Gale, Karen] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA		Forcelli, PA (corresponding author), Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC USA.	paf22@georgetown.edu		Forcelli, Patrick/0000-0003-1763-060X	National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD046388]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD046388] Funding Source: NIH RePORTER	PAF was supported by grant number T32HD046388 from the National Institutes of Health/National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 1997, NATURE, V387, P360, DOI 10.1038/387360a0; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; Brim RL, 2013, J MED ETHICS, V39, P703, DOI 10.1136/medethics-2012-101045; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Cohen PD, 2012, LANCET NEUROL, V11, P1022, DOI 10.1016/S1474-4422(12)70277-6; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Finger S, 2001, NEUROSURGERY, V48, P911, DOI 10.1097/00006123-200104000-00045; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Forcelli PA, 2011, EPILEPSIA, V52, pE20, DOI 10.1111/j.1528-1167.2010.02971.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 2011, NEUROTHERAPEUTICS, V8, P549, DOI 10.1007/s13311-011-0082-9; Galpern WR, 2012, LANCET NEUROL, V11, P643, DOI 10.1016/S1474-4422(12)70064-9; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; JORGENSEN JB, 1988, ACTA NEUROCHIR, V93, P3, DOI 10.1007/BF01409893; Katariwala NM, 2001, NEUROLOGY, V57, P1505, DOI 10.1212/WNL.57.8.1505; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; LOSCHER W, 1993, NEUROCHEM RES, V18, P775, DOI 10.1007/BF00966772; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Lv XL, 2013, WORLD NEUROSURG, V80, P897, DOI 10.1016/j.wneu.2012.08.009; Mann JM, 2009, J NEUROL NEUROSUR PS, V80, P794, DOI 10.1136/jnnp.2008.159558; Missios Symeon, 2007, Neurosurg Focus, V23, pE11; Morishita T, 2010, J NEUROSURG, V112, P491, DOI 10.3171/2009.7.JNS09150; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ng MSM, 2006, EPILEPSY RES, V72, P97, DOI 10.1016/j.eplepsyres.2006.06.007; Olanow CW, 2001, NEW ENGL J MED, V345, P146; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Papagrigorakis MJ, 2014, WORLD NEUROSURG, V81, P431, DOI 10.1016/j.wneu.2013.01.044; Redmond DE, 2001, NEW ENGL J MED, V345, P146; Schulze-Bonhage A, 2010, J NEUROL NEUROSUR PS, V81, P352, DOI 10.1136/jnnp.2009.180075; Tykocki T, 2013, STEREOT FUNCT NEUROS, V91, P12, DOI 10.1159/000342161; Verano JW, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P223; Vonck K, 2003, ACTA NEUROL BELG, V103, P212; Wan DC, 2008, J CRANIOFAC SURG, V19, P1292, DOI 10.1097/SCS.0b013e3181843609; Wellmer J, 2012, EPILEPSIA, V53, P1322, DOI 10.1111/j.1528-1167.2012.03545.x; Wobbrock J.O., 2011, P ACM C HUM FACTORS, P143; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e81401	10.1371/journal.pone.0081401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	WOS:000327949300091	24324691	Green Published, gold, Green Submitted			2022-02-06	
J	Caminiti, F; Ciurleo, R; Bramanti, P; Marino, S				Caminiti, Fabrizia; Ciurleo, Rosella; Bramanti, Placido; Marino, Silvia			Persistent anosmia in a traumatic brain injury patient: Role of orbitofrontal cortex	BRAIN INJURY			English	Article						Anosmia; frontal lobe; orbitofrontal cortex; sniffin' sticks test; traumatic brain injury	ODOR DISCRIMINATION; OLFACTORY THRESHOLDS; IDENTIFICATION; TESTS	Background: The olfactory loss due to traumatic brain injury is a common clinical condition. The understanding of the cortical areas involved in ability to detect, discriminate and identify the odours is still limited. However, it has been shown that the orbitofrontal cortex (OFC) is involved in the discrimination and recognition of odours and in particular the right OFC has a dominant role in the central processing of smell. Method: This study used the Sniffin' Sticks Test to evaluate olfactory function of a 40-year-old female with persistent post-traumatic anosmia and to have a objective measure method for the follow-up. Results: A marked decrease in the ability to identify and discriminate odours was found. On the other hand the ability to perceive the odours was little compromised. A cerebral Magnetic Resonance Imaging, performed 10 months after the trauma, showed the presence of a post-traumatic scarring in the right frontal lobe involving the OFC. Conclusions: In this case of post-traumatic anosmia, the ability to perceive and recognize odours does not seem to be compromised in the same measure. It is postulated that the post-traumatic outcomes, involving areas of multisensory integration such as the OFC, have an important pathogenetic role in the loss of ability to recognize and discriminate odours.	[Caminiti, Fabrizia; Ciurleo, Rosella; Bramanti, Placido; Marino, Silvia] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy		Marino, S (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113,Via Palermo, I-98124 Messina, Italy.	silvimarino@gmail.com	Marino, Silvia/T-5118-2019; Bramanti, Placido/K-5117-2016; Caminiti, Fabrizia/B-9458-2017; Ciurleo, Rosella/T-4590-2019	Marino, Silvia/0000-0002-1088-6808; Caminiti, Fabrizia/0000-0002-2527-8063; Ciurleo, Rosella/0000-0003-0709-5914			Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	12	13	13	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1715	1718		10.3109/02699052.2013.823667			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400030	24088167				2022-02-06	
J	Elder, H				Elder, Hinemoa			Indigenous Theory Building for Maori Children and Adolescents with Traumatic Brain Injury and their Extended Family	BRAIN IMPAIRMENT			English	Article						indigenous; child and adolescent; traumatic brain injury; theory building; Maori	FUNCTIONAL OUTCOMES; ETHNIC DISPARITIES; MENTAL-HEALTH; HEAD-INJURY; NEW-ZEALAND; REHABILITATION; AMERICAN; CARE	Background: International research identifies indigeneity as a risk factor for traumatic brain injury (TBI). Aotearoa New Zealand studies show that mokopuna (grandchildren; used here to encompass the ages and stages of infant, child and adolescent development and those in young adulthood) are significantly overrepresented in TBI populations. The important role of whanau (family) is also well established in child and adolescent TBI scholarship. Despite awareness of these factors, no studies have been identified that explore whanau knowledge about mokopuna TBI. The aim of this study was to explore two questions: (1) What do Maori people say about mokopuna TBI in the context of the Maori cultural belief that the head is the most sacred part of the body? and (2) How could this information be used to build theory that could inform addressing the rehabilitation needs of this group? Method: Eighteen marae wananga (culture-specific fora in traditional meeting houses) were held. The wananga typically lasted approximately 2 hours. Footage and written transcripts were analysed using Rangahau Kaupapa Maori (Maori indigenous research methods). Results: The wairua theory of mokopuna TBI proposes that TBI not only injures brain anatomy and physiology but also injures wairua (defined here as a unique connection between Maori and all aspects of the universe). Injury to wairua means that culturally determined interventions are both indicated and expected. The wairua theory of mokopuna TBI thereby provides a guide to intervention. Conclusion: A Maori theory of mokopuna TBI has been identified which describes a culture-specific aspect of TBI. This theory proposes that pre-existing whanau knowledge salient to TBI is critical to optimising recovery. Further research is needed to test this theory not only in TBI but also in other areas such as in mental illness, neurodegenerative disease and addiction.	[Elder, Hinemoa] Whare Wananga Awanuiarangi, Oneroa, Waiheke Island, New Zealand		Elder, H (corresponding author), Whare Wananga Awanuiarangi, POB 334, Oneroa, Waiheke Island, New Zealand.	hinemoa@xtra.co.nz					Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Barker-Collo S.L., 2012, WORLD C NEUR 16 19 M; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Blackmer J, 1999, BRAIN INJURY, V13, P627; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Cheung M., 2010, CELLULAR CULTURAL ST; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M.H., 1994, WHAIORA MAORI HLTH D; Durie M, 2011, TRANSCULT PSYCHIATRY, V48, P24, DOI 10.1177/1363461510383182; Elder H., 2013, BRAIN IMPAIRMENT; Faleafa Monique, 2009, Pac Health Dialog, V15, P28; Glavish N., 2007, TIKANGA BEST PRACTIC; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Jansen P., 2008, RITNGA WHAKAARO MAOR; Keightley M, 2011, BRAIN INJURY, V25, P142, DOI 10.3109/02699052.2010.541898; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Kokiri Te Puni, 2007, TIROHANGA KI MAORI M; Kukutai T, 2004, SOC POLICY J N Z, V23, P86; Langlois J., 2003, MORBIDITY MORTALITY, V52, pSS; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; McClintock K, 2012, INT J SOC PSYCHIATR, V58, P96, DOI 10.1177/0020764010387067; Nelson LA, 2007, J HEAD TRAUMA REHAB, V22, P105, DOI 10.1097/01.HTR.0000265098.52306.a9; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Pomedli S., 2008, MATARIKI, V1, P91; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Robson B., 2001, EHTNICITY MATTERS RE; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Smith Graham Hingangaroa, 2003, KAUP MAOR S NZARE AA; Statistics New Zealand, 2012, QUICKST MAOR; Statistics New Zealand & Ministry of Culture and Heritage, 2003, MEAS CULT CULT EXP C; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Taylor H.G., 1999, NEUROPSYCHOLOGY, V7, P755; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TAYLOR HG, 1995, TRAUMATIC HEAD INJUR; Te Puni Kokiri, 2010, 2009 RANGAHAU NGA WA; Uomoto J.M., 2005, REHABILITATION TRAUM, P247; Wereta W., 2002, INT S CULT STAT 21 2; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	47	13	13	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2013	14	3					406	414		10.1017/BrImp.2013.28			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	300MD	WOS:000330467100003					2022-02-06	
J	Gao, L; Wu, XH; Hu, J; Jin, Y; Han, X; Wu, X; Mao, Y; Zhou, LF				Gao, Liang; Wu, Xuehai; Hu, Jin; Jin, Yi; Han, Xi; Wu, Xing; Mao, Ying; Zhou, Liangfu			Intensive Management and Prognosis of 127 Cases with Traumatic Bilateral Frontal Contusions	WORLD NEUROSURGERY			English	Article						Bifrontal contusions; Intracranial pressure; Traumatic brain injury	BIFRONTAL DECOMPRESSIVE CRANIECTOMY; INJURY	BACKGROUND: With the development of edema and the possible enlargement of the hemorrhagic contusion, patients with a bifrontal contusion may deteriorate rapidly or even die as the result of central brain herniation. Therefore, close monitoring and in time treatment may be important to these patients. METHODS: A 127 patients with bifrontal contusions were reviewed retrospectively. Among them, 63 patients accepted operations, 39 cases underwent intracranial pressure (ICP) monitoring, and 24 cases did not. We compared the GlasgowOutcome Scale (GOS) for prognosis, length of osmolar therapy, and length in intensive care unit (ICU) and hospital stay between ICP and non-ICP groups. RESULTS: Compared with the non-ICP operation group, there was no significant difference in Glasgow Coma Scale score in the ICP group, both at admission (average 8.62 vs. 8.91, P = 0.711) and at discharge (average 11.32 vs. 10.45, P = 0.427). However, the length of stay in the ICU was much shorter in the ICP operation group than that of the non-ICP group (15.67 +/- 8.72 days vs. 25.32 +/- 18.78 days, P = 0.013). Hospital stay was also shortened significantly in the ICP operation group compared with the non-ICP operation group (18.94 +/- 8.92 days vs. 34.29 +/- 22.64 days, P = 0.001). The length of osmolar therapy with mannitol was also decreased in the ICP operation group compared with the non-ICP group (14.11 +/- 6.65 days vs. 21.84 +/- 12.02, P = 0.008). However, there was no difference in mortality between two groups (5/39 vs. 4/24). We followed up 29 ICP operation patients and nineteen non-ICP operation patients using GOS 6 months later. The average GOS was 4.21 and 3.32 for the ICP and non-ICP groups respectively (P = 0.025). CONCLUSION: ICP is one of the most important intensive types of monitoring for patients with moderate-to-severe bifrontal contusions and may be beneficial in creating a better prognosis. Intensive care and proper management are necessary to reduce stays in ICU, hospitalization, and mannitol osmolar therapy, and to improve GOS.	[Gao, Liang; Wu, Xuehai; Hu, Jin; Jin, Yi; Han, Xi; Wu, Xing; Mao, Ying; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Mao, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	yingmao168@hotmail.com		Mao, Ying/0000-0001-8055-115X	Shanghai Nature Science Foundation [08411952000, 10ZR1405400]; Shanghai Health Bureau [2008114]	This study was supported by grants (08411952000, 10ZR1405400) from Shanghai Nature Science Foundation, and the Shanghai Health Bureau (2008114).	Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B, P59; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Pittella JEH, 1999, ARQ NEURO-PSIQUIAT, V57, P848, DOI 10.1590/S0004-282X1999000500018; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	8	13	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2013	80	6					879	888		10.1016/j.wneu.2013.01.020			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	290DL	WOS:000329733300088	23313235				2022-02-06	
J	Gautschi, OP; Huser, MC; Smoll, NR; Maedler, S; Bednarz, S; von Hessling, A; Lussmann, R; Hildebrandt, G; Seule, MA				Gautschi, Oliver P.; Huser, Melanie C.; Smoll, Nicolas R.; Maedler, Sven; Bednarz, Stephan; von Hessling, Alexander; Lussmann, Roger; Hildebrandt, Gerhard; Seule, Martin A.			Long-term neurological and neuropsychological outcome in patients with severe traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; ICP-targeted therapy; Neuropsychological outcome; Glasgow Outcome Scale; Long-term outcome	SEVERE HEAD-INJURY; PROGNOSTIC MODELS; SCALE; MODERATE; THERAPY; VALIDATION; PRINCIPLES; PREDICTION; GUIDELINES; RETURN	Background: Severe traumatic brain injury (TBI) remains a major cause of death and disability worldwide, The aim of the study was to evaluate predictors for neurological and neuropsychological long-term outcome in patients with severe TBI treated according to an intracranial pressure (ICP-) targeted therapy. Methods: From 08/2005 to 12/2008, 46 patients with severe TBI and more than 12 h of intensive care treatment were included in this study. Neurological outcome was assessed with the Glasgow Outcome Scale (GOS). Neuropsychological performance assessing 9 different domains was evaluated at long-term follow-up (median 20.5 months; range 10-46). Logistic regression was used to identify favourable outcomes according to the GOS and Fisher's exact tests were used to identify predictors of severe neuropsychological impairments at follow-up. Results: Twenty-nine patients were available for neuropsychological assessment at long-term follow-up. Only 2 out of 29 patients presented normal or average neuropsychological findings throughout all 9 neuropsychological domains at long-term follow-up. The percentage of a favourable outcome (GOS 4-5) increased from 13.8% at hospital discharge to 75.8% at rehabilitation discharge to 79.3% at long-term follow-up, respectively. Age <= 40 was found to be a strong predictor of favourable outcome at follow-up (OR 5.95, 95% CI 1.41 25.00, p = 0.015). The GOS at hospital discharge was not a predictor for severe impairments in any of the 9 different neuropsychological domains (all p-values were p >0.268). In contrast, the GOS at rehabilitation discharge was found to be a predictor of severe impairments at follow-up in all but one domain assessed (all p-values less than p <0.038). Conclusions: The GOS at rehabilitation discharge should be regarded as a better predictor for neuropsychological impairments at long-term follow-up than the GOS at hospital discharge. Even in patients with favourable GOS after finishing a course of rehabilitation, three quarters of these patients may have at least one severe neuropsychological deficit. Therefore, it remains of paramount importance to provide long-term neuropsychological support to further improve outcome after TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Gautschi, Oliver P.; Huser, Melanie C.; Hildebrandt, Gerhard; Seule, Martin A.] Kantonsspital, Dept Neurosurg, St Gallen, Switzerland; [Gautschi, Oliver P.; Smoll, Nicolas R.] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; [Gautschi, Oliver P.; Smoll, Nicolas R.] Univ Hosp Geneva, Fac Med, Geneva, Switzerland; [Maedler, Sven; Bednarz, Stephan; Lussmann, Roger] Kantonsspital, Surg Intens Care Unit, St Gallen, Switzerland; [von Hessling, Alexander] Kantonsspital, Dept Neuroradiol, St Gallen, Switzerland		Gautschi, OP (corresponding author), Hop Cantonal Univ Geneva, Dept Clin Neurosci, Serv Neurochirurg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	oliver.gautschi@hcuge.ch	Smoll, Nicolas/D-3322-2013	Smoll, Nicolas/0000-0002-6923-9701			ANNONI JM, 1991, SCHWEIZ MED WSCHR, V121, P207; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Clifton GL, 1993, NEUROSURGERY, V33, P8; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Harting C., 2000, WECHSLER GEDACHTNIST; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horn R., 2006, WECHSLER INTELLIGENZ; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petermann F, 2012, WECHSLER MEMORY SCAL; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Ruff RM, 1993, PERCEPTUAL MOTOR S 2, V76, P1219; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	49	13	13	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2013	115	12					2482	2488		10.1016/j.clineuro.2013.09.038			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	299TB	WOS:000330417500013	24184064				2022-02-06	
J	Harris, MA; Shen, H; Marion, SA; Tsui, JKC; Teschke, K				Harris, M. Anne; Shen, Hui; Marion, Stephen A.; Tsui, Joseph K. C.; Teschke, Kay			Head injuries and Parkinson's disease in a case-control study	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							OCCUPATIONAL-EXPOSURE; RISK; RECALL; EPIDEMIOLOGY; TRAUMA	Background Head injury is a hypothesised risk factor for Parkinson's disease, but there is a knowledge gap concerning the potential effect of injury circumstances (eg, work-related injuries) on risk. The objective of this study is to address this gap while addressing issues of recall bias and potential for reverse causation by prediagnosis symptoms. Methods We conducted a population based case-control study of Parkinson's disease in British Columbia, Canada (403 cases, 405 controls). Interviews queried injury history; whether injuries occurred at work, in a motor vehicle accident or during sports. Participants were also asked to report their suspicions about the causes of Parkinson's disease to provide an indicator of potential recall bias. Associations were estimated with logistic regression, adjusted for age, sex and smoking history. Results Associations were strongest for injuries involving concussion (OR: 2.08, 95% CI 1.30 to 3.33) and unconsciousness (OR: 2.64, 95% CI 1.39 to 5.03). Effects remained for injuries that occurred long before diagnosis and after adjustment for suspicion of head injury as a cause of Parkinson's disease. Injuries that occurred at work were consistently associated with stronger ORs, although small numbers meant that estimates were not statistically significant. Conclusions This study adds to the body of literature suggesting a link between head injury and Parkinson's disease and indicates further scrutiny of workplace incurred head injuries is warranted.	[Harris, M. Anne] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON M5B 2K3, Canada; [Shen, Hui; Marion, Stephen A.; Teschke, Kay] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Tsui, Joseph K. C.] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada		Harris, MA (corresponding author), Ryerson Univ, Sch Occupat & Publ Hlth, 350 Victoria St,Podium Bldg, Toronto, ON M5B 2K3, Canada.	anne.harris@ryerson.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); WorkSafeBC [RS2000/01-010, RS2007-OG05]	Financial support for this study came from the operating grants from Medical Research Council of Canada (now the Canadian Institutes of Health Research) and WorkSafeBC (Operating grants RS2000/01-010 and and RS2007-OG05) and direct and in-kind support from the Pacific Parkinson's Research Centre. The funders were not involved in study conduct or publication of findings.	Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; DREWS CD, 1990, INT J EPIDEMIOL, V19, P1107, DOI 10.1093/ije/19.4.1107; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Fayerman P, 2008, VANCOUVER SUN   0109; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hachiya NS, 2008, MED HYPOTHESES, V70, P1034, DOI 10.1016/j.mehy.2007.06.043; Harris MA, 2008, CAN J PUBLIC HEALTH, V99, P293, DOI 10.1007/BF03403758; Harris MA, 2012, AM J EPIDEMIOL, V176, P299, DOI 10.1093/aje/kws017; Harris MA, 2012, MOVEMENT DISORD, V27, P1111, DOI 10.1002/mds.25077; Harris MA, 2011, PARKINSONISM RELAT D, V17, P464, DOI 10.1016/j.parkreldis.2011.04.007; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Rugbjerg K, 2011, SCAND J WORK ENV HEA, V37, p: 10; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; Silva M, 1996, BRIT MED J, V312, P703; Tan EK, 2005, INT J CLIN PRACT, V59, P511, DOI 10.1111/j.1368-5031.2005.00426.x; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Teschke K, 2000, AM J IND MED, V38, P385, DOI 10.1002/1097-0274(200010)38:4<385::AID-AJIM3>3.3.CO;2-H	24	13	13	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711	1470-7926		OCCUP ENVIRON MED	Occup. Environ. Med.	DEC	2013	70	12					839	844		10.1136/oemed-2013-101444			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	251GT	WOS:000326916500005	24142978				2022-02-06	
J	Jacobson, NA; Buzas, D; Morawa, LG				Jacobson, Nathan A.; Buzas, David; Morawa, Lawrence G.			Concussions From Youth Football Results From NEISS Hospitals Over an 11-Year Time Frame, 2002-2012	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; epidemiology; NEISS; pediatrics; head injuries		Background: Youth football programs across the United States represent an at-risk population of approximately 3.5 million athletes for sports-related concussions. The frequency of concussions in this population is not known. Study Design: Descriptive epidemiology study. Methods: Over an 11-year span from January 2002 to December 2012, the authors reviewed the concussions sustained by athletes aged 5 to 13 years while playing football, as evaluated in emergency departments (EDs) in the United States and captured by the National Electronic Injury Surveillance System (NEISS) database of the US Consumer Product Safety Commission. Results: There were 2028 (national estimate, 49,185) young football players evaluated in NEISS EDs with concussion from 2002 to 2012. There were 1987 (97.9%) males and 41 (2.1%) females, with a mean age of 11.2 years. The total number of concussions reported increased with age and by year. The majority of concussions were treated in the outpatient setting, with 1878 (91.7%) being treated and released. The total number of head-to-head injury mechanisms mirrored the total number of concussions by year, which increased throughout the 11-year span. The total number of players experiencing a loss of consciousness increased throughout the study period but did not match the total number of concussions over the 11-year time period. Fractures occurred in 11 (0.5%) patients, with 2 being severe (1 skull fracture and 1 thoracic compression fracture). Conclusion: Within the 5-to 13-year age range, there were a significant number of young athletes who presented to EDs with concussion as a result of playing organized football. Older children may be at greater risk for sustaining concussions, fractures, and catastrophic injuries while playing football when compared with younger children.	[Jacobson, Nathan A.; Buzas, David; Morawa, Lawrence G.] Wayne State Univ, Taylor, MI USA; Wayne State Univ, Dept Orthopaed Surg, 10000 Telegraph Rd, Taylor, MI 48124 USA; [Jacobson, Nathan A.; Buzas, David; Morawa, Lawrence G.] Wayne State Univ, Dept Orthopaed Surg, Taylor, MI USA		Buzas, D (corresponding author), Wayne State Univ, Dept Orthopaed Surg, 10000 Telegraph Rd, Taylor, MI 48124 USA.	dbuzas@med.wayne.edu					Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Fox M., 2013, NBC NEWS; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lowrey KM, 2012, SUMMARY MATRIX STATE; Mueller FO, 2010, ANN REPORT U N CAROL; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pop Warner Little Scholars, 2013 SEAS AG; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Schroeder T., 2001, NEISS SAMPLE DESIGN; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	25	13	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2013	1	7							2325967113517860	10.1177/2325967113517860			6	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	V0R0S	WOS:000216481300006	26535262	Green Published, gold			2022-02-06	
J	Leonardi, AD; Keane, NJ; Hay, K; Ryan, AG; Bir, CA; VandeVord, PJ				Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Hay, Kathryn; Ryan, Anne G.; Bir, Cynthia A.; VandeVord, Pamela J.			Methodology and Evaluation of Intracranial Pressure Response in Rats Exposed to Complex Shock Waves	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Blast; IED; TBI; Skull flexure; Complex wave environment	BLAST OVERPRESSURE; CORTICAL-NEURONS; INJURY; EPIDEMIOLOGY	Studies on blast neurotrauma have focused on investigating the effects of exposure to free-field blast representing the simplest form of blast threat scenario without considering any reflecting surfaces. However, in reality personnel are often located within enclosures or nearby reflecting walls causing a complex blast environment, that is, involving shock reflections and/or compound waves from different directions. The purpose of this study was to design a complex wave testing system and perform a preliminary investigation of the intracranial pressure (ICP) response of rats exposed to a complex blast wave environment (CBWE). The effects of head orientation in the same environment were also explored. Furthermore, since it is hypothesized that exposure to a CBWE would be more injurious as compared to a free-field blast wave environment (FFBWE), a histological comparison of hippocampal injury (cleaved caspase-3 and glial fibrillary acidic protein (GFAP)) was conducted in both environments. Results demonstrated that, regardless of orientation, peak ICP values were significantly elevated over the peak static air overpressure. Qualitative differences could be noticed compared to the ICP response in rats exposed to simulated FFBWE. In the CBWE scenario, after the initial loading the skull/brain system was not allowed to return to rest and was loaded again reaching high ICP values. Furthermore, results indicated consistent and distinct ICP-time profiles according to orientation, as well as distinctive values of impulse associated with each orientation. Histologically, cleaved caspase-3 positive cells were significantly increased in the CBWE as compared to the FFBWE. Overall, these findings suggest that the geometry of the skull and the way sutures are distributed in the rats are responsible for the difference in the stresses observed. Moreover, this increase stress contributes to correlation of increased injury in the CBWE.	[Leonardi, Alessandra Dal Cengio; Ryan, Anne G.; VandeVord, Pamela J.] Virginia Tech Univ, Blacksburg, VA USA; [Keane, Nickolas J.; Hay, Kathryn; Bir, Cynthia A.] Wayne State Univ, Detroit, MI USA		VandeVord, PJ (corresponding author), Virginia Tech Univ, Blacksburg, VA USA.	pvord@vt.edu		Bir, Cynthia/0000-0002-0777-0951	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]; Office of Naval ResearchOffice of Naval Research [N000140810585]	We would like to thank the WSU Bioengineering Center Staff for assisting with this project, especially Sujith Sajja, Dr. Bin Wu for her indispensable contribution in surgery and Mr. Dave Ritzel for his blast physics expertise. This project was partially funded by the Department of Defense (Award no. W81XWH-08-2-0207) and the Office of Naval Research (Award Number N000140810585).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bolander R., 2012, THESIS WAYNE STATE U; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bowen I. G., 1968, DASA2113, P1; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Ganpule S., 2012, BIOMECH MODEL MECHAN, P1, DOI 1007/s10237-012-0421-8; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Leonardi A.D., 2011, THESIS WAYNE STATE U; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mackenzie IMJ, 2011, PHILOS T R SOC B, V366, P295, DOI 10.1098/rstb.2010.0252; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Phillips Y. Y., 1991, CONVENTIONAL WARFARE, P221; Richmond D. R., 1968, ANN NY ACAD SCI, P103; Richmond D. R., 1985, 9 INT S MABS 9 OXF E, V9; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Yelverton J. T., 1993, BLAST OVERPRESSURE S	29	13	13	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2013	41	12					2488	2500		10.1007/s10439-013-0850-2			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	249UN	WOS:000326803700003	23904049				2022-02-06	
J	Taylor, SR; Smith, C; Harris, BT; Costine, BA; Duhaime, AC				Taylor, Sabrina R.; Smith, Colin; Harris, Brent T.; Costine, Beth A.; Duhaime, Ann-Christine			Maturation-dependent response of neurogenesis after traumatic brain injury in children	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; neurogenesis; subventricular zone; hippocampus; subgranular zone; development; trauma	CONTROLLED CORTICAL IMPACT; SUBVENTRICULAR ZONE CELLS; ADULT HUMAN BRAIN; DENTATE GYRUS; ENHANCED NEUROGENESIS; NEURONAL MIGRATION; CEREBRAL-CORTEX; HEAD-INJURY; HIPPOCAMPAL NEUROGENESIS; DOUBLECORTIN EXPRESSION	Object. Traumatic brain injury (TBI) is the leading cause of acquired disability in children, yet innate repair mechanisms are incompletely understood. Given data from animal studies documenting neurogenesis in response to trauma and other insults, the authors investigated whether similar responses could be found in children of different ages after TBI. Methods. Immunohistochemistry was used to label doublecortin (DCX), a protein expressed by immature migrating neuroblasts (newborn neurons), in specimens from patients ranging in age from 3 weeks to 10 years who had died either after TBI or from other causes. Doublecortin-positive (DCX+) cells were examined in the subventricular zone (SVZ) and periventricular white matter (PWM) and were quantified within the granule cell layer (GCL) and subgranular zone (SGZ) of the dentate gyms to determine if age and/or injury affect the number of DCX+ cells in these regions. Results. The DCX+ cells decreased in the SVZ as patient age increased and were found in abundance around a focal subacute infarct in a 1-month-old non-TBI patient, but were scarce in all other patients regardless of age or history of trauma. The DCX+ cells in the PWM and dentate gyrus demonstrated a migratory morphology and did not co-localize with markers for astrocytes, microglia, or macrophages. In addition, there were significantly more DCX+ cells in the GCL and SGZ of the dentate gyms in children younger than 1 year old than in older children. The density of immature migrating neuroblasts in infants (under 1 year of age) was significantly greater than in young children (2-6 years of age, p = 0.006) and older children (7-10 years of age, p = 0.007). Conclusions. The main variable influencing the number of migrating neuroblasts observed in the SVZ, PWM, and hippocampus was patient age. Trauma had no discernible effect on the number of migrating neuroblasts in this cohort of patients in whom death typically occurred within hours to days after TBI.	[Taylor, Sabrina R.] Dartmouth Coll, Program Expt & Mol Med, Hanover, NH 03755 USA; [Taylor, Sabrina R.; Costine, Beth A.; Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Taylor, Sabrina R.; Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Colin] Univ Edinburgh, Dept Neuropathol, Edinburgh EH8 9YL, Midlothian, Scotland; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Harris, Brent T.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA		Taylor, SR (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 149 13th St,3-328, Charlestown, MA 02129 USA.	srtaylor@partners.org		Costine-Bartell, Beth/0000-0001-7559-9378	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS 045776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD083759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045776] Funding Source: NIH RePORTER	We thank Igor Bageyev for his expertise and assistance in obtaining images, and Dr. Christian Waeber (Center for Neuroscience, Massachusetts General Hospital) for access to microscopy facilities, which are funded through NIH Grant No. P30 NS 045776.	ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; Amrein I, 2004, HIPPOCAMPUS, V14, P1000, DOI 10.1002/hipo.20018; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cha BH, 2004, BRAIN DEV-JPN, V26, P394, DOI 10.1016/j.braindev.2003.12.006; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Faul M, 2010, TRAUMATIC BRAIN INJU; FISHELL G, 1991, DEVELOPMENT, V113, P755; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gerber J, 2009, NEUROLOGY, V73, P1026, DOI 10.1212/WNL.0b013e3181b9c892; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Haynes RL, 2011, PEDIATR RES, V69, P62, DOI 10.1203/PDR.0b013e3181ff3792; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; McCabe BK, 2001, J NEUROSCI, V21, P2094, DOI 10.1523/JNEUROSCI.21-06-02094.2001; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; Panizzo RA, 2009, NEUROIMAGE, V44, P1239, DOI 10.1016/j.neuroimage.2008.10.062; Pekcec A, 2008, AGING CELL, V7, P368, DOI 10.1111/j.1474-9726.2008.00392.x; Qin J, 2000, BRAIN RES, V863, P225, DOI 10.1016/S0006-8993(00)02099-0; Qiu L, 2007, J CEREBR BLOOD F MET, V27, P785, DOI 10.1038/sj.jcbfm.9600385; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; RAKIC P, 1981, J COMP NEUROL, V196, P99, DOI 10.1002/cne.901960109; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taylor S, 2010, 40 ANN M SOC NEUR SA; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55	77	13	13	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2013	12	6					545	554		10.3171/2013.8.PEDS13154			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	257EV	WOS:000327367300004	24053630				2022-02-06	
J	Villapol, S; Wang, Y; Adams, M; Symes, AJ				Villapol, Sonia; Wang, Yu; Adams, Matthew; Symes, Aviva J.			Smad3 deficiency increases cortical and hippocampal neuronal loss following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TGF-beta; T beta RII; Smad3; pSmad3; Neurodegeneration; Neuron; Astrocyte; Cell death; CA1; Caspase-3	GROWTH-FACTOR-BETA; MIDBRAIN DOPAMINERGIC-NEURONS; CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE-B; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SCAR FORMATION; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; CELL-DEATH	Transforming growth factor-beta (TGF-beta) signaling is involved in pathological processes following brain injury. TGF-beta signaling through Smad3 contributes significantly to the immune response and glial scar formation after brain injury. However, TGF-beta is also neuroprotective, suggesting that Smad3 signaling may also be involved in neuroprotection after injury. We found expression of the TGF-beta type II receptor (T beta RII) and Smad3 protein to be strongly and rapidly induced in neurons in the ipsilateral cortex and CA1 region of the hippocampus after stab wound injury. In contrast, astrocytic expression of T beta RII and Smad3 was induced more slowly. Comparison of the response of wild-type and Smad3 null mice to cortical stab wound injury showed a more pronounced loss of neuronal viability in Smad3 null mice. Neuronal density was more strongly reduced in Smad3 null mice than in wild-type mice at 1 and 3 days post lesion in both the ipsilateral cortex and hippocampal CA1 region. Fluoro-Jade B, TUNEL staining, and cleaved caspase-3 staining also demonstrated increased neuronal degeneration at early time points after injury in the ipsilateral hemisphere in Smad3 null mice. Taken together, our results suggest that TGF-beta cytokine family signaling through Smad3 protects neurons in the damaged cortex and hippocampus at early time points after injury. Published by Elsevier Inc.	[Villapol, Sonia; Wang, Yu; Adams, Matthew; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Villapol, Sonia; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Wang, Yu] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei 230022, Peoples R China		Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu	Villapol, Sonia/D-1949-2014; Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939; Villapol, Sonia/0000-0002-6174-4113	Defense Brain and Spinal Cord Injury Program; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30970997]	This work was supported by a translational research grant from the Defense Brain and Spinal Cord Injury Program (AJS), by a post-doctoral fellowship from the Center for Neuroscience and Regenerative Medicine (SV), and by a natural science grant (30970997) from the National Natural Science Foundation of China (YW). We would like to thank M. Balarezo for her technical help and D. McDaniel for the confocal microscopy assistance. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences or the US Department of Defense.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Andrews ZB, 2006, NEUROBIOL DIS, V21, P568, DOI 10.1016/j.nbd.2005.09.001; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Battaglia G, 2011, J CELL MOL MED, V15, P555, DOI 10.1111/j.1582-4934.2010.01011.x; Blottner D, 1996, EUR J NEUROSCI, V8, P202, DOI 10.1111/j.1460-9568.1996.tb01181.x; Bonner HP, 2010, J NEUROCHEM, V114, P606, DOI 10.1111/j.1471-4159.2010.06790.x; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bruno V, 1998, J NEUROSCI, V18, P9594; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Dunker N, 2000, EUR J BIOCHEM, V267, P6982, DOI 10.1046/j.1432-1327.2000.01825.x; Farkas LM, 2003, J NEUROSCI, V23, P5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Gonzalez-Aparicio R, 2010, EXP NEUROL, V226, P136, DOI 10.1016/j.expneurol.2010.08.016; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOEPPNER TJ, 1986, EXP NEUROL, V94, P519, DOI 10.1016/0014-4886(86)90235-9; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Li LY, 2013, J MOL NEUROSCI, V50, P109, DOI 10.1007/s12031-012-9879-1; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EXP NEUROL, V159, P504, DOI 10.1006/exnr.1999.7180; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Moreira T, 2007, NEUROSCIENCE, V144, P1169, DOI 10.1016/j.neuroscience.2006.10.054; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sofroniew M.V., 2009, TRENDS NEUROSCI, P1; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tapia-Gonzalez S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-72; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Tsuchiya T, 2011, EUR J NEUROSCI, V33, P401, DOI 10.1111/j.1460-9568.2010.07538.x; Ueberham U, 2006, EUR J NEUROSCI, V24, P2327, DOI 10.1111/j.1460-9568.2006.05109.x; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Walshe TE, 2011, NEUROSCIENCE, V189, P123, DOI 10.1016/j.neuroscience.2011.05.020; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wang Y, 2010, J MOL NEUROSCI, V41, P383, DOI 10.1007/s12031-010-9329-x; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; WyssCoray T, 1997, J NEUROIMMUNOL, V77, P45, DOI 10.1016/S0165-5728(97)00049-0; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	73	13	13	2	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2013	250						353	365		10.1016/j.expneurol.2013.10.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	270FZ	WOS:000328305600038	24120438	Green Published			2022-02-06	
J	Xu, JH; Zhang, TZ; Peng, XF; Jin, CJ; Zhou, J; Zhang, YN				Xu, Ji-Hong; Zhang, Tie-Zheng; Peng, Xiao-Feng; Jin, Chun-Ji; Zhou, Jin; Zhang, Yi-Nan			Effects of sevoflurane before cardiopulmonary bypass on cerebral oxygen balance and early postoperative cognitive dysfunction	NEUROLOGICAL SCIENCES			English	Article						Sevoflurane; Cardiopulmonary bypass; Cerebral oxygen balance; Cognitive dysfunction	BLOOD-FLOW AUTOREGULATION; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; ANESTHESIA; PROTECTION; LACTATE; RATS	Postoperative cognitive dysfunction (POCD) is associated with cardiopulmonary bypass (CPB). We investigated the effect of different doses of inhaled sevoflurane administered prior to CPB on cerebral oxygen supply and demand, and the incidence of associated early POCD. One hundred and twenty patients were randomly allocated into four treatment groups (n = 30, each) and administered a high- [1.5 minimum alveolar concentration (MAC)], moderate- (1.0 MAC), low- (0.5 MAC), or no- sevoflurane dose prior to CPB. Standard blood gas parameters, serum S-100 protein, and neuron-specific enolase (NSE) were measured at different time points. The mini-mental state examination (MMSE) was administered 1 day before and 24 and 72 h after surgery. The jugular bulb venous oxygen saturation (SjvO(2)) in the moderate- and high-dose groups at a nasopharyngeal temperature of 25-28 A degrees C was significantly higher compared with the control group, while the arteriovenous oxygen content difference (AVDO(2)) and cerebral extraction of oxygen (CEO2) were significantly reduced. The serum S-100 protein and NSE concentrations of the moderate- and high-dose groups at 1 and 6 h after the cessation of CPB were significantly lower than that of the control group. The 24 h postoperative MMSE scores of the moderate- and high-dose groups were significantly higher than those of the low-dose and control groups. An inhaled optimal concentration of sevoflurane may be beneficial for cerebral oxygen balance during CPB, and may ameliorate cognitive damage. However, the effect is dose-dependent.	[Xu, Ji-Hong; Zhang, Tie-Zheng; Peng, Xiao-Feng; Jin, Chun-Ji; Zhou, Jin; Zhang, Yi-Nan] Gen Hosp Shenyang Mil Reg, Dept Anesthesiol, Shenyang 110016, Peoples R China		Zhang, TZ (corresponding author), Gen Hosp Shenyang Mil Reg, Dept Anesthesiol, 83 Wenhua Rd, Shenyang 110016, Peoples R China.	tzzhang@hotmail.com			Natural Science Fund of Liaoning Province of China [20102244]	This study was supported by the Natural Science Fund of Liaoning Province of China (20102244).	Alves OL, 2004, CURR PHARM DESIGN, V10, P2163, DOI 10.2174/1381612043384187; American Psychiatric Association, 1987, AM PSYCH ASS DIAGN S; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Chieregato A, 2007, J NEUROSURG ANESTH, V19, P222, DOI 10.1097/ANA.0b013e31806589f6; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; Fita G, 1999, Rev Esp Anestesiol Reanim, V46, P438; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hans P, 1998, AGRESSOLOGIE, V29, P233; Kadoi Y, 2007, J ANESTH, V21, P330, DOI 10.1007/s00540-007-0537-7; Kurth CD, 2001, ANESTHESIOLOGY, V95, P959; Li Shu, 2005, J Extra Corpor Technol, V37, P180; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; McKeating EG, 1998, ACT NEUR S, V71, P117; MILLS SA, 1993, ANN THORAC SURG, V56, pS86, DOI 10.1016/0003-4975(93)91142-A; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MURKIN JM, 1993, ANN THORAC SURG, V56, P1461, DOI 10.1016/0003-4975(93)90730-6; Nader ND, 2004, J CARDIOTHOR VASC AN, V18, P269, DOI 10.1053/j.jvca.2004.03.004; Nakamura Shunsuke, 2011, Nihon Rinsho, V69, P704; Ogawa Y, 2006, ANESTH ANALG, V102, P552, DOI 10.1213/01.ane.0000189056.96273.48; Parolari A, 2000, EUR J CARDIO-THORAC, V18, P575, DOI 10.1016/S1010-7940(00)00552-2; Reinsfelt B, 2011, ACTA ANAESTH SCAND, V55, P118, DOI 10.1111/j.1399-6576.2010.02324.x; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; SMITHIES MN, 1991, CRIT CARE MED, V19, P1401, DOI 10.1097/00003246-199111000-00017; Werner C, 2005, ANESTH ANALG, V101, P509, DOI 10.1213/01.ANE.0000160586.71403.A4	25	13	20	1	13	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	DEC	2013	34	12					2123	2129		10.1007/s10072-013-1347-3			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	268ZN	WOS:000328209500006	23525738				2022-02-06	
J	Lu, H; Lei, XY; Hu, H; He, ZP				Lu Hong; Lei Xiao-yan; Hu Hui; He Zhan-ping			Relationship between AQP4 expression and structural damage to the blood-brain barrier at early stages of traumatic brain injury in rats	CHINESE MEDICAL JOURNAL			English	Article						brain injury; edema; blood-brain barrier; aquaporins; animal experiment	AQUAPORIN-4 EXPRESSION; EDEMA; TISSUE; MICE	Background Although some studies have reported that aquaporin-4 (AQP4) plays an important role in the brain edema after traumatic brain injury (TBI), little is known about the AQP4 expression in the early stage of TBI, or about the correlation between the structural damage to the blood-brain barrier (BBB) and angioedema. The aim of this project was to investigate the relationship between AQP4 expression and damage to the BBB at early stages of TBI. Methods One hundred and twenty healthy adult Wistar rats were randomly divided into two groups: sham operation group (SO) and TBI group. The TBI group was divided into five sub-groups according to the different time intervals: 1, 3, 6, 12, and 24 hours. The brains of the animals were taken out at different time points after TBI to measure brain water content. The cerebral edema and BBB changes in structure were examined with an optical microscopy (OM) and transmission electron microscopy (TEM), and the IgG content and AQP4 protein expression in traumatic brain tissue were determined by means of immunohistochemistry and Western blotting. The data were analyzed with SPSS 13.0 statistical software. Results In the SO group, tissue was negative for IgG, and there were no abnormalities in brain water content or AQP4 expression. In the TBI group, brain water content significantly increased at 6 hours and peaked at 24 hours following injury. IgG expression significantly increased from 1 to 6 hours following injury, and remained at a high level at 24 hours. Pathological observation revealed BBB damage at 1 hour following injury. Angioedenna appeared at 1 hour, was gradually aggravated, and became obvious at 6 hours. Intracellular edema occurred at 3 hours, with the presence of large glial cell bodies and mitochondrial swelling. These phenomena were aggravated with time and became obvious at 12 hours. In addition, microglial proliferation was visible at 24 hours. AQP4 protein expression were reduced at 1 hour, lowest at 6 hours, and began to increase at 12 hours, showing a V-shaped curve. Conclusions The angioedenna characterized by BBB damage was the primary type of early traumatic brain edema. It was followed by mixed cerebral edema that consisted of angioedema and cellular edema and was aggravated with time. AQP4 expression was down-regulated during the angioedema attack, but AQP4 expression was upregulated during intracellular edema.	[Lu Hong; Lei Xiao-yan; He Zhan-ping] Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Radiol, Haikou 570208, Hainan, Peoples R China; [Hu Hui] Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Nursing, Haikou 570208, Hainan, Peoples R China		Lu, H (corresponding author), Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Radiol, Haikou 570208, Hainan, Peoples R China.	471739847@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; International Cooperation Project of Hainan Province [Qiongke (2012) 65]	This project was supported by the National Natural Science Foundation of China (No. 81160181) and the International Cooperation Project of Hainan Province (No. Qiongke (2012) 65).	Akiguchi I, 1998, ACTA NEUROPATHOL, V95, P78, DOI 10.1007/s004010050768; Cui Y, 2006, CHIN J REHABIL THEOR, V12, P649; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Easton AS, 2013, ADV EXP MED BIOL, V763, P1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hu H, 2012, NEURAL REGEN RES, V7, P1659, DOI 10.3969/j.issn.1673-5374.2012.21.009; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li M, 2011, PROGR ANATOM SCI, V17, P12; [刘辉 Liu Hui], 2009, [解剖学杂志, Chinese Journal of Anatomy], V32, P68; Lo Pizzo M, 2012, NEUROL SCI; Lu H, 2011, CHINESE J ANATOMY, V34, P47; [鲁宏 Lu Hong], 2012, [解剖学杂志, Chinese Journal of Anatomy], V35, P4; Lu H, 2011, CHINESE MED J-PEKING, V124, P3148, DOI 10.3760/cma.j.issn.0366-6999.2011.19.034; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Ren Z, 2013, J CEREB BLOOD F 0227, DOI [10.1038/jcbfm.2013.30, DOI 10.1038/JCBFM.2013.30.EPUB]; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Sabre L, 2013, SPINAL CORD, DOI [10.1038/sc.2013.41, DOI 10.1038/SC.2013.41.EPUB]; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Yeung CM, 2010, J NEUROSCI RES, V88, P2026, DOI 10.1002/jnr.22349; Zhang L, 2008, SHOUDU YIKE DAXUE XU, V29, P732; [张曙光 Zhang Shuguang], 2010, [中华创伤杂志, Chinese Journal of Trauma], V26, P589; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	29	13	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	NOV 20	2013	126	22					4316	4321		10.3760/cma.j.issn.0366-6999.20131139			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264YJ	WOS:000327916600025	24238521				2022-02-06	
J	Abookasis, D; Volkov, B; Mathews, MS				Abookasis, David; Volkov, Boris; Mathews, Marlon S.			Closed head injury-induced changes in brain pathophysiology assessed with near-infrared structured illumination in a mouse model	JOURNAL OF BIOMEDICAL OPTICS			English	Article						closed head injury; structured illumination; optical properties; cerebral hemodynamics; scattering parameters	CEREBRAL-BLOOD-FLOW; TISSUE OPTICAL-PROPERTIES; PHASE-MEASURING-PROFILOMETRY; DIGITAL MICROMIRROR DEVICE; OXYGEN-SATURATION; LIGHT-PROPAGATION; SHAPE MEASUREMENT; COMPLEX OBJECT; SPECTROSCOPY; MICROSCOPY	Use of near-infrared (NIR) structured illumination technique has recently received great interest in biomedical research and clinical studies because of its ability to perform wide-field imaging and quantitatively map changes in tissue hemodynamic properties and morphological features in a noncontact and scan-free fashion. We report on the feasibility of using the same to quantitatively monitor and map changes in brain optical properties and physiological parameters pre-and post-closed head injury in a mouse model. Five anesthetized male mice underwent head injury by weight-drop model using a similar to 50-g cylindrical metal object falling from a height of 90 cm onto the intact scalp. During experiments, NIR structured illumination was projected on the mouse head at two spatial frequencies and six different NIR wavelengths. A CCD camera positioned perpendicular to the head recorded the diffuse-reflected light. Computer analysis performed off-line on the captured data reveals spatiotemporal changes in the distribution of brain tissue absorption and reduced scattering coefficients. Using Beer's law and Mie theory, hemodynamic (hemoglobin, oxygen saturation, and lipids) and morphological (scattering amplitude and power) changes up to 1-h post-trauma were observed in comparison with baseline measurements. Functional maps of different brain properties were also generated. Following injury, we found difference in both brain hemodynamic and morphologic properties with respect to baseline levels, where in some properties, this difference was considered statistically significant. Specifically, a t-test indicates a substantial decrease in oxyhemoglobin (HbO(2)) concentration and tissue oxygen saturation (StO(2)) post-injury (p < 0.01 and p < 0.001, respectively). Overall, our preliminary results demonstrate the potential application of NIR structured illumination technique to track and spatially map changes in intact mouse brain pathophysiological parameters following head injury. (C) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Abookasis, David; Volkov, Boris] Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel; [Mathews, Marlon S.] Univ Calif Irvine, Med Ctr, Dept Neurol Surg, Orange, CA 92868 USA		Abookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel.	davida@ariel.ac.il					Abookasis D., 2008, P SOC PHOTO-OPT INS, V6842; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.045003; Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Abrahamson EE, 2013, J CEREBR BLOOD F MET, V33, P826, DOI 10.1038/jcbfm.2013.24; Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bednarkiewicz A, 2008, APPL OPTICS, V47, P1193, DOI 10.1364/AO.47.001193; Berryman F, 2008, EUR SPINE J, V17, P663, DOI 10.1007/s00586-007-0581-x; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Bouma B. E., 2002, HDB OPTICAL COHERENC; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Broich K, 1994, J Stroke Cerebrovasc Dis, V4, P271, DOI 10.1016/S1052-3057(10)80106-5; Cao YP, 2003, PROC SPIE, V5254, P496, DOI 10.1117/12.546556; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; Chen JL, 2013, OPT EXPRESS, V21, P112, DOI 10.1364/OE.21.000112; Cheung C, 2001, PHYS MED BIOL, V46, P2053, DOI 10.1088/0031-9155/46/8/302; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Cuccia D. J., 2009, IN VIVO OPTICAL IMAG; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; Cuccia DJ, 2005, OPT LETT, V30, P1354, DOI 10.1364/OL.30.001354; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Delica S, 2007, APPL OPTICS, V46, P7237, DOI 10.1364/AO.46.007237; DePiero F., 1996, ADV COMPUT, V43, P243, DOI DOI 10.1016/S0065-2458(08)60646-4; Dognitz N, 1998, LASER MED SCI, V13, P55, DOI 10.1007/BF00592960; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Doornbos RMP, 1999, PHYS MED BIOL, V44, P967, DOI 10.1088/0031-9155/44/4/012; Eker C., 1999, THESIS LUND I TECHNO; Fiolka R, 2008, OPT LETT, V33, P1629, DOI 10.1364/OL.33.001629; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukano T, 2003, APPL OPTICS, V42, P4119, DOI 10.1364/AO.42.004119; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gioux S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3614566; Gonzalez-Quevedo A., 2012, BRAIN DAMAGE BRIDGIN; GRAAFF R, 1992, APPL OPTICS, V31, P1370, DOI 10.1364/AO.31.001370; Grossman R. G., 1990, NEUROBEHAVIORAL CONS; Hagen N, 2012, OPT EXPRESS, V20, P403, DOI 10.1364/OE.20.000403; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Huang PSS, 2003, OPT ENG, V42, P163, DOI 10.1117/1.1525272; Hull EL, 2001, J OPT SOC AM A, V18, P584, DOI 10.1364/JOSAA.18.000584; Ioroi T, 2002, EXP BRAIN RES, V144, P172, DOI 10.1007/s00221-002-1030-z; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Jacques SL, 2010, BIOMED OPT EXPRESS, V1, P157, DOI 10.1364/BOE.1.000157; Kakaboura A, 2007, J MATER SCI-MATER M, V18, P155, DOI 10.1007/s10856-006-0675-8; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Konecky SD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056008; Kristensson E, 2008, APPL OPTICS, V47, P3927, DOI 10.1364/AO.47.003927; Krzewina LG, 2006, OPT LETT, V31, P477, DOI 10.1364/OL.31.000477; Kurth CD, 2009, ANESTH ANALG, V108, P1268, DOI 10.1213/ane.0b013e318196ac8e; Lee CK, 2005, OPT EXPRESS, V13, P8339, DOI 10.1364/OPEX.13.008339; Lin AJ, 2011, ANN BIOMED ENG, V39, P1349, DOI 10.1007/s10439-011-0269-6; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nachabe R, 2010, BIOMED OPT EXPRESS, V1, P1432, DOI 10.1364/BOE.1.001432; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; O'Sullivan TD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071311; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; PODBIELSKA H, 1991, OPT ENG, V30, P1981, DOI 10.1117/12.56009; Powell T. J., 2004, HEAD INJURY PRACTICA; Quan C, 2001, OPT COMMUN, V189, P21, DOI 10.1016/S0030-4018(01)01038-0; Reilly P., 1997, HEAD INJURY; Richardson JTE, 2001, CLIN NEUROPSYCHOLOGI; Shafer R, 2011, J NEUROINTERV SURG, V3, P395, DOI 10.1136/jnis.2010.004184; Shi ZZ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067004; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; SRINIVASAN V, 1984, APPL OPTICS, V23, P3105, DOI 10.1364/AO.23.003105; Su XY, 2001, OPT LASER ENG, V35, P263, DOI 10.1016/S0143-8166(01)00023-9; Su XY, 1996, P SOC PHOTO-OPT INS, V2866, P460, DOI 10.1117/12.263022; SU XY, 1994, P SOC PHOTO-OPT INS, V2132, P484, DOI 10.1117/12.176592; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; Tkaczyk TS, 2004, OPT EXPRESS, V12, P3745, DOI 10.1364/OPEX.12.003745; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Wang LV, 2009, OPT SCI ENG-CRC, V144, P1, DOI 10.1201/9781420059922; Wang LV, 2007, BIOMEDICAL OPTICS PR, P5; Wang X, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098607; Weber JR, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528628; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Xue L, 2001, APPL OPTICS, V40, P1207, DOI 10.1364/AO.40.001207; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yeganeh HZ, 2012, BIOMED OPT EXPRESS, V3, P2761, DOI 10.1364/BOE.3.002761; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhao J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891345; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814	95	13	13	1	11	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	NOV	2013	18	11							116007	10.1117/1.JBO.18.11.116007			15	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	278MT	WOS:000328895100034	24220698				2022-02-06	
J	Choudhry, OJ; Prestigiacomo, CJ; Gala, N; Slasky, S; Sifri, ZC				Choudhry, Osamah J.; Prestigiacomo, Charles J.; Gala, Nihar; Slasky, Shira; Sifri, Ziad C.			Delayed Neurological Deterioration After Mild Head Injury: Cause, Temporal Course, and Outcomes	NEUROSURGERY			English	Article						Acute neurologic deterioration; Delayed neurologic deterioration; Elderly; GOS; Mild head injury; Mild traumatic brain injury; Talk and deteriorate	TRAUMATIC BRAIN-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; INDEPENDENT PREDICTOR; ANTIPLATELET THERAPY; ELDERLY-PATIENTS; TALK; MORTALITY; AGE	BACKGROUND: Mild head injury (MHI) complicated by an intracranial hemorrhage (ICH) is a common cause of hospital admission after head trauma. Most patients are treated nonoperatively, remain neurologically stable, and are discharged uneventfully. However, a small percentage of patients suffer delayed neurological deterioration (DND). Little is known about the characteristics of DND after an MHI complicated by ICH. OBJECTIVE: To identify the cause, temporal course, and outcomes of patients who deteriorated neurologically after presenting with MHI and ICH. METHODS: A retrospective review was performed of all adult patients presenting over 54 consecutive months with MHI and ICH. Patients who were treated nonoperatively after initial head computed tomography and had a subsequent DND (Glasgow Coma Scale score decrease >= 2) were identified. Demographics, neurological status, clinical course, radiographic findings, and outcome data were collected. RESULTS: Over 54 months, 757 patients with MHI plus ICH were admitted for observation; of these, 31 (4.1%) experienced DND. Eighty-seven percent of patients deteriorated within 24 hours after admission. Twenty-one patients (68%) deteriorated as a result of progressive intracranial hemorrhage, and 10 patients (32%) deteriorated as a result of medical causes. Seven patients (23%) died. Variables significantly associated with mortality included age. 60 years, coagulopathy, and change in Marshall computed tomography classification. CONCLUSION: The incidence of delayed neurological deterioration after MHI with ICH is low and usually occurs within 24 hours after admission. It results in significant morbidity and mortality if it is the result of progressive intracranial hemorrhage. Further research is needed to identify risk factors that can allow early detection and improve outcomes in these patients.	[Choudhry, Osamah J.; Prestigiacomo, Charles J.; Gala, Nihar] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07101 USA; [Prestigiacomo, Charles J.; Slasky, Shira] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Radiol, Newark, NJ 07101 USA; [Sifri, Ziad C.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma Surg, Newark, NJ 07101 USA		Sifri, ZC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma Surg, 90 Bergen St, Newark, NJ 07101 USA.	sifrizi@umdnj.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378			AFGEIJERSTAM JL, 2003, ACTA NEUROCHIR WIEN, V145, P850; Bouzat P, 2009, ANN FR ANESTH, V28, P135, DOI 10.1016/j.annfar.2008.12.019; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; Brown CVR, 2012, AM SURGEON, V78, P57; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; MORAN SG, 1994, AM SURGEON, V60, P533; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ratanalert S, 2002, J CLIN NEUROSCI, V9, P640, DOI 10.1054/jocn.2002.1085; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Roquer J, 2005, J NEUROL, V252, P412, DOI 10.1007/s00415-005-0659-5; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sing RF, 2006, J TRAUMA, V60, P499; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	37	13	13	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2013	73	5					753	760		10.1227/NEU.0000000000000105			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	300MH	WOS:000330467500013	23867298				2022-02-06	
J	Miyake, H; Inoue, A; Tanaka, M; Matsuki, N				Miyake, Hizuru; Inoue, Akiko; Tanaka, Miho; Matsuki, Naoaki			Serum Glial Fibrillary Acidic Protein as a Specific Marker for Necrotizing Meningoencephalitis in Pug Dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; glial fibrillary acidic protein; necrotizing meningoencephalitis; serum	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; AUTOANTIBODY; GFAP	To evaluate the ability of serum glial fibrillary acidic protein (GFAP) concentration as a diagnostic marker for canine central nervous system (CNS) disorders, sera from dogs with various CNS (n=47) and non-CNS (n=56) disorders were measured for GFAP by using an ELISA kit. Healthy Beagles (n=15) and Pug dogs (n=12) were also examined as controls. Interestingly, only Pug dogs with necrotizing meningoencephalitis (NME) showed elevated serum GFAP concentrations (<0.01 to 1.14 ng/ml), while other breeds of dogs with NME did not. Among the Pug dogs with NME, serum GFAP concentrations did not correlate with their clinical features, such as ages or survival times. Our data indicate the usefulness of serum GFAP as a novel marker for Pug dogs with NME.	[Miyake, Hizuru; Inoue, Akiko; Tanaka, Miho; Matsuki, Naoaki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Clin Pathobiol, Bunkyo Ku, Tokyo 1138657, Japan		Matsuki, N (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Clin Pathobiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amki@mail.ecc.u-tokyo.ac.jp					Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Fujiwara K, 2008, VET REC, V162, P592, DOI 10.1136/vr.162.18.592; Matsuki N, 2004, J VET MED SCI, V66, P295, DOI 10.1292/jvms.66.295; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Park ES, 2012, VET PATHOL, V49, P682, DOI 10.1177/0300985811429311; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Toda Y, 2007, VET REC, V161, P261, DOI 10.1136/vr.161.8.261; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	10	13	13	0	3	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	NOV	2013	75	11					1543	1545		10.1292/jvms.13-0252			3	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	AC3QW	WOS:000332437300023	23856761	Bronze, Green Published			2022-02-06	
J	Stevens, LF; Perrin, PB; Gulin, S; Rogers, HL; Cabrera, TV; Jimenez-Maldonado, M; Arango-Lasprilla, JC				Stevens, Lillian Flores; Perrin, Paul B.; Gulin, Shaina; Rogers, Heather L.; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Carlos Arango-Lasprilla, Juan			Examining the Influence of Three Types of Social Support on the Mental Health of Mexican Caregivers of Individuals with Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						TBI; Caregivers; Social Support; Mental Health Outcomes	TRAIT ANXIETY INVENTORY; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; FAMILY; BURDEN; REHABILITATION; PREDICTORS; DISTRESS; CARERS; STRESS	Objective: The aim of this study was to examine the influence of three types of social support (appraisal, belonging, and tangible) on caregiver mental health (anxiety, burden, depression, and satisfaction with life) among Mexican caregivers of individuals with traumatic brain injury. Design: This is a cross-sectional study of 90 family caregivers from Hospital Civil Fray Antonio Alcade in Guadalajara, Mexico. Results: More months spent caregiving was associated with decreases in all three types of social support. Older age and fewer years of education were associated with lower appraisal social support. More hours per week spent caregiving was associated with lower caregiver state anxiety and greater satisfaction with life. Appraisal, belonging, and tangible social support were all significantly correlated with more salubrious caregiver mental health outcomes, except satisfaction with life. Appraisal social support independently predicted lower caregiver depression. Conclusions: Particularly in Latin America, strong social support networks and family connections seem closely tied to key mental health outcomes such as depression. Rehabilitation interventions aimed at strengthening perceptions of social support of caregivers of individuals with traumatic brain injury that specifically target availability of advice may improve mental health and contribute to more optimal informal care for individuals with traumatic brain injury.	[Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Perrin, Paul B.; Gulin, Shaina] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Rogers, Heather L.; Carlos Arango-Lasprilla, Juan] Univ Deusto, Bilbao 48007, Spain; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Basque Fdn Sci, Dept Psychol, Avda Univ 24, Bilbao 48007, Spain.		Rogers, Heather L./AAB-8486-2022; Perrin, Paul/L-5373-2015	Rogers, Heather L./0000-0002-7562-4542; Perrin, Paul/0000-0003-2070-215X			Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Atienza FL, 2000, PSICOTHEMA, V12, P314; Campos B, 2008, CULT DIVERS ETHN MIN, V14, P155, DOI 10.1037/1099-9809.14.2.155; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; COHEN R, 1979, CULTURE DIS STRESS L; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Folkman S., 1984, STRESS; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; GREBLER L, 1970, MEXICAN AM PEOPLE; Gurung R.A., 2006, HLTH PSYCHOL CULTURA; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KARLIKAYA G, 2005, INTERNET J NEUROL, V4; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; SANCHEZAYENDEZ M, 1998, LATINO ELDERS 21 CEN, V30, P75; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Spielberger C., 1975, IDARE INVENTARIO ANS; Spielberger C.D., 2010, CORSINI ENCY PSYCHOL, P1; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; SPSS Inc, 2010, SPSS BAS 19 0 WIND U; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	54	13	13	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV	2013	92	11					959	967		10.1097/PHM.0b013e31828cd549			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	299DK	WOS:000330375100002	23552337				2022-02-06	
J	Yeo, SS; Jang, SH				Yeo, Sang Seok; Jang, Sung Ho			RECOVERY OF AN INJURED FORNIX IN A STROKE PATIENT	JOURNAL OF REHABILITATION MEDICINE			English	Article						fornix; memory; diffusion tensor imaging; brain plasticity; stroke	TRAUMATIC BRAIN-INJURY; TENSOR TRACTOGRAPHY; HEMORRHAGE	Objective: Knowledge about recovery of an injured fornix following brain injury is limited. We describe here a patient who showed recovery of an injured fornix following stroke. Case report: A 57-year-old female patient underwent coiling for a ruptured anterior communicating cerebral artery aneurysm, and conservative management for subarachnoid and intraventricular haemorrhage. The patient showed severe cognitive impairment 6 weeks after onset. However, her cognition showed continuous improvement with time; based on the Mini-Mental State Examination and the Memory Assessment Scale, her cognition was within the normal range 7 months after onset. Results: Findings from diffusion tensor tractography at 6 weeks and 7 months showed discontinuations in both columns of the fornix. The proximal portion of both crus also showed discontinuation on diffusion tensor tractography at 6 weeks and 7 months; however, on 7-month diffusion tensor tractography, the end of the fornical body was shown to be connected to the splenium of the corpus callosum and then branched to the right medial temporal lobe and right thalamus. Conclusion: The unusual neural connection between the injured fornix and the thalamus appears to be a recovery phenomenon, which allows the injured fornix and the medial temporal lobe to obtain cholinergic innervation from cholinergic nuclei in the brainstem rather than from cholinergic nuclei in the basal forebrain.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Concha L, 2005, AM J NEURORADIOL, V26, P2267; GAFFAN EA, 1991, BRAIN, V114, P1297, DOI 10.1093/brain/114.3.1297; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; MESULAM MM, 1990, PROG BRAIN RES, V84, P231; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wechsler D, 1981, WECHSLER ADULT INTEL; Williams JM., 1991, MAS MEMORY ASSESSMEN; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469; Yeo SS, 2011, EUR NEUROL, V66, P235, DOI 10.1159/000330942	16	13	14	1	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2013	45	10					1078	1080		10.2340/16501977-1232			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	251TE	WOS:000326952800014	24145830	Green Submitted, gold			2022-02-06	
J	Blakeman, TC				Blakeman, Thomas C.			Evidence for Oxygen Use in the Hospitalized Patient: Is More Really the Enemy of Good?	RESPIRATORY CARE			English	Article						oxygen therapy; normoxia; hypoxemia; hyperoxemia; oxygen efficacy; oxygen safety	OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; ACUTE MYOCARDIAL-INFARCTION; SURGICAL-WOUND-INFECTION; ACUTE ISCHEMIC-STROKE; ACUTE LUNG INJURY; HIGH-FLOW OXYGEN; SUPPLEMENTAL OXYGEN; POSTOPERATIVE NAUSEA	Oxygen in arguably one of the most frequently utilized drugs in modern healthcare, but is often administered to patients at caregivers' discretion with scant evidence as to its efficacy or safety. Although oxygen is administered for varied medical conditions in the hospital setting, published literature supports the use of oxygen to reverse hypoxemia, for trauma victims with traumatic brain injury and hemorrhagic shock, for resuscitation during cardiac arrest, and for carbon monoxide poisoning. Oxygen should be titrated to target an S-pO2 of 94-98%, except with carbon monoxide poisoning (100% oxygen), ARDS (88-95%), those at risk for hypercapnia (S-pO2 88-92%), and premature infants (S-pO2 88-94%). Evidence for use with other conditions for which oxygen is administered relies on anecdotal experiences, case reports, or small, underpowered studies. Definitive conclusions for oxygen use in these conditions where efficacy and/or safety are uncertain will require large randomized controlled clinical trials.	[Blakeman, Thomas C.] Univ Cincinnati, Dept Surg, Coll Med, Div Trauma & Crit Care, Cincinnati, OH 45267 USA		Blakeman, TC (corresponding author), Univ Cincinnati, Dept Surg, ML 0558,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Thomas.Blakeman@uc.edu					Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2005, PALLIATIVE MED, V19, P168, DOI 10.1177/026921630501900219; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Akca O, 2002, Minerva Anestesiol, V68, P166; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; American Association for Respiratory Care, 2002, RESP CARE, V47, P707; American College of Surgeons, 1997, ADV TRAUM LIF SUPP; American Heart Association, 2002, HDB EM CARD CAR HEAL; American Lung Association, STAT LUNG DIS DIV CO; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; [Anonymous], 1920, BMJ-BRIT MED J, V1, P150; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Bateman NT, 1998, BRIT MED J, V317, P798, DOI 10.1136/bmj.317.7161.798; Bausewein C, 2010, PALLIATIVE MED, V24, P777, DOI 10.1177/0269216310378785; BENSON JM, 1992, CLIN PHARMACY, V11, P965; Blodgett AN., 1890, BOSTON MED SURG J, V123, P481, DOI [10.1056/NEJM189011201232101, DOI 10.1056/NEJM189011201232101]; BREMMELGAARD A, 1989, J HOSP INFECT, V13, P1, DOI 10.1016/0195-6701(89)90090-X; *BRIT THOR SOC, 1997, THORAX S5, V52, pS16; Brower RG, 2001, CHEST, V120, P347; Burls A, 2011, EMERG MED J, V28, P917, DOI 10.1136/emj.2010.103564; CAMPBELL K, 1951, Med J Aust, V2, P48; Centers for Disease Control and Prevention, HEART DIS FACTS; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen AS, 2009, JAMA-J AM MED ASSOC, V302, P2451, DOI 10.1001/jama.2009.1855; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; DALY WJ, 1962, J CLIN INVEST, V41, P126, DOI 10.1172/JCI104454; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Denniston AKO, 2002, CLIN MED, V2, P449, DOI 10.7861/clinmedicine.2-5-449; DOUGLAS ME, 1977, CHEST, V71, P18, DOI 10.1378/chest.71.1.18; Downs JB., 1984, MAJOR ISSUES CRITICA, P149; Downs John B, 2003, Respir Care, V48, P611; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75, DOI 10.1152/jappl.1962.17.1.75; FOGAN L, 1985, ARCH NEUROL-CHICAGO, V42, P362, DOI 10.1001/archneur.1985.04060040072015; FOSTER GL, 1969, CARDIOVASC RES, V3, P179, DOI 10.1093/cvr/3.2.179; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Fu ES, 1999, ANESTH ANALG, V88, pU40; GANZ W, 1972, CIRCULATION, V45, P763, DOI 10.1161/01.CIR.45.4.763; GARNER WL, 1989, SURGERY, V105, P747; Garza I, 2011, CURR NEUROL NEUROSCI, V11, P121, DOI 10.1007/s11910-010-0171-x; Geerlings RPJ, 2011, CEPHALALGIA, V31, P1145, DOI 10.1177/0333102411412087; Ghods Ali Asghar, 2005, J Perianesth Nurs, V20, P200; Grainge C, 2004, J ROY SOC MED, V97, P489, DOI 10.1258/jrsm.97.10.489; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Haldane JBS, 1927, BIOCHEM J, V21, P1068, DOI 10.1042/bj0211068; Haldane JS, 1917, BRIT MED J, V1917, P181, DOI 10.1136/bmj.1.2928.181; Haldane JS, 1922, RESPIRATION; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; Harris W., 1926, NEURITIS NEURALGIA; Heffner JE, 2013, RESP CARE, V58, P18, DOI 10.4187/respcare.01831; Holtzapple GE, 1887, NEW YORK MED J, V46, P264; HORTON B T, 1952, J Lancet, V72, P92; Hua Shao-dong, 2009, Zhonghua Er Ke Za Zhi, V47, P757; Johnson MJ, 2013, J PAIN SYMPTOM MANAG, V45, P763, DOI 10.1016/j.jpainsymman.2012.03.017; Joris JL, 2003, BRIT J ANAESTH, V91, P857, DOI 10.1093/bja/aeg267; Kallet RH, 2007, RESP CARE, V52, P461; Kallstrom Thomas J, 2002, Respir Care, V47, P717; KEELING NJ, 1995, ANN ROY COLL SURG, V77, P245; KENMURE ACF, 1968, BMJ-BRIT MED J, V4, P360, DOI 10.1136/bmj.4.5627.360; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; KINSEY VE, 1977, PEDIATRICS, V60, P655; Knight AR, 2011, NURS CRIT CARE, V16, P28, DOI 10.1111/j.1478-5153.2010.00403.x; Koivuranta M, 1997, ANAESTHESIA, V52, P443, DOI 10.1111/j.1365-2044.1997.117-az0113.x; Kones R, 2011, AM J MED, V124, P1000, DOI 10.1016/j.amjmed.2011.04.034; KUDROW L, 1981, HEADACHE, V21, P1, DOI 10.1111/j.1526-4610.1981.hed2101001.x; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Mayzler O, 2005, Minerva Anestesiol, V71, P21; McNulty PH, 2005, AM J PHYSIOL-HEART C, V288, pH1057, DOI 10.1152/ajpheart.00625.2004; MCSWAIN NE, 2003, PREHOSPITAL TRAUMA L; MICKEL HS, 1987, STROKE, V18, P426, DOI 10.1161/01.STR.18.2.426; MILES AA, 1957, BRIT J EXP PATHOL, V38, P79; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; MURDOCH C, 1995, ANESTHESIOLOGY, V83, pA258; Negovsky V A, 1972, Resuscitation, V1, P1, DOI 10.1016/0300-9572(72)90058-5; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; O'Driscoll BR, 2011, CLIN MED, V11, P372, DOI 10.7861/clinmedicine.11-4-372; Pancioli AM, 2002, ARCH INTERN MED, V162, P49, DOI 10.1001/archinte.162.1.49; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; QUINN AC, 1994, ANAESTHESIA, V49, P62, DOI 10.1111/j.1365-2044.1994.tb03316.x; Raju TNK, 1999, LANCET, V353, P1281, DOI 10.1016/S0140-6736(05)75208-9; REGISTER SD, 1987, CRIT CARE MED, V15, P598, DOI 10.1097/00003246-198706000-00012; Richmond S, 2008, SEMIN FETAL NEONAT M, V13, P368, DOI 10.1016/j.siny.2008.04.002; Robertson AF, 2005, SEMIN FETAL NEONAT M, V10, P23, DOI 10.1016/j.siny.2004.09.006; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Severinghaus J W, 1986, J Clin Monit, V2, P174, DOI 10.1007/BF01620550; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x; SLOANE PJ, 1992, AM REV RESPIR DIS, V146, P419, DOI 10.1164/ajrccm/146.2.419; SMALL D, 1992, AM J MED, V92, P591, DOI 10.1016/0002-9343(92)90775-7; Steele C., 1900, BMJ-BRIT MED J, V2, P1568; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Stockinger ZT, 2004, MIL MED, V169, P609, DOI 10.7205/MILMED.169.8.609; Stofft H, 1997, Hist Sci Med, V31, P341; SUCHYTA MR, 1992, CHEST, V101, P1074, DOI 10.1378/chest.101.4.1074; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Terry T L, 1944, Trans Am Ophthalmol Soc, V42, P383; The Acute Respiratory Distress Syndrome Network, 2001, NEW ENGL J MED, V342, P1301; THOMAS M, 1965, BRIT HEART J, V27, P401; Thomson AJ, 2006, J APPL PHYSIOL, V101, P809, DOI 10.1152/japplphysiol.01185.2005; TIBBLES PM, 1994, ANN EMERG MED, V24, P269, DOI 10.1016/S0196-0644(94)70141-5; Treschan TA, 2005, ANESTHESIOLOGY, V103, P6, DOI 10.1097/00000542-200507000-00005; USHER RH, 1961, NEW YORK STATE J MED, V61, P1677; Waring WS, 2003, J CARDIOVASC PHARM, V42, P245, DOI 10.1097/00005344-200308000-00014; Weaver LK, 2000, CHEST, V117, P801, DOI 10.1378/chest.117.3.801; Weaver LK, 1995, UNDERSEA HYPERB ME S, V22, P14; Western Australia Department of Health, US AC OX THER W AUST; WESTLAKE EK, 1955, Q J MED, V24, P155; WETCHLER BV, 1992, BRIT J ANAESTH, V69, pS33, DOI 10.1093/bja/69.supplement_1.33S; Wijesinghe M, 2009, HEART, V95, P198, DOI 10.1136/hrt.2008.148742; World Health Organization, 2010, CHRON RESP DIS CHRON; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	125	13	14	0	5	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	OCT	2013	58	10					1679	1693		10.4187/respcare.02677			15	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	245RH	WOS:000326481000015	24064627	Bronze			2022-02-06	
J	Nonterah, CW; Jensen, BJ; Perrin, PB; Stevens, LF; Cabrera, TV; Jimenez-Maldonado, M; Arango-Lasprilla, JC				Nonterah, Camilla W.; Jensen, Bryan J.; Perrin, Paul B.; Stevens, Lillian Flores; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Carlos Arango-Lasprilla, Juan			The influence of TBI impairments on family caregiver mental health in Mexico	BRAIN INJURY			English	Article						Caregiver; cultural; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION; DISTRESS; BURDEN; DEPRESSION; RELATIVES	Purpose: This study examined the influence of five types of impairments in individuals with traumatic brain injury (TBI)-and caregiver stress due to these impairments-on the mental health of family caregivers in Guadalajara, Mexico. Method: Ninety caregivers completed measures of TBI impairments and of their own mental health. The majority were female (92.20%) with a mean age of 47.12 years (SD = 12.67). Caregivers dedicated a median of 50 hours weekly to caregiving and had spent a median of 11 months providing care. Results: Two canonical correlation analyses suggested that these two sets of variables were broadly related, such that more severe impairments in individuals with TBI and more caregiver stress due to those impairments were associated with lower caregiver mental health. Across both analyses, social impairments were most associated with increased caregiver burden. Follow-up analyses also uncovered that caregiver stress due to cognitive impairments was uniquely associated with caregiver burden and anxiety. Conclusions: These results are the first to provide evidence that social and cognitive impairments in individuals with TBI from Latin America are the impairments most associated with caregiver mental health and highlight the need for interventions that target social and cognitive functioning.	[Nonterah, Camilla W.; Jensen, Bryan J.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, IKERBASQUE, Bilbao 48007, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Belgrave F. Z., 2010, AFRICAN AM PSYCHOL A; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Cohen J., 2013, STAT POWER ANAL BEHA; Coy AE, 2013, ARCH PHYS MED REHAB, V94, P362, DOI 10.1016/j.apmr.2012.08.210; Cuellar I, 1995, J COMMUNITY PSYCHOL, V23, P339, DOI 10.1002/1520-6629(199510)23:4<339::AID-JCOP2290230406>3.0.CO;2-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; Diaz-Guerrero R, 1976, CROSS CULTURAL ANXIE; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Ownsworth T, 2009, BRAIN IMPAIR, V10, P149, DOI 10.1375/brim.10.2.149; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rosenberg M., 1965, SOC ADOLESCENT SELF; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183; Spielberger C. D, 2010, CORSINI ENCY PSYCHOL; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; SPSS Inc, 2010, SPSS BAS 19 0 WIND C; TEASDALE G, 1974, LANCET, V2, P81; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1	48	13	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1287	1293		10.3109/02699052.2013.812243			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800008	24020441				2022-02-06	
J	Park, Y; Luo, TF; Zhang, F; Liu, CL; Bramlett, HM; Dietrich, WD; Hu, BR				Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Bramlett, Helen M.; Dietrich, W. Dalton; Hu, Bingren			Downregulation of Src-kinase and glutamate-receptor phosphorylation after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						NMDA receptor; PSD93; Src family kinases; traumatic brain injury; tyrosine phosphorylation	D-ASPARTATE RECEPTORS; TRANSIENT CEREBRAL-ISCHEMIA; NMDA RECEPTORS; TYROSINE-PHOSPHORYLATION; POSTSYNAPTIC DENSITIES; SURFACE EXPRESSION; RATS; DAMAGE; RELEASE; COMPLEX	Phosphorylation of N-methyl-D-aspartate (NMDA) receptors is a major regulatory mechanism underlying synaptic plasticity. However, changes in NMDA receptors and phosphorylation after traumatic brain injury (TBI) remain incompletely understood. Using an animal TBI model, we observed that the protein level of NMDA receptor subunit NR2B was downregulated in synaptosomal fractions obtained from the ipsilateral neocortical injury region, whereas the levels of NR2A, NR1, and PSD93 were not significantly altered at 4 and 24 hours after TBI. Further investigation showed that tyrosine phosphorylations of NR2B Y1472 and PSD93 Y340 in synaptosomal fractions were significantly decreased relative to their total protein level after TBI. Correspondingly, phosphorylation of the Src-kinase-inhibitory site Y527 was increased, whereas phosphorylation of the activation site Y416 was decreased, indicating that the activity of Src kinase is significantly inhibited after TBI. In comparison, other Src family kinase substrates of NMDA receptor, NR2A Y1246, NR2A Y1325, and NR2B Y1070 were not obviously affected after TBI. The results suggest that TBI downregulates the Src-kinase-mediated phosphorylation of NR2 and PSD93 to destabilize the synaptic localization of NMDA receptors. Therefore, post-TBI loss of NMDA receptors may contribute to the depression of synaptic activity after TBI.	[Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Hu, Bingren] Univ Maryland, Sch Med, Dept Anesthesiol, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA; [Park, Yujung; Luo, Tianfei; Zhang, Fan; Liu, Chunli; Hu, Bingren] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL USA		Hu, BR (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA.	bhu@anes.umm.edu		Zhang, Fan/0000-0002-0744-673X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040407, NS030291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS040407] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS040407 and NS030291.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Groveman BR, 2012, FEBS J, V279, P20, DOI 10.1111/j.1742-4658.2011.08413.x; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hu BR, 1998, J NEUROSCI, V18, P625; Jiang XN, 2011, NEUROSCI LETT, V503, P215, DOI 10.1016/j.neulet.2011.08.039; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Liu CL, 2005, NEUROSCIENCE, V134, P1273, DOI 10.1016/j.neuroscience.2005.05.015; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Nada S, 2003, J BIOL CHEM, V278, P47610, DOI 10.1074/jbc.M303873200; O'Leary TJ, 2009, BIOTECH HISTOCHEM, V84, P217, DOI 10.1080/10520290903039086; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sato Y, 2008, NEUROSCIENCE, V153, P700, DOI 10.1016/j.neuroscience.2008.03.006; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253	35	13	15	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2013	33	10					1642	1649		10.1038/jcbfm.2013.121			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	228PV	WOS:000325199600019	23838828	Green Published, Bronze			2022-02-06	
J	Perrin, PB; Stevens, LF; Sutter, M; Hubbard, R; Sosa, DMD; Jove, IGE; Arango-Lasprilla, JC				Perrin, Paul B.; Stevens, Lillian F.; Sutter, Megan; Hubbard, Rebecca; Diaz Sosa, Dulce Maria; Espinosa Jove, Irma Guadalupe; Carlos Arango-Lasprilla, Juan			Exploring the Connections Between Traumatic Brain Injury Caregiver Mental Health and Family Dynamics in Mexico City, Mexico	PM&R			English	Article							PSYCHOLOGICAL DISTRESS; LIFE SATISFACTION; FACES IV; PREDICTORS; REHABILITATION; DEPRESSION; TBI; QUESTIONNAIRE; INDIVIDUALS; ADAPTATION	Objective: To examine the patterns of family dynamics that are most associated with the mental health of traumatic brain injury (TBI) caregivers from Mexico. It was hypothesized that healthier family dynamics would be associated with better caregiver mental health. Design: A cross-sectional study of self-reported data collected from TBI caregivers through the Mexican National Institute of Rehabilitation in Mexico City, Mexico, the premier public medical facility in Mexico that provides rehabilitation services to patients with various disabilities. Setting: One public outpatient medical and rehabilitation facility. Participants: Sixty-eight caregivers of individuals with moderate-to-severe TBI from Mexico City, Mexico, were related to an individual with TBI who was >= 3 months after injury, a primary caregiver for >= 3 months, familiar with the patient's history, and without neurologic or psychiatric conditions. The average (standard deviation) age of caregivers was 50.94 +/- 12.85 years), and 82% were women. Methods: The caregivers completed Spanish versions of instruments that assessed their own mental health and family dynamics. Main Outcome Measurements: Outcomes assessed included family dynamics (Family Adaptability and Cohesion Evaluation Scale Fourth Edition; Family Communication Scale; Family Satisfaction Scale; Family Assessment Device General Functioning; and Relationship-Focused Coping Scale), and caregiver mental health (Patient Health Questionnaire-9, Zarit Burden Interview, and Satisfaction with Life Scale). Results: Results of canonical correlation analyses suggested that caregiver mental health and family dynamics were positively related, with a large effect size. Caregivers with high family satisfaction and cohesion tended to have a low burden and high satisfaction with life. In addition, caregiver depression and burden were positively related to each other and were both inversely related to caregiver satisfaction with life. Conclusions: TBI caregiver interventions in Latino populations would likely benefit from including programming or techniques to improve family dynamics, especially family cohesion, given the strong potentially reciprocal influence of these dynamics on caregiver mental health.	[Perrin, Paul B.; Sutter, Megan; Hubbard, Rebecca] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Diaz Sosa, Dulce Maria] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Espinosa Jove, Irma Guadalupe] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Dept Methodol & Expt Psychol, IKERBASQUE, Basque Fdn Sci, Bilbao 48007, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Methodol & Expt Psychol, IKERBASQUE, Basque Fdn Sci, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Sutter, Megan/L-9770-2019; Perrin, Paul/L-5373-2015	Sutter, Megan/0000-0001-9816-9549; Perrin, Paul/0000-0003-2070-215X			Anderson M. I., 2006, STRESS ITS IMPACT SO, P23; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Cohen J., 2013, STAT POWER ANAL BEHA; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hora Edilene Curvelo, 2005, Rev. Latino-Am. Enfermagem, V13, P93; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KARLIKAYA G, 2005, INTERNET J NEUROL, V4; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Martin M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; OBrien TB, 1996, J PERS, V64, P775, DOI 10.1111/j.1467-6494.1996.tb00944.x; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Olson DH, 2010, FACES 4 MANUAL; Pavot L, 1995, PSYCHOL ASSESSMENT, V5, P164; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Perrin PB, 2013, NEUROREHABILITATION, V32, P679, DOI 10.3233/NRE-130891; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivero N, 2010, FAM J, V18, P288, DOI 10.1177/1066480710372084; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Scharlach A, 2006, FAM RELAT, V55, P625, DOI 10.1111/j.1741-3729.2006.00431.x; Serna Edilene Curvelo Hora, 2006, Rev. Latino-Am. Enfermagem, V14, P183; Steinglass P., 1987, FAMILY INTERACTION P, P25, DOI DOI 10.1007/978-1-4899-0840-7_2; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Thomas V, 1999, J FAM THER, V21, P78, DOI 10.1111/1467-6427.00105; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villarreal R, HISP J BEHAV SCI, V35, P409; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	56	13	13	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2013	5	10					839	849		10.1016/j.pmrj.2013.05.018			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	250LY	WOS:000326855500005	23735587				2022-02-06	
J	Xu, GZ; Wang, MD; Liu, KG; Bai, YA; Wu, W; Li, W				Xu, Gang-Zhu; Wang, Mao-De; Liu, Kai-Ge; Bai, Yin-An; Wu, Wei; Li, Wen			A meta-analysis of treating acute traumatic brain injury with calcium channel blockers	BRAIN RESEARCH BULLETIN			English	Article						Traumatic subarachnoid haemorrhage; Calcium channel blockers; Acute traumatic brain injury; Meta-analysis	SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; OXYGEN-CONSUMPTION; FLOW VELOCITIES; DOUBLE-BLIND; HIT-I; NIMODIPINE; TRIAL; NEUROPROTECTION; INCREASES	The purpose of this systematic review was to evaluate and meta-analyse the current evidence for the use of calcium channel blockers (CCBs) in the treatment of acute traumatic brain injury (TBI) and traumatic subarachnoid haemorrhage (tSAH). A systematic search of clinical trials.gov, Cochrane library databases, EMBASE, MEDLINE, Web of science search and WHO trial registry, plus hand-searching of grey literature, was undertaken in March 2013. Two reviewers independently extracted the data using a pre-defined data extraction form. RevMan 5 software was used to synthesise data and calculate the risk ratio (RR) based on event rates as well as the 95% confidence interval (Cl). Finally, nine RCTs with a total of 2182 patients were included. Meta-analysis showed that there was no difference between CCBs and control groups for rates of mortality (n = 1337, 5 RCTs, RR 0.93 CI 0.77-1.12). In a subgroup tSAH analysis, the difference was not significant (n = 389, 2 RCTs, RR 0.73 CI 0.53-1.02). There were slightly fewer unfavourable outcomes in the treatment group, but the difference was not statistically significant (n = 2101, 8 RCTs, RR 0.90 CI 0.76-1.08). In the subgroup tSAH analysis, again, the difference did not reach statistical significance (n = 1074, 5 RCTs, RR 0.95 CI 0.73-1.24). It seems that larger, well-designed RCTs are necessary in order to ascertain any clinical benefit CCBs may or may not have for the treatment of acute TBI. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.	[Xu, Gang-Zhu; Liu, Kai-Ge; Bai, Yin-An; Wu, Wei; Li, Wen] Xian Med Univ, Affiliated Hosp, Dept Neurosurg, Xian 710077, Shaanxi, Peoples R China; [Wang, Mao-De] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China		Xu, GZ (corresponding author), Xian Med Univ, Affiliated Hosp, Dept Neurosurg, 48 Fenghao West Rd, Xian 710077, Shaanxi, Peoples R China.	xgz917@126.com; maodewang@163.com					[Anonymous], 2011, REV MAN REVMAN COMP; Asian A., 2009, PHARM RES, V59, P120; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; Farhoudi M, 2007, NEUROSCIENCES, V12, P285; Feng Dongxia, 2000, Chin J Traumatol, V3, P85; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V7905, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kostron H, 1985, Neurochirurgia (Stuttg), V28 Suppl 1, P103; Langham J., 2009, CDS REV, V1, DOI DOI 10.1002/14651858; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; MATTHEWS DSF, 1995, J NEUROL NEUROSUR PS, V59, P359, DOI 10.1136/jnnp.59.4.359; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Muizelaar JP, 1996, NEUROTRAUMA, P553; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Pillai SV, 2003, NEUROL INDIA, V51, P361; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; RINKEL GJ, 2005, COCHRANE DB SYST REV, V1; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Roos YBWEM, 2001, STROKE, V32, P1860, DOI 10.1161/01.STR.32.8.1860; Sahuquillo J, 2000, REV NEUROLOGIA, V30, P401, DOI 10.33588/rn.3005.99063; Sprenger K, 2003, EFFECT 3 WEEK UNPUB; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; TEASDALE G, 1990, ACT NEUR S, V51, P315; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Tse YH, 2005, SURG PRACT, V9, P122, DOI 10.1111/j.1744-1633.2005.00271.x; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Zubkov AY, 2000, ACT NEUR S, V76, P223	42	13	13	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2013	99						41	47		10.1016/j.brainresbull.2013.09.011			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	285TX	WOS:000329419000008	24099981				2022-02-06	
J	Mondragon-Lozano, R; Diaz-Ruiz, A; Rios, C; Gonzalez, RO; Favila, R; Salgado-Ceballos, H; Roldan-Valadez, E				Mondragon-Lozano, Rodrigo; Diaz-Ruiz, Araceli; Rios, Camilo; Olayo Gonzalez, Roberto; Favila, Rafael; Salgado-Ceballos, Hermelinda; Roldan-Valadez, Ernesto			Feasibility of In Vivo Quantitative Magnetic Resonance Imaging With Diffusion Weighted Imaging, T2-Weighted Relaxometry, and Diffusion Tensor Imaging in a Clinical 3 Tesla Magnetic Resonance Scanner for the Acute Traumatic Spinal Cord Injury of Rats Technical Note	SPINE			English	Article						magnetic resonance imaging; diffusion-weighted imaging; diffusion tensor imaging; fractional anisotropy; apparent diffusion coefficient; T-2 relaxometry mapping; biomarker; spinal cord injury; weight-drop device	LOCOMOTOR OUTCOMES; MRI; BRAIN; ANISOTROPY; CORRELATE; DEVICE; TIME	Study Design. Prospective longitudinal study. Objective. To verify the feasibility of performing in vivo quantitative magnetic resonance imaging evaluation of moderate traumatic spinal cord injury (SCI) in rats using a clinical 3T scanner. Summary of Background Data. Animal models of human diseases are essential for translational medicine. Potential treatments of SCI are evaluated in 2 ways: anatomical and functional. Advanced magnetic resonance sequences allow a noninvasive assessment of the spinal cord depicting both. This study describes and validates a very reproducible, feasible, affordable, and reliable method, designed to be applied in commercial 3T equipment, using a novel stereotactic device for spinal cord, leading to a readily available assessment of the progression of damage generated after traumatic SCI in rats. Methods. Four Long-Evans female rats were injured with a New York University weight-drop device to produce the SCI by contusion at thoracic level 10. All animals were placed in a fixation system, using a commercial wrist antenna to obtain magnetic resonance imaging data of the relaxometry time, apparent diffusion coefficient, and fractional anisotropy. Three sets of data obtained before SCI and 1 and 4 weeks after injury were compared. Results. The data showed a progressive decline in fractional anisotropy measurements after SCI comparing baseline versus the 1-week period (P < 0.001) and baseline versus the 4-week period (P < 0.019), with a significant progressive increase in apparent diffusion coefficient values and T 2 after SCI only in the baseline versus the 4-week period (P < 0.045 and P < 0.024, respectively). Conclusion. Our results helped us to validate a novel method to acquire highly reproducible and reliable quantitative biomarkers of traumatic SCI in vivo by using a 3T clinical MR scanner coupled with a novel stereotactic device for rats.	[Mondragon-Lozano, Rodrigo] Univ Autonoma Metropolitana, Dept Ingn Elect, Mexico City, DF, Mexico; [Diaz-Ruiz, Araceli; Rios, Camilo] Inst Nacl Neurol & Neurocirug, Dept Neuroquim, Mexico City, DF, Mexico; [Rios, Camilo] Univ Autonoma Metropolitana, Dept Sistemas Biol, Mexico City, DF, Mexico; [Olayo Gonzalez, Roberto] Univ Autonoma Metropolitana, Dept Fis, Mexico City, DF, Mexico; [Favila, Rafael] GE Healthcare, Mexico City, DF, Mexico; [Salgado-Ceballos, Hermelinda] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Especialidades, Unidad Invest Med Enfermedades Neurol, Mexico City, DF, Mexico; [Roldan-Valadez, Ernesto] Med Sur Clin & Fdn, Magnet Resonance Unit, Mexico City 14050, DF, Mexico		Roldan-Valadez, E (corresponding author), Med Sur Clin & Fdn, Magnet Resonance Unit, Puente Piedra 150, Mexico City 14050, DF, Mexico.	ernest.roldan@usa.net	Olayo, Roberto/B-4635-2008; Mondragon-Lozano, Rodrigo/Y-9663-2019; Roldan-Valadez, Ernesto/D-1661-2011	Olayo, Roberto/0000-0002-1728-958X; Mondragon-Lozano, Rodrigo/0000-0002-7060-6185; Roldan-Valadez, Ernesto/0000-0002-7116-5289; Diaz-Ruiz, Araceli/0000-0002-1481-0966			[Anonymous], 2010, J PHARMACOL PHARMACO, V1, P42; [Anonymous], GUIDE CARE USE LAB A, Veighth; Bartlett PA, 2007, AM J NEURORADIOL, V28, P1095, DOI 10.3174/ajnr.A0505; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Bonny JM, 2004, NEUROBIOL DIS, V15, P474, DOI 10.1016/j.nbd.2003.11.026; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Callot V, 2008, NMR BIOMED, V21, P868, DOI 10.1002/nbm.1274; Callot V, 2011, METHODS MOL BIOL, V771, P355, DOI 10.1007/978-1-61779-219-9_19; CAPIZZI RL, 1971, ANN INTERN MED, V74, P74, DOI 10.7326/0003-4819-74-1-74; Carneiro AAO, 2006, BRAZ J PHYS, V36, P9; Cortez-Conradis D, 2013, EUR RADIOL, V23, P1112, DOI 10.1007/s00330-012-2688-7; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; Galvan EE, 2010, STEREOT FUNCT NEUROS, V88, P115, DOI 10.1159/000289355; Griffin JF, 2013, J MAGN RESON IMAGING, V37, P632, DOI 10.1002/jmri.23862; Gupta RK, 2005, AM J NEURORADIOL, V26, P1107; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2012, EXP NEUROL, V235, P188, DOI 10.1016/j.expneurol.2011.11.015; Kulkarni M V, 1988, Radiographics, V8, P1059; Liang ZJ, 2007, J NEUROL NEUROSUR PS, V78, P581, DOI 10.1136/jnnp.2006.099077; Mukherjee P, 2005, NEUROIMAG CLIN N AM, V15, P655, DOI 10.1016/j.nic.2005.08.010; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Pallant J., 2011, SPSS SURVIVAL MANUAL, P249; Parizel PM, 2010, EUR SPINE J, V19, P8, DOI 10.1007/s00586-009-1123-5; Pease A, 2011, VET RADIOL ULTRASOUN, V52, P492, DOI 10.1111/j.1740-8261.2011.01837.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Rugg-Gunn FJ, 2005, NEUROLOGY, V64, P318, DOI 10.1212/01.WNL.0000149642.93493.F4; Sandner B, 2009, J MAGN RESON IMAGING, V29, P725, DOI 10.1002/jmri.21477; Schaefers G, 2008, IEEE ENG MED BIOL, V27, P23, DOI 10.1109/EMB.2007.910267; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Van Goethem JWM, 2005, EUR RADIOL, V15, P582, DOI 10.1007/s00330-004-2625-5	36	13	15	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	SEP 15	2013	38	20					E1242	E1249		10.1097/BRS.0b013e31829ef69c			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	299BM	WOS:000330369600002	23759823				2022-02-06	
J	Blakely, ML; Kao, LS; Tsao, K; Huang, EY; Tsai, A; Tanaka, S; Younas, S; Lu, ZQ; Lally, KP				Blakely, Martin L.; Kao, Lillian S.; Tsao, Kuojen; Huang, Eunice Y.; Tsai, Anthony; Tanaka, Stacy; Younas, Shiraz; Lu, Zengqi; Lally, Kevin P.		Pediat Surg Res Collaborative	Adherence of Randomized Trials Within Children's Surgical Specialties Published During 2000 to 2009 to Standard Reporting Guidelines	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	98th Annual Clinical Congress of the American-College-of-Surgeons (ACS) / 67th Annual Sessions of the Owen H Wangensteen Forum on Fundamental Surgical Problems	SEP 30-OCT 04, 2012	Chicago, IL	Amer Coll Surg			SUPRACONDYLAR HUMERAL FRACTURES; ASSISTED THORACOSCOPIC SURGERY; HYPERTROPHIC PYLORIC-STENOSIS; PEDIATRIC CARDIAC-SURGERY; PLACEBO-CONTROLLED TRIAL; CENTRAL VENOUS CATHETERS; TRAUMATIC BRAIN-INJURY; BLALOCK-TAUSSIG SHUNT; QUALITY-OF-LIFE; DOUBLE-BLIND	BACKGROUND: Randomized clinical trials (RCTs) are uncommon in pediatric surgical specialties and the quality of reporting is unknown. Our primary purpose was to analyze published surgical RCTs involving children to measure adherence to the Consolidated Standards of Reporting Trials (CONSORT) guidelines. STUDY DESIGN: Published RCTs from January 1, 2000 through December 31, 2009 were reviewed. The trials were evaluated for the presence of 7 CONSORT guidelines and also graded according to the Jadad scale. RESULTS: Two hundred and twenty-eight trials were included. Five trials met all 7 CONSORT criteria (2%) and 53 had a Jadad score of >= 3 (23%). Slightly more than 50% of all trials specified primary outcomes and <25% described power calculations according to CONSORT. Adherence to CONSORT guidelines for allocation concealment, randomization description, and attrition details was even lower. There were significant differences between surgical specialties with regard to CONSORT adherence to the majority of the guidelines. Pediatric general surgery had the largest number of published RCTs. Pediatric orthopaedic surgery had the highest proportion of trials with a Jadad score >= 3 (40%). CONCLUSIONS: Adherence to CONSORT guidelines is low across the spectrum of children's surgical specialties, although significant differences do exist. Future RCTs in children's surgical specialties should specifically focus on areas of low adherence to reporting guidelines. ((c) 2013 by the American College of Surgeons)	[Blakely, Martin L.] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Sch Med, Dept Pediat Surg, Nashville, TN 37232 USA; [Tanaka, Stacy] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Sch Med, Div Pediat Urol, Nashville, TN 37232 USA; [Lu, Zengqi] Vanderbilt Univ, Dept Biostat, Sch Med, Nashville, TN 37232 USA; [Huang, Eunice Y.; Tsai, Anthony] Univ Tennessee, Ctr Hlth Sci, Div Pediat Surg, LeBonheur Childrens Hosp, Memphis, TN 38163 USA; [Kao, Lillian S.; Tsao, Kuojen; Younas, Shiraz; Lally, Kevin P.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Childrens Mem Hermann Hosp, Houston, TX 77030 USA		Blakely, ML (corresponding author), Vanderbilt Univ, Dept Pediat Surg, Sch Med, 2200 Childrens Way,DOT 7104, Nashville, TN 37232 USA.	martin.blakely@vanderbilt.edu		Huang, Eunice/0000-0003-1413-7860			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Adibe OO, 2012, ARCH SURG-CHICAGO, V147, P899, DOI 10.1001/archsurg.2012.1796; Agati S, 2006, J THORAC CARDIOV SUR, V131, P1306, DOI 10.1016/j.jtcvs.2006.02.013; Al-Mazrou KA, 2009, INT J PEDIATR OTORHI, V73, P1650, DOI 10.1016/j.ijporl.2009.08.019; Albers MJIJ, 2005, ANN SURG, V241, P599, DOI 10.1097/01.sla.0000157270.24991.71; Altman DG, 1996, BRIT MED J, V313, P570; Aminsharifi A, 2008, UROLOGY, V72, P305, DOI 10.1016/j.urology.2008.02.034; Arda IS, 2001, SCAND J UROL NEPHROL, V35, P505; Arda RS, 2002, PEDIATR INT, V44, P78, DOI 10.1046/j.1442-200X.2002.01502.x; Austin PF, 2008, PEDIATRICS, V122, P1027, DOI 10.1542/peds.2007-3691; Ayan S, 2007, J UROLOGY, V177, P2325, DOI 10.1016/j.juro.2007.02.001; Aydogdu O, 2009, J UROLOGY, V182, P2880, DOI 10.1016/j.juro.2009.08.061; Barret JP, 2000, PLAST RECONSTR SURG, V105, P62, DOI 10.1097/00006534-200001000-00010; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Ben Meir D, 2004, J UROLOGY, V171, P2621, DOI 10.1097/01.ju.0000124007.55430.d3; Blank J, 2003, J SPINAL DISORD TECH, V16, P508, DOI 10.1097/00024720-200312000-00004; Bohm ER, 2006, J BONE JOINT SURG AM, V88A, P1, DOI 10.2106/JBJS.E.00320; Bolla G, 2008, MED SURG PEDIAT, V30, P89; Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007; Branski LK, 2007, CRIT CARE MED, V35, P2615, DOI 10.1097/01.CCM.0000285991.36698.E2; Brooke BS, 2009, ANN SURG, V249, P162, DOI 10.1097/SLA.0b013e31819291f9; Brown JK, 2009, J PEDIATR SURG, V44, P1418, DOI 10.1016/j.jpedsurg.2009.02.051; Bu LN, 2003, J PEDIATR SURG, V38, P590, DOI 10.1053/jpsu.2003.50128; Burgu B, 2010, UROLOGY, V76, P169, DOI 10.1016/j.urology.2009.09.080; Capozza N, 2002, J PEDIATR-US, V140, P230, DOI 10.1067/mpd.2002.121380; Caputo M, 2002, ANN THORAC SURG, V74, P530, DOI 10.1016/S0003-4975(02)03695-0; Cartwright PC, 2009, J UROLOGY, V182, P1548, DOI 10.1016/j.juro.2009.06.058; Casselbrant ML, 2009, INT J PEDIATR OTORHI, V73, P1718, DOI 10.1016/j.ijporl.2009.09.007; Cassidy C, 2005, BURNS, V31, P890, DOI 10.1016/j.burns.2005.04.029; Cavusoglu YH, 2009, EUR J PEDIATR SURG, V19, P171, DOI 10.1055/s-0029-1202776; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan KH, 2004, ARCH OTOLARYNGOL, V130, P1303, DOI 10.1001/archotol.130.11.1303; Chan KL, 2005, SURG ENDOSC, V19, P927, DOI 10.1007/s00464-004-8224-3; Chang KW, 2008, OTOLARYNG HEAD NECK, V138, P153, DOI 10.1016/j.otohns.2007.11.006; Chattopadhyay A, 2004, PEDIATR SURG INT, V20, P127, DOI 10.1007/s00383-003-1104-4; Chauhan S, 2004, J CARDIOTHOR VASC AN, V18, P141, DOI 10.1053/j.jvca.2004.01.016; Chen YL, 2007, INT J PEDIATR OTORHI, V71, P921, DOI 10.1016/j.ijporl.2007.03.002; Chertin B, 2007, J UROLOGY, V178, P1744, DOI 10.1016/j.juro.2007.03.171; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Chin-Peuckert L, 2004, J UROLOGY, V172, P1657, DOI 10.1097/01.ju.0000138520.95101.02; Clarke MCC, 2009, J PEDIATR SURG, V44, P1268, DOI 10.1016/j.jpedsurg.2009.02.031; Clarke MCC, 2009, J PEDIATR SURG, V44, P408, DOI 10.1016/j.jpedsurg.2008.10.100; Clarke SA, 2005, J PEDIATR SURG, V40, P568, DOI 10.1016/j.jpedsurg.2004.11.027; Codispoti M, 2002, EUR J CARDIO-THORAC, V22, P200, DOI 10.1016/S1010-7940(02)00271-3; Collins KK, 2004, J THORAC CARDIOV SUR, V127, P721, DOI 10.1016/S0022-5223(03)01055-9; Cowley CG, 2005, CIRCULATION, V111, P3453, DOI 10.1161/CIRCULATIONAHA.104.510198; Curry JI, 2004, J PEDIATR SURG, V39, P565, DOI 10.1016/j.jpedsurg.2003.12.020; D'Agostino R, 2008, INT J PEDIATR OTORHI, V72, P1077, DOI 10.1016/j.ijporl.2008.03.018; D'Eredita R, 2006, INT J PEDIATR OTORHI, V70, P1077, DOI 10.1016/j.ijporl.2005.11.003; D'Eredita R, 2004, OTOLARYNG HEAD NECK, V131, P732, DOI 10.1016/j.otohns.2004.04.031; D'Eredita R, 2009, LARYNGOSCOPE, V119, P1897, DOI 10.1002/lary.20210; Davenport M, 2007, HEPATOLOGY, V46, P1821, DOI 10.1002/hep.21873; De Moura CP, 2008, J LARYNGOL OTOL, V122, P1318, DOI 10.1017/S002221510800279X; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Derkay CS, 2006, OTOLARYNG HEAD NECK, V134, P114, DOI 10.1016/j.otohns.2005.10.039; Dillon PW, 2004, J CLIN ONCOL, V22, P2718, DOI 10.1200/JCO.2004.07.019; Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P796, DOI 10.1001/archsurg.136.7.796; Doniger SJ, 2009, PEDIATR EMERG CARE, V25, P154, DOI 10.1097/PEC.0b013e31819a8946; Ekemen S, 2008, PEDIATR SURG INT, V24, P695, DOI 10.1007/s00383-008-2147-3; Ekingen G, 2005, NUTRITION, V21, P142, DOI 10.1016/j.nut.2004.10.003; El-Ghoneimi A, 2002, J UROLOGY, V168, P694, DOI 10.1016/S0022-5347(05)64726-X; Erfanian K, 2003, J PEDIATR SURG, V38, P1059, DOI 10.1016/S0022-3468(03)00192-1; Ericsson E, 2007, LARYNGOSCOPE, V117, P654, DOI 10.1097/mlg.0b013e318030ca69; Fanta K, 2006, J PEDIATR SURG, V41, P277, DOI 10.1016/j.jpedsurg.2005.10.049; Farrokhyar F, 2010, ANN SURG, V251, P409, DOI 10.1097/SLA.0b013e3181cf863d; Foead A, 2004, J Orthop Surg (Hong Kong), V12, P76; Ford Henri R, 2005, Surg Infect (Larchmt), V6, P313, DOI 10.1089/sur.2005.6.313; Frommelt PC, 2007, J AM SOC ECHOCARDIOG, V20, P1364, DOI 10.1016/j.echo.2007.04.009; Ghanayem NS, 2006, ANN THORAC SURG, V82, P1603, DOI 10.1016/j.athoracsur.2006.05.103; Giguere CM, 2002, ARCH OTOLARYNGOL, V128, P1137, DOI 10.1001/archotol.128.10.1137; Glat PM, 2009, J BURN CARE RES, V30, P262, DOI 10.1097/BCR.0b013e318198a2e8; Goldberg CS, 2007, J THORAC CARDIOV SUR, V133, P880, DOI 10.1016/j.jtcvs.2006.11.029; Gopal SC, 2008, J PEDIATR SURG, V43, P1869, DOI 10.1016/j.jpedsurg.2008.04.022; Gorecki WJ, 2001, MED SCI MONITOR, V7, P289; Graubert C, 2000, J PEDIATR ORTHOPED, V20, P496, DOI 10.1097/00004694-200007000-00014; Green R, 2005, PEDIATRICS, V116, P978, DOI 10.1542/peds.2005-0273; Gross CW, 2001, LARYNGOSCOPE, V111, P259, DOI 10.1097/00005537-200102000-00014; Guarino N, 2009, J UROLOGY, V181, P1318, DOI 10.1016/j.juro.2008.10.056; Gudas R, 2009, J PEDIATR ORTHOPED, V29, P741, DOI 10.1097/BPO.0b013e3181b8f6c7; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Hall NJ, 2009, LANCET, V373, P390, DOI 10.1016/S0140-6736(09)60006-4; Hall NJ, 2005, PEDIATR SURG INT, V21, P507, DOI 10.1007/s00383-005-1478-6; Hanasono MM, 2004, ARCH OTOLARYNGOL, V130, P917, DOI 10.1001/archotol.130.8.917; Hardin WD, 1999, J PEDIATR SURG, V34, P908, DOI 10.1016/S0022-3468(99)90396-2; Hartnick CJ, 2001, ARCH OTOLARYNGOL, V127, P1260, DOI 10.1001/archotol.127.10.1260; Hegazy HM, 2008, J LARYNGOL OTOL, V122, P369, DOI 10.1017/S0022215107008328; Henkel KO, 2004, CLEFT PALATE-CRAN J, V41, P1, DOI 10.1597/02-011; Hernandez-Gonzalez M, 2003, ARCH MED RES, V34, P305, DOI 10.1016/S0188-4409(03)00055-9; Hirschl RB, 2003, J PEDIATR SURG, V38, P283, DOI 10.1053/jpsu.2003.50095; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotz Gillian A, 2004, Traffic Inj Prev, V5, P132, DOI 10.1080/15389580490435097; Hung T, 2002, J LARYNGOL OTOL, V116, P33; Inoue M, 2005, J PEDIATR SURG, V40, P1301, DOI 10.1016/j.jpedsurg.2005.05.015; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jagannathan N, 2009, PEDIATR ANESTH, V19, P892, DOI 10.1111/j.1460-9592.2009.03092.x; Jallouli M, 2009, UROLOGY, V73, P1251, DOI 10.1016/j.urology.2008.10.078; Jonas NE, 2007, INT J PEDIATR OTORHI, V71, P1687, DOI 10.1016/j.ijporl.2007.07.001; Jonas NE, 2007, INT J PEDIATR OTORHI, V71, P1555, DOI 10.1016/j.ijporl.2007.06.008; Kaewpornsawan K, 2001, J PEDIATR ORTHOP B, V10, P131, DOI 10.1097/00009957-200104000-00010; Kaewpornsawan Kamolporn, 2007, Journal of the Medical Association of Thailand, V90, P936; Kaiser S, 2004, ACAD RADIOL, V11, P971, DOI 10.1016/j.acra.2004.05.023; Kaiser S, 2002, RADIOLOGY, V223, P633, DOI 10.1148/radiol.2233011076; Kajbafzadeh AM, 2009, UROLOGY, V74, P324, DOI 10.1016/j.urology.2008.12.085; Kamikawa S, 2001, MINIM INVAS NEUROSUR, V44, P25, DOI 10.1055/s-2001-13587; Karaman I, 2004, EUR J PEDIATR SURG, V14, P250, DOI 10.1055/s-2004-817840; Kargi E, 2010, UROLOGY, V75, P672, DOI 10.1016/j.urology.2009.06.108; Kaya C, 2008, J UROLOGY, V179, P684, DOI 10.1016/j.juro.2007.09.098; Kazem MM, 2010, J PEDIATR UROL, V6, P258, DOI 10.1016/j.jpurol.2009.08.007; Keshtgar AS, 2007, J PEDIATR SURG, V42, P672, DOI 10.1016/j.jpedsurg.2006.12.045; Kestle JRW, 2003, J NEUROSURG, V98, P284, DOI 10.3171/jns.2003.98.2.0284; Kibar Y, 2010, UROLOGY, V75, P1472, DOI 10.1016/j.urology.2009.09.008; Kim EK, 2009, J CRANIOFAC SURG, V20, P1886, DOI 10.1097/SCS.0b013e3181b2d1d1; Kinnari TJ, 2007, LARYNGOSCOPE, V117, P2213, DOI 10.1097/MLG.0b013e3181468631; Kinnari TJ, 2004, LARYNGOSCOPE, V114, P2038, DOI 10.1097/01.mlg.0000147944.20676.17; Kiris T, 2000, NEUROSURG FOCUS, V8, P1, DOI DOI 10.3171/FOC.2000.8.3.9; Kiss A, 2001, J UROLOGY, V165, P219, DOI 10.1097/00005392-200101000-00062; Klijn AJ, 2006, J UROLOGY, V175, P2263, DOI 10.1016/S0022-5347(06)00331-4; Kocaturk S, 2005, AM J OTOLARYNG, V26, P123, DOI 10.1016/j.amjoto.2004.11.004; Kocher MS, 2007, J BONE JOINT SURG AM, V89A, P706, DOI 10.2106/JBJS.F.00379; Koivusalo AI, 2009, PEDIATRICS, V123, P332, DOI 10.1542/peds.2007-3752; Kono T, 2006, LASER SURG MED, V38, P112, DOI 10.1002/lsm.20257; Korkmaz O, 2008, INT J PEDIATR OTORHI, V72, P1007, DOI 10.1016/j.ijporl.2008.03.003; Kovacs AF, 2008, J PEDIATR SURG, V43, P2075, DOI 10.1016/j.jpedsurg.2008.03.057; Kramer SA, 2005, J UROLOGY, V173, P2121, DOI 10.1097/01.ju.0000157689.98314.69; Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x; Kurt BA, 2006, PEDIATRICS, V118, pE547, DOI 10.1542/peds.2005-2719; Lal S, 2000, SHOCK, V14, P314, DOI 10.1097/00024382-200014030-00013; Lally KP, 2006, J PEDIATR SURG, V41, P668, DOI 10.1016/j.jpedsurg.2005.12.007; Lassen K, 2012, REV RECENT CLIN TRIA, V7, P244, DOI 10.2174/157488712802281402; Leaper M, 2006, INT J PEDIATR OTORHI, V70, P1389, DOI 10.1016/j.ijporl.2006.02.004; Leclair MD, 2007, J PEDIATR SURG, V42, P692, DOI 10.1016/j.jpedsurg.2006.12.016; Lee T, 2005, J UROLOGY, V174, P1084, DOI 10.1097/01.ju.0000169160.84418.15; Lemler MS, 2002, CIRCULATION, V105, P207, DOI 10.1161/hc0202.102237; Letendre J, 2009, J UROLOGY, V182, P1759, DOI 10.1016/j.juro.2009.03.016; Levy I, 2005, PEDIATR INFECT DIS J, V24, P676, DOI 10.1097/01.inf.0000172934.98865.14; Li HCW, 2008, J SPEC PEDIATR NURS, V13, P63, DOI 10.1111/j.1744-6155.2008.00138.x; Licameli G, 2008, INT J PEDIATR OTORHI, V72, P1323, DOI 10.1016/j.ijporl.2008.05.018; Lintula H, 2002, J PEDIATR SURG, V37, P1317, DOI 10.1053/jpsu.2002.34998; Lintula H, 2009, LANGENBECK ARCH SURG, V394, P999, DOI 10.1007/s00423-008-0425-0; Lister MT, 2006, ARCH OTOLARYNGOL, V132, P599, DOI 10.1001/archotol.132.6.599; Lodge AJ, 2008, ANN THORAC SURG, V86, P614, DOI 10.1016/j.athoracsur.2008.04.103; Logghe HL, 2005, J PEDIATR SURG, V40, P1726, DOI 10.1016/j.jpedsurg.2005.07.047; Lund L, 2000, SCAND J UROL NEPHROL, V34, P267, DOI 10.1080/003655900750042013; Lund L, 2005, SCAND J UROL NEPHROL, V39, P78, DOI 10.1080/00365590410002519; Luo WJ, 2001, ANN THORAC SURG, V71, P473, DOI 10.1016/S0003-4975(00)02443-7; McHoney M, 2005, J PEDIATR SURG, V40, P908, DOI 10.1016/j.jpedsurg.2005.03.003; McLauchlan GJ, 2002, J BONE JOINT SURG BR, V84B, P413, DOI 10.1302/0301-620X.84B3.11432; McLorie G, 2001, J UROLOGY, V165, P1669, DOI 10.1016/S0022-5347(05)66388-4; Mendez-Gallart R, 2009, J PEDIATR SURG, V44, P2048, DOI 10.1016/j.jpedsurg.2009.06.008; Merei JM, 2006, PEDIATR SURG INT, V22, P446, DOI 10.1007/s00383-006-1677-9; Merei JM, 2004, J PEDIATR SURG, V39, P1871, DOI 10.1016/j.jpedsurg.2004.08.017; Merguerian PA, 2004, J UROLOGY, V172, P1621, DOI 10.1097/01.ju.0000139953.04938.07; Mitchell C, 2006, EUR J CANCER, V42, P2554, DOI 10.1016/j.ejca.2006.05.026; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Morpeth JF, 2001, INT J PEDIATR OTORHI, V61, P99, DOI 10.1016/S0165-5876(01)00552-3; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Moss RL, 2001, J PEDIATR SURG, V36, P1182, DOI 10.1053/jpsu.2001.25749; Moss RL, 2001, J PEDIATR SURG, V36, P1739, DOI 10.1053/jpsu.2001.28809; Navali AM, 2008, J HAND SURG-EUR VOL, V33E, P424, DOI 10.1177/1753193408090761; Neel KF, 2007, J UROLOGY, V178, P2593, DOI 10.1016/j.juro.2007.08.032; Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051; Newcomb AE, 2005, EUR J CARDIO-THORAC, V27, P395, DOI 10.1016/j.ejcts.2004.11.023; Nguyen LHP, 2004, LARYNGOSCOPE, V114, P863, DOI 10.1097/00005537-200405000-00014; Nijman RJM, 2005, J UROLOGY, V173, P1334, DOI 10.1097/01.ju.0000152322.17542.63; Nunez DA, 2000, ARCH OTOLARYNGOL, V126, P837, DOI 10.1001/archotol.126.7.837; Oka T, 2004, SURG ENDOSC, V18, P242, DOI 10.1007/s00464-003-8140-y; Oko MO, 2005, OTOLARYNG HEAD NECK, V133, P579, DOI 10.1016/j.otohns.2005.08.002; Ong CCP, 2002, PEDIATR SURG INT, V18, P553, DOI 10.1007/s00383-002-0728-0; Ordorica-Flores R, 2001, J PEDIATR SURG, V36, P1000, DOI 10.1053/jpsu.2001.24724; Ostlie DJ, 2010, J PEDIATR SURG, V45, P1940, DOI 10.1016/j.jpedsurg.2010.05.008; Oswald J, 2002, UROLOGY, V60, P894, DOI 10.1016/S0090-4295(02)01903-9; Palmu S, 2008, J BONE JOINT SURG AM, V90A, P463, DOI 10.2106/JBJS.G.00072; Park A, 2007, INT J PEDIATR OTORHI, V71, P1205, DOI 10.1016/j.ijporl.2007.04.010; Pasquale K, 2003, LARYNGOSCOPE, V113, P139, DOI 10.1097/00005537-200301000-00026; Pastor AC, 2008, J PEDIATR SURG, V43, P1807, DOI 10.1016/j.jpedsurg.2008.04.003; Patikas D, 2006, ARCH PHYS MED REHAB, V87, P619, DOI 10.1016/j.apmr.2006.01.023; Pereira PL, 2003, J UROLOGY, V170, P1978, DOI 10.1097/01.ju.0000085667.05190.ad; Peter SDS, 2008, J PEDIATR SURG, V43, P981, DOI 10.1016/j.jpedsurg.2008.02.018; Petratos PB, 2002, J UROLOGY, V167, P677, DOI 10.1016/S0022-5347(01)69123-7; Pileggi FD, 2007, J PEDIATR SURG, V42, P1749, DOI 10.1016/j.jpedsurg.2007.05.035; Pittner DE, 2008, J PEDIATR ORTHOPED, V28, P250, DOI 10.1097/BPO.0b013e318164f8e7; Pizzuto MP, 2000, INT J PEDIATR OTORHI, V52, P239, DOI 10.1016/S0165-5876(00)00293-7; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Podkamenev VV, 2002, J PEDIATR SURG, V37, P727, DOI 10.1053/jpsu.2002.32264; Poetker DM, 2006, ARCH OTOLARYNGOL, V132, P1294, DOI 10.1001/archotol.132.12.1294; Polkki Tarja, 2008, J Pediatr Nurs, V23, P217, DOI 10.1016/j.pedn.2006.11.001; Ragab SM, 2005, OTOLARYNG HEAD NECK, V133, P961, DOI 10.1016/j.otohns.2005.07.037; Ramadan HH, 2001, ARCH OTOLARYNGOL, V127, P188, DOI 10.1001/archotol.127.2.188; Ramkumar S, 2006, J PLAST RECONSTR AES, V59, P969, DOI 10.1016/j.bjps.2006.01.011; Rebello G, 2009, J PEDIATR ORTHOPED, V29, P626, DOI 10.1097/BPO.0b013e3181b2ba1b; Rees CM, 2008, ANN SURG, V248, P44, DOI 10.1097/SLA.0b013e318176bf81; Reilly CW, 2009, J PEDIATR ORTHOPED, V29, P275, DOI 10.1097/BPO.0b013e31819bcd14; Rice HE, 2001, ARCH SURG-CHICAGO, V136, P1391, DOI 10.1001/archsurg.136.12.1391; Rodriguez RA, 2001, J THORAC CARDIOV SUR, V121, P3, DOI 10.1067/mtc.2001.111177; Rozzelle CJ, 2008, J NEUROSURG-PEDIATR, V2, P111, DOI 10.3171/PED/2008/2/8/111; Sakellaris G, 2004, J PEDIATR SURG, V39, P1400, DOI 10.1016/j.jpedsurg.2004.05.002; Sampaio ALL, 2007, INT J PEDIATR OTORHI, V71, P645, DOI 10.1016/j.ijporl.2006.12.016; Sarhan O, 2009, J UROLOGY, V182, P682, DOI 10.1016/j.juro.2009.04.034; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwentner C, 2006, EUR UROL, V49, P388, DOI 10.1016/j.eururo.2005.11.015; Schwentner C, 2005, J UROLOGY, V173, P974, DOI 10.1097/01.ju.0000153562.07287.77; Shah UK, 2002, ARCH OTOLARYNGOL, V128, P672, DOI 10.1001/archotol.128.6.672; Sharma S, 2007, PEDIATR SURG INT, V23, P1215, DOI 10.1007/s00383-007-2008-5; Shehata EM, 2005, LARYNGOSCOPE, V115, P162, DOI 10.1097/01.mlg.0000150704.13204.20; Sidman JD, 2008, LARYNGOSCOPE, V118, P1765, DOI 10.1097/MLG.0b013e31817f18e7; Sinha M, 2006, PEDIATRICS, V117, P1162, DOI 10.1542/peds.2005-1100; Smith DP, 2004, J UROLOGY, V172, P1760, DOI 10.1097/01.ju.0000139830.42599.a6; Smith HAB, 2006, J THORAC CARDIOV SUR, V132, P58, DOI 10.1016/j.jtcvs.2006.02.012; Sobol SE, 2006, ARCH OTOLARYNGOL, V132, P270, DOI 10.1001/archotol.132.3.270; Sonmez K, 2002, J PEDIATR SURG, V37, P1313, DOI 10.1053/jpsu.2002.34997; Sonnappa S, 2006, AM J RESP CRIT CARE, V174, P221, DOI 10.1164/rccm.200601-027OC; St Peter SD, 2006, ANN SURG, V244, P363, DOI 10.1097/01.sla.0000234647.03466.27; St Peter SD, 2009, J PEDIATR SURG, V44, P106, DOI 10.1016/j.jpedsurg.2008.10.018; Stanislaw P, 2000, ARCH OTOLARYNGOL, V126, P845, DOI 10.1001/archotol.126.7.845; Stringer MD, 2007, J PEDIATR SURG, V42, P1324, DOI 10.1016/j.jpedsurg.2007.03.026; Sud A, 2008, INT ORTHOP, V32, P409, DOI 10.1007/s00264-007-0332-y; Tander B, 2003, PEDIATR SURG INT, V19, P548, DOI 10.1007/s00383-003-1029-y; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Temple RH, 2001, INT J PEDIATR OTORHI, V61, P195, DOI 10.1016/S0165-5876(01)00553-5; Testa B, 2001, LARYNGOSCOPE, V111, P1486, DOI 10.1097/00005537-200108000-00028; Thakur A, 2001, J PEDIATR SURG, V36, P1160, DOI 10.1053/jpsu.2001.25737; Tripuraneni KR, 2009, J PEDIATR ORTHOP B, V18, P93, DOI 10.1097/BPB.0b013e32832989ff; Tsai S, 2005, J PEDIATR SURG, V40, P263, DOI 10.1016/j.jpedsurg.2004.09.036; Upadhyaya VD, 2007, WORLD J SURG, V31, P2412, DOI 10.1007/s00268-007-9244-7; van den Ende ED, 2004, J PEDIATR SURG, V39, P1249, DOI 10.1016/j.jpedsurg.2004.04.013; Van Savage JG, 2000, J UROLOGY, V164, P981, DOI 10.1016/S0022-5347(05)67231-X; Venter M, 2007, BURNS, V33, P464, DOI 10.1016/j.burns.2006.08.008; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vogt M, 2010, BJU INT, V105, P1456, DOI 10.1111/j.1464-410X.2009.08872.x; Waldhausen JH, 2002, J AM COLL SURGEONS, V194, P411, DOI 10.1016/S1072-7515(02)01113-4; Washington A Eugene, 2011, N Engl J Med, V365, pe31, DOI 10.1056/NEJMp1109407; Webb GR, 2006, J BONE JOINT SURG AM, V88A, P9, DOI 10.2106/JBJS.E.00131; Wei B, 2004, ANN THORAC SURG, V77, P918, DOI 10.1016/j.athoracsur.2003.09.072; Whitelaw A, 2007, PEDIATRICS, V119, pE1071, DOI 10.1542/peds.2006-2841; Wilson YL, 2009, LARYNGOSCOPE, V119, P162, DOI 10.1002/lary.20024; Wright JG, 2005, LANCET, V365, P1153, DOI 10.1016/S0140-6736(05)71878-X; Yang SSD, 2005, J UROLOGY, V173, P1361, DOI 10.1097/01.ju.0000156556.11235.3f; Yellin AE, 2007, AM J SURG, V194, P367, DOI 10.1016/j.amjsurg.2007.01.023; Yurtcu M, 2009, WORLD J GASTROENTERO, V15, P4919, DOI 10.3748/wjg.15.4919; Zeifang F, 2005, J BONE JOINT SURG BR, V87B, P1663, DOI 10.1302/0301-620X.87B12.16551; Zhu XL, 2001, CLIN THER, V23, P1281, DOI 10.1016/S0149-2918(01)80107-7; Zwick EB, 2009, CLIN ORTHOP RELAT R, V467, P2668, DOI 10.1007/s11999-009-0819-5	245	13	13	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	SEP	2013	217	3					394	+		10.1016/j.jamcollsurg.2013.03.032			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	213GK	WOS:000324043300003	23969114				2022-02-06	
J	Franschman, G; Andriessen, TMJC; Boer, C; Van der Naalt, J; Horn, J; Haitsma, I; Vos, PE				Franschman, G.; Andriessen, T. M. J. C.; Boer, C.; Van der Naalt, J.; Horn, J.; Haitsma, I.; Vos, P. E.			Physician-based emergency medical service deployment characteristics in severe traumatic brain injury: A Dutch multicenter study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Emergency medical service; Regional; Physician; Paramedic; Advanced life support	HELICOPTER; MANAGEMENT; IMPACT; HYPERVENTILATION; ASSOCIATION; VENTILATION; GUIDELINES; TRANSPORT; DISPATCH; SCORE	Introduction: Prehospital guidelines advise advanced life support in all patients with severe traumatic brain injury (TBI). In the Netherlands, it is recommended that prehospital advanced life support is particularly provided by a physician-based helicopter emergency medical service (P-HEMS) in addition to paramedic care (EMS). Previous studies have however shown that a substantial part of severe TBI patients is exclusively treated by an EMS team. In order to better understand this phenomenon, we evaluated P-HEMS deployment characteristics in severe TBI in a multicenter setting. Methods: The database included patient demographics, prehospital and injury severity parameters and determinants of EMS or EMS/P-HEMS dispatch in 334 patients with severe TBI admitted to level 1 trauma centres in the Netherlands. Results: P-HEMS was deployed in 62% of patients with severe TBI. Patients treated by the P-HEMS had a higher injury severity score (29 (20-38)) vs. (25 (16-30); P < 0.001), more frequently required blood product transfusions (41% vs. 29%; P = 0.03) and recurrently suffered from TBI with extracranial injuries (33% vs. 6%; P < 0.001) than patients solely treated by an EMS. The prehospital endotracheal intubation rate was higher in the P-HEMS group in isolated TBI (93% vs. 19%; P < 0.001) or TBI with extracranial injuries (96% vs. 43%; P < 0.001) compared to the EMS group. In the EMS group, more patients were secondary referred to a level 1 trauma centre (32% vs. 4%; P < 0.001 vs. P-HEMS). Despite higher injury severity levels in P-HEMS patients, 6-month mortality rates were similar among groups, irrespective of the presence of extracranial injuries in addition to TBI. Deployment of P-HEMS estimated 52% and 72% (P < 0.001) in urban and rural regions, respectively, with comparable endotracheal intubation rates among regions. Conclusions: This study shows that a physician-based HEMS was more frequently deployed in patients with severe TBI in the presence of extracranial injuries, and in rural trauma regions. Treatment of severe TBI patients by a paramedic EMS only was associated with a higher incidence of secondary referrals to a level I trauma centre. Our data support adjustment of local prehospital guidelines for patients with severe TBI to the geographical context. (C) 2013 Elsevier Ltd. All rights reserved.	[Franschman, G.; Boer, C.] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands; [Andriessen, T. M. J. C.; Vos, P. E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Horn, J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [Haitsma, I.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands		Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl		van der Naalt, Joukje/0000-0001-9873-2418; Boer, Christa/0000-0002-7781-6951	Netherlands Brain Foundation [HSN-07-01]	This study was financially supported by the Netherlands Brain Foundation (HSN-07-01).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2011, FDN NAT AMB EM ROOM; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; DEANE SA, 1990, AUST NZ J SURG, V60, P441, DOI 10.1111/j.1445-2197.1990.tb07399.x; di Bartolomeo S, 2003, EUR J EMERG MED, V10, P268, DOI 10.1097/01.mej.0000103466.32882.7b; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hoogerwerf Nico, 2010, Ned Tijdschr Geneeskd, V154, pA2149; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Lemson J, 2008, Ned Tijdschr Geneeskd, V152, P1106; Rose MK, 2012, AM SURGEON, V78, P794; ten Duis HJ, 2003, INJURY, V34, P722, DOI 10.1016/S0020-1383(03)00162-1; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Wigman LD, 2011, INJURY, V42, P525, DOI 10.1016/j.injury.2010.03.015	24	13	13	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1232	1236		10.1016/j.injury.2013.06.002			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600017	23816167				2022-02-06	
J	Lannsjo, M; Raininko, R; Bustamante, M; von Seth, C; Borg, J				Lannsjo, Marianne; Raininko, Raili; Bustamante, Mariana; von Seth, Charlotta; Borg, Jorgen			BRAIN PATHOLOGY AFTER MILD TRAUMATIC BRAIN INJURY: AN EXPLORATORY STUDY BY REPEATED MAGNETIC RESONANCE EXAMINATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; brain concussion; magnetic resonance imaging; Rivermead Post-Concussion Symptoms Questionnaire; Glasgow Outcome Scale Extended	GLASGOW OUTCOME SCALE; CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; AXONAL INJURY; MRI; RECOVERY; CT; PREDICTION; VALIDITY; ATROPHY	Objective: To explore brain pathology after mild traumatic brain injury by repeated magnetic resonance examination. Design: A prospective follow-up study. Subjects: Nineteen patients with mild traumatic brain injury presenting with Glasgow Coma Scale (GCS) 14-15. Methods: The patients were examined on day 2 or 3 and 3-7 months after the injury. The magnetic resonance protocol comprised conventional T1- and T2-weighted sequences including fluid attenuated inversion recovery (FLAIR), two susceptibility-weighted sequences to. reveal haemorrhages, and diffusion-weighted sequences. Computer-aided volume comparison was performed. Clinical outcome was assessed by the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), Hospital Anxiety and Depression Scale (HADS) and Glasgow Outcome Scale Extended (GOSE). Results: At follow-up, 7 patients (37%) reported >= 3 symptoms in RPQ, 5 reported some anxiety and 1 reported mild depression. Fifteen patients reported upper level of good recovery and 4 patients lower level of good recovery (GOSE 8 and 7, respectively). Magnetic resonance pathology was found in 1 patient at the first examination, but 4 patients (21%) showed volume loss at the second examination, at which 3 of them reported <3 symptoms and 1 >= 3 symptoms, all exhibiting GOSE scores of 8. Conclusion: Loss of brain volume, demonstrated by computer-aided magnetic resonance imaging volumetry, may be a feasible marker of brain pathology after mild traumatic brain injury.	[Lannsjo, Marianne; von Seth, Charlotta] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lannsjo, Marianne] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Uppsala, Sweden; [Raininko, Raili] Uppsala Univ, Dept Radiol, Uppsala, Sweden; [Bustamante, Mariana] Uppsala Univ, Ctr Image Anal, Uppsala, Sweden; [Borg, Jorgen] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden		Lannsjo, M (corresponding author), Sandviken Hosp, SE-81189 Sandviken, Sweden.	marianne.lannsjo@lg.se		Borg, Jorgen/0000-0002-2372-7478; Bustamante, Mariana/0000-0002-1958-1672	Centre for Research & Development, Uppsala University/County Council of Gavleborg	This study was supported by grants from the Centre for Research & Development, Uppsala University/County Council of Gavleborg.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Gustafsson O, 1999, ACTA RADIOL, V40, P360, DOI 10.3109/02841859909177748; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Ibanez L, 2006, ITK SOFTWARE GUIDE; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Johnson VE, 2012, EXP NEUROL; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lannsjo, 2012, EUR J NEUROL, DOI [10.1111/j.1468-1331.2012.03813.x, DOI 10.1111/J.1468-1331.2012.03813.X]; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leibson CL, 2012, J NEUROTRAUM, V29, P1; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pierpaoli C, 1996, J CEREBR BLOOD F MET, V16, P892, DOI 10.1097/00004647-199609000-00013; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ripoll MA, 2003, ACTA RADIOL, V44, P199, DOI 10.1034/j.1600-0455.2003.00038.x; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1993, ICD 10 CLASS MENT BE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	13	13	0	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					721	728		10.2340/16501977-1169			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500005	24002306	Green Submitted, gold			2022-02-06	
J	Rowson, S; Daniel, RW; Duma, SM				Rowson, Steven; Daniel, Ray W.; Duma, Stefan M.			Biomechanical performance of leather and modern football helmets Technical note	JOURNAL OF NEUROSURGERY			English	Article						concussion; helmet; football; head acceleration; Summation of Tests for the Analysis of Risk (STAR) evaluation system; injury risk	CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPACT PERFORMANCE; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION	With the increased national concern about concussions in football, recent research has focused on evaluating the impact performance of modern football helmets. Specifically, this technical note offers a biomechanical analysis of classic leather helmets compared with modern helmets. Furthermore, modern helmets were examined to illustrate the performance differences between the better- and worse-performing ones. A total of 1224 drop tests were performed from a range of drop heights and impact locations on 11 different helmet types (10 modern and 1 leather helmet model). The resulting head acceleration was used to assess the risk of concussion for each drop test. The results of this analysis demonstrate that modern helmets are significantly and substantially superior to leather helmets in all impact scenarios, and that notable differences exist among modern helmets.	[Rowson, Steven; Daniel, Ray W.; Duma, Stefan M.] Virginia Polytech Inst & State Univ, Ctr Injury Biomech, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Duma, Stefan/A-8368-2012; Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Daniel, Ray/0000-0002-8666-0979			Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Cantu R, 2012, J NEUROSURG, V117, P187, DOI 10.3171/2011.12.JNS112108; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004248; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Newman J A, 2000, Stapp Car Crash J, V44, P215; NOCSAE, STAND PERF SPEC NEWL; NOCSAE, STAND TEST METH EQ U; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2010, CLIN J SPORT MED, V20, P344, DOI 10.1097/JSM.0b013e3181ed7e50; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	24	13	14	0	38	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2013	119	3					805	809		10.3171/2013.3.JNS121735			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	204IJ	WOS:000323358700037	23651012	Bronze			2022-02-06	
J	Stenberg, M; Koskinen, LO; Levi, R; Stalnacke, BM				Stenberg, Maud; Koskinen, Lars-Owe; Levi, Richard; Stalnacke, Britt-Marie			SEVERE TRAUMATIC BRAIN INJURIES IN NORTHERN SWEDEN: A PROSPECTIVE 2-YEAR STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; outcome; demographics; critical pathways	ALCOHOL; REHABILITATION; OUTCOMES; LEVEL; SCALE; COMA; INTOXICATION; POPULATION; PRINCIPLES; MORTALITY	Objective: To assess: (1) the clinical characteristics and injury descriptors of patients with severe traumatic brain injury in Northern Sweden admitted to the single Neurotrauma Center (NC) serving this region; (it) the care pathway of patients from injury to 3 months after discharge from the NC; and (iii) the outcomes at 3 months post-injury. Design: Population-based prospective 2-year cohort study. Patients: Patients age 17-65 years with acute severe traumatic brain injury, lowest non-sedated Glasgow Coma Scale (GCS) score of 3-8 within 24 h post-trauma. Methods: Patients were treated according to an intracranial pressure-oriented protocol based on the Lund concept at the NC. They were assessed at 3 weeks after injury with Rancho Los Amigos Cognitive Scale Revised (RLAS-R), Levels of Cognitive functioning, and at 3 months with RLAS-R and Glasgow Outcome Scale Extended (GOSE). Results: A total of 37 patients were included. Hospital deaths within 3 months post-injury occurred in 5 patients. After 3 months the RLAS-R scores were significantly improved (p<0.001). Eight patients had both "superior cognitive functioning" on the RLAS-R and "favourable outcome" on the GOSE. Thirty-four patients (92%) were directly admitted to the NC. By contrast, after discharge patients were transferred back to one of several county hospitals or to one of several local hospitals, and some had multiple transfers between different hospitals and departments. Conclusion: Overall outcomes were surprisingly good in this group of severely injured patients. The routines for transferring patients with severe traumatic brain injury from a geographically large, sparsely populated region to a regional NC to receive well-monitored neurosurgical care seem to work very well. The post-acute clinical pathways are less clearly reflecting an optimized medical and rehabilitative strategy.	[Stenberg, Maud; Levi, Richard; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, SE-90185 Umea, Sweden; [Koskinen, Lars-Owe] Umea Univ, Dept Pharmacol & Clin Neurosci, Div Neurosurg, SE-90185 Umea, Sweden		Stenberg, M (corresponding author), Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil, Bldg 9A, SE-90185 Umea, Sweden.	maud.stenberg@vll.se	Stenberg, Maud/AAX-4366-2021; Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Levi, Richard/0000-0001-7994-372X	Vasterbotten County Council	The authors would like to thank the patients and their relatives, the clinical staff of our unit, especially psychologist Anna-Lisa Nilsson. The authors also thank neuroradiologist, senior consultant Per Jonasson for assessing the CT scans and colleagues at the NC for helping us to recruit patients, colleagues in the intensive care unit and colleagues in rehabilitation department in the NHR. This study was supported by grants from Vasterbotten County Council.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Eker C, 2000, BRAIN INJURY, V14, P605; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Hagen C, 1987, REHABILITATION HEAD; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Rootman DB, 2007, J TRAUMA, V63, P1370, DOI 10.1097/TA.0b013e31815b837a; Schootman M, 1999, BRAIN INJURY, V13, P995; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	32	13	16	0	4	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					792	800		10.2340/16501977-1200			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500015	24002316	gold, Green Published, Green Submitted			2022-02-06	
J	Zhang, MY; Shan, HY; Wang, YQ; Wang, T; Liu, WL; Wang, L; Zhang, L; Chang, P; Dong, WW; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Wang, Yaoqi; Wang, Tao; Liu, Weili; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang			The Expression Changes of Cystathionine-beta-synthase in Brain Cortex After Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Cystathionine-beta-synthase; Traumatic brain injury; Apoptosis; Mice	INDUCED CELL-DEATH; HYDROGEN-SULFIDE; HUMAN-LIVER; RAT LIVER; MICE; ENZYME; MOUSE; HISTOPATHOLOGY; PROLIFERATION; PURIFICATION	Cystathionine-beta-synthase (CBS) catalyzes the condensation of serine with homocysteine to form cystathionine and occupies a crucial regulatory position between the methionine cycle and the biosynthesis of cysteine by transsulfuration. It was reported that CBS was a novel marker of both differentiation and proliferation for certain cell types, suggesting that CBS represents a survival-promoting protein. However, its expression and function in the central nervous system lesion are not well understood. To investigate changes of CBS after traumatic brain injury (TBI) and its possible role, mice TBI model was established by controlled cortical impact system, and the expression and cellular localization of CBS after TBI was investigated in the present study. Western blot analysis revealed that CBS was present in normal mice brain cortex. It gradually decreased, reached a valley at the third day after TBI, and then restored to basal level. Importantly, more CBS was colocalized with neuron. In addition, Western blot detection showed that the third day postinjury was also the apoptosis peak indicated by the elevated expression of caspase-3. Importantly, immunohistochemistry analysis revealed that injury-induced expression of CBS was colabeled by Bcl-2 and had no co-localization with caspase-3. These data suggested that CBS may be implicated in the apoptosis of neuron and involved in the pathophysiology of brain after TBI.	[Zhang, Mingyang; Wang, Yaoqi; Wang, Tao; Liu, Weili; Wang, Long; Zhang, Lu; Chang, Pan; Dong, Wenwen; Chen, Xiping; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Jiangsu, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China		Chen, XP (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911, 81271379]; Natural Science Foundation of Medical College of Nantong University [Y201003]; The Priority Academic Program Development of Jiangsu Higher Education Institutions; The Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation [CXLX12_0824]	This work was supported by the National Natural Science Foundation of China (No. 30872666, 81172911, and No. 81271379), Natural Science Foundation of Medical College of Nantong University (No. Y201003), The Priority Academic Program Development of Jiangsu Higher Education Institutions, and The Colleges and Universities in Jiangsu Province Plans to Graduate Research and Innovation (CXLX12_0824).	Abe K, 1996, J NEUROSCI, V16, P1066; Abekhoukh S, 2012, MOL NEUROBIOL, DOI [10.1007/s12035-12012-18326-12031, DOI 10.1007/S12035-12012-18326-12031]; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Dutta S, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-25; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Ganapathy PS, 2009, INVEST OPHTH VIS SCI, V50, P4460, DOI 10.1167/iovs.09-3402; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Han Y, 2005, NEUROSCI RES, V53, P216, DOI 10.1016/j.neures.2005.07.002; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Janel N, 2012, J MOL NEUROSCI, DOI [10.1007/s12031-12012-19835-12030, DOI 10.1007/S12031-12012-19835-12030]; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P488, DOI 10.1016/0005-2744(70)90255-X; KASHIWAMATA S, 1970, BIOCHIM BIOPHYS ACTA, V212, P501; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; KRAUS J, 1978, J BIOL CHEM, V253, P6523; KRAUS JP, 1983, ARCH BIOCHEM BIOPHYS, V222, P44, DOI 10.1016/0003-9861(83)90500-3; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Regnier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029056; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shao C, 2012, RADIAT RES, DOI [10.1667/RR2967.1661, DOI 10.1667/RR2967.1661]; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Talaei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022568; Tyagi SC, 2012, MOL CELL BIOCHEM, DOI [10.1007/s11010-11012-11425-11015, DOI 10.1007/S11010-11012-11425-11015]; Wang HY, 2012, CELL RES, DOI [10.1038/cr.2012.1135, DOI 10.1038/CR.2012.1135]; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhong WX, 2012, J BIOL CHEM, V287, P34189, DOI 10.1074/jbc.M112.383646; Zhou Xiao-hong, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P199	43	13	14	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2013	51	1					57	67		10.1007/s12031-012-9948-5			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	211PJ	WOS:000323921000007	23315129				2022-02-06	
J	Beer-Furlan, A; de Almeida, CC; Noleto, G; Paiva, W; Ferreira, AA; Teixeira, MJ				Beer-Furlan, Andre; de Almeida, Cesar Cimonari; Noleto, Gustavo; Paiva, Wellingson; Ferreira, Almir Andrade; Teixeira, Manoel Jacobsen			Dural sinus and internal jugular vein thrombosis complicating a blunt head injury in a pediatric patient	CHILDS NERVOUS SYSTEM			English	Article						Closed head injury; Cerebral venous sinus; Thrombosis; Blunt trauma	CEREBRAL VENOUS THROMBOSIS; SUPERIOR SAGITTAL SINUS; SINOVENOUS THROMBOSIS; TRAUMA PATIENTS; CT VENOGRAPHY; CHILDREN; OBSTRUCTION; CHILDHOOD	Cerebral venous sinus thrombosis (CVST) following a blunt head trauma is a rare condition, described in the literature along with the lack of consensus regarding diagnosis and management. We present a case of a pediatric patient with a blunt head injury and epidural hematoma, who developed dural sinus and internal jugular vein thrombosis with fatal outcome. Most of reports show good outcome and recovery, but CVST might be related to poor recovery and even lead to death. The diagnosis and management of this condition are discussed based on a literature review. It is important to keep a high degree of suspicion of CVST since early diagnosis may prevent potentially treatable catastrophic outcomes.	[Beer-Furlan, Andre; de Almeida, Cesar Cimonari; Noleto, Gustavo; Paiva, Wellingson; Ferreira, Almir Andrade; Teixeira, Manoel Jacobsen] Univ Sao Paulo Med Sch FMUSP, Dept Neurosurg, BR-05410001 Sao Paulo, Brazil		Beer-Furlan, A (corresponding author), Univ Sao Paulo Med Sch FMUSP, Dept Neurosurg, Rua Alves Guimaraes 643,Ap 132 Sao Paulo, BR-05410001 Sao Paulo, Brazil.	beerfurlan@uol.com.br	Paiva, Wellingson S/G-5517-2013; Noleto, Gustavo Sousa/ABB-7684-2021	Paiva, Wellingson S/0000-0002-5165-7040; Noleto, Gustavo Sousa/0000-0002-1907-3774; Cimonari de Almeida, Cesar/0000-0002-2073-4509			Akhtar W, 2010, RADIOLOGY, V256, P1014, DOI 10.1148/radiol.100960; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Bagley C, 1934, SURG GYNECOL OBSTET, V58, P498; Bakar B, 2010, ULUS TRAVMA ACIL CER, V16, P98; Barbati G, 2003, Minerva Anestesiol, V69, P919; BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; Bishop FS, 2009, J NEUROSURG, V111, P17, DOI 10.3171/2009.2.JNS08491; BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; Caplan JM, 2008, EMERG MED J, V25, P777, DOI 10.1136/emj.2008.061952; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; Carvalho KS, 2001, J CHILD NEUROL, V16, P574, DOI 10.2310/7010.2001.16834; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; Daligic A, 2008, TURK NEUROSURG, V18, P70; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; Erdogan B, 2004, CHILD NERV SYST, V20, P239, DOI 10.1007/s00381-003-0845-7; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Georgoulis G, 2014, WORLD NEUROSURG, V81, pE7, DOI 10.1016/j.wneu.2011.11.006; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; Huisman TAGM, 2001, EUR RADIOL, V11, P1760, DOI 10.1007/s003300100822; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Kumar GSS, 2004, NEUROL INDIA, V52, P123; Lee W T, 1995, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V36, P425; MARTIN JP, 1955, BRIT MED J, V2, P467, DOI 10.1136/bmj.2.4937.467; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Meena AK, 2000, NEUROL INDIA, V48, P195; Muthukumar N, 2004, J CLIN NEUROSCI, V11, P924, DOI 10.1016/j.jocn.2003.10.032; Nehme J, 2009, INT J PEDIATR OTORHI, V73, P629, DOI 10.1016/j.ijporl.2008.10.025; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Owler BK, 2005, CHILD NERV SYST, V21, P262, DOI 10.1007/s00381-004-1014-3; Peeters E, 2001, AM J NEURORADIOL, V22, P1949; Renowden S, 2004, EUR RADIOL, V14, P215, DOI 10.1007/s00330-003-2021-6; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; Rottger C, 2004, HEADACHE, V44, P812, DOI 10.1111/j.1526-4610.2004.04150.x; Saad DF, 2005, J TRAUMA, V58, P1066, DOI 10.1097/01.TA.0000162726.74081.F3; Saadatnia M, 2009, INT J STROKE, V4, P111, DOI 10.1111/j.1747-4949.2009.00260.x; Satoh H, 2000, NEUROL MED-CHIR, V40, P361, DOI 10.2176/nmc.40.361; Shigemori Y, 2007, SURG NEUROL, V68, P660, DOI 10.1016/j.surneu.2006.11.037; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	47	13	13	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2013	29	8					1231	1234		10.1007/s00381-013-2184-7			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	185FT	WOS:000321952500005	23748465				2022-02-06	
J	Blaine, H; Sullivan, KA; Edmed, SL				Blaine, Hannah; Sullivan, Karen A.; Edmed, Shannon L.			The Effect of Varied Test Instructions on Neuropsychological Performance following Mild Traumatic Brain Injury: An Investigation of "Diagnosis Threat"	JOURNAL OF NEUROTRAUMA			English	Article						diagnosis threat; mild traumatic brain injury; neurocognitive disorder; post-concussion syndrome	POST-CONCUSSION SYNDROME; WOMENS MATH PERFORMANCE; WORD-ASSOCIATION TEST; BLACK-AND-WHITE; STEREOTYPE THREAT; HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE PERFORMANCE; MEMORY; SYMPTOMS	Diagnosis threat is a psychosocial factor that has been proposed to contribute to poor outcomes following mild traumatic brain injury (mTBI). This threat is thought to impair the cognitive test performance of individuals with mTBI because of negative injury stereotypes. University students (N = 45, 62.2% female) with a history of mTBI were randomly allocated to a diagnosis threat (DT; n = 15), reduced threat (DT-reduced; n = 15), or neutral (n = 15) group. The reduced threat condition invoked a positive stereotype (i.e., that people with mTBI can perform well on cognitive tests). All participants were given neutral instructions before they completed baseline tests of objective cognitive function across a number of domains, psychological symptoms, and PCS symptoms, including self-reported cognitive and emotional difficulties. Participants then received either neutral, DT, or DT-reduced instructions before repeating the tests. Results were analyzed using separate mixed model analysis of variances (ANOVAs); one for each dependent measure. The only significant result was for the 2 x 3 ANOVA on an objective test of attention/working memory, Digit Span (p < 0.05), such that the DT-reduced group performed better than the other groups, which were not different from each other. Although not consistent with predictions or earlier DT studies, the absence of group differences on most tests fits with several recent DT findings. The results of this study suggest that it is timely to reconsider the role of DT as a unique contributor to poor mTBI outcome.	[Blaine, Hannah; Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counseling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-QUT-HREC # 1200000165) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The authors acknowledge Chloe Kempe for assistance with randomization and cross scoring, Sherrie-Anne Kaye for advice on the pilot study, and Dr. April Thames whose correspondence with us influenced our writing of this paper.	Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Beilock SL, 2006, PERS SOC PSYCHOL B, V32, P1059, DOI 10.1177/0146167206288489; Ben-Zeev T, 2005, J EXP SOC PSYCHOL, V41, P174, DOI 10.1016/j.jesp.2003.11.007; BENTON AL, 1961, ARCH GEN PSYCHIAT, V4, P79; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Brown RP, 2006, J APPL PSYCHOL, V91, P979, DOI 10.1037/0021-9010.91.4.979; CHARTER RA, 1987, INT J CLIN NEUROPSYC, V9, P28; Chong CS, 2008, HONG KONG J OCCUP TH, V18, P59, DOI 10.1016/S1569-1861(09)70004-X; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DELANEY RC, 1992, ARCH CLIN NEUROPSYCH, V7, P523, DOI 10.1016/0887-6177(92)90142-A; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; Frazen MD, 1996, CLIN NEUROPSYCHOL, V10, P125; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Kellow JT, 2008, J BLACK PSYCHOL, V34, P94, DOI 10.1177/0095798407310537; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King P.R., 2011, THESIS STATE U NEW Y; Kinkela J.H., 2008, THESIS OHIO U; Kit K.A., 2009, THESIS U VICTORIA; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McMinn M. R., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI [10.1080/13854048808520087, DOI 10.1080/13854048808520087]; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silva M. A., 2008, GRAD J COUNS PSYCHOL, V1, P11; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith JL, 2004, EDUC PSYCHOL REV, V16, P177, DOI 10.1023/B:EDPR.0000034020.20317.89; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spitzer C, 2011, FORTSCHR NEUROL PSYC, V79, P517, DOI 10.1055/s-0031-1281602; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan K.A., 2013, J HEAD TRAUMA REHABI; Sumerall SW, 1997, J CLIN PSYCHOL, V53, P517, DOI 10.1002/(SICI)1097-4679(199708)53:5<517::AID-JCLP14>3.0.CO;2-H; Thames AD, 2013, J INT NEUROPSYCH SOC, V19, P583, DOI 10.1017/S1355617713000076; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tulsky D., 1997, WAIS 3 WMS 3 TECHNIC; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; ZIMMERMAN DW, 1993, CAN J EXP PSYCHOL, V47, P523, DOI 10.1037/h0078850	57	13	13	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1405	1414		10.1089/neu.2013.2865			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500004	23410235	Green Published, Green Submitted			2022-02-06	
J	Miller, KL; Kontos, PC				Miller, Karen-Lee; Kontos, Pia C.			The intraprofessional and interprofessional relations of neurorehabilitation nurses: a negotiated order perspective	JOURNAL OF ADVANCED NURSING			English	Article						allied health; collaboration; interprofessional practice; intraprofessional practice; negotiated order theory; nursing; traumatic brain injury	GENERAL INTERNAL-MEDICINE; HEALTH-CARE; REHABILITATION; QUALITY; COLLABORATION; PROFESSIONS; ASSISTANTS; BOUNDARY; POLITICS	AimsTo report a study of the negotiation practices of neurorehabilitation nurses with one another and with allied health professionals to understand nursing relations. BackgroundNegotiated order theory offers a promising theoretical lens with which to explore negotiation between nurses and other professionals. This study is the first to apply the perspective to nurse-nurse and nurse-allied health professional relations. DesignThe study is a secondary analysis of findings from a multi-site arts-based intervention to improve patient-centred neurorehabilitation practice. MethodsInterviews and ethnographic observations were conducted (2008-2011) in two neurorehabilitation units in Ontario, Canada. Participants (n=31) included registered and practical nurses, nurse leaders, and allied health professionals from physical, occupational, and recreational therapy, speech language pathology, and social work. FindingsNeurorehabilitation nursing is characterized by heavy workload, high patient acuity, and poor interprofessional collaboration. This practice context was negotiated by nurses through two strategies: (1) intraprofessional collegialism, accomplished through tactics including task and knowledge sharing, emotional support, coercive threats, and suppression of dissension; and (2) vying for an autonomous essential nursing role in interprofessional practice, accomplished by claiming unique nursing knowledge based on 24/7 nursing proximity, the expansion of the division of professional labour with allied health professionals and modifying physical therapy care plans. ConclusionThe intraprofessional context and negotiations therein were linked in significant ways to interprofessional negotiations. Understanding this complexity has important implications for improving patient safety and interprofessional practice interventions.	[Miller, Karen-Lee; Kontos, Pia C.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Miller, Karen-Lee] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada		Miller, KL (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.	karen-lee.miller@uhn.ca		Miller, Karen-Lee/0000-0001-7583-6724; Kontos, Pia/0000-0002-8893-2544	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP - 86624, MSH - 87726]; Toronto Rehabilitation InstituteUniversity of Toronto; Ministry of Health and Long-Term Care in OntarioMinistry of Health and Long-Term Care, Ontario	The authors disclosed receipt of the following financial support for the research and/or authorship of this article: Canadian Institutes of Health Research Operating Grant (2008-2011, MOP - 86624); Pia Kontos holds a Canadian Institutes of Health Research New Investigator Award (2009 -2014, MSH - 87726). The authors acknowledge the support of Toronto Rehabilitation Institute that receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. The views expressed do not necessarily reflect those of our supporters or funders.	Allen D, 1997, SOCIOL HEALTH ILL, V19, P498; Balogun JA, 2006, J ADV NURS, V56, P532, DOI 10.1111/j.1365-2648.2006.04045.x; Barker P, 2000, INT J NURS STUD, V37, P329, DOI 10.1016/S0020-7489(00)00012-2; Bowen, 2006, INT J QUAL METH, V5, P12, DOI [DOI 10.1177/160940690600500304, 10.1177/160940690600500304]; Briskin L., 2011, NURSING INQUIRY, DOI 10.1111/j.1440-1800.2011.00585.x; Cohen H.A., 1981, NURSES QUEST PROFESS; Colantonio A., 2008, J CONTIN EDUC HEALTH, V28, P1; Colyer HM, 2004, J ADV NURS, V48, P406, DOI 10.1111/j.1365-2648.2004.03209.x; Conn LG, 2009, QUAL HEALTH RES, V19, P943, DOI 10.1177/1049732309338282; Daykin N, 2000, SOCIOL HEALTH ILL, V22, P349, DOI 10.1111/1467-9566.00208; Embree JL, 2010, NURS FORUM, V45, P166, DOI 10.1111/j.1744-6198.2010.00185.x; Evans T., 2007, QUAL SOC WORK, V6, P213, DOI [10.1177/1473325007077254, DOI 10.1177/1473325007077254]; Geva E., 2000, DEV FRAMEWORK INTERP, P1; Gladstone BM, 2007, J BEHAV HEALTH SER R, V34, P431, DOI 10.1007/s11414-007-9079-x; Gold R., 1997, QUALITATIVE INQUIRY, V3, P387, DOI DOI 10.1177/107780049700300401; Hall LM, 2003, MED CARE, V41, P1096; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huynh T., 2011, NURSING RES PRACTICE, V2011, P1, DOI [10. 1155/2011/501790, DOI 10.1155/2011/501790]; Kenaszchuk C, 2010, CAN J NURS RES, V42, P120; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; LECOMPTE MD, 1993, ETHNOGRAPHIC QUALITA; Lincoln YS, 1985, NAT INQ, V289, P289, DOI DOI 10.1016/0147-1767(85)90062-8; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCallin Antoinette, 2007, J Nurs Manag, V15, P386, DOI 10.1111/j.1365-2834.2007.00711.x; McKenna BG, 2003, J ADV NURS, V42, P90, DOI 10.1046/j.1365-2648.2003.02583.x; MCPHERSON K, 1996, BEDSIDE MATTERS TRAN; Medjedovic I., 2007, FORUM QUALITATIVE SO, V6; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KL, 2008, J ADV NURS, V64, P332, DOI 10.1111/j.1365-2648.2008.04768.x; Miyata H., 2009, INT J QUAL METH, V8, P64, DOI DOI 10.1177/160940690900800106; Norris P, 2001, SOCIOL HEALTH ILL, V23, P24, DOI 10.1111/1467-9566.00239; Nugus P, 2010, SOC SCI MED, V71, P898, DOI 10.1016/j.socscimed.2010.05.029; Patton M.Q., 1990, QUALITATIVE EVALUATI; Peter Elizabeth, 2004, Nurs Inq, V11, P218, DOI 10.1111/j.1440-1800.2004.00236.x; Pryor J., 2007, COLLEGIAN, V14, P26; Pryor J, 2010, J ADV NURS, V66, P978, DOI 10.1111/j.1365-2648.2009.05237.x; Reeves S, 2008, NURS INQ, V15, P1, DOI 10.1111/j.1440-1800.2008.00396.x; Reeves S, 2009, J INTERPROF CARE, V23, P633, DOI 10.3109/13561820902886295; Rheaume A, 2003, J ADV NURS, V41, P435, DOI 10.1046/j.1365-2648.2003.02550.x; Salhan D, 2009, SOC SCI MED, V68, P1221, DOI 10.1016/j.socscimed.2009.01.041; SANDS RG, 1990, SOC WORK HEALTH CARE, V14, P55, DOI 10.1300/J010v14n03_04; Sinclair LB, 2009, ARCH PHYS MED REHAB, V90, P1196, DOI 10.1016/j.apmr.2009.01.021; Spano R, 2005, SOC SCI RES, V34, P591, DOI 10.1016/j.ssresearch.2004.05.003; STEIN LI, 1967, ARCH GEN PSYCHIAT, V16, P699; STRAUSS A, 1978, NEGOTIATION VARIETIE; Strauss A, 1963, HOSP MODERN SOC, P147; Strauss A., 1966, STRUCTURE IDEOLOGY A, P60; Strauss Anselm, 1993, CONTINUAL PERMUTATIO; Svensson R, 1996, SOCIOL HEALTH ILL, V18, P379, DOI 10.1111/1467-9566.ep10934735; Takhashi Y, 2011, INT C REHAB ROBOT; Thorogood N, 2004, QUALITATIVE METHODS; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; WITZ A, 1990, SOCIOLOGY, V24, P675, DOI 10.1177/0038038590024004007	53	13	13	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	AUG	2013	69	8					1797	1807		10.1111/jan.12041			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	262YE	WOS:000327773000013	23157380				2022-02-06	
J	Tanoue, K; Aida, N; Matsui, K				Tanoue, Koji; Aida, Noriko; Matsui, Kiyoshi			Apparent diffusion coefficient values predict outcomes of abusive head trauma	ACTA PAEDIATRICA			English	Article						Abusive head trauma; Apparent diffusion coefficient; Inflicted traumatic brain injury; Outcome; Shaken baby syndrome	SHAKEN BABY SYNDROME; BRAIN-INJURY; PERINATAL ASPHYXIA; YOUNG-CHILDREN; IMPACT SYNDROME; INFANTS	Aim To evaluate the apparent diffusion coefficient (ADC) values for predicting the long-term neurodevelopmental outcomes of patients with abusive head trauma (AHT). Methods Apparent diffusion coefficient maps were retrospectively reviewed for 14 patients who presented with AHT at a mean age of 6.7months (range 1-18months), and the clinical outcomes of the survivors were based on the Glasgow Outcome Score. Results One of 14 infants died, and two were severely disabled. One had mild impairment and four had moderate disability. In the 4days after admission, the ADC values in all brain regions were strongly associated with a poor neurodevelopmental outcome (p<0.05): basal ganglia, thalamus, brain stem, corpus callosum, frontal white matter, central white matter, parietal white matter, frontal grey matter, parietal grey matter, cerebellar vermis, cerebellar cortex and mean total brain. Conclusion Apparent diffusion coefficient values during the acute phase of AHT were significantly associated with poor long-term neurodevelopmental outcomes.	[Tanoue, Koji; Matsui, Kiyoshi] Kanagawa Childrens Med Ctr, Dept Gen Med, Yokohama, Kanagawa 2328555, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa 2328555, Japan		Tanoue, K (corresponding author), Kanagawa Childrens Med Ctr, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	ktanoue@kcmc.jp					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Brissaud O, 2010, AM J NEURORADIOL, V31, P282, DOI 10.3174/ajnr.A1805; Demaerel P, 2002, EUR RADIOL, V12, P849, DOI 10.1007/s00330-001-1145-9; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Forbes KPN, 2000, AM J NEURORADIOL, V21, P1490; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Hunt RW, 2004, PEDIATRICS, V114, P999, DOI 10.1542/peds.2003-0935-L; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Rutherford M, 2004, PEDIATRICS, V114, P1004, DOI 10.1542/peds.2004-0222; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Talvik I, 2006, ACTA PAEDIATR, V95, P799, DOI 10.1080/08035250500464923; Tanoue K, 2012, ACTA PAEDIATR, V101, P614, DOI 10.1111/j.1651-2227.2012.02635.x; Wolf RL, 2001, RADIOLOGY, V218, P825, DOI 10.1148/radiology.218.3.r01fe47825; Zarifi MK, 2002, RADIOLOGY, V225, P859, DOI 10.1148/radiol.2253011797	27	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	AUG	2013	102	8					805	808		10.1111/apa.12281			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	169KA	WOS:000320777700020	23631484				2022-02-06	
J	Zhou, SZ; Zhang, X; Ma, HL				Zhou, Shuangzhen; Zhang, Xiong; Ma, Honglei			NUMERICAL SIMULATION OF HUMAN HEAD IMPACT USING THE MATERIAL POINT METHOD	INTERNATIONAL JOURNAL OF COMPUTATIONAL METHODS			English	Article						Human head impact; material point model; injury	SKULL	In this paper, a three-dimensional material point human head model is constructed from the computed tomography (CT) scanned images of an adult male volunteer, and used to study the dynamic response of human head under the impact of a three-dimensional cylindrical lead projectile with a speed of 6.4m/s. The model consists of skull bone, brain tissue and membrane of human head, which is close to the real one. The skull and membrane are modeled by an elastic constitutive model, and the brain tissue is modeled by an anisotropic viscoelastic constitutive model. These constitutive models have been implemented in our three-dimensional explicit material point method code, MPM3D, and is verified by comparing its numerical results for a ball impact problem with those obtained by LS-DYNA. The simulation results help illustrate the response of skull bone, membrane and brain tissues subjected to impact, which contributes to the understanding of the biomechanics and mechanisms of head injury.	[Zhou, Shuangzhen; Zhang, Xiong] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China; [Zhou, Shuangzhen; Ma, Honglei] China Astronaut Res & Training Ctr, Beijing 100094, Peoples R China		Zhou, SZ (corresponding author), Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China.	xzhang@tsinghua.edu.cn	Zhang, Xiong/B-6733-2012	Zhang, Xiong/0000-0001-9905-281X	National Basic Research Program of ChinaNational Basic Research Program of China [2010CB832701]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [10872107, 60971094]	This work was supported by the National Basic Research Program of China (2010CB832701) and National Natural Science Foundation of China (10872107, 60971094)	Aomura S, 2003, JSME INT J C-MECH SY, V46, P583, DOI 10.1299/jsmec.46.583; Charalambopoulos A, 1998, MATH COMPUT MODEL, V27, P81, DOI 10.1016/S0895-7177(97)00261-6; Faleh H, 2011, ADV STRUCT ENG, V14, P777, DOI 10.1260/1369-4332.14.5.777; Gan Y, 2011, CMES-COMP MODEL ENG, V73, P45; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gong SW, 2008, IEEE T BIO-MED ENG, V55, P1226, DOI 10.1109/TBME.2007.912431; Guilkey JE, 2006, J BIOMECH, V39, P2074, DOI 10.1016/j.jbiomech.2005.06.017; Hallquist JO, 2006, LS DYNA THEORY MANUA; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; HERTZ E, 1993, 37 ANN P ASS ADV AUT, P303; Hosey R. R., 1980, P INT C FIN EL BIOM, P851; Kang HS, 1997, P 41 STAPP CAR CRASH, P329; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lankarani H. M., 1997, 971457 SAE; Lian YP, 2011, INT J IMPACT ENG, V38, P238, DOI 10.1016/j.ijimpeng.2010.10.031; Ma S, 2007, P 2007 INT S COMP ME, P156; Ma S, 2009, CMES-COMP MODEL ENG, V39, P101; SULSKY D, 1994, COMPUT METHOD APPL M, V118, P179, DOI 10.1016/0045-7825(94)00033-6; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Zhang X., 2007, COMPUTATIONAL DYNAMI; Zhao Wei, 2011, Chinese Journal of Biomedical Engineering, V30, P110, DOI 10.3969/j.issn.0258-8021.2011.01.019	21	13	14	3	29	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8762			INT J COMP METH-SING	Int. J. Comput. Methods	AUG	2013	10	4							1350014	10.1142/S021987621350014X			14	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematics	137MO	WOS:000318440200004					2022-02-06	
J	Baumann, G; Travieso, L; Liebl, DJ; Theus, MH				Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.; Theus, Michelle H.			Pronounced hypoxia in the subventricular zone following traumatic brain injury and the neural stem/progenitor cell response	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						Hypoxia; Eph; ephrin; subventricular zone; AKT; Hif1-alpha; neural stem/progenitor cell; traumatic brain injury	ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; COMMISSURAL AXONS; PROGENITOR CELLS; OLFACTORY-BULB; PROLIFERATION; NEUROGENESIS; DIFFERENTIATION; SURVIVAL	Traumatic brain injury (TBI) elicits identifiable changes within the adult subventricular zone (SVZ). Previously, we demonstrated that EphB3/ephrinB3 interaction inhibits neural stem/progenitor cell (NSPC) proliferation and downregulating this pathway following TBI plays a pivotal role in the expansion of the SVZ neurogenic compartment. It remains unclear, however, what early initiating factors may precede these changes. Using hypoxyprobe-1 (HPb) to identify regions of low oxygen tension or hypoxia (<1%), we found HPb uptake throughout the cortex (CTX), corpus callosum (CC) and SVZ within the first 24 h following controlled cortical impact (CCI) injury. At this early time point, HPb co-localized with EphB3 in the SVZ. NSPC specific markers also co-localized with HPb staining throughout the lateral wall of the ventricle. To determine the cell autonomous effects of hypoxia on EphB3/ephrinB3 signaling in NSPCs, we used an in vitro model of hypoxia to mimic 1% oxygen in the presence and absence of soluble aggregated ephrinB3 (eB3). As expected, hypoxia stimulated the uptake of 5-bromo-2'-deoxyuridine (BrdU) and reduced cell death. Coincident with these proliferative changes, both Hif1-alpha and phospho (p)-AKT were increased while EphB3 expression was decreased. Stimulation of EphB3 attenuated hypoxia-induced proliferation and prevented phosphorylation of AKT. Hif1-alpha accumulation, on the other hand, was not affected by EphB3/ephrinB3 signaling. These findings indicate that this pathway limits the NSPC response to hypoxic stimuli. These studies also suggest that early transient changes in oxygen tension following localized cortical injury may initiate a growth-promoting response in the SVZ.	[Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.] Univ Miami, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Baumann, Gisela; Travieso, Lissette; Liebl, Daniel J.] Univ Miami, Dept Neurol Surg, Miami, FL 33136 USA; [Theus, Michelle H.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA		Theus, MH (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	mtheus@vt.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291, NS007459, NS064699]; Virginia Tech's Open Access Subvention Fund; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS064699, P50NS030291, R01NS049545] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS NS049545 (DJL), NS30291 (DJL), NS007459 (MHT), NS064699 (MHT), Virginia Tech's Open Access Subvention Fund and the Miami Project to Cure Paralysis.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Chakraborty D, 2012, CELL CYCLE, V11, P2427, DOI 10.4161/cc.20542; Chen BS, 2012, ENDOCRINOLOGY, V153, P4946, DOI 10.1210/en.2012-1472; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Culver JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053546; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nelersa CM, 2012, J BIOMOL SCREEN, V17, P785, DOI 10.1177/1087057112440880; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI 10.1089/ARS.2008.2308; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Ostrakhovitch EA, 2013, ARCH BIOCHEM BIOPHYS, V534, P44, DOI 10.1016/j.abb.2012.08.002; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Roy S, 2012, EUR J HAEMATOL, V88, P396, DOI 10.1111/j.1600-0609.2012.01759.x; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Studer L, 2000, J NEUROSCI, V20, P7377; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Xing SH, 2008, BRAIN RES, V1230, P237, DOI 10.1016/j.brainres.2008.06.097; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	51	13	13	0	5	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	1535-3702			EXP BIOL MED	Exp. Biol. Med.	JUL	2013	238	7					830	841		10.1177/1535370213494558			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	203ZY	WOS:000323335200013	23828590	Green Published			2022-02-06	
J	Forsgren, E; Antonsson, M; Saldert, C				Forsgren, Emma; Antonsson, Malin; Saldert, Charlotta			Training conversation partners of persons with communication disorders related to Parkinson's disease-a protocol and a pilot study	LOGOPEDICS PHONIATRICS VOCOLOGY			English	Article						Cognition; communication; conversation partner training; Parkinson's disease; significant other	TRAUMATIC BRAIN-INJURY; CONTROLLED-TRIAL; APHASIA; PEOPLE; PERSPECTIVE; DYSARTHRIA; STROKE; ADULTS	This paper reports on the adaptation of a training programme for conversation partners of persons with Parkinson's disease, and a protocol for assessment of possible changes in conversational interaction as a result of intervention. We present data from an explorative multiple case study with three individuals with Parkinson's disease and their spouses. Repeated analysis of natural conversational interaction and measures of the participants' perception of communication as well as measures of different cognitive abilities were obtained. The results show that the communication in all three dyads was affected by both speech and language problems and that the conversation training model and the assessment protocol may work well after minor adjustments. Influence of different aspects of cognition on communication is discussed.	[Forsgren, Emma; Antonsson, Malin; Saldert, Charlotta] Univ Gothenburg, Inst Neurosci & Physiol, Div Speech & Language Pathol, Gothenburg, Sweden; [Forsgren, Emma; Saldert, Charlotta] Univ Gothenburg, GPCC, Gothenburg, Sweden		Saldert, C (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Div Speech & Language Pathol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610; Forsgren, Emma/0000-0002-2402-0909			Altmann L, 2011, PARKINSONS DIS, P1, DOI DOI 10.4061/21011/238956; Apt P., 2008, TOKEN TEST; Berg E, 2003, CLIN LINGUIST PHONET, V17, P63, DOI 10.1080/0269920021000055540; Bloch S., 2004, AUGMENTATIVE ALTERNA, V20, P272; Bloch S, 2009, INT J LANG COMM DIS, V44, P769, DOI 10.1080/13682820802546969; Bloch S, 2008, CLIN LINGUIST PHONET, V22, P974, DOI 10.1080/02699200802394831; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; Delis DC., 2001, DELIS KAPLAN EXECUTI; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Friedman O, 2005, DEVELOPMENTAL SCI, V8, P218, DOI 10.1111/j.1467-7687.2005.00410.x; Griffiths S, 2011, INT J LANG COMM DIS, V46, P497, DOI 10.1111/j.1460-6984.2011.00012.x; HARTELIUS L, 1994, FOLIA PHONIATR LOGO, V46, P9, DOI 10.1159/000266286; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kent R.D., 1992, INTELLIGIBILITY SPEE; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lock S, 2001, SUPPORTING PARTNERS; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Perkins L., 1997, CONVERSATION ANAL PR; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Sorin-Peters R, 2004, APHASIOLOGY, V18, P951, DOI 10.1080/02687030444000453; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Whitworth A, 1999, APHASIOLOGY, V13, P407, DOI 10.1080/026870399402154; Wilkinson R, 1998, Int J Lang Commun Disord, V33 Suppl, P144; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; World Health Organization, 2007, INT CLASS FUNCT DIS; Yin R., 2017, CASE STUDY RES DESIG	34	13	13	1	27	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1401-5439			LOGOP PHONIATR VOCO	Logop. Phoniatr. Vocology.	JUL	2013	38	2					82	90		10.3109/14015439.2012.731081			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	192ZC	WOS:000322525500007	23072445				2022-02-06	
J	Kernic, MA; Rivara, FP; Zatzick, DF; Bell, MJ; Wainwright, MS; Groner, JI; Giza, CC; Mink, RB; Ellenbogen, RG; Boyle, L; Mitchell, PH; Kannan, N; Vavilala, MS				Kernic, Mary A.; Rivara, Frederick P.; Zatzick, Douglas F.; Bell, Michael J.; Wainwright, Mark S.; Groner, Jonathan I.; Giza, Christopher C.; Mink, Richard B.; Ellenbogen, Richard G.; Boyle, Linda; Mitchell, Pamela H.; Kannan, Nithya; Vavilala, Monica S.		PEGASUS Pediat Guideline Adh	Triage of Children with Moderate and Severe Traumatic Brain Injury to Trauma Centers	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; pediatrics; trauma; trauma center	PEDIATRIC TRAUMA; CENTER DESIGNATION; CARE; VALIDATION; CALIFORNIA; SURGEONS; SYSTEM; IMPACT	Outcomes after pediatric traumatic brain injury (TBI) are related to pre-treatment factors including age, injury severity, and mechanism of injury, and may be positively affected by treatment at trauma centers relative to non-trauma centers. This study estimated the proportion of children with moderate to severe TBI who receive care at trauma centers, and examined factors associated with receipt of care at adult (ATC), pediatric (PTC), and adult/pediatric trauma centers (APTC), compared with care at non-trauma centers (NTC) using a nationally representative database. The Kids' Inpatient Database was used to identify hospitalizations for moderate to severe pediatric TBI. Pediatric inpatients ages 0 to 17 years with at least one diagnosis of TBI and a maximum head Abbreviated Injury Scale score of 3 were studied. Multinomial logistic regression was performed to examine factors predictive of the level and type of facility where care was received. A total of 16.7% of patients were hospitalized at NTC, 44.2% at Level I or II ATC, 17.9% at Level I or II PTC, and 21.2% at Level I or II APTC. Multiple regression analyses showed receipt of care at a trauma center was associated with age and polytrauma. We concluded that almost 84% of children with moderate to severe TBI currently receive care at a Level I or Level II trauma center. Children with trauma to multiple body regions in addition to more severe TBI are more likely to receive care a trauma center relative to a NTC.	[Kernic, Mary A.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98104 USA; [Boyle, Linda] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98104 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98104 USA; [Kannan, Nithya] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Pediat Neurol, Los Angeles, CA USA; [Mink, Richard B.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu		Groner, Jonathan/0000-0002-0998-593X	Dr. Vavilala's National Institutes of Health R01 award "Pediatric Guideline Adherence and Outcomes Project'' [R01 NS072308-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	We would like to respectfully acknowledge the contributors to the Healthcare Cost and Utilization Project data partners who contributed to the Kids' Inpatient Database. A list of contributing partners is found at www.hcup-us.ahrq.gov/hcupdatapartners.jsp. Funding for this study came from Dr. Vavilala's National Institutes of Health R01 award "Pediatric Guideline Adherence and Outcomes Project'' R01 NS072308-01.	Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; [Anonymous], 1999, RES OPT CAR INJ PAT; [Anonymous], 2009, STAT STAT SOFTW REL; [Anonymous], 2010, INT CLASS DIS 9 REV; BENSARD DD, 1994, J PEDIATR SURG, V29, P11, DOI 10.1016/0022-3468(94)90514-2; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Clark DE, 2009, ICDPIC STATA MODULE; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; DAMELIO LF, 1995, AM SURGEON, V61, P968; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Faul M, 2010, TRAUMATIC BRAIN INJU; FORTUNE JB, 1992, J TRAUMA, V33, P130, DOI 10.1097/00005373-199207000-00024; Haas B, 2009, J AM COLL SURGEONS, V208, P28, DOI 10.1016/j.jamcollsurg.2008.09.004; Healthcare Cost and Utilization Project, 2006, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project, 2005, CALC KIDS INP DAT KI; Healthcare Cost and Utilization Project, 2008, KID DESCR DAT EL; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; KNUDSON MM, 1992, J TRAUMA, V32, P729, DOI 10.1097/00005373-199206000-00009; Long S. J., 2006, REGRESSION MODELS CA; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 1986, P AAAM, V30, P135; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Wang NE, 2008, ANN EMERG MED, V52, P607, DOI 10.1016/j.annemergmed.2008.05.011	33	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1129	1136		10.1089/neu.2012.2716			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400004	23343131	Green Published			2022-02-06	
J	Plurad, DS; Kim, D; Bricker, S; Lemesurier, L; Neville, A; Bongard, F; Putnam, B				Plurad, David S.; Kim, Dennis; Bricker, Scott; Lemesurier, Louis; Neville, Angela; Bongard, Frederic; Putnam, Brant			Ventilator-associated pneumonia in severe traumatic brain injury: the clinical significance of admission chest computed tomography findings	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Ventilator-associated pneumonia; Computed tomography; Enterobacter; Morbidity	PULMONARY INFECTION SCORE; DIAGNOSIS; SCAN	Background: Ventilator-associated pneumonia (VAP) in severe traumatic brain injury (STBI) is a significant morbidity. Bilateral dependent consolidation (BDC) can be seen on admission chest computed tomography (CCT) in STBI. We hypothesize that this finding may be associated with VAP. Materials and methods: We retrospectively studied patients who sustained STBI after blunt injury and survived >48 h, who were admitted over a 40-mo period. We defined STBI as an admission Glasgow Coma Scale Score <= 8. We identified VAP by an elevated white blood cell count, a new infiltrate on chest x-ray, and a positive respiratory culture in a ventilated patient. Variables included demographics, injury, admission CCT, and culture data. We compared BDC-positive and BDC-negative patients. Results: There were 33 cases of VAP in 94 study patients (35.1%), in whom the incidence of intracranial pressure (ICP) monitoring (66.7% versus 39.3%; P = 0.011) was significantly increased. Ventilator-associated pneumonia was significantly increased in the 28 patients (29.8%) in the BDC-positive group (16 [57.1%] versus 17 (25.6%); P = 0.004). Bilateral dependent consolidation independently predicted VAP. In the 33 VAP cases, gram-negative organisms were present in 27 patients (81.8%), with a predominance of Enterobacteriaceae (16 patients [48.5%]). Culture results did not significantly differ between the early (<4 d) versus late or BDC-positive versus BDC-negative VAP groups. Conclusions: Ventilator-associated pneumonia is common after STBI, and BDC is independently associated; however, there is no predilection for specific organisms. Admission CCT findings may prove useful in identifying a group of STBI patients at higher risk for VAP. (C) 2013 Elsevier Inc. All rights reserved.	[Plurad, David S.; Kim, Dennis; Bricker, Scott; Lemesurier, Louis; Neville, Angela; Bongard, Frederic; Putnam, Brant] Univ Calif Los Angeles, David Geffen Sch Med, Div Trauma Acute Care Surg & Surg Crit Care, Harbor UCLA Med Ctr, Torrance, CA USA		Plurad, DS (corresponding author), Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, 1000 W Carson St,Box 42, Torrance, CA 91024 USA.	dplurad@dhs.lacounty.gov					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Campbell W, 1999, CRIT CARE MED, V21, P365; Croce MA, 2006, J TRAUMA, V60, P523, DOI 10.1097/01.ta.0000204033.78125.1b; Croce MA, 2001, AM SURGEON, V67, P105; de Moya MA, 2011, J TRAUMA, V71, P1543, DOI 10.1097/TA.0b013e31822c4a8b; Demetriades D, 1998, ARCH SURG-CHICAGO, V133, P1084, DOI 10.1001/archsurg.133.10.1084; Franquet T, 2000, RADIOGRAPHICS, V20, P673, DOI 10.1148/radiographics.20.3.g00ma01673; Hanpeter DE, 2000, J TRAUMA, V49, P689, DOI 10.1097/00005373-200010000-00017; Karaaslan T, 1995, J TRAUMA, V39, P1081, DOI 10.1097/00005373-199512000-00012; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Lauzier F, 2008, J CRIT CARE, V23, P50, DOI 10.1016/j.jcrc.2008.01.006; Liberati A, 2009, COCHRANE DB SYST REV, V4, P22, DOI [10.1002/14651858.CD000022.pub2, DOI 10.1002/14651858]; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Plurad D, 2007, J TRAUMA, V62, P631, DOI 10.1097/TA.0b013e31802bf009; Plurad D, 2011, J TRAUMA, V71, P1035, DOI 10.1097/TA.0b013e31821282bb; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; RELLO J, 1994, AM J RESP CRIT CARE, V150, P1545, DOI 10.1164/ajrccm.150.6.7952612; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Sirgo G, 2002, SEM RESP CRIT CARE M, V23, P435, DOI 10.1055/s-2002-35714; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Zilberberg MD, 2010, CLIN INFECT DIS, V51, pS131, DOI 10.1086/653062; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	23	13	17	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2013	183	1					371	376		10.1016/j.jss.2013.01.036			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	166ZK	WOS:000320599600054	23434213				2022-02-06	
J	Bergman, K; Given, B; Fabiano, R; Schutte, D; von Eye, A; Davidson, S				Bergman, Karen; Given, Barbara; Fabiano, Robert; Schutte, Debra; von Eye, Alexander; Davidson, Scott			Symptoms Associated With Mild Traumatic Brain Injury/Concussion: The Role of Bother	JOURNAL OF NEUROSCIENCE NURSING			English	Article						bother; brain injury; concussion; symptoms	HEAD-INJURY; PREDICTION; CONCUSSION; MANAGEMENT; OUTCOMES; CHILDREN	Traumatic brain injury (TBI) affects 1.4 million Americans annually, and mild TBI (MTBI) accounts for approximately 75% of those injured. For those with mild injury who seek treatment in an emergency department, there is inconsistency in the management and follow-up recommendations. Approximately, 38% of patients treated in the emergency department for MTBI are discharged with no recommendations for follow-up. In addition, there are an unknown number of persons with MTBI who do not seek healthcare after their injury. Persons with MTBI are, for the most part, managing their concussion symptoms on their own. The purpose of this study was to describe the symptom experience for persons with mild TBI and identify whether there was an association between being bothered by symptoms and self-management of symptoms. The sample for this study included 30 persons with MTBI and a 30-person comparison group. Results indicate that persons within 3 months of their MTBI report an average of 19 symptoms, whereas the comparison group reported six symptoms, and that the most frequently reported symptoms are not always the symptoms rated as most severe or most bothersome. Persons with MTBI reported their most common symptoms to be headache (n = 25, 83%), feeling tired (n = 24, 80%), difficulty thinking and being irritable (each n = 22, 73%), dizziness, trouble remembering, and being forgetful (each n = 21, 70%). There is a significant relationship between overall reports of being bothered by symptoms and the use of symptom management strategies (F = 8.322, p = .008). Persons are more likely to use symptom management strategies when they are bothered by the symptoms. Nurses can assist with symptom self-management by providing simple symptom management strategies to assist with the symptom management process. Early symptom management for the MTBI population may improve the outcomes such as return to work and role functions, for this population.	[Bergman, Karen] Western Michigan Univ, Kalamazoo, MI 49008 USA; [Bergman, Karen] Bronson Methodist Hosp, Kalamazoo, MI USA; [Given, Barbara; Schutte, Debra; von Eye, Alexander] Michigan State Univ, E Lansing, MI USA; [Fabiano, Robert] PAR Rehabil, Lansing, MI USA; [Davidson, Scott] Bronson Hosp, Kalamazoo, MI USA		Bergman, K (corresponding author), Western Michigan Univ, Kalamazoo, MI 49008 USA.	bergmank@bronsonhg.org		Schutte, Debra/0000-0002-1563-719X			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2011, AANN ARN CLIN PRACT; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control, 2006, TRAUM BRAIN INJ; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU, DOI [10.1682/JRRD.2009.06.0076, DOI 10.1682/JRRD.2009.06.0076]; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dodd M, 2001, J ADV NURS, V33, P668, DOI 10.1046/j.1365-2648.2001.01697.x; Dunn KM, 2005, SPINE, V30, P1887, DOI 10.1097/01.brs.0000173900.46863.02; Faul M, 2010, TRAUMATIC BRAIN INJU; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fultz NH, 2003, AM J OBSTET GYNECOL, V189, P1275, DOI 10.1067/S0002-9378(03)00598-2; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hockenberry MJ, 2003, J PAIN SYMPTOM MANAG, V25, P319, DOI 10.1016/S0885-3924(02)00680-2; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee YS, 2011, J UROLOGY, V185, P1003, DOI 10.1016/j.juro.2010.10.085; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; O'leary Michael P, 2005, Rev Urol, V7, P1; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	28	13	13	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2013	45	3					124	132		10.1097/JNN.0b013e31828a418b			9	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	138BO	WOS:000318483500004	23558978				2022-02-06	
J	Calik, M; Abuhandan, M; Aycicek, A; Taskin, A; Selek, S; Iscan, A				Calik, Mustafa; Abuhandan, Mahmut; Aycicek, Ali; Taskin, Abdullah; Selek, Sahabettin; Iscan, Akin			Increased oxidant status in children with breath-holding spells	CHILDS NERVOUS SYSTEM			English	Article						Antioxidants; Breath-holding spells; Infants; Iron-deficiency anemia; Oxidative stress	IRON-DEFICIENCY ANEMIA; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT STATUS; NERVOUS-SYSTEM; SUSCEPTIBILITY; CELLS	Breath-holding spells (BHS) are the most common form of non-epileptic paroxysmal events in infancy. The pathophysiology of BHS is not fully understood. Iron-deficiency anemia (IDA) may be a factor contributing to breath-holding spells. Although numerous reports have shown that elevated oxidative stress is implicated in the pathophysiology of neurodegenerative diseases and neurological conditions, such as epileptic seizures, brain damage, and neurotrauma, there are no data regarding the role of oxidative stress in the development of BHS. This study aimed to investigate oxidative stress in children with BHS. This case-control study was conducted at the Department of Pediatric Neurology, Harran University School of Medicine, Sanliurfa, in Turkey. Blood samples from 31 patients (14 females, 17 males) with BHS which were taken at least 24 h after the BHS attack, and a control group of 35 healthy individuals (13 females, 22 males) were used for the measurement of the plasma total antioxidant capacity, total oxidant status, and oxidative stress index, hemoglobin concentration, serum iron, transferrin saturation and serum ferritin levels. The plasma total antioxidant capacity values were markedly lower and total oxidant status and oxidative stress index values in the BHS group were significantly higher than that in the controls (P a parts per thousand currency signaEuro parts per thousand 0.01). Our data suggest that the value of oxidative stress was significantly higher in patients with BHS than in the controls. Conditions associated with increased oxidative stress such as IDA may be a risk factor for the development of BHS.	[Calik, Mustafa] Harran Univ, Fac Med, Sanliurfa, Turkey; [Calik, Mustafa] Harran Univ, Div Pediat Neurol, Dept Pediat, Fac Med, TR-63100 Yenisehir, Sanliurfa, Turkey; [Abuhandan, Mahmut] Harran Univ, Dept Pediat, Fac Med, Sanliurfa, Turkey; [Aycicek, Ali] Harran Univ, Fac Med, Dept Pediat, Div Pediat Hematol & Oncol, Sanliurfa, Turkey; [Taskin, Abdullah; Selek, Sahabettin] Harran Univ, Dept Biochem & Clin Biochem, Fac Med, Sanliurfa, Turkey; [Iscan, Akin] Bezmialem Vakif Univ, Dept Pediat Neurol, Fac Med, Istanbul, Turkey		Calik, M (corresponding author), Harran Univ, Div Pediat Neurol, Dept Pediat, Fac Med, TR-63100 Yenisehir, Sanliurfa, Turkey.	m.calik80@hotmail.com	Selek, Sahabettin/N-9323-2019; CALIK, Mustafa/Q-8105-2019; Taskin, Abdullah/ABF-5740-2020; Aycicek, Ali/ABI-3846-2020	Selek, Sahabettin/0000-0003-1235-3957; CALIK, Mustafa/0000-0001-9963-5724; Aycicek, Ali/0000-0001-8951-4750; ABUHANDAN, Mahmut/0000-0002-5315-3209			Aslan M, 2011, TURK J HEMATOL, V28, P42, DOI 10.5152/tjh.2011.04; Brugnara C, 2009, NATHAN OSKIS HEMATOL, P456; CORRONS JLV, 1995, EUR J HAEMATOL, V55, P327; Daoud AS, 1997, J PEDIATR-US, V130, P547, DOI 10.1016/S0022-3476(97)70237-3; DiMario FJ, 1997, J PEDIATR-US, V130, P647, DOI 10.1016/S0022-3476(97)70251-8; DiMario FJ, 2001, PEDIATRICS, V107, P265, DOI 10.1542/peds.107.2.265; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Handan U, 2005, PEDIATR HEMAT ONCOL, V22, P711, DOI 10.1080/08880010500278855; Harma M, 2003, SWISS MED WKLY, V133, P563; Isler M, 2002, CROAT MED J, V43, P16; JANSSON LT, 1985, ACTA HAEMATOL-BASEL, V74, P218, DOI 10.1159/000206222; Kumerova Ausma, 1998, Materia Medica Polona, V30, P12; Kurtoglu E, 2003, BIOL TRACE ELEM RES, V96, P117, DOI 10.1385/BTER:96:1-3:117; MACDOUGA.LG, 1972, J PEDIATR-US, V80, P775, DOI 10.1016/S0022-3476(72)80130-6; Mocan H, 1999, ARCH DIS CHILD, V81, P261, DOI 10.1136/adc.81.3.261; Orii KE, 2002, J CHILD NEUROL, V17, P337, DOI 10.1177/088307380201700505; Patel M, 2003, NEUROSCIENCE, V118, P431, DOI 10.1016/S0306-4522(02)00979-X; RAMACHANDRAN M, 1984, EXPERIENTIA, V40, P173, DOI 10.1007/BF01963584; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; Simsek Orhon Filiz, 2006, Turk J Haematol, V23, P15; Tekin D, 2001, PEDIATR INT, V43, P74, DOI 10.1046/j.1442-200x.2001.01329.x; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	25	13	13	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2013	29	6					1015	1019		10.1007/s00381-012-2001-8			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	148FE	WOS:000319227800019	23250250				2022-02-06	
J	Moore, NA; Brennan, PM; Baillie, JK				Moore, N. A.; Brennan, P. M.; Baillie, J. K.			Wide variation and systematic bias in expert clinicians' perceptions of prognosis following brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; intensive care; neurosurgery; prognosis; traumatic brain injury	INTENSIVE-CARE; DECISIONS; DOCTORS; TRIAGE; ILL	Background. The heterogeneous nature of traumatic brain injury (TBI) makes outcome prediction difficult. Although a considerable evidence base exists in the form of well-validated predictive models, these models are not widely used. We hypothesised that this prognostic gap, between the availability and use of prognostic data, leads to inaccurate perceptions of patient outcome. We investigated whether outcome predictions in TBI made by expert clinicians were consistent and accurate when compared to a well-validated prognostic model (IMPACT). Methods. Neurosurgeons and neurointensivists were asked to predict probability of death at 6 months for 12 case vignettes describing patients with isolated TBI. Predictions were compared to IMPACT prognosis for each vignette. To interrogate potential sources of bias in clinical predictions, respondents were given one of two sets of vignettes (A or B) identical apart from one critical factor known to make a large difference to outcome. Results. 27 of 33 questionnaires were returned. Clinicians were consistently more pessimistic about outcomes than the IMPACT model, predicting a significantly greater probability of death (mean difference + 16.3%, 95% CI 13.3-19.4, p < 0.001). There was wide variation between clinicians predicting outcomes for any given vignette (mean range 68.3%), and within the predictions made by each individual: 30% of clinicians were both the most pessimistic respondent, and the most optimistic, for at least one vignette. Clinicians modified their predictions appropriately for most of the factors altered between corresponding vignettes. However when the reported blood glucose was changed, clinicians 'predictions deviated widely from IMPACT predictions, indicating that clinicians systematically overlooked the prognostic relevance of this information. Conclusion. Clinical experts 'predictions of outcome in TBI are widely variable and systematically pessimistic compared to IMPACT. Clinicians overlook important factors in formulating these predictions. Use of well-validated outcome models may add value and consistency to prognostication.	[Moore, N. A.] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Brennan, P. M.] Western Gen Hosp, Dept Clin Neurosci, Honorary SPR Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Baillie, J. K.] Univ Edinburgh, Dept Crit Care Med, Edinburgh EH16 4TJ, Midlothian, Scotland		Baillie, JK (corresponding author), Univ Edinburgh, Dept Crit Care Med, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, John Kenneth/F-3124-2011	Baillie, John Kenneth/0000-0001-5258-793X			ALEXANDER E, 1992, SURG NEUROL, V38, P478, DOI 10.1016/0090-3019(92)90124-6; Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Sprung CL, 1997, INTENS CARE MED, V23, P1011, DOI 10.1007/s001340050449; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525	12	13	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2013	27	3					340	343		10.3109/02688697.2012.754402			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	136HR	WOS:000318353500010	23461749				2022-02-06	
J	Nabiuni, M; Nazari, Z; Safaeinejad, Z; Delfan, B; Miyan, JA				Nabiuni, Mohammad; Nazari, Zahra; Safaeinejad, Zahra; Delfan, Bahram; Miyan, Jaleel A.			Curcumin Downregulates Aquaporin-1 Expression in Cultured Rat Choroid Plexus Cells	JOURNAL OF MEDICINAL FOOD			English	Article						AQP1; cerebrospinal fluid; choroid plexus; curcumin	FLUID PRODUCTION; WATER CHANNELS; BRAIN; HYDROCEPHALUS; MIGRATION; OCCLUSION; DELETION; EDEMA; FLOW	Aquaporin-1 (AQP1) is a water channel that is highly expressed on the apical side of the choroid plexus epithelium (CP) and thought to be one of the major pathways for the high water permeability of this structure. Blockade of AQP1 in the CP reduce the production of cerebrospinal fluid (CSF). Downregulation of AQP1 might be protective against some neurological disorders correlated with increased intracranial pressure and/or poor drainage of CSF. Curcumin, the major constituent of the rhizome of Curcuma longa, has been shown to inhibit potassium channels, Na+-K+ ATPase, as well as AQP3 in some cells. We therefore speculated that curcumin might be a useful tool to inhibit and/or decrease AQP1, and thus might be useful in the regulation of CSF production in pathophysiological conditions, including traumatic brain injury, hydrocephalus, stroke, systemic hyponatremia, acute cerebral edema, and hypertension. Choroidal epithelial cells of the lateral ventricle of Wistar rats were isolated and grown in in-vitro cultures for 24 h. Curcumin was then added to the medium at different concentrations, and the cell viability tested by the (3,4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assay. Additional wells of cells were tested for AQP1 protein expression using immunocytochemistry, immunoblotting, and flow cytometry. Our results showed that curcumin treatment decreases AQP1 expression in rat choroid epithelium cells in a dose-dependent manner. We conclude that curcumin may be a useful tool to regulate CSF production in pathophysiological conditions such as hydrocephalus, systemic hyponatremia, hypertension, and other neurological conditions.	[Nabiuni, Mohammad; Nazari, Zahra; Safaeinejad, Zahra] Kharazmi Univ TMU, Fac Biol Sci, Dept Cell & Mol Biol, Tehran, Iran; [Delfan, Bahram] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Tehran, Iran; [Miyan, Jaleel A.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England		Miyan, JA (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	j.miyan@manchester.ac.uk	Miyan, Jaleel/AAB-1910-2021; nazari, Zahra/AAA-6867-2022	Miyan, Jaleel/0000-0002-1835-0143; nazari, Zahra/0000-0003-3951-7798; Nabiuni, Mohammad/0000-0002-0349-6676; delfan, bahram/0000-0001-6481-9777	Razi Herbal Medicine Research Center at the Lorestan University of Medical Sciences	This study was carried in the Laboratory of Cell and Developmental Biology at Kaharazmi University, and the authors wish to thank Prof. Shahrbanoo Oryan for her support as well as the financial support of the Razi Herbal Medicine Research Center at the Lorestan University of Medical Sciences.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; FARACI FM, 1994, AM J PHYSIOL, V266, pH393, DOI 10.1152/ajpheart.1994.266.2.H393; Filippidis AS, 2012, ACTA NEUROCHIR SUPPL, V113, P55, DOI 10.1007/978-3-7091-0923-6_12; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Johansson PA, 2005, CELL TISSUE RES, V322, P353, DOI 10.1007/s00441-005-1120-x; Kalani MYS, 2012, ACTA NEUROCHIR SUPPL, V113, P51, DOI 10.1007/978-3-7091-0923-6_11; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Liu HY, 2006, BIOCHEM BIOPH RES CO, V344, P1161, DOI 10.1016/j.bbrc.2006.04.020; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Mao XY, 2006, EUR J NEUROSCI, V23, P2929, DOI 10.1111/j.1460-9568.2006.04829.x; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; Moon Y, 2006, NEUROSCI LETT, V395, P1, DOI 10.1016/j.neulet.2005.10.060; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2003, ACT NEUR S, V86, P525; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Wang DW, 2011, MOL CELL NEUROSCI, V46, P318, DOI 10.1016/j.mcn.2010.10.003; Watanabe Y, 2005, NEUROSCI LETT, V379, P158, DOI 10.1016/j.neulet.2004.12.068; Wu Q, 1998, AM J PHYSIOL-CELL PH, V275, pC1565, DOI 10.1152/ajpcell.1998.275.6.C1565; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1; Zhang D, 2002, J GEN PHYSIOL, V119, P561, DOI 10.1085/jgp.20028597; Zheng W, 1998, IN VITRO CELL DEV-AN, V34, P40	31	13	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-620X	1557-7600		J MED FOOD	J. Med. Food	JUN	2013	16	6					504	510		10.1089/jmf.2012.0208			7	Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics	163YY	WOS:000320376000005	23735000				2022-02-06	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			Traumatic thalamic injury demonstrated by diffusion tensor tractography of the spinothalamic pathway	BRAIN INJURY			English	Article						Spinothalamic tract; diffusion tensor imaging; head trauma; traumatic axonal injury	CENTRAL POSTSTROKE PAIN; BRAIN-INJURY; CORTICAL PATHWAY; AXONAL INJURY; HEAD TRAUMA; ABNORMALITIES; FEATURES; STATE	Background: This study reports on a patient with traumatic brain injury (TBI) with a thalamic lesion in the ventroposterolateral nucleus which was demonstrated by diffusion tensor tractography (DTT) for the spinothalamic tract and its thalamocortical pathway (STP). Methods: One patient with TBI and eight normal control subjects were recruited. A 64-year-old woman who had suffered a motor vehicle accident presented with a persisting tingling sensation and pain in her right upper and lower extremities at 3 weeks after onset. The patient showed impaired touch sensation, but normal proprioception. Diffusion tensor imaging was performed at 1 month after onset. Fractional anisotropy (FA) and mean diffusivity were measured using a region of interest method along the STP. Results: DTT showed normal STP integrities as compared with normal controls. However, the FA values of the left STP at the thalamus were more than 2 SD decreased. The diminished FA value of the left STP in the left thalamus seems to indicate injury of the left ventrolateroposterior nucleus. Central pain and impaired touch sensation of right extremities supports the presence of left STP injury at the ventroposterolateral nucleus in this patient. Conclusion: It is believed that DTT for the STP provides a useful means of detecting thalamic injury in TBI.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Namku 705717, Taegu, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Namku 705717, Taegu, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Haines D.E., 2002, FUNDAMENTAL NEUROSCI; Hattori N, 2003, J NUCL MED, V44, P1709; Hong JH, 2011, AM J NEURORADIOL, V32, P1358, DOI 10.3174/ajnr.A2497; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lincoln N., 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Miller M D, 1993, Fam Pract Res J, V13, P15; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Yamada K, 2010, AM J NEURORADIOL, V31, P732, DOI 10.3174/ajnr.A1870; Yang DS, 2009, NEUROSCI LETT, V459, P19, DOI 10.1016/j.neulet.2009.04.058; Yeo SS, 2012, BRAIN INJURY, V26, P891, DOI 10.3109/02699052.2012.661119	28	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					749	753		10.3109/02699052.2013.771794			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500013	23672449				2022-02-06	
J	Skoch, J; Ansay, TL; Lemole, GM				Skoch, Jesse; Ansay, Tracy L.; Lemole, G. M.			Injury to the Temporal Lobe via Medial Transorbital Entry of a Toothbrush	JOURNAL OF NEUROLOGICAL SURGERY REPORTS			English	Article						foreign body; penetrating; superior orbital fissure; superior orbital fissure syndrome; toothbrush; traumatic brain injury		Objectives Intracranial penetration by foreign bodies entering via the orbit represent an unusual form of traumatic brain injury. Nevertheless, much is at stake with high risk for cranial nerve and neurovascular injury. We present a case where the bristled end of a toothbrush entered the brain as a projectile via the superior orbital fissure and discuss considerations for surgical management. Setting A 35-year-old woman suffered a periorbital injury after her husband threw an electric toothbrush at a wall and the head of the toothbrush became a missile that projected through her superior orbital fissure and into her right temporal lobe. She complained of headache and incomplete vision loss in the affected eye. Intervention After obtaining a cerebrovascular angiogram, we proceeded with emergent orbital decompression and anterograde extraction of the foreign body via a modified frontotemporal orbitozygomatic approach with drilling of the skull base allowing for en bloc removal of the toothbrush. Conclusions The patient recovered well with improvement in her vision and partial third and sixth nerve palsies. This report illustrates a unique mechanism of injury with a novel intracranial foreign body. We review the neurosurgeon's need for prompt management with an approach customized to the structure of the offending object, the damaged elements, and the surrounding cranial nerves and vascular anatomy.	[Skoch, Jesse; Lemole, G. M.] Univ Arizona, Univ Med Ctr, Div Neurosurg, Tucson, AZ 85721 USA; [Ansay, Tracy L.] Univ Cincinnati, Neurosci Inst, Dept Neurosurg, Cincinnati, OH USA; [Ansay, Tracy L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ansay, Tracy L.] Mayfield Clin, Cincinnati, OH USA		Skoch, J (corresponding author), Univ Arizona, Div Neurosurg, 1501 N Campbell Ave, Tucson, AZ 85721 USA.	jskoch@email.arizona.edu	Skoch, Jesse/I-4424-2019	Skoch, Jesse/0000-0001-8869-6804			BARD LA, 1964, ARCH OPHTHALMOL-CHIC, V71, P332; Cato-Addison WB, 2007, ORBIT, V26, P279, DOI 10.1080/01676830601169130; Chen CT, 2010, CRANIOMAX TRAUM REC, V3, P9, DOI 10.1055/s-0030-1249369; Dunn IF, 2009, NEUROSURGERY, V65, P383, DOI 10.1227/01.NEU.0000347474.69080.A1; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GREENE KA, 1993, SURG NEUROL, V40, P499, DOI 10.1016/0090-3019(93)90054-5; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Koutroumanidis M, 2001, EPILEPSIA, V42, P686, DOI 10.1046/j.1528-1157.2001.32700.x; Large M, 2012, AM J FOREN MED PATH, V33, P13, DOI 10.1097/PAF.0b013e3181dd5b47; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lemole GM, 2003, J NEUROSURG, V99, P924, DOI 10.3171/jns.2003.99.5.0924; Lunetta P, 2002, AM J FOREN MED PATH, V23, P334, DOI 10.1097/00000433-200212000-00006; MACEWEN CJ, 1986, BRIT J OPHTHALMOL, V70, P147, DOI 10.1136/bjo.70.2.147; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; MILLER CF, 1977, SURG NEUROL, V7, P95; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Navarro V, 2006, EPILEPSIA, V47, P1971, DOI 10.1111/j.1528-1167.2006.00822.x; NELSON FP, 2000, PEDIAT DENT, V22, P381; ONEILL OR, 1994, SURG NEUROL, V42, P494, DOI 10.1016/0090-3019(94)90079-5; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Strub William M, 2003, Emerg Radiol, V10, P109, DOI 10.1007/s10140-003-0296-1; Taji SS, 1998, AUST DENT J, V43, P128, DOI 10.1111/j.1834-7819.1998.tb06101.x; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; UDWADIA RA, 1994, J LARYNGOL OTOL, V108, P441, DOI 10.1017/S0022215100127033	24	13	14	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2193-6358	2193-6366		J NEUROL SURG REP	J. Neurol. Surg. Rep.	JUN	2013	74	1					23	28		10.1055/s-0033-1346976			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V31ZJ	WOS:000215667800004	23943716	gold, Green Submitted, Green Published			2022-02-06	
J	Straits-Troster, K; Gierisch, JM; Strauss, JL; Dyck, DG; Dixon, LB; Norell, D; Perlick, DA				Straits-Troster, Kristy; Gierisch, Jennifer M.; Strauss, Jennifer L.; Dyck, Dennis G.; Dixon, Lisa B.; Norell, Diane; Perlick, Deborah A.			Multifamily Group Treatment for Veterans With Traumatic Brain Injury: What Is the Value to Participants?	PSYCHIATRIC SERVICES			English	Article							THERAPY; SCHIZOPHRENIA; INTERVENTION; FAMILIES	Objective: This study evaluated the feasibility, acceptability, and helpfulness of implementation of multifamily group treatment for traumatic brain injury (TBI) among veterans who sustained a TBI during the wars in Iraq and Afghanistan and their families or caregivers. Methods: Veterans and their family members who participated in an open clinical trial (August 2010-March 2011) of multifamily psychoeducation for TBI at two Veterans Affairs medical centers were invited to one of three focus groups. Participants were asked about problems experienced before and during the intervention, aspects of treatment that were helpful, and improvements that would facilitate effective implementation of multifamily group treatment for TBI. Postintervention focus group transcripts were analyzed by utilizing qualitative content analysis. Results: Participants included eight veterans with TBI and eight family members. Five themes emerged: exploring common struggles and reducing isolation, building skills to cope with TBI and related problems, restoring relationships through communication and understanding, increasing understanding of the interconnection between TBI and posttraumatic stress disorder, and improving the multifamily group experience and increasing treatment engagement of veterans and families. Veterans and family members found multifamily group treatment for TBI highly acceptable and offered recommendations to improve and increase access to the program. Conclusions: The results supported the feasibility and acceptability of multifamily group treatment for TBI. Specific recommendations to improve this psychoeducational intervention and its implementation are offered.	[Straits-Troster, Kristy] Dept Vet Affairs VA Midatlantic Reg Mental Illnes, Durham, NC USA; [Straits-Troster, Kristy] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA; [Gierisch, Jennifer M.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Gierisch, Jennifer M.] Duke Univ, Dept Med, Durham, NC 27706 USA; [Strauss, Jennifer L.] Durham VA Med Ctr, Hlth Serv Res & Dev Serv, Durham, NC USA; [Strauss, Jennifer L.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Dyck, Dennis G.] Washington State Univ, Dept Psychol, Spokane, WA USA; [Dixon, Lisa B.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dixon, Lisa B.] New York State Psychiat Inst & Hosp, Ctr Practice Innovat, New York, NY 10032 USA; [Norell, Diane] Eastern Washington Univ, Dept Occupat Therapy, Cheney, WA 99004 USA; [Perlick, Deborah A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Perlick, Deborah A.] VA MIRECC, Bronx, NY USA		Straits-Troster, K (corresponding author), Dept Vet Affairs VA Midatlantic Reg Mental Illnes, Durham, NC USA.	kristy.straits-troster@va.gov		Gierisch, Jennifer/0000-0002-5057-4964	U.S. Department of DefenseUnited States Department of Defense [W81XWH-08-2-0054]; Mental Illness Research, Education and Clinical Centers in Veterans Integrated Service Networks 3 and 6; Veterans Affairs Research Career Development AwardUS Department of Veterans Affairs	This study was supported by an award (W81XWH-08-2-0054) from the U.S. Department of Defense to Dr. Perlick, by the Mental Illness Research, Education and Clinical Centers in Veterans Integrated Service Networks 3 and 6, and by a Veterans Affairs Research Career Development Award to Dr. Strauss. The authors are grateful for the assistance of Joy Close, M. S. W., Caitlyn Campbell, B. S., Meenal Misal, B. A., and Caroline Holman, B. A., and appreciate the courage and sacrifice of the injured veterans and their families who participated in this study.	Chacon-Moscoso S., 2002, EVALUATION-US, V8, P413, DOI [10.1177/13563890260620612, DOI 10.1177/13563890260620612]; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dausch BM, 2009, J TELEMED TELECARE, V15, P211, DOI 10.1258/jtt.2009.081216; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Glynn SM, 2006, SCHIZOPHRENIA BULL, V32, P451, DOI 10.1093/schbul/sbj066; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Krueger R.A., 1994, FOCUS GROUPS PRACTIC, V2d; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Perlick DA, 2012, PSYCHIAT SERVICES; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Rotondi AJ, 2010, PSYCHIAT SERV, V61, P1099, DOI 10.1176/ps.2010.61.11.1099; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Sautter FJ, 2009, J MARITAL FAM THER, V35, P343, DOI 10.1111/j.1752-0606.2009.00125.x; Sherman MD, 2012, PSYCHOL SERVICES; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Sherman MD, 2009, PSYCHIAT SERV, V60, P254, DOI 10.1176/appi.ps.60.2.254; Voils CI, 2008, FIELD METHOD, V20, P3, DOI 10.1177/1525822X07307463	22	13	14	0	4	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN	2013	64	6					541	546		10.1176/appi.ps.001632012			6	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255XF	WOS:000327272700008	23450326				2022-02-06	
J	Wang, SY; Chopp, M; Nazem-Zadeh, MR; Ding, GL; Nejad-Davarani, SP; Qu, CS; Lu, M; Li, L; Davoodi-Bojd, E; Hu, JN; Li, QJ; Mahmood, A; Jiang, Q				Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Qu, Changsheng; Lu, Mei; Li, Lian; Davoodi-Bojd, Esmaeil; Hu, Jiani; Li, Qingjiang; Mahmood, Asim; Jiang, Quan			Comparison of Neurite Density Measured by MRI and Histology after TBI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; NONRIGID REGISTRATION; WATER DIFFUSION; AXON DIAMETER; TRANSPLANTATION; STROKE; MODEL; RATS; QUANTIFICATION	Background: Functional recovery after brain injury in animals is improved by marrow stromal cells (MSC) which stimulate neurite reorganization. However, MRI measurement of neurite density changes after injury has not been performed. In this study, we investigate the feasibility of MRI measurement of neurite density in an animal model of traumatic brain injury (TBI) with and without MSC treatment. Methods: Fifteen male Wistar rats, were treated with saline (n = 6) or MSCs (n = 9) and were sacrificed at 6 weeks after controlled cortical impact (CCI). Healthy non-CCI rats (n = 5), were also employed. Ex-vivo MRI scans were performed two days after the rats were sacrificed. Multiple-shell hybrid diffusion imaging encoding scheme and spherical harmonic expansion of a two-compartment water diffusion displacement model were used to extract neurite related parameters. Bielshowski and Luxol Fast blue was used for staining axons and myelin, respectively. Modified Morris water maze and neurological severity score (mNSS) test were performed for functional evaluation. The treatment effects, the correlations between neurite densities measured by MRI and histology, and the correlations between MRI and functional variables were calculated by repeated measures analysis of variance, the regression correlation analysis tests, and spearman correlation coefficients. Results: Neurite densities exhibited a significant correlation (R-2>0.80, p<1E-20) between MRI and immuno-histochemistry measurements with 95% lower bound of the intra-correlation coefficient (ICC) as 0.86. The conventional fractional anisotropy (FA) correlated moderately with histological neurite density (R-2 = 0.59, P<1E-5) with 95% lower bound of ICC as 0.76. MRI data revealed increased neurite reorganization with MSC treatment compared with saline treatment, confirmed by histological data from the same animals. mNSS were significantly correlated with MRI neurite density in the hippocampus region. Conclusions: The present studies demonstrated that neurite density can be estimated by MRI after TBI and MRI measurement of neurite density is a sensitive marker to MSC treatment response.	[Wang, Shiyang; Chopp, Michael; Nazem-Zadeh, Mohammad-Reza; Ding, Guangliang; Nejad-Davarani, Siamak P.; Li, Lian; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Wang, Shiyang; Chopp, Michael; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Nazem-Zadeh, Mohammad-Reza] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Hu, Jiani] Wayne State Univ, Harper Hosp, MR Ctr, Detroit, MI USA		Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901; Li, Lian/0000-0003-0097-1184	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506, HL64766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134, R01NS048349, P01NS023393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	The research presented herein was supported by National Institute of Neurological Disorders and Stroke, grants P01 NS23393, RO1 NS064134, RO1 NS48349, RO1 AG037506 and HL64766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Denton ERE, 1999, J COMPUT ASSIST TOMO, V23, P800, DOI 10.1097/00004728-199909000-00031; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kybic J, 2008, METH APPL MAGEJ US D; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Pfeifer JD, 2008, WASHINGTON MANUAL SU; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ueno Y, 2009, NEUROSCIENCE, V162, P317, DOI 10.1016/j.neuroscience.2009.04.065; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	44	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63511	10.1371/journal.pone.0063511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	WOS:000320362700029	23717439	Green Submitted, gold, Green Published			2022-02-06	
J	Peck, CP; Schroeder, RW; Heinrichs, RJ; VonDran, EJ; Brockman, CJ; Webster, BK; Baade, LE				Peck, C. P.; Schroeder, R. W.; Heinrichs, R. J.; VonDran, E. J.; Brockman, C. J.; Webster, B. K.; Baade, L. E.			Differences in MMPI-2 FBS and RBS Scores in Brain Injury, Probable Malingering, and Conversion Disorder Groups: A Preliminary Study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Conversion disorder; Malingering; Minnesota Multiphasic Personality Inventory-2; Symptom Validity Scale; Response Bias Scale	FAKE BAD SCALE; VALIDITY SCALES; RESPONSE BIAS; NEUROCOGNITIVE DYSFUNCTION; PERFORMANCE; VALIDATION; SAMPLES; CLAIMS	This study examined differences in raw scores on the Symptom Validity Scale and Response Bias Scale (RBS) from the Minnesota Multiphasic Personality Inventory-2 in three criterion groups: (i) valid traumatic brain injured, (ii) invalid traumatic brain injured, and (iii) psychogenic non-epileptic seizure disorders. Results indicate that a >30 raw score cutoff for the Symptom Validity Scale accurately identified 50% of the invalid traumatic brain injured group, while misclassifying none of the valid traumatic brain injured group and 6% of the psychogenic non-epileptic seizure disorder group. Using a >15 RBS raw cutoff score accurately classified 50% of the invalid traumatic brain injured group and misclassified fewer than 10% of the valid traumatic brain injured and psychogenic non-epileptic seizure disorder groups. These cutoff scores used conjunctively did not misclassify any members of the psychogenic non-epileptic seizure disorder or valid traumatic brain injured groups, while accurately classifying 44% of the invalid traumatic brain injured individuals. Findings from this preliminary study suggest that the conjunctive use of the Symptom Validity Scale and the RBS from the Minnesota Multiphasic Personality Inventory-2 may be useful in differentiating probable malingering from individuals with brain injuries and conversion disorders.	[Peck, C. P.] Univ Florida, Gainesville, FL 32610 USA; [Schroeder, R. W.; Heinrichs, R. J.; VonDran, E. J.; Brockman, C. J.; Webster, B. K.; Baade, L. E.] Univ Kansas, Sch Med, Wichita, KS 67214 USA		Peck, CP (corresponding author), Univ Florida, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	CalebPPeck@Yahoo.com					An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Boone K. B., 2007, ASSESSMENT FEIGNED C; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Denney R. L., 1999, J FORENSIC NEUROPSYC, V1, P5; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Drane DL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P521, DOI 10.1007/978-0-387-76978-3_17; Frederick R. I., 1997, VALIDITY INDICATOR P; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P., 2003, GREENS WORLD MEMORY; Green P, 2004, GREENS MED SYMPTOM V; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hurwitz TA, 2004, CAN J PSYCHIAT, V49, P172, DOI 10.1177/070674370404900304; Johnson AL, 2010, CLIN NEUROPSYCHOL, V24, P220, DOI 10.1080/13854040903266902; Kaemmer, 1989, MINNESOTA MULTIPHASI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Psychological Corporation, 2009, ADV CLIN SOL WAIS 4; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tellegen, 2008, MINNESOTA MULTIPHASI; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073	36	13	13	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY 1	2013	27	4					693	707		10.1080/13854046.2013.779032			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	163TZ	WOS:000320361100235	23510271				2022-02-06	
J	Popovic, V				Popovic, Vera			Approach to Testing Growth Hormone (GH) Secretion in Obese Subjects	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; QUALITY-OF-LIFE; REPLACEMENT THERAPY; (GH)-RELEASING HORMONE; HYPOPITUITARY ADULTS; PREMATURE MORTALITY; CONSENSUS STATEMENT; ENDOCRINE-SOCIETY; PROVOCATIVE TESTS; DEFICIENT ADULTS	Identification of adults with GH deficiency (GHD) is challenging because clinical features of adult GHD are not distinctive and because clinical suspicion must be confirmed by biochemical tests. Adults are selected for testing for adult GHD if they have a high pretest probability of GHD, ie, if they have hypothalamic-pituitary disease, if they have received cranial irradiation or central nervous system tumor treatment, or if they survived traumatic brain injury or subarachnoid hemorrhage. Testing should only be carried out if a decision has already been made that if deficiency is found it will be treated. There are many pharmacological GH stimulation tests for the diagnosis of GHD; however, none fulfill the requirements for an ideal test having high discriminatory power; being reproducible, safe, convenient, and economical; and not being dependent on confounding factors such as age, gender, nutritional status, and in particular obesity. In obesity, GH secretion is reduced, GH clearance is enhanced, and stimulated GH secretion is reduced, causing a false-positive result. This functional hyposomatotropism in obesity is fully reversed by weight loss. In conclusion, GH stimulation tests should be avoided in obese subjects with very low pretest probability.	[Popovic, Vera] Univ Belgrade, Dept Neuroendocrinol, Ctr Clin, Fac Med, Belgrade 11000, Serbia		Popovic, V (corresponding author), Univ Belgrade, Dept Neuroendocrinol, Clin Ctr Serbia, Fac Med, Dr Subotic 13, Belgrade 11000, Serbia.	popver@eunet.rs			Ministry of Science Republic Serbia [175033]	This work was supported by research grant no. 175033 from the Ministry of Science Republic Serbia.	Abs R, 1999, CLIN ENDOCRINOL, V50, P703, DOI 10.1046/j.1365-2265.1999.00695.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; BARINAGA M, 1985, NATURE, V314, P279, DOI 10.1038/314279a0; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; BOWERS CY, 1993, J PEDIATR ENDOCRINOL, V6, P21; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P3995, DOI 10.1210/jc.2009-0438; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Clayton P, 2007, GROWTH HORM IGF RES, V17, P369, DOI 10.1016/j.ghir.2007.04.010; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Darzy Ken H., 2009, V15, P1, DOI 10.1159/000207607; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Franco C, 2006, J CLIN ENDOCR METAB, V91, P4408, DOI 10.1210/jc.2006-0887; Friend K, 1996, J CLIN ENDOCR METAB, V81, P3746, DOI 10.1210/jc.81.10.3746; Gaillard RC, 2012, EUR J ENDOCRINOL, V166, P1069, DOI 10.1530/EJE-11-1028; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gleeson HK, 2005, J CLIN ENDOCR METAB, V90, P1061, DOI 10.1210/jc.2004-0501; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hoeck HC, 2000, J CLIN ENDOCR METAB, V85, P1467, DOI 10.1210/jc.85.4.1467; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; JOHANSSON JO, 1994, ARTERIOSCLER THROMB, V14, P434, DOI 10.1161/01.ATV.14.3.434; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Koltowska-Haggstrom M, 2006, EUR J ENDOCRINOL, V155, P109, DOI 10.1530/eje.1.02176; Lee P, 2009, CLIN ENDOCRINOL, V71, P82, DOI 10.1111/j.1365-2265.2008.03466.x; Lissett CA, 2004, HORM RES, V62, P44, DOI 10.1159/000080758; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Micic D, 1998, J CLIN ENDOCR METAB, V83, P2569, DOI 10.1210/jc.83.7.2569; Micmacher E, 2009, ARQ BRAS ENDOCRINOL, V53, P853, DOI 10.1590/S0004-27302009000700009; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; NASS R, 1995, J CLIN ENDOCR METAB, V80, P552, DOI 10.1210/jc.80.2.552; Pfeifer M, 2001, CLIN ENDOCRINOL, V54, P17, DOI 10.1046/j.1365-2265.2001.01179.x; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Popovic V, 2004, CLIN ENDOCRINOL, V60, P185, DOI 10.1046/j.1365-2265.2003.01955.x; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; ROTH J, 1963, SCIENCE, V140, P987, DOI 10.1126/science.140.3570.987; Russell-Aulet M, 2001, J GERONTOL A-BIOL, V56, pM124, DOI 10.1093/gerona/56.2.M124; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Toogood AA, 1996, CLIN ENDOCRINOL, V45, P399, DOI 10.1046/j.1365-2265.1996.8310842.x; Utz AL, 2008, J CLIN ENDOCR METAB, V93, P4033, DOI 10.1210/jc.2008-0930; van Dam EWCM, 2002, J CLIN ENDOCR METAB, V87, P4225, DOI 10.1210/jc.2002-012006; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	62	13	13	1	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	MAY	2013	98	5					1789	1796		10.1210/jc.2013-1099			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	140WX	WOS:000318688200032	23650336	Bronze			2022-02-06	
J	Ding, GL; Chopp, M; Poulsen, DJ; Li, L; Qu, CS; Li, QJ; Nejad-Davarani, SP; Budaj, JS; Wu, HT; Mahmood, A; Jiang, Q				Ding, Guang Liang; Chopp, Michael; Poulsen, David J.; Li, Lian; Qu, Changsheng; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Wu, Hongtao; Mahmood, Asim; Jiang, Quan			MRI of Neuronal Recovery after Low-Dose Methamphetamine Treatment of Traumatic Brain Injury in Rats	PLOS ONE			English	Article							MARROW STROMAL CELL; DIFFUSE AXONAL INJURY; WHITE-MATTER INJURY; CEREBRAL-ISCHEMIA; EMBOLIC STROKE; ATROPHY; TRANSPLANTATION; SUBPOPULATION; ARCHITECTURE; EXPRESSION	We assessed the effects of low dose methamphetamine treatment of traumatic brain injury (TBI) in rats by employing MRI, immunohistology, and neurological functional tests. Young male Wistar rats were subjected to TBI using the controlled cortical impact model. The treated rats (n = 10) received an intravenous (iv) bolus dose of 0.42 mg/kg of methamphetamine at eight hours after the TBI followed by continuous iv infusion for 24 hrs. The control rats (n = 10) received the same volume of saline using the same protocol. MRI scans, including T2-weighted imaging (T2WI) and diffusion tensor imaging (DTI), were performed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks. The lesion volumes of TBI damaged cerebral tissue were demarcated by elevated values in T-2 maps and were histologically identified by hematoxylin and eosin (H&E) staining. The fractional anisotropy (FA) values within regions-of-interest (ROI) were measured in FA maps deduced from DTI, and were directly compared with Bielschowsky's silver and Luxol fast blue (BLFB) immunohistological staining. No therapeutic effect on lesion volumes was detected during 6 weeks after TBI. However, treatment significantly increased FA values in the recovery ROI compared with the control group at 5 and 6 weeks after TBI. Myelinated axons histologically measured using BLFB were significantly increased (p<0.001) in the treated group (25.84 +/- 1.41%) compared with the control group (17.05 +/- 2.95%). Significant correlations were detected between FA and BLFB measures in the recovery ROI (R = 0.54, p<0.02). Methamphetamine treatment significantly reduced modified neurological severity scores from 2 to 6 weeks (p<0.05) and foot-fault errors from 3 days to 6 weeks (p<0.05) after TBI. Thus, the FA data suggest that methamphetamine treatment improves white matter reorganization from 5 to 6 weeks after TBI in rats compared with saline treatment, which may contribute to the observed functional recovery.	[Ding, Guang Liang; Chopp, Michael; Li, Lian; Li, Qingjiang; Nejad-Davarani, Siamak P.; Budaj, John S.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Qu, Changsheng; Wu, Hongtao; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021	Li, Lian/0000-0003-0097-1184; Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689	Department of DefenseUnited States Department of Defense [CDMRP DR080702 (W81XWH-11-2-0026)]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS064134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER	This work was financially supported by Department of Defense Grant CDMRP DR080702 (W81XWH-11-2-0026) and National Institutes of Health RO1 NS064134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Braun AA, 2011, NEUROSCIENCE, V184, P164, DOI 10.1016/j.neuroscience.2011.03.045; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DZIABIS MD, 1958, STAIN TECHNOL, V33, P96; GOTTRON F, 1995, NEUROSCI LETT, V194, P1, DOI 10.1016/0304-3940(95)11698-V; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042845; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; KALCHEVA N, 1995, P NATL ACAD SCI USA, V92, P10894, DOI 10.1073/pnas.92.24.10894; Lazar M, 2008, MAGN RESON MED, V60, P774, DOI 10.1002/mrm.21725; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Llewellyn BD, 2009, BIOTECH HISTOCHEM, V84, P159, DOI 10.1080/10520290903052899; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntosh A, 2006, NEUROLOGY, V67, P2259, DOI 10.1212/01.wnl.0000249180.61312.d3; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; PECK DJ, 1992, MAGNET RESON MED, V26, P259, DOI 10.1002/mrm.1910260207; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	54	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61241	10.1371/journal.pone.0061241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	WOS:000317908700017	23637800	gold, Green Published, Green Submitted			2022-02-06	
J	Barcelos, GK; Tholance, Y; Grousson, S; Renaud, B; Perret-Liaudet, A; Dailler, F; Zimmer, L				Barcelos, Gleicy K.; Tholance, Yannick; Grousson, Sebastien; Renaud, Bernard; Perret-Liaudet, Armand; Dailler, Frederic; Zimmer, Luc			Outcome of Poor-Grade Subarachnoid Hemorrhage as Determined by Biomarkers of Glucose Cerebral Metabolism	NEUROCRITICAL CARE			English	Article						Cerebral ischemia; Glucose metabolism; Hyperglycolysis; Neurologic outcome; Subarachnoid hemorrhage	HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; SPECIAL WRITING GROUP; VENOUS DIFFERENCES; STROKE-COUNCIL; HEAD-INJURY; LACTATE; OXYGEN; DYSFUNCTION; ISCHEMIA	The aim of this study was to determine if the measurement of blood biomarkers of glucose cerebral metabolism, performed with retrograde jugular catheter, could predict the outcome of poor-grade aneurysmal subarachnoid hemorrhage (aSAH) patients. This study was conducted in 68 poor-grade aSAH patients. A total of 4,024 blood samples obtained from jugular and radial catheters were analyzed for glucose, lactate, and oxygen content every 8 h for 10 +/- A 0.5 days. Metabolic ratio (MR) and lactate-oxygen index (LOI) were obtained by ratios using arterio-jugular differences. Functional outcome was evaluated at 12 months with the Glasgow Outcome Scale. Outcome was unfavorable in 40 patients. In this group of patients, the MR was significantly lower (p < 0.0001) and the LOI was significantly higher (p = 0.0001) than in the group with favorable outcome. The MR cutoff value, below which the patients are likely to have an unfavorable outcome, was determined to be 3.35. More interestingly, the data obtained in this study demonstrated that the patients achieving an unfavorable outcome were distinguished from those with a favorable outcome by having at least three events of MR inferior to 3.35 (sensitivity = 90 %, specificity = 82.1 %). Moreover, in patients who developed cerebral vasospasm, we observed a significant decrease in the MR. Our data provide additional support to the view that the MR is a reliable marker for predicting the outcome of poor-grade aSAH patients. Prospective studies are needed to confirm its value in multimodal monitoring.	[Barcelos, Gleicy K.; Perret-Liaudet, Armand; Zimmer, Luc] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, BioRaN Team,Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Grousson, Sebastien; Dailler, Frederic] Hosp Civils Lyon, Neurol Hosp, Intens Care Unit, Lyon, France; [Barcelos, Gleicy K.] Univ Hosp Geneva, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; [Barcelos, Gleicy K.; Tholance, Yannick; Renaud, Bernard; Perret-Liaudet, Armand] Hosp Civils Lyon, Neurol Hosp, Dept Biochem, Neurochem Unit, Lyon, France; [Tholance, Yannick] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, WAKING Team,Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Renaud, Bernard] Lyon Neurosci Res Ctr, Lyon, France; [Zimmer, Luc] Hosp Civils Lyon, Neurol Hosp, CERMEP, Lyon, France; [Barcelos, Gleicy K.] Hop Univ Geneve, Dept APSI, CH-1211 Geneva 14, Switzerland		Barcelos, GK (corresponding author), Hop Univ Geneve, Dept APSI, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	gleicy.barcelos@hcuge.ch	ZIMMER, Luc/AAG-1986-2019; ZIMMER, Luc/G-6538-2011	ZIMMER, Luc/0000-0002-2805-7098; ZIMMER, Luc/0000-0002-2805-7098; tholance, yannick/0000-0002-1826-3031			Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Coppadoro A, 2011, MINERVA ANESTESIOL, V77, P74; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; CRUZ J, 1994, CRIT CARE MED, V22, P1465, DOI 10.1097/00003246-199409000-00018; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Gibbs EL, 1942, J BIOL CHEM, V144, P325; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lieutaud T, 2007, HBK BEHAV NEUROSCI, V16, P659, DOI 10.1016/S1569-7339(06)16035-X; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Moritz S, 2008, J NEUROSURG ANESTH, V20, P8, DOI 10.1097/ANA.0b013e31814b1459; Naval NS, 2013, J CRIT CARE, V28, P182, DOI 10.1016/j.jcrc.2012.05.008; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oertel MF, 2007, J CLIN NEUROSCI, V14, P948, DOI 10.1016/j.jocn.2006.11.002; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Rabinstein Alejandro A, 2009, Neurocrit Care, V10, P414, DOI 10.1007/s12028-009-9218-8; Risselada R, 2010, EUR J EPIDEMIOL, V25, P261, DOI 10.1007/s10654-010-9432-x; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Stuart RM, 2011, NEUROCRIT CARE, V15, P146, DOI 10.1007/s12028-009-9264-2; Taylor CJ, 2011, NEUROCRIT CARE, V14, P341, DOI 10.1007/s12028-010-9377-7; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd; Wartenberg KE, 2011, CURR OPIN CRIT CARE, V17, P85, DOI 10.1097/MCC.0b013e328342f83d; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	41	13	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					234	244		10.1007/s12028-012-9810-1			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700011	23292767	Green Submitted			2022-02-06	
J	Bell-Sprinkel, TL; Boone, KB; Miora, D; Cottingham, M; Victor, T; Ziegler, E; Zeller, M; Wright, M				Bell-Sprinkel, Tiffanie L.; Boone, Kyle Brauer; Miora, Deborah; Cottingham, Maria; Victor, Tara; Ziegler, Elizabeth; Zeller, Michelle; Wright, Matthew			Re-Examination of the Rey Word Recognition Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Rey Word Recognition Test; Malingering; Symptom Validity Test	SUSPECT EFFORT; RESPONSE BIAS; SENSITIVITY; SCORES; SPECIFICITY; PERFORMANCE; TRIAL; DYSFUNCTION; VALIDITY	The Rey Word Recognition Test, a brief and simple to administer free-standing neurocognitive performance validity test, was examined in a large known-groups sample (122 credible patients and 134 non-credible patients). Total correctly recognized was the most sensitive score, identifying 54% of non-credible participants using a cut-off of 6, while maintaining specificity of approximately 90%. However, specifically rates were somewhat lower in credible individuals with <12 years of education or borderline intelligence, or who were bilingual (spoke English as a second language, or learned English concurrently with another language), indicating that cut-offs may require minor adjustment in these groups. Sensitivity rates were much higher in non-credible female versus male mild traumatic brain injury patients (mTBI; 68% versus 48% for total correct), suggesting that the Rey Word Recognition Test is particularly effective in identifying performance invalidity in female mTBI compensation seekers.	[Bell-Sprinkel, Tiffanie L.; Boone, Kyle Brauer; Miora, Deborah] Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA USA; [Cottingham, Maria] Henry M Jackson Fdn Adv Mil Med, Def & Vet Brain Injury Ctr, Camp Pendleton, CA USA; [Victor, Tara] Calif State Univ Dominguez Hills, Dept Psychol, Carson, CA USA; [Ziegler, Elizabeth] Spokane Vet Adm, Spokane, WA USA; [Zeller, Michelle] West Los Angeles Vet Adm, Los Angeles, CA USA; [Wright, Matthew] Harbor UCLA Med Ctr, Dept Psychiat, Los Angeles, CA USA; [Wright, Matthew] Los Angeles Biomed Inst, Los Angeles, CA USA		Bell-Sprinkel, TL (corresponding author), Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA USA.	tbellsprinkel@att.net	Victor, Tara/K-6581-2019				Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Curiel AR, 2012, REEXAMINATION UNPUB; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Frederick RI, 2000, J CLIN EXP NEUROPSYC, V22, P720, DOI 10.1076/jcen.22.6.720.951; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MANN VA, 1990, NEUROPSYCHOLOGIA, V28, P1063, DOI 10.1016/0028-3932(90)90141-A; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682	24	13	13	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					516	527		10.1080/13854046.2012.744853			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100014	23216255				2022-02-06	
J	Boone, DR; Sell, SL; Hellmich, HL				Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen Lee			Laser Capture Microdissection of Enriched Populations of Neurons or Single Neurons for Gene Expression Analysis After Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 74; Neurobiology; Medicine; Biomedical Engineering; Anatomy; Physiology; Cellular Biology; Molecular Biology; Genetics; Surgery; Anesthesiology; Micromanipulation; Microdissection; Laser Capture Microdissection; LCM; Investigative Techniques; traumatic brain injury; TBI; hippocampus; Fluoro-Jade; gene expression analysis; gene expression; neurons; animal model	FLUORO-JADE; RNA	Long-term cognitive disability after TBI is associated with injury-induced neurodegeneration in the hippocampus-a region in the medial temporal lobe that is critical for learning, memory and executive function.(1,2) Hence our studies focus on gene expression analysis of specific neuronal populations in distinct subregions of the hippocampus. The technique of laser capture microdissection (LCM), introduced in 1996 by Emmert-Buck, et al.,(3) has allowed for significant advances in gene expression analysis of single cells and enriched populations of cells from heterogeneous tissues such as the mammalian brain that contains thousands of functional cell types.(4) We use LCM and a well established rat model of traumatic brain injury (TBI) to investigate the molecular mechanisms that underlie the pathogenesis of TBI. Following fluid-percussion TBI, brains are removed at pre-determined times post-injury, immediately frozen on dry ice, and prepared for sectioning in a cryostat. The rat brains can be embedded in OCT and sectioned immediately, or stored several months at -80 degrees C before sectioning for laser capture microdissection. Additionally, we use LCM to study the effects of TBI on circadian rhythms. For this, we capture neurons from the suprachiasmatic nuclei that contain the master clock of the mammalian brain. Here, we demonstrate the use of LCM to obtain single identified neurons (injured and degenerating, Fluoro-Jade-positive, or uninjured, Fluoro-Jade-negative) and enriched populations of hippocampal neurons for subsequent gene expression analysis by real time PCR and/or whole-genome microarrays. These LCM-enabled studies have revealed that the selective vulnerability of anatomically distinct regions of the rat hippocampus are reflected in the different gene expression profiles of different populations of neurons obtained by LCM from these distinct regions. The results from our single-cell studies, where we compare the transcriptional profiles of dying and adjacent surviving hippocampal neurons, suggest the existence of a cell survival rheostat that regulates cell death and survival after TBI.	[Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen Lee] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu			Moody Foundation; Department of Anesthesiology;  [R01 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	This work is funded by R01 NS052532 (to HLH), the Moody Foundation, and the Department of Anesthesiology. We thank Laurie Bolding, Christine Courteau Butler and Christy Perry for their editorial assistance, and Christy Perry for layout and excellent production of all figures, tables and artwork.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Banks RE, 1999, ELECTROPHORESIS, V20, P689, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<689::AID-ELPS689>3.0.CO;2-J; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; ZENG YC, 1995, MECH AGEING DEV, V79, P169, DOI 10.1016/0047-6374(94)01559-5	21	13	13	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2013		74							e50308	10.3791/50308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V36QY	WOS:000209227100031	23603738	Green Submitted, Green Published, Bronze			2022-02-06	
J	Chen, X; Yin, J; Wu, XN; Li, R; Fang, JQ; Chen, R; Zhang, B; Zhang, WG				Chen, Xiao; Yin, Jun; Wu, Xiaoning; Li, Ran; Fang, Jingqin; Chen, Rong; Zhang, Bo; Zhang, Weiguo			Effects of magnetically labeled exogenous endothelial progenitor cells on cerebral blood perfusion and microvasculature alterations after traumatic brain injury in rat model	ACTA RADIOLOGICA			English	Article						Traumatic brain injury; endothelial progenitor cells; computed tomography perfusion imaging; microvascular density; superparamagnetic iron oxide	MARROW STROMAL CELLS; HEAD-INJURY; ANGIOGENESIS; GROWTH; NEUROGENESIS; INCREASES; MICE; CT	Background: Increasing evidence suggests that endothelial progenitor cells (EPCs), a subgroup of bone marrow hematopoietic stromal cells, play a critical role in neovascularization and tissue repair. Purpose: To explore the effect of exogenous EPCs on the cerebral blood perfusion and microvessels in the injured region in rat model with traumatic brain injury (TBI). Material and Methods: EPCs were collected from the spleens of healthy Sprague-Dawley rats. Fifty-four Sprague-Dawley rats were randomly divided into six groups. The controlled cortical impact TBI was performed. Spleen-derived exogenous EPCs labeled with super-paramagnetic iron oxide (SPIO) (SPIO-EPCs) were transplanted into the blood by tail vein of rats at 6 and 12 h after TBI, respectively. Magnetic resonance imaging (MRI) and computed tomography perfusion imaging were performed at various time points. Microvascular density was determined by immunohistochemistry. Results: In SPIO-EPCs group, patchlike hypointensities were detected in the injured region at 24 h after transplantation, and the range of hypointensities tended to expand gradually over time on MRI, which was confirmed by Prussian blue staining. Computed tomography perfusion imaging parameters were gradually developed from hyperperfusion to normal, while, microvascular density was gradually increased during 72 to 168 h after injury. The values of these indices in SPIO-EPCs group were significantly lower than those in SPIO-alone group at the same time point, but no significant differences were found in different time groups. Conclusion: The intravenously transplanted EPCs diminish the brain injury through restoring cerebral blood perfusion and increasing the cerebral microvasculature in the injured region in rat model with TBI.	[Chen, Xiao; Wu, Xiaoning; Li, Ran; Fang, Jingqin; Chen, Rong; Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Yin, Jun] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Med Engn, Chongqing, Peoples R China; [Zhang, Bo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 4, Chongqing, Peoples R China; [Zhang, Bo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China		Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China.	wguo.zhang@gmail.com			National Key Basic Research and Development Plan of ChinaNational Basic Research Program of China [2011CB964701]; Scientific Foundation of Third Military Medical University [2009XHG14]; Initiation Foundation for Returned Overseas Researchers by Ministry of Education [2010-1561]	This study was supported by the Grant of National Key Basic Research and Development Plan of China (2011CB964701), the Scientific Foundation of Third Military Medical University (2009XHG14), the Initiation Foundation for Returned Overseas Researchers by Ministry of Education (2010-1561).	Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; de Lussanet QG, 2005, RADIOLOGY, V235, P65, DOI 10.1148/radiol.2351040411; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Fang JQ, 2011, ACAD RADIOL, V18, P892, DOI 10.1016/j.acra.2011.02.017; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jain R, 2008, AM J NEURORADIOL, V29, P694, DOI 10.3174/ajnr.A0899; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wang SA, 2011, J NEURO-ONCOL, V105, P67, DOI 10.1007/s11060-011-0569-6; Wintermark M, 2008, J NEURORADIOLOGY, V35, P253, DOI 10.1016/j.neurad.2008.03.005; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	28	13	14	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	APR	2013	54	3					313	323		10.1258/ar.2012.120605			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	190EN	WOS:000322321900012	23528570				2022-02-06	
J	Williams, G; Schache, A; Morris, ME				Williams, Gavin; Schache, Anthony; Morris, Meg E.			Running abnormalities after traumatic brain injury	BRAIN INJURY			English	Article						Brain injuries; gait; rehabilitation; biomechanics; running	HIGH-LEVEL MOBILITY; GAIT ANALYSIS; POWER-GENERATION; CLUSTER-ANALYSIS; DECISION-MAKING; ASSESSMENT-TOOL; WALKING SPEED; HIP FLEXORS; STROKE; ANKLE	Primary objectives: The aim of this study was to identify the type and incidence of running abnormalities following TBI when compared to a group of healthy controls (HC) and report if these abnormalities were similar to those which are present during gait. Research design: A convenience sample of 44 people with TBI receiving therapy for mobility limitations and a sample of 15 healthy controls (HCs). Main outcomes and results: Spatio-temporal, kinematic and kinetic data at self-selected walking and running speeds were collected. People with TBI ran at significantly slower self-selected speeds than HCs. At matched running speeds, people with TBI used a higher cadence and shorter step length. The most commonly observed biomechanical abnormalities occurred at the knee during stance phase. Few trunk, pelvic or hip abnormalities were detected. Ankle power generation at push-off was significantly reduced, whereas hip extensor power generation at initial contact was significantly increased. Conclusion: Many people with TBI may actually be capable of running, despite the presence of significant biomechanical abnormalities during gait. A stable trunk may be an important requirement for people following TBI to achieve running.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Sch Hlth Sci, Melbourne, Vic, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic, Australia; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Morris, Meg/0000-0002-0114-4175; Williams, Gavin/0000-0003-2758-7473	Victorian Neurotrauma Initiative	This project was supported by a fellowship from the Victorian Neurotrauma Initiative.	Badke Mary Beth, 1993, Physiotherapy Canada, V45, P15; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Chua KSG, 2001, BRAIN INJURY, V15, P733, DOI 10.1080/02699050010009775; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kay RM, 2000, CLIN ORTHOP RELAT R, P217; Kerrigan DC, 1996, ARCH PHYS MED REHAB, V77, P645, DOI 10.1016/S0003-9993(96)90002-7; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Milot MH, 2007, J ELECTROMYOGR KINES, V17, P184, DOI 10.1016/j.jelekin.2006.01.001; Moriello G, 2009, J NEUROL PHYS THER, V33, P111, DOI 10.1097/NPT.0b013e3181a6ab6b; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Novacheck TF, 1995, AAOS INSTR COURS LEC, V44, P497; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Requiao LF, 2005, J ELECTROMYOGR KINES, V15, P393, DOI 10.1016/j.jelekin.2004.12.004; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Saunders SW, 2005, CLIN BIOMECH, V20, P784, DOI 10.1016/j.clinbiomech.2005.04.004; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; SEABY L, 1989, Physiotherapy Canada, V41, P264; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; WINTER DA, 1983, J BIOMECH, V16, P91, DOI 10.1016/0021-9290(83)90050-7	49	13	13	1	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2013	27	4					434	443		10.3109/02699052.2012.750754			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117LG	WOS:000316954300008	23473505				2022-02-06	
J	Audi, L; Fernandez-Cancio, M; Camats, N; Carrascosa, A				Audi, L.; Fernandez-Cancio, M.; Camats, N.; Carrascosa, A.			Growth hormone deficiency: an update	MINERVA ENDOCRINOLOGICA			English	Article						Growth hormone; Pituitary hormones; Phenotype	TRAUMATIC BRAIN-INJURY; ISOLATED GH DEFICIENCY; INSULIN TOLERANCE-TEST; BODY-MASS INDEX; IGF-I; ANTERIOR-PITUITARY; RECEPTOR GENE; DIFFERENT IMMUNOASSAYS; FUNCTIONAL-ANALYSIS; MOLECULAR ANALYSIS	Growth hormone (GH) deficiency (GHD) in humans manifests differently according to the individual developmental stage (early after birth, during childhood, at puberty or in adulthood), the cause or mechanism (genetic, acquired or idiopathic), deficiency intensity and whether it is the only pituitary-affected hormone or is combined with that of other pituitary hormones or forms part of a complex syndrome. Growing knowledge of the genetic basis of GH deficiency continues to provide us with useful information to further characterise mutation types and mechanisms for previously described and new candidate genes. Despite these advances, a high proportion of Gil deficiencies with no recognisable acquired basis continue to be labelled as idiopathic, although less frequently when they are congenital and/or familial. The clinical and biochemical diagnoses continue to be a conundrum despite efforts to harmonise biochemical assays for GH and IGF-1 analysis, probably because the diagnosis based on the so-called GH secretion stimulation tests will prove to be of limited usefulness for predicting therapy indications.	[Audi, L.; Camats, N.; Carrascosa, A.] Autonomous Univ Barcelona, CIBERER Ctr Biomed Res Rare Dis, Inst Salud Carlos III,Pediat Serv, Vall dHebron Hosp,Pediat Endocrinol Res Unit,VHIR, Barcelona, Spain		Audi, L (corresponding author), Autonomous Univ Barcelona, CIBERER Ctr Biomed Res Rare Dis, Inst Salud Carlos III,Pediat Serv, Vall dHebron Hosp,Pediat Endocrinol Res Unit,VHIR, Barcelona, Spain.	laura.audi@vhir.org		Camats Tarruella, Nuria/0000-0002-4863-8201; Fernandez Cancio, Monica/0000-0003-1872-3488			Acharya SV, 2011, INDIAN J PEDIATR, V78, P49, DOI 10.1007/s12098-010-0211-1; Ahmad T, 2011, GROWTH HORM IGF RES, V21, P37, DOI 10.1016/j.ghir.2010.12.003; Alatzoglou KS, 2012, INDIAN J PEDIATR, V79, P99, DOI 10.1007/s12098-011-0614-7; Alatzoglou KS, 2011, J CLIN ENDOCR METAB, V96, pE685, DOI 10.1210/jc.2010-1239; Alatzoglou KS, 2010, NAT REV ENDOCRINOL, V6, P562, DOI 10.1038/nrendo.2010.147; Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3191, DOI 10.1210/jc.2008-2783; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Audi L, 2001, MED CLIN-BARCELONA, V116, P6; Bechtold-Dalla Pozza S, 2012, HORM RES PAEDIAT, V77, P41, DOI 10.1159/000335929; Berberoglu M, 2008, J CLIN RES PEDIATR E, V1, P30, DOI [10.4008/jcrpe.v1i1.721318062, DOI 10.4008/JCRPE.V1I1.721318062]; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Berton A, 2012, EUR J ENDOCRINOL; Bidlingmaier M, 2010, GROWTH HORM IGF RES, V20, P19, DOI 10.1016/j.ghir.2009.09.005; Bidlingmaier M, 2009, HORM RES, V71, P30, DOI 10.1159/000178034; Binder G, 2011, GROWTH HORM IGF RES, V21, P314, DOI 10.1016/j.ghir.2011.07.009; Binder G, 2011, GROWTH HORM IGF RES, V21, P212, DOI 10.1016/j.ghir.2011.05.007; Binder Gerhard, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P535; Bogazzi F, 2011, EUR J ENDOCRINOL, V164, P685, DOI 10.1530/EJE-10-1068; Brabant G, 2009, EUR J ENDOCRINOL, V161, pS25, DOI 10.1530/EJE-09-0273; Buscher AK, 2012, EUR J ENDOCRINOL, V166, P923, DOI 10.1530/EJE-11-0923; Camats N, 2012, CLIN ENDOCRINOL, V77, P564, DOI 10.1111/j.1365-2265.2012.04410.x; Carlomagno Y, 2009, J ENDOCRINOL INVEST, V32, P653, DOI 10.1007/BF03345736; Carrascosa A, 2011, HORM RES PAEDIAT, V75, P106, DOI 10.1159/000318782; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Clemmons DR, 2007, ENDOCRIN METAB CLIN, V36, P109, DOI 10.1016/j.ecl.2006.11.008; Clemmons DR, 2011, CLIN CHEM, V57, P555, DOI 10.1373/clinchem.2010.150631; Cody JD, 2010, J PEDIATR ENDOCR MET, V23, P1159, DOI 10.1515/jpem.2010.181; Colao A, 2009, J CLIN ENDOCR METAB, V94, P4414, DOI 10.1210/jc.2009-1134; Corneli G, 2008, J ENDOCRINOL INVEST, V31, P689, DOI 10.1007/BF03346416; Cruz JB, 2010, ARQ BRAS ENDOCRINOL, V54, P482, DOI 10.1590/S0004-27302010000500009; Cuatrecasas G, 2010, J CLIN ENDOCR METAB, V95, P4331, DOI 10.1210/jc.2010-0061; Dateki S, 2008, J CLIN ENDOCR METAB, V93, P3697, DOI 10.1210/jc.2008-0720; Dateki S, 2010, J CLIN ENDOCR METAB, V95, P756, DOI 10.1210/jc.2009-1334; De Bellis A, 2012, J CLIN ENDOCR METAB, V97, P3684, DOI 10.1210/jc.2012-2269; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; de Graaff LCG, 2009, CLIN ENDOCRINOL, V70, P742, DOI 10.1111/j.1365-2265.2008.03414.x; Del Blanco DG, 2012, EUR J ENDOCRINOL, V167, P441, DOI 10.1530/EJE-12-0333; Del Blanco DG, 2011, EUR J ENDOCRINOL, V165, P537, DOI 10.1530/EJE-11-0478; Delvecchio M, 2009, J ENDOCRINOL INVEST, V32, P637, DOI [10.1007/BF03345733, 10.3275/6332]; Desai MP, 2012, INDIAN J PEDIATR, V79, P875, DOI 10.1007/s12098-011-0588-5; Di Somma C, 2011, MINERVA ENDOCRINOL, V36, P243; Di Somma C, 2008, J Endocrinol Invest, V31, P21; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Domene HM, 2011, BEST PRACT RES CL EN, V25, P101, DOI 10.1016/j.beem.2010.08.010; Domene Horacio M, 2010, Pediatr Endocrinol Rev, V7, P339; Duche L, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-29; Eskes SA, 2009, NETH J MED, V67, P127; Esteban C, 2007, CLIN ENDOCRINOL, V66, P258, DOI 10.1111/j.1365-2265.2006.02718.x; Federico G, 2010, HORM RES PAEDIAT, V74, P145, DOI 10.1159/000314895; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; Franca MM, 2011, J CLIN ENDOCR METAB, V96, pE1457, DOI 10.1210/jc.2011-0170; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Franca MM, 2012, CLIN ENDOCRINOL OXF; Galluzzi F, 2010, J PEDIATR ENDOCR MET, V23, P1273, DOI 10.1515/jpem.2010.201; Gasco V, 2008, EUR J ENDOCRINOL, V159, pS45, DOI 10.1530/EJE-08-0293; Gat-Yablonski G, 2011, AM J MED GENET A, V155A, P2242, DOI 10.1002/ajmg.a.34136; Giacomozzi C, 2012, J ENDOCRINOL INVEST, V35, P742, DOI 10.3275/8008; Glynn N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/972617; Godi M, 2009, J CLIN ENDOCR METAB, V94, P3939, DOI 10.1210/jc.2009-0833; Goldenberg N, 2007, ENDOCRIN METAB CLIN, V36, P37, DOI 10.1016/j.ecl.2006.11.003; Granada ML, 2008, CLIN ENDOCRINOL, V68, P942, DOI 10.1111/j.1365-2265.2007.03120.x; GRANADA ML, 1990, ACTA PAEDIATR SCAND, P63; Granada ML, 1990, ACTA PAEDIAT SC S370, V370, P71; Gucev Z, 2012, HORM RES PAEDIAT, V77, P1, DOI 10.1159/000334643; Gucev ZS, 2009, J GENET, V88, P239, DOI 10.1007/s12041-009-0033-y; Hamid R, 2009, J CLIN ENDOCR METAB, V94, P4728, DOI 10.1210/jc.2009-0746; Hazem A, 2011, EUR J ENDOCRINOL, V165, P841, DOI 10.1530/EJE-11-0476; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hess O, 2012, J PEDIATR ENDOCR MET, V25, P537, DOI 10.1515/jpem-2012-0044; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Inoue H, 2011, CLIN ENDOCRINOL, V74, P223, DOI 10.1111/j.1365-2265.2010.03911.x; Inoue H, 2011, J CLIN ENDOCR METAB, V96, pE373, DOI 10.1210/jc.2010-1570; Jagtap VS, 2012, PITUITARY, V15, P243, DOI 10.1007/s11102-011-0321-4; Janssen JAMJL, 2011, HORM RES PAEDIAT, V76, P106, DOI 10.1159/000329191; Kargi AY, 2012, CURR OPIN ENDOCRINOL, V19, P300, DOI 10.1097/MED.0b013e32835430da; Kayemba-Kay's S, 2011, ANN ENDOCRINOL-PARIS, V72, P218, DOI 10.1016/j.ando.2011.01.002; Kelberman D, 2009, CLIN ENDOCRINOL, V70, P96, DOI 10.1111/j.1365-2265.2008.03326.x; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Kelberman D, 2009, ENDOCR DEV, V14, P67, DOI 10.1159/000207478; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Kinoshita Y, 2012, ENDOCR J; Klose M, 2009, EUR J ENDOCRINOL, V161, pS75, DOI 10.1530/EJE-09-0328; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lee HS, 2011, NEUROENDOCRINOLOGY, V93, P259, DOI 10.1159/000326838; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Martari M, 2009, PROG MOL BIOL TRANSL, V88, P57, DOI 10.1016/S1877-1173(09)88003-4; Marui S, 2012, HORM RES PAEDIAT, V78, P165, DOI 10.1159/000342760; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Meazza C, 2012, HORM METAB RES; Mehta A, 2009, CLIN ENDOCRINOL, V71, P376, DOI 10.1111/j.1365-2265.2009.03572.x; Mohamadi A, 2009, J CLIN ENDOCR METAB, V94, P2565, DOI 10.1210/jc.2009-0512; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Muller A, 2011, CLIN CHEM LAB MED, V49, P1135, DOI 10.1515/CCLM.2011.201; Mukherjee A, 2009, EUR J ENDOCRINOL, V161, pS33, DOI 10.1530/EJE-09-0247; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; Mullis Primus E, 2010, J Clin Res Pediatr Endocrinol, V2, P52, DOI 10.4274/jcrpe.v2i2.52; Murray PG, 2009, CLIN ENDOCRINOL, V71, P215, DOI 10.1111/j.1365-2265.2009.03554.x; Nakagama Y, 2012, ACTA PAEDIATR, V101, pe259, DOI 10.1111/j.1651-2227.2012.02606.x; Nystrom HF, 2011, PITUITARY, V14, P208, DOI 10.1007/s11102-010-0278-8; Oliveira CRP, 2012, J CLIN ENDOCR METAB, V97, P1013, DOI 10.1210/jc.2011-2590; Padidela R, 2009, J CLIN ENDOCR METAB, V94, P2686, DOI 10.1210/jc.2008-2788; Pantel J, 2009, J CLIN ENDOCR METAB, V94, P4334, DOI 10.1210/jc.2009-1327; Pedicelli Stefania, 2009, J Clin Res Pediatr Endocrinol, V1, P105, DOI 10.4008/jcrpe.v1i3.53; Pellecchia MT, 2010, EUR J NEUROL, V17, P666, DOI 10.1111/j.1468-1331.2009.02896.x; Petkovic V, 2011, GROWTH HORM IGF RES, V21, P160, DOI 10.1016/j.ghir.2011.04.002; Petkovic V, 2010, J CLIN ENDOCR METAB, V95, P731, DOI 10.1210/jc.2009-1247; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaffle Roland, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P529; Rohrer TR, 2009, J ENDOCRINOL INVEST, V32, P294, DOI 10.1007/BF03345714; Ronchi CL, 2009, EUR J ENDOCRINOL, V161, P37, DOI 10.1530/EJE-09-0222; Sara M, 2011, RADIOTHER ONCOL, V99, P23, DOI 10.1016/j.radonc.2011.02.015; Saveanu A, 2012, PITUITARY; Secco A, 2009, J CLIN ENDOCR METAB, V94, P4195, DOI 10.1210/jc.2009-0602; Shohreh R, 2011, J CLIN ENDOCR METAB, V96, P2982, DOI 10.1210/jc.2011-1031; Siklar Zeynep, 2010, J Clin Res Pediatr Endocrinol, V2, P164, DOI 10.4274/jcrpe.v2i4.164; Spiliotis BE, 2009, HORM-INT J ENDOCRINO, V8, P117, DOI 10.14310/horm.2002.1228; Stanley TL, 2009, J CLIN ENDOCR METAB, V94, P4875, DOI 10.1210/jc.2009-1369; Tajima T, 2009, J CLIN ENDOCR METAB, V94, P314, DOI 10.1210/jc.2008-1219; Tanimoto K, 2011, ENDOCR J, V58, P193, DOI 10.1507/endocrj.K10E-405; Tanriverdi F, 2012, CLIN ENDOCRINOL OXF; Tenenbaum-Rakover Y, 2011, CLIN ENDOCRINOL, V75, P214, DOI 10.1111/j.1365-2265.2011.04028.x; Toogood A, 2012, ENDOCR PRACT, V18, P325, DOI 10.4158/EP11146.OR; Turton JP, 2012, CLIN ENDOCRINOL, V76, P387, DOI 10.1111/j.1365-2265.2011.04236.x; Tzanela M, 2010, EUR J ENDOCRINOL, V162, P29, DOI 10.1530/EJE-09-0390; van Vught AJAH, 2009, J PEDIATR ENDOCR MET, V22, P679; Varewijck AJ, 2011, J CLIN ENDOCR METAB, V96, P2248, DOI 10.1210/jc.2011-0051; Veldhuis JD, 2012, METHOD ENZYMOL, V514, P231, DOI 10.1016/B978-0-12-381272-8.00014-3; Verhelst J, 2011, EUR J ENDOCRINOL, V165, P881, DOI 10.1530/EJE-11-0599; Vivenza D, 2011, EUR J ENDOCRINOL, V164, P705, DOI 10.1530/EJE-11-0047; Wang Q, 2009, MOL CELL ENDOCRINOL, V313, P50, DOI 10.1016/j.mce.2009.08.021; Wit JM, 2011, BEST PRACT RES CL EN, V25, P1, DOI 10.1016/j.beem.2010.06.007; Wit Jan M, 2008, Pediatr Endocrinol Rev, V5 Suppl 3, P862; Yamada S, 2011, EUR J ENDOCRINOL, V165, P873, DOI 10.1530/EJE-11-0657; Yamamoto M, 2012, EXP CLIN ENDOCR DIAB, V120, P308, DOI 10.1055/s-0032-1309011; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; Yuen Kevin C J, 2011, ISRN Endocrinol, V2011, P608056, DOI 10.5402/2011/608056; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zueger T, 2011, EUR J ENDOCRINOL, V165, P723, DOI 10.1530/EJE-11-0539	141	13	15	0	10	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0391-1977	1827-1634		MINERVA ENDOCRINOL	Minerva Endocrinol.	MAR	2013	38	1					1	16					16	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	127NF	WOS:000317705000001	23435439				2022-02-06	
J	Boycott, N; Yeoman, P; Vesey, P				Boycott, Naomi; Yeoman, Paddy; Vesey, Patrick			Factors Associated With Strain in Carers of People With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						carer; Caregiver Strain Index (CSI); Glasgow Outcome Scale (GOS); head injury; neurobehavioral functioning; Neurobehavioral Functioning Inventory (NFI); strain; traumatic brain injury (TBI)	GLASGOW OUTCOME SCALE; BLUNT HEAD-INJURY; FAMILY-MEMBERS; RELATIVES; INTERVENTION; DISTRESS; STRESS; SATISFACTION; VALIDATION; CAREGIVERS	Objective: To explore factors associated with strain in carers of patients with traumatic brain injury. Design: Cross-sectional cohort study. Participants: Forty-eight carers of patients with traumatic brain injury admitted to a neurosurgical unit over a 9-year period were assessed an average of 9.3 years after injury. Measures: Caregiver Strain Index (CSI), Neurobehavioral Functioning Inventory (NFI), Glasgow Outcome Scale (GOS), Virginia Prediction Tree Score, and carer and patient demographics. Procedure: Carers were assessed via postal survey for levels of strain using the CSI and for their perception of the patients' disabilities using the NFI. Results: Elevated levels of strain were found in 42% of carers. Using logistic regression, outcome as rated by the patients' general practitioner on the GOS and all subscales of the NFI (except Somatic) explained 41% to 57% of the variance in strain and predicted group membership correctly in 72.9% of cases. No individual variable contributed significantly to the explained variance in the model. Conclusion: A number of factors appear to combine to result in feelings of strain, but the GOS could be used as a crude screening tool. Interventions for cognitive, behavioral, and emotional difficulties may be most useful for carers.	[Boycott, Naomi] Nottinghamshire Healthcare NHS Trust, CLAHRC, Nottingham, England; [Yeoman, Paddy; Vesey, Patrick] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England		Boycott, N (corresponding author), Univ Nottingham, CLAHRCNDL, Innovat Pk,Sir Colin Campbell Bldg,Triumph Rd, Nottingham NG7 2TU, England.	naomi.boycott@nottshc.nhs.uk			University of Nottingham	The authors thank the research tutors and supervisors at the University of Nottingham for the advice and support they provided. The project was funded as part of doctoral thesis in clinical psychology at the University of Nottingham.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Blake H, 2000, CLIN REHABIL, V14, P307, DOI 10.1191/026921500667530134; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1986, J HEAD TRAUMA REHAB, V2, P1; Bugge C, 1999, STROKE, V30, P1517, DOI 10.1161/01.STR.30.8.1517; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Derogatis L.R., 1975, BRIEF SYMPTOM INVENT; Field A., 2017, DISCOVERING STAT USI, V5th; Folkman S., 1984, STRESS; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; KAY T, 1991, HEAD INJURY FAMILY M, P121; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KREUTZER JS, 1994, BRAIN INJURY, V1, P102; Leathem J, 1996, BRAIN INJURY, V10, P27; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SULLIVAN MT, 2004, DERMATOLOGY NURSING, V16, P385; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910	39	13	13	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					106	115		10.1097/HTR.0b013e31823fe07e			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300004	22495101				2022-02-06	
J	Casoli, T; Balietti, M; Giorgetti, B; Solazzi, M; Scarpino, O; Fattoretti, P				Casoli, Tiziana; Balietti, Marta; Giorgetti, Belinda; Solazzi, Moreno; Scarpino, Osvaldo; Fattoretti, Patrizia			Platelets in Alzheimer's Disease-Associated Cellular Senescence and Inflammation	CURRENT PHARMACEUTICAL DESIGN			English	Article						Alzheimer's disease; platelets; inflammation; senescence; amyloid; therapeutic targets; aging	BETA-AMYLOID PEPTIDE; LYMPHOCYTE SUBSET PATTERNS; TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; A-BETA; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; TELOMERES SHORTEN; T-LYMPHOCYTES; FREE-RADICALS	Alzheimer's disease (AD) is a complex degenerative disorder of the brain, associated with a progressive cognitive decline. Age is the main risk factor with almost half of the population above 90 years affected by this pathology. AD and brain aging share common molecular changes, so it has been hypothesized that AD could be a form of accelerated brain aging. In this context, senescence-associated mechanisms could be a valuable target of investigation both to analyze the causes of this disease and to define therapeutic strategies. Senescent phenotypes of glia and neurons, as well as of peripheral cells, have been described in AD. Much evidence indicate that vascular impairment is a fundamental contributor to AD pathology and platelets are generally considered a key element because they represent the link between amyloid-beta (A beta) deposition, peripheral inflammation and endothelial senescence. Both activated and senescent platelets are a source of A beta, in addition activated platelets secrete many proinflammatory mediators that could contribute to increased peripheral inflammation and endothelial senescence. Treatments aimed to target peripheral endothelial senescence include antioxidants and some substances, such as aspirin, that modulate platelet aggregation and inflammatory response. Heparin has been proposed as a treatment for senile dementia and exhibits anti-inflammatory action as well as inhibitory effects on A beta assembly. Identifying peripheral targets for AD treatments could also result advantageous as it would be possible to monitor directly their efficacy. Nevertheless more research is needed to clarify all the different aspects and interactions of blood cells, vascular cells and their secretory products.	[Casoli, Tiziana; Balietti, Marta; Giorgetti, Belinda; Solazzi, Moreno; Fattoretti, Patrizia] INRCA Ancona, Neurobiol Aging Ctr, I-60121 Ancona, Italy; [Balietti, Marta; Solazzi, Moreno; Fattoretti, Patrizia] INRCA Ancona, Cellular Bioenerget Lab, Sci Technol Area, I-60121 Ancona, Italy; [Scarpino, Osvaldo] INRCA Ancona, Geriatr Hosp, Neurol Unit, I-60127 Ancona, Italy		Casoli, T (corresponding author), INRCA Sci Technol Area, Neurobiol Aging Ctr, Via Birarelli 8, I-60121 Ancona, Italy.	t.casoli@inrca.it	Casoli, Tiziana/AAC-2787-2019; Balietti, Marta/AAD-9098-2020	Casoli, Tiziana/0000-0002-0512-2934; Fattoretti, Patrizia/0000-0003-1998-0080; Balietti, Marta/0000-0002-3123-7903	Italian Ministry of HealthMinistry of Health, Italy [RF-INR-2006-346774]	The present study was supported by Italian Ministry of Health, grant RF-INR-2006-346774.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; ADIBZADEH M, 1995, MECH AGEING DEV, V83, P171, DOI 10.1016/0047-6374(95)01625-A; Afanas'ev I, 2009, FRONT BIOSCI-LANDMRK, V14, P3899, DOI 10.2735/3499; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Allain H, 2003, FUND CLIN PHARMACOL, V17, P419, DOI 10.1046/j.1472-8206.2003.00153.x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; BERRY IJ, 1994, MOL CARCINOGEN, V9, P134, DOI 10.1002/mc.2940090305; BERTONIFREDDARI C, 1990, BRAIN RES, V517, P69, DOI 10.1016/0006-8993(90)91009-6; BERTONIFREDDARI C, 1993, BRAIN RES, V628, P193, DOI 10.1016/0006-8993(93)90955-M; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blasko I, 1999, FASEB J, V13, P63, DOI 10.1096/fasebj.13.1.63; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Borenstein, 2004, NEUROEPIDEMIOLOGY PR; Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Casadesus G, 2004, CNS NEUROL DISORD-DR, V3, P281, DOI 10.2174/1568007043337265; Casoli T, 2008, MECH AGEING DEV, V129, P154, DOI 10.1016/j.mad.2007.11.004; Casoli T, 2010, BIOGERONTOLOGY, V11, P627, DOI 10.1007/s10522-010-9281-8; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; de Magalhaes JP, 2004, EXP GERONTOL, V39, P1379, DOI 10.1016/j.exger.2004.06.004; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; EFFROS RB, 1994, J GERONTOL, V49, pB65, DOI 10.1093/geronj/49.2.B65; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Esmon CT, 2002, J EXP MED, V196, P561, DOI 10.1084/jem.20021088; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fernandez M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-87; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894; Flanary BE, 2004, GLIA, V45, P75, DOI 10.1002/glia.10301; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Galluzzi L, 2008, CURR MOL MED, V8, P78; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; Giulian D, 1996, J NEUROSCI, V16, P6021; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7; Grodstein F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001590; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046/j.1440-1681.2000.03200.x; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hartley PS, 2007, CLIN LAB, V53, P157; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Helmbold H, 2006, ONCOGENE, V25, P5257, DOI 10.1038/sj.onc.1209613; Herholz K, 2003, ANN NUCL MED, V17, P79, DOI 10.1007/BF02988444; Hochstrasser T, 2012, EXP GERONTOL, V47, P160, DOI 10.1016/j.exger.2011.11.012; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huguenin S, 2004, PROSTATE, V61, P132, DOI 10.1002/pros.20081; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075; Kokjohn TA, 2011, BBA-MOL BASIS DIS, V1812, P1508, DOI 10.1016/j.bbadis.2011.07.004; KOROTZER AR, 1993, BRAIN RES, V624, P121, DOI 10.1016/0006-8993(93)90068-X; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; LANDFIELD PW, 1981, NEUROBIOL AGING, V2, P265, DOI 10.1016/0197-4580(81)90034-8; Larbi A, 2009, J ALZHEIMERS DIS, V17, P91, DOI 10.3233/JAD-2009-1015; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li QX, 1998, LAB INVEST, V78, P461; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Lo D, 2011, EXPERT REV NEUROTHER, V11, P1359, DOI [10.1586/ERN.11.132, 10.1586/ern.11.132]; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Ma Q, 2007, CURR PHARM DESIGN, V13, P1607, DOI 10.2174/138161207780765918; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Matsushima H, 1995, ALZ DIS ASSOC DIS, V9, P213; McDonald DR, 1997, J NEUROSCI, V17, P2284; McGinn MJ, 2012, J NEUROSCI RES, V90, P1159, DOI 10.1002/jnr.23012; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2004, CURR VASC PHARMACOL, V2, P141, DOI 10.2174/1570161043476393; Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Padovani A, 2001, MECH AGEING DEV, V122, P1997, DOI 10.1016/S0047-6374(01)00315-3; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086; Passos JF, 2006, FREE RADICAL RES, V40, P1277, DOI 10.1080/10715760600917151; Pera MF, 2000, J CELL SCI, V113, P5; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; PERLMUTTER LS, 1994, MOL NEUROBIOL, V9, P33, DOI 10.1007/BF02816103; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PILETZ JE, 1991, NEUROBIOL AGING, V12, P401, DOI 10.1016/0197-4580(91)90064-Q; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Poon HF, 2004, CLIN GERIATR MED, V20, P329, DOI 10.1016/j.cger.2004.02.005; Porchet R, 2003, PROTEOMICS, V3, P1476, DOI 10.1002/pmic.200300456; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Rand ML, 2004, J THROMB HAEMOST, V2, P651, DOI 10.1111/j.1538-7836.2004.00670.x; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sevush S, 1998, ARCH NEUROL-CHICAGO, V55, P530, DOI 10.1001/archneur.55.4.530; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Song DK, 2001, J NEUROCHEM, V76, P1326, DOI 10.1046/j.1471-4159.2001.00121.x; Sortino MA, 2004, NEUROPHARMACOLOGY, V47, P1198, DOI 10.1016/j.neuropharm.2004.08.011; Speciale L, 2007, NEUROBIOL AGING, V28, P1163, DOI 10.1016/j.neurobiolaging.2006.05.020; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Streit WJ, 2004, J NEUROSCI RES, V77, P1, DOI 10.1002/jnr.20093; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Streit WJ, 2009, J NEUROIMMUNE PHARM, V4, P371, DOI 10.1007/s11481-009-9163-5; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; STURROCK RR, 1987, J HIRNFORSCH, V28, P505; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X; Tang K, 2006, J NEUROL SCI, V240, P53, DOI 10.1016/j.jns.2005.09.002; Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Ueberham U, 2005, CNS NEUROL DISORD-DR, V4, P293, DOI 10.2174/1568007054038175; van Heemst D, 2007, EUR J CANCER, V43, P2144, DOI 10.1016/j.ejca.2007.07.011; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; VANNOSTRAND WE, 1991, ANN NY ACAD SCI, V640, P140; Vaziri H, 1999, ONCOGENE, V18, P7676, DOI 10.1038/sj.onc.1203016; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Webber KM, 2006, CURR PHARM DESIGN, V12, P691, DOI 10.2174/138161206775474305; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1; WISNIEWSKI HM, 1994, ACTA NEUROPATHOL, V87, P233; Wisniewski HM, 2000, ANN NY ACAD SCI, V903, P6, DOI 10.1111/j.1749-6632.2000.tb06344.x; WOJCICKI J, 1991, ATHEROSCLEROSIS, V87, P9, DOI 10.1016/0021-9150(91)90227-T; Wolozin B, 2006, NEUROL RES, V28, P630, DOI 10.1179/016164106X130515; Woo DH, 2004, LIFE SCI, V75, P2439, DOI 10.1016/j.lfs.2004.04.042; Xue SR, 2009, CHINESE MED J-PEKING, V122, P1469, DOI 10.3760/cma.j.issn.0366-6999.2009.12.022; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yew DT, 1999, EXP GERONTOL, V34, P117, DOI 10.1016/S0531-5565(98)00017-5; Yi TN, 2009, CHINESE MED J-PEKING, V122, P3055, DOI 10.3760/cma.j.issn.0366-6999.2009.24.027; Young NT, 2002, TRENDS IMMUNOL, V23, P71, DOI 10.1016/S1471-4906(01)02113-5; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang ZH, 2004, WORLD J GASTROENTERO, V10, P2954; Zhu XW, 2000, NEUROBIOL AGING, V21, P807, DOI 10.1016/S0197-4580(00)00217-7	167	13	15	0	19	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design	MAR	2013	19	9					1727	1738					12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	110OF	WOS:000316453200020	23061730				2022-02-06	
J	Cho, HK; Jang, SH; Lee, E; Kim, SY; Kim, S; Kwon, YH; Son, SM				Cho, H. K.; Jang, S. H.; Lee, E.; Kim, S. Y.; Kim, S.; Kwon, Y. H.; Son, S. M.			Diffusion Tensor Imaging-Demonstrated Differences between Hemiplegic and Diplegic Cerebral Palsy with Symmetric Periventricular Leukomalacia	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							GROSS MOTOR FUNCTION; TRAUMATIC BRAIN-INJURY; PRETERM INFANTS; FIBER TRACTOGRAPHY; CHILDREN; LESIONS; MRI; ABNORMALITIES; RELIABILITY; ULTRASOUND	BACKGROUND AND PURPOSE: Patients with cerebral palsy have variable clinical presentations such as hemiplegic, diplegic, or quadriplegic patterns though they have PVL on conventional MR images. The authors investigated whether DTT can differentiate between hemiplegic and diplegic CP in patients presenting with symmetric PVL on conventional MR images. MATERIALS AND METHODS: One hundred thirteen consecutive pediatric patients with definite hemiplegic (59 patients; 30 boys, 29 girls; mean age, 34.19 months; range, 24-52 months) or diplegic (54 patients; 27 boys, 27 girls; mean age, 31.07 months; range, 24-48 months) symptoms and bilateral symmetric PVL on conventional brain MR imaging were recruited. The states of CSTs were examined by using DTT, and the asymmetries of right and left CSTs in the hemiplegic and diplegic groups were compared by using asymmetric anisotropy indexes and asymmetric mean diffusivity indexes. RESULTS: All patients in the hemiplegic group with asymmetric results exhibited disrupted integrities of more affected CSTs and sparing of less affected CSTs. However, diplegic patients revealed symmetric disrupted findings of the right and left CSTs at the upper periventricular level. Asymmetric anisotropy index and asymmetric mean diffusivity index values were significantly higher in the hemiplegic group than in the diplegic group (P < .05), and these results of DTT significantly corresponded with their typical clinical manifestation. CONCLUSIONS: DTT may be very useful for the detailed estimation of the CST state in patients with bilateral symmetric PVL.	[Cho, H. K.; Jang, S. H.; Son, S. M.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Lee, E.; Kim, S.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Pediat, Taegu 705717, South Korea; [Kwon, Y. H.] Yeungnam Univ, Coll Med, Coll Sci & Technol, Dept Phys Therapy, Taegu 705717, South Korea; [Kim, S. Y.] Eulji Univ, Coll Med, Dept Pediat, Taejon, South Korea		Son, SM (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	sumin430@hanmail.net		Kim, Seung Yeon/0000-0002-7004-4821	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2011-0003426]	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0003426).	Argyropoulou MI, 2010, PEDIATR RADIOL, V40, P811, DOI 10.1007/s00247-010-1585-y; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Benedict RE, 2011, PAEDIATR PERINAT EP, V25, P88, DOI 10.1111/j.1365-3016.2010.01164.x; Chang MC, 2012, NEUROSCI LETT, V512, P53, DOI 10.1016/j.neulet.2012.01.065; Fan GG, 2006, CLIN RADIOL, V61, P358, DOI 10.1016/j.crad.2006.01.001; Faria AV, 2010, DEV MED CHILD NEUROL, V52, P887, DOI 10.1111/j.1469-8749.2010.03693.x; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Jang SH, 2008, ANN NEUROL, V64, P460, DOI 10.1002/ana.21444; Jinnou H, 2009, PEDIATR INT, V51, P780, DOI 10.1111/j.1442-200X.2009.02857.x; Kakita H, 2009, BRAIN DEV-JPN, V31, P641, DOI 10.1016/j.braindev.2008.10.008; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nagae LM, 2007, AM J NEURORADIOL, V28, P1213, DOI 10.3174/ajnr.A0534; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nanba Y, 2007, PEDIATRICS, V120, pE10, DOI 10.1542/peds.2006-1844; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Rha DW, 2012, NEURORADIOLOGY, V54, P615, DOI 10.1007/s00234-011-0996-2; Roelants-van Rijn AM, 2001, NEUROPEDIATRICS, V32, P80, DOI 10.1055/s-2001-13875; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Son SM, 2009, NEUROSCI LETT, V451, P94, DOI 10.1016/j.neulet.2008.12.033; STEWART AL, 1987, DEV MED CHILD NEUROL, V29, P3; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tzarouchi LC, 2009, PEDIATR RADIOL, V39, P1327, DOI 10.1007/s00247-009-1389-0; van Haastert IC, 2008, DEV MED CHILD NEUROL, V50, P684, DOI 10.1111/j.1469-8749.2008.03061.x; Wahl M, 2010, PEDIATR RADIOL, V40, P59, DOI 10.1007/s00247-009-1448-6; Wilson-Costello D, 1998, PEDIATRICS, V102, P315, DOI 10.1542/peds.102.2.315	33	13	16	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAR	2013	34	3					650	654		10.3174/ajnr.A3272			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	291RN	WOS:000329846900033	22976239	Green Published, hybrid			2022-02-06	
J	Lapitskaya, N; Moerk, SK; Gosseries, O; Nielsen, JF; de Noordhout, AM				Lapitskaya, Natallia; Moerk, Sofie Kirial; Gosseries, Olivia; Nielsen, Joergen Feldbaek; de Noordhout, Alain Maertens			Corticospinal excitability in patients with anoxic, traumatic, and non-traumatic diffuse brain injury	BRAIN STIMULATION			English	Article						Brain injury; Motor evoked potential; Transcranial magnetic stimulation; Short latency afferent inhibition	TRANSCRANIAL MAGNETIC STIMULATION; LATENCY AFFERENT INHIBITION; MOTOR EVOKED-POTENTIALS; INTRACORTICAL INHIBITION; UNAFFECTED HEMISPHERE; CHRONIC STROKE; HEAD-INJURY; CORTICAL EXCITABILITY; CORTEX DISINHIBITION; VISUAL-CORTEX	Background: Transcranial magnetic stimulation (TMS) have been frequently used to explore changes in motor cortex excitability in stroke and traumatic brain injury, while the extent of motor cortex reorganization in patients with diffuse non-traumatic brain injury remains largely unknown. Objective/Hypothesis: It was hypothesized that the motor cortex excitability would be decreased and would correlate to the severity of brain injury and level of functioning in patients with anoxic, traumatic, and non-traumatic diffuse brain injury. Methods: TMS was applied to primary motor cortices of 19 patients with brain injury (5 traumatic and 14 non-traumatic causes; on average four months after insult), and 9 healthy controls. The test parameters included resting motor threshold (RMT), short intracortical inhibition (SICI), intracortical facilitation (ICF), and short latency afferent inhibition (SAD. Excitability parameters were correlated to the severity of brain injury measured with Glasgow Coma Scale and the level of functioning assessed using the Ranchos Los Amigos Levels of Cognitive Functioning Assessment Scale and Functional Independence Measure. Results: The patient group revealed a significantly decreased SICI and SAI compared to healthy controls with the amount of SICI correlated significantly to the severity of brain injury. Other electrophysiological parameters did not differ between the groups and did not exhibit any significant relationship with clinical functional scores. Conclusions: The present study demonstrated the impairment of the cortical inhibitory circuits in patients with brain injury of traumatic and non-traumatic aetiology. Moreover, the significant correlation was found between the amount of SICI and the severity of brain injury. (C) 2013 Elsevier Inc. All rights reserved.	[Lapitskaya, Natallia; Moerk, Sofie Kirial; Nielsen, Joergen Feldbaek] Hammel Neurorehabil & Res Ctr, Res Dept, DK-8450 Hammel, Denmark; [Gosseries, Olivia] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, B-4000 Liege, Belgium; [de Noordhout, Alain Maertens] Univ Liege, Dept Neurol, Ctr Hosp Reg Citadelle, B-4000 Liege, Belgium		Lapitskaya, N (corresponding author), Hammel Neurorehabil & Res Ctr, Res Dept, Voldbyvej 15, DK-8450 Hammel, Denmark.	natlap@rm.dk	Gosseries, Olivia/AAB-6469-2020; Nielsen, Jorgen Feldbak/AAR-6384-2021	Gosseries, Olivia/0000-0001-9011-7496; Nielsen, Jorgen Feldbak/0000-0001-5339-171X	European Neurological Society; Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS	NL is supported by the European Neurological Society Fellowship and Danish Medical Research Council. OG is supported by the Belgian National Funds for Scientific Research (FNRS).	Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Butefisch CM, 2003, BRAIN, V126, P470, DOI 10.1093/brain/awg044; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Celnik P, 2007, ARCH PHYS MED REHAB, V88, P1369, DOI 10.1016/j.apmr.2007.08.001; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; DENOORDHOUT AM, 1992, J PHYSIOL-LONDON, V447, P535, DOI 10.1113/jphysiol.1992.sp019016; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Di Lazzaro V, 2006, NEUROLOGY, V66, P1111, DOI 10.1212/01.wnl.0000204183.26231.23; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P2494, DOI 10.1016/j.clinph.2008.08.010; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Di Lazzaro V, 1999, CLIN NEUROPHYSIOL, V110, P1297, DOI 10.1016/S1388-2457(99)00060-7; Di Lazzaro V, 2010, CEREB CORTEX, V20, P1523, DOI 10.1093/cercor/bhp216; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fujiki M, 2006, NEUROSCI LETT, V405, P226, DOI 10.1016/j.neulet.2006.07.005; Hagen C, 1987, PROFESSIONAL STAFF A; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; HOMBERG V, 1991, ELECTROEN CLIN NEURO, V81, P377, DOI 10.1016/0168-5597(91)90027-U; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lapitskaya N, 2009, PROG BRAIN RES, V177, P191, DOI 10.1016/S0079-6123(09)17713-0; Liepert J, 2001, NEUROSCI LETT, V300, P149, DOI 10.1016/S0304-3940(01)01572-5; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P671, DOI 10.1016/S1388-2457(99)00312-0; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Manganelli F, 2008, CLIN NEUROPHYSIOL, V119, P351, DOI 10.1016/j.clinph.2007.10.011; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; METHERATE R, 1995, EXP BRAIN RES, V107, P59; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Nardone R, 2008, J NEURAL TRANSM, V115, P1557, DOI 10.1007/s00702-008-0129-1; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Oliviero A, 2005, CLIN NEUROPHYSIOL, V116, P2592, DOI 10.1016/j.clinph.2005.07.015; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Puksa L, 2003, CLIN NEUROPHYSIOL, V114, P1079, DOI 10.1016/S1388-2457(03)00028-2; REID AE, 2002, HDB TRANSCRANIAL MAG, P97; Roricht S, 1998, J NEUROL, V245, P280, DOI 10.1007/s004150050219; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Sakuma K, 2007, CLIN NEUROPHYSIOL, V118, P1460, DOI 10.1016/j.clinph.2007.03.018; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Talelli P, 2006, CLIN NEUROPHYSIOL, V117, P1641, DOI 10.1016/j.clinph.2006.01.016; Taverni JP, 1998, BRAIN INJURY, V12, P77; TEASDALE G, 1974, LANCET, V2, P81; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379	66	13	15	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	MAR	2013	6	2					130	137		10.1016/j.brs.2012.03.010			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	115VM	WOS:000316840000006	22542389	Green Published			2022-02-06	
J	Poyry, T; Luoto, TM; Kataja, A; Brander, A; Tenovuo, O; Iverson, GL; Ohman, J				Poyry, Tiina; Luoto, Teemu M.; Kataja, Anneli; Brander, Antti; Tenovuo, Olli; Iverson, Grant L.; Ohman, Juha			Acute Assessment of Brain Injuries in Ground-Level Falls	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computed tomograhpy; risk factors; traumatic brain injuries	MINOR HEAD-INJURY; OLDER-ADULTS; MILD; MANAGEMENT; MORTALITY; MECHANISM; PEOPLE; TRAUMA; COSTS	Objective: The purpose of this study was to characterize traumatic brain injuries (TBI) sustained in ground-level falls (GLFs). The focus was on factors associated with acute computed tomographic (CT) findings. Methods: The sample included 575 subjects examined and treated at the Tampere University Hospital emergency department (ED). Retrospective data collection consisted of subject-and injury-related data and clinical information from the emergency department. All CT scans were analyzed and systematically coded. Results: Ground-level falls were the mechanism of injury in 48.3% (n = 278) of the subjects. In the GLF group, independent risk factors for acute traumatic CT findings were long-term alcohol abuse, older age, being found on the ground, and left temporoparietal and occipital location of direct head impact. There were no significant differences in the incidence of any intracranial traumatic lesion type between those with GLFs and other causes of TBI. None of the classic clinical TBI severity markers studied were associated with acute traumatic CT findings in patients with GLFs. Conclusions: Older age and long-term alcohol abuse increase the likelihood of acute intracranial CT abnormalities. The pattern of intracranial traumatic CT findings does not differ from other causes of TBI. Clinical signs and indices of TBI severity did not predict traumatic CT findings.	[Poyry, Tiina; Luoto, Teemu M.; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, FI-33521 Tampere, Finland; Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; [Tenovuo, Olli] Turku Univ, Cent Hosp, Turku, Finland; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Luoto, TM (corresponding author), Tampere Univ Hosp, POB 2000, FI-33521 Tampere, Finland.	teemu.luoto@pshp.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570			Ashley J, 1990, Health Trends, V22, P135; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chang CM, 2011, INT J GERIATR PSYCH, V26, P602, DOI 10.1002/gps.2569; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Harad FT, 1992, J TRAUMA, V32, P361; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018976; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STEIN SC, 1993, NEUROSURGERY, V32, P30; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Vivanti A, 2011, J NUTR HEALTH AGING, V15, P388, DOI 10.1007/s12603-010-0302-8; Whitfield PC, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1, DOI 10.1017/CBO9780511576515	31	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2013	28	2					89	97		10.1097/HTR.0b013e318250eadd			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	105HU	WOS:000316058300002	22613946				2022-02-06	
J	Puljula, J; Makinen, E; Cygnel, H; Kortelainen, ML; Hillbom, M				Puljula, J.; Makinen, E.; Cygnel, H.; Kortelainen, M-L; Hillbom, M.			Incidence of moderate-to-severe traumatic brain injuries after reduction in alcohol prices	ACTA NEUROLOGICA SCANDINAVICA			English	Article						alcohol; alcohol consumption; alcohol price; alcohol-related traumatic brain injury; moderate-to-severe traumatic brain injury; outcome	EMERGENCY-DEPARTMENT; TAX CUTS; VIOLENCE; MORTALITY; COUNTRIES; DRINKING; FINLAND; PATTERN	Objective Alcohol may be involved in 4050% of traumatic brain injuries (TBI). In Finland, the cutting of alcohol taxes by one third in 2004 resulted in a marked increase in per capita alcohol consumption. We investigated the consequences of increased alcohol consumption on the incidence of moderate-to-severe traumatic brain injury among a defined population. Material and methods We identified all residents of Northern Ostrobothia with acute moderate-to-severe TBI admitted to Oulu University Hospital in 1999 and in 2007 as well as those who died on the scene without being admitted to the hospital. Alcohol involvement was recorded by similar methods and equally often during both years. Incidence rates were calculated as number of subjects per 100,000 population. Logistic regression was performed to determine which factors predicted fatal TBI and associated with alcohol-related TBI. Results No significant increase from 1999 to 2007 occurred in the incidence of alcohol-related moderate-to-severe TBIs among the population of Northern Ostrobothnia. The total number of alcohol-related TBIs were 61/135 (45.2%) in 2007 and 52/126 (41.3%) 1999. Fall-related TBIs were more frequent in 2007 than in 1999. Alcohol and older age predicted fatal outcome. Alcohol was significantly (P<0.001) more often present in fatal TBIs (83/156, 53.2%) than in non-fatal TBIs (30/105, 28.6%). Male sex, fall, suicide, and assault significantly associated with alcohol-related TBI. Conclusions The reduction in alcohol prices and the concomitant increase in alcohol consumption did not increase the incidence of alcohol-related moderate-to-severe TBI.	[Puljula, J.; Makinen, E.; Cygnel, H.; Hillbom, M.] Univ Oulu, Dept Neurol, Oulu, Finland; [Puljula, J.; Makinen, E.; Cygnel, H.; Hillbom, M.] Oulu Univ Hosp, Oulu 90029, Oys, Finland; [Kortelainen, M-L] Univ Oulu, Dept Forens Med, Oulu, Finland		Puljula, J (corresponding author), Oulu Univ Hosp, Dept Neurol, Box 25, Oulu 90029, Oys, Finland.	jpuljula@paju.oulu.fi					BRUST JCM., 2004, NEUROLOGICAL ASPECTS, P317; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Elder RW, 2004, J STUD ALCOHOL, V65, P297, DOI 10.15288/jsa.2004.65.297; HELAKORPI S, 2007, KANSANTERVEYS, V14, P5; Herttua K, 2008, J EPIDEMIOL COMMUN H, V62, P995, DOI 10.1136/jech.2007.069575; Herttua K, 2010, FINNISH YB POPULAT S, VXLV; Herttua K, 2008, AM J EPIDEMIOL, V168, P1110, DOI 10.1093/aje/kwn216; Herttua K, 2007, ALCOHOL ALCOHOLISM, V42, P456, DOI 10.1093/alcalc/agl099; Hiltunen Laura, 2009, Duodecim, V125, P1802; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Koski A, 2007, ADDICTION, V102, P362, DOI 10.1111/j.1360-0443.2006.01715.x; Luke LC, 2002, EMERG MED J, V19, P542, DOI 10.1136/emj.19.6.542; MAKELA P, 2009, YHTEISKUNTAPOLITIIKK, V0074; Makela P, 2001, ADDICTION, V96, P1575; Makela P, 2008, ADDICTION, V103, P181, DOI 10.1111/j.1360-0443.2007.02049.x; Makela P, 2009, ADDICTION, V104, P554, DOI 10.1111/j.1360-0443.2009.02517.x; MOLLERMADSEN B, 1986, Z RECHTSMED, V97, P141; National Institute of Health and Welfare, SCH HLTH PROM STUD; National Supervisory Authority for Welfare And Health, REG DEL ALC BEV I HL; Norstrom T, 1998, ADDICTION, V93, P689, DOI 10.1046/j.1360-0443.1998.9356895.x; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PEPPIATT R, 1978, RESUSCITATION, V6, P37, DOI 10.1016/0300-9572(78)90034-5; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Raitasalo K, 2011, YHTEISKUNTAPOLITIIKK, V76, P17; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Sivarajasingam V, 2006, INJURY, V37, P388, DOI 10.1016/j.injury.2006.01.035; Skog OJ, 2001, ADDICTION, V96, pS49; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	31	13	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	MAR	2013	127	3					192	197		10.1111/j.1600-0404.2012.01697.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	092CJ	WOS:000315096100011	22712513				2022-02-06	
J	Wang, T; Zhang, L; Zhang, M; Bao, H; Liu, W; Wang, Y; Wang, L; Dai, D; Chang, P; Dong, W; Chen, X; Tao, L				Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.			[GLY14]-HUMANIN REDUCES HISTOPATHOLOGY AND IMPROVES FUNCTIONAL OUTCOME AFTER TRAUMATIC BRAIN INJURY IN MICE	NEUROSCIENCE			English	Article						traumatic brain injury; humanin; neuroprotection; apoptosis; autophagy	CONTROLLED CORTICAL IMPACT; INDUCED CELL-DEATH; MEMORY IMPAIRMENT; HUMANIN BINDS; AUTOPHAGY; APOPTOSIS; DEFICITS; NEUROPROTECTION; PERMEABILITY; CONTRIBUTES	Humanin (HN) has been identified as an endogenous peptide that inhibited AD-relevant neuronal cell death. HNG, a variant of HN in which the 14th amino acid serine was replaced with glycine, can reduce infarct volume and improve neurological deficits after ischemia/reperfusion injury. In this study, we aimed to examine the neuroprotective effect of HNG on traumatic brain injury (TBI) in mice and explored whether the protective effect was associated with regulating apoptosis and autophagy. Compared to vehicle-treated groups, mice administered HNG intracerebroventricularly (i.c.v.) prior to TBI had decreased cells with plasmalemma permeability in the injured cortex and hippocampus (48 h, P < 0.01), reduced brain lesion volume (days 14 and 28, P < 0.05), improved motor performance (days 1-4, P < 0.05) and ameliorated performance in the Morris water maze test (days 11-13, P < 0.05) post TBI. Reduced lesion volume (day 14, P < 0.05) was also observed even when HNG was administered intraperitoneally (i.p.) at 1 h and 2 h post TBI, and minor amelioration in motor and Morris water maze test deficits was also observed. Immunoblotting results showed that HNG pretreatment (i.c.v.) reversed TBI-induced cleavage of cysteinyl aspartate-specific protease-3 and poly ADPribose-polymerase and decline of Bcl-2, suppressed LC3II, Beclin-1 and vacuolar sorting protein 34 activation and maintained p62 levels in the injured cortex and hippocampus post TBI (compared with vehicle). In conclusion, HNG treatment improved morphological and functional outcomes after TBI in mice and the protective effect of HNG against TBI may be associated with down-regulating apoptosis and autophagy. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.] Soochow Univ, Coll Med, Dept Forens Sci, Suzhou 215123, Peoples R China; [Wang, T.; Zhang, L.; Zhang, M.; Bao, H.; Liu, W.; Wang, Y.; Wang, L.; Dai, D.; Chang, P.; Dong, W.; Chen, X.; Tao, L.] Soochow Univ, Coll Med, Lab Brain Injury, Suzhou 215123, Peoples R China; [Zhang, M.] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Peoples R China		Chen, X (corresponding author), Soochow Univ, Coll Med, Dept Forens Sci, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	xiping.chen@163.com; luyang.tao@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911, 81271379]; Shanghai Forensic Key Lab Foundation [KF1005]; Program Granted for Scientific Innovation Research of College Graduate in Jangsu Province [CXLX12_0823]	This study was supported by grants 30872666, 81172911 and 81271379 from the National Natural Science Foundation of China (to TL), the Shanghai Forensic Key Lab Foundation (KF1005, to CX), and Program Granted for Scientific Innovation Research of College Graduate in Jangsu Province (CXLX12_0823, to WT). The authors have no conflict of interest to declare. Authorship credit was based on the contributions to experimental conception and design (WT, ZL, ZM, CP, CX, and TL), data acquisition (WT, ZL, DD, DW, BH and LW), data analysis and interpretation (WT, WY, WL, ZM, CX, and TL), and manuscript preparation (WT, CX, and TL). We thank Dr. Robert Wu who polished this paper.	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Choi JY, 2007, CHEM BIOL DRUG DES, V70, P383, DOI 10.1111/j.1747-0285.2007.00576.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gray NA, 2003, J CLIN PSYCHIAT, V64, P3; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hunsberger JG, 2009, BRAIN RES, V1293, P76, DOI 10.1016/j.brainres.2009.06.103; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Regan RF, 2001, J NEUROCHEM, V79, P545, DOI 10.1046/j.1471-4159.2001.00590.x; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012; Zhao ST, 2012, NEUROCHEM RES, V37, P153, DOI 10.1007/s11064-011-0593-0	47	13	15	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 12	2013	231						70	81		10.1016/j.neuroscience.2012.11.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	087EN	WOS:000314744200007	23178909				2022-02-06	
J	Li, YJ; Wang, ZH; Zhang, B; Zhe, X; Wang, MJ; Bai, J; Lin, T; Zhang, SJ				Li, Yajun; Wang, Zhenghai; Zhang, Bei; Zhe, Xiao; Wang, Mingjue; Bai, Jing; Lin, Tao; Zhang, Shijun			Cerebrospinal fluid ubiquitin C-terminal hydrolase as a novel marker of neuronal damage after epileptic seizure	EPILEPSY RESEARCH			English	Article						Ubiquitin; UCH-L1; Biomarker; Cerebrospinal fluid; Epilepsy	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SERUM-LEVELS; ENOLASE; BIOMARKER; PROTEIN; PROLACTIN	Background: Ubiquitin carboxy-terminal hydrolase (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. The effects of seizures on UCH-L1 levels in cerebrospinal fluid (CSF) has not been investigated in epileptic patients. The aim of the present study was to evaluate whether CSF UCH-L1 levels are a reliable marker of brain damage from epileptic seizures. Methods: Thirty-three patients with epilepsy (mean age 45 years) participated. Twenty-five patients had generalized seizures and eight had partial seizures. CSF was sampled by lumbar puncture. The control samples were obtained from 23 adult patients on whom lumbar puncture was performed to exclude neurological disease. CSF UCH-L1 levels were determined using an enzyme-linked immunosorbent assay (ELISA) kit. Results: Patients with epilepsy had significantly elevated CSF levels of UCH-L1 after seizures compared with controls (p < 0.001). CSF UCH-L1 levels were significantly higher in patients with generalized seizures than in patients with partial seizures and controls (p < 0.001). Moreover, patients with repetitive generalized tonic clonic (GTC) seizures had higher CSF UCH-L1 levels than those with a single GTC seizure (p < 0.001). CSF UCH-L1 levels in seizure patients showed strong correlation with severity of seizures (r = 0.56) and seizure duration (r = 0.77). Conversely, CSF UCH-L1 levels in seizure patients did not correlate with the age of patients, duration of epilepsy, age of first seizure, time from last seizure or number of seizures. Conclusions: Our results suggest that UCH-L1 may serve as a novel biomarker for neuronal damage after epileptic seizure. (c) 2012 Elsevier B.V. All rights reserved.	[Li, Yajun; Zhang, Bei; Zhe, Xiao; Wang, Mingjue; Bai, Jing; Lin, Tao; Zhang, Shijun] Xian Med Univ, Affiliated Hosp, Dept Neurol, Xian 710077, Shaanxi Provinc, Peoples R China; [Li, Yajun; Zhang, Bei; Wang, Mingjue; Bai, Jing] Xian Med Univ, Inst Neurosci, Xian 710077, Shaanxi Provinc, Peoples R China; [Wang, Zhenghai] Ningxia Med Univ, Gen Hosp, Dept Neurol, Ningxia, Peoples R China		Li, YJ (corresponding author), Xian Med Univ, Affiliated Hosp, Dept Neurol, 48 West Fenghao Rd, Xian 710077, Shaanxi Provinc, Peoples R China.	liyajun9@hotmail.com			Natural Science Foundation of Shaanxi ProvinceNatural Science Foundation of Shaanxi Province [2009JM4035]; Science and technology plan projects of Xi'an [YF07168]	This work was supported by grants from Natural Science Foundation of Shaanxi Province (No. 2009JM4035) and from Science and technology plan projects of Xi'an (No. YF07168). We thank Dr. Austin Cape for careful reading of the manuscript.	BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Buttner T, 1999, J NEUROL, V246, P459, DOI 10.1007/s004150050383; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Duncan JS, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.9_suppl_5.S15; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Lee SY, 2010, J NEUROL, V257, P1708, DOI 10.1007/s00415-010-5608-2; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu RSN, 2005, EPILEPSIA, V46, P1482, DOI 10.1111/j.1528-1167.2005.51603.x; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; ODonoghue MF, 1996, EPILEPSIA, V37, P563, DOI 10.1111/j.1528-1157.1996.tb00610.x; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rejdak K, 2012, EPILEPSIA, V53, P922, DOI 10.1111/j.1528-1167.2012.03459.x; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Tumani H, 1999, EPILEPSIA, V40, P713, DOI 10.1111/j.1528-1157.1999.tb00768.x; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Wang L, 2010, CLIN CHIM ACTA, V411, P581, DOI 10.1016/j.cca.2010.01.022; Willert C, 2004, ACTA NEUROL SCAND, V109, P318, DOI 10.1046/j.1600-0404.2003.00232.x; Young G Bryan, 2006, Adv Neurol, V97, P217	28	13	15	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	FEB	2013	103	2-3					205	210		10.1016/j.eplepsyres.2012.08.001			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	095ZD	WOS:000315372600009	22920679				2022-02-06	
J	Schaaf, KPW; Kreutzer, JS; Danish, SJ; Pickett, TC; Rybarczyk, BD; Nichols, MG				Schaaf, Kathryn P. Wilder; Kreutzer, Jeffrey S.; Danish, Steven J.; Pickett, Treven C.; Rybarczyk, Bruce D.; Nichols, Michelle G.			Evaluating the Needs of Military and Veterans' Families in a Polytrauma Setting	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; polytrauma; military family needs; family needs questionnaire	TRAUMATIC BRAIN-INJURY; CAREGIVER BURDEN; REHABILITATION; INTERVENTION; INDIVIDUALS; PREDICTORS; SEQUELAE; OUTCOMES; SUPPORT; TEAM	Objective: To examine the perceived importance of needs and the extent to which they are Met among a sample of family members in an inpatient polytrauma setting. Method: The Family Needs Questionnaire was administered to 44 family members of patients at the Polytrauma Rehabilitation Center at McGuire Veterans Affairs Medical Center over a 30-month period. Results: Families rated health information needs as most important and most frequently met. conversely, family members rated emotional support and instrumental support needs as least important and most frequently unmet. Conclusion: Preliminary data suggest that the similarity between family needs in military and civilian settings is noteworthy, and provide direction for development of empirically based family intervention models for polytrauma settings.	[Schaaf, Kathryn P. Wilder; Kreutzer, Jeffrey S.; Pickett, Treven C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Kreutzer, Jeffrey S.; Pickett, Treven C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA; [Danish, Steven J.; Rybarczyk, Bruce D.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; [Pickett, Treven C.; Nichols, Michelle G.] McGuire VA Med Ctr, Richmond, VA USA; [Nichols, Michelle G.] Def & Vet Brain Injury Ctr, Washington, DC USA		Schaaf, KPW (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.	wilderkp@vcu.edu	Nichols, Michelle/AAV-2740-2020	Nichols, Michelle/0000-0002-2078-9649			Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Department of Veterans Affairs Veterans Health Administration, 2005, VHA HDB; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Kim JW, 2007, SOC WORK HEALTH CARE, V45, P81, DOI 10.1300/J010v45n01_06; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Moules S, 1999, BRAIN INJURY, V13, P983; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	27	13	13	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2013	58	1					106	110		10.1037/a0031693			5	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	095VA	WOS:000315361900014	23438007				2022-02-06	
J	Wamstad, JB; Norwood, KW; Rogol, AD; Gurka, MJ; DeBoer, MD; Blackman, JA; Buck, ML; Kuperminc, MN; Darring, JG; Patrick, PD				Wamstad, Julia B.; Norwood, Kenneth W.; Rogol, Alan D.; Gurka, Matthew J.; DeBoer, Mark D.; Blackman, James A.; Buck, Marcia L.; Kuperminc, Michelle N.; Darring, Jodi G.; Patrick, Peter D.			Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: A preliminary study	BRAIN INJURY			English	Article						Brain injury; growth hormone deficiency; neuropsychology; quality-of-life; cognition	TRAUMATIC BRAIN-INJURY; PITUITARY-FUNCTION; COGNITIVE FUNCTION; GH DEFICIENCY; PLASMA-LEVELS; HYPOPITUITARISM; CHILDHOOD; DIAGNOSIS; INSULIN; REPLACEMENT	Objective: To compare neurocognition and quality-of-life (QoL) in a group of children and adolescents with or without growth hormone deficiency (GHD) following moderate-to-severe traumatic brain injury (TBI). Study designs: Thirty-two children and adolescents were recruited from the TBI clinic at a children's hospital. Growth hormone (GH) was measured by both spontaneous overnight testing and following arginine/glucagon stimulation administration. Twenty-nine subjects participated in extensive neuropsychological assessment. Results: GHD as measured on overnight testing was significantly associated with a variety of neurocognitive and QoL measures. Specifically, subjects with GHD had significantly (p<0.05) lower scores on measures of visual memory and health-related quality-of-life. These scores were not explained by severity of injury or IQ (p>0.05). GHD noted in response to provocative testing was not associated with any neurocognitive or QoL measures. Conclusions: GHD following TBI is common in children and adolescents. Deficits in neurocognition and QoL impact recovery after TBI. It is important to assess potential neurocognitive and QoL changes that may occur as a result of GHD. It is also important to consider the potential added benefit of overnight GH testing as compared to stimulation testing in predicting changes in neurocognition or QoL.	[Wamstad, Julia B.; Norwood, Kenneth W.; Rogol, Alan D.; DeBoer, Mark D.; Blackman, James A.; Buck, Marcia L.; Kuperminc, Michelle N.; Darring, Jodi G.; Patrick, Peter D.] Riley Childrens Hosp, Dept Pediat, Indianapolis, IN USA; [Gurka, Matthew J.] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA		Patrick, PD (corresponding author), Univ Virginia, 2270 Ivy Rd, Charlottesville, VA 22903 USA.	peterpatrick@embarqmail.com	Rogol, A.D./H-5871-2019	Rogol, A.D./0000-0002-7526-3142	Commonwealth Neurotrauma Initiative Trust Fund [07-302]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [M01RR000847, K08HD060739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD060739] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000847] Funding Source: NIH RePORTER	This study has been supported by the following grants: Peter D. Patrick, PhD: Grant #07-302 of the Commonwealth Neurotrauma Initiative Trust Fund, administered by VA Department of Rehabilitative Services and GCRC, NIH Grant #M01RR000847. Mark D. DeBoer, MD, MSc, MCR: NIH Grant #K08HD060739. There are no additional declarations of interest.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aleman A, 2000, NEUROPSYCHOBIOLOGY, V41, P73, DOI 10.1159/000026636; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Arwert LI, 2005, NEUROENDOCRINOLOGY, V82, P32, DOI 10.1159/000090123; Badaru A, 2004, TRENDS ENDOCRIN MET, V15, P252, DOI 10.1016/j.tem.2004.06.004; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Delis DC., 2001, DELIS KAPLAN EXECUTI; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Florkowski CM, 1998, PSYCHONEUROENDOCRINO, V23, P57, DOI 10.1016/S0306-4530(97)00093-0; Gandrud LM, 2004, GROWTH HORM IGF RES, V14, P185, DOI 10.1016/j.ghir.2003.11.003; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gioia GA IP, 2000, BEHAV RATING INVENTO; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Juul A, 2002, HORM RES, V58, P233, DOI 10.1159/000066265; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Patrick PD, 2006, BRIAN INJURY TREATME; Patrick PD, 2011, INT NEUROTRAUMA LETT, V2, P25; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Roemmich JN, 2005, METABOLISM, V54, P1374, DOI 10.1016/j.metabol.2005.04.029; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; Rose SR, 1996, J CLIN ENDOCR METAB, V81, P1063, DOI 10.1210/jc.81.3.1063; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Stojanovic M, 2008, END ABSTR, V16, pP396; Tanaka T, 2002, GROWTH HORM IGF RES, V12, P323, DOI 10.1016/S1096-6374(02)00045-X; Tanner J. M., 1978, GROWTH ADOLESCENCE; Tillmann V, 1997, J CLIN ENDOCR METAB, V82, P531, DOI 10.1210/jc.82.2.531; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Wechsler D., 2003, WISC 4 ADM SCORING M; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	50	13	14	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					200	208		10.3109/02699052.2012.672786			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500008	23384217	Green Accepted			2022-02-06	
J	Wang, MM; Xi, GH; Keep, RF				Wang, Michael M.; Xi, Guohua; Keep, Richard F.			Should the STAIR Criteria Be Modified for Preconditioning Studies?	TRANSLATIONAL STROKE RESEARCH			English	Article						Translational research; Preconditioning; Ischemic tolerance; STAIR; Remote ischemic preconditioning	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; INDUCED NEUROPROTECTION; EXPERIMENTAL STROKE; FOREBRAIN ISCHEMIA; RAPID TOLERANCE; PROTEIN-KINASE	Diverse preconditioning (PC) stimuli protect against a wide variety of neuronal insults in animal models, engendering enthusiasm that PC could be used to protect the brain clinically. Candidate clinical applications include cardiac and vascular surgery, after subarachnoid hemorrhage, and prior to conditions in which acute neuronal injury is anticipated. However, disappointments in clinical validation of multiple neuroprotectants suggest potential problems translating animal data into successful human therapies. Thus, despite strong promise of preclinical PC studies, caution should be maintained in translating these findings into clinical applications. The Stroke Therapy Academic Industry Roundtable working group and the National institute of Neurological Diseases and Stroke proposed working guidelines to improve the utility of preclinical studies that form the foundation of therapies for neurological disease. Here, we review the applicability of these consensus criteria to preconditioning studies and discuss additional considerations for PC studies. We propose that special attention should be paid to several areas, including (1) safety and dosage of PC treatments, (2) meticulously matching preclinical modeling to the human condition to be tested, and (3) timing of both the initiation and discontinuation of the PC stimulus relative to injury ictus.	[Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.; Keep, Richard F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Xi, Guohua; Keep, Richard F.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA		Wang, MM (corresponding author), Univ Michigan, Dept Neurol, 1137 Catherine St,Box 5622, Ann Arbor, MI 48109 USA.	micwang@med.umich.edu		Keep, Richard/0000-0001-6441-5334	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS054724, NS039866, NS34709]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS054724, R01NS034709, R01NS039866, R01NS062816] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants NS054724 (MMW), NS039866 (GX), and NS34709 (RFK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abe H, 2004, J CEREBR BLOOD F MET, V24, P84, DOI 10.1097/01.WCB.0000098607.42140.4B; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Bilgin-Freiert A, 2012, TRANSL STROKE RES, V3, P266, DOI 10.1007/s12975-012-0153-1; Blanck TJJ, 2000, ANESTHESIOLOGY, V93, P1285, DOI 10.1097/00000542-200011000-00023; Brambrink AM, 2006, ANESTHESIOLOGY, V104, P1208, DOI 10.1097/00000542-200606000-00016; Chan MTV, 2005, ACTA NEUROCHIR SUPPL, V95, P93; Chang CZ, 2010, ACTA NEUROCHIR, V152, P1399, DOI 10.1007/s00701-010-0652-3; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Clarkson AN, 2007, LIFE SCI, V80, P1157, DOI 10.1016/j.lfs.2006.12.022; Codaccioni JL, 2009, ANESTHESIOLOGY, V110, P1271, DOI 10.1097/ALN.0b013e3181a1fe68; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dowden J, 1999, STROKE, V30, P1240, DOI 10.1161/01.STR.30.6.1240; Fairbanks SL, 2010, BEST PRACT RES-CLIN, V24, P521, DOI 10.1016/j.bpa.2010.10.004; Faries PL, 2008, VASCULAR, V16, P1, DOI 10.2310/6670.2008.00012; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Feuerstein GZ, 2008, J CEREBR BLOOD F MET, V28, P217, DOI 10.1038/sj.jcbfm.9600516; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fisher M, 2012, TRANSL STROKE RES, V3, pS39, DOI 10.1007/s12975-012-0185-6; Geng XK, 2012, NEUROL RES, V34, P143, DOI 10.1179/1743132811Y.0000000073; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; Gigante PR, 2011, ACTA NEUROCHIR SUPPL, V111, P141, DOI 10.1007/978-3-7091-0693-8_23; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Gonzalez NR, 2011, STROKE, V42, pE553, DOI 10.1161/STROKEAHA.111.622464; Green AR, 2008, BRIT J PHARMACOL, V153, pS325, DOI 10.1038/sj.bjp.0707594; Hahn CD, 2011, STROKE, V42, P2960, DOI 10.1161/STROKEAHA.111.622340; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; He YD, 2012, TRANSL STROKE RES, V3, pS180, DOI 10.1007/s12975-012-0171-z; He Z, 2005, CURR NEUROVASC RES, V2, P365, DOI 10.2174/156720205774962674; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hu S, 2010, J NEUROSURG ANESTH, V22, P46, DOI 10.1097/ANA.0b013e3181c572bd; Hua Y, 2005, NEUROL RES, V27, P261, DOI 10.1179/016164105X25270; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Keep RF, 2010, TRANSL STROKE RES, V1, P4, DOI 10.1007/s12975-009-0007-7; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kim SH, 2008, CURR NEUROVASC RES, V5, P28; Kirino T, 1996, ADV NEUROL, V71, P505; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1377, DOI 10.1038/sj.jcbfm.9600444; Koch S, 2011, STROKE, V42, P1387, DOI 10.1161/STROKEAHA.110.605840; Koerner IP, 2007, ANESTHESIOLOGY, V106, P538, DOI 10.1097/00000542-200703000-00019; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Li LL, 2008, EUR J PHARMACOL, V586, P106, DOI 10.1016/j.ejphar.2008.02.073; Li Y, 2011, J CARDIOTHOR VASC AN, V25, P908, DOI 10.1053/j.jvca.2011.06.017; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Malhotra S, 2011, BRAIN RES, V1386, P184, DOI 10.1016/j.brainres.2011.02.032; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nasu I, 2006, ANESTH ANALG, V103, P413, DOI 10.1213/01.ane.0000223686.50202.38; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Payne RS, 2005, BRAIN RES, V1034, P147, DOI 10.1016/j.brainres.2004.12.006; Pera J, 2004, J NEUROSCI RES, V78, P132, DOI 10.1002/jnr.20232; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Petcu EB, 2008, CURR NEUROVASC RES, V5, P214, DOI 10.2174/156720208786413424; Przyklenk K, 2011, DRUG AGING, V28, P331, DOI 10.2165/11587190-000000000-00000; Puisieux F, 2000, EUR J PHARMACOL, V389, P71, DOI 10.1016/S0014-2999(99)00893-6; Purcell JE, 2003, NEUROSCI LETT, V339, P151, DOI 10.1016/S0304-3940(02)01476-3; Qin Zhiyong, 2007, Neurosurg Focus, V22, pE13, DOI 10.3171/foc.2007.22.5.14; Rehni AK, 2007, INDIAN J EXP BIOL, V45, P247; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Sack MN, 2011, J CARDIOVASC PHARM T, V16, P267, DOI 10.1177/1074248411408313; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Saxena P, 2009, PERFUSION-UK, V24, P207, DOI 10.1177/0267659109346902; Schaller BJ, 2007, EXP NEUROL, V205, P9, DOI 10.1016/j.expneurol.2006.01.017; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Steiger HJ, 2007, ACTA NEUROCHIR, V149, P1, DOI 10.1007/s00701-006-1057-1; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tymianski M, 2010, STROKE, V41, pS87, DOI 10.1161/STROKEAHA.110.595496; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vellimana AK, 2011, STROKE, V42, P776, DOI 10.1161/STROKEAHA.110.607200; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Wang L, 2008, CURR OPIN PHARMACOL, V8, P104, DOI 10.1016/j.coph.2007.09.005; Wang Q, 2005, NEUROSCI LETT, V381, P158, DOI 10.1016/j.neulet.2005.02.019; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wegener S, 2004, STROKE, V35, P616, DOI 10.1161/01.STR.0000115767.17923.6A; Wei DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030892; Xi G, 2000, ACTA NEUROCHIR SUPPL, V76, P501; Xiong L, 2003, CHINESE MED J-PEKING, V116, P108; Xu T, 2011, MED SCI MONITOR, V17, pBR299, DOI 10.12659/MSM.882038; Yamashita S, 2009, BRAIN RES, V1301, P171, DOI 10.1016/j.brainres.2009.08.096; Yeh CH, 2004, J THORAC CARDIOV SUR, V128, P203, DOI 10.1016/j.jtcvs.2003.12.010; Yu Qiong, 2011, Front Biosci (Elite Ed), V3, P978; Yung LM, 2012, STROKE, V43, P199, DOI 10.1161/STROKEAHA.111.626911; Zhang HP, 2010, ANESTH ANALG, V111, P506, DOI 10.1213/ANE.0b013e3181e45519; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172	104	13	15	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2013	4	1					3	14		10.1007/s12975-012-0219-0			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	109WG	WOS:000316399900002	23458885	Green Accepted			2022-02-06	
J	Weaver, CM; Trafton, JA; Kimerling, R; Timko, C; Moos, R				Weaver, Christopher M.; Trafton, Jodie A.; Kimerling, Rachel; Timko, Christine; Moos, Rudolf			Prevalence and Nature of Criminal Offending in a National Sample of Veterans in VA Substance Use Treatment Prior to the Operation Enduring Freedom/Operation Iraqi Freedom Conflicts	PSYCHOLOGICAL SERVICES			English	Article						veterans; criminal offending; substance use; violence	ADDICTION SEVERITY INDEX; ALCOHOL-OUTLET DENSITY; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-ILLNESS; DRUG-USE; PARTNER VIOLENCE; SPATIAL-ANALYSIS; CRIME; ABUSE	This study evaluated the prevalence and types of criminal arrest among 99,512 male veterans in substance use disorder (SUD) treatment across 150 VA facilities from 1998 to 2001. Participants were assessed with the Addiction Severity Index (ASI), which includes detailed information about lifetime criminal activity. A majority of the patients (58.2%) had three or more previous arrests, with 46.0% reporting one or more criminal convictions. Criminal arrests were frequent and varied. A majority of patients (69.3%) had at least one arrest that was not due to drug possession, drug sale, or intoxication. Nearly 24% reported at least one arrest for a violent crime. Patterns of arrest for specific crimes varied across SUD diagnostic categories. Screening for specific types of offending is informative and viable. Existing VA SUD treatment is a potentially underrecognized point of intervention for justice involvement among veterans.	[Weaver, Christopher M.] Palo Alto Univ, Clin Psychol PhD Program, Palo Alto, CA 94143 USA; [Weaver, Christopher M.; Trafton, Jodie A.; Kimerling, Rachel; Timko, Christine; Moos, Rudolf] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Trafton, Jodie A.; Timko, Christine; Moos, Rudolf] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA		Weaver, CM (corresponding author), Palo Alto Univ, Forens Psychol Program, 1791 Arastradero Rd, Palo Alto, CA 94143 USA.	cweaver@paloaltou.edu		Kimerling, Rachel/0000-0003-0996-4212			Alterman AI, 2007, PSYCHOL ASSESSMENT, V19, P119, DOI 10.1037/1040-3590.19.1.119; BARTELS SJ, 1991, SCHIZOPHRENIA BULL, V17, P163, DOI 10.1093/schbul/17.1.163; Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Bennett T, 2005, INT J OFFENDER THER, V49, P63, DOI 10.1177/0306624X04269003; Block RL., 1995, CRIME PLACE, P145; BLOMHOFF S, 1990, HOSP COMMUNITY PSYCH, V41, P771; Britt HR, 2005, ENVIRON ECOL STAT, V12, P411, DOI 10.1007/s10651-005-1518-3; Chermack ST, 2000, DRUG ALCOHOL DEPEN, V58, P43, DOI 10.1016/S0376-8716(99)00067-8; Claassen CA, 2007, J EMERG MED, V32, P141, DOI 10.1016/j.jemermed.2006.05.041; Coid JW, 2011, J FORENSIC PSYCHI PS, V22, P3, DOI 10.1080/14789949.2010.495990; Cormier, 1998, VIOLENT OFFENDERS AP, DOI [10.1037/10304-000, DOI 10.1037/10304-000]; Cunradi CB, 2011, J URBAN HEALTH, V88, P191, DOI 10.1007/s11524-011-9549-6; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Erickson SK, 2008, PSYCHIAT SERV, V59, P178, DOI 10.1176/ps.2008.59.2.178; Eronen M, 1996, ARCH GEN PSYCHIAT, V53, P497; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fergusson DM, 2000, ADDICTION, V95, P1525, DOI 10.1046/j.1360-0443.2000.951015257.x; French Michael T., 2000, Subst Abus, V21, P95, DOI 10.1023/A:1007763129628; Gorman DM, 1998, AM J PUBLIC HEALTH, V88, P97, DOI 10.2105/AJPH.88.1.97; Greenberg GA, 2009, PSYCHIAT QUART, V80, P41, DOI 10.1007/s11126-009-9092-8; Grubesic TH, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-30; HALL W, 1993, DRUG ALCOHOL DEPEN, V31, P123, DOI 10.1016/0376-8716(93)90064-W; HARRIS GT, 1993, CRIM JUSTICE BEHAV, V20, P315, DOI 10.1177/0093854893020004001; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Hodgins S., 1990, CANADAS MENTAL HLTH, V38, P1; HOFFMAN PB, 1985, CRIM JUSTICE BEHAV, V12, P501, DOI 10.1177/0093854885012004007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hser YI, 2008, ADDICT BEHAV, V33, P1581, DOI 10.1016/j.addbeh.2008.07.024; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; KLASSEN D, 1994, VIOLENCE MENTAL DISO, P229; Kouri EM, 1997, AM J DRUG ALCOHOL AB, V23, P413, DOI 10.3109/00952999709016886; Kraanen FL, 2011, CLIN PSYCHOL REV, V31, P478, DOI 10.1016/j.cpr.2010.11.006; Kraanen FL, 2010, INT J OFFENDER THER, V54, P430, DOI 10.1177/0306624X08330189; KRONER D, 2007, PSYCHOL SERVICES, V0004, P00085, DOI DOI 10.1037/1541-1559.4.2.85; Livingston M, 2008, ADDICTION, V103, P619, DOI 10.1111/j.1360-0443.2008.02136.x; Livingston M, 2011, ADDICTION, V106, P919, DOI 10.1111/j.1360-0443.2010.03333.x; Makela K, 2004, ADDICTION, V99, P398, DOI 10.1111/j.1360-0443.2003.00665.x; Mays Darren M, 2005, Subst Abus, V26, P33; McGuire J, 2003, PSYCHIAT SERV, V54, P201, DOI 10.1176/appi.ps.54.2.201; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moos RH, 2000, J STUD ALCOHOL, V61, P704, DOI 10.15288/jsa.2000.61.704; MOOS RH, 1998, OUTCOMES MONITORING; Mumola CJ., 2007, VETERANS STATE FEDER; Munetz MR, 2006, PSYCHIAT SERV, V57, P544, DOI 10.1176/appi.ps.57.4.544; National Institute of Justice, 1989, NIJ REP, V215; Nielsen AL, 2010, SOC SCI RES, V39, P165, DOI 10.1016/j.ssresearch.2009.04.006; NURCO DN, 1984, AM J DRUG ALCOHOL AB, V10, P481, DOI 10.3109/00952998409001486; Patterson S, 2000, INT J OFFENDER THER, V44, P667, DOI 10.1177/0306624X00446004; Schwester R., 2010, PUBLIC ADM MANAGEMEN, V15, P365; Scribner RA, 2010, J STUD ALCOHOL DRUGS, V71, P184, DOI 10.15288/jsad.2010.71.184; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Sussner B., 2008, PSYCHOL SERV, V5, P341, DOI DOI 10.1037/A0013791; Swanson JW., 1994, VIOLENCE MENTAL DISO, P101, DOI DOI 10.1371/JOURNAL.PMED.1000120; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Taylor PJ, 1994, VIOLENCE MENTAL DISO, P161; Theriot MT, 2005, PSYCHIAT SERV, V56, P179, DOI 10.1176/appi.ps.56.2.179; Truman J ., 2011, NATL CRIME VICTIMIZA; Valdez A, 2007, AM J DRUG ALCOHOL AB, V33, P595, DOI 10.1080/00952990701407637; Villafranca SW, 2006, DRUG ALCOHOL DEPEN, V83, P218, DOI 10.1016/j.drugalcdep.2005.11.020; Wilson JK, 2011, PSYCHOL SERV, V8, P319, DOI 10.1037/a0025330; Yarvis R M, 1990, Bull Am Acad Psychiatry Law, V18, P249; Zanis DA, 1997, COMMUNITY MENT HLT J, V33, P213, DOI 10.1023/A:1025085310814	64	13	13	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2013	10	1					54	65		10.1037/a0030504			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	090TI	WOS:000315002500006	23148768				2022-02-06	
J	White, NJ; Wang, X; Bradbury, N; Moon-Massat, PF; Freilich, D; Auker, C; McCarron, R; Scultetus, A; Stern, SA				White, Nathan J.; Wang, Xu; Bradbury, Nicole; Moon-Massat, Paula F.; Freilich, Daniel; Auker, Charles; McCarron, Richard; Scultetus, Anke; Stern, Susan A.			FLUID RESUSCITATION OF UNCONTROLLED HEMORRHAGE USING A HEMOGLOBIN-BASED OXYGEN CARRIER: EFFECT OF TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Hemorrhage; traumatic brain injury; shock; fluid resuscitation; hemoglobin-based oxygen carrier	BOVINE POLYMERIZED HEMOGLOBIN; SWINE MODEL; CEREBRAL-ISCHEMIA; SHOCK; HBOC-201; HYPOTENSION; MORTALITY; RESPONSES; SURVIVAL; DELAY	Animal models of combined traumatic brain injury (TBI) and hemorrhagic shock (HS) suggest a benefit of hemoglobin-based oxygen carrier (HBOC)-based resuscitation, but their use remains controversial, and little is known of the specific effects of TBI and high-pressure (large arterial injury) bleeding on resuscitation. We examine the effect of TBI and aortic tear injury on low-volume HBOC resuscitation in a swine polytrauma model and hypothesize that HBOC-based resuscitation will improve survival in the setting of aortic tear regardless of the presence of TBI. Anesthetized swine subjected to HS with aortic tear with or without fluid percussion TBI underwent equivalent limited resuscitation with HBOC, lactated Ringer's solution, or HBOC + nitroglycerine (vasoattenuated HBOC) and were observed for 6 h. There was no independent effect of TBI on survival time after adjustment for fluid type, and there was no interaction between TBI and resuscitation fluid type. However, total catheter hemorrhage volume required to reach target shock blood pressure was less with TBI (14.0 mL . kg(-1) [confidence interval, 12.4-15.6 mL . kg(-1)]) versus HS only (21.0 mL . kg(-1) [confidence interval, 19.5-22.5 mL . kg(-1)]), with equivalent lactate accumulation. Traumatic brain injury did not affect survival in this polytrauma model, but less hemorrhage was required in the presence of TBI to achieve an equivalent degree of shock suggesting globally impaired cardiovascular response to hemorrhage in the presence of TBI. There was also no benefit of HBOC-based fluid resuscitation over lactated Ringer's solution, contrary to models using liver injury as the source of hemorrhage, considering wound location is of paramount importance when choosing resuscitation strategy.	[White, Nathan J.; Wang, Xu; Bradbury, Nicole; Stern, Susan A.] Univ Washington, Harborview Med Ctr, Div Emergency Med, Seattle, WA 98104 USA; [Moon-Massat, Paula F.; Auker, Charles; McCarron, Richard; Scultetus, Anke] USN, NeuroTrauma Dept, OUMD, Med Res Ctr, Silver Spring, MD USA; [Freilich, Daniel] Bur Med & Surg, Washington, DC USA		White, NJ (corresponding author), Univ Washington, Harborview Med Ctr, Div Emergency Med, Box 359702,325 9th Ave, Seattle, WA 98104 USA.	whiten4@uw.edu		White, Nathan/0000-0002-3752-310X	Naval Medical Research Center (NMRC) [W81XWH-08-2-0166, HBOC-201]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000421]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025015]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER	This study was supported by the Naval Medical Research Center (NMRC) (CDMRP grant W81XWH-08-2-0166) and, in part, by the National Center for Advancing Translational Sciences (NCATS) (grant KL2 TR000421), a component of the National Institutes of Health (NIH); NMRC also provided HBOC-201 (Biopure; OPK Biotech). Dr White was funded under NCRR (grant KL2 RR025015).	American College of Surgeons Committee on Trauma, 2008, ATLS DOCT STUD MAN; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; BARCROFT H, 1945, J PHYSIOL-LONDON, V104, P161, DOI 10.1113/jphysiol.1945.sp004113; Brain Trauma Foundation, 2003, UPD GUID MAN PROGN S; Bruttig SP, 2005, SHOCK, V24, P92, DOI 10.1097/01.shk.0000168872.37660.d2; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2838, DOI 10.1097/CCM.0b013e318186f6b3; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johnson T, 2006, CRIT CARE MED, V34, P1464, DOI 10.1097/01.CCM.0000215824.85190.89; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; OVERMAN RR, 1947, AM J PHYSIOL, V148, P289, DOI 10.1152/ajplegacy.1947.148.2.289; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Rice J, 2006, SHOCK, V26, P302, DOI 10.1097/01.shk.0000226338.48033.c2; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Sapsford W, 2007, J TRAUMA, V62, P868, DOI 10.1097/ta.0b013e318034204b; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Stern SA, 2001, SHOCK, V15, P16, DOI 10.1097/00024382-200115010-00003; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Teranishi K, 2012, INJURY, V43, P585, DOI 10.1016/j.injury.2010.09.042; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	35	13	16	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2013	39	2					210	219		10.1097/SHK.0b013e31827fd62b			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	080ZF	WOS:000314282900015	23324891	Green Accepted			2022-02-06	
J	Bendorf, A; Kerridge, IH; Stewart, C				Bendorf, Aric; Kerridge, Ian H.; Stewart, Cameron			Intimacy or utility? Organ donation and the choice between palliation and ventilation	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; CIRCULATORY DEATH; LIFE; CARE; END; DONORS; TRANSPLANTATION; CULTURE; TRENDS; IMPACT	Organ donation after brain death provides the most important source for deceased organs for transplantation, both because of the number of potential organ donors that it makes available and also because of the unparalleled viability of the organs retrieved. Analysis of worldwide deceased organ donation rates demonstrates that all countries with high deceased organ donation rates (>20 donors per million population per year) have high brain death rates (>40 brain deaths per million population per year). This analysis makes it clear that countries striving to increase their deceased organ donor rates to world leading levels must increase the rates of donation after brain death. For countries with end-of-life care strategies that stress palliation, advance care planning and treatment withdrawal for the terminally ill, the adoption of initiatives to meaningfully raise deceased donor rates will require increasing the rate at which brain death is diagnosed. This poses a difficult, and perhaps intractable, medical, ethical and sociocultural challenge as the changes that would be required to increase rates of brain death would mean conjugating an intimate clinical and cultural focus on the dying patient with the notion of how this person's death might be best managed to be of benefit to others.	[Bendorf, Aric; Kerridge, Ian H.; Stewart, Cameron] Univ Sydney, Ctr Values Eth & Law Med VELiM, Sydney, NSW 2006, Australia; [Kerridge, Ian H.] Royal N Shore Hosp, Dept Haematol, St Leonards, NSW 2065, Australia; [Stewart, Cameron] Univ Sydney, Sydney Law Sch, Ctr Hlth Governance Law & Eth, Sydney, NSW 2006, Australia		Bendorf, A (corresponding author), Univ Sydney, Ctr Values Eth & Law Med VELiM, Level 1,Med Fdn Bldg K25,92-94 Parramatta Rd, Sydney, NSW 2006, Australia.	aric.bendorf@sydney.edu.au		Stewart, Cameron/0000-0003-3625-0899; Kerridge, Ian/0000-0001-7445-4660			Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Agence de la Biomedecine, 2011, RAPP ANN 2010 ACT DO; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; [Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1979, Br Med J, V1, P332; Aries Philippe, 1974, W ATTITUDES DEATH; Ball CG, 2010, J TRAUMA, V69, P1323, DOI 10.1097/TA.0b013e3181f66878; Bellingham JM, 2011, SURGERY, V150, P692, DOI 10.1016/j.surg.2011.07.057; Bendorf A, 2012, INTERN MED J, V42, P866, DOI 10.1111/j.1445-5994.2012.02792.x; Bendorf A, 2012, 24 INT C TRANSPL SOC; British Medical Association, 2012, BUILD PROGR NEXT ORG; Busic M, 2012, ORGAN DONATION TRANS; Centro Nazionale Trapianti Istituto Superiore di Sanita, 2011, VAL QUAL ATT TRAP 20; Colheita e Transplantacao de Orgaos e Tecidos, 2010, REL EST 2009; Council of Europe, 2011, NEWSLETT TRANSPL, V16, P25; Council of Europe, 2006, NEWSLETT TRANSPL, P11; Devictor Denis J, 2004, Pediatr Crit Care Med, V5, P211, DOI 10.1097/01.PCC.0000123553.22405.E3; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; DonateLife Australia, 2012, PERF REP 2011; FEEST TG, 1990, LANCET, V335, P1133, DOI 10.1016/0140-6736(90)91134-V; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Higginson IJ, 1998, PALLIATIVE MED, V12, P353, DOI 10.1191/026921698672530176; Kehl Karen A, 2006, Am J Hosp Palliat Care, V23, P277, DOI 10.1177/1049909106290380; Kerridge IH, 2002, J MED ETHICS, V28, P89, DOI 10.1136/jme.28.2.89; Machado C, 1995, DEVEL NEUR, V9, P57; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Matesanz R, 2012, AM J TRANSPLANT, V12, P2498, DOI 10.1111/j.1600-6143.2012.04128.x; Mendcloff J, 2004, TRANSPLANTATION, V78, P1704, DOI 10.1097/01.TP.0000149787.97288.A2; Monette M, 2010, CAN MED ASS J; Nath J, 2011, LANCET, V377, P203, DOI 10.1016/S0140-6736(11)60038-X; National Health Service, 2011, POT DON AUD SUMM REP; Oosterlee A, 2006, EUROTRANSPLANT INT F; Organ Procurement and Transplantation Network, 2010, DEC DON REC US MECH; Organizacion Nacional de Trasplantes, 2010, PROGR GAR CAL PROC D; Orman ES, 2013, LIVER TRANSPLANT, V19, P59, DOI 10.1002/lt.23547; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Smith II G.P., 2012, LAW BIOETHICS INTERS; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stewart CL, 2011, PUBLIC HEALTH, V125, P905, DOI 10.1016/j.puhe.2011.10.001; Van Gelder F, 2007, TRANSPL INT, V20, P37; Walter T, 2003, BMJ-BRIT MED J, V327, P218, DOI 10.1136/bmj.327.7408.218; Zych B, 2012, EUR J CARDIO-THORAC, V42, P542, DOI 10.1093/ejcts/ezs096	45	13	13	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	3							316	10.1186/cc12553			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	285YN	WOS:000329431100072	23714404	gold, Green Published			2022-02-06	
J	Brooks, BL; Iverson, GL; Koushik, NS; Mazur-Mosiewicz, A; Horton, AM; Reynolds, CR				Brooks, Brian L.; Iverson, Grant L.; Koushik, Nikhil S.; Mazur-Mosiewicz, Anya; Horton, Arthur MacNeill, Jr.; Reynolds, Cecil R.			Prevalence of Low Scores in Children and Adolescents on the Test of Verbal Conceptualization and Fluency	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						assessment; base rates; executive functioning; low scores; misdiagnosis; multivariate	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; WECHSLER-INTELLIGENCE-SCALE; BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; OLDER-ADULTS; BIPOLAR DISORDER; HEALTHY-CHILDREN; BASE RATES	It is important to consider the prevalence of low scores when administering a battery of psychological tests. Understanding the prevalence of low scores is important for minimizing false-positive diagnoses of cognitive deficits in clinical practice. The purpose of this study was to expand the literature on base rates for use in children and adolescents. Participants were 408 healthy children and adolescents (M-age = 13.1 years, SD = 3.7) and 139 children and adolescents (M-age = 12.4 years, SD = 3.1) diagnosed with a medical, neurological, or learning condition. All participants were administered the Test of Verbal Conceptualization and Fluency (TVCF; Reynolds & Horton, 2006). The clinical sample performed significantly lower compared with the healthy control participants on three of the five TVCF scores. When all scores were considered simultaneously, 38% of healthy children obtained one or more scores below the 16th percentile and 15% had one or more scores in the 5th percentile or lower. By comparison, significantly higher proportions of children in the clinical sample had low scores below each of the five cutoffs (i.e., 63% had one or more test scores below the 16th percentile and 37% had one or more scores in the 5th percentile or lower). Our findings illustrate the importance of considering the prevalence of low TVCF scores in everyday clinical practice with children and adolescents.	[Brooks, Brian L.; Koushik, Nikhil S.; Mazur-Mosiewicz, Anya] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Horton, Arthur MacNeill, Jr.] Psychol Associates Maryland LLC, Neuropsychol Sect, Towson, MD USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca		Iverson, Grant/0000-0001-7348-9570	Psychological Assessment Resources Inc.	Dr. Brooks receives funding from Psychological Assessment Resources Inc. and in-kind research support from the CNS Vital Signs test publishing company. Dr. Iverson has received past research funding and support from Psychological Assessment Resources Inc., other test publishing companies, and the pharmaceutical industry for studies relating to the reliability, validity, and accuracy of neuropsychological tests. Drs. Koushik and Mazur-Mosiewicz report no perceived or actual conflicts of interest related to this article. Dr. Horton and Dr. Reynolds are developers of the Test of Verbal Conceptualization and Fluency.	Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks B. L., 2012, PEDIAT FORENSIC NEUR, P66; Brooks BL, 2012, APPL NEUROPSYCH-ADUL, V19, P61, DOI 10.1080/09084282.2012.651951; Brooks BL, 2011, CHILD NEUROPSYCHOL, V17, P281, DOI 10.1080/09297049.2010.537255; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, PSYCHOL ASSESSMENT, V22, P650, DOI 10.1037/a0019781; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P14, DOI 10.1093/arclin/acp100; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Brown TM, 2008, CHILD NEUROPSYCHOL, V14, P118, DOI 10.1080/09297040601147605; Cohen M.J., 1997, CHILDRENS MEMORY SCA; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 1991, COMPREHENSIVE NORMS; Hoie B, 2006, DEV MED CHILD NEUROL, V48, P519, DOI 10.1017/S0012162206001095; Iverson G. L., 2008, NEUROPSYCHOLOGY HDB, P279; Kern ML, 2009, ANN BEHAV MED, V37, P154, DOI 10.1007/s12160-009-9095-6; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Korkman M., 2007, NEPSY 2 DEV NEUROPSY; Laws KR, 2008, PSYCHIAT RES, V160, P8, DOI 10.1016/j.psychres.2007.06.004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mares D, 2007, CAN J PSYCHIAT, V52, P527, DOI 10.1177/070674370705200811; Marx I, 2011, WORLD J BIOL PSYCHIA, V12, P70, DOI 10.3109/15622975.2011.599213; Marzocchi GM, 2008, J CHILD PSYCHOL PSYC, V49, P543, DOI 10.1111/j.1469-7610.2007.01859.x; Nybo T, 1999, BRAIN INJURY, V13, P759; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Passarotti AM, 2011, EXPERT REV NEUROTHER, V11, P897, DOI [10.1586/ERN.11.71, 10.1586/ern.11.71]; Qian Y, 2010, CLIN NEUROPSYCHOL, V24, P793, DOI 10.1080/13854041003749342; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Reynolds C. R., 2003, COMPREHENSIVE TRAIL; Reynolds CR, 2006, TEST VERBAL CONCEPTU; Rucklidge JJ, 2006, BIOL PSYCHIAT, V60, P921, DOI 10.1016/j.biopsych.2006.03.067; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Semrud-Clikeman M, 2008, NEUROPSYCHOLOGY, V22, P329, DOI 10.1037/0894-4105.22.3.329; Sherman EMS, 2006, EPILEPSIA, V47, P1936, DOI 10.1111/j.1528-1167.2006.00816.x; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Swanson HL, 2006, J LEARN DISABIL-US, V39, P252; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Walshaw PD, 2010, NEUROPSYCHOL REV, V20, P103, DOI 10.1007/s11065-009-9126-x; Wechsler D, 2003, WECHSLER INTELLIGENC; Williams TS, 2012, DEV MED CHILD NEUROL, V54, P30, DOI 10.1111/j.1469-8749.2011.04144.x; Zhang HY, 2011, J HUAZHONG U SCI-MED, V31, P131, DOI 10.1007/s11596-011-0164-2	47	13	13	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					70	77		10.1080/21622965.2012.742792			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300010	23427779				2022-02-06	
J	Cockerham, GC; Lemke, S; Glynn-Milley, C; Zumhagen, L; Cockerham, KP				Cockerham, Glenn C.; Lemke, Sonne; Glynn-Milley, Catherine; Zumhagen, Lars; Cockerham, Kimberly P.			Visual Performance and the Ocular Surface in Traumatic Brain Injury	OCULAR SURFACE			English	Article						anticholinergic drugs; blast injury; corneal sensitivity; dry eye; medications; Ocular Surface Disease Index; pathophysiology; tear osmolarity; tear production; tear quality; traumatic brain injury; veteran rehabilitation	DRY EYE DISEASE; UNITED-STATES; RISK-FACTORS; RAT-BRAIN; PREVALENCE; DYSFUNCTION; IRAQI; GLAND; BIOMECHANICS; RELIABILITY	The pathophysiology of neurotrauma is reviewed and an original study investigating the prevalence of dry eye disease in a sample of veterans with traumatic brain injury (TBI) is presented. Fifty-three veterans with TBI were evaluated by history of injury, past ocular history, and medication use. Ocular Disease Surface Index (OSDI), ocular examination, cranial nerve evaluation, tear osmolarity, tear film break-up time (TFBUT), ocular surface staining and tear production testing were performed. A matched comparison group underwent similar testing. TBI causes were blast (44) or non-blast (9). TBI subjects scored significantly worse on the OSDI (P<.001), and ocular surface staining by Oxford scale (P<.001) than non-TBI subjects. Scores for tear film breakup (P=.6), basal tear production less than 3 mm (P=.13), and tear osmolarity greater than 314 mOsm/L (P=.15) were all higher in TBI subjects; significantly more TBI subjects had at least one abnormal dry eye measure than comparisons (P<.001). The OSDI related to presence of dry eye symptoms (P<.01). These effects were present in both blast and non-blast TBI. Seventy percent of TBI subjects were taking at least one medication in the following classes: antidepressant, atypical antipsychotic, anticonvulsant, or h1-antihistamine. There was no association between any medication class and the OSDI or dry eye measures. Reduced corneal sensation in 21 TBI subjects was not associated with OSDI, tear production, or TFBUT, but did correlate with reduced tear osmolarity (P=.05). History of refractive surgery, previous contact lens wear, facial nerve weakness, or meibomian gland dysfunction was not associated with DED. In summary, we found a higher prevalence of DED in subjects with TBI, both subjectively and objectively. This effect is unrelated to medication use, and it may persist for months to years. We recommend that patients with TBI from any cause be evaluated for DED using a battery of standard testing methods described in a protocol presented in this article. Further research into the pathophysiology and outcomes of DED in neurotrauma is needed.	[Cockerham, Glenn C.; Glynn-Milley, Catherine; Cockerham, Kimberly P.] Vet Adm Palo Alto Hlth Care Syst, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Cockerham, Kimberly P.] Stanford Univ, Sch Med, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Lemke, Sonne] Vet Adm Palo Alto Hlth Care Syst, Ctr Hlth Care Evaluat, Palo Alto, CA 94304 USA; [Zumhagen, Lars] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany		Cockerham, GC (corresponding author), Vet Adm Palo Alto Hlth Care Syst, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	glenn.cockerham@va.gov	Cockerham, Kimberly/AAR-5917-2021		Veterans Administration Merit Review AwardUS Department of Veterans Affairs [C5018R]	Veterans Administration Merit Review Award C5018R. The sponsor had no role in the design or conduct of this research.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2007, LANCET, V370, P1879; Berntsen DA, 2006, CORNEA, V25, P695, DOI 10.1097/01.ico.0000208814.94495.a6; Beuerman RW, 2004, DRY EYE OCULAR SURFA; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; CAVANAGH HD, 1989, ACTA OPHTHALMOL, V67, P115; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Colyer MH, 2008, OPHTHALMOLOGY, V115, P2087, DOI 10.1016/j.ophtha.2008.05.013; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dastjerdi Mohammad H, 2009, Int Ophthalmol Clin, V49, P11, DOI 10.1097/IIO.0b013e31819242c9; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Dolgonos S, 2011, INVEST OPHTH VIS SCI, V52, P7852, DOI 10.1167/iovs.11-7604; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Erdurman FC, 2011, EYE, V25, P1491, DOI 10.1038/eye.2011.212; Faul M, 2010, TRAUMATIC BRAIN INJU; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM, 2009, GULF WAR HLTH, V7; JEPPESEN KV, 1985, PHARMACOPSYCHIATRY, V18, P231, DOI 10.1055/s-2007-1017371; JONES LT, 1966, AM J OPHTHALMOL, V62, P47, DOI 10.1016/0002-9394(66)91676-X; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McCann J D, 1994, Curr Opin Ophthalmol, V5, P3, DOI 10.1097/00055735-199412000-00002; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Murray CJL, 1996, GLOBAL HLTH STAT; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nassiri N, 2011, CORNEA, V1, P425; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owen-Smith MS, 1981, MED B US ARMY EUR, V38, P36; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Phillips YY, 1989, TXB MILITARY MED CON, P221; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schein OD, 1999, ARCH INTERN MED, V159, P1359, DOI 10.1001/archinte.159.12.1359; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Stanek S, 2000, MIL MED, V165, P591; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; WARNER JEA, 1995, INT OPHTHALMOL CLIN, V35, P57, DOI 10.1097/00004397-199503510-00007; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wirtshafter JD, 1998, WALSH HOYTS CLIN NEU, V1, P917; Wong J, 2011, OCUL SURF, V9, P212, DOI 10.1016/S1542-0124(11)70034-9; Yazdani C, 2001, CLIN THER, V23, P1672, DOI 10.1016/S0149-2918(01)80136-3; Zhang X, 2006, NEUROLOGY, V66, P906, DOI 10.1212/01.wnl.0000203913.12088.93	77	13	13	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1542-0124	1937-5913		OCUL SURF	Ocul. Surf.	JAN	2013	11	1					25	34		10.1016/j.jtos.2012.09.004			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	080RF	WOS:000314260300007	23321357				2022-02-06	
J	Dulla, CG; Tani, H; Brill, J; Reimer, RJ; Huguenard, JR				Dulla, C. G.; Tani, H.; Brill, J.; Reimer, R. J.; Huguenard, J. R.			Glutamate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; Cortex; Astrocyte; Glutamate; Imaging; Malformation	TRAUMATIC BRAIN-INJURY; FREEZE-LESION MODEL; EPILEPTIFORM ACTIVITY; RAT MODEL; IN-VIVO; POSTSYNAPTIC CURRENTS; REACTIVE ASTROCYTES; EXPRESSION; EPILEPSY; DYSPLASIA	Cortical malformations can cause intractable epilepsy, but the underlying epileptogenic mechanisms are poorly understood. We used high-speed glutamate biosensor imaging to ask how glutamatergic signaling is altered in cortical malformations induced by neonatal freeze-lesions (FL). In non-lesion neocortical slices from 2 to 8 week old rats, evoked glutamate signals were symmetrical in the medio-lateral axis and monotonic, correlating with simple, brief (approximate to 50 ms) local field potentials (LFPs). By contrast, in FL cortex glutamate signals were prolonged, increased in amplitude, and polyphasic, which paralleled a prolongation of the LFP. Using glutamate biosensor imaging, we found that glutamate signals propagated throughout large areas of FL cortex and were asymmetric (skewed toward the lesion). Laminar analysis demonstrated a shift in the region of maximal glutamate release toward superficial layers in FL cortex. The ability to remove exogenous glutamate was increased within the FL itself but was decreased in immediately adjacent regions. There were corresponding alterations in astrocyte density, with an increase within the lesion and a decrease in deep cortical layers surrounding the lesion. These findings demonstrate both network connectivity and glutamate metabolism are altered in this cortical malformation model and suggests that the regional ability of astrocytes to remove released glutamate may be inversely related to local excitability. (C) 2012 Elsevier Inc. All rights reserved.	[Dulla, C. G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Dulla, C. G.; Tani, H.; Brill, J.; Reimer, R. J.; Huguenard, J. R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA		Dulla, CG (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Chris.Dulla@tufts.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Dulla, Chris/0000-0002-6560-6535	American Epilepsy Society/Epilepsy Foundation of America [NS12151]; Dana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012151, R01NS076885, R01NS034774, R01NS006477, P50NS012151] Funding Source: NIH RePORTER	Funding for this article was provided by NS12151, American Epilepsy Society/Epilepsy Foundation of America, and the Dana Foundation.	Albertson A.J., 2011, J NEUROPHYS; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bordey A, 2001, J NEUROPHYSIOL, V85, P1719, DOI 10.1152/jn.2001.85.4.1719; Brill J, 2010, CEREB CORTEX, V20, P2926, DOI 10.1093/cercor/bhq040; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell S, 2005, EPILEPSIA, V46, P129, DOI 10.1111/j.1528-1167.2005.01020.x; Campbell S.L., 2008, NEUROBIOL DIS; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Crino PB, 2005, J CHILD NEUROL, V20, P330, DOI 10.1177/08830738050200041101; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Crino PB, 1999, NEUROLOGY, V53, P1384, DOI 10.1212/WNL.53.7.1384; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Dulla C, 2008, J NEUROSCI METH, V168, P306, DOI 10.1016/j.jneumeth.2007.10.017; DVORAK K, 1978, ACTA NEUROPATHOL, V44, P121; Furuta A, 1997, J NEUROSCI, V17, P8363; Gonzalez-Martinez JA, 2011, J NEUROSURG, V114, P1195, DOI 10.3171/2010.10.JNS10715; Hablitz JJ, 2000, EPILEPSIA, V41, pS82, DOI 10.1111/j.1528-1157.2000.tb01562.x; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Isaeva E, 2010, EUR J NEUROSCI, V31, P1446, DOI 10.1111/j.1460-9568.2010.07179.x; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Jacobs KM, 2005, J NEUROPHYSIOL, V93, P687, DOI 10.1152/jn.00288.2004; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Jacobs KM, 1999, J NEUROPHYSIOL, V81, P159, DOI 10.1152/jn.1999.81.1.159; Jacobs KM, 1999, CEREB CORTEX, V9, P733, DOI 10.1093/cercor/9.7.733; Kakita A, 2005, J CHILD NEUROL, V20, P341, DOI 10.1177/08830738050200041301; Leventer RJ, 2010, BRAIN, V133, P1415, DOI 10.1093/brain/awq078; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Namiki S, 2007, EUR J NEUROSCI, V25, P2249, DOI 10.1111/j.1460-9568.2007.05511.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Okubo Y, 2010, P NATL ACAD SCI USA, V107, P6526, DOI 10.1073/pnas.0913154107; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; Patrick SL, 2006, EPILEPSY RES, V70, P161, DOI 10.1016/j.eplepsyres.2006.04.001; Redecker C, 2000, J NEUROSCI, V20, P5045; Redecker C, 2005, EXP NEUROL, V192, P288, DOI 10.1016/j.expneurol.2004.11.018; Rosen GD, 2000, J COMP NEUROL, V418, P423; Rosen GD, 1998, CEREB CORTEX, V8, P753, DOI 10.1093/cercor/8.8.753; Rosen GD, 2001, NEUROSCIENCE, V103, P931, DOI 10.1016/S0306-4522(01)00044-6; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Schmidt S, 2006, EXP NEUROL, V201, P270, DOI 10.1016/j.expneurol.2006.03.027; Schwartzkroin PA, 2000, MENT RETARD DEV D R, V6, P268, DOI 10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B; Shimizu-Okabe C, 2007, NEUROSCI RES, V59, P288, DOI 10.1016/j.neures.2007.07.010; Takahashi DK, 2010, NEUROBIOL DIS, V40, P573, DOI 10.1016/j.nbd.2010.07.018; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tani H, 2010, J NEUROSCI, V30, P1288, DOI 10.1523/JNEUROSCI.0106-09.2010; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; Ulu MO, 2010, ACTA NEUROCHIR, V152, P845, DOI 10.1007/s00701-009-0548-2; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zsombok A, 2007, J NEUROPHYSIOL, V98, P178, DOI 10.1152/jn.00106.2007	55	13	13	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	JAN	2013	49						232	246		10.1016/j.nbd.2012.09.001			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	044BO	WOS:000311594600025	22982711	Green Accepted			2022-02-06	
J	Eilander, HJ; van Heugten, CM; Wijnen, VJM; Croon, MA; de Kort, PLM; Bosch, DA; Prevo, AJH				Eilander, Henk J.; van Heugten, Caroline M.; Wijnen, Viona J. M.; Croon, Marcel A.; de Kort, Paul L. M.; Bosch, D. Andries; Prevo, Arie J. H.			Course of recovery and prediction of outcome in young patients in a prolonged vegetative or minimally conscious state after severe brain injury: An exploratory study	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Brain injury; level of consciousness; long-term outcome; paediatric rehabilitation; minimally conscious state; vegetative state		AIMS: To explore the course of recovery of consciousness and factors predicting the outcome of severe brain injury with a prolonged period of unconsciousness in children and young adults receiving a specialized rehabilitation treatment, the Early Intensive Neurorehabilitation Programme (EINP). METHODS: A cohort of forty-four patients aged 1.6-25.5 years (M = 16.0) with traumatic acquired brain injury (TBI) or non-traumatic acquired brain injury (nTBI) were examined using the Western Neuro Sensory Stimulation Profile every two weeks, from the application for EINP until discharge. The level of consciousness was assessed with the Post-Acute Level of Consciousness Scale, and the level of disability was determined by the Disability Rating Scale. Long-term level of disability of all TBI patients (N = 32) was assessed between 2.0 and 4.4 years after discharge from EINP. RESULTS: Two-thirds of all patients recovered to consciousness. Three recovery patterns were identified: remaining in a vegetative state (VS), slow recovery of consciousness, and fast recovery of consciousness. In the long-term, 11 of the TBI patients were severely disabled, 13 were moderately disabled, and 4 were mildly disabled. All TBI patients who were in VS at discharge either had deceased, or recovered to a very severely disabled state. CONCLUSIONS: Three recovery patterns identified in an early stage after starting EINP made it possible to predict long-term level of disability.	[Eilander, Henk J.; Wijnen, Viona J. M.] Rehabil Ctr Leijpark, Div Res, Project VLB NAH, Tilburg, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Croon, Marcel A.] Tilburg Univ, Stat & Methodol Dept, Fac Social Sci, Tilburg, Netherlands; [de Kort, Paul L. M.] St Elizabeth Hosp, Div Neurol, Tilburg, Netherlands; [Bosch, D. Andries] Acad Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [Prevo, Arie J. H.] Rehabil Ctr Hoogstr, Utrecht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands		Eilander, HJ (corresponding author), Bankven 17, NL-5052 BA Goirle, Netherlands.	h.j.eilander@brain-consult.nl	Wijnen, Viona/AAX-3041-2021; Wijnen, Viona/G-1328-2016	Wijnen, Viona/0000-0001-7797-1882	Stichting Centraal Fonds RVVZ; Johanna Kinderfonds; Stichting Bio Kinder-revalidatie; CZ groep Zorgverzekeringen; Zorgverzekeraar VGZ; Zorg en zekerheid; Hersenstichting Nederland; Gerritsen Beheer groep	The study was funded by: Stichting Centraal Fonds RVVZ, Johanna Kinderfonds, Stichting Bio Kinder-revalidatie, CZ groep Zorgverzekeringen, Zorgverzekeraar VGZ, Zorg en zekerheid, and Hersenstichting Nederland. Further financial support provided by Gerritsen Beheer groep was essential for starting and continuation of the overall project.	Andrews K, 2005, NEUROPSYCHOL REHABIL, V15, P461, DOI 10.1080/09602010443000326; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ANSELL BJ, 1989, W NEURO SENSORY STIM; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ashwal S, 2004, NEUROREHABILITATION, V19, P349; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Coleman MR, 2005, NEUROPSYCHOL REHABIL, V15, P161, DOI 10.1080/09602010443000669; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Dolce G, 2008, BRAIN INJURY, V22, P617, DOI 10.1080/02699050802132503; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2009, NEUROPSYCHOL REHABIL, V19, P1, DOI 10.1080/09602010701694822; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Jennett B, 2005, NEUROPSYCHOL REHABIL, V15, P163, DOI 10.1080/09602010443000632; JENNETT B, 1993, NEUROPSYCHOL REHABIL, V3, P99; KORNERBITENSKY N, 1994, ARCH PHYS MED REHAB, V75, P1287; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LeGrand SA, 2007, J NEUROTRAUM, V24, P1437, DOI 10.1089/neu.2007.0293; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Melchers P, 1999, RESTOR NEUROL NEUROS, V14, P153; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shiel A, 2005, NEUROPSYCHOL REHABIL, V15, P494, DOI 10.1080/09602010443000551; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; TEASDALE G, 1974, LANCET, V2, P81; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wilson FC, 2007, DISABIL REHABIL, V29, P1751, DOI 10.1080/09638280601118432	38	13	16	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2013	6	2					73	83		10.3233/PRM-130241			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7KM	WOS:000448281000003	23803340	Green Published			2022-02-06	
J	Hannold, EM; Classen, S; Winter, S; Lanford, DN; Levy, CE				Hannold, Elizabeth Lisa M.; Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.			Exploratory pilot study of driving perceptions among OIF/OEF Veterans with mTBI and PTSD	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; automobile driving; blast injuries; brain injuries; combat disorders; Iraq; occupational therapy; qualitative research methods; stress disorders/posttraumatic; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; PERFORMANCE; IRAQ	Veterans of Iraq and Afghanistan may experience driving-related challenges postdeployment, including more at-fault crashes. Causes may include defensive driving tactics learned for combat zones and consequences of traumatic brain injuries (TBIs) and posttraumatic stress disorder (PTSD). Tailoring driver interventions to meet Veterans' needs requires an understanding of their driving perceptions. We explored the driving perceptions of five combat Veterans (4 men, I woman) with mild TBI and PTSD using grounded theory methods. Veterans participated in single, semistructured interviews during a comprehensive driving evaluation. Interviews were digitally recorded, transcribed verbatim, verified, and imported into NVivo 8 software for coding and analysis. Veterans were insightful about driving and identified specific environmental triggers for anxious driving, speeding, and road rage. Veterans used strategies to moderate driving behaviors, but continued to drive aggressively. Themes were used to develop a conceptual framework of driving postdeployment, laying the foundation for intervention studies.	[Hannold, Elizabeth Lisa M.; Winter, Sandra; Levy, Charles E.] North Florida South Georgia NFSG Dept Vet Affairs, Res Enhancement Award Program, Rehabil Outcomes Res Ctr, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.] Univ Florida, Coll Publ Hlth & Hlth Profess, Inst Mobil Act & Participat, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Occupat Therapy, Gainesville, FL USA; [Levy, Charles E.] NF SG VAHS, Phys Med & Rehabil Serv, Gainesville, FL 32608 USA		Hannold, EM (corresponding author), NF SG VAHS, RORC REAP, 151-B,1601 SW Archer Rd, Gainesville, FL 32608 USA.	lisa.hannold@va.gov			NF/SG Malcom Randall VA Medical Center [VA 00066678]	This material was based on work supported by the NF/SG Malcom Randall VA Medical Center (project VA 00066678; PI: Classen). The Institute for Mobility, Activity, and Participation at University of Florida's College of Public Health and Health Profession is also gratefully acknowledged for providing infrastructure.	Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P2; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brookhuis K.A., 2001, ASSESSMENT DRIVERS W; Charmaz K., 2014, BROKERAGE CLOSURE IN; Classen S, 2013, AM J OCCUP THER, V67, P108, DOI 10.5014/ajot.2013.005116; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Collins C., 2014, PTSD TBI WE ARE NOW; Florida Institute on Disability and Rehabilitation and Florida Trauma Rehabilitation Center for Returning Military Personnel, 2014, EFF DRIV INT PROGR S; Folkman S., 1984, STRESS; GAGE M, 1992, AM J OCCUP THER, V46, P353, DOI 10.5014/ajot.46.4.353; Glaser B., 1967, DISCOVERY GROUNDED T; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kashdan TB, 2006, BEHAV RES THER, V44, P457, DOI 10.1016/j.brat.2005.03.001; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Kraft M, 2010, AM J PHYS MED REHAB, V89, P336, DOI 10.1097/PHM.0b013e3181d3eb5f; Kuhn E, 2010, J TRAUMA STRESS, V23, P399, DOI 10.1002/jts.20536; Lazarus RS., 2006, STRESS EMOTION NEW S; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Michon J.A., 1985, HUMAN BEHAV TRAFFIC; Miles MB, 1994, EXPANDED SOURCEBOOK; Military Health System Office of Strategic Communications, 2012, DOD NUMB TRAUM BRAIN; National Center for PTSD, 2013, DSM CRIT PTSD; National Research Council: Committee on Gulf War and Health, 2008, GULF WAR HLTH, V7; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pierce S., 2010, AM J OCCUPATIONAL S, V64, pS112, DOI DOI 10.5014/AJOT.2010.64S112; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Stern E., 2011, OT PRACTICE, V16, P6; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Tanielian T., 2008, INVISIBLE WOUNDS WAR; United States Automobile Association, 2012, RET WARR DRIV SAF RE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zamorski MA, 2012, PSYCHOL ASPECTS DEPL; [No title captured]	44	13	13	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	10					1315	1330		10.1682/JRRD.2013.04.0084			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AE0LR	WOS:000333658300004	24699968	Bronze			2022-02-06	
J	Hou, YM; Huang, Q; Prakash, R; Chaudhury, S				Hou, Yongmei; Huang, Qin; Prakash, Ravi; Chaudhury, Suprakash			Infrequent near death experiences in severe brain injury survivors - A quantitative and qualitative study	ANNALS OF INDIAN ACADEMY OF NEUROLOGY			English	Article						Near- death experiences; post- traumatic coma; qualitative analysis	CARDIAC-ARREST SURVIVORS; OF-BODY EXPERIENCES; POSTTRAUMATIC COMA; PERSPECTIVE; STATE	Background: Near death experiences (NDE) are receiving increasing attention by the scientific community because not only do they provide a glimpse of the complexity of the mind-brain interactions in 'near-death' circumstances but also because they have significant and long lasting effects on various psychological aspects of the survivors. The over-all incidence-reports of NDEs in literature have varied widely from a modest Figure of 10% to around 35%, even up to an incredible Figure of 72% in persons who have faced close brush with death. Somewhat similar to this range of difference in incidences are the differences prevalent in the opinions that theorists and researchers harbor around the world for explaining this phenomena. None the less, objective evidences have supported physiological theories the most. A wide range of physiological processes have been targeted for explaining NDEs. These include cerebral anoxia, chemical alterations like hypercapnia, presence of endorphins, ketamine, and serotonin, or abnormal activity of the temporal lobe or the limbic system. In spite of the fact that the physiological theories of NDEs have revolved around the derangements in brain, no study till date has taken up the task of evaluating the experiences of near-death in patients where specific injury has been to brain. Most of them have evaluated NDEs in cardiac-arrest patients. Post-traumatic coma is one such state regarding which the literature seriously lacks any information related to NDEs. Patients recollecting any memory of their post-traumatic coma are valuable assets for NDE researchers and needs special attention. Materials and Methods: Our present study was aimed at collecting this valuable information from survivors of severe head injury after a prolonged coma. The study was conducted in the head injury department of Guangdong 999 Brain hospital, Guangzhou, China. Patients included in the study were the ones Recovered from the posttraumatic coma following a severe head injury. A total of 86 patients were chosen. Near death experience scale (NDES) score of 7 or more was used as the criteria of screening NDE experiences. After identifying such individuals, the Prakash-modification of the Interpretative Phenomenological Analysis (IPA) was used to interview and record the data for qualitative analysis. Results: We found that contrary to earlier incidence reports, NDEs in post head injury patients were markedly low. Only 3 out of 86 of the patients recruited had a clear and confident experience of NDE. We conducted a qualitative study to explore further into these experiences. IPA of these 3 patients revealed four master themes: 1. Unique light visions 2. Intense feelings of astonishment, pleasure, and fear 3. The sense of helplessness 4. Supernatural but rationality of experience. Conclusion: NDE is uncommon in head-injury cases as compared to other near-death conditions. But the persons experiencing it have immense impacts on their belief systems and emotions. This experience should be further explored by studies of larger samples.	[Hou, Yongmei] Guangdong Med Coll, Dept Psychol, Zhanjiang, Guangdong, Peoples R China; [Huang, Qin] Guangdong 999 Brain Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Prakash, Ravi; Chaudhury, Suprakash] Ranchi Inst Neuropsychiat & Allied Sci, Ranchi 834006, Bihar, India		Prakash, R (corresponding author), Ranchi Inst Neuropsychiat & Allied Sci, Ranchi 834006, Bihar, India.	drravi2121@gmail.com	Chaudhury, Suprakash/H-2904-2019; chaudhury, suprakash/ABB-2185-2021	Chaudhury, Suprakash/0000-0002-0115-1703; chaudhury, suprakash/0000-0002-0115-1703			Arzy S, 2005, MED HYPOTHESES, V65, P841, DOI 10.1016/j.mehy.2005.04.044; Atwater P.M.H., 1988, COMING BACK LIFE AFT; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Belanti J, 2008, TRANSCULT PSYCHIATRY, V45, P121, DOI 10.1177/1363461507088001; Bhaskar R., 1978, REALIST THEORY SCI; Blackmore SJ, 1996, J ROY SOC MED, V89, P73, DOI 10.1177/014107689608900204; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BMJ-BRIT MED J, V329, P1414, DOI 10.1136/bmj.329.7480.1414; Britton WB, 2004, PSYCHOL SCI, V15, P254, DOI 10.1111/j.0956-7976.2004.00661.x; BROOKS N, 1984, CLOSED HEAD INJURY P; CARR D.B., 1982, J NEAR DEATH STUDIES, VII, P75; Carter Ch, 2010, SCI NEAR DEATH EXPER, p[150, 235]; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; Fenwick P., 1995, TRUTH LIGHT; Fiske ST, 1991, SOC COGNITION, P94; French CC, 2005, PROG BRAIN RES, V150, P351, DOI 10.1016/S0079-6123(05)50025-6; French CC, 2001, LANCET, V358, P2010, DOI 10.1016/S0140-6736(01)07133-1; Greyson B, 2003, PSYCHIAT SERV, V54, P1649, DOI 10.1176/appi.ps.54.12.1649; Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2; GREYSON B, 1993, PSYCHIATRY, V56, P390; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B., 2009, HDB NEAR DEATH EXPER, P213; Griffith Linda J, 2009, Psychiatry (Edgmont), V6, P35; Groth-Marnat G, 1998, J HUMANIST PSYCHOL, V38, P110, DOI 10.1177/00221678980383005; Husserl E., 1970, CRISIS EUROPEAN SCI; Jansen KL, 1997, J NEAR DEATH STUD, V16, P79; JUDSON IR, 1983, LANCET, V2, P561; Kenneth R, 1993, J NEAR DEATH STUD, V11, P223; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; Michael M, 1998, LIGHT DEATH ONE DOCT; Moody R.A., 1975, LIFE LIFE; Morse M., 1989, J NEAR DEATH STUDIES, V8, P45, DOI [10.1007/BF01076138, DOI 10.1007/BF01076138]; Murray M, HLTH PSYCHOL, P218; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Pasricha A, 1993, J SCI EXPLOR, V7, P161; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; Prakash R, 2009, P IASTED INT C COMP; Ravi P, 2009, J CONSCIOUSNESS STUD, V16, P2; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; RODIN EA, 1980, J NERV MENT DIS, V168, P259, DOI 10.1097/00005053-198005000-00001; Shevchenko KN, 2008, 3 INT C COGN SCI MOS, V2, P497; Smith J.A., 2003, QUALITATIVE PSYCHOL; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8; Van Lommel P, 2010, CONSCIOUSNESS LIFE S, p[105, 135]; Yamamura H, 1998, Nihon Ronen Igakkai Zasshi, V35, P103; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	47	13	14	0	23	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-2327	1998-3549		ANN INDIAN ACAD NEUR	Ann. Indian Acad. Neurol.	JAN-MAR	2013	16	1					75	81		10.4103/0972-2327.107715			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	116TY	WOS:000316907100014	23661968	Green Published, gold			2022-02-06	
J	Miyamoto, K; Ohtaki, H; Dohi, K; Tsumuraya, T; Song, DD; Kiriyama, K; Satoh, K; Shimizu, A; Aruga, T; Shioda, S				Miyamoto, Kazuyuki; Ohtaki, Hirokazu; Dohi, Kenji; Tsumuraya, Tomomi; Song, Dandan; Kiriyama, Keisuke; Satoh, Kazue; Shimizu, Ai; Aruga, Tohru; Shioda, Seiji			Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice	BIOMED RESEARCH INTERNATIONAL			English	Article							FREE-RADICAL SCAVENGER; NEURONAL CELL-DEATH; UNITED-STATES; ANTIOXIDANT; INFARCTION; ISCHEMIA; OUTCOMES; MCI-186; NEUROPROTECTION; PROTECTS	Traumatic brain injury (TBI) is a major cause of death and disability in young people. No effective therapy is available to ameliorate its damaging effects. Our aim was to investigate the optimal therapeutic time window of edaravone, a free radical scavenger which is currently used in Japan. We also determined the temporal profile of reactive oxygen species (ROS) production, oxidative stress, and neuronal death. Male C57Bl/6 mice were subjected to a controlled cortical impact (CCI). Edaravone (3.0 mg/kg), or vehicle, was administered intravenously at 0, 3, or 6 hours following CCI. The production of superoxide radicals (O-2(center dot-)) as a marker of ROS, of nitrotyrosine (NT) as an indicator of oxidative stress, and neuronal death were measured for 24 hours following CCI. Superoxide radical production was clearly evident 3 hours after CCI, with oxidative stress and neuronal cell death becoming apparent after 6 hours. Edaravone administration after CCI resulted in a significant reduction in the injury volume and oxidative stress, particularly at the 3-hour time point. Moreover, the greatest decrease in O-2(center dot-) levels was observed when edaravone was administered 3 hours following CCI. These findings suggest that edaravone could prove clinically useful to ameliorate the devastating effects of TBI.	[Miyamoto, Kazuyuki; Ohtaki, Hirokazu; Tsumuraya, Tomomi; Song, Dandan; Kiriyama, Keisuke; Satoh, Kazue; Shimizu, Ai; Shioda, Seiji] Showa Univ Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Miyamoto, Kazuyuki; Dohi, Kenji; Aruga, Tohru] Showa Univ Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan		Shioda, S (corresponding author), Showa Univ Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23592683]; MEXTMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	The project was supported by a Grant-in-Aid for Young Scientists B from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Kazuyuki Miyamoto), JSPS KAKENHI (23592683) Grant-in-Aid for Scientific Research (C). This work was also supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Dawson J, 2009, CEREBROVASC DIS, V28, P202, DOI 10.1159/000226580; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Dohi K, 2010, ACTA NEUROCHIR SUPPL, V106, P315, DOI 10.1007/978-3-211-98811-4_59; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Inoue H, 2007, J NEUROSCI RES, V85, P1427, DOI 10.1002/jnr.21279; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Koizumi T, 2006, ARCH SURG-CHICAGO, V141, P992, DOI 10.1001/archsurg.141.10.992; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Manno EM, 2008, CRIT CARE, V12, DOI 10.1186/cc7112; Miyamoto K., ACTA NEUROC IN PRESS; Mizushima H, 2002, J COMP NEUROL, V448, P203, DOI 10.1002/cne.10262; Munakata A, 2009, NEUROSURGERY, V64, P423, DOI 10.1227/01.NEU.0000338067.83059.EB; Nakase T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-39; Ohta S, 2005, SPINE, V30, P1154, DOI 10.1097/01.brs.0000162402.79482.fd; Ohtaki H, 2003, ACT NEUR S, V86, P191; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Oyama JI, 2010, HEART VESSELS, V25, P379, DOI 10.1007/s00380-009-1221-7; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sano Y, 2010, CHEM PHARM BULL, V58, P1020, DOI 10.1248/cpb.58.1020; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sharma P, 2011, ANN INDIAN ACAD NEUR, V14, P103, DOI 10.4103/0972-2327.82794; Sonoda A, 2009, BRIT J RADIOL, V82, P711, DOI 10.1259/bjr/13797020; Tabrizchi R, 2000, Curr Opin Investig Drugs, V1, P347; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103; Vandelle E, 2011, PLANT SCI, V181, P534, DOI 10.1016/j.plantsci.2011.05.002; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Yamaguchi S, 2011, TOHOKU J EXP MED, V223, P235, DOI 10.1620/tjem.223.235; Yoshida H, 2006, CNS DRUG REV, V12, P9, DOI 10.1111/j.1527-3458.2006.00009.x; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	41	13	14	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								379206	10.1155/2013/379206			13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	128JP	WOS:000317765600001	23710445	Green Published, Green Submitted, gold			2022-02-06	
J	O'Neil, RL; Skeel, RL; Ustinova, KI				O'Neil, Rochelle L.; Skeel, Reid L.; Ustinova, Ksenia I.			Cognitive ability predicts motor learning on a virtual reality game in patients with TBI	NEUROREHABILITATION			English	Article						Cognitive ability; virtual reality; traumatic brain injury	REHABILITATION; ENVIRONMENTS; RELIABILITY; SEVERITY; SKILL; TASK	BACKGROUND: Virtual reality games and simulations have been utilized successfully for motor rehabilitation of individuals with traumatic brain injury (TBI). Little is known, however, how TBI-related cognitive decline affects learning of motor tasks in virtual environments. OBJECTIVE: To fill this gap, we examined learning within a virtual reality game involving various reaching motions in 14 patients with TBI and 15 healthy individuals with different cognitive abilities. METHODS: All participants practiced ten 90-second gaming trials to assess various aspects of motor learning. Cognitive abilities were assessed with a battery of tests including measures of memory, executive functioning, and visuospatial ability. RESULTS: Overall, participants with TBI showed both reduced performance and a slower learning rate in the virtual reality game compared to healthy individuals. Numerous correlations between overall performance and several of the cognitive ability domains were revealed for both the patient and control groups, with the best predictor being overall cognitive ability. CONCLUSIONS: The results may provide a starting point for rehabilitation programs regarding which cognitive domains interact with motor learning.	[O'Neil, Rochelle L.; Skeel, Reid L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Ustinova, Ksenia I.] Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48859 USA		O'Neil, RL (corresponding author), Cent Michigan Univ, Dept Psychol, Sloan Hall 101, Mt Pleasant, MI 48859 USA.	ONeil1rl@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	US Department of DefenseUnited States Department of Defense	The study was supported by the US Department of Defense.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Batson CD, 2011, EXP BRAIN RES, V209, P515, DOI 10.1007/s00221-011-2574-6; Benton A., 1976, MULTILINGUAL APHASIA; BERG K, 1989, Physiotherapy Canada, V41, P304; Boyd LA, 2007, NEUROREHAB NEURAL RE, V21, P444, DOI 10.1177/1545968307300438; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; Cirstea MC, 2003, EXP BRAIN RES, V152, P476, DOI 10.1007/s00221-003-1568-4; Cohen J., 2013, STAT POWER ANAL BEHA; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Halstead W.C., 1947, BRAIN INTELLIGENCE; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Kerr R., 1982, PSYCHOMOTOR LEARNING; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; KlOve H, 1963, MED CLIN N AM; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MAGILL RA, 2004, MOTOR LEARNING CONTR; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Meyers JE., 1995, REY COMPLEX FIGURE T; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Pearson Assessment, 2009, ADV CLIN SOL WAIS 4; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; ROBINSONRIEGLER G, 2004, COGNITIVE PSYCHOL AP; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Schmidt R. A., 2004, MOTOR LEARNING PERFO; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Smith A., 1991, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Suarez Hamlet, 2006, Int Tinnitus J, V12, P41; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Winstein CJ, 1999, NEUROPSYCHOLOGIA, V37, P975, DOI 10.1016/S0028-3932(98)00145-6; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wulf G, 2010, MED EDUC, V44, P75, DOI 10.1111/j.1365-2923.2009.03421.x; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	44	13	13	2	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	4					667	680		10.3233/NRE-130985			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	275QA	WOS:000328690700017	24018367				2022-02-06	
J	Parrish, J; Baldwin-Johnson, C; Volz, M; Goldsmith, Y				Parrish, Jared; Baldwin-Johnson, Cathy; Volz, Margaret; Goldsmith, Yvonne			Abusive head trauma among children in Alaska: a population-based assessment	INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH			English	Article						child maltreatment; child abuse; abusive head trauma; traumatic brain injury; surveillance; epidemiology	PUBLIC-HEALTH SURVEILLANCE; BRAIN-INJURIES; UNITED-STATES; MALTREATMENT; MORTALITY; UNDERASCERTAINMENT; CERTIFICATES	Background. Serious physical abuse resulting in a traumatic brain injury (TBI) has been implicated as an underreported cause of infant mortality. Nearly 80% of all abusive head trauma (AHT) occurs among children <2 years of age, with infants experiencing an incidence nearly 8 times that of 2-year olds. Objective. This study describes the validation of the CDC Pediatric Abusive Head Trauma (PAHT) definitions when applied to a multi-source database at the state level and provides a robust annual incidence estimate of AHT among children <2 years of age in Alaska. Design. AHT cases among children residing in Alaska during 2005-2010 were identified by applying the PAHT coding schema to a multi-source database which included vital death records, the Violent Death Reporting System (AK-VDRS), the Maternal Infant Mortality Review - Child Death Review (MIMR-CDR), the Alaska Trauma Registry (ATR), the inpatient Hospital Discharge Database (HDD) and Medicaid claims. Using these data, we calculated statewide AHT annual incidence rates. Results. The databases with the highest case capture rates were the ATR and Medicaid systems, both at 51%, followed by HDD at 38%. Combined, the ATR, HDD and Medicaid systems captured 91% of all AHT cases. The linkage and use of the PAHT definitions yielded an estimated sensitivity of 91% and specificity of 98%. During the study period, we detected an annual average incidence of 34.4 cases per 100,000 children aged <2 years (95% CI 25.1, 46.1) and a case fatality proportion of 22% (10/45). Among the AHT cases, 82% were infants. Significant differences (p<0.05) in AHT were noted by age and race, but not by sex. Conclusions. In Alaska, applying the CDC PAHT definition to the multi-source database enabled us to capture 49% more AHT cases than any of the individual database used in this analysis alone.	[Parrish, Jared; Goldsmith, Yvonne] Alaska Div Publ Hlth, MCH Epidemiol Unit, Anchorage, AK USA; [Parrish, Jared] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Baldwin-Johnson, Cathy; Volz, Margaret] Childrens Hosp Providence, Anchorage, AK USA		Parrish, J (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Bank Amer Bldg,Suite 500 137 East Franklin St,CB, Chapel Hill, NC 27599 USA.	jwp22@live.unc.edu					Alaska Division of Public Health, 2010, AL DIV PUBL HLTH EP; Alaska Health Care Commission, 2011, AL HOSP DIS IN PRESS; Barlow KM, 1998, SCOT MED J, V43, P112, DOI 10.1177/003693309804300407; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CDC, PREV SHAK BAB SYNDR; Crume TL, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e18; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Fujiwara T, 2012, AM J PREV MED, V43, P215, DOI 10.1016/j.amepre.2012.04.028; Herman-Giddens ME, 1999, JAMA-J AM MED ASSOC, V282, P463, DOI 10.1001/jama.282.5.463; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jurczyk P, FRIL FINE GRAINED RE; Kaltner M, 2013, INJURY PREV, V19, P139, DOI 10.1136/injuryprev-2012-040331; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; McKenzie K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-7; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Parrish JW, 2010, CHILD ABUSE NEGLECT, V34, P951, DOI 10.1016/j.chiabu.2010.07.002; Parrish JW, 2008, STATE ALASKA EPIDEMI; R Core Team, 2012, R LANG ENV STAT COMP; Schnitzer PG, 2008, AM J PUBLIC HEALTH, V98, P296, DOI 10.2105/AJPH.2006.087783; Schnitzer PG, 2004, AM J PREV MED, V27, P379, DOI 10.1016/j.amepre.2004.08.007; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Steenkamp M, 2006, INJURY PREV, V12, P3, DOI 10.1136/ip.2006.012518; WINN DG, 1995, PUBLIC HEALTH REP, V110, P277; Zolotor AJ, 2005, N C MED J, V66, P412	28	13	13	0	6	CO-ACTION PUBLISHING	JARFALLA	RIPVAGEN 7, JARFALLA, SE-175 64, SWEDEN	1239-9736	2242-3982		INT J CIRCUMPOL HEAL	Int. J. Circumpolar Health		2013	72			1			472	479	21216	10.3402/ijch.v72i0.21216			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	235LZ	WOS:000325721900151	23986886	Green Published, gold			2022-02-06	
J	Rauh, MJ; Aralis, HJ; Melcer, T; Macera, CA; Sessoms, P; Bartlett, J; Galarneau, MR				Rauh, Mitchell J.; Aralis, Hilary J.; Melcer, Ted; Macera, Caroline A.; Sessoms, Pinata; Bartlett, Jamie; Galarneau, Michael R.			Effect of traumatic brain injury among US servicemembers with amputation	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						amputation; blasts; combat-related; military; occupational therapy; odds ratio; physical therapy; postinjury complications; prosthetic use; rehabilitative use; service discharge; traumatic brain injury	ARMY MEDICAL-CENTER; OPERATION IRAQI FREEDOM; ORTHOPEDIC TRAUMA; BATTLE CASUALTIES; AMPUTEE SOLDIERS; CARE; REHABILITATION; SEVERITY; PREVALENCE; DEPRESSION	Servicemembers with combat-related limb loss often require substantial rehabilitative care. The prevalence of traumatic brain injury (TBI), which may impair cognitive and functional abilities, among servicemembers has increased. The primary objectives of this study were to determine the frequency of TBI among servicemembers with traumatic amputation and examine whether TBI status was associated with discharge to civilian status and medical and rehabilitative service use postamputation. U.S. servicemembers who had a combat-related amputation while deployed in Iraq or Afghanistan between 2001 and 2006 were followed for 2 yr postamputation. Data collected includes injury mechanism; postinjury complications; Injury Severity Score (ISS); and follow-up data, including military service discharge status and number of medical, physical, occupational therapy, and prosthetic-related visits. Of the 546 servicemembers with combat-related amputations, 127 (23.3%) had a TBI diagnosis. After adjusting for ISS and amputation location, those with TBI had a significantly greater mean number of medical and rehabilitative outpatient and inpatient visits combined (p < 0.01). Those with TBI were also at greater odds of developing certain postinjury complications. We recommend that providers treating servicemembers with limb loss should assess for TBI because those who sustained TBI required increased medical and rehabilitative care.	[Rauh, Mitchell J.; Aralis, Hilary J.; Macera, Caroline A.; Sessoms, Pinata; Bartlett, Jamie] USN, Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [Rauh, Mitchell J.] San Diego State Univ, Doctor Phys Therapy Program, San Diego, CA 92182 USA; [Rauh, Mitchell J.; Melcer, Ted; Galarneau, Michael R.] USN, Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA; [Macera, Caroline A.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA		Rauh, MJ (corresponding author), USN, Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	mrauh@mail.sdsu.edu	Bartlett, Jamie/B-9756-2014	Bartlett, Jamie/0000-0001-7934-7119; Sessoms, Pinata/0000-0002-6960-0659	Wounded, Ill, and Injured/Traumatic Brain Injury program of the U.S. Navy Bureau of Medicine and Surgery (DOD work unit) [60818]	This material was based on work supported by the Wounded, Ill, and Injured/Traumatic Brain Injury program of the U.S. Navy Bureau of Medicine and Surgery (DOD work unit no. 60818).	Army Medical Surveillance Activity, 2005, MED SURVEILLANCE MON, V11, P2; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Blumentritt S., 2009, JPO J PROSTHETICS OR, V21, P2, DOI [10.1097/JPO. 0b013-318192e96a, DOI 10.1097/JPO.0B013-318192E96A]; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chwalisz K, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P537, DOI 10.1037/10361-025; Cole PA, 2005, J BONE JOINT SURG AM, V87A, P2823, DOI 10.2106/JBJS.E.01068; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Covey Dana C, 2008, Instr Course Lect, V57, P65; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; CURLEY MD, 1982, MIL MED, V147, P572, DOI 10.1093/milmed/147.7.572; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Fischer H., 2013, US MILITARY CASUALTY; Gajewski Donald, 2006, J Am Acad Orthop Surg, V14, pS183; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gunawardena NS, 2006, MIL MED, V171, P283, DOI 10.7205/MILMED.171.4.283; Gunderson EKE, 2005, MIL MED, V170, P172; Hafner BJ, 2007, ARCH PHYS MED REHAB, V88, P207, DOI 10.1016/j.apmr.2006.10.030; Hebela N, 2004, J BONE JOINT SURG AM, V86A, P2577, DOI 10.2106/00004623-200411000-00050; Heinemann AW, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P261, DOI 10.1037/10361-012; Hoaglund F T, 1983, J Rehabil R D, V20, P57; Javernick MA, 2006, MIL MED, V171, P200, DOI 10.7205/MILMED.171.3.200; KISHBAUGH D, 1995, MIL MED, V160, P82, DOI 10.1093/milmed/160.2.82; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lin DL, 2004, J ORTHOP TRAUMA, V18, pS48, DOI 10.1097/00005131-200409001-00008; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pasquina PF, 2008, J REHABIL RES DEV, V45, P953, DOI 10.1682/JRRD.2007.10.0163; Pasquina PF, 2006, ARCH PHYS MED REHAB, V87, pS34, DOI 10.1016/j.apmr.2005.11.026; Pasquina PF, 2006, MIL MED, V171, P206, DOI 10.7205/MILMED.171.3.206; Pasquina PF, 2004, J REHABIL RES DEV, V41, pVII; Pasquina PF, 2006, J PROSTHET ORTHOT, V18, P119; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Rybarczyk B, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P29, DOI 10.1037/10361-002; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Springer BA, 2006, MIL MED, V171, P203, DOI 10.7205/MILMED.171.3.203; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; Stinner DJ, 2010, J TRAUMA, V68, P1476, DOI 10.1097/TA.0b013e3181bb9a6c; STONE LR, 1990, AM J PHYS MED REHAB, V69, P135, DOI 10.1097/00002060-199006000-00007; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; Uzun O, 2003, MIL MED, V168, P106, DOI 10.1093/milmed/168.2.106; WHITNEY MR, 2005, MIL MED TECH, V9, P38	46	13	13	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	2					161	172		10.1682/JRRD.2011.11.0212			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FF	WOS:000319303700005	23760997	Bronze			2022-02-06	
J	Stead, LG; Bodhit, AN; Patel, PS; Daneshvar, Y; Peters, KR; Mazzuoccolo, A; Kuchibhotla, S; Pulvino, C; Hatchitt, K; Lottenberg, L; Elie-Turenne, MC; Hoelle, RM; Vedula, A; Gabrielli, A; Miller, BD; Slish, JH; Falgiani, M; Falgiani, T; Tyndall, JA				Stead, Latha Ganti; Bodhit, Aakash N.; Patel, Pratik Shashikant; Daneshvar, Yasamin; Peters, Keith R.; Mazzuoccolo, Anna; Kuchibhotla, Sudeep; Pulvino, Christa; Hatchitt, Kelsey; Lottenberg, Lawrence; Elie-Turenne, Marie-Carmelle; Hoelle, Robyn M.; Vedula, Abhijna; Gabrielli, Andrea; Miller, Bayard D.; Slish, John H.; Falgiani, Michael; Falgiani, Tricia; Tyndall, J. Adrian		Emergency Med Traumatic Brai	TBI surveillance using the common data elements for traumatic brain injury: a population study	INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE			English	Article							EPIDEMIOLOGY; OUTCOMES	Background: To characterize the patterns of presentation of adults with head injury to the Emergency Department. Methods: This is a cohort study that sought to collect injury and outcome variables with the goal of characterizing the very early natural history of traumatic brain injury in adults. This IRB-approved project was conducted in collaboration with our Institution's Center for Translational Science Institute. Data were entered in REDCap, a secure database. Statistical analyses were performed using JMP 10.0 pro for Windows. Results: The cohort consisted of 2,394 adults, with 40% being women and 79% Caucasian. The most common mechanism was fall (47%) followed by motor vehicle collision (MVC) (36%). Patients sustaining an MVC were significantly younger than those whose head injury was secondary to a fall (P < 0.0001). Ninety-one percent had CT imaging; hemorrhage was significantly more likely with worse severity as measured by the Glasgow Coma Score (chi-square, P < 0.0001). Forty-four percent were admitted to the hospital, with half requiring ICU admission. In-hospital death was observed in 5.4%, while neurosurgical intervention was required in 8%. For all outcomes, worse TBI severity per GCS was significantly associated with worse outcomes (logistic regression, P < 0.0001, adjusted for age). Conclusion: These cohort data highlight the burden of TBI in the Emergency Department and provide important demographic trends for further research.	[Stead, Latha Ganti; Bodhit, Aakash N.; Patel, Pratik Shashikant; Daneshvar, Yasamin; Peters, Keith R.; Mazzuoccolo, Anna; Kuchibhotla, Sudeep; Pulvino, Christa; Hatchitt, Kelsey; Lottenberg, Lawrence; Elie-Turenne, Marie-Carmelle; Hoelle, Robyn M.; Vedula, Abhijna; Slish, John H.; Falgiani, Michael; Falgiani, Tricia; Tyndall, J. Adrian] Univ Florida, Coll Med, Ctr Brain Injury Res & Educ, Gainesville, FL 32611 USA; [Stead, Latha Ganti; Bodhit, Aakash N.; Patel, Pratik Shashikant; Daneshvar, Yasamin; Mazzuoccolo, Anna; Elie-Turenne, Marie-Carmelle; Hoelle, Robyn M.; Vedula, Abhijna; Slish, John H.; Falgiani, Michael; Falgiani, Tricia; Tyndall, J. Adrian] Univ Florida, Coll Med, Dept Emergency Med, Gainesville, FL USA; [Lottenberg, Lawrence] Univ Florida, Coll Med, Dept Acute Care Surg, Gainesville, FL USA; [Gabrielli, Andrea] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA; [Miller, Bayard D.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Stead, Latha Ganti; Peters, Keith R.] Univ Florida, Coll Med, Dept Neurol Surg, Gainesville, FL USA; [Peters, Keith R.] Univ Florida, Coll Med, Dept Radiol, Gainesville, FL 32610 USA		Stead, LG (corresponding author), Univ Florida, Coll Med, Ctr Brain Injury Res & Educ, Gainesville, FL 32611 USA.	lstead@ufl.edu	Ganti, Latha/AAF-6268-2020; Bodhit, Aakash/AAM-5786-2021; Elie-Turenne, Marie-Carmelle/G-6895-2013	Ganti, Latha/0000-0001-7717-3864; Bodhit, Aakash/0000-0003-2722-025X; Elie-Turenne, Marie-Carmelle/0000-0002-4807-9403	Toral Family Foundation, Davie, Florida, USA; NIH/NCRR Clinical and Translational Science Award [UL1 RR029890]	This work supported by grant funding from:; 1) The Toral Family Foundation, Davie, Florida, USA.; 2) The NIH/NCRR Clinical and Translational Science Award to the University of Florida UL1 RR029890.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 2002 FLOR STAT; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finkelstein E., 2006, INCIDENCE EC BURDEN; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8098; TEASDALE G, 1974, LANCET, V2, P81; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	22	13	14	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1865-1372	1865-1380		INT J EMERG MED	Int. J. Emergency Medicine		2013	6								5	10.1186/1865-1380-6-5			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V22TM	WOS:000215044100005	23445771	Green Published, gold			2022-02-06	
J	Crowe, LM; Catroppa, C; Anderson, V; Babl, FE				Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki; Babl, Franz E.			Head injuries in children under 3 years	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injuries; Infants	TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; COMPUTED-TOMOGRAPHY; RISK-FACTORS; COMA SCALE; INFANTS; CHILDHOOD; AGE; EPIDEMIOLOGY; MECHANISMS	Background: A significant number of children under 3 years sustain a head injury every year. Despite this few studies have provided detailed information about these injuries. Methods: A retrospective review of the medical files all children aged 0-3 years who attended a paediatric emergency department for treatment over a 2-year period. Results: Children aged 0-6 months had the highest rate of moderate head injury. Children under 12 months were at the greatest risk of injury. Falls were the most common cause of injury including falls from caregiver's arms. Conclusions: Children under 12 months are at significant risk of head injury, many of these injuries could be prevented by increased parental supervision or improved home safety. (C) 2012 Elsevier Ltd. All rights reserved.	[Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia; [Crowe, Louise M.; Catroppa, Cathy; Anderson, Vicki; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia		Crowe, LM (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Crowe, Louise/0000-0003-4619-9708	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This study was supported by the Foundation for Children and the Victorian Government's Operational Infrastructure Support Program.	Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Crowe L, CHILD NEUROPSYCHOL, P1; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dedoukou X, 2004, ARCH PEDIAT ADOL MED, V158, P1002, DOI 10.1001/archpedi.158.10.1002; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Johnson K, 2005, CLIN RADIOL, V60, P464, DOI 10.1016/j.crad.2004.09.013; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kieslich M, 2001, DISABIL REHABIL, V23, P665; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Lawlor DA, 2004, J ROY SOC MED, V97, P121, DOI 10.1258/jrsm.97.3.121; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Ng SM, 2002, J PAEDIATR CHILD H, V38, P388, DOI 10.1046/j.1440-1754.2002.00012.x; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Settle F, 2005, J PAEDIATR CHILD H, V41, P130, DOI 10.1111/j.1440-1754.2005.00562.x; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; World Health Organization, 1992, INT CLASS DIS	40	13	15	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2141	2145		10.1016/j.injury.2012.07.195			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600031	22921385				2022-02-06	
J	Liu, H; Sarnaik, SM; Manole, MD; Chen, YM; Shinde, SN; Li, WJ; Rose, M; Alexander, H; Chen, J; Clark, RSB; Graham, SH; Hickey, RW				Liu, Hao; Sarnaik, Syana M.; Manole, Mioara D.; Chen, Yaming; Shinde, Sunita N.; Li, Wenjin; Rose, Marie; Alexander, Henry; Chen, Jie; Clark, Robert S. B.; Graham, Steven H.; Hickey, Robert W.			Increased cytochrome c in rat cerebrospinal fluid after cardiac arrest and its effects on hypoxic neuronal survival	RESUSCITATION			English	Article						Cerebrospinal fluid; Brain ischemia; Cardiac arrest; Cytochrome c	ACUTE BRAIN-DAMAGE; COGNITIVE IMPAIRMENT; SURROGATE MARKERS; CEREBRAL-ISCHEMIA; CELL-DEATH; RELEASE; APOPTOSIS; INJURY; STROKE; RESUSCITATION	Cerebrospinal fluid (CSF) proteins may be useful biomarkers of neuronal death and ultimate prognosis after hypoxic-ischemic brain injury. Cytochrome c has been identified in the CSF of children following traumatic brain injury. Cytochrome c is required for cellular respiration but it is also a central component of the intrinsic pathway of apoptosis. Thus, in addition to serving as a biomarker, cytochrome c release into CSF may have an effect upon survival of adjacent neurons. In this study, we use Western blot and ELISA to show that cytochrome c is elevated in CSF obtained from pediatric rats following resuscitation from cardiac arrest. Using biotinylated human cytochrome c in culture media we show that cytochrome c crosses the cell membrane and is incorporated into mitochondria of neurons exposed to anoxia. Lastly, we show that addition of human cytochrome c to primary neuronal culture exposed to anoxia improves survival. To our knowledge, this is the first study to show cytochrome c is elevated in CSF following hypoxic ischemic brain injury. Results from primary neuronal culture suggest that extracellular cytochrome c is able to cross the cell membrane of injured neurons, incorporate into mitochondria, and promote survival following anoxia. (c) 2012 Elsevier Ireland Ltd. All rights reserved.	[Liu, Hao; Li, Wenjin; Rose, Marie; Graham, Steven H.] VA Pittsburgh Healthcare Ctr, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Liu, Hao; Shinde, Sunita N.; Li, Wenjin; Rose, Marie; Chen, Jie; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Sarnaik, Syana M.; Manole, Mioara D.; Hickey, Robert W.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Chen, Yaming; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Chen, Yaming; Alexander, Henry; Clark, Robert S. B.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Hickey, RW (corresponding author), UPMC, Childrens Hosp Pittsburgh, 1Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	Robert.Hickey@chp.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21HD058846, K08HD40848, NIH R0137549, K08HD058798]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD058798] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD058846, K08HD040848] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER	This work was supported by NIH R21HD058846 and K08HD40848 (RWH), NIH R0137549 (SHG) and NIH K08HD058798 (MDM). The authors thank Pat Strickler for secretarial support.	Ahlemeyer B, 2002, BRAIN RES, V934, P107, DOI 10.1016/S0006-8993(02)02365-X; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Hosoya M, 2005, PEDIATR INFECT DIS J, V24, P467, DOI 10.1097/01.inf.0000160995.07461.b8; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li WJ, 2010, J NEUROCHEM, V113, P965, DOI 10.1111/j.1471-4159.2010.06674.x; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; MartinAncel A, 1997, PEDIATRICS, V100, P789, DOI 10.1542/peds.100.5.789; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Papaliagkas VT, 2009, CURR ALZHEIMER RES, V6, P279, DOI 10.2174/156720509788486626; Piel DA, 2008, SHOCK, V29, P612, DOI 10.1097/SHK.0b013e318157e962; Piel DA, 2007, CRIT CARE MED, V35, P2120, DOI 10.1097/01.CCM.0000278914.85340.FE; Radhakrishnan J, 2007, AM J PHYSIOL-HEART C, V292, pH767, DOI 10.1152/ajpheart.00468.2006; Renz A, 2001, BLOOD, V98, P1542, DOI 10.1182/blood.V98.5.1542; Riikonen RS, 1999, PEDIATR NEUROL, V20, P137, DOI 10.1016/S0887-8994(98)00122-2; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Tarkowski E, 1999, STROKE, V30, P321, DOI 10.1161/01.STR.30.2.321; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao H, 2005, J CEREBR BLOOD F MET, V25, P1119, DOI 10.1038/sj.jcbfm.9600111	25	13	13	1	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	DEC	2012	83	12					1491	1496		10.1016/j.resuscitation.2012.04.009			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	053IH	WOS:000312264200026	22554683	Green Accepted			2022-02-06	
J	Matsuoka, K; Kotani, I; Yamasato, M				Matsuoka, Keiko; Kotani, Izumi; Yamasato, Michihiko			Correct information unit analysis for determining the characteristics of narrative discourse in individuals with chronic traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; discourse; executive function; working memory	CLOSED-HEAD-INJURY; ADULTS; COMMUNICATION; CHILDREN; PERFORMANCE; ADOLESCENTS; ABILITIES; LANGUAGE; DEFICITS; APHASIA	Primary objective: To investigate differences between individuals with traumatic brain injury (TBI) and a control group regarding quantitative characteristics of narrative discourse including correct information units (CIUs). The secondary objective was to explore cognitive correlations with narrative discourse measurements. Research design: Case-control study. Methods: Twenty-six individuals with TBI and 24 age-, gender- and education-matched subjects without brain injury were examined. Four-frame comic strips were used for elicitation of narrative discourse. Six variables of discourse measurements (total time, total number of units and CIUs, units per time, CIUs per time and CIUs per unit) were calculated. The relationships between the 6 discourse measurements and results of standard cognitive tests were also examined, including logical memory, working memory and executive functions. Main outcomes and results: The time efficiency for narrative discourse (i.e. total time, units per time and CIUs per time) was significantly decreased in the TBI group. Moreover, time efficiency was significantly related to measurements of working memory and executive function. The TBI group did not differ from the control group with regard to total number of units and CIUs and CIUs per unit. Conclusion: Decreased time efficiency is the most critical characteristic of narrative discourse in individuals with TBI.	[Matsuoka, Keiko] Kamata TERAKOYA, Ota Ku, Tokyo 1460095, Japan; [Yamasato, Michihiko] Tsukuba Mem Hosp, Tsukuba, Ibaraki, Japan		Matsuoka, K (corresponding author), Kamata TERAKOYA, Ota Ku, Tamagawa 1-21-21, Tokyo 1460095, Japan.	keiko_matsuoka@nifty.ne.jp			 [19905015]	This study was financially supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Encouragement of Scientists, No. 19905015.	Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Body R., 1999, BRAIN DAM B; Burgess P, 1996, BEHAV ASSESSMENT DYS; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Coelho C. A., 1999, BRAIN DAM B; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Honda R, 1999, APHASIOLOGY, V13, P475, DOI 10.1080/026870399402037; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; KASHIMA H, 2003, JAPANESE VERSION BEH; Kertesz A., 1982, W APHASIA BATTERY WA; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Nihon-Koujinou-Kinou-Syougai-Gakkai, 1999, SUPPL TESTS STAND LA; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; SUGISHITA M, 2001, JAPANESE VERSION WEC; Sugishita M, 1986, JAPANESE VERSION W A; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D, 1987, MANUAL WECHSLER MEMO; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Youse KM, 2005, APHASIOLOGY, V19, P297, DOI 10.1080/02687030444000769	38	13	14	0	17	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1723	1730		10.3109/02699052.2012.698789			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700018	22794783				2022-02-06	
J	Pruthi, N; Ashok, M; Kumar, VS; Jhavar, K; Sampath, S; Devi, BI				Pruthi, Nupur; Ashok, M.; Kumar, Shiva, V; Jhavar, Ketaki; Sampath, S.; Devi, B. Indira			Magnitude of pedestrian head injuries & fatalities in Bangalore, south India: A retrospective study from an apex neurotrauma center	INDIAN JOURNAL OF MEDICAL RESEARCH			English	Article						Head injuries; mortality; pedestrian trauma; postmortem; traffic injuries		Background & objectives: Pedestrians contribute to 30-40 per cent of all road traffic injuries in India. However, there is a paucity of literature on pedestrian head injury as compared to two wheeler trauma. The purpose of the present study was to study the pattern of pedestrian injuries and their outcome with a special focus on head injuries. Methods: The study was conducted in two parts in the Trauma Center at National Institute of Mental Health & Neuro Sciences, Bangalore. A retrospective study was conducted at the casualty services of the hospital in which 529 consecutive pedestrians who sustained injury in a road traffic accident were studied from June to September 2009. In the second part, records from the hospital mortuary were retrospectively analyzed from 2007 to 2009. An analysis of 326 patients who died as a pedestrian in road accidents during this period was performed. Results: Patients in both paediatric and elderly age groups constituted 47.6 per cent (252/529) of all casualty admissions. Majority of the pedestrian injuries (41.7%, 221/529) occurred between 1600 2100 h; 87.1 per cent of all patients received some primary care before admission. The most common offending vehicle was a two wheeler (49.1%, 260/529). At the time of admission, 55.2 per cent (292/529) patients had sustained a moderate or severe head injury (GCS 3-13), and 40.5 per cent (214/529) had an abnormal CT scan. In addition, 90.4 per cent (478/529) patients had also sustained associated injuries. Major thoracoabdominal trauma was seen in 4 per cent and spine injury in 2.3 per cent of the patients. The mortality rate was 6.6 per cent. In the postmortem group, pedestrian deaths constituted 26.2 per cent of all the postmortems conducted. Two wheelers were the offending vehicle in the majority of the fatal crashes (39.9%). Interpretation & conclusions: Pedestrian injuries form a major part of the workload of a neurotrauma emergency. Majority of them sustained moderate to severe head injury. More attention, infrastructure and strict implementation of rules may help reduce this burden.	[Pruthi, Nupur; Ashok, M.; Kumar, Shiva, V; Jhavar, Ketaki; Sampath, S.; Devi, B. Indira] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India		Pruthi, N (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Hosur Rd, Bangalore 560029, Karnataka, India.	pruthi_nupur@yahoo.co.in					Baldwin A, 2008, EMERG MED J, V25, P843, DOI 10.1136/emj.2007.057596; Dandona R, 2011, INJURY, V42, P97, DOI 10.1016/j.injury.2009.10.048; Gururaj G., 2006, ROAD TRAFFIC INJURY; Hotz G, 2009, J TRAUMA, V66, P1492, DOI 10.1097/TA.0b013e31819d9c9b; Martin ND, 2010, J SURG RES, V163, P323, DOI 10.1016/j.jss.2010.03.073; Ministry of Urban Development (MOUD), 2008, STUD TRAFF TRANSP PO STUD TRAFF TRANSP PO; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; National Crime Records Bureau, 2007, ACC DEATHS SUIC IND; Peden M., 2004, WORLD REPORT ROAD TR; Pruthi N, 2010, INDIAN J NEUROTRAUM, V7, P123, DOI 10.1016/S0973-0508(10)80026-7; Tokdemir M, 2009, MED SCI MONIT, V15, pPI1; Umaru H, 2007, Niger J Med, V16, P169	12	13	15	0	2	INDIAN COUNCIL MEDICAL RES	NEW DELHI	PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA	0971-5916			INDIAN J MED RES	Indian J. Med. Res.	DEC	2012	136						1039	1043					5	Immunology; Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; General & Internal Medicine; Research & Experimental Medicine	V30YV	WOS:000208852200019	23391802				2022-02-06	
J	Urban, JE; Whitlow, CT; Edgerton, CA; Powers, AK; Maldjian, JA; Stitzel, JD				Urban, Jillian E.; Whitlow, Christopher T.; Edgerton, Colston A.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.			Motor Vehicle Crash-Related Subdural Hematoma from Real-World Head Impact Data	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; CIREN; head trauma; radiology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MIDLINE SHIFT; SEVERITY; RISK; MASS; CONSCIOUSNESS; HEMORRHAGE; MORTALITY; CHILDREN	Approximately 1,700,000 people sustain a traumatic brain injury (TBI) each year and motor vehicle crashes (MVCs) are a leading cause of hospitalization from TBI. Acute subdural hematoma (SDH) is a common intracranial injury that occurs in MVCs associated with high mortality and morbidity rates. In this study, SDH volume and midline shift have been analyzed in order to better understand occupant injury by correlating them to crash and occupant parameters. Fifty-seven head computed tomography (CT) scans were selected from the Crash Injury Research Engineering Network (CIREN) with Abbreviated Injury Scale (AIS) level 3 + SDH. Semi-automated methods were used to isolate the intracranial volume. SDH and additional occupant intracranial injuries were segmented across axial CT images, providing a total SDH injury volume. SDH volume was correlated to crash parameters and occupant characteristics. Results show a positive correlation between SDH volume and crash severity in near-side and frontal crashes. Additionally, the location of the resulting hemorrhage varied by crash type. Those with greater SDH volumes had significantly lower Glasgow Coma Scale (GCS) scores at the crash site in near-side crashes. Age and fracture type were found to be significant contributors to SDH volume. This study is a volumetric analysis of real world brain injuries and known MVC impacts. The results of this study demonstrate a relationship among SDH volume, crash mechanics, and occupant characteristics that provide a better understanding of the injury mechanisms of MVC-associated TBI.	[Urban, Jillian E.; Whitlow, Christopher T.; Edgerton, Colston A.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27101 USA; [Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Ctr Injury Biomech, Virginia Tech, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.; Maldjian, Joseph A.] Wake Forest Univ, Dept Radiol Neuroradiol, Winston Salem, NC 27101 USA; [Whitlow, Christopher T.] Wake Forest Univ, Translat Sci Inst, Winston Salem, NC 27101 USA		Stitzel, JD (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Biotech Pl Bldg,575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	jdstitzel@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Maldjian, Joseph/0000-0002-6384-1072	National Highway Traffic Safety Administration [DTNH22-09-H-00265, DTNH22-10-H-00294]; Toyota Motor North America Inc [DTNH22-05-H-61001]; Medical Student Research Program (MSRP); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35DK007400-32]; Wake Forest Division of Surgical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK007400] Funding Source: NIH RePORTER	Work was performed for the CIREN Project at Wake Forest University School of Medicine in cooperation with the United States Department of Transportation/National Highway Traffic Safety Administration (USDOT/NHTSA). Funding has been provided by National Highway Traffic Safety Administration under Cooperative Agreement Numbers DTNH22-09-H-00265 and DTNH22-10-H-00294. Views expressed are those of the authors and do not represent the views of NHTSA. Previous funding of the Wake Forest University CIREN center has been provided by Toyota Motor North America Inc under Cooperative Agreement Number DTNH22-05-H-61001.; Support for Colston A. Edgerton was provided through the Medical Student Research Program (MSRP) funded by National Institutes of Health (NIH Short-term Training Grant 5T35DK007400-32 and the Wake Forest Division of Surgical Sciences.	Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 U; Bohman K, 2011, TRAFFIC INJ PREV, V12, P62, DOI 10.1080/15389588.2010.526159; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; Bruce DA, 2000, CHILD NERV SYST, V16, P755, DOI 10.1007/PL00013720; Chiewvit Pipat, 2010, Journal of the Medical Association of Thailand, V93, P99; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Faul M, 2010, TRAUMATIC BRAIN INJU; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Loftis Kathryn L, 2011, Ann Adv Automot Med, V55, P81; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; Nance ML, 2010, TRAFFIC INJ PREV, V11, P600, DOI 10.1080/15389588.2010.513072; National Highway Traffic Safety Administration, 2010, CRASH INJ RES ENG NE; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Ryb GE, 2008, J TRAUMA, V64, P406, DOI 10.1097/TA.0b013e31802beff9; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Strik HM, 2005, NEURORADIOLOGY, V47, P417, DOI 10.1007/s00234-005-1373-9; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Takhounts E. G., 2011, 22 ENH SAF VEH C P; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Weninger P, 2007, RESUSCITATION, V75, P35, DOI 10.1016/j.resuscitation.2007.03.011; Westhoff J., 2001, J TRAUMA, V51, P10; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P267; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	44	13	13	1	8	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2774	2781		10.1089/neu.2012.2373			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800006	22928543	Green Published			2022-02-06	
J	Whiting, DL; Simpson, GK; McLeod, HJ; Deane, FP; Ciarrochi, J				Whiting, Diane L.; Simpson, Grahame K.; McLeod, Hamish J.; Deane, Frank P.; Ciarrochi, Joseph			Acceptance and Commitment Therapy (ACT) for Psychological Adjustment after Traumatic Brain Injury: Reporting the Protocol for a Randomised Controlled Trial	BRAIN IMPAIRMENT			English	Article						Acceptance and Commitment Therapy; traumatic brain injury; psychological distress; randomised controlled trial; participation	COGNITIVE-BEHAVIOR THERAPY; HOSPITAL ANXIETY; DEPRESSION; REHABILITATION; PARTICIPATION; INDIVIDUALS; MANAGEMENT; AWARENESS; OUTCOMES; PROGRAM	Following a severe traumatic brain injury (TBI) there is a complex presentation of psychological symptoms which may impact on recovery. Validated treatments addressing these symptoms for this group of people are limited. This article reports on the protocol for a single-centre, two-armed, Phase II Randomised Control Trial (RCT) to address the adjustment process following a severe TBI. Participants will be recruited from Liverpool Brain Injury Rehabilitation Unit and randomly allocated to one of two groups, Acceptance and Commitment Therapy (ACT) or an active control (Befriending). The active treatment group utilises the six core processes of ACT with the intention of increasing participation and psychological flexibility and reducing psychological distress. A number of primary and secondary outcome measures, administered at assessment, post-treatment and 1-month follow-up, will be used to assess clinical outcomes. The publication of the protocol before the trial results are available addresses fidelity criterion (intervention design) for RCTs. This ensures transparency in the RCT and that it meets the guidelines according to the CONSORT statement. The protocol has also been registered on the Australian New Zealand Clinical Trials Registry ACTRN12610000851066.	[Whiting, Diane L.; Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Whiting, Diane L.; Deane, Frank P.] Univ Wollongong, Sch Psychol, Wollongong, NSW 2522, Australia; [Simpson, Grahame K.] Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [McLeod, Hamish J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8QQ, Lanark, Scotland; [Ciarrochi, Joseph] Univ Western Sydney, Sch Social Sci & Psychol, Penrith, NSW 1797, Australia		Whiting, DL (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	diane.whiting@sswahs.nsw.gov.au	Whiting, Diane/AAN-2522-2021; Simpson, Grahame K/W-1074-2019; Ciarrochi, Joseph/F-5823-2016	Simpson, Grahame K/0000-0001-8156-9060; Ciarrochi, Joseph/0000-0003-0471-8100; Whiting, Diane/0000-0003-1912-6626; McLeod, Hamish/0000-0002-4225-1815; Deane, Frank/0000-0002-6247-7416			Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bendall S, 2003, BEFRIENDING MANUAL; Bendall S, 2006, BEHAV COGN PSYCHOTH, V34, P277, DOI 10.1017/S1352465806002815; Bentler P., 2006, EQS 6 STRUCTURAL EQU, DOI 10.1080/1612197X.2016.1153130; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Brown FJ, 2009, J INTELLECT DISABILI, V13, P195, DOI 10.1177/1744629509346173; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chawla N, 2007, J CLIN PSYCHOL, V63, P871, DOI 10.1002/jclp.20400; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Ciarrochi J., 2008, CBT PRACTITIONERS GU; Dahl J, 2004, BEHAV THER, V35, P785, DOI 10.1016/S0005-7894(04)80020-0; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Feeley N, 2009, CAN J NURS RES, V41, P84; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336; Guillamondegui OD, 2011, COMP EFFECTIVENESS R, V25; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hayes SC, 2004, PRACTICAL GUIDE ACCE; Hayes SC, 2003, ACCEPTANCE COMMITMEN; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hesser H, 2009, BEHAV RES THER, V47, P523, DOI 10.1016/j.brat.2009.02.002; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kinney A, 2001, J CONTEMP PSYCHOTHER, V31, P89; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Mead N, 2010, BRIT J PSYCHIAT, V196, P96, DOI 10.1192/bjp.bp.109.064089; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mooney C. Z., 1993, SAGE U PAPER SERIES; MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Randolph C., 1998, RBANS MANUAL REPEATA; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ruiz FJ., 2010, INT J PSYCHOL PSYCHO, V10, P125, DOI DOI 10.1080/028457199439937; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Soo C, 2009, COCHRANE DATABASE SY, V3; Soo C, 2011, BRAIN IMPAIR, V12, P54, DOI 10.1375/brim.12.1.54; Sylvester M., 2011, THESIS U NEVADA RENO; Tate RL, 2011, BRAIN IMPAIR, V12, P1, DOI 10.1375/brim.12.1.1; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whitehouse A. M., 1994, J COGN PSYCHOTHER, V8, P141; Whiting D, 2012, BRAIN INJURY, V26, P588; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; WRIGHT BA, 1960, PHYS DISABILITY PSYC; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	83	13	13	2	47	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2012	13	3					360	376		10.1017/BrImp.2012.28			17	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	072HI	WOS:000313660300006		Green Submitted			2022-02-06	
J	Crystal, JD				Crystal, Jonathon D.			Prospective cognition in rats	LEARNING AND MOTIVATION			English	Article						Prospective cognition; Prospective memory; Comparative cognition; Animal model; Episodic memory; Mental time travel	EPISODIC-LIKE MEMORY; MENTAL TIME-TRAVEL; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; TASK INTERFERENCE; TRANSGENIC MICE; FUTURE EVENTS; RADIAL MAZE; SCRUB-JAYS; IMPAIRMENT	Efforts to develop animal models of memory are critical for understanding the neural substrate of memory. Memory is essential for daily life and enables information to be stored and retrieved after seconds to years. The ability to remember episodes from the past is thought to be related to the ability to plan for the future. Here we focus on a particular aspect of prospective cognition, namely the ability to remember to take action when a future scenario occurs. This review focuses on a recently developed method to evaluate prospective memory in the rat. Available evidence suggests that rats remember to take action in the future, but little is known about the temporal specificity of such memories or about the flexibility and limitations of prospective memories. Recent studies that suggest that rats remember a specific past episode are reviewed to underscore potential approaches that may be used to explore the range and limits of prospective cognition. The review highlights some directions to explore, including the temporal specificity of prospective cognition, the range of flexibility or creativity within prospective cognition, and the constraints imposed by multiple motivational systems. (C) 2012 Elsevier Inc. All rights reserved.	Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA		Crystal, JD (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jcrystal@indiana.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080052] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH080052] Funding Source: Medline		Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Babb SJ, 2005, LEARN MOTIV, V36, P177, DOI 10.1016/j.lmot.2005.02.009; Babb SJ, 2006, CURR BIOL, V16, P1317, DOI 10.1016/j.cub.2006.05.025; Beran MJ, 2012, LEARN MOTIV, V43, P192, DOI 10.1016/j.lmot.2012.05.002; Bird LR, 2003, J COMP PSYCHOL, V117, P176, DOI 10.1037/0735-7036.117.2.176; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cheke LG, 2012, BIOL LETTERS, V8, P171, DOI 10.1098/rsbl.2011.0909; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; Crystal J. D., 2012, OXFORD HDB COMP EVOL, P261; Crystal Jonathon D, 2011, Int J Comp Psychol, V24, P412; Crystal JD, 2010, BEHAV BRAIN RES, V215, P235, DOI 10.1016/j.bbr.2010.03.005; Crystal JD, 2009, BEHAV PROCESS, V80, P269, DOI 10.1016/j.beproc.2008.09.009; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; Eacott MJ, 2012, LEARN MOTIV, V43, P200, DOI 10.1016/j.lmot.2012.05.012; Eacott MJ, 2005, LEARN MEMORY, V12, P221, DOI 10.1101/lm.92505; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Einstein, 2007, PROSPECTIVE MEMORY O; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Foster ER, 2009, NEUROPSYCHOLOGY, V23, P347, DOI 10.1037/a0014692; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Hwang DY, 2004, EXP NEUROL, V186, P20, DOI 10.1016/j.expneurol.2003.09.021; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Keri RA, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P2673; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; Maxwell MM, 2009, CURR PHARM DESIGN, V15, P3977, DOI 10.2174/138161209789649295; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; Naqshbandi M, 2007, BEHAV PROCESS, V74, P217, DOI 10.1016/j.beproc.2006.10.010; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Pizzo MJ, 2004, LEARN BEHAV, V32, P240; Raskin SA, 2011, NEUROPSYCHOLOGY, V25, P201, DOI 10.1037/a0020999; Roberts WA, 2002, J GEN PSYCHOL, V129, P415, DOI 10.1080/00221300209602105; Roberts WA, 2008, SCIENCE, V320, P113, DOI 10.1126/science.1152709; Roberts WA, 2012, LEARN MOTIV, V43, P169, DOI 10.1016/j.lmot.2012.05.005; Roberts WA, 2009, TRENDS COGN SCI, V13, P271, DOI 10.1016/j.tics.2009.03.003; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Ueberham U, 2006, INT J DEV NEUROSCI, V24, P177, DOI 10.1016/j.ijdevneu.2005.11.007; Wenyi Z., 2012, CURR BIOL, V22, P1149; Wilson AG, 2012, ANIM COGN, V15, P349, DOI 10.1007/s10071-011-0459-5; Zentall TR, 2010, LEARN MOTIV, V41, P225, DOI 10.1016/j.lmot.2010.08.001; Zentall TR, 2006, BEHAV PROCESS, V72, P173, DOI 10.1016/j.beproc.2006.01.009; Zentall TR, 2005, LEARN MOTIV, V36, P208, DOI 10.1016/j.lmot.2005.03.001; Zhou WY, 2011, ANIM COGN, V14, P325, DOI 10.1007/s10071-010-0367-0; Zhou WY, 2009, P NATL ACAD SCI USA, V106, P9525, DOI 10.1073/pnas.0904360106	66	13	13	2	28	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0023-9690			LEARN MOTIV	Learn. Motiv.	NOV	2012	43	4			SI		181	191		10.1016/j.lmot.2012.05.006			11	Psychology, Biological; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	024ND	WOS:000310115000003	23180886	Green Accepted			2022-02-06	
J	Franschman, G; Greuters, S; Jansen, WH; Posthuma, LM; Peerdeman, SM; Wattjes, MP; Loer, SA; Boer, C				Franschman, Gaby; Greuters, Sjoerd; Jansen, Wim H.; Posthuma, Linda M.; Peerdeman, Saskia M.; Wattjes, Mike P.; Loer, Stephan A.; Boer, Christa			Haemostatic and cranial computed tomography characteristics in patients with acute and delayed coagulopathy after isolated traumatic brain injury	BRAIN INJURY			English	Article						Neurotrauma; cranial computed tomography; haemostasis; coagulation disorder; outcome	HEAD-INJURY; CLASSIFICATION; COAGULATION; DIAGNOSIS; AGE; PREDICTION	Primary objective: To investigate whether the development of coagulopathy at different stages after isolated traumatic brain injury (TBI) is associated with distinct cranial computed tomography characteristics. Research design: Retrospective cohort study in 226 patients with moderate-to-severe isolated TBI who were categorized as subjects without coagulopathy or with acute temporary, acute sustained or delayed coagulopathy. Methods and procedures: Coagulopathy was defined as an activated partial thromboplastin time >40 seconds and/or prothrombin time (PT) >1.2 and/or platelet count <120*109l(-1). Cranial CT scans were assigned to the six-point Traumatic Coma Data Bank (TCDB) CT-classification. Main outcomes and results: Coagulopathy occurred in 44% of patients in the first 24-hours post-trauma. Patients with acute, sustained coagulopathy showed a prolonged PT (1.64 +/- 0.89) when compared to patients without (1.03 +/- 0.07), acute temporary (1.27 +/- 0.22) or delayed coagulopathy (1.08 +/- 0.06; p<0.05). Patients with acute temporary or delayed coagulopathy had the worst TCDB CT classification scores, while mortality rates were the highest in patients with sustained or delayed coagulopathy. Conclusions: Not only the mere presence of coagulopathy, but also the course of haemostatic alterations following neurotrauma may hold predictive value for patient outcome, irrespective of the severity level of cerebral injury.	[Franschman, Gaby; Greuters, Sjoerd; Jansen, Wim H.; Posthuma, Linda M.; Loer, Stephan A.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Wattjes, Mike P.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Radiol, NL-1081 HV Amsterdam, Netherlands		Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl		Boer, Christa/0000-0002-7781-6951			Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Yuan S, 2007, THROMB RES, V120, P29, DOI 10.1016/j.thromres.2006.07.002; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	33	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1464	1471		10.3109/02699052.2012.694566			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400007	22721350				2022-02-06	
J	Gosselin, N; Chen, JK; Bottari, C; Petrides, M; Jubault, T; Tinawi, S; de Guise, E; Ptito, A				Gosselin, Nadia; Chen, Jen-Kai; Bottari, Carolina; Petrides, Michael; Jubault, Thomas; Tinawi, Simon; de Guise, Elaine; Ptito, Alain			The Influence of Pain on Cerebral Functioning after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						functional magnetic resonance imaging; pain; prefrontal cortex; traumatic brain injury; working memory	SPORTS-RELATED CONCUSSION; RECIPROCAL RELATIONSHIP; STATISTICAL-ANALYSIS; PREFRONTAL CORTEX; FMRI DATA; DEPRESSION; MRI; ACTIVATION; ANATOMY; NETWORK	More than 75% of patients with mild traumatic brain injury (MTBI) report chronic pain whose potential detrimental effects on cognitive recovery need to be identified. The objective of this study was to investigate the relationship between pain, performance on a working memory task, gray matter density, and mid-dorsolateral prefrontal cortex (mid-DLPFC) activation in subjects with a MTBI. For comparison purposes, we performed identical correlation analyses with a group of subjects without MTBI who sustained sports injuries. Twenty-four subjects who experienced a MTBI in the past 12 months, 16 control subjects, and 29 subjects with sport injuries were included. One hour prior to entering the magnetic resonance scanner, the subjects were asked to fill out the pain Visual Analogue Scale. Subsequently, a high-resolution T1-weighted image was acquired followed by a functional magnetic resonance imaging session using the visual externally ordered working memory task. Results showed that MTBI subjects reporting severe pain in the hour preceding the testing had reduced mid-DLPFC activation during the working memory task and poorer performance on the task. Subjects with sport injuries and severe levels of pain showed the reverse pattern: pain was associated with higher activation in the mid-DLPFC and did not correlate with performance. Gray matter density measures were independent of pain level. This study showed that behavioral performance and cerebral functioning are affected by pain after a MTBI. Moreover, this study suggests that pain, cognition, and cerebral functioning interactions could not easily be generalized from one clinical population to another.	[Gosselin, Nadia; Petrides, Michael; Ptito, Alain] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Gosselin, Nadia; Petrides, Michael; de Guise, Elaine; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Chen, Jen-Kai] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Jubault, Thomas] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Tinawi, Simon; de Guise, Elaine] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Ptito, Alain] McGill Univ, Dept Psychol, Ctr Hlth, Montreal, PQ, Canada		Ptito, A (corresponding author), Montreal Neurol Inst, Cognit Neurosci Unit, Neuropsychol Dept, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds pour la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec	This study was supported by the Canadian Institutes of Health Research (grants to A.P. and M.P. and fellowships to N.G. and C.B.) and by the Fonds pour la Recherche en Sante du Quebec (fellowships to N.G. and J.K.C.). The authors are grateful to Dr. Diane Diorio, Mitra Feyz, Isabel Roy, and Cindy Hovington for their help with subject recruitment and/or technical support. We would also like to thank the staff of the Magnetic Resonance Imaging Unit of the McConnell Brain Imaging Centre, Montreal, Quebec, Canada for their assistance.	Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chou KL, 2007, J AFFECT DISORDERS, V102, P115, DOI 10.1016/j.jad.2006.12.013; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick BD, 2003, CLIN NEUROPHYSIOL, V114, P1497, DOI 10.1016/S1388-2457(03)00133-0; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUSKISSON EC, 1982, J RHEUMATOL, V9, P768; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maletic V, 2009, FRONT BIOSCI-LANDMRK, V14, P5291, DOI 10.2741/3598; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; PETRIDES M, 1995, J NEUROSCI, V15, P359; Ruscheweyh R, 2011, PAIN, V152, P904, DOI 10.1016/j.pain.2011.01.013; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wood Patrick B, 2010, Curr Rheumatol Rep, V12, P462, DOI 10.1007/s11926-010-0129-7; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2003, STAT METHODS MED RES, V12, P401, DOI 10.1191/0962280203sm340ra	41	13	13	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2625	2634		10.1089/neu.2012.2312			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400004	23016544				2022-02-06	
J	O'Neil, B; Prichep, LS; Naunheim, R; Chabot, R				O'Neil, Brian; Prichep, Leslie S.; Naunheim, Roseanne; Chabot, Robert			Quantitative Brain Electrical Activity in the Initial Screening of Mild Traumatic Brain Injuries	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article								Introduction: The incidence of emergency department (ED) visits for Traumatic Brain Injury (TBI) in the United States exceeds 1,000,000 cases/year with the vast majority classified as mild (mTBI). Using existing computed tomography (CT) decision rules for selecting patients to be referred for CT, such as the New Orleans Criteria (NOC), approximately 70% of those scanned are found to have a negative CT. This study investigates the use of quantified brain electrical activity to assess its possible role in the initial screening of ED mTBI patients as compared to NOC. Methods: We studied 119 patients who reported to the ED with mTBI and received a CT. Using a hand-held electroencephalogram (EEG) acquisition device, we collected data from frontal leads to determine the likelihood of a positive CT. The brain electrical activity was processed off-line to generate an index (TBI-Index, biomarker). This index was previously derived using an independent population, and the value found to be sensitive for significant brain dysfunction in TBI patients. We compared this performance of the TBI-Index to the NOC for accuracy in prediction of positive CT findings. Results: Both the brain electrical activity TBI-Index and the NOC had sensitivities, at 94.7% and 92.1% respectively. The specificity of the TBI-Index was more than twice that of NOC, 49.4% and 23.5% respectively. The positive predictive value, negative predictive value and the positive likelihood ratio were better with the TBI-Index. When either the TBI-Index or the NOC are positive (combining both indices) the sensitivity to detect a positive CT increases to 97%. Conclusion: The hand-held EEG device with a limited frontal montage is applicable to the ED environment and its performance was superior to that obtained using the New Orleans criteria. This study suggests a possible role for an index of brain function based on EEG to aid in the acute assessment of mTBI patients.	[O'Neil, Brian] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Prichep, Leslie S.; Chabot, Robert] NYU, Sch Med, Dept Psychiat, Brain Res Labs, New York, NY USA; [Naunheim, Roseanne] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA		Prichep, LS (corresponding author), Brain Res Labs, Old Bellevue Adm Bldg,8th Floor 462 First Ave, New York, NY 10016 USA.	leslie.prichep@nyumc.org			BrainScope, Co., Inc.	This research was supported in part by funding from BrainScope, Co., Inc., which covered expenses related to data acquisition. The authors acknowledge the contribution of the research assistants at all clinical sites. EEG data was collected on the BrainScope device in development.	Barr WB, BRAIN INJ IN PRESS; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Bey T, 2009, WEST J EMERG MED, V10, P6; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Duff J., 2004, CLIN EEG NEUROSCIENC, V35; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kohavi R., 1995, INT C ART INT; Kondacs A, 1999, CLIN NEUROPHYSIOL, V110, P1708, DOI 10.1016/S1388-2457(99)00122-4; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Malloy, 1998, Semin Clin Neuropsychiatry, V3, P186; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Redberg RF, 2009, ARCH INTERN MED, V169, P2049, DOI 10.1001/archinternmed.2009.453; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Semelka RC, 2007, J MAGN RESON IMAGING, V25, P900, DOI 10.1002/jmri.20895; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tebano M.T., 1988, CLIN NEUROPHYSIOL, V70, P185; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	37	13	13	0	0	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	NOV	2012	13	5					394	400		10.5811/westjem.2011.12.6815			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9W8O	WOS:000422596900003	23359586	Green Published, gold			2022-02-06	
J	Price, J; Malliaras, P; Hudson, Z				Price, Jo; Malliaras, Peter; Hudson, Zoe			Current practices in determining return to play following head injury in professional football in the UK	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objective To investigate the awareness of English football team doctors of the 'Consensus in Sport' (CIS) guidelines for the assessment and management of concussion, and to identify adherence to these internationally accepted recommendations. Method A questionnaire was sent to Club Medical Officers of all the 92 English Football league teams. Results The majority (55.6%) of teams in the English Football Association (FA) do not routinely follow the CIS guidelines. Only 21% of teams routinely record an approved preseason cognitive score and only 42% complete a recommended postconcussion assessment. One-third are still using outdated fixed periods of abstinence following a concussion. Conclusions FA players are not being treated according to the guidelines recommended by International sporting organisations. The endorsement of the CIS guidelines by the English FA would ensure that all medical teams have a sound and safe protocol for managing concussed players and making return to play decisions.	[Price, Jo; Malliaras, Peter; Hudson, Zoe] Queen Mary Univ, Ctr Sports & Exercise Med, Mile End Hosp, London E1 4DG, England		Hudson, Z (corresponding author), Queen Mary Univ, Ctr Sports & Exercise Med, Mile End Hosp, Bancroft Rd, London E1 4DG, England.	z.Hudson@qmul.ac.uk		Malliaras, Peter/0000-0001-5879-4139				0	13	13	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	NOV	2012	46	14					1000	1003		10.1136/bjsports-2011-090687			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	027MX	WOS:000310357900009	22926934				2022-02-06	
J	Barmparas, G; Singer, M; Ley, E; Chung, R; Malinoski, D; Margulies, D; Salim, A; Bukur, M				Barmparas, Galinos; Singer, Matthew; Ley, Eric; Chung, Rex; Malinoski, Darren; Margulies, Daniel; Salim, Ali; Bukur, Marko			Decreased Intracranial Pressure Monitor Use At Level II Trauma Centers Is Associated with Increased Mortality	AMERICAN SURGEON			English	Article							CENTER DESIGNATION; CRITICALLY-ILL; AMERICAN-COLLEGE; INJURED PATIENTS; UNITED-STATES; HEAD-INJURY; MANAGEMENT; DEMOGRAPHICS; OUTCOMES; IMPACT	Previous investigations suggest outcome differences at Level I and Level II trauma centers. We examined use of intracranial pressure (ICP) monitors at Level I and Level II trauma centers after traumatic brain injury (TBI) and its effect on mortality. The 2007 to 2008 National Trauma Databank was reviewed for patients with an indication for ICP monitoring based on Brain Trauma Foundation (BTF) guidelines. Demographic and clinical outcomes at Level I and Level II centers were compared by regression modeling. Overall, 15,921 patients met inclusion criteria; 11,017 were admitted to a Level I and 4,904 to a Level II trauma center. Patients with TBI admitted to a Level II trauma center had a lower rate of Injury Severity Score greater than 16 (80 vs 82%, P < 0.01) and lower frequency of head Abbreviated Injury Score greater than 3 (80 vs 82%, P < 0.01). After regression modeling, patients with TBI admitted to a Level II trauma center were 31 per cent less likely to receive an ICP monitor (adjusted odds ratio [AOR], 0.69; P < 0.01) and had a significantly higher mortality (AOR, 1.12; P < 0.01). Admission to a Level II trauma center after severe TBI is associated with a decreased use of ICP monitoring in patients who meet BTF criteria as well as an increased mortality. These differences should be validated prospectively to narrow these discrepancies in care and outcomes between Level I and Level II centers.	[Barmparas, Galinos; Singer, Matthew; Ley, Eric; Chung, Rex; Malinoski, Darren; Margulies, Daniel; Salim, Ali; Bukur, Marko] Cedars Sinai Med Ctr, Div Acute Care Surg, Los Angeles, CA 90048 USA		Bukur, M (corresponding author), Cedars Sinai Med Ctr, Div Acute Care Surg, 8635 W 3rd St,Suite 650W, Los Angeles, CA 90048 USA.	Marko.Bukur@cshs.org	Barmparas, Galinos/L-6530-2019	Bukur, Marko/0000-0002-1850-7147			American College of Surgeons, 2006, RES OPT CAR INJ PAT; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Balas EA, 1998, JAMA-J AM MED ASSOC, V279, P54, DOI 10.1001/jama.279.1.54; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Celli P, 1997, Minerva Chir, V52, P1467; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; COSENTINO CM, 1991, J PEDIATR SURG, V26, P306, DOI 10.1016/0022-3468(91)90507-P; Davenport RA, 2010, BRIT J SURG, V97, P109, DOI 10.1002/bjs.6806; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Eastridge BJ, 2010, J TRAUMA, V69, pS5, DOI 10.1097/TA.0b013e3181e421f3; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Harrington D, 2011, J TRAUMA, V71, P1453; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Kraus JF, 1993, HEAD INJURY, P1; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Recinos G, 2009, INJURY, V40, P856, DOI 10.1016/j.injury.2008.11.001; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; ROBERTS I, 2000, COCHRANE DB SYST REV, V2; Sarkar B, 2011, J TRAUMA, V71, P1447, DOI 10.1097/TA.0b013e3182325d32; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Ziran BH, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-18	40	13	13	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2012	78	10					1166	1171					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	V32MB	WOS:000208954200034	23025964				2022-02-06	
J	Carlson, GA				Carlson, Gabrielle A.			Differential diagnosis of bipolar disorder in children and adolescents	WORLD PSYCHIATRY			English	Article						Bipolar disorder; mania; irritability; children; adolescents	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN INJURY; MANIC SYMPTOMS; LONGITUDINAL COURSE; MOOD DYSREGULATION; SPECTRUM DISORDERS; MENTAL-DISORDERS; STEP-BD; YOUTH; IRRITABILITY	Issues complicating the differential diagnosis of bipolar disorder in young people are discussed. They include: a) the subtype of bipolar disorder being considered; b) the person's age and stage of development; c) whether one views bipolar disorder more conservatively, requiring clear episodes that mark a distinct change from premorbid levels of function, or more liberally, focusing for instance on severe irritability/explosive outbursts as the mood change; d) who is reporting manic symptoms, and whether symptoms are past and must be recalled or current and more likely to be observed; e) impact of family history. The diagnosis of mania/bipolar I disorder may not become clear for a number of years. This is an impairing disorder, but so are the conditions from which it must be distinguished. Family history may increase the odds that certain symptoms/behaviors are manifestations of bipolar disorder but it does not make the diagnosis. Until there are biomarkers that can confirm the diagnosis, and treatments unique to the condition, it is wise to make a diagnosis of bipolar disorder in children and adolescents provisionally and keep an open mind to the likelihood that revisions may be necessary.	SUNY Stony Brook, Sch Med, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA		Carlson, GA (corresponding author), SUNY Stony Brook, Sch Med, Dept Psychiat & Behav Sci, Putnam Hall,South Campus, Stony Brook, NY 11794 USA.						Akiskal HS, 1979, PSYCHIAT CLIN N AM, V2, P527, DOI DOI 10.1016/S0193-953X(18)30995-X; Arnold LE, 2011, BIPOLAR DISORD, V13, P509, DOI 10.1111/j.1399-5618.2011.00948.x; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Benazzi F, 2004, EUR PSYCHIAT, V19, P85, DOI 10.1016/j.eurpsy.2003.09.008; Biederman J, 2009, BIPOLAR DISORD, V11, P298, DOI 10.1111/j.1399-5618.2009.00671.x; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; Brotman MA, 2006, BIOL PSYCHIAT, V60, P991, DOI 10.1016/j.biopsych.2006.08.042; Carlson G, 2005, JUVENILE-ONSET SCHIZOPHRENIA: ASSESSMENT, NEUROBIOLOGY, AND TREATMENT, P1; Carlson GA, 2003, J CHILD ADOL PSYCHOP, V13, P13, DOI 10.1089/104454603321666162; Carlson GA, 1999, J CHILD ADOL PSYCHOP, V9, P221, DOI 10.1089/cap.1999.9.221; Carlson GA, 1998, J AFFECT DISORDERS, V51, P113, DOI 10.1016/S0165-0327(98)00210-9; CARLSON GA, 1988, J AFFECT DISORDERS, V15, P219, DOI 10.1016/0165-0327(88)90019-5; Carlson GA, 1998, J AFFECT DISORDERS, V51, P177, DOI 10.1016/S0165-0327(98)00179-7; Carlson GA, 2006, DEV PSYCHOPATHOL, V18, P939, DOI 10.1017/S0954579406060470; Carlson GA, 2012, BIPOLAR DISORD, V14, P19, DOI 10.1111/j.1399-5618.2012.00982.x; Carlson GA, 2011, J AM ACAD CHILD PSY, V50, P1202, DOI 10.1016/j.jaac.2010.07.008; Carlson GA, 2011, J CHILD ADOL PSYCHOP, V21, P399, DOI 10.1089/cap.2011.0007; Carlson GA, 2011, WORLD PSYCHIATRY, V10, P195; Carlson GA, 2009, J CHILD ADOL PSYCHOP, V19, P281, DOI 10.1089/cap.2008.0108; Cicero DC, 2009, J ABNORM PSYCHOL, V118, P431, DOI 10.1037/a0015919; DELONG GR, 1988, J AUTISM DEV DISORD, V18, P593; Dubicka G, 2007, EUR J CHILD ADOLESC, V17, P153; Duffy A, 2011, AM AC CHILD AD PSYCH; Findling RL, 2010, J CLIN PSYCHIAT, V71, P1664, DOI 10.4088/JCP.09m05859yel; Galanter CA, 2008, CHILD ADOL PSYCH CL, V17, P325, DOI 10.1016/j.chc.2007.11.001; Gottesman II, 2010, ARCH GEN PSYCHIAT, V67, P252, DOI 10.1001/archgenpsychiatry.2010.1; Grof P, 2009, ACTA PSYCHIAT SCAND, V120, P378, DOI 10.1111/j.1600-0447.2009.01454.x; Hillegers MH, 2005, BIPOLAR DISORD, V7, P344, DOI 10.1111/j.1399-5618.2005.00215.x; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Lapalme M, 1997, CAN J PSYCHIAT, V42, P623, DOI 10.1177/070674379704200609; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Lewinsohn PM, 2002, CHILD ADOL PSYCH CL, V11, P461, DOI 10.1016/S1056-4993(02)00005-6; Margulies DM, 2012, BIPOLAR DISORD, V14, P488, DOI 10.1111/j.1399-5618.2012.01029.x; Martel MM, 2009, J CHILD PSYCHOL PSYC, V50, P1042, DOI 10.1111/j.1469-7610.2009.02105.x; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Meyer SE, 2009, J AFFECT DISORDERS, V113, P227, DOI 10.1016/j.jad.2008.05.024; Mick E, 2005, BIOL PSYCHIAT, V58, P576, DOI 10.1016/j.biopsych.2005.05.037; MILBERGER S, 1995, AM J PSYCHIAT, V152, P1793; Nierenberg AA, 2009, DEPRESS ANXIETY, V26, P106, DOI 10.1002/da.20547; Parens E, 2010, NEW ENGL J MED, V362, P1853, DOI 10.1056/NEJMp1003175; Pavuluri MN, 2006, J AM ACAD CHILD PSY, V45, P550, DOI 10.1097/01.chi.0000205700.40700.50; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; Potegal M, 2009, CHILD PSYCHIAT HUM D, V40, P621, DOI 10.1007/s10578-009-0148-7; Sala R, 2010, J CLIN PSYCHIAT, V71, P1344, DOI 10.4088/JCP.09m05845gre; Serrano E, J ATTEN DIS IN PRESS; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; Stringaris A, 2009, PSYCHOL MED, V39, P1237, DOI 10.1017/S0033291708004662; Stringaris A, 2012, AM J PSYCHIAT, V169, P47, DOI 10.1176/appi.ajp.2011.10101549; Stringaris A, 2011, J ABNORM CHILD PSYCH, V39, P925, DOI 10.1007/s10802-011-9520-8; Stringaris A, 2009, AM J PSYCHIAT, V166, P1048, DOI 10.1176/appi.ajp.2009.08121849; Tillman R, 2004, AM J PSYCHIAT, V161, P1278, DOI 10.1176/appi.ajp.161.7.1278; Towbin KE, 2005, J CHILD ADOL PSYCHOP, V15, P452, DOI 10.1089/cap.2005.15.452; Wilens TE, 1999, J AM ACAD CHILD PSY, V38, P680, DOI 10.1097/00004583-199906000-00014; Youngstrom EA, 2004, J AFFECT DISORDERS, V82, pS5, DOI 10.1016/j.jad.2004.05.016; Youngstrom EA, 2008, J CLIN PSYCHIAT, V69, P831, DOI 10.4088/JCP.v69n0517	58	13	13	1	8	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1723-8617			WORLD PSYCHIATRY	World Psychiatry	OCT	2012	11	3					146	152					7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	018XF	WOS:000309699800003	23024665				2022-02-06	
J	Puggina, ACG; da Silva, MJP; Schnakers, C; Laureys, S				Giesbrecht Puggina, Ana Claudia; Paes da Silva, Maria Julia; Schnakers, Caroline; Laureys, Steven			Nursing Care of Patients With Disorders of Consciousness	JOURNAL OF NEUROSCIENCE NURSING			English	Article						coma; consciousness disorders; nursing care; persistent vegetative state	PERSISTENT VEGETATIVE STATE; LOCKED-IN SYNDROME; CONTEMPORARY MOTION-PICTURES; TRAUMATIC COMA PATIENTS; SEVERE HEAD-INJURY; INTENSIVE-CARE; VERBAL COMMUNICATION; FAMILY-MEMBERS; BRAIN; SCALE	Management of severely brain-injured patients constitutes a social, economical, and ethical dilemma as well as a real challenge for the medical staff, as it requires specific expertise. The aim of this article is to explore the aspects of nursing care in patients recovering from coma such as difficulty of diagnosis, residual perception, clinical assessment, care and management, and communication with the patient and the family. The nursing care of patients with disorder of consciousness must be particular and specific for various reasons such as the difficult diagnosis, the problem of unconsciousness or lack of demonstration of consciousness, extremely complex clinical assessment, daily management with total dependence, communication with patients that requires special attention and training by health professionals, and communication with the family of these patients that requires more sensitivity and full involvement by the team.	[Paes da Silva, Maria Julia] Univ Sao Paulo EE USP, Sch Nursing, Sao Paulo, Brazil; [Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium			claudiapuggina@usp.br	Laureys, Steven/A-3349-2011; PUGGINA, ANA CLAUDIA/B-5396-2014; Laureys, Steven/AAN-2097-2021	PUGGINA, ANA CLAUDIA/0000-0001-8095-6560; Laureys, Steven/0000-0002-3096-3807	Belgian Fund for Scientific ResearchFonds de la Recherche Scientifique - FNRS; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; Fondation Medicale Reine Elisabeth; University of LiegeUniversity of Liege; CNRS/FNRS-CGRICentre National de la Recherche Scientifique (CNRS)Fonds de la Recherche Scientifique - FNRS; University of Sao Paulo and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	The Coma Science Group research is funded by the Belgian Fund for Scientific Research, European Commission, James McDonnell Foundation, Mind Science Foundation, French Speaking Community Concerted Research Action (ARC-06/11-340), Fondation Medicale Reine Elisabeth, University of Liege and the CNRS/FNRS-CGRI collaboration funds. The School of Nursing is funded by University of Sao Paulo and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo collaboration funds.	*AM ASS NEUR NURS, 2008, AANN CLIN PRACT GUID; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baker C, 1996, J CLIN NURS, V5, P185, DOI 10.1111/j.1365-2702.1996.tb00248.x; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Cardim M. G., 2004, ENFERMAGEM BRASIL, V3, P131; Carpenito-Moyet L. J, 2006, MANUAL DIAGNOSTICOS; Casarett D., 2005, BRIT MED J, V331, P24; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Demertzi A, 2009, PROG BRAIN RES, V177, P329, DOI 10.1016/S0079-6123(09)17722-1; Demertzi Athena, 2008, Expert Rev Neurother, V8, P1719, DOI 10.1586/14737175.8.11.1719; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Elliott R, 1999, J ADV NURS, V29, P1412, DOI 10.1046/j.1365-2648.1999.01028.x; Ferreira M. I. P. R, 2000, THESIS U FEDERAL SAN; Fife C, 2001, CRIT CARE MED, V29, P283, DOI 10.1097/00003246-200102000-00011; Finch H, 2005, NEUROPSYCHOL REHABIL, V15, P537, DOI 10.1080/09602010443000542; Fins JJ, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253019.00880.72; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S., 2009, ENCY NEUROSCI, V2, P1133; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; *N AM NURS DIAGN A, 2006, DIAGN ENF NANDA DEF; Owen AM, 2009, PROG BRAIN RES, V177, P399, DOI 10.1016/S0079-6123(09)17728-2; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Plum F, 1977, DIAGNOSTICO ESTUPOR; Rosenberg RN, 2009, JAMA-J AM MED ASSOC, V301, P1172, DOI 10.1001/jama.2009.224; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; Schnakers C, 2007, CURR OPIN NEUROL, V20, P620, DOI 10.1097/WCO.0b013e3282f169d9; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; SMELTZER SC, 2002, TRATADO ENFERMAGEM M; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2008, NEUROLOGY, V71, P1374, DOI 10.1212/01.wnl.0000320110.70134.60; Verhaeghe STL, 2007, J CLIN NURS, V16, P1488, DOI 10.1111/j.1365-2702.2006.01807.x; Verhaeghe STL, 2007, QUAL HEALTH RES, V17, P730, DOI 10.1177/1049732307303242; Wijdicks EFM, 2006, NEUROLOGY, V66, P1300, DOI 10.1212/01.wnl.0000210497.62202.e9; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; WILD K, 2007, EUR J TRAUMA EMERG S, V33, P268	48	13	14	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2012	44	5					260	270		10.1097/JNN.0b013e3182666407			11	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	004GQ	WOS:000308669400006	22955240				2022-02-06	
J	Hermann, NV; Lauridsen, E; Ahrensburg, SS; Gerds, TA; Andreasen, JO				Hermann, Nuno Vibe; Lauridsen, Eva; Ahrensburg, Soren Steno; Gerds, Thomas Alexander; Andreasen, Jens Ove			Periodontal healing complications following concussion and subluxation injuries in the permanent dentition: a longitudinal cohort study	DENTAL TRAUMATOLOGY			English	Article						tooth luxation; concussion injury; subluxation injury; crown fracture; periodontal healing; root resorption; tooth loss	EXPERIMENTAL LUXATION INJURIES; IMMATURE RAT TEETH; ROOT RESORPTION; REPLANTATION; MONKEYS; INCISORS	Purpose The purpose of the study was to analyze the risk of periodontal ligament (PDL) healing complications following concussion and subluxation injuries in the permanent dentition. Material and method A total 469 permanent teeth (358 patients) with concussion and 404 permanent teeth with subluxation were included in the study. All teeth were examined according to a standardized protocol including clinical, photographic, and radiographic registration. Statistics: The risk of repair-related resorption (surface resorption), infection-related resorption (inflammatory resorption), replacement-related resorption (ankylosis), marginal bone loss, and tooth loss were analyzed with the KaplanMeier method. Results Concussion: In teeth with immature root development, no healing complications were observed. For teeth with mature root development, the risk of repair related resorption after 3 years was 3.2% (95% CI: 0.36.0%) and occurred only in cases where several teeth were injured simultaneously (multiple-trauma cases). The risk of marginal bone loss in teeth with mature root development was 0.7% (95% CI: 01.6%). Infection-related resorption, replacement resorption, and tooth loss were not observed among teeth with concussion. Subluxation: In teeth with immature root development, the risk of infection-related resorption after 3 years was 1.7% [95% confidence interval (CI): 03.8%]. Infection-related resorption occurred significantly more often in teeth with concomitant crown fracture (P = 0.004). For teeth with mature root development, the risk of periodontal healing complications after 3 years was: repair-related resorption, 3.6% (95% CI: 07.6%); infection-related resorption, 0.6% (95% CI: 01.7%); replacement-related resorption, 0.6% (95% CI: 01.7%); and marginal bone loss, 0.6% (95% CI: 01.7%). No teeth were lost in the observation period. Conclusion The risk of periodontal healing complications after concussion as well as subluxation injuries in permanent teeth is very low.	[Hermann, Nuno Vibe; Lauridsen, Eva] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Hermann, Nuno Vibe] Univ Copenhagen, Sch Dent, Craniofacial Image Res Lab 3D, DK-2200 Copenhagen N, Denmark; [Hermann, Nuno Vibe] Copenhagen Univ Hosp, Rigshosp, Craniofacial Image Res Lab 3D, Copenhagen, Denmark; [Hermann, Nuno Vibe] Tech Univ Denmark, DTU Informat, Craniofacial Image Res Lab 3D, Copenhagen, Denmark; [Lauridsen, Eva; Ahrensburg, Soren Steno; Andreasen, Jens Ove] Copenhagen Univ Hosp, Rigshosp, Resource Ctr Rare Oral Dis, Copenhagen, Denmark; [Gerds, Thomas Alexander] Univ Copenhagen, Fac Hlth Sci, Dept Biostat, DK-2200 Copenhagen N, Denmark; [Andreasen, Jens Ove] Copenhagen Univ Hosp, Rigshosp, Dept Oral & Maxillofacial Surg, Copenhagen, Denmark		Hermann, NV (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sch Dent, Norre Alle 20, DK-2200 Copenhagen N, Denmark.	nuno@sund.ku.dk		Gerds, Thomas Alexander/0000-0002-5955-816X; Hermann, Nuno Vibe/0000-0002-8079-8571			ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P9; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P21; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P160; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P90; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P103; ANDREASEN FM, 1988, ENDOD DENT TRAUMATOL, V4, P170; ANDREASEN FM, 1989, ENDOD DENT TRAUMATOL, V5, P111; Andreasen FM, 1995, THESIS U COPENHAGEN; ANDREASEN JO, 1980, SWED DENT J, V4, P101; ANDREASEN JO, 1981, ACTA ODONTOL SCAND, V39, P15, DOI 10.3109/00016358109162254; ANDREASEN JO, 1980, SWED DENT J, V4, P135; ANDREASEN JO, 2003, TRAUMATIC DENT INJUR; Andreasen JO, 1972, TRAUMATIC INJURIES T; Chuang SK, 2001, J DENT RES, V80, P2016, DOI 10.1177/00220345010800111301; Gerds TA, 2009, STAT METHODOLOGICAL; HENRY JL, 1951, J AM DENT ASSOC, V42, P270, DOI 10.14219/jada.archive.1951.0045; Lauridsen E, 2012, DENT TRAUMATOL, V28, P371, DOI 10.1111/j.1600-9657.2011.01101.x; Lauridsen E, 2012, DENT TRAUMATOL, V28, P364, DOI 10.1111/j.1600-9657.2011.01102.x; MIYASHIN M, 1990, ENDOD DENT TRAUMATOL, V6, P121; MIYASHIN M, 1991, ENDOD DENT TRAUMATOL, V7, P26; Stalhane I, 1975, Sven Tandlak Tidskr, V68, P157	22	13	13	0	18	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	OCT	2012	28	5					386	393		10.1111/j.1600-9657.2012.01165.x			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	009ZC	WOS:000309063100009	22804794				2022-02-06	
J	Paredes-Andrade, E; Solid, CA; Rockswold, SB; Odland, RM; Rockswold, GL				Paredes-Andrade, Eduardo; Solid, Craig A.; Rockswold, Sarah B.; Odland, Rick M.; Rockswold, Gaylan L.			Hypertonic Saline Reduces Intracranial Hypertension in the Presence of High Serum and Cerebrospinal Fluid Osmolalities	NEUROCRITICAL CARE			English	Article						Cerebrospinal fluid osmolality; Hypertonic saline; Intracranial pressure; Osmotherapy; Serum osmolality; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SODIUM-CHLORIDE; CEREBRAL EDEMA; CELL-VOLUME; PRESSURE; MANNITOL; MANAGEMENT; OSMOTHERAPY; TRIAL	Osmotherapy has been the cornerstone in the management of patients with elevated intracranial pressure (ICP) following traumatic brain injury (TBI). Several studies have demonstrated that hypertonic saline (HTS) is a safe and effective osmotherapy agent. This study evaluated the effectiveness of HTS in reducing intracranial hypertension in the presence of a wide range of serum and cerebrospinal fluid (CSF) osmolalities. Forty-two doses of 23.4% saline boluses for treatment of refractory intracranial hypertension were reviewed retrospectively. Thirty milliliters of 23.4% NaCl was infused over 15 min for intracranial hypertension, defined as ICP > 20 mmHg. The CSF and serum osmolalities from frozen stored samples were measured with an osmometer. The values of serum sodium, hourly ICP, blood urea nitrogen (BUN), and creatinine were obtained directly from the medical records. The serum and CSF osmolalities correlated very closely to serum sodium (r > 0.9, P < 0.0001). The reduction in ICP from the baseline (measured from either the mean ICP or the lowest ICP measurement in the first 6 h after bolus HTS treatment) was statistically significant regardless of serum osmolality. The mean reduction from baseline to follow-up values was 8.8 mm Hg (P < 0.0001). The decrease in ICP was as evident with serum osmolalities > 320 as it was at a parts per thousand currency sign320. This study demonstrates that 23.4% HTS bolus is effective for the reduction of elevated ICP in patients with severe TBI even in the presence of high serum and CSF osmolalities.	[Paredes-Andrade, Eduardo; Rockswold, Sarah B.; Rockswold, Gaylan L.] Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, Minneapolis, MN 55415 USA; [Solid, Craig A.] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Analyt Serv, Minneapolis, MN USA; [Rockswold, Sarah B.] Hennepin Cty Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN 55415 USA; [Odland, Rick M.] Hennepin Cty Med Ctr, Dept Otolaryngol, Minneapolis, MN 55415 USA; [Odland, Rick M.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA; [Rockswold, Gaylan L.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Rockswold, Sarah B.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA		Rockswold, GL (corresponding author), Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, 701 Pk Ave, Minneapolis, MN 55415 USA.	gaylan.rockswold@hcmed.org					Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Becker DP, 1972, INTRACRANIAL PRESSUR, P309; Berger S., 2005, TRANSFUS ALTERN TRAN, V6, P59; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Conn, 2008, NEUROSCIENCE MED, P173, DOI [10.1007/978-1-60327-455-5_11, DOI 10.1007/978-1-60327-455-5_11]; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; FISHMAN RA, 1959, J CLIN INVEST, V38, P1698, DOI 10.1172/JCI103948; FISHMAN RA, 1992, CEREBROSPINAL FLUID, P43; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Nau R, 1997, EUR J CLIN PHARMACOL, V53, P271, DOI 10.1007/s002280050375; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Palma L, 2006, J Neurosurg Sci, V50, P63; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Polderman KH, 2003, CRIT CARE MED, V31, P584, DOI 10.1097/01.CCM.0000050287.68977.84; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Swanson PD, 1976, HDB CLIN NEUROLOGY, V28, P443; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	36	13	13	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2012	17	2					204	210		10.1007/s12028-011-9574-z			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	002QU	WOS:000308548800008	21725694				2022-02-06	
J	Atkins, CM; Kang, Y; Furones, C; Truettner, JS; Alonso, OF; Dietrich, WD				Atkins, C. M.; Kang, Y.; Furones, C.; Truettner, J. S.; Alonso, O. F.; Dietrich, W. D.			Postinjury treatment with rolipram increases hemorrhage after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						blood-brain barrier; cAMP; cerebral blood flow; cytokine; phosphodiesterase	TUMOR-NECROSIS-FACTOR; PHOSPHODIESTERASE TYPE-IV; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; TNF-ALPHA PRODUCTION; INHIBITOR ROLIPRAM; NEURONAL DAMAGE; HEAD-INJURY; DIFFERENTIAL REGULATION; FUNCTIONAL RECOVERY	The pathology caused by traumatic brain injury (TBI) is exacerbated by the inflammatory response of the injured brain. Two proinflammatory cytokines that contribute to inflammation after TBI are tumor necrosis factor-a (TNF-a) and interleukin-1 beta (IL-1 beta). From previous studies using the parasagittal fluid-percussion brain injury model, we reported that the anti-inflammatory drug rolipram, a phosphodiesterase 4 inhibitor, reduced TNF-a and IL-1 beta levels and improved histopathological outcome when administered 30 min prior to injury. We now report that treatment with (+/-)-rolipram given 30 min after injury significantly reduced TNF-a levels in the cortex and hippocampus. However, postinjury administration of (+/-)-rolipram significantly increased cortical contusion volume and increased atrophy of the cortex compared with vehicle-treated animals at 10 days postinjury. Thus, despite the reduction in proinflammatory cytokine levels, histopathological outcome was worsened with post-TBI (+/-)-rolipram treatment. Further histological analysis of (+/-)-rolipram-treated TBI animals revealed significant hemorrhage in the contused brain. Given the well-known role of (+/-)-rolipram of increasing vasodilation, it is likely that (+/-)-rolipram worsened outcome after fluid-percussion brain injury by causing increased bleeding. (c) 2012 Wiley Periodicals, Inc.	[Atkins, C. M.] Univ Miami, Miller Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis,Dept Neurol Surg, Miami, FL 33136 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis,Dept Neurol Surg, 1095 NW 14 Terrace,3-17, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS056072, NS069721]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056072, R01NS069721, P50NS030291] Funding Source: NIH RePORTER	Contract grant sponsor: National Institute of Neurological Disorders and Stroke; Contract grant number: NS056072; Contract grant number: NS069721.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barnette MS, 1996, BIOCHEM PHARMACOL, V51, P949; Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039; Birk S, 2004, EUR J PHARMACOL, V489, P93, DOI 10.1016/j.ejphar.2004.02.038; Block F, 2001, NEUROREPORT, V12, P1507, DOI 10.1097/00001756-200105250-00041; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Chang YC, 2008, PEDIATR RES, V64, P234, DOI 10.1203/PDR.0b013e31817cfc87; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Dlaboga D, 2006, BRAIN RES, V1096, P104, DOI 10.1016/j.brainres.2006.04.032; Faul M, 2010, TRAUMATIC BRAIN INJU; Foey AD, 2003, ARTHRITIS RES THER, V5, pR317, DOI 10.1186/ar999; Giorgi M, 2004, BEHAV BRAIN RES, V154, P99, DOI 10.1016/j.bbr.2004.01.024; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hosseini-Sharifabad A, 2012, PHARMACOL BIOCHEM BE, V101, P311, DOI 10.1016/j.pbb.2012.01.017; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu W, 2011, PSYCHOPHARMACOLOGY, V218, P331, DOI 10.1007/s00213-011-2290-8; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jacobitz S, 1996, MOL PHARMACOL, V50, P891; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Lee HT, 2004, ANN NEUROL, V56, P611, DOI 10.1002/ana.20259; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Losco PE, 2004, TOXICOL PATHOL, V32, P295, DOI 10.1080/01926230490431493; Maeda T, 2005, J NEUROTRAUM, V22, P763, DOI 10.1089/neu.2005.22.763; Mecklenburg L, 2006, TOXICOL LETT, V163, P54, DOI 10.1016/j.toxlet.2005.09.037; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; MERRILL JE, 1991, DEV NEUROSCI-BASEL, V13, P130, DOI 10.1159/000112150; Miwa T, 2009, EUR J PHARMACOL, V602, P112, DOI 10.1016/j.ejphar.2008.10.060; Nagakura A, 2002, BRIT J PHARMACOL, V135, P1783, DOI 10.1038/sj.bjp.0704629; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PRABHAKAR U, 1994, INT J IMMUNOPHARMACO, V16, P805, DOI 10.1016/0192-0561(94)90054-X; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Santos-Silva AJ, 2008, EUR J PHARMACOL, V582, P102, DOI 10.1016/j.ejphar.2007.12.017; SCHNEIDER HH, 1986, EUR J PHARMACOL, V127, P105, DOI 10.1016/0014-2999(86)90210-4; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Silvestre JS, 1999, J PSYCHOPHARMACOL, V13, P274, DOI 10.1177/026988119901300309; Souness JE, 1997, CELL SIGNAL, V9, P227, DOI 10.1016/S0898-6568(96)00173-8; Suzumura A, 1999, BRAIN RES, V837, P203, DOI 10.1016/S0006-8993(99)01666-2; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tilley DG, 2002, MOL PHARMACOL, V62, P497, DOI 10.1124/mol.62.3.497; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Ueda Y, 2004, STROKE, V35, P601, DOI 10.1161/01.STR.0000113693.56783.73; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Willette RN, 1997, J CEREBR BLOOD F MET, V17, P210, DOI 10.1097/00004647-199702000-00011; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1191/135245899678847194; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang J, 2008, TOXICOL PATHOL, V36, P827, DOI 10.1177/0192623308322308; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao Y, 2003, J PHARMACOL EXP THER, V305, P565, DOI 10.1124/jpet.102.47407; Zhu B, 2004, BIOCHEM PHARMACOL, V68, P479, DOI 10.1016/j.bcp.2004.03.039; Zhu WH, 1998, LIFE SCI, V63, P265, DOI 10.1016/S0024-3205(98)00270-7; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	13	14	1	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	SEP	2012	90	9					1861	1871		10.1002/jnr.23069			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972IZ	WOS:000306272100020	22535545	Green Accepted			2022-02-06	
J	Clarke, MC; Kelleher, I; Clancy, M; Cannon, M				Clarke, Mary C.; Kelleher, Ian; Clancy, Maurice; Cannon, Mary			Predicting Risk and the Emergence of Schizophrenia	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Schizophrenia; Psychiatric risk factors; Environmental risk factors; Genetic risk factors; Prenatal stress; Obstetric complications; Cannabis	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; NMDA-RECEPTOR ENCEPHALITIS; PSYCHOTIC-LIKE EXPERIENCES; PROSPECTIVE BIRTH COHORT; GENOME-WIDE ASSOCIATION; CLINICAL HIGH-RISK; PRENATAL EXPOSURE; CHILDHOOD TRAUMA; ADULT SCHIZOPHRENIA	This article gives an overview of genetic and environmental risk factors for schizophrenia. The presence of certain molecular, biological, and psychosocial factors at certain points in the life span, has been linked to later development of schizophrenia. All need to be considered in the context of schizophrenia as a lifelong brain disorder. Research interest in schizophrenia is shifting to late childhood/early adolescence for screening and preventative measures. This article discusses those environmental risk factors for schizophrenia for which there is the largest evidence base.	[Clarke, Mary C.; Kelleher, Ian; Clancy, Maurice; Cannon, Mary] Beaumont Hosp, Dept Psychiat, Royal Coll Surg Ireland, Educ & Res Ctr, Dublin 9, Ireland; [Clarke, Mary C.] Dept Psychol, Div Populat Hlth Sci, Dublin 2, Ireland		Clarke, MC (corresponding author), Beaumont Hosp, Dept Psychiat, Royal Coll Surg Ireland, Educ & Res Ctr, Dublin 9, Ireland.	maryclarke@rcsi.ie	Kelleher, Ian/C-4855-2013; Cannon, Mary/D-8227-2012	Cannon, Mary/0000-0002-0910-299X; Kelleher, Ian/0000-0003-1484-651X			ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Addington J, 2007, SCHIZOPHRENIA BULL, V33, P665, DOI 10.1093/schbul/sbl075; Agerbo E, 2012, SCHIZOPHR RES, V134, P246, DOI 10.1016/j.schres.2011.10.025; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; BALDRIDGE E B, 1990, Emergency Medicine Clinics of North America, V8, P541; Barr WB, 1997, BRIT J PSYCHIAT, V170, P515, DOI 10.1192/bjp.170.6.515; Barry H, 2011, BRIT J PSYCHIAT, V199, P508, DOI 10.1192/bjp.bp.111.092197; Blanchard MM, 2010, SCHIZOPHR RES, V123, P71, DOI 10.1016/j.schres.2010.05.028; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Boog G, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P720; Brown AS, 2007, ARCH GEN PSYCHIAT, V64, P31, DOI 10.1001/archpsyc.64.1.31; Brown AS, 2006, AM J PSYCHIAT, V163, P2178, DOI 10.1176/appi.ajp.163.12.2178; Brown AS, 2000, SCHIZOPHRENIA BULL, V26, P287, DOI 10.1093/oxfordjournals.schbul.a033453; Brown AS, 2000, AM J PSYCHIAT, V157, P438, DOI 10.1176/appi.ajp.157.3.438; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Brown AS, 2001, BIOL PSYCHIAT, V49, P473, DOI 10.1016/S0006-3223(01)01068-X; Brown AS, 2011, ORIGINS SCHIZOPHRENI, P25; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Byrne M, 2007, SCHIZOPHR RES, V97, P51, DOI 10.1016/j.schres.2007.07.018; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon M, 2002, EPIDEMIOLOGY SCHIZOP, P74; Cannon M, 2006, BRIT J PSYCHIAT, V189, P463, DOI 10.1192/bjp.bp.105.020552; Cannon TD, 2000, SCHIZOPHR B, V26, P249; Cannon TD, 2008, BIOL PSYCHIAT, V64, P797, DOI 10.1016/j.biopsych.2008.04.012; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Casadio P, 2011, ORIGINS SCHIZOPHRENI, P157; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Clarke MC, 2012, BIOL PSYCHIAT, V71, P836, DOI 10.1016/j.biopsych.2012.01.011; Clarke MC, 2009, AM J PSYCHIAT, V166, P1025, DOI 10.1176/appi.ajp.2009.08010031; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; Clarke MC, 2011, ORIGINS SCHIZOPHRENI, P96; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Cui X, 2011, ORIGINS SCHIZOPHRENI, P282; Dalman Christina, 2003, Lakartidningen, V100, P1974; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davidson K, 1969, SPECIAL PUBLICATION, pS113; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; Devlin B, 2007, HUM GENET, V121, P675, DOI 10.1007/s00439-007-0358-7; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Dickinson D, 2008, BRIT J PSYCHIAT, V193, P354, DOI 10.1192/bjp.bp.108.049387; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Eastvold AD, 2007, SCHIZOPHR RES, V93, P266, DOI 10.1016/j.schres.2007.03.013; Epel E, 2001, PSYCHONEUROENDOCRINO, V26, P37, DOI 10.1016/S0306-4530(00)00035-4; Esquirol E, 1838, MALADIES MENTALES CO; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fleminger S., 2009, LISHMANS ORGANIC PSY, P167; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; Frommann I, 2011, SCHIZOPHRENIA BULL, V37, P861, DOI 10.1093/schbul/sbp155; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; GIBBS EL, 1948, ARCH NEURO PSYCHIATR, V60, P331, DOI 10.1001/archneurpsyc.1948.02310040002001; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; GOTTESMAN II, 1982, SCHIZOPHRENIA EPIGEN; Gschwandtner U, 2006, EUR ARCH PSY CLIN N, V256, P201, DOI 10.1007/s00406-005-0626-2; GUDMUNDS.G, 1966, ACTA NEUROL SCAND, VS 43, P9; Gunnell D, 2005, SCHIZOPHR RES, V79, P315, DOI 10.1016/j.schres.2005.07.022; Gunnell D, 2003, AM J EPIDEMIOL, V158, P291, DOI 10.1093/aje/kwg118; Hambrecht M, 2002, BRIT J PSYCHIAT, V181, pS30, DOI 10.1192/bjp.181.43.s30; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; Harper KN, 2011, ORIGINS SCHIZOPHRENI, P58; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Henquet C, 2005, SCHIZOPHRENIA BULL, V31, P608, DOI 10.1093/schbul/sbi027; Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; HUTTUNEN MO, 1978, ARCH GEN PSYCHIAT, V35, P429; Iampietro MC, 2011, ORIGINS SCHIZOPHRENI, P120; Ibi D, 2010, BEHAV BRAIN RES, V206, P32, DOI 10.1016/j.bbr.2009.08.027; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Imamura Y, 1999, ACTA PSYCHIAT SCAND, V100, P344; Ingraham LJ, 2000, AM J MED GENET, V97, P18, DOI 10.1002/(SICI)1096-8628(200021)97:1<18::AID-AJMG4>3.0.CO;2-L; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Jahshan C, 2010, NEUROPSYCHOLOGY, V24, P109, DOI 10.1037/a0016791; JENSEN I, 1979, J NEUROL NEUROSUR PS, V42, P256, DOI 10.1136/jnnp.42.3.256; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kelleher I, SCHIZOPHR B IN PRESS; Kelleher I, 2012, PSYCHOL MED; Kelleher I, COGN NEUROP IN PRESS; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kim E, 2008, CURR OPIN PSYCHIATR, V21, P286, DOI 10.1097/YCO.0b013e3282fbcd21; Kim KR, 2011, COMPR PSYCHIAT, V52, P33, DOI 10.1016/j.comppsych.2010.04.010; Koenig JI, 2002, NEUROPSYCHOPHARMACOL, V27, P309; Kraeplin E, 1913, PSYCHIAT LEHRBUCH ST; KRINGLEN E, 1989, ARCH GEN PSYCHIAT, V46, P873; Laurens KR, 2007, SCHIZOPHR RES, V90, P130, DOI 10.1016/j.schres.2006.11.006; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Masurel-Paulet A, 2010, CLIN GENET, V78, P149, DOI 10.1111/j.1399-0004.2010.01374.x; McGlashan TH, 2001, SCHIZOPHRENIA BULL, V27, P563, DOI 10.1093/oxfordjournals.schbul.a006896; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 2003, SCHIZOPHR RES, V63, P73, DOI 10.1016/S0920-9964(02)00435-8; McGrath JJ, 2011, AM J PSYCHIAT, V168, P1235, DOI 10.1176/appi.ajp.2011.11081300; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Mitchell KJ, 2011, PSYCHOL MED, V41, P19, DOI 10.1017/S003329171000070X; Mittal VA, 2008, SCHIZOPHRENIA BULL, V34, P1083, DOI 10.1093/schbul/sbn080; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Myhrman A, 1996, BRIT J PSYCHIAT, V169, P637, DOI 10.1192/bjp.169.5.637; Need Anna C, 2010, Dialogues Clin Neurosci, V12, P37; Nelson B, 2010, AUST NZ J PSYCHIAT, V44, P625, DOI 10.3109/00048671003620210; Nicodemus KK, 2008, MOL PSYCHIATR, V18, P180; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Tuathaigh CMP, 2010, EUR J NEUROSCI, V31, P349, DOI 10.1111/j.1460-9568.2009.07069.x; Patterson PH, 2011, ORIGINS SCHIZOPHRENI, P335; Patterson PH, 2011, ORIGINS SCHIZOPHRENI, P255; Pflueger MO, 2007, SCHIZOPHR RES, V97, P14, DOI 10.1016/j.schres.2007.09.003; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Pukrop R, 2006, J CLIN EXP NEUROPSYC, V28, P1388, DOI 10.1080/13803390500434425; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schmitz B, 1995, J EPILEPSY, V8, P295, DOI 10.1016/0896-6974(95)00051-8; Schwartz S., 2006, PSYCHIAT EPIDEMIOLOG; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Simon AE, 2007, SCHIZOPHRENIA BULL, V33, P761, DOI 10.1093/schbul/sbm018; SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; Smith CW, 2006, SCHIZOPHR RES, V81, P211, DOI 10.1016/j.schres.2005.09.019; Sorensen HJ, 2004, BRIT J PSYCHIAT, V185, P366, DOI 10.1192/bjp.185.5.366; Sorensen HJ, 2003, AM J PSYCHIAT, V160, P464, DOI 10.1176/appi.ajp.160.3.464; Sorensen HJ, 2011, SCHIZOPHRENIA BULL, V37, P982, DOI 10.1093/schbul/sbp167; Sperner-Unterweger B, 2005, DRUGS, V65, P1493, DOI 10.2165/00003495-200565110-00004; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sundram F, 2010, BRIT J PSYCHIAT, V197, P482, DOI 10.1192/bjp.bp.110.080218; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; Tarantino LM, 2011, ORIGINS SCHIZOPHRENI, P300; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Trimble MR, 1991, PSYCHOSES EPILEPSY; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Vassos E, 2010, HUM MOL GENET, V19, P3477, DOI 10.1093/hmg/ddq259; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Wood SJ, 2003, PSYCHOL MED, V33, P1239, DOI 10.1017/S0033291703008067; Woods SW, 2009, SCHIZOPHRENIA BULL, V35, P894, DOI 10.1093/schbul/sbp027; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Ziermans TB, 2011, SCHIZOPHR RES, V126, P58, DOI 10.1016/j.schres.2010.10.022	167	13	14	0	41	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2012	35	3					585	+		10.1016/j.psc.2012.06.003			29	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	016EF	WOS:000309499600004	22929868	Green Accepted, Green Published			2022-02-06	
J	Davidson, PL; Taylor, MC; Wilson, SJ; Walsh, KAJ; Kieser, JA				Davidson, Peter L.; Taylor, Michael C.; Wilson, Suzanne J.; Walsh, Kevan A. J.; Kieser, Jules A.			Physical Components of Soft-Tissue Ballistic Wounding and Their Involvement in the Generation of Blood Backspatter	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; bloodstain pattern analysis; blood backspatter; projectile wound mechanics; impact biomechanics; phenomenological model	ENDOTHELIAL-CELL INJURY; CLOSE-RANGE SHOTS; GUNSHOT WOUNDS; PENETRATION; MECHANISMS; CAVITY; ENTRY; BRAIN; HEAD; SKIN	Gunshot backspatter comprises biological material expelled backward through bullet entry holes. Crime scene investigators analyze backspatter patterns to infer wounding circumstances. An understanding of the mechanism of backspatter generation, and the relationship between spatter patterns and bullet and tissue characteristics, would enhance the predictive value of such analysis. We examined soft-tissue ballistic wounding responses to determine the underlying components and how these might be relevant to the generation of backspatter. We identified five mechanistic components to ballistic wounding (elastic, viscous, crushing, cutting, and thermal), each related to mechanical disciplines (respectively, solid mechanics, fluid mechanics, fracture mechanics, rheology, and thermodynamics). We identified potential roles for these five components in backspatter formation and provide a scenario whereby a sequence of events incorporating these components could lead to backspatter generation and expulsion. This research provides a framework for the mathematical representation, and subsequent computational predictive modeling, of backspatter generation and pattern formation.	[Davidson, Peter L.; Wilson, Suzanne J.] Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [Taylor, Michael C.] Inst Environm Sci & Res Ltd ESR, Christchurch Sci Ctr, Christchurch, New Zealand; [Walsh, Kevan A. J.] Inst Environm Sci & Res Ltd ESR, Auckland Sci Ctr, Auckland, New Zealand; [Kieser, Jules A.] Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dunedin 9054, New Zealand		Davidson, PL (corresponding author), Univ Otago, Injury Prevent Res Unit, Dept Prevent & Social Med, POB 56, Dunedin 9054, New Zealand.	peter.davidson@otago.ac.nz			Crown Research Institute Capability Fund, Institute of Environmental Science and Research Ltd (ESR), New Zealand	Supported by a Crown Research Institute Capability Fund Grant from the Institute of Environmental Science and Research Ltd (ESR), New Zealand.	Atkins P.W., 1984, 2 LAW; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; COOPER GJ, 1990, BRIT J SURG, V77, P606, DOI 10.1002/bjs.1800770604; Di Maio VJM, 1999, GUNSHOT WOUNDS PRACT; Fackler ML, 1996, ANN EMERG MED, V28, P194, DOI 10.1016/S0196-0644(96)70062-8; FACKLER ML, 1985, J TRAUMA, V25, P522, DOI 10.1097/00005373-198506000-00009; Fung Y. C., 1993, BIOMECHANICS MECH PR; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Jussila J, 2005, INJURY, V36, P282, DOI 10.1016/j.injury.2004.09.010; Jussila J., 2005, THESIS U HELSINKI HE; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 1997, INT J LEGAL MED, V110, P27; Karger B, 2008, FORENSIC PATHOL REV, V5, P139, DOI 10.1007/978-1-59745-110-9_9; Lew E., 2005, FORENSIC PATHOLOGY P, P163; Maiden N, 2009, FORENSIC SCI MED PAT, V5, P85, DOI 10.1007/s12024-009-9090-z; MARTY W, 1994, AM J FOREN MED PATH, V15, P1, DOI 10.1097/00000433-199403000-00001; Peters CE, 1996, J TRAUMA, V40, pS16, DOI 10.1097/00005373-199603001-00003; PEX JO, 1987, J FORENSIC SCI, V32, P1587; Sellier KG, 1994, WOUND BALLISTICS SCI; Shergold OA, 2005, J BIOMECH ENG-T ASME, V127, P838, DOI 10.1115/1.1992528; Shi HH, 2000, J FLUID ENG-T ASME, V122, P806, DOI 10.1115/1.1310575; Shkrum M.J., 2007, FORENSIC PATHOLOGY T; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Sonden A, 2002, LASER SURG MED, V31, P233, DOI 10.1002/lsm.10093; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; SWGSTAIN, 2009, FORENSIC SCI COMM, V11; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Volgas DA, 2005, INJURY, V36, P373, DOI 10.1016/j.injury.2004.08.037; Young, 1999, CAVITATION; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	30	13	13	1	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2012	57	5					1339	1342		10.1111/j.1556-4029.2012.02143.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	000MX	WOS:000308391500030	22494340				2022-02-06	
J	Dethier, M; Blairy, S				Dethier, Marie; Blairy, Sylvie			Capacity for Cognitive and Emotional Empathy in Alcohol-Dependent Patients	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article						alcohol-dependence; alcoholism typology; empathy; emotional facial expressions; social relationship satisfaction	FACIAL EXPRESSION RECOGNITION; INTIMATE PARTNER VIOLENCE; HIGH-FUNCTIONING AUTISM; TRAUMATIC BRAIN-INJURY; LONG-TERM ABSTINENCE; INTERPERSONAL PROBLEMS; ANTISOCIAL PERSONALITY; MARITAL ADJUSTMENT; GENDER-DIFFERENCES; ASPERGER-SYNDROME	This study assessed two previously unexplored facets of empathy in alcohol-dependent patients (ADS) divided into two groups according to Cloninger's alcoholism typology: the attribution of intentions according to emotional facial expressions (EFEs) and emotional contagion in reaction to EFEs. Twenty-three male Type-I ADs, 21 male Type-II ADs, and 24 male control participants were compared in two computerized tasks. First, participants rated the extent to which an adjective descriptive of personality weighted on interpersonal dimensions (of rejection, aggressiveness, dominance, and affiliation) corresponded with a video of a neutral EFE that changed to an intense EFE. Second, participants evaluated their own emotional states after watching a series of videos that depicted EFEs while their own face was being filmed. The results showed that Type-I ADs attributed more rejection intentions and fewer affiliation intentions to EFEs compared with controls; however, depression might better explain this biased attribution. Furthermore, AD subtypes showed a different pattern of intention attribution according to the emotions that were portrayed and the sex of the stimulus. In addition, angry EFE mimicry was stronger in Type-II ADs than other participants. Finally, ADs expressed fewer positive emotions and more negative emotions than controls when watching EFEs. These findings emphasize the importance of differentiating alcoholism subtypes and contribute to the understanding of AD interpersonal behaviors.	[Dethier, Marie; Blairy, Sylvie] Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, B-4000 Liege, Belgium		Dethier, M (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, Blvd Rectorat 3,B33, B-4000 Liege, Belgium.	marie.dethier@ulg.ac.be					Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartek J K, 1999, Nurs Diagn, V10, P158; Beck A., 1996, BECK DEPRESSION INVE; Benton A. L., 1983, FACIAL RECOGNITION S; Bjork JM, 2004, ALCOHOL, V34, P133, DOI 10.1016/j.alcohol.2004.06.012; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Blanchard J. J., 1998, HDB SOCIAL FUNCTIONI; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Caetano R, 2008, J FAM VIOLENCE, V23, P37, DOI 10.1007/s10896-007-9127-6; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cloninger CR, 1996, ALCOHOL HEALTH RES W, V20, P18; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Combs DR, 2007, SCHIZOPHR RES, V91, P112, DOI 10.1016/j.schres.2006.12.010; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; Davis, 1994, EMPATHY SOCIAL PSYCH; Dethier M., 2010, REV FRANCOPHONE CLIN, V15, P1; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Douilliez C., 2008, REV FRANCOPHONE CLIN, V13, P1; Driessen M, 1998, ALCOHOL CLIN EXP RES, V22, P77, DOI 10.1111/j.1530-0277.1998.tb03619.x; DUBERSTEIN PR, 1993, J NERV MENT DIS, V181, P80, DOI 10.1097/00005053-199302000-00002; Epstein EE, 1997, ALCOHOL CLIN EXP RES, V21, P547; ERIKSEN L, 1986, ADDICT BEHAV, V11, P309, DOI 10.1016/0306-4603(86)90058-4; EVANS CM, 1980, BRIT J ALCOHOL ALCOH, V15, P104; Fals-Stewart W, 2005, J CONSULT CLIN PSYCH, V73, P239, DOI 10.1037/0022-006X.73.2.239; Feldman R. S., 1991, FUNDAMENTALS NONVERB, P329, DOI DOI 10.1037/A0036052; Floyd FJ, 2006, J ABNORM PSYCHOL, V115, P121, DOI 10.1037/0021-843X.115.1.121; Foisy ML, 2007, ALCOHOL CLIN EXP RES, V31, P404, DOI 10.1111/j.1530-0277.2006.00321.x; Foisy ML, 2005, J STUD ALCOHOL, V66, P673, DOI 10.15288/jsa.2005.66.673; Fridlund A. J., 1997, PSYCHOL FACIAL EXPRE, P103, DOI DOI 10.1017/CBO9780511659911.007; Fridlund AJ., 1994, HUMAN FACIAL EXPRESS; Frigerio E, 2002, PSYCHIAT RES, V113, P161, DOI 10.1016/S0165-1781(02)00244-5; Frommann N, 2003, PSYCHIAT RES, V117, P281, DOI 10.1016/S0165-1781(03)00039-8; Gendre F., 2007, PRAT PSYCHOL, V13, P255, DOI [10.1016/j.prps.2007.01.004, DOI 10.1016/J.PRPS.2007.01.004]; Gendre F., 2002, PSYCHOL PSYCHOMETRIE, V23, P101; Gilman SE, 2001, DRUG ALCOHOL DEPEN, V63, P277, DOI 10.1016/S0376-8716(00)00216-7; Glick P, 1997, PERS SOC PSYCHOL B, V23, P1323, DOI 10.1177/01461672972312009; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Halberstadt AG, 2011, J NONVERBAL BEHAV, V35, P35, DOI 10.1007/s10919-010-0099-5; Hale WW, 1998, PSYCHIAT RES, V80, P265, DOI 10.1016/S0165-1781(98)00070-5; Hallman J, 1996, J STUD ALCOHOL, V57, P155, DOI 10.15288/jsa.1996.57.155; Hatfield E., 1992, EMOTION SOCIAL BEHAV, P151, DOI DOI 10.1017/CBO9781139174138; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; HOROWITZ LM, 1988, J CONSULT CLIN PSYCH, V56, P885, DOI 10.1037/0022-006X.56.6.885; Ichiyama MA, 1996, J CONSULT CLIN PSYCH, V64, P1245, DOI 10.1037/0022-006X.64.6.1245; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Karno MP, 2004, J STUD ALCOHOL, V65, P501, DOI 10.15288/jsa.2004.65.501; Knutson B, 1996, J NONVERBAL BEHAV, V20, P165, DOI 10.1007/BF02281954; Kornreich C, 2003, PSYCHIAT RES, V119, P251, DOI 10.1016/S0165-1781(03)00130-6; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; Kornreich C, 2001, PSYCHIAT RES, V102, P235, DOI 10.1016/S0165-1781(01)00261-X; Kornreich C, 2001, J STUD ALCOHOL, V62, P533, DOI 10.15288/jsa.2001.62.533; Lipps T., 1907, PSYCHOL UNTERSUCHUNG, Vvol I, P694; Lynskey MT, 1998, DRUG ALCOHOL DEPEN, V52, P201, DOI 10.1016/S0376-8716(98)00095-7; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V61, P13, DOI 10.2466/pms.1985.61.1.13; Marlatt GA, 1996, ADDICTION, V91, pS37, DOI 10.1111/j.1360-0443.1996.tb02326.x; Marshal Michael P, 2003, Clin Psychol Rev, V23, P959, DOI 10.1016/j.cpr.2003.09.002; Martinotti G, 2009, AM J ADDICTION, V18, P157, DOI 10.1080/10550490802544391; Matsumoto D., 1988, JAPANESE CAUCASIAN F; Matyassy A, 2006, ALCOHOL ALCOHOLISM, V41, P512, DOI 10.1093/alcalc/agl045; Maurage P, 2009, ALCOHOL ALCOHOLISM, V44, P476, DOI 10.1093/alcalc/agp037; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McIntosh DN, 2006, POL PSYCHOL BULL, V371, P31; McNally AM, 2003, ADDICT BEHAV, V28, P1115, DOI 10.1016/S0306-4603(02)00224-1; Miller W., 1998, TREATING ADDICTIVE B, P203; Modestin J, 1997, EUR PSYCHIAT, V12, P335, DOI 10.1016/S0924-9338(97)80002-8; Mueller SE, 2009, INT J ENV RES PUB HE, V6, P3010, DOI 10.3390/ijerph6123010; Murphy CM, 2001, J CONSULT CLIN PSYCH, V69, P528, DOI 10.1037//0022-006X.69.3.528; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; NIXON SJ, 1992, ALCOHOL CLIN EXP RES, V16, P684, DOI 10.1111/j.1530-0277.1992.tb00661.x; Patock-Peckham JA, 2010, J STUD ALCOHOL DRUGS, V71, P95, DOI 10.15288/jsad.2010.71.95; Pekala RJ, 2009, ALCOHOL TREAT Q, V27, P94, DOI 10.1080/07347320802587005; Philippot P, 2005, CLAR SYMP, P17; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1111/j.1530-0277.1999.tb04221.x; Philippot P, 2003, NONVERBAL BEHAV CLIN, P209; Pombo S, 2009, ALCOHOL ALCOHOLISM, V44, P46, DOI 10.1093/alcalc/agn080; Raes F, 2006, J NERV MENT DIS, V194, P796, DOI 10.1097/01.nmd.0000240187.80270.bb; REILLY PM, 1994, J PSYCHOACTIVE DRUGS, V26, P401, DOI 10.1080/02791072.1994.10472460; Roper L, 2010, COGNITIVE THER RES, V34, P207, DOI 10.1007/s10608-009-9252-z; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; RYCHTARIK RG, 1989, J STUD ALCOHOL, V50, P24, DOI 10.15288/jsa.1989.50.24; Schachner DA, 2005, J NONVERBAL BEHAV, V29, P141, DOI 10.1007/s10919-005-4847-x; SCHIFFENBAUER A, 1974, J PERS SOC PSYCHOL, V30, P31, DOI 10.1037/h0036643; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; SHER KJ, 1991, J ABNORM PSYCHOL, V100, P427, DOI 10.1037/0021-843X.100.4.427; Sonnby-Borgstrom M, 2008, SCAND J PSYCHOL, V49, P111, DOI 10.1111/j.1467-9450.2008.00626.x; StatSoft, 2011, STATISTICA VERS 10 S; STOCKWELL T, 1979, BRIT J ADDICT, V74, P79; Tivis LJ, 1998, ALCOHOL CLIN EXP RES, V22, P902, DOI 10.1097/00000374-199806000-00021; Uekermann J, 2008, ADDICTION, V103, P726, DOI 10.1111/j.1360-0443.2008.02157.x; VONKNORRING AL, 1985, ACTA PSYCHIAT SCAND, V72, P51; VONKNORRING L, 1987, J STUD ALCOHOL, V48, P523, DOI 10.15288/jsa.1987.48.523; Windle M, 1999, DEV PSYCHOPATHOL, V11, P823, DOI 10.1017/S0954579499002345; Witkiewitz K, 2009, J CONSULT CLIN PSYCH, V77, P633, DOI 10.1037/a0015647; Young J. E, 1994, COGNITIVE THERAPY PE; ZWEBEN A, 1986, J STUD ALCOHOL, V47, P167, DOI 10.15288/jsa.1986.47.167	100	13	14	0	23	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	SEP	2012	26	3					371	383		10.1037/a0028673			13	Substance Abuse; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Substance Abuse; Psychology	005XZ	WOS:000308784700001	22642862	Green Submitted			2022-02-06	
J	Lee, SY; Kim, SS; Kim, CH; Park, SW; Park, JH; Yeo, M				Lee, Seo-Young; Kim, Sam Soo; Kim, Choong-Hyo; Park, Seung-Woo; Park, Jae Hyo; Yeo, Minjoo			Prediction of Outcome after Traumatic Brain Injury Using Clinical and Neuroimaging Variables	JOURNAL OF CLINICAL NEUROLOGY			English	Article						traumatic brain injury; outcome; magnetic resonance imaging	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; PROGNOSTIC VALUE; MODERATE; LESIONS; IMPACT; MR	Background and Purpose The functional outcome of traumatic brain injury (TBI) varies widely. The aim of this study was to identify the factors predicting outcome following TBI. Methods We prospectively enrolled acute TBI patients, and assessed them clinically and radio-logically using brain magnetic resonance imaging (MRI). Functional outcome was measured using the Glasgow Outcome Scale (GOS) at 3 months after TBI. A GOS score of <= 4 was regarded as an unfavorable outcome. We performed multivariate analysis to investigate the association between clinicoradiological variables and outcome. Results Forty-two patients completed the clinical evaluation in the acute phase and outcome measurement at 3 months. Motorcycle accident was associated with unfavorable outcome [odds ratio (OR)=38.3,p=0.022]. If the patients were the victims of the accident, they were more likely to have an unfavorable outcome (OR=21.3, p=0.037). All seven patients with a low Glasgow Coma Scale (GCS) score (i.e., <= 8) at 24 or 48 h after TBI were also found to have an unfavorable outcome. The presence of diffuse axonal injury (DAI) was a significant predicting factor of an unfavorable outcome (OR=8.48,p=0.042). Conclusions Motorcycle accident, being an accident victim, and a lower GCS score at 24 hours or more after the accident were found to be unfavorable prognostic variables. DAI was the only radiologic variable predicting an unfavorable outcome. Thus, it is important to identify DAI by applying MRI in the acute phase. J Clin Neurol 2012;8:224-229	[Kim, Choong-Hyo; Park, Seung-Woo] Kangwon Natl Univ Hosp, Dept Neurosurg, Chunchon 200722, South Korea; [Lee, Seo-Young; Yeo, Minjoo] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon 200722, South Korea; [Kim, Sam Soo] Kangwon Natl Univ Hosp, Dept Radiol, Chunchon 200722, South Korea; [Park, Jae Hyo] Dongguk Univ, Ilsan Hosp, Dept Neurosurg, Goyang, South Korea		Kim, CH (corresponding author), Kangwon Natl Univ Hosp, Dept Neurosurg, 156 Baengnyeong Ro, Chunchon 200722, South Korea.	jeuel@kangwon.ac.kr; mdmju@naver.com			Kangwon National University Hospital	This study was supported by a 2008 Kangwon National University Hospital Grant.	Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	22	13	14	1	7	KOREAN NEUROLOGICAL ASSOC	SEOUL	1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA	1738-6586	2005-5013		J CLIN NEUROL	J. Clin. Neurol.	SEP	2012	8	3					224	229		10.3988/jcn.2012.8.3.224			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016BG	WOS:000309491700010	23091533	Green Published, Green Submitted			2022-02-06	
J	Olivecrona, M; Koskinen, LOD				Olivecrona, Magnus; Koskinen, Lars-Owe D.			The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy	ACTA NEUROCHIRURGICA			English	Article						Prognosis; Severe traumatic brain injury; ICP-targeted therapy; IMPACT	SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; ADMISSION CHARACTERISTICS; MULTICENTER TRIAL; VALIDATION; EFFICACY; DESIGN	The prognosis of severe traumatic brain injury (sTBI) is important. The International Mission on Prognosis in Traumatic Brain Injury (IMPACT) study group has developed a prediction calculator for the outcome of patients with sTBI, and this has been made available on the World Wide Web. We have studied the use of the IMPACT calculator on sTBI patients treated with an ICP-targeted therapy based on the Lund concept. The individual clinical data of patients in a prospective sTBI protocol-driven trial of the treatment of sTBI using the Lund concept were entered into the prognosis calculator, and the individual prognosis for each patient was calculated and compared with the actual outcome at 6 months. The use of the IMPACT calculator led to an overestimation of mortality and of an unfavourable outcome. Compared with the IMPACT database, the absolute risk reduction (ARR) for mortality was 13.6 %. There is a statistically significant probability for the prediction of mortality and unfavourable outcome. A ROC curve analysis shows an area under the curve (AUC) in the Core model for mortality of 0.744 and of unfavourable outcome of 0.731, in the Extended model of 0.751 and 0.721 respectively, and in the Lab model of 0.779 and 0.810 respectively. The IMPACT prognosis calculator should be used with caution for the prediction of outcome for an individual patient with sTBI treated with an ICP-targeted therapy based on the Lund concept. We conclude that we have to initiate treatment in all patients with blunt sTBI and an initial ICP > 10 mmHg. It seems that the outcome in sTBI patients treated in this fashion is better than would have been expected from the IMPACT prognosis.	[Olivecrona, Magnus] Umea Univ, Dept Neurosurg, SE-90185 Umea, Sweden; [Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden		Olivecrona, M (corresponding author), Umea Univ, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@neuro.umu.se; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Olivecrona, Magnus/0000-0001-8457-4711; Koskinen, Lars-Owe/0000-0003-3528-8502	Foundation for Clinical Neurosciences at Umea University; Umea University Hospital; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	This study was financially supported by the Foundation for Clinical Neurosciences at Umea University, Umea University Hospital, Tore Nilsson Foundation, the Kempe Foundation, and Capio Research Foundation.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Hippocrates, 1928, SURG FRACTURES JOINT, VIII, P7; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	18	13	13	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2012	154	9					1567	1573		10.1007/s00701-012-1351-z			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	994UF	WOS:000307957500005	22543506				2022-02-06	
J	Walker, ML; Akpele, I; Spence, SD; Henderson, V				Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon			The Role of Repeat Computed Tomography Scan in the Evaluation of Blunt Bowel Injury	AMERICAN SURGEON			English	Article							SOLID-ORGAN INJURY; INTRAABDOMINAL FREE FLUID; ORAL CONTRAST SOLUTION; ABDOMINAL-TRAUMA; DIAGNOSIS; RISK; CT	The precise role of repeat abdominal computed tomography (CT) imaging in the diagnosis and management of bowel injury is unclear. We reviewed 540 patients with blunt abdominal trauma managed at a Level II trauma center over a 5-year period to better define the role of repeat imaging. One hundred patients had a repeat abdominal CT scan within 72 hours of admission. These patients were young with multisystem injuries (mean +/- standard deviation age, 34 +/- 15 years; Injury Severity Score, 21 +/- 12; Glasgow Coma Score [GCS], 12 +/- 5). There were 14 patients with bowel injuries. All bowel-injured patients survived without abdominal morbidity. Time to repeat CT was shortest in the bowel injured group (20 +/- 10 hours). The repeat CT was most helpful in patients with significant closed head injury (mean GCS, 3 +/- 1) and in those with occult bowel injury. The repeat scan resulted in a change in clinical management in 26 patients. Regarding the presence of bowel perforation, the follow-up scan enhanced sensitivity from 30 to 82 per cent. The repeat abdominal CT is best used selectively in patients with blunt abdominal trauma and can provide clinically useful information to exclude bowel injury.	[Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon] Atlanta Med Ctr, Dept Surg, Atlanta, GA 30315 USA; [Walker, Mark L.; Akpele, Ignatius; Spence, Stanston D.; Henderson, Vernon] Surg Hlth Collect, Atlanta, GA USA; [Akpele, Ignatius] AIE Surg Practice, Atlanta, GA USA		Walker, ML (corresponding author), Atlanta Med Ctr, Dept Surg, 777 Cleveland Ave SW,Suite 305, Atlanta, GA 30315 USA.	ContactUs@surgicalhealthcollective.com					Allen TL, 2004, J TRAUMA, V56, P314, DOI 10.1097/01.TA.0000058118.86614.51; Brasel KJ, 2005, J TRAUMA, V59, P1057, DOI 10.1097/01.ta.0000187798.37920.4c; Brasel KJ, 1998, J TRAUMA, V44, P889, DOI 10.1097/00005373-199805000-00024; Deunk J, 2010, ANN SURG, V251, P512, DOI 10.1097/SLA.0b013e3181cfd342; Fakhry SM, 2003, J TRAUMA, V54, P295, DOI 10.1097/01.TA.0000046256.80836.AA; Gonzalez RP, 2004, J TRAUMA, V57, P739, DOI 10.1097/01.TA.0000147518.96480.B3; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Killeen KL, 2001, J TRAUMA, V51, P26, DOI 10.1097/00005373-200107000-00005; Lawson CM, 2011, J TRAUMA, V70, P452, DOI 10.1097/TA.0b013e3182028d71; Livingston DH, 2001, AM J SURG, V182, P6, DOI 10.1016/S0002-9610(01)00665-1; Malinoski DJ, 2010, J TRAUMA, V69, P84, DOI 10.1097/TA.0b013e3181db37f5; Mitsuhide K, 2005, J TRAUMA, V58, P696, DOI 10.1097/01.TA.0000159242.93309.F6; Molina DK, 2007, J TRAUMA, V63, P625, DOI 10.1097/01.ta.0000236055.33085.77; Ng AKT, 2002, J TRAUMA, V52, P1134, DOI 10.1097/00005373-200206000-00019; Poletti PA, 2004, J TRAUMA, V57, P1072, DOI 10.1097/01.TA.0000092680.73274.E1; Salottolo K, 2009, CRIT CARE MED, V37, P1336, DOI 10.1097/CCM.0b013e31819d6739; Stafford RE, 1999, ARCH SURG-CHICAGO, V134, P622, DOI 10.1001/archsurg.134.6.622; Stuhlfaut JW, 2004, RADIOLOGY, V233, P689, DOI 10.1148/radiol.2333031972; Venkatesh KR, 2007, J TRAUMA, V62, P216, DOI 10.1097/01.ta.0000222585.76302.17; Williams MD, 2003, J TRAUMA, V55, P906, DOI 10.1097/01.TA.0000093243.01377.9B; Wu CH, 2011, J TRAUMA, V71, P543, DOI 10.1097/TA.0b013e3181fef15e	21	13	13	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2012	78	9					979	985					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	101AL	WOS:000315747300014	22964208				2022-02-06	
J	Wang, Y; Huang, X; Liang, QH; Fan, R; Qin, F; Guo, Y; Yan, KP; Liu, W; Luo, JK; Li, YH; Mao, XL; Liu, ZQ; Zhou, HH				Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Guo Yong; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui; Mao Xi-lian; Liu Zhao-qian; Zhou Hong-hao			A strategy for detecting absorbed bioactive compounds for quality control in the water extract of rhubarb by ultra performance liquid chromatography with photodiode array detector	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						quality control; absorbed bioactive compounds; rhubarb; ultra performance liquid chromatography; craniocerebral injury; anthraquinones	ANTHRAQUINONE DERIVATIVES; CONSTITUENTS; INJECTION; MEDICINE; PLANTS; UPLC; HPLC	To detect absorbed bioactive compounds of the water extract whose pharmacodynamic effect was craniocerebral protection for quality control assessment. Anthraquinones in water extract of rhubarb (WER), in cerebrospinal fluid (CSF) of patients with traumatic brain injury (TBI) and in ipsilateral cortex of TBI rats following oral WER were respectively explored by ultra performance liquid chromatography with photodiode array detector (UPLC-PDA) method developed in the present study. The effects of anthraquinones absorbed into injured cortex on superoxidase dismutase (SOD) activity in TBI rats were detected. The antioxidative anthraquinones absorbed into target organ were evaluated for quality control of WER. Anthraquinones in WER were aloe-emodin, rhein, emodin, chrysophanol, and physcion. Only the last anthraquinone was found in CSF and in ipsilateral cortex under this chromatographic condition. Physcion increased SOD activity in TBI rats significantly. Physcion was the main active compound of rhubarb against craniocerebral injury via antioxidant pathway. According to our strategy, the exploration of physcion suggested the possibility of a novel quality control of WER in treating TBI injury.	[Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China; [Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Qin Feng; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui] Cent S Univ, Xiangya Hosp, Natl Key Clin Specialist Vocat, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China; [Wang Yang; Huang Xi; Liang Qing-hua; Fan Rong; Yan Kui-po; Liu Wei; Luo Jie-kun; Li Yun-hui; Mao Xi-lian] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha 410008, Hunan, Peoples R China; [Guo Yong] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu Zhao-qian; Zhou Hong-hao] Cent S Univ, Inst Clin Pharmacol, Changsha 410008, Hunan, Peoples R China		Huang, X (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Sch Tradit Chinese Med Encephalopathy, Changsha 410008, Hunan, Peoples R China.	tcmhuangx59@163.com		Liu, Zhaoqian/0000-0003-0428-3928; Qin, Feng/0000-0001-9521-7146	Fund for Key Laboratory of Traditional Chinese Medicine Gan of State Administration of Traditional Chinese Medicine; Major Research Plan of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [90409010]; Huge Project to Boost Chinese Drug Development [2009ZX09304-003]	Supported by the Fund for Key Laboratory of Traditional Chinese Medicine Gan of State Administration of Traditional Chinese Medicine, the Major Research Plan of the National Natural Science Foundation of China (No. 90409010), and was partly supported by the Huge Project to Boost Chinese Drug Development (No. 2009ZX09304-003)	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Chinese Pharmacopoeia Commission, 2005, PHARM PEOPL REP CHIN, VI, P17; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Ding L, 2008, TALANTA, V74, P1344, DOI 10.1016/j.talanta.2007.09.001; Ding MY, 2003, ANAL SCI, V19, P1163, DOI 10.2116/analsci.19.1163; Drasar P, 2004, J CHROMATOGR B, V812, P3, DOI 10.1016/j.jchromb.2004.09.037; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao GW, 2002, CENTRAL PLAINS MED J, V29, P8; Gao XY, 2009, J CHROMATOGR A, V1216, P2118, DOI 10.1016/j.chroma.2008.11.104; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Gu JW, 2005, NEUROPHARMACOLOGY, V49, P103, DOI 10.1016/j.neuropharm.2005.02.003; He DX, 2009, J PHARMACEUT BIOMED, V49, P1123, DOI 10.1016/j.jpba.2009.02.014; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huang X, 2009, J ETHNOPHARMACOL, V121, P68, DOI 10.1016/j.jep.2008.10.029; Iizuka A, 2004, J ETHNOPHARMACOL, V91, P89, DOI 10.1016/j.jep.2003.11.021; Jin W, 2007, RAPID COMMUN MASS SP, V21, P2351, DOI 10.1002/rcm.3086; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Koyama J, 2007, J CHROMATOGR A, V1145, P183, DOI 10.1016/j.chroma.2007.01.076; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lee JH, 2003, J ETHNOPHARMACOL, V84, P5, DOI 10.1016/S0378-8741(02)00222-2; Lin CC, 2006, J SEP SCI, V29, P2584, DOI 10.1002/jssc.200500307; Liu LH, 2005, ELECTROPHORESIS, V26, P2999, DOI 10.1002/elps.200500069; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mao Y, 2007, J PHARMACEUT BIOMED, V45, P510, DOI 10.1016/j.jpba.2007.05.031; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P41, DOI 10.1016/S0968-0896(00)00215-7; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Ren P, 2009, CHROMATOGRAPHIA, V70, P1515, DOI 10.1365/s10337-009-1341-3; Singh NP, 2005, J CHROMATOGR A, V1077, P202, DOI 10.1016/j.chroma.2005.03.130; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Verma SC, 2005, J CHROMATOGR A, V1097, P59, DOI 10.1016/j.chroma.2005.08.018; Wang FX, 2006, TALANTA, V70, P1170, DOI 10.1016/j.talanta.2006.03.008; Wang JB, 2008, J PHARMACEUT BIOMED, V47, P765, DOI 10.1016/j.jpba.2008.03.011; Wang Y, 2011, J ETHNOPHARMACOL, V133, P735, DOI 10.1016/j.jep.2010.11.006; Wang YS, 1990, CHIN TRADIT PATENT M, V12, P5; Wang ZJ, 2009, J PHARMACEUT BIOMED, V50, P232, DOI 10.1016/j.jpba.2009.04.001; Wu T, 2008, CHROMATOGRAPHIA, V68, P803, DOI 10.1365/s10337-008-0788-y; Xie PS, 2009, J CHROMATOGR A, V1216, P1933, DOI 10.1016/j.chroma.2008.08.045; Yan SK, 2005, J CHROMATOGR A, V1090, P90, DOI 10.1016/j.chroma.2005.07.066; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; 黄熙, 2002, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V22, P251	45	13	15	2	42	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	SEP	2012	18	9					690	698		10.1007/s11655-012-1053-7			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	998GT	WOS:000308226200007	22936323				2022-02-06	
J	Green, SE; Bosch, M; McKenzie, JE; O'Connor, DA; Tavender, EJ; Bragge, P; Chau, M; Pitt, V; Rosenfeld, JV; Gruen, RL				Green, Sally E.; Bosch, Marije; McKenzie, Joanne E.; O'Connor, Denise A.; Tavender, Emma J.; Bragge, Peter; Chau, Marisa; Pitt, Veronica; Rosenfeld, Jeffrey V.; Gruen, Russell L.			Improving the care of people with traumatic brain injury through the Neurotrauma Evidence Translation (NET) program: protocol for a program of research	IMPLEMENTATION SCIENCE			English	Article						Knowledge translation research; Study protocol; Neurotrauma; Traumatic brain injury	QUALITY IMPROVEMENT INTERVENTIONS; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; HEALTH-CARE; HEAD-INJURIES; UNITED-STATES; MANAGEMENT; GUIDELINE; BEHAVIOR; REHABILITATION	The Neurotrauma Evidence Translation (NET) program was funded in 2009 to increase the uptake of research evidence in the clinical care of patients who have sustained traumatic brain injury. This paper reports the rationale and plan for this five-year knowledge translation research program. The overarching aims of the program are threefold: to improve outcomes for people with traumatic brain injury; to create a network of neurotrauma clinicians and researchers with expertise in knowledge translation and evidence-based practice; and to contribute knowledge to the field of knowledge translation research. The program comprises a series of interlinked projects spanning varying clinical environments and disciplines relevant to neurotrauma, anchored within four themes representing core knowledge translation activities: reviewing research evidence; understanding practice; developing and testing interventions for practice change; and building capacity for knowledge translation in neurotrauma. The program uses a range of different methods and study designs, including: an evidence fellowship program; conduct of and training in systematic reviews; mixed method study designs to describe and understand factors that influence current practices (e. g., semi-structured interviews and surveys); theory-based methods to develop targeted interventions aiming to change practice; a cluster randomised trial to test the effectiveness of a targeted theory-informed intervention; stakeholder involvement activities; and knowledge translation events such as consensus conferences.	[Green, Sally E.; McKenzie, Joanne E.; O'Connor, Denise A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Bragge, Peter; Chau, Marisa; Pitt, Veronica] Monash Univ, Natl Trauma Res Inst, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst,Dept Neurosurg, Dept Surg, Melbourne, Vic 3181, Australia; [Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst,Dept Trauma, Dept Surg, Melbourne, Vic 3181, Australia		Green, SE (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	sally.green@monash.edu	O'Connor, Denise/ABC-6655-2020; McKenzie, Joanne E/I-2925-2014; Rosenfeld, Jeffrey V/B-7249-2011	O'Connor, Denise/0000-0002-6836-122X; McKenzie, Joanne E/0000-0003-3534-1641; Tavender, Emma/0000-0002-7230-712X; Bragge, Peter/0000-0003-0745-5131; Green, Sally Elizabeth/0000-0002-9564-9050	Victorian Transport Accident Commission, Australia	This protocol is based on the grant titled 'Improving evidence-based care and the outcomes of patients with traumatic brain injury and spinal cord injury through a program to facilitate knowledge transfer and exchange.' This study was funded by the Victorian Transport Accident Commission, Australia. We thank Ms Kate Phillips and the wider investigator team: Dr Mark Bayley; Dr Heather Buchan; Professor Peter Cameron; Professor Jamie Cooper; Dr David Cooksley; Professor Niki Ellis; Associate Professor Mark Fitzgerald; Professor Jill Francis; Professor Jeremy Grimshaw; Dr Sophie Hill; Ms Sue Huckson; Dr Tony Joseph; Dr Fary Khan; Dr Jonathan Knott; Professor John Lavis; Associate Professor Shawn Marshall; Professor Susan Michie; Associate Professor Peter Morley; Dr Andrew Pearce; Professor Jennie Ponsford; Mr Nick Rushworth; Dr Elisabeth (Lisa) Sherry.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; [Anonymous], 1999, JAMA, V282, P974; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chau M, 2011, COCHRANE DATABASE S3; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gauden AJ, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009661, DOI 10.1002/14651858.CD009661]; Glaser B., 1967, DISCOVERY GROUNDED T; Glynn RJ, 2007, MED CARE, V45, pS38, DOI 10.1097/MLR.0b013e318070c0a0; Graham Ian D, 2007, Healthc Q, V10, P20; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimshaw JM, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-38; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gururaj G, 2005, NATL I MENTAL HLTH N, P61; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kitson A, 2010, CAN MED ASSOC J, V182, pE73, DOI 10.1503/cmaj.081231; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall MN, 2003, QUAL SAF HEALTH CARE, V12, P8, DOI 10.1136/qhc.12.1.8; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; McKenzie JE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-86; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Miller L, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-7; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057; Phillips K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008929, DOI 10.1002/14651858.CD008929]; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Short J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-37; Shortell SM, 2008, JAMA-J AM MED ASSOC, V299, P445, DOI 10.1001/jama.299.4.445; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Sitzia John, 2002, Intensive Crit Care Nurs, V18, P230, DOI 10.1016/S0964339702000125; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; STRAUS S, 2009, KNOWLEDGE TRANSLATIO; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Trevena L, 2011, AUST FAM PHYSICIAN, V40, P956; Walker AE, 2000, J EVAL CLIN PRACT, V6, P185, DOI 10.1046/j.1365-2753.2000.00235.x; Wensing M, 2010, CAN MED ASSOC J, V182, pE85, DOI 10.1503/cmaj.081233; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	61	13	13	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	AUG 7	2012	7								74	10.1186/1748-5908-7-74			7	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	104AL	WOS:000315961200001	22866892	gold, Green Published			2022-02-06	
J	Lee, GE; Bae, H; Yoon, TS; Kim, JS; Yi, TI; Park, JS				Lee, Ga Eun; Bae, Hasuk; Yoon, Tae Sik; Kim, Joo Sup; Yi, Tae Im; Park, Jun Sung			Factors that Influence Quiet Standing Balance of Patients with Incomplete Cervical Spinal Cord Injuries	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Spinal cord injury; Balance; Posture; Barthel index		Objective To investigate the factors influencing the quiet standing balance of patients with incomplete cervical spinal cord injuries. Also to find the correlations between posturographic parameters and clinical balance tests as well as to find the correlation between posturographic parameters and functional independence. Method We conducted a tetra-ataxiometric posturography, lower extremity motor score (LEMS), Korean version of the Berg Balance Scale (K-BBS), Timed Up and Go test (TUG), and Korean Version of the Modified Barthel Index (K-MBI) of 10 patients. 10 healthy adults carried out the posturography. We checked stability, weight distribution, Fourier and synchronization indices of eight positions, and the fall index of the posturography. Results The patient group showed significantly higher stability and weight distribution indices in all eight positions. Stability indices significantly increased with eyes closed or standing on pillows. Weight distribution indices were significantly higher with eyes closed or the head bent backwards. The patient group showed significantly higher Fourier indices of low, low-medium, and high frequency in eight positions. The Fourier indices at high-medium frequency were significantly higher with eyes closed on pillows or in variable head positions. There were no significant differences of synchronization indices between the patient and the control group. The falling index of the patient group significantly correlated with K-BBS, TUG, and K-MBI. LEMS had significant correlation with some synchronization indices, but not with the falling index. Conclusion The quiet standing balance of the patients was influenced by somatosensory limitations or insufficient visual compensation. We should try to improve the postural balance and functional independence of patients through proper proprioceptive and lower extremity strength training for better postural and pedal control, and to make efforts to minimize environmental hazards.	[Lee, Ga Eun] Daegu Workers Compensat Hosp, Dept Rehabil Med, 515 Hakjeong Ro, Daegu 702911, South Korea; [Bae, Hasuk; Yoon, Tae Sik] Ewha Womans Univ, Coll Med, Seoul 158710, South Korea; [Kim, Joo Sup; Yi, Tae Im; Park, Jun Sung] Bundang Jesaeng Gen Hosp, Seongnam 463774, South Korea		Lee, GE (corresponding author), Daegu Workers Compensat Hosp, Dept Rehabil Med, 515 Hakjeong Ro, Daegu 702911, South Korea.	smart0416@hotmail.com		Yi, Taeim/0000-0001-6369-4677			Afifi AK, 2005, FUNCTIONAL NEUROANAT, P412; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Braddom RL, 2007, PHYS MED REHABILITAT, P489; Chon JM, 2010, CLIN PAIN, V9, P27; Ditunno JE, 2007, NEUROREHAB NEURAL RE, V21, P539, DOI 10.1177/1545968307301880; Harkema SJ, 2011, ARCH PHYS MED REHA S, V20, pS1; Hocking C, 1999, CLIN REHABIL, V13, P141, DOI 10.1191/026921599668105029; Jacobson GP, 1993, HDB BALANCE FUNCTION, P259; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Kim BR, 2009, ANN REHABIL MED-ARM, V33, P538; Kim CR, 2009, ANN REHABIL MED-ARM, V33, P429; Kim MO, 2010, ANN REHABIL MED-ARM, V34, P513; KOHENRAZ R, 1991, PERCEPT MOTOR SKILL, V73, P635, DOI 10.2466/PMS.73.5.635-656; Morganti B, 2005, SPINAL CORD, V43, P27, DOI 10.1038/sj.sc.3101658; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Patrick M, 2003, J SPINAL CORD MED S, V26, pS41; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004; Yelnik A, 2008, NEUROPHYSIOL CLIN, V38, P439, DOI 10.1016/j.neucli.2008.09.008	20	13	14	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	AUG	2012	36	4					530	537		10.5535/arm.2012.36.4.530			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC5DO	WOS:000433808600012	22977779	Green Submitted, gold, Green Published			2022-02-06	
J	Samanta, S; Ghoshal, A; Bhattacharya, K; Saha, B; Walden, P; Mandal, C				Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Saha, Bibhuti; Walden, Peter; Mandal, Chitra			Sialoglycosylation of RBC in Visceral Leishmaniasis Leads to Enhanced Oxidative Stress, Calpain-Induced Fragmentation of Spectrin and Hemolysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACETYLATED SIALIC ACIDS; TRAUMATIC BRAIN-INJURY; ERYTHROCYTE-MEMBRANE; BINDING LECTIN; PHOSPHATIDYLSERINE EXTERNALIZATION; 9-O-ACETYLATED SIALOGLYCOPROTEINS; DIFFERENTIAL EXPRESSION; DONOVANI PROMASTIGOTES; MEDIATED HEMOLYSIS	Visceral leishmaniasis (VL) caused by the intracellular parasite Leishmania donovani accounts for an estimated 12 million cases of human infection. It is almost always associated with anemia, which severely complicates the disease course. However, the pathological processes leading to anemia in VL have thus far not been adequately characterized to date. In studying the glycosylation patterns of peripheral blood cells we found that the red blood cells (RBC) of VL patients (RBCVL) express eight 9-O-acetylated sialoglycoproteins (9-O-AcSGPs) that are not detected in the RBC of healthy individuals (RBCN). At the same time, the patients had high titers of anti-9-O-AcSGP IgG antibodies in their sera. These two conditions appear to be linked and related to the anemic state of the patients, as exposure of RBCVL but not RBCN to anti-9-O-AcSGPs antibodies purified from patient sera triggered a series of responses. These included calcium influx via the P/Q-type but not L-type channels, activation of calpain I, proteolysis of spectrin, enhanced oxidative stress, lipid peroxidation, externalization of phosphatidyl serine with enhanced erythrophagocytosis, enhanced membrane fragility and, finally, hemolysis. Taken together, this study suggests that the enhanced hemolysis is linked to an impairment of membrane integrity in RBCVL which is mediated by ligand-specific interaction of surface 9-O-AcSGPs. This affords a potential explanation for the structural and functional features of RBCVL which are involved in the hemolysis related to the anemia which develops in VL patients.	[Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Mandal, Chitra] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India; [Saha, Bibhuti] Sch Trop Med, Dept Trop Med, Kolkata, India; [Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, Berlin, Germany		Samanta, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.	chitra_mandal@yahoo.com			CSIR-IICB; Department of Biotechnology [GAP235]; Indian Council of Medical Research, New DelhiIndian Council of Medical Research (ICMR) [GAP266]; J.C. Bose FellowshipDepartment of Science & Technology (India); Department of Science and Technology, Govt. of IndiaDepartment of Science & Technology (India) [P90807]	This work received financial support from the CSIR-IICB, Department of Biotechnology (GAP235) (http://dbtindia.nic.in/index.asp), Indian Council of Medical Research (GAP266) (http://www.icmr.nic.in/), New Delhi, J.C. Bose Fellowship, Department of Science and Technology (P90807) (http://www.dst.gov.in/), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED H, 1989, J BIOL CHEM, V264, P18673; Ansar W, 2009, GLYCOCONJUGATE J, V26, P1151, DOI 10.1007/s10719-009-9236-y; Bandyopadhyay S, 2004, GLYCOCONJUGATE J, V20, P531; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BLUMENFELD N, 1991, BLOOD, V77, P849; BORENSTAINBENYASHAR V, 1993, AM J HEMATOL, V44, P63; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chatterjee M, 1998, GLYCOCONJUGATE J, V15, P1141, DOI 10.1023/A:1006963806318; Chava AK, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P71; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; Chava AK, 2002, J IMMUNOL METHODS, V270, P1, DOI 10.1016/S0022-1759(02)00216-8; CROALL DE, 1986, BIOCHIM BIOPHYS ACTA, V882, P287, DOI 10.1016/0304-4165(86)90250-3; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; de Jong K, 2001, BLOOD, V98, P860, DOI 10.1182/blood.V98.3.860; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Ghosh S, 2005, ANN HEMATOL, V84, P76, DOI 10.1007/s00277-004-0933-0; Ghosh S, 2007, GLYCOCONJUGATE J, V24, P17, DOI 10.1007/s10719-006-9007-y; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Ghoshal A, 2011, GLYCOCONJ J, V26, P675; Ghoshal A, 2008, MINI-REV MED CHEM, V8, P358, DOI 10.2174/138955708783955980; Ghoshal A, 2009, CLIN VACCINE IMMUNOL, V16, P889, DOI 10.1128/CVI.00453-08; GLASER T, 1994, P NATL ACAD SCI USA, V91, P7879, DOI 10.1073/pnas.91.17.7879; HU RJ, 1991, J BIOL CHEM, V266, P18200; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Lee JC, 2006, NEUROCHEM RES, V31, P989, DOI 10.1007/s11064-006-9104-0; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lijnen P, 1998, AM J HYPERTENS, V11, P81, DOI 10.1016/S0895-7061(97)00368-3; Mahajan V, 2007, J TROP PEDIATRICS, V53, P284, DOI 10.1093/tropej/fmm018; Malorni W, 2000, FEBS LETT, V468, P125, DOI 10.1016/S0014-5793(00)01187-X; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Mandal D, 2002, FEBS LETT, V513, P184, DOI 10.1016/S0014-5793(02)02294-9; MORTENSEN AM, 1991, TOXICOL APPL PHARM, V110, P435, DOI 10.1016/0041-008X(91)90045-G; Mukherjee K, 2007, BIOCHEM BIOPH RES CO, V362, P651, DOI 10.1016/j.bbrc.2007.08.048; Pal S, 2000, GLYCOBIOLOGY, V10, P539, DOI 10.1093/glycob/10.6.539; Pal S, 2004, GLYCOBIOLOGY, V14, P859, DOI 10.1093/glycob/cwh111; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; PANT HC, 1983, BIOCHEM BIOPH RES CO, V117, P372, DOI 10.1016/0006-291X(83)91210-X; PRADHAN D, 1994, MOL MEMBR BIOL, V11, P181, DOI 10.3109/09687689409162237; Resmi H, 2001, CLIN EXP MED, V1, P187, DOI 10.1007/s102380100002; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Sen G, 2001, ANN HEMATOL, V80, P32, DOI 10.1007/s002770000240; SEN GT, 1995, CARBOHYD RES, V268, P115, DOI 10.1016/0008-6215(94)00311-3; Sharma V, 1998, AM J TROP MED HYG, V58, P551, DOI 10.4269/ajtmh.1998.58.551; Sharma V, 2000, GLYCOCONJUGATE J, V17, P887, DOI 10.1023/A:1010925414222; Shukla M, 2006, NEUROCHEM INT, V48, P108, DOI 10.1016/j.neuint.2005.09.001; Siebert HC, 1996, GLYCOBIOLOGY, V6, P561, DOI 10.1093/glycob/6.6.561-b; Sinha D, 2000, TRENDS GLYCOSCI GLYC, V12, P17, DOI 10.4052/tigg.12.17; Starodubtseva MN, 2008, B EXP BIOL MED+, V145, P99, DOI 10.1007/s10517-008-0036-3; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WILSON MJ, 1993, BIOCHEMISTRY-US, V32, P11302, DOI 10.1021/bi00093a006; WOODRUFF AW, 1972, BRIT J HAEMATOL, V22, P319, DOI 10.1111/j.1365-2141.1972.tb05678.x; World Health Organization, 2010, TECH REP SER, V949, P186; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	61	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42361	10.1371/journal.pone.0042361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	WOS:000307045600094	22860118	Green Submitted, Green Published, gold			2022-02-06	
J	Joseph, MS; Ying, Z; Zhuang, YM; Zhong, H; Wu, AG; Bhatia, HS; Cruz, R; Tillakaratne, NJK; Roy, RR; Edgerton, VR; Gomez-Pinilla, F				Joseph, M. Selvan; Ying, Zhe; Zhuang, Yumei; Zhong, Hui; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando			Effects of Diet and/or Exercise in Enhancing Spinal Cord Sensorimotor Learning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; DOCOSAHEXAENOIC ACID; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; MEMBRANE HOMEOSTASIS; BDNF; RECOVERY; RATS	Given that the spinal cord is capable of learning sensorimotor tasks and that dietary interventions can influence learning involving supraspinal centers, we asked whether the presence of omega-3 fatty acid docosahexaenoic acid (DHA) and the curry spice curcumin (Cur) by themselves or in combination with voluntary exercise could affect spinal cord learning in adult spinal mice. Using an instrumental learning paradigm to assess spinal learning we observed that mice fed a diet containing DHA/Cur performed better in the spinal learning paradigm than mice fed a diet deficient in DHA/Cur. The enhanced performance was accompanied by increases in the mRNA levels of molecular markers of learning, i.e., BDNF, CREB, CaMKII, and syntaxin 3. Concurrent exposure to exercise was complementary to the dietary treatment effects on spinal learning. The diet containing DHA/Cur resulted in higher levels of DHA and lower levels of omega-6 fatty acid arachidonic acid (AA) in the spinal cord than the diet deficient in DHA/Cur. The level of spinal learning was inversely related to the ratio of AA: DHA. These results emphasize the capacity of select dietary factors and exercise to foster spinal cord learning. Given the non-invasiveness and safety of the modulation of diet and exercise, these interventions should be considered in light of their potential to enhance relearning of sensorimotor tasks during rehabilitative training paradigms after a spinal cord injury.	[Joseph, M. Selvan; Ying, Zhe; Wu, Aiguo; Bhatia, Harsharan S.; Cruz, Rusvelda; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Zhuang, Yumei; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Zhong, Hui; Tillakaratne, Niranjala J. K.; Roy, Roland R.; Edgerton, V. Reggie; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Joseph, MS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Bhatia, Harsharan singh/AAR-4628-2021	Bhatia, Harsharan Singh/0000-0001-9912-8263; Joseph, Michael Selvan/0000-0002-0620-9249	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS056413, NS056413, R01 NS050465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health R01 NS056413, Diversity Supplement NS056413, and R01 NS050465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; ARAUJO DM, 1989, BRAIN RES, V484, P130, DOI 10.1016/0006-8993(89)90355-7; Baumbauer KM, 2009, J NEUROSCI, V29, P14383, DOI 10.1523/JNEUROSCI.3583-09.2009; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Chung WL, 2008, J NUTR, V138, P1165, DOI 10.1093/jn/138.6.1165; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Cole Greg M., 2006, Nutrition and Health (Bicester), V18, P249; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Edgerton VE, 2009, ENCY NEUROSCIENCE, P629; Edgerton VR, 2001, J PHYSIOL-LONDON, V533, P15, DOI 10.1111/j.1469-7793.2001.0015b.x; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujita S, 2001, BRIT J PHARMACOL, V132, P1417, DOI 10.1038/sj.bjp.0703970; Gomez-Pinilla F, 2007, NEUROSCIENCE, V148, P893, DOI 10.1016/j.neuroscience.2007.05.051; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2011, PREV MED, V52, pS75, DOI 10.1016/j.ypmed.2011.01.023; Grau James W, 2006, Behav Cogn Neurosci Rev, V5, P191, DOI 10.1177/1534582306289738; Grau JW, 1998, BEHAV NEUROSCI, V112, P1366, DOI 10.1037/0735-7044.112.6.1366; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Harkema S. J., 2011, ARCH PHYS MED REHABI; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; HORRIDGE G. A., 1962, NATURE, V193, P697, DOI 10.1038/193697a0; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Huie JR, 2012, NEUROSCIENCE, V200, P74, DOI 10.1016/j.neuroscience.2011.10.028; Igarashi M, 2011, J NEUROCHEM; Igarashi M., 2011, BIOCH BIOPHYS ACTA; Jindrich DL, 2009, J NEUROSCI METH, V182, P250, DOI 10.1016/j.jneumeth.2009.06.001; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lim SY, 2001, J NUTR, V131, P319, DOI 10.1093/jn/131.2.319; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma DX, 2010, BRAIN RES, V1330, P1, DOI 10.1016/j.brainres.2010.03.002; Maher P, 2010, NEUROBIOL AGING, V31, P706, DOI 10.1016/j.neurobiolaging.2008.05.020; Marini AM, 2008, CNS NEUROL DISORD-DR, V7, P382, DOI 10.2174/187152708786441849; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Rodger J, 1998, J NEUROCHEM, V71, P666; Rongo C, 2002, BIOESSAYS, V24, P223, DOI 10.1002/bies.10057; ROY RR, 1992, LAB ANIM SCI, V42, P335; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Shah Prithvi K, 2012, Eur J Neurosci, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Teague WE, 2002, CELL MOL BIOL LETT, V7, P262; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Yamashima T, 2008, PROG NEUROBIOL, V84, P105, DOI 10.1016/j.pneurobio.2007.11.002; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	87	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41288	10.1371/journal.pone.0041288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	WOS:000306644600067	22911773	Green Published, gold, Green Submitted			2022-02-06	
J	Harris, AW; Jones, CA; Rowe, BH; Voaklander, DC				Harris, Andrew W.; Jones, C. Allyson; Rowe, Brian H.; Voaklander, Donald C.			A population-based study of sport and recreation-related head injuries treated in a Canadian health region	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head injury; Mild traumatic brain injury; Sports and recreation; Emergency department; Population-based; Canadian	PROFESSIONAL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURIES; UNITED-STATES; EMERGENCY-DEPARTMENTS; RECURRENT CONCUSSION; REFERRAL CENTER; HIGH-SCHOOLS; EPIDEMIOLOGY; AUSTRALIA; VICTORIA	Objectives: To report the rates of SR-related HIs presenting to EDs in a Canadian population-based sample. Design: Descriptive epidemiology study. Methods: Using administrative data, sport and recreation-related emergency department presentations for persons 0-35 years of age, from April 1997 through March 2008, were obtained from the Edmonton Zone (formerly the Capital Health Region), Alberta Health Services through the Ambulatory Care Classification System. Results: Of the 3,230,890 visits to the emergency departments of the five hospitals in Edmonton, 63,219 sport and recreation-related injury records and 4935 sport and recreation-head injury records were identified. Head injuries were most frequently treated for the activities of hockey (20.7%), cycling (12.0%), and skiing/snowboarding/sledding. Males accounted for 71.9% (n=3546) and patients less than 18 years of age sustained 3446 (69.8%) sport and recreation-head injuries. Conclusions: Sport and recreation-related head injuries most frequently treated in emergency departments involve common activities such as hockey, cycling, skiing/snowboarding/sledding, and soccer. Males and those less than 18 years of age sustain the majority of sport and recreation-related head injuries treated in emergency departments. These findings underscore the importance of sport-specific policies and safety promotion for the prevention of head injuries, in sports and recreational activities. (c) 2011 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Harris, Andrew W.; Jones, C. Allyson; Rowe, Brian H.; Voaklander, Donald C.] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2M7, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Fac Med & Dent, Edmonton, AB T6G 2M7, Canada			awharris@ualberta.ca			Western Regional Training Centre for Health Services Research; Population Health Investigator Award from the Alberta Heritage Foundation; New Investigator Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); 21st Century Canada Research Chairs program of the Canadian Institutes of Health Research through the Government of Canada (Ottawa, ON)	The authors would like to thank the Edmonton Zone, Alberta Health Services (formerly the Capital Health Region) for providing the data for this research, as well as Brian Humeniuk at Alberta Health Services for extracting the data from the ACCS. AWH was supported by a graduate studentship from the Western Regional Training Centre for Health Services Research. CAJ is supported by a Population Health Investigator Award from the Alberta Heritage Foundation, and a New Investigator Award from the Canadian Institutes of Health Research. BHR is supported by the 21st Century Canada Research Chairs program of the Canadian Institutes of Health Research through the Government of Canada (Ottawa, ON).	Alberta Centre for Injury Control & Research, DAT HELD ALB CTR INJ; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; *CAN ASS EM PHYS, IMPL GUID CAN EM DEP; Canadian Institute for Health Information, 2009, INT STAT CLASS DIS H; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Davidson JA, 2005, EUR J EMERG MED, V12, P24, DOI 10.1097/00063110-200502000-00007; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PUCKETT CD, 1998, ED ANNOTATION ICD 9; Sikic M, 2009, MED J AUSTRALIA, V190, P353, DOI 10.5694/j.1326-5377.2009.tb02446.x; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	30	13	13	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2012	15	4					298	304		10.1016/j.jsams.2011.12.005			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	966YV	WOS:000305874200004	22244346				2022-02-06	
J	Lin, KH; Guo, NW; Liao, SC; Kuo, CY; Hu, PY; Hsu, JH; Hwang, YH; Guo, YL				Lin, Kuan-Han; Guo, Nai-Wen; Liao, Shih-Cheng; Kuo, Chun-Ya; Hu, Pei-Yi; Hsu, Jin-Huei; Hwang, Yaw-Huei; Guo, Yue Leon			Psychological Outcome of Injured Workers at 3 Months after Occupational Injury Requiring Hospitalization in Taiwan	JOURNAL OF OCCUPATIONAL HEALTH			English	Article						Comorbidity; Major depression; Occupational injury; Partial post-traumatic stress disorder (PPTSD); Post-traumatic stress disorder (PTSD)	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PSYCHIATRIC MORBIDITY; EARTHQUAKE VICTIMS; RISK-FACTORS; HEAD-INJURY; FULL PTSD; COMORBIDITY; COMMUNITY; IMPAIRMENT	Psychological Outcome of Injured Workers at 3 Months after Occupational Injury Requiring Hospitalization in Taiwan: Kuan-Han LIN, et al. Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University School of Public Health, Taiwan-Introduction: After a traumatic event, a significant proportion of victims develop psychiatric disorders. Trauma has been an important ailment among workers. This study aimed to determine the prevalence of post-traumatic stress disorder (PTSD) and other psychiatric disorders at three months after occupational injuries. Methods: Our study candidates were injured workers in Taiwan who were hospitalized for 3 days or longer aid received hospitalization benefits from the Labor Insurance program. A two-staged survey study was conducted. A self-reported questionnaire including the Brief Symptom Rating Scale (BSRS-50) and Post-traumatic Symptom Checklist (PTSC) was sent to workers at 3 months after injury. Those who met the criteria were recruited for the second stage phone interview with a psychiatrist using the Mini-international Neuropsychiatric Interview (MINI). Results: A total of 2001 workers completed the questionnaire (response rate 45.5%). Among them, 357 (17.8%) fulfilled the criteria for the MINI interview and were invited. A total of 148 (41.5%) completed the phone interview. The estimated rates of PTSD, partial PTSD (PPTSD), major depression, comorbid PTSD/PPTSD and major depression, and either PTSD/PPTSD or major depression were 2.7, 4.1, 3.0, 2.3, and 7.5%, respectively. The estimated rates of either PTSD/PPTSD or major depression among workers who suffered from intracranial injury, fracture, burn, crushing injury, and open wound of upper limbs were 10.4, 6.9, 5.9, 5.8 and 0%, respectively. Conclusions: At three months after occupational injuries, a significant proportion of workers suffered from psychiatric disorders. The rates of psychiatric disorders occurring after intracranial injuries were significantly higher than those occurring after non-intracranial injuries. (J Occup Health 2012; 54: 289-298)	[Lin, Kuan-Han; Guo, Yue Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Taipei 100, Taiwan; [Lin, Kuan-Han; Hwang, Yaw-Huei; Guo, Yue Leon] Natl Taiwan Univ, Sch Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Liao, Shih-Cheng; Kuo, Chun-Ya] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Guo, Nai-Wen] Natl Cheng Kung Univ, Inst Behav Med, Tainan 70101, Taiwan; [Hu, Pei-Yi; Hsu, Jin-Huei] Councils Labor Affairs, Inst Occupat Safety & Hlth, Taipei, Taiwan		Guo, YL (corresponding author), Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Rm 339,I7,Xuzhou Rd, Taipei 100, Taiwan.	leonguo@ntu.edu.tw	Guo, Yue-Liang Leon/ABF-2314-2020; Lin, Kuan-Han/AAF-7584-2020; LIAO, SHIH-CHENG/C-5665-2017	HWANG, YAW-HUEI/0000-0003-1817-8969; LIAO, SHIH-CHENG/0000-0003-4129-0879; GUO, Yue Leon/0000-0002-8530-4809; Lin, Kuan-Han/0000-0003-2047-6025	Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R. O. C. [IOSH98-M315]	This study was supported by grant IOSH98-M315 from the Institute of Occupational Safety & Health, Council of Labor Affairs, Taiwan, R. O. C.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th, P427; [Anonymous], 2008, REAL OCC BEN PAYM; [Anonymous], 2006, MAIN CAUS DEATH WORK; [Anonymous], 1996, REC NOT OCC ACC DIS, P3; Asmundson GJG, 1998, J ANXIETY DISORD, V12, P57, DOI 10.1016/S0887-6185(97)00049-2; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Blanchard EB, 1996, BEHAV RES THER, P34; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Breslau N, 2004, PSYCHOL MED, V34, P889, DOI 10.1017/S0033291703001612; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Cheung E, 2003, REHABIL PSYCHOL, V48, P109, DOI 10.1037/0090-5550.48.2.109; Chien IC, 2004, PSYCHIAT SERV, V55, P691, DOI 10.1176/appi.ps.55.6.691; COMPTON WM, 1991, AM J PSYCHIAT, V148, P1697; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; GARRISON CZ, 1995, J AM ACAD CHILD PSY, V34, P1193, DOI 10.1097/00004583-199509000-00017; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; Jeon HJ, 2007, DEPRESS ANXIETY, V24, P577, DOI 10.1002/da.20270; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kuo CY, 2012, PSYCHIAT RE IN PRESS; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Lee M B, 1990, J Formos Med Assoc, V89, P1081; Lee MB, 1990, CHINESE PSYCHIAT, V4, P10; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MacDonald HA, 2003, J OCCUP REHABIL, V13, P63, DOI 10.1023/A:1022563930482; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Statistic of General Health, 2008, STAT GEN HLTH; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Strauser DR, 2001, J REHABIL, V67, P26; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Yang YK, 2003, GEN HOSP PSYCHIAT, V25, P253, DOI 10.1016/S0163-8343(03)00022-7	44	13	13	0	15	JAPAN SOC OCCUPATIONAL HEALTH	TOKYO	1-29-8 SHINJUKU, SHINJUKU-KU, TOKYO, 160, JAPAN	1341-9145			J OCCUP HEALTH	J. Occup. Health	JUL	2012	54	4					289	298		10.1539/joh.11-0211-OA			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	983UW	WOS:000307145200005	22672883	Bronze			2022-02-06	
J	Armstead, WM; Riley, J; Yarovoi, S; Cines, DB; Smith, DH; Higazi, A				Armstead, William M.; Riley, John; Yarovoi, Serge; Cines, Douglas B.; Smith, Douglas H.; Higazi, Abd Al-Roof			tPA-S481A Prevents Neurotoxicity of Endogenous tPA in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cerebral autoregulation; cerebral circulation; signal transduction; tissue plasminogen activator	TISSUE-PLASMINOGEN ACTIVATOR; NMDA CEREBROVASODILATION; CEREBRAL HEMODYNAMICS; AGE; AUTOREGULATION; IMPAIRMENT; POTASSIUM; INCREASES; CHILDREN; NOC/OFQ	Traumatic brain injury (TBI) is associated with loss of autoregulation due to impaired responsiveness to cerebrovascular dilator stimuli, which leads to cerebral hypoperfusion and neuronal impairment or death. Upregulation of tissue plasminogen activator (tPA) post-TBI exacerbates loss of cerebral autoregulation and NMDA-receptor-mediated impairment of cerebral hemodynamics, and enhances excitotoxic neuronal death. However, the relationship between NMDA-receptor activation, loss of autoregulation, and neurological dysfunction is unclear. Here, we evaluated the potential therapeutic efficacy of a catalytically inactive tPA variant, tPA S481A, that acts by competing with wild-type tPA for binding, cleavage, and activation of NMDA receptors. Lateral fluid percussion brain injury was produced in anesthetized piglets. Pial artery reactivity was measured via a closed cranial window, and cerebrospinal fluid (CSF) extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) was quantified by enzyme-linked immunosorbent assay (ELISA). tPA-S481A prevented impairment of cerebral autoregulation and reduced histopathologic changes after TBI by inhibiting upregulation of the ERK isoform of MAPK. Treatment with this tPA variant provides a novel approach for limiting neuronal toxicity caused by untoward NMDA-receptor activation mediated by increased tPA and glutamate following TBI.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Yarovoi, Serge; Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Dept Clin Biochem, Sch Med, Jerusalem, Israel		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS53410, HD57355, HL76406, CA83121, HL76206, HL07971, HL81864, HL77760, HL82545]; University of Pennsylvania Institute for Translational Medicine and Therapeutics; Israeli Science FoundationIsrael Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL077760, R01HL076206, T32HL007971, P01HL076406, R21HL081864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053410] Funding Source: NIH RePORTER	This research was funded by National Institutes of Health grants NS53410 and HD57355 to W. M. A., HL76406, CA83121, HL76206, HL07971, and HL81864 to D. B. C., and HL77760 and HL82545 to A. A. R. H., the University of Pennsylvania Institute for Translational Medicine and Therapeutics (to D. B. C.), and the Israeli Science Foundation (to A.A.R.H.).	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; MERCHANT RE, 1999, ANN NY ACAD SCI, V890, P41; Nassar T, 2011, AM J RESP CELL MOL, V45, P1015, DOI 10.1165/rcmb.2010-0302OC; Nassar T, 2011, AM J PHYSIOL-LUNG C, V301, pL307, DOI 10.1152/ajplung.00429.2010; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Otani N, 2003, ACT NEUR S, V86, P287; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	30	13	13	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2012	29	9					1794	1802		10.1089/neu.2012.2328			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	954CN	WOS:000304924000009	22435890	Green Published			2022-02-06	
J	Caterino, JM; Raubenolt, A				Caterino, Jeffrey M.; Raubenolt, Amy			The prehospital simplified motor score is as accurate as the prehospital Glasgow coma scale: analysis of a statewide trauma registry	EMERGENCY MEDICINE JOURNAL			English	Article							BRAIN-INJURY OUTCOMES; EMERGENCY-DEPARTMENT; RELIABILITY; PREDICTION	Objectives The simplified motor score (SMS) is a three-point measure of traumatic brain injury (TBI) severity, which is easier to calculate than the 15-point Glasgow coma scale (GCS). Using a state trauma registry, the accuracy of the emergency medical services (EMS)obtained SMS was compared with the GCS for predicting neurological outcomes and mortality. Methods A retrospective, observational analysis was performed of patients aged 16 years and older in the 2002-7 Ohio Trauma Registry. Those not initially transported by EMS or with incomplete EMS GCS scores were excluded. Outcomes included inhospital mortality, TBI, neurosurgical intervention, any emergency intubation and emergency department intubation. Discriminatory ability was compared using area under the receiver-operating characteristic curves (AUC). Sensitivity and specificity for each outcome were calculated at a SMS cutoff of one or less (any abnormal SMS) and a GCS cutoff of 13 or less. Results 52 412 patients were identified. Sensitivity, specificity and AUC were similar between the SMS and GCS for all outcomes. Sensitivity for mortality was 72.2% for SMS and 74.6% for GCS. Sensitivity for TBI was 40.8% for SMS and 45.4% for GCS. Sensitivity for neurosurgical intervention was 52.9% for SMS and 60.0% for GCS. Sensitivity for any intubation was 72.7% for SMS and 75.5% for GCS. Specificity was less than 2% different for all outcomes. Discriminatory ability was similar with the difference in AUC between SMS and GCS no greater than 6% for any outcome. Conclusions In a state trauma registry including both trauma and non-trauma centres, the EMS-obtained SMS performs as well as the 15-point GCS.	[Caterino, Jeffrey M.] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA; [Caterino, Jeffrey M.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Raubenolt, Amy] Michigan State Univ, Dept Emergency Med, Kalamazoo, MI USA		Caterino, JM (corresponding author), 146 Means Hall,1654 Upham Dr, Columbus, OH 43210 USA.	jeffrey.caterino@osumc.edu	Caterino, Jeffrey/E-2859-2011		Ohio Department of Public Safety	This study was supported by a Trauma Grant from the Ohio Department of Public Safety. The sponsoring agency had no role in or control over the design, methods, subject recruitment, data collection, analysis, or paper preparation.	[Anonymous], 1999, STATA TECHNICAL B ST, V52, P19; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Limmer Daniel, 2002, Emerg Med Serv, V31, P54; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Nirula R, 2006, J TRAUMA, V61, P268, DOI 10.1097/01.ta.0000230305.36456.4e; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009	16	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	JUN	2012	29	6					492	496		10.1136/emj.2010.110437			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	964KN	WOS:000305693500012	21795294				2022-02-06	
J	Greiner, MV; Lawrence, AP; Horn, P; Newmeyer, AJ; Makoroff, KL				Greiner, Mary V.; Lawrence, Alice P.; Horn, Paul; Newmeyer, Amy J.; Makoroff, Kathi L.			Early clinical indicators of developmental outcome in abusive head trauma	CHILDS NERVOUS SYSTEM			English	Article						Abuse; Developmental outcome; Head trauma; Intensive care; Seizure	AUDITORY MILESTONE SCALE; GLASGOW COMA SCALE; YOUNG-CHILDREN; BRAIN-INJURIES; BAYLEY SCALES; CAT/CLAMS; INFANTS; PREDICT; DEMOGRAPHICS; VALIDITY	The purpose of the study was to determine the developmental prognostic significance of early clinical indicators in abusive head trauma. Seventy-one children were diagnosed with abusive head trauma and followed in a post-injury growth and development clinic. A retrospective chart review was completed to gather clinical features at the time of injury, including presence or absence of early post-traumatic seizures, presence or absence of intubation, and presence or absence of pediatric intensive care unit admission. Children then underwent developmental testing with use of the Capute Scales of the Cognitive Adaptive Test (CAT) and the Clinical Linguistic and Auditory Milestone Scale (CLAMS) during follow-up clinic visits. Clinical features at initial injury were compared to developmental outcome. Thirty-four of 71 patients with seizures during their admission hospitalization scored significantly lower on follow-up developmental testing than patients who did not have seizures. Twenty-one of 71 patients who required intubation scored lower on developmental testing than patients who did not require intubation. Thirty-five of 71 patients who required pediatric intensive care unit admission scored lower on developmental testing than patients who did not require pediatric intensive care unit admission. This study demonstrates that clinical factors at the time of injury, such as early post-traumatic seizures and intubation requirement, are associated with poorer developmental outcome. This study also suggests that close developmental follow-up should be obtained for all children with abusive head trauma, regardless of whether or not the child was admitted to the PICU.	[Greiner, Mary V.; Horn, Paul; Makoroff, Kathi L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Lawrence, Alice P.] Childrens Hosp Vanderbilt, Dept Pediat, Nashville, TN USA; [Newmeyer, Amy J.] Childrens Hosp Kings Daughter, Dept Pediat, Norfolk, VA USA		Greiner, MV (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	mary.greiner@cchmc.org					ACCARDO PJC, 2008, CAPUTE ACCARDOS NEUR; Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Capute A J, 1996, Curr Probl Pediatr, V26, P279; Capute A J, 1996, Curr Probl Pediatr, V26, P238, DOI 10.1016/S0045-9380(06)80061-7; Chang Y C, 1998, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V39, P306; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Hoon Jr AH, 1993, J PEDIAT, V123; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kube DA, 2000, PEDIATR NEUROL, V23, P208, DOI 10.1016/S0887-8994(00)00191-0; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Macias MM, 1998, J DEV BEHAV PEDIATR, V19, P155, DOI 10.1097/00004703-199806000-00002; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Myers SE, 2007, AM J MED GENET A, V143A, P443, DOI 10.1002/ajmg.a.31468; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Pittock ST, 2002, CLIN PEDIATR, V41, P397, DOI 10.1177/000992280204100604; ROSSMAN MJ, 1994, CLIN PEDIATR, V33, P404, DOI 10.1177/000992289403300705; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Vanprapar Nirun, 2005, J Med Assoc Thai, V88 Suppl 8, pS211; Vincer MJ, 2005, PEDIATRICS, V116, pE864, DOI 10.1542/peds.2005-0447; Visintainer PF, 2004, J CHILD NEUROL, V19, P967, DOI 10.1177/08830738040190121101; Voigt RG, 2003, CLIN PEDIATR, V42, P427, DOI 10.1177/000992280304200507; WACHTEL RC, 1994, CLIN PEDIATR, V33, P410, DOI 10.1177/000992289403300706; Wang LW, 2005, J DEV BEHAV PEDIATR, V26, P412, DOI 10.1097/00004703-200512000-00004; Wickremasinghe AC, 2011, CHILD CARE HLTH DEV	37	13	13	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2012	28	6					889	896		10.1007/s00381-012-1714-z			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	949DO	WOS:000304556600012	22367916				2022-02-06	
J	Saini, NS; Rampal, V; Dewan, Y; Grewal, SS				Saini, Navdeep Singh; Rampal, Vikas; Dewan, Yashbir; Grewal, Sarvpreet S.			Factors predicting outcome in patients with severe head injury: Multivariate analysis	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Severe head injury; Glasgow coma score; Glasgow outcome score		Background: Outcome prediction after severe head injury is of great clinical importance especially for countries like India for better targeting of limited healthcare resources. This study was undertaken to evaluate various factors as predictors of outcome in severe head injury. Patients and Methods: This study is based on prospective analysis of 110 patients admitted over a period of one and half year with severe head injury. Patients with associated severe chest, abdominal or orthopedic trauma were excluded. Clinical outcome was evaluated at the time of discharge and after six months, according to Glasgow outcome score. Results: Road traffic accident was commonest (83.64%) mode of severe head injury. Only 5.71% of patients were following traffic rules. Increasing age of patients, hypoxia, low GCS and abnormal pupillary reflex were found to be significant predictors of adverse clinical outcome. Early operative intervention, when indicated as per CT findings, was significantly associated with favorable outcome. Greater degree of midline shift and effacement of Basal cisterns were associated with adverse outcome. Conclusion: Predicting outcome is an assimilative and integrative process of various pre-injury, injury and post-injury variables. Strict enforcement of traffic rules can help us to save precious life. Hypoxia should be avoided on absolute basis. CT scan should be done on urgent basis to look for operable mass lesions. Copyright (C) 2012, Neurotrauma Society of India. All rights reserved.	[Saini, Navdeep Singh; Rampal, Vikas; Dewan, Yashbir; Grewal, Sarvpreet S.] Christian Med Coll & Hosp, Ludhiana, Punjab, India		Saini, NS (corresponding author), Christian Med Coll & Hosp, Dept Neurosurg, Brown Rd, Ludhiana 141008, Punjab, India.	navmalwai@yahoo.com	Dewan, Yashbir/C-6503-2013	Dewan, Yashbir/0000-0002-7154-1301			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Miller JD, J NEUROSURG; Mukherjee KK, NEUROL INDIA; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Pillai SV, 2003, NEUROL INDIA, V51, P345; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Sperry J, J TRAUMA; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Waxman K, 1991, ARCH SURG-CHICAGO, V126, P142	26	13	13	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2012	9	1					45	48		10.1016/j.ijnt.2012.04.009			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M3E	WOS:000218385700008					2022-02-06	
J	Stroman, PW; Bosma, RL; Kornelsen, J; Lawrence-Dewar, J; Wheeler-Kingshott, C; Cadotte, D; Fehlings, MG				Stroman, P. W.; Bosma, R. L.; Kornelsen, J.; Lawrence-Dewar, J.; Wheeler-Kingshott, C.; Cadotte, D.; Fehlings, M. G.			Advanced MR imaging techniques and characterization of residual anatomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Magnetic resonance imaging (MRI); Clinical applications; Functional MRI; Diffusion tensor imaging; Perfusion; Relaxation times; Multiple sclerosis; Traumatic brain injury	DEFAULT-MODE NETWORK; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; MULTIPLE-SCLEROSIS; DIFFUSION TENSOR; RESTING-STATE; CERVICAL CORD; ALZHEIMERS-DISEASE	Advances in technology in recent decades have contributed to rapid developments in non-invasive methods for imaging human anatomy, and advanced imaging methods are now one of the primary tools for clinical diagnosis after neurological trauma or disease. Here we review the current and upcoming capabilities of one of the most rapidly developing methods, magnetic resonance imaging (MRI). The underlying theory is introduced so that the reasons for the strengths, weaknesses, and future expectations of this method, can be explained. Current techniques for imaging anatomical changes, inflammation, and changes in white matter, axonal integrity, blood flow and function, are reviewed. Applications for specific purposes of assessing traumatic injury in the brain or spinal cord, and for multiple-sclerosis are also presented, and are used as examples of how the advanced techniques are being used in practice. (C) 2012 Elsevier B.V. All rights reserved.	[Stroman, P. W.; Bosma, R. L.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Stroman, P. W.] Queens Univ, Dept Diagnost Radiol, Kingston, ON K7L 3N6, Canada; [Stroman, P. W.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Kornelsen, J.] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada; [Lawrence-Dewar, J.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Wheeler-Kingshott, C.] UCL, Inst Neurol, London, England; [Cadotte, D.; Fehlings, M. G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Fehlings, M. G.] Toronto Western Hosp, Univ Hlth Network, Spinal Program, Toronto, ON M5T 2S8, Canada		Stroman, PW (corresponding author), Queens Univ, Ctr Neurosci Studies, 19 Stuart St, Kingston, ON K7L 3N6, Canada.	stromanp@queensu.ca	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Fehlings, Michael/0000-0002-5722-6364; Kornelsen, Jennifer/0000-0003-0658-5321; Lawrence-Dewar, Jane/0000-0003-1529-5748			Agosta F, 2008, MAGN RESON MED, V59, P1035, DOI 10.1002/mrm.21595; Agosta F, 2008, NEUROIMAGE, V39, P1542, DOI 10.1016/j.neuroimage.2007.10.048; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; BINNIE CD, 1994, J NEUROL NEUROSUR PS, V57, P1308, DOI 10.1136/jnnp.57.11.1308; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cheung MM, 2009, C P IEEE ENG MED BIO, V2009, P2715; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Deshpande G, 2009, HUM BRAIN MAPP, V30, P13, DOI 10.1002/hbm.20482; Dowell NG, 2009, J MAGN RESON IMAGING, V29, P454, DOI 10.1002/jmri.21656; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Figley CR, 2010, MAGN RESON IMAGING, V28, P1234, DOI 10.1016/j.mri.2010.01.005; Filippi M, 2004, HUM BRAIN MAPP, V21, P108, DOI 10.1002/hbm.10160; Filippi M, 2009, NEUROIMAG CLIN N AM, V19, P59, DOI 10.1016/j.nic.2008.08.004; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Freund P, 2010, MULT SCLER J, V16, P1193, DOI 10.1177/1352458510376180; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Hillary FG, 2011, INT J PSYCHOPHYSIOL; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Jezzard P, 2006, J MAGN RESON IMAGING, V23, P787, DOI 10.1002/jmri.20581; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones CK, 2004, MAGN RESON MED, V51, P495, DOI 10.1002/mrm.10713; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kim JH, 2011, NMR BIOMED, V24, P163, DOI 10.1002/nbm.1567; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2007, NAT NEUROSCI, V10, P1230, DOI 10.1038/nn1007-1230; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Michielsen ME, 2011, NEUROREHAB NEURAL RE, V25, P223, DOI 10.1177/1545968310385127; Minty EP, 2009, MAGN RESON MED, V61, P883, DOI 10.1002/mrm.21936; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murayama T, 2011, BRAIN INJURY, V25, P1047, DOI 10.3109/02699052.2011.607785; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Petry KG, 2010, J NEURAL TRANSM, V117, P907, DOI 10.1007/s00702-010-0432-5; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Puig J, 2011, AM J NEURORADIOL, V32, P857, DOI 10.3174/ajnr.A2400; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ronchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021070; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schneider T, 2010, ANN M INT SOC MAGN R, P1561; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Stroman PW, 2008, MAGN RESON MED, V59, P700, DOI 10.1002/mrm.21534; Stroman PW, 2011, ESSENTIALS FUNCTIONA, P217; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Tavazzi E, 2010, INT J IMMUNOPATH PH, V23, P693, DOI 10.1177/039463201002300302; Toosy AT, 2002, NEUROSCI LETT, V330, P255, DOI 10.1016/S0304-3940(02)00700-0; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wig GS, 2008, P NATL ACAD SCI USA, V105, P18555, DOI 10.1073/pnas.0804546105; Wong EC, 2005, J MAGN RESON IMAGING, V22, P727, DOI 10.1002/jmri.20459; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang JJ, 2010, CORTEX, V46, P354, DOI 10.1016/j.cortex.2009.05.002; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	109	13	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		460	470		10.1016/j.clineuro.2012.01.003			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600008	22326716				2022-02-06	
J	Fujita, M; Wei, EP; Povlishock, JT				Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.			Effects of Hypothermia on Cerebral Autoregulatory Vascular Responses in Two Rodent Models of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal models of injury; pial vessels; therapeutic intervention; vascular reactivity	SEVERE HEAD-INJURY; BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; CEREBROVASCULAR RESPONSES; PRESSURE AUTOREGULATION; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; AUTO-REGULATION; RAT; HYPOTENSION	Traumatic brain injury (TBI) can trigger disturbances of cerebral pressure autoregulation that can translate into the generation of secondary insults and increased morbidity/mortality. Few therapies have been developed to attenuate the damaging consequences of disturbed autoregulatory control, although some suggest that hypothermia may exert such protection. Here we reexamine this issue of traumatically induced autoregulatory disturbances and their modulation by hypothermic intervention, examining these phenomena in two different models of TBI. Adult rats were subjected to either impact acceleration injury (IAI) or lateral fluid percussion injury (LFPI) followed by the insertion of cranial windows to assess the pial arteriolar cerebral autoregulatory vascular response to the post-traumatic induction of sequential reductions of arterial blood pressure. The potential for continued pial vasodilation in response to declining blood pressure was directly measured post-injury and compared with that in injured groups subjected to 33 degrees C of hypothermia of 1-2 h duration initiated 1 h post-injury. We observed that the TBI resulted in either impaired or abolished cerebral vascular dilation in response to the sequential declines in blood pressure. Following IAI there was a 50% reduction in the vasculature's ability to dilate in response to the induced hypotension. In contrast, following LFPI, the vascular response to hypotension was abolished both ipsilateral and contralateral to the LFPI. In animals sustaining IAI, the use of 1 h post-traumatic hypothermia preserved vascular dilation in response to declines in blood pressure in contrast to the LFPI in which the use of the same strategy afforded no improvement. However, with LFPI, the use of 2 h of hypothermia provided partial vascular protection. These results clearly illustrate that TBI can alter the cerebral autoregulatory vascular response to sequentially induced hypotensive insult, whereas the use of post-traumatic hypothermia provides benefit. Collectively, these studies also demonstrate that different animal models of TBI can evoke different biological responses to injury.	[Fujita, Motoki; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Fujita, Motoki] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS047463]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463] Funding Source: NIH RePORTER	We thank Susan Walker and Lynn Davis for their excellent technical assistance. This study is supported by NIH grants HD055813 and NS047463.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Ueda Y, 2004, STROKE, V35, P601, DOI 10.1161/01.STR.0000113693.56783.73; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	37	13	14	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1491	1498		10.1089/neu.2011.2278			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600021	22364620	Green Published			2022-02-06	
J	Graziani, G; Cucchiari, D; Aroldi, A; Angelini, C; Gaetani, P; Selmi, C				Graziani, Giorgio; Cucchiari, David; Aroldi, Adriana; Angelini, Claudio; Gaetani, Paolo; Selmi, Carlo			Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HYPONATREMIA	Objective To outline the role of a new drug, tolvaptan, in treating severe and chronic hyponatraemia. Tolvaptan decreases aquaporin expression in renal collecting ducts, by inhibiting antidiuretic hormone (ADH)-V2 receptors, to promote free water clearance. Given its mechanism of action, this drug seems the ideal treatment for the syndrome of inappropriate antidiuretic hormone secretion (SIADH) when the osmotic imbalance leads to life threatening complications. Data sources A case is described of severe hyponatraemia deriving from SIADH secondary to meningoencephalitis in a patient admitted to hospital for traumatic brain injury. Data extraction Clinical, laboratory and radiological data at presentation and for a 1 year of follow-up were analysed. Data synthesis Tolvaptan ameliorated hyponatraemia, brain oedema and consciousness, and drug withdrawal led to recurrence of hyponatraemia and coma. Conclusions In patients with SIADH, which is not self-limited, and is associated with severe cognitive impairment, the use Tolvaptan may prove life saving and should be rigorously evaluated.	[Graziani, Giorgio; Cucchiari, David; Angelini, Claudio] Ist Clin Humanitas IRCCS, Dept Med, Nephrol & Dialysis Unit, Milan, Italy; [Aroldi, Adriana] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Med, Nephrol & Dialysis Unit, Milan, Italy; [Gaetani, Paolo] Ist Clin Humanitas IRCCS, Dept Neurol, Neurosurg Unit, Milan, Italy; [Selmi, Carlo] IRCCS Ist Clin Humanitas, Dept Med, Autoimmun & Metab Unit, Milan, Italy		Graziani, G (corresponding author), Ist Clin Humanitas IRCCS, Via Manzoni 56, I-20089 Rozzano, MI, Italy.	giorgio.graziani@humanitas.it	Selmi, Carlo/ABG-4899-2021	Selmi, Carlo/0000-0002-0323-0376; Gaetani, Paolo/0000-0003-0662-5872			Cole Chad D, 2004, Neurosurg Focus, V16, pE9; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Hannon MJ, 2010, EUR J ENDOCRINOL, V162, pS5, DOI 10.1530/EJE-09-1063; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Renneboog B, 2006, AM J MED, V119, p71e1, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Schrier RW, 2010, NAT REV NEPHROL, V6, P185, DOI 10.1038/nrneph.2010.21; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819	9	13	15	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2012	83	5					510	512		10.1136/jnnp-2011-300576			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	925TX	WOS:000302785600010	22323742				2022-02-06	
J	Kim, JP; Chang, WS; Chang, JW				Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo			The long-term surgical outcomes of secondary hemidystonia associated with post-traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Deep brain stimulation; Globus pallidus internus; Hemidystonia; Post-traumatic dystonia	PALLIDUS INTERNUS STIMULATION; GLOBUS-PALLIDUS; BASAL GANGLIA; DELAYED-ONSET; GENERALIZED DYSTONIA; NEURONAL-ACTIVITY; HEAD TRAUMA; SYMPTOMATIC HEMIDYSTONIA; PALLIDOTOMY; HEMIBALLISMUS	The aim was to assess the effect of deep brain stimulation for secondary hemidystonias associated with focal post-traumatic brain injuries. Four patients underwent deep brain stimulation for the treatment of medically refractory secondary hemidystonia associated with post-traumatic brain injury. Clinical outcome assessments were based on Burke-Fahn-Marsden Dystonia Rating Scale movement and disability scores. Health-related quality of life was assessed using a 36-item short-form general health survey questionnaire administered preoperatively and at the last follow-up visit. Burke-Fahn-Marsden Dystonia Rating Scale movement scores had improved by 73.2% (range, 38.1-94.1) and disability scores had improved by 75% (range, 60-100) at the 2-year follow-up visit. The health-related quality of life assessment revealed satisfactory results at follow-up, such that body pain, general health, vitality, social functioning, as well as emotional and mental health improved significantly. Globus pallidus internus deep brain stimulation can be used to modulate and ameliorate secondary hemidystonia associated with focal post-traumatic brain injury.	[Kim, Joo Pyung; Chang, Won Seok; Chang, Jin Woo] Yonsei Univ, Dept Neurosurg, Brain Korea Project Med Sci 21, Severance Hosp,Brain Res Inst,Coll Med, Seoul 120752, South Korea		Chang, JW (corresponding author), Yonsei Univ, Dept Neurosurg, Brain Korea Project Med Sci 21, Severance Hosp,Brain Res Inst,Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.	jchang@yuhs.ac		Chang, Jin Woo/0000-0002-2717-0101	Industrial Source Technology Department of the Ministry of Knowledge Economy (MKE) of Korea [10033812]	The authors would like to thank Eun Jung Kweon (R.N.) for clinical data acquisition and assistance with this paper. We are also grateful to Yong Ho Kwak (Ph.D.), Bae Hwan Lee (Ph.D.) from the MER Analysis team of the Medical Research Support Section, Department of Physiology, Yonsei University College of Medicine for their help with the figures. This study was supported by the Industrial Source Technology Department Program (no. 10033812) of the Ministry of Knowledge Economy (MKE) of Korea.	Alkhani A, 2006, MOVEMENT DISORD, V21, P852, DOI 10.1002/mds.20838; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; BURKE RE, 1980, J NEUROL NEUROSUR PS, V43, P789, DOI 10.1136/jnnp.43.9.789; BURTON K, 1984, NEUROLOGY, V34, P962, DOI 10.1212/WNL.34.7.962; Chang JW, 2002, J NEUROL NEUROSUR PS, V73, P588, DOI 10.1136/jnnp.73.5.588; Eltahawy HA, 2004, NEUROSURGERY, V54, P613, DOI 10.1227/01.NEU.0000108643.94730.21; Fernandez HH, 1999, MOVEMENT DISORD, V14, P695, DOI 10.1002/1531-8257(199907)14:4<695::AID-MDS1024>3.0.CO;2-3; Hutchison WD, 2003, ANN NEUROL, V53, P480, DOI 10.1002/ana.10474; Iacono RP, 1996, PEDIATR NEUROL, V14, P145, DOI 10.1016/0887-8994(96)00003-3; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; King RB, 2001, J NEUROSURG, V94, P309, DOI 10.3171/jns.2001.94.2.0309; Krauss JK, 2004, J CLIN NEUROPHYSIOL, V21, P18, DOI 10.1097/00004691-200401000-00004; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; Krystkowiak P, 1998, J NEUROL NEUROSUR PS, V65, P703, DOI 10.1136/jnnp.65.5.703; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; Lenz FA, 1998, J NEUROL NEUROSUR PS, V65, P767, DOI 10.1136/jnnp.65.5.767; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; Lozano AM, 1997, MOVEMENT DISORD, V12, P865, DOI 10.1002/mds.870120606; MAKI Y, 1980, CHILD BRAIN, V7, P113; Marks, 2004, NEUROSURG FOCUS, V17, pE4, DOI [10.3171/foc.2004.17.1.4, DOI 10.3171/foc.2004.17.1.4]; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; MESSIMY R, 1977, REV NEUROL, V133, P199; Munchau A, 2000, J NEUROL NEUROSUR PS, V69, P494, DOI 10.1136/jnnp.69.4.494; Ondo WG, 1998, MOVEMENT DISORD, V13, P693, DOI 10.1002/mds.870130415; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; SELLAL F, 1993, MOVEMENT DISORD, V8, P515, DOI 10.1002/mds.870080418; SILVER JK, 1994, ARCH PHYS MED REHAB, V75, P885, DOI 10.1016/0003-9993(94)90113-9; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006	30	13	13	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	MAY	2012	154	5					823	830		10.1007/s00701-012-1306-4			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	934PG	WOS:000303455800008	22367408				2022-02-06	
J	Leon-Carrion, J; Dominguez-Morales, MR; Martin, JMBY; Leon-Dominguez, U				Leon-Carrion, Jose; Rosario Dominguez-Morales, Maria; Barroso y Martin, Juan Manuel; Leon-Dominguez, Umberto			RECOVERY OF COGNITIVE FUNCTION DURING COMPREHENSIVE REHABILITATION AFTER SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			cognitive functions; neuropsychological rehabilitation; neurorehabilitation; traumatic brain injury		Objective: To explore the course and timing of functional recovery in patients who have emerged from coma after undergoing severe traumatic brain injury. Methods: An observational study involving 19 patients with traumatic brain injury recovered from coma who underwent holistic, intensive and multidisciplinary neurorehabilitation. Daily performance in each cognitive function (long-term memory, short-term memory, orientation, calculation, attention; mental control, automation, and planning) was clinically scored and compared at admission and discharge. Results: The course of cognitive recovery after post-traumatic coma is not uniform, offering a curve with many ups, downs and plateaus. To achieve a good response and outcome nearing normalcy, a patient needs over 300 h of intensive rehabilitation. Conclusion: The consolidation of functional recovery in patients with traumatic brain injury requires time and adequate training, and discharge is not recommended until cognitive improvement is established.	[Leon-Carrion, Jose; Rosario Dominguez-Morales, Maria; Leon-Dominguez, Umberto] Univ Seville, Ctr Brain Injury Rehabil CRE CER, ES-41002 Seville, Spain; [Leon-Carrion, Jose; Barroso y Martin, Juan Manuel] Univ Seville, Dept Expt Psychol, ES-41002 Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Ctr Brain Injury Rehabil CRE CER, C Torneo 23, ES-41002 Seville, Spain.	leoncarrion@us.es	Barroso y Martin, Juan Manuel/AAB-9758-2020	Leon-Dominguez, Umberto/0000-0001-5170-2553			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Fuster JM, 2003, CORTEX MIND UNIFYING; Leon-Carrion J, 2000, NEUROREHABILITATION, V14, P33; Leon-Carrion J., 2010, COMPUTERIZED SEVILLA; Leon-Carrion J., 1998, BRAIN INJURY SOURCES, V3, P16; Leon-Carrion J., 1997, NEUROPSYCHOL REHABIL, P371; Leon-Carrion J., 1999, REV ESPANOLA NEUROPS, V1, P49; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P385; Leon-Carrion J, 2010, BEHAV BRAIN RES, V208, P502, DOI 10.1016/j.bbr.2009.12.026; Lezack M., 1995, NEUROPSYCHOLOGICAL A; Lincoln N, 1999, COGNITIVE NEUROREHAB, P203; Machuca F., 1997, NEUROPSYCHOL REHABIL, p453 ; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Miller EH, 2007, ARCH DIS CHILD, V92, pA3; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; Prigatano GP., 1999, J HEAD TRAUMA REHAB, P322; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; YU J, 1976, ARCH PHYS MED REHAB, V57, P38	20	13	13	1	19	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		505	511		10.2340/16501977-0982			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	956TW	WOS:000305113000006	22661001	gold, Green Submitted			2022-02-06	
J	Li, Z; Cui, G; Wang, JX; Yu, ZH; Zhao, L; Lv, ZW				Li, Zhen; Cui, Gang; Wang, Junxiang; Yu, Zhihua; Zhao, Li; Lv, ZhengWen			Nemo-like Kinase (NLK) Involves in Neuronal Apoptosis after Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; NLK; PC12 cell; Glutamate; Apoptosis	DEATH; CASPASE-3; PATHWAY; CATENIN; MICE; RECEPTORS; BCL-2	Traumatic brain injury (TBI) consists of two phases: an immediate phase in which damage is caused as a direct result of the mechanical impact: and a late phase of altered biochemical events that results in delayed tissue damage and is therefore amenable to therapeutic treatment. Because the molecular mechanisms of delayed post-traumatic neuronal cell death are still poorly understood, we investigated whether nemo-like kinase (NLK), an evolutionarily conserved serine/threonine kinase involved in neuronal apoptosis following TBI. In the model of TBI, western blot analysis, double immunofluorescent staining and immunohistochemistry were used to analyze the role of NLK in the process. The results showed a significant down-regulation of NLK and a concomitant up-regulation of caspase-3 during the early stage of TBI. In the model of glutamate inducing PC12 apoptosis, we analyzed the effect of over-expression of NLK on the neuronal cell line PC12 apoptosis by cck-8, western blot and TUNEL assays. Together with previous reports. We hypothesize NLK was related to the down-regulation of caspase-3 expression after TBI, and such an event may be associated with neuronal apoptosis.	[Li, Zhen; Zhao, Li; Lv, ZhengWen] Cent Hosp TaiAN, Tai An 27100, Shandong, Peoples R China; [Cui, Gang; Wang, Junxiang; Yu, Zhihua] Suzhou Univ, Affiliated Hosp 1, Suzhou 215104, Peoples R China		Lv, ZW (corresponding author), Cent Hosp TaiAN, Tai An 27100, Shandong, Peoples R China.	lizhen840320@163.com; lvzhengwen1388@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2006547]	The plasmid was kindly given by laboratory of genetics, FuDAN. This study was supported by the National Natural Science Foundation of China (No. 30770488 and No. 30870320); Natural Science Foundation of Jiangsu province (No. BK2006547).	Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden H, 2002, PEDIATR INFECT DIS J, V21, P791, DOI 10.1097/00006454-200208000-00020; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	26	13	15	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2012	32	3					381	389		10.1007/s10571-011-9766-2			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	934AE	WOS:000303409700007	22127415				2022-02-06	
J	Schmidt, J; Fleming, J; Ownsworth, T; Lannin, N; Khan, A				Schmidt, Julia; Fleming, Jennifer; Ownsworth, Tamara; Lannin, Natasha; Khan, Asad			Feedback interventions for improving self-awareness after brain injury: A protocol for a pragmatic randomised controlled trial	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						feedback; rehabilitation; traumatic brain injury	ANXIETY STRESS SCALES; STATISTICS NOTES; TREATMENT ALLOCATION; VALIDITY; SAMPLE	Background: Occupational therapists working in brain injury rehabilitation use functional tasks as a means of providing feedback to improve self-awareness of people who have a brain injury and ultimately improve their occupational performance. Purpose: To compare the effectiveness of video, verbal and experiential feedback for improving self-awareness in people with traumatic brain injury. Methods: A randomised controlled trial will be conducted to compare the efficacy of video and verbal feedback during occupational therapy. Fifty-four participants with traumatic brain injury will be randomly allocated into three intervention groups: (i) video plus verbal feedback, (ii) verbal feedback and (iii) experiential feedback (control condition). Participants will receive the allocated intervention based on performance of a meal preparation task. The intervention sessions will occur four times during a two-week period. Blinded assessment will occur at baseline, post-intervention, and two months follow up. The primary outcome will be a measure of on-line self-awareness (number of self-corrected and therapist corrected errors). Secondary outcomes to be assessed include levels of intellectual self-awareness, emotional distress, and acceptance of disability. Data will be analysed using an intention to treat approach. Linear mixed effects models will be used to investigate the intervention effects. Findings and Implications: Results will contribute to evidence-based guidelines to support therapists to choose the most effective form of feedback for people with decreased self-awareness after traumatic brain injury.	[Schmidt, Julia] Royal Rehabil Ctr Sydney, Ryde, NSW 1680, Australia; [Schmidt, Julia; Fleming, Jennifer; Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Fleming, Jennifer; Khan, Asad] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Lannin, Natasha] Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, Sydney, NSW 2006, Australia		Schmidt, J (corresponding author), Royal Rehabil Ctr Sydney, POB 6, Ryde, NSW 1680, Australia.	julia.schmidt@royalrehab.com.au	Khan, Asad/R-8484-2016; Lannin, Natasha A/A-4195-2013; Khan, Asaduzzaman/F-8739-2010; Khan, Asad/N-7481-2019; Ownsworth, Tamara/ABB-6961-2021	Khan, Asad/0000-0003-4188-2065; Lannin, Natasha A/0000-0002-2066-8345; Khan, Asaduzzaman/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Ownsworth, Tamara/0000-0003-1835-7094; Schmidt, Julia/0000-0003-2004-4871			Altman DG, 1999, BRIT MED J, V318, P1209; Altman DG, 2001, BRIT MED J, V323, P446, DOI 10.1136/bmj.323.7310.446; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barco PP, 1991, COGNITIVE REHABILITA, P129; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Brown H, 2006, APPL MIXED MODELS ME; Burgess P, 1996, BEHAV ASSESSMENT DYS; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming J, 2009, INTERNATIONAL HANDBOOK OF OCCUPATIONAL THERAPY INTERVENTIONS, P225, DOI 10.1007/978-0-387-75424-6_20; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T., 2009, 6 S NEUR REH TALL ES; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherer M, 2004, AWARENESS QUESTIONNA; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tango T, 2009, STAT PROBABIL LETT, V79, P466, DOI 10.1016/j.spl.2008.09.016; Tham K, 1997, ARCH PHYS MED REHAB, V78, P410, DOI 10.1016/S0003-9993(97)90234-3; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC	35	13	13	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2012	59	2					138	146		10.1111/j.1440-1630.2012.00998.x			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	914BH	WOS:000301923200005	22448994				2022-02-06	
J	Sherif, C; Di Ieva, A; Gibson, D; Pakrah-Bodingbauer, B; Widhalm, G; Krusche-Mandl, I; Erdoes, J; Gilloon, B; Matula, C				Sherif, Camillo; Di Ieva, Antonio; Gibson, Daniel; Pakrah-Bodingbauer, Bita; Widhalm, Georg; Krusche-Mandl, Irena; Erdoes, Jozsef; Gilloon, Benjamin; Matula, Christian			A management algorithm for cerebrospinal fluid leak associated with anterior skull base fractures: detailed clinical and radiological follow-up	NEUROSURGICAL REVIEW			English	Article						Anterior skull base fractures; Cerebrospinal fluid (CSF) leak; Intradural bicoronal approach; Microsurgery; Traumatic brain injury	FRONTOBASAL FRACTURES; SUBCRANIAL APPROACH; CLASSIFICATION; DIAGNOSIS; FISTULAS; REPAIR; TRAUMA	Detailed outcome data for the management of anterior skull base fractures associated with cerebrospinal fluid (CSF) leakage is lacking. We present detailed follow-up data of a single-center study using a predetermined algorithm for the management of CSF leakage secondary to traumatic fractures. A number of 138 consecutive patients were included in the analysis; all patients underwent high-resolution computed tomography (CT) scanning at time of admission with beta(2)-transferrin testing used to confirm CSF leakage. Patients with acute surgical indications were operated as emergent; leaks were repaired at the time of initial surgery in patients with intracranial pressure < 15 cm H2O. The remainder of the study population was managed conservatively including use of prophylactic antibiotics; lumbar drainage (LD) catheters were placed in those patients with leakage persisting beyond 48 h. Leaks lasting longer than 5 days underwent microsurgical repair using an intradural bicoronal approach. One-year follow-up assessment included evaluation of neurological status, Glasgow Outcome Scale (GOS), and repeat head CT. Twenty eight patients (26.9%) underwent emergent surgery, 15 of whom had simultaneous CSF leak repair, whereas 76 patients (73.1%) underwent delayed CSF leak repair between days 5 and 14. Postoperative meningitis rate was low (1.9%). Postoperative CSF leak (1.9%) was managed by intradural or transnasal endoscopic operation. Comparable rates of anosmia and frontal lobe hypodensities were seen in the surgical and conservatively managed subgroups. The presented algorithm, utilizing prophylactic antibiotics, trial of LD, acute and/or delayed intradural microsurgery, yields favorable outcomes. Large randomized controlled trials are needed to better define the role of prophylactic antibiotics and to better characterize the optimal timing and approach of surgical repair.	[Sherif, Camillo; Di Ieva, Antonio; Widhalm, Georg; Matula, Christian] Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria; [Sherif, Camillo; Pakrah-Bodingbauer, Bita] KA Rudolfstiftung, Dept Neurosurg, A-1030 Vienna, Austria; [Di Ieva, Antonio] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Systemat Anat, A-1090 Vienna, Austria; [Gibson, Daniel; Gilloon, Benjamin] Dartmouth Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA; [Krusche-Mandl, Irena; Erdoes, Jozsef] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria		Sherif, C (corresponding author), Med Univ Vienna, Dept Neurosurg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	camillo.sherif@meduniwien.ac.at	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Widhalm, Georg/0000-0001-6014-0273; Di Ieva, Antonio/0000-0002-5341-5416			Bachli H, 2009, J CRANIO MAXILL SURG, V37, P305, DOI 10.1016/j.jcms.2009.01.008; Basu D, 2006, OTOLARYNG HEAD NECK, V135, P769, DOI 10.1016/j.otohns.2006.05.025; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chesnut R, 2000, MANAGEMENT PROGNOS 2; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Georgantopoulou A, 2003, BRIT J PLAST SURG, V56, P10, DOI 10.1016/S0007-1226(03)00013-4; Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kral T, 1997, NEUROSURG REV, V20, P19, DOI 10.1007/BF01390521; Kruse J, 2006, J CRANIOMAXILLOFAC T, V4, P8; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Locatelli D, 2006, NEUROSURGERY, V58, P246, DOI 10.1227/01.NEU.0000193924.65297.3F; Loew F, 1984, Adv Tech Stand Neurosurg, V11, P169; Madhusudan G, 2006, PLAST RECONSTR SURG, V117, P2382, DOI 10.1097/01.prs.0000218794.28670.07; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; OBERASCHER G, 1988, Rhinology (Utrecht), V26, P89; PROBST C, 1990, ACTA NEUROCHIR, V106, P37, DOI 10.1007/BF01809331; RAVEH J, 1988, J CRANIO MAXILL SURG, V16, P160, DOI 10.1016/S1010-5182(88)80042-8; Rocchi G, 2005, SURG NEUROL, V63, P559, DOI 10.1016/j.surneu.2004.07.047; ROUSSEAUX P, 1981, NEUROCHIRURGIE, V27, P15; Sakas DE, 1998, J NEUROSURG, V88, P471, DOI 10.3171/jns.1998.88.3.0471; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Schaller B, 2005, ACTA NEUROCHIR, V147, P355, DOI 10.1007/s00701-005-0487-5; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Sepehrnia A, 1999, NEUROSURGERY, V44, P113, DOI 10.1097/00006123-199901000-00068; Talamonti G, 1995, J Neurosurg Sci, V39, P191; Wax MK, 1997, OTOLARYNG HEAD NECK, V116, P442, DOI 10.1016/S0194-5998(97)70292-4; Zapalac JS, 2002, OTOLARYNG HEAD NECK, V126, P669, DOI 10.1067/mhn.2002.125755	29	13	15	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	APR	2012	35	2					227	237		10.1007/s10143-011-0352-3			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	911HD	WOS:000301707000017	21947554				2022-02-06	
J	Xu, WW; Jiang, GS; Chen, YW; Wang, XY; Jiang, XD				Xu, Weiwei; Jiang, Gengsi; Chen, Yanwei; Wang, Xiangyu; Jiang, Xiaodan			Prediction of minimally conscious state with somatosensory evoked potentials in long-term unconscious patients after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Somatosensory evoked potentials; traumatic brain injury; minimally conscious state; outcome	COMATOSE PATIENTS; VEGETATIVE STATE; PROGNOSTIC VALUE; CONDUCTION TIME; BILATERAL LOSS; HEAD-INJURY; RECOVERY; DISORDERS; DIAGNOSIS	BACKGROUND: To evaluate the predictive power of somatosensory evoked potentials (SEPs) for minimally conscious state (MCS) in long-term unconscious patients after traumatic brain injury (TBI). METHODS: SEPs were recorded in 58 patients with duration of unconsciousness >30 days after TBI. SEPs were classified into three grades. Predictors including age, sex, Glasgow Coma Scale (GCS), and cause of injury were also analyzed, respectively. The outcome was divided into two groups including unconscious group and MCS group. The outcome was assessed at 12 months after TBI. RESULTS: In 58 patients, 22 of 58 were minimally conscious, 3 of 58 dead, and 33 of 57 were still in vegetative state at 12 months after TBI. SEPs grade (p = 0.001) and GCS (p = 0.010) were significantly associated with the outcome. The area under the receiver operator characteristic curve of SEPs was 0.891 +/- 0.048 (p < 0.001; 95% confidence interval, 0.798-0.984) for predicting outcome, and of GCS score was only 0.746 +/- 0.066 (p < 0.002; 95% confidence interval, 0.616-0.876). The accuracy of the whole model for predicting unconscious and MCS was 91.7% and 86.4%, respectively. The overall correct prediction was as high as 89.7% (p < 0.001). CONCLUSIONS: SEPs are excellent in predicting the outcome of long-term unconscious patients after TBI. SEPs should be considered more often and more routinely used after TBI. (J Trauma. 2012;72:1024-1030. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Xu, Weiwei; Wang, Xiangyu; Jiang, Xiaodan] So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China; [Xu, Weiwei; Wang, Xiangyu; Jiang, Xiaodan] Guangdong Neurosci Inst, Guangzhou 510282, Guangdong, Peoples R China; [Jiang, Gengsi] Dongguan Peoples Hosp, Dept Neurosurg, Dongguan, Peoples R China; [Chen, Yanwei] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China		Wang, XY (corresponding author), So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China.	wang_xy123@yahoo.cn; xiaodan_jiang@sina.com					BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; Cant B R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P250; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Chiappa KH, 1998, ELECTROEN CLIN NEURO, V106, P149, DOI 10.1016/S0013-4694(97)00118-1; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Giacino JT, 1997, SEMIN NEUROL, V17, P105, DOI 10.1055/s-2008-1040919; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; NEWLON PG, 1983, NEUROSURGERY, V12, P613, DOI 10.1227/00006123-198306000-00003; Plum F., 1983, DIAGNOSIS STUPOR COM; Pohlmann-Eden, 1997, INTENS CARE MED, V23, P301; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; Schwarz S, 1999, CRIT CARE MED, V27, P182, DOI 10.1097/00003246-199901000-00049; Serafetinides, 1965, BRAIN, V88, P107; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Theilen HJ, 2000, J NEUROL NEUROSUR PS, V68, P657, DOI 10.1136/jnnp.68.5.657; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	25	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					1024	1029		10.1097/TA.0b013e31824475cc			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	925TO	WOS:000302784600049	22491621				2022-02-06	
J	Hinton-Bayre, AD				Hinton-Bayre, Anton D.			Choice of Reliable Change Model Can Alter Decisions Regarding Neuropsychological Impairment After Sports-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; neuropsychology; reilable change; return to play	CHANGE INDEXES; SCORES	Objective: Impaired neuropsychological test performance after concussion has been used to guide restraint from play, in particular using reliable change indices (RCI). It remains unclear which of the RCI is most appropriate. Design: Athletes were assessed prospectively before and after cerebral concussion and compared with control athletes. Setting: Athletes were assessed in a clinical office environment after referral from a Sports Physician. Participants: One hundred ninety-four Australian rugby league athletes were assessed preseason (time 1). Interventions: Twenty-seven concussed athletes were assessed 2 days after trauma (time 2) and compared with 26 distribution-matched volunteer uninjured controls. Main Outcome Measures: Cognitive performance was assessed on 5 neuropsychological measures of speed of information processing, psychomotor speed, and response inhibition. Four previously reported RCI models used in sports concussion were contrasted, as described by Barr and McCrea (2001) and Maassen et al (2006). Results: Reliable change index models were marginally comparable in classifying the control sample. In the concussed sample, no one model seemed to be consistently more or less sensitive. Moreover, the same model could be most sensitive for one individual and least sensitive for another, even on the same test. Conclusions: Reliable change index models can yield different outcomes regarding whether an athlete has experienced cognitive impairment after concussion. Reliable change index model sensitivity to impairment depends on multiple test and situational factors, including test-retest reliability, differences in test and retest variances, and the individual's relative position on initial testing. In the absence of consensus, the clinician must use highly reliable measures with suitably matched controls if using an RCI.	[Hinton-Bayre, Anton D.] Univ Queensland, Sch Med, Brisbane, Qld, Australia		Hinton-Bayre, AD (corresponding author), Royal Perth Hosp, Dept Otolaryngol Head & Neck Surg, Wellington Rd, Perth, WA 6001, Australia.	anton.hb@hotmail.com					Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Chelune GJ, 2003, NEUROPSYCHOLOGY, V7, P41; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hinton-Bayre A, 2005, BRIT J SPORT MED, V39, P488; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Maassen GH, 2005, BRIT J SPORT MED, V39, P483, DOI 10.1136/bjsm.2004.015594; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCSWEENY AJ, 1993, CLIN NEUROPSYCHOL, V7, P460; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876	18	13	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2012	22	2					105	108		10.1097/JSM.0b013e318248a526			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	908RG	WOS:000301507200006	22343968				2022-02-06	
J	Shin, SS; Bray, ER; Dixon, CE				Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward			Effects of Nicotine Administration on Striatal Dopamine Signaling after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; nicotine; striatum; TBI	CONTROLLED CORTICAL IMPACT; TYROSINE-HYDROXYLASE GENE; MORRIS WATER MAZE; CATECHOLAMINE SYNTHESIS; CHROMAFFIN CELLS; FRONTAL-CORTEX; PHOSPHORYLATION; ACTIVATION; EXPRESSION; DARPP-32	Previous studies on the therapeutic potential of agents affecting the dopamine system in traumatic brain injury (TBI) suggest that dopamine dysregulation may have a major role in behavioral deficit after TBI. We have previously identified that TBI reduces striatal dopamine synthesis and release at 7 days post-injury. In order to reverse deficits in the activity of tyrosine hydroxylase and dopamine release following TBI, we administered nicotine by intraperitoneal injection into rats for 7 days. Tyrosine hydroxylase activity assay demonstrated recovery of activity with nicotine treatment in injured animals. Microdialysis experiments using potassium stimulation to induce dopamine release showed recovery of dopamine release in injured animals receiving nicotine treatment. There was no effect of nicotine injection on extracellular dopamine metabolite levels, indicating the specificity of nicotine's effect on dopamine synthesis and release. Also, the activation of downstream postsynaptic molecule dopamine and cAMP regulated phosphoprotein 32 (DARPP-32) was assessed by Western blots for DARPP-32 phosphorylated at threonine 34 (pDARPP-32-T34). Injury reduced pDARPP-32-T34 levels, but nicotine treatment of injured animals did not alter pDARPP-32-T34 levels, indicating that postsynaptic dopamine signaling is complex, and the recovery of dopamine release may not be sufficient for the recovery of DARPP-32 activity.	[Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Shin, Samuel S.; Bray, Eric R.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F30NS067731-01, 5R01NS060672-02]; Veterans AdministrationUS Department of Veterans Affairs [B6761R]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060672, F30NS067731] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health grants 1F30NS067731-01 and 5R01NS060672-02, and Veterans Administration Rehabilitation Research and Development grant B6761R.	Bales J.W., 2011, EXP NEUROL; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; BLOCK F, 1993, NEUROSCI LETT, V149, P126, DOI 10.1016/0304-3940(93)90752-7; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Brown GP, 2000, J NEUROSCI, V20, P7880; BUSTOS G, 1980, J NEUROCHEM, V35, P47, DOI 10.1111/j.1471-4159.1980.tb12488.x; CARR LA, 1989, NEUROCHEM RES, V14, P511, DOI 10.1007/BF00964911; CHOI DW, 1987, J NEUROSCI, V7, P369; CRAVISO GL, 1992, J NEUROCHEM, V59, P2285; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; ERINOFF L, 1979, BRAIN RES, V164, P195, DOI 10.1016/0006-8993(79)90015-5; FAIRBROTHER IS, 1990, J NEUROCHEM, V54, P1844, DOI 10.1111/j.1471-4159.1990.tb04881.x; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAYCOCK JW, 1993, NEUROCHEM RES, V18, P15, DOI 10.1007/BF00966919; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; HIREMAGALUR B, 1993, J BIOL CHEM, V268, P23704; KING MM, 1984, J BIOL CHEM, V259, P8847; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; LEVIN ED, 1990, BEHAV NEURAL BIOL, V53, P269, DOI 10.1016/0163-1047(90)90509-5; Levin ED, 1996, PSYCHOPHARMACOLOGY, V127, P25, DOI 10.1007/BF02805971; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Marshall DL, 1997, J NEUROCHEM, V68, P1511; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nishi A, 1997, J NEUROSCI, V17, P8147; Osterhout CA, 2005, J NEUROCHEM, V94, P731, DOI 10.1111/j.1471-4159.2005.03222.x; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Rahman S, 2007, NEUROPHARMACOLOGY, V52, P755, DOI 10.1016/j.neuropharm.2006.09.012; Sabban EL, 2002, ANN NY ACAD SCI, V971, P39, DOI 10.1111/j.1749-6632.2002.tb04430.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sgambato V, 1998, J NEUROSCI, V18, P8814; Shiflett MW, 2011, BEHAV BRAIN RES, V218, P240, DOI 10.1016/j.bbr.2010.12.010; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Smith AM, 2010, BIOCHEM PHARMACOL, V80, P402, DOI 10.1016/j.bcp.2010.03.018; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Tang KC, 1997, J CLIN INVEST, V100, P1180, DOI 10.1172/JCI119630; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	57	13	13	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					843	850		10.1089/neu.2011.1966			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900012	21815786	Green Published			2022-02-06	
J	Li, CY; Wu, PM; Wu, ZZ; Ahn, CH; LeDoux, D; Shutter, LA; Hartings, JA; Narayan, RK				Li, Chunyan; Wu, Pei-Ming; Wu, Zhizhen; Ahn, Chong H.; LeDoux, David; Shutter, Lori A.; Hartings, Jed A.; Narayan, Raj K.			Brain temperature measurement: A study of in vitro accuracy and stability of smart catheter temperature sensors	BIOMEDICAL MICRODEVICES			English	Article						Temperature microsensor; Smart catheter; Accuracy; Drift; Hypothermia; Traumatic brain injury	HEAD-INJURED PATIENTS; HYPOTHERMIA; MANAGEMENT; TUBE	The injured brain is vulnerable to increases in temperature after severe head injury. Therefore, accurate and reliable measurement of brain temperature is important to optimize patient outcome. In this work, we have fabricated, optimized and characterized temperature sensors for use with a micromachined smart catheter for multimodal intracranial monitoring. Developed temperature sensors have resistance of 100.79 +/- 1.19 Omega and sensitivity of 67.95 mV/A degrees C in the operating range from15-50A degrees C, and time constant of 180 ms. Under the optimized excitation current of 500 mu A, adequate signal-to-noise ratio was achieved without causing self-heating, and changes in immersion depth did not introduce clinically significant errors of measurements (< 0.01A degrees C). We evaluated the accuracy and long-term drift (5 days) of twenty temperature sensors in comparison to two types of commercial temperature probes (USB Reference Thermometer, NIST-traceable bulk probe with 0.05A degrees C accuracy; and IT-21, type T type clinical microprobe with guaranteed 0.1A degrees C accuracy) under controlled laboratory conditions. These in vitro experimental data showed that the temperature measurement performance of our sensors was accurate and reliable over the course of 5 days. The smart catheter temperature sensors provided accuracy and long-term stability comparable to those of commercial tissue-implantable microprobes, and therefore provide a means for temperature measurement in a microfabricated, multimodal cerebral monitoring device.	[Li, Chunyan; Wu, Pei-Ming; Narayan, Raj K.] N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Wu, Zhizhen; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA; [LeDoux, David] N Shore Univ Hosp, Neurosurg Intens Care Unit, Manhasset, NY 11030 USA; [Shutter, Lori A.; Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Inst Neurosci, Cincinnati, OH 45219 USA; [Narayan, Raj K.] N Shore Univ Hosp, Dept Neurosurg, Harvey Cushing Inst Neurosci, Manhasset, NY 11030 USA		Li, CY (corresponding author), N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA.	cli11@nshs.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Hartings, Jed/0000-0001-8583-3471	US Department of DefenseUnited States Department of Defense [PT090526P4 (W81XWH-10-1-0978)]	This work was supported by the US Department of Defense under project No. PT090526P4 (W81XWH-10-1-0978). The authors gratefully acknowledge Mr. Joseph A. Green at the North Shore University Hospital for performing polyethylene gas sterilization and Dr. Nadeen Chahine and Ms. Neena Rajan at the Feinstein Institute for Medical Research for their valuable discussion.	Axelrod YK, 2008, NEUROL CLIN, V26, P585, DOI 10.1016/j.ncl.2008.02.005; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Deyne C.S.D., 2010, CURR OPIN ANESTHESIO, V23, P258; Duck F.A., 1990, PHYS PROPERTIES TISS; Fountas KN, 2004, NEUROCRIT CARE, V1, P195, DOI 10.1385/NCC:1:2:195; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Kurth CD, 2000, ANESTHESIOLOGY, V93, P598, DOI 10.1097/00000542-200009000-00006; Kurth CD, 1997, CIRCULATION, V96, P358; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043; Li CY, 2010, LAB CHIP, V10, P1476, DOI 10.1039/c000897d; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Liptak B.G., 1995, PROCESS MEASUREMENT, P690; Liu P, 2009, SENSORS-BASEL, V9, P9533, DOI 10.3390/s91209533; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; MM Elizabeth, 2011, INT J CARE IN PRESS; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Seymour JP, 2009, BIOMATERIALS, V30, P6158, DOI 10.1016/j.biomaterials.2009.07.061; Thomas J.L., 1948, NBS CIRCULAR, V470, P13; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; VERLOOY J, 1995, ACTA NEUROCHIR, V134, P76, DOI 10.1007/BF01428508	23	13	13	0	15	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176			BIOMED MICRODEVICES	Biomed. Microdevices	FEB	2012	14	1					109	118		10.1007/s10544-011-9589-4			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics	899YC	WOS:000300851600010	21952982				2022-02-06	
J	Halldorsson, JG; Flekkoy, KM; Arnkelsson, GB; Tomasson, K; Magnadottir, HB; Arnarson, EO				Halldorsson, Jonas G.; Flekkoy, Kjell M.; Arnkelsson, Gudmundur B.; Tomasson, Kristinn; Magnadottir, Hulda Bra; Arnarson, Eirikur Orn			The scope of early traumatic brain injury as a long-term health concern in two nationwide samples: Prevalence and prognostic factors	BRAIN INJURY			English	Article						Adolescents; children; disability; health concern; long-term; nationwide; paediatric; prevalence; prospective; traumatic brain injury; young adults	MILD HEAD-INJURY; UNITED-STATES; EARLY-CHILDHOOD; BIRTH COHORT; CLINICAL MANAGEMENT; ACADEMIC OUTCOMES; YOUNG-ADULTS; CHILDREN; POPULATION; EPIDEMIOLOGY	Primary objectives: To examine the scope of paediatric traumatic brain injury (TBI) as a health concern and to identify prognostic factors for TBI-related sequelae. Methods and procedures: The study was prospective and nationwide. A questionnaire was sent to a study group (SG) of all 0-19 years old in Iceland, diagnosed similar to 16 years earlier with TBI during a 1-year period, 1992-1993 (n = 550) and to a control group (CG) (n = 1232), selected from the National Register. Main outcomes and results: In the CG 49.5% reported having sustained TBI and 7.0% reported long-term disability. In the group with TBI, force of impact to the head, more than one incident of TBI and the injury severity by gender interaction predicted late symptoms. TBI severity had substantially less effect than force of impact and was close to non-existent for females. Conclusions: Based on two independent nationwide samples, the scope of TBI as a health concern in adolescence and young adulthood is greater than previously documented. The findings suggest that TBI event-related factors, especially force of impact, have greater predictive value than clinical symptoms of severity at the acute stage, females being more sensitive to the effects of mild TBI than males.	[Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland; [Halldorsson, Jonas G.; Arnarson, Eirikur Orn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Flekkoy, Kjell M.] Univ Oslo, Oslo, Norway; [Arnkelsson, Gudmundur B.] Univ Iceland, Dept Psychol, Reykjavik, Iceland; [Tomasson, Kristinn] Adm Occupat Safety & Hlth, Reykjavik, Iceland		Halldorsson, JG (corresponding author), Landspitali Univ Hosp, Psychol Serv, IS-108 Reykjavik, Iceland.	jonasgh@landspitali.is	Arnarson, Eirikur O/N-7731-2014; Arnarson, Eirikur Orn/AAE-4476-2021	Arnarson, Eirikur O/0000-0002-6816-148X; Arnarson, Eirikur Orn/0000-0002-6816-148X	Statistics Iceland; Icelandic Directorate of Health; Landspitali University Hospital; University of Iceland; Margret Bjorgolfsdottir memorial fund; Olafia Jonsdottir memorial fund; Helga Jonsdottir and Sigurlidi Kristjansson memorial fund; Alcan in Iceland community	The authors are grateful for support, assistance and information provided by Statistics Iceland, the Icelandic Directorate of Health, Landspitali University Hospital and other state hospitals, emergency departments and healthcare centres. The study was funded in part with grants from the University of Iceland doctoral fund, the Landspitali University Hospital science fund, the Margret Bjorgolfsdottir memorial fund, the Olafia Jonsdottir memorial fund, the Helga Jonsdottir and Sigurlidi Kristjansson memorial fund and the Alcan in Iceland community fund.	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; [Anonymous], 2006, SPSS WIND 15 0 0; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BERNARDI B, 1993, TOP MAGN RESON IMAG, V5, P161; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cordon IM, 2004, DEV REV, V24, P101, DOI 10.1016/j.dr.2003.09.003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dillman DA, 2006, MAIL INTERNET SURVEY; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Halldorsson Jonas G, 2008, Neuropsychiatr Dis Treat, V4, P405; Halldorsson Jonas G, 2007, Neuropsychiatr Dis Treat, V3, P935; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1975, LANCET, V1, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine SC, 2005, BRAIN COGNITION, V59, P114, DOI 10.1016/j.bandc.2005.05.008; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Locker D, 2007, DENT TRAUMATOL, V23, P291, DOI 10.1111/j.1600-9657.2006.00457.x; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Peterson C, 2005, LAW HUMAN BEHAV, V29, P527, DOI 10.1007/s10979-005-6833-6; Peterson C, 1999, DEV PSYCHOL, V35, P1493, DOI 10.1037/0012-1649.35.6.1493; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; R Development Core Team, 2010, R LANG ENV STAT COMP; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stefansdottir A, 1997, SCAND J PRIM HEALTH, V15, P30, DOI 10.3109/02813439709043426; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Teasdale TW, 2003, J NEUROL NEUROSUR PS, V74, P933, DOI 10.1136/jnnp.74.7.933; VANE DW, 1995, J TRAUMA, V38, P867, DOI 10.1097/00005373-199506000-00006; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; [No title captured]; [No title captured]; [No title captured]	82	13	13	2	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					1	13		10.3109/02699052.2011.635359			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900001	22149441				2022-02-06	
J	Johnson, SC; Silverberg, ND; Millis, SR; Hanks, RA				Johnson, Season C.; Silverberg, Noah D.; Millis, Scott R.; Hanks, Robin A.			Symptom Validity Indicators Embedded in the Controlled Oral Word Association Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity; Verbal fluency; Controlled Oral Word Association Test; COWAT	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; MILD COGNITIVE IMPAIRMENT; VERBAL FLUENCY; RESPONSE BIAS; PERFORMANCE PATTERNS; CHRONIC PAIN; BASE RATES; ADULTS	Embedded symptom validity measures facilitate the detection of below-capacity performance in neuropsychological assessment. A number of such indicators have been proposed for the Controlled Oral Word Association Test (COWAT), a widely used test of word generation. However, several of these embedded indicators have not been cross-validated and it is currently unclear which represent the optimal combination of predictors. This study used Bayesian Model Averaging (BMA) to determine the set of predictors that best differentiate between patients presenting with (n = 46) and without (n = 55) malingered neurocognitive dysfunction (MND). Mild traumatic brain injury was the most common diagnosis in the MND group (96%). BMA selected the COWAT total score and a measure of change in output over time. A logistic regression model combining these variables yielded good discriminability, with an AUC of .774, (95% confidence interval = .679 to .869), 78% of cases were classified correctly, with 67% sensitivity and 88% specificity. Two alternative models performed similarly, but the variables involved required slightly longer administration and/or calculation time, making them somewhat less desirable. These results support the use of a weighted combination of embedded symptom validity measures in the COWAT.	[Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 2G9, Canada; [Johnson, Season C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Dept Phys Med & Rehabil, Vancouver, BC, Canada; [Millis, Scott R.; Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Benton AL, 1994, MULTILINGUAL APHASIA; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Boone K.B., 2007, ASSESSMENT FEIGNED C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Crowe SF, 2001, BRAIN COGNITION, V47, P323; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Hardin JW, 2007, GEN LINEAR MODEL EXT; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 2002, J FORENSIC NEUROPSYC, V3, P227, DOI DOI 10.1300/J151V03N01_03; Murphy KI, 2006, J INT NEUROPSYCH SOC, V12, P570, DOI 10.1017/S1355617706060590; Nutter-Upham KE, 2008, ARCH CLIN NEUROPSYCH, V23, P229, DOI 10.1016/j.acn.2008.01.005; R Core Team, 2012, R LANG ENV STAT COMP; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silverberg ND, 2008, CLIN NEUROPSYCHOL, V22, P140, DOI 10.1080/13854040601160597; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; StataCorp, 2011, STAT STAT SOFTW REL; Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128; Traykov L, 2007, COGN BEHAV NEUROL, V20, P219, DOI 10.1097/WNN.0b013e31815e6254; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	38	13	14	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	7					1230	1241		10.1080/13854046.2012.709886			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	027DE	WOS:000310331200013	22856612				2022-02-06	
J	Kaplan, JB; Bodhit, AN; Falgiani, ML				Kaplan, Joshua B.; Bodhit, Aakash N.; Falgiani, Michael L.			Communicating carotid-cavernous sinus fistula following minor head trauma	INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE			English	Article							MANAGEMENT	Introduction: A case of communicating carotid-cavernous sinus fistula (CCF) after minor closed head injury is presented. Case presentation: A 45-year-old Caucasian male presented to the emergency department of a tertiary care hospital with the chief complaint of blurred vision and facial numbness. The patient had experienced a minor head injury 1 month ago with loss of consciousness. After a 2-week symptom-free period, he developed scalp and facial numbness, along with headache and vision problems. His vital signs were within normal limits, but on examination the patient was noted to have orbital and carotid bruits with several concerning neurological findings. CT and MRI confirmed the suspicion of carotid-cavernous sinus fistula, which was managed by cerebral angiography with coil embolization of this fistula. The patient was symptom free at the 8-month follow-up. Discussion: Carotid-cavernous sinus fistula is a rare condition that is usually caused by blunt or penetrating trauma to the head, but can develop spontaneously in about one fourth of patients with CCF. The connection between the carotid artery and cavernous sinus leads to increased pressure in the cavernous sinus and compression of its contents, and thereby produces the clinical symptoms and signs seen. Diagnosis depends on clinical examination and neuroimaging techniques. The aim of management is to reduce the pressure within the cavernous sinus, which results in gradual resolution of symptoms.	[Kaplan, Joshua B.; Bodhit, Aakash N.; Falgiani, Michael L.] Univ Florida, Coll Med, Dept Emergency Med, 1329 SW 16th St,POB 100186, Gainesville, FL 32610 USA		Bodhit, AN (corresponding author), Univ Florida, Coll Med, Dept Emergency Med, 1329 SW 16th St,POB 100186, Gainesville, FL 32610 USA.	aakashnb@ufl.edu	Bodhit, Aakash/AAM-5786-2021	Bodhit, Aakash/0000-0003-2722-025X			ABRAHAMSON IA, 1955, AM J OPHTHALMOL, V39, P521, DOI 10.1016/0002-9394(55)92249-2; AQUINI MG, 1994, SKULL BASE SURG, V4, P145, DOI 10.1055/s-2008-1058966; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Chaudhry IA, 2009, MIDDLE EAST AFR J OP, V16, P57, DOI 10.4103/0974-9233.53862; CORRADINO G, 1988, SOUTHERN MED J, V81, P660, DOI 10.1097/00007611-198805000-00030; DEBRUN G, 1981, J NEUROSURG, V55, P678, DOI 10.3171/jns.1981.55.5.0678; Gemmete JJ, 2010, CURR TREAT OPTION N, V12, P43, DOI 10.1007/s11940-009-0051-3; HALBACH VV, 1987, AM J ROENTGENOL, V149, P587, DOI 10.2214/ajr.149.3.587; HALBACH VV, 1987, RADIOLOGY, V163, P437, DOI 10.1148/radiology.163.2.3562823; Higashida R T, 1986, Acta Radiol Suppl, V369, P580; Jiamsripong P, 2007, EMERG MED J, V24, DOI 10.1136/emj.2006.045195; KELTNER JL, 1987, OPHTHALMOLOGY, V94, P1585; Lewis AI, 1996, J NEUROSURG, V84, P400, DOI 10.3171/jns.1996.84.3.0400; LEWIS AI, 1995, NEUROSURGERY, V36, P239, DOI 10.1227/00006123-199502000-00001; Locke CE, 1924, ANN SURG, V80, P1; VINUELA F, 1984, J NEUROSURG, V60, P976, DOI 10.3171/jns.1984.60.5.0976	16	13	15	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1865-1372	1865-1380		INT J EMERG MED	Int. J. Emergency Medicine		2012	5								10	10.1186/1865-1380-5-10			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V22SV	WOS:000215042400010	22330699	gold, Green Published			2022-02-06	
J	Martinez, E; Navarro, A; Ordonez, C; del Valle, E; Tolivia, J				Martinez, Eva; Navarro, Ana; Ordonez, Cristina; del Valle, Eva; Tolivia, Jorge			Amyloid-beta(25-35) Induces Apolipoprotein D Synthesis and Growth Arrest in HT22 Hippocampal Cells	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid-beta(25-35); apolipoprotein D; growth arrest; HT22; oxidative stress	MESSENGER-RNA EXPRESSION; AMYLOID-BETA; ALZHEIMERS-DISEASE; D GENE; OXIDATIVE STRESS; MOLECULAR CHARACTERIZATION; TISSUE DISTRIBUTION; RETINOIC ACID; MECHANISMS; BRAIN	Apolipoprotein D (ApoD) is a secreted glycoprotein that is markedly induced in several pathological and stressful conditions in the nervous system. In the central nervous system, ApoD expression is upregulated during aging, after traumatic brain injury, and in several human neuropathologies such as Alzheimer's disease (AD), where it is found associated with amyloid-beta (A beta) plaques. Recent studies have indicated that ApoD has an important function as a neuroprotective and antioxidant protein. The aim of this work is to study the effect of the peptide fragment A beta(25-35), which is believed to play a major role in the neurodegenerative process of AD, in ApoD expression in a mouse hippocampal cell line. In addition, we studied whether direct addition of exogenous human recombinant ApoD protein has neuroprotective effect against A beta(25-35) treatment on neuronal cells. Our results demonstrate that A beta(25-35) induces ApoD expression in hippocampal cells in response to stress-induced growth arrest. This observed relationship between A beta and ApoD expression could explain the elevated levels of ApoD found in AD brain, where it may be a neuroprotective molecule in the course of AD, probably related to its lipid transport function or a direct antioxidant property. However, the addition of exogenous human recombinant ApoD does not exert any protective effect, most likely due to its major structural modifications.	[Martinez, Eva; Navarro, Ana; del Valle, Eva; Tolivia, Jorge] Univ Oviedo, Dept Morfol & Biol Celular, Fac Biol & Med, E-33006 Oviedo, Spain; [Ordonez, Cristina] CIMA, Area Neurociencias, Pamplona, Spain		Tolivia, J (corresponding author), Univ Oviedo, Dept Morfol & Biol Celular, Fac Biol & Med, Julian Claveria S-N, E-33006 Oviedo, Spain.	jtolivia@uniovi.es	Tolivia, Jorge/D-2248-2010; del Valle, Eva/D-6820-2012; Martinez-Pinilla, Eva/C-7907-2013; Navarro, Ana/N-2092-2014	Tolivia, Jorge/0000-0001-8984-8849; del Valle, Eva/0000-0002-7959-4790; Martinez-Pinilla, Eva/0000-0002-0572-0926; Navarro, Ana/0000-0001-6206-6505	MECEuropean Commission; FEDEREuropean Commission [SAF2007-64076/, UNOV-11-MA-16]	This work was supported by MEC and FEDER (SAF2007-64076/) and UNOV-11-MA-16. EM was predoctoral fellow from "Ministerio de Educacion y Ciencia" Spain (AP-2005-3815) and CO was a predoctoral fellow from "Gobierno del Principado de Asturias" Spain (BP05-064).	Alvarez ML, 2003, OPHTHALMIC RES, V35, P111, DOI 10.1159/000069130; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; BOYLES JK, 1990, J LIPID RES, V31, P2243; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulbarelli A, 2009, MOL CELL NEUROSCI, V40, P365, DOI 10.1016/j.mcn.2008.12.006; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; del Valle E, 2003, J HISTOCHEM CYTOCHEM, V51, P1285, DOI 10.1177/002215540305101005; Desai PP, 2005, NEUROBIOL DIS, V20, P574, DOI 10.1016/j.nbd.2005.04.012; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Do Carmo S, 2009, AM J PHYSIOL-ENDOC M, V296, pE802, DOI 10.1152/ajpendo.90725.2008; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; Gillardon F, 1996, BRAIN RES, V706, P169, DOI 10.1016/0006-8993(95)01332-6; Glockner F, 2003, NEUROSCIENCE, V122, P103, DOI 10.1016/S0306-4522(03)00529-3; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Hu CY, 2001, J NEUROCYTOL, V30, P209, DOI 10.1023/A:1012797623620; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Lee WS, 2006, LIFE SCI, V78, P1268, DOI 10.1016/j.lfs.2005.06.036; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; LopezBoado YS, 1996, J BIOL CHEM, V271, P32105, DOI 10.1074/jbc.271.50.32105; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Nasreen A, 2006, PROTEIN SCI, V15, P190, DOI 10.1110/ps.051775606; Navarro A, 2004, J HISTOCHEM CYTOCHEM, V52, P1031, DOI 10.1369/jhc.3a6213.2004; Navarro A, 2003, EXP NEUROL, V184, P697, DOI 10.1016/S0014-4886(03)00315-7; Navarro A, 2001, J HISTOTECHNOL, V24, P45; Navarro A, 2008, HISTOL HISTOPATHOL, V23, P995, DOI 10.14670/HH-23.995; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Ordonez C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.010; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perdomo G, 2009, AGING-US, V1, P17; Perez C, 2012, AGE, V34, P895, DOI 10.1007/s11357-011-9286-5; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1991, J LIPID RES, V32, P1959; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rickhag M, 2008, J CEREBR BLOOD F MET, V28, P551, DOI 10.1038/sj.jcbfm.9600552; Ruiz M, 2011, EXP GERONTOL, V46, P579, DOI 10.1016/j.exger.2011.02.014; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sung YJ, 2003, J BIOMED SCI, V10, P379, DOI 10.1159/000071157; Suresh S, 1998, J NEUROCHEM, V70, P242; Thomas EA, 2003, CURR MOL MED, V3, P408, DOI 10.2174/1566524033479681; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, J NEUROCHEM, V79, P1059, DOI 10.1046/j.1471-4159.2001.00654.x; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; Wernyj RP, 1999, MOL BRAIN RES, V64, P69, DOI 10.1016/S0169-328X(98)00307-6; Yagami T, 2004, BIOCHEM PHARMACOL, V67, P1153, DOI 10.1016/j.bcp.2003.11.005; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Zhang HY, 2008, CELL BIOL INT, V32, P1230, DOI 10.1016/j.cellbi.2008.07.006; Zhang L, 2010, NEUROCHEM INT, V57, P547, DOI 10.1016/j.neuint.2010.06.021; Zhang Y, 2011, MOL BIOL REP, V38, P1847, DOI 10.1007/s11033-010-0301-1	71	13	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2012	30	2					233	244		10.3233/JAD-2012-112102			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	947BD	WOS:000304400700002	22398376				2022-02-06	
J	Nordvik, JE; Schanke, AK; Walhovd, K; Fjell, A; Grydeland, H; Landro, NI				Nordvik, Jan E.; Schanke, Anne-Kristine; Walhovd, Kristine; Fjell, Anders; Grydeland, Hakon; Landro, Nils I.			Exploring the relationship between white matter microstructure and working memory functioning following stroke: A single case study of computerized cognitive training	NEUROCASE			English	Article						Cognitive rehabilitation; Computerized cognitive training; Stroke; Diffusion tensor imaging; Fractional anisotropy	TRAUMATIC BRAIN-INJURY; SUBJECT DIFFUSION DATA; MULTIPLE-SCLEROSIS; SPATIAL STATISTICS; STRUCTURAL-CHANGES; VOXELWISE ANALYSIS; CONTROLLED-TRIAL; D1 RECEPTOR; MRI; PLASTICITY	Cognitive impairment is a well-known consequence of acquired brain injuries, including stroke. Computerized cognitive training (CCT) is a rehabilitation approach intended to enhance cognitive functioning. It is unclear whether CCT leads to generalized cognitive improvements in daily life functioning, or if the subjects improve performance only on the exercises involved in the training. The current study explores whether fractional anisotropy (FA), a measure of white matter microstructure, may serve as an indirect biological indicator of enhanced neuropsychological functioning, particularly working memory, following CCT. The findings suggest a possible relationship between changes in FA measures and working memory.	[Nordvik, Jan E.; Schanke, Anne-Kristine; Walhovd, Kristine; Fjell, Anders; Grydeland, Hakon; Landro, Nils I.] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, N-0317 Oslo, Norway; [Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway		Nordvik, JE (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, POB 1094 Blindern, N-0317 Oslo, Norway.	j.e.nordvik@psykologi.uio.no		Grydeland, Hakon/0000-0001-5061-464X; Nordvik, Jan E./0000-0003-0981-648X			Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Batchelor J, 1988, J HEAD TRAUMA REHAB, V3, P78, DOI DOI 10.1097/00001199-198809000-00012; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Chen SHA, 1997, BRAIN INJURY, V11, P197; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; De Groof G, 2008, EUR J NEUROSCI, V28, P2475, DOI 10.1111/j.1460-9568.2008.06545.x; DeFelipe J, 2006, NAT REV NEUROSCI, V7, P811, DOI 10.1038/nrn2005; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dickinson D, 2010, AM J PSYCHIAT, V167, P170, DOI 10.1176/appi.ajp.2009.09020264; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones S, 2006, NEUROSCI BIOBEHAV R, V30, P864, DOI 10.1016/j.neubiorev.2006.06.012; Klingberg T, 2007, EUR NEUROPSYCHOPHARM, V17, pS192, DOI 10.1016/S0924-977X(07)70216-X; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Klingberg T, 2009, AM J PSYCHIAT, V166, P515, DOI 10.1176/appi.ajp.2009.09030343; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Landro NI, 2004, J NEUROL SCI, V217, P211, DOI 10.1016/j.jns.2003.10.012; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Nestor PG, 2010, NEUROPSYCHOLOGY, V24, P121, DOI 10.1037/a0016981; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Ravizza SM, 2005, NEUROPSYCHOLOGIA, V43, P2057, DOI 10.1016/j.neuropsychologia.2005.03.014; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sachdev PS, 2009, J INT NEUROPSYCH SOC, V15, P915, DOI 10.1017/S1355617709990579; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Williamson J, 2010, J CLIN EXP NEUROPSYC, V32, P673, DOI 10.1080/13803390903427406; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	66	13	14	0	19	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	1355-4794			NEUROCASE	Neurocase		2012	18	2					139	151		10.1080/13554794.2011.568501			13	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	920JP	WOS:000302400900008	21780988				2022-02-06	
J	Pape, TLB; Rosenow, JM; Harton, B; Patil, V; Guernon, A; Parrish, T; Froehlich, K; Burress, C; McNamee, S; Herrold, AA; Weiss, B; Wang, X				Pape, Theresa Louise-Bender; Rosenow, Joshua M.; Harton, Brett; Patil, Vijaya; Guernon, Ann; Parrish, Todd; Froehlich, Kathleen; Burress, Catherine; McNamee, Shane; Herrold, Amy A.; Weiss, Bessie; Wang, Xue			Preliminary framework for Familiar Auditory Sensory Training (FAST) provided during coma recovery	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						auditory stimulation; coma; disordered or impaired consciousness; minimally conscious state; plasticity; rehabilitation; story; traumatic brain injury; treatment; vegetative state	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; EVENT-RELATED POTENTIALS; VEGETATIVE STATE; MISMATCH NEGATIVITY; NEURAL PLASTICITY; OWN NAME; DISORDERS; CORTEX; REHABILITATION	Since there remains a need to examine the nature of the neural effect and therapeutic efficacy/effectiveness of sensory stimulation provided to persons in states of seriously impaired consciousness, a passive sensory stimulation intervention, referred to as the Familiar Auditory Sensory Training (FAST) protocol, was developed for examination in an ongoing, double-blind, randomized clinical trial (RCT). The FAST protocol is described in this article according to the preliminary framework, which is a synthesis of knowledge regarding principles of plasticity and capabilities of the human brain to automatically and covertly process sensory input. Feasibility issues considered during the development of the intervention are also described. To enable replication of this intervention, we describe procedures to create the intervention and lessons learned regarding the creation process. The potential effect of the intervention is illustrated using functional brain imaging of nondisabled subjects. This illustration also demonstrates the relevance of the rationale for designing the FAST protocol. To put the intervention within the context of the scientific development process, the article culminates with a description of the study design for the ongoing RCT examining the efficacy of the FAST protocol.	[Pape, Theresa Louise-Bender; Harton, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA Ctr Management Complex Chron, Ctr Excellence, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender; Harton, Brett; Guernon, Ann; Herrold, Amy A.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender; Guernon, Ann] Marianjoy Rehabil Hosp, Wheaton, IL USA; [Rosenow, Joshua M.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Rosenow, Joshua M.; Weiss, Bessie] Northwestern Mem Hosp, Chicago, IL USA; [Pape, Theresa Louise-Bender; Patil, Vijaya] Edward Hines Jr VA Hosp, Hines, IL 60141 USA; [Patil, Vijaya] Loyola Univ Chicago, Stritch Sch Med, Dept Neurol, Maywood, IL USA; [Parrish, Todd; Wang, Xue] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Froehlich, Kathleen; Burress, Catherine] Rehabil Inst Chicago, Brain Injury Program, Chicago, IL 60611 USA; [McNamee, Shane] Hunter Holmes McGuire VA Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, POB 5000 M-C 151H,Bldg 1, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Parrish, Todd/0000-0002-1184-1572; Bender Pape, Theresa/0000-0001-7738-5963	VA Office of Research and Development, Rehabilitation Research and Development Service [B4591R, B4949N]; Northwestern University's Clinical and Translation Sciences Institute; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741]; Nick Kot Charity for TBI; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025741] Funding Source: NIH RePORTER	This material was based on work supported by VA Office of Research and Development, Rehabilitation Research and Development Service (grant B4591R and career development transition award B4949N); Northwestern University's Clinical and Translation Sciences Institute, which is supported by the National Center for Research Resources, National Institutes of Health (grant UL1RR025741); and The Nick Kot Charity for TBI (http://www.nkc4tbi.com).	Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Chiappa Keith H., 1997, P199; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Garagnani M, 2011, NEUROIMAGE, V54, P170, DOI 10.1016/j.neuroimage.2010.08.031; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; GUTZMANN H, 1987, ARCH GERONTOL GERIAT, V6, P61, DOI 10.1016/0167-4943(87)90039-2; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Imaizumi S, 1997, NEUROREPORT, V8, P2809, DOI 10.1097/00001756-199708180-00031; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kartje GL, 2006, BASIC NEUROCHEMISTRY, P517; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KURTZ D, 1977, REV EEG NEUROPHYSIOL, V7, P62, DOI 10.1016/S0370-4475(77)80036-1; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Ludlow CL, 2008, J SPEECH LANG HEAR R, V51, pS240, DOI 10.1044/1092-4388(2008/019); MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; May PJ, 2009, EUR J NEUROSCI, V29, P575, DOI 10.1111/j.1460-9568.2008.06596.x; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Institutes of Health, 1998, CONS DEV C BRAIN INJ; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Overgaard M, 2009, PROG BRAIN RES, V177, P11, DOI 10.1016/S0079-6123(09)17702-6; Pantev C, 2011, NEUROSCI BIOBEHAV R, V35, P2140, DOI 10.1016/j.neubiorev.2011.06.010; Pape T., 2011, DISORDERS CONSCIOUSN; Pape T, 2012, NEURAL REPAIR REHABI; Pape T, 2001, ARCH PHYS MED REHAB, V82, P1291; Pape TLB, 2009, PM&R, V1, P152, DOI 10.1016/j.pmrj.2008.11.002; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHROGER E, 1992, NEUROSCI LETT, V146, P183, DOI 10.1016/0304-3940(92)90073-G; SCHWENDER D, 1994, ANESTHESIOLOGY, V80, P493, DOI 10.1097/00000542-199403000-00004; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; SIGNORINO M, 1995, LANCET, V345, P255, DOI 10.1016/S0140-6736(95)90252-X; Spierer L, 2011, HEARING RES, V271, P88, DOI 10.1016/j.heares.2010.03.086; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Vanier M, 2002, ACT NEUR S, V79, P53; VANLANCKER DR, 1989, J CLIN EXP NEUROPSYC, V11, P665, DOI 10.1080/01688638908400923; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Yasuda K, 2000, APHASIOLOGY, V14, P1067, DOI 10.1080/02687030050174638; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21	75	13	14	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1137	1152		10.1682/JRRD.2011.08.0154			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100015	23341285	Bronze			2022-02-06	
J	Soeker, MS; Van Rensburg, V; Travill, A				Soeker, Mogammad Shaheed; Van Rensburg, Viki; Travill, Andre			Are rehabilitation programmes enabling clients to return to work? Return to work perspectives of individuals with mild to moderate brain injury in South Africa	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Vocational rehabilitation; traumatic brain injury; qualitative research; enablers and barriers	EMPLOYMENT; PERCEPTIONS	Objective: To describe the perceptions and experiences of individuals with brain injury with regard to return to work rehabilitation programmes. Participants: Nine males and one female who were diagnosed with a moderate to mild brain injury participated in the study. Methods: In-depth interviews were conducted and data were analyzed using a qualitative approach to explicate patterns and themes. Results: Two themes emerged that reflected the lived experiences of individuals with brain injury regarding intervention programmes that influenced their ability to return to work after the brain injury: 1) Enablers of return to work programmes, 2) Barriers related to return to work programmes. Conclusions: Occupational therapy practitioners as well as rehabilitation personnel should identify and eliminate the barriers that impact on return to work intervention programmes, incorporate the enablers identified in this study when designing return to work programmes.	[Soeker, Mogammad Shaheed; Van Rensburg, Viki; Travill, Andre] Univ Western Cape, Dept Occupat Therapy, ZA-7535 Bellville, South Africa		Soeker, MS (corresponding author), Univ Western Cape, Dept Occupat Therapy, Private Bag X17, ZA-7535 Bellville, South Africa.	msoeker@uwc.ac.za					Abreu BC, 1996, AM J OCCUP THER, V50, P417, DOI 10.5014/ajot.50.6.417; [Anonymous], 2005, TYG HOSP BRAIN INJ S; BassHaugen, 2005, OCCUPATIONAL THERAPY; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Cook JA, 2002, BEHAV SCI LAW, V20, P541, DOI 10.1002/bsl.515; Creswell J.W., 2017, RES DESIGN QUALITATI; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; DUFFY ME, 1993, PRACTICAL RES PLANNI; FONTANA A, 1994, HDB QUALITATIVE RES; Friesen Margaret N., 2001, Work, V17, P11; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Holzberg Emily, 2001, Work, V16, P245; Jansen P, 1994, S AFRICAN J OCCUPATI, V24, P20; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; MCGEE RA, 1989, J COUNS PSYCHOL, V36, P345, DOI 10.1037/0022-0167.36.3.345; Morse J. M., 1996, NURSING RES APPL QUA; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Philpott S, 1997, DISABILITY S AFRICAN; Pierce L L, 1988, Rehabil Nurs, V13, P189; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sanders M, 2008, OCCUPATIONAL THERAPY; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schultz-Krohn W, 2005, PEDRETTIS OCCUPATION; Statistics South Africa, 2005, S AFR MORT RAT DEATH; Sumsion T, 1999, CLIENT CTR PRACTISE; Townsend L, 1992, NATIONAL, V9, P8; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27	30	13	14	0	19	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2012	43	2					171	182		10.3233/WOR-2012-1413			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	012CX	WOS:000309214100007	22927624				2022-02-06	
J	Soeker, MS; Van Rensburg, V; Travill, A				Soeker, Mogammad Shaheed; Van Rensburg, Viki; Travill, Andre			Individuals with traumatic brain injuries perceptions and experiences of returning to work in South Africa	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; human occupation; work; occupational science; occupational therapy; occupational deprivation; vocational rehabilitation and client-centred approach	EMPLOYMENT; OUTCOMES	Objective: The aim of this study was to identify the central concepts of a model that would facilitate the return to work process of individuals with brain injury. However for the purpose of this paper there will be a focus only on the barriers and facilitators that influence the return to work process. Participants: Ten individuals who were diagnosed with a mild to moderate brain injury participated in this study. Methods: Qualitative research methods were used in order to explore the research question. The participants were selected by means of purposive sampling and the data was collected by means of in depth interviews. Results: The results of the study revealed that the participants experienced a sense of loss of function after the brain injury, a fear of the future and loss of confidence in their worker roles. The participants also indicated that by means of adapting occupational routines and actively engaging in rehabilitation they developed confidence in their worker roles. Conclusion: Occupational therapists have to use a client centred holistic work integrative approach in order to successfully rehabilitate as well as facilitate the return to work process with people who have suffered a traumatic brain injury.	[Soeker, Mogammad Shaheed; Travill, Andre] Univ Western Cape, Dept Occupat Therapy, ZA-7535 Bellville, South Africa; [Van Rensburg, Viki] Univ Cape Town, ZA-7925 Cape Town, South Africa		Soeker, MS (corresponding author), Univ Western Cape, Dept Occupat Therapy, Private Bag X17, ZA-7535 Bellville, South Africa.	msoeker@uwc.ac.za					[Anonymous], 2005, TYGERBERG HOSP BRAIN; Bailey DM, 1997, RES HLTH PROFESSIONA; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Blundon G, 2000, Can J Occup Ther, V67, P184; Cook JA, 2002, BEHAV SCI LAW, V20, P541, DOI 10.1002/bsl.515; Creswell J.W., 2017, RES DESIGN QUALITATI; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; DUFFY ME, 1993, PRACTICAL RES PLANNI; FONTANA A, 1994, HDB QUALITATIVE RES; GUTMAN SA, 2000, OCCUPATIONAL THERAPY, V15, P1; Gutman SA, 2001, OCCUPATIONAL THERAPY; Jansen P., 1994, S AFRICAN J OCCUPATI, V24, P20; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Jones CJ, 2001, PSYCHIATR REHABIL J, V25, P53, DOI 10.1037/h0095050; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Lee S S, 2001, Can J Occup Ther, V68, P41; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Morse J.M., 2002, NURSING RES APPL QUA; Moyers P., 2005, OCCUPATIONAL THERAPY; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Philpott S., 1997, S AFRICAN HLTH REV; Rudman D.L., 2001, QUALITATIVE RES OCCU; Statistics South Africa, 2005, S AFR MORT RAT DEATH; Tipton-Burton M, 2005, PEDRETTIS OCCUPATION; Townsend Elizabeth, 2004, Can J Occup Ther, V71, P75; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; Wilcock A., 1993, J OCCUP SCI, V1, P17; Wilcock AA, 2005, OCCUPATIONAL THERAPY; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	30	13	15	0	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2012	42	4					589	600		10.3233/WOR-2012-1414			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	992WN	WOS:000307811000014	22523048	Green Submitted			2022-02-06	
J	Gray, H; Van Waerebeek, K				Gray, Howard; Van Waerebeek, Koen			Postural instability and akinesia in a pantropical spotted dolphin, Stenella attenuata, in proximity to operating airguns of a geophysical seismic vessel	JOURNAL FOR NATURE CONSERVATION			English	Article						Acoustic distress; Behaviour; Catatonia; Injury; Liberia; Myopathy; Stress; Seismic survey	CETACEANS; RESPONSES; CONJUNCTION; HEALTH; SOUND; GAS	Aberrant behaviour including erratic locomotion was observed in a pantropical spotted dolphin 600 m ahead of an airgun array during 3D seismic explorations off Liberia in March 2009. The dolphin, presumably in acoustic distress, lifted its head and cervical region above the surface in an oblique, strikingly rigid posture during 5 min. Turbulent white-water evidenced a major propulsory thrust. Incremental postural instability and apparent exhaustion progressed to a catatonic-like state of akinesia as the dolphin rolled over onto one side, then its back before sinking virtually motionless close to the airgun array. Unless it recovered full locomotory control, asphyxiation was inevitable. Potential internal injury is discussed, both acoustic-mediated and from extreme exertion (exertional myopathy, rhabdomyolysis and myoglobinuric nephrosis). As behaviour was spatially and temporally closely associated with firing seismic airguns, we suggest a cause-effect relationship. Differential diagnoses of pre-existing morbidity, senescence, or intoxication are considered possible but unlikely. (C) 2011 Elsevier GmbH. All rights reserved.	[Gray, Howard] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Van Waerebeek, Koen] Museo Delfines, Ctr Peruano Estudios Cetol CEPEC, Cetacean Conservat Med Grp, Lima 20, Peru		Gray, H (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	howard_gray@btinternet.com					Bain DE, 2006, SC58E35 INT WHAL COM; Bargu S, 2002, MAR ECOL PROG SER, V237, P209, DOI 10.3354/meps237209; Bateson M, 2007, INT J COMP PSYCHOL, V20, P169; BOWLES AE, 1994, J ACOUST SOC AM, V96, P2469, DOI 10.1121/1.410120; Calambokidis J., 1998, MARINE MAMMAL RES MI; COE JM, 1980, FISH B-NOAA, V78, P535; Curry B, 1999, NOAATMNMFSSWFSC261; Di Guardo G, 2010, VET PATHOL, V47, P245, DOI 10.1177/0300985809358036; DOMINGO M, 1995, VET MICROBIOL, V44, P229, DOI 10.1016/0378-1135(95)00016-4; Edwards E.F., 2007, INT J COMP PSYCHOL, V20, P217; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; FERNANDEZ A, 2004, NATURE, V10, P1038; Goold JC, 1998, J ACOUST SOC AM, V103, P2177, DOI 10.1121/1.421363; Goold JC, 1996, J MAR BIOL ASSOC UK, V76, P811, DOI 10.1017/S0025315400031477; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Greenfield JG, 1939, BRAIN, V62, P129, DOI 10.1093/brain/62.2.129; Herman L.M., 1980, CETACEAN BEHAV MECH; Hernandez-Mora G, 2008, EMERG INFECT DIS, V14, P1430, DOI 10.3201/eid1409.071056; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Jefferson T. A., 2008, MARINE MAMMALS WORLD; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Ketten D.R., 1993, J ACOUST SOC AM, V94, P1849; Konrad H. R, 1990, CLIN METHODS HIST PH, P604; Madsen C. J., 1980, CETACEAN BEHAV MECH, P101; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Oelschlager H. H. A., 2002, ENCY MARINE MAMMALS, P133; Olendorf D., 2006, GALE ENCY MED; Oliveros E. S., 2002, LJ0236C NMFS SW FIS; Perrin William F., 2001, Mammalian Species, V683, P1, DOI 10.1644/1545-1410(2001)683<0001:SA>2.0.CO;2; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P819; Popov V. V., 2008, Doklady Akademii Nauk, V419, P842; Popper A.N., 1980, CETACEAN BEHAV MECH, P1; Richardson W.J., 1999, J ACOUST SOC AM, V106, P2281, DOI [10.1121/1.427801, DOI 10.1121/1.427801]; Richardson W.J., 1995, MARINE MAMMALS NOISE; Richardson WJ, 1997, MAR FRESHW BEHAV PHY, V29, P183, DOI 10.1080/10236249709379006; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI 10.1139/F04-055; SHEPHARD RH, 1956, BRAIN, V79, P282, DOI 10.1093/brain/79.2.282; Slijper E. J., 1979, WHALES, P511; Southall B. l., 2007, AQUAT MAMM, V33, P411, DOI DOI 10.1578/AM.33.4.2007.411; Stone C. J, 2003, 232 JOINT NAT CONS C; Stone Carolyn J., 2006, Journal of Cetacean Research and Management, V8, P255; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Weilgart L. S., 2007, INT J COMP PSYCHOL, V20, P159, DOI DOI 10.3354/MEPS07117; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71; Williams Elizabeth S., 1996, P181; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298	47	13	13	0	18	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	1617-1381	1618-1093		J NAT CONSERV	J. Nat. Conserv.	DEC	2011	19	6					363	367		10.1016/j.jnc.2011.06.005			5	Biodiversity Conservation; Ecology	Science Citation Index Expanded (SCI-EXPANDED)	Biodiversity & Conservation; Environmental Sciences & Ecology	849VR	WOS:000297153900006					2022-02-06	
J	Moeller, JJ; Tu, B; Bazil, CW				Moeller, Jeremy J.; Tu, Bin; Bazil, Carl W.			Quantitative and Qualitative Analysis of Ambulatory Electroencephalography During Mild Traumatic Brain Injury	ARCHIVES OF NEUROLOGY			English	Article							EEG; CONCUSSION	Objectives: To characterize the neurophysiological changes in a patient with mild traumatic brain injury (mTBI) and to compare these changes with a small cohort of patients with neurocardiogenic syncope, an analogous cause of transient neurological dysfunction. Design: Case report and quantitative analysis of a small electroencephalography (EEG) cohort. Setting: University-affiliated teaching hospital. Patients: A 64-year-old man with mTBI recorded on ambulatory EEG. The comparison group was 4 patients with spontaneous neurocardiogenic syncope during continuous video EEG recording. Intervention: Quantitative and qualitative analysis of EEG. Main Outcome Measures: Changes in quantitative EEG measurements between the patient with mTBI and the comparison group. Results: In the patient with mTBI, there was an abrupt decrease in high-frequency (beta) power and alpha-delta ratio immediately after the injury and a corresponding increase in lower-frequency (alpha, theta, delta) power. The change in beta power resolved within 5 minutes of the injury, but the increases in low-frequency power persisted up to 20 minutes after the injury before resolving. Similar but smaller changes were seen in the patients with syncope, but these changes resolved within 5 minutes, with no intermediate or long-term changes. Conclusions: The quantitative EEG changes in mTBI are initially similar to those in syncope, suggesting acute transient cortical dysfunction. However, there are longer-lasting increases in low-frequency power during mTBI, suggesting ongoing disruption of cortical-thalamic circuits. Arch Neurol. 2011; 68(12):1595-1598	[Moeller, Jeremy J.; Tu, Bin; Bazil, Carl W.] Columbia Univ, Med Ctr, New York, NY USA		Bazil, CW (corresponding author), Columbia Comprehens Epilepsy Ctr, 7th Floor,710 W 168th St, New York, NY 10032 USA.	cwb11@columbia.edu	Moeller, Jeremy/AAE-6153-2020				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Brenner RP, 1997, J CLIN NEUROPHYSIOL, V14, P197, DOI 10.1097/00004691-199705000-00004; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Olejniczak P, 2006, J CLIN NEUROPHYSIOL, V23, P186, DOI 10.1097/01.wnp.0000220079.61973.6c; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107	12	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	DEC	2011	68	12					1595	1598		10.1001/archneurol.2011.1080			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	861BJ	WOS:000297993500016	22159059	Bronze			2022-02-06	
J	Bulger, EM; Tower, CM; Warner, KJ; Garland, T; Cuschieri, J; Rizoli, S; Rhind, S; Junger, WG				Bulger, Eileen M.; Tower, Cindy M.; Warner, Keir J.; Garland, Tara; Cuschieri, Joseph; Rizoli, Sandro; Rhind, Shawn; Junger, Wolfgang G.			INCREASED NEUTROPHIL ADENOSINE A3 RECEPTOR EXPRESSION IS ASSOCIATED WITH HEMORRHAGIC SHOCK AND INJURY SEVERITY IN TRAUMA PATIENTS	SHOCK			English	Article						Adenosine A3 receptor; hypovolemic shock; neutrophil activation; hypertonic saline	HYPERTONIC SALINE RESUSCITATION; ORGAN DYSFUNCTION; LUNG INJURY; ACTIVATION; RELEASE; SEPSIS	Hypertonic saline (HS) has been investigated as an immune modulator following hemorrhagic shock and sepsis. The polymorphonuclear neutrophil (PMN) response to HS is regulated by the release of ATP, which is converted to adenosine and activates adenosine receptors. Binding to A3 adenosine receptors promotes PMN activation, and inhibition of A3 receptors improves the efficacy of HS resuscitation. A3 receptor expression of PMNs has not been previously evaluated in injured patients. Whole blood was obtained from 10 healthy volunteers and 60 injured patients within 2 h of injury. Inclusion criteria were blunt or penetrating injury with evidence of hypovolemic shock (systolic blood pressure [SBP] <= 90 mmHg and base deficit >= 6 mEq/L or need for blood transfusion) or evidence of severe traumatic brain injury including initial Glasgow Coma Scale score of 8 or less or evidence of traumatic brain injury on head computed tomography scan (head Abbreviated Injury Score >= 3) or intubation in the field or emergency department. A3 receptor expression was assessed by flow cytometry. Polymorphonuclear neutrophils were also exposed to fMLP or HS (20-40 mM) in vitro. Clinical data were collected including admission physiology, injury severity (Injury Severity Score [ISS]), development of multiple organ failure, and survival. In normal volunteers, less than 1% of PMNs expressed A3 receptors on the cell surface. A3 receptor expression was significantly higher in injured patients, and the level of expression correlated with the severity of injury (ISS >= 25: A3 positive PMN 36.6% vs. ISS <25: 16.2%; P = 0.019) and degree of hypovolemic shock (SBP <= 90 mmHg: A3 positive PMN 43.8% vs. SBP>90 mmHg: 20.6%; P = 0.008). Stimulation with fMLP or HS increased A3 expression in normal volunteers, but only in patients with ISS of less than 25 or without hypovolemic shock. A3 receptor expression on the surface of PMNs is upregulated by injury, and increased expression levels are associated with greater injury severity and hypovolemic shock. Hypertonic saline increases A3 expression of PMNs from healthy volunteers and less severely injured patients.	[Bulger, Eileen M.; Tower, Cindy M.; Warner, Keir J.; Garland, Tara; Cuschieri, Joseph] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Rizoli, Sandro] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Rhind, Shawn] Def Res & Dev Canada Toronto, Toronto, ON, Canada; [Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA		Bulger, EM (corresponding author), Box 359796 Harborview Med Ctr,325 9th Ave, Seattle, WA 98104 USA.	ebulger@u.washington.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Rhind, Shawn/0000-0003-2300-0620	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1R01GM76101-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM076101] Funding Source: NIH RePORTER	This study was supported by National Institute of General Medical Sciences (1R01GM76101-01).	Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chen Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1051, DOI 10.1152/ajpcell.00216.2005; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Curry N, 2011, CRIT CARE, V15, DOI 10.1186/cc10096; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Grassi F, 2010, J MOL CELL BIOL, V2, P176, DOI 10.1093/jmcb/mjq014; Inoue Y, 2008, CRIT CARE MED, V36, P2569, DOI 10.1097/CCM.0b013e3181841a91; Inoue Y, 2011, SHOCK, V35, P178, DOI 10.1097/SHK.0b013e3181f221fb; Junger WG, 2008, CELL MOL LIFE SCI, V65, P2528, DOI 10.1007/s00018-008-8095-1; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218	21	13	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2011	36	5					435	439		10.1097/SHK.0b013e318231ee2e			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	837TX	WOS:000296227600002	21841534	Green Accepted			2022-02-06	
J	Laker, SR				Laker, Scott R.			Return-to-Play Decisions	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Sport; Concussion; Brain; Post-concussion syndrome	CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY SURVEILLANCE SYSTEM; METABOLIC BRAIN VULNERABILITY; 3RD INTERNATIONAL-CONFERENCE; COLLEGIATE FOOTBALL PLAYERS; REPETITIVE HEAD-INJURY; HIGH-SCHOOL; DESCRIPTIVE EPIDEMIOLOGY; POSTCONCUSSION SYNDROME; SPORTS CONCUSSION	Concussions occur as a result of forces directed to the head or neck, or from impulsive forces transmitted from the body to the head. They result in the rapid onset and spontaneous recovery of short-lived impairment of neurologic function. Concussions represent a functional, rather than structural, disturbance, and do not result in abnormalities on standard structural imaging. This article discusses a comprehensive approach to return to play in sports concussion, including managing athletes returning after prolonged postconcussion syndrome, multiple concussions, and intracranial hematomas and craniotomy.	Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA		Laker, SR (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Mail Stop F493,12631 E 17th Ave,Room 2513, Aurora, CO 80045 USA.	scott.laker@ucdenver.edu	Laker, Scott/ABE-7455-2021				Agel J, 2007, J ATHL TRAINING, V42, P270; *AM AC NEUR, PRACT GUID ANN ANN C; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis G, 2010, BRIT J SPORT MED, V44, P1139, DOI 10.1136/bjsm.2008.048215; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P221; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heads Up: Concussion in Youth Sports, 2009, HEADS CONCUSSION YOU; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KUBLERROSS E, 1997, DEATH DYING; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; KUTCHER JS, 2010, CLIN PRACTICE REFERE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2002, J SCI MED SPORT, V5, P169, DOI 10.1016/S1440-2440(02)80002-0; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; *NCAA, 2011, 2010 2011 SPORTS MED; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pearsall AW, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000159896.64176.72; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; VAGNOZZI R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; PROTECT YOUNG ATHLET	81	13	13	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					619	+		10.1016/j.pmr.2011.08.004			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600005	22050939				2022-02-06	
J	Mao, HJ; Guan, FJ; Han, X; Yang, KH				Mao, Haojie; Guan, Fengjiao; Han, Xu; Yang, King H.			Strain-Based Regional Traumatic Brain Injury Intensity in Controlled Cortical Impact: A Systematic Numerical Analysis	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; finite element; rat brain model; regional injury; response surface methodology; strain	CONTUSION INJURY; SERUM-LEVELS; CELL-DEATH; RAT; DEFICITS; DAMAGE; EDEMA; BIOMECHANICS; HIPPOCAMPUS; ANTIOXIDANT	Regional strain-based brain injury intensity during controlled cortical impact (CCI) was studied using a three-dimensional numerical rat brain model. A full factorial design of CCI computer experiments was performed using two typical impactor shapes (flat or hemispherical) at a fixed impact velocity of 4 m/s with various impact depths (1, 1.5, 1.6, 2, 2.5, 2.7, and 3mm) and various impactor diameters (4, 5, 6, 8, and 9.5 mm). In total, 70 CCI cases were simulated numerically. Two injury assessment measures, the cumulative strain damage measure (CSDM), which accounts for the volume of brain tissue with elevated strains, and cumulative strain damage percentage measure (CSDPM), which is a strain-based estimate of the neuronal cell loss percentage, were used to evaluate the risk of brain injury. Results demonstrated positive nonlinear relationships between impact depth and these injury assessment measures in six regions of interest: ipsilateral cortex, ipsilateral corpus callosum, ipsilateral hippocampus, ipsilateral thalamus, cerebellum, and brainstem. However, the impactor diameter was not always positively correlated with regional tissue strains. For the flat impactor group, the 5mm diameter impactor induced more tissue strain in the corpus callosum/hippocampus, and a smaller impactor induced more strain in the thalamus. For the hemispherical impactor group, a larger impactor tended to induce more tissue strain in subcortical regions, with the exception of the 6mm diameter impactor. This study systematically predicts regional intensity of primary brain injury according to tissue strain distributions in the hope that strain distribution maps may become a common platform to compare CCI severities with different configurations.	[Mao, Haojie; Yang, King H.] Wayne State Univ, Ctr Bioengn, Detroit, MI 48201 USA; [Guan, Fengjiao; Han, Xu] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China		Yang, KH (corresponding author), Wayne State Univ, Ctr Bioengn, 818 W Hancock, Detroit, MI 48201 USA.	king.yang@wayne.edu	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	Injury Control Research Center at the University of Alabama in Birmingham; Bioengineering Center, Wayne State University; State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body of Hunan University; China Scholarship CouncilChina Scholarship Council	We thank Christina D. Wagner for proofreading the manuscript. The development of the finite element rat brain model is financially supported by the Injury Control Research Center at the University of Alabama in Birmingham. The project is partially supported by the Bioengineering Center, Wayne State University, and State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body of Hunan University. We thank LSTC for providing LS-Dyna and Esteco for providing modeFrontier. Financial support of Fengjiao Guan is provided by the China Scholarship Council.	Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; Bain A.C., 1999, 43 STAPP CAR CRASH C; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bates RA, 1996, J ROY STAT SOC B MET, V58, P77; Billings SA, 1998, NEURAL NETWORKS, V11, P479, DOI 10.1016/S0893-6080(97)00132-9; Boyd JP, 2009, APPL MATH COMPUT, V215, P2215, DOI 10.1016/j.amc.2009.08.037; Buhmann M.D., 2003, C MO AP C M, DOI 10.1017/CBO9780511543241; Carlson S, 2009, J NEUROTRAUM, V26, pA50; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cowper MR, 2002, SIGNAL PROCESS, V82, P775, DOI 10.1016/S0165-1684(02)00155-X; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Kawamata T, 1997, ACT NEUR S, V70, P191; Kim K.B., 2000, INF SCI, V130, P163; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; KOEHLER JR, 1996, HANDB STAT, V0013, P00261; Lapeer RJ, 2010, COMPUT BIOL MED, V40, P1, DOI 10.1016/j.compbiomed.2009.10.002; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Pena A, 2005, ACT NEUR S, V95, P333; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Portella G, 2000, ACT NEUR S, V76, P273; Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SACKS J, 1989, TECHNOMETRICS, V31, P41, DOI 10.2307/1270363; Sacks J., 1989, STAT SCI, V4, P409; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sheta AF, 2001, INFORM SCIENCES, V133, P221, DOI 10.1016/S0020-0255(01)00086-X; SHREIBER DI, 1997, 41 STAPP CAR CRASH C; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Woertgen C, 2002, ACT NEUR S, V81, P205; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Yang RJ, 2005, J MECH DESIGN, V127, P1014, DOI 10.1115/1.1906264	63	13	13	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2011	28	11			SI		2263	2276		10.1089/neu.2010.1600			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	849VY	WOS:000297154600006	21488718				2022-02-06	
J	Mattei, TA; Bond, BJ; Hafner, JW; Morris, MJ; Travis, J; Hannah, G; Webster, J; Lin, JJ				Mattei, Tobias A.; Bond, Brandon J.; Hafner, John W., Jr.; Morris, Martin J.; Travis, Jennifer; Hannah, Greg; Webster, Jim; Lin, Julian J.			Definition and measurement of rider-intrinsic physical attributes influencing all-terrain vehicle safety	NEUROSURGICAL FOCUS			English	Article						all-terrain vehicle; safety legislation; wingspan; pediatric traumatic brain injury	INJURIES; CRASHES	Object. All-terrain vehicle (ATV) usage has grown tremendously over the years, reaching 9.5 million vehicles in use in 2007. Accompanying this growth has been a concomitant increase in rider morbidity (including traumatic brain and spine injuries) and death, especially in children. The purpose of this study was to define and measure, through field testing, those physical attributes intrinsic to riders, such as height, weight, and wingspan, which may have implications for ATV riders' safety. Methods. Three field tests (J-hook, brake, and bump) were developed and performed to allow direct measurement of the lateral, longitudinal, and vertical dynamics in 5 riders of varying heights, weights, and wingspans. Two ATVs, a utility and a sport model, were tested for further comparisons. Data were acquired using a comprehensive data acquisition system attached to the ATVs. Assignment of individual rider/ATV test safety ratings and a rider/ATV Total Safety Rating were made from the results of these field tests. Results. The J-hook test results demonstrated that larger rider wingspans positively influence ATV rider safety and mitigate against lateral instability. From the brake test it was determined that a 10-in (25.4-cm) longitudinal displacement, such as that experienced during a sharp deceleration, for a rider of any height or weight, breached the level of defined safety. As rider weight increased, displacement decreased. The bump test provided evidence that increased rider weight also mitigates against vertical displacement. Conclusions. Individuals with light weights and small wingspans, such as those in the pediatric population, are under considerable risk of injury when operating an ATV due to lateral, longitudinal, and vertical operational instability. (DOI: 10.3171/2011.9.FOCUS11176)	[Mattei, Tobias A.; Lin, Julian J.] Illinois Neurol Inst, Dept Neurosurg, Peoria, IL 61637 USA; [Bond, Brandon J.; Hafner, John W., Jr.; Lin, Julian J.] Univ Illinois, Coll Med, Peoria, IL 61656 USA; [Hafner, John W., Jr.] OSF St Francis Med Ctr, Dept Emergency Med, Peoria, IL USA; [Morris, Martin J.; Travis, Jennifer; Hannah, Greg; Webster, Jim] Bradley Univ, Dept Mech Engn, Peoria, IL 61625 USA		Mattei, TA (corresponding author), Illinois Neurol Inst, Dept Neurosurg, 530 NE Glen Oak, Peoria, IL 61637 USA.	tobiasmattei@yahoo.com	Mattei, Tobias A./U-7166-2019; Hafner, John W/A-2586-2008				Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; Cvijanovich NZ, 2001, PEDIATRICS, V108, P631, DOI 10.1542/peds.108.3.631; Finn MA, 2010, NEUROSURGERY, V67, P993, DOI 10.1227/NEU.0b013e3181f209db; *GOV ACC OFF, 2010, GAO10418; Hafner JW, 2010, J RURAL HEALTH, V26, P67, DOI 10.1111/j.1748-0361.2009.00267.x; Haney P., 2003, RACING HIGH PERFORMA; Humphries RL, 2006, PEDIATR EMERG CARE, V22, P491, DOI 10.1097/01.pec.0000227383.69014.36; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Levenson M. S., 2003, ALL TERRAIN VEHICLE; Long G, 2011, PEDIATR EMERG CARE, V27, P409, DOI 10.1097/PEC.0b013e31821d86ea; MAYERCIK VA, 2011, INJURY; McBride AS, 2011, PEDIATR EMERG CARE, V27, P97, DOI 10.1097/PEC.0b013e31820942f8; Merrigan TL, 2011, TRAFFIC INJ PREV, V12, P251, DOI 10.1080/15389588.2011.561455; Milliken W., 1995, RACE CAR VEHICLE DYN; Murphy N, 2004, J TRAUMA, V56, P1185, DOI 10.1097/01.TA.0000123038.94864.E2; Myers ML, 2009, J AGROMEDICINE, V14, P312, DOI 10.1080/10599240903041885; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; Sawyer JR, 2011, J AM ACAD ORTHOP SUR, V19, P219, DOI 10.5435/00124635-201104000-00006; Scott A, 2011, ANZ J SURG, V81, P172, DOI 10.1111/j.1445-2197.2010.05484.x; Shults RA, 2005, PEDIATRICS, V116, pE608, DOI 10.1542/peds.2005-0937; Smith LM, 2005, J TRAUMA, V58, P783, DOI 10.1097/01.TA.0000158252.11002.6E; Streeter RA, 2008, 2007 ANN REPORT ATV; *US CONS PROD SAF, AN ATV REL FAT DAT C	24	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E6	10.3171/2011.9.FOCUS11176			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300007	22044105				2022-02-06	
J	Salter, K; McClure, JA; Foley, NC; Teasell, R				Salter, Katherine; McClure, J. Andrew; Foley, Norine C.; Teasell, Robert			Community integration following TBI: An examination of community integration measures within the ICF framework	BRAIN INJURY			English	Article						Community integration; measurement; traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NORMAL LIVING INDEX; INTERNATIONAL-CLASSIFICATION; HEALTH ICF; PSYCHOMETRIC PROPERTIES; DISABILITY; PARTICIPATION; REINTEGRATION; REHABILITATION	Purpose: The objectives of the present study are ( 1) to examine whether the content of existing community integration measures used following traumatic brain injury (TBI) is represented in the International Classification of Functioning, Disability and Health (ICF) and ( 2) to determine if the ICF provides a reasonable framework within which such measurement tools may be compared. Method: Five commonly-used assessment instruments were selected for inclusion. Independent raters mapped identified measurement concepts to the ICF using established linking rules. Results: One hundred and eighty-five concepts were identified from 85 items in five scales. Of these more than 75%% could be linked to the ICF. The majority of linked concepts were assigned to 64 categories within the activities and participation component of the ICF; however, the focus of assessment within each instrument varied considerably. Conclusion: Through a standardized process of item mapping to the ICF, one may examine operationalizations of community integration. This may help inform selection of a method of assessment appropriate to both the subject population and clinical or research purpose. However, this process allows comparison of only the objective content of measurement tools. Subjective evaluations may also be necessary to provide comprehensive assessment of community integration.	[Salter, Katherine; McClure, J. Andrew; Foley, Norine C.; Teasell, Robert] Lawson Hlth Res Inst, Aging Rehabil & Geriatr Care Program, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, Dept Phys Med & Rehabil, Schulich Sch Med, London, ON, Canada		Salter, K (corresponding author), Ctr Aging Rehabil & Geriatr Res, Room B-3019-C,Parkwood Hosp,801 Commissioners Rd, London, ON N6C 5J1, Canada.	katherine.salter@sjhc.london.on.ca		McClure, Andrew/0000-0001-5595-730X			Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bluvol A, 2004, J ADV NURS, V48, P322, DOI 10.1111/j.1365-2648.2004.03004.x; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Stark SL, 2005, ARCH PHYS MED REHAB, V86, P344, DOI 10.1016/j.apmr.2004.03.020; Steiner A, 1996, GERONTOLOGIST, V36, P54, DOI 10.1093/geront/36.1.54; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Teasell R, 2010, COMMUNITY REINTEGRAT; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; World Health Organization, 2007, INT CLASS FUNCT DIS	35	13	13	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1147	1154		10.3109/02699052.2011.613088			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200001	21961571				2022-02-06	
J	Asgari, S; Vespa, P; Bergsneider, M; Hu, X				Asgari, Shadnaz; Vespa, Paul; Bergsneider, Marvin; Hu, Xiao			Lack of consistent intracranial pressure pulse morphological changes during episodes of microdialysis lactate/pyruvate ratio increase	PHYSIOLOGICAL MEASUREMENT			English	Article						intracranial pressure; hemodynamic signal; microdialysis; lactate/pyruvate ratio; waveform morphology	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID; SIGNALS; WAVE; HYPOGLYCEMIA; RECOGNITION; CHEMISTRY; ELEVATION; ISCHEMIA	Lactate/pyruvate ratio (LPR) from microdialysis is a well-established marker of cerebral metabolic crisis. For brain injury patients, abnormally high LPR could indicate cerebral ischemia or failure of O-2 uptake. However, there is a debate on the primary factor responsible for LPR increase. Exploiting the potential of using the morphology of a high temporal resolution signal such as intracranial pulse (ICP) to characterize cerebrovascular changes, a data analysis experiment is taken to test whether consistent changes in ICP pulse morphological metrics accompany the LPR increase. We studied 3517 h of LPR and continuous ICP data from 19 severe traumatic brain injury patients. Our morphological clustering and analysis of intracranial pressure (MOCAIP) algorithm was applied to ICP pulses, which were matched in time to the LPR measurements, and 128 pulse morphological metrics were extracted. We automatically identified the episodes of LPR increases using a moving time window of 10-20 h. We then studied the trending patterns of each of the 128 ICP MOCAIP metrics within these identified periods and determined them to be one of the following three types: increasing, decreasing or no trend. A binomial test was employed to investigate whether any MOCAIP metrics show a consistent trend among all episodes of LPR increase per patient. Regardless of the selected values for different parameters of the proposed method, for the majority of the subjects in the study (78%), none of the ICP metrics show any consistent trend during the episodes of LPR increase. Even for the few subjects who have at least one ICP metric with a consistent trend during the LPR increase episodes, the number of such metrics is small and varies from subject to subject. Given the fact that ICP pulse morphology is influenced by the cerebral vasculature, our results suggest that a dominant cerebral vascular cause may be behind the changes in LPR when LPR trends correlate with ICP pulse morphological changes. However, the incidence of such correlation seems to be low.	[Asgari, Shadnaz; Vespa, Paul; Bergsneider, Marvin; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Neural Syst & Dynam Lab, Dept Neurosurg, Los Angeles, CA 90095 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Neurocrit Care Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Bergsneider, Marvin] Univ Calif Los Angeles, Biomed Engn Grad Program, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA USA		Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neural Syst & Dynam Lab, Dept Neurosurg, Los Angeles, CA 90095 USA.	xhu@mednet.ucla.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS059797, NS054881, NS066008]; UC Brain Injury Research Center (BIRC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054881, R21NS059797, R01NS066008] Funding Source: NIH RePORTER	This work was partially supported by NINDS awards (NS059797, NS054881 and NS066008) and UC Brain Injury Research Center (BIRC).	ADOLPH RJ, 1967, AM J PHYSIOL, V212, P840, DOI 10.1152/ajplegacy.1967.212.4.840; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Asgari S, 2010, IEEE T INF TECHNOL B, V14, P166, DOI 10.1109/TITB.2009.2034845; Asgari S, 2009, PHYSIOL MEAS, V30, P1211, DOI 10.1088/0967-3334/30/11/006; Bjerring PN, 2010, J HEPATOL, V53, P1054, DOI 10.1016/j.jhep.2010.05.032; CARDOSO ER, 1988, J NEUROSURG, V69, P712, DOI 10.3171/jns.1988.69.5.0712; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Ellis T, 2007, IEEE T BIO-MED ENG, V54, P1552, DOI 10.1109/TBME.2007.892918; HADI AS, 1993, J AM STAT ASSOC, V88, P1264, DOI 10.2307/2291266; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kawai Nobuyuki, 2010, No Shinkei Geka, V38, P795; Kennan R P, 2005, J CEREB BLOOD FLOW M, V25, P527; LAITINEN L, 1968, ACTA NEUROL SCAND, V44, P168, DOI 10.1111/j.1600-0404.1968.tb05563.x; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; Sotheim O, 2008, SEIZURE-EUR J EPILEP, V17, P740, DOI 10.1016/j.seizure.2008.05.006; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F	35	13	14	0	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	OCT	2011	32	10					1639	1651		10.1088/0967-3334/32/10/011			13	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	823VT	WOS:000295155400011	21904021	Green Accepted			2022-02-06	
J	Grande, PO				Grande, Per-Olof			The Lund Concept for the Treatment of Patients With Severe Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Lund concept; brain edema; cerebral perfusion pressure; intracranial pressure; positive endexpiratory pressure; arterial blood pressure; bloodbrain barrier; traumatic head injury; US Trauma Foundation guideline	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PHYSIOLOGICAL PRINCIPLES; VOLUME REGULATION; VENOUS-PRESSURE; HYPERTENSION; MANAGEMENT; ARTERIAL; ABSENCE	Two different main concepts for the treatment of a severe traumatic brain injury have been established during the last 15 years, namely the more conventional concept recommended in well-established guidelines (eg, U.S. Guideline, European Guideline, Addelbrook's Guideline from Cambridge), on the one hand, and the Lund concept from the University Hospital of Lund, Sweden, on the other. Owing to the lack of well-controlled randomized outcome studies comparing these 2 main therapeutic approaches, we cannot conclude that one is better than the other. This paper is the PRO part in a PRO-CON debate in this journal on the Lund concept. Although the Lund concept is based on a physiology-oriented approach dealing with the hemodynamic principles of brain volume and brain perfusion regulation, traditional treatments are primarily based on a meta-analytic approach from clinical studies. High cerebral perfusion pressure has been an essential goal in the conventional treatments (the cerebral perfusion pressure-guided approach), even though it has been modified in a recent up date of U.S. guidelines. The Lund concept has instead concentrated on management of brain edema and intracranial pressure, along with improvement of cerebral perfusion and oxygenation (the intracranial pressure and perfusion-guided approach). Although conventional guidelines are restricted to clinical data from meta-analytic surveys, the physiological approach of Lund therapy finds support in both experimental and clinical studies. It offers a wider base and can also provide recommendations regarding fluid therapy, lung protection, optimal hemoglobin concentration, temperature control, the use of decompressive craniotomy, and ventricular drainage. This paper puts forward arguments in support of Lund therapy.	[Grande, Per-Olof] Univ Lund Hosp, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden; [Grande, Per-Olof] Lund Univ, Dept Anesthesia & Intens Care, S-22100 Lund, Sweden		Grande, PO (corresponding author), Univ Lund Hosp, Dept Anesthesia & Intens Care, SE-22185 Lund, Sweden.	per-olof.grande@med.lu.se			Faculty of Medicine, Lund University, Sweden [11581]; Region Skane, Sweden	Supported by grants from the Swedish Research Council (#11581), from the Faculty of Medicine, Lund University, Sweden, and from Region Skane, Sweden.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dubniks M, 2007, INTENS CARE MED, V33, P2192, DOI 10.1007/s00134-007-0756-2; Grande PO, 2009, ACTA ANAESTH SCAND, V53, P1233, DOI 10.1111/j.1399-6576.2009.02074.x; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Holbeck S, 2002, CRIT CARE MED, V30, P212, DOI 10.1097/00003246-200201000-00030; Jungner M, 2011, CRIT CARE MED, V39, P135, DOI 10.1097/CCM.0b013e3181fb7c94; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kongstad L, 1999, ACTA ANAESTH SCAND, V43, P501, DOI 10.1034/j.1399-6576.1999.430503.x; Kongstad L, 2001, J TRAUMA, V51, P490, DOI 10.1097/00005373-200109000-00011; Liu Chang-Wen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P610; LUCIA M, 2010, ANESTH ANALG, V111, P736; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nygren A, 2010, ACTA ANAESTH SCAND, V54, P814, DOI 10.1111/j.1399-6576.2010.02244.x; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rise IR, 1998, J NEUROSURG, V89, P454, DOI 10.3171/jns.1998.89.3.0454; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004	30	13	14	2	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2011	23	4					358	362		10.1097/01.ana.0000405612.20356.84			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	818ML	WOS:000294755700013	21908989				2022-02-06	
J	Vazquez-Valls, E; Flores-Soto, ME; Chaparro-Huerta, V; Torres-Mendoza, BM; Gudino-Cabrera, G; Rivera-Cervantes, MC; Pallas, M; Camins, A; Armendariz-Borunda, J; Beas-Zarate, C				Vazquez-Valls, E.; Flores-Soto, M. E.; Chaparro-Huerta, V.; Torres-Mendoza, B. M.; Gudino-Cabrera, G.; Rivera-Cervantes, M. C.; Pallas, M.; Camins, A.; Armendariz-Borunda, J.; Beas-Zarate, C.			HIF-1 alpha expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Hippocampus; Macrophages; HIF-1 alpha; VEGF; EPO; Excitotoxicity	ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; TRAUMATIC BRAIN-INJURY; NEURONAL DEATH; NEONATAL-RATS; NEURODEGENERATIVE DISEASES; GENE-EXPRESSION; CEREBRAL-CORTEX; NITRIC-OXIDE; SPINAL-CORD	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master transcription factor that regulates the response to hypoxia and ischemia and induces the expression of various genes, including vascular endothelial growth factor (VEGF) and erythropoietin (EPO). This study shows the systemic response of increased HIF-1 alpha, EPO, and VEGF mRNA and protein. In addition, VEGF expression was increased in neurons and over-expressed in glial cells in a model of neuroexcitotoxicity in the hippocampus, in which rats were neonatally exposed to high glutamate concentrations. Simultaneous increases in HIF-1 alpha, EPO and VEGF mRNA in peritoneal macrophages were also observed. Our study is consistent with the hypothesis that these genes exert a protective effect in response to neurotoxicity. (C) 2011 Elsevier B.V. All rights reserved.	[Vazquez-Valls, E.] Hosp Especialidades Ctr Med La Raza, Unidad Invest Med Epidemiol Clin, UMAE, CMNO,IMSS, Mexico City, DF, Mexico; [Flores-Soto, M. E.; Chaparro-Huerta, V.; Torres-Mendoza, B. M.; Beas-Zarate, C.] IMSS, CIBO, Lab Neurobiol Celular & Mol, Div Neurociencias, Guadalajara 44340, Jalisco, Mexico; [Torres-Mendoza, B. M.] CUCS, Inst Patol Infecciosa & Expt, Mexico City, DF, Mexico; [Gudino-Cabrera, G.; Beas-Zarate, C.] CUCBA, Lab Regenerac & Desarrollo Neural, Inst Neurobiol, Dept Biol Celular & Mol, Mexico City, DF, Mexico; [Rivera-Cervantes, M. C.] CUCBA, Lab Neurobiol Celular & Mol, Mexico City, DF, Mexico; [Pallas, M.; Camins, A.] Univ Barcelona, Unitat Farmacol & Farmacognosia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Farm, E-08028 Barcelona, Spain; [Pallas, M.; Camins, A.] Univ Barcelona, Inst Biomed IBUB, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Farm, E-08028 Barcelona, Spain; [Armendariz-Borunda, J.] CUCS, Inst Biol Mol & Terapia Gen, Guadalajara, Jalisco, Mexico		Beas-Zarate, C (corresponding author), IMSS, CIBO, Lab Mol & Cell Neurobiol, Div Neurosci, Sierra Mojada 800, Guadalajara 44340, Jalisco, Mexico.	carlosbeas55@gmail.com	Pallas, Merce/H-3129-2016; Torres-Mendoza, Blanca Miriam/O-5793-2019; Armendariz-Borunda, Juan/AAU-1471-2021; de Guadalupe Torres Mendoza, Blanca Miriam/ABC-3523-2020; Camins, Antonio/J-5126-2019	Pallas, Merce/0000-0003-3095-4254; Camins, Antonio/0000-0002-1229-5956; GUDINO CABRERA, GRACIELA/0000-0002-4247-9246; Vazquez-Valls, Eduardo/0000-0002-9639-5339; Chaparro-Huerta, Veronica/0000-0001-8647-5071; Cervantes, Rivera/0000-0002-7601-6944; Torres-Mendoza, Blanca Miriam/0000-0003-2233-571X; Gudino Cabrera, Graciela/0000-0003-3170-6535; Flores Soto, Eduardo/0000-0001-9409-4690	Spain's "Ministerio de Educacion y Ciencia"Spanish Government [SAF2009-13093]; Fondo de Investigacion SanitariaInstituto de Salud Carlos III; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI080400, PS09/01789]; Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED) [610RT0405]; Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [2009/SGR00853]; Fundacio la Marato TV3 [063230]	This study was supported by grants from Spain's "Ministerio de Educacion y Ciencia" SAF2009-13093, the "Fondo de Investigacion Sanitaria", and the "Instituto de Salud Carlos III" PI080400 and PS09/01789 (FEDER FOUNDS). 610RT0405 from Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED). We would like to thank the "Generalitat de Catalunya" for supporting the research groups (2009/SGR00853) and the "Fundacio la Marato TV3" (063230). We wish to thank the Language Assessment Service of the University of Barcelona for revising the manuscript.	Beas-Zarate C, 2001, NEUROCHEM INT, V39, P1, DOI 10.1016/S0197-0186(01)00008-0; Beas-Zarate C, 2007, INT J DEV NEUROSCI, V25, P53, DOI 10.1016/j.ijdevneu.2006.10.001; Bogaert E, 2010, NEUROBIOL AGING, V31, P2185, DOI 10.1016/j.neurobiolaging.2008.12.007; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Castellani RJ, 2008, J NEUROPATH EXP NEUR, V67, P523, DOI 10.1097/NEN.0b013e318177eaf4; Chaparro-Huerta V, 2008, INT J DEV NEUROSCI, V26, P487, DOI 10.1016/j.ijdevneu.2008.02.008; Chaparro-Huerta V, 2005, J NEUROIMMUNOL, V165, P53, DOI 10.1016/j.jneuroim.2005.04.025; Chaparro-Huerta V, 2002, NEUROSCI LETT, V333, P95, DOI 10.1016/S0304-3940(02)01006-6; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Fujiki M, 2010, EXP NEUROL, V225, P377, DOI 10.1016/j.expneurol.2010.07.010; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gras G, 2006, J LEUKOCYTE BIOL, V80, P1067, DOI 10.1189/jlb.0306153; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Khan Haseeb Ahmad, 2004, Inflammopharmacology, V12, P81, DOI 10.1163/156856004773121392; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Lemus-Varela ML, 2010, CLIN BIOCHEM, V43, P234, DOI 10.1016/j.clinbiochem.2009.09.022; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunn JS, 2009, DEV NEUROBIOL, V69, P871, DOI 10.1002/dneu.20747; Manoonkitiwongsa PS, 2011, CNS NEUROL DISORD-DR, V10, P215; Martinez-Contreras A, 2002, J NEUROSCI RES, V67, P200, DOI 10.1002/jnr.10093; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Moxon-Emre I, 2010, J NEUROPATH EXP NEUR, V69, P1, DOI 10.1097/NEN.0b013e3181c3ce6c; Nicoletti JN, 2010, EPILEPSY BEHAV, V19, P272, DOI 10.1016/j.yebeh.2010.07.011; Pacheco R, 2007, J NEUROIMMUNOL, V185, P9, DOI 10.1016/j.jneuroim.2007.01.003; Porcheray F, 2006, AM J PHYSIOL-CELL PH, V291, pC618, DOI 10.1152/ajpcell.00021.2006; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Seta KA, 2004, J APPL PHYSIOL, V96, P765, DOI 10.1152/japplphysiol.00836.2003; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tian You-yong, 2006, Zhonghua Yi Xue Za Zhi, V86, P2054; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Toyooka K, 2009, CURR OPIN NEUROL, V22, P475, DOI 10.1097/WCO.0b013e32832fbc52; Vezzani Annamaria, 2008, Epilepsy Curr, V8, P135, DOI 10.1111/j.1535-7511.2008.00269.x; Wang Yong-Quan, 2007, Sheng Li Ke Xue Jin Zhan, V38, P202; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Zhang B, 2004, NEUROSCIENCE, V126, P433, DOI 10.1016/j.neuroscience.2004.03.057; Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	47	13	17	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	SEP 15	2011	238	1-2					12	18		10.1016/j.jneuroim.2011.06.001			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	831CK	WOS:000295706100002	21807419				2022-02-06	
J	Goldberg, J; McClaine, RJ; Cook, B; Garcia, VF; Brown, RL; Crone, K; Falcone, RA				Goldberg, Jillian; McClaine, Rebecca J.; Cook, Becky; Garcia, Victor F.; Brown, Rebeccah L.; Crone, Kerry; Falcone, Richard A., Jr.			Use of a mild traumatic brain injury guideline to reduce inpatient hospital imaging and charges	JOURNAL OF PEDIATRIC SURGERY			English	Article						Head CT; Length of stay; Charges; Guideline	DECISION RULE; HEAD; PREDICTION	Purpose: In children, mild traumatic brain injuries (TBI) account for 70% to 90% of head injuries. Without clear guidelines, many of these children may be exposed to excess radiation owing to unnecessary imaging. The purpose of this study was to evaluate the impact of a mild TBI guideline in reducing hospital charges and repeated imaging of pediatric patients. Methods: Charts of all children who had at least one head computed tomography and were admitted to our level 1 trauma center with a blunt TBI and Glasgow Coma Scale of 13 to 15 were retrospectively reviewed. Patients were divided into 2 groups relative to the implementation of a TBI management guideline. Results: A total of 742 patients were included, 389 preguideline and 353 postguideline. Implementation of the guideline was associated with reductions in the average number of head computed tomographies performed (1.6 vs 1.3, P = .006), length of stay (2.3 vs 1.7 days, P < .0001), and overall hospital charges ($21,760 vs $13,980, P = .006). No children were readmitted for missed injuries. Conclusions: Implementation of a simple guideline for the care of children with mild TBI can have significant impact on charges and length of stay while simultaneously reducing radiation exposure. Widespread implementation of such guidelines will improve efficiency without sacrificing quality of care in the management of mild TBI in the pediatric population. (C) 2011 Elsevier Inc. All rights reserved.	[Goldberg, Jillian; McClaine, Rebecca J.; Cook, Becky; Garcia, Victor F.; Brown, Rebeccah L.; Falcone, Richard A., Jr.] Univ Cincinnati, Dept Surg, Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Crone, Kerry] Univ Cincinnati, Dept Surg, Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurosurg, Cincinnati, OH 45229 USA		Falcone, RA (corresponding author), Univ Cincinnati, Dept Surg, Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg, Cincinnati, OH 45229 USA.	richard.falcone@cchmc.org					Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; *BRAIN SPINALCORD, BRAIN INJ STAT; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Dutton RP, 2003, J TRAUMA, V55, P913, DOI 10.1097/01.TA.0000093395.34097.56; HELLING TS, 1995, J TRAUMA, V39, P980, DOI 10.1097/00005373-199511000-00027; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; National Cancer Institute, RAD RISKS PED COMP T; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Schweer Lynn H, 2006, J Trauma Nurs, V13, P6; Shebesta Kaaren Fanta, 2006, J Trauma Nurs, V13, P66; *STAT TOP 10 CAUS, LEAD CAUS DEATH KIDS	15	13	13	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	SEP	2011	46	9					1777	1783		10.1016/j.jpedsurg.2011.02.052			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	827XA	WOS:000295461900023	21929989				2022-02-06	
J	McLellan, TL; McKinlay, A				McLellan, Tracey L.; McKinlay, Audrey			Does the way concussion is portrayed affect public awareness of appropriate concussion management: the case of rugby league	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; ASSOCIATION; STATEMENT; COHORT	It is important to identify factors that might adversely affect appropriate medical consultation and management of concussion. One factor that might present a barrier to timely intervention is media portrayal of concussion in sporting events, such as professional rugby league. Accordingly, the current study employed a surveillance method of publicly available broadcast information to establish the incidence rate of probable concussion in the National Rugby League's Telstra Premiership 2010 season and examined how these injury events were shown to be managed with respect to return-to-play procedures. The incident rate for probable concussion was higher than previously reported: 11.10\1000 player hours (95% CI 5.78 to 16.40) and was likely underestimated. Importantly, most injured players were shown to continue playing or return to play despite being visibly concussed and described as such by the commentary team. Although 'return-to-play decisions' for professional players are guided by medical assessment, the authors discuss whether the way concussion is portrayed might affect public awareness of appropriate concussion management.	[McLellan, Tracey L.; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia		McLellan, TL (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	tracey.mclellan@canterbury.ac.nz		McKinlay, Audrey/0000-0001-9846-8514	Department of Psychology, University of Canterbury, New Zealand	The current study was funded by the Department of Psychology, University of Canterbury, New Zealand.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x	16	13	13	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	SEP	2011	45	12					993	996		10.1136/bjsm.2011.083618			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	816PM	WOS:000294614600014	21540191				2022-02-06	
J	Que, HP; Liu, Y; Jia, YF; Liu, SJ				Que, Haiping; Liu, Yong; Jia, Yufeng; Liu, Shaojun			Establishment and assessment of a simple and easily reproducible incision model of spinal cord neuron cells in vitro	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						In vitro studies; Models of injury; Neural injury; Traumatic spinal cord injury	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SCIATIC-NERVE; FOS PROTEIN; RAT; EXPRESSION; TRANSECTION; IMMUNOREACTIVITY; INDUCTION; APOPTOSIS	A growing number of in vitro models have been introduced to study the mechanisms of spinal cord injury. A potential drawback of these models is that they are difficult to reproduce. In this study, an in vitro incision model was established using primary cultured neuronal cells from fetal rat spinal cords. The neurons were subjected to incision in a simple and reproducible way. To assess whether this model could simulate the responses of spinal cord neuron cells in vivo after a spinal cord transection, apoptosis, and the expression of immediate early genes were detected in the neurons at various time points after injury. The results indicated that: (1) significantly more terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells were observed at 1, 3, and 7 d following injury and (2) the expression of both c-Jun and c-Fos was induced 10 min after incision and had markedly higher levels 2 h post-injury. These results suggested that our model can partially imitate the responses of in vivo neuronal cells after a spinal cord transection and such models may facilitate further understanding of biochemical and cellular events associated with spinal cord injury.	[Que, Haiping; Liu, Yong; Jia, Yufeng; Liu, Shaojun] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Dept Neurobiol, Beijing 100730, Peoples R China		Liu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Dept Neurobiol, Beijing 100730, Peoples R China.	liuyongxiao1225@yahoo.com.cn; liusj@nic.bmi.ac.cn			Chinese National Basic Research ProgramNational Basic Research Program of China [2009CB918301]; State Key Laboratory of Proteomics [SKLP2010yx-004]	This work was supported by grants from Chinese National Basic Research Program (grant no. 2009CB918301) and Open Project Program of the State Key Laboratory of Proteomics (SKLP2010yx-004).	Akhtar AZ, 2008, REV NEUROSCIENCE, V19, P47; BALENTINE JD, 1988, LAB INVEST, V58, P93; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Buchanan K M, 2001, Axone, V22, P16; Campagnolo D I, 2000, J Spinal Cord Med, V23, P121; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Casanovas A, 2001, J NEUROSCI RES, V63, P469, DOI 10.1002/jnr.1041; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; CHI SI, 1993, BRAIN RES, V617, P220, DOI 10.1016/0006-8993(93)91089-B; Del-Bel EA, 2000, BRAZ J MED BIOL RES, V33, P521, DOI 10.1590/S0100-879X2000000500006; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; GROSS GW, 1983, J NEUROSCI, V3, P1979; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Hirata Y, 1998, J NEUROCHEM, V71, P1607; Hughes PE, 1999, PROG NEUROBIOL, V57, P421, DOI 10.1016/S0301-0082(98)00057-4; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; Kajander KC, 1996, NEUROSCI LETT, V206, P9, DOI 10.1016/0304-3940(96)12447-2; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliveira ALR, 2002, J COMP NEUROL, V447, P381, DOI 10.1002/cne.10248; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Ribotta MGY, 1996, BRAIN RES, V707, P245, DOI 10.1016/0006-8993(95)01266-4; Ruggiero DA, 1997, BRAIN RES, V763, P21, DOI 10.1016/S0006-8993(97)00356-9; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410	35	13	13	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	SEP	2011	47	8					558	564		10.1007/s11626-011-9443-2			7	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	864HS	WOS:000298229800009	21792724				2022-02-06	
J	Schluter-Brust, K; Leistenschneider, P; Dargel, J; Springorum, HP; Eysel, P; Michael, JWP				Schlueter-Brust, K.; Leistenschneider, P.; Dargel, J.; Springorum, H. P.; Eysel, P.; Michael, J. W-P.			Acute Injuries in Taekwondo	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						injuries; acute; taekwondo; martial art; epidemiology	MARTIAL ARTS INJURIES; COMPETITION; SPORTS; CHAMPIONSHIPS; CONCUSSION; BLOWS; HEAD	Although Taekwondo is becoming an increasingly popular sport, there is a lack of reliable epidemiologic data on Taekwondo injuries. To perform an epidemiologic study on the variety of types of injury in professional and amateur Taekwondo athletes and to find a relation between Taekwondo style, skill level, weight-class and warm-up routine and the occurrence of injuries, we analysed the injury data using a 7-page questionnaire from a total of 356 Taekwondo athletes who were randomly selected. Overall, we registered a total of 2 164 injuries in 356 athletes. Most traumas were contusions and sprains in the lower extremities. Professional Taekwondo athletes have an increased risk of injury in comparison to recreational athletes. Taekwondo style, weight class and tournament frequency have an influence on the athlete's injury profile. Warm-up routines were found to have a positive effect on injury rates. Overall, Taekwondo may be considered a rather benign activity, if injuries during Taekwondo tournaments can be avoided. If not, Taekwondo can result in serious musculoskeletal problems.	[Schlueter-Brust, K.; Leistenschneider, P.; Dargel, J.; Springorum, H. P.; Eysel, P.; Michael, J. W-P.] Univ Cologne, Dept Orthoped Surg, D-50931 Cologne, Germany		Michael, JWP (corresponding author), Univ Cologne, Dept Orthoped Surg, Joseph Stelzmann St 9, D-50931 Cologne, Germany.	joern.michael@uk-koeln.de					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Beis K, 2001, EUR J SPORT TRAUMA R, V23, P130; Birrer R B, 1983, Br J Sports Med, V17, P131; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; Burke DT, 2003, BRIT J SPORT MED, V37, P401, DOI 10.1136/bjsm.37.5.401; DICK R, 1988, NATL COLLEGIATE ATHL; Gong HS, 2007, BRIT J SPORT MED, V41, P917, DOI 10.1136/bjsm.2007.035501; Harriss DJ, 2009, INT J SPORTS MED, V30, P701, DOI 10.1055/s-0029-1237378; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kazemi M, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-22; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; Lee KT, 2009, PHYS THER SPORT, V10, P101, DOI 10.1016/j.ptsp.2009.05.002; MCLATCHIE GR, 1994, ENCY SPORTS MED, V5, P609; Pary LF, 2003, NEUROLOGY, V60, P1392, DOI 10.1212/01.WNL.0000055924.12065.A0; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pieter W, 1998, J ROY SOC HEALTH, V118, P272, DOI 10.1177/146642409811800512; Pieter W, 1997, J TRAUMA, V43, P89, DOI 10.1097/00005373-199707000-00020; PIETER W, 1998, KINESIOLOGY, V30, P22, DOI DOI 10.1589/JPTS.28.231; PIETER W, 2002, ACSM 49 ANN M ST LOU; Zemper E D, 1989, Br J Sports Med, V23, P161; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322	23	13	13	0	17	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2011	32	8					629	634		10.1055/s-0031-1275302			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	801SG	WOS:000293460100012	21563037				2022-02-06	
J	Zafonte, R				Zafonte, Ross			Diagnosis and Management of Sports-Related Concussion A 15-Year-Old Athlete With a Concussion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC-BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; MILD HEAD-INJURY; HIGH-SCHOOL; RECURRENT CONCUSSION; NEUROCOGNITIVE PERFORMANCE; POSTTRAUMATIC MIGRAINE; INTELLECTUAL ABILITY; MAGNETIC-RESONANCE; POSTURAL STABILITY	Concussion in youth athletes is a growing problem worldwide. During the past decade, significant progress has been made in standardization of the assessment of young athletes, and a growing appreciation of metabolic vulnerability, activity, and cognitive challenges has led to guidelines and suggestions for rest from the field as well as cognitive rest from school. Outcome data have begun to establish groups linked to symptom class, genetics, and sex who are at risk of worse outcomes from concussions. Decisions regarding return to activity are now based on at-rest symptoms, graded increases in activity, and neuropsychological testing. Using the case of Ms X, a 15-year-old otherwise healthy high school student who fell while skiing, evaluation, prognosis, and management of concussion are discussed.	[Zafonte, Ross] Spaulding Rehabil Hosp Network, Boston, MA 02114 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA		Zafonte, R (corresponding author), Spaulding Rehabil Hosp Network, 125 Nashua St, Boston, MA 02114 USA.	rzafonte@partners.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Disability and Rehabilitation Research; Department of DefenseUnited States Department of Defense; US Food and Drug Administration	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Zafonte reports receiving research funding from the National Institutes of Health, the National Institute on Disability and Rehabilitation Research, and the Department of Defense. He is principal investigator on a study funded by the US Food and Drug Administration orphan drug program in collaboration with Neurohealing. He is a member of Neurohealing's scientific advisory board but receives no compensation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Barth JT, 2009, PM&R, V1, P769, DOI 10.1016/j.pmrj.2009.07.001; Bey T, 2009, WEST J EMERG MED, V10, P6; Bouma G J, 1995, New Horiz, V3, P384; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Centers for Disease Control and Prevention, WHAT SHOULD I DO IF; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins M. W., 2007, BRAIN INJURY MED PRI, P407; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mathew NT, 1997, NEUROL CLIN, V15, P167, DOI 10.1016/S0733-8619(05)70302-9; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Runkle D, 2010, NCAA COMMITTEE COMPE; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SHEFTELL FD, 1994, HEADACHE, V34, P67, DOI 10.1111/j.1526-4610.1994.hed3402067.x; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Weir DR., 2009, NATL FOOTBALL LEAGUE; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x	81	13	13	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					79	86		10.1001/jama.2011.819			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	WOS:000292378700023	21632470				2022-02-06	
J	Carlesimo, GA; Costa, A; Serra, L; Bozzali, M; Fadda, L; Caltagirone, C				Carlesimo, G. A.; Costa, A.; Serra, L.; Bozzali, M.; Fadda, L.; Caltagirone, C.			Prospective memory in thalamic amnesia	NEUROPSYCHOLOGIA			English	Article						Prospective memory; Thalamus; Amnesia; Executive functions	MILD COGNITIVE IMPAIRMENT; CLOSED-HEAD INJURY; PARKINSONS-DISEASE; BRAIN-INJURY; NEUROPSYCHOLOGY; TRACTOGRAPHY; INTENTIONS; DEFICITS; TASK	The contribution of the thalamus to the functioning of prospective memory (PM) is currently unknown. Here we report an experimental investigation of the performance of two patients with bilateral infarcts in the anterior-mesial regions of the thalami on an event-based PM paradigm. One patient, G.P., had a pervasive declarative memory impairment but no significant executive deficit. The other patient, R.F., had a memory deficit limited to verbal material with associated behavioral abnormalities (inertia and apathy); she performed poorly on tests of executive functions. Although both patients performed poorly on the PM task, a qualitative analysis of performance revealed different mechanisms at the base of their impaired PM. G.P. had reduced declarative memory for target words compared with normal controls; but, unforgotten words were normally able to elicit his recall of the prospective intention. Conversely, R.F.'s declarative memory for target words was as accurate as that of normal controls, but she presented a dramatically reduced ratio between the number of target words she recalled and the number of times she activated the prospective intention on the PM task, suggesting that her deficit consisted of difficulty in activating the intention despite normal declarative memory for the target events. In conclusion, results of the present study demonstrate that thalamic structures have an important role in PM processes. They also document that damage to the anterior-mesial regions of the thalami affects PM abilities by two different mechanisms, respectively based on the relative disruption of declarative memory or executive processes functioning, which, in turn, is related to the specific intrathalamic structures involved by the lesions. Indeed, while G.P.'s pervasive declarative memory deficit was underlain by bilateral involvement of the mammillo-thalamic tract, R.F.'s executive and behavioral abnormalities were likely related to bilateral damage of the midline, intralaminar, and medio-dorsal nuclei. (C) 2010 Elsevier Ltd. All rights reserved.	[Carlesimo, G. A.; Fadda, L.; Caltagirone, C.] Tor Vergata Univ, Neurol Clin, Rome, Italy; [Carlesimo, G. A.; Costa, A.; Fadda, L.; Caltagirone, C.] IRCCS, Santa Lucia Fdn, Unit Clin & Behav Neurol, Rome, Italy; [Serra, L.; Bozzali, M.] IRCCS, Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy		Carlesimo, GA (corresponding author), IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.	memolab@hsantalucia.it	Serra, Laura/K-5637-2016; Caltagirone, Carlo/B-4930-2013; Costa, Alberto/AAA-7038-2019; Bozzali, Marco/AAC-1031-2022	Serra, Laura/0000-0002-2717-1286; Fadda, Lucia/0000-0003-0659-9416; COSTA, Alberto/0000-0002-4784-5524; Bozzali, Marco/0000-0002-0568-2026			Adda CC, 2008, NEUROPSYCHOLOGIA, V46, P1954, DOI 10.1016/j.neuropsychologia.2008.01.016; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BORTOLINI V, 1971, LESSICO FREQUENZE LI; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlesimo G, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Carlesimo GA, 2007, NEUROPSYCHOLOGIA, V45, P2467, DOI 10.1016/j.neuropsychologia.2007.03.025; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Carlesimo GA, 2009, BEHAV NEUROL, V22, P101, DOI [10.3233/ben-2009-0251, 10.3233/BEN-2009-0251]; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; Cipolotti L, 2008, NEUROPSYCHOLOGIA, V46, P2745, DOI 10.1016/j.neuropsychologia.2008.05.009; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kazui H, 2005, DEMENT GERIATR COGN, V19, P331, DOI 10.1159/000084559; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Mai JK, 2004, ATLAS HUMAN BRAIN; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; MAURI M, 1997, ARCH PSICOLOGIA NEUR, V5, P621; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Nocentini U., 2002, NUOVA RIV NEUROLOGIA, V12, P13; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Steriade M, 1997, THALAMUS ORG FUNCTIO; Tognoni, 1987, ITALIAN J NEUROLOGIC, V8, P35; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; Wang Y, 2009, SCHIZOPHR RES, V114, P64, DOI 10.1016/j.schres.2009.07.009; Warrington EK, 1996, CAMDEN MEMORY TEST	47	13	17	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2011	49	8			SI		2199	2208		10.1016/j.neuropsychologia.2010.11.013			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	793FL	WOS:000292805700007	21115022				2022-02-06	
J	Deng, P; Xu, ZC				Deng, Ping; Xu, Zao C.			Contribution of I-h to Neuronal Damage in the Hippocampus after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						HCN channel; hilar cell; neuronal excitability; neuroprotection; trauma	CORTICAL IMPACT MODEL; PROTEIN-KINASE-C; STRIATAL CHOLINERGIC INTERNEURONS; TRANSIENT FOREBRAIN ISCHEMIA; ACTIVATED PACEMAKER CHANNELS; CA1 PYRAMIDAL NEURONS; CATION CHANNELS; DENDRITIC I(H); DENTATE GYRUS; UP-REGULATION	Traumatic brain injury (TBI) causes selective neuronal damage in the hippocampus; however, the underlying mechanisms are still unclear. Post-traumatic alterations of ion channel activity, which actively regulate neuronal excitability and thus impact on excitotoxicity, may be involved in TBI-induced neuronal injury. Here we report that hyperpolarization-activated cation current (I-h) contributes to the distinct vulnerability of hippocampal neurons in TBI. In a rat model of controlled cortical injury, moderate TBI produced neuronal death of both hippocampal CA3 neurons and mossy cells in the hilus, but not CA1 pyramidal cells. Treatment with lamotrigine, which enhances dendritic I-h, ameliorated TBI-induced neuronal damage to CA3 neurons and mossy cells. In contrast, intraventricular administration of I-h channel blocker caused cell death in the CA1 region after TBI. Whole-cell recordings revealed that, differently from CA3 neurons, CA1 pyramidal cells expressed larger Ih and exhibited a post-traumatic increase of I-h amplitude. Moreover, blocking I-h led to an increase of neuronal excitability, with greater effects seen in post-traumatic CA1 pyramidal cells than in CA3 neurons. In addition, the I-h in mossy cells was dramatically inhibited early after TBI. Our findings indicate that differential changes of I-h in hippocampal neurons may be one of the mechanisms of selective cell death, and that an enhancement of functional I-h may protect hippocampal neurons against TBI.	[Deng, Ping; Xu, Zao C.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA		Deng, P (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 507, Indianapolis, IN 46202 USA.	zcxu@iupui.edu; pideng@iupui.edu			Indiana Spinal Cord and Brain Injury Fund [ISDH/A70-0-079212]; American Heart AssociationAmerican Heart Association [0630172N]	This work was supported by the Indiana Spinal Cord and Brain Injury Fund (ISDH/A70-0-079212) and American Heart Association grant 0630172N to P.D.	Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Deng P, 2008, J CEREBR BLOOD F MET, V28, P939, DOI 10.1038/sj.jcbfm.9600583; Deng P, 2007, J NEUROSCI, V27, P3148, DOI 10.1523/JNEUROSCI.5535-06.2007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/j.cell.2004.11.020; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Toth Z, 1997, J NEUROSCI, V17, P8106; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	59	13	13	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1173	1183		10.1089/neu.2010.1683			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600006	21463147				2022-02-06	
J	Geary, EK; Kraus, MF; Rubin, LH; Pliskin, NH; Little, DM				Geary, Elizabeth K.; Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.; Little, Deborah M.			Verbal Learning Strategy Following Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Post-concussive syndrome; Concussion; Semantic; Cognition; Executive functions; Brain/behavior relationships	SCHIZOPHRENIA-SPECTRUM DISORDERS; FRONTAL LESIONS; FREE-RECALL; EXECUTIVE DYSFUNCTION; MEMORY REHABILITATION; COGNITIVE IMPAIRMENT; QUALITATIVE ASPECTS; MULTIPLE-SCLEROSIS; DIFFUSION-TENSOR; TEST-2ND EDITION	That learning and memory deficits persist many years following mild traumatic brain injury (mTBI) is controversial due to inconsistent objective evidence supporting subjective complaints. Our prior work demonstrated significant reductions in performance on the initial trial of a verbal learning task and overall slower rate of learning in well-motivated mTBI participants relative to demographically matched controls. In our previous work, we speculated that differences in strategy use could explain the differences in rate of learning. The current study serves to test this hypothesis by examining strategy use on the California Verbal Learning Test-Second Edition. Our present findings support the primary hypothesis that mTBI participants under-utilize semantic clustering strategies during list-learning relative to control participants. Despite achieving comparable total learning scores, we posit that the persisting learning and memory difficulties reported by some mTBI patients may be related to reduced usage of efficient internally driven strategies that facilitate learning. Given that strategy training has demonstrated improvements in learning and memory in educational and occupational settings, we offer that these findings have translational value in offering an additional approach in remediation of learning and memory complaints reported by some following mTBI. (JINS, 2011, 17, 709-719)	[Geary, Elizabeth K.; Kraus, Marilyn F.; Pliskin, Neil H.; Little, Deborah M.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL 60612 USA; [Geary, Elizabeth K.; Little, Deborah M.] Univ Illinois, Coll Med, Ctr Stroke Res, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.] Univ Illinois, Coll Med, Ctr Cognit Med, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Anat, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Ophthalmol, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Psychol, Chicago, IL 60612 USA		Little, DM (corresponding author), Univ Illinois, Coll Med, Dept Neurol, MC 796,912 S Wood St 855 N, Chicago, IL 60612 USA.	deborahmlittle@gmail.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 MH068787]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32-MH067631]; Marshall Goldberg Traumatic Brain Injury Fund; NICHD/ORWHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH Office of Research on Women's Health (ORWH) [K12HD055892]; Department of DefenseUnited States Department of Defense [PT 075675]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH068787, T32MH067631] Funding Source: NIH RePORTER	This work is supported in part by NIH grant K23 MH068787 (MFK) and T32-MH067631 (EKG) from the National Institute of Mental Health, the Marshall Goldberg Traumatic Brain Injury Fund, NICHD/ORWH grant K12HD055892 (LHR), and a grant from the Department of Defense/Congressionally Directed Medical Research Program grant PT 075675. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the University of Illinois at Chicago, Department of Defense, Congressionally Directed Medical Research Program, Department of the Army, National Institute of Child Health and Human Development, the National Institutes of Health, or the National Institute of Mental Health. Special thanks to Sarung Kashyap for his contribution in the preparation of the raw data for these analyses. The authors have no financial and/or relationship conflicts of interest to disclose.	Alexander M, 2006, J INT NEUROPSYCH SOC, V12, P192, DOI 10.1017/S1355617706060292; Alexander MP, 2009, J COGNITIVE NEUROSCI, V21, P1422, DOI 10.1162/jocn.2009.21094; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; Becker S, 2003, J COGNITIVE NEUROSCI, V15, P821, DOI 10.1162/089892903322370744; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan AS, 2000, SCHIZOPHR RES, V41, P431, DOI 10.1016/S0920-9964(99)00078-X; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC, 2010, CLIN NEUROPSYCHOL, V24, P70, DOI 10.1080/13854040903002232; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DEROSA DV, 1970, J VERB LEARN VERB BE, V9, P269, DOI 10.1016/S0022-5371(70)80060-3; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ellis H.C., 1965, TRANSFER LEARNING; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fiszdon JM, 2006, PSYCHIAT RES, V143, P159, DOI 10.1016/j.psychres.2005.09.012; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gongvatana A, 2007, J NEUROPSYCH CLIN N, V19, P36, DOI 10.1176/appi.neuropsych.19.1.36; GSOTTSCHNEIDER A, 2010, J NEUROPSYCHOLOGY; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jefferies E, 2008, J MEM LANG, V58, P66, DOI 10.1016/j.jml.2007.06.004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LUEK SP, 1976, MEM COGNITION, V4, P476, DOI 10.3758/BF03213207; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P1854, DOI 10.1016/j.pnpbp.2008.08.018; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ranjith N, 2010, ANN INDIAN ACAD NEUR, V13, P117, DOI 10.4103/0972-2327.64639; Ribeiro F, 2007, J CLIN EXP NEUROPSYC, V29, P187, DOI 10.1080/13803390600629775; Roofeh D, 2006, SCHIZOPHR RES, V85, P201, DOI 10.1016/j.schres.2006.03.030; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schweizer TA, 2010, BEHAV NEUROL, V23, P31, DOI [10.1155/2010/102421, 10.3233/BEN-2010-0269]; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; STERNBERG RJ, 1977, PSYCHOL BULL, V84, P539, DOI 10.1037/0033-2909.84.3.539; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Turner MS, 2007, NEUROPSYCHOLOGIA, V45, P1540, DOI 10.1016/j.neuropsychologia.2006.11.013; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.007; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; West L. K., 2010, J NEUROPSYCHOLOGY; YOUNG RK, 1965, J EXP PSYCHOL, V70, P338, DOI 10.1037/h0022257; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B	71	13	13	0	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2011	17	4					709	719		10.1017/S1355617711000646			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	781NL	WOS:000291939900015	21554788	Green Submitted			2022-02-06	
J	Muellenbach, RM; Redel, A; Kustermann, J; Brack, A; Gorski, A; Rosner, T; Roewer, N; Wurmb, T				Muellenbach, R. M.; Redel, A.; Kuestermann, J.; Brack, A.; Gorski, A.; Roesner, T.; Roewer, N.; Wurmb, T.			Extracorporeal membrane oxygenation and severe traumatic brain injury. Is the ECMO-therapy in traumatic lung failure and severe traumatic brain injury really contraindicated?	ANAESTHESIST			German	Article						Multiple trauma; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Brain injuries; Anticoagulation	RESPIRATORY-DISTRESS-SYNDROME; ARDS	Veno-venous extracorporeal membrane oxygenation (ECMO) may be lifesaving in multiple injured patients with acute respiratory distress syndrome (ARDS) due to chest trauma. To prevent circuit thrombosis or thrombembolic complications during ECMO systemic anticoagulation is recommended. Therefore, ECMO treatment is contraindicated in patients with intracranial bleeding. The management of veno-venous ECMO without systemic anticoagulation in a patient suffering from traumatic lung failure and severe traumatic brain injury is reported.	[Muellenbach, R. M.; Redel, A.; Kuestermann, J.; Brack, A.; Roewer, N.; Wurmb, T.] Unve Klinikum Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, D-97080 Wurzburg, Germany; [Redel, A.] Univ Klinikum Regensburg, Anasthesiol Klin, Regensburg, Germany; [Gorski, A.; Roesner, T.] Unve Klinikum Wurzburg, Klin & Poliklin Herz Thorax & Thorakale Gefasschi, D-97080 Wurzburg, Germany		Muellenbach, RM (corresponding author), Unve Klinikum Wurzburg, Zentrum Operat Med, Klin & Poliklin Anasthesiol, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.	Muellenbac_r@klinik.uni-wuerzburg.de					Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Brower RG, 2004, NEW ENGL J MED, V351, P327; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Henzler D, 2004, ANAESTHESIST, V53, P235, DOI 10.1007/s00101-004-0653-9; Hilbert P, 2010, DTSCH ARZTEBL INT, V107, P463, DOI 10.3238/arztebl.2010.0463; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Moller T, 2010, ANASTH INTENSIV NOTF, V45, P544, DOI 10.1055/s-0030-1265745; Oliver WC, 2009, SEMIN CARDIOTHORAC V, V13, P154, DOI 10.1177/1089253209347384; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Robinson CM, 2001, J BONE JOINT SURG BR, V83B, P781, DOI 10.1302/0301-620X.83B6.12440; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Trupka A, 1994, Eur J Emerg Med, V1, P1, DOI 10.1097/00063110-199403000-00002; Wassermann J, 1998, CAN J ANAESTH, V45, P1044, DOI 10.1007/BF03012389	17	13	14	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	JUL	2011	60	7					647	652		10.1007/s00101-011-1872-5			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	797NU	WOS:000293135400007	21424309				2022-02-06	
J	Niemeier, JP; Kreutzer, JS; Marwitz, JH; Gary, KW; Ketchum, JM				Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Gary, Kelli W.; Ketchum, Jessica M.			Efficacy of a brief acute neurobehavioural intervention following traumatic brain injury: A preliminary investigation	BRAIN INJURY			English	Article						Neurobehavioural; intervention; rehabilitation; efficacy	RANDOMIZED CONTROLLED-TRIAL; CLOSED-HEAD-INJURY; MINI-MENTAL-STATE; RATING-SCALE; COGNITIVE REHABILITATION; INPATIENT REHABILITATION; MULTICENTER ANALYSIS; LIFE SCALE; SATISFACTION; RELIABILITY	Primary objective: To evaluate the effectiveness of a brief acute neurobehavioural intervention, the First Steps Acute Neurobehavioural and Cognitive Intervention (FANCI), with persons who have traumatic brain injury (TBI). Research design: Prospective, controlled, repeated measures design. Methods and procedures: Seventy-two patients in acute TBI rehabilitation participated either as FANCI subjects or as control participants who watched videos to control for time and attention. Outcome measures included the Neurobehavioural Rating Scale-Revised (NRS-R), Functional Independence Measure (FIM (TM)), a FANCI Learning Assessment (LA) and the Satisfaction with Life Scale (SWLS). Main outcomes and results: In comparison with controls, FANCI participants had significantly greater neurobehavioural (cognitive, emotional and behavioural) as well as FIM motor improvements. Significantly greater learning occurred and persisted over time for FANCI subjects as compared to controls. Pre-treatment cognitive and neurobehavioural status, length of coma and number of sessions completed were moderating variables for functional and cognitive outcomes. Conclusions: Persons with TBI can benefit from comprehensive, manualized neurobehavioural interventions, over and above standard rehabilitation care, even during the acute phase of recovery.	[Niemeier, Janet P.; Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Gary, Kelli W.; Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Niemeier, JP (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980542, Richmond, VA 23298 USA.	jhmarwit@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691	National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C. [H133A020516, H133A070036]	This work was supported by Grants # H133A020516 and H133A070036 from the National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special Education and Rehabilitative Services (OSERS), Dept. of Education, Washington, D.C.	BASSETT SF, 2003, PHYSIOTHERAPY, V31, P60; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brown H, 2006, APPL MIXED MODELS ME; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC8; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; KEYSER L, 1995, NEUROREHABILITATION, V5, P255, DOI 10.3233/NRE-1995-5308; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; Kolb B., 1995, BRAIN PLASTICITY BEH; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; Niemeier J., 2004, 1 STEPS NEUROBEHAVIO; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; NIEMEIER JP, 2001, 1 STEPS RECOVERY BRA; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pavot L, 1993, PSYCHOL ASSESSMENTS, V5, P164; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; SAS Institute Inc, 2002, SAS 9 2; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Thies S, 2008, REHABILITATION, V47, P308, DOI 10.1055/s-2008-1076709; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams GC, 1996, J PERS SOC PSYCHOL, V70, P115, DOI 10.1037/0022-3514.70.1.115; Williams GC, 1998, HEALTH PSYCHOL, V17, P269, DOI 10.1037/0278-6133.17.3.269; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644	59	13	13	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					680	690		10.3109/02699052.2011.573520			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600004	21604926				2022-02-06	
J	Formica, V; Del Monte, G; Giacchetti, I; Grenga, I; Giaquinto, S; Fini, M; Roselli, M				Formica, Vincenzo; Del Monte, Girolamo; Giacchetti, Ilaria; Grenga, Italia; Giaquinto, Salvatore; Fini, Massimo; Roselli, Mario			Rehabilitation in Neuro-Oncology: A Meta-Analysis of Published Data and a Mono-Institutional Experience	INTEGRATIVE CANCER THERAPIES			English	Article						neuro-oncology rehabilitation; meta-analysis; Functional Independence Motricity scale; Barthel Index	SPINAL-CORD COMPRESSION; TRAUMATIC BRAIN-INJURY; LOW-GRADE GLIOMAS; INPATIENT REHABILITATION; FUNCTIONAL OUTCOMES; ACUTE STROKE; TUMORS; SURVIVAL; SURGERY; RESECTION	Rehabilitation for cancer patients with central nervous system (CNS) involvement is rarely considered and data on its use are limited. The purpose of the present study is to collect all available published data on neuro-oncology rehabilitation and perform a meta-analysis where results were presented in a comparable manner. Moreover, the authors report results on cancer patients with neurological disabilities undergoing rehabilitation at their unit. Study design. A PubMed search was performed to identify studies regarding cancer patients with CNS involvement undergoing inpatient physical rehabilitation. Studies with a complete functional evaluation at admission and discharge were selected. As the most common evaluation scales were Functional Independence Measure (FIM) and Barthel Index (BI), only articles with complete FIM and/or BI data were selected for the meta-analysis. Moreover, 23 cancer patients suffering from diverse neurological disabilities underwent standard rehabilitation program between April 2005 and December 2007 at the San Raffaele Pisana Rehabilitation Center. Patient demographics and relevant clinical data were collected. Motricity Index, Trunk Control Test score, and BI were monitored during rehabilitation to assess patient progresses. BI results of patients in this study were included in the meta-analysis. Results. The meta-analysis included results of a total of 994 patients. A statistically significant (P < .05) improvement of both BI and FIM scores was demonstrated after rehabilitation (standardized mean difference = 0.60 and 0.75, respectively). Functional status determined by either FIM or BI improved on average by 36%. Conclusion. Published data demonstrate that patients with brain tumors undergoing inpatient rehabilitation appear to make functional gains in line with those seen in similar patients with nonneoplastic conditions.	[Formica, Vincenzo] Univ Rome, Med Oncol Unit, Tor Vergata Clin Ctr, I-00133 Rome, Italy; [Formica, Vincenzo; Giacchetti, Ilaria; Giaquinto, Salvatore; Fini, Massimo; Roselli, Mario] IRCCS San Raffaele Pisana, I-00133 Rome, Italy; [Del Monte, Girolamo] San Raffaele Rocca di Papa Clin Ctr, Rome, Italy		Formica, V (corresponding author), Univ Rome, Med Oncol Unit, Tor Vergata Clin Ctr, Viale Oxford 81, I-00133 Rome, Italy.	v.formica@fastwebnet.it	Fini, Massimo/AAA-9948-2021; Roselli, Mario/AAJ-5481-2020	Roselli, Mario/0000-0002-2431-6689	Italian Ministry of HealthMinistry of Health, Italy [RO 2006]	The present research has been partially funded by the Italian Ministry of Health as a part of the national project RO 2006 titled "Quality of Life in Oncological Frail Patients. The Role of Oncological Rehabilitation: From Care to Take Care.	Boake C, 1993, ARCH PHYS MED REHAB, V74, P1247; Chaichana KL, 2010, J NEUROSURG, V112, P10, DOI 10.3171/2008.10.JNS08608; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Eriks IE, 2004, SPINAL CORD, V42, P235, DOI 10.1038/sj.sc.3101555; Franceschini M, 2009, AM J PHYS MED REHAB, V88, P679, DOI 10.1097/PHM.0b013e3181b20a4d; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Greenberg E, 2006, AM J PHYS MED REHAB, V85, P568, DOI 10.1097/01.phm.0000223218.38152.53; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Kilic T, 2002, J CLIN NEUROSCI, V9, P549, DOI 10.1054/jocn.2002.1136; Kirshblum S, 2001, CANCER, V92, P1029, DOI 10.1002/1097-0142(20010815)92:4+<1029::AID-CNCR1416>3.0.CO;2-P; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1253, DOI 10.1016/S0003-9993(99)90025-4; McKinley WO, 2000, AM J PHYS MED REHAB, V79, P138, DOI 10.1097/00002060-200003000-00005; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Pouratian N, 2007, NAT CLIN PRACT NEURO, V3, P628, DOI 10.1038/ncpneuro0634; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Tang V, 2007, SPINAL CORD, V45, P671, DOI 10.1038/sj.sc.3102024; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; Tosoni A, 2008, CRIT REV ONCOL HEMAT, V68, P212, DOI 10.1016/j.critrevonc.2008.04.004; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; YOSHIOKA H, 1994, AM J PHYS MED REHAB, V73, P199, DOI 10.1097/00002060-199406000-00009	28	13	13	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-7354	1552-695X		INTEGR CANCER THER	Integr. Cancer Ther.	JUN	2011	10	2					119	126		10.1177/1534735410392575			8	Oncology; Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Integrative & Complementary Medicine	784OD	WOS:000292165700001	21196433	Green Published, gold			2022-02-06	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			Effect of concurrent cognitive tasks on gait features among children post-severe traumatic brain injury and typically-developed controls	BRAIN INJURY			English	Article						Concurrent tasks; gait characteristics; traumatic brain injury (TBI)	STABILITY FOLLOWING CONCUSSION; ALZHEIMERS-DISEASE; DIVIDED ATTENTION; STRIDE VELOCITY; OLDER-ADULTS; VARIABILITY; PERFORMANCE; WALKING; BALANCE	Aim: To investigate and compare the influence of concurrent cognitive tasks on gait characteristics in children post-traumatic brain injury (TBI) and typically-developed (TD) controls. Methods: Fifteen children post-TBI (aged 9.5 +/- 2.2 years) and 15 TD controls (aged 9.9 +/- 1.3 years) were included in the study. The children were asked to walk under three conditions: (1) walking at a self-selected speed, (2) walking at a self-selected speed while memorizing and recalling a series of three random numbers and (3) walking at a self-selected speed while listening and identifying commonly experienced sounds. Gait parameters include walking speed, step time and length and step time and length variability as measured with the GAITRite(R) system. Results: Introduction of a concurrent task led to decreased walking speed and step length and increased step time and step length variability in both groups, but with a significantly prominent effect in children post-TBI. The results also showed that the effect of a concurrent cognitive task on walking depended on the complexity level of the task. Conclusion: When children were asked to perform an additional task while they were walking, this had a negative effect on their gait. One may deduce from these results that control of the rhythmic stepping mechanism at a self-selected walking speed in children is dependant to an extent on their ability to focus attention on their gait. In children post-TBI who usually have an attention deficit anyway, this ability is severely disturbed.	[Katz-Leurer, Michal] Tel Aviv Univ, Phys Therapy Dept, Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Alyn Childrens Orthoped Hosp & Rehabil Ctr, Jerusalem, Israel; [Keren, Ofer] Tel Aviv Univ, Chaim Sheba Med Ctr, Rehabil Dept, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Katz-Leurer, M (corresponding author), Tel Aviv Univ, Phys Therapy Dept, Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Beauchet Olivier, 2006, Psychol Neuropsychiatr Vieil, V4, P215; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cocchini G, 2004, REV NEUROL-FRANCE, V160, P74, DOI 10.1016/S0035-3787(04)70849-8; Dubost V, 2008, GAIT POSTURE, V27, P138, DOI 10.1016/j.gaitpost.2007.03.011; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Heiderscheit BC, 2000, J APPL BIOMECH, V16, P419, DOI 10.1123/jab.16.4.419; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Logie RH, 2004, NEUROPSYCHOLOGY, V18, P504, DOI 10.1037/0894-4105.18.3.504; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Silsupadol P, 2006, PHYS THER, V86, P269, DOI 10.1093/ptj/86.2.269; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; WHITALL J, 1991, J EXP CHILD PSYCHOL, V51, P245, DOI 10.1016/0022-0965(91)90035-Q; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	25	13	13	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					581	586		10.3109/02699052.2011.572943			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300004	21534735				2022-02-06	
J	Rivara, FP; Koepsell, TD; Wang, J; Durbin, D; Jaffe, KM; Vavilala, M; Dorsch, A; Roper-Caldbeck, M; Houseknecht, E; Temkin, N				Rivara, Frederick P.; Koepsell, Thomas D.; Wang, Jin; Durbin, Dennis; Jaffe, Kenneth M.; Vavilala, Monica; Dorsch, Andrea; Roper-Caldbeck, Maria; Houseknecht, Eileen; Temkin, Nancy			Comparison of Telephone with World Wide Web-Based Responses by Parents and Teens to a Follow-Up Survey after Injury	HEALTH SERVICES RESEARCH			English	Article						Injuries; surveys; Internet; telephone; children	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; DIGITAL DIVIDE; ALCOHOL-USE; RELIABILITY; MODE; NONRESPONSE; VALIDITY; DESIGN; INCOME	Objective To identify sociodemographic factors associated with completing a follow-up survey about health status on the web versus by telephone, and to examine differences in reported health-related quality of life by method of response. Data Sources/Study Settings Survey about child health status of 896 parents of children aged 0-17 years treated in a hospital emergency department or admitted for a traumatic brain injury or arm injury, and 227 injured adolescents aged 14-17 years. Study Design The main outcomes were characteristics of those who completed a follow-up survey on the web versus by telephone and health-related quality of life by method of response. Principal Findings Email addresses were provided by 76.9 percent of parents and 56.5 percent of adolescents at baseline. The survey was completed on the web by 64.9 percent of parents and 40.2 percent of adolescents through email. Parents with email access who were Blacks, Hispanics, had lower incomes, and those who were not working were less likely to choose the web mode for completing the survey. Unlike adolescents, the amount of time for parents to complete the survey online was significantly shorter than completion by telephone. Differences by survey mode were small but statistically significant in some of the six functional outcome measures examined. Conclusions Survey mode was associated with several sociodemographic characteristics. Sole use of web surveys could provide biased data.	[Rivara, Frederick P.; Koepsell, Thomas D.; Wang, Jin; Jaffe, Kenneth M.; Vavilala, Monica; Dorsch, Andrea; Roper-Caldbeck, Maria] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Rivara, Frederick P.; Wang, Jin; Jaffe, Kenneth M.; Vavilala, Monica] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Koepsell, Thomas D.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Vavilala, Monica] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Dorsch, Andrea] Seattle Childrens Hosp, Seattle, WA USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Pediat, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	fpr@uw.edu	Durbin, Dennis/AAD-7829-2022		National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025014] Funding Source: NIH RePORTER	This study was funded by a grant (grant number R49 CE 001021) from the National Center for Injury Prevention and Control and Centers for Disease Control and Prevention. The study sponsor had no role in the review or approval of the manuscript.	AQUILINO WS, 1994, PUBLIC OPIN QUART, V58, P210, DOI 10.1086/269419; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Beckjord EB, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e20; Bedell G., 2006, BRAIN INJ PROF, V3, P14; Chakraborty J, 2005, PROF GEOGR, V57, P395, DOI 10.1111/j.0033-0124.2005.00486.x; *COMM F C, 2010, HIGH SPEED SERV INT; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; de Leeuw Edith D., 1988, TELEPHONE SURVEY MET, P273; Dillman DA, 2007, AM J PREV MED, V32, pS90, DOI 10.1016/j.amepre.2007.03.008; Fahimi Mansour, 2008, Prev Chronic Dis, V5, pA80; Fairlie Robert W, 2007, Electronic Commerce Research, V7, P265, DOI 10.1007/s10660-007-9006-5; Fricker S, 2005, PUBLIC OPIN QUART, V69, P370, DOI 10.1093/poq/nfi027; Galesic M, 2006, AM J PREV MED, V31, P437, DOI 10.1016/j.amepre.2006.07.023; Graham AL, 2006, NICOTINE TOB RES, V8, pS49, DOI 10.1080/14622200601045367; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.987; Hargittai Eszter., 2008, SOCIAL STRATIFICATIO, P936; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; JELLINEK MS, 1988, AM J DIS CHILD, V142, P1153, DOI 10.1001/archpedi.1988.02150110031013; LENJNIEKS C, 2009, GENERATION UNPLUGGED; Link MW, 2005, EPIDEMIOLOGY, V16, P701, DOI 10.1097/01.ede.0000172138.67080.7f; Link MW, 2005, J STUD ALCOHOL, V66, P239, DOI 10.15288/jsa.2005.66.239; Martin SP, 2007, SOC PROBL, V54, P1, DOI 10.1525/sp.2007.54.1.1; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McMorris BJ, 2009, EVALUATION REV, V33, P138, DOI 10.1177/0193841X08326463; Parks KA, 2006, J STUD ALCOHOL, V67, P318, DOI 10.15288/jsa.2006.67.318; Pena-Purcell N, 2008, J MED LIBR ASSOC, V96, P101, DOI 10.3163/1536-5050.96.2.101; Rankin KM, 2008, CANCER EPIDEM BIOMAR, V17, P2639, DOI 10.1158/1055-9965.EPI-08-0304; Santuzzi Nicole R, 2009, Qual Manag Health Care, V18, P3, DOI 10.1097/01.QMH.0000344589.61971.41; Simon G, 2009, PSYCHIAT SERV, V60, P67, DOI 10.1176/appi.ps.60.1.67; Stein REK, 2003, J DEV BEHAV PEDIATR, V24, P9, DOI 10.1097/00004703-200302000-00004; Tourangeau R, 2004, ANNU REV PSYCHOL, V55, P775, DOI 10.1146/annurev.psych.55.090902.142040; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wilson KR, 2003, SOC SCI COMPUT REV, V21, P133, DOI [10.1177/0894439303021002001, 10.1177/0894439303251554]	34	13	13	1	7	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0017-9124			HEALTH SERV RES	Health Serv. Res.	JUN	2011	46	3					964	981		10.1111/j.1475-6773.2010.01236.x			18	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	758NN	WOS:000290171600016	21275989	Green Published			2022-02-06	
J	Wang, XH; Xu, MH; Liang, H; Xu, LS				Wang, Xuhui; Xu, Minhui; Liang, Hong; Xu, Lunshan			Comparison of CT and MRI in diagnosis of cerebrospinal leak induced by multiple fractures of skull base	RADIOLOGY AND ONCOLOGY			English	Article						MRI; diagnosis; multiple basilar skull fracture; cerebrospinal leak	HIGH-RESOLUTION CT; FLUID LEAKS; CSF LEAKS; CISTERNOGRAPHY	Background. Multiple basilar skull fracture and cerebrospinal leak are common complications of traumatic brain injury, which required a surgical repair. But due to the complexity of basilar skull fracture after severe trauma, preoperatively an exact radiological location is always difficult. Multi-row spiral CT and MRI are currently widely applied in the clinical diagnosis. The present study was performed to compare the accuracy of cisternography by multi-row spiral CT and MRI in the diagnosis of cerebrospinal leak. Methods. A total of 23 patients with multiple basilar skull fracture after traumatic brain injury were included. The radiological and surgical data were retrospectively analyzed. 64-row CT (mm/row) scan and three-dimensional reconstruction were performed in 12 patients, while MR plain scan and cisternography were performed in another 11 patients. The location of cerebrospinal leak was diagnosed by 2 experienced physicians majoring neurological radiology. Surgery was performed in all patients. The cerebrospinal leak location was confirmed and repaired during surgery. The result was considered as accurate when cerebrospinal leak was absent after surgery. Results. According to the surgical exploration, the preoperative diagnosis of the active cerebrospinal leak location was accurate in 9 out of 12 patients with CT scan. The location could not be confirmed by CT because of multiple fractures in 2 patients and the missed diagnosis occurred in 1 patient. The preoperative diagnosis was accurate in 10 out of 11 patients with MRI examination. Conclusions. MRI cisternography is more advanced than multi-row CT scan in multiple basilar skull fracture. The combination of the two examinations may increase the diagnostic ratio of active cerebrospinal leak.	[Xu, Lunshan] Third Mil Med Univ, Dept Neurosurg, Daping Hosp, Chongqing 400042, Peoples R China; Third Mil Med Univ, Dept Neurosurg, Inst Surg Res, Chongqing 400042, Peoples R China		Xu, LS (corresponding author), Third Mil Med Univ, Dept Neurosurg, Daping Hosp, Chongqing 400042, Peoples R China.	david0608@yeah.net					Arbelaez A, 2007, AM J ROENTGENOL, V188, pW560, DOI 10.2214/AJR.05.1280; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Hilinski JM, 2001, OTOL NEUROTOL, V22, P701, DOI 10.1097/00129492-200109000-00025; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; McMains KC, 2004, LARYNGOSCOPE, V114, P1833, DOI 10.1097/00005537-200410000-00029; Prokop M, 2003, EUR J RADIOL, V45, pS4, DOI 10.1016/S0720-048X(02)00358-3; Rajer M, 2008, RADIOL ONCOL, V42, P23, DOI 10.2478/v10019-007-0035-4; Schlosser RJ, 2004, LARYNGOSCOPE, V114, P255, DOI 10.1097/00005537-200402000-00015; Selcuk H, 2010, AM J NEURORADIOL, V31, P71, DOI 10.3174/ajnr.A1788; Shetty PG, 1998, AM J NEURORADIOL, V19, P633; Stanic K, 2010, RADIOL ONCOL, V44, P180, DOI 10.2478/v10019-010-0038-4; Stone JA, 1999, AM J NEURORADIOL, V20, P706	14	13	13	0	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1318-2099	1581-3207		RADIOL ONCOL	Radiol. Oncol.	JUN	2011	45	2					91	96		10.2478/v10019-011-0007-6			6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	772XJ	WOS:000291271200003	22933941	Green Published, gold			2022-02-06	
J	Zeckey, C; Hildebrand, F; Pape, HC; Mommsen, P; Panzica, M; Zelle, BA; Sittaro, NA; Lohse, R; Krettek, C; Probst, C				Zeckey, Christian; Hildebrand, Frank; Pape, Hans-Christoph; Mommsen, Philipp; Panzica, Martin; Zelle, Boris A.; Sittaro, Nicola Alexander; Lohse, Ralf; Krettek, Christian; Probst, Christian			Head injury in polytrauma-Is there an effect on outcome more than 10 years after the injury?	BRAIN INJURY			English	Article						Head injury; multiple trauma; rehabilitation; polytrauma	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; MULTIPLE INJURIES; HEALTH SURVEY; MAJOR TRAUMA; FOLLOW-UP; SEVERITY; IMPACT; PREVALENCE; RECOVERY	Introduction: Head injuries are of great relevance for the prognosis of polytrauma patients during acute care. However, knowledge about the impact on the long-term outcome is sparse. Therefore, this study analysed the role of head injuries on the outcome of polytrauma patients more than 10 years after injury in a matched-pair analysis. Patients and methods: Out of 620 polytrauma patients with and without head injury, a matched-pair analysis with comparable age, injury severity and gender distribution and a minimum of 10 years follow-up was performed. The outcome and quality-of-life were measured using the Hannover Score for Polytrauma Outcome (HASPOC), Short Form 12 (SF-12), Glasgow Outcome Scale (GOS) and other parameters. Results: The matched-pair analysis consisted of 125 pairs (age 27.9 +/- 1.2 years, ISS 20.0 +/- 0.8 [head injury] vs ISS 19.8 +/- 0.8 [no head injury]). A significant difference was shown for the GOS Score only (GOS head injury 4.3 +/- 0.3 vs no head injury 4.9 +/- 0.2, p = 0.01). The psychological outcome was similar in both groups. Both groups reported comparable subjective rehabilitation satisfaction. Conclusions: Matching pairs of equally injured polytrauma patients of same gender with and without head injury 10 years following trauma indicated significantly worse results in the GOS due to head injury.	[Zeckey, Christian; Hildebrand, Frank; Mommsen, Philipp; Panzica, Martin; Krettek, Christian; Probst, Christian] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany; [Pape, Hans-Christoph] Univ Aachen, Dept Orthopaed Trauma Surg, D-5100 Aachen, Germany; [Zelle, Boris A.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Sittaro, Nicola Alexander; Lohse, Ralf] Hannover Re Insurance, Hannover, Germany		Zeckey, C (corresponding author), Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany.	zeckey.christian@mh-hannover.de	Hildebrand, Frank/J-3176-2017; Mommsen, Philipp/ABC-3510-2020	Krettek, Christian/0000-0001-9807-0020; Pape, Hans-Christoph/0000-0002-2059-4980			Baez AA, 2007, PREHOSP DISASTER MED, V22, P230, DOI 10.1017/S1049023X00004726; Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; BURKE JM, 1994, BRAIN INJURY, V8, P71, DOI 10.3109/02699059409150960; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Ellert U, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P1027, DOI 10.1007/s00103-004-0933-1; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gabbe BJ, 2006, J TRAUMA, V61, P1393, DOI 10.1097/01.ta.0000225926.34180.47; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Luchette F, 2010, J TRAUMA, V69, P530; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Probst C, 2007, CHIRURG, V78, P875, DOI 10.1007/s00104-007-1410-9; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; Shifflette VK, 2010, J TRAUMA, V69, P88, DOI 10.1097/TA.0b013e3181e291e9; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZECKEY C, 2010, ALCOHOL         0913; Zelle BA, 2005, INJURY, V36, P169, DOI 10.1016/j.injury.2004.06.004	46	13	13	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					551	559		10.3109/02699052.2011.568036			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300002	21534733				2022-02-06	
J	Zhang, LY; Gurao, M; Yang, KH; King, AI				Zhang, Liying; Gurao, Manish; Yang, King H.; King, Albert I.			Material characterization and computer model simulation of low density polyurethane foam used in a rodent traumatic brain injury model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Rodent head impact acceleration device; Traumatic brain injury; Low density polyurethane foam; Compression test; Rate dependency; Finite element modeling	AXONAL INJURY; DIFFUSE; IMPAIRMENT; ENERGY; RATS	Computer models of the head can be used to simulate the events associated with traumatic brain injury (TBI) and quantify biomechanical response within the brain. Marmarou's impact acceleration rodent model is a widely used experimental model of TBI mirroring axonal pathology in humans. The mechanical properties of the low density polyurethane (PU) foam, an essential piece of energy management used in Marmarou's impact device, has not been fully characterized. The foam used in Marmarou's device was tested at seven strain rates ranging from quasi-static to dynamic (0.014-42.86 s(-1)) to quantify the stress-strain relationships in compression. Recovery rate of the foam after cyclic compression was also determined through the periods of recovery up to three weeks. The experimentally determined stress-strain curves were incorporated into a material model in an explicit Finite Element (FE) solver to validate the strain rate dependency of the FE foam model. Compression test results have shown that the foam used in the rodent impact acceleration model is strain rate dependent. The foam has been found to be reusable for multiple impacts. However the stress resistance of used foam is reduced to 70% of the new foam. The FU_CHANG_FOAM material model in an FE solver has been found to be adequate to simulate this rate sensitive foam. (C) 2011 Elsevier B.V. All rights reserved.	[Zhang, Liying; Gurao, Manish; Yang, King H.; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	lzhang@wayne.edu			National Highway Transportation Safety Administration (NHTSA) through the UAB Southern Consortium of Injury Biomechanics; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB006508]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006508] Funding Source: NIH RePORTER	The study was funded in part by the National Highway Transportation Safety Administration (NHTSA) through the UAB Southern Consortium of Injury Biomechanics (AIK) and NIH R01 EB006508 (LYZ).	Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chang FS, 1998, J ENG MATER-T ASME, V120, P212, DOI 10.1115/1.2812345; Davies OL, 1999, CELL POLYM, V18, P117; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2; Hager SL, 1992, J CELL PLAST, V28, P284; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HOSFORD WF, 1993, METAL FORMING MECH M, P80; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kim JS, 2002, INT J MECH SCI, V44, P2285, DOI 10.1016/S0020-7403(02)00176-5; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mills NJ, 2002, CELL POLYM, V21, P343, DOI 10.1177/026248930202100502; Mills NJ, 2000, CELL POLYM, V19, P389; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REHKOPF JD, 1994, P INT C EXP; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Sengul G, 2008, J CLIN NEUROSCI, V15, P1125, DOI 10.1016/j.jocn.2007.11.005; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Suresh S., 1991, FATIGUE MAT; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; VORSPOHL K, 1994, J CELL PLAST, V30, P361, DOI 10.1177/0021955X9403000410; Youssef S, 2005, ACTA MATER, V53, P719, DOI 10.1016/j.actamat.2004.10.024; ZHANG L, 2006, P ASME BIOENG C; ZHANG L, 2010, J NEUROTRAUM, V26, P42	28	13	13	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAY 15	2011	198	1					93	98		10.1016/j.jneumeth.2011.03.024			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	771FM	WOS:000291142600013	21459114	Green Accepted			2022-02-06	
J	Moon, Y; Kim, JY; Choi, SY; Kim, K; Kim, H; Sun, W				Moon, Younghye; Kim, Joo Yeon; Choi, So Yoen; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Induction of ezrin-radixin-moesin molecules after cryogenic traumatic brain injury of the mouse cortex	NEUROREPORT			English	Article						ezrin-radixin-moesin; macrophage; microglia; traumatic brain injury	ADULT SUBVENTRICULAR ZONE; ROSTRAL MIGRATORY STREAM; ERM PROTEINS; EXPRESSION; CELLS	Traumatic brain injury promotes rapid induction of microglial cells and infiltration of peripheral macrophages to the injury sites. Such inflammatory responses are mediated by the activation and migration of immune cells, which are influenced by the actin cytoskeleton remodeling. In this study, we observed that the phosphorylation and expressions of ezrin-radixin-moesin (ERM) proteins, which are linkers for cell surface with actin cytoskeleton, are induced in the activated microglia/macrophages, whereas ERM molecules are only marginally expressed in quiescent microglia in the normal brain. These results suggest that ERM activation in the injury penumbra is implicated in the inflammatory immune responses after traumatic brain injury. NeuroReport 22:304-308 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Kim, Joo Yeon; Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Joo Yeon; Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Brain & Neuroendocrine Lab, Sch Biol Sci, Seoul 151742, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	sun, woong/0000-0003-1792-4894; Kim, Hyun/0000-0002-7210-5798; Moon, Younghye/0000-0002-3737-0043	Korean Ministry of Education, Science, and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010K000803]; National Research Foundation of KoreaNational Research Foundation of Korea [20100020237]	This work is supported by Grants from the Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience (2010K000803) and the National Research Foundation of Korea (20100020237).	BERRYMAN M, 1993, J CELL SCI, V105, P1025; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; Cernuda-Morollon E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012393; Cleary MA, 2006, NEUROSCIENCE, V143, P851, DOI 10.1016/j.neuroscience.2006.08.028; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Soares HD, 1995, J NEUROSCI, V15, P8223	16	13	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 20	2011	22	6					304	308		10.1097/WNR.0b013e3283460265			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	743AQ	WOS:000288987800009	21451358				2022-02-06	
J	Tate, DF; Neeley, ES; Norton, MC; Tschanz, JT; Miller, MJ; Wolfson, L; Hulette, C; Leslie, C; Welsh-Bohmer, KA; Plassman, B; Bigler, ED				Tate, D. F.; Neeley, E. S.; Norton, M. C.; Tschanz, J. T.; Miller, M. J.; Wolfson, L.; Hulette, C.; Leslie, C.; Welsh-Bohmer, K. A.; Plassman, B.; Bigler, Erin D.			Intracranial volume and dementia: Some evidence in support of the cerebral reserve hypothesis	BRAIN RESEARCH			English	Article						Alzheimer's disease; Intracranial volume; Cognitive or brain reserve; APOE; Dementia	APOLIPOPROTEIN-E GENOTYPE; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; HEAD CIRCUMFERENCE; CACHE-COUNTY; COGNITIVE RESERVE; SIZE; ASSOCIATION; CHILDREN; INTELLIGENCE	The brain reserve hypothesis has been posited as being one important mediating factor for developing dementia, especially Alzheimer's disease (AD). Evidence for this hypothesis is mixed though different methodologies have made these findings difficult to interpret. We examined imaging data from a large cohort (N=194) of mixed dementia patients and controls, 65 years old and older from the Cache County, Utah Study of Memory and Aging for evidence of the brain reserve hypothesis using total intracranial volume (TICV) as a quantitative measure of pre-morbid brain size and a vicarious indicator of reserve. A broader spectrum of non-demented elderly control subjects from previous studies was also included for comparison (N=423). In addition, non-parametric Classification and Regression Tree (CART) analyses were performed to model group heterogeneity and identify any subgroups of patients where TICV might be an important predictor of dementia. Parametrically, no main effect was found for TICV when predicting a dementia diagnosis; however, the CART analysis did reveal important TICV subgroups, including a sex differential wherein epsilon 4 APOE allele presence in males and low TICV predicted AD classification. TICV, APOE, and other potential mediator/moderator variables are discussed in the context of the brain reserve hypothesis. (C) 2010 Published by Elsevier B.V.	[Tate, D. F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Imaging, Boston, MA 02115 USA; [Tate, D. F.] Boston Univ, Med Ctr, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Neeley, E. S.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Norton, M. C.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA; [Norton, M. C.; Tschanz, J. T.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Miller, M. J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Miller, M. J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Wolfson, L.] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland; [Hulette, C.; Leslie, C.; Welsh-Bohmer, K. A.; Plassman, B.] Duke Univ, Med Ctr, Durham, NC USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA		Tate, DF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Imaging, 221 Longwood Ave, Boston, MA 02115 USA.	dtate1@partners.org; sneeley@stat.byu.edu; maria.norton@usu.edu; joann.tschanz@usu.edu; wolfsonl@who.int; kwe@duke.edu; brenda.plassman@duke.edu; erin_bigler@byu.edu	Plassman, Brenda L/K-2620-2015; Tate, David F/I-3963-2013; Wolfson, Lara/AAC-1400-2019; Norton, Maria C/E-6994-2013; Welsh-Bohmer, Kathleen/AAA-3178-2020; Tate, David/G-5166-2011; Tschanz, JoAnn T./E-5986-2010	Tate, David F/0000-0003-0213-1920; Wolfson, Lara/0000-0002-6454-3368; Tate, David/0000-0003-0213-1920; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG-1380]; Ira Fulton Foundation; Radiology Department at Logan Regional Medical Center Logan, Utah; John C.S. Breitner, M.D.; Boston University Alzheimer's Disease Core Center [RO1-AG11380, RO1-AG21136, K23MH073416, P30-AG013486]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH073416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG011380, R01AG021136] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health Grant AG-1380 and the Ira Fulton Foundation. The support from the Radiology Department at Logan Regional Medical Center Logan, Utah, where the imaging studies were performed, is gratefully acknowledged, along with the support of John C.S. Breitner, M.D. and other investigators of the Cache County Memory in Aging Project. We would like to acknowledge the following funding sources as being instrumental in the completion of this project: RO1-AG11380 (K.W.B.), RO1-AG21136 (J.T.T.), K23MH073416 (D.F.T.), and P30-AG013486 (Boston University Alzheimer's Disease Core Center).	Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; ANDREASEN NC, 1993, AM J PSYCHIAT, V150, P130; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; ARMSTRONG E, 1982, PRIMATE BRAIN EVOLUT; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2001, ARCH NEUROL-CHICAGO, V58, P831, DOI 10.1001/archneur.58.5.831; Bigler ED, 2001, INVEST RADIOL, V36, P539, DOI 10.1097/00004424-200109000-00006; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Breiman L., 1983, CLASSIFICATION REGRE; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Coffey CE, 1999, NEUROLOGY, V53, P189, DOI 10.1212/WNL.53.1.189; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; Daly E, 2000, ARCH NEUROL-CHICAGO, V57, P675, DOI 10.1001/archneur.57.5.675; DAVIS PJM, 1977, NEUROPATH APPL NEURO, V3, P341, DOI 10.1111/j.1365-2990.1977.tb00595.x; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; DeMeyer W., 1994, PEDIAT NEUROLOGY PRI, P205; DIAMOND MC, 1986, BIOL SUBSTRATES ALZH, P55; Drachman DA, 2002, NEUROLOGY, V59, P156, DOI 10.1212/WNL.59.2.156; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Espinosa PS, 2006, J ALZHEIMERS DIS, V9, P77; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Frisk V, 2002, DEV NEUROPSYCHOL, V22, P565, DOI 10.1207/S15326942DN2203_2; Ganguli M, 2000, NEUROLOGY, V54, P1109, DOI 10.1212/WNL.54.5.1109; GLASSMAN RB, 1987, NEUROSCI BIOBEHAV R, V11, P275, DOI 10.1016/S0149-7634(87)80014-3; GOSCH A, 1997, DEV MED CHILD NEUROL, V39, P295; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P761, DOI 10.1001/archpsyc.57.8.761; Hall KS, 2000, NEUROLOGY, V54, P95, DOI 10.1212/WNL.54.1.95; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Jenkins R, 2000, ARCH NEUROL-CHICAGO, V57, P220, DOI 10.1001/archneur.57.2.220; Jerison H.J., 1987, ENCY NEUROSCIENCE, V1, P168; JOHNSON FP, 1991, BRIT J ORAL MAX SURG, V29, P282, DOI 10.1016/0266-4356(91)90200-O; Jorm AF, 1997, PERS INDIV DIFFER, V23, P371; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; KATZMAN R, 1993, NEUROLOGY, V43, P12; Kim KR, 2008, AM J GERIAT PSYCHIAT, V16, P819, DOI 10.1097/JGP.0b013e3181800551; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Martyn CN, 1996, BRIT MED J, V312, P1393; Moore W.J., 1974, GROWTH FACIAL SKELET; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; PAGEL MD, 1988, AM NAT, V132, P344, DOI 10.1086/284857; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Reddick WE, 1998, MAGN RESON IMAGING, V16, P413, DOI 10.1016/S0730-725X(98)00014-9; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P108, DOI 10.1001/archneurol.2007.11; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SCHEIBEL A, 1990, BRAIN COGNITION, V12, P85, DOI 10.1016/0278-2626(90)90006-A; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SCHOFIELD PW, 1995, ARCH NEUROL-CHICAGO, V52, P95, DOI 10.1001/archneur.1995.00540250103019; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Sperber, 2001, CRANIOFACIAL DEV; Stathis SL, 1999, DEV MED CHILD NEUROL, V41, P375, DOI 10.1017/S0012162299000833; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2007, COGNITIVE RESERVE TH; Tate DF, 2007, NEUROPEDIATRICS, V38, P18, DOI 10.1055/s-2007-981450; Tschanz JT, 2006, NEUROLOGY, V67, P229, DOI 10.1212/01.wnl.0000224748.48011.84; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; Van der Flier WM, 2008, DEMENT GERIATR COGN, V25, P433, DOI 10.1159/000124750; Vernon PA., 2000, HDB INTELLIGENCE, P245, DOI DOI 10.1017/CBO9780511807947.013; WILLERMAN L, 1991, INTELLIGENCE, V15, P223, DOI 10.1016/0160-2896(91)90031-8; ZHANG H, 1998, ENCY BIOSTATISTICS; Zhang HSB, 1999, RECURSIVE PARTITIONI; [No title captured]	86	13	13	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	APR 18	2011	1385						151	162		10.1016/j.brainres.2010.12.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	753WL	WOS:000289810800017	21172323	Green Accepted			2022-02-06	
J	Boudreau, D; Costanza-Smith, A				Boudreau, Donna; Costanza-Smith, Amy			Assessment and Treatment of Working Memory Deficits in School-Age Children: The Role of the Speech-Language Pathologist	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article						working memory; language impairment; language assessment; language intervention; phonological memory	COMPLEX SENTENCE COMPREHENSION; TRAUMATIC BRAIN-INJURY; LESS SKILLED READERS; SHORT-TERM-MEMORY; NONWORD REPETITION; PHONOLOGICAL MEMORY; INDIVIDUAL-DIFFERENCES; READING DISABILITIES; VOCABULARY ACQUISITION; LEARNING-DISABILITIES	Purpose: To review research addressing the relationship of working memory (WM) to language development and academic functioning and to consider the role of the speech-language pathologist (SLP) in assessment and intervention of WM difficulties in school-age children. Method: Aspects of WM critical to language acquisition and academic success are defined, and the importance of WM to language development and learning is discussed. Subsequently, strategies for assessing WM skills in children are presented. Following a discussion regarding the assessment of WM demands in the classroom, intervention strategies are provided. Results: Children with poor WM skills are likely to experience significant difficulty in academic settings. Evidence-based strategies for both reducing WM demands and improving functional WM skills are reviewed. Conclusion: Research to date has documented that children with language impairments frequently have poor WM skills. SLPs can support poor WM skills by considering both modifications to the environment and child-enacted knowledge and skills, which may serve to reduce the impact of poor WM skills on learning and academic success.	[Boudreau, Donna] Univ No Colorado, Greeley, CO 80639 USA; [Costanza-Smith, Amy] Oregon Hlth & Sci Univ, Portland, OR USA		Boudreau, D (corresponding author), Univ No Colorado, Greeley, CO 80639 USA.	donna.boudreau@unco.edu					Adams A.M., 2001, WORKING MEMORY PERSP, P79; ADAMS AM, 1995, J SPEECH HEAR RES, V38, P403, DOI 10.1044/jshr.3802.403; Adams AM, 1999, INT J PSYCHOL, V34, P364, DOI 10.1080/002075999399701; Alloway TP, 2005, BRIT J DEV PSYCHOL, V23, P417, DOI 10.1348/026151005X26804; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Alloway TP, 2009, LEARN INDIVID DIFFER, V19, P242, DOI 10.1016/j.lindif.2008.10.003; Alloway TP, 2009, EUR J PSYCHOL ASSESS, V25, P92, DOI 10.1027/1015-5759.25.2.92; Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Avons SE, 1998, APPL PSYCHOLINGUIST, V19, P583, DOI 10.1017/S0142716400010377; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A., 1990, NEUROPSYCHOLOGICAL I, P54; Baddeley AD, 2000, J EXP CHILD PSYCHOL, V77, P128, DOI 10.1006/jecp.2000.2592; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Berninger VW, 2008, READ WRIT, V21, P95, DOI 10.1007/s11145-007-9066-x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Boardman, 2007, TEACHING READING COM; Botting N, 2001, INT J LANG COMM DIS, V36, P421, DOI 10.1080/13682820110074971; Boudreau D., 2007, LANGUAGE DISORDERS D, P331, DOI 10.4324/9781315092041-13; Brocki KC, 2008, J CLIN EXP NEUROPSYC, V30, P749, DOI 10.1080/13803390701754720; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Campbell T, 1997, J SPEECH LANG HEAR R, V40, P519, DOI 10.1044/jslhr.4003.519; Carretti B, 2009, LEARN INDIVID DIFFER, V19, P246, DOI 10.1016/j.lindif.2008.10.002; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Conti-Ramsden G, 2007, J CHILD PSYCHOL PSYC, V48, P147, DOI 10.1111/j.1469-7610.2006.01703.x; COWAN N, 1998, TOP LANG DISORD, V17, P1; DANCY MLW, 1997, TOP LANG DISORD, V18, P32; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Duff SC, 2001, Q J EXP PSYCHOL-A, V54, P31, DOI 10.1080/02724980042000011; Edwards J, 2004, J SPEECH LANG HEAR R, V47, P421, DOI 10.1044/1092-4388(2004/034); Ehrlich M.F., 2005, READ WRIT, V18, DOI [10.1007/s11145-005-2038-0, DOI 10.1007/S11145-005-2038-0]; Engel PMJ, 2008, J SPEECH LANG HEAR R, V51, P1580, DOI 10.1044/1092-4388(2008/07-0210); Engle RW, 2001, SCI CON SER, P297, DOI 10.1037/10394-016; Fazio BB, 1996, TOP LANG DISORD, V17, P58, DOI 10.1097/00011363-199611000-00007; GALE R, 2003, STANFORD BINET INTEL; Gathercole S., 2001, WORKING MEMORY TEST; Gathercole S.E., 2003, EDUC CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Gathercole S. E., 2008, APPL COGNITIVE RES K, P17; Gathercole S.E., 1993, WORKING MEMORY LANGU; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; GATHERCOLE SE, 1995, MEM COGNITION, V23, P83, DOI 10.3758/BF03210559; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; GATHERCOLE SE, 1993, EUR J PSYCHOL EDUC, V8, P259, DOI 10.1007/BF03174081; Gathercole SE., 1996, CHILDRENS TEST NONWO; GATHERCOLE SE, 2004, WORKING MEMORY ED, P219; Gathercole SE, 2008, PSYCHOLOGIST, V21, P382; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Georgiou GK, 2008, J EDUC PSYCHOL, V100, P566, DOI 10.1037/0022-0663.100.3.566; Gill CB, 2003, CHILD LANG TEACH THE, V19, P85, DOI DOI 10.1191/0265659003CT245OA; Gillam RB, 1997, TOP LANG DISORD, V18, P72, DOI 10.1097/00011363-199711000-00008; Gillam RB, 2002, TOP LANG DISORD, V22, P30, DOI 10.1097/00011363-200205000-00005; Gillam RB, 1996, TOP LANG DISORD, V17, P72, DOI 10.1097/00011363-199611000-00008; Gilliver ML, 2009, READ WRIT, V22, P637, DOI 10.1007/s11145-008-9155-5; GLENBERG AM, 2005, IMPROVING READ UNPUB; Glenberg AM, 2007, CONTEMP EDUC PSYCHOL, V32, P389, DOI 10.1016/j.cedpsych.2006.03.001; Gupta P, 2009, J MEM LANG, V61, P481, DOI 10.1016/j.jml.2009.08.001; HITCH GJ, 2001, J EXP PSYCHOL, V130, P194; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Hood Jane, 2005, Pediatr Rehabil, V8, P272, DOI 10.1080/13638490400022303; Horohov JE, 2004, APPL PSYCHOLINGUIST, V25, P43, DOI 10.1017/S0142716404001031; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Imbo I, 2007, J EXP CHILD PSYCHOL, V96, P284, DOI 10.1016/j.jecp.2006.09.001; Isaki E, 2008, J COMMUN DISORD, V41, P512, DOI 10.1016/j.jcomdis.2008.03.006; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jones G, 2007, DEVELOPMENTAL SCI, V10, P853, DOI 10.1111/j.1467-7687.2007.00638.x; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kail R., 1990, DEV MEMORY CHILDREN; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; KLINGBERG T, 2001, COGNITIVE MEMORY TRA; Lahey M, 1994, LANGUAGE LEARNING DI, P354; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); LINDBLOM B, 1989, BRAIN READING, P27; Maridaki-Kassotaki K, 2002, EUR J PSYCHOL EDUC, V17, P63, DOI 10.1007/BF03173205; Marton K, 2008, INT J LANG COMM DIS, V43, P181, DOI 10.1080/16066350701340719; Marton K, 2007, PSYCHOLOGIA, V50, P110, DOI 10.2117/psysoc.2007.110; McCabe A, 2003, PATTERNS NARRATIVE D; Minear M., 2006, WORKING MEMORY ED, P273; Montgomery JW, 2008, J PSYCHOLINGUIST RES, V37, P331, DOI 10.1007/s10936-008-9077-z; Montgomery JW, 2010, AM J SPEECH-LANG PAT, V19, P78, DOI 10.1044/1058-0360(2009/09-0028); Montgomery JW, 2009, APPL PSYCHOLINGUIST, V30, P485, DOI 10.1017/S0142716409090249; Montgomery JW, 2009, J SPEECH LANG HEAR R, V52, P269, DOI 10.1044/1092-4388(2008/07-0116); Montgomery JW, 2000, APPL PSYCHOLINGUIST, V21, P117, DOI 10.1017/S0142716400001065; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; Montgomery JW, 2002, AM J SPEECH-LANG PAT, V11, P77, DOI 10.1044/1058-0360(2002/009); MONTGOMERY JW, 1995, J SPEECH HEAR RES, V38, P187, DOI 10.1044/jshr.3801.187; Nation K, 1999, J EXP CHILD PSYCHOL, V73, P139, DOI 10.1006/jecp.1999.2498; O'Shaughnessy TE, 2000, J LEARN DISABIL-US, V33, P257, DOI 10.1177/002221940003300304; O'Shaughnessy TE, 1998, LEARN DISABILITY Q, V21, P123, DOI 10.2307/1511341; Oetting JB, 2006, CLIN LINGUIST PHONET, V20, P553, DOI 10.1080/02699200500266455; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Parente R, 1999, NEUROREHABILITATION, V13, P13; Passolunghi MC, 2004, J EXP CHILD PSYCHOL, V88, P348, DOI 10.1016/j.jecp.2004.04.002; Quail M, 2009, INT J SPEECH-LANG PA, V11, P220, DOI 10.1080/17549500802495581; Rankin Peter M, 2005, Pediatr Rehabil, V8, P283, DOI 10.1080/13638490400022436; Riccio CA, 2007, APPL NEUROPSYCHOL, V14, P255, DOI 10.1080/09084280701719203; Ricks TR, 2009, J MEM LANG, V61, P519, DOI 10.1016/j.jml.2009.07.007; Rodekohr RK, 2001, J COMMUN DISORD, V34, P255, DOI 10.1016/S0021-9924(01)00050-8; SALTHOUSE R, 1989, J EXPT PSYCHOL LEARN, V15, P507; Seigneuric A, 2000, READ WRIT, V13, P81, DOI 10.1023/A:1008088230941; Semel E., 2003, CLIN EVALUATION LANG; Snyder LE, 2002, TOP LANG DISORD, V22, P1, DOI 10.1097/00011363-200205000-00003; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; St Clair-Thompson H, 2010, EDUC PSYCHOL-UK, V30, P203, DOI 10.1080/01443410903509259; Swanson HL, 2007, J EXP CHILD PSYCHOL, V96, P249, DOI 10.1016/j.jecp.2006.12.004; Swanson HL, 2010, J LEARN DISABIL-US, V43, P24, DOI 10.1177/0022219409338743; Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471; SWANSON HL, 1989, J ABNORM CHILD PSYCH, V17, P145, DOI 10.1007/BF00913790; SWANSON HL, 1995, INTELLIGENCE, V21, P83, DOI 10.1016/0160-2896(95)90040-3; Thordardottir E, 2008, J SPEECH LANG HEAR R, V51, P922, DOI 10.1044/1092-4388(2008/068); Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tompkins C.A., 1995, RIGHT HEMISPHERE COM; Torppa M, 2006, DEV PSYCHOL, V42, P1128, DOI 10.1037/0012-1649.42.6.1128; Turley-Ames KJ, 2003, J MEM LANG, V49, P446, DOI 10.1016/S0749-596X(03)00095-0; Vallat C, 2005, BRAIN INJURY, V19, P1157, DOI 10.1080/02699050500110595; van Kleeck A, 1998, AM J SPEECH-LANG PAT, V7, P65, DOI 10.1044/1058-0360.0703.65; Vanderberg R, 2007, READ WRIT, V20, P721, DOI 10.1007/s11145-006-9046-6; Vukovic R.K., 2010, LEARNING DISABILITIE, V25, P25, DOI [10.1111/j.1540-5826.2009.00298.x, DOI 10.1111/J.1540-5826.2009.00298.X]; Wagner RK., 1999, COMPREHENSIVE TEST P; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Weismer SE, 1999, J SPEECH LANG HEAR R, V42, P1249, DOI 10.1044/jslhr.4205.1249; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865; Weismer SE, 2005, J SPEECH LANG HEAR R, V48, P405, DOI 10.1044/1092-4388(2005/028); Weismer SE, 1996, J SPEECH HEAR RES, V39, P177, DOI 10.1044/jshr.3901.177; Weismer SE, 2002, TOP LANG DISORD, V22, P15, DOI 10.1097/00011363-200205000-00004; Weismer SE, 2006, APPL PSYCHOLINGUIST, V27, P556, DOI 10.1017/S0142716406240396; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; YUILL N, 1989, BRIT J PSYCHOL, V80, P351, DOI 10.1111/j.2044-8295.1989.tb02325.x; [No title captured]	137	13	13	1	40	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	0161-1461	1558-9129		LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	APR 1	2011	42	2					152	166		10.1044/0161-1461(2010/09-0088)			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	744AE	WOS:000289062800004	21173396				2022-02-06	
J	Gamache, PL; Lavalliere, M; Tremblay, M; Simoneau, M; Teasdale, N				Gamache, Pierre-Luc; Lavalliere, Martin; Tremblay, Mathieu; Simoneau, Martin; Teasdale, Normand			In-simulator training of driving abilities in a person with a traumatic brain injury	BRAIN INJURY			English	Article						Driving rehabilitation; traumatic brain injury; training; learning	REHABILITATION; STROKE	Aim: This study reports the case of a 23-year-old woman (MC) who sustained a severe traumatic brain injury in 2004. After her accident, her driving license was revoked. Despite recovering normal neuropsychological functions in the following years, MC was unable to renew her license, failing four on-road evaluations assessing her fitness to drive. Method: In hope of an eventual license renewal, MC went through an in-simulator training programme in the laboratory in 2009. The training programme aimed at improving features of MC's driving behaviour that were identified as being problematic in prior on-road evaluations. To do so, proper driving behaviour was reinforced via driving-specific feedback provided during the training sessions. Results: After 25 sessions in the simulator (over a period of 4 months), MC significantly improved various components of her driving. Notably, compared to early sessions, later ones were associated with a reduced cognitive load, less jerky speed profiles when stopping at intersections and better vehicle control and positioning. A 1-year retention test showed most of these improvements were consistent. Conclusions: The learning principles underlying well conducted simulator-based education programmes have a strong scientific basis. A simulator training programme like this one represents a promising avenue for driving rehabilitation. It allows individuals without a driving license to practice and improve their skills in a safe and realistic environment.	[Gamache, Pierre-Luc; Lavalliere, Martin; Tremblay, Mathieu; Simoneau, Martin; Teasdale, Normand] Univ Laval, Fac Med, GRAME, PEPS, Quebec City, PQ G1V 0A6, Canada; [Gamache, Pierre-Luc; Lavalliere, Martin; Simoneau, Martin; Teasdale, Normand] CHA, Ctr Rech FRSQ, Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada		Gamache, PL (corresponding author), Univ Laval, CHA Hop St Sacrement,Fac Med, Ctr Excellence Vieillissement Quebec,Div Kinesiol, Ctr Rech FRSQ,Grp Rech Anal Mouvement & Ergon, 2300 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada.	pierre-luc.gamache@psy.ulaval.ca	Simoneau, Martin/AAE-3727-2020	Simoneau, Martin/0000-0003-3207-1973			ALM H, 1994, ACCIDENT ANAL PREV, V26, P441, DOI 10.1016/0001-4575(94)90035-3; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Brenner LA, 2008, REHABIL PSYCHOL, V53, P18, DOI 10.1037/0090-5550.53.1.18; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; CALVANIO R, 1993, NEUROL CLIN, V11, P25, DOI 10.1016/S0733-8619(18)30169-5; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; de Waard, 1996, THESIS U GRONINGEN G; De Waard D, 1997, TRAFFIC TRANSPORT PS; Fisher D.L., 2003, INJ INSIGHTS, P2; Gamache PL, 2010, CURR DIR PSYCHOL SCI, V19, P370, DOI 10.1177/0963721410388641; HANCOCK PA, 1990, ACCIDENT ANAL PREV, V22, P281, DOI 10.1016/0001-4575(90)90019-H; Kantak SS, 2010, NAT NEUROSCI, V13, P923, DOI 10.1038/nn.2596; Kendall F. P., 1983, MUSCLE TESTING FUNCT; Lavalliere M., 2009, 5 INT DRIV S HUM FAC; LAVALLIERE M, 2011, TRAFFIC INJ IN PRESS; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Michon J.A., 1985, HUMAN BEHAV TRAFFIC; MICHON JA, 1979, WORKSH TRAFF RES CTR; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Oxford university press, 1998, COMPENDIUM NEUROPSYC; ROSOMER M, 2009, HUM FACTORS, V51, P652; Schmidt R, 2005, MOTOR CONTROL LEARNI, V4th; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; TEASDALE N, 2004, ADV TRANSPORTATION S, P29; The Psychological Corporation, 1997, WAIS 3 WMS 2 TECHN M; Tulving E., 1983, ELEMENTS EPISODIC ME; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	27	13	14	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					416	425		10.3109/02699052.2011.558039			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600012	21355675				2022-02-06	
J	Luton, LM; Reed-Knight, B; Loiselle, K; O'Toole, K; Blount, R				Luton, Lindsay M.; Reed-Knight, Bonney; Loiselle, Kristin; O'Toole, Kathleen; Blount, Ronald			A pilot study evaluating an abbreviated version of the cognitive remediation programme for youth with neurocognitive deficits	BRAIN INJURY			English	Article						Cognitive remediation; attention; children; intervention	TRAUMATIC BRAIN-INJURY; ATTENTION; CHILDHOOD; CHILDREN	Primary objective: To determine the effectiveness of an abbreviated version of an established cognitive remediation programme for children with neurological disorders and attention problems in an outpatient setting. Methods and procedures: Eighteen 6-15-year-old children diagnosed with neurological and attention difficulties completed a six-module training programme aimed at improving attention. This programme was a shorter version of the Cognitive Remediation Programme (CRP), which has been successfully implemented with children with neurocognitive deficits. Parents completed measures of their children's attention and children completed neuropsychological measures of attention. Main outcomes and results: The programme was associated with improvement in several aspects of parent-reported attention and children's performance on tasks measuring attention. Conclusions: The shortened version of the CRP shows promise as a brief treatment for attention problems in outpatient neurological populations. Future research should assess programme effectiveness using a control group, longer-term follow-up and teacher reports.	[Luton, Lindsay M.; O'Toole, Kathleen] Childrens Healthcare Atlanta, Atlanta, GA USA; [Reed-Knight, Bonney; Loiselle, Kristin; Blount, Ronald] Univ Georgia, Athens, GA 30602 USA		Luton, LM (corresponding author), Dept Neuropsychol, 5455 Meridian Mark Rd,Suite 180, Atlanta, GA 30342 USA.	lindsay.luton@choa.org		Reed, Bonney/0000-0003-1808-6132			Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; Duncan CC, 2008, INT J PSYCHOPHYSIOL, V69, P207, DOI 10.1016/j.ijpsycho.2008.05.011; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gioia GA IP, 2000, BEHAV RATING INVENTO; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Loss N, 1998, CHILD NEUROPSYCHOL, V4, P7, DOI 10.1076/chin.4.1.7.3192; Manly T., 1998, TEST EVERYDAY ATTENT; Pfiffner L. J., 2006, ATTENTION DEFICIT HY, P547; Pruitt DW, 2009, PHYS MED REH CLIN N, V20, P455, DOI 10.1016/j.pmr.2009.06.002; Sohlberg MM., 1999, ATTENTION PROCESS TR; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED	16	13	13	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					409	415		10.3109/02699052.2011.558044			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600011	21355674				2022-02-06	
J	Rutkoski, JD; Sippey, M; Gaines, BA				Rutkoski, John Daniel; Sippey, Megan; Gaines, Barbara A.			Traumatic Television Tip-Overs in the Pediatric Patient Population	JOURNAL OF SURGICAL RESEARCH			English	Article						pediatric trauma; television; tip-over	CHILDREN; INJURIES; TODDLERS; TIPOVERS; OUTCOMES; TRENDS	Background. Head trauma is the leading cause of injury in the pediatric patient population. Although falls are the most common reason for head injury, blunt objects are a significant contributor. The Consumer Product Safety Commission (CPSC) released the top five hidden hazards of the home in 2007 and listed "tip-overs'' as the third leading cause of morbidity and mortality. We, therefore, hypothesize that televisions continue to be a significant source of injury to children. Our intent is to examine the most common mechanisms, resulting injuries, and factors associated with television-related injuries so as to increase public awareness of this threat. Methods. Trauma patients admitted to our institution are entered into a state-mandated performance-improvement data collection system. After obtaining IRB approval, the medical records of all children admitted to our Level I Pediatric Trauma Center between 1/1/1999 and 7/27/2009 with television-related injuries were reviewed. Data points extracted included standard demographics, as well as television size, television support, final trauma level, Glasgow coma scale (GCS), injury severity score (ISS), intensive care unit (ICU) requirements, surgical procedures, final diagnoses, and hospital length of stay (LOS). Descriptive statistics were performed for the demographic data and intervals. Tests of significance were performed using Student's t-test and chi(2)/Fisher's exact test as appropriate. A P value < 0.05 was considered to be statistically significant. Results. Fifty-two children were seen at our institution with television tip-over related injuries during the study period. Nearly all injuries (50/52) occurred in the home, and 83% were an unwitnessed event. The mean age was 36 mo. The most common television size responsible for insult was 27 in., and the majority of these (26/52) were supported by a dresser. The mean ISS was 8.3. Patients admitted to the ICU had a higher ISS (12.2 [8.0-16.4] versus 6.8 [5.-8.4]; P = 0.003); however, there was no statistically significant association between television size and ISS (7.5 [4.6-10.4] < 27 in. versus 7.5 [7.8-13.4] >= 27 in.; P = 0.111). Injuries to the head were by far the most common (43/52) followed by orthopedic (n = 6) and blunt abdominal (n = 3). There was one death in the study population, and this resulted from a closed head injury. Conclusions. Television tip-overs continue to pose a threat to children and can result in significant injury. Most often affected are the toddlers learning to walk and exploring their surrounding environments. The use of a dresser as a stand appears to convey the greatest risk. These injuries are potentially preventable by adequately securing televisions to appropriate stands. (C) 2011 Elsevier Inc. All rights reserved.	[Rutkoski, John Daniel; Sippey, Megan; Gaines, Barbara A.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat Gen & Thorac Surg, Pittsburgh, PA 15224 USA		Rutkoski, JD (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat Gen & Thorac Surg, 400 45th St,Suite 7000 62, Pittsburgh, PA 15224 USA.	jdrutkoski@gmail.com					Bernard PA, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e32; Borgenicht David, 1998, SESAME STREET UNPAVE; Cho JH, 2009, J PAEDIATR CHILD H, V45, P505, DOI 10.1111/j.1440-1754.2009.01556.x; DiScala C, 2001, ARCH PEDIAT ADOL MED, V155, P145, DOI 10.1001/archpedi.155.2.145; Gaines J, 2009, ACCIDENT ANAL PREV, V41, P1070, DOI 10.1016/j.aap.2009.06.010; Herr N, 2007, TELEVISION HLTH; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MARGANITT B, 1992, PEDIATRICS, V89, P608; Morrison L, 2002, J PAEDIATR CHILD H, V38, P587, DOI 10.1046/j.1440-1754.2002.00059.x; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P415, DOI 10.1093/jpepsy/jsh046; Murray KJ, 2009, INJURY PREV, V15, P240, DOI 10.1136/ip.2009.021550; Scheidler MG, 2002, J PEDIATR SURG, V37, P572, DOI 10.1053/jpsu.2002.31612; Sikron F, 2007, CHILD CARE HLTH DEV, V33, P45, DOI 10.1111/j.1365-2214.2006.00622.x; *UND LAB, 1996, 1667 UL; Yahya RR, 2005, J NEUROSURG, V103, P219, DOI 10.3171/ped.2005.103.3.0219	15	13	13	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	APR	2011	166	2					199	204		10.1016/j.jss.2010.05.051			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	732ER	WOS:000288168300021	20863529				2022-02-06	
J	Scherwath, A; Sommerfeldt, DW; Bindt, C; Nolte, A; Boiger, A; Koch, U; Petersen-Ewert, C				Scherwath, Angela; Sommerfeldt, Dirk W.; Bindt, Carola; Nolte, Achim; Boiger, Annette; Koch, Uwe; Petersen-Ewert, Corinna			Identifying children and adolescents with cognitive dysfunction following mild traumatic brain injury-Preliminary findings on abbreviated neuropsychological testing	BRAIN INJURY			English	Article						Abbreviated neuropsychological testing; cognitive function; mild traumatic brain injury; children; adolescents	CLOSED-HEAD-INJURY; POPULATION; MANAGEMENT; RECOVERY; CONCUSSION; TBI	Objective: Studies on cognitive function in paediatric patients suffering head trauma suggest neuropsychological impairment even after mild traumatic brain injury (MTBI). The present study examined the feasibility of abbreviated neuropsychological testing in different settings in children and adolescents following MTBI. Methods: Within the scope of two prospective studies on psychosocial and cognitive outcome, 71 school-aged children with mild, moderate or severe TBI were assessed. In addition, 15 healthy children were included in the study. The abbreviated instrument comprises three standardized tests measuring attention and memory functions (Digit Symbol, Digit Span, learning trials of the German Auditory Verbal Learning Test). Impairment rates were calculated according to a defined cut-off score for clinically significant cognitive impairment. Results: Abbreviated testing could easily be implemented both in the acute and post-acute clinical setting. Out of the children with MTBI, 12% (shortly after injury) and 30% (2 months after injury), respectively, were classified as cognitively impaired. Following moderate or severe TBI, impairment occurred in 50% of the patients. Healthy children showed the best performance, while children with severe TBI performed worst. Conclusion: Results suggest that abbreviated testing allows detection of MTBI-related cognitive dysfunction. Identified children should be referred to a clinical neuropsychologist for comprehensive assessment.	[Scherwath, Angela] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, D-20246 Hamburg, Germany; [Sommerfeldt, Dirk W.; Boiger, Annette] Altona Childrens Hosp, Hamburg, Germany; [Nolte, Achim] HELIOS Clin Geesthacht, Geesthacht, Germany; [Petersen-Ewert, Corinna] Hamburg Univ Appl Sci, Hamburg, Germany		Scherwath, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Martinistr 52-W26, D-20246 Hamburg, Germany.	a.scherwath@uke.uni-hamburg.de	Koch, Uwe/A-5825-2009; Scherwath, Angela/Q-4197-2016	Scherwath, Angela/0000-0002-7338-5218	ZNS-Hannelore Kohl Stiftung; Stiftung Wohlfahrtspflege Nordrhein-Westfalen; Hamburg macht Kinder gesund e.V	This study was supported by funding from the 'ZNS-Hannelore Kohl Stiftung', the 'Stiftung Wohlfahrtspflege Nordrhein-Westfalen' and the 'Hamburg macht Kinder gesund e.V.'.	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Gruters A, 2007, HORM RES, V68, P107, DOI 10.1159/000110591; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Helmstaedter C., 2001, VERBALER LERN MERKFA; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Kahl H, 2007, BUNDESGESUNDHEITSBLA, V50, P718, DOI 10.1007/s00103-007-0233-7; Kamerling SN, 2003, PEDIATR EMERG CARE, V19, P431, DOI 10.1097/01.pec.0000092590.40174.1f; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCrea M., 2000, STANDARDIZED ASSESSM; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; TEWES U, 2001, HAMBURGWECHSLER INTE; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; von Aster M., 2006, WECHSLER INTELLIGENZ; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017	36	13	13	0	24	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					401	408		10.3109/02699052.2011.557351			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600010	21355673				2022-02-06	
J	Shem, K; Medel, R; Wright, J; Kolakowsky-Hayner, SA; Duong, T				Shem, K.; Medel, R.; Wright, J.; Kolakowsky-Hayner, S. A.; Duong, T.			Return to work and school: a model mentoring program for youth and young adults with spinal cord injury	SPINAL CORD			English	Article						mentoring; peer support; spinal cord injury; disability	TRAUMATIC BRAIN INJURY; EMPLOYMENT	Study design: This is a prospective study. Objectives: Young individuals with spinal cord injury (SCI) need support to actively participate in the community after their injuries. The 'Back on Track' mentoring program was developed to match mentees with SCI with mentors to assist with post-injury adjustment. The objectives of this study were to improve the percentage of youth and young adults with SCI, who access post-secondary education or employment opportunities and to improve quality of life. Setting: This study had a community-based setting. Methods: Each mentee with SCI was matched with a community-based mentor, with or without a disability. The mentoring relationship was planned for 2 years. Participants were evaluated with standardized questionnaires at intake, at the time of post-secondary education or employment entry and 4 months post entry. Results: In total, 39 individuals with SCI, age 16-26 years, were enrolled. Average age of mentees was 19.8 years (s.d = 3.0). In total, 29 participants were matched with mentors, and 10 participants (34%) completed the program, with seven (24%) returning to school, two (6.9%) returning to work and one individual (3.4%) attending school part time. Conclusion: Although multiple barriers to success occurred, this program demonstrated that it could assist the youth and young adults with SCI to obtain post-secondary education and employment. This type of support system should be encouraged in order to improve the quality and satisfaction of life for young adults with disabilities. Spinal Cord (2011) 49, 544-548; doi: 10.1038/sc.2010.166; published online 7 December 2010	[Shem, K.; Medel, R.; Wright, J.; Kolakowsky-Hayner, S. A.; Duong, T.] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA		Shem, K (corresponding author), Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, 751 S Bascome Ave, San Jose, CA 95128 USA.	kazuko.shem@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	Rehabilitation Services Administration [H235S040052]	This study was supported by a Rehabilitation Services Administration Grant # H235S040052.	CASTLE R, 1994, PARAPLEGIA, V32, P182, DOI 10.1038/sc.1994.33; DEVIVO MJ, 1987, ARCH PHYS MED REHAB, V68, P494; Inge K, 1998, J VOCATIONAL REHABIL, V10, P141, DOI DOI 10.1016/S1052-2263(98)00010-5; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kraus JF, 1993, HEAD INJURY, P1; Krause JS, 1998, ARCH PHYS MED REHAB, V79, P615, DOI 10.1016/S0003-9993(98)90033-8; KRAUSE JS, 1992, ARCH PHYS MED REHAB, V73, P564; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Lidal IB, 2009, DISABIL REHABIL, V31, P2174, DOI 10.3109/09638280902946952; *NAT SPIN CORD INJ, 2008, FACTS FIG GLANC; *NAT SPIN CORD INJ, 2003, FACTS FIG GLANC; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Patterson RW, 2005, TOP SPINAL CORD INJ, V10, P30; TARGETT P, 2003, SCI PSYCHOSOC PROCES, V16, P1; Wehman P, 2000, AM J PHYS MED REHAB, V79, P161, DOI 10.1097/00002060-200003000-00009; Yasuda S, 2002, NEUROREHABILITATION, V17, P177; Young AE, 2009, INT J REHABIL RES, V32, P1, DOI 10.1097/MRR.0b013e32831c8b19; YOUNG ME, 1994, REHABIL COUNS BULL, V37, P229	20	13	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	APR	2011	49	4					544	548		10.1038/sc.2010.166			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	744BZ	WOS:000289069400010	21135861	Bronze			2022-02-06	
J	Armstead, WM; Kreipke, CW				Armstead, William M.; Kreipke, Christian W.			Endothelin-1 is upregulated after traumatic brain injury: a cross-species, cross-model analysis	NEUROLOGICAL RESEARCH			English	Article						Endothelin; Microcirculation; Rat; Porcine	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION MODEL; AXONAL INJURY; HEAD-INJURY; RAT; MICROCIRCULATION	Objectives: This work was designed to compare levels of endothelin-1 following brain injury in both rat and porcine models of head injury. In a broader sense, this work also determines the feasibility of testing traumatic brain injury-related phenomenology across species and models. Methods: Male Sprague-Dawley rats (400-450 g) were subjected to traumatic brain injury using a weight acceleration impact injury device (n=5 per group). Following impact, cerebrospinal fluid was collected for enzyme-linked immunosorbent assay analysis of endothelin-1 concentration using a standard endothelin-1 detection kit at 4 hours, 24 hours, 48 hours, and 7 days post-traumatic brain injury. Sham operated animals (n=5) were used as controls. In another set of experiments, traumatic brain injury was induced in newborn and juvenile pigs (n=6 per group) using a lateral fluid percussion model of brain injury. Cerebrospinal fluid was collected at 4 hours, 8 hours, 72 hours, and 7 days post-injury and endothelin-1 levels were measured using a radiolabeled kit. Results: Endothelin-1 levels rapidly increased from similar to 35 in sham operated animals to over 200 pg/g tissue 4 hours post-impact in both rat cortex and hippocampus. This elevation was sustained through 48 hours post-impact. By 7 days post-injury, endothelin-1 levels returned to normal, control concentrations. This trend was consistent with the porcine model, being more pronounced in newborn versus juvenile pigs. Conclusion: These results show that endothelin-1 peptide concentration elevation is a consistent finding between rat and pig and between weight acceleration and fluid percussion models of traumatic brain injury. This suggests that endothelin-1 elevation is not only a conserved phenomenon in different models of traumatic brain injury, but that it is a likely target for understanding the observed enhanced vascular response to traumatic brain injury and ultimately developing strategies to improve outcome following traumatic brain injury.	[Kreipke, Christian W.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Armstead, William M.] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Kreipke, Christian W.] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA		Kreipke, CW (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	ckreipke@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS064976, NS34932]; VA Rehabilitation Research & Development Merit Award [RX000224]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064976, R01NS034932] Funding Source: NIH RePORTER	This work was supported by grants from National Institutes of Health (C. W. Kreipke: NINDS NS064976; W. Armstead: NS34932) and a VA Rehabilitation Research & Development Merit Award (C. W. Kreipke: RX000224).	BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hayes R L, 1987, Brain Inj, V1, P1, DOI 10.3109/02699058709034437; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	28	13	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2011	33	2					133	136		10.1179/016164111X12881719352174			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600004	21801588				2022-02-06	
J	Kahraman, S; Hu, P; Stein, DM; Stansbury, LG; Dutton, RP; Xiao, Y; Hess, JR; Scalea, TM				Kahraman, Sibel; Hu, Peter; Stein, Deborah M.; Stansbury, Lynn G.; Dutton, Richard P.; Xiao, Yan; Hess, John R.; Scalea, Thomas M.			Dynamic Three-Dimensional Scoring of Cerebral Perfusion Pressure and Intracranial Pressure Provides a Brain Trauma Index That Predicts Outcome in Patients With Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	69th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-25, 2010	Boston, MA	Amer Assoc Surg Trauma (AAST)		ICP; CPP; TBI; Electronic monitoring; Automated vital signs	HYPERTENSION; SYSTEMS	Background: Data on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) guide therapy in severe traumatic brain injury (TBI), but current linear analytic methods are insufficiently sensitive and specific for prognosis in dynamic situations over time. Methods: We have developed algorithms incorporating continuous, automated, digital ICP and CPP monitoring data into a pressure times time "dose" function. In this study, we calculated cumulative doses using thresholds of ICP > 20 mm Hg and CPP < 60 mm Hg and graphed these as a Brain Trauma Index (BTI or CPP/ICP). Using receiver operator characteristics analysis, we examined BTI < 3 and BTI < 2 and various threshold levels of pressure times time doses of ICP and CPP as predictors of 30-day mortality and Extended Glasgow Outcome Scale (GOSE) < 5 at 6 months and 12 months. Using the data processing and analysis tools underlying this work, we are also piloting a real-time bedside and telemetric display system as a means of indentifying and monitoring critical changes in physiologic metrics, including BTI, CPP, and ICP. Results: Sixty subjects yielded 8678.1 hours of data (5,206,860 data points). BTI < 2 was better than CPP < 60 mm Hg in predicting unfavorable Extended Glasgow Outcome Scale at 6 months (p < 0.05). An example of linear and graphically processed BTI, CPP, and ICP data from a representative TBI patient is provided. Conclusion: Calculation of a BTI from continuous digital data predicts outcome in severe TBI and has potential for the design of real-time bedside early warning systems.	[Kahraman, Sibel; Hu, Peter; Stein, Deborah M.; Stansbury, Lynn G.; Dutton, Richard P.; Xiao, Yan; Hess, John R.; Scalea, Thomas M.] Shock Trauma & Anesthesia Res Ctr, R Adams Cowley Shock Truma Ctr, Baltimore, MD 21201 USA		Stansbury, LG (corresponding author), Shock Trauma & Anesthesia Res Ctr, R Adams Cowley Shock Truma Ctr, 419 W Redwood St, Baltimore, MD 21201 USA.	Istansbury@STAPA.umm.edu	Xiao, Yan/A-7506-2009	Xiao, Yan/0000-0003-2805-0619; Stein, Deborah/0000-0003-3683-3963			Box GE., 2015, TIME SERIES ANAL FOR; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Duda RO., 2000, PATTERN CLASSIFICATI, V2; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; GERSHENFELD N, 2000, NATURE MATH MODELING; Heldt T., 2006, 28 ANN INT C IEEE EN, P350; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; Tarassenko L, 2006, BRIT J ANAESTH, V97, P64, DOI 10.1093/bja/ael113; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; 2007, J NEUROTRAUMA, V24, pS1	14	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2011	70	3					547	552		10.1097/TA.0b013e31820c768a			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	732PU	WOS:000288201200011	21610341				2022-02-06	
J	Lemoyne, R; Mastroianni, T; Kale, H; Luna, J; Stewart, J; Elliot, S; Bryan, F; Coroian, C; Grundfest, W				Lemoyne, Robert; Mastroianni, Timothy; Kale, Halo; Luna, Jorge; Stewart, Joshua; Elliot, Stephen; Bryan, Filip; Coroian, Cristian; Grundfest, Warren			FOURTH GENERATION WIRELESS REFLEX QUANTIFICATION SYSTEM FOR ACQUIRING TENDON REFLEX RESPONSE AND LATENCY	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Reflex quantification; wireless accelerometers; accelerometers; neurorehabilitation; traumatic brain injury	QUANTITATIVE-EVALUATION; HOFFMANN REFLEX; RELIABILITY; PATELLAR; ELECTROMYOGRAPHY; REQUESTS; DEVICE; GAIT	An intrinsic aspect of the standard neurological examination is the deep tendon reflex. A clinician is tasked with qualitatively evaluating reflex parameters, such as reflex response and latency. The tendon reflex is capable of providing preliminary insight with respect to dysfunction of the central and peripheral nervous systems. The qualitative assessment of the tendon reflex can be classified through the implementation of an ordinal scale, such as the NINDS scale which spans five ordinal components from 0 to 4. The reliability and accuracy of the ordinal-scale method for classifying reflex characteristics have been demonstrated to be an issue of controversy. Ordinal scales lack the capacity to properly classify the temporal features of the tendon reflex. Electrodiagnostic testing traditionally provides higher fidelity evaluation of peripheral neuropathy; however, a study by Cocito et al., has discovered 28% of the prescriptions were inappropriate. The fourth-generation wireless reflex quantification system provides a less resource intensive, highly accurate, reliable, and reproducible alternative. The patellar tendon reflex is evoked through a predetermined potential energy derived swing arm attached to a standard reflex hammer. Tandem wireless 3D MEMS accelerometers quantify reflex response and latency. The reflex response maximum and minimum are acquired from the wireless 3D MEMS accelerometer positioned above the ankle joint. The latencies derived from the maximum and minimum of the reflex responses are derived from the temporal disparity relative to the acceleration waveforms of the reflex response and swing arm evoking the tendon reflex. The fourth-generation wireless reflex quantification system has been evolved with a more user-convenient wirelessly activated datalogger mode, which is subsequently downloaded to a local PC wirelessly. The wireless datalogger mode enables sampling at a greater rate relative to the real-time streaming data mode. An automated MATLAB software program is implemented for acquiring reflex parameters. Enclosed is the longitudinal study of the fourth-generation wireless reflex quantification system that demonstrates considerable precision for accuracy, reliability, and reproducibility. As a supplement to the research, a brief reflex modulation study is amended to the longitudinal study.	[Lemoyne, Robert; Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Cognit Engn, Pittsburgh, PA USA; [Kale, Halo; Luna, Jorge; Stewart, Joshua; Elliot, Stephen; Bryan, Filip] Glendale Coll, Glendale, AZ USA; [Coroian, Cristian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn IDP, 5121 Engn V,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			CHUNGW, 2008, P 30 ANN INT C IEEE, P1120; Cocito D, 2006, NEUROL SCI, V26, P419, DOI 10.1007/s10072-006-0525-y; Cozens JA, 2000, J NEUROL NEUROSUR PS, V68, P581, DOI 10.1136/jnnp.68.5.581; ENGLUND C, 2004, THESIS ROYAL I TECHN; Faist M, 1999, BRAIN, V122, P567, DOI 10.1093/brain/122.3.567; Frijns CJM, 1997, CLIN NEUROL NEUROSUR, V99, P31, DOI 10.1016/S0303-8467(96)00593-8; HOFFMAN MA, 1995, BRAIN RES, V700, P303, DOI 10.1016/0006-8993(95)01082-7; KAMEN G, 1989, NEUROBIOL AGING, V10, P311, DOI 10.1016/0197-4580(89)90041-9; KAMEYAMA O, 1989, AM J PHYS MED REHAB, V68, P277, DOI 10.1097/00002060-198912000-00004; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; KOCEJA DM, 1988, MED SCI SPORT EXER, V20, P172, DOI 10.1249/00005768-198820020-00012; KURUOGLU HR, 1994, MUSCLE NERVE, V17, P145, DOI 10.1002/mus.880170203; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; LeMoyne R., 2009, P IEEE ICME INT C CO, P1, DOI DOI 10.1109/ICCME.2009.4906657; LEMOYNE R, 2005, UCLA COMMUNICATION N; LEMOYNE R, 2005, 35 SOC NEUR ANN M WA; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; Lemoyne R, 2008, J MECH MED BIOL, V8, P491, DOI 10.1142/S0219519408002772; Litvan I, 1996, NEUROLOGY, V47, P969, DOI 10.1212/WNL.47.4.969; Mamizuka N, 2007, J BIOMECH, V40, P2107, DOI 10.1016/j.jbiomech.2006.10.003; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; MASTROIANNI T, 2003, COMPUTATIONAL ANAL I; Mitchell TM, 1997, MACH LEARN; Mondelli M, 1998, ITAL J NEUROL SCI, V19, P195, DOI 10.1007/BF02427600; Pagliaro P, 1999, J ELECTROMYOGR KINES, V9, P141, DOI 10.1016/S1050-6411(98)00045-5; Podnar S, 2005, EUR J NEUROL, V12, P150, DOI 10.1111/j.1468-1331.2004.00979.x; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; STAM J, 1990, J NEUROL, V237, P427, DOI 10.1007/BF00314735; Szilagy P.G., 2003, BATES GUIDE PHYS EXA; Tate P, 2003, ANATOMY PHYSL; van Dijk GW, 1999, NEUROLOGY, V53, P1573, DOI 10.1212/WNL.53.7.1573; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/0006-8993(96)00885-2; Voerman GE, 2005, DISABIL REHABIL, V27, P33, DOI 10.1080/09638280400014600; Zhang LQ, 2000, ARCH PHYS MED REHAB, V81, P901, DOI 10.1053/apmr.2000.5582	35	13	13	0	3	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	MAR	2011	11	1					31	54		10.1142/S0219519410003654			24	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	764MD	WOS:000290632700003					2022-02-06	
J	Zgaljardic, DJ; Guttikonda, S; Grady, JJ; Gilkison, CR; Mossberg, KA; High, WM; Masel, BE; Urban, RJ				Zgaljardic, Dennis J.; Guttikonda, Sreedevi; Grady, James J.; Gilkison, Charles R.; Mossberg, Kurt A.; High, Walter M., Jr.; Masel, Brent E.; Urban, Randall J.			Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing	CLINICAL ENDOCRINOLOGY			English	Article							ADULT GH DEFICIENCY; INSULIN TOLERANCE-TEST; REPLACEMENT; GUIDELINES	P>Objective The diagnosis of growth hormone deficiency (GHD) in adults is established through growth hormone (GH) stimulation testing, which is often complex, expensive, time-consuming and may be associated with adverse side effects. The decision to perform GH provocative testing is influenced by clinical findings, medical history and biochemical evidence. We report in this study our experience using the glucagon stimulation test (GST) in assessing GHD in adult patients with traumatic brain injury (TBI) as it relates to baseline serum insulin-like growth factor-1 (IGF-1) concentrations. Design A receiver operating characteristic (ROC) curve analysis was performed to determine the optimal IGF-1 cut-off for diagnosis of GHD at different potential diagnostic GST cut-off values (< 3, < 5, & < 10 mu g/l). Patients One hundred and thirty-eight patients (98 men and 40 women) with a documented history of moderate to severe TBI were assessed for GHD using serum IGF-1 concentrations and the GST. Measurements IGF-1 values were compared with peak GH values obtained following the GST. Results An IGF-1 cut-off value of 175 mu g/l minimized the misclassification of GHD patients and GH-sufficient patients and provided a sensitivity of 83% and specificity of 40%, as well as a negative predictive power of 90% considering a criterion for peak GH response of < 3 mu g/l. Conclusions Our current findings are consistent with previous work assessing peak GH response using the insulin tolerance test (ITT) in a non-TBI sample, suggesting that diagnostic accuracy may be optimized if the GST is used when obtained serum IGF-1 concentrations are below 175 mu g/l. While the decision to perform provocative testing to assess GHD in adult patients should be based on the clinician's clinical impression, the findings from this retrospective study can provide useful clinical information and serve as a guide.	[Zgaljardic, Dennis J.] Univ Texas Med Branch, Dept Neuropsychol, Transit Learning Ctr, Galveston, TX 77550 USA; Univ Texas Med Branch, Dept Neurol, Galveston, TX 77550 USA; Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77550 USA; [Guttikonda, Sreedevi; Gilkison, Charles R.; Urban, Randall J.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Grady, James J.] Univ Texas Med Branch, Dept PMCH Epidemiol & Biostat, Galveston, TX 77550 USA; [Mossberg, Kurt A.] Univ Texas Med Branch, Dept Phys Therapy, Galveston, TX 77550 USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA		Zgaljardic, DJ (corresponding author), Univ Texas Med Branch, Dept Neuropsychol, Transit Learning Ctr, 1528 PO St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org			Moody Endowment; Pfizer, Inc.Pfizer	This study was supported by grants from the Moody Endowment and Pfizer, Inc. We gratefully acknowledge Maria Briones-Galang, MD and Gerard Francisco, MD for research coordination and Renee Pearcy for editorial assistance. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Ghigo E, 2008, GROWTH HORM IGF RES, V18, P1, DOI 10.1016/j.ghir.2007.07.004; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Hadjadj S, 2007, ANN ENDOCRINOL-PARIS, V68, P449, DOI 10.1016/j.ando.2007.08.004; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; *SPSS INC, 2001, SPSS WIND; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299	19	13	14	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0300-0664			CLIN ENDOCRINOL	Clin. Endocrinol.	MAR	2011	74	3					365	369		10.1111/j.1365-2265.2010.03935.x			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	718AY	WOS:000287093200013	21114510				2022-02-06	
J	Anderson, JW; Schmitter-Edgecombe, M				Anderson, Jonathan W.; Schmitter-Edgecombe, Maureen			Recovery of Time Estimation Following Moderate to Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						time estimation; temporal perception; temporal cognition; traumatic brain injury; closed head injury	CLOSED-HEAD-INJURY; SUBJECTIVE TIME; POSTTRAUMATIC AMNESIA; DURATION JUDGMENTS; BODY-TEMPERATURE; WORKING-MEMORY; INTERNAL CLOCK; REPRODUCTION; ORIENTATION; ATTENTION	Objective: Accurate time estimation abilities are thought to play an important role in efficient performance of many daily activities. This study investigated the role of episodic memory in the recovery of time estimation abilities following moderate to severe traumatic brain injury (TBI). Method: Using a prospective verbal time estimation paradigm, TBI participants were tested in the early phase of recovery from TBI and then again approximately one year later. Verbal time estimations were made for filled intervals both within (i.e., 10 s, 25 s) and beyond (i.e., 45 s 60 s) the time frame of working memory. Results: At baseline, when compared to controls, the TBI group significantly underestimated time durations at the 25 s, 45 s and 60 s intervals, indicating that the TBI group perceived less time as having passed than actually had passed. At follow-up, despite the presence of continued episodic memory impairment and little recovery in episodic memory performance, the TBI group exhibited estimates of time passage that were similar to controls. Conclusion: The pattern of data was interpreted at suggesting that episodic memory performance did not play a noteworthy role in the recovery of temporal perception in TB! participants.	[Anderson, Jonathan W.] Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA; [Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Anderson, JW (corresponding author), Eastern Washington Univ, Dept Psychol, Cheney, WA 99004 USA.	janderson@ewu.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by Grant R01 NS47690 from NINDS. We thank Randi McDonald, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright, and Ellen Woo for their support in coordinating data collection. We would also like to thank the TBI participants and the members of the Head Injury Research Team for their help in collecting and scoring the data.	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Benton AL, 1994, MULTILINGUAL APHASIA; Block R.A., 1990, COGNITIVE MODELS PSY, P1; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; BURNSIDE W, 1971, PERCEPT PSYCHOPHYS, V9, P404, DOI 10.3758/BF03210238; CAHOON RL, 1969, PERCEPT MOTOR SKILL, V28, P259, DOI 10.2466/pms.1969.28.1.259; *CEDR CORP, 1999, SUPERLAB PROB VERS E; Chaston A, 2004, BRAIN COGNITION, V55, P286, DOI 10.1016/j.bandc.2004.02.013; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Doob LW, 1971, PATTERNING TIME; Eagleman DM, 2005, J NEUROSCI, V25, P10369, DOI 10.1523/JNEUROSCI.3487-05.2005; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fraisse P., 1963, PSYCHOL TIME; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; HANCOCK PA, 1993, J GEN PSYCHOL, V120, P197, DOI 10.1080/00221309.1993.9711144; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; HICKS RE, 1992, NATO ADV SCI INST SE, V66, P97; KIELHOFNER G, 1977, AM J OCCUP THER, V31, P235; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kinsbourne M., 2000, NEUROBEHAV LANGUAGE, P315; Kinsbourne M., 1990, NEUROPSYCHOLOGICAL I, P319, DOI DOI 10.1017/CBO9780511665547.017; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LICHT D, 1985, INT J AGING HUM DEV, V21, P211, DOI 10.2190/RBYL-67QW-YJN0-ELBQ; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; MARUM KD, 1972, PERCEPT MOTOR SKILL, V34, P244, DOI 10.2466/pms.1972.34.1.244; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Myers J. L., 2003, RES DESIGN STAT ANAL; NICHELLI P, 1993, COGNITIVE BRAIN RES, V1, P87, DOI 10.1016/0926-6410(93)90014-V; Ornstein R., 1969, EXPERIENCE TIME; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2000, NEUROCASE, V6, P347, DOI 10.1093/neucas/6.4.347; POLYUKHOV AM, 1989, Z GERONTOL, V22, P79; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RICHARDS W, 1973, ACTA PSYCHOL, V37, P279, DOI 10.1016/0001-6918(73)90020-6; Rueda AD, 2009, NEUROPSYCHOLOGY, V23, P178, DOI 10.1037/a0014289; SCHMITTEREDGECO.M, 2008, J CLIN EXPT NEUROPSY, V30, P1; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Smith A., 1991, SYMBOL DIGIT MODALIT; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick B.G., 2001, COMPUTER ASSISTED RE; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Ulbrich P, 2007, ACTA PSYCHOL, V125, P51, DOI 10.1016/j.actpsy.2006.06.004; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS JM, 1989, J CLIN EXP NEUROPSYC, V11, P713, DOI 10.1080/01688638908400927; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zakay D, 1999, ATTENTION PERFORM, V17, P557; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96), DOI 10.1016/S0166-4115(96)80057-4, 10.1016/S0166-4115(96)80057-4]; Zakay D., 1990, COGNITIVE MODELS PSY, P59	68	13	13	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2011	25	1					36	44		10.1037/a0020333			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	711AQ	WOS:000286558500004	20919767	Green Accepted			2022-02-06	
J	Barbe, MF; Ruggieri, MR				Barbe, Mary F.; Ruggieri, Michael R., Sr.			Innervation of Parasympathetic Postganglionic Neurons and Bladder Detrusor Muscle Directly After Sacral Root Transection and Repair Using Nerve Transfer	NEUROUROLOGY AND URODYNAMICS			English	Article						carbocyanines; denervation; nerve regrowth; urinary bladder	SPINAL-CORD-INJURY; URINARY-BLADDER; FUNCTIONAL REINNERVATION; CANINE BLADDER; REFLEX PATHWAY; RATS; RECONSTRUCTION; REGENERATION; ORGANIZATION; MICTURITION	Aims: This is a continuation of studies examining the effectiveness of root repairs and nerve transfers for bladder reinnervation. Our previous retrograde fluorogold tracing studies from the bladder to the spinal cord found regrowth of axons from the spinal cord through the nerve repair site to the bladder which was confirmed electrophysiologically [Ruggieri et al. J Neurotrauma 25: 214-24, 2006]. The current study determines whether the pattern of axonal regrowth from the repaired nerves or roots to the bladder is different between the surgical reanastomosis methods. Methods: The canine bladder was denervated by transection of all nerve roots from the sacral spinal cord mediating bladder contraction. Reinnervation surgeries included end-on-end repair of transected sacral ventral roots, transfer of coccygeal to sacral ventral roots (CGNT), or transfer of genitofemoral to pelvic nerves (GFNT). Results: Postmortem dialkylcarbocyanine dye tracing with Neurotrace DiI from the distal pelvic nerve to the bladder wall, combined with PGP9.5 neuronal immunohistochemistry, demonstrated innervation by DiI-labeled axons of only parasympathetic postganglionic intramural ganglia in normal controls and sham operated controls, but reinnervation of both intramural ganglia and detrusor muscle directly after repair of sacral ventral roots. GF NT and CG NT also resulted in reinnervation of both intramural ganglia and detrusor muscle, although to a lesser extent than repaired roots. Conclusions: Bladder reinnervation with either the same nerve (orthotopic reinnervation) or with either a primarily somatic nerve (coccygeal) or a primarily sensory nerve (genitofemoral) results in reinnervation of both intramural ganglia as well as direct innervation of detrusor muscle. Neurourol. Urodynam. 30:599-605, 2011. (C) 2011 Wiley-Liss, Inc.	[Ruggieri, Michael R., Sr.] Temple Univ, Sch Med, Dept Urol, Philadelphia, PA 19140 USA; [Barbe, Mary F.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140 USA; [Ruggieri, Michael R., Sr.] Temple Univ, Dept Comp & Elect Engn, Philadelphia, PA 19140 USA		Ruggieri, MR (corresponding author), Temple Univ, Sch Med, Dept Urol, 3400 N Broad St,715 OMS, Philadelphia, PA 19140 USA.	rugg@temple.edu	Ruggieri, Michael/C-6262-2011	Ruggieri, Michael/0000-0003-3052-3630; Barbe, Mary/0000-0002-5235-9803	Pfizer corporationPfizer; Shriners Hospitals; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS070267]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070267] Funding Source: NIH RePORTER	MRR is principal investigator of a competitive research grant from the Pfizer corporation designed to determine the role of muscarinic receptor internalization in the sensitivity of the human bladder to cholinergic stimulation.; Grant sponsor: Shriners Hospitals; Grant sponsor: National Institutes of Health; Grant Numbers: R01NS070267.	Bradley W E, 1974, Urol Clin North Am, V1, P3; BROOKES SJH, 1991, NEUROSCIENCE, V42, P863, DOI 10.1016/0306-4522(91)90050-X; CONZEN MA, 1982, UROL RES, V10, P141; DEGROAT WC, 1981, J AUTONOM NERV SYST, V3, P135, DOI 10.1016/0165-1838(81)90059-X; DIXON JS, 1987, J ANAT, V151, P199; Gabella G, 1998, J NEUROCYTOL, V27, P141, DOI 10.1023/A:1006903507321; Hou CL, 2000, CHINESE J REPARATIVE, V14, P10; KOKOTAS NS, 1978, INVEST UROL, V16, P179; Lin HD, 2009, J NEUROSURG-SPINE, V10, P452, DOI 10.3171/2009.1.SPINE08540; Livshits A, 2004, SPINAL CORD, V42, P211, DOI 10.1038/sj.sc.3101574; Malessy MJA, 1998, J NEUROSURG, V89, P568, DOI 10.3171/jns.1998.89.4.0568; PETRAS JM, 1978, BRAIN RES, V153, P363, DOI 10.1016/0006-8993(78)90416-X; Ruggieri MR, 2008, J NEUROTRAUM, V25, P214, DOI 10.1089/neu.2007.0328; Ruggieri MR, 2008, J NEUROTRAUM, V25, P401, DOI 10.1089/neu.2007.0335; Ruggieri MR, 2006, J NEUROTRAUM, V23, P1125, DOI 10.1089/neu.2006.23.1125; Shefchyk SJ, 2002, PROG BRAIN RES, V137, P71; SUNDIN T, 1972, SCAND J UROL NEPHROL, V6, P176, DOI 10.3109/00365597209133634; Tsai EC, 2001, J HISTOCHEM CYTOCHEM, V49, P1111, DOI 10.1177/002215540104900905; WATANABE H, 1979, J ANAT, V128, P873; Xiao CG, 2005, J UROLOGY, V173, P2112, DOI 10.1097/01.ju.0000158072.31086.af; XIAO CG, 1994, PARAPLEGIA, V32, P300, DOI 10.1038/sc.1994.52; Xiao CG, 1999, J UROLOGY, V162, P936, DOI 10.1097/00005392-199909010-00094; Zhang CG, 2006, J PLAST RECONSTR AES, V59, P717, DOI 10.1016/j.bjps.2005.10.023; Zhang CG, 2004, MICROSURG, V24, P232, DOI 10.1002/micr.20015	24	13	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0733-2467			NEUROUROL URODYNAM	Neurourol. Urodyn.		2011	30	4					599	605		10.1002/nau.21042			7	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	749BM	WOS:000289437100023	21254198	Green Accepted			2022-02-06	
J	Boehncke, S; Ackermann, H; Badenhoop, K; Sitzer, M				Boehncke, Sandra; Ackermann, Hanns; Badenhoop, Klaus; Sitzer, Matthias			Pituitary Function and IGF-I Levels following Ischemic Stroke	CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; IGF-I; Pituitary dysfunction; NIHSS; Stroke outcome	GROWTH-FACTOR-I; ANEURYSMAL SUBARACHNOID HEMORRHAGE; BASE-LINE; SCALE; RISK; DYSFUNCTION; DEPRESSION	Background: Pituitary dysfunction is a known complication of traumatic brain injury and subarachnoidal hemorrhage but there are few data about pituitary dysfunction as a complication of ischemic stroke. Methods: We prospectively studied patients 66-274 days after an ischemic stroke, evaluating the prevalence of pituitary dysfunction (by combined releasing hormone testing: GHRH, CRH), stroke severity, outcome and incidence of anxiety and depression. Results: Thirty-two patients (82%) presented with some degree of pituitary dysfunction with predominantly impaired growth hormone response (79.5%) and secondary adrenal failure (14.6%). Abnormal anxiety and/or depression was found in 28.3 and 32.7% of the patients. NIHSS (National Institute of Health Stroke Scale) varied between 1 and 15. Improvement in neurological deficit (Delta NIHSS) correlated significantly with NIHSS at baseline (p < 0.001) but not with pituitary function. Conclusions: Patients with ischemic stroke may suffer from pituitary dysfunction with predominantly impaired growth hormone response and secondary adrenal failure. We suggest that patients who suffer from stroke should undergo pituitary testing. Copyright (C) 2010 S. Karger AG, Basel	[Boehncke, Sandra; Badenhoop, Klaus] Goethe Univ Frankfurt, Dept Internal Med 1, Div Endocrinol Diabet & Metab, DE-60590 Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ Frankfurt, Dept Biostat, DE-60590 Frankfurt, Germany; [Sitzer, Matthias] Goethe Univ Frankfurt, Stroke Unit, Dept Neurol, DE-60590 Frankfurt, Germany		Boehncke, S (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 1, Div Endocrinol Diabet & Metab, Theodor Stern Kai 7, DE-60590 Frankfurt, Germany.	Sandra.Boehncke@kgu.de			Novo Nordisk Corp., Mainz, Germany	This project was partially supported by a research grant from Novo Nordisk Corp., Mainz, Germany, to S. B. The sponsors had no role in the design of the study, in the collection, analyses and interpretation of data, in the writing of the report and in the decision to submit the article for publication. The researchers are independent from the sponsors. All authors had full access to all of the data in the study. Parts of this study were reported at the 10th European Congress of Endocrinology in Berlin, Germany, May 3-7, 2008.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Allolio B, 1996, PRAKTISCHE ENDOKRINO, P219; Appelros P, 2004, CEREBROVASC DIS, V17, P21, DOI 10.1159/000073894; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; ASTROM M, 1993, STROKE, V24, P52, DOI 10.1161/01.STR.24.1.52; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Denti L, 2004, AM J MED, V117, P312, DOI 10.1016/j.amjmed.2004.02.049; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Johansson A, 1997, J NEUROL SCI, V147, P43; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; MAHONEY F I, 1965, Md State Med J, V14, P61; Reschke K, 2003, INTERNIST, V44, P98, DOI 10.1007/s00108-002-0783-6; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Rijn MJE, 2006, J NEUROL NEUROSUR PS, V77, P24, DOI 10.1136/jnnp.2005.067447; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; Weber-Hamann B, 2009, PHARMACOPSYCHIATRY, V42, P23, DOI 10.1055/s-0028-1085442; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	13	14	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.		2011	31	2					163	169		10.1159/000321738			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	779XK	WOS:000291815300008	21135552				2022-02-06	
J	de Guise, E; Gosselin, N; LeBlanc, J; Champoux, MC; Couturier, C; Lamoureux, J; Dagher, J; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; Gosselin, Nadia; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Dagher, Jehane; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Clock Drawing and Mini-Mental State Examination in Patients with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						clock drawing; level 1 trauma center; Mini-Mental State Examination; outcome; traumatic brain injury	SEVERE HEAD-INJURY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PREDICTIVE-VALUE; DEMENTIA; PERFORMANCE; COMA; CARE	The aim of this study was to compare the performances of patients with mild, moderate, and severe traumatic brain injury (TBI) on the Clock Drawing Test (CDT), the Mini-Mental State Examination (MMSE), and neuropsychological measures as well as to correlate these measures with outcome assessed by the Extended Glasgow Outcome Score. This study was conducted in an acute care early rehabilitation setting on 102 patients with mild, 30 with moderate, and 30 with severe TBI. Patients with moderate and severe TBI showed more impairment on the CDT compared with those with mild TBI. Similar results were obtained for the MMSE, F-(2,F-159df)= 3.789, p = .025. Finally, a receiver-operating characteristic analysis showed that the CDT and the Trail-Making Test-Part B (TMT-B) in combination have the potential for prediction of outcome in a TBI population. In conclusion, this combination of the CDT and the TMT-B seems to be useful for early assessment of TBI patients.	[de Guise, Elaine] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; [Gosselin, Nadia] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dagher, Jehane] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Rehabil Med, Montreal, PQ H3G 1A4, Canada; [Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurosurg, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	elaine.deguise@muhc.mcgill.ca		Lamoureux, Julie/0000-0002-4986-2504			Adunsky A, 2002, CLIN REHABIL, V16, P414, DOI 10.1191/0269215502cr514oa; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Esteban-Santillan C, 1998, J AM GERIATR SOC, V46, P1266, DOI 10.1111/j.1532-5415.1998.tb04543.x; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FISHER BW, 1995, J AM GERIATR SOC, V43, P175, DOI 10.1111/j.1532-5415.1995.tb06385.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Freedman M., 1994, CLOCK DRAWING NEUROP; Goodglass H., 1972, ASSESSMENT APHASIA R; Hagen C, 1972, RANCHO LOS AMIGOS SC; HAMILTON BB, 1987, REHABILITATION OUTCO, P135; Hawkins ML, 2003, AM SURGEON, V69, P497; Hubbard EJ, 2008, ARCH CLIN NEUROPSYCH, V23, P295, DOI 10.1016/j.acn.2007.12.003; HUNTZINGER JA, 1992, GEN HOSP PSYCHIAT, V14, P142, DOI 10.1016/0163-8343(92)90040-H; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LIBON DJ, 1993, ARCH CLIN NEUROPSYCH, V8, P405, DOI 10.1016/0887-6177(93)90004-K; Lieberman D, 1999, INT J GERIATR PSYCH, V14, P325, DOI 10.1002/(SICI)1099-1166(199905)14:5<325::AID-GPS904>3.3.CO;2-H; Long CJ, 1992, HDB HEAD TRAUMA ACUT, P107; Milne A, 2008, INT PSYCHOGERIATR, V20, P911, DOI 10.1017/S1041610208007394; Paganini-Hill A, 2001, J AM GERIATR SOC, V49, P941, DOI 10.1046/j.1532-5415.2001.49185.x; Peters R, 2008, DEMENT GERIATR COGN, V26, P351, DOI 10.1159/000162261; REICHMAN WE, 1993, PERCEPT MOTOR SKILL, V76, P793, DOI 10.2466/pms.1993.76.3.793; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; ROYALL DR, 1994, J NEUROPSYCH CLIN N, V6, P62; Ruchinskas RA, 2001, ARCH PHYS MED REHAB, V82, P920, DOI 10.1053/apmr.2001.23993; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; SIGNORET JL, 1989, EVALUATION TROUBLES; Suhr JA, 1999, ARCH PHYS MED REHAB, V80, P773, DOI 10.1016/S0003-9993(99)90226-5; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tranel D, 2008, NEUROPSYCHOLOGY, V22, P553, DOI 10.1037/0894-4105.22.5.553; von Gunten A, 2008, EUR NEUROL, V60, P73, DOI 10.1159/000131895; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wechsler D., 1997, WECHSLER MEMORY SCAL; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; Zhou AH, 2008, INT J GERIATR PSYCH, V23, P422, DOI 10.1002/gps.1897	40	13	13	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	3					179	190		10.1080/09084282.2011.595444			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	884YJ	WOS:000299744500004	21846217				2022-02-06	
S	Keller, E; Froehlich, J; Muroi, C; Sikorski, C; Muser, M		Feng, H; Mao, Y; Zhang, JH		Keller, E.; Froehlich, J.; Muroi, C.; Sikorski, C.; Muser, M.			Neuromonitoring in Intensive Care: A New Brain Tissue Probe for Combined Monitoring of Intracranial Pressure (ICP) Cerebral Blood Flow (CBF) and Oxygenation	EARLY BRAIN INJURY OR CEREBRAL VASOSPASM, VOL 2: CLINICAL MANAGEMENT	Acta Neurochirurgica Supplementum		English	Article; Book Chapter						Subarachnoid haemorrhage; Traumatic brain injury; Cerebral blood flow; Brain tissue probe; Intracranial pressure	NEAR-INFRARED SPECTROSCOPY; OPTICAL SPECTROSCOPY; VOLUME	Background: The benefits of monitoring cerebral blood flow (CBF) in stroke patients are apparent. New techniques combining near infrared spectroscopy (NIRS) and indocyanine green (ICG) dye dilution to estimate cerebral hemodynamics are available. However, with transcutaneous NIRS and optodes applied over the skin, the signal is contaminated by extracerebral tissues. The objective is to develop a new brain tissue probe for combined monitoring of intracranial pressure (ICP), CBF and cerebral blood volume (CBV). Methods: Conventional intraparenchymal probes for ICP monitoring are supplied with optical fibers. The light is coupled into the brain tissue and collected after absorption and scattering with a light detector. Venous injections of 0.2 mg/kgbw ICG are performed. The mean transit time of ICG (mttICG), CBF and CBV are calculated. Results: With a prototype of the probe in a first patient with subarachnoid hemorrhage 6 pairs of repetitive measurements were performed. Mean values were for mttICG 5.6 +/- 0.2 s, CBF 22.3 +/- 2.8 ml/100 g/min and CBV 2.1 +/- 0.3 ml/100 g. Conclusions: NIR spectroscopy allows the synchronous determination of multiple parameters with one single device. By measurements in parallel with the NeMo Probe and NIRS optodes placed over the skin, new algorithms can be developed to subtract the extracerebral contamination from the NIRS signal.	[Keller, E.; Muroi, C.; Sikorski, C.] Univ Zurich Hosp, Neurocrit Care Unit, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Froehlich, J.] ETH, Lab Electromagnet Fields & Microwave Elect, Zurich, Switzerland; [Muser, M.] NeMoDevices, Zurich, Switzerland		Keller, E (corresponding author), Univ Zurich Hosp, Neurocrit Care Unit, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	emanuela.keller@usz.ch	Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261; /0000-0001-9999-3345; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574			AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Colacino J M, 1981, Neurol Res, V3, P17; Germon TJ, 1997, J NEUROL NEUROSUR PS, V63, P660, DOI 10.1136/jnnp.63.5.660; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Hopton P, 1999, J APPL PHYSIOL, V87, P1981, DOI 10.1152/jappl.1999.87.5.1981; Keller E, 2003, ACTA NEUROCHIR, V145, P1111, DOI 10.1007/s00701-003-0102-6; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; MCCORMICK PW, 1991, CRIT CARE MED, V19, P89, DOI 10.1097/00003246-199101000-00020; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; ROBERTS I, 1993, LANCET, V342, P1425, DOI 10.1016/0140-6736(93)92786-S; Rossi S, 1998, ACT NEUR S, V71, P91; Schwarz G, 1996, J NEUROSURG ANESTH, V8, P189, DOI 10.1097/00008506-199607000-00001; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; VAJLOCZY P, 2003, J NEUROSURG, V98, P1227	19	13	14	0	8	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, A-1201 VIENNA, AUSTRIA	0065-1419	2197-8395	978-3-7091-0355-5	ACTA NEUROCHIR SUPPL	Acta Neurochir. Suppl.		2011	110		2				217	220		10.1007/978-3-7091-0356-2_39	10.1007/978-3-7091-0356-2		4	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BTE37	WOS:000286639100039	21125474	Green Accepted			2022-02-06	
J	Krueger, CE; Rosen, HJ; Taylor, HG; Espy, KA; Schatz, J; Rey-Casserly, C; Kramer, JH				Krueger, Casey E.; Rosen, Howard J.; Taylor, H. Gerry; Espy, Kimberly A.; Schatz, Jeffrey; Rey-Casserly, Celiane; Kramer, Joel H.			Know Thyself: Real-World Behavioral Correlates of Self-Appraisal Accuracy	CLINICAL NEUROPSYCHOLOGIST			English	Article						Self-assessment; Self-concept; Awareness; Child behavior; Executive Function; Metacognition	TRAUMATIC BRAIN-INJURY; MEDIAL PREFRONTAL CORTEX; POSITIVE ILLUSORY BIAS; SICKLE-CELL-DISEASE; LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; METACOGNITIVE EXPERIENCES; RATING INVENTORY; ACHIEVEMENT GAP; FRONTAL-CORTEX	Accurate appraisal of one's own abilities is one metacognitive skill considered to be an important factor affecting learning and behavior in childhood. The present study measured self-appraisal accuracy in children using tasks of executive function, and investigated relations between self-appraisal and informant ratings of real-world behaviors measured by the BRIEF. We examined self-appraisal accuracy on fluency tasks in 91 children ages 10-17. More accurate self-appraisal was correlated with fewer informant ratings of real-world behavior problems in inhibition and shifting, independent of actual performance. Findings suggest that self-appraisal represents cognitive processes that are at least partially independent of other functions putatively dependent on the frontal lobes, and these self-appraisal-specific processes have unique implications for optimal daily function.	[Krueger, Casey E.; Rosen, Howard J.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Krueger, Casey E.] Baylor Hlth Care Syst, Frisco, TX USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Espy, Kimberly A.] Univ Nebraska Lincoln, Res Off, Lincoln, NE USA; [Schatz, Jeffrey] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Rey-Casserly, Celiane] Harvard Univ, Sch Med, Dept Psychiat, Childrens Hosp Boston, Boston, MA 02115 USA		Krueger, CE (corresponding author), 7010 Preston Rd,Suite 240, Frisco, TX 75034 USA.	Casey.Krueger@BaylorHealth.edu			National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1 RO1-AG022983-01]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN-271200623661C]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG022983, R01AG030688] Funding Source: NIH RePORTER	This work was supported by the National Institute on Aging (NIA) [grant number 1 RO1-AG022983-01 to J.K.] and National Institute of Neurological Disorders and Stroke (NINDS) [grant number HHSN-271200623661C to J.K.]. The authors report no conflicts of interest.	Al-Kandari FA, 2007, ANN NUCL MED, V21, P439, DOI 10.1007/s12149-007-0050-y; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barell J, 1992, MINDS MATTER FOREWOR, V1; Berkelhammer LD, 2007, CHILD NEUROPSYCHOL, V13, P120, DOI 10.1080/09297040600800956; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; College Board, 1976, STUD DESCR QUEST; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Dennis M., 1996, DEV NEUROPSYCHOL, V12, P17; Dermitzaki I, 2005, PSYCHOL REP, V97, P759, DOI 10.2466/pr0.97.3.759-768; Efklides A, 2009, PSICOTHEMA, V21, P76; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; Evangelista NM, 2008, J ABNORM CHILD PSYCH, V36, P779, DOI 10.1007/s10802-007-9210-8; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; FELSON RB, 1981, SOC PSYCHOL QUART, V44, P64, DOI 10.2307/3033866; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Godefroy O., 2008, REV NEUROL-FRANCE, V164, P119; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Kircher TTJ, 2007, PSYCHOPATHOLOGY, V40, P254, DOI 10.1159/000101730; Koriat A., 2002, METACOGNITION PROCES; Krebs SS, 2010, BRIT J EDUC PSYCHOL, V80, P325, DOI 10.1348/000709910X485719; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LARWOOD L, 1977, J APPL PSYCHOL, V62, P194, DOI 10.1037/0021-9010.62.2.194; Lawrence Vivienne, 2004, J Atten Disord, V7, P137, DOI 10.1177/108705470400700302; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Mahone EM, 2007, CLIN NEUROPSYCHOL, V21, P569, DOI 10.1080/13854040600762724; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; Owens JS, 2003, J CONSULT CLIN PSYCH, V71, P680, DOI 10.1037/0022-006X.71.4.680; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pickup GJ, 2008, PSYCHOPATHOLOGY, V41, P206, DOI 10.1159/000125554; REEVE RA, 1985, J ABNORM CHILD PSYCH, V13, P343, DOI 10.1007/BF00912721; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roebers CM, 2007, J EXP CHILD PSYCHOL, V97, P117, DOI 10.1016/j.jecp.2006.12.006; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider W, 2000, COGNITIVE DEV, V15, P115, DOI 10.1016/S0885-2014(00)00024-1; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Semrud-Clikeman M, 2010, J AUTISM DEV DISORD, V40, P1017, DOI 10.1007/s10803-010-0951-9; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; SIDAK Z, 1967, J AM STAT ASSOC, V62, P623; Skranes J, 2009, NEUROREPORT, V20, P263, DOI 10.1097/WNR.0b013e32832027fe; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Williamson C, 2010, J NEUROL NEUROSUR PS, V81, P140, DOI 10.1136/jnnp.2008.166041	49	13	14	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					741	756		10.1080/13854046.2011.569759			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000004	21547852	Green Accepted			2022-02-06	
J	Liu, Q; Cui, XR; Abbod, MF; Huang, SJ; Han, YY; Shieh, JS				Liu, Quan; Cui, Xingran; Abbod, Maysam F.; Huang, Sheng-Jean; Han, Yin-Yi; Shieh, Jiann-Shing			Brain death prediction based on ensembled artificial neural networks in neurosurgical intensive care unit	JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS			English	Article						Brain death prediction; Ensembled artificial neural networks; Sensitivity analysis; ROC curve analysis	SENSITIVITY; MANAGEMENT	A novel ensembled artificial neural networks (EANN) model was used for brain death prediction in this study. The experimental material for this study focused on the severe head injury patients with different level of Glasgow Coma Scale (GCS) in neurosurgical and traumatic intensive care unit (ICU) of National Taiwan University Hospital (NTUH) in Taipei. Two prediction models were established, i.e., the first has 11 input variables while the second has 14 input variables. The root mean square error (RMSE) and the receiver operating characteristic (ROC) curve analysis were applied to examine the performance of the prediction models. Regression analysis was developed to compare the prediction results with EANN model. Besides, sensitivity analysis was carried out to evaluate the significance ranking of the input variables. For the 11 input variables models, the topologies of 11-5-1, 11-6-1, 11-20-1, 11-22-1, 11-11-10-1 and 11-20-10-1 gave similar results, which had the best performance with the value of area under curve (AUC) (0.96) and accuracy (0.9167), while the topology of 11-5-1 presented the smallest RMSE (0.2023 for test data). For the 14 input variables models, all of the topologies performed very well with all the parameters in ROC curve analysis were 1.0; however the 14-14-5-1 topology when choosing the best networks in ensemble model showed the best performance (RMSE for test data was 0.0423), which are much better than the results of regression analysis (RMSE for test data was 0.38 for 11 variables and 0.171 for 14 variables). With the help of sensitivity analysis, the significance ranking results for the 11 and 14 input variables in this study were presented. In conclusion, the successful results of RMSE and ROC curve analysis confirm that EANN model is useful to be applied to predict such a complicated issue as brain death. (C) 2010 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.	[Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Liu, Quan; Cui, Xingran] Wuhan Univ Technol, Dept Informat Engn, Wuhan 430070, Peoples R China; [Abbod, Maysam F.] Brunel Univ, Sch Engn & Design, London, England; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Han, Yin-Yi] Natl Taiwan Univ Hosp, Dept Trauma, Taipei, Taiwan		Shieh, JS (corresponding author), Yuan Ze Univ, Dept Mech Engn, Tao Yuan, Taiwan.	jsshieh@saturn.yzu.edu.tw		HAN, YIN-YI/0000-0001-8831-7835	National Science Council (NSC) of TaiwanMinistry of Science and Technology, Taiwan [NSC97-2915-I-155-001]; Yuan Ze University in Taiwan; Wuhan University of Technology (WUT) in China; WUT	The authors wish to thank the National Science Council (NSC) of Taiwan (Grant Number: NSC97-2915-I-155-001) for supporting this research. The authors also wish to thank the exchange PhD student program of Yuan Ze University in Taiwan and Wuhan University of Technology (WUT) in China for supporting this research. This paper is also financially supported by self-determined and innovative research funds of WUT.	AHMET Y, 2009, APPL SOFT COMPUT, V9, P1029; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ANDREW H, 2000, COMPUT METH PROG BIO, V62, P11; Ashwal S, 2001, BRAIN DEATH, P91; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bugge JF, 2009, ACTA ANAESTH SCAND, V53, P1239, DOI 10.1111/j.1399-6576.2009.02064.x; CHATFIELD C, 1993, J BUS ECON STAT, V11, P121, DOI 10.2307/1391361; Corder GW., 2009, NONPARAMETRIC STAT N; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Cuende N, 2002, ORGANS TISSUES, V5, P109; Delen D, 2006, ACCIDENT ANAL PREV, V38, P434, DOI 10.1016/j.aap.2005.06.024; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Fahlman S., 1988, P 1988 CONN MOD SUMM; Fish K.E., 2003, J TARGET MEASURE ANA, V11, P244, DOI [10.1057/palgrave.jt.5740081, DOI 10.1057/PALGRAVE.JT.5740081]; Fish KE, 2004, KYBERNETES, V33, P1127, DOI 10.1108/03684920410534461; Freeman J.A., 1991, NEURAL NETWORKS ALGO; GERALD FF, 2003, J CLIN DENSITOM, V6, P231; GULER I, 2005, P EMBS SHANG CHIN; Guler I, 2007, IEEE T INF TECHNOL B, V11, P117, DOI 10.1109/TITB.2006.879600; Guler I, 2009, EXPERT SYST APPL, V36, P10424, DOI 10.1016/j.eswa.2009.01.036; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hong Y, 2009, PATTERN RECOGN LETT, V30, P298, DOI 10.1016/j.patrec.2008.10.007; JEAN JSN, 1994, IEEE T NEURAL NETWOR, V5, P752, DOI 10.1109/72.317727; Kennedy J, 1997, P IEEE INT C COMP CY; KENNETH JO, 2001, J CLIN EPIDEMIOL, V54, P1159; KONNO Y, 2007, IEEE DEST, P547; Kung SY, 1998, P IEEE, V86, P1244, DOI 10.1109/5.687838; Lazzus JA, 2009, J TAIWAN INST CHEM E, V40, P213, DOI 10.1016/j.jtice.2008.08.001; LEK S, 2000, APPL ECOLOGY EVOLUTI; Lin C. T., 1999, NEURAL FUZZY SYSTEMS; Mizraji R, 2009, TRANSPL P, V41, P3489, DOI 10.1016/j.transproceed.2009.09.008; Nathan HM, 2003, AM J TRANSPLANT, V3, P29, DOI 10.1034/j.1600-6143.3.s4.4.x; Nathan S., 2006, SEMIN ANESTH PERIO M, V25, P225, DOI [10.1053/j.sane.2006.09.005, DOI 10.1053/j.sane.2006.09.005]; NORMAN GA, 1999, ANESTHESIOLOGY, V91, P275; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Ottenbacher KJ, 2004, ANN EPIDEMIOL, V14, P551, DOI 10.1016/j.annepidem.2003.10.005; Park YS, 2007, ECOL MODEL, V204, P427, DOI 10.1016/j.ecolmodel.2007.01.021; Popovic D, 1998, IEE P-GENER TRANSM D, V145, P355, DOI 10.1049/ip-gtd:19981977; Poularas J, 2006, TRANSPL P, V38, P1213, DOI 10.1016/j.transproceed.2006.02.127; RECKNAGEL F, 2003, UNDERSTANDING ECOLOG; Rizk ML, 2009, J TAIWAN INST CHEM E, V40, P595, DOI 10.1016/j.jtice.2009.05.003; Rosendale JD, 2003, TRANSPLANTATION, V75, P482, DOI 10.1097/01.TP.0000045683.85282.93; SHIEH JS, 2009, HARD SOFT COMPUTING; Sinha RK, 2007, MED ENG PHYS, V29, P120, DOI 10.1016/j.medengphy.2006.01.011; STALENHOEF PA, 2002, J CLIN EPIDEMIOL; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; Vuk M., 2006, METODOLOSKI ZVEZKI, V1, P89; Wijdicks EFM, 2006, NEUROLOGY, V66, P460, DOI 10.1212/01.wnl.0000209204.87339.ef; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Wu B, 2010, EXPERT SYST APPL, V37, P4058, DOI 10.1016/j.eswa.2009.11.051; Yang ACC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108103; Yang S, 2004, EXPERT SYST, V21, P279, DOI 10.1111/j.1468-0394.2004.00285.x; Yu HL, 2010, MATH COMPUT MODEL, V51, P1375, DOI 10.1016/j.mcm.2009.10.028; Zhou ZH, 2003, LECT NOTES ARTIF INT, V2639, P476; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	56	13	13	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1876-1070	1876-1089		J TAIWAN INST CHEM E	J. Taiwan Inst. Chem. Eng.	JAN	2011	42	1					97	107		10.1016/j.jtice.2010.05.006			11	Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	714YL	WOS:000286847500014					2022-02-06	
J	Nelson, JA				Nelson, James A.			Local Skull Trephination Before Transfer Is Associated With Favorable Outcomes in Cerebral Herniation from Epidural Hematoma	ACADEMIC EMERGENCY MEDICINE			English	Article							TRAUMATIC EXTRADURAL HEMATOMA; BURR HOLE; DECOMPRESSIVE SURGERY; SUBDURAL HEMATOMAS; HEAD-INJURIES; BRAIN-INJURY; EMERGENCY; MANAGEMENT; NEUROSURGERY; PROGNOSIS	P>Objectives: The patient with epidural hematoma and cerebral herniation has a good prognosis with immediate drainage, but a poor prognosis with delay to decompression. Such patients who present to nonneurosurgical hospitals are commonly transferred without drainage to the nearest neurosurgical center. This practice has never been demonstrated to be the safest approach to treating these patients. A significant minority of emergency physicians (EPs) have advised and taught bedside burr hole drainage or skull trephination before transfer for herniating patients. The objective of this study was to assess the effect of nonneurosurgeon drainage on neurologic outcome in patients with cerebral herniation from epidural hematoma. Methods: A structured literature review was performed using EMBASE, the Cochrane Library, and the Emergency Medicine Abstracts database. Results: No evidence meeting methodologic criteria was found describing outcomes in patients transferred without decompressive procedures. For patients receiving local drainage before transfer, 100% had favorable outcomes. Conclusions: Although the total number of patients is small and the population highly selected, the natural history of cerebral herniation from epidural hematoma and the best available evidence suggests that herniating patients have improved outcomes with drainage procedures before transport.	[Nelson, James A.] Pioneers Mem Hosp, Emergency Dept, Brawley, CA 92227 USA; [Nelson, James A.] Univ Calif San Diego, Emergency Dept, San Diego, CA 92103 USA		Nelson, JA (corresponding author), Pioneers Mem Hosp, Emergency Dept, Brawley, CA 92227 USA.	jamesnelsonmd@gmail.com					BATTERSBY RDE, 1990, BRIT J HOSP MED, V44, P276; Biros MH, 2009, ROSENS EMERGENCY MED; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Brock M, 1994, Zentralbl Neurochir, V55, P204; Bulters D, 2009, ANAESTHESIA, V64, P277, DOI 10.1111/j.1365-2044.2008.05779.x; Burton C, 1965, J Trauma, V5, P643, DOI 10.1097/00005373-196509000-00008; Caird J, 1999, IRISH MED J, V92, P270; Caird JD, 2003, BRIT J NEUROSURG, V17, P509, DOI 10.1080/02688690310001627722; Campana Bruce A, 2004, CMAJ, V171, P444, DOI 10.1503/cmaj.1040006; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Deverill J, 2007, EMERG MED AUSTRALAS, V19, P325, DOI 10.1111/J.1742-6723.2007.00969.x; GHANDI Y, 2004, EMERGENCY MED PROCED, P881; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JENNETT B, 1975, LANCET, V1, P480; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Latronico N, 2003, Minerva Anestesiol, V69, P159; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Liu JT, 2006, ACTA NEUROCHIR, V148, P313, DOI 10.1007/s00701-005-0723-z; MAHONEY BD, 1981, NEUROSURGERY, V8, P551, DOI 10.1227/00006123-198105000-00006; Marion DW, 2006, NEUROSURGERY, V58, P655; MCLELLAN K, 1998, CAN J RURAL MED, V3, P223; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; O'SULLIVAN M G, 1990, British Journal of Neurosurgery, V4, P473, DOI 10.3109/02688699008993795; Offner PJ, 2006, AM J SURG, V192, P801, DOI 10.1016/j.amjsurg.2006.08.047; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Posner J. B., 2007, PLUM POSNERS DIAGNOS, P95; REYNA TM, 1981, MIL MED, V146, P504; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Rottger J, 1997, J Telemed Telecare, V3, P59, DOI 10.1258/1357633971930210; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Smith SW, 2010, J EMERG MED, V39, P377, DOI 10.1016/j.jemermed.2009.04.062; SPRINGER MFB, 1988, AM J EMERG MED, V6, P640, DOI 10.1016/0735-6757(88)90110-6; Tallon JM, 2008, CAN J SURG, V51, P339; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Valadka AB, 2006, J AM COLL SURGEONS, V203, P962, DOI 10.1016/j.jamcollsurg.2006.08.014; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; WOODRUFF M, 2008, ESSENTIAL EMERGENCY, P153; World Health Organization, SURG CAR DISTR HOSP; WRAY AA, 2002, EMERGENCY PROCEDURES, P186; 2009, BBC NEWS        0520; 1998, BBC NEWS        0713; 1998, BBC NEWS        0904	52	13	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2011	18	1					78	85		10.1111/j.1553-2712.2010.00949.x			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	704LE	WOS:000286053700012	21414061	Bronze			2022-02-06	
J	Scheibel, RS; Newsome, MR; Wilde, EA; McClelland, MM; Hanten, G; Krawczyk, DC; Cook, LG; Chu, ZD; Vasquez, AC; Yallampalli, R; Lin, XD; Hunter, JV; Levin, HS				Scheibel, Randall S.; Newsome, Mary R.; Wilde, Elisabeth A.; McClelland, Michelle M.; Hanten, Gerri; Krawczyk, Daniel C.; Cook, Lori G.; Chu, Zili D.; Vasquez, Ana C.; Yallampalli, Ragini; Lin, Xiaodi; Hunter, Jill V.; Levin, Harvey S.			Brain activation during a social attribution task in adolescents with moderate to severe traumatic brain injury	SOCIAL NEUROSCIENCE			English	Article						Traumatic brain injury; fMRI; Social cognition; Adolescents; Diffusion tensor imaging	WORKING-MEMORY; EMOTION RECOGNITION; MIND; CHILDREN; CHILDHOOD; COGNITION; OUTCOMES; IMPACT; FMRI; REORGANIZATION	The ability to make accurate judgments about the mental states of others, sometimes referred to as theory of mind (ToM), is often impaired following traumatic brain injury (TBI), and this deficit may contribute to problems with interpersonal relationships. The present study used an animated social attribution task (SAT) with functional magnetic resonance imaging (fMRI) to examine structures mediating ToM in adolescents with moderate to severe TBI. The study design also included a comparison group of matched, typically developing (TD) adolescents. The TD group exhibited activation within a number of areas that are thought to be relevant to ToM, including the medial prefrontal and anterior cingulate cortex, fusiform gyrus, and posterior temporal and parietal areas. The TBI subjects had significant activation within many of these same areas, but their activation was generally more intense and excluded the medial prefrontal cortex. Exploratory regression analyses indicated a negative relation between ToM-related activation and measures of white matter integrity derived from diffusion tensor imaging, while there was also a positive relation between activation and lesion volume. These findings are consistent with alterations in the level and pattern of brain activation that may be due to the combined influence of diffuse axonal injury and focal lesions.	[Scheibel, Randall S.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Scheibel, Randall S.; Newsome, Mary R.; Wilde, Elisabeth A.; Yallampalli, Ragini; Lin, Xiaodi; Levin, Harvey S.] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Chu, Zili D.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McClelland, Michelle M.; Krawczyk, Daniel C.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [McClelland, Michelle M.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA		Scheibel, RS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	scheibel@bcm.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grant NS021889. We thank the adolescents and their families for their participation, Xiaoqi Li for statistical assistance, and Dr Sandra Chapman for advice regarding the design of this study. Recruitment and imaging of the subjects were facilitated by the General Clinical Research Center at Texas Children's Hospital and Ben Taub General Hospital in Houston, as well as the Children's Medical Center and Our Children's House at the Baylor Medical Center in Dallas and the Advanced Imaging Center at the University of Texas Southwestern Medical Center. The South Central Mental Illness Research, Education, and Clinical Center (MIRECC) and the Michael E. DeBakey Veteran's Affairs Medical Center provided access to laboratory facilities used for the analysis of the image data.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Aldrich NJ, 2011, BRIT J DEV PSYCHOL, V29, P86, DOI 10.1348/026151010X533238; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chevallier C, 2011, NEUROPSYCHOLOGIA, V49, P507, DOI 10.1016/j.neuropsychologia.2010.11.042; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes C., 2010, J EXPT CHILD PSYCHOL, V108, P96; Hynes C. A., 2011, SOCIAL NEUROSCIENCE, VXX, pXXX; Jacobs DM, 2000, PERCEPT PSYCHOPHYS, V62, P1332, DOI 10.3758/BF03212135; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kobayashi C, 2007, NEUROPSYCHOLOGIA, V45, P1522, DOI 10.1016/j.neuropsychologia.2006.11.017; LaBar KS, 2001, NEUROREPORT, V12, P3461, DOI 10.1097/00001756-200111160-00017; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Moriguchi Y, 2007, PSYCHIAT CLIN NEUROS, V61, P355, DOI 10.1111/j.1440-1819.2007.01687.x; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Stocks EL, 2011, J APPL SOC PSYCHOL, V41, P1, DOI 10.1111/j.1559-1816.2010.00699.x; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 2011, WECHSLER ABBREVIATED; Weiderholt J.L., 2001, GRAY ORAL READING TE, V4th; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	70	13	14	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2011	6	5-6			SI		582	598		10.1080/17470919.2011.588844			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	882NL	WOS:000299570500013	21777109	Green Accepted			2022-02-06	
J	van Rijn, CM; Perescis, MFJ; Vinogradova, L; van Luijtelaar, G				van Rijn, Clementine M.; Perescis, Martin F. J.; Vinogradova, Lyudmila; van Luijtelaar, Gilles			Endocannabinoid system protects against cryptogenic seizures	PHARMACOLOGICAL REPORTS			English	Article						cannabis; rimonabant; endocannabinoid system; epilepsy; cryptogenic seizures	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL-NEURONS; EPILEPSY; EXCITOTOXICITY; ANTAGONISTS; DAMAGE; TESTS; MODEL	Effects of the cannabinoid antagonist rimonabant on the EEG were investigated in healthy, non-epileptic rats. The drug was administered orally at 30 mg/kg/day for 3 weeks. The EEG was recorded continuously. In 3 out of 13 rats, limbic convulsive seizures, which were not related to the time of drug administration, were observed after 5-8 days. We hypothesize that an accumulation of micro-injuries in the brain is responsible for these "spontaneous" seizures.	[van Rijn, Clementine M.; Perescis, Martin F. J.; Vinogradova, Lyudmila; van Luijtelaar, Gilles] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands		van Rijn, CM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, POB 9104, NL-6500 HE Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	van Luijtelaar, Gilles/D-2290-2010; Vinogradova, Ljudmila/F-9578-2017; van Rijn, Clementina/D-5828-2012	Vinogradova, Lyudmila/0000-0003-0336-606X; van Rijn, Clementina/0000-0002-1103-6338			Alger BE, 2006, NEURON, V51, P393, DOI 10.1016/j.neuron.2006.08.003; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; CORCORAN ME, 1978, EPILEPSIA, V19, P47; COURT A, 1996, EPILEPSIA, V37, P141; Deshpande LS, 2007, NEUROSCI LETT, V411, P11, DOI 10.1016/j.neulet.2006.09.046; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Karanian DA, 2007, J PHARMACOL EXP THER, V322, P1059, DOI 10.1124/jpet.107.120147; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Leppik IE, 2006, EPILEPSIA, V47, P65, DOI 10.1111/j.1528-1167.2006.00664.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; MEHTA CR, 1993, AM STAT, V47, P91, DOI 10.2307/2685184; Nagayama T, 1999, J NEUROSCI, V19, P2987; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Patrylo PR, 2007, EPILEPSIA, V48, P1964, DOI 10.1111/j.1528-1167.2007.01139.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rohmel J, 1999, BIOMETRICAL J, V41, P149; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Solbrig MV, 2005, EXP NEUROL, V194, P355, DOI 10.1016/j.expneurol.2005.02.017; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06	28	13	13	0	2	POLISH ACAD SCIENCES INST PHARMACOLOGY	KRAKOW	SMETNA 12, 31-343 KRAKOW, POLAND	1734-1140			PHARMACOL REP	Pharmacol. Rep.	JAN-FEB	2011	63	1					165	168					4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	750ZZ	WOS:000289588400019	21441624				2022-02-06	
J	Chen, X; Lin, YP; Wang, D; Zhang, JN				Chen, Xin; Lin, Yun-Peng; Wang, Dong; Zhang, Jian-Ning			Dexamethasone exacerbates spatial acquisition deficits after traumatic brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						Tramatic brain injury; Spatial acquisition deficits; Dexamethasone	PROLONGED GLUCOCORTICOID EXPOSURE; WATER-MAZE; STRESS; MEMORY; HIPPOCAMPUS; PRIMATES; NUMBER; MICE	Objectives: Given after traumatic brain injury (TBI), Dexamethasone (DXM) reduces cerebral edema but impairs retrograde memory. This study was designed to test the hypothesis that administration of DXM to rats with TBI promotes learning deficits that are correlated with the morphological changes of hippocampal pyramidal neurons. Methods: Adult male Wistar rats were subjected to fluid percussion injury (FPI), received DXM (5 and 10 mg/kg), and then trained for spatial acquisition. Brain sections were examined by H. E. and Golgi impregnation to quantitatively measure the morphological changes of hippocampal pyramidal neurons. Results: The latency and path length were significantly higher in rats with FPI than those in control groups, particularly in rats receiving post-trauma high-dose DXM. At the same time, Golgi impregnation revealed a significant decrease in the number of apical and basal dendrites of pyramidal neurons of ipsilateral hippocampus in rats after injury, but the decrease was greatest of CA3 pyramidal neurons of ipsilateral hippocampus in injured rats that also received high-dose DXM. Discussion: These findings indicate that the administration of high-dose DXM after TBI could worsen the dendritic atrophy of hippocampal CA3 pyramidal neurons and, as a result, exacerbate spatial acquisition deficits.	[Chen, Xin; Lin, Yun-Peng; Wang, Dong; Zhang, Jian-Ning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg,Lab TJIVR, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg,Lab TJIVR, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National 973 Project of ChinaNational Basic Research Program of China [2005CB522604]; Tianjin Science and Techonology Development Plan [05-YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]; Tianjin Medical University	This work is supported by National 973 Project of China (grant no. 2005CB522604), Tianjin Science and Techonology Development Plan (grant no. 05-YFGDSF02500), Tianjin Natural Science Foundation (grant no. 033611511), and "211 Project" Graduate Innovation Grant of Tianjin Medical University. The authors sincerely appreciate Li Liu, Weiyun Cui, Fanglian Chen, Yan Chai, and Lei Zhou for excellent technical support.	ALLEN TC, 1992, METHODS HISTOTECHNOL, P53; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; FLUGGE G, 1988, EXP BRAIN RES, V72, P417; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; He WB, 2008, CELL MOL NEUROBIOL, V28, P277, DOI 10.1007/s10571-007-9180-y; JOHREN O, 1994, ANN NY ACAD SCI, V746, P429; LAURER HL, 2002, ENCY HUMAN BRAIN; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MICCO DJ, 1980, J COMP PHYSIOL PSYCH, V94, P624, DOI 10.1037/h0077700; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SHOLL DA, 1953, J ANAT, V87, P387; Tata DA, 2006, J COMP NEUROL, V498, P363, DOI 10.1002/cne.21071; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yao YY, 2007, EUR J PHARMACOL, V574, P20, DOI 10.1016/j.ejphar.2007.07.021	26	13	13	0	3	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	DEC	2010	32	10					1097	1102		10.1179/016164110X12681290831162			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	670LD	WOS:000283422300013	20483023				2022-02-06	
J	Croce, A; Moretti, A; Vitullo, F; Castriotta, A; De Rosa, M; Citraro, L				Croce, A.; Moretti, A.; Vitullo, F.; Castriotta, A.; De Rosa, M.; Citraro, L.			Transparotid approach for mandibular condylar neck and subcondylar fractures	ACTA OTORHINOLARYNGOLOGICA ITALICA			English	Article						Mandible; Condylar neck fractures; Subcondylar fractures; Facial nerve	OPEN REDUCTION; INTERNAL-FIXATION; SURGICAL-TREATMENT; OSTEOSYNTHESIS; OSTEOTOMY; REPAIR	Mandibular condylar neck fractures and subcondylar fractures represent, respectively, 19-29% and 62-70% of all mandibular fractures; treatment involves some problems, common to both, concerning the choice of an adequate approach. Herewith, personal experience is reported related to the surgical treatment of some cases of mandibular condylar neck and subcondylar fractures by transparotid approaches with partial parotidectomy, removing the salivary tissue overlying the condylar neck and/or the subcondylar region. Over the last 5 years, we observed 22 fractures of the condylar neck and 10 fractures of the subcondylar region. In 13 patients (11 male, 2 female, age range 10-68 years, mean 33 years), 10 of whom had other mandibular and/or other maxillo-facial and skeleton fractures -50% of these with dislocated condylar heads -and the other 3 for their free choice, regarding the different treatments, 18 transparotid approaches with partial parotidectomy (bilateral in 5 cases), were performed reducing and fixing 12 condylar neck fractures and 5 subcondylar region fractures with appropriate plates (2.0 mm) and screws. After surgery, no intermaxillary fixation was performed. Complications included 4 salivary fistulae (bilateral in 1 patient), which closed spontaneously after 4 or 5 weeks with a dressing, 1 case of Frey's syndrome, which healed after 2 treatments with botulin and 6 cases of transient facial palsy lasting 4-8 weeks (1 case bilateral) affecting zygomatic, buccal and marginal mandibular nerves. During follow-up, functional parameters considered were: restoration of original pre-injury occlusion; vertical, lateral and protrusion mandibular movements. All patients re-acquired the original pre-injury occlusion; the maximal post-operative intrinsical distance was at least 40 mm after a variable period of rehabilitation and lateral and protrusion movements also led to satisfactory final results. All patients were free of pain and had no deflection or clicking upon opening or chewing. None suffered from haematoma, miniplate fractures, bone resorption or condylar necrosis. In our experience, the Transparotid approaches with partial parotidectomy permits very good anatomical repositioning of the displaced condylar or subcondylar osseous segments in all cases, since isolation of the facial nerve branches and removal of a limited part of the parotid gland tissue overlying the lesion allow perfect exposure of the fracture site. The wide operation field allows the facial nerve to be preserved and permits easy internal rigid fixation with plates, as the drill, screws and screwdriver can be positioned exactly perpendicular to the bone surface instead of obliquely, as occurs with many different approaches.	[Croce, A.; Moretti, A.; Vitullo, F.; Castriotta, A.; De Rosa, M.; Citraro, L.] G DAnnunzio Univ Chieti Pescara, Dept Surg Sci, Otorhinolaryngol Unit, Chieti, Italy		Croce, A (corresponding author), Univ G dAnnunzio, Clin Otorinolaringoiatr, Osped Clin SS Annunziata, Via Vestini, I-66013 Chieti, Scalo, Italy.	acroce@unich.it					Anastassov GE, 1997, J CRANIO MAXILL SURG, V25, P9, DOI 10.1016/S1010-5182(97)80018-2; BOYNE PJ, 1989, J ORAL MAXIL SURG, V47, P228, DOI 10.1016/0278-2391(89)90223-1; Chen CT, 1999, PLAST RECONSTR SURG, V103, P60, DOI 10.1097/00006534-199901000-00011; Choi BH, 1999, ORAL SURG ORAL MED O, V88, P292, DOI 10.1016/S1079-2104(99)70030-2; Choung PH, 1998, J ORAL MAXIL SURG, V56, P563, DOI 10.1016/S0278-2391(98)90452-9; Devlin MF, 2002, BRIT J ORAL MAX SURG, V40, P23, DOI 10.1054/bjom.2001.0748; Downie JJ, 2009, BRIT J ORAL MAX SURG, V47, P370, DOI 10.1016/j.bjoms.2008.11.002; Dunaway DJ, 1996, BRIT J PLAST SURG, V49, P79; Ellis E, 2000, J ORAL MAXIL SURG, V58, P27, DOI 10.1016/S0278-2391(00)80010-5; ELLIS E, 1989, ORAL SURG ORAL MED O, V68, P369, DOI 10.1016/0030-4220(89)90130-8; Guerrissi JO, 2002, J CRANIOFAC SURG, V13, P568; Hammer B, 1997, BRIT J ORAL MAX SURG, V35, P288, DOI 10.1016/S0266-4356(97)90050-4; Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868; Haug RH, 2001, PARAMETERS PATHWAYS, P1; HAYWARD JR, 1993, J ORAL MAXIL SURG, V51, P57, DOI 10.1016/S0278-2391(10)80391-X; Hyde N, 2002, BRIT J ORAL MAX SURG, V40, P19, DOI 10.1054/bjom.2001.0734; KENT JN, 1990, ORAL MAXILLOFAC SURG, V2, P69; Killey HC, 1974, FRACTURES MANDIBLE; KONSTANTINOVIC VS, 1992, J ORAL MAXIL SURG, V50, P349, DOI 10.1016/0278-2391(92)90395-G; LASKIN DM, 1991, J ORAL MAXIL SURG, V49, P1141, DOI 10.1016/0278-2391(91)90403-9; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; MACLENNAN W D, 1969, British Journal of Oral Surgery, V7, P31, DOI 10.1016/S0007-117X(69)80058-2; MIKKONEN P, 1989, INT J ORAL MAX SURG, V18, P267, DOI 10.1016/S0901-5027(89)80092-X; Miloro M, 2003, ORAL SURG ORAL MED O, V96, P387, DOI 10.1016/j.tripleo.2003.07.004; Newman L, 1998, BRIT J ORAL MAX SURG, V36, P176, DOI 10.1016/S0266-4356(98)90492-2; Oezmen Y, 1998, INT J ORAL MAX SURG, V27, P33, DOI 10.1016/S0901-5027(98)80092-1; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Sawazaki R, 2010, J ORAL MAXIL SURG, V68, P1252, DOI 10.1016/j.joms.2009.03.064; Schon R, 2003, J ORAL MAXIL SURG, V61, P49, DOI 10.1053/joms.2003.50009; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; Smets LMH, 2003, J CRANIO MAXILL SURG, V31, P162, DOI 10.1016/S1010-5182(03)00025-8; SOREL B, 1998, ORAL MAXILLOFAC SURG, V10, P541; TAKENOSHITA Y, 1990, J ORAL MAXIL SURG, V48, P1191, DOI 10.1016/0278-2391(90)90535-A; VELAVER A, 2005, J CRANIOMAXILLOFAC S, V33, P169; Vogt A, 2005, ORAL MAXILLOFAC SURG, V9, P246, DOI 10.1007/s10006-005-0621-9; Wilson AW, 2005, BRIT J ORAL MAX SURG, V43, P57, DOI 10.1016/j.bjoms.2004.09.011; XIEN Z, 1991, J ORAL MAXIL SURG, V49, P1181, DOI 10.1016/0278-2391(91)90414-H; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8; ZIDE MF, 1989, CLIN PLAST SURG, V16, P69	40	13	14	0	2	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	0392-100X	1827-675X		ACTA OTORHINOLARYNGO	Acta Otorhinolaryngol. Ital.	DEC	2010	30	6					303	309					7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	742SY	WOS:000288966000007	21808452				2022-02-06	
J	Isaradisaikul, S; Navacharoen, N; Hanprasertpong, C; Kangsanarak, J; Panyathong, R				Isaradisaikul, Suwicha; Navacharoen, Niramon; Hanprasertpong, Charuk; Kangsanarak, Jaran; Panyathong, Rapeepun			Causes and time-course of vertigo in an ear, nose, and throat clinic	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Vertigo; Vestibular disorder; Outpatient clinic	EXPERIENCE; DIZZINESS	The purpose of this study is to review etiologies and identify the time-course of vertigo presenting in an ear, nose, and throat clinic, and serve as a reference guide for other clinics. The study includes retrospective chart review in a tertiary care, university hospital. The patient data with reported ICD-10 codes as causes of vertigo between April 2005 and December 2007 were extracted from the database. At each visit, the main diagnosis as to etiology, characteristics of the vertigo, its time-course, and patient demographic data were recorded. Of 547 cases, 17 diagnoses were made in 73.9%. Diagnostic categories included peripheral vertigo 72.9%, central vertigo 0.8%, psychogenic cause 0.2%, and unknown 26.1%. Common causes of vertigo were benign paroxysmal positional vertigo (BPPV) 52.5%, Meniere's disease 14.6%, and sudden idiopathic hearing loss 2.9%. Less common diagnoses were benign paroxysmal vertigo of childhood 0.7%, labyrinthitis 0.7%, and vestibular schwannoma 0.3%. Rare conditions were delayed endolymphatic hydrops, Ramsey Hunt syndrome, otosyphilis, vestibular neuritis, temporal bone fracture, post-concussion syndrome, cerebellar infarction, epilepsy, cervical vertigo, Streptococcus suis meningitis, and psychogenic vertigo. Ninety-nine cases who reported remission of vertigo during the study period had median onset of the remission at 4 weeks. In the ear, nose, and throat clinic at Chiang Mai University, a tertiary university hospital, peripheral vestibular disorders were the main etiology of vertigo. The three most common causes were BPPV, Meniere's disease, and sudden idiopathic hearing loss. Half of the cases who returned for follow up had remitted symptoms within 4 weeks.	[Isaradisaikul, Suwicha; Navacharoen, Niramon; Hanprasertpong, Charuk; Kangsanarak, Jaran; Panyathong, Rapeepun] Chiang Mai Univ, Dept Otolaryngol, Fac Med, Chiang Mai 50200, Thailand		Isaradisaikul, S (corresponding author), Chiang Mai Univ, Dept Otolaryngol, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	sisaradi@mail.med.cmu.ac.th; nnavacha@mail.med.cmu.ac.th; jrukhan@yahoo.com; jarank@mail.med.cmu.ac.th; rapee_rapee@hotmail.com		Isaradisaikul Kaewsiri, Suwicha/0000-0003-1332-9940	Faculty of Medicine, Chiang Mai University	Grant support for this project was provided by the Faculty of Medicine, Chiang Mai University. The authors would like to thank Prof. Herman A. Jenkins for proof read the manuscript.	Asawavichianginda S., 2007, EAR VERTIGO HEARING, P47; BANGPOOPHAMORN K, 2007, 11 AS OC ORL HEAD NE; Bath AP, 2000, AM J OTOL, V21, P92, DOI 10.1016/S0196-0709(00)80081-2; Guilemany JM, 2004, ACTA OTO-LARYNGOL, V124, P49, DOI 10.1080/00016480310002122; Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004; Heaton JM, 1999, J LARYNGOL OTOL, V113, P19, DOI 10.1017/S0022215100143063; KATSARKAS A, 1994, OTOLARYNG HEAD NECK, V110, P296, DOI 10.1016/S0194-5998(94)70772-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Navacharoen N, 2009, J LARYNGOL OTOL, V123, P857, DOI 10.1017/S0022215109004939; Navacharoen N, 1995, VERTIGO, P67; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432	11	13	20	0	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477			EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	DEC	2010	267	12					1837	1841		10.1007/s00405-010-1309-9			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	673NQ	WOS:000283670600003	20567978				2022-02-06	
J	Jagoda, AS				Jagoda, Andy S.			Mild Traumatic Brain Injury: Key Decisions in Acute Management	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Mild traumatic brain injury; postconcussive disorders; Rehabilitation; Neurobehavioral; Sequelae	MINOR HEAD-INJURY; EMERGENCY-DEPARTMENT DISCHARGE; COMPUTED-TOMOGRAPHY; RELIABILITY; IMPACT; RULE	The definition of a mild traumatic brain injury (TBI) has come under close scrutiny and is changing as a result of refined diagnostic testing Although up to 15% of patients with a mild TBI will have an acute intracranial lesion identified on head computed tomography (CT), less than 1% of these patients will have a lesion requiring a neurosurgical intervention Evidence-based guideline methodology has assisted in generating recommendations to facilitate clinical decision making however no set of guidelines is 100% sensitive and specific Evidence supports the safety of discharging patients with mild TBI who have a negative CT However though patients with a negative CT are at almost no risk of deteriorating from a neurosurgical lesion, a key intervention is to provide these patients at discharge from the emergency department with counseling regarding postconcussive symptoms when to return to work school, or sports, and when to seek additional medical care	Mt Sinai Sch Med, Dept Emergency Med, New York, NY 10029 USA		Jagoda, AS (corresponding author), Mt Sinai Sch Med, Dept Emergency Med, 1 Gustave L Levy Pl,Box 1620, New York, NY 10029 USA.						af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 2006, RESTOR NEUROL NEUROS, V24, P163; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bergman DA, 1999, PEDIATRICS, V104, P1407; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Center for Disease Control and Prevention, 2003, CTR DIS CONTR FACT S, P1; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kelly JP, 1997, NEUROLOGY, V48, P581; LEVITT MA, 1994, AM J EMERG MED, V12, P172, DOI 10.1016/0735-6757(94)90240-2; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214	34	13	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					797	+		10.1016/j.psc.2010.09.004			12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700005	21093679				2022-02-06	
J	Milani, P; Mondelli, M; Ginanneschi, F; Mazzocchio, R; Rossi, A				Milani, Paolo; Mondelli, Mauro; Ginanneschi, Federica; Mazzocchio, Riccardo; Rossi, Alessandro			Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy	JOURNAL OF BRACHIAL PLEXUS AND PERIPHERAL NERVE INJURY			English	Article							TRAUMATIC BRAIN-INJURY; NEUROACTIVE STEROIDS; MEDIAN NERVE; FOLLOW-UP; COMPLICATIONS; MYELIN; ULTRASONOGRAPHY; CLASSIFICATION; NEUROSTEROIDS; CONDUCTION	Background: Local corticosteroid injection for carpal tunnel syndrome (CTS) provides greater clinical improvement in symptoms one month after injection compared to placebo but significant symptom relief beyond one month has not been demonstrated and the relapse of symptoms is possible. Neuroprotection and myelin repair actions of the progesterone was demonstrated in vivo and in vitro study. We report the design of a randomized controlled trial for the local injection of cortisone versus progesterone in "mild" idiopathic CTS. Methods: Sixty women with age between 18 and 60 years affected by "mild" idiopathic CTS, diagnosed on the basis of clinical and electrodiagnostic tests, will be enrolled in one centre. The clinical, electrophysiological and ultasonographic findings of the patients will be evaluate at baseline, 1, 6 and 12 months after injection. The major outcome of this study is to determine whether locally-injected progesterone may be more beneficial than cortisone in CTS at clinical levels, tested with symptoms severity self-administered Boston Questionnaire and with visual analogue pain scale. Secondary outcome measures are: duration of experimental therapy; improvement of electrodiagnostic and ultrasonographic anomalies at various follow-up; comparison of the beneficial and harmful effects of the cortisone versus progesterone. Conclusion: We have designed a randomized controlled study to show the clinical effectiveness of local progesterone in the most frequent human focal peripheral mononeuropathy and to demonstrate the neuroprotective effects of the progesterone at the level of the peripheral nervous system in humans.	[Milani, Paolo; Ginanneschi, Federica; Mazzocchio, Riccardo; Rossi, Alessandro] Univ Siena, Dept Neurol Neurosurg & Behav Sci, Siena, Italy; [Milani, Paolo] Hop Lariboisiere, AP HP, Serv Physiol Explorat Fonct, F-75010 Paris, France; [Milani, Paolo] Univ Paris 07, F-75010 Paris, France; [Mondelli, Mauro] EMG Serv, Local Hlth Unit 7, Siena, Italy		Milani, P (corresponding author), Univ Siena, Dept Neurol Neurosurg & Behav Sci, Siena, Italy.	dr.milani@yahoo.com	Mazzocchio, Riccardo/H-4223-2012	Mazzocchio, Riccardo/0000-0002-0628-2868			Abrams R, 2009, J HAND SURG-AM, V34A, P535, DOI 10.1016/j.jhsa.2009.01.013; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Benson LS, 2006, ARTHROSCOPY, V22, P919, DOI 10.1016/j.arthro.2006.05.008; Bland JDP, 2007, MUSCLE NERVE, V36, P167, DOI 10.1002/mus.20802; Boya H, 2008, MUSCLE NERVE, V38, P1443, DOI 10.1002/mus.21068; Braun RM, 2002, HAND CLIN, V18, P347, DOI 10.1016/S0749-0712(01)00013-0; Cobb TK, 1996, HAND CLIN, V12, P313; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; Giannini F, 2002, CLIN NEUROPHYSIOL, V113, P71, DOI 10.1016/S1388-2457(01)00704-0; Gilliatt RW, 1980, PHYSL PERIPHERAL NER, P316; Ginanneschi F, 2006, CLIN NEUROPHYSIOL, V117, P2467, DOI 10.1016/j.clinph.2006.08.002; Ginanneschi F, 2008, CLIN NEUROL NEUROSUR, V110, P1025, DOI 10.1016/j.clineuro.2008.07.006; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Hagebeuk EEO, 2004, CLIN NEUROPHYSIOL, V115, P1464, DOI 10.1016/j.clinph.2004.01.005; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hobson-Webb LD, 2009, MUSCLE NERVE, V40, P94, DOI 10.1002/mus.21286; Jablecki CK, 2002, MUSCLE NERVE, V25, P918, DOI 10.1002/mus.10185; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KATZ JN, 1990, J RHEUMATOL, V17, P1495; Kovacic U, 2004, EXP NEUROL, V189, P94, DOI 10.1016/j.expneurol.2004.05.015; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; LOUIS DS, 1985, J NEUROSURG, V62, P352, DOI 10.3171/jns.1985.62.3.0352; Ly-Pen D, 2005, ARTHRITIS RHEUM-US, V52, P612, DOI 10.1002/art.20767; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; Martini L, 2003, STEROIDS, V68, P825, DOI 10.1016/S0039-128X(03)00134-X; Melcangi R C, 2001, Prog Brain Res, V132, P31; Melcangi RC, 2005, BRAIN RES REV, V48, P328, DOI 10.1016/j.brainresrev.2004.12.021; Melcangi RC, 2003, EXP NEUROL, V184, P930, DOI 10.1016/S0014-4886(03)00338-8; Melcangi RC, 2003, J STEROID BIOCHEM, V85, P323, DOI 10.1016/S0960-0760(03)00228-0; Melcangi RC, 2003, PROG NEUROBIOL, V71, P57, DOI 10.1016/j.pneurobio.2003.09.003; Melcangi RC, 2001, INT REV NEUROBIOL, V46, P145; Mondelli M, 2008, SCAND J RHEUMATOL, V37, P219, DOI 10.1080/03009740801914850; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; Mondelli M, 2008, ARTHRIT RHEUM-ARTHR, V59, P357, DOI 10.1002/art.23317; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; OCHOA J, 1973, J NEUROL SCI, V19, P491, DOI 10.1016/0022-510X(73)90045-2; Padua L, 1997, ACTA NEUROL SCAND, V96, P211; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Padua L, 1998, ITAL J NEUROL SCI, V19, P357, DOI 10.1007/BF02341782; Peng HY, 2009, PAIN, V143, P12, DOI 10.1016/j.pain.2008.12.023; Piazzini D, 2007, CLIN REHABIL, V21, P299, DOI 10.1177/0269215507077294; Press W. H., 1986, NUMERICAL RECIPES; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Roglio I, 2008, BRAIN RES REV, V57, P460, DOI 10.1016/j.brainresrev.2007.04.010; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Urbaniak JR, 1996, HAND CLIN, V12, P325; van Wingen G, 2007, J NEUROSCI, V27, P11416, DOI 10.1523/JNEUROSCI.1715-07.2007; Vasiliadis HS, 2010, ARTHROSCOPY, V26, P26, DOI 10.1016/j.arthro.2009.06.027; Veiga S, 2006, NEUROSCI LETT, V402, P150, DOI 10.1016/j.neulet.2006.03.058; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; WILSON JR, 1995, MUSCLE NERVE, V18, P660, DOI 10.1002/mus.880180614; Witt JC, 2000, MAYO CLIN PROC, V75, P409, DOI 10.4065/75.4.409; Wong SM, 2001, NEUROLOGY, V56, P1565, DOI 10.1212/WNL.56.11.1565; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932	58	13	15	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1749-7221			J BRACHIAL PLEX PERI	J. Brachial Plex. Peripher. Nerve Inj.	DEC	2010	5	1							11	10.1186/1749-7221-5-11			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V17NV	WOS:000214691400011	20420674	Green Published, gold			2022-02-06	
J	Schultke, E; Griebel, RW; Juurlink, BHJ				Schueltke, E.; Griebel, R. W.; Juurlink, B. H. J.			Quercetin attenuates inflammatory processes after spinal cord injury in an animal model	SPINAL CORD			English	Article						myeloperoxidase; neurotrauma; quercetin; rat; secondary injury	MYELOPEROXIDASE ACTIVITY; CELL-DEATH; RECOVERY	Objectives: We have shown earlier that administration of the flavonoid quercetin significantly contributed to recovery of motor function after spinal cord compression injury in the adult rat. Using the same animal model, we have now designed a set of experiments to test the hypothesis that quercetin attenuates oxidative stress-related inflammatory processes early after spinal cord trauma. Methods: Mid-thoracic spinal cord compression injury in adult male Wistar rats was caused by extradural application and closure of a 50 g calibrated aneurysm clip for 5 s. Myeloperoxidase (MPO) levels were determined in spinal cord tissue and serum of quercetin-treated animals and controls at 6, 12, 24 and 72 h after injury. The white blood count was followed until 72 h after injury. Results: In quercetin-treated animals, MPO activity was significantly decreased in tissue at 12 and 24 h and in serum at 6, 12 and 24 h after injury, compared with saline controls. In quercetin-treated animals, the prevalence of ED-1 and MPO positive cells was significantly lower than in saline controls. White blood count in venous blood was significantly decreased in quercetin-treated animals at 12 and 24 h after injury. Conclusion: Quercetin attenuated the recruitment of neutrophils to the site of injury. The resulting lower MPO release in the injured tissue is likely to decrease the extent of secondary injury and might at least partially explain the neuroprotective effect of the flavonoid quercetin. Spinal Cord (2010) 48, 857-861; doi:10.1038/sc.2010.45; published online 4 May 2010	[Schueltke, E.] Univ Freiburg, Dept Stereotact Neurosurg, Freiburg, Germany; [Schueltke, E.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Schueltke, E.; Griebel, R. W.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Juurlink, B. H. J.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia		Schultke, E (corresponding author), Univ Freiburg, Dept Stereotact Neurosurg, Breisacher Str 64,BW S7N5E5, Freiburg, Germany.	elisabeth.schueltke@uniklinik-freiburg.de	Schultke, Elisabeth/M-3959-2013		Saskatchewan Health Research Foundation; Christopher Reeve Paralysis Foundation	We thank our technical assistants Arlene Drimmie and Connie Wong (Department of Anatomy and Cell Biology) and the students Angela Damant and Viktor Skihar for help with the animal care. Lloyd Jennett from RUH is thanked for technical support, fixing our anaesthesia machine whenever it breaks down. This work was supported by the Saskatchewan Health Research Foundation and by the Christopher Reeve Paralysis Foundation.	ANDERSON DK, 1992, J NEUROTRAUM, V9, P143, DOI 10.1089/neu.1992.9.143; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BADWEY JA, 1991, ADV EXP MED BIOL, V341, P19; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beattie MS, 2000, CONT NEUROS, P1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; CARLSON SL, 1988, EXP NEUROL, V15, P77; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; PINCEMAIL J, 1988, EXPERIENTIA, V44, P450, DOI 10.1007/BF01940544; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Schultke E, 2010, SPINAL CORD, V48, P112, DOI 10.1038/sc.2009.111; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1979, CAN MED ASSOC J, V121, P1453; WINTERBOURN CC, 1985, BIOCHEM J, V228, P583, DOI 10.1042/bj2280583	20	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	DEC	2010	48	12					857	861		10.1038/sc.2010.45			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	688SZ	WOS:000284875100004	20440299	Bronze			2022-02-06	
J	Truelle, JL; Fayol, P; Montreuil, M; Chevignard, M				Truelle, Jean-Luc; Fayol, Patrick; Montreuil, Michele; Chevignard, Mathilde			Community integration after severe traumatic brain injury in adults	CURRENT OPINION IN NEUROLOGY			English	Article						community integration; health-related quality of life; long-term outcome; rehabilitation programs; traumatic brain injury	QUALITY-OF-LIFE; VOCATIONAL-REHABILITATION; INDIVIDUALS; WORK; PHARMACOTHERAPY; DISABILITY; HEALTH	Purpose of review Despite being the main cause of death and disability in young adults, traumatic brain injury (TBI) is a rather neglected epidemic. Community integration of persons with TBI was, until recently, insufficiently informed by clinical research. Recent findings To bridge the gap between rehabilitation and community re-entry, the first task is to assess the person, using TBI-specific outcome measures. The second task is to provide re-entry programs, the effectiveness of which is assessed by those measures, using well designed studies. There are very few such studies. However, there are some effective comprehensive programs and others which are specifically targeted dealing mainly with return to work, behavior, and family issues. The complex psychological and environmental components of the disability require individualized and often long-term care. Summary For persons with severe TBI trying to achieve the best possible community integration a new semiology is required, not just limited to medical care, but also involving social and psychological care that is tailored to the needs of each individual and family, living within his/her environment. Currently, only a minority benefit from well validated programs.	[Truelle, Jean-Luc] Raymond Poincare Univ Hosp, Dept Neurol Rehabil, F-92380 Garches, France; [Fayol, Patrick] Ctr Hosp Esquirol, Serv Psychorehabil, Limoges, France; [Montreuil, Michele] Univ Paris 08, Lab Psychopathol & Neuropsychol, St Denis, France; [Chevignard, Mathilde] Hop Natl St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Chevignard, Mathilde] Univ Paris 06, Paris 10, France		Truelle, JL (corresponding author), Raymond Poincare Univ Hosp, Dept Neurol Rehabil, F-92380 Garches, France.	jean-luc.truelle@wanadoo.fr					ALTMAN IM, 2010, BRAIN IMPAIR, V11, P199; *BABICM, 2010, BRIT ASS BRAIN INJ C; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; BROOKS DN, 1994, HEAD INJURY EVALUATI, P1; *C BRAIN INJ TASK, 2009, CLIN PSYCHOL, V8, P1283; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; *COMM ACCR REH FAC, 2005, MED REH STAND MAN; COPE ND, 2009, J WORKERS COMPENSATI, V18, P17; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hoffman SW, 2010, NEUROREHABILITATION, V26, P257, DOI 10.3233/NRE-2010-0561; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; Johnstone B, 2009, BRAIN INJURY, V23, P411, DOI 10.1080/02699050902788501; KNEIPP S, 2007, BRAIN INJURY MED, P1091; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Lezak, 2008, MANUAL MAYO PORTLAND; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Newby G, 2010, NEUROPSYCHOL REHABIL, V20, P264, DOI 10.1080/09602010903175034; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Prigatano GP, 2009, CURR OPIN NEUROL, V22, P606, DOI 10.1097/WCO.0b013e328332a1e7; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Sivan M, 2010, CLIN REHABIL, V24, P110, DOI 10.1177/0269215509343234; SULLIVAN K, 2007, BRAIN INJURY MED, P929; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Truelle J-L, 2010, Asian J Neurosurg, V5, P24; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Tsiouris JA, 2010, J INTELL DISABIL RES, V54, P1, DOI 10.1111/j.1365-2788.2009.01232.x; Uprichard S, 2009, BRAIN INJURY, V23, P278, DOI 10.1080/02699050902788444; VANSON AW, 2009, J REHABIL MED, V41, P521; WEED R, 2007, BRAIN INJURY MED, P1223; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; West SL, 2009, ALCOHOL TREAT Q, V27, P280, DOI 10.1080/07347320903008166; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	13	16	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2010	23	6					688	694		10.1097/WCO.0b013e3283404258			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	675SJ	WOS:000283852400022	20962638				2022-02-06	
J	Zlotnik, A; Gurevich, B; Artru, AA; Gruenbaum, SE; Dubilet, M; Leibowitz, A; Shaked, G; Ohayon, S; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Gurevich, Boris; Artru, Alan A.; Gruenbaum, Shaun E.; Dubilet, Michael; Leibowitz, Akiva; Shaked, Gad; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			The Effect of Hyperthermia on Blood Glutamate Levels	ANESTHESIA AND ANALGESIA			English	Article							TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; IN-VIVO; EXTRACELLULAR GLUTAMATE; SCAVENGING ACTIVITY; RAT; BARRIER; PLASMA	INTRODUCTION: Glutamate neurotoxicity is determined by the balance between glutamate release within the brain and efflux of excess glutamate from the brain. Brain-to-blood efflux of glutamate is increased by decreasing the concentration of glutamate in blood. Little is known about the effect of hyperthermia on blood glutamate concentrations, and the effectiveness of blood glutamate-decreasing mechanisms in these conditions. Although hyperthermia is hypothesized to decrease blood glutamate concentrations by activation of stress mechanisms, blunting the stress response by blocking beta-adrenergic receptors should prevent this decrease. Furthermore, during hyperthermia there should be a concurrent process of leakage of glutamate from muscle tissue into blood, resulting in a contradictory increase of blood glutamate concentrations. In this study we investigated the effects of hyperthermia on blood glutamate levels and studied the effects of the beta-adrenergic receptor antagonist propranolol on stress-induced changes in glutamate levels. We then studied the effectiveness of the blood glutamate scavenger oxaloacetate on hyperthermia-induced increases of glutamate levels. MATERIALS AND METHODS: Twenty-four rats were randomly divided into 3 groups. Rats' body temperatures were increased (by 1 degrees C every 40 minutes) from 37 degrees C to 42 degrees C. The first group received 1 mL per 100 g of isotonic saline (control). The second group received 1 mL per 100 g of 1M oxaloacetate when the temperature reached 39 degrees C. The third group received 10 mg/kg of propranolol before initiation of the warming. RESULTS: Warming the rats from 37 degrees C to 39 degrees C decreased the blood glutamate levels in the control group (P < 0.01) and oxaloacetate treatment group (P < 0.0001), whereas further increases in temperature from 40 degrees C to 42 degrees C increased the blood glutamate levels (P < 0.01 and P < 0.0001, respectively). Pretreatment with propranolol prevented the decrease in blood glutamate concentrations seen in mild hyperthermia and did not affect the increase in blood glutamate levels seen at temperatures of 41 degrees C and 42 degrees C (P < 0.005). DISCUSSION: The results of this study demonstrated that hyperthermia leads to decreases in glutamate levels in the blood, presumably by activation of the sympathetic nervous system. Oxaloacetate, previously reported to reduce blood glutamate levels at 37 degrees C, was ineffective at temperatures over 40 degrees C. Propranolol pretreatment blunted the initial decrease in blood glutamate, and thereafter had no effect when compared with control and treatment groups. Understanding the mechanisms underlying glutamate regulation in the blood during states of hyperthermia and stress has important clinical implications in treating neurodegenerative conditions.	[Zlotnik, Alexander; Gurevich, Boris; Gruenbaum, Shaun E.; Dubilet, Michael; Leibowitz, Akiva; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, IL-84105 Beer Sheva, Israel; [Artru, Alan A.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Shaked, Gad] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Surg, IL-84105 Beer Sheva, Israel		Leibowitz, A (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Anesthesiol & Crit Care, POB 151, IL-84105 Beer Sheva, Israel.		Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915			Al-Sarraf H, 2003, BRAIN RES, V994, P181, DOI 10.1016/j.brainres.2003.09.034; Al-Sarraf Hameed, 1997, Developmental Brain Research, V102, P47, DOI 10.1016/S0165-3806(97)00075-8; AlSarraf H, 1995, DEV BRAIN RES, V90, P151, DOI 10.1016/0165-3806(96)83495-X; AlSarraf H, 1997, DEV BRAIN RES, V102, P127, DOI 10.1016/S0165-3806(97)00089-8; Arakawa H, 1997, J PHARMACOL EXP THER, V280, P1296; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Benrabh H, 1996, NEUROSCI LETT, V210, P9, DOI 10.1016/0304-3940(96)12635-5; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; Blomstrand E, 2009, AMINO ACIDS, V37, P629, DOI 10.1007/s00726-008-0182-y; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DREWES LR, 1977, AM J PHYSIOL, V233, pE320, DOI 10.1152/ajpendo.1977.233.4.E320; El-Wazir YM, 2008, AUTON NEUROSCI-BASIC, V143, P33, DOI 10.1016/j.autneu.2008.07.004; Falciglia M, 2007, CURR OPIN CLIN NUTR, V10, P498, DOI 10.1097/MCO.0b013e3281a3bf0a; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.8.1171-1178; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarqvist F, 2001, CLIN PHYSIOL, V21, P44, DOI 10.1046/j.1365-2281.2001.00291.x; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hawkins RA, 2009, AM J CLIN NUTR, V90, p867S, DOI 10.3945/ajcn.2009.27462BB; Hosoya K, 1999, J NEUROCHEM, V73, P1206, DOI 10.1046/j.1471-4159.1999.0731206.x; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KANE RL, 1999, J BIOL CHEM, V274, P31891; KAYASHIMA S, 1995, EUR J APPL PHYSIOL O, V70, P413, DOI 10.1007/BF00618492; Kempski O, 1990, Adv Neurol, V52, P219; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Koura SS, 1998, ACT NEUR S, V71, P244; MARLISS EB, 1971, J CLIN INVEST, V50, P814, DOI 10.1172/JCI106552; MUKHERJEE K, 1987, AVIAT SPACE ENVIR MD, V58, P18; Newsholme EA, 1996, EXPERIENTIA, V52, P413, DOI 10.1007/BF01919308; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Oehmichen M, 1979, Beitr Gerichtl Med, V37, P271; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; PALMER AM, 1993, J NEUROCHEM, V61, pS284; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265; SERSHEN H, 1976, EXP NEUROL, V53, P465, DOI 10.1016/0014-4886(76)90086-8; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Shuaib A, 1996, ACT NEUR S, V67, P53; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Stover JF, 2000, ACT NEUR S, V76, P375; Suckow MA, 2006, AM COLL LAB, P1; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Waynforth H.B., 1992, EXPT SURG TECHNIQUE, V2nd; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang Hong, 2008, Neurosci Bull, V24, P7, DOI 10.1007/s12264-008-1227-7; ZLOTNIK A, 2009, AM SOC AN ANN M NEW; ZLOTNIK A, 2008, 36 ANN M SOC NEUR AN; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022	63	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	DEC	2010	111	6					1497	1504		10.1213/ANE.0b013e3181fc0112			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	690AU	WOS:000284973300026	21048094				2022-02-06	
J	Balik, V; Lehto, H; Hoza, D; Sulla, I; Hernesniemi, J				Balik, V.; Lehto, H.; Hoza, D.; Sulla, I.; Hernesniemi, J.			Posterior Fossa Extradural Haematomas	CENTRAL EUROPEAN NEUROSURGERY			English	Article						extradural haematoma; posterior cranial fossa; occipital extension	TRAUMATIC EPIDURAL HEMATOMAS; CRANIAL FOSSA; CHILDREN; VERTEX; CT; PROGNOSIS; SURVIVAL	Background: Posttraumatic epidural haematoma (EDH) of the temporal region is the most common site of supratentorial extradural bleeding; other locations are considered atypical. We reviewed 24 patients with EDH located in the posterior cranial fossa (PFEDH) treated at two neurosurgical centres between January 2000 and November 2006. Material and Methods: In the retrospective study we analysed gender and age distribution, type of injury, clinical presentation, Glasgow Coma Scale (GCS) score on admission, radiological images, interval between trauma and surgery, and outcome. Results: 24 patients with PFEDH constituted 11.5 % of 209 surgically treated individuals with EDH. The best outcomes were obtained by patients with GCS scores of 15-14 on admission. Patients in the fourth to seventh decade of life had less favourable outcomes than younger ones. More than half of the patients with PFEDH had associated intradural lesions. Only patients with concomitant brain contusion had a more favourable recovery. The 3 worst levels on the Glasgow Outcome Scale (GOS) were observed in patients suffering from subdural or intracerebral haematoma, or both, associated with the PFEDHs. The majority of patients with concurrent lesions and supratentorial extension of the haemorrhage were in the subgroup undergoing craniotomy between 24 and 72 h after injury. Patients treated in this time interval also had the most unfavourable outcomes. A classical lucid interval was observed only in one patient. The mortality rate in the series was 4.2 %. Conclusion: The most significant factors influencing outcome in our patients were GCS on admission, age, and associated intradural lesions.	[Sulla, I.] Safarik Univ, Fac Med, AD Ctr, Dept Neurosurg, Kosice 04011, Slovakia; [Lehto, H.; Hernesniemi, J.] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Hoza, D.] Charles Univ Prague, Univ Hosp Motol, Fac Med, Dept Neurosurg, Prague, Czech Republic		Sulla, I (corresponding author), Safarik Univ, Fac Med, AD Ctr, Dept Neurosurg, Kosice Trieda SNP 1, Kosice 04011, Slovakia.	isulla@upjs.sk					AGBI CB, 1987, SURG NEUROL, V28, P123, DOI 10.1016/0090-3019(87)90085-1; ARKINS TJ, 1977, AM J DIS CHILD, V131, P690, DOI 10.1001/archpedi.1977.02120190084019; Asanin B, 2009, ACTA CLIN CROAT, V48, P27; Balik V, 2007, BRATISL MED J, V108, P409; BESSON G, 1978, NEUROCHIRURGIE, V24, P53; BOITEN J, 1989, J NEUROL NEUROSUR PS, V52, P914, DOI 10.1136/jnnp.52.7.914-a; BORZONE M, 1988, ACTA NEUROCHIR, V93, P55, DOI 10.1007/BF01409903; BORZONE M, 1991, J NEUROSURG SCI, V35, P260; Bozbuga M, 1999, NEUROSURG REV, V22, P34, DOI 10.1007/s101430050006; BRAMBILLA G, 1986, ACTA NEUROCHIR, V80, P24, DOI 10.1007/BF01809553; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; CAMPBELL E, 1953, ANN SURG, V138, P509, DOI 10.1097/00000658-195310000-00003; CERVANTES LA, 1983, J NEUROSURG, V59, P351, DOI 10.3171/jns.1983.59.2.0351; CHOUX M, 1975, CHILD BRAIN, V1, P337; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; CORDOBES F, 1980, ACTA NEUROCHIR, V53, P275, DOI 10.1007/BF02074800; Dorizzi A, 1968, Sist Nerv, V20, P63; GARZAMERCADO R, 1983, J NEUROSURG, V59, P664, DOI 10.3171/jns.1983.59.4.0664; Gdovinova Z, 2009, TXB GEN NEUROLOGY, P152; Gelabert M, 1997, BRIT J NEUROSURG, V11, P573; Gruskiewicz J, 1976, Surg Neurol, V5, P122; GUTHKELCH AN, 1949, J NEUROSURG, V6, P180, DOI 10.3171/jns.1949.6.2.0180; HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151; Holzschuh M, 1989, Br J Neurosurg, V3, P171, DOI 10.3109/02688698909002792; HOOPER RS, 1954, BRIT J SURG, V42, P19, DOI 10.1002/bjs.18004217103; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JAMIESON KG, 1972, J NEUROSURG, V36, P644, DOI 10.3171/jns.1972.36.5.0644; JENNETT B, 1975, LANCET, V1, P480; KALYANARAMAN S, 1972, P I NEUROL MADRAS, V2, P22; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; Karasu A, 2008, SURG NEUROL, V69, P247, DOI 10.1016/j.surneu.2007.02.024; KINOMOTO T, 1985, NEUROTRAUMATOLOGY, V8, P77; Li TD, 2007, ACTA CRYSTALLOGR E, V63, pM1870, DOI 10.1107/S1600536807027237; LUI TN, 1993, J TRAUMA, V34, P211, DOI 10.1097/00005373-199302000-00005; Maggi G, 1998, J Neurosurg Sci, V42, P95; Mahajan R. K., 1993, Annals Academy of Medicine Singapore, V22, P410; Malik NK, 2007, SURG NEUROL, V68, P155, DOI 10.1016/j.surneu.2006.10.051; MCCULLOCH GAJ, 1976, MED J AUSTRALIA, V2, P303, DOI 10.5694/j.1326-5377.1976.tb130189.x; Mckenzie KG, 1938, BRIT J SURG, V26, P346, DOI 10.1002/bjs.18002610215; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Mracek Z, 1999, CESK SLOV NEUROL N, V62, P336; NAGAMINE Y, 1979, NO SHINKEI GEKA, V9, P357; NEUBAUER UJ, 1987, ACTA NEUROCHIR, V87, P105, DOI 10.1007/BF01476060; ONUMA T, 1990, SHINKEUI GAISHO, V13, P57; OTSUKA S-I, 1990, Neurologia Medico-Chirurgica, V30, P24, DOI 10.2176/nmc.30.24; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; Pereira CU, 2004, J BRAS NEUROCIRURG, V15, P18; POZZATI E, 1989, SURG NEUROL, V32, P300, DOI 10.1016/0090-3019(89)90234-6; RIVANO C, 1991, Zentralblatt fuer Neurochirurgie, V52, P77; RIVANO C, 1992, NEUROCHIRURGIA, V35, P43; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; RODA JM, 1983, SURG NEUROL, V19, P419, DOI 10.1016/0090-3019(83)90138-6; SCHIEFER W, 1964, BEITR NEUROCHIR, V8, P39; Sinha AK, 2009, CENT EUR NEUROSURG, V70, P52, DOI 10.1055/s-2008-0042; Steno J, 1990, Rozhl Chir, V69, P358; STJOHN JN, 1986, SURG NEUROL, V25, P457, DOI 10.1016/0090-3019(86)90085-6; STONE JL, 1979, SURG NEUROL, V11, P419; SUBRAHMANIAN MV, 1975, BRIT J SURG, V62, P397, DOI 10.1002/bjs.1800620517; Sulla I., 2003, Folia Veterinaria, V47, P95; Wang E. C. M., 1998, SMJ, V39, P107; WONG CW, 1994, ACTA NEUROCHIR, V126, P124, DOI 10.1007/BF01476421; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402; ZUCCARELLO M, 1981, NEUROSURGERY, V8, P434, DOI 10.1227/00006123-198104000-00005	63	13	13	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1868-4904	1868-4912		CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	NOV	2010	71	4					167	172		10.1055/s-0030-1249046			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	681WW	WOS:000284355500002	20422510				2022-02-06	
J	Ko, SB; Kim, CK; Lee, SH; Bae, HJ; Yoon, BW				Ko, Sang-Bae; Kim, Chi Kyung; Lee, Seung-Hoon; Bae, Hee-Joon; Yoon, Byung-Woo			Morphine-Sensitive Paroxysmal Sympathetic Storm in Pontine Intracerebral Hemorrhage	NEUROLOGIST			English	Article						autonomic; paroxysmal sympathetic storm; pontine hemorrhage	DIENCEPHALIC SEIZURES; BRAIN-INJURY	Paroxysmal sympathetic storm (PSS) is a rare complication of severe traumatic brain injury or cerebrovascular disease. Various medications have been tried in patients with PSS, but the clinical responses of the patients were variable. We report a classic case of PSS after spontaneous pontine hemorrhage in which the patient's fluctuating blood pressure and body temperature were dramatically stabilized using morphine.	[Ko, Sang-Bae; Kim, Chi Kyung; Lee, Seung-Hoon; Yoon, Byung-Woo] Seoul Natl Univ Hosp, Dept Neurol, Coll Med, Clin Res Ctr Stroke,Clin Res Inst, Seoul 110744, South Korea; [Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seoul, South Korea		Ko, SB (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Coll Med, Clin Res Ctr Stroke,Clin Res Inst, Yongon Dong 28, Seoul 110744, South Korea.	sangbai1378@gmail.com	Yoon, Byung Woo/J-5557-2012; Kim, Chi Kyung/AAR-9819-2020	Ko, Sang-Bae/0000-0002-9429-9597	Ministry of Health, Welfare and Family Affairs, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A060171]	Supported by the Korea Health 21 R&D project, Ministry of Health, Welfare and Family Affairs, Republic of Korea, grant (A060171).	Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Diamond AL, 2005, NEUROCRIT CARE, V2, P288, DOI 10.1385/NCC:2:3:288; Gondim FAA, 2003, ARCH NEUROL-CHICAGO, V60, P1803, DOI 10.1001/archneur.60.12.1803; Reed MJ, 2006, EUR J EMERG MED, V13, P41, DOI 10.1097/00063110-200602000-00011	7	13	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1074-7931			NEUROLOGIST	Neurologist	NOV	2010	16	6					384	385		10.1097/NRL.0b013e3181b1cdff			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	679YH	WOS:000284196200010	21150389				2022-02-06	
J	Koizumi, H; Fujisawa, H; Kurokawa, T; Suehiro, E; Iwanaga, H; Nakagawara, J; Suzuki, M				Koizumi, Hiroyasu; Fujisawa, Hirosuke; Kurokawa, Tetsu; Suehiro, Eiichi; Iwanaga, Hideyuki; Nakagawara, Jyoji; Suzuki, Michiyasu			Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain imaging; brain recovery; brain trauma; neuroradiology; SPECT	POSITRON-EMISSION-TOMOGRAPHY; TEMPORAL-LOBE EPILEPSY; I-123-IOMAZENIL SPECT; COMPUTED-TOMOGRAPHY; CEREBRAL INFARCTION; CORTICAL DAMAGE; SEVERITY; IOMAZENIL; IDENTIFICATION; INTEGRITY	We evaluated cortical damages following traumatic brain injury (TBI) in the acute phase with [(123)I] iomazenil (IMZ) single photon emission computed tomography (SPECT). In all, 12 patients with cerebral contusion following TBI were recruited. All patients underwent IMZ SPECT within 1 week after TBI. To investigate the changes in distribution of IMZ in the cortex in the chronic phase, after conventional treatment, patients underwent IMZ SPECT again. A decrease in the accumulation of radioligand for the central benzodiazepine receptor in the cortex corresponding to the contusion revealed with computed tomography (CT) scans and magnetic resonance imaging (MRI) were shown on IMZ SPECT in the acute phase in all patients. In 9 of 12 patients (75%), images of IMZ SPECT obtained in the chronic phase of TBI showed that areas with a decreased distribution of IMZ were remarkably reduced in comparison with those obtained in the acute phase. Both CT scans and MRI showed a normal appearance of the cortex morphologically, where the binding potential of IMZ recovered in the chronic phase. Reduced binding potential of radioligand for the central benzodiazepine receptor is considered to be an irreversible reaction; however, in this study, IMZ accumulation in the cortex following TBI was recovered in the chronic phase in several patients. [(123)I] iomazenil SPECT may have a potential to disclose a reversible vulnerability of neurons following TBI. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 1673-1681; doi:10.1038/jcbfm.2010.75; published online 4 August 2010	[Koizumi, Hiroyasu; Fujisawa, Hirosuke; Kurokawa, Tetsu; Suehiro, Eiichi; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan; [Iwanaga, Hideyuki] Yamaguchi Univ, Sch Med, Dept Radiol, Yamaguchi 7558505, Japan		Koizumi, H (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan.	hiroyasu@yamaguchi-u.ac.jp	Suehiro, Eiichi/I-5852-2019				Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; BEER HF, 1990, J NUCL MED, V31, P1007; BENAVIDES J, 1989, PHARM CEREBRAL ISCHE, P39; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; DEGIROLAMI U, 1984, J NEUROPATH EXP NEUR, V43, P57, DOI 10.1097/00005072-198401000-00005; DEY HM, 1994, J NUCL MED, V35, P399; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; HATAZAWA J, 1995, J NUCL MED, V36, P2154; HATAZAWA J, 1995, STROKE, V26, P2267, DOI 10.1161/01.STR.26.12.2267; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Kaneko K, 2006, NUCL MED COMMUN, V27, P893, DOI 10.1097/01.mnm.0000243380.79872.32; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; MIES G, 1983, STROKE, V14, P22, DOI 10.1161/01.STR.14.1.22; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Muller V, 2002, NUCL MED COMMUN, V23, P1191, DOI 10.1097/01.mnm.0000046211.83338.0c; Nakagawara J, 1997, STROKE, V28, P124, DOI 10.1161/01.STR.28.1.124; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Saur D, 2006, STROKE, V37, P2713, DOI 10.1161/01.STR.0000244827.36393.8f; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Umeoka S, 2007, J NEUROSURG, V107, P352, DOI 10.3171/JNS-07/08/0352; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	31	13	14	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2010	30	10					1673	1681		10.1038/jcbfm.2010.75			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	657AK	WOS:000282382200002	20683454	Green Published, Bronze			2022-02-06	
J	Turkoglu, OF; Eroglu, H; Gurcan, O; Bodur, E; Sargon, MF; Oner, L; Beskonakli, E				Turkoglu, Omer Farltk; Eroglu, Hakan; Gurcan, Oktay; Bodur, Ebru; Sargon, Mustafa F.; Oner, Levent; Beskonakli, Etem			Local administration of chitosan microspheres after traumatic brain injury in rats: a new challenge for cyclosporine - a delivery	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Cyclosporine-A; traumatic brain injury; chitosan; microsphere	INDUCED AXONAL DAMAGE; SPINAL-CORD-INJURY; MITOCHONDRIAL DYSFUNCTION; ULTRASTRUCTURAL-CHANGES; ALBUMIN MICROSPHERES; LIPID-PEROXIDATION; DOSE-RESPONSE; PERMEABILITY; FORMULATION; MECHANISMS	The major aim of this study was to evaluate the efficiency of chitosan microspheres containing cyclosporine-A (Cs-A) on mitochondrial damage in traumatic brain injury (TBI) animal model. Trauma was introduced to male Sprague-Dawley (SD) rats similar to that of modified Feeney Method. Briefly, after craniectomy in the left parietal region (5 mm). Trauma was performed by dropping 24 g metal sterile rods through a teflon guide tube (9.3 cm) on a foot plate placed over the duramater. Just after the trauma, 20 mg/kg Cs-A (Sandimmune (R) has been administered to the traumatised SD rats intraperitoneally (i.p.). On the other hand, only chitosan microspheres containing 10 mg/kg was implanted at the craniectomy area locally after trauma in Group E. A small piece of surgicell was placed over the craniectomy hole and the scalp incision was sutured. 24 h after injury and the brain tissues were removed intact. The results were evaluated through lipid peroxidation ratio and ultrastructural grading system. The statistical comparisons were evaluated by using Mann Whitney U test at the significance level p = 0.05. The lipid peroxidation ratios of sham (78.4 +/- 6.0 nmol/g tissue) and vehicle (80.2 +/- 10.6 nmol/g tissue) were significantly increased 24 h after TBI. However, for treatment groups (i.p. Cs-A; 20 mg/kg) and (10 mg/kg Cs-A in microspheres), statistically significant lower lipid peroxidation ratios were determined as 53.5 +/- 9.7 and 47.9 +/- 8.1 nmol/g tissue, respectively (p < 0.05). The mitochondrial damage scores of the treatment groups were recorded as 21.7 +/- 2.6 and 19.4 +/- 3.9 for Group D and Group E, respectively. Both of these scores of the treatment groups were found as significantly different from the sham and vehicle groups' scores individually. The implantation of microsphere formulation has provided a better efficiency in keeping the uniformity of mitochondrial structure in this complex cascade of events after TBI.	[Turkoglu, Omer Farltk; Beskonakli, Etem] Ankara Ataturk Res & Educ Hosp, Dept Neurosurg, TR-06800 Ankara, Turkey; [Eroglu, Hakan; Oner, Levent] Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, TR-06100 Ankara, Turkey; [Gurcan, Oktay] Ankara Numune Training & Res Hosp, Dept Neurosurg, TR-06100 Ankara, Turkey; [Bodur, Ebru] Hacettepe Univ, Dept Biochem, Fac Med, TR-06100 Ankara, Turkey; [Sargon, Mustafa F.] Hacettepe Univ, Dept Anat, Fac Med, TR-06100 Ankara, Turkey		Turkoglu, OF (corresponding author), Tevfik Saglam Cd Aral Sk 2-4 Etlik, Ankara, Turkey.	ofturkoglu@yahoo.com	BODUR, EBRU/AAR-8545-2020; Sargon, Mustafa F./AAZ-5470-2021; EROGLU, HAKAN/J-1040-2013; ONER, LEVENT/J-1032-2013; gurcan, oktay/AAW-7810-2021; BODUR, EBRU/I-8382-2013	BODUR, EBRU/0000-0001-5829-5487; Sargon, Mustafa F./0000-0001-6360-6008; ONER, LEVENT/0000-0002-6510-7680; BODUR, EBRU/0000-0001-5829-5487; Eroglu, Hakan/0000-0001-6361-0074			Almond BA, 2003, J CONTROL RELEASE, V91, P147, DOI 10.1016/S0168-3659(03)00214-1; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bejugam NK, 2008, J MICROENCAPSUL, V25, P577, DOI [10.1080/02652040802476187, 10.1080/02652040802476187 ]; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HUGHES RL, 1990, NEW ENGL J MED, V323, P420; Ibarra A, 2006, CURR MED CHEM, V13, P2703, DOI 10.2174/092986706778201503; Jameela SR, 1996, J PHARM PHARMACOL, V48, P685, DOI 10.1111/j.2042-7158.1996.tb03951.x; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880; Povlishock JT, 1996, ACT NEUR S, V66, P81; REECE DE, 1991, BONE MARROW TRANSPL, V8, P393; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinder AF, 1996, J NEUROSCI, V16, P6125; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Siwale RC, 2009, J MICROENCAPSUL, V26, P411, DOI 10.1080/02652040802420409; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Solaroglu I, 2004, BIOL NEONATE, V85, P221, DOI 10.1159/000075835; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun Y, 2009, DRUG DEV IND PHARM, V35, P379, DOI 10.1080/03639040802395185 ; Tsubokawa T, 2007, STROKE, V38, P1057, DOI 10.1161/01.STR.0000257978.70312.1d; Wang HM, 2008, CHINESE J INORG CHEM, V24, P1; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	40	13	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2010	24	5					578	583		10.3109/02688697.2010.487126			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	670HV	WOS:000283412700013	20868245				2022-02-06	
J	Jiang, H; Peng, J; Zhou, ZY; Duan, Y; Chen, W; Cai, B; Yang, H; Zhang, W				Jiang Hua; Peng Jin; Zhou Zhi-yuan; Duan Yu; Chen Wei; Cai Bin; Yang Hao; Zhang Wei			Establishing H-1 nuclear magnetic resonance based metabonomics fingerprinting profile for spinal cord injury: a pilot study	CHINESE MEDICAL JOURNAL			English	Article						metabonomic; spinal cord injury; H-1 nuclear magnetic resonance; principal component analysis	POLYUNSATURATED FATTY-ACIDS; TRAUMATIC BRAIN-INJURY; METABOLIC RESPONSE; AMINO-ACIDS; DIAGNOSIS; HMDB; N-3	Background Spinal cord injury (SCI) is a complex trauma that consists of multiple pathological mechanisms involving cytotoxic, oxidation stress and immune-endocrine. This study aimed to establish plasma metabonomics fingerprinting atlas for SCI using H-1 nuclear magnetic resonance (NMR) based metabonomics methodology and principal component analysis techniques. Methods Nine Sprague-Dawley (SD) male rats were randomly divided into SCI, normal and sham-operation control groups. Plasma samples were collected for H-1 NMR spectroscopy 3 days after operation. The NMR data were analyzed using principal component analysis technique with Matlab software. Results Metabonomics analysis was able to distinguish the three groups (SCI, normal control, sham-operation). The fingerprinting atlas indicated that, compared with those without SCI, the SCI group demonstrated the following characteristics with regard to second principal component: it is made up of fatty acids, myc-inositol, arginine, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), triglyceride (TG), glucose, and 3-methyl-histamine. Conclusions The data indicated that SCI results in several significant changes in plasma metabolism early on and that a metabonomics approach based on H-1 NMR spectroscopy can provide a metabolic profile comprising several metabolite classes and allow for relative quantification of such changes. The results also provided support for further development and application of metabonomics technologies for studying SCI and for the utilization of multivariate models for classifying the extent of trauma within an individual. Chin Med J 2010;123(17):2315-2319	[Peng Jin; Duan Yu; Zhang Wei] Sichuan Univ, Dept Histol Embryol & Neurobiol, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China; [Jiang Hua; Cai Bin] Sichuan Acad Med Sci, Metabon & Multidisciplinary Lab Trauma Res, East Branch, Chengdu 610101, Sichuan, Peoples R China; [Jiang Hua; Cai Bin] Sichuan Prov Peoples Hosp, Chengdu 610101, Sichuan, Peoples R China; [Zhou Zhi-yuan] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China; [Chen Wei] Beijing Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing 100730, Peoples R China; [Yang Hao] Sichuan Univ, Dept Math, Chengdu 610041, Sichuan, Peoples R China		Zhang, W (corresponding author), Sichuan Univ, Dept Histol Embryol & Neurobiol, W China Med Sch, Chengdu 610041, Sichuan, Peoples R China.	zhangwi25091@gmail.com			Administration of Science and Technology of Sichuan Province [2007jy076]	This work was supported by a grant from Administration of Science and Technology of Sichuan Province (No. 2007jy076).	Aberg KM, 2009, ANAL BIOANAL CHEM, V394, P151, DOI 10.1007/s00216-009-2628-9; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Betenbaugh M, 2008, CURR OPIN BIOTECH, V19, P411, DOI 10.1016/j.copbio.2008.08.009; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Ciosek P, 2005, TALANTA, V67, P590, DOI 10.1016/j.talanta.2005.03.006; Endres S, 1996, CURR OPIN LIPIDOL, V7, P48, DOI 10.1097/00041433-199602000-00011; Facheris M, 2004, J ALZHEIMERS DIS, V6, P177; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Jacobs WB, 2003, NEUROSURGERY, V53, P943, DOI 10.1227/01.NEU.0000083592.74383.B1; KEARNS PJ, 1992, JPEN-PARENTER ENTER, V16, P11, DOI 10.1177/014860719201600111; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Li J., 2004, CHIN J REHABIL THEOR, V10, P412; Liu CL, 2002, CHINESE MED J-PEKING, V115, P740; NINNI W, 1998, ARCH PHYS MED REHAB, V79, P1433; Pan J., 2009, J TONGJI U MED SCI, V30, P131; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PORTOCARRERO V, 2002, BRAIN RES, V927, P104; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rodriguez DJ, 1997, SPINAL CORD, V35, P599, DOI 10.1038/sj.sc.3100439; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Tashiro T, 1998, NUTRITION, V14, P551, DOI 10.1016/S0899-9007(98)00048-3; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	25	13	15	1	8	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	SEP 5	2010	123	17					2315	2319		10.3760/cma.j.issn.0366-6999.2010.17.006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	654FM	WOS:000282153900006	21034541				2022-02-06	
J	Fabbri, A; Servadei, F; Marchesini, G; Negro, A; Vandelli, A				Fabbri, Andrea; Servadei, Franco; Marchesini, Giulio; Negro, Antonella; Vandelli, Alberto			The changing face of mild head injury: Temporal trends and patterns in adolescents and adults from 1997 to 2008	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Epidemiology; Mild head injury; Outcome; Temporal trends	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; IMPACT; POPULATION; COMMUNITY; PEOPLE	Objective: To explore the temporal trend of incidence, causes of injury and main characteristics of adolescent and adult subjects with mild head injury (MHI). Design: This study had a retrospective design. Setting: The study was conducted in a longitudinal database of an Italian Emergency Department (ED). Participants: The study comprised 19 124 consecutive subjects who visited and were managed within 24 h from the event, according to a predefined protocol for MHI from 1997 to 2008. Main outcome measures: Incidence, demography, cause of injury and characteristics of any post-traumatic intracranial lesion within 7 days from MHI. Results: The number of subjects with MHI decreased from 2019 per year (1997-1999) to 1232 per year (2006-2008; P for linear trend < 0.001), without differences in the total number of subjects visited in the ED. The decrease was observed in all age-decades, in particular, in subjects in the age ranges of 20-29 and 30-39 years. Over time, the age of subjects with MHI lost a bimodal distribution, and the mean age increased from 43 (25-69) years (median (interquartile range)) in 1997-1999 to 56 (33-78) years in 2006-2008 (P < 0.001). The prevalence of falls increased from 36.5% to 55.0%, whereas crashes fell from 53.2% to 31.9%. The incidence of subdural haematoma (SDH) and epidural haematoma (EDH) did not change over time, whereas traumatic subarachnoid haemorrhage (t-SAH) and intra-cerebral haematoma/brain contusion (ICH) increased (from 0.7% to 1.9% and from 2.5% to 3.2%; P for trend: < 0.001 for both. Conclusions: The incidence and the clinical characteristics of MHI subjects are rapidly changing in our setting. These data need to be considered in defining the effectiveness of preventive measures and deciding resource allocation. (C) 2010 Elsevier Ltd. All rights reserved.	[Fabbri, Andrea; Vandelli, Alberto] Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, Azienda USL Forli, I-47100 Forli, Italy; [Servadei, Franco] Univ Parma, Azienda Osped, Unita Operat Neurochirurg, I-43100 Parma, Italy; [Marchesini, Giulio] Univ Bologna, Bologna, Italy; [Negro, Antonella] Agenzia Sanit & Sociale Reg, Bologna, Italy		Fabbri, A (corresponding author), Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, Azienda USL Forli, Via Forlanini 34, I-47100 Forli, Italy.	dr.andrea.fabbri@gmail.com	Fabbri, Andrea/K-9994-2016	Fabbri, Andrea/0000-0002-9837-4638; Servadei, Franco/0000-0002-3595-3464; Marchesini, Giulio/0000-0003-2407-9860	U.O. Unita Operativa di Neurochirurgia, Azienda Ospedaliero-Universitaria di Parma, Italy	We are grateful to the Dr. Fernanda Tagliaferri U.O. Unita Operativa di Neurochirurgia, Azienda Ospedaliero-Universitaria di Parma, Italy for helpful support and critical review of the manuscript.	Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; GIANNOUDIS PV, 2009, J TRAUMA; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	26	13	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					913	917		10.1016/j.injury.2010.03.002			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500007	20362983				2022-02-06	
J	Qu, CS; Mahmood, A; Ning, RZ; Xiong, Y; Zhang, L; Chen, JL; Jiang, H; Chopp, M				Qu, Changsheng; Mahmood, Asim; Ning, Ruizhuo; Xiong, Ye; Zhang, Li; Chen, Jieli; Jiang, Hao; Chopp, Michael			The Treatment of Traumatic Brain Injury with Velcade	JOURNAL OF NEUROTRAUMA			English	Article						neuroprotection; rats; traumatic brain injury; Velcade	NF-KAPPA-B; PROTEASOME INHIBITOR BORTEZOMIB; FOCAL CEREBRAL-ISCHEMIA; MANTLE CELL LYMPHOMA; MATRIX METALLOPROTEINASES; EMBOLIC STROKE; UP-REGULATION; PHASE-II; RATS; ACTIVATION	Traumatic brain injury (TBI) elicits a strong inflammatory response that contributes to the acute pathological processes seen following TBI, including cerebral edema and disruption of the blood-brain barrier (BBB), in addition to longer-term neurological damage and cognitive impairment. Proteasome inhibitors reduce vascular thrombotic and inflammatory events and consequently protect vascular function. In the present study we evaluated the neuroprotective effect of Velcade (R) (bortezomib), a potent and selective inhibitor of proteasomes, which is in clinical use for the treatment of multiple myeloma. When administered within 2 h after TBI onset, Velcade reduced inflammatory responses, lesion volume, and neurological functional deficits, and enhanced neuronal survival. Western blot and ELISA showed that Velcade decreased the expression of NF-kB. These results suggest that in the experimental setting, Velcade is an effective neuroprotective agent for the treatment of TBI.	[Chopp, Michael] Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Syst, Detroit, MI 48202 USA; [Qu, Changsheng; Mahmood, Asim; Ning, Ruizhuo; Xiong, Ye] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA		Chopp, M (corresponding author), Henry Ford Hosp, Dept Neurol, Henry Ford Hlth Syst, E&R Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS42345, RO1 NS42259]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345, R01NS062832, R01NS042259] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants PO1 NS42345 and RO1 NS42259. Special thanks to Susan MacPhee-Gray for editorial assistance.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; CARRION JS, 2000, COMPLUTUM, V11, P1; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; CLAUSEN F, 2004, THESIS FM, V1359, P1; Clemens JA, 1997, STROKE, V28, P1073, DOI 10.1161/01.STR.28.5.1073; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; Dechend R, 1999, CIRCULATION, V100, P1369, DOI 10.1161/01.CIR.100.13.1369; DelZoppo GJ, 1997, ANN NY ACAD SCI, V823, P132; Di Napoli Mario, 2003, Curr Opin Investig Drugs, V4, P333; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Gilardini A, 2008, CURR MED CHEM, V15, P3025, DOI 10.2174/092986708786848622; Henninger N, 2006, NEUROSCI LETT, V398, P300, DOI 10.1016/j.neulet.2006.01.015; Jakob C, 2007, BLOOD, V109, P2100, DOI 10.1182/blood-2006-04-016360; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Koreth J, 2009, BIOL BLOOD MARROW TR, V15, P1502, DOI 10.1016/j.bbmt.2009.07.016; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SW, 2009, ANN RHEUM DIS, V68, P1761, DOI 10.1136/ard.2008.097709; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nawrocki ST, 2004, MOL CANCER THER, V3, P59; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; O'Connor OA, 2005, J CLIN ONCOL, V23, P676, DOI 10.1200/JCO.2005.02.050; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; REH T, 1982, J COMP NEUROL, V211, P276, DOI 10.1002/cne.902110306; Roman-Blas JA, 2008, INT REV IMMUNOL, V27, P351, DOI 10.1080/08830180802295740; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Schenkein D, 2002, CLIN LYMPHOMA, V3, P49, DOI 10.3816/CLM.2002.n.011; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shah SA, 2001, J CELL BIOCHEM, V82, P110, DOI 10.1002/jcb.1150; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sinn DI, 2007, NEUROSCI RES, V58, P12, DOI 10.1016/j.neures.2007.01.006; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Zhang L, 2006, THROMB HAEMOSTASIS, V95, P166, DOI 10.1160/TH05-07-0477	51	13	13	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1625	1634		10.1089/neu.2010.1359			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500009	20649468	Green Published			2022-02-06	
J	Sonna, LA; Kuhlmeier, MM; Khatri, P; Chen, D; Lilly, CM				Sonna, Larry A.; Kuhlmeier, Matthew M.; Khatri, Purvesh; Chen, Dechang; Lilly, Craig M.			A microarray analysis of the effects of moderate hypothermia and rewarming on gene expression by human hepatocytes (HepG2)	CELL STRESS & CHAPERONES			English	Article						Cold stress; Cell stress response; DNA microarray; Heat shock proteins	TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; THERAPEUTIC HYPOTHERMIA; DNA MICROARRAY; CARDIAC-ARREST; COLD-EXPOSURE; ONTO-EXPRESS; RAT-BRAIN; STRESS; CELLS	The gene expression changes produced by moderate hypothermia are not fully known, but appear to differ in important ways from those produced by heat shock. We examined the gene expression changes produced by moderate hypothermia and tested the hypothesis that rewarming after hypothermia approximates a heat-shock response. Six sets of human HepG2 hepatocytes were subjected to moderate hypothermia (31A degrees C for 16 h), a conventional in vitro heat shock (43A degrees C for 30 min) or control conditions (37A degrees C), then harvested immediately or allowed to recover for 3 h at 37A degrees C. Expression analysis was performed with Affymetrix U133A gene chips, using analysis of variance-based techniques. Moderate hypothermia led to distinct time-dependent expression changes, as did heat shock. Hypothermia initially caused statistically significant, greater than or equal to twofold changes in expression (relative to controls) of 409 sequences (143 increased and 266 decreased), whereas heat shock affected 71 (35 increased and 36 decreased). After 3 h of recovery, 192 sequences (83 increased, 109 decreased) were affected by hypothermia and 231 (146 increased, 85 decreased) by heat shock. Expression of many heat shock proteins was decreased by hypothermia but significantly increased after rewarming. A comparison of sequences affected by thermal stress without regard to the magnitude of change revealed that the overlap between heat and cold stress was greater after 3 h of recovery than immediately following thermal stress. Thus, while some overlap occurs (particularly after rewarming), moderate hypothermia produces extensive, time-dependent gene expression changes in HepG2 cells that differ in important ways from those induced by heat shock.	[Sonna, Larry A.] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Sonna, Larry A.; Kuhlmeier, Matthew M.] USA, Environm Med Res Inst, Thermal & Mt Med Div, Natick, MA 01760 USA; [Khatri, Purvesh] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Chen, Dechang] Uniformed Serv Univ Hlth Sci, Div Epidemiol & Biostat, Bethesda, MD 20814 USA; [Lilly, Craig M.] Univ Massachusetts, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Worcester, MA 01655 USA		Sonna, LA (corresponding author), Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA.	larry_sonna@yahoo.com			US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-64104, HL-072114]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064104, R01HL072114] Funding Source: NIH RePORTER	Funding was provided by the US Army Medical Research and Materiel Command (USAMRMC). National Heart, Lung, and Blood Institute Grants HL-64104 and HL-072114 also supported this work.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boss O, 1997, FEBS LETT, V412, P111, DOI 10.1016/S0014-5793(97)00755-2; Cotto JJ, 1999, BIOCHEM SOC SYMP, P105; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Denjean F, 1999, FEBS LETT, V444, P181, DOI 10.1016/S0014-5793(99)00056-3; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; FARRELL RE, 1998, DETERMINATION NUCL A, P94; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Fuller BJ, 2003, CRYOLETTERS, V24, P95; Ganta CK, 2006, AM J PHYSIOL-REG I, V291, pR558, DOI 10.1152/ajpregu.00846.2005; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; KHATRI P, 2006, 0705 USARIEM TR; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Niemann CU, 2010, J SURG RES, V158, P43, DOI 10.1016/j.jss.2008.08.030; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Ohta H, 2007, NEUROSCI RES, V57, P424, DOI 10.1016/j.neures.2006.12.002; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Remick DG, 2006, FRONT BIOSCI-LANDMRK, V11, P1006, DOI 10.2741/1858; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Sonna LA, 2003, PHYSIOL GENOMICS, V12, P195, DOI 10.1152/physiolgenomics.00104.2002; Sonna LA, 2002, J APPL PHYSIOL, V92, P2208, DOI 10.1152/japplphysiol.01002.2001; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Sonna LA, 2006, PHYSIOL GENOMICS, V26, P91, DOI 10.1152/physiolgenomics.00296.2005; Wood RJ, 2004, PHYSIOL GENOMICS, V17, P122, DOI 10.1152/physiolgenomics.00002.2003; Yamashita H, 1999, FEBS LETT, V458, P157, DOI 10.1016/S0014-5793(99)01143-6; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	33	13	13	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	SEP	2010	15	5					687	702		10.1007/s12192-010-0181-2			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	636YQ	WOS:000280781800021	20526826	Green Published			2022-02-06	
J	Savard, M; Turgeon, AF; Gariepy, JL; Trottier, F; Langevin, S				Savard, Martin; Turgeon, Alexis F.; Gariepy, Jean-Luc; Trottier, Francois; Langevin, Stephan			Selective 4 Vessels Angiography in Brain Death: A Retrospective Study	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; NEUROLOGICAL DETERMINATION; BLOOD-FLOW; SPIRAL CT; DIAGNOSIS; RECOMMENDATIONS; PRESSURE; INJURY	Background: In Canada, ancillary tests, such as selective four vessels angiography (S4VA), are sometimes necessary for brain death (BD) diagnosis when the clinical exam cannot be completed or confounding factors are present. Recent Canadian guidelines assert that brain death is supported by the absence of arterial blood flow at the surface of the brain and that venous return should not be considered. However, neuropathologic and angiographic studies have suggested that arteries might still be patent in BD patients. Current clinical practices in BD diagnosis following S4VA need to be better understood. Methods: We conducted a retrospective study of all S4VA performed for the determination of BD in a level 1 NeuroTrauma centre from 2003 to 2007. The objective of the study was to describe the prevalence of intracranial arterial, capillary (parenchymogram) and venous opacification in our study population. All tests were reviewed independently by two neuroradiologists. Disagreements were resolved by consensus. Results: Thirty two patients were declared BD following S4VA during the study period. Nine of these patients (28%) presented some proximal opacification of intracranial arteries (95% CI 15-45%). As opposed, none had a cerebral capillary and deep venous drainage opacification (95% CI 0-10%). Conclusion: The absence of cerebral deep venous drainage or parenchymogram might represent a better objective marker of cerebral circulatory arrest for brain death diagnosis when the use of S4VA is required. These findings open the path for further research in enhancing our interpretation of angiographic studies for brain death diagnosis.	[Savard, Martin] Univ Laval, Hop Enfants Jesus, Dept Neurol Sci, Ctr Hosp Affill,Univ Quebec, Quebec City, PQ G1J 1Z4, Canada; [Turgeon, Alexis F.; Langevin, Stephan] Univ Laval, Hop Enfants Jesus, Dept Anaesthesiol, Serv Soins Intensifs, Quebec City, PQ G1J 1Z4, Canada; [Turgeon, Alexis F.] Univ Laval, Hop Enfants Jesus, Unite Rech Traumatol Urgence Soins Intensifs, Ctr Rech CHA, Quebec City, PQ G1J 1Z4, Canada; [Gariepy, Jean-Luc; Trottier, Francois] Univ Laval, Hop Enfants Jesus, Dept Radiol, Ctr Hosp Affill,Univ Quebec, Quebec City, PQ G1J 1Z4, Canada		Savard, M (corresponding author), Univ Laval, Hop Enfants Jesus, Dept Neurol Sci, Ctr Hosp Affill,Univ Quebec, 1401 18E Rue Quebec, Quebec City, PQ G1J 1Z4, Canada.		Savard, Martin/O-2549-2019		Fonds de la Recherche en Sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [015102]	The authors thank Dr. Robert Laforce Jr. for his help in the final redaction of this manuscript. Dr. Turgeon is a recipient of a Clinical Research Career Award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and is supported by an operational grant from the FRSQ (#015102).	Altman D.G., 1990, PRACTICAL STAT MED R; BRADAC GB, 1974, NEURORADIOLOGY, V7, P25, DOI 10.1007/BF00344671; Braun M, 1997, NEURORADIOLOGY, V39, P400, DOI 10.1007/s002340050432; Combes JC, 2007, TRANSPLANT P, V39, P16, DOI 10.1016/j.transproceed.2006.10.204; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; de Freitas GR, 2003, J NEUROL SCI, V210, P31, DOI 10.1016/S0022-510X(03)00065-0; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Dupas B, 1998, AM J NEURORADIOL, V19, P641; KOREIN J, 1977, ANN NEUROL, V2, P195, DOI 10.1002/ana.410020304; Kricheff I I, 1978, Ann N Y Acad Sci, V315, P168, DOI 10.1111/j.1749-6632.1978.tb50338.x; Langfitt T W, 1966, Acta Neurochir (Wien), V14, P96, DOI 10.1007/BF01401893; Leclerc X, 2007, J NEURORADIOLOGY, V34, P217, DOI 10.1016/j.neurad.2007.07.008; Leclerc X, 2006, J NEURORADIOLOGY, V33, P90, DOI 10.1016/S0150-9861(06)77237-6; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; Munari M, 2005, CRIT CARE MED, V33, P2068, DOI 10.1097/01.CCM.0000179143.19233.6A; Park MK, 2005, PEDIATR CARDIOL, V26, P601, DOI 10.1007/s00246-004-0828-9; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; Quesnel C, 2007, INTENS CARE MED, V33, P2129, DOI 10.1007/s00134-007-0789-6; Shemie SD, 2008, CAN J NEUROL SCI, V35, P140, DOI 10.1017/S0317167100008544; Shemie SD, 2006, CAN MED ASSOC J, V174, pS1, DOI 10.1503/cmaj.045142; VANBUNNEN Y, 1989, ANN RADIOL, V32, P279; VLAHOVITCH B, 1971, NEURO-CHIR, V17, P81	23	13	14	0	0	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2010	37	4					492	497		10.1017/S0317167100010520			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630DX	WOS:000280253900011	20724258	Bronze			2022-02-06	
J	Yen, LE; Gregory, A; Kuhn, JE; Markle, R				Yen, Leslianne E.; Gregory, Andrew; Kuhn, John E.; Markle, Ross			The Ultimate Frisbee Injury Study: The 2007 Ultimate Players Association College Championships	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						ultimate; frisbee; injury; college	DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; SOCCER INJURIES; SPORTS; RISK; KNEE	Objective: To quantify and characterize the injuries incurred by ultimate players during the 2007 Ultimate Players Association College Championships. Design: Cross-sectional study. Setting: The Ultimate Players Association College Championships in Columbus, Ohio, in May 2007. Participants: Athletes who left the field of play due to injury time-outs (ITOs). There were 107 recorded ITOs. Interventions: During the 3 days of the 2007 College Championships, 86 games were observed by the research staff. Athletes calling an ITO were interviewed. Sex, activity at time of injury, type of injury, and associated contact, if any, were recorded. Main Outcome Measures: Return to play, injury type, and injured body part. Results: One injury prevented return to play in each of the 2 sex divisions, equivalent to 1.66 per 1000 athlete-exposures in championships bracket games. The majority of ITOs were related to contact, 53% in the men's division and 68% in the women's division. The lower extremities were injured in 53% and 51% of cases in the men's and women's divisions, respectively. Laying out was one of the most common activities at time of ITO (29% and 22% in men's and women's divisions, respectively) and accounted for all of the men's closed head injuries and 2 of the 3 women's closed head injuries. Conclusions: There was a low rate of play-ending injuries. There were no statistically significant associations. Physical contact and laying out were frequently linked with ITO.	[Yen, Leslianne E.] Minor & James Med, Seattle, WA 98104 USA; [Gregory, Andrew; Kuhn, John E.] Vanderbilt Orthopaed Inst, Nashville, TN USA; [Markle, Ross] James Madison Univ, Ctr Assessment & Res Studies, Harrisonburg, VA 22807 USA		Yen, LE (corresponding author), Minor & James Med, 515 Minor Ave,Ste 300, Seattle, WA 98104 USA.	Leslianne.Yen@minorandjames.com			2006 Ultimate Players Association; Vanderbilt Sports Medicine Fellowship	Funding was provided by a 2006 Ultimate Players Association Innovation Grant and by the Vanderbilt Sports Medicine Fellowship.; The authors thank the Vanderbilt Sports Medicine faculty who made this research possible through their fellowship program, support, and funding. The authors also acknowledge the Ultimate Players Association for the Innovation Grant that partially funded this research, Matt Lane for his photography, the volunteer research staff, and Jon Ladd, PhD.	Agel J, 2007, J ATHL TRAINING, V42, P270; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Boden BP, 2000, ORTHOPEDICS, V23, P573, DOI 10.3928/0147-7447-20000601-15; Dick R, 2007, J ATHL TRAINING, V42, P278; Emery CA, 2005, MED SPORT SCI, V48, P179, DOI [10.1159/000084289, 10.1159/000085396]; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Kofotolis ND, 2007, AM J SPORT MED, V35, P458, DOI 10.1177/0363546506294857; MADDEN CC, 2003, DELEE DREZS ORTHOPAE; Marfleet P, 1991, Br J Sports Med, V25, P235; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; NOYES FR, 1983, J BONE JOINT SURG AM, V65, P154, DOI 10.2106/00004623-198365020-00003; Renstrom P, 2008, BRIT J SPORT MED, V42, P394, DOI 10.1136/bjsm.2008.048934; Reynolds Kristen H, 2006, WMJ, V105, P46; RISSER WL, 1994, PEDIATRICS, V94, P757; STRAND T, 1990, J NOR MED ASS, V110, P45; *UPA, UPA MEMB BREAKD; Yu B, 2007, BRIT J SPORT MED, V41, pI47, DOI 10.1136/bjsm.2007.037192; 2009 COLL RC PACKET; ULTIMATE FAQ	23	13	13	3	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2010	20	4					300	305		10.1097/JSM.0b013e3181ea8b1c			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	622EA	WOS:000279641800009	20606516				2022-02-06	
J	Bitner, BR; Brink, DC; Mathew, LC; Pautler, RG; Robertson, CS				Bitner, Brittany R.; Brink, Danielle C.; Mathew, Leela C.; Pautler, Robia G.; Robertson, Claudia S.			Impact of arginase II on CBF in experimental cortical impact injury in mice using MRI	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						arginase II; CBF; MRI; NO; TBI	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; L-ARGININE; MOUSE; HEMODYNAMICS; WATER	Traumatic brain injury (TBI) results in reduced cerebral blood flow (CBF) and low levels of the vasodilator nitric oxide (NO) may be involved. Arginase II negatively regulates NO production through competition for the substrate L-arginine. We determined whether arginase II-deficient (ArgII(-/-)) mice would show improved CBF after TBI through arterial spin-labeling magnetic resonance imaging (MRI). The ArgII(-/-) mice exhibit a significantly improved CBF recovery after trauma in the perilesional brain (P=0.0015) and in various other brain regions. In conclusion, arginase II deficiency leads to a better CBF recovery after TBI and implicates arginase II in hemodynamic processes. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 1105-1109; doi: 10.1038/jcbfm.2010.47; published online 7 April 2010	[Brink, Danielle C.; Mathew, Leela C.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, MEDT 7-84,Mail Stop BCM650, Houston, TX 77030 USA.	claudiar@bcm.edu			Mission Connect; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [POI-N538660]; Howard Hughes Medical Institutes Med into Grad Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This project was funded by a grant from Mission Connect (LCM) and the NIH grant POI-N538660 (CSR). The interdepartmental Program in Translational Biology and Molecular Medicine is funded in part by the Howard Hughes Medical Institutes Med into Grad Initiative.	Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2009, J NEUROTRAUM, V26, pA96; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Huynh NN, 2009, HYPERTENSION, V54, P294, DOI 10.1161/HYPERTENSIONAHA.108.121731; Lim HK, 2007, AM J PHYSIOL-HEART C, V293, pH3317, DOI 10.1152/ajpheart.00700.2007; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	13	13	13	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2010	30	6					1105	1109		10.1038/jcbfm.2010.47			5	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	604GH	WOS:000278267000004	20372170	Green Published, Bronze			2022-02-06	
J	Dolezal, DN; Kurtz, PF				Dolezal, Danielle N.; Kurtz, Patricia F.			EVALUATION OF COMBINED-ANTECEDENT VARIABLES ON FUNCTIONAL ANALYSIS RESULTS AND TREATMENT OF PROBLEM BEHAVIOR IN A SCHOOL SETTING	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						combined-antecedent variables; functional communication training; motivating operations; problem behavior; structured descriptive assessment	ESCAPE	Call, Wacker, Ringdahl, and Boelter (2005) conducted an analysis in which a single-antecedent condition was compared to a multiple-antecedent condition. The present study extended Call et al. by conducting a structured descriptive assessment (SDA) to identify the antecedent variables most associated with problem behavior in a student with traumatic brain injury and intellectual disabilities. Results indicated that the SDA was effective in identifying relevant antecedent variables that led to the development of an effective intervention in the classroom.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA		Dolezal, DN (corresponding author), Seattle Childrens Hosp, Dept Psychiat & Behav Hlth, W-3636 Child Psychiat,4800 Sand Point Way NE, Seattle, WA 98105 USA.	danielle.dolezal@seattlechildrens.org					Anderson CM, 2002, J APPL BEHAV ANAL, V35, P137, DOI 10.1901/jaba.2002.35-137; Call NA, 2005, J APPL BEHAV ANAL, V38, P385, DOI 10.1901/jaba.2005.51-04; Golonka Z, 2000, J APPL BEHAV ANAL, V33, P243, DOI 10.1901/jaba.2000.33-243; Lang R, 2009, J APPL BEHAV ANAL, V42, P393, DOI 10.1901/jaba.2009.42-393; Mueller MM, 2005, SCHOOL PSYCHOL REV, V34, P425; Zarcone JR, 1996, J APPL BEHAV ANAL, V29, P247, DOI 10.1901/jaba.1996.29-247	6	13	13	2	9	JOURNAL APPL BEHAV ANAL	LAWRENCE	DEPT HUMAN DEVELOPMENT, UNIV KANSAS, LAWRENCE, KS 66045 USA	0021-8855			J APPL BEHAV ANAL	J. Appl. Behav. Anal.	SUM	2010	43	2					309	314		10.1901/jaba.2010.43-309			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	610YI	WOS:000278776300013	21119906	Green Published, Bronze			2022-02-06	
J	Ozen, LJ; Skinner, EI; Fernandes, MA				Ozen, Lana J.; Skinner, Erin I.; Fernandes, Myra A.			Rejecting familiar distracters during recognition in young adults with traumatic brain injury and in healthy older adults	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Brain concussion; Aging; Memory disorders; Frontal lobe; Neuropsychological tests	CLOSED-HEAD-INJURY; DEPRESSION FOLLOWING MILD; AGE-RELATED DIFFERENCES; FALSE MEMORIES; WORKING-MEMORY; COGNITIVE IMPAIRMENT; EXPLICIT MEMORY; TEMPORAL-ORDER; LONG; PERFORMANCE	The most common cognitive complaint reported by healthy older adults and young adults with traumatic brain injury (TB!) is memory difficulties. We investigated the effects of normal aging and the long-term effects of TBI in young adults on the susceptibility to incorrectly endorse distracter information on a memory test. Prior to a study phase, participants viewed a "pre-exposure" list containing distracter words, presented once or three times, and half of the target study words. Subsequently, during the study phase, all target words were presented such that, across lists, study words were viewed either once or three times. On the recognition test. TBI and older adult participants were more likely to falsely endorse "pre-exposed" distracter words viewed three times as being from the target study list, compared to non-head-injured young controls. Normal aging and head injury in young may similarly compromise one's ability to reject highly familiar, but distracting, information during recognition. Older adult and TBI participants were also slower to complete the Trail Making task and had poorer output on a Digit Span task, suggesting these two populations share a deficit in executive function and working memory. Similar changes in frontal lobe function may underlie these shared cognitive deficits. (JINS, 2010, 16, 556-565.)	[Ozen, Lana J.; Skinner, Erin I.; Fernandes, Myra A.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada		Ozen, LJ (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	lozen@uwaterloo.ca			National Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a discovery grant from the National Sciences and Engineering Research Council of Canada (NSERC) awarded to ME and post-graduate scholarships from NSERC awarded to LO and to ES.	Alves W., 1992, PHYS MED REHABIL STA, V6, P21; BARTLETT JC, 1991, MEM COGNITION, V19, P177, DOI 10.3758/BF03197115; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Bopp KL, 2007, J GERONTOL B-PSYCHOL, V62, pP239, DOI 10.1093/geronb/62.5.P239; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; BURKE DM, 1981, PSYCHOL BULL, V90, P513, DOI 10.1037/0033-2909.90.3.513; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COHEN G, 1989, PSYCHOL AGING, V4, P10, DOI 10.1037/0882-7974.4.1.10; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1990, PSYCHOL AGING, V5, P148, DOI 10.1037/0882-7974.5.1.148; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dobbins IG, 1998, J MEM LANG, V38, P381, DOI 10.1006/jmla.1997.2554; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HASHTROUDI S, 1989, PSYCHOL AGING, V4, P106, DOI 10.1037/0882-7974.4.1.106; Jacoby LL, 1999, J EXP PSYCHOL LEARN, V25, P3, DOI 10.1037/0278-7393.25.1.3; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kensinger EA, 1999, COGNITIVE NEUROPSYCH, V16, P399, DOI 10.1080/026432999380852; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; LIGHT LL, 1987, J EXP PSYCHOL LEARN, V13, P531, DOI 10.1037/0278-7393.13.4.531; Luo L, 2007, PSYCHOL AGING, V22, P269, DOI 10.1037/0882-7974.22.2.269; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; PARK DC, 1985, J GERONTOL, V40, P198, DOI 10.1093/geronj/40.2.198; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; PRULL MW, 2000, HDB AGING COGNITION, P91; *PSYCH SOFTW TOOLS, 2002, E PRIM VERS 1 2; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Reitan R, 1985, HALSTEAD REITAN NEUR; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Tun PA, 1998, PSYCHOL AGING, V13, P230, DOI 10.1037/0882-7974.13.2.230; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2003, J CLIN EXP NEUROPSYC, V25, P274, DOI 10.1076/jcen.25.2.274.13637; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Vakil E, 1997, J Int Neuropsychol Soc, V3, P327; van Rijn, 1995, CELEX LEXICAL DATABA; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Watson JM, 2001, NEUROPSYCHOLOGY, V15, P254, DOI 10.1037//0894-4105.15.2.254; Watson JM, 2004, MEM COGNITION, V32, P135, DOI 10.3758/BF03195826; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	71	13	14	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2010	16	3					556	565		10.1017/S1355617710000202			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	594ZA	WOS:000277579000016	20211048				2022-02-06	
J	Palmer, HS; Garzon, B; Xu, J; Berntsen, EM; Skandsen, T; Haberg, AK				Palmer, Helen S.; Garzon, Benjamin; Xu, Jian; Berntsen, Erik M.; Skandsen, Toril; Haberg, Asta K.			Reduced Fractional Anisotropy Does Not Change the Shape of the Hemodynamic Response in Survivors of Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood oxygenation level-dependent signal; diffuse axonal injury; diffusion tensor imaging; functional magnetic resonance imaging; visual stimuli	WHITE-MATTER PATHWAYS; PROCESSING SPEED; VISUAL-CORTEX; DIFFUSION ANISOTROPY; WORKING-MEMORY; OPTIC NEURITIS; BOLD-RESPONSE; ADULT CAT; FMRI; RECOVERY	The hemodynamic response (HDR) function is the basis for standard functional magnetic resonance imaging (fMRI) analysis. HDR is influenced by white matter inflammation. Traumatic brain injury (TBI) is frequently accompanied by diffuse white matter injury, but the effect of this on the HDR has not been investigated. The aims of the present study were to describe the HDR in visual cortex and examine its relationship with the microstructure of the optic radiation in severe TBI survivors and controls. Ten severe TBI survivors without visual impairments, but with known diffuse axonal injury, and 9 matched controls underwent diffusion tensor imaging (DTI) and fMRI. From the fMRI time series obtained during brief randomized visual stimuli, blood oxygenation level-dependent (BOLD) signal changes for each subject were estimated in V1, and group HDR curves were produced. Standard between-group analysis of BOLD activation in V1+V2 was performed. For each individual the optic radiations were identified and fractional anisotropy (FA) plus mean apparent diffusion coefficient (ADC(mean)) values for these tracts were calculated. Group HDR curves from the visual cortex were fully transposable between TBI survivors and controls, despite a significant reduction in FA in the optic radiation in TBI survivors. A significant correlation between BOLD signal in the visual cortex and FA values in the optical tract was present in controls, but not in TBI survivors. Between-group comparisons showed that TBI survivors had increased areas of activation in V1 and V2. The HDR appears to be intact in traumatic white matter damage, supporting the validity of using standard fMRI methodology to study neuroplasticity in TBI.	[Skandsen, Toril; Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neuromed, N-7034 Trondheim, Norway; [Palmer, Helen S.; Garzon, Benjamin; Xu, Jian; Berntsen, Erik M.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Skandsen, Toril] St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Xu, Jian; Berntsen, Erik M.; Haberg, Asta K.] St Olavs Hosp, Dept Med Imaging, Trondheim, Norway		Haberg, AK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neuromed, N-7489 Trondheim, Norway.	asta.haberg@ntnu.no	Berntsen, Erik Magnus/AAM-7134-2020; Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338; Garzon, Benjamin/0000-0002-4647-7280			Ashburner J., 2006, STAT PARAMETRIC MAPP, V1st ed.; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Barth AL, 2002, PHYSIOL BEHAV, V77, P545, DOI 10.1016/S0031-9384(02)00932-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2004, CURR BIOL, V14, pR523, DOI 10.1016/j.cub.2004.06.044; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Friedman L, 2008, NEUROIMAGE, V40, P1181, DOI 10.1016/j.neuroimage.2007.12.040; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V14, P823; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jensen U, 2008, CEREBROVASC DIS, V26, P231, DOI 10.1159/000147449; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Krainik A, 2005, STROKE, V36, P1146, DOI 10.1161/01.STR.0000166178.40973.a7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langkilde AR, 2002, EUR J NEUROL, V9, P277, DOI 10.1046/j.1468-1331.2002.00399.x; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu YL, 2006, NEUROIMAGE, V32, P238, DOI 10.1016/j.neuroimage.2005.11.040; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Roc AC, 2006, STROKE, V37, P382, DOI 10.1161/01.STR.0000198807.31299.43; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Rombouts SARB, 1998, NEUROLOGY, V50, P1896, DOI 10.1212/WNL.50.6.1896; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; SCHROETER ML, 2009, NEUROPSYCHOLOGIA; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SKANDSEN T, 2009, J NEUROSURG; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stufflebeam SM, 2008, NEUROIMAGE, V42, P710, DOI 10.1016/j.neuroimage.2008.04.264; TEASDALE G, 1974, LANCET, V2, P81; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Werring DJ, 2000, J NEUROL NEUROSUR PS, V68, P441, DOI 10.1136/jnnp.68.4.441; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	62	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2010	27	5					853	862		10.1089/neu.2009.1225			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	599LX	WOS:000277915400007	20199173				2022-02-06	
J	Williams, GP; Schache, AG				Williams, Gavin P.; Schache, Anthony G.			Evaluation of a Conceptual Framework for Retraining High-Level Mobility Following Traumatic Brain Injury: Two Case Reports	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						high-level mobility assessment tool; quantitative gait analysis; rehabilitation; running; traumatic brain injury	ASSESSMENT-TOOL HIMAT; BOTULINUM-TOXIN; CHRONIC STROKE; EXERCISE; GAIT; WALKING; PHYSIOTHERAPISTS; BIOMECHANICS; INDIVIDUALS; HEMIPARESIS	Traumatic brain injury (TBI) is the primary cause of death and disability for 18- to 45-year-olds. High-level mobility is important for many of the social, leisure, sporting, and employment roles of young adults. The aim of these case reports was to evaluate a conceptual framework for retraining high-level mobility after TBI. The progression of 2 patients who had sustained a severe TBI but had contrasting clinical presentations was monitored over 6 months. Patient 1 presented with left hemiplegia following a TBI 10 years earlier, whereas patient 2 presented with ataxia 2 months following a TBI. Quantitative gait analysis and clinical measures of mobility were used to evaluate outcomes of a 6-month intervention phase. Intervention strategies were based on a conceptual framework comprising 2 main elements: (1) the hierarchical ordering of high-level mobility tasks and (2) the key biomechanical features of able-bodied running. Both patients achieved the ability to run by the end of the intervention phase. Patient 1 displayed improved gait symmetry associated with improved high-level mobility, despite the long-standing duration of his injury. Patient 2 demonstrated improved postural control and stability in gait that resulted in an ability to run, skip, hop, and jump. Findings of these case reports provide evidence supporting "proof of concept" that clinical interventions can lead to improvement in high-level mobility following severe TBI.	[Williams, Gavin P.] Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic, Australia; [Williams, Gavin P.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Sch Physiotherapy, Melbourne, Vic 3010, Australia; [Schache, Anthony G.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic 3010, Australia		Williams, GP (corresponding author), Epworth Med Fdn, Physiotherapy Dept, Melbourne, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473			Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Collen F M, 1991, Int Disabil Stud, V13, P50; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Kahn JH, 2009, PHYS THER, V89, P474, DOI 10.2522/ptj.20080237; Levy CE, 2007, AM J PHYS MED REHAB, V86, P696, DOI 10.1097/PHM.0b013e31813e2b4d; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Molteni F, 1995, EUR J NEUROL, V2, P61; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Olney SJ, 2006, STROKE, V37, P476, DOI 10.1161/01.STR.0000199061.85897.b7; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Quinn B, 2000, BRAIN INJURY, V14, P1063; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; SIMONDSON J, 1998, MOBILITY SCALE ACUTE; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Toro B, 2003, ARCH PHYS MED REHAB, V84, P1878, DOI 10.1016/S0003-9993(03)00482-9; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2009, INT J THER REHABIL, V16, P188, DOI 10.12968/ijtr.2009.16.4.41186; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762	34	13	13	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2010	25	3					164	172		10.1097/HTR.0b013e3181dc120b			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	606KG	WOS:000278423300003	20473090				2022-02-06	
J	Chien, LC; Cheng, HM; Chen, WC; Tsai, MC				Chien, Li-Chien; Cheng, Hon-Mei; Chen, Weng-Chau; Tsai, Ming-Che			Pelvic Fracture and Risk Factors for Mortality: A Population-Based Study in Taiwan	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Pelvic injury; Resource utilization; Incidence; Risk factor; Mortality	RETROSPECTIVE ANALYSIS; TRAUMA ADMISSIONS; SACRAL FRACTURES; INJURIES; OSTEOPOROSIS; BURDEN; RING; EPIDEMIOLOGY; AUSTRALIA; WEATHER	Objective: To study the incidence, demographics, distribution of fracture sites, associated injuries, and risk factors for the outcomes of pelvic fracture on a population basis. Methods: An annual claim dataset from 2001 to 2003 was retrieved from the Bureau of National Health Insurance (BNHI) trauma database with any International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) coded as pelvic fracture. Statistical analyses were conducted to discover the association between variables such as age, gender, month of injury, injury mechanisms, associated injuries, and outcome. Results: Pelvic fracture was diagnosed in 10,109 patients (4,693 males, 46.4%) and 384 patients (3.8%) died. The incidence was 14.97/100,000 person-years. The mean length of stay was 9.3 days (females, 8.8 days; males, 9.9 days; p < 0.01) and the average cost per patient was US$1,475. Both were affected by age, gender, and hospital accreditation level and ownership. There were more female cases in the age groups over 44 years old. Head injury (excluding concussion), associated chest and abdominal injuries, open pelvic fracture, and the transfusion of more than four units of blood significantly increased the risk of mortality. Conclusions: The incidence rate of pelvic fracture was higher in females over 44 years of age, but the average medical resource use was higher in males. Associated injuries were stronger positive factors for the risk of mortality than gender, fracture sites, injury mechanisms, and the characteristics of the treating hospitals.	[Chien, Li-Chien; Chen, Weng-Chau; Tsai, Ming-Che] Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan 70004, Taiwan; [Cheng, Hon-Mei] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan		Tsai, MC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Emergency Med, 138 Sheng Li Rd, Tainan 70004, Taiwan.	t2195@mail.ncku.edu.tw					Atherton WG, 2005, INJURY, V36, P40, DOI 10.1016/j.injury.2003.10.027; Bassam D, 1998, AM SURGEON, V64, P862; Boufous S, 2005, INJURY, V36, P1323, DOI 10.1016/j.injury.2005.02.008; Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113; DENIS F, 1988, CLIN ORTHOP RELAT R, P67; FLINT L, 1990, ANN SURG, V211, P703, DOI 10.1097/00000658-199006000-00008; Graham CA, 2005, INJURY, V36, P1040, DOI 10.1016/j.injury.2004.09.011; Guggenbuhl P, 2005, JOINT BONE SPINE, V72, P372, DOI 10.1016/j.jbspin.2004.04.002; Han TH, 2005, BURNS, V31, P465, DOI 10.1016/j.burns.2004.11.014; Hauschild O, 2008, J TRAUMA, V64, P449, DOI 10.1097/TA.0b013e31815982b1; Inaba K, 2004, INJURY, V35, P759, DOI 10.1016/S0020-1383(03)00308-5; Kido A, 2008, J ORTHOP SCI, V13, P21, DOI 10.1007/s00776-007-1190-6; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Muir L, 1996, INJURY, V27, P199, DOI 10.1016/0020-1383(95)00195-6; Pocock NA, 1999, MED J AUSTRALIA, V170, P486, DOI 10.5694/j.1326-5377.1999.tb127851.x; RICHARDSON JD, 1982, J TRAUMA, V22, P533, DOI 10.1097/00005373-198207000-00002; RIEMER BL, 1993, J TRAUMA, V35, P671, DOI 10.1097/00005373-199311000-00003; Rising WR, 2006, J TRAUMA, V60, P1096, DOI 10.1097/01.ta.0000197435.82141.27; Rittmeister M, 2001, ARCH ORTHOP TRAUM SU, V121, P43, DOI 10.1007/s004020000179; Rowe SA, 2004, SURGERY, V136, P842, DOI 10.1016/j.surg.2004.07.003; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Smith W, 2007, J ORTHOP TRAUMA, V21, P31, DOI 10.1097/BOT.0b013e31802ea951; Starr AJ, 2002, J ORTHOP TRAUMA, V16, P553, DOI 10.1097/00005131-200209000-00003; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; Totterman A, 2006, SPINE, V31, pE628	26	13	15	0	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2010	36	2					131	137		10.1007/s00068-009-9094-0			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	587JR	WOS:000276988300008	26815687				2022-02-06	
J	Hokari, M; Kuroda, S; Iwasaki, Y				Hokari, Masaaki; Kuroda, Satoshi; Iwasaki, Yoshinobu			Pretreatment with the ciclosporin derivative NIM811 reduces delayed neuronal death in the hippocampus after transient forebrain ischaemia	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						delayed neuronal death; hippocampus; NIM811; reduced mitochondrial permeability transition; transient forebrain ischaemia	MITOCHONDRIAL PERMEABILITY TRANSITION; INTERMEMBRANE JUNCTIONAL COMPLEXES; BRAIN-DAMAGE; FOCAL ISCHEMIA; PORE; INVOLVEMENT; INHIBITION; MEMBRANE; IMMUNOSUPPRESSANT; POSTTREATMENT	Objectives There have been several previous studies showing that ciclosporin, a ligand for cyclophilin D (CypD), reduces mitochondrial permeability transition (mPT) and ameliorates delayed neuronal death. NIM811 is a non-immunosuppressive ciclosporin derivative that also inhibits mPT, but has significantly less cytotoxicity than ciclosporin. Actually, in animal experiments, several investigators have reported that NIM811 ameliorates central nervous system disorders, such as traumatic brain injury, transient focal cerebral ischaemia and spinal cord injury. Therefore, we evaluated whether the ciclosporin derivative, NIM811 reduces mPT and ameliorates delayed neuronal death in the hippocampal CA1 sectors in mice when subjected to transient forebrain ischaemia. Methods Male C57BL/6 mice were treated with 50 mg/kg ciclosporin, 10,50 or 100 mg/kg NIM811 or phosphate-buffered saline. At 30 min post-injection, all mice were subjected to 20 min bilateral common carotid artery occlusion (BCCAO). To estimate delayed neuronal death, the sections were prepared for HE staining and terminal deoxynucleotidyl transferase-mediated dUTP end-labelling (TUNEL) staining at 72 h after 20 min BCCAO. Furthermore, using 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine iodide (JC-1) staining technique, we evaluated whether NIM811 (1, 10, 100 or 1000 pm) inhibited mPT in the neurons exposed to 100 pm glutamate. Results Both delayed neuronal injury and apoptosis in the hippocampal CA1 sectors were significantly ameliorated at 72 h after transient forebrain ischaemia in the mice treated with 100 mg/kg NIM811 or 50 mg/kg ciclosporin. The treatments with 100 pm and 1000 pm NIM811 significantly inhibited the reduction of mitochondrial membrane potential in the neurons exposed to 100 pm glutamate. Conclusions These findings strongly suggest that NIM811 inhibits mPT and ameliorates delayed neuronal death in mice subjected to transient forebrain ischaemia.	[Hokari, Masaaki] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan		Hokari, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	karimasa@med.hokudai.ac.jp	Hokari, Masaaki/G-5395-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17390389, 18390387, 19390371]	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.17390389, No.18390387 and No.19390371).	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; ATKINSON K, 1984, TRANSPLANTATION, V38, P34, DOI 10.1097/00007890-198407000-00009; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Crompton M, 2003, CURR MED CHEM, V10, P1473, DOI 10.2174/0929867033457197; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Kikuchi S, 2002, J NEUROSCI RES, V69, P373, DOI 10.1002/jnr.10298; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; KUNZENDORF U, 1988, LANCET, V1, P1223; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; OGAWA N, 1993, NEUROSCI LETT, V152, P173, DOI 10.1016/0304-3940(93)90511-I; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SZABO I, 1992, J BIOL CHEM, V267, P2940; SZABO I, 1991, J BIOL CHEM, V266, P3376; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Yamaguchi T, 2006, J PHARMACOL SCI, V100, P73, DOI 10.1254/jphs.FP0050799; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	44	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	APR	2010	62	4					485	490		10.1211/jpp.62.04.0011			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	588VJ	WOS:000277102200011	20604838				2022-02-06	
J	Ibrahim, NG; Natesh, R; Szczesny, SE; Ryall, K; Eucker, SA; Coats, B; Margulies, SS				Ibrahim, Nicole G.; Natesh, Rahul; Szczesny, Spencer E.; Ryall, Karen; Eucker, Stephanie A.; Coats, Brittany; Margulies, Susan S.			In Situ Deformations in the Immature Brain During Rapid Rotations	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						brain tissue strains; finite element model validation; brain deformation; pediatric head injury	TRAUMATIC AXONAL INJURY; SIMPLE ELONGATION; SKULL; MODEL; HEAD	Head trauma is the leading cause of death and debilitating injury in children. Computational models are important tools used to understand head injury mechanisms but they must be validated with experimental data. In this communication we present in situ measurements of brain deformation during rapid, nonimpact head rotation in juvenile pigs of different ages. These data will he used to validate computational models identifying age-dependent thresholds of axonal injury. Fresh 5 days (n = 3) and 4 weeks (n = 2) old piglet heads were transected horizontally and secured in a container The cut sulface of each brain was marked and covered with a transparent, lubricated plate that allowed the brain to move freely in the plane of rotation. For each brain, a rapid (20-28 ms) 65 deg rotation was applied sequentially at 50 rad/s, 75 rad/s, and 75 rad/s. Each rotation was digitally captured at 2500 frames/s (480 X 320 pixels) and mark locations were tracked and used to compute strain using an in-house program in MATLAB. Peak values of principal strain (E(peak)) were significantly larger during deceleration than during acceleration of the head rotation (p<0.05), and doubled with a 50% increase in velocity. Epeak was also significantly higher during the second 75 rad/s rotation than during the first 75 rad/s rotation (p<0.0001), suggesting structural alteration at 75 racily and the possibility that similar changes may have occurred at 50 rad/s. Analyzing only lower velocity (50 rad/s) rotations, E peak significantly increased with age (16.5% versus 12.4%, p<0.003), which was likely due to the larger brain mass and smaller viscoelastic modulus of the 4 weeks old pig brain compared with those of the 5 days old. Strain measurement error for the overall methodology was estimated to be 1%. Brain tissue strain during rapid, nonimpact head rotation in the juvenile pig varies significantly with age. The empirical data presented will be used to validate computational model predictions of brain motion under similar loading conditions and to assist in the development of age-specific thresholds for axonal injury Future studies will examine the brain-skull displacement and will be used to validate brain-skull interactions in computational models. [DOI: 10.1115/1.4000956]	[Ibrahim, Nicole G.; Natesh, Rahul; Szczesny, Spencer E.; Ryall, Karen; Eucker, Stephanie A.; Coats, Brittany; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Ibrahim, NG (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu	Coats, Brittany/A-4523-2009; Szczesny, Spencer/AAL-9217-2021; Eucker, Stephanie/AAL-1828-2021	Eucker, Stephanie/0000-0001-9986-5773; Szczesny, Spencer/0000-0002-7691-949X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER	The authors would like to thank Jill Ralston for her technical expertise throughout the study. Support provided by NIH Grant No. R01 NS039679.	Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GOSCH H H, 1969, Surgical Forum (Chicago), V20, P425; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; HARDY WN, 1997, CRASHWORTHINESS OCCU, V225, P241; HODGSON VR, 1966, J NEUROSURG, V25, P549, DOI 10.3171/jns.1966.25.5.0549; IBRAHIM NG, 1992, J NEUROSURG PE UNPUB; IBRAHIM NG, 2009, HEAD INJURY BIOMECHA; LJUNG C, 1975, J BIOMECH, V8, P263, DOI 10.1016/0021-9290(75)90078-0; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MILLER RT, 1998, P 42 STAPP CAR CRASH, P155; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH, P41; PRANGE M, 2002, BIOMECHANICS TRAUMAT; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PUDENZ RH, 1946, J NEUROSURG, V3, P87; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; SHATSKY SA, 1973, P 17 STAPP CAR CRASH, P361; 2006, DEATHS INJURIES 2001	24	13	13	1	3	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2010	132	4							044501	10.1115/1.4000956			4	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	585FN	WOS:000276810000011	20387974				2022-02-06	
J	Kukaswadia, A; Warsh, J; Mihalik, JP; Pickett, W				Kukaswadia, Atif; Warsh, Joel; Mihalik, Jason P.; Pickett, William			Effects of Changing Body-Checking Rules on Rates of Injury in Minor Hockey	PEDIATRICS			English	Article						child; hockey; injury; physical activity; sports; trauma	ICE HOCKEY; BODYCHECKING; CONCUSSIONS	OBJECTIVE: In this study we explored the effects of the 2002 rule change in Ontario minor hockey, in which body-checking was introduced at the atom (ages 9-10) instead of the peewee (previously ages 12-13) age level. It was hypothesized that the introduction of body-checking at younger ages would result in higher overall rates of injury to minor hockey players, with concomitant increases in neurotraumatic injuries. PATIENTS AND METHODS: Participants included injured minor hockey players between the ages of 7 and 14 years in the Kingston area of Ontario, Canada. The Kingston sites of the Canadian Hospitals Injury Reporting and Prevention Program were used to identify injuries that presented to the only 2 emergency departments in this community. In our analyses, we compared rates and patterns of injury that required hospital-based emergency medicine care before (1997-1998 to 2001-2002 seasons) and after (2002-2003 to 2006-2007 seasons) implementation of the body-checking rule change. RESULTS: Overall rates of injury to minor hockey players declined in the years after the rule change. Rates of injury attributable to body-checking, as well as the natures and anatomic sites of injury caused by body-checking, remained consistent in the 2 study periods. CONCLUSIONS: In this historical study, we did not observe an increase in the overall rates of injury and concomitant neurotraumatic events. Increased enforcement of playing rules as well as temporal declines in emergency department use may have contributed to these findings. Pediatrics 2010;125:735-741	[Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Pickett, William] Kingston Gen Hosp, Clin Res Ctr, Kingston, ON K7L 2V7, Canada; [Kukaswadia, Atif; Warsh, Joel; Pickett, William] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON, Canada; [Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON, Canada		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 209 Fetzer Gymnasium,South Rd,CB 8700, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu	Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322	Ontario Neurotrauma Foundation; Public Health Agency of Canada	Funding for this research was obtained from a summer internship grant from the Ontario Neurotrauma Foundation and from the Public Health Agency of Canada, which funds the CHIRPP.	Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; BERNARD D, 1993, ASTM STP, V1212, P44; BIASCA N, 2005, EUR J TRAUMA, V31, P369; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; *HOCK CAN, BACKGR CHECK; *HOCK CAN, PLAYER REG; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; King WJ, 2006, CAN MED ASSOC J, V175, P163, DOI 10.1503/cmaj.060620; Mackenzie S G, 1999, Inj Prev, V5, P208; Macpherson A, 2006, PEDIATRICS, V117, P2334, DOI 10.1542/peds.2006-0929; Macpherson A, 2006, PEDIATRICS, V117; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MONTELPARE WJ, 2004, ASTM INT, V1; Pickett W, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e365; Regnier G., 1989, SAFETY ICE HOCKEY, P84; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; *STAT CAN, COMM HIGHL KINGST; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; SULLIVAN P, 1992, CMAJ, V142, P157; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	26	13	13	0	7	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2010	125	4					735	741		10.1542/peds.2009-2083			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	577QR	WOS:000276239600018	20308211				2022-02-06	
J	Guitton, TG; Ring, D				Guitton, Thierry G.; Ring, David			Nonsurgically Treated Terrible Triad Injuries of the Elbow: Report of Four Cases	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Dislocations; elbow; nonsurgical; terrible triad	RADIAL HEAD; FRACTURES; DISLOCATIONS	This case series describes 4 patients with terrible triad injury of the elbow (dislocation with fractures of the radial head and coronoid) who were treated nonsurgically. Following nonsurgical treatment in this select group of patients, the elbow was well aligned, and the patients regained good elbow function. Three of these 4 patients had good results. One patient had surgery for residual stiffness, ulnar neuropathy, and a radial head deformity. We conclude that, in selected terrible triad cases, when the elbow is well aligned and the radial head and coronoid fractures are relatively small and minimally displaced after closed reduction and there is no mechanical block to motion, patients might regain good elbow function without surgery. (J Hand Surg 2010;35A:464-467.(C) 2010 Published by Elsevier Inc. on behalf of the American Society for Surgery of the Hand.)	[Ring, David] Harvard Univ, Massachusetts Gen Hosp, Yawkey Ctr, Orthopaed Hand & Upper Extrem Serv,Med Sch, Boston, MA 02114 USA		Ring, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Yawkey Ctr, Orthopaed Hand & Upper Extrem Serv,Med Sch, Suite 2100,55 Fruit St, Boston, MA 02114 USA.	dring@partners.org	Ring, David/AAV-9035-2021	Ring, David/0000-0002-6506-4879; Guitton, Thierry/0000-0002-2599-1985	Small Bone Innovations; Wright Medical; Stichting Anna FondsFWO; Stichting Wetenschappelijk Ondernek Orthopaedisch Chirurgie; VSB Fonds; Smith and Nephew; Acumed; Tornier	Funding was received from Small Bone Innovations (DR.), Wright Medical (DR.), Stichting Anna Fonds (T.G.G.),Stichting Wetenschappelijk Ondernek Orthopaedisch Chirurgie (T.G.G.), VSB Fonds (T.G.G.), Smith and Nephew (D.R.), Acumed (DA.), and Tornier (DA.).	BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Closkey RF, 2000, J BONE JOINT SURG AM, V82A, P1749, DOI 10.2106/00004623-200012000-00009; Doornberg JN, 2006, J HAND SURG-AM, V31A, P794, DOI 10.1016/j.jhsa.2006.01.004; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Hotchkiss Robert N., 1996, P929; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JOSEFSSON PO, 1989, CLIN ORTHOP RELAT R, P126; Jupiter JB, 1993, ELBOW ITS DISORDERS, P328; King GJW, 1999, J SHOULDER ELB SURG, V8, P351; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006	13	13	20	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	MAR	2010	35A	3					464	467		10.1016/j.jhsa.2009.12.015			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	588SB	WOS:000277092800017	20193862				2022-02-06	
J	Sharp, NCC				Sharp, N. C. Craig			The Human Genome and Sport, Including Epigenetics, Gene Doping, and Athleticogenomics	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Athleticogenomics; Epigenetics; Gene doping; Genome sport	TRAUMATIC BRAIN-INJURY; CHRONIC-FATIGUE; ACTN3 GENOTYPE; EXPRESSION; EXERCISE	Hugh Montgomery's discovery of the first of more than 239 fitness genes together with rapid advances in human gene therapy have created a prospect of using genes, genetic elements, and cells that have the capacity to enhance athletic performance (to paraphrase the World Anti-Doping Agency's definition of gene doping). This brief overview covers the main areas of interface between genetics and sport, attempts to provide a context against which gene doping may be viewed, and predicts a futuristic legitimate use of genomic (and possibly epigenetic) information in sport.	Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England		Sharp, NCC (corresponding author), Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, West London, England.	c.sharp90@btinternet.com					Abbott A, 2006, NATURE, V443, P488, DOI 10.1038/443488a; [Anonymous], BBC; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Brenner S, 2007, NATURE, V446, P725, DOI 10.1038/446725a; Budgett R, 2000, BRIT J SPORT MED, V34, P67, DOI 10.1136/bjsm.34.1.67; Check E, 2007, NATURE, V448, P11; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; COX JC, 2006, NATURE, V444, P9; CULVER KW, 1991, HUM GENE THER, V2, P107, DOI 10.1089/hum.1991.2.2-107; DELACHAPELLE A, 1993, LANCET, V341, P82, DOI 10.1016/0140-6736(93)92558-B; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Hooper R, 2005, NEW SCI, V187, P9; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KODADEK T, 2007, NATURE, V446, P472; LAVITRANO M, 2006, P NATL ACAD SCI USA, V103, P17672; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Lyon Mary F., 2007, Biologist (London), V54, P94; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; MACARTHUR DG, 2007, E AFRICAN RUNNING CR, P217; MIAH A, 2004, GENETICALLY MODIFIED; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Noakes TD, 2004, BRIT J SPORT MED, V38, P511, DOI 10.1136/bjsm.2003.009860; PANDO OJ, 2007, CELL, V128, P655; PARISOTTO R, 2006, ITS GENES BLOOD SPOR, P207; Puri BK, 2007, J CLIN PATHOL, V60, P122, DOI 10.1136/jcp.2006.042424; RIDLEY M, 2000, GENOME; RIGGS AD, 1996, EPIGENETICS MECH GEN, P34; RMCNEILL A, 1992, HUMAN MACHINE, P74; Santiago C, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.039172; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shadan S, 2007, NATURE, V447, P275, DOI 10.1038/447275b; Sharp C, 1999, NATURE, V398, P675; Sharp NCC, 2008, J SPORT SCI, V26, P1127, DOI 10.1080/02640410801912117; SHARP NCC, 2007, E AFRICAN RUNNING CR, P1; SHARP NCC, 2006, PEAK PERFORMANCE, V230, P8; SHARP NCC, 2004, PHYSL NEWS, V57, P15; SLOT O, 2006, RAISING BAR CHEATING; SPURWAY N, 2006, INTRO MOL EXERCISE P, P61; Sweeney HL, 2004, SCI AM, V291, P62, DOI 10.1038/scientificamerican0704-62; TAMBURRINE C, 2005, GENETIC TECHNOLOGY S; Wackerhage H, 2009, J SPORT SCI, V27, P1109, DOI 10.1080/02640410903114364; WAGNER R, 1990, NATURE, V391, P744; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	56	13	13	0	43	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	MAR	2010	39	1					201	+		10.1016/j.ecl.2009.10.010			16	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	627JR	WOS:000280035800017	20122459				2022-02-06	
J	Heskestad, B; Waterloo, K; Baardsen, R; Helseth, E; Romner, B; Ingebrigtsen, T				Heskestad, Ben; Waterloo, Knut; Baardsen, Roald; Helseth, Eirik; Romner, Bertil; Ingebrigtsen, Tor			No impact of early intervention on late outcome after minimal, mild and moderate head injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; FOLLOW-UP; SEQUELAE; LIFE	Objectives: To evaluate the effect of an educational intervention on outcome after minimal, mild and moderate head injury. Methods: Three hundred and twenty six patients underwent stratified randomization to an intervention group (n = 163) or a control group (n = 163). Every second patient was allocated to the intervention group. Participants in this group were offered a cognitive oriented consultation two weeks after the injury, while subjects allocated to the control group were not. Both groups were invited to follow up 3 and 12 months after injury. Results: A total of 50 (15%) patients completed the study (intervention group n = 22 (13%), control group n = 28 (17%), not significant). There were no statistically significant differences between the intervention group and the control group. Conclusions: There was no effect on outcomes from an early educational intervention two weeks after head injury.	[Waterloo, Knut; Romner, Bertil; Ingebrigtsen, Tor] Univ Hosp N Norway, Dept Neurosurg, Tromso, Norway; [Heskestad, Ben; Baardsen, Roald] Stavanger Univ Hosp, Dept Neurosurg, Stavanger, Norway; [Heskestad, Ben; Helseth, Eirik] Oslo Univ Hospital Ulleval, Dept Neurosurg, Oslo, Norway; [Waterloo, Knut] Univ Hosp N Norway, Dept Psychol, Tromso, Norway; [Romner, Bertil; Ingebrigtsen, Tor] Univ Tromso, Fac Hlth Sci, Inst Clin Med, Tromso, Norway		Ingebrigtsen, T (corresponding author), Univ Hosp N Norway, Dept Neurosurg, Tromso, Norway.	tor.ingebrigtsen@unn.no	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; DE KRUIJK, 2002, J NEUROL NEUROSUR PS, V73, P167; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STEIN SC, 1996, NEUROSURGERY, V38, P245; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; THORNHILL S, 2000, BRIT MED J, V320, P727; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478	23	13	13	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 24	2010	18								10	10.1186/1757-7241-18-10			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	665NH	WOS:000283041900001	20181239	gold, Green Published			2022-02-06	
J	Hanlon, RE; Rubin, LH; Jensen, M; Daoust, S				Hanlon, Robert E.; Rubin, Leah H.; Jensen, Marie; Daoust, Sarah			Neuropsychological Features of Indigent Murder Defendants and Death Row Inmates in Relation to Homicidal Aspects of Their Crimes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Homicide; Forensic evaluation; Neuropsychology; Criminal behavior; Violence; Prisoners; Capital punishment; Murder	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; ANTISOCIAL-BEHAVIOR; SUBSTANCE-ABUSE; PRISON-INMATES; UNITED-STATES; HEAD-INJURY; VIOLENCE; AGGRESSION; DEFICITS	Neuropsychological features of 77 indigent murder defendants and death row inmates were examined in relation to criminal variables underlying their homicidal acts. Clinically, the sample was characterized by elevated rates of developmental disorders (49%), personality disorders (54%), Axis I psychiatric disorders (45%), substance abuse (86%), and history of violence (43%). By statute, killing more than one person is an aggravating factor in many jurisdictions that renders a murder defendant eligible for the death penalty. Individuals who committed a single murder were characterized by executive dysfunction, lower intelligence, slower speed of information processing, and a higher frequency of developmental disorders (58%), relative to those charged and/or convicted of killing two or more people, who were characterized by a significantly higher rate of personality disorders (79%) and a lower rate of developmental disorders (34%). Additionally, using the FBI criminal classification system for categorizing homicide by motive, a significant difference in the frequency of psychosis was found among subgroups associated with the following motives: Criminal enterprise; personal cause; and sex. The collective neuropsychological profile of the sample revealed that executive functions were significantly decreased, relative to memory functions, with over half of the sample (55%) demonstrating executive dysfunction.	[Hanlon, Robert E.] Neuropsychol Associates Chicago, Chicago, IL 60611 USA; [Hanlon, Robert E.; Daoust, Sarah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Rubin, Leah H.] Univ Illinois, Chicago, IL USA; [Jensen, Marie] Depaul Univ, Chicago, IL 60604 USA		Hanlon, RE (corresponding author), Neuropsychol Associates Chicago, 645 N Michigan Ave,Suite 410, Chicago, IL 60611 USA.	r-hanlon@northwestern.edu					Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; BARR WB, 2008, CLIN NEUROPSYCHOLOGY, P238; BARR WB, 2005, FORENSIC NEUROPSYCHO, P239; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; BRICKMAN AS, 1984, J AM ACAD CHILD PSY, V23, P453, DOI 10.1016/S0002-7138(09)60324-1; Brook JS, 2001, J GENET PSYCHOL, V162, P228, DOI 10.1080/00221320109597963; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; BRYANT ET, 1984, J CONSULT CLIN PSYCH, V52, P323, DOI 10.1037/0022-006X.52.2.323; Coccaro EF, 1997, BIOL PSYCHIAT, V41, P273, DOI 10.1016/S0006-3223(96)00257-0; DABBS JM, 1987, PSYCHOSOM MED, V49, P174, DOI 10.1097/00006842-198703000-00007; Dahlberg LL, 1998, AM J PREV MED, V14, P259, DOI 10.1016/S0749-3797(98)00009-9; Denney R.L., 2008, CLIN NEUROPSYCHOLOGY, P91; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; DENNEY RL, 2005, FORENSIC NEUROPSYCHO, P425; Federici AB, 2008, HAEMOPHILIA, V14, P1; FOSTER HG, 1993, PROG NEURO-PSYCHOPH, V17, P939, DOI 10.1016/0278-5846(93)90021-J; GARTNER J, 1996, ANN NY ACAD SCI, V794, P13; Gatzke-Kopp LM, 2001, J NEUROPSYCH CLIN N, V13, P486, DOI 10.1176/appi.neuropsych.13.4.486; Golden CJ, 1996, AGGRESS VIOLENT BEH, V1, P3, DOI 10.1016/1359-1789(95)00002-X; Golden CJ., 2002, STROOP COLOR WORD TE; Goodman M, 2004, ANN NY ACAD SCI, V1032, P104, DOI 10.1196/annals.1314.008; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2005, WORD MEMORY TEST WIN; GROVE WM, 1990, BIOL PSYCHIAT, V27, P1293, DOI 10.1016/0006-3223(90)90500-2; Hanlon R. E., 2005, FORENSIC NEUROPSYCHO, P268; Hare R.D., 1993, CONSCIENCE DISTURBIN; Heaton R.K., 2003, WISCONSIN CARD SORTI; HEATON RK, 2008, REVISED COMPREHENSIV; Ishikawa S. S., 2002, NEUROBIOLOGY CRIMINA, P81; Krakowski M, 2003, J NEUROPSYCH CLIN N, V15, P294, DOI 10.1176/appi.neuropsych.15.3.294; Langevin R., 1987, BEHAVIORAL SCI LAW, V5, P77; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; Lewis DO, 2004, J AM ACAD PSYCHIATRY, V32, P408; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Marcopulos B. A., 2008, CLIN NEUROPSYCHOLOGY, P176; MARTELL DA, 1992, LAW HUMAN BEHAV, V16, P313, DOI 10.1007/BF01044772; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Pham TH, 2003, AGGRESSIVE BEHAV, V29, P393, DOI 10.1002/ab.10051; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 1996, ARCH GEN PSYCHIAT, V53, P544; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raine A, 1993, PSYCHOPATHOLOGY CRIM; REY A, 1958, L EXAMEN CLIN PSYCHO; ROGERS R, 1992, SIRS STRUCTURED INTE; Rogers R., 1997, CLIN ASSESSMENT MALI; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Slick D.J., 1997, VICTORIA SYMPTOM VAL; SMITH SS, 1992, PERS INDIV DIFFER, V13, P1233, DOI 10.1016/0191-8869(92)90259-R; SPELLACY F, 1977, J CLIN PSYCHOL, V33, P966, DOI 10.1002/1097-4679(197710)33:4<966::AID-JCLP2270330409>3.0.CO;2-4; THOMSON, 2009, TOMM TEST MEMORY MAL; Tonkonogy J M, 1991, J Neuropsychiatry Clin Neurosci, V3, P189; Vitelli R, 1996, INT J OFFENDER THER, V40, P263, DOI 10.1177/0306624X96404002; Volavka J, 2002, NEUROBIOLOGY VIOLENC; YATES KF, 2008, CLIN NEUROPSYCHOLOGY, P204; [No title captured]	64	13	15	1	34	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2010	25	1					1	13		10.1093/arclin/acp099			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	547DI	WOS:000273865400001	20015966	Bronze, Green Published			2022-02-06	
J	Shen, HY; Zhao, Y; Chen, XY; Xiong, RP; Lu, JL; Chen, JF; Chen, LY; Zhou, YG				Shen, Hai-Ying; Zhao, Yan; Chen, Xing-Yun; Xiong, Ren-Ping; Lu, Jin-Li; Chen, Jiang-Fan; Chen, Li-Yong; Zhou, Yuan-Guo			Differential Alteration of Heat Shock Protein 90 in Mice Modifies Glucocorticoid Receptor Function and Susceptibility to Trauma	JOURNAL OF NEUROTRAUMA			English	Article						geldanamycin; glucocorticoid receptor; heat shock protein; traumatic susceptibility; whole-body blast injury	NEUROGENIC PULMONARY-EDEMA; BRAIN-INJURY; HSP90; EXPRESSION; STRESS; GELDANAMYCIN; BINDING; RESISTANCE	Heat shock protein 90 (Hsp90), encoded by the murine hsp84 and hsp86 genes in mice, is a pivotal regulator of glucocorticoid receptor (GR) function in the hypothalamus-pituitary-adrenal axis and affords stress protection. To explore the underlying molecular mechanisms of strain susceptibility to traumatic stress, we investigated the alteration by Hsp90 of the function of the glucocorticoid-glucocorticoid receptor (GC-GR) pathway in attenuating stress responses in C57BL/6 and BALB/c mice using the whole-body blast injury (WBBI) model. We found that C57BL/6 mice had a lower WBBI-induced mortality, higher nuclear GR level, and higher glucocorticoid-response element (GRE) binding activity than BALB/c mice. This study is the first report identifying four genetic variations of the murine hsp84 gene: 226A>C, 996G>C, 1483G>C, and 2000G>T. These nucleotide changes occur in the functional domains associated with the nuclear/cytosolic translocation of GR, GR-Hsp90 interaction, ATP binding, and self-dimerization of Hsp90, respectively. Further, we used a specific Hsp90 inhibitor, geldanamycin (GA), to assess the role of Hsp90 in the discriminative traumatic response in C57BL/6 mice. Pretreatment with GA reduced nuclear GR levels and GRE binding activity, and enhanced WBBI-induced mortality. These findings suggest that Hsp90 may underlie the strain-selective (C57BL/6 versus BALB/c) susceptibility to WBBI by mediating the nuclear translocation of GRs and GRE binding. Thus, pharmacological manipulation of Hsp90 may represent a therapeutic strategy to modify the function of the GC-GR pathway and traumatic stress response.	[Zhou, Yuan-Guo] Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Ctr Mol Biol, Chongqing 400042, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Dept Anesthesiol, Inst Surg Res, Chongqing 400042, Peoples R China; [Shen, Hai-Ying; Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Inst Surg Res, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	ygzhou@cta.cq.cn		Shen, Hai-Ying/0000-0001-8430-2978; Chen, Xingyun/0000-0001-7699-4425	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30871170, 30470988]; Foundation for the Author of National Excellent Doctoral Dissertation of P. R. ChinaFoundation for the Author of National Excellent Doctoral Dissertation of China [200156]; National Basic Research Program of ChinaNational Basic Research Program of China [2005CB522602]	This work was supported by grants from National Natural Science Foundation of China (to H. Y. S., no. 30871170; and to Y. G. Z., no. 30470988), the Foundation for the Author of National Excellent Doctoral Dissertation of P. R. China (no. 200156), and National Basic Research Program of China (No. 2005CB522602).	Bahloul M, 2006, AM J CRIT CARE, V15, P462; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DeKloet ER, 1996, ANN NY ACAD SCI, V794, P179; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hashiguchi N, 2001, J TRAUMA, V50, P102, DOI 10.1097/00005373-200101000-00018; Jibard N, 1999, EXP CELL RES, V247, P461, DOI 10.1006/excr.1998.4375; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Li XM, 2001, HEREDITY, V86, P668, DOI 10.1046/j.1365-2540.2001.00879.x; Liu DH, 2002, BURNS, V28, P315, DOI 10.1016/S0305-4179(02)00011-6; Liu JM, 1999, MOL ENDOCRINOL, V13, P355, DOI 10.1210/me.13.3.355; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; MOORE SK, 1987, GENE, V56, P29, DOI 10.1016/0378-1119(87)90155-7; Murphy EK, 2002, ENDOCRINOLOGY, V143, P1362, DOI 10.1210/en.143.4.1362; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; RADOJICIC C, 1990, J TRAUMA, V30, P211; Ramaglia V, 2004, J EXP BIOL, V207, P3775, DOI 10.1242/jeb.01211; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Wang Z G, 1989, Zhonghua Yi Xue Za Zhi, V69, P7; WANG ZG, 1989, ZHONGHUA YI XUE ZHI, V69, P12; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Yan P, 1999, J NEUROSCI, V19, P9355; Zhao Xiao-hui, 2007, Zhonghua Shao Shang Za Zhi, V23, P265	38	13	14	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2010	27	2					373	381		10.1089/neu.2009.0926			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	557JG	WOS:000274664800010	19845467				2022-02-06	
J	Castano, B; Capdevila, E				Castano, Beatriz; Capdevila, Elisabet			Eating disorders in patients with traumatic brain injury: A report of four cases	NEUROREHABILITATION			English	Article						Brain injury; eating disorder; anorexia; hyperphagia; obesity; behavior disorder	FOOD-INTAKE; ANOREXIA-NERVOSA; LESIONS	Background: Traumatic brain injury (TBI) can lead to changes in eating behavior patterns with significant clinical manifestations. Methods: Medical records of four patients with severe TBI and eating disorders attending the neurorehabilitation program of our brain injury unit were reviewed. Conclusions: Several eating disorders observed among the four cases, may be present from early phases and remain years after the lesion. Symptoms do not adhere to the typical forms of anorexia and bulimia. Factors influencing the weight changes experienced by patients with brain injury included reduction in physical activity, metabolic disorders and treatment with psychotropic drugs.	[Castano, Beatriz; Capdevila, Elisabet] Neurorehabil Hosp, Guttmann Inst, Brain Injury Unit, Barcelona, Spain		Castano, B (corresponding author), Neurorehabil Hosp, Guttmann Inst, Brain Injury Unit, Cami Can Ruti S-N, Badalona 08916, Spain.	34618bcm@comb.cat					DOLAN RJ, 1988, PSYCHOL MED, V18, P349, DOI 10.1017/S0033291700007893; ERB JL, 2006, INT J EAT DISORDER, V8, P117; Fujii M, 1998, BRAIN INJURY, V12, P709, DOI 10.1080/026990598122278; GENTILINI M, 1987, J NEUROL NEUROSUR PS, V50, P900, DOI 10.1136/jnnp.50.7.900; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; KAUFMAN HH, 1987, NEUROSURGERY, V20, P254, DOI 10.1227/00006123-198702000-00010; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NEWCOMER JW, J CLIN PSYCHIAT S1, V68, P20; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Trummer M, 2002, ACTA NEUROCHIR, V144, P797, DOI 10.1007/s00701-002-0934-5; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	17	13	13	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	27	2					113	116		10.3233/NRE-2010-0586			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	647VW	WOS:000281649100001	20871139				2022-02-06	
J	Clarke, SE; Chafetz, RS; Kozin, SH				Clarke, Sylvan E.; Chafetz, Ross S.; Kozin, Scott H.			Ossification of the Proximal Humerus in Children With Residual Brachial Plexus Birth Palsy: A Magnetic Resonance Imaging Study	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						shoulder; anatomy; brachial plexus injury; obstetrical palsy; ossification	GLENOHUMERAL DEFORMITY SECONDARY; INTERNAL-ROTATION CONTRACTURES; SHOULDER DEFORMITIES; TENDON TRANSFERS; CLOSED REDUCTION; BONE-MARROW; DISLOCATION; PARALYSIS; MANAGEMENT; GROWTH	Background: Children with residual brachial plexus birth palsy may develop deformities of the humeral head and the glenoid. Surgical treatment has been described to maximize function and to lessen deformity by means of glenohumeral remodeling. The timing and technique of surgical intervention have not been resolved. The timing of the appearance on magnetic resonance imaging of the ossific nuclei in patients with brachial plexus birth palsy has not been described. We examined the timing of ossification about the proximal humerus. Our hypothesis was that the timing of ossification of the proximal humerus differs between the side involved in brachial plexus palsy and the uninvolved side. Methods: A retrospective study was performed of 117 children with residual brachial plexus birth palsy (aged 5mo to 10y) who had magnetic resonance imaging scans of the bilateral shoulders performed at our institution between 2000 and 2007. All axial slices were reviewed by a single observer for evidence of ossification of the humeral head epiphysis, the greater tuberosity, and the lesser tuberosity, as well as for evidence that the 3 were coalesced. Statistical analysis was performed to compare the involved and uninvolved sides. Results: The appearance of the greater tuberosity ossific nucleus on the involved side was significantly delayed. There was a trend towards delay in the appearance of the lesser tuberosity ossific nucleus and the coalescence of the 3 ossific nuclei on the involved side. The duration during which ossification of the involved brachial plexus side occurred was generally shorter compared with the uninvolved side. Conclusion: There is delay in the ossification of the involved side in brachial plexus birth palsy, and a shorter duration of ossification.	[Clarke, Sylvan E.] Temple Univ, Dept Orthopaed Surg, Sch Med, Shriners Hosp Children,Albert Einstein Med Ctr, Philadelphia, PA 19140 USA; [Chafetz, Ross S.] Temple Univ, Shriners Hosp Children, Dept Clin Res, Sch Med, Philadelphia, PA 19140 USA		Kozin, SH (corresponding author), Temple Univ, Dept Orthopaed Surg, Sch Med, Shriners Hosp Children,Albert Einstein Med Ctr, 3551 N Broad St, Philadelphia, PA 19140 USA.	clarkes@alumni.upenn.edu; skozin@shrinenet.org					BABBITT DP, 1968, J BONE JOINT SURG AM, VA 50, P1447, DOI 10.2106/00004623-196850070-00015; Bahm J, 2007, J PEDIATR ORTHOP B, V16, P243, DOI 10.1097/BPB.0b013e3280925681; BAXTER MP, 1986, J BONE JOINT SURG BR, V68, P570, DOI 10.1302/0301-620X.68B4.3733832; BROWNER BD, 1998, SKELETAL TRAUMA FRAC, P2; Doyle JR, 2003, SURG ANATOMY HAND UP, P721; DUNKERTON MC, 1989, J BONE JOINT SURG BR, V71, P764, DOI 10.1302/0301-620X.71B5.2684988; GREEN NE, 1998, SKELETAL TRAUMA CHIL, P608; GUDINCHET F, 1992, SKELETAL RADIOL, V21, P19; Gudinchet F, 1995, PEDIATR RADIOL, V25, pS125; HERNANDEZ RJ, 1988, PEDIATR RADIOL, V18, P333, DOI 10.1007/BF02389004; Hoeksma AF, 2003, J BONE JOINT SURG AM, V85A, P316, DOI 10.2106/00004623-200302000-00020; Hui JHP, 2003, J PEDIATR ORTHOPED, V23, P109, DOI 10.1097/00004694-200301000-00022; JARAMILLO D, 1991, RADIOLOGY, V180, P809, DOI 10.1148/radiology.180.3.1871298; Kambhampati SBS, 2006, J BONE JOINT SURG BR, V88B, P213, DOI 10.1302/0301-620X.88B2.17185; KATTAN K R, 1968, Radiology, V91, P462; KERET D, 1991, J BONE JOINT SURG AM, V73A, P410, DOI 10.2106/00004623-199173030-00012; Kim HM, 2009, J BONE JOINT SURG AM, V91A, P879, DOI 10.2106/JBJS.H.00088; Kon DS, 2004, RADIOLOGY, V231, P791, DOI 10.1148/radiol.2313021057; Kozin SH, 2006, J SHOULDER ELB SURG, V15, P554, DOI 10.1016/j.jse.2005.11.004; Kozin SH, 2004, J PEDIATR ORTHOPED, V24, P189, DOI 10.1097/01241398-200403000-00011; LIEBOLT FL, 1953, J BONE JOINT SURG AM, V35-A, P227, DOI 10.2106/00004623-195335010-00024; Lucas JC, 2004, J PEDIATR ORTHOPED, V24, P249, DOI 10.1097/01241398-200405000-00002; MALVITZ TA, 1994, J BONE JOINT SURG AM, V76A, P1777, DOI 10.2106/00004623-199412000-00004; OGDEN JA, 1990, SKELETAL INJURY CHIL, P930; Pearl ML, 1998, J BONE JOINT SURG AM, V80A, P659, DOI 10.2106/00004623-199805000-00006; Pearl ML, 2006, J BONE JOINT SURG AM, V88A, P564, DOI 10.2106/JBJS.D.02872; Pearl ML, 2003, J BONE JOINT SURG AM, V85A, P890, DOI 10.2106/00004623-200305000-00018; POLLOCK AN, 1989, SKELETAL RADIOL, V18, P295, DOI 10.1007/BF00361211; Poyhia TH, 2005, PEDIATR RADIOL, V35, P402, DOI 10.1007/s00247-004-1377-3; PRICE AE, 1995, HAND CLIN, V11, P607; ROCKWOOD CA, 2006, ROCKWOOD WILKINS FRA, P1200; Saifuddin A, 2002, J BONE JOINT SURG BR, V84B, P100, DOI 10.1302/0301-620X.84B1.11813; Sanchez-Sotelo Joaquin, 2002, J Am Acad Orthop Surg, V10, P321; Soldado F, 2005, J PEDIATR ORTHOPED, V25, P666, DOI 10.1097/01.bpo.0000164873.41485.19; TACCONE A, 1995, PEDIATR RADIOL, V25, P596, DOI 10.1007/BF02011826; Terzis JK, 2003, J PEDIATR ORTHOPED, V23, P254, DOI 10.1097/00004694-200303000-00023; van der Sluijs J A, 2004, Neurosurg Focus, V16, pE9; van der Sluijs JA, 2003, J PEDIATR ORTHOP B, V12, P211, DOI 10.1097/00009957-200305000-00008; van der Sluijs JA, 2001, J BONE JOINT SURG BR, V83B, P551, DOI 10.1302/0301-620X.83B4.11205; Vitale M G, 2001, J Am Acad Orthop Surg, V9, P401; Waters PM, 2008, J BONE JOINT SURG AM, V90A, P2171, DOI 10.2106/JBJS.G.01517; Waters PM, 2005, J PEDIATR ORTHOP B, V14, P233, DOI 10.1097/01202412-200507000-00001; Waters PM, 2005, J PEDIATR ORTHOPED, V25, P116, DOI 10.1097/00004694-200501000-00025; Waters PM, 1998, J BONE JOINT SURG AM, V80A, P668, DOI 10.2106/00004623-199805000-00007; ZAWIN JK, 1993, RADIOLOGY, V188, P159, DOI 10.1148/radiology.188.1.8511291; Zouari O, 2004, REV CHIR ORTHOP, V90, P132	46	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN-FEB	2010	30	1					60	66		10.1097/BPO.0b013e3181c6c344			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	538QF	WOS:000273198300011	20032744				2022-02-06	
J	Cottingham, ME; Boone, KB				Cottingham, Maria E.; Boone, Kyle B.			[image omitted] Non-credible language deficits following mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Somatoform disorder; Feigned language; Aphasia; Dysarthria	FOREIGN ACCENT SYNDROME; SUSPECT EFFORT; DIFFERENTIAL-DIAGNOSIS; HEAD-INJURY; VERBAL FLUENCY; NORMATIVE DATA; ADULT ONSET; MEMORY; DISORDER; TESTS	Identification of non-credible memory and other cognitive symptoms has received widespread attention within the past two decades. However, minimal information is available regarding patterns of non-credible language symptoms. We present the case of a 36-year-old female civil litigant who displayed delayed onset, severe, relatively focal speech and language symptoms, including difficulties with articulation, dysfluent speech, expressive language impairments with minor receptive difficulties, and lack of prosody, subsequent to a minor head trauma. On neuropsychological evaluation 3 years post injury, the patient presented with the same speech/language characteristics, but additionally exhibited a vague oforeign accent.o Cognitive scores generally were normal with the exception of poor performance on many language tasks and processing/motor speed. The patient showed passing performance on most measures of response bias, but she failed effort indicators requiring rapid letter discrimination (b Test), rapid verbal repetition (timed forward digit span), and sensory function (finger agnosia errors) while passing effort indicators falling within the domains of memory, math/number skills, visuo-constructional ability, and attention. Thus, the type of failed effort indicators predicted the categories of standard cognitive tests on which she underperformed. Personality testing revealed patterns generally consistent with hysterical personality orientation. Given her long-standing history of multiple unexplained medical symptoms, the patient was diagnosed with a somatization disorder, as well as a current conversion disorder involving language symptoms. However, given her compensation-seeking status, the possibility of additional conscious feigning of symptoms could not be ruled out. The need for validation of additional measures to detect feigned language impairment is recommended.	[Cottingham, Maria E.] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; [Boone, Kyle B.] Alliant Int Univ, Calif Sch Forens Studies, Torrance, CA USA		Cottingham, ME (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA.	mecottingham@gmail.com					Abudarham S, 2001, INT J LANG COMM DIS, V36, P58, DOI 10.3109/13682820109177859; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BAUMGARTNER JM, 1999, STUTTERING RELATED D, P269; BEESON PM, 2008, CLIN NEUROPSYCHOLOGY, P436; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bloodstein O., 2008, HDB STUTTERING, V6th; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K. B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Christoph DH, 2004, EUR NEUROL, V52, P198, DOI 10.1159/000082035; Coughlan T, 2004, J ROY SOC MED, V97, P242, DOI 10.1258/jrsm.97.5.242; Croot Karen, 2002, Seminars in Speech and Language, V23, P267, DOI 10.1055/s-2002-35800; Demick J., 1997, ROLE COGNITIVE STYLE; Duffy, 2005, MOTOR SPEECH DISORDE; Edwards RJ, 2005, EUR NEUROL, V53, P87, DOI 10.1159/000085503; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Goodglass H, 1997, CLIN NEUROSCI, V4, P51; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; Hamsher K., 1989, MULTILINGUAL APHASIA; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P157; HEINLY MT, 2008, DISS ABSTR INT B, V68, P534; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; JOHNSON AF, 1998, MED SPEECH LANGUAGE, P337; KALLEN D, 1986, BRIT J DISORD COMMUN, V21, P377; Katz WF, 2008, CLIN LINGUIST PHONET, V22, P537, DOI 10.1080/02699200802106284; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; Kwon M, 2006, EUR NEUROL, V56, P249, DOI 10.1159/000096674; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GL, 2004, 32 ANN M INT NEUR SO; Laures-Gore J, 2006, CLIN LINGUIST PHONET, V20, P781, DOI 10.1080/02699200500391105; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lippert-Gruener M, 2005, BRAIN INJURY, V19, P955, DOI 10.1080/02699050500109506; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MAHR G, 1992, J SPEECH HEAR RES, V35, P283, DOI 10.1044/jshr.3502.283; Marien P, 2006, CLIN NEUROL NEUROSUR, V108, P518, DOI 10.1016/j.clineuro.2005.06.006; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Munson Patrick D, 2005, S D J Med, V58, P187; Naidoo R, 2008, CAN J NEUROL SCI, V35, P360, DOI 10.1017/S0317167100008970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Osmon DC, 2006, CLIN NEUROPSYCHOL, V20, P315, DOI 10.1080/13854040590947434; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reeves RR, 2007, J NEUROPSYCH CLIN N, V19, P70, DOI 10.1176/appi.neuropsych.19.1.70; Reeves RR, 2001, NEUROPSY NEUROPSY BE, V14, P135; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; ROTH CR, 1989, J SPEECH HEAR DISORD, V54, P634, DOI 10.1044/jshd.5404.634; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Seery CH, 2005, AM J SPEECH-LANG PAT, V14, P284, DOI 10.1044/1058-0360(2005/028); SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; SEVUSH S, 1983, PSYCHOSOMATICS, V24, P847, DOI 10.1016/S0033-3182(83)73158-0; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tsuruga Koji, 2008, Seishin Shinkeigaku Zasshi, V110, P79; Van Borsel J, 2005, J COMMUN DISORD, V38, P421, DOI 10.1016/j.jcomdis.2005.03.004; Verhoeven J, 2005, BEHAV NEUROL, V16, P225, DOI 10.1155/2005/989602; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; WEPMAN JM, 1957, AUDITORY DISCRIMINAT; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C, P346; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	87	13	13	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	6					1006	1025	PII 923893079	10.1080/13854046.2010.481636			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	636WE	WOS:000280773600004	20614387				2022-02-06	
J	Dennis, M				Dennis, Maureen			Language disorders in children with central nervous system injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Language disorders; Pragmatic; Semantic; Syntactic; Motor speech; Central nervous system injury	EARLY-ONSET HYDROCEPHALUS; ACQUIRED CHILDHOOD APHASIA; NEUROMOTOR SPEECH DEFICITS; TRAUMATIC BRAIN-INJURY; POSTERIOR-FOSSA TUMORS; CLOSED HEAD-INJURY; SPINA-BIFIDA; NARRATIVE DISCOURSE; CORPUS-CALLOSUM; FLUENT APHASIA	Children with injury to the central nervous system (CNS) exhibit a variety of language disorders that have been described by members of different disciplines, in different journals, using different descriptors and taxonomies. This paper is an overview of language deficits in children with CNS injury, whether congenital or acquired after a period of normal development. It first reviews the principal CNS conditions associated with language disorders in childhood. It then describes a functional taxonomy of language, with examples of the phenomenology and neurobiology of clinical deficits in children with CNS insults. Finally, it attempts to situate language in the broader realm of cognition and in current theoretical accounts of embodied cognition.	[Dennis, Maureen] Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	maureen.dennis@sickkids.ca			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01 HD35946, P01 HD35946-06]; National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01NS 21889-16]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1 HD04946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD035946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	Preparation of this paper was supported in part by National Institute of Child Health and Human Development Grants P01 HD35946 and P01 HD35946-06, "Spina Bifida: Cognitive and Neurobiological Variability," by National Institute of Neurological Diseases and Stroke Grant 2R01NS 21889-16, "Neurobehavioral Outcome of Head Injury in Children," and by National Institutes of Health Grant 1RO1 HD04946, "Social Outcomes in Pediatric Traumatic Brain Injury." I thank Arianna Stefanatos for assistance with manuscript preparation.	ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; American Speech-Language-Hearing Association, 2007, CHILDH APR SPEECH; AMMIRATI M, 1989, CHILD NERV SYST, V5, P12, DOI 10.1007/BF00706739; Anderson VA, 2000, SCI PRACT NEUROPSYCH, P117; APPLETON RE, 1995, ARCH DIS CHILD, V72, P386, DOI 10.1136/adc.72.5.386; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; Aram DMNJE, 1982, CHILD LANGUAGE DISOR; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Band GPH, 2000, J EXP CHILD PSYCHOL, V75, P263, DOI 10.1006/jecp.1999.2538; Barnes MA, 1996, READING COMPREHENSION DIFFICULTIES, P251; Barnes MA, 2004, BRAIN LANG, V89, P47, DOI 10.1016/S0093-934X(03)00295-5; Barnes MA, 1998, BRAIN LANG, V61, P309, DOI 10.1006/brln.1998.1843; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Barnes MA, 1996, J EXP CHILD PSYCHOL, V61, P216, DOI 10.1006/jecp.1996.0015; Barnes MA, 2007, J INT NEUROPSYCH SOC, V13, P854, DOI 10.1017/S1355617707071172; Bates E, 1999, DEV COGN NEUROSCI, P533; BATES E, 1992, HDB NEUROPSYCHOLOGY, V7, P69; Berndt RS, 1997, BRAIN LANG, V60, P197, DOI 10.1006/brln.1997.1799; BEUN RJ, 1994, J PRAGMATICS, V21, P191, DOI 10.1016/0378-2166(94)90019-1; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brentano Franz, 1973, PSYCHOL EMPIRICAL ST, V2nd; BRINTON B, 1985, J COMMUN DISORD, V18, P245, DOI 10.1016/0021-9924(85)90002-4; BROWN JR, 1970, INT J NEUROL, V7, P302; BUCK R, 1994, J PRAGMATICS, V22, P265, DOI 10.1016/0378-2166(94)90112-0; Buckingham HW, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P127; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Cain K, 2001, MEM COGNITION, V29, P850, DOI 10.3758/BF03196414; CAPLAN D, 2006, LIFESPAN COGNITION M, P253; Caplan D., 1988, DISORDERS SYNTACTIC; Caplan D., 1992, LANGUAGE STRUCTURE P; Caplan D, 2007, BRAIN LANG, V101, P103, DOI 10.1016/j.bandl.2006.06.225; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chomsky Noam., 1968, SOUND PATTERN ENGLIS; Clifton C, 2001, ANNU REV PSYCHOL, V52, P167, DOI 10.1146/annurev.psych.52.1.167; COHEN MJ, 1994, BRAIN LANG, V47, P171, DOI 10.1006/brln.1994.1047; COOPER JA, 1978, J SPEECH HEAR DISORD, V43, P176, DOI 10.1044/jshd.4302.176; COOPER JA, 1987, J SPEECH HEAR DISORD, V52, P251, DOI 10.1044/jshd.5203.251; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; CRYSTAL D, 1973, LINGUA, V32, P1; CURTISS S, 1997, P 21 ANN BOST U C LA, P103; DAILEY AT, 1995, J NEUROSURG, V83, P467, DOI 10.3171/jns.1995.83.3.0467; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Dempster F. N., 1993, EMERGING THEMES COGN, VI, P3, DOI DOI 10.1007/978-1-4613-9220-0_1; Denes G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P361; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1994, BRAIN LANG, V46, P129, DOI 10.1006/brln.1994.1008; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; DENNIS M, 1975, BRAIN LANG, V2, P472, DOI 10.1016/S0093-934X(75)80084-8; DENNIS M, 1976, BRAIN LANG, V3, P404, DOI 10.1016/0093-934X(76)90036-5; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; DENNIS M, 1993, J PEDIATR PSYCHOL, V18, P639, DOI 10.1093/jpepsy/18.5.639; DENNIS M, 1976, BRAIN LANG, V3, P147, DOI 10.1016/0093-934X(76)90013-4; DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P593, DOI 10.1080/01688638708410771; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, 2000, AUTISM, V4, P371; DENNIS M, 2004, BRAIN SPINAL TUMORS, P213; Di Cataldo A, 2001, PEDIATR HEMAT ONCOL, V18, P117; DOGIL G, 1995, APHASIOLOGY, V9, P577, DOI 10.1080/02687039508248716; Doxey D, 1999, PEDIATR NEUROSURG, V31, P131, DOI 10.1159/000028848; Edelstein K, 2004, J INT NEUROPSYCH SOC, V10, P877, DOI 10.1017/S1355617704106085; Eisele JA, 1998, BRAIN LANG, V61, P376, DOI 10.1006/brln.1997.1883; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FELDMAN H, 1989, TOP EARLY CHILD SPEC, V9, P32, DOI 10.1177/027112148900900104; Fernandino L, 2010, BRAIN LANG, V112, P44, DOI 10.1016/j.bandl.2009.02.003; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Fletcher Jack M, 2002, Semin Pediatr Neurol, V9, P201, DOI 10.1053/spen.2002.35500; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher JM, 2000, SCI PRACT NEUROPSYCH, P25; Fletcher JM, 1996, CHILD NERV SYST, V12, P192, DOI 10.1007/BF00301250; Fletcher P., 2005, DEV THEORY LANGUAGE; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Gernsbacher M.A, 1990, LANGUAGE COMPREHENSI; GERNSBACHER MA, 1991, J EXP PSYCHOL LEARN, V17, P245, DOI 10.1037/0278-7393.17.2.245; Gernsbacher MA, 1999, J PRAGMATICS, V31, P1619, DOI 10.1016/S0378-2166(99)00007-7; GERNSBACHER MA, 1995, CAN PSYCHOL, V36, P49, DOI 10.1037/h0084720; GIBBS RW, 1991, J SPEECH HEAR RES, V34, P613, DOI 10.1044/jshr.3403.613; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Guttmann E, 1942, BRAIN, V65, P205, DOI 10.1093/brain/65.2.205; Hall W. S., 1986, MODELS MODULES STUDI, P26; Hannay HJ, 2000, J INT NEUROPSYCH SOC, V6, P351, DOI 10.1017/S1355617700633106; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; HARNISHFEGER KK, 1994, LEARN INDIVID DIFFER, V6, P331, DOI 10.1016/1041-6080(94)90021-3; Harris M, 2003, DISCOURSE PROCESS, V36, P147, DOI 10.1207/S15326950DP3603_1; HASAN KM, 2008, J MAGN RESON, V7, P700; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; HAVERKATE H, 1990, J PRAGMATICS, V14, P77, DOI 10.1016/0378-2166(90)90065-L; HECAEN H, 1983, NEUROPSYCHOLOGIA, V21, P581, DOI 10.1016/0028-3932(83)90055-6; Heidolph K.E., 1970, PROGR LINGUISTICS, P143, DOI DOI 10.1515/9783111350219.143; Hetherington R, 2004, CHILD NEUROPSYCHOL, V10, P117, DOI 10.1080/09297040490911122; HOFFMAN HJ, 1979, CHILD BRAIN, V5, P233; Houghton George, 1994, P53; Huber JF, 2006, CHILD NERV SYST, V22, P132, DOI 10.1007/s00381-005-1223-4; Huber JF, 2007, J CHILD NEUROL, V22, P848, DOI 10.1177/0883073807303995; Huber-Okrainec J, 2005, BRAIN LANG, V93, P349, DOI 10.1016/j.bandl.2004.11.002; Huber-Okrainec J, 2002, BRAIN LANG, V80, P592, DOI 10.1006/brln.2001.2620; HUDSON LJ, 1989, APHASIOLOGY, V3, P1, DOI 10.1080/02687038908248972; HUDSON LJ, 1990, ACQUIRED NEUROLOGICA, P245; Humphreys RP, 1989, CONCEPTS PEDIATR NEU, P57; HYND GW, 1995, J CHILD NEUROL, V10, P289, DOI 10.1177/088307389501000406; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jarema G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P137, DOI 10.1016/B978-0-08-045352-1.00013-6; Johnson, 1989, LANG SPEECH HEAR SER, V20, P420, DOI [10.1044/0161-1461.2004.420, DOI 10.1044/0161-1461.2004.420]; JORDAN F M, 1990, Brain Injury, V4, P27; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; KARTTUNEN L, 1971, LANGUAGE, V47, P340, DOI 10.2307/412084; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kempson R. M., 1975, PRESUPPOSITION DELIM; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kipp K, 2005, BIOL PSYCHIAT, V57, P1256, DOI 10.1016/j.biopsych.2005.03.012; KLEIN SK, 1992, J CHILD NEUROL, V7, P50, DOI 10.1177/088307389200700109; KOHN B, 1980, BRAIN LANG, V9, P350, DOI 10.1016/0093-934X(80)90154-6; LANDAU WM, 1957, NEUROLOGY, V7, P523, DOI 10.1212/WNL.7.8.523; Levelt W.J.M., 1989, SPEAKING INTENTION A; Libben G, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P147, DOI 10.1016/B978-0-08-045352-1.00014-8; Lidzba K, 2008, BRAIN LANG, V106, P204, DOI 10.1016/j.bandl.2007.11.003; Liegeois F, 2008, BRAIN LANG, V106, P195, DOI 10.1016/j.bandl.2008.01.010; LINEBARGER M C, 1990, P55; LOONEN MCB, 1990, ARCH NEUROL-CHICAGO, V47, P1324, DOI 10.1001/archneur.1990.00530120068012; Love T, 2008, BRAIN LANG, V107, P203, DOI 10.1016/j.bandl.2007.11.004; LOVETT MW, 1986, BRAIN LANG, V29, P224, DOI 10.1016/0093-934X(86)90046-5; Lustig AP, 2002, APHASIOLOGY, V16, P507, DOI 10.1080/02687030244000211; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; MACWHINNEY B, 1991, COGNITION, V40, P121, DOI 10.1016/0010-0277(91)90048-9; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Majerus S, 2004, COGN NEUROPSYCHOL, V21, P491, DOI 10.1080/02643290342000104; MAKINO A, 1988, SURG NEUROL, V29, P393, DOI 10.1016/0090-3019(88)90048-1; Malle B. F., 2001, INTENTIONS INTENTION, P1; Martin A, 2003, COGN NEUROPSYCHOL, V20, P195, DOI 10.1080/02643290342000050; McMillan HJ, 2009, CHILD NERV SYST, V25, P677, DOI 10.1007/s00381-008-0777-3; MENN L, 1990, CROSS LANGUAGE STUDY; Moleski M, 2000, ARCH CLIN NEUROPSYCH, V15, P603, DOI 10.1016/S0887-6177(99)00050-5; MORROW DG, 1990, INFERENCES TEXT COMP, P123; MURDOCH BE, 1990, ACQUIRED NEUROLOGICA, P177; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Noveck IA, 2008, TRENDS COGN SCI, V12, P425, DOI 10.1016/j.tics.2008.07.009; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PAQUIER P, 1993, APHASIOLOGY, V7, P421, DOI 10.1080/02687039308248618; PAQUIER P, 1989, APHASIOLOGY, V3, P667, DOI 10.1080/02687038908249032; PAQUIER P, 1991, APHASIOLOGY, V5, P235, DOI 10.1080/02687039108248526; Pascual-Leone J, 2001, BEHAV BRAIN SCI, V24, P136, DOI 10.1017/S0140525X01453921; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Perfetti CA, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P165, DOI 10.1016/B978-0-08-045352-1.00016-1; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; Pitchford NJ, 2000, BRAIN LANG, V72, P129, DOI 10.1006/brln.1999.2267; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Pollio H. R., 1977, PSYCHOL POETICS GROW; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; RAPIN I, 1995, J CHILD NEUROL, V10, P267, DOI 10.1177/088307389501000401; Reilly JS, 1998, BRAIN LANG, V61, P335, DOI 10.1006/brln.1997.1882; REKATE HL, 1985, ARCH NEUROL-CHICAGO, V42, P697, DOI 10.1001/archneur.1985.04060070091023; Richards J. E., 2003, COGNITIVE NEUROSCIEN, P73; Ris MD, 2000, SCI PRACT NEUROPSYCH, P320; Saarni C., 1999, DEV EMOTIONAL COMPET; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; SARTORI G, 1988, COGNITIVE NEUROPSYCH, V5, P105, DOI 10.1080/02643298808252928; Schmalhofer F, 2002, DISCOURSE PROCESS, V33, P105, DOI 10.1207/S15326950DP3302_01; SCHWARTZ RG, 2008, HDB LANGUAGE DISORDE; Searle John R., 1969, SPEECH ACTS ESSAY PH; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P286, DOI 10.1044/jslhr.4002.286; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P273, DOI 10.1044/jslhr.4002.273; Simos PG, 2000, CEREB CORTEX, V10, P809, DOI 10.1093/cercor/10.8.809; SMYTH V, 1990, ACQUIRED NEUROLOGICA, P148; Stark RE, 1995, BRAIN LANG, V51, P406, DOI 10.1006/brln.1995.1068; Stemmer B, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P175, DOI 10.1016/B978-0-08-045352-1.00017-3; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Swinney D, 1996, J COGNITIVE NEUROSCI, V8, P174, DOI 10.1162/jocn.1996.8.2.174; TAYLOR EM, 1961, PSYCHOL APPRAISAL CH; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Ullman MT, 2008, HANDBOOK OF THE NEUROSCIENCE OF LANGUAGE, P189, DOI 10.1016/B978-0-08-045352-1.00018-5; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; van den Broek P, 1999, CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING, P71; Van Dijk TA., 1983, STRATEGIES DISCOURSE; van Mourik M, 1998, PEDIATR NEUROL, V18, P411, DOI 10.1016/S0887-8994(97)00232-4; VANDONGEN HR, 1985, ANN NEUROL, V17, P306, DOI 10.1002/ana.410170316; VANDONGEN HR, 1994, NEUROLOGY, V44, P2040, DOI 10.1212/WNL.44.11.2040; VANDONGEN HR, 1977, CORTEX, V13, P131, DOI 10.1016/S0010-9452(77)80004-X; VANDONGEN HR, 1991, NATO ADV SCI I D-BEH, V60, P125; VANHOUT A, 1985, DEV MED CHILD NEUROL, V27, P231; VANHOUT A, 1991, NATO ADV SCI I D-BEH, V60, P117; VANLANCKERSIDTI.D, 2008, HDB NEUROSCIENCE LAN, P199; VISCHBRINK EG, 1984, BRAIN LANG, V23, P258, DOI 10.1016/0093-934X(84)90067-1; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WHITNEY P, 1987, READ RES QUART, V22, P299, DOI 10.2307/747970; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Williams J, 2000, SCI PRACT NEUROPSYCH, P47; Williams LJ, 2005, PEDIATRICS, V116, P580, DOI 10.1542/peds.2005-0592; Winner E., 1997, PROBLEM MEANING BEHA, V122, P377, DOI DOI 10.1016/S0166-4115(97)80142-2; WITHERS HR, 1992, LANCET, V339, P156; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; ZWAAN RA, 1995, PSYCHOL SCI, V6, P292, DOI 10.1111/j.1467-9280.1995.tb00513.x; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162; ZWAAN RA, BRAIN LANGU IN PRESS	215	13	14	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	4					417	432		10.1080/13803390903164355			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Psychology; Neurosciences & Neurology	589YV	WOS:000277191000009	20397297	Green Accepted			2022-02-06	
J	Huang, SJ; Ho, HL; Yang, CC				Huang, Sheng-Jean; Ho, Hsueh-Lin; Yang, Chi-Cheng			Longitudinal outcomes of patients with traumatic brain injury: A preliminary study	BRAIN INJURY			English	Article						Traumatic brain injury; outcome measures; longitudinal; GOSE	QUALITY-OF-LIFE; MILD HEAD-INJURY; SCALE; DISABILITY; MODERATE; RETURN; WORK; DISORDERS; SYMPTOMS; COHORT	Primary objective: To examine the long-term global clinical outcomes of TBI patients from 1 week to 10 years post-injury. Research design: A retrospective study was conducted at a level I trauma centre. Methods and procedures: A total of 327 TBI patients were recruited retrospectively in this longitudinal study and the score of Glasgow Outcome Scale Extended (GOSE) was then documented as an indicator of the clinical outcomes. Main outcomes and results: The results presented that less than one-in-three patients recovered well within 2 weeks after trauma. Around 40% of patients were evaluated as favourable outcomes within 6 months post-injury. Less than 30% of TBI patients could gain favourable outcomes at 3 years post-injury and over half of patients still could not recover well at 6 years. Five patients' outcomes were continuously followed until 10 years and the results indicated that they started to have good outcomes after 3 years post-injury. Conclusions: This study might be the first one to longitudinally evaluate the outcomes of patients from 1 week to 10 years post-injury and revealed that patients still may have difficulties in social interactions and family relationships until 6 years post-injury, even though they could live and work independently. Hence, professionals should pay attention to the underlying factors causing their difficulties within the long-term recovery process.	[Yang, Chi-Cheng] Chang Gung Univ, Dept Occupat Therapy, Kwei Shan, Tao Yuan County, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Ho, Hsueh-Lin] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan		Yang, CC (corresponding author), Chang Gung Univ, Dept Occupat Therapy, 259,Wen Hwa 1st Rd, Tao Yuan, Taiwan.	ccyang@mail.cgu.edu.tw					Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; GRANACHER RP, 2003, TRAUMATIC BRAIN INJU, P49; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Possl O, 2001, BRAIN INJURY, V15, P15; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2001, BRAIN DAM B, P3; Yang CC, 2005, ARCH CLIN PSYCHOL, V2, P49; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543	52	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	13-14					1606	1615		10.3109/02699052.2010.523056			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800010	20973628				2022-02-06	
J	Nijboer, JMM; van der Naalt, J; ten Duis, HJ				Nijboer, Johanna M. M.; van der Naalt, Joukje; ten Duis, Hendrik-Jan			Patients beyond salvation? Various categories of trauma patients with a minimal Glasgow Coma Score	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Glasgow Coma Scale; Brain injury; Haemorrhagic shock; Outcome	SEVERE HEAD-INJURY; BRAIN-INJURY; PRACTICAL SCALE; MORTALITY; IMPACT; HYPOTHERMIA; VARIABLES; RECOVERY	Introduction: Trauma patients in an unresponsive state upon presentation to the Emergency Department have a poor prognosis. Rapid assessment of injuries combined with life-preserving therapy is required but de. ning the optimal strategy can be complicated when multiple organ systems are involved. This study analysed various categories of trauma patients with a Glasgow Coma Scale (GCS) of 3 on admission and evaluated the relation between injuries, clinical condition, treatment and outcome. Patients and methods: A retrospective cohort-study, performed at a level 1 Trauma Center from 2002 to 2005. Trauma patients of all ages with GCS of 3 (without sedation) and Injury Severity Score (ISS) >= 16 were included. The collected patient data comprised data on demographics, mechanism of injury, physiological condition on admission, diagnosis, ISS, treatment, admission to Intensive Care Unit, complications and outcome. Results: Ninety-seven patients were included and divided into three groups based on the pathology that caused the GCS of 3: traumatic brain injury N = 48 (49%), anoxic brain injury N = 27 (28%) and haemorrhagic shock N = 22 (23%). The overall mortality was 81%; 91% of the haemorrhagic shock patients, 81% of the ABI patients and 77% of the TBI patients died. Eighteen patients survived of whom five patients (5%) made a good recovery. The pupillary light response and pH on admission were related to mortality. No relation with ISS, age or hypothermia was found. Discussion: Distinguishing salvageable patients from those beyond salvation remains problematic. This study illustrated the diversity of patients, their injuries and their condition upon presentation to the hospital as well as the limitations of therapy. Conclusion: Trauma patients with a GCS of 3 have a poor outcome. Despite aggressive treatment only 5% of the patients made a good recovery. Pupil reactivity and the pH on admission were found to be related to mortality. (C) 2009 Elsevier Ltd. All rights reserved.	[Nijboer, Johanna M. M.; ten Duis, Hendrik-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 AB Groningen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9700 AB Groningen, Netherlands		Nijboer, JMM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 AB Groningen, Netherlands.	j.m.m.nijboer@chir.umcg.nl; j.van.der.naalt@neuro.umcg.nl; h.j.ten.duis@chir.umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Probst C, 2006, EUR J TRAUMA, V32, P357; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Rixen D, 2001, UNFALLCHIRURG, V104, P230, DOI 10.1007/s001130050719; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	30	13	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2010	41	1					52	57		10.1016/j.injury.2009.05.030			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	547ND	WOS:000273895400010	19570534				2022-02-06	
J	Perkins, RA; Ryalls, JH; Carson, CK; Whiteside, JD				Perkins, Rosalie A.; Ryalls, Jack H.; Carson, Cecyle K.; Whiteside, Janet D.			Acoustic analyses of two recovered cases of foreign accent syndrome	APHASIOLOGY			English	Article						Foreign accent syndrome; Brain injury; Acoustic analysis; Formant frequencies; Voice onset time; Vowel duration	SPEECH; APHASIA	Recently, a growing number of studies have been published involving phonetic and acoustic analyses on the rare motor-speech disorder known as Foreign Accent Syndrome (FAS). These studies have relied on pre- and post-trauma speech samples to investigate the acoustic and phonetic properties of individual cases of FAS speech. This study presents detailed acoustic analyses of the speech characteristics of two new cases of FAS using identical pre- and post-recovery speech samples, thus affording a new level of control in the study of Foreign Accent Syndrome. Participants include a 48-year-old female who began speaking with an "Eastern European" accent following a traumatic brain injury, and a 45-year-old male who presented with a "British" accent following a subcortical cerebral vascular accident (CVA). The acoustic analysis was based on 18 real words comprised of the stop consonants /p/, /t/, /k/; /b/, /d/, /g/ combined with the peripheral vowels /i/, /a/ and /u/ and ending in a voiceless stop. Computer-based acoustic measures included: (1) voice onset time (VOT), (2) vowel durations, (3) whole word durations, (4) first, second and third formant frequencies, and (5) fundamental frequency. Formant frequencies were measured at three points in the vowel duration: (a) 20%, (b) 50%, and (c) 80% to assess differences in vowel 'onglides' and 'offglides'. The acoustic analysis allowed precise quantification of the major phonetic features associated with the foreign quality of participants' FAS speech. Results indicated post-recovery changes in both duration and frequency measures, including a tendency toward more normal VOT production of voiced stops, changes in average vowel durations, as well as evidence from formant frequency values of vowel backing for both participants. The implications of this study for future research and clinical applications are also considered.	[Perkins, Rosalie A.] Univ Cent Florida, Dept Commun Sci & Disorders, Orlando, FL 32816 USA		Perkins, RA (corresponding author), Univ Cent Florida, Dept Commun Sci & Disorders, POB 162215, Orlando, FL 32816 USA.	RosaliePerkins@gmail.com					ARDILA A, 1988, APHASIOLOGY, V2, P493, DOI 10.1080/02687038808248955; Armorer A. N., 2003, THESIS U S FLORIDA T; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; BLUMSTEIN SE, 1980, BRAIN LANG, V9, P153, DOI 10.1016/0093-934X(80)90137-6; Coelho CA, 2001, J MED SPEECH-LANG PA, V9, P227; Dankovicova J, 2001, CLIN LINGUIST PHONET, V15, P195, DOI 10.1080/02699200010004656; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; GRAFFRADFORD NR, 1986, BRAIN LANG, V28, P86, DOI 10.1016/0093-934X(86)90093-3; Gurd JM, 2006, J NEUROLINGUIST, V19, P424, DOI 10.1016/j.jneuroling.2006.03.004; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; INGRAM JCL, 1992, J PHONETICS, V20, P457, DOI 10.1016/S0095-4470(19)30650-3; KENT RD, 1979, J SPEECH HEAR RES, V22, P627, DOI 10.1044/jshr.2203.627; Kurowski K., 2006, J NEUROLINGUIST, V54, P1; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; MERTUS J, 1999, BROWN LAB INTERACTIV; Miller N, 2006, J NEUROLINGUIST, V19, P385, DOI 10.1016/j.jneuroling.2006.03.005; Moen I, 2000, APHASIOLOGY, V14, P5, DOI 10.1080/026870300401577; PERKINS RA, 2007, THESIS U CENTRAL FLO; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; Ryalls J., 2004, J MULTILINGUAL COMMU, V2, P61, DOI DOI 10.1080/1476967031000090980; Ryalls J., 2000, INTRO SPEECH SCI BAS; Varley R, 2006, J NEUROLINGUIST, V19, P356, DOI 10.1016/j.jneuroling.2006.03.002; Whitaker H., 1982, NEUROPSYCHOLOGY COGN, V1, P168; Whiteside SP, 1998, CORTEX, V34, P221, DOI 10.1016/S0010-9452(08)70749-4	28	13	13	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology		2010	24	10					1132	1154		10.1080/02687030903022211			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	659PV	WOS:000282580300002					2022-02-06	
J	Yoneyama-Sarnecky, T; Olivas, AD; Azari, S; Ferriero, DM; Manvelyan, HM; Noble-Haeusslein, LJ				Yoneyama-Sarnecky, Tomoko; Olivas, Andrea D.; Azari, Soraya; Ferriero, Donna M.; Manvelyan, Hovhannes M.; Noble-Haeusslein, Linda J.			Heme Oxygenase-2 Modulates Early Pathogenesis after Traumatic Injury to the Immature Brain	DEVELOPMENTAL NEUROSCIENCE			English	Article						Oxidative damage; Cell death; Motor recovery; Neuroprotection; Murine; Cortical lesion; Dentate	GLUTATHIONE-PEROXIDASE ACTIVITY; OXIDATIVE STRESS; RAT-BRAIN; CEREBRAL-ISCHEMIA; MESSENGER-RNA; NITRIC-OXIDE; INTRACEREBRAL HEMORRHAGE; ENDOTHELIAL-CELLS; IRON ACCUMULATION; CARBON-MONOXIDE	We determined if heme oxygenase-2 (HO-2), an enzyme that degrades the pro-oxidant heme, confers neuroprotection in the developing brain after traumatic brain injury (TBI). Male HO-2 wild-type (WT) and homozygous knockout (KO) mice at postnatal day 21 were subjected to TBI and euthanized 1, 7, and 14 days later. Relative cerebral blood flow, measured by laser Doppler, cortical and hippocampal pathogenesis, and motor recovery were evaluated at all time points. Cerebral blood flow was found to be similar between experimental groups. Blood flow significantly decreased immediately after injury, returned to baseline by 1 day, and was significantly elevated by 7 days, post-injury. Nonheme iron preferentially accumulated in the ipsilateral cortex, hippocampus, and external capsule in both WT and KO brain-injured genotypes. There were, however, a significantly greater number of TUNEL-positive cells in the hippocampal dentate gyrus and a significantly greater cortical lesion volume in KOs relative to WTs within the first week post-injury. By 14 days post-injury, however, cortical lesion volume and cell density in the hippocampal CA3 region and dorsal thalamus were similar between the two groups. Assays of fine motor function (grip strength) over the first 2 weeks post-injury revealed a general pattern of decreased strength in the contralateral forelimbs of KOs as compared to WTs. Together, these findings demonstrate that deficiency in HO-2 alters both the kinetics of secondary damage and fine motor recovery after TBI. Copyright (C) 2010 S. Karger AG, Basel	[Yoneyama-Sarnecky, Tomoko; Olivas, Andrea D.; Azari, Soraya; Manvelyan, Hovhannes M.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA		Noble-Haeusslein, LJ (corresponding author), 521 Parnassus Ave,Room C-224, San Francisco, CA 94143 USA.	linda.noble@ucsf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050159]; Alvera Kan Endowed Chair; UCSF Linker Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS065937, R01NS050159, R01NS077767] Funding Source: NIH RePORTER	This research was supported by NIH grant NS050159, the Alvera Kan Endowed Chair, and a UCSF Linker Foundation Fellowship.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; APPLEGATE LA, 1991, CANCER RES, V51, P974; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Dwyer BE, 1996, MOL BRAIN RES, V38, P251, DOI 10.1016/0169-328X(95)00341-O; DWYER BE, 1995, MOL BRAIN RES, V30, P37, DOI 10.1016/0169-328X(94)00273-H; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438, DOI 10.1111/paa.1999.111.5.438; ESCALONA SK, 1982, PEDIATRICS, V70, P670; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Geddes JW, 1996, NEUROSCI LETT, V210, P205, DOI 10.1016/0304-3940(96)12703-8; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Hua Y, 2008, ACTA NEUROCHIR SUPPL, V105, P3; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAINES MD, 1992, BIOCHIM BIOPHYS ACTA, V1131, P166, DOI 10.1016/0167-4781(92)90072-8; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Maines MD, 1996, BRAIN RES, V722, P83, DOI 10.1016/0006-8993(96)00184-9; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Soares MP, 2002, ANTIOXID REDOX SIGN, V4, P321, DOI 10.1089/152308602753666370; Stone BS, 2008, ANN NEUROL, V64, P535, DOI 10.1002/ana.21517; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Wong RJ, 2002, PEDIATR RES, V51, p328A; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1	57	13	13	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	1					81	90		10.1159/000258700			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	574FQ	WOS:000275975000007	20389079	Green Published, Bronze			2022-02-06	
J	Apivatthakakul, T; Phornphutkul, C; Laohapoonrungsee, A; Sirirungruangsarn, Y				Apivatthakakul, Theerachai; Phornphutkul, Chanakarn; Laohapoonrungsee, Anupong; Sirirungruangsarn, Yuddhasert			Less Invasive Plate Osteosynthesis in Humeral Shaft Fractures	OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE			English	Article						Less invasive plate osteosynthesis; Humeral shaft fracture; Radial nerve palsy		Objective Stable internal fixation of the humeral shaft by less invasive percutaneous plate insertion using two separate (proximal and distal) incisions, indirect reduction by closed manipulation and fixation to preserve the soft tissue and blood supply at the fracture zone. Early mobilization of the shoulder and elbow to ensure a good functional outcome. Indications Humeral shaft fractures (classified according to AO classification as: 12-A, B, C). Humeral shaft fractures extending to the proximal or distal shaft, small or deformed medullary canal or open growth plate. Contraindications Humeral shaft fractures with primary radial nerve palsy. Proximal humeral shaft fractures extending to the humeral head. Distal humeral fractures extending to the elbow joint. Surgical Technique Two incisions proximal and distal to the fracture zone are used. A 3-cm proximal incision lies between the lateral border of the proximal part of the biceps and the medial border of the deltoid. Distally, a 3-cm incision is made along the lateral border of the biceps. The interval between biceps and brachialis is identified. The biceps is retracted medially to expose the musculocutaneous nerve. The brachialis muscle has dual innervation, the medial half being innervated by the musculocutaneous nerve and the lateral half by the radial nerve. The brachialis is split longitudinally at its midline. The musculocutaneous nerve is retracted along with the medial half of the brachialis, while the lateral half of the brachialis serves as a cushion to protect the radial nerve. A deep subbrachial tunnel is created from the distal to the proximal incision. The selected plate is tied with a suture to a hole at the tip of the tunneling instrument for pulling the plate back along the prepared track. The plate is aligned in the correct position on the anterior surface of the humerus. Traction is applied and the fracture reduced to restore alignment by image intensifier, followed by plate fixation with at least two bicortical locking screws or three bicortical conventional screws in each fragment. Results Between January 2003 and January 2006,23 patients were operated on using the less invasive plate osteosynthesis technique. The minimum follow-up period of 12 months was completed in 20 patients. The mean healing time was 14.6 weeks, defined as three of four cortices having stable bridging callus. In one patient with delayed union, healing was observed after 28 weeks. Functional outcomes were evaluated using the Constant Score and the Hospital for Special Surgery (HSS) Score. 19 patients had good to excellent elbow function with a mean HSS Score Of 93.5 points. All patients achieved satisfactory shoulder function with a mean Constant Score Of 85.8 points compared to 90.6 on the healthy side. Complications observed were one paresthesia of lateral cutaneous nerve of forearm (no radial nerve injury) and one loosening of the LCP (Locking Compression Plate) screws due to technical error.	[Apivatthakakul, Theerachai; Phornphutkul, Chanakarn; Laohapoonrungsee, Anupong; Sirirungruangsarn, Yuddhasert] Chiang Mai Univ, Fac Med, Dept Orthopaed, Chiang Mai 50200, Thailand		Apivatthakakul, T (corresponding author), Chiang Mai Univ, Fac Med, Dept Orthopaed, Chiang Mai 50200, Thailand.	tapivath@gmail.com		Apivatthakakul, Theerachai/0000-0001-8374-9540			Apivatthakakul T, 2005, INJURY, V36, P530, DOI 10.1016/j.injury.2004.05.036; APIVATTHAKAKUL T, 2006, AO MANUAL FRACTURE M, P145; CAMDEN P, 1992, INJURY, V23, P245, DOI 10.1016/S0020-1383(05)80008-7; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Dabezies E J, 1992, J Orthop Trauma, V6, P10; DELLOCA AAF, 2002, INJURY, V33, pA1; Farragos AF, 1999, J ORTHOP TRAUMA, V13, P258, DOI 10.1097/00005131-199905000-00006; FIGGIE MP, 1990, CLIN ORTHOP RELAT R, P123; HELFET DL, 1997, INJURY S, V28, P42; Jiang R, 2007, ARCH ORTHOP TRAUM SU, V127, P531, DOI 10.1007/s00402-007-0313-z; Krettek C, 2001, INJURY, V32, P4, DOI 10.1016/S0020-1383(01)00056-0; KRETTEK C, 1997, INJURY S1, V28, P20; Lin J, 1999, CLIN ORTHOP RELAT R, P201, DOI 10.1097/00003086-199908000-00025; Livani B, 2004, INJURY, V35, P587, DOI 10.1016/j.injury.2003.12.003; Oh CW, 2003, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000048137.30533.06; SARMIENTO A, 1977, J BONE JOINT SURG AM, V59, P596, DOI 10.2106/00004623-197759050-00004	16	13	17	0	19	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	0934-6694	1439-0981		OPER ORTHOP TRAUMATO	Oper. Orthopade Traumatol.	DEC	2009	21	6					602	613		10.1007/s00064-009-2008-9			12	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	538AR	WOS:000273156600008	20087720				2022-02-06	
J	Lewandowski, L; Rieger, B; Smyth, J; Perry, L; Gathje, R				Lewandowski, Lawrence; Rieger, Brian; Smyth, Joshua; Perry, Lorraine; Gathje, Rebecca			Measuring Post-concussion Symptoms in Adolescents: Feasibility of Ecological Momentary Assessment	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Symptoms; Assessment; Adolescents	POSTCONCUSSION SYNDROME; MILD; INJURY	Although there is a large literature examining head trauma in general, several areas remain understudied. Notably, little is known about symptom expression over the course of a day for adolescents recovering from concussion. Furthermore, intra-individual symptom variability has not been well characterized. This pilot study examined the feasibility of a momentary data-gathering method, as well as the sensitivity of the assessment to the subtle and dynamic changes in symptoms of concussion. Six adolescents, three of whom suffered a concussion and three non-injured controls, provided symptom ratings five times per day for 5 days. This ecological momentary assessment (EMA) was conducted on a personal digital assistant to capture variability in symptom reports while in the natural environment. Preliminary results indicated that the EMA method showed great promise as a research tool in natural settings (e. g., school and home). Adolescents were able to comply with all tasks with little interference in their daily activities. Students with concussion showed generally higher symptom ratings across physical, cognitive, and affective domains, and temporal and diurnal patterns for symptoms emerged. Implications for future research and patient care are discussed.	[Lewandowski, Lawrence; Smyth, Joshua; Perry, Lorraine; Gathje, Rebecca] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Rieger, Brian] SUNY Upstate Med Univ, Rehabil Psychol Dept, Syracuse, NY USA		Lewandowski, L (corresponding author), Syracuse Univ, Dept Psychol, 472 Huntington Hall, Syracuse, NY 13244 USA.	ljlewand@syr.edu		Smyth, Joshua/0000-0002-0904-5390			Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smyth J.M., 2003, J HAPPINESS STUD, V4, P35, DOI 10.1023/A:1023657221954; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	12	13	13	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2009	24	8					791	796		10.1093/arclin/acp087			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	524VO	WOS:000272172700008	19892712	Bronze			2022-02-06	
J	Walilko, T; North, C; Young, LA; Lux, WE; Warden, DL; Jaffee, MS; Moore, DF				Walilko, Timothy; North, Carol; Young, Lee Ann; Lux, Warren E.; Warden, Deborah L.; Jaffee, Michael S.; Moore, David F.			Head Injury as a PTSD Predictor Among Oklahoma City Bombing Survivors	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Posttraumatic stress disorder; Head injury; Injury correlation	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY	Background: The aim of the Oklahoma City (OKC) bombing retrospective review was to investigate the relationship between physical injury, environmental contributors, and psychiatric disorders such as posttraumatic stress disorder (PTSD) in an event-based, matched design study focused on injury. Methods: The 182 selected participants were a random subset of the 1,092 direct survivors from the OKC bombing. Only 124 of these 182 cases had a full complement of medical/clinical data in the OKC database. These 124 cases were assessed to explore relationships among PTSD diagnoses, levels of blast exposure, and physical injuries. Associations among variables were statistically tested using contingency analysis and logistic regression. Results: Comparison of the PTSD cases to symptoms/diagnoses reported in the medical records reveals a statistically significant association between PTSD and head/brain injuries associated with head acceleration. PTSD was not highly correlated with other injuries. Although blast pressure and impulse were highly correlated with head injuries, the correlation with PTSD was not statistically significant. Thus, a correlation between blast pressure and PTSD may exist, but higher fidelity pressure calculations are required to elucidate this potential relationship. Conclusions: This study provides clear evidence that head injury is associated with subsequent PTSD, giving caregivers' information on what physical injuries may suggest the development of psychologic disorders to aid them in developing a profile for the identification of future survivors of terrorist attacks and Warfighters with brain injuries and potential PTSD.	[Warden, Deborah L.; Jaffee, Michael S.; Moore, David F.] Walter Reed Army Med Ctr, DVBIC, HQ, Washington, DC 20012 USA; [Walilko, Timothy; Young, Lee Ann] Appl Res Associates, San Antonio, TX USA; [North, Carol] VA N Texas Hlth Care Syst, Dept Psychiat, Dallas, TX USA; [North, Carol] Univ Texas SW Med Ctr Dallas, Div Emergency Med, Dept Psychiat & Surg, Dallas, TX 75390 USA; [Lux, Warren E.] US EPA, Washington, DC 20460 USA		Moore, DF (corresponding author), Walter Reed Army Med Ctr, DVBIC, HQ, Room B207,Bldg 1,6900 Georgia Ave NW, Washington, DC 20012 USA.	david.f.moore@amedd.army.mil			Henry M. Jackson Foundation [0000104862]	Supported by the Henry M. Jackson Foundation contract No. 0000104862 for the Defense and Veterans Brain Injury Center.	*AP ASS, 1987, DSM 3 R DIAGN STAT M, P247; Britt JR, 1994, 405942 SAIC; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; CREPEAU JE, 2003, SHAMRC 2 ORDER HYDRO; *DIR FEMAM, 1996, OKL CIT BOMB IMPR BU; DOOLITTLE C, 2002, OKLAHOMA CITY MURRAH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; MERBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P1; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; PERRY S, 1992, AM J PSYCHIAT, V155, P625; PITMAN RK, 1989, AM J PSYCHIAT, V146, P667; SHALEV AY, 1992, J NERV MENT DIS, V180, P505, DOI 10.1097/00005053-199208000-00005; STUHMILLER J, 2001, CONVENTIONAL WARFARE; Ursano RJ, 1999, AM J PSYCHIAT, V156, P1808; Ursano RJ, 2007, PROG BRAIN RES, V167, P203, DOI 10.1016/S0079-6123(07)67014-9	19	13	13	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2009	67	6					1311	1319		10.1097/TA.0b013e31819adc36			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	531IL	WOS:000272658100038	20009683				2022-02-06	
J	Kim, T; Chung, S; Lanzino, G				Kim, TaeHong; Chung, SeungEun; Lanzino, Giuseppe			Carotid artery-hypoglossal nerve relationships in the neck: an anatomical work	NEUROLOGICAL RESEARCH			English	Article						Hypoglossal nerve; sternocleidomastoid artery; carotid endarterectomy	SURGICAL ANATOMY; ENDARTERECTOMY; INJURIES; RELEVANCE; SURGERY	Objective: To review the surgical anatomy of the hypoglossal nerve in the neck, analyse its relationship to surrounding structures and offer landmarks to identify the nerve during carotid endarterectomy. Method: The carotid bifurcation, external carotid artery, internal carotid artery, extracranial part of the hypoglossal nerve, occipital artery, sternocleidomastoid artery and surrounding neurovascular structures were dissected and studied on 15 formalin-fixed adult cadaver heads (30 sides and 15 pairs) via a surgical microscope. Landmarks for the hypoglossal nerve and measurements of its distance from the carotid bifurcation are described. The relationship between the sternocleidomastoid artery and the occipital artery is also described. Results: The distance from the carotid bifurcation to the point at which the hypoglossal nerve crosses over the internal carotid artery was variable, ranging from 3.89 to 37.03 mm (mean, 20.95 +/- 7.78 mm). The distance from the bifurcation to the point at which the hypoglossal nerve crosses over the external carotid artery ranged from 2.63 to 29.43 mm (mean, 15.33 +/- 7.86 mm; Table 1). The sternocleidomastoid artery had a very characteristic course and close relationship with the hypoglossal nerve. Ascending for a short distance in a cranial direction, it crossed over the hypoglossal nerve and then descended toward the sternocleidomastoid muscle. The sternocleidomastoid artery originated from the occipital artery (33.4%), the external carotid artery-internal carotid artery junction (30%), the external carotid artery itself (30%) or even the lingual artery (6.6%). Conclusion: The relationship between the hypoglossal nerve and the carotid bifurcation is quite variable, and this explains the vulnerability of the nerve during carotid endarterectomy. The sternocleidomastoid artery is a good landmark for identifying the hypoglossal nerve. If there is exact anatomical knowledge about the relationship between the sternocleidomastoid artery and the hypoglossal nerve, the incidence of nerve injuries during carotid endarterectomy can be minimized. [Neurol Res 2009; 31: 895-899]	[Lanzino, Giuseppe] Mayo Clin, Mayo Coll Med, Dept Neurol Surg, Rochester, MN 55905 USA; [Kim, TaeHong; Lanzino, Giuseppe] Univ Illinois, Coll Med, Microneurosurg Lab, Dept Neurosurg, Peoria, IL 61656 USA; [Chung, SeungEun] Wooridul Hosp, Dept Radiol, Seoul, South Korea; [Kim, TaeHong] Inje Univ, Sanggyepaik Hosp, Dept Neurosurg, Seoul, South Korea		Lanzino, G (corresponding author), Mayo Clin, Mayo Coll Med, Dept Neurol Surg & Radiol, 200 1st St SW, Rochester, MN 55905 USA.	lanzino.giuseppe@mayo.edu					ALDOORI MI, 1988, J CARDIOVASC SURG, V29, P432; Alvernia JE, 2006, NEUROSURGERY, V58, P114, DOI 10.1227/01.NEU.0000193519.00443.34; Bademci G, 2005, CEREBROVASC DIS, V19, P404, DOI 10.1159/000086101; Bademci G, 2005, MINIM INVAS NEUROSUR, V48, P108, DOI 10.1055/s-2004-830228; Bademci G, 2006, J CLIN NEUROSCI, V13, P841, DOI 10.1016/j.jocn.2005.12.028; Ballotta E, 1999, SURGERY, V125, P85, DOI 10.1016/S0039-6060(99)70292-8; Bejjani GK, 1998, NEUROSURGERY, V43, P842, DOI 10.1097/00006123-199810000-00072; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Delenge D, 1974, RADIOLOGY SKULL BRAI, V2, P1202; EVANS WE, 1982, ANN SURG, V196, P461, DOI 10.1097/00000658-198210000-00009; Fernando DA, 1999, CARDIOVASC SURG, V7, P287, DOI 10.1016/S0967-2109(98)00070-2; FISHER DF, 1984, J VASC SURG, V1, P727, DOI 10.1067/mva.1984.avs0010727; Gray H., 1980, GRAYS ANATOMY, P676; HANS SS, 1989, AM J SURG, V157, P431, DOI 10.1016/0002-9610(89)90593-X; Hayashi N, 2005, NEUROL MED-CHIR, V45, P25, DOI 10.2176/nmc.45.25; Imparato AM, 1972, STROKE, V3, P576, DOI 10.1161/01.STR.3.5.576; Kierner AC, 1999, ARCH SURG-CHICAGO, V134, P144, DOI 10.1001/archsurg.134.2.144; LIAPIS CD, 1981, SURGERY, V89, P56; MANIGLIA AJ, 1991, HEAD NECK-J SCI SPEC, V13, P121, DOI 10.1002/hed.2880130207; RABSON JA, 1985, BRIT J PLAST SURG, V38, P208, DOI 10.1016/0007-1226(85)90051-7; THEODOTOU B, 1985, STROKE, V16, P894, DOI 10.1161/01.STR.16.5.894; WEISS K, 1987, J CARDIOVASC SURG, V28, P171	22	13	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2009	31	9					895	899		10.1179/174313209X385590			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530XQ	WOS:000272626700003	19215658				2022-02-06	
J	Park, SA; Yang, CY; Kim, CG; Shin, YI; Oh, GJ; Lee, M				Park, Soon-Ah; Yang, Chung-Yong; Kim, Chang-Guhn; Shin, Yong-Il; Oh, Gyung-Jae; Lee, Moonyoung			Patterns of Three-Phase Bone Scintigraphy According to the Time Course of Complex Regional Pain Syndrome Type I After a Stroke or Traumatic Brain Injury	CLINICAL NUCLEAR MEDICINE			English	Article						pain; complex regional pain syndrome; three-phase bone scintigraphy	REFLEX SYMPATHETIC DYSTROPHY; QUANTITATIVE-EVALUATION; EXTREMITIES; MECHANISMS; HEMIPLEGIA; DIAGNOSIS; CRITERIA	We have proposed to evaluate different patterns represented on 3-phase bone scintigraphy (TPBS) according to the time course of complex regional pain syndrome (CRPS) type I (CRPS-I) after a stroke or traumatic brain injury. TPBS was performed in 50 consecutive patients for the evaluation of CRPS. We divided the patients into CRPS and non-CPRS groups based on the use of International Association for the Study of Pain criteria. We evaluated the changes on TPBS according to clinical stages based on time course. In the early acute stage within 6 weeks, minimal uptake on all TPBS phases was observed in the 90% of the patients in the CRPS-I group and in 75% of the patients in the non-CRPS group. In the acute stage of CRPS in the range of 2 to 20 weeks, moderately increased uptake was seen for 78%, 83%, and 83% of the patients in the CRPS group for the 3 phases, respectively. However, only 16% of the patients in the non-CRPS group had moderately increased uptake as seen on all TPBS phases. In the late stage of more than 21 weeks, there was no distinct difference in uptake between the 2 groups. A sequential change during the time course for the CPRS-I group was statistically significant (P < 0.05). Therefore, performance of follow-tip TPBS may be useful to diagnose CPRS-I in uncertain cases of the early acute stage after a stroke or traumatic brain injury.	[Park, Soon-Ah; Kim, Chang-Guhn] Wonkwang Univ, Coll Med, Dept Nucl Med, Iksan 570749, Jeollabuk Do, South Korea; [Park, Soon-Ah; Oh, Gyung-Jae; Lee, Moonyoung] Inst Wonkwang Med Sci, Iksan, South Korea; [Yang, Chung-Yong; Shin, Yong-Il] Wonkwang Univ, Coll Med, Dept Phys Med & Rehabil, Iksan 570749, Jeollabuk Do, South Korea		Park, SA (corresponding author), Wonkwang Univ, Coll Med, Dept Nucl Med, 344-2 Shinyong Dong, Iksan 570749, Jeollabuk Do, South Korea.	nmbach@wonkwang.ac.kr			Wonkwang University	Supported by Wonkwang University in 2007.	Bogduk N., 1994, CLASSIFICATION CHRON, P40; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Daviet JC, 2002, AM J PHYS MED REHAB, V81, P34, DOI 10.1097/00002060-200201000-00006; DAVIS SW, 1977, ARCH PHYS MED REHAB, V58, P353; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; GIBBONS JJ, 1992, CLIN J PAIN, V8, P260, DOI 10.1097/00002508-199209000-00012; Gokkaya NKO, 2006, INT J REHABIL RES, V29, P275; Harden RN, 2006, CLIN J PAIN, V22, P420; Harvey RL, 2007, PHYS MED REHABILITAT, P1175; HOLDER LE, 1984, RADIOLOGY, V152, P517, DOI 10.1148/radiology.152.2.6739825; INTENZO C, 1989, CLIN NUCL MED, V14, P657, DOI 10.1097/00003072-198909000-00004; Intenzo CM, 2005, CLIN NUCL MED, V30, P400, DOI 10.1097/01.rlu.0000162605.14734.11; LEE GW, 1995, J HAND SURG-AM, V20A, P458, DOI 10.1016/S0363-5023(05)80107-8; ODONOGHUE JP, 1993, CLIN NUCL MED, V18, P829, DOI 10.1097/00003072-199310000-00002; Park SG, 2007, NUCL MED COMMUN, V28, P766, DOI 10.1097/MNM.0b013e32828e513f; SCHWARTZMAN RJ, 1987, ARCH NEUROL-CHICAGO, V44, P555, DOI 10.1001/archneur.1987.00520170081028; van de Vusse AC, 2003, EUR J PAIN, V7, P259, DOI 10.1016/S1090-3801(02)00123-4; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wasner G, 2003, SPINAL CORD, V41, P61, DOI 10.1038/sj.sc.3101404; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; WEISS L, 1993, ARCH PHYS MED REHAB, V74, P716, DOI 10.1016/0003-9993(93)90032-6; Zyluk A, 1999, NUCL MED COMMUN, V20, P327, DOI 10.1097/00006231-199904000-00008	22	13	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	NOV	2009	34	11					773	776		10.1097/RLU.0b013e3181b7d980			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	515UU	WOS:000271499200007	19851172				2022-02-06	
J	Vickery, CD; Evans, CC; Lee, JE; Sepehri, A; Jabeen, LN				Vickery, Chad D.; Evans, Clea C.; Lee, Jae Eun; Sepehri, Arash; Jabeen, Linsa N.			Multilevel Modeling of Self-Esteem Change During Acute Inpatient Stroke Rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						stroke; self-esteem; rehabilitation; multilevel modeling	TRAUMATIC BRAIN-INJURY; POSTSTROKE DEPRESSION; PHYSICAL REHABILITATION; LESION LOCATION; LATE-LIFE; SYMPTOMS; MOOD; VALIDATION; DISABILITY; PHASE	Objective: To explore self-esteem change during inpatient stroke rehabilitation and moderators of change. Research Method: One hundred twenty survivors of stroke serially completed the State Self-Esteem Scale (SSES) during inpatient rehabilitation, as well as measures of mood and perceived recovery as potential moderators of change. Age, gender, prior stroke, prestroke depression, stroke laterality, and admission Functional Independence Measure (FIM) self-care, mobility, and cognitive scores were also included as moderators. Results: Multilevel modeling of the repeated administrations of the SSES indicated that self-esteem significantly improved during rehabilitation. Female gender, left hemisphere stroke, prior stroke, and lower admission FIM cognitive scores were associated with lower self-esteem ratings at admission, but only age and admission FIM self-care and mobility scores were associated with self-esteem change. Older individuals showed less self-esteem improvement than younger individuals, and higher self-care and mobility scores at admission were associated with greater self-esteem improvement. While mood change significantly covaried with self-esteem, the rate of mood change did not appear to influence rate of self-esteem change. Greater improvement in self-esteem over time was related to lower levels of perceived recovery, but this was likely because of the relationship between perceived recovery and self-esteem at rehabilitation admission. Implications: These results suggest that self-esteem improves during inpatient rehabilitation, and this change may be partially dependent on functional status. Implications for facilitating self-esteem change by the clinician are discussed, as well as future research directions.	[Vickery, Chad D.; Evans, Clea C.; Sepehri, Arash; Jabeen, Linsa N.] Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS 39216 USA; [Vickery, Chad D.; Evans, Clea C.; Lee, Jae Eun] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA; [Lee, Jae Eun] Jackson State Univ, SRCMI Tranlsat Res Network, Jackson, MS USA		Vickery, CD (corresponding author), Methodist Rehabil Ctr, Dept Neuropsychol, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	chadvickery@hotmail.com					ANDERSEN G, 1995, ACTA PSYCHIAT SCAND, V92, P193, DOI 10.1111/j.1600-0447.1995.tb09567.x; Balloun JL, 1997, QUAL QUANT, V31, P317, DOI 10.1023/A:1004254515556; Barbisoni P, 1996, ARCH PHYS MED REHAB, V77, P346, DOI 10.1016/S0003-9993(96)90082-9; Bennett HE, 2006, BRIT J CLIN PSYCHOL, V45, P367, DOI 10.1348/014466505X58277; Berg A, 2001, CEREBROVASC DIS, V12, P14, DOI 10.1159/000047675; Bruce ML, 2001, AM J GERIAT PSYCHIAT, V9, P102, DOI 10.1176/appi.ajgp.9.2.102; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Chang AM, 1999, J CLIN NURS, V8, P477, DOI 10.1046/j.1365-2702.1999.0196a.x; Chang AM, 1998, STROKE, V29, P2325, DOI 10.1161/01.STR.29.11.2325; Fung LCL, 2006, J CLIN NURS, V15, P505, DOI 10.1111/j.1365-2702.2006.01328.x; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; HARRIS RE, 1988, J AM GERIATR SOC, V36, P890, DOI 10.1111/j.1532-5415.1988.tb05781.x; Hastie T. J., 1990, GEN ADDITIVE MODELS; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lieberman D, 1999, INT J GERIATR PSYCH, V14, P549, DOI 10.1002/(SICI)1099-1166(199907)14:7<549::AID-GPS960>3.0.CO;2-4; Mruk C.J., 2006, SELF ESTEEM ISSUES A, P164; Narushima K, 2003, J NEUROPSYCH CLIN N, V15, P422, DOI 10.1176/appi.neuropsych.15.4.422; Nezlek JB, 2001, PERS SOC PSYCHOL B, V27, P201, DOI 10.1177/0146167201272006; Oosterwegel A, 2001, J PERS, V69, P689, DOI 10.1111/1467-6494.695160; Paolucci S, 1998, CEREBROVASC DIS, V8, P228, DOI 10.1159/000015856; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Paolucci S, 1999, ARCH PHYS MED REHAB, V80, P985, DOI 10.1016/S0003-9993(99)90048-5; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Robins RW, 2005, CURR DIR PSYCHOL SCI, V14, P158, DOI 10.1111/j.0963-7214.2005.00353.x; SCHUBERT DSP, 1992, GEN HOSP PSYCHIAT, V14, P135, DOI 10.1016/0163-8343(92)90039-D; SCHULZ R, 1994, J SOC BEHAV PERS, V9, P139; SCHWARTZ JA, 1993, BIOL PSYCHIAT, V33, P694, DOI 10.1016/0006-3223(93)90118-W; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Stern R. A., 1997, VISUAL ANALOG MOOD S; *UB FDN ACT, 1996, UN DAT SET MED REH V; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2008, CLIN REHABIL, V22, P179, DOI 10.1177/0269215507080142; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Vickery CD, 2009, REHABIL PSYCHOL, V54, P432, DOI 10.1037/a0017752; Vickery CD, 2009, REHABIL PSYCHOL, V54, P332, DOI 10.1037/a0016434; Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404; Zalewski Christine, 1994, Clinical Gerontologist, V14, P62	40	13	14	1	13	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2009	54	4					372	380		10.1037/a0017854			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	526YF	WOS:000272331600003	19929118				2022-02-06	
J	Balaratnasingam, C; Pham, D; Morgan, WH; Bass, L; Cringle, SJ; Yu, DY				Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Bass, Louise; Cringle, Stephen J.; Yu, Dao-Yi			Mitochondrial Cytochrome C Oxidase Expression in the Central Nervous System Is Elevated at Sites of Pressure Gradient Elevation but Not Absolute Pressure Increase	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						axon; CNS; cytochrome c oxidase; mitochondria; optic nerve; pressure	CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE; INTRAOCULAR-PRESSURE; AXOPLASMIC-TRANSPORT; AXONAL-TRANSPORT; TISSUE PRESSURE; LAMINA-CRIBROSA; BRAIN-INJURY; ULTRASTRUCTURE; HISTOCHEMISTRY	The paucity of suitable experimental models has made it difficult to isolate the pathogenic role of mitochondria in central nervous system diseases associated with absolute pressure elevation and increased pressure gradients. Experimental models of traumatic brain injury (TBI) and hydrocephalus have been useful for examining the mitochondrial response following pressure increase in the central nervous system; however, the presence of multiple pathogenic factors acting on the brain in these previous studies has made it difficult to determine whether the induced changes were a result of mechanical damage, intracranial pressure elevation, or other pathogenic factors. By direct monitoring and control of pressures in the intraocular, intracranial, and vascular compartments, we use the pig optic nerve, a typical central white matter tract, to compare the temporal sequence of cytochrome c oxidase (CcO) levels between regions of absolute pressure elevation and pressure gradient increase. We demonstrate that a rise in pressure gradient without traumatic injury up-regulates CcO levels across the site of the gradient, in a manner similar to what has been previously reported for hydrocephalus. We also demonstrate that CcO changes do not occur following an absolute pressure rise. These findings taken together with our recent reports suggest that mitochondria initiate an early compensatory response to axonal damage following pressure gradient increase. Extrapolation of our results also suggests that decreased CcO levels in TBI may be secondary to mechanical damage. This study emphasises the importance of pressure gradients in regulating mitochondrial function in the central nervous system. (C) 2009 Wiley-Liss, Inc.	[Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Cringle, Stephen J.; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Cringle, Stephen J.; Yu, Dao-Yi] Univ Western Australia, ARC Ctr Excellence Vis Sci, Perth, WA 6009, Australia; [Bass, Louise] Murdoch Univ, Vet Hosp, Dept Anesthesia, Perth, WA, Australia		Yu, DY (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia.			Cringle, Stephen/0000-0002-5427-554X; Yu, Dao-Yi/0000-0002-9490-534X			ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P659, DOI 10.1001/archopht.1969.00990020653015; Balaratnasingam C, 2008, INVEST OPHTH VIS SCI, V49, P986, DOI 10.1167/iovs.07-1090; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; BAZZY AR, 1992, J APPL PHYSIOL, V72, P266, DOI 10.1152/jappl.1992.72.1.266; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; Brooks Dennis E., 1998, Veterinary Ophthalmology, V1, P129, DOI 10.1046/j.1463-5224.1998.00029.x; Buki A, 2000, J NEUROSCI, V20, P2825; CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A; Ding Y, 2001, NEUROSCIENCE, V106, P659, DOI 10.1016/S0306-4522(01)00166-X; GORDON SR, 1988, J HISTOCHEM CYTOCHEM, V36, P701, DOI 10.1177/36.6.3367053; HAHNENBERGER RW, 1980, ACTA PHYSIOL SCAND, V109, P117, DOI 10.1111/j.1748-1716.1980.tb06575.x; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; OCHS S, 1974, FED PROC, V33, P1049; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POCETA JS, 1981, ANAT RECORD, V200, P349, DOI 10.1002/ar.1092000315; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; WehbyGrant MC, 1996, PEDIATR NEUROSURG, V24, P79, DOI 10.1159/000121021; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5	23	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2009	87	13					2973	2982		10.1002/jnr.22120			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	492SB	WOS:000269678600016	19437548				2022-02-06	
J	Fu, YK; Chang, CJ; Chen, KY; Hwang, LC; Wu, KH; Chang, KW; Jan, ML; Chen, CC; Chang, CH				Fu, Ying-Kai; Chang, Chia-Jung; Chen, Kuan-Yin; Hwang, Li-Chung; Wu, Kuo-Hung; Chang, Kang-Wei; Jan, Meei-Ling; Chen, Chia-Chieh; Chang, Chih-Hsien			Imaging of regional metabolic activity by F-18-FDG/PET in rats with transient cerebral ischemia	APPLIED RADIATION AND ISOTOPES			English	Article						F-18-FDG; MicroPET; Rat ischemia model	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; OCCLUSION; RECOVERY; PET	Changes in regional metabolic activities induced by middle cerebral artery occlusion (MCAO) can influence patient outcome. Our aim was to demonstrate in a rat model that F-18-FDG with positron emission tomography (PET) imaging is a quantitative, reproducible approach for identifying acute and sub-acute metabolic variations in infarct regions. We found that imaging with F-18-FDG/PET enabled detection and quantification of ischemia-induced metabolic deficits and provided a sensitive and reliable means of assessing cerebral ischemic lesions compared with conventional neurological scoring systems in rodents. (C) 2009 Elsevier Ltd. All rights reserved,	[Fu, Ying-Kai] Inst Nucl Energy Res, Atom Energy Council, Tao Yuan 32546, Taiwan; [Fu, Ying-Kai] Chung Yuan Christian Univ, Dept Chem, Chungli 32023, Taiwan		Fu, YK (corresponding author), Inst Nucl Energy Res, Atom Energy Council, Execut Yuan 1000,Wunhua Rd, Tao Yuan 32546, Taiwan.	fufrank@iner.gov.tw			National Science CouncilMinistry of Science and Technology, Taiwan; Institute of Nuclear Energy Research, Taiwan, ROC	This research was supported by the National Science Council and the Institute of Nuclear Energy Research, Taiwan, ROC. The authors are grateful to Dr. Wuu-Jyh Lin for providing <SUP>18</SUP>F-FDG, to Mr. Kuo-Wei Chen for his help with image data reconstruction to Professor Yui-whei Chen-Yang, Chung Yuan Christian University, for her knowledgeable discussion on the manuscript, and to Ms. Hsueh-Hsuan Liu for her supervision on animal experiments.	Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Kornblum HI, 2000, NAT BIOTECHNOL, V18, P655, DOI 10.1038/76509; Kudo T, 2002, CIRCULATION, V106, P118, DOI 10.1161/01.CIR.0000020221.28996.78; Liu HG, 2003, CLIN NUCL MED, V28, P241, DOI 10.1097/00003072-200303000-00021; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Mirrione MM, 2006, SYNAPSE, V59, P119, DOI 10.1002/syn.20216; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Mountz JM, 2003, SEMIN NUCL MED, V33, P56, DOI 10.1053/snuc.2003.127293; Sakai N, 1996, BEHAV BRAIN RES, V77, P181, DOI 10.1016/0166-4328(95)00232-4; vanderStaay FJ, 1996, BRAIN RES, V715, P180, DOI 10.1016/0006-8993(95)01581-7; Yang Y.R., 2000, J PHYS THER, V25, P223	15	13	15	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	OCT	2009	67	10					1743	1747		10.1016/j.apradiso.2009.03.002			5	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	504TV	WOS:000270641500001	19372040				2022-02-06	
J	Stell, A; Sinnott, R; Jiang, JP; Donald, R; Chambers, I; Citerio, G; Enblad, P; Gregson, B; Howells, T; Kiening, K; Nilsson, P; Ragauskas, A; Sahuquillo, J; Piper, I				Stell, Anthony; Sinnott, Richard; Jiang, Jipu; Donald, Rob; Chambers, Iain; Citerio, Giuseppe; Enblad, Per; Gregson, Barbara; Howells, Tim; Kiening, Karl; Nilsson, Pelle; Ragauskas, Arminas; Sahuquillo, Juan; Piper, Ian			Federating distributed clinical data for the prediction of adverse hypotensive events	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES			English	Article; Proceedings Paper	UK e-Science All Hands Meeting	SEP 08-11, 2008	Edinburgh, SCOTLAND			data federation; hypotension prediction; clinical grids	HEAD-INJURED PATIENTS; BRAIN-INJURY; MANAGEMENT; CARE	The ability to predict adverse hypotensive events, where a patient's arterial blood pressure drops to abnormally low (and dangerous) levels, would be of major benefit to the fields of primary and secondary health care, and especially to the traumatic brain injury domain. A wealth of data exist in health care systems providing information on the major health indicators of patients in hospitals (blood pressure, temperature, heart rate, etc.). It is believed that if enough of these data could be drawn together and analysed in a systematic way, then a system could be built that will trigger an alarm predicting the onset of a hypotensive event over a useful time scale, e. g. half an hour in advance. In such circumstances, avoidance measures can be taken to prevent such events arising. This is the basis for the Avert-IT project (http://www.avert-it.org), a collaborative EU-funded project involving the construction of a hypotension alarm system exploiting Bayesian neural networks using techniques of data federation to bring together the relevant information for study and system development.	[Stell, Anthony; Sinnott, Richard; Jiang, Jipu] Univ Glasgow, Natl E Sci Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Donald, Rob] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; [Donald, Rob] C3 Amulet Ltd, Dingwall IV15 9XL, Scotland; [Chambers, Iain] James Cook Univ Hosp, Middlesbrough TS4, Cleveland, England; [Citerio, Giuseppe] Hosp San Gerardo, I-20052 Monza, Italy; [Enblad, Per; Howells, Tim; Nilsson, Pelle] Univ Uppsala Hosp, Dept Neurosurg, S-75185 Uppsala, Sweden; [Gregson, Barbara] Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Kiening, Karl] Univ Heidelberg Hosp, D-69120 Heidelberg, Germany; [Ragauskas, Arminas] Kaunas Univ Hosp, LT-44029 Kaunas, Lithuania; [Sahuquillo, Juan] Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Piper, Ian] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland		Stell, A (corresponding author), Univ Glasgow, Natl E Sci Ctr, Glasgow G12 8QQ, Lanark, Scotland.	a.stell@nesc.gla.ac.uk	Sahuquillo, Juan/B-3577-2008; Ragauskas, Art/J-7486-2016; Citerio, Giuseppe/B-1839-2015; sinnott, richard/E-7197-2014	Sahuquillo, Juan/0000-0003-0713-5875; Ragauskas, Art/0000-0002-3536-554X; Citerio, Giuseppe/0000-0002-5374-3161; Gregson, Barbara/0000-0003-4868-9137; sinnott, richard/0000-0001-5998-222X; Donald, Rob/0000-0001-5301-0219			Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DONALD R, 2008, EVENT DEFINITION ANA; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; SINNOTT RO, 2008, P HEALTHGRID CHIC IL; SINNOTT RO, 2008, HDB RES COMPUTATIONA; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Tarassenko L., 2005, 3rd IEE International Seminar on Medical Applications of Signal Processing, P71, DOI 10.1049/ic:20050334	14	13	13	0	3	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1364-503X	1471-2962		PHILOS T R SOC A	Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.	JUL 13	2009	367	1898					2679	2690		10.1098/rsta.2009.0042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Science & Technology - Other Topics	461PW	WOS:000267281800007	19487204	Green Submitted			2022-02-06	
J	Chang, CM; Lee, MH; Wang, TC; Weng, HH; Chung, CY; Yang, JT				Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Weng, Hsu-Huei; Chung, Chiu-Yen; Yang, Jen-Tsung			Brain protection by methylprednisolone in rats with spinal cord injury	NEUROREPORT			English	Article						apoptosis; ascending brain injury; methylprednisolone; spinal cord injury	INDUCED MYOCARDIAL APOPTOSIS; CELL-DEATH; IMMATURE HEARTS; GRANULOSA-CELLS; TNF-ALPHA; KAPPA-B; GLUCOCORTICOIDS; DEXAMETHASONE; ACTIVATION; EXPRESSION	Traumatic spinal cord injury is clinically treated by high doses of methylprednisolone. However, the effect of methylprednisolone on the brain in spinal cord injury patients has been little investigated. This experimental study examined Bcl-2 and Bax protein expression and Nissl staining to evaluate an apoptosis-related intracellular signaling event and final neuron death, respectively. Spinal cord injury produced a significant apoptotic change and cell death not only in the spinal cord but also in the supraventricular cortex and hippocampal cornu ammonis 1 region in the rat brains. The treatment of methylprednisolone increased the Bcl-2/Bax ratio and prevented neuron death for 1-7 days after spinal cord injury. These findings suggest that rats with spinal cord injury show ascending brain injury that could be restricted through methylprednisolone management, NeuroReport 20:968-972 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Weng, Hsu-Huei] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Weng, Hsu-Huei] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan; [Chung, Chiu-Yen] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi, Taiwan; [Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Dept Neurosurg, Tao Yuan, Taiwan; [Chang, Chia-Mao; Lee, Ming-Hsueh; Wang, Ting-Chung; Yang, Jen-Tsung] Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan		Yang, JT (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 6 Sect W,Chia Pu Rd, Pu Tz City 613, Chia Yi, Taiwan.	jents716@ms32.hinet.net	Yang, Jen-Tsung/C-3187-2011; Lee, Ming-Hsueh/H-8034-2015; Weng, Hsu-Huei/N-8329-2014	Lee, Ming-Hsueh/0000-0001-5341-7764; Chang, Chia Mao/0000-0003-3862-791X; Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Medical Research Council [660302, 660342]; National Science Council of TaiwanMinistry of Science and Technology, Taiwan [3191]	The authors acknowledge Tsong-Hai Lee for valuable discussions. This work was supported by Grant CMRPG 660302 and CMRPG 660342 from the Chang Gung Medical Research Council and Grant NMRPG 3191 from the National Science Council of Taiwan.	Costas MA, 2000, BBA-MOL CELL RES, V1499, P122, DOI 10.1016/S0167-4889(00)00113-0; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Ekert P, 1997, BRAIN RES, V747, P9, DOI 10.1016/S0006-8993(96)01201-2; Evans-Storms RB, 2000, ENDOCRINOLOGY, V141, P1854, DOI 10.1210/en.141.5.1854; FENG ZW, 1995, J CELL BIOL, V131, P1095, DOI 10.1083/jcb.131.4.1095; Fumagalli F, 2009, NEUROSCIENCE, V159, P936, DOI 10.1016/j.neuroscience.2009.01.030; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; HALL ED, 1993, CELL MOL NEUROBIOL, V13, P415, DOI 10.1007/BF00711581; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Huang TS, 1998, AM J PHYS MED REHAB, V77, P108, DOI 10.1097/00002060-199803000-00004; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; Nemoto S, 2002, ANN THORAC SURG, V74, P836; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; Pearl JM, 2002, ANN THORAC SURG, V74, P830, DOI 10.1016/S0003-4975(02)03843-2; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ramu J, 2007, EXP NEUROL, V204, P58, DOI 10.1016/j.expneurol.2006.09.015; Sasson R, 2002, BIOCHEM BIOPH RES CO, V294, P51, DOI 10.1016/S0006-291X(02)00431-X; Sasson R, 2001, ENDOCRINOLOGY, V142, P802, DOI 10.1210/en.142.2.802; Sinha S, 2004, J NEUROL NEUROSUR PS, V75, P1632, DOI 10.1136/jnnp.2003.028647; SUZUKI S, 1994, ACTA NEUROCHIR, V131, P184, DOI 10.1007/BF01808610; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Xu YJ, 2006, BRAIN RES, V1087, P175, DOI 10.1016/j.brainres.2006.03.003; Zurita M, 2002, J NEUROSURG, V96, P83, DOI 10.3171/spi.2002.96.1.0083	26	13	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 1	2009	20	10					968	972		10.1097/WNR.0b013e32832d0a28			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	466AW	WOS:000267633600014	19525878				2022-02-06	
J	Hashimoto, K; Abo, M				Hashimoto, Keiji; Abo, Masahiro			ABNORMAL REGIONAL BENZODIAZEPINE RECEPTOR UPTAKE IN THE PREFRONTAL CORTEX IN PATIENTS WITH MILD TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; MTBI; single photon emission tomography; SPECT; neuropsychological dysfunction	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; POSTCONCUSSION SYNDROME; SPECT; PERFUSION; CT	Objective: The diagnosis and management of mild traumatic brain injury continues to he a subject of debate, with varying opinions regarding the extent to which organically based impairments vs the impact of other stressors cause ongoing disability. The aim of this stud), was to elucidate the possible abnormalities in benzodiazepine receptor uptake in the brains of patients with mild traumatic brain injury. Nine unmedicated patients with mild traumatic brain injury were investigated using (123)I-iomazenil single photon emission computerized tomography (SPECT). Design: A descriptive study comparing patients after mild traumatic brain injury with matched control subjects. Subjects: Nine patients with mild traumatic brain injury and 5 controls. Methods: The SPECT scan was taken 180 min after injection of tracer. Results and conclusion: All 9 patients had a significant increase (> 2 standard deviations higher than the mean of controls) in benzodiazepine receptor uptake in the prefrontal cortex and significantly higher frontal association cortex-to-average global brain activity ratios than in controls. This SPECT study demonstrated focally altered benzodiazepine receptor uptake in the prefrontal cortices in patients with mild traumatic brain injury.	[Hashimoto, Keiji] Jikei Univ, Div Rehabil Med, Natl Ctr Child Hlth & Dev, Sch Med, Tokyo 1578535, Japan; [Abo, Masahiro] Jikei Univ, Dept Rehabil Med, Sch Med, Tokyo 1578535, Japan		Hashimoto, K (corresponding author), Jikei Univ, Div Rehabil Med, Natl Ctr Child Hlth & Dev, Sch Med, 2-10-1 Okura, Tokyo 1578535, Japan.	hashimoto-k@ncchd.go.jp		Abo, Masahiro/0000-0001-6701-4974; Hashimoto, Keiji/0000-0003-2412-860X			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; JACOBS A, 1994, J NUCL MED, V35, P942; KUIKKA JT, 1995, NUCL MED COMMUN, V16, P273, DOI 10.1097/00006231-199504000-00159; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; TIKOFSKY RS, 1994, J NUCL MED, V35, P947	17	13	14	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUL	2009	41	8					661	665		10.2340/16501977-0388			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	474WY	WOS:000268316700010	19565161	gold			2022-02-06	
J	Lambru, G; Castellini, P; Manzoni, GC; Torelli, P				Lambru, Giorgio; Castellini, Paola; Manzoni, Gian Camillo; Torelli, Paola			Post-Traumatic Cluster Headache: From the Periphery to the Central Nervous System?	HEADACHE			English	Article						cluster headache; mild head trauma; post-traumatic cluster headache	INJURY; PATHOGENESIS	A correlation between head trauma and cluster headache is believed to exist. We report a case of post-traumatic episodic cluster headache that fulfills the criteria of the International Classification of Headache Disorders, 2nd edition. The distinctive features of this case are: a close temporal relation between head trauma and headache onset; pain ipsilateral to the side of trauma; mild severity of trauma; episodic course well-responsive to low doses of verapamil. Given the close temporal relation between the 2 events, multiple hypotheses can be advanced about a possible role of head trauma in the pathogenesis of cluster headache.	[Lambru, Giorgio; Castellini, Paola; Manzoni, Gian Camillo; Torelli, Paola] Univ Parma, Osped Maggiore, Dept Neurol, Headache Ctr, I-43100 Parma, Italy		Lambru, G (corresponding author), Univ Parma, Osped Maggiore, Dept Neurol, Headache Ctr, Via Gramsci 14, I-43100 Parma, Italy.			Torelli, Paola/0000-0002-4072-2353			Carter Dale M, 2004, Curr Pain Headache Rep, V8, P133, DOI 10.1007/s11916-004-0027-7; Evers S, 1997, CEPHALALGIA, V17, P680, DOI 10.1046/j.1468-2982.1997.1706680.x; FORMISANO R, 1990, ITAL J NEUROL SCI, V11, P303, DOI 10.1007/BF02333864; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Levy MJ, 2005, BRAIN, V128, P1921, DOI 10.1093/brain/awh525; Matharu M, 2008, CURR PAIN HEADACHE R, V12, P132, DOI 10.1007/s11916-008-0025-2; MATHEW NT, 1988, HEADACHE, V28, P297; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; NAPPI G, 1985, HEADACHE DIAGNOSTIC; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Rahmann A, 2003, HEADACHE, V43, P130, DOI 10.1046/j.1526-4610.2003.03031.x; REIK L, 1987, HEADACHE, V27, P509, DOI 10.1111/j.1526-4610.1987.hed2709509.x; Rigamonti A, 2008, HEADACHE, V48, P467, DOI 10.1111/j.1526-4610.2007.01034.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; YOUNG WB, 2005, CHRONIC DAILY HEADAC, P185	20	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUL-AUG	2009	49	7					1059	1061		10.1111/j.1526-4610.2009.01456.x			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467PM	WOS:000267752100014	19496832				2022-02-06	
J	Zetterling, M; Hillered, L; Samuelsson, C; Karlsson, T; Enblad, P; Ronne-Engstrom, E				Zetterling, Maria; Hillered, Lars; Samuelsson, Carolina; Karlsson, Torbjorn; Enblad, Per; Ronne-Engstrom, Elisabeth			Temporal patterns of interstitial pyruvate and amino acids after subarachnoid haemorrhage are related to the level of consciousness-a clinical microdialysis study	ACTA NEUROCHIRURGICA			English	Article						Amino acids; Microdialysis; Pyruvate; Subarachnoid haemorrhage	TRAUMATIC BRAIN-INJURY; NEUROINTENSIVE CARE; INTRACEREBRAL MICRODIALYSIS; GLUCOSE PHOSPHORYLATION; CEREBRAL MICRODIALYSIS; NEUROLOGICAL DEFICITS; CEREBROSPINAL-FLUID; METABOLISM; ISCHEMIA; MECHANISMS	Temporal patterns of brain interstitial amino acids after subarachnoid haemorrhage (SAH) were studied in relation to energy metabolite levels and to the severity of the initial global ischaemia as reflected by the level of consciousness at admission. Intracerebral microdialysis was used to measure brain interstitial amino acids and the energy metabolites glucose, lactate, and pyruvate during five days in 19 patients. Patients who were conscious (n = 11) were compared to those who were unconscious on admission (n = 8). Eight non-transmitter amino acids (alanine, aspargine, glutamine, isoleucine, leucine, phenylalanine, serine and tyrosine), as well as glycine and pyruvate showed a pattern of increasing concentrations starting at 60-70 h after the onset of SAH. The conscious patients showed more pronounced elevations of non-transmitter amino acids, glycine, taurine and pyruvate compared to the unconscious patient group. Pyruvate levels were initially critically low for all patients, then normalised in the conscious patients but remained low in the unconscious group. There was an increase of the cerebral interstitial levels of non-transmitter amino acids and glycine which correlated temporally to pyruvate levels, more pronounced in patients conscious on admission. Pyruvate levels in these patients normalised, but remained reduced in the unconscious patients. The increase of the non-transmitter amino acids and glycine could reflect an increased amino acid turnover in an attempt at repairing the injured brain, which could have been hampered by the lower pyruvate levels. Interstitial pyruvate may be a useful marker of the energy metabolic situation in the acutely injured brain.	[Zetterling, Maria; Hillered, Lars; Samuelsson, Carolina; Enblad, Per; Ronne-Engstrom, Elisabeth] Univ Uppsala Hosp, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden; [Karlsson, Torbjorn] Univ Uppsala Hosp, Dept Surg Anaesthesia & Intens Care, S-75185 Uppsala, Sweden		Zetterling, M (corresponding author), Univ Uppsala Hosp, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden.	maria.zetterling@telia.com		Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Selander Foundation; Uppsala University Hospital	The Swedish Research Council, the Selander Foundation and Uppsala University Hospital supported the study financially.	Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BIELICKI L, 1976, N-S ARCH PHARMACOL, V293, P25, DOI 10.1007/BF00498867; Bosche B, 2003, STROKE, V34, P2908, DOI 10.1161/01.STR.0000100158.51986.EB; Cesarini KG, 1999, J NEUROSURG, V90, P664, DOI 10.3171/jns.1999.90.4.0664; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Dahlbacka S, 2006, HEART SURG FORUM, V9, pE710, DOI 10.1532/HSF98.20061022; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; EDVINSSON K, 2002, CEREBRAL BLOOD FLOW, P162; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Engstrom ER, 2005, NEUROSCI LETT, V384, P7, DOI [10.1016/j.neurlet.2005.04.030, 10.1016/j.neulet.2005.04.030]; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GOLDSMITH JD, 1995, HEARING RES, V83, P80, DOI 10.1016/0378-5955(94)00193-T; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; LEHMANN A, 1991, J NEUROCHEM, V56, P690, DOI 10.1111/j.1471-4159.1991.tb08204.x; LEHMANN A, 1990, TAURINE FUNCTIONAL N, V351, P337; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; NAGELHUS EA, 1994, ADV EXP MED BIOL, V359, P325; O'Kane RL, 2004, AM J PHYSIOL-ENDOC M, V287, pE622, DOI 10.1152/ajpendo.00187.2004; O'Kane RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1167, DOI 10.1152/ajpendo.00193.2003; Ori C, 1997, LIFE SCI, V60, P1349, DOI 10.1016/S0024-3205(97)00080-5; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Runnerstam M, 1997, NEUROL RES, V19, P361, DOI 10.1080/01616412.1997.11740826; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; SAMUELSSON C, 2007, J CEREB; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; VONHOLST H, 1985, ACTA NEUROCHIR, V78, P46, DOI 10.1007/BF01809241	47	13	13	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2009	151	7					771	780		10.1007/s00701-009-0384-4			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	462WL	WOS:000267388600007	19430719				2022-02-06	
J	Afinowi, R; Tisdall, M; Keir, G; Smith, M; Kitchen, N; Petzold, A				Afinowi, R.; Tisdall, M.; Keir, G.; Smith, M.; Kitchen, N.; Petzold, A.			Improving the recovery of S100B protein in cerebral microdialysis: Implications for multimodal monitoring in neurocritical care	JOURNAL OF NEUROSCIENCE METHODS			English	Article						S100B; Protein; Microdialysis; Brain injury; Intensive care; Monitoring	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; SERUM S100B; IN-VITRO; METHODOLOGY; PERFORMANCE; FUTURE	Introduction: Cerebral microdialysis is an established research too] that is used by an increasing number of neurocritical care units as a component of bedside multimodality monitoring. Body fluid biomarkers are an emerging tool for the assessment of brain injury. The correct interpretation of body fluid biomarker levels depends on the degree of recovery, i.e. relative recovery and the accuracy of the analytical technique. Methods: In vitro recovery experiments were performed on 100 mL volumes of cerebrospinal fluid and solutions of S100B, glucose, lactate and pyruvate comparing relative recoveries using commercially available 20 kDa (CMA70) and 100 kDa (CMA71) microdialysis catheters. We also compared the CMA 600 microdialysis analyzer with a YSI 2003 STAT Plus (TM) analyzer for glucose and lactate to determine its reliability. Results: Significantly, we demonstrate the improved recovery of the protein S100B using a larger molecular weight (MW) cut-off catheter (20 kDa range: 0.1-9%; 100 kDa range: 1.7-18.3%) while maintaining comparable performance for the conventional markers glucose, lactate and pyruvate. Additionally we found that the CMA 600 analyzer may be prone to overestimation of lactate readings at higher concentration with implications for clinical decision-making. Conclusion: Our data demonstrates that the 100 kDa MW cut-off catheter allows for the improved recovery of macromolecules in cerebral microdialysis research while maintaining the value of existing MD data for routine clinical use. (C) 2009 Published by Elsevier B.V.	[Afinowi, R.; Tisdall, M.; Keir, G.; Kitchen, N.] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England; [Afinowi, R.; Petzold, A.] UCL Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England; [Tisdall, M.; Smith, M.; Petzold, A.] Natl Hosp Neurol & Neurosurg, Dept Neuroanaesthesia, London WC1N 3BG, England		Afinowi, R (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Box 31, London WC1N 3BG, England.	R.Afinowi@ion.ucl.ac.uk	Smith, Martin/B-2616-2009; Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Tisdall, Martin/0000-0001-8880-8386	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701458] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701458] Funding Source: UKRI		Abrahamsson P, 2005, J PHARMACEUT BIOMED, V39, P730, DOI 10.1016/j.jpba.2005.04.036; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; *CMA MICR, 2004, 2 CMA MICR; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; GREEN AJ, 1999, BRAIN SPECIFIC PROTE; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; HILLMAN J, 2006, ACTA NEUROCHIR WIEN, V19, P19; Hutchinson PJ, 2006, NEUROCRIT CARE, V5, P202, DOI 10.1385/NCC:5:3:202; Hutchinson PJ, 2005, ACTA NEUROCHIR SUPPL, V95, P441; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; Larsen FS, 2006, NEUROCRIT CARE, V5, P173, DOI 10.1385/NCC:5:3:173; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Maurer Martin H, 2003, Proteome Sci, V1, P7, DOI 10.1186/1477-5956-1-7; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosenbloom AJ, 2006, J IMMUNOL METHODS, V309, P55, DOI 10.1016/j.jim.2005.11.013; Rosenbloom AJ, 2005, J NEUROSCI METH, V148, P147, DOI 10.1016/j.jneumeth.2005.04.018; Sakowitz OW, 2002, ACT NEUR S, V81, P351; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schutte RJ, 2004, ANAL CHEM, V76, P6058, DOI 10.1021/ac0493626; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; TISDALL MM, 2006, BRIT J ANAESTH, V12, P12; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	36	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUN 30	2009	181	1					95	99		10.1016/j.jneumeth.2009.02.021			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	463RT	WOS:000267450300013	19467712				2022-02-06	
J	Barklin, A; Tonnesen, E; Ingerslev, J; Sorensen, B; Fenger-Eriksen, C				Barklin, Anne; Tonnesen, Else; Ingerslev, Jorgen; Sorensen, Benny; Fenger-Eriksen, Christian			Coagulopathy during Induced Severe Intracranial Hypertension in a Porcine Donor Model	ANESTHESIOLOGY			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; BRAIN-DEATH; TISSUE FACTOR; HEAD-INJURY; INFLAMMATORY RESPONSE; PROFILES; PLASMA	Background: Development of coagulopathy is a serious complication arising from isolated traumatic brain injury, and it predicts poor outcome. The underlying mechanism has not yet been established, although coagulopathy arising from brain tissue injury and the release of tissue factor may represent the pathophysiology. The authors investigated dynamic whole-blood clot formation (ROTEM(R)) in a recently developed porcine model of induced severe intracranial hypertension. Methods: In this prospective, randomized experimental study, 17 pigs were designated for severe intracranial hypertension or sham operation. Intracranial hypertension was induced by inflation of an intracranial balloon. Whole-blood clot formation was assessed by clot initiation, and clot propagation and clot strength through thrombelastometry. The authors also assessed thrombin generation and prothrombin time, which were obtained at baseline, immediately after intervention, and 5 h after intervention. Results: A dramatic shortening in time to clot initiation and an increase in clot propagation were observed after induction of intracranial hypertension as compared to the control group. These results were further substantiated by a pronounced increase in thrombin generation and a significantly shortened prothrombin time in the intervention group. No difference in clot strength was detected between the groups. Conclusions: In a porcine model, induction of increased intracranial pressure causing severe intracranial hypertension was associated with a pronounced activation of the coagulation system. Taken together, the various results indicate that tissue factor probably represents the main trigger of hypercoagulopathy found in these pigs.	[Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, DK-8200 Aarhus N, Denmark; [Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, Skejby, Denmark; [Ingerslev, Jorgen; Sorensen, Benny; Fenger-Eriksen, Christian] Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Clin Biochem, Skejby, Denmark; [Sorensen, Benny] Guys & St Thomas Hosp, Ctr Haemostasis & Thrombosis, London SE1 9RT, England		Fenger-Eriksen, C (corresponding author), Aarhus Univ Hosp, Ctr Haemophilia & Thrombosis, Dept Anesthesiol, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	chfen@dadlnet.dk		Fenger-Eriksen, Christian/0000-0003-0536-560X	Aarhus University [100301]; Faculty of Health Science, Institute of Clinical Medicine, Denmark	Received from the Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark. Submitted for publication October 7, 2008. Accepted for publication January 28, 2009, Supported by all Unrestricted grant (project number 100301) from Aarhus University, Faculty of Health Science, Institute of Clinical Medicine, Denmark.	Barklin A, 2008, ACTA ANAESTH SCAND, V52, P628, DOI 10.1111/j.1399-6576.2008.01606.x; Barklin A, 2008, ACTA ANAESTH SCAND, V52, P621, DOI 10.1111/j.1399-6576.2008.01607.x; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chen EP, 1996, CRIT CARE MED, V24, P1352, DOI 10.1097/00003246-199608000-00014; Clark R, 1997, VET ECON, V38, P41; Esmon CT, 2004, THROMB RES, V114, P321, DOI 10.1016/j.thromres.2004.06.028; Fenger-Eriksen C, 2005, BRIT J ANAESTH, V94, P324, DOI 10.1093/bja/aei052; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kozek-Langenecker SA, 2005, ANESTHESIOLOGY, V103, P654, DOI 10.1097/00000542-200509000-00031; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Larsen OH, 2007, ANN HEMATOL, V86, P217, DOI 10.1007/s00277-006-0223-0; Lwaleed BA, 2007, BIOL RES NURS, V9, P97, DOI 10.1177/1099800407305733; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; O'Donnell J, 2004, BLOOD COAGUL FIBRIN, V15, P207, DOI 10.1097/00001721-200404000-00002; Papa M. L., 2007, Experimental Oncology, V29, P111; Pasternak JJ, 2008, J NEUROSURG ANESTH, V20, P15, DOI 10.1097/ANA.0b013e318155b1c4; PFENNINGER J, 1982, Z KINDERCHIR, V37, P53; Poulsen LH, 2006, SCAND J CLIN LAB INV, V66, P329, DOI 10.1080/00365510600672783; Pratschke J, 2005, TRANSPLANT INT, V18, P15, DOI 10.1111/j.1432-2277.2004.00018.x; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Roelsgaard K, 1996, HEPATOLOGY, V24, P871; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Sorensen B, 2005, HAEMOPHILIA, V11, P1, DOI 10.1111/j.1365-2516.2005.01156.x; Sorensen B, 2004, SEMIN HEMATOL, V41, P140, DOI 10.1053/j.seminhematol.2003.11.024; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003	31	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUN	2009	110	6					1287	1292		10.1097/ALN.0b013e3181a10352			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	450ET	WOS:000266384500015	19417611	Bronze			2022-02-06	
J	Rhodes, J; Sharke, J; Andrews, P; Stahel, PF; Flierl, MA; Smith, WR				Rhodes, Jonathan; Sharke, John; Andrews, Peter; Stahel, Philip F.; Flierl, Michael A.; Smith, Wade R.			Serum IL-8 and MCP-1 Concentration Do Not Identify Patients With Enlarging Contusions After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cerebral contusion; IL-8; MCP-1; Outcome; TBI	CLOSED-HEAD INJURY; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; RAT-BRAIN; INFLAMMATORY RESPONSE; INTERLEUKIN-8; CHEMOKINES; DAMAGE; PLASMA; ACCUMULATION	Background. Cerebral contusions contain numerous leukocytes, and a temporal relationship exists among cerebral chemokine expression, leukocyte recruitment, and contusion enlargement. This would suggest a role for chemokines in contusion development However, it has not been established if serum concentrations of chemokines such as interleukin-8 (IL-8) or monocyte chemoattractant protein-1 (MCP-1) change with contusion enlargement. Methods. Eighteen adult patients with severe contusional traumatic brain injury, on computerized tomography, were identired. Patients with diffuse injuries or extradural and subdural hematomas associated with mass effect were not included in the study. Daily serum samples were taken for the measurement of EL-8 and MCP-I concentrations for up to 11 days postinjury. Results. In the patients who died while in intensive care, IL-8 and MCP-1 were significantly greater than in those patients discharged (18 [0-202] vs. 0 [0-156] pg/mL and 498 [339-1,063] vs. 368 [86-11,289] pg/mL for IL-8 and MCP-I, respectively). No difference was seen in serum chemokine levels in patients who deteriorated with contusion enlargement compared with those that did not. The IL-8 and MCP-1 concentrations did not change significantly over time either in the group as a whole or in the subgroup of patients who deteriorated. Conclusions: These inflammatory mediators may be predictive of a poor outcome in patients with traumatic brain injury in which contusions are the predominant abnormality. However, they do not distinguish those patients who will deteriorate because of contusion enlargement.	[Rhodes, Jonathan] Univ Edinburgh, Intens Care Unit, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Sharke, John] Univ Dundee, Ninewells Hosp & Med Sch, Sch Life & Sci Res, Dundee DD1 9SY, Scotland; [Stahel, Philip F.; Flierl, Michael A.; Smith, Wade R.] Univ Colorado, Sch Med, Dept Orthopaed Surg, Denver Hlth Med Ctr, Denver, CO USA		Rhodes, J (corresponding author), Univ Edinburgh, Intens Care Unit, Western Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	j.k.j.rhodes@sms.ed.ac.uk		Sharkey, John/0000-0001-8288-1857			Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Castellanos M, 2002, STROKE, V33, P982, DOI 10.1161/hs0402.105339; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CSUKA E, 1997, SHOCK S, V8, P6; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; FREVERT CW, 1995, INFLAMMATION, V19, P133, DOI 10.1007/BF01534386; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Losy J, 2001, STROKE, V32, P2695, DOI 10.1161/hs1101.097380; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Muller M, 2001, Eur J Ultrasound, V12, P203, DOI 10.1016/S0929-8266(00)00118-X; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; Soares HD, 1995, J NEUROSCI, V15, P8223; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	35	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2009	66	6					1591	1598		10.1097/TA.0b013e31819a0344			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	457PN	WOS:000266944500012	19509619				2022-02-06	
J	Bailey, CM; Barth, JT; Bender, SD				Bailey, Christopher M.; Barth, Jeffrey T.; Bender, Scott D.			SLAM on the Stand: How the Sports-Related Concussion Literature Can Inform the Expert Witness	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; forensic neuropsychology; sports	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; HIGH-SCHOOL; POSTCONCUSSION-SYNDROME; ACCIDENT NEUROSIS; FOOTBALL PLAYERS; SYMPTOM REPORT; CHRONIC PAIN; RECOVERY; PERFORMANCE	Mild head injury is a controversial topic because patients may have subtle deficits and widely varied outcomes. Accordingly, neuropsychologists are frequently asked to provide expert testimony about the nature of mild head injury. This article discusses how the sports-related concussion literature, including the concept of baseline assessment, can inform expert witnesses who are asked to provide such testimony. We first provide a review of several of the controversies surrounding mild head injury, both within and outside of the forensic context. This is followed by a review of the sports as a laboratory assessment model literature, which demonstrates consistent and meaningful evidence of cognitive sequelae following mild head injury. We conclude with a description of how the sports as a laboratory assessment model literature may be utilized in a forensic neuropsychology context to address some of the identified controversies. We end with a call for more research that will further inform the forensic neuropsychologist about mild head injury and those factors that may result in poor recovery.	[Bailey, Christopher M.; Barth, Jeffrey T.; Bender, Scott D.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA		Bailey, CM (corresponding author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, POB 800203, Charlottesville, VA 22908 USA.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BARTH JT, 2002, ENCY HUMAN BRAIN, V3, P81; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER RL, 1991, AM J PSYCHIAT, V148, P1073; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ECHEMENDIA RJ, 1997, M NAT AC NEUR LAS VE; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FRANZEN MD, 2006, CLIN NEUROPSYCHOLOGY, P102; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVY A, 1992, Brain Injury, V6, P401, DOI 10.3109/02699059209008136; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P405; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; [No title captured]	65	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2009	24	2					123	130		10.1097/HTR.0b013e31819c1caa			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427WF	WOS:000264809100006	19333067				2022-02-06	
J	Seckin, H; Ates, O; Bauer, AM; Baskaya, MK				Seckin, Hakan; Ates, Oezkan; Bauer, Andrew M.; Baskaya, Mustafa K.			Microsurgical anatomy of the posterior spinal artery via a far-lateral transcondylar approach	JOURNAL OF NEUROSURGERY-SPINE			English	Article						far-lateral approach; posterior inferior cerebellar artery; posterior spinal artery; spinal cord; vertebral artery	INFERIOR CEREBELLAR ARTERY; FORAMEN-MAGNUM; PARACONDYLAR EXTENSIONS; VERTEBRAL ARTERY; TECHNICAL NOTE; LESIONS; CORD; SUPRACONDYLAR; INFARCTION; VARIANTS	Object. The posterior spinal artery (PSA) is a clinically significant vessel that may frequently be encountered during the far-lateral transcondylar approach. There have been a limited number of reports on the specific origin of the PSA in the literature. The aim of this study was to demonstrate the origin of the PSA. Methods. Thirteen cadaveric heads (26 sides) were injected with colored silicon. A bilateral far-lateral transcondylar approach was performed on each side. In every specimen the site of the origin of the PSAs, as well as their course, branching pattern and anastomoses, external diameters, and neighboring vascular and nervous structures were recorded. Microanatomical dissections were performed using the surgical microscope. In addition, 8 surgical cases in which the far-lateral approach was used were collected prospectively to record the course and origin of the PSA. Altogether, a total of 34 sides were analyzed for their PSA origin and course. Results. In the cadaveric specimens, the PSA was found to originate from the vertebral artery (VA) in 25 sides (96%). In 13 specimens (50%) the PSA originated from the V-4 segment of the VA intradurally. In 12 specimens (46%) the PSA originated from the V-3 segment of the VA extradurally. In 1 specimen (4%), in whom the posterior inferior cerebellar artery (PICA) had an early origin from the VA extradurally at the C-I level, the PSA originated from the PICA. Of the 8 surgical cases, 2 patients had extradural origin of the PSA from the V, segment of the VA, whereas 6 patients had intradural origin of the PSA from the V-4 segment. Conclusions. Although the usual origin of the PSA is from the VA either intra- or extradurally, its origin is closely related to the origin of the PICA. The PSA originates from the PICA in cases in which the PICA originates extradurally from the VA. In the far-lateral transcondylar approach, the dura is opened in close proximity to the VA. Knowledge of the origin and course of the PSA is critically important when executing the far-lateral approach to avoid its injury. (DOI: 10.3171/2008.12.SPINE08289)	[Seckin, Hakan; Ates, Oezkan; Bauer, Andrew M.; Baskaya, Mustafa K.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA		Baskaya, MK (corresponding author), Univ Wisconsin Hosp & Clin, Dept Neurol Surg, 600 Highland Ave,UWHC Neurosurg F4-315,CSC-8660, Madison, WI 53792 USA.	m.baskaya@neurosurg.wisc.edu		Bauer, Andrew/0000-0001-9458-6951			Bergqvist CAG, 1997, NEUROLOGY, V48, P1112, DOI 10.1212/WNL.48.4.1112; Bruneau M, 2008, NEUROSURG REV, V31, P19, DOI 10.1007/s10143-007-0097-1; DEOLIVEIRA E, 1985, SURG NEUROL, V24, P293, DOI 10.1016/0090-3019(85)90042-4; Fine AD, 1999, J NEUROSURG, V91, P645, DOI 10.3171/jns.1999.91.4.0645; GEORGE B, 1995, SKULL BASE SURG, V5, P9, DOI 10.1055/s-2008-1058945; GEORGE B, 1988, SURG NEUROL, V29, P484, DOI 10.1016/0090-3019(88)90145-0; HEROS RC, 1986, J NEUROSURG, V64, P559, DOI 10.3171/jns.1986.64.4.0559; Huber P, 1982, CEREBRAL ANGIOGRAPHY; Ito S, 2005, J NEUROL, V252, P850, DOI 10.1007/s00415-005-0758-3; KANEKI M, 1994, J NEUROL NEUROSUR PS, V57, P629, DOI 10.1136/jnnp.57.5.629; Kawashima M, 2003, NEUROSURGERY, V53, P662, DOI 10.1227/01.NEU.0000080070.16099.BB; LASJAUNIAS P, 1985, J NEUROSURG, V63, P235, DOI 10.3171/jns.1985.63.2.0235; LASJAUNIAS P, 2001, SURG NEUROANGIOGRAPH, V1, P135; LISTER JR, 1982, NEUROSURGERY, V10, P170; Macchi V, 2004, SURG RADIOL ANAT, V26, P60, DOI 10.1007/s00276-003-0190-2; MAILLOT C, 1970, C R ASSOC ANAT, V149, P837; MARGOLIS MT, 1974, RADIOLOGY SKULL BRAI, V2, P1710; Mascalchi M, 1998, AM J NEURORADIOL, V19, P361; Nanda A, 2002, J NEUROSURG, V96, P302, DOI 10.3171/jns.2002.96.2.0302; NEWTON TH, 1974, RADIOLOGY SKULL BRAI, V2, P1659; Osborn AG, 1999, DIAGNOSTIC CEREBRAL; Rhoton AL, 2000, NEUROSURGERY, V47, pS195, DOI 10.1097/00006123-200009001-00020; Rhoton AL., 2003, CRANIAL ANATOMY SURG; Sanan A, 1999, NEUROSURGERY, V45, P1267, DOI 10.1097/00006123-199911000-00058; SCHECHTER MM, 1966, ACTA RADIOL DIAGN, V5, P1124, DOI 10.1177/02841851660050P256; Siclari F, 2007, AM J NEURORADIOL, V28, P1185, DOI 10.3174/ajnr.A0498; Stopford JSB, 1916, J ANAT PHYSIOL, V50, P131; Wen HT, 1997, J NEUROSURG, V87, P555, DOI 10.3171/jns.1997.87.4.0555; WILLIAMS P, 1985, GRAYS ANATOMY, P751; YASARGIL MG, 1984, MICRONEUROSURGERY, V1, P130	30	13	15	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2009	10	3					228	233		10.3171/2008.12.SPINE08289			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	414MN	WOS:000263868200009	19320582				2022-02-06	
J	Wan, JJ; Cohen, MJ; Rosenthal, G; Haitsma, IK; Morabito, DJ; Derugin, N; Knudson, MM; Manley, GT				Wan, Jennifer J.; Cohen, Mitchell J.; Rosenthal, Guy; Haitsma, Iain K.; Morabito, Diane J.; Derugin, Nikita; Knudson, M. Margaret; Manley, Geoffrey T.			Refining Resuscitation Strategies Using Tissue Oxygen and Perfusion Monitoring in Critical Organ Beds	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	38th Annual Meeting of the Western-Trauma-Association	FEB 24-MAR 01, 2008	Squaw Creek, CA	Western Trauma Assoc			HEMORRHAGIC-SHOCK; PRESSURE; PROTOCOL; TENSION	Background: Muscle tissue oxygen monitoring (Pmo(2)) holds promise as a continuous guide to resuscitation after hemorrhagic shock, but the relationship of muscle tissue oxygen to perfusion has not been described previously. On the other hand, brain tissue oxygen PbrO(2), and perfusion as measured by cerebral blood flow (CBF) are already used clinically, especially as guides to vasopressor use in cerebral perfusion targeted therapy in patients with traumatic brain injury. This laboratory study was undertaken to describe the relative contributions of muscle perfusion and arterial oxygen tension (Pao(2)) to muscle tissue oxygen (Pmo(2)) levels. Second, we wanted to compare the relationship between muscle oxygen and muscle blood flow (MBF) with simultaneously measured brain tissue oxygen and perfusion during the administration of a vasopressor and during experimental hemorrhagic shock. We hypothesized that muscle perfusion would be an important contributor to Pmo(2) thus underscoring the need for optimal fluid resuscitation after shock. We further hypothesized that Pmo(2) would decrease even as Pbro(2), increased when vasopressor therapy was used. Methods: Eight pigs were anesthetized, intubated, underwent splenectomies, and were instrumented to monitor Pmo(2) MBF, Pbro(2), and CBF. Oxygen challenges were performed by increasing Pao(2), from 100 to 500 mm Hg during three different experimental phases: baseline, vasopressor administration, and hemorrhage. Mean Pmo(2) and MBF were compared at the beginning and end of each experimental phase and correlations between Pmo(2) MBF, Pbro(2) CBF, and traditional endpoints of resuscitation were investigated. Results: During oxygen challenges in all phases, Pmo(2) increased (31.2 +/- 16.6 mm Hg to 56.6 +/- 34.1 mm Hg; p < 0.01), whereas MBF did not change significantly (16.4 +/- 11.3 mL/100 g/min to 15.4 +/- 11.9 mL/100 g/min). On administration of vasopressors, MBF decreased (18 +/- 8.8 mL/100 g/min to 5.3 +/- 3 mL/100 g/min; p = 0.03), but no change in Pmo(2), was detected. During hemorrhage, both Pmo(2) and MBF declined (Pmo(2): 40 +/- 8.8 mm Hg to 7.7 +/- 9.6 mm Hg; p = 0.002; MBF: 9.8 +/- 5.8 mL/100 g/min to 3.3 +/- 2.4 mL/100 g/min; p = 0.046). Both Pmo(2) and MBF showed strong relationships with measurements of resuscitation, base deficit (Pmo(2) and MBF: p < 0.01), and mean arterial pressure (Pmo(2): P < 0.01, MBF: p = 0.02). Like Pmo(2) and MBF, Pbro(2), and CBF decreased uniformly during hemorrhage. However, on vasopressor administration, CBF and Pbro(2) increased significantly, whereas MBF decreased. Conclusion: Pmo(2) and MBF can be monitored simultaneously and continuously and correlate well with measurements of resuscitation. Pmo(2) values reflect both local perfusion and arterial oxygen tension. The clinical application of Pmo(2) as a continuous endpoint of resuscitation and its relationship to muscle perfusion warrants further study in critically injured patients and these investigations may help to refine resuscitation strategies.	[Wan, Jennifer J.; Cohen, Mitchell J.; Morabito, Diane J.; Knudson, M. Margaret] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Rosenthal, Guy; Haitsma, Iain K.; Derugin, Nikita; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; San Francisco Injury Ctr Res & Prevent, San Francisco, CA USA		Knudson, MM (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A, 1001 Potrero Ave, San Francisco, CA 94110 USA.	pknudson@sfghsurg.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008258] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM08258] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR90369] Funding Source: Medline		*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BUCKMAN RF, 1994, J TRAUMA, V36, P856; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Knudson MM, 1997, J TRAUMA, V42, P608, DOI 10.1097/00005373-199704000-00005; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Lee SK, 2002, ACAD EMERG MED, V9, P969; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; McKinley BA, 1998, J TRAUMA, V44, P119, DOI 10.1097/00005373-199801000-00015; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sims C, 2001, J TRAUMA, V51, P1137, DOI 10.1097/00005373-200112000-00020; WAXMAN K, 1994, J TRAUMA, V36, P852, DOI 10.1097/00005373-199406000-00016	16	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2009	66	2					353	357		10.1097/TA.0b013e318195e222			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	408NX	WOS:000263442800009	19204507				2022-02-06	
J	Corral, L; Herrero, JI; Monfort, JL; Ventura, JL; Javierre, CF; Juncadella, M; Garcia-Huete, L; Bartolome, C; Gabarros, A				Corral, Luisa; Ignacio Herrero, Jose; Luis Monfort, Jose; Luis Ventura, Jose; Javierre, Casimiro F.; Juncadella, Montserrat; Garcia-Huete, Lucia; Bartolome, Carlos; Gabarros, Andreu			First CT findings and improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury	BRAIN INJURY			English	Article						Severe traumatic brain injury; Glasgow Outcome Scale; Glasgow Coma Scale; computerized tomography; prognosis	SEVERE HEAD-INJURY; GLASGOW-OUTCOME-SCALE; EARLY COMPUTED-TOMOGRAPHY; DECISION-TREE ANALYSIS; TERM FOLLOW-UP; COMA DATA-BANK; INTRAVENTRICULAR HEMORRHAGE; STRUCTURED INTERVIEWS; MULTICENTER TRIAL; RATING-SCALE	Primary objective: To analyse the association between individual initial computerized tomography (CT) scan characteristics and Glasgow Outcome Scale (GOS) and Extended Glasgow Outcome Scale (GOSE) improvement between 6 months and 1 year. Methods and procedures: Two hundred and twenty-four adult patients with severe traumatic brain injury and Glasgow Coma Scale (GCS) score of 8 or less who were admitted to an intensive care unit were studied. GOS and GOSE scores were obtained 6 and 12 months after injury in 203 subjects. Patients were predominantly male (84%) and median age was 35 years. Main outcomes and results: Traumatic Coma Data Bank (TCDB) CT classification was associated with GOS/GOSE improvement between 6 months and 1 year, with diffuse injury type I, type II and evacuated mass improving more than diffuse injury type III, type IV and non-evacuated mass; for GOS 43/155 (28%) vs 3/48 (6%) (2 = 9.66, p 0.01) and for GOSE 71/155 (46%) vs 7/48 (15%) (2 = 15.1, p 0.01). CT individual abnormalities were not associated with GOS/GOSE improvement, with the exception of subarachnoid haemorrhage, which showed a negative association with GOSE improvement (2 = 4.08, p 0.05). Conclusions: TCDB CT scan classification and subarachnoid haemorrhage were associated with GOS/GOSE improvement from 6-12 months, but individual CT abnormalities were not associated.	[Corral, Luisa; Ignacio Herrero, Jose; Luis Ventura, Jose] Bellvitge Univ Hosp, Intens Care Unit, Barcelona 08907, Spain; [Luis Monfort, Jose] Bellvitge Univ Hosp, Dept Neuroradiol, Barcelona 08907, Spain; [Javierre, Casimiro F.] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [Juncadella, Montserrat] Bellvitge Univ Hosp, Dept Neuropsychol, Barcelona 08907, Spain; [Garcia-Huete, Lucia; Bartolome, Carlos] Bellvitge Univ Hosp, Dept Anaesthesiol, Barcelona 08907, Spain; [Gabarros, Andreu] Bellvitge Univ Hosp, Dept Neurosurg, Barcelona 08907, Spain		Corral, L (corresponding author), Bellvitge Univ Hosp, Intens Care Unit, Feixa Llarga S-N, Barcelona 08907, Spain.	lcorral@bellvitgehospital.cat		Corral, Luisa/0000-0002-2888-7833			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CHESTNUT RM, 2000, GUIDELINES MANAGEMEN; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GENARELLI TA, 1982, J NEUROSURG, V56, P26; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Woischneck D, 1998, ACT NEUR S, V71, P138	44	13	13	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	5					403	410	PII 909709429	10.1080/02699050902788477			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439NL	WOS:000265633700004	19301165				2022-02-06	
J	Han, SD; Suzuki, H; Drake, AI; Jak, AJ; Houston, WS; Bondi, MW				Han, S. Duke; Suzuki, Hideo; Drake, Angela I.; Jak, Amy J.; Houston, Wes S.; Bondi, Mark W.			Clinical, Cognitive, and Genetic Predictors of Change in Job Status Following Traumatic Brain Injury in a Military Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						apolipoprotein E; military; neurocognition; optimal data analysis; traumatic brain injury	APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; GENOTYPE; ASSOCIATION; DEPOSITION; EPSILON-4; PROTEIN; ALLELE	Objective: Traumatic brain injury (TBI) is a risk associated with military duty, and residual effects from TBI may adversely affect a service member's ability to complete duties. It is, therefore, important to identify factors associated with a change in job status following TBI in an active military population. On the basis of previous research, we predicted that apolipoprotein E (APOE) genotype may be 1 factor. Design: Cohort study of military personnel who sustained a mild to moderate TBI. Setting: Military medical clinics. Patients or Other Participants: Fifty-two military participants were recruited through the Defense and Veterans Brain Injury Center, affiliated with Naval Medical Center San Diego and the Defense and Veterans Brain Injury Center Concussion Clinic located at the First Marine Division at Camp Pendleton. Intervention(s): A multivariate statistical classification approach called optimal data analysis allowed for consideration of APOE genotype alongside cognitive, emotional, psychosocial, and physical functioning. Main Outcome Measure(s): APOE genotype, neuropsychological, psychosocial, and clinical outcomes. Results: We identified a model of factors that was associated with a change in job status among military personnel who experienced a mild or moderate TBI. Conclusions: Factors associated with a change in job status are different when APOE genotype is considered. We conclude that APOE genotype may be an important genetic factor in recovery from mild to moderate head injury.	[Han, S. Duke; Suzuki, Hideo] Loyola Univ, Dept Psychol, Chicago, IL 60626 USA; [Han, S. Duke] Loyola Univ, Med Ctr, Dept Neurol, Maywood, IL 60153 USA; [Han, S. Duke] Loyola Univ, Med Ctr, Inst Neurosci, Maywood, IL 60153 USA; [Jak, Amy J.; Bondi, Mark W.] Univ Calif San Diego, Dept Psychiat, San Diego Sch Med, San Diego, CA 92103 USA; [Jak, Amy J.; Bondi, Mark W.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Drake, Angela I.] USN, Dept Neurosci, Def & Vet Brain Injury Ctr, Med Ctr, San Diego, CA 92152 USA; [Houston, Wes S.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Houston, Wes S.] VA Cincinnati Healthcare Syst, Cincinnati, OH USA		Han, SD (corresponding author), Loyola Univ, Dept Psychol, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	dhan2@luc.edu	Han/N-1246-2019		Medical Research Service of the Department of Veterans AffairsUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG026431] Funding Source: NIH RePORTER	This work was supported by a merit review research program from the Medical Research Service of the Department of Veterans Affairs and by the Defense and Veterans Brain Injury Center; resources and use of facilities were also provided by the Naval Medical Center San Diego. The authors gratefully acknowledge the staff, patients, and volunteers at Naval Medical Center San Diego and US Marine Corps Base Camp Pendleton for their assistance with this study.	Arendt T, 1997, J NEUROSCI, V17, P516; BELANGER HG, J INT NEURO IN PRESS; BLOSS CS, NEUROBIOL A IN PRESS; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS D N, 1975, Cortex, V11, P329; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Graham DI, 1999, CELL MOL NEUROBIOL, V19, P19, DOI 10.1023/A:1006937205905; GRONWALL D, 1975, LANCET, V2, P995; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KELTIKANGASJARVINEN L, 1993, PSYCHOSOM MED, V55, P155, DOI 10.1097/00006842-199303000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; SOLTYSIK RC, 1993, ODA 1 0 OPTIMAL DATA; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yarnold PR, 1997, STAT MED, V16, P1451, DOI 10.1002/(SICI)1097-0258(19970715)16:13&lt;1451::AID-SIM571&gt;3.0.CO;2-F; Yarnold PR, 2005, OPTIMAL DATA ANAL GU	36	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					57	64		10.1097/HTR.0b013e3181957055			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500009	19158597	Green Accepted			2022-02-06	
J	Yoganandan, N; Maiman, DJ; Guan, YB; Pintar, F				Yoganandan, Narayan; Maiman, Dennis J.; Guan, Yabo; Pintar, Frank			Importance of Physical Properties of the Human Head on Head-Neck Injury Metrics	TRAFFIC INJURY PREVENTION			English	Article						Sled test; Injury; Spine injury; Crashworthiness; Side impact; Three-dimensional	CERVICAL-SPINE; NORMAL RANGE; WHIPLASH; DRIVERS; ACCELERATIONS; KINEMATICS; MOTION; PAIN	Objectives: To demonstrate the importance of using specimen-specific head physical properties in head-neck dynamics. Methods: Eight postmortem human subjects were subjected to side impact. A 9-axis accelerometer package was used to obtain head translational accelerations. After test, the head was isolated at the skull base, circumference, breadth, and length were obtained, and mass, center of gravity, and occipital condylar locations and moments of inertia were determined. Using specimen-specific and gathered accelerations, 3-dimensional head center of gravity accelerations and forces and moments at the occipital condyles were computed. Head physical properties were also extracted from regression equations using external dimensions of each subject. Using these properties and gathered kinematics, above-described accelerations and forces and moments were computed and compared with specimen-specific results. Results: Head masses predicted by stature and total body mass were more in close agreement with specimen-specific data than head masses predicted by head circumference or head circumference and head length. The center of gravity to the occipital condyle vector was shorter in the literature-based dataset than the actual specimen-specific vector. Differences in moments of inertias between predicted and specimen-specific data ranged from -15 to 59 percent. Variations in peak antero-posterior shear, lateral shear, and axial force ranged from -12 to 46 percent, -21 to 78 percent, and -17 to 50 percent. Differences in peak lateral moment, sagittal moment, and axial torque ranged from -45 to 78 percent, -86 to 327 percent, and -96 to 112 percent. These were normalized using specimen-specific data. Conclusions: Considerable variations in physical properties and injury metrics between data obtained from literature-based regression equations and actual data for each specimen suggest the critical importance of specimen-specific data to accurately describe the biodynamic response and establish tolerance criteria. Because neck dynamics control head kinematics (and vice versa), these results emphasize the need to determine physical properties of each specimen following impact tests.	[Yoganandan, Narayan; Maiman, Dennis J.; Guan, Yabo; Pintar, Frank] Med Coll Wisconsin, VA Med Ctr, Milwaukee, WI 53226 USA		Yoganandan, N (corresponding author), Med Coll Wisconsin, VA Med Ctr, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	yoga@mcw.edu			VA Medical ResearchUS Department of Veterans Affairs; Federal Aviation Administration	This study was supported in part by VA Medical Research and the Federal Aviation Administration. The assistance of John Humm is gratefully acknowledged.	BACKAITIS SH, 1993, BIOMECHANICS IMPACT; Beier G., 1980, IRCOBI C BIRM UK, P218; Chapline JF, 2000, ACCIDENT ANAL PREV, V32, P287, DOI 10.1016/S0001-4575(99)00126-8; Clark CR, 1998, CERVICAL SPINE; Clauser CE, 1969, WEIGHT VOLUME CTR MA; Cusick JF, 2001, SPINE, V26, P1252, DOI 10.1097/00007632-200106010-00015; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; EWING C, 1978, P 22 STAPP CAR CRASH, P103; Ewing C. L., 1973, P 17 STAPP CAR CRASH, V17, P309, DOI 10.4271/730976; Ewing CL, 1977, SAE INT, P549; EWING CL, 1975, P 19 STAPP CAR CRASH, P487; HALL MC, 1965, LUSCHKAS JOINT; HEITPLATZ F, 2003, P 18 TECHN C ENH SAF, P1; Kallieris D, 1996, SHOCK VIB, V3, P337, DOI 10.1155/1996/878572; KALLIERIS D, 1981, P STAPP CAR CRASH C; Kim A, 2003, Stapp Car Crash J, V47, P489; KIM A, 2000, FRONTIERS WHIPLASH T, P435; Kleinberger M, 1998, DEV IMPROVED INJURY; Kumaresan S, 1997, BIO-MED MATER ENG, V7, P221; Kumaresan S, 1999, MED ENG PHYS, V21, P689, DOI 10.1016/S1350-4533(00)00002-3; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; McIntosh AS, 2007, ACCIDENT ANAL PREV, V39, P326, DOI 10.1016/j.aap.2006.09.001; MELVIN JW, 1985, REV BIOMECHANICAL IM; Mertz H. J., 1967, THESIS WAYNE STATE U; Myers Barry S., 1995, Critical Reviews in Biomedical Engineering, V23, P307; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Philippens M., 2000, P IRCOBI MONTP FRANC, P363; Pintar FA, 1998, SPINE, V23, P1957, DOI 10.1097/00007632-199809150-00007; Pintar Frank A, 2005, Stapp Car Crash J, V49, P33; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Schmera G, 2002, FLUCT NOISE LETT, V2, pL117, DOI 10.1142/S0219477502000695; Stemper BD, 2004, SPINE, V29, P1764, DOI 10.1097/01.BRS.0000134563.10718.A7; Stemper BD, 2003, J BIOMECH, V36, P1281, DOI 10.1016/S0021-9290(03)00159-3; Stemper BD, 2007, P IRCOBI, P249; Thunnissen J, 1995, P 39 STAPP CAR CRASH, P439, DOI [DOI 10.4271/952721, 10.4271/952721]; VANDENKROONENBE.A, 1998, P 42 STAPP CAR CRASH, P207; Viano David C, 2003, Traffic Inj Prev, V4, P228, DOI 10.1080/15389580309880; WALKER LB, 1973, P 17 STAPP CAR CRASH, P525; Winkelstein BA, 1998, BIOM HLTH R, V21, P266; WISMANS J, 1983, P 27 STAPP CAR CRASH, P137; WISMANS J, 1987, P 31 STAPP CAR CRASH, P1; WISMANS J, 1986, P 30 STAPP CAR CRASH, P131; WISMANS J, 1984, P 28 STAPP CAR CRASH, P161; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016; Yoganandan N, 1999, SPINE, V24, P83, DOI 10.1097/00007632-199901010-00021; Yoganandan N, 1997, J BIOMECH ENG-T ASME, V119, P87, DOI 10.1115/1.2796070; Yoganandan N, 2003, SPINE, V28, P2317, DOI 10.1097/01.BRS.0000085356.89103.A5; Yoganandan N, 2000, Stapp Car Crash J, V44, P189; YOGANANDAN N, 1986, SPINE, V11, P855, DOI 10.1097/00007632-198611000-00001; Yoganandan N, 1996, MED ENG PHYS, V18, P289, DOI 10.1016/1350-4533(95)00054-2; Yoganandan N, 1990, SAE T, V98, P1790; YOGANANDAN N, 1998, FRONTIERS HEAD NECK; Yoganandan N, 2009, TRAFFIC INJ PREV, V10, P51, DOI 10.1080/15389580802524876; Yoganandan N, 2008, TRAFFIC INJ PREV, V9, P162, DOI 10.1080/15389580701775942; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770	55	13	14	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2009	10	5					488	496	PII 914724058	10.1080/15389580903132801			9	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	493JR	WOS:000269733200013	19746313				2022-02-06	
J	Avila, MA; Sell, SL; Kadoi, Y; Prough, DS; Hellmich, HL; Velasco, M; Dewitt, DS				Avila, Marcela A.; Sell, Stacy L.; Kadoi, Yuji; Prough, Donald S.; Hellmich, Helen L.; Velasco, Marco; Dewitt, Douglas S.			L-Arginine decreases fluid-percussion injury-induced neuronal nitrotyrosine immunoreactivity in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						immunoreactivity; L-arginine; nitrotyrosine; rats; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; OXIDE SYNTHASE EXPRESSION; CORTICAL IMPACT INJURY; NITRIC-OXIDE; IN-VIVO; TYROSINE NITRATION; POLY(ADP-RIBOSE) POLYMERASE; LIPID-PEROXIDATION	Peroxynitrite is a powerful oxidant capable of nitrating phenolic moieties, such as tyrosine or tyrosine residues in proteins and increases after traumatic brain injury (TBI). First, we tested the hypothesis that TBI increases nitrotyrosine (NT) immunoreactivity in the brain by measuring the number of NT-immunoreactive neurons in the cerebral cortex and hippocampus of rats subjected to parasagittal fluid-percussion TBI. Second, we tested the hypothesis that treatment with L-arginine, a substrate for nitric oxide synthase, further increases NT immunoreactivity over TBI alone. Rats were anesthetized with isoflurane and subjected to TBI, sham TBI, or TBI followed by treatment with L-arginine (100 mg/kg). Twelve, 24, or 72 h after TBI, brains were harvested. Coronal sections (10 mu m) were incubated overnight with rabbit polyclonal anti-NT antibody, rinsed, and incubated with a biotinylated secondary antibody. The antigen-antibody complex was visualized using a peroxidase-conjugated system with diaminobenzidine as the chromagen. The number of NT-positive cortical and hippocampal neurons increased significantly in both ipsilateral and contralateral hemispheres up to 72 h after TBI compared with the sham-injured group. Remarkably, treatment with L-arginine reduced the number of NT-positive neurons after TBI in both cortex and hippocampus. Our results indicate that L-arginine actually prevents TBI-induced increases in NT immunoreactivity.	[Avila, Marcela A.; Sell, Stacy L.; Kadoi, Yuji; Prough, Donald S.; Hellmich, Helen L.; Dewitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; [Velasco, Marco] Vel Lab Res, Houston, TX USA		Dewitt, DS (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, 610 Texas Ave, Galveston, TX 77555 USA.	ddewitt@utmb.edu	De Velasco, Marco/R-1022-2019; Prough, Donald S/G-5793-2013; AVILA, MATIAS A/Y-6342-2019	De Velasco, Marco/0000-0002-4011-6572; Prough, Donald S/0000-0001-7994-532X; AVILA, MATIAS A/0000-0001-6570-3557	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS019355]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health Grant no. 5R01NS019355.	Ahn Edward S, 2005, Clin Neurosurg, V52, P348; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Duguet A, 2001, AM J RESP CRIT CARE, V164, P1119, DOI 10.1164/ajrccm.164.7.2010085; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hlatky R, 2002, ACT NEUR S, V81, P331; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kumura E, 1996, AM J PHYSIOL-CELL PH, V270, pC748, DOI 10.1152/ajpcell.1996.270.3.C748; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; National Research Council, 1996, GUID CAR US LAB AN; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; PICKARD JD, 1981, J CEREBR BLOOD F MET, V1, P361, DOI 10.1038/jcbfm.1981.41; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Rauhala P, 1996, SYNAPSE, V23, P58, DOI 10.1002/(SICI)1098-2396(199605)23:1<58::AID-SYN7>3.0.CO;2-G; Rehman A, 1997, BRIT J PHARMACOL, V122, P1702, DOI 10.1038/sj.bjp.0701556; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; VESPA PM, 2007, CRIT CARE MED, V35, P1216; Viera L, 1999, METHOD ENZYMOL, V301, P373; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Whiteman M, 1999, BIOCHEM BIOPH RES CO, V258, P168, DOI 10.1006/bbrc.1999.0564; Whiteman M, 2003, J BIOL CHEM, V278, P8380, DOI 10.1074/jbc.M211086200; Wu GY, 2007, J NUTR, V137, p1673S, DOI 10.1093/jn/137.6.1673S; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	59	13	13	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2008	28	10					1733	1741		10.1038/jcbfm.2008.66			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	351SB	WOS:000259445100010	18612319				2022-02-06	
J	Figaji, AA; Zwane, E; Fieggen, AG; Peter, JC; LeRoux, PD				Figaji, Anthony A.; Zwane, Eugene; Fieggen, A. Graham; Peter, Jonathan C.; LeRoux, Peter D.			Acute clinical grading in pediatric severe traumatic brain injury and its association with subsequent intracranial pressure, cerebral perfusion pressure, and brain oxygenation	NEUROSURGICAL FOCUS			English	Article						brain oxygenation; cerebral perfusion pressure; clinical assessment; Glasgow Coma Scale; secondary insult; traumatic brain injury	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC FACTORS; CHILDREN; HYPOTENSION; MORTALITY; CARE; EXPERIENCE; HYPOXIA; SCALE	Object. The goal of this paper was to examine the relationship between methods of acute clinical assessment and measures of secondary cerebral insults in severe traumatic brain injury in children. Methods. Patients who underwent intracranial pressure (ICP), cerebral perfusion pressure (CPP), and brain oxygenation (PbtO(2)) monitoring and who had an initial Glasgow Coma Scale score, Pediatric Trauma Score, Pediatric Index of Mortality 2 score, and CT classification were evaluated. The relationship between these acute clinical scores and secondary cerebral insult measures, including ICP, CPP, PbtO(2), and systemic hypoxia were evaluated using univariate and multivariate analysis. Results. The authors found significant associations between individual acute clinical scores and select physiological markers of secondary injury. However, there was a large amount of variability in these results, and none of the scores evaluated predicted each and every insult. Furthermore, a number of physiological measures were not predicted by any of the scores. Conclusions. Although they may guide initial treatment, grading systems used to classify initial injury severity appear to have a limited value in predicting who is at risk for secondary cerebral insults.	[Figaji, Anthony A.; Fieggen, A. Graham; Peter, Jonathan C.] Univ Cape Town, Red Cross Childrens Hosp, Inst Child Hlth, Sch Child & Adolescent Hlth,Div Neurosurg, ZA-7925 Cape Town, South Africa; [Figaji, Anthony A.; Fieggen, A. Graham] Univ Cape Town, Red Cross Childrens Hosp, Inst Child Hlth, Sch Child & Adolescent Hlth,Div Pediat Neurosci, ZA-7925 Cape Town, South Africa; [Zwane, Eugene] Univ Cape Town, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit Biostat, ZA-7700 Rondebosch, South Africa; [LeRoux, Peter D.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Figaji, AA (corresponding author), Red Cross War Mem Childrens Hosp, Inst Child Hlth 617, Klipfontein Rd, ZA-7700 Rondebosch, Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Fieggen, Anthony Graham/AAT-6510-2021	Fieggen, Anthony Graham/0000-0001-6541-8377; Figaji, Anthony/0000-0002-3357-6490	Integra Foundation	Anthony Figaji and Peter LeRoux have received a grant for the study of perfusion pressure thresholds in pediatric traumatic brain injury from the Integra Foundation.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Ananda A, 1999, ACTA NEUROCHIR SUPPL, V73, P99; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Grinkeviciute DE, 2007, MEDICINA-LITHUANIA, V43, P861, DOI 10.3390/medicina43110111; JENNETT B, 1975, LANCET, V1, P480; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	31	13	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2008	25	4							E4	10.3171/FOC.2008.25.10.E4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	355HX	WOS:000259701100004	18828702	Bronze			2022-02-06	
J	Cengiz, P; Zemlan, F; Ellenbogen, R; Hawkins, D; Zimmerman, JJ				Cengiz, Pelin; Zemlan, Frank; Ellenbogen, Richard; Hawkins, Douglas; Zimmerman, Jerry J.			Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hydrocephalus; cleaved-tau protein; 9-hydroxyoctadecadienoic acid; cerebrospinal fluid; neurological injury; neuronal injury; lipid peroxidation	TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION PROCESSES; CHILDHOOD HYDROCEPHALUS; INTRACRANIAL-PRESSURE; BACTERIAL-MENINGITIS; NEURONAL DAMAGE; LINOLEIC-ACID; FATTY-ACID; RAT-BRAIN; C-TAU	Objective: To ascertain if cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid, reflecting potential biomarkers of overall neuronal injury and lipid peroxidation, respectively, are elevated in hydrocephalus patients compared with controls, and if cleaved-tau and 9-hydroxyoctadecadienoic acid levels correlate with each other. Design: Prospective clinical observational study. Setting: Tertiary-care children's hospital. Patients: Children younger than or equal to 18 yrs who underwent ventriculoperitoneal shunt placement or revision surgery for intrinsic hydrocephalus. Measurements and Main Results: During the study period 12 patients with intrinsic hydrocephalus required ventriculoperitoneal shunt placement or revision. Cerebrospinal fluid cleaved-tau levels were significantly elevated in patients with hydrocephalus (44.7 +/- 9.6 ng/mL, n = 11) compared with control patients (0.0 +/- 0.0 ng/mL, n = 9; p < 0.0001). Cleaved-tau levels correlated with patient age (r = .609, p = 0.047) and duration of symptoms (r = .755, p = 0.007). No significant difference in cerebrospinal fluid 9-hydroxyoctadecadienoic acid levels between patients with hydrocephalus (24.6 +/- 5.7, n = 8) and control patients (24.9 +/- 9.3 ng/mL, n = 7) was detected (p = 0.25). There was also no statistically significant correlation between 9-hydroxyoctadecadienoic acid levels and duration of symptoms (r = .668, p = 0.07), nor was there a significant correlation between 9-hydroxyoctadecadienoic acid levels and patient age (r = -.011, p > 0.10). There was no significant relationship between 9-hydroxyoctadecadienoic acid levels and signs of elevated intracranial pressure, nor was there a correlation between 9-hydroxyoctadecadienoic acid levels and cleaved-tau levels. Conclusion: Children with hydrocephalus who have clinical signs of increased intracranial pressure and require ventriculoperitoneal shunt placement or revision exhibit markedly elevated cerebrospinal fluid cleaved-tau levels, suggesting evidence of axonal damage. However, this axonal injury does not seem to be associated with significant lipid peroxidation, at least as assessed by quantifying cerebrospinal fluid 9-hydroxyoctadecadienoic acid at a single, concurrent time point. The significant relationship between age and cerebrospinal fluid cleaved-tau levels suggest that brain injury associated with hydrocephalus may be more pronounced in older children. (Pediatr Crit Care Med 2008; 9:524-529)	[Cengiz, Pelin] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Cengiz, Pelin] Univ Wisconsin, Childrens Hosp, Dept Pediat, Madison, WI USA; [Zemlan, Frank] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA; [Ellenbogen, Richard] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hawkins, Douglas; Zimmerman, Jerry J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Cengiz, P (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	cengiz@pediatrics.wisc.edu					Balasubramaniam J, 2002, EXP NEUROL, V173, P105, DOI 10.1006/exnr.2001.7831; Barnes NP, 2002, ARCH DIS CHILD, V87, P198, DOI 10.1136/adc.87.3.198; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Beems T, 2003, ACTA NEUROCHIR, V145, P37, DOI 10.1007/s00701-002-1019-1; CAMACHO M, 1995, J BIOL CHEM, V270, P17279, DOI 10.1074/jbc.270.29.17279; CANER H, 1993, ACTA NEUROCHIR, V121, P68, DOI 10.1007/BF01405185; COBBS CS, 1995, CANCER RES, V55, P727; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Felderhoff-Mueser U, 2001, ARCH DIS CHILD, V84, P369, DOI 10.1136/adc.84.4.369; Fischer B, 2002, J IMMUNOL, V168, P2828, DOI 10.4049/jimmunol.168.6.2828; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOH D, 1995, CHILD NERV SYST, V11, P392, DOI 10.1007/BF00717403; HENRICKS PAJ, 1991, PROSTAGLANDINS, V41, P21, DOI 10.1016/0090-6980(91)90101-K; Hochhaus F, 2001, BMC Pediatr, V1, P2, DOI 10.1186/1471-2431-1-2; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; ILLINGWORTH DR, 1971, J NEUROCHEM, V18, P769, DOI 10.1111/j.1471-4159.1971.tb12006.x; Inouye M, 1999, BBA-MOL CELL BIOL L, V1438, P204, DOI 10.1016/S1388-1981(99)00052-9; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; Irazuzta JE, 2002, CRIT CARE MED, V30, P2553, DOI 10.1097/00003246-200211000-00025; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Iskandar BJ, 1998, PEDIATRICS, V101, P1031, DOI 10.1542/peds.101.6.1031; Koehne P, 2002, CHILD NERV SYST, V18, P137, DOI 10.1007/s00381-002-0567-2; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Kreil P, 1998, Z NATURFORSCH C, V53, P876; KU G, 1992, J BIOL CHEM, V267, P14183; Kudo T, 2000, PSYCHIAT CLIN NEUROS, V54, P199, DOI 10.1046/j.1440-1819.2000.00658.x; Li WG, 2003, FREE RADICAL BIO MED, V34, P937, DOI 10.1016/S0891-5849(03)00032-7; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; METZGER K, 1995, FREE RADICAL BIO MED, V18, P185, DOI 10.1016/0891-5849(94)00108-V; Nussinovitch M, 2001, ACTA PAEDIATR, V90, P972; ONODERA Y, 1977, CHILD BRAIN, V3, P101; ONODERA Y, 1982, CHILD BRAIN, V9, P95; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Radwanska-Wala B, 2002, PATHOL RES PRACT, V198, P421, DOI 10.1078/0344-0338-00275; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Spindler SA, 1996, BIOCHEM BIOPH RES CO, V218, P187, DOI 10.1006/bbrc.1996.0033; Spiteller G, 2003, MED HYPOTHESES, V60, P69, DOI 10.1016/S0306-9877(02)00333-X; STOLL LL, 1994, AM J PHYSIOL, V266, pC990, DOI 10.1152/ajpcell.1994.266.4.C990; Straiko MMW, 2006, J NEUROSCI RES, V84, P1116, DOI 10.1002/jnr.21002; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TICHY J, 1979, J CHROMATOGR, V162, P185, DOI 10.1016/S0378-4347(00)81912-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Yoshida Y, 2006, NUTRITION, V22, P303, DOI 10.1016/j.nut.2005.07.020; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2003, NEUROSCIENCE, V121, P399, DOI 10.1016/S0306-4522(03)00459-7; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	51	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535			PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2008	9	5					524	529		10.1097/PCC.0b013e3181849dc9			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	360NK	WOS:000260064000011	18679140				2022-02-06	
J	Patomella, AH; Kottorp, A; Tham, K				Patomella, Ann-Helen; Kottorp, Anders; Tham, Kerstin			Awareness of driving disability in people with stroke tested in a simulator	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Automobile driving; metacognition; occupational therapy; rehabilitation; simulation; stroke	TRAUMATIC BRAIN-INJURY; COMPETENCE RATING-SCALE; SELF-AWARENESS; ALZHEIMER-DISEASE; OLDER DRIVERS; PERFORMANCE; ABILITY; DEFICITS; FITNESS; ADULTS	The aim of this study was to explore and describe awareness of driving disability in people with driving difficulties after stroke. The study comprised a consecutive sample of 38 participants with stroke who showed difficulties in a technically advanced, interactive driving simulator. Driving ability in the simulator was measured using Performance Analysis of Driving Ability (P-Drive). Awareness of driving disability was measured using a modified version of Assessment of Awareness of Disability (AAD), measuring the discrepancy between observed driving actions and self-reported disability after a driving evaluation in a simulator. A majority of the participants (n =36) demonstrated driving ability that was below the cut-off criterion for P-Drive. Furthermore, a majority of the items measuring awareness of driving disability were scored low, indicating that participants with stroke who did not pass a driving evaluation also had limited awareness of driving disability. A General Linear Model analysis indicated that awareness of driving disability and cognitive screening outcome explained 74% of the variance in driving ability. This study indicated that a majority of the people with stroke who fail a driving evaluation also have limited awareness of their disability, which indicates the need to address awareness in driving evaluations.	[Patomella, Ann-Helen; Kottorp, Anders; Tham, Kerstin] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, S-14183 Stockholm, Sweden		Patomella, AH (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, Alfred Nobels Alle 23, S-14183 Stockholm, Sweden.	ann-helen.patomella@ki.se	; Tham, Kerstin/T-3964-2018	Patomella, Ann-Helen/0000-0003-2667-4073; Kottorp, Anders/0000-0002-8976-2612; Tham, Kerstin/0000-0001-7025-5226	Postgraduate School of Health Care Sciences at Karolinska Institutet; Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)	The study was supported by the Postgraduate School of Health Care Sciences at Karolinska Institutet and the Swedish Council for Working Life and Social Research. The authors would like to thank Gorel Caneman, Karolinska University Hospital for her support.	Bond T, 2001, APPL RASCH MODEL FUN; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; Ekstam L, 2007, AM J OCCUP THER, V61, P503, DOI 10.5014/ajot.61.5.503; Evans L., 2004, TRAFFIC SAFETY; Fisher A.G., 2006, ASSESSMENT MOTOR PRO, V1; Fisher AG, 1998, AM J OCCUP THER, V52, P509, DOI 10.5014/ajot.52.7.509; Fisk GD, 1997, ARCH PHYS MED REHAB, V78, P1338, DOI 10.1016/S0003-9993(97)90307-5; Fleming JM, 1996, BRAIN INJURY, V10, P1; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; Hatakka M., 2002, TRANSPORT RES F TRAF, V5, P201, DOI 10.1016/s1369-8478(02)00018-9; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Kottorp A, 2003, J INTELL DISABIL RES, V47, P597, DOI 10.1046/j.1365-2788.2003.00475.x; Kottorp A., 2006, ASSESSMENT AWARENESS; LARSSON H, 2007, SCAND J OCCUP THER, V4, P215; Lincoln N., 1992, CLIN REHABIL, V6, P275, DOI DOI 10.1177/026921559200600402; Lundberg C, 2003, SCAND J PSYCHOL, V44, P23, DOI 10.1111/1467-9450.00317; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Michon JA., 1985, CRITICAL VIEW DRIVER; *NAT STROK REG SWE, 2006, RIKS STROK AN RAPP R; Patomella A, 2005, P 3 INT DRIV S HUM F; Patomella A-H., 2004, SCAND J OCCUP THER, V11, DOI [10.1080/11038120410020520, DOI 10.1080/11038120410020520.]; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; PRIGATANO GP, 1991, AWARENESS DEFICITS B; Reckase M.D., 1979, J EDUC BEHAV STAT, V4, P207, DOI DOI 10.3102/10769986004003207; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Tham K, 2001, AM J OCCUP THER, V55, P46, DOI 10.5014/ajot.55.1.46; Tham K, 1996, Occup Ther Health Care, V10, P65, DOI 10.1080/J003v10n03_07; Tham K., 1999, SCAND J OCCUP THER, V6, P184; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; Wright B, 1994, MEASUREMENT T, V8, P370	41	13	13	0	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1103-8128			SCAND J OCCUP THER	Scand. J. Occup. Ther.	SEP	2008	15	3					184	192		10.1080/11038120802087600			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	364QR	WOS:000260350700006	18609244				2022-02-06	
J	Brossart, DF; Meythaler, JM; Parker, RI; McNamara, J; Elliott, TR				Brossart, Daniel F.; Meythaler, Jay M.; Parker, Richard I.; McNamara, James; Elliott, Timothy R.			Advanced regression methods for single-case designs: Studying propranolol in the treatment for agitation associated with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article						single-case design; logistic regression; propranolol; brain injury; agitation	CLOSED HEAD-INJURY; LOGISTIC-REGRESSION; VISUAL INSPECTION; SUBJECT RESEARCH; PRESSURE SORES; EFFECT SIZES; BASE-LINE; REHABILITATION; BEHAVIOR; RESTLESSNESS	Objective: The use of single-case designs in intervention research is discussed. Regression methods for analyzing data from these designs are considered, and an innovative use of logistic regression to analyze data from a double-blind, randomized clinical trial of propranolol for agitation among persons with traumatic brain injury (TBI) is used. Method. Double-blind, randomized clinical trial performed in an outpatient rehabilitation setting. Participants: Nine men and 4 women with TBI. Results: Logistic models indicated that propranolol was not associated with less agitation for most participants (phi=.135; 90% exact confidence interval was -.03 <.135 <.29). Four participants displayed a significant response to propanolol. Two participants demonstrated significant improvement, and the other 2 experienced significantly more agitation in the treatment phase. Summary: Advanced regression methods can be used to analyze data from single-case designs to obtain information of clinical and statistical significance from a variety of psychological and medical treatments.	[Brossart, Daniel F.; Parker, Richard I.; McNamara, James; Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Meythaler, Jay M.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Meythaler, Jay M.] Rehabil Inst Michigan, Detroit, MI USA		Brossart, DF (corresponding author), Texas A&M Univ, Dept Educ Psychol, 4225 TAMU, College Stn, TX 77845 USA.	brossart@tamu.edu	Brossart, Daniel/B-9770-2015; Elliott, Timothy R./I-5301-2012	Brossart, Daniel/0000-0003-2619-1450; Elliott, Timothy R./0000-0002-6608-7714			AESCHLEMAN SR, 1991, REHABIL PSYCHOL, V36, P43, DOI 10.1037/0090-5550.36.1.43; ALLISON DB, 1993, BEHAV RES THER, V31, P621, DOI 10.1016/0005-7967(93)90115-B; ALLISON DB, 1994, BEHAV RES THER, V32, P885, DOI 10.1016/0005-7967(94)90170-8; Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Baltes P. B., 1979, LONGITUDINAL RES STU, P1; Barlow DH, 1984, SINGLE CASE EXPT DES; Blampied NM, 2000, AM PSYCHOL, V55, P960, DOI 10.1037/0003-066X.55.8.960; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brossart DF, 2006, BEHAV MODIF, V30, P531, DOI 10.1177/0145445503261167; BROSSART DF, 2001, HOUST 2001 NAT COUNS; BRUCKER BS, 1977, ARCH PHYS MED REHAB, V58, P49; Busk P. L., 1992, SINGLE CASE RES DESI, P159; Callahan CD, 2005, REHABIL PSYCHOL, V50, P24, DOI 10.1037/0090-5550.50.1.24; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CASSIDY JW, 1990, J HEAD TRAUMA REHAB, V5, P83; CENTER BA, 1985, J SPEC EDUC, V19, P387, DOI 10.1177/002246698501900404; Cohen J., 2013, STAT POWER ANAL BEHA; COLTART DJ, 1970, BRIT MED J, V3, P731, DOI 10.1136/bmj.3.5725.731; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Cox D.R., 1989, ANAL BINARY DATA, V2nd ed.; CROSBIE J, 1993, J CONSULT CLIN PSYCH, V61, P966, DOI 10.1037/0022-006X.61.6.966; Davison A.C., 1997, BOOTSTRAP METHODS TH; DEPROSPERO A, 1979, J APPL BEHAV ANAL, V12, P573, DOI 10.1901/jaba.1979.12-573; DUNN D, REHABILITAT IN PRESS; EICHELMAN B, 1987, 3 GENERATION PROGR; Elliott TR, 2007, EXP CLIN PSYCHOPHARM, V15, P511, DOI 10.1037/1064-1297.15.6.511; Faith M. S., 1996, DESIGN ANAL SINGLE C, P245, DOI DOI 10.4324/9781315806402; Fidler F, 2002, EDUC PSYCHOL MEAS, V62, P749, DOI 10.1177/001316402236876; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; FLOR H, 1985, J CONSULT CLIN PSYCH, V53, P354, DOI 10.1037/0022-006X.53.3.354; Fox J., 2000, MULTIPLE GEN NONPARA; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Goldfried MR, 1996, AM PSYCHOL, V51, P1007, DOI 10.1037/0003-066X.51.10.1007; Good P.I., 2001, RESAMPLING METHODS P; GORSUCH RL, 1983, BEHAV ASSESS, V5, P141; Gottman J.M., 1995, ANAL CHANGE, P361; HARBST KB, 1991, PHYS THER, V71, P107, DOI 10.1093/ptj/71.2.107; HILLIARD RB, 1993, J CONSULT CLIN PSYCH, V61, P373, DOI 10.1037/0022-006X.61.3.373; Hintze J, 2007, NCSS PASS GESS COMPU; Huitema B. E., 2004, Understanding Statistics, V3, P27, DOI 10.1207/s15328031us0301_2; INCE LP, 1978, J COMP PHYSIOL PSYCH, V92, P796, DOI 10.1037/h0077545; Kazdin A., 1982, SINGLE CASE RES DESI; KRATOCHWILL TR, 1978, BEHAV MODIF, V2, P291, DOI 10.1177/014544557823001; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lunneborg CE, 2000, DATA ANAL RESAMPLING; MALAMENT IB, 1975, ARCH PHYS MED REHAB, V56, P161; MATYAS TA, 1996, DESIGN ANAL SINGLE C, P215; Menard S., 2002, APPL LOGISTIC REGRES, V2nd; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Morgan DL, 2001, AM PSYCHOL, V56, P119, DOI 10.1037/0003-066X.56.2.119; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NESSELROADE JR, 1991, RECENT ADV UNANSWERE, P92; Oakley A, 2002, EDUC REV, V54, P277, DOI 10.1080/0013191022000016329; OTTENBACHER KJ, 1990, MENT RETARD, V28, P283; Pampel F.C., 2000, LOGISTIC REGRESSION; PARK HS, 1990, J EXP EDUC, V58, P311, DOI 10.1080/00220973.1990.10806545; Parker RI, 2006, SCHOOL PSYCHOL QUART, V21, P46, DOI 10.1521/scpq.2006.21.1.46; Parker RI, 2003, BEHAV THER, V34, P189, DOI 10.1016/S0005-7894(03)80013-8; Parker RI, 2005, SCHOOL PSYCHOL REV, V34, P116; Parker RI, 2007, BEHAV THER, V38, P95, DOI 10.1016/j.beth.2006.05.002; Parker RI, 2007, BEHAV MODIF, V31, P919, DOI 10.1177/0145445507303452; Parker RI, 2006, BEHAV THER, V37, P326, DOI 10.1016/j.beth.2006.01.007; Parker RI, 2006, SCHOOL PSYCHOL QUART, V21, P418, DOI 10.1037/h0084131; PARSONSON BS, 1992, 1 CASE RES DESIGN AN, P15; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pijnenborg GHM, 2007, REHABIL PSYCHOL, V52, P236, DOI 10.1037/0090-5550.52.2.236; PRESS SJ, 1978, J AM STAT ASSOC, V73, P699, DOI 10.2307/2286261; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; ROSENTHAL R, 1991, META ANAL PROCEDURES; ROWLAND T, 1995, NEUROREHABILITATION, V5, P219, DOI 10.3233/NRE-1995-5305; Shavelson R., 2002, SCI RES ED; Silver Jonathan M., 1994, P313; Spring B, 2005, ANN BEHAV MED, V30, P125, DOI 10.1207/s15324796abm3002_5; Stevens JP., 2007, INTERMEDIATE STAT MO, V3rd; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tucker JA, 2006, ADDICTION, V101, P918, DOI 10.1111/j.1360-0443.2006.01396.x; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WHITE GW, 1989, J APPL BEHAV ANAL, V22, P287, DOI 10.1901/jaba.1989.22-287; Whyte J, 1993, REHABILITATION MED P, P825; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218; [No title captured]	85	13	13	0	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2008	53	3					357	369		10.1037/a0012973			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	343XQ	WOS:000258890000010					2022-02-06	
J	Li, G; Wen, L; Yang, XF; Zheng, XJ; Zhan, RY; Liu, WG				Li Gu; Wen Liang; Yang Xiao-feng; Zheng Xiu-jue; Zhan Ren-ya; Liu Wei-guo			Efficacy of large decompressive craniectomy in severe traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Craniectomy, decompressive; Brain injuries; Complications; Wounds and injuries		Objective: To investigate the role of large decompressive craniectomy (LDC) in the management of severe and very severe traumatic brain injury (TBI) and compare it with routine decompressive craniectomy (RDC). Methods: The clinical data of 263 patients with severe TBI (GCS <= 8) treated by either LDC or RDC in our department were studied retrospectively in this article. One hundred and thirty-five patients with severe TBI, including 54 patients with very severe TBI (GCS <= 5), underwent LDC (LDC group). The other 128 patients with severe TBI, including 49 patients with very severe TBI, underwent RDC (RDC group). The treatment outcome and postoperative complications of the two treatment methods were compared and analyzed in a 6-month follow-up period. Results: Ninety-six patients (71.7 %) obtained satisfactory treatment outcome in the LDC group, while only 75 cases (58.6 %) obtained satisfactory outcome in the RDC group (P<0.05). Moreover, the efficacy of LDC in treating very severe TBI was higher than that of RDC(63.0% vs. 36.7 %, P < 0.01). The chance of reoperation due to refractory intracranial pressure (ICP) in the LDC group was significantly lower than that of the RDC group (P < 0.05), while the incidences of delayed intracranial hematoma and subdural effusion were significantly higher than those of the RDC group (P<0.05). Conclusions: LDC is superior to RDC in improving the treatment outcome of severe TBI, especially the very severe ones. LDC can also efficiently reduce the chances of reoperation due to refractory ICP. However, it increases the incidences of delayed intracranial hematoma and contralateral subdural effusion.	[Li Gu; Wen Liang; Yang Xiao-feng; Zheng Xiu-jue; Zhan Ren-ya] Zhejiang Univ, Med Coll, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China; [Liu Wei-guo] Zhejiang Univ, Med Coll, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China; [Li Gu; Wen Liang; Yang Xiao-feng; Zheng Xiu-jue; Zhan Ren-ya; Liu Wei-guo] Zhejiang Univ, Inst Brain Med, Hangzhou 310000, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Med Coll, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China.	brain2005@126.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Chinese Medical Assocsiation, 2006, CHINA FORESTRY IND, P5; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Marion DW, 2006, NEUROSURGERY, V58, P655; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; 王忠诚, 2001, 中华神经外科杂志, V17, P133	8	13	17	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2008	11	4					253	256		10.1016/S1008-1275(08)60052-8			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0VT	WOS:000441869500012	18667125	hybrid			2022-02-06	
J	Tanriverdi, F; Alp, E; Demiraslan, H; Dokmetas, HS; Unluhizarci, K; Doganay, M; Casanueva, FF; Kelestimur, F				Tanriverdi, F.; Alp, E.; Demiraslan, H.; Dokmetas, H. S.; Unluhizarci, K.; Doganay, M.; Casanueva, F. F.; Kelestimur, F.			Investigation of pituitary functions in patients with acute meningitis: A pilot study	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						GH deficiency; GHRH plus arginine; hypopituitarism; meningitis; pituitary	TRAUMATIC BRAIN-INJURY; TUBERCULOUS MENINGITIS; HYPOPITUITARISM; INSUFFICIENCY; MENINGOENCEPHALITIS; COMPLICATION; MASS	Objective: Although long-term pituitary consequences of tuberculous meningitis are well documented in the literature, there have been few case reports of pituitary dysfunction after acute bacteria[ or viral meningitis. In this preliminary study, we have assessed the pituitary functions in adult patients who had acute bacterial or viral meningitis. Design and methods: Fourteen patients (8 men, 6 women; mean age 35.3 +/- 13.3) were included in the study. The diagnosis of bacterial and viral meningitis was proven by clinical findings, cerebrospinal fluid (CSF) examination, gram staining, and blood and CSF cultures. Pituitary functions were evaluated ranging from 6 to 48 months (mean 20 months) after acute meningitis. GH deficiency was investigated by the GHRH+arginine stimulation test. Results: Four of 14 patients (28.6%) had isolated GH deficiency. In GH-deficient patients, the earliest duration was 6 months and the latest duration was 48 months after the diagnosis of acute meningitis. Three of the GH-deficient patients had acute bacterial meningitis and I patient had acute viral meningitis. Pituitary magnetic resonance imaging revealed normal pituitary gland in the patients with GH deficiency. Conclusions: This is the first systematic study evaluating the anterior pituitary function long term after the diagnosis of acute meningitis. Based on the present study, it is tempting to speculate that pituitary dysfunction is a more common sequel of acute bacterial or viral meningitis than hitherto reported. Studies with high numbers of patients are warranted to ascertain the prevalence of meningitis-induced hypopituitarism.	[Tanriverdi, F.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Alp, E.; Demiraslan, H.; Doganay, M.] Erciyes Univ, Sch Med, Dept Infect Dis, TR-38039 Kayseri, Turkey; [Dokmetas, H. S.] Cumhuriyet Univ, Sch Med, Dept Endocrinol, Sivas, Turkey; [Casanueva, F. F.] Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain; [Casanueva, F. F.] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Santiago De Compostela, Spain		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Doganay, Mehmet/G-4250-2019	Doganay, Mehmet/0000-0003-3922-4901			BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P9939, DOI 10.1073/pnas.89.20.9939; DRURY MI, 1968, BRIT MED J, V1, P842, DOI 10.1136/bmj.1.5595.842; GARG SK, 1987, TROP GEOGR MED, V39, P296; HAGG E, 1978, ACTA MED SCAND, V203, P231; HALL R, 1980, FUNDAMENTALS CLIN EN; JEW K, 1984, NEUROSURGERY, V14, P567, DOI 10.1227/00006123-198405000-00008; Katsuno Makoto, 2003, No To Shinkei, V55, P967; KUPARI M, 1980, ACTA ENDOCRINOL-COP, V94, P433, DOI 10.1530/acta.0.0940433; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LICHTENSTEIN MJ, 1982, J ENDOCRINOL INVEST, V5, P111, DOI 10.1007/BF03350501; Lynch C, 2007, BRIT J HOSP MED, V68, P272, DOI 10.12968/hmed.2007.68.5.23336; Muraoka A, 1989, Nihon Naika Gakkai Zasshi, V78, P684; PAI KG, 1976, J PEDIATR-US, V88, P289, DOI 10.1016/S0022-3476(76)81002-5; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TUNKEL AR, 2005, PRINCIPLES PRACTICE, P1083	19	13	13	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	JUN	2008	31	6					489	491		10.1007/BF03346395			3	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	327HP	WOS:000257720500001	18591878				2022-02-06	
J	Wenzel, V; Raab, H; Dunser, MW				Wenzel, Volker; Raab, Helmut; Dunser, Martin W.			Arginine vasopressin: a promising rescue drug in the treatment of uncontrolled haemorrhagic shock	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						arginine vasopressin; haemorrhagic shock; uncontrolled; traumatic brain injury; VITRIS	CATECHOLAMINE-RESISTANT SHOCK; TRAUMA CENTER DESIGNATION; FLUID RESUSCITATION; IMPROVES SURVIVAL; CARDIAC-ARREST; LIVER TRAUMA; CARDIOVASCULAR-SYSTEM; PRESSURE; THERAPY; VOLUME	Haemorrhagic shock is one of the most frequent types of shock. If haemorrhage cannot be controlled and fluid resuscitation as well as catecholamines are insufficient to stabilize cardiovascular function, uncontrolled haemorrhagic shock occurs. Several approaches have been suggested as promising alternatives to volume resuscitation. The rationale for the use of arginine vasopressin (AVP) is the pharmacologic amplification of the neuroendocrine stress response. AVP-mediated vasoconstriction is the first physiologic step to haemostasis and shifts blood away from the bleeding site towards the heart, lungs and brain. Particularly, when uncontrolled haemorrhage is accompanied by traumatic brain injury this may help to reduce secondary neurological damage. Since AVP can prevent acute death only transiently, it must comprehensively be combined with rapid hospital admission, immediate control of haemorrhage followed by aggressive fluid resuscitation and blood transfusion. This review article summarizes current experimental and clinical evidence on the use of AVP in uncontrolled haemorrhagic shock.	[Wenzel, Volker; Raab, Helmut; Dunser, Martin W.] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria		Dunser, MW (corresponding author), Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria.	Martin.Duenser@i-med.ac.at			Science Foundation of the Austrian National Bank,Vienna, Austria [11448]	Supported in part by the Science Foundation of the Austrian National Bank grant 11448, Vienna, Austria.	BAEK SM, 1992, J RECONSTR MICROSURG, V8, P455, DOI 10.1055/s-2007-1006730; BENEDICT CR, 1978, Q J MED, V47, P1; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Cannon WB, 1918, J AMER MED ASSOC, V70, P618; Cheung ATW, 2007, ARTIF CELL BLOOD SUB, V35, P173, DOI 10.1080/10731190601188257; Cohn SM, 2007, J TRAUMA, V68, P56; Deitch EA, 2006, CRIT CARE MED, V34, P2294, DOI 10.1097/01.CCM.0000233857.94604.73; Demetriades D, 2006, J AM COLL SURGEONS, V202, P212, DOI 10.1016/j.jamcollsurg.2005.09.027; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Deusch E, 2003, ANESTH ANALG, V97, P680, DOI 10.1213/01.ANE.0000073353.31894.BE; Dolich M, 1999, CURRENT OPINION CRIT, V5, P523; Driessen B, 2007, CRIT CARE MED, V35, P2101, DOI 10.1097/01.CCM.0000277040.31978.3D; Dunser MW, 2006, CRIT CARE MED, V34, P562, DOI 10.1097/01.CCM.0000196093.42087.5D; Elster E, 2007, J TRAUMA, V62, pS54, DOI 10.1097/TA.0b013e318065aab4; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Fries D, 2004, ANASTH INTENSIV NOTF, V39, P745, DOI 10.1055/s-2004-825912; GOFF JS, 1993, GASTROENTEROL CLIN N, V22, P779; GOODIN TH, 1994, CRIT CARE MED, V22, P680, DOI 10.1097/00003246-199404000-00026; Guyton AC, 2000, TXB MED PHYSL, P419; Guyton AC, 2000, TXB MED PHYSL, P253; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Haisch G, 2001, J CARDIOTHOR VASC AN, V15, P316, DOI 10.1053/jcan.2001.23276; Henrion J, 2003, MEDICINE, V82, P392, DOI 10.1097/01.md.0000101573.54295.bd; HOCK CE, 1984, AM J PHYSIOL, V246, pH174, DOI 10.1152/ajpheart.1984.246.2.H174; Holmes CL, 2004, CRIT CARE, V8, P15, DOI 10.1186/cc2338; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Jochberger S, 2006, CRIT CARE MED, V34, P293, DOI 10.1097/01.CCM.0000198528.56397.4F; Johnson KB, 2006, J CARDIOTHOR VASC AN, V20, P167, DOI 10.1053/j.jvca.2005.11.015; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Krismer AC, 2006, CRIT CARE MED, V34, P2175, DOI 10.1097/01.CCM.0000229886.98002.2B; Kwan I, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lienhart HG, 2007, ANAESTHESIST, V56, P145, DOI 10.1007/s00101-006-1114-4; LOCK G, 1995, HEPATO-GASTROENTEROL, V42, P234; Luckner G, 2005, CRIT CARE MED, V33, P2659, DOI 10.1097/01.CCM.0000186749.34028.40; Martinowitz U, 2002, CAN J ANAESTH, V49, pS15; Mayr VD, 2004, RESUSCITATION, V62, P229, DOI 10.1016/j.resuscitation.2004.03.012; Meybohm P, 2007, RESUSCITATION; Meybohm P, 2007, J TRAUMA, V62, P640, DOI 10.1097/01.ta.0000240962.62319.c8; Meyer S, 2007, ACTA ANAESTH SCAND, V51, P957, DOI 10.1111/j.1399-6576.2007.01357.x; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mutlu GM, 2004, INTENS CARE MED, V30, P1276, DOI 10.1007/s00134-004-2283-8; Nissenson AR, 1998, KIDNEY INT, V53, pS7; Nozari A, 2004, J TRAUMA, V57, P1266, DOI 10.1097/01.TA.0000124268.24159.8B; OTA K, 1988, AM J PHYSIOL, V255, pR731, DOI 10.1152/ajpregu.1988.255.5.R731; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Safar Peter J, 2002, Curr Opin Anaesthesiol, V15, P203, DOI 10.1097/00001503-200204000-00010; Salluh JIF, 2007, ACTA ANAESTH SCAND, V51, P505, DOI 10.1111/j.1399-6576.2006.01252.x; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Sharma RM, 2005, ANESTH ANALG, V101, P833, DOI 10.1213/01.ANE.0000175209.61051.7F; Sharshar T, 2003, CRIT CARE MED, V31, P1752, DOI 10.1097/01.CCM.0000063046.82359.4A; SHELLY MP, 1988, INTENS CARE MED, V14, P526, DOI 10.1007/BF00263525; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Szabo C, 1996, SHOCK, V5, P391, DOI 10.1097/00024382-199606000-00001; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Voelckel WG, 2003, CRIT CARE MED, V31, P2552, DOI 10.1097/01.CCM.0000089944.54391.D6; Voelckel WG, 2000, ANESTH ANALG, V91, P627, DOI 10.1213/00000539-200009000-00024; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Westermann I, 2007, SHOCK; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6; Yoo JH, 2007, J VET MED SCI, V69, P459, DOI 10.1292/jvms.69.459; Yoo JH, 2006, J VET MED SCI, V68, P967, DOI 10.1292/jvms.68.967	65	13	13	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRACT RES-CLIN	Best Pract. Res.-Clin Anaesth.	JUN	2008	22	2					299	316		10.1016/j.bpa.2008.02.003			18	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V27TQ	WOS:000215382500007	18683476				2022-02-06	
J	Vassar, M; Ridge, JW; Hill, AD				Vassar, Matt; Ridge, Jason W.; Hill, Aaron D.			Inducing score reliability from previous reports: An examination of life satisfaction studies	SOCIAL INDICATORS RESEARCH			English	Article						reliability induction; life satisfaction; satisfaction with life scale; SWLS	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; REHABILITATION OUTCOMES; PERCEIVED STRESS; COLLEGE-STUDENTS; SOCIAL SUPPORT; CEREBRAL-PALSY; SELF-ESTEEM; SCALE	The sample specific nature of reliability is often overlooked in substantive research, with investigators frequently referencing reliability estimates from previous studies as the basis for presuming the score integrity for their data. The purpose of the current study was to examine this practice, known as reliability induction, across studies using a popular life satisfaction (LS) measure, the Satisfaction with Life Scale. A comprehensive literature search was conducted, yielding a final sample of 196 studies using the instrument. Fifty-two studies involving 76 samples induced reliability coefficients from other sources. These studies were coded in terms of sample characteristics and variability estimates to derive comparisons in these two areas between the induced reports and the original studies. Results suggest that none of the studies inducing reliability had sufficient justification for induction. It was also found that estimating reliability coefficients for the data in hand has increased relative to induced reports and studies omitting reliability information. Practical implications for substantive researchers are discussed and suggestions for additional research are provided.	[Vassar, Matt] Oklahoma State Univ, Coll Osteopath Med, Tulsa, OK 74107 USA; [Ridge, Jason W.; Hill, Aaron D.] Oklahoma State Univ, William S Spears Sch Business, Dept Management, Stillwater, OK 74078 USA		Vassar, M (corresponding author), Oklahoma State Univ, Coll Osteopath Med, 1111 W 17th St, Tulsa, OK 74107 USA.	matt.vassar@okstate.edu	Vassar, Matt/AAD-5385-2020	Vassar, Ben Matthew/0000-0003-2859-6152			ARRINDELL WA, 1991, PERS INDIV DIFFER, V12, P117, DOI 10.1016/0191-8869(91)90094-R; ATKINSON M, 1996, QUALITY LIFE MEASURE; Baker LM, 2004, WOMEN HEALTH, V39, P83, DOI 10.1300/J013v39n02_06; Bettencourt BA, 1997, PERS SOC PSYCHOL B, V23, P955, DOI 10.1177/0146167297239005; Biswas-Diener R., 2005, J HAPPINESS STUDIES, V6, P205, DOI DOI 10.1007/S10902-005-5683-8; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Brillhart Barbara, 2004, Rehabil Nurs, V29, P122; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Buhi ER, 2005, J SCHOOL HEALTH, V75, P63, DOI 10.1111/j.1746-1561.2005.tb00012.x; Carless David, 2006, Eur J Cardiovasc Nurs, V5, P237, DOI 10.1016/j.ejcnurse.2006.03.004; Compton WC, 1998, PSYCHOL REP, V83, P371, DOI 10.2466/PR0.83.5.371-381; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Crocker L., 1986, INTRO CLASSICAL MODE; Diener E, 1996, PSYCHOL SCI, V7, P181, DOI 10.1111/j.1467-9280.1996.tb00354.x; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Dominy NL, 2000, J PSYCHOL, V134, P23, DOI 10.1080/00223980009600846; Dorahy M. J., 1996, J PERSONALITY CLIN S, V12, P1; Dowler R, 2001, J Spinal Cord Med, V24, P87; EMMONS RA, 1985, PERS SOC PSYCHOL B, V11, P89, DOI 10.1177/0146167285111008; Engel JM, 2003, ARCH PHYS MED REHAB, V84, P1125, DOI 10.1016/S0003-9993(03)00263-6; FERRARI JR, 1997, J PREVENTION INTERVE, V15, P83; Ferrario SR, 2003, PSYCHO-ONCOL, V12, P1, DOI 10.1002/pon.626; GULLICKSEN H, 1950, THEORY MENTAL TESTS; Halpin SA, 2004, J HOMOSEXUAL, V47, P109, DOI 10.1300/J082v47n02_07; Hamarat E, 2001, EXP AGING RES, V27, P181, DOI 10.1080/036107301750074051; HAMILTON SB, 1989, J ADOLESCENCE, V12, P55, DOI 10.1016/0140-1971(89)90089-4; Hammarberg K, 2001, HUM REPROD, V16, P374, DOI 10.1093/humrep/16.2.374; Harrington R, 2001, J PSYCHOL, V135, P439, DOI 10.1080/00223980109603710; HONG SM, 1994, PSYCHOL REP, V74, P99, DOI 10.2466/pr0.1994.74.1.99; Kafka GJ, 2002, SOC INDIC RES, V57, P171, DOI 10.1023/A:1014451725204; LARSEN RJ, 1986, J PERS SOC PSYCHOL, V51, P803, DOI 10.1037/0022-3514.51.4.803; Linn, 1990, MEASUREMENT EVALUATI; Meade MA, 2004, ARCH PHYS MED REHAB, V85, P1782, DOI 10.1016/j.apmr.2004.05.001; Minardi HA, 2004, J ADV NURS, V46, P23, DOI 10.1111/j.1365-2648.2003.02962.x; NETO F, 1993, J YOUTH ADOLESCENCE, V22, P125, DOI 10.1007/BF01536648; Oishi S, 2006, J RES PERS, V40, P411, DOI 10.1016/j.jrp.2005.02.002; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; PEDHAZUR EJ, 1991, MEASUREMENT DESIGN A; Perna FM, 1999, SPORT PSYCHOL, V13, P144, DOI 10.1123/tsp.13.2.144; Petersen RW, 2005, GYNECOL ONCOL, V97, P535, DOI 10.1016/j.ygyno.2005.01.015; Pilcher JJ, 1998, SOC INDIC RES, V43, P291, DOI 10.1023/A:1006883231707; Prince PN, 2001, QUAL LIFE RES, V10, P117, DOI 10.1023/A:1016742628834; Putzke JD, 2000, REHABIL PSYCHOL, V45, P386, DOI 10.1037/0090-5550.45.4.386; Putzke JD, 2003, J SPINAL CORD MED, V26, P37; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Putzke JD, 2001, J CLIN PSYCHOL MED S, V8, P101, DOI 10.1023/A:1009555910604; Putzke JD, 2001, AM J PHYS MED REHAB, V80, P404, DOI 10.1097/00002060-200106000-00002; REINHARDT B, 1996, ADV SOCIAL SCI METHO, P3; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Richards JS, 1999, ARCH PHYS MED REHAB, V80, P1501; Riley BB, 1998, ARCH PHYS MED REHAB, V79, P258, DOI 10.1016/S0003-9993(98)90004-1; Sawilowsky SS, 2000, EDUC PSYCHOL MEAS, V60, P157, DOI 10.1177/00131640021970439; SCHUMAKER JF, 1993, J PSYCHOL, V127, P65, DOI 10.1080/00223980.1993.9915543; Schwarz, 1999, WELL BEING FDN HEDON, P61, DOI DOI 10.7758/9781610443258; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Sibiya T.A., 1998, MENTAL HLTH RELIG CU, V1, P37, DOI [10.1080/13674679808406496, DOI 10.1080/13674679808406496]; Simpson PL, 1996, J SOC PSYCHOL, V136, P783, DOI 10.1080/00224545.1996.9712255; Skok A, 2006, J INTELLECT DEV DIS, V31, P53, DOI 10.1080/13668250600561929; SMEAD VS, 1991, MEASUINGG WELL BEING; Smith D, 2005, J SPORT MED PHYS FIT, V45, P401; STOLBERG VB, 2003, J ETHNICITY SUBSTANC, V2, P77; Tate DG, 1997, ARCH PHYS MED REHAB, V78, pS18, DOI 10.1016/S0003-9993(97)90217-3; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tucker KL, 2006, SOC INDIC RES, V78, P341, DOI 10.1007/s11205-005-1037-5; Vacha-Haase T, 2000, EDUC PSYCHOL MEAS, V60, P509, DOI 10.1177/00131640021970682; Vacha-Haase T, 1998, EDUC PSYCHOL MEAS, V58, P6, DOI 10.1177/0013164498058001002; Vacha-Haase T, 2002, EDUC PSYCHOL MEAS, V62, P562, DOI 10.1177/001316402128775012; VASSAR M, IN PRESS SOCIAL INDI; Vassar M, 2007, SOC INDIC RES, V83, P487, DOI 10.1007/s11205-006-9074-2; Wardell DW, 2006, J HOLIST NURS, V24, P231, DOI 10.1177/0898010106289840; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEINMAN J, 1995, HLTH STATUS HLTH REL; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wu CH, 2006, PERS INDIV DIFFER, V40, P1259, DOI 10.1016/j.paid.2005.11.012; YETIM U, 1993, SOC INDIC RES, V29, P277, DOI 10.1007/BF01079516; Yetim U, 2003, SOC INDIC RES, V61, P297, DOI 10.1023/A:1021911504113	83	13	13	1	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300			SOC INDIC RES	Soc. Indic. Res.	MAY	2008	87	1					27	45		10.1007/s11205-007-9157-8			19	Social Sciences, Interdisciplinary; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	283GT	WOS:000254625400002					2022-02-06	
J	McDonald, A; Lindell, M; Dunger, DB; Acerini, CL				McDonald, Anna; Lindell, Margaretha; Dunger, David B.; Acerini, Carlo L.			Traumatic brain injury is a rarely reported cause of growth hormone deficiency	JOURNAL OF PEDIATRICS			English	Article							ANTERIOR-PITUITARY DYSFUNCTION; OF-THE-LITERATURE; HEAD-INJURY; LONG-TERM; HYPOPITUITARISM; CHILDREN; ABNORMALITIES; PREVALENCE; TBI	We determined the frequency of traumatic brain injury (TBI)-related growth hormone deficiency (GHD) from a large registry of growth hormone-deficient subjects and compared these subjects' clinical characteristics with those of children with idiopathic growth hormone deficiency (IGHD). A surprisingly small number of subjects with TBI-induced GHD (n = 141) were registered compared with those with IGHD (n = 23,722). At onset of treatment, the subjects with TBI-induced GHD were older (P = .045), had lower height velocity (P < .001), had a greater number of other pituitary hormone deficiencies (P < .001) and, after a year of recombinant human GH treatment, demonstrated a greater change in height velocity (P = .016). We speculate that TBI-induced GHD may be a neglected phenomenon in childhood, and recommend prospective longitudinal studies to explore its natural history and frequency.	[McDonald, Anna; Dunger, David B.; Acerini, Carlo L.] Univ Cambridge, Dept Pediat, Cambridge, England; [Lindell, Margaretha] Pfizer Inc, KIGS, Stockholm, Sweden		Acerini, CL (corresponding author), Addenbrookes Hosp, Dept Pediat, Level 8,Box 116, Cambridge CB2 2OO, England.	cla22@cam.ac.uk		Dunger, Professor David/0000-0002-2566-9304; Acerini, Carlo/0000-0003-2121-5871			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Dogru O, 2005, NEUROENDOCRINOL LETT, V26, P311; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lehnung M, 2001, CHILD NEUROPSYCHOL, V7, P59, DOI 10.1076/chin.7.2.59.3129; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Verger K, 2000, BRAIN INJURY, V14, P495	21	13	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2008	152	4					590	593		10.1016/j.jpeds.2007.12.046			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	282BS	WOS:000254543200040	18346522				2022-02-06	
J	Jussen, D; Papaioannou, C; Heimann, A; Kempski, O; Alessandri, B				Jussen, Daniel; Papaioannou, Chrysostomos; Heimann, Axel; Kempski, Oliver; Alessandri, Beat			Effects of hypertonic/hyperoncotic treatment and surgical evacuation after acute subdural hematoma in rats	CRITICAL CARE MEDICINE			English	Article						rats; acute subdural hematoma; hypertonic hyperoncotic treatment; neurologic deficit; surgical evacuation; intracranial pressure	CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; SALINE HYDROXYETHYL STARCH; SMALL-VOLUME RESUSCITATION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; CLINICAL-TRIAL; DAMAGE; REDUCTION; ISCHEMIA	Objective. The treatment of acute subdural hematoma (ASDH) consists mainly of surgical evacuation of the hematoma. It is conceivable that early preoperative neuroprotection with hypertonic/hyperoncotic treatment (HHT) can improve survival rates. The present study investigated the benefit of treatment with hypertonic/hyperoncotic solution on functional and histologic outcome as supportive therapy accompanying surgical intervention. Design: Laboratory experiment. Setting: University laboratory. Subjects: Male Sprague-Dawley rats weighing 296-350 g (n = 56). Interventions: ASDH was induced through subdural infusion of 400 ILL of autologous venous blood. Thirty minutes after subdural blood infusion, the rats received either HyperHAES (7.2% saline/6% hydroxyethyl starch) or vehicle (NaCI 0.9%) intravenously, followed by surgical evacuation of the hematoma 1 hr after ASDH induction in those rats scheduled for surgical treatment. The experiment was divided into two parts: an acute study, which explored acute effects of HHT on blood variables, ASDH-induced changes of intracranial pressure (ICP), and cerebral perfusion pressure (CPP), and a chronic study, which investigated the chronic effects of HHT, surgical blood clot evacuation, and the combination of both on the functional and histologic outcome following ASDH (12 days). Measurements and Main Results: In the acute study, HHT expectedly raised the serum sodium concentration and lowered hematocrit. ASDH increased ICP and decreased CPP in all groups. HHT improved CPP by reducing ICP. In the chronic study, all treated groups showed a better recovery with respect to neurologic function and neuronal cell death compared with the vehicle-treated ASDH group. HHT with surgical evacuation or HHT alone improved functional and histologic outcome slightly more than surgical evacuation alone. Conclusions: In this rat model, HHT led to a decrease of ICP after ASDH. This significantly improved functional and histologic outcome, which was comparable to the effects after blood evacuation alone. The combination of evacuation of subdural blood and early HHT improved histologic outcome further but not significantly, which was due to the strong effects of single treatments and a ceiling effect of the combined treatment in this model.	[Jussen, Daniel; Papaioannou, Chrysostomos; Heimann, Axel; Kempski, Oliver; Alessandri, Beat] Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany		Jussen, D (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Mainz, Germany.	beat.alessandri@uni-mainz.de		Heimann, Axel/0000-0003-2510-3228			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alessandri B, 2006, J NEUROTRAUM, V23, P800; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bullock MR, 2006, NEUROSURGERY S, V58, P16; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Eijkenboom M, 2000, NEUROPHARMACOLOGY, V39, P817, DOI 10.1016/S0028-3908(00)00002-2; Fischer M, 1996, RESUSCITATION, V32, P227, DOI 10.1016/0300-9572(96)00953-7; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Hartl R, 1997, ACT NEUR S, V70, P126; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Heimann A, 2003, CRIT CARE MED, V31, P2495, DOI 10.1097/01.CCM.0000084893.44650.CB; INGLIS FM, 1990, ACT NEUR S, V51, P277; JUVELA S, 1991, J NEUROSURG, V74, P386, DOI 10.3171/jns.1991.74.3.0386; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kempski O, 1996, ACT NEUR S, V66, P114; KRAUS GE, 1991, SURG NEUROL, V35, P20, DOI 10.1016/0090-3019(91)90197-H; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; Lepeintre JF, 2004, NEUROCHIRURGIE, V50, P83; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Mazzoni MC, 1995, INT J MICROCIRC, V15, P265, DOI 10.1159/000179028; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Noppens RR, 2006, CRIT CARE MED, V34, P2194, DOI 10.1097/01.CCM.0000228915.94169.B1; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Patel TR, 1999, J NEUROTRAUM, V16, P1049, DOI 10.1089/neu.1999.16.1049; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sehba FA, 2000, J CEREBR BLOOD F MET, V20, P604, DOI 10.1097/00004647-200003000-00018; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Thomas D, 2004, IEEE SOFTWARE, V21, P12, DOI 10.1109/MS.2004.49; Tsuchida E, 1997, J NEUROTRAUM, V14, P409, DOI 10.1089/neu.1997.14.409; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE	56	13	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2008	36	2					543	549		10.1097/01.CCM.0B013E3181620A0F			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257JB	WOS:000252794000024	18091536				2022-02-06	
J	Matschke, J; Glatzel, M				Matschke, J.; Glatzel, M.			Neuropathological assessment of non-accidental head injury in infants and toddlers	RECHTSMEDIZIN			English	Article						non-accidental head injury; shaken baby syndrome; neuropathology; forensic expertise	SHAKEN BABY SYNDROME; AMYLOID PRECURSOR PROTEIN; DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; ABUSE; DIAGNOSIS; HEMORRHAGE; PATTERNS; HEMATOMA	Non-accidental head injury/shaken baby syndrome (NAHI/SBS) is the most common cause of unnatural death in toddlers and infants. Clinically NAHI/SBS features encephalopathy, subdural and intraocular bleeding as well as fractures of the long bones in various combinations. It is estimated that between 15-30/100,000 children suffer from NAHI/SBS per year, but the neuropathology has received relatively little attention. Since a full assessment of the neuropathology in a given case requires sophisticated laboratory techniques and extensive morphological experience, histological investigations of the brain and spinal cord including the dura mater as well as the eyeballs by an experienced forensic neuropathologist should be mandatory in each case. We review the neuropathology most pertinent for the forensic practitioner.	[Matschke, J.; Glatzel, M.] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany		Matschke, J (corresponding author), Univ Klinikum Hamburg Eppendorf, Martinistr 52, D-20246 Hamburg, Germany.	matschke@uke.de	Matschke, Jakob/F-6641-2013; Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011	Matschke, Jakob/0000-0001-6080-0198; Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agner C, 2005, CHILD NERV SYST, V21, P416, DOI 10.1007/s00381-004-1056-6; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Gleckman AM, 2000, J FORENSIC SCI, V45, P1151; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Golden N, 2005, J CLIN NEUROSCI, V12, P235, DOI 10.1016/j.jocn.2004.11.001; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Herrmann B, 2008, RECHTSMEDIZIN, V18, P9, DOI 10.1007/s00194-007-0482-7; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Kairys SW, 2001, PEDIATRICS, V108, P206; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Matschke J, 2008, RECHTSMEDIZIN, V18, P7, DOI 10.1007/s00194-007-0490-7; Maxeiner H, 2002, KLIN PADIATR, V214, P30, DOI 10.1055/s-2002-19862; Maxeiner H, 2001, J FORENSIC SCI, V46, P85; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104	39	13	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819			RECHTSMEDIZIN	Rechtsmedizin	FEB	2008	18	1					29	35		10.1007/s00194-007-0487-2			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	316KH	WOS:000256947800006					2022-02-06	
J	Duff, MC; Wszalek, T; Tranel, D; Cohen, NJ				Duff, Melissa C.; Wszalek, Tracey; Tranel, Daniel; Cohen, Neal J.			Successful life outcome and management of real-world memory demands despite profound anterograde amnesia	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Amnesia; Outcome; Compensation; Rehabilitation	COGNITIVE NEUROSCIENCE; PATIENT; IMPAIRMENT; SELF; DISSOCIATION; RECOGNITION; INFORMATION; RETENTION; KNOWLEDGE; PATTERN	We describe the case of Angie, a 50-year-old woman with profound amnesia (General Memory Index = 49, Full Scale IQ = 126) following a closed head injury in 1985. This case is unique in comparison to other cases reported in the literature in that, despite the severity of her amnesia, she has developed remarkable real-world life abilities, shows impressive self-awareness and insight into the impairment and sparing of various functional memory abilities, and exhibits ongoing maturation of her identity and sense of self following amnesia. The case provides insights into the interaction of different memory and cognitive systems in handling real-world memory demands and has implications for rehabilitation and for successful life outcome after amnesia.	[Duff, Melissa C.; Tranel, Daniel] Univ Iowa, Dept Neurol, Coll Med, Div Cognit Neurosci, Iowa City, IA 52242 USA; [Wszalek, Tracey] Univ Illinois, Biomed Imaging Ctr, Urbana, IL 61801 USA; [Cohen, Neal J.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA		Duff, MC (corresponding author), Univ Iowa, Dept Neurol, Coll Med, Div Cognit Neurosci, 200 Hawkins Dr,2100 RCP, Iowa City, IA 52242 USA.	melissa-duff@uiowa.edu		Tranel, Daniel/0000-0002-1338-1389	NIDCD (National Institute on Deafness and Other Communication Disorders)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1F32DC008825]; NINDS (National Institute of Neurological Disorders and Stroke)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 19632]; NIMH (National Institute of Mental Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RO1 MH062500]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632, P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F32DC008825] Funding Source: NIH RePORTER	This research was supported by NIDCD (National Institute on Deafness and Other Communication Disorders) Grant 1F32DC008825, NINDS (National Institute of Neurological Disorders and Stroke) Program Project Grant NINDS NS 19632, and NIMH (National Institute of Mental Health) Grant RO1 MH062500.	ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BENTON A, 1994, BENTON LAB TESTS; Benton AL, 1994, MULTILINGUAL APHASIA; Burgess P, 1996, BEHAV ASSESSMENT DYS; BUTTERS N, 1986, ALCOHOLIC KORSAKOFFS; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Claparede E, 1911, ARCH PSYCHOLOGIE, V11, P79; Cohen, 2001, CONDITIONING CONSCIO; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COHEN NJ, 2003, NEUROPSYCHOLOGY NEUR; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; CORKIN S, 1984, SEMINARS NEUROLOGY, V4, P252; Damasio A., 1999, FEELING WHAT HAPPENS; DAMASIO A, 1989, HDB NEUROPSYCHOLOGY, V3; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P263, DOI 10.1001/archneur.1985.04060030081013; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P252, DOI 10.1001/archneur.1985.04060030070012; DERENZI E, 1987, BRAIN, V110, P1099, DOI 10.1093/brain/110.5.1099; DESPOSITO M, 1995, NEUROLOGY, V45, P1546, DOI 10.1212/WNL.45.8.1546; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Duff MC, 2006, NAT NEUROSCI, V9, P140, DOI 10.1038/nn1601; ELLIOTT M, 1990, COGNITIVE REHABILITA, V8, P8; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Golden CJ, 1978, STROOP COLOR WORD TE; Grant D. A., 1993, WISCONSIN CARD SORTI; Hutchins E, 1995, COGNITION WILD; Jones RD, 1998, NEUROCASE, V4, P471, DOI 10.1080/13554799808410640; Kaplan E, 1983, BOSTON NAMING TEST; Kihlstrom JF, 2003, HANDBOOK OF SELF AND IDENTITY, P68; Klein SB, 2002, SOC COGNITION, V20, P105, DOI 10.1521/soco.20.2.105.20991; Klein SB, 1996, J EXP PSYCHOL GEN, V125, P250, DOI 10.1037/0096-3445.125.3.250; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; MORRIS MK, 1992, BRAIN, V115, P1827, DOI 10.1093/brain/115.6.1827; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; OCONNOR MG, 1995, BROKEN MEMORIES CASE, P45; Parkin A. J., 1993, NEUROPSYCHOLOGY AMNE; Reitan RM, 1985, HALSTEADREITAN NEURO; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, NEUROPSYCHOLOGIA, V42, P497, DOI 10.1016/j.neuropsychologia.2003.08.011; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; Sokol K, 1999, 127 ANN M AM PUBL HL; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TATE R, 2002, HDB MEMORY DISORDERS, P785; Tranel D, 2006, J CLIN EXP NEUROPSYC, V28, P43, DOI 10.1080/13803390490919344; Tranel D, 2006, NEUROPSYCHOLOGY, V20, P1, DOI 10.1037/0894-4105.20.1.1; Tranel D, 2005, J CLIN EXP NEUROPSYC, V27, P102, DOI 10.1080/138033990513663; TRANEL D, 1993, J COGNITIVE NEUROSCI, V5, P79, DOI 10.1162/jocn.1993.5.1.79; Tranel D., 2000, HDB NEUROPSYCHOLOGY, P85; VERDERWERF Y, 2000, NEUROPSYCHOLOGIA, V38, P613; Verfaellie M, 1995, J Int Neuropsychol Soc, V1, P443; Vygotsky LS., 1978, MIND SOC DEV HIGHER; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson B, 1999, CASE STUDIES NEUROPS; Wilson B.A., 2002, HDB MEMORY DISORDERS, P655; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; WILSON BA, 1995, BROKEN MEMORIES CASE, P14; Ylvisaker M., 1998, COLLABORATIVE BRAIN; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; [No title captured]	69	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	8					931	945		10.1080/13803390801894681			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	362OJ	WOS:000260206700008	18608659	Green Accepted			2022-02-06	
J	Elting, JW; Maurits, N; van Weerden, T; Spikman, J; De Keyser, J; van der Naalt, J				Elting, Jan Willem; Maurits, Natasha; van Weerden, Tom; Spikman, Joke; De Keyser, Jacques; van der Naalt, Joukje			P300 analysis techniques in cognitive impairment after brain injury: Comparison with neuropsychological and imaging data	BRAIN INJURY			English	Article						P300; brain injury; source analysis; imaging	CLOSED-HEAD-INJURY; EVENT-RELATED POTENTIALS; AUDITORY ODDBALL TASK; CLINICAL UTILITY; DIAGNOSIS THREAT; LATENCY; LONG; ATTENTION; DISTRACTIBILITY; DETERMINANTS	Primary objective: To compare P300 source analysis with conventional analysis in patients with cognitive impairment after brain injury. Methods and procedures: P300 results were compared with neuropsychological test data and imaging data in 21 healthy control subjects and 33 patients with brain injury. Latency and amplitude parameters were obtained for both P300 analysis methods. Magnetic Resonance Imaging (MRI) was performed between 3-12 months after the injury. Main outcomes and results: For both P300 analysis methods, only amplitude parameters correlated with neuropsychological test data. Diagnostic accuracy was better with source analysis than conventional analysis, when compared to the VLT (p = 0.03) and the PASAT (p = 0.04, only for those patients with imaging abnormalities). Patients with normal MRI results and patients with MRI abnormalities had decreased mean P3A amplitude compared to controls. In patients with focal frontal or temporal injury, the presence of mediofrontal lesions was associated with P3A amplitude reduction, while orbitofrontal lesions tended to increase P3A amplitude. Conclusions: Source analysis of P300 resulted in improved detection of neuropsychological abnormality in patients with brain injury. It is advisable to analyse P300 results in conjunction with imaging results. This approach may further facilitate the interpretation and diagnostic applicability of source analysis P300 results in patients with brain injury.	[Elting, Jan Willem; Maurits, Natasha; van Weerden, Tom; Spikman, Joke; De Keyser, Jacques; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9731 GZ Groningen, Netherlands		Elting, JW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9731 GZ Groningen, Netherlands.	j.w.j.elting@neuro.umcg.nl	De Keyser, Jacques/D-3725-2013; De Keyser, Jacques/AAA-8721-2021	De Keyser, Jacques/0000-0002-3394-7757; De Keyser, Jacques/0000-0002-3394-7757; van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763; Maurits, Natasha/0000-0001-6231-7044			Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Elting JW, 2005, CLIN NEUROPHYSIOL, V116, P2606, DOI 10.1016/j.clinph.2005.07.014; Elting JW, 2003, J CLIN NEUROPHYSIOL, V20, P26, DOI 10.1097/00004691-200302000-00003; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; GOODIN D, 1994, ELECTROEN CLIN NEURO, V91, P18, DOI 10.1016/0013-4694(94)90014-0; GOODIN DS, 1990, ELECTROEN CLIN NEURO, V76, P2, DOI 10.1016/0013-4694(90)90051-K; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PFEFFERBAUM A, 1990, ELECTROEN CLIN NEURO, V76, P6, DOI 10.1016/0013-4694(90)90052-L; POLICH J, 1989, J CLIN NEUROPHYSIOL, V6, P277, DOI 10.1097/00004691-198907000-00003; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 1998, J CLIN NEUROPHYSIOL, V15, P14, DOI 10.1097/00004691-199801000-00004; POLICH J, 1998, P300 CLIN APPL ELECT, P1073; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; REY A, 1964, EXAMIN PSYCHOL CAS E; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Simons RF, 2001, BIOL PSYCHOL, V56, P207, DOI 10.1016/S0301-0511(01)00078-3; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANDERNAALT J, 1998, J NEUROTRAUM, V15, P454; VANZOMEREN AH, 2003, ASSESSMENT ATTENTION; von Bierbrauer A, 1998, ACTA NEUROL BELG, V98, P21; WIRSEN A, 1992, ELECTROEN CLIN NEURO, V84, P127, DOI 10.1016/0168-5597(92)90017-6	46	13	15	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	11					870	881		10.1080/02699050802403581			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	371RT	WOS:000260849700006	18850345				2022-02-06	
J	Kristman, VL; Cote, P; Van Eerd, D; Vidmar, M; Rezai, M; Hogg-Johnson, S; Wennberg, RA; Cassidy, JD				Kristman, Vicki L.; Cote, Pierre; Van Eerd, Dwayne; Vidmar, Marjan; Rezai, Mana; Hogg-Johnson, Sheilah; Wennberg, Richard A.; Cassidy, J. David			Prevalence of lost-time claims for mild traumatic brain injury in the working population: Improving estimates using workers compensation databases	BRAIN INJURY			English	Article						administrative database; bias; diagnosis; measurement; mild traumatic brain injury; workers' compensation; occupational injury; prevalence; stratified estimates; whiplash	BACK; NECK; PAIN	Primary objective: To test the usefulness of a method to improve the measurement of prevalent mild traumatic brain injury (MTBI) among injured workers with a workers compensation claim. Methods: Database codes were selected to identify MTBI cases in the Ontario workers compensation lost-time claims database. A random sample of 210 claims was selected, classified as MTBI or not, and used to calculate proportions with MTBI among code groups. The annual prevalence of MTBI in 1997 and 1998 was calculated by weighting the numerators with the appropriate proportions of MTBI within each code group. Results: Four code groups were created: the head region, cranial region, concussion code group and the brain region. The proportion of MTBI in each group was 29%, 19%, 92% and 32%, respectively. The 1997 prevalence depended on the codes used, from 39/10 000 (95% confidence interval (CI): 35-44) for a weighted version of the 'concussion' code to 58/10 000 (95% CI: 50-65) for inclusion of all identified MTBI codes. Conclusions: Restricting the enumeration of MTBI to specific 'concussion' codes can lead to under-estimation of the prevalence of MTBI in epidemiological studies using workers compensation data. Approximately six out of every 1000 lost-time claims are associated with MTBI. Given lost-time estimates of disability under-estimate the prevalence of this mild injury, MTBI, is an important workplace injury.	[Kristman, Vicki L.; Cote, Pierre; Cassidy, J. David] Toronto Western Hosp, Univ Hlth Network, CREIDO, Toronto, ON M5T 2S8, Canada; [Kristman, Vicki L.; Cote, Pierre; Rezai, Mana; Hogg-Johnson, Sheilah; Cassidy, J. David] Univ Toronto, Fac Med, Dept Publ Hlth Sci, Toronto, ON, Canada; [Kristman, Vicki L.; Cote, Pierre; Van Eerd, Dwayne; Vidmar, Marjan; Rezai, Mana; Hogg-Johnson, Sheilah] Inst Work & Hlth, Toronto, ON, Canada; [Hogg-Johnson, Sheilah; Cassidy, J. David] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wennberg, Richard A.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada		Kristman, VL (corresponding author), Toronto Western Hosp, Univ Hlth Network, CREIDO, 399 Bathurst St,Fell Pavil 4-132, Toronto, ON M5T 2S8, Canada.	vicki.kristman@uhnresearch.ca	Cote, Pierre/AAG-5358-2021; Kristman, Vicki/G-8317-2011	Cote, Pierre/0000-0002-6986-6676; Kristman, Vicki/0000-0001-5508-0552			Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; *ASS WORK COMP BOA, 1999, NAT WORK INJ DIS FAT; Azaroff LS, 2002, AM J PUBLIC HEALTH, V92, P1421, DOI 10.2105/AJPH.92.9.1421; BEATON DE, 1995, THESIS U TORONTO TOR; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Johnson WG, 1999, J RISK INSUR, V66, P185, DOI 10.2307/253608; ROOS LL, 1991, J CLIN EPIDEMIOL, V44, P881, DOI 10.1016/0895-4356(91)90050-J; SAS Institute, 1990, SAS STAT US GUID VER; Silverstein B, 2002, AM J IND MED, V41, P149, DOI 10.1002/ajim.10054; Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193; Van Eerd D, 2006, AM J IND MED, V49, P557, DOI 10.1002/ajim.20329; Wasiak R, 2003, SPINE, V28, P2283, DOI 10.1097/01.BRS.0000085032.00663.83; *WSIB, 2005, COV DIS PAP; Zakaria D, 2003, AM J IND MED, V43, P507, DOI 10.1002/ajim.10217	17	13	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	1					51	59		10.1080/02699050701849991			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400007	18183509				2022-02-06	
J	Lawson, S; Delamere, FM; Hutchinson, SL				Lawson, Suzanne; Delamere, Fern M.; Hutchinson, Susan L.			A Personal Narrative of Involvement in Post-Traumatic Brain Injury Rehabilitation: What Can We Learn for Therapeutic Recreation Practice?	THERAPEUTIC RECREATION JOURNAL			English	Article						Health Care; Illness Narrative; Personal Narrative; Patient Self-Determination; Traumatic Brain Injury; Therapeutic Recreation		This paper is an autoethnographic exploration of one woman's illness narrative. It provides an in-depth understanding of her lived experience of rehabilitation after sustaining a traumatic brain injury and poly-trauma. The narrative confirms the importance of providing people with self-determined choice as a primary component of rehabilitation. The voice and values of clients are integral to professional judgment. This narrative supports clients' personal choice and freedom during the rehabilitation process as a means of increasing their sense of self-determination and empowerment while improving overall health outcomes. Today I go past the accident site. They have closed off that service road to Jean Talon where the truck brought me down .... Lying under that truck with its two sets of large back wheels advancing; I thought that this is the end. Nothing more, nothing less; clear and simple. Suzanne Lawson - Journal Entry, September 1, 1998	[Lawson, Suzanne] McGill Univ, Montreal, PQ, Canada; [Delamere, Fern M.] Concordia Univ, Appl Human Sci, Montreal, PQ, Canada; [Hutchinson, Susan L.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada					Hutchinson, Susan/0000-0001-8107-6557			Brody H., 1997, STORIES SICKNESS; Bruner J., 1986, ACTUAL MINDS POSSIBL; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Carter M. J., 2003, THERAPEUTIC RECREATI; Curtis RS, 1998, J REHABIL, V64, P42; DeHope E, 1999, NEUROREHABILITATION, V13, P3; Delamere F, 2006, 10 CAN THER RECR ASS; Ellis C., 2000, HDB QUALITATIVE RES, V2nd ed., P733; Farlow D, 1990, AM J HEALTH PROMOT, P2; Frank A, 1993, SOCIOLOGICAL Q, V31, P39; Gergen K.J., 1997, MEMORY IDENTITY COMM, P161; GIBSON CH, 1995, J ADV NURS, V21, P1201, DOI 10.1046/j.1365-2648.1995.21061201.x; Hutchinson S. L, PROFESSIONAL ISSUES; Hutchinson SL, 2003, LEISURE SCI, V25, P143, DOI 10.1080/01490400306566; Kleinman Arthur, 1988, ILLNESS NARRATIVES S; Krouse H J, 1989, West J Nurs Res, V11, P717, DOI 10.1177/019394598901100606; Lawson S, 2006, BRIT COL THER RECR A; Lindsey E, 1996, J ADV NURS, V24, P465, DOI 10.1046/j.1365-2648.1996.02135.x; Lindsey E, 1996, J ADV NURS, V23, P106, DOI 10.1111/j.1365-2648.1996.tb03142.x; Mattingly Cheryl, 2000, NARRATIVE CULTURAL C; Orem D., 1985, NURSING CONCEPTS PRA; Perkins DD, 1995, AM J COMMUN PSYCHOL, V23, P569, DOI 10.1007/BF02506982; Polkinghorne D.E., 1991, J NARRAT LIFE HIST, V1, P135, DOI [DOI 10.1075/JNLH.1.2-3.04NAR, https://doi.org/10.1075/jnlh.1.2-3.04nar]; Possl J, 1996, BRAIN INJURY, V10, P125, DOI 10.1080/026990596124610; Richardson L, 2000, SOCIOL SPORT J, V17, P5, DOI 10.1123/ssj.17.1.5; Rissel C, 1996, J ROY SOC HEALTH, V116, P211, DOI 10.1177/146642409611600403; Roberts S J, 1988, Nurse Pract, V13, P50; Sacks, 1987, MAN WHO MISTOOK HIS; Sakalys Jurate A, 2003, J Holist Nurs, V21, P228, DOI 10.1177/0898010103256204; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; ZIMMERMAN MA, 1992, AM J COMMUN PSYCHOL, V20, P707, DOI 10.1007/BF01312604; Zimmerman MA, 1995, AM J COMMUN PSYCHOL, V23, P581, DOI 10.1007/BF02506983; ZIMMERMAN MA, 1988, AM J COMMUN PSYCHOL, V16, P725, DOI 10.1007/BF00930023; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3	34	13	13	0	0	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	0040-5914	2159-6433		THER RECREAT J	Ther. Recreat. J.		2008	42	4					236	250					15	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VF4MH	WOS:000442893800004					2022-02-06	
J	Nayak, CD; Nayak, DM; Raja, A; Ra, A				Nayak, Chandrika D.; Nayak, Dinesh M.; Raja, Annaswamy; Ra, Anjali			Erythrocyte indicators of oxidative changes in patients with graded traumatic head injury	NEUROLOGY INDIA			English	Article						erythrocytes; glutathione. head injury; lipid peroxidation; superoxide dismutase	TIME-LEVEL RELATIONSHIP; CENTRAL NERVOUS-SYSTEM; GLASGOW COMA SCALE; LIPID-PEROXIDATION; BRAIN-INJURY; FREE-RADICALS; SUPEROXIDE-DISMUTASE; STRESS; MECHANISMS; GLUTATHIONE	Context: Acute oxidative stress following a traumatic head injury (HI) has been implicated in inducing severe secondary brain damage and influencing the clinical outcome of HI patients. Aims: This study was performed to evaluate and compare the oxidative changes in patients with varying severity of HI in the early posttraumatic period using erythrocyte indicators. Settings and Design: Head injury patients were divided into two groups based on their Glasgow Coma Scale (GCS) scores recorded at admission to the hospital on the day of trauma itself. Accordingly, the study included 30 severe HI (SHI, GCS scores 8 or less) and 25 Mild HI (MHI, GCS scores more than 8) patients. Thirty age and sex-matched healthy individuals were included in this comparative study as controls. Materials and Methods: Blood samples were obtained from controls and HI patients (within 24 h of trauma onset). Erythrocyte oxidative changes were studied by estimating thiobarbituric acid reactive substances (TBARS), glutathione (GSH), superoxide dismutase (SOD) and glutathione reductase (GR). Results: Erythrocyte TBARS levels were significantly higher and GSH levels were significantly lower in SHI and MHI patients as compared to controls. The SOD activity was significantly increased only in SHI patients and remained unchanged in MHI patients as compared to controls. As compared to MHI patients, erythrocyte TBARS levels were significantly higher, GSH levels were significantly lower and SOD activity was markedly elevated in SHI patients. Erythrocyte GR activity did not show significant changes in both groups of patients as compared to controls. Conclusion: Oxidative stress is evident in both SHI and MHI patients in the early posttraumatic period as reflected by their erythrocyte indicators, but the severity of oxidative stress has varied relatively with the severity of head injury. The present findings provide indications that early oxidative changes could influence the neurological recovery of HI patients.	[Nayak, Chandrika D.] Manipal Univ, Melaka Manipal Med Coll, Dept Biochem, Manipal 576104, Karnataka, India; [Nayak, Dinesh M.] Kasturba Med Coll & Hosp, Dept Pediat, Manipal, Karnataka, India; [Raja, Annaswamy] Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal, Karnataka, India; [Ra, Anjali] Kasturba Med Coll & Hosp, Dept Biochem, Manipal, Karnataka, India		Nayak, CD (corresponding author), Manipal Univ, Melaka Manipal Med Coll, Dept Biochem, Manipal Campus, Manipal 576104, Karnataka, India.	chandrikadinesh@yahoo.com		Rao, Anjali/0000-0002-2676-2762; Nayak, Dinesh M/0000-0001-7384-8916; Nayak, Chandrika D/0000-0002-4674-7359			BEAUCHAMP CO, 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CADET JL, 1988, INT J NEUROSCI, V40, P13, DOI 10.3109/00207458808985722; Chen J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-10; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Giustarini D, 2003, CLIN CHEM, V49, P327, DOI 10.1373/49.2.327; Hall E. D, 1996, NEUROSURGERY, P505; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Horn H.D., 1978, METHODS ENZYMATIC AN, P875; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LYNCH RE, 1978, J BIOL CHEM, V253, P1838; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nayak C, 2006, CLIN CHEM LAB MED, V44, P460, DOI 10.1515/CCLM.2006.068; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak Chandrika D, 2007, Indian J Med Sci, V61, P381; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; Sagara Y, 1998, FREE RADICAL BIO MED, V24, P1375, DOI 10.1016/S0891-5849(97)00457-7; SELMBERT D, 2001, J NEUROSCI, V21, P7455; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Siems WG, 2000, CLIN NEPHROL, V53, pS9; SUDHA K, 1998, THESIS MANIPAL ACAD; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Yamamoto T, 1999, ACT NEUR S, V75, P17	41	13	15	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JAN-MAR	2008	56	1					31	35		10.4103/0028-3886.39309			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	283YA	WOS:000254671200007	18310834	Green Submitted			2022-02-06	
J	Satish, U; Streufert, S; Eslinger, PJ				Satish, Usha; Streufert, Siegfried; Eslinger, Paul J.			Simulation-based executive cognitive assessment and rehabilitation after traumatic frontal lobe injury: A case report	DISABILITY AND REHABILITATION			English	Article						cognitive simulation assessment; cognitive rehabilitation; traumatic brain injury; executive functions	CLOSED-HEAD-INJURY; BRAIN-INJURY; DEFICITS; MANAGEMENT; COMPLEXITY; DAMAGE	Purpose.To investigate whether identifying specific deficits after brain injury can lead to a more focused and potentially effective cognitive rehabilitation technology. Method.Cognitive simulation assessment was undertaken in a 47-year-old man with trauma-related prefrontal damage and persisting occupational and cognitive-behavioral difficulties at 15 months post brain injury. Results.Results revealed significant difficulties in measured levels of activity, initiative, information utilization, response flexibility, and effective decision-making strategies which accorded well with his real-life complaints despite normal neuropsychological test scores. This profile of findings was then used to design a two-stage intervention program. The first stage focused on participant education and awareness about his simulation-based problem solving difficulties. In the second stage specific goals were formulated to improve problem solving impairments that were then the target of weekly training sessions using pertinent decision-making and problem-solving vignettes. A parallel version of the cognitive simulation assessment was undertaken post-cognitive training (3 months after initial assessment) and revealed significant improvements in targeted executive cognitive-behavioral areas. Conclusion.Results of this cognitive rehabilitation probe supported the feasibility and validity of undertaking a cognitive simulation approach to identify residual executive function deficits after traumatic brain injury, even with a normal neuropsychological test profile. Further studies are needed to establish the reliability, generalizability and maintenance of such gains.	[Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neural & Behav Sci,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Radiol,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neurol,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Satish, Usha; Streufert, Siegfried] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Hershey, PA USA		Eslinger, PJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol H037, POB 50, Hershey, PA 17033 USA.	peslinger@psu.edu					BREUER K, 1996, CORPORATE TRAINING E; BREUILLE D, 1996, CLIN NUTR, V15, P21; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Eslinger Paul J., 1996, P415; ESLINGER PJ, IN PRESS NEUROREHABI; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Levine B, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P80; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RIZZO M, 1996, HEAD INJURY POSTCONC; Robertson I., 1996, GOAL MANAGEMENT TRAI; Satish U, 2006, PSYCHOL REC, V56, P181, DOI 10.1007/BF03395543; Satish U, 1999, NEUROCASE, V5, P355, DOI 10.1093/neucas/5.4.355; Satish U, 1997, J APPL SOC PSYCHOL, V27, P2047, DOI 10.1111/j.1559-1816.1997.tb01640.x; STREUFERT S, 1988, PERS PSYCHOL, V41, P537, DOI 10.1111/j.1744-6570.1988.tb00643.x; Streufert S, 1997, J APPL SOC PSYCHOL, V27, P2068, DOI 10.1111/j.1559-1816.1997.tb01641.x; Streufert S., 1988, Computers in Human Behaviour, V4, P77, DOI 10.1016/0747-5632(88)90034-9; Streufert S, 1978, BEHAV COMPLEX ENV; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Swezey RW, 1986, COMPLEXITY MANAGERS; *WHO, 2000, 1C1DH2 WHO	32	13	13	1	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2008	30	6					468	478		10.1080/09638280701625401			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	267LX	WOS:000253511600006	18297501				2022-02-06	
J	Sivak, S; Kurca, E; Hladka, M; Zelenak, K; Turcanova-Koprusakova, M; Michalik, J				Sivak, S.; Kurca, E.; Hladka, M.; Zelenak, K.; Turcanova-Koprusakova, M.; Michalik, J.			Early and delayed auditory oddball ERPs and brain MRI in patients with MTBI	BRAIN INJURY			English	Article						mild traumatic brain injury; cognitive impairment; magnetic resonance imaging; event-related potentials; oddball paradigm	CLOSED-HEAD INJURY; P300; CONCUSSION; LATENCY; INDEXES; LONG	Introduction: Mild traumatic brain injury (MTBI) is a common neurotraumatologic diagnosis. It is possible to confirm objective cognitive impairment in MTBI patients not only by complex neuropsychological testing but also by event-related potentials (ERPs). The most common ERPs used in clinical practice are based on an oddball paradigm. Magnetic resonance imaging (MRI) is not routinely used in MTBI despite its proven greater sensitivity and specificity in comparison with computer tomography (CT). Methods: This study investigated 31 MTBI patients and 31 sex and age-matched healthy controls. Both groups underwent clinical neurological examinations. Auditory oddball ERPs and brain MRI were done early after the injury and 3-7 months later. Results: There were no significant sex, age and education differences between the analysed groups. No significant differences were found in N2 and P3 wave parameters in both ERP examinations. Conclusion: Standard auditory oddball ERPs are not sensitive enough to detect and/or quantify subtle objective neuropsychological changes in selected MTBI patients, especially those with traumatic MRI brain lesions. More complex auditory or other oddball paradigms have to be tested in the future.	[Sivak, S.; Kurca, E.; Turcanova-Koprusakova, M.; Michalik, J.] Comenius Univ, Neurol Clin, Jessenius Fac Med, Martin 06359, Slovakia; [Hladka, M.; Zelenak, K.] Comenius Univ, Clin Radiol, Jessenius Fac Med, Martin 03659, Slovakia		Sivak, S (corresponding author), Comenius Univ, Neurol Clin, Jessenius Fac Med, Kollarova 2, Martin 06359, Slovakia.	sivak@jfmed.uniba.sk	Zelenak, Kamil/X-6293-2018; Sivak, Stefan/O-4237-2018	Zelenak, Kamil/0000-0002-0416-2985; Sivak, Stefan/0000-0002-0348-3082			Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Gaetz M, 2000, BRAIN INJURY, V14, P815; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Lew HL, 1999, AM J PHYS MED REHAB, V78, P367, DOI 10.1097/00002060-199907000-00014; NAATANEN R, 1991, PSYCHOPHYSIOLOGY, V28, P478, DOI 10.1111/j.1469-8986.1991.tb00735.x; ONOFRJ M, 1991, ACTA NEUROL SCAND, V83, P273, DOI 10.1111/j.1600-0404.1991.tb04700.x; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Rousseff R T, 2006, Electromyogr Clin Neurophysiol, V46, P275; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; von Bierbrauer A, 1998, ACTA NEUROL BELG, V98, P21; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31	18	13	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	2					193	197		10.1080/02699050801895431			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	258DW	WOS:000252849600010	18240048				2022-02-06	
J	Winder, MJ; Monteith, SJ; Lightfoot, N; Mee, E				Winder, Mark J.; Monteith, Stephen J.; Lightfoot, Nicholas; Mee, Edward			Penetrating head injury from nailguns: A case series from New Zealand	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						nailgun; head injury; head trauma; New Zealand	TRAUMATIC INTRACRANIAL ANEURYSMS; OF-THE-LITERATURE; UNUSUAL DELAYED-ONSET; GUN INJURIES; CRANIAL INJURY; CRANIOCEREBRAL INJURIES; DIABETES-INSIPIDUS; ARTERY ANEURYSM; BRAIN WOUNDS; SUICIDE	Penetrating head injury from nailguns has become increasingly recognised due to their frequent use in the construction industry and home. We report a New Zealand case series of 12 penetrating nailgun head injuries, the largest of its type, detailing presentation, management, risk factors and outcomes. Recommendations based on these factors are provided, suggesting a minimal surgical approach and an individually case-assessed need for antibiotic prophylaxis and anti-epileptic drugs. Prognostic factors on initial imaging are discussed. The majority of injuries, despite being visually impressive, are associated with minimal neurological impairment. (C) 2007 Elsevier Ltd. All rights reserved.	[Winder, Mark J.; Monteith, Stephen J.; Lightfoot, Nicholas; Mee, Edward] Univ Auckland, Auckland City Hosp & Starship Childrens Hosp, Dept Neurosurg, Auckland 1, New Zealand		Monteith, SJ (corresponding author), Univ Auckland, Auckland City Hosp & Starship Childrens Hosp, Dept Neurosurg, Auckland 1, New Zealand.	smonty@ihug.co.nz					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Alaca R, 2002, AM J PHYS MED REHAB, V81, P788, DOI 10.1097/00002060-200210000-00013; ALMEFTY O, 1986, AM J NEURORADIOL, V7, P164; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA S2, V51, pS34; Ardill W, 2003, SURG NEUROL, V60, P120, DOI 10.1016/S0090-3019(03)00158-7; BAGGS J, 1999, PROF SAF, V46, P33; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Beautrais Annette, 2003, N Z Med J, V116, pU460; Beautrais Annette, 2003, N Z Med J, V116, pU461; Beaver AC, 1999, AM SURGEON, V65, P1113; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Boahene KO, 2004, J TRAUMA, V56, P716, DOI 10.1097/01.TA.0000038551.42592.C2; Bock H, 2002, INT J LEGAL MED, V116, P279, DOI 10.1007/s00414-001-0281-8; Buchalter Gregory M, 2002, Ear Nose Throat J, V81, P779; Caldicott DGE, 2004, INJURY, V35, P1044, DOI 10.1016/j.injury.2003.10.026; Carey ME, 1998, MIL MED, V163, P581, DOI 10.1093/milmed/163.9.581; Carey ME, 2003, SURG NEUROL, V60, P112, DOI 10.1016/S0090-3019(03)00352-5; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; CROMWELL R, 1995, TRAUMATIC INTRACRANI; Dement John M, 2003, Appl Occup Environ Hyg, V18, P374, DOI 10.1080/10473220301365; Gnjidic Z, 2002, ACTA NEUROCHIR, V144, P1271, DOI 10.1007/s00701-002-1018-2; GUTHKELCH AN, 1960, BMJ-BRIT MED J, V5202, P842; HADANI M, 1985, J NEUROSURG, V63, P456, DOI 10.3171/jns.1985.63.3.0456; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Jithoo R, 2001, S AFR MED J, V91, P316; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Kusanagi Hiroaki, 2000, Journal of Nippon Medical School, V67, P130, DOI 10.1272/jnms.67.130; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lee BL, 1996, OPHTHALMOLOGY, V103, P1453, DOI 10.1016/S0161-6420(96)30484-3; LEO DD, 2003, SUICIDE LIFE-THREAT, V33, P151; Lipscomb HJ, 2003, INJ PREV, V9, P20, DOI 10.1136/ip.9.1.20; Litvack ZN, 2006, J NEUROSURG, V104, P828, DOI 10.3171/jns.2006.104.5.828; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Musa BS, 1997, BRIT J NEUROSURG, V11, P564; Nadesan K, 2000, MED SCI LAW, V40, P83, DOI 10.1177/002580240004000116; New Zealand Department of Labour, 2001, GUID SAF US PORT MEC; NORTH JB, 1970, MED J AUSTRALIA, V2, P183, DOI 10.5694/j.1326-5377.1970.tb87380.x; *NZ MIN HLTH, 2001, SUIC TRENDS NZ 1978; Oehmichen M, 2003, ACTA NEUROPATHOL, V105, P570, DOI 10.1007/s00401-003-0683-4; OHAEGBULAM SC, 1980, SURG NEUROL, V14, P393; Okada Takashi, 1993, Neurologia Medico-Chirurgica, V33, P703, DOI 10.2176/nmc.33.703; OPESKIN K, 1990, AM J FOREN MED PATH, V11, P282, DOI 10.1097/00000433-199012000-00002; PARKINSON D, 1985, SURG NEUROL, V23, P453, DOI 10.1016/0090-3019(85)90236-8; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; Prahlow JA, 2001, AM J FOREN MED PATH, V22, P358, DOI 10.1097/00000433-200112000-00005; Rahman NU, 1997, INT OPHTHALMOL, V21, P13, DOI 10.1023/A:1005834913614; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; Richards T J, 2000, Med Econ, V77, P143; RICHARDS TJ, 2000, MED ECON, V77, P143; RICHARDS TJ, 2000, MED ECON, V77, P140; Sakuta Y, 1997, NEUROL SURG TOKYO, V25, P357; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCHOR JS, 1991, SOUTHERN MED J, V84, P922, DOI 10.1097/00007611-199107000-00027; Shakir A, 2003, J FORENSIC SCI, V48, P409; Shandera WX, 2001, NEW ENGL J MED, V345, P339, DOI 10.1056/NEJM200108023450505; SOLOMON KD, 1993, J TRAUMA, V34, P285, DOI 10.1097/00005373-199302000-00020; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; THOMAS MD, 1987, MED J AUSTRALIA, V147, P602, DOI 10.5694/j.1326-5377.1987.tb133698.x; VISWANATHAN R, 1994, SCOT MED J, V39, P83, DOI 10.1177/003693309403900310; WEBER W, 1974, Z RECHTSMED, V74, P111, DOI 10.1007/BF02114697; WILSON PJE, 1968, BMJ-BRIT MED J, V1, P511, DOI 10.1136/bmj.1.5590.511-a; Wooltorton E, 2002, CAN MED ASSOC J, V166, P778; Wu W Q, 1975, Surg Neurol, V3, P83; 2001, J TRAUMA S2, V51, pS7; 2001, J TRAUMA S2, V51, pS29	69	13	14	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2008	15	1					18	25		10.1016/j.jocn.2007.06.020			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248ZZ	WOS:000252197300004	18032048				2022-02-06	
J	Crawford, FC; Wood, M; Ferguson, S; Mathura, VS; Faza, B; Wilson, S; Fan, T; O'Steen, B; Ait-Ghezala, G; Hayes, R; Mullan, MJ				Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Fan, Tao; O'Steen, Barbara; Ait-Ghezala, Ghania; Hayes, Ronald; Mullan, Michael J.			Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease(APPsw)	BRAIN RESEARCH			English; Estonian	Article						traumatic brain injury; Alzheimer's; amyloid; inflammation; genomic	CLOSED-HEAD INJURY; A-BETA DEPOSITION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; ALTERED EXPRESSION; GENE-EXPRESSION; CELL-CYCLE; HIPPOCAMPUS	Numerous studies have shown that the beta-amyloid peptide (A beta) or beta-amyloid deposits impact many processes that can contribute to neurodegeneration, ranging from immune and inflammatory processes to cell death and apoptosis, processes characteristic of both Alzheimer's disease and head injury. Human and animal studies of traumatic brain injury (TBI) have shown that A production is increased acutely following injury, and there is evidence for increased amyloid deposition and risk for Alzheimer's disease following TBI. Given the poorer outcome after injury observed both in transgenic mice overproducing A beta, as well as in humans subjected to repetitive head injury, one may conclude that the presence of elevated brain levels of A beta, whether endogenous or as a consequence of previous injury, exacerbates many of the deleterious processes triggered by TBI. We sought to test this hypothesis by examining the genomic response to injury in wild-type mice and in transgenic mice (APPsw) overexpressing and accumulating cerebral A beta/beta-amyloid. Gene expression was investigated by microarray 24 h after controlled cortical impact (CCI) injury or sham injury in aged APPsw transgenic mice and wild-type controls. Stringent statistical analysis revealed differential expression of a total of 129 genes in the transgenic TBI vs. sham comparison and 119 genes in the wild-type TBI vs. sham comparison. Of these, only 28 genes were common to both comparisons, suggesting considerable differences in response to injury in the Alzheimer models compared to wild-type mice. We focused our analyses by creating a "genotype-dependent" data set of response to injury which contained the genes that were uniquely altered in response to injury in either wild-type or APPsw mice, as well as those which were significantly differently modulated following TBI in one genotype compared to the other. The cellular functions predicted to be influenced by these changes in gene expression thus indicate the adverse pathways triggered by increased levels of A beta, and the potentially favorable (recovery) pathways which are activated in wild-type mice but suppressed when A beta levels are high. The results show that the cellular functions most influenced by the cerebral A beta levels following TBI include inflammation, immune response, and cell death, which suggest a particular vulnerability to head injury in the Alzheimer brain. (C) 2007 Elsevier B.V. All rights reserved.	[Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Ait-Ghezala, Ghania; Mullan, Michael J.] Roskamp Inst, Sarasota, FL 34243 USA; [Crawford, Fiona C.; Wood, Marcie; Ferguson, Scott; Mathura, Venkatarajan S.; Faza, Brandon; Wilson, Sarah; Mullan, Michael J.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Fan, Tao; O'Steen, Barbara; Hayes, Ronald] Univ Florida, Ctr Traumat Brain Injury Studies, Evelyn F & William L McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA		Crawford, FC (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	fcrawford@rfdn.org		Ait-Ghezala, Ghania/0000-0002-9836-8617; Mullan, Michael/0000-0002-1473-7527			ALLSOP D, 1990, AM J PATHOL, V136, P255; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Cousar JL, 2006, DEV NEUROSCI-BASEL, V28, P342, DOI 10.1159/000094160; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI 10.1172/JCI0216143; Decourt B, 2005, DEV BRAIN RES, V159, P36, DOI 10.1016/j.devbrainres.2005.06.013; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; GHIMIKAR RS, 1996, J NEUROSCI RES, V46, P727; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Nilsson CL, 2001, PEPTIDES, V22, P2105, DOI 10.1016/S0196-9781(01)00571-X; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomas T, 1997, J SUBMICR CYTOL PATH, V29, P293; Ueberham U, 2005, CNS NEUROL DISORD-DR, V4, P293, DOI 10.2174/1568007054038175; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	43	13	13	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 14	2007	1185						45	58		10.1016/j.brainres.2007.09.042			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FY	WOS:000252064400005	17961517				2022-02-06	
J	McCarter, RJ; Walton, NH; Moore, C; Ward, A; Nelson, I				McCarter, R. J.; Walton, N. H.; Moore, C.; Ward, A.; Nelson, I.			PTA testing, the westmead post traumatic amnesia scale and opiate analgesia: A cautionary note	BRAIN INJURY			English	Article						post-traumatic amnesia; Westmead PTA scale; opiates	CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; RECOVERY; MEMORY; PSYCHOMOTOR; COGNITION; DURATION; SEDATION; PROPOFOL; MORPHINE	Objective: To assess the validity of the Westmead PTA scale in patients treated with opiate analgesia. Method: Seventeen non-head injured, non-traumatic, electively hospitalized orthopaedic patients treated with opiate analgesia were tested on the Westmead PTA scale for a minimum of 2 consecutive days (n = 17) to a maximum of 4 consecutive days (n = 10). Results: Only 20% of participants tested over 4 days reached criteria of three consecutive 12/12 scores on the Westmead PTA scale. Daily failure rates on the 12 item scale ranged from 36-70%. All failures were on the 'new learning' items, orientation items were never failed. Conclusions: The low pass rate of non-head injured patients treated with opiate analgesics indicates that the Westmead PTA scale is non-specific to traumatic brain injury and is probably an invalid measure of post-traumatic amnesia in patients actively treated with opiates. Implications for the measurement and accurate classification of traumatic brain injury patients are discussed.	[McCarter, R. J.; Walton, N. H.; Moore, C.] Frenchay Hosp, Dept Neuropsychol, Bristol BS16 1LE, Avon, England; [Ward, A.; Nelson, I.] Frenchay Hosp, Dept Orthopaed, Bristol BS16 1LE, Avon, England		McCarter, RJ (corresponding author), Ashover House,133 Long Ashton Rd, Bristol BS41 9JQ, Avon, England.	rjmccarter@npsych.co.uk					Ahmed S, 2000, BRAIN INJURY, V14, P765; Andrade J, 1996, ANESTH ANALG, V83, P1279, DOI 10.1097/00000539-199612000-00026; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BELL DS, 1992, MEDICOLEGAL ASSESSME; BOYLE CA, 1988, PSYCHOPHARMACOLOGY S, V6, P146; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Curran HV, 1998, PSYCHOPHARMACOLOGY, V135, P27, DOI 10.1007/s002130050482; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Jennett B, 1981, MANAGEMENT HEAD INJU; Jones C, 2000, MEMORY, V8, P81; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; KRAUS JF, 1989, MILD HEAD INJURY, P8; LARABEE GL, 2005, FORENSIC NEUROPSYCHO, P209; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Sarasin DS, 1996, J ORAL MAXIL SURG, V54, P1187, DOI 10.1016/S0278-2391(96)90348-1; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M., 2005, FORENSIC NEUROPSYCHO, P237; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Walker DJ, 1998, PSYCHOPHARMACOLOGY, V140, P191, DOI 10.1007/s002130050757; Whittington MA, 1998, P NATL ACAD SCI USA, V95, P5807, DOI 10.1073/pnas.95.10.5807; Whitty CW, 1966, AMNESIA; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; [No title captured]	33	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2007	21	13-14					1393	1397		10.1080/02699050701793793			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	253AA	WOS:000252488200007	18066941				2022-02-06	
